diff --git "a/ED_exam_all.json" "b/ED_exam_all.json" new file mode 100644--- /dev/null +++ "b/ED_exam_all.json" @@ -0,0 +1,8597 @@ +[ + { + "\ufeffQuestion": "10 \u500b\u6708\u5927\u7684\u7537\u7ae5\u56e0\u8e81\u52d5\u4e14\u610f\uf9fc\u6539\u8b8a\u800c\u88ab\u7236\u6bcd\u9001\u81f3\u6025\u8a3a\u3002\u6bcd\u89aa\uf9a1\u7537\u7ae5\u81ea\u6628 \u665a\u958b\u59cb\u5c31\u767c\u751f\u5614\u5410\u548c\u8179\u7009\uff0c\u56e0\u70ba\u4e00\u5403\u5c31\u5410\uff0c\u6240\u4ee5\u5927\u7d04\u6709\u5c07\u8fd1\u534a\u5929\u7684\u6642\u9593\u662f \u6ef4\u6c34\u672a\u9032\u3002\uf9e4\u5b78\u6aa2\u67e5\u767c\u73fe\u7537\u7ae5\u5f88\u55dc\u7761\u3001\u9ecf\u819c\u4e7e\u71e5\u3002\u5e8a\u908a\u8840\ufa03\u5feb\u901f\u6aa2\u9a57\u767c\u73fe \u8840\ufa03\u503c\u70ba 35 mg/dL\u3002\u8a66\u554f\uff0c\u4e0b\uf99c\u4f55\u8005\u5c0d\u6b64\u75c5\u7ae5\u662f\u6700\u9069\u7576\u7684\u8655\u7f6e\uff1f", + "Options": "(A)\u975c\u8108\u6ce8\u5c04\u6bcf\u516c\u65a4\u9ad4\u91cd 1 ml \u7684 50% \u8461\u8404\ufa03\u6c34\u3002 (B)\u975c\u8108\u6ce8\u5c04\u6bcf\u516c\u65a4\u9ad4\u91cd 10 ml \u7684 5% \u8461\u8404\ufa03\u6c34\u3002 (C)\u975c\u8108\u6ce8\u5c04\u6bcf\u516c\u65a4\u9ad4\u91cd 5 ml \u7684 10% \u8461\u8404\ufa03\u6c34\u3002 (D)\u975c\u8108\u6ce8\u5c04\u6bcf\u516c\u65a4\u9ad4\u91cd 2 ml \u7684 25% \u8461\u8404\ufa03\u6c34\u3002 (E)\u89c0\u5bdf\u751f\u547d\u5fb5\u8c61\uff0c\u7b49\u5230\u6b63\u5f0f\u5be6\u9a57\u5ba4\u7684\u8840\ufa03\u5831\u544a\u51fa\uf92d\u5f8c\uff0c\u518d\u4f9d\u64da\u8840\ufa03\u503c \u9ad8\u4f4e\uf92d\u9032\ufa08\u8655\u7f6e\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "16 \u6b72\u7537\u6027\u75c5\u4eba\u88ab\u9001\u81f3\u6025\u8a3a\uff0c\u5230\u9662\u6642\ufa19\u667a\u6df7\uf91b\uff0c\u5168\u8eab\u5192\u6c57\u4e14\u8863\u670d\u6ebc\u900f\uff0c\u5fc3 \u96fb\u5716\u76e3\u8996\u5668\u4e0a\u986f\u793a\u5fc3\uf9db 180 \u6b21/\u5206\u9418\uff0c\u8840\u58d3 220/110 mmHg\uff0c\uf978\u5074\u77b3\u5b54\u5927 \u5c0f\u70ba 8 mm\uff0clight reflex \uf967\u751a\u660e\u986f\uff0c\u8acb\u554f\u53ef\u80fd\u70ba\u4e0b\uf99c\u4f55\u7a2e\u85e5\u7269\u4e2d\u6bd2\uff1f", + "Options": "(A)Lithium\u3002 (B)Meperidine\u3002 (C)Organophosphates\u3002 (D)Amphetamine\u3002 (E)Antihistamine\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "20 \u6b72\uf981\u6027\u7531\u6bcd\u89aa\u5e36\u5165\u91ab\u9662\u6c42\u8a3a\uff0c\u4e3b\u8a34\u89ba\u5f97\u547c\u5438\uf967\u9806\u53ca\u8179\u75db\uff0c\u6700\u8fd1\u5f88\u5bb9\uf9e0 \u89ba\u5f97\u53e3\u6e34\u4ee5\u53ca\u5c0f\uf965\u5f88\u591a\uff0c\u8840\u58d3 92/60 mmHg\u3001\u5fc3\uf9db 120 \u6b21/\u5206\u9418\u3001\u547c\u5438 32 \u6b21/\u5206\u9418\u3001\u9ad4\u6eab 35.2 \u2103\uff0c\u767d\u8840\u7403\u8a08\uf969 6800 /mm3\u3001\u8840\u8272\u7d20 13.2 g/dL\u3001\u8840\u5c0f \u677f 182000 /mm3\u3001glucose 520 mg/dL\u3001blood ketone(+)\u3002\u6709\u95dc\u6b64\u75c5\u60a3\u53ef \u80fd\u51fa\u73fe\u7684\u75c7\uf9fa\u53ca\u5fb5\u5019\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u75c5\u60a3\u53ef\u80fd\u6703\u51fa\u73fe Kussmaul \u547c\u5438\u3002 (B)\u75c5\u60a3\u53ef\u80fd\u6703\u6709\u6c34\u679c\u5473\u7684\u547c\u6c23\u3002 (C)\u75c5\u60a3\u6975\u53ef\u80fd\u6703\u51fa\u73fe Chvostek \u6216 Trousseau sign\u3002 (D)\u6cbb\uf9c1\u904e\u7a0b\u4e2d\uf974\u767c\u73fe\u75c5\u4eba\u6709\u982d\u75db\u3001\u5641\u5fc3\u53ca\u55dc\u7761\u7684\u75c7\uf9fa\uff0c\u8981\u8003\u616e\u8166\u6c34\u816b \u7684\u53ef\u80fd\u6027\u3002 (E)\u9ad4\u6eab\u8f03\u4f4e\u4e3b\u8981\u662f\u5468\u908a\u8840\u7ba1\u64f4\u5f35\u6240\u9020\u6210\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u9ad4\u91cd 70 \u516c\u65a4\u7684\u5065\u5eb7\u7537\u6027\uff0c\u56e0\u5916\u50b7\u5931\u8840\u7d04 1800 \u6beb\u5347\uff0c\u95dc\u65bc\u5176\u751f\uf9e4\u7684\u8868 \u73fe\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u75c5\u60a3\u7684\u8108\u58d3(pulse pressure)\u6703\u589e\u52a0\uff0c\u8840\u58d3\u6b63\u5e38\uff0c\u5fc3\uf9db\u6b63\u5e38\u3002 (B)\u75c5\u60a3\u7684\u8108\u58d3\u6703\u6b63\u5e38\u6216\u7a0d\u5fae\ufa09\u4f4e\uff0c\u8840\u58d3\u6b63\u5e38\uff0c\u5fc3\uf9db\u52a0\u5feb(> 100 \u6b21/\u5206 \u9418)\u3002 (C)\u75c5\u60a3\u7684\u8108\u58d3\u6703\ufa09\u4f4e\uff0c\u8840\u58d3\ufa09\u4f4e\uff0c\u5fc3\uf9db\u52a0\u5feb(> 120 \u6b21/\u5206\u9418)\u3002 (D)\u75c5\u60a3\u7684\u8108\u58d3\u6703\u589e\u52a0\uff0c\u8840\u58d3\ufa09\u4f4e\uff0c\u5fc3\uf9db\u52a0\u5feb(> 120 \u6b21/\u5206\u9418)\u3002 (E)\u75c5\u60a3\u7684\u8108\u58d3\u6703\u589e\u52a0\uff0c\u8840\u58d3\u6b63\u5e38\uff0c\u5fc3\uf9db\u52a0\u5feb(> 100 \u6b21/\u5206\u9418)\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "25 \u6b72\uf981\u6027\uff0c\u73fe\u61f7\u5b55 28 \u9031\uff0c\u56e0\u4e0b\uf94c\u68af\u6454\u5012\uff0c\u649e\u50b7\u53f3\u8170\u90e8\u81f3\u6025\u8a3a\uff0c\u75c5\u4eba\u751f \u547d\u8de1\u8c61\u6b63\u5e38\u4e14\u7a69\u5b9a\uff0c\u7121\u8179\u75db\u3001\u5bae\u7e2e\u3001\u7834\u6c34\u6216\u9670\u9053\u51fa\u8840\u3002\u63a5\u4e0b\uf92d\u4f55\u8005\u8655\uf9e4\u6700 \u9069\u7576\ufe56", + "Options": "(A)\u5b89\u6392\u8d85\u97f3\u6ce2\u6aa2\u67e5\uff0c\u7121\uf962\u5e38\u5247\u51fa\u9662\u56de\u5bb6\u89c0\u5bdf\u3002 (B)\u5b89\u6392\u8179\u90e8\u96fb\u8166\u65b7\u5c64\u3002 (C)\u51fa\u9662\u56de\u5bb6\u89c0\u5bdf\uff0c\u7d66\u4e88\u885b\u6559\uff0c\u5b89\u6392\u9580\u8a3a\u8ffd\u8e64\u3002 (D)\u4f4f\u9662\u89c0\u5bdf\u81f3\u5c11 48 \u5c0f\u6642\u3002 (E)\u9ad4\u5916 tocodynamometric monitoring \u81f3\u5c11 4 \u5c0f\u6642\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "25 \u6b72\uf981\u6027\u56e0\u53f3\u4e0b\u8179\u75db\u81f3\u6025\u8a3a\u5c31\u91ab\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u61f7\u7591\u6025\u6027\u95cc\u5c3e\u708e\u7684\u80b2\u9f61\u5a66\uf981\u9700\u9032\ufa08\u61f7\u5b55\u6e2c\u8a66\u3002 (B)\u80b2\u9f61\u5a66\uf981\u8981\u8a3a\u65b7\u6025\u6027\u95cc\u5c3e\u708e\u662f\u500b\u6311\u6230\uff0c\u56e0\u5176\u4ed6\u5a66\u7522\u79d1\u75be\u75c5\u5bb9\uf9e0\u8aa4\u8a3a \u70ba\u6025\u6027\u95cc\u5c3e\u708e\u3002 (C)\u5982\u679c\u9a57\u5b55\u662f\u967d\u6027\uff0c\uf965\u53ef\u8a3a\u65b7\u70ba ectopic pregnancy\uff0c\u53ef\u6392\u9664\u6025\u6027\u95cc\u5c3e \u708e\u7684\u8a3a\u65b7\u3002 (D)\u5982\u679c\u6709\u9670\u9053\u5206\uf968\u7269\u3001\u5b50\u5bae\u9838\u6709 motion tenderness\uff0c\u6bd4\u8f03\u61f7\u7591\u662f\u9aa8\u76c6 \u8154\u767c\u708e\uff0c\u800c\uf967\u662f\u6025\u6027\u95cc\u5c3e\u708e\u3002 (E)\u5982\u679c\u6709\u75bc\u75db\u8f49\u79fb(migration of pain)\u4e26\u4e14\u58d3\u75db\u96c6\u4e2d\u5728\u53f3\u4e0b\u8179\uff0c\u6bd4\u8f03 \u61f7\u7591\u662f\u6025\u6027\u95cc\u5c3e\u708e\uff0c\u800c\uf967\u662f\u9aa8\u76c6\u8154\u767c\u708e\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "26 \u6b72\uf981\u6027\u75c5\u60a3\u56e0\u547c\u5438\u56f0\u96e3\u81f3\u6025\u8a3a\u5c31\u91ab\u30023 \u5929\u524d\u5979\u5c31\u611f\u89ba\u547c\u5438\u6bd4\u8f03\u8cbb\uf98a\uff0c\u60c5 \u6cc1\u4e00\u5929\u6bd4\u4e00\u5929\u56b4\u91cd\u3002\u5979\u4e5f\u767c\u73fe\u81ea\u5df1\u6700\u8fd1\u8b8a\u5f97\u865b\u5f31\uff0c\u96d9\u624b\u7121\uf98a\u68b3\u982d\u9aee\uff0c\u800c\u4e14 \u770b\u6771\u897f\u6703\u6709\u96d9\u5f71\u7684\u60c5\u5f62\u3002\u4ee5\u4e0a\u7684\u75c7\uf9fa\ufa26\u662f\u65e9\u4e0a\u8d77\u5e8a\u6642\u6bd4\u8f03\u8f15\u5fae\uff0c\u8d8a\u5230\u508d\u665a \u8d8a\u56b4\u91cd\u3002\u8acb\u554f\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\u662f\uff1f", + "Options": "(A)Guillain-Barre syndrome\u3002 (B)Cervical cord myelopathy\u3002 (C)Myasthenia gravis\u3002 (D)Duchenne muscular dystrophy\u3002 (E)Amyotrophic lateral sclerosis\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "3 \u6b72\uf981\u5b69\u7d93\u6551\u8b77\u6280\u8853\u54e1\u5728\u706b\u5834\u6551\u8b77\u5f8c\u9001\u81f3\u6025\u8a3a\u5c31\u91ab\u3002\uf981\u5b69\u610f\uf9fc\uf9fa\u614b GCS\uff1a E3M5V4\uff0c\u547c\u5438\u6025\u4fc3\uff0c\u81c9\u90e8\u53ca\u80f8\u8179\u90e8\u5ee3\u6cdb\u5927\u9762\u7a4d\u707c\u50b7\uff0c\uf9a1\u8a71\u8072\u97f3\u6c99\u555e\uff0c\u8840\u58d3 110/45 mmHg\uff0c\u5fc3\uf9db 120 \u6b21/\u5206\u9418\uff0c\u9ad4\u6eab 36.5 \u00b0C\uff0c\u547c\u5438 32 \u6b21/\u5206\u9418\uff0cSpO2 87 %\uff0c\u9700\u8981\u7dca\u6025\u63d2\u7ba1\u4e26\u4f7f\u7528\u547c\u5438\u5668\uff0c\u6709\u95dc\u547c\u5438\u9053\u7684\u8655\u7f6e\u63aa\u65bd\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55 \u8005\u932f\u8aa4?", + "Options": "(A)\u6700\u597d\u9078\u64c7\u6c92\u6709 cuff \u7684\u6c23\u7ba1\u5167\u7ba1\u3002 (B)\u6e2c\u5b9a\u8840\u6db2\u4e2d carboxyhemoglobin \u6fc3\ufa01\uff0c\u4e26\u8003\u616e\u7528\u9ad8\u58d3\u6c27\u6cbb\uf9c1\u3002 (C)\u63d2\u7ba1\u4f7f\u7528\u4e4b\u8f14\u52a9\u85e5\u7269\uff0c\u808c\u8089\u9b06\u5f1b\u5291\u4ee5 succinylcholine \u70ba\u9996\u9078\u3002 (D)\u61c9\u4f7f\u7528\u63d2\u7ba1\u4e4b\u93ae\u975c\u8f14\u52a9\u85e5\u7269\uff0c\u5982 midazolam\u3002 (E)\uf974\u63d2\u7ba1\uf967\u9806\uf9dd\u6642\uff0c\u4e5f\u61c9\u5118\uf97e\u907f\u514d\u505a tracheostomy\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "30 \u6b72\u7537\u6027\u75c5\u4eba\u7531\u6551\u8b77\uf902\u9001\u9054\u6025\u8a3a\uff0c\u4e3b\u8a34\u525b\u525b\u767c\u751f\uf902\u798d\u6709\u649e\u64ca\u5230\u80f8\u53e3\uff0c\u73fe \u89ba\u80f8\u53e3\u60b6\u75db\u4e14\u547c\u5438\uf967\u9806\u66a2\u3002\u8840\u58d3 98/62 mmHg\u3001\u5fc3\uf9db 120 \u6b21/\u5206\u9418\u3001\u547c\u5438 26 \u6b21/\u5206\u9418\u3001\u9ad4\u6eab 37.2 \u2103\u3002\u6709\u95dc\u6b64\u75c5\u60a3\u53ef\u80fd\u51fa\u73fe\u7684\u75c7\uf9fa\u53ca\u5fb5\u5019\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55 \u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u5fc3\u5305\u819c\u586b\uf96c\u8868\u73fe\u51fa\uf92d\u7684 Beck triad \u5305\u62ec\u9838\u975c\u8108\uf960\u5f35\u3001\u4f4e\u8840\u58d3\u53ca\u4f4e\u6c89 \u7684\u5fc3\u97f3\u3002 (B)\u5fc3\u5305\u819c\u586b\uf96c\u53ef\u80fd\u6703\u6709\u7684 Kussmaul signs\uff0c\u75c5\u4eba\u6df1\u5410\u6c23\u6642\u9838\u975c\u8108\u6703\uf901 \u52a0\u64f4\u5f35\u3002 (C)\uf974\u75c5\u4eba\u51fa\u73fe Hamman sign\uff0c\u8981\u8003\u616e\u75c5\u4eba\u6709 pneumomediastinum \u7684 \u53ef\u80fd\u6027\u3002 (D)\uf974\uf9e4\u5b78\u6aa2\u67e5\u767c\u73fe\u75c5\u4eba\u7684\u53f3\u9396\u9aa8\u4e2d\u7dda\u6709\u7a7f\uf9ff\u50b7\uff0c\u9700\u5c07\u5fc3\u81df\u640d\u50b7\uf99c\u5165\u9451 \u5225\u8a3a\u65b7\u3002 (E)\u5275\u50b7\u6027\u4e3b\u52d5\u8108\u7834\uf9a0\u5728\u80f8\u90e8 X \u5149\u4e0a\u53ef\u80fd\u51fa\u73fe\u98df\u9053\u504f\uf9ea\u80f8\u690e\u7b2c 4 \u7bc0\u68d8 \u7a81(spinous process)\u7684\u53f3\u5074\u5927\u65bc 1\uff0d2 \u516c\u5206\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "30 \u6b72\uf981\u6027\u75c5\u60a3\u56e0\u767c\u71d2\u3001\u5589\u56a8\u75db\u3001\u4ee5\u53ca\u5168\u8eab\u75e0\u75db\u4e00\u65e5\u81f3\u6025\u8a3a\uff0c\u524d\u591c\u767c\u751f\u4f34\u96a8 \u6d3b\u52d5\uf9b9\u5316\u7684\u982d\u75db\u53ca\u5614\u5410\uff0c\u4e14\u6709\u9593\u6b47\u6027\u610f\uf9fc\u6df7\uf91b\uff0c\uf92d\u9662\u524d\u51fa\u73fe\u904d\u4f48\u5168\u8eab\u7684\u7600 \u6591(petechiae)\uff0c\u75c5\u4eba\u7121\uf983\u904a\u53f2\u3002\u5230\u9662\u6642\u9ad4\u6eab 38.3 \u00b0C\uff0c\u5fc3\uf9db 120 \u6b21/\u5206\u9418\uff0c \u547c\u5438 18 \u6b21/\u5206\u9418\uff0c\u8840\u58d3 80/60 mmHg\u3002\u767d\u8840\u7403\u8a08\uf969 17600 /mm3\u3001\u8840\u8272\u7d20 13.6 g/dL\u3001\u8840\u5c0f\u677f 54000 /mm3\u3001blood urea nitrogen 57 mg/dL\u3001creatinine 3.3 mg/dL\u3001activated partial thromboplastin time > 120 \u79d2\u3001international normalized ratio (INR) 2.14\u3001D-dimer \uff1e 10 \u00b5g/mL\u3002\u8acb\u554f\u4e0b\uf99c\u4f55\u8005\u70ba\u6700 \u53ef\u80fd\u4e4b\u8a3a\u65b7\uff1f", + "Options": "(A)\u6bd2\u6027\u4f11\u514b\u75c7\u5019\u7fa4(toxic shock syndrome)\u3002 (B)\u6025\u6027\uf9f5\u75c5\u7403\u83cc\u83cc\u8840\u75c7(acute gonococcemia)\u3002 (C)\uf915\u78ef\u5c71\u6591\u75b9\u71b1(Rocky Mountain spotted fever)\u3002 (D)\u611f\u67d3\u6027\u5fc3\u5167\u819c\u708e(infective endocarditis)\u3002 (E)\u8166\u819c\u708e\u7403\u83cc\u83cc\u8840\u75c7(meningococcemia)\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "32 \u6b72\u7537\u6027\u4e3b\u8a34\u56db\u80a2\u7121\uf98a\uff0c\u610f\uf9fc\u6e05\u695a\uff0c\u8fd1\u7aef\u80a2\u9ad4\u8f03\u9060\u7aef\u7121\uf98a\uff0c\u773c\u7403\u6d3b\u52d5\uf98a \uf962\u5e38\uff0c\u77b3\u5b54\u5c0d\u5149\u53cd\u5c04\uf967\uf97c\uff0c\u56db\u80a2\u611f\u89ba\u548c\u53cd\u5c04\u7686\u6b63\u5e38\uff0c\u4e0b\uf99c\u4f55\u8005\u70ba\u6700\u53ef\u80fd\u4e4b \u8a3a\u65b7?", + "Options": "(A)\u8089\u6bd2\u687f\u83cc\u4e2d\u6bd2(botulism)\u3002 (B)\u91cd\u75c7\u808c\u7121\uf98a\u75c7(myasthenia gravis)\u3002 (C)\u6025\u6027\u9593\u6b47\u6027\u7d2b\u8cea\u75c7(acute intermittent porphyria)\u3002 (D)\u925b\u4e2d\u6bd2(lead poisoning)\u3002 (E)Guillain-Barre syndrome\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "34 \u6b72\uf981\u6027\uff0c\u56e0\u547c\u5438\u6025\u4fc3\u7531\u6551\u8b77\uf902\u9001\u81f3\u6025\u8a3a\uff0c\u75c5\u4eba\u61f7\u5b55 8 \u9031\uff0c\u8840\u58d3 70/40 mmHg\u3001\u547c\u5438 32 \u6b21/\u5206\u9418\u3001\u5fc3\uf9db 130 \u6b21/\u5206\u9418\u3002\u6839\u64da\u5bb6\u5c6c\u8868\u793a\uff0c\u75c5\u4eba\u8fd1\u65e5 \u56e0\u611f\u5192\u5230\u8a3a\u6240\u62ff\u85e5\uff0c\u5403\u5b8c\u7b2c\u4e00\u5291\u85e5\uff0c20 \u5206\u9418\u5f8c\u5c31\u958b\u59cb\u62b1\u6028\u982d\uf9c5\u3001\u547c\u5438\u6025 \u4fc3\u3001\u4e14\u81c9\u90e8\u660e\u986f\u6d6e\u816b\u3002\u547c\u5438\u97f3\u70ba\uf978\u5074\u5598\u9cf4\u8072\u3002\u4ee5\u4e0b\u8655\u7f6e\u4f55\u8005\u8f03\u70ba\u6b63\u78ba?", + "Options": "(A)\u7d66\u4e88\u6c27\u6c23\u3001epinephrine 0.3 mg IM\u3001diphenhydramine 20 mg IV\u3001 methylprednisolone 125 mg IV\u3001\u751f\uf9e4\u98df\u9e7d\u6c34 1000 ml \u5feb\u901f\u6ef4\u6ce8\u3002 (B)\u7d66\u4e88\u6c27\u6c23\u3001diphenhydramine 20 mg IV\u3001methylprednisolone 125 mg IV\u3001 \u751f\uf9e4\u98df\u9e7d\u6c34 1000 ml \u5feb\u901f\u6ef4\u6ce8\u3002 (C)\u7d66\u4e88\u6c27\u6c23\u3001methylprednisolone 125 mg IV\u3001\u751f\uf9e4\u98df\u9e7d\u6c34 1000 ml \u5feb \u901f\u6ef4\u6ce8\u3002 (D)\u7d66\u4e88\u6c27\u6c23\u3001diphenhydramine 20 mg IV\u3001\u751f\uf9e4\u98df\u9e7d\u6c34 1000 ml \u5feb\u901f \u6ef4\u6ce8\u3002 (E)\u7d66\u4e88\u6c27\u6c23\u3001\u751f\uf9e4\u98df\u9e7d\u6c34 1000 ml \u5feb\u901f\u6ef4\u6ce8\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "34 \u6b72\u7537\u6027\u56e0\u610f\uf9fc\uf967\u6e05\u3001\u547c\u5438\u6025\u4fc3\u800c\u81f3\u6025\u8a3a\uff0c\u5176\u9ad4\u6eab 36.4 \u2103\uff0c\u8840\u58d3 86/50 mmHg\uff0c\u5fc3\u8df3 110 \u6b21/\u5206\u9418\uff0c\u547c\u5438 30 \u6b21/\u5206\u9418\u3002\u52d5\u8108\u8840\u6c23\u9ad4\u5206\u6790 pH\uff1a7.10\uff0c PCO2\uff1a20 mmHg\uff0cPO2\uff1a96 mmHg\uff0cHCO3 \uff0d\uff1a8 mEq/L\uff0c\u8840\u4e2d Na+\uff1a145 mEq/L\uff0c K+\uff1a2.7 mEq/L\uff0cCl \uff0d\uff1a105 mEq/L\u3002\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u75c5\u4eba\u53ef\u80fd\u70ba\u6c30\u5316\u7269(cyanide)\u4e2d\u6bd2\u3002 (B)\u75c5\u4eba\u53ef\u80fd\u70ba\u9435(iron)\u4e2d\u6bd2\u3002 (C)\u75c5\u4eba\u53ef\u80fd\u70ba metformin \u4e2d\u6bd2\u3002 (D)\u75c5\u4eba\u53ef\u80fd\u70ba\u7532\u9187(methanol)\u4e2d\u6bd2\u3002 (E)\u75c5\u4eba\u53ef\u80fd\u70ba\uf962\u4e19\u9187(isopropyl alcohol)\u4e2d\u6bd2\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "35 \u6b72\u5a66\u4eba\u61f7\u5b55 24 \u9031\u3001\u9ad4\u91cd 65 \u516c\u65a4\uff0c\u65bc\u4eba\ufa08\u9053\u906d\u8173\u8e0f\uf902\u64e6\u649e\u8179\u90e8\uff0c\u88ab\u6551 \u8b77\uf902\u9001\uf92d\u6025\u8a3a\u6642\uff0c\u9ad4\u6eab 36.7\u2103\uff0c\u547c\u5438 23 \u6b21/\u5206\u9418\uff0c\u5fc3\uf9db 110 \u6b21/\u5206\u9418\uff0c\u8840 \u58d3 120/80 mmHg\u3002\u75c5\u4eba\u4e3b\u8a34\u5287\uf99f\u4e0b\u8179\u75db\u4e26\u611f\u89ba\u6709\u5bae\u7e2e\u3002\uf9e4\u5b78\u6aa2\u67e5\u767c\u73fe\u4e0b\u8179 \u58d3\u75db\u4f46\u7121\u53cd\u5f48\u75db\u5408\u4f75\u9670\u9053\u5c11\uf97e\u51fa\u8840\uff0c\u4ee5\u4e0b\u95dc\u65bc\u6b64\u5b55\u5a66\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u5b55\u5a66\uf967\u77e5\u81ea\u5df1\u7684\u8840\u578b\uff0c\u4f46\u5df2\u77e5\u5b55\u5a66\u4e08\u592b\u7684\u8840\u578b\u70ba type O Rh(-)\uff0c \u56e0\u6b64\uf967\uf941\u9a57\u51fa\u7522\u5a66\u7684\u8840\u578b\u70ba\u4f55\uff0c\ufa26\uf967\u9700\u8981\u7d66\u4e88 Rh0D immune globulin\u3002 (B)\u5916\u50b7\u5f15\u8d77\u80ce\u5152\u6700\u5e38\ufa0a\u7684\u6b7b\u56e0\u70ba\u6bcd\u89aa\u6b7b\u4ea1\uff0c\u7b2c\u4e8c\u5e38\ufa0a\u70ba\u80ce\u76e4\u524d\u7f6e\u3002 (C)\u5b89\u80ce\u85e5\u53ef\u80fd\u6703\u5f71\u97ff\u5230\u521d\u6b65\u5275\u50b7\u8a55\u4f30\u3002 (D)\u96d6\u7136\u6b64\u5b55\u5a66\u7684\u8840\u58d3\u4ecd\u5728\u6b63\u5e38\u7bc4\u570d\uff0c\u4f46\u5176\u51fa\u8840\uf97e\u4ecd\u6709\u53ef\u80fd\u8d85\u904e 1500 ml\u3002 (E)\uf974\u6bcd\u89aa\u5728\u6025\u8a3a\u8655\u7f6e\u5f8c\u4ecd\uf967\u5e78\u5fc3\u8df3\u505c\u6b62\uff0c\u53ef\u8003\u616e\u7dca\u6025\u5256\u8179\u751f\u7522\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "36 \u6b72\u7537\u6027\uff0c\u53f3\u624b\u63a5\u89f8\u6c2b\u6c1f\u9178\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u5982\u56b4\u91cd\u707c\u50b7\u53ef\u4ee5\u7531\u4e0a\u6e38\u52d5\u8108\u704c\u6ce8\u8461\u8404\ufa03\u9178\u9223\u3002 (B)\u53ef\u6ce8\u5c04\u6c2f\u5316\u9223\u6eb6\u6db2\u4f5c\u6ef2\u900f\u6cbb\uf9c1(infiltration therapy)\u3002 (C)\u5176\u76ae\u819a\u5982\u6709\u75bc\u75db\u53ca\u7d05\u816b\uf967\u6703\u5728 6 \u5c0f\u6642\u5f8c\u624d\u767c\u751f\u3002 (D)\u5982\u60a3\u90e8\u8d77\u6c34\u6ce1\u6642\uff0c\uf967\u5efa\u8b70\u7834\u58de\u6c34\u6ce1\u4ee5\u514d\u611f\u67d3\u3002 (E)\u9700\u6ce8\u610f\u4f4e\u8840\u9223\u548c\u4f4e\u8840\u9240\u800c\u7522\u751f\u5fc3\uf9d8\uf967\u6574\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "4 \u5929\u5927\u7684\uf981\u5b30\uff0c\u56e0\u8840\uf965\u53ca\u6301\u7e8c\u8179\u8139\u88ab\u9001\u81f3\u6025\u8a3a\uff0c\u96fb\u8166\u65b7\u5c64\u767c\u73fe pneumatosis intestinalis \u61f7\u7591\u662f\u58de\u6b7b\u6027\u8178\u708e(necrotizing enterocolitis)\uff0c\u95dc\u65bc\u58de\u6b7b\u6027\u8178 \u708e\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u597d\u767c\u7684\u65cf\u7fa4\u662f\u65e9\u7522\u5152\u548c\u4f4e\u9ad4\u91cd\u7684\u65b0\u751f\u5152\u3002 (B)\u6bcd\u89aa\u4f7f\u7528\u53e4\u67ef\u9e7c\u662f\u8db3\u6708\u5b30\u5152\u767c\u751f\u58de\u6b7b\u6027\u8178\u708e\u7684\u5371\u96aa\u56e0\u5b50\u4e4b\u4e00\u3002 (C)\u5982\u679c\u592a\u665a\u8a3a\u65b7\u51fa\uf92d\u53ef\u80fd\u5c0e\u81f4\u8178\u7a7f\u5b54\uff0c\u6557\u8840\u6027\u4f11\u514b\u3002 (D)\u5be6\u9a57\u5ba4\u8a3a\u65b7\u5c0d\u65bc\u8a3a\u65b7\u58de\u6b7b\u6027\u8178\u708e\u4e26\u7121\u7279\uf962\u6027\u3002 (E)\uf967\u7ba1\u6709\u7121\u8178\u7a7f\u5b54\uff0c\u58de\u6b7b\u6027\u8178\u708e\u7684\u75c5\u4eba\u7686\u9808\u5916\u79d1\u624b\u8853\u6cbb\uf9c1\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "45 \u6b72\uf981\u6027\uff0c\u904e\u53bb\u6709\uf9d0\u98a8\u6fd5\u6027\u95dc\u7bc0\u708e\u75c5\u53f2\uff0c\u56e0\u65e9\u6668\u505a\u6668\u64cd\u5f4e\u4e0b\u8116\u5b50\u6642\uff0c\u7a81 \u7136\u89ba\u5f97\u80cc\u90e8\u88ab\u96fb\u5230\u7684\u611f\u89ba\uff0c\u800c\uf92d\u5230\u6025\u8a3a\uff0c\uf9e4\u5b78\u6aa2\u67e5\u4e26\u7121\uf962\u5e38\uff0c\u540c\u6642\uf978\u5074\u808c \uf98a\u76f8\u7576\u3002\u63a5\u4e0b\uf92d\u9032\ufa08\u54ea\u500b\u6b65\u9a5f\u6700\u6070\u7576?", + "Options": "(A)\uf9f7\u523b\u975c\u8108\u6ce8\u5c04 methylprednisolone 30 mg/kg\u3002 (B)\u6025\u505a\u9838\u690e\u96fb\u8166\u65b7\u5c64\u3002 (C)\u544a\u77e5\u75c5\u4eba\u591a\u6d3b\u52d5\u5373\u53ef\u6e1b\u5c11\u6b64\uf962\u5e38\u611f\u89ba\u3002 (D)\uf9f7\u5373\u975c\u8108\u6ce8\u5c04\u5927\uf97e\u751f\uf9e4\u98df\u9e7d\u6c34\u3002 (E)\u62bd\u8840\u6aa2\u67e5\u767c\u708e\uf9fa\u614b\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "45 \u6b72\u7537\u6027\u65bc\u5927\uf94c\u5de5\u5730\u7531\u5927\u7d04 3 \u516c\u5c3a\u8655\u8dcc\uf918\u5730\u9762\u3002\u76ee\u64ca\u8005\u767c\u73fe\u75c5\u4eba\u70ba\u982d\u90e8 \u8457\u5730\u3002\u75c5\u4eba\u77ed\u66ab\u5931\u53bb\u610f\uf9fc\u5f8c\u9192\uf92d\u5fd8\u8a18\u81ea\u5df1\u767c\u751f\u610f\u5916\u3002\u88ab\u6551\u8b77\uf902\u9001\uf92d\u6025\u8a3a \u6642\uff0c\u9ad4\u6eab 36.7\u2103\uff0c\u547c\u5438 16 \u6b21/\u5206\u9418\uff0c\u5fc3\uf9db 102 \u6b21/\u5206\u9418\uff0c\u8840\u58d3 120/67 mmHg\u3002\u75c5\u4eba\u4e3b\u8a34\u56db\u80a2\u7121\uf98a\u53ca\u611f\u89ba\uf962\u5e38\u3002\u95dc\u65bc\u75c5\u4eba\u53ef\u80fd\u767c\u751f\u7684\u810a\u9ad3\u640d\u50b7\uff0c \u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)Anterior cord syndrome \u901a\u5e38\u7531\u65bc\u9838\u90e8 flexion \u5f15\u8d77\uff0c\u53d7\u50b7\u90e8\u4f4d\u4ee5 \u4e0b\u50c5\u4fdd\uf9cd proprioception \u548c vibration\u3002 (B)Central cord syndrome \u5728\uf98e\u8f15\u4eba\u8f03\uf9e0\u767c\u751f\uff0c\u4e0b\u80a2\u7121\uf98a\u6703\u5927\u65bc\u4e0a\u80a2\u7121 \uf98a\u3002 (C)Brown-Sequard syndrome \u70ba\u540c\u5074\u7121\uf98a\uff0c\u540c\u5074\u5931\u53bb proprioception\uff0c \u5408\u4f75\u5c0d\u5074\u5931\u53bb\u75db\u89ba\u6eab\u89ba\u3002 (D)Cauda equina syndrome \u7684\u9810\u5f8c\u8f03\u597d\uff0c\u4e3b\u8981\u662f\u56e0\u70ba\u53d7\u50b7\u7684\ufa19\u7d93\u70ba\u5468 \u908a\ufa19\u7d93\uff0c\u6709\u518d\u751f\u7684\u6a5f\u6703\u3002 (E)\uf974\u78ba\u5b9a\ufa19\u7d93\u640d\u50b7\u5728 C5 \u7684\u4f4d\u7f6e\uff0c\u5247\u9700\u8981\u8003\u616e\u9810\u5148\u63d2\u7ba1\u4ee5\u9632\u547c\u5438\u8870\u7aed\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "45 \u6b72\u809d\u786c\u5316\u75c5\u60a3\u56e0\u767c\u71d2\u53ca\u8179\u8139\u800c\u4f4f\u9662\u3002\uf9e4\u5b78\u6aa2\u67e5\u767c\u73fe\u6709\u8179\u6c34\uff0c\u4e14\u8179\u90e8\u6709 \u58d3\u75db\u53ca\u53cd\u5f48\u75db\u4e4b\u73fe\u8c61\u3002\u8179\u6c34\u6aa2\u9a57\u986f\u793a\uff0c\u5176\u5167\u4e4b\u767d\u8840\u7403\u8a08\uf969\u70ba 1000 /mm3\uff0c \u5176\u4e2d\u591a\u6838\u7403\u4f54 90%\u3002\u95dc\u65bc\u81ea\u767c\u6027\u7d30\u83cc\u6027\u8179\u819c\u708e\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u6297\u751f\u7d20\u53ef\u9078\u64c7\u7b2c\u4e09\u4ee3 cephalosporin\u3002 (B)\uf974\u8179\u6c34\u4e2d\u7684\u86cb\u767d\u8cea\u6fc3\ufa01\u5927\u65bc 1 g/dL\uff0c\u767c\u751f\u81ea\u767c\u6027\u8179\u819c\u708e\u7684\u6a5f\uf9db\u4e0a\u5347\u3002 (C)\u6700\u5e38\ufa0a\u83cc\u7a2e\u662f\u9769\uf91f\u6c0f\u9670\u6027\u83cc\uff0c\u5982 Escherichia coli\u3002 (D)\u8179\u6c34\u4e2d\u7684\u591a\u6838\u7403\u5927\u65bc 250 /mm3 \u53ef\u78ba\u5b9a\u8a3a\u65b7\uff0c\u4e26\u958b\u59cb\u6297\u751f\u7d20\u6cbb\uf9c1\u3002 (E)\u5c0d\u65bc\u6709\u8179\u6c34\u7684\u9ad8\u5371\u96aa\u75c5\u60a3\u4f7f\u7528\u9810\u9632\u6027\u6297\u751f\u7d20\uff0c\u53ef\ufa09\u4f4e\u81ea\u767c\u6027\u7d30\u83cc\u6027 \u8179\u819c\u708e\u7684\u767c\u751f\u6a5f\uf9db\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "5 \u6b72\uf981\u5b69\u5168\u8eab(\u5c24\u5176\u662f\u8ec0\u5e79)\u9577\uf9ba\u8a31\u591a\u534a\u9846\u7c73\uf9f9\u5927\u7684\u4e18\u75b9\uff0c\u9019\u4e9b\u4e18\u75b9\u6709\u4e9b \u5448\u6c34\u75b1\u6a23\u548c\u986f\u8457\u7d05\uf9c5\uff0c\u6709\u4e9b\u5247\u70ba\u5c0f\u75c2\u76ae\uff0c\u4e14\uf978\u4e09\u5929\u524d\u6709\u767c\u71d2\u7684\u60c5\u5f62\u3002\u4ee5\u4e0b \u8a3a\u65b7\u4f55\u8005\u6700\u6709\u53ef\u80fd\uff1f", + "Options": "(A)\u75f2\u75b9(measles)\u3002 (B)\u6c34\u75d8(chickenpox)\u3002 (C)\u73ab\u7470\u7ce0\u75b9(pityriasis rosea) (D)\u6fd5\u75b9(eczema)\u3002 (E)\u8461\u8404\u7403\u83cc\u6027\u812b\u76ae\u75c7\u5019\u7fa4(staphylococcal scalded skin syndrome)\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "5 \u6b72\uf981\u7ae5\uff0c\u9ad4\u91cd 20 \u516c\u65a4\uff0c\uf9e6\u60a3\ufa03\uf9bd\u75c5\u916e\u9178\u4e2d\u6bd2\uff0c\u5448\u73fe\u55dc\u7761\uff0c\u547c\u5438\u6025\u4fc3\uff0c \u7531\u5bb6\u5c6c\u9001\uf92d\u6025\u8a3a\u5ba4\uff0c\u7576\u6642\u8840\u58d3 70/40 mmHg\uff0c\u5fc3\uf9db 120 \u6b21/\u5206\u9418\uff0c\u8840\ufa03 420 mg/dL\uff0c\u6025\u8a3a\u91ab\u5e2b\u8a55\u4f30\u6709 10% \u812b\u6c34\u60c5\u5f62\uff0c\u95dc\u65bc\u6cbb\uf9c1\u53ca\u5176\u9810\u5f8c\uff0c\u4e0b\uf99c\u6558\u8ff0 \u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u512a\u5148\u7d66\u4e88 0.9% \u751f\uf9e4\u98df\u9e7d\u6c34 200\uff0d400 ml \u704c\u6ce8\uff0c\u4f7f capillary refilling time \u6062\uf966\u6b63\u5e38\u3002 (B)\uf974\u7d66\u4e88 0.9% \u751f\uf9e4\u98df\u9e7d\u6c34 400 ml \u704c\u6ce8\u4e00\u6b21\u5f8c\uff0c\u75c5\u5152\u610f\uf9fc\u8f49\u597d\u4e14\u704c \uf9ca\u4e5f\u5df2\u9069\u7576\uff0c48 \u5c0f\u6642\u5167\u8f38\u6db2\u88dc\u5145\u4ee5\uf967\u8d85\u904e\u7dad\u6301\u8f38\u6db2\uf97e 1.5 \u500d\u70ba\u539f \u5247\u3002 (C)\u7d66\u4e88 0.9% \u751f\uf9e4\u98df\u9e7d\u6c34\u704c\u6ce8\u524d\uff0c\u5148\u7d66\u4e88\uf9f7\u5373 regular insulin 2 units IV bolus \u4ee5\u53ca\u6bcf\u5c0f\u6642 regular insulin 2 units \u6301\u7e8c\u975c\u8108\u8f38\u6ce8\u3002 (D)\uf974\u8840\ufa03\u77ef\u6b63\u5f8c\uff0c\u4f4e\u8840\u9209\u60c5\u5f62\u4ecd\u7121\u6cd5\u7a69\u5b9a\u56de\u5347\uff0c\u662f\u767c\u751f\u8166\u6c34\u816b\u7684\u98a8\u96aa \u56e0\u5b50\u4e4b\u4e00\u3002 (E)\u88dc\u5145 bicarbonate \u901a\u5e38\u662f\uf967\u9700\u8981\u7684\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "56 \u6b72\u7537\u5b50\u56e0\u767c\u71d2\u81f3 39.2 \u2103 1 \u5929\u88ab\u9001\u5230\u6025\u8a3a\uff0c\u75c5\u60a3\u540c\u6642\u6709\u982d\u75db\u3001\u5168\u8eab\u4e4f \uf98a\u3001\u5641\u5fc3\u5614\u5410\u3002\u91ab\u5e2b\u9032\ufa08\u8170\u690e\u7a7f\uf9ff\u6aa2\u67e5\u3002\u4e0b\uf99c\u8166\u810a\u9ad3\u6db2\u5206\u6790\u7684\u7d50\u679c\uff0c\u4f55\u8005 \u4e26\uf967\u7b26\u5408\u7d30\u83cc\u6027\u8166\u819c\u708e\u7684\u8868\u73fe\uff1f", + "Options": "(A)Sugar 80 mg/dL\u3002 (B)\u767d\u8840\u7403\u8a08\uf969 1500 /mm3\u3002 (C)\u767d\u8840\u7403\u5206\uf9d0 85% neutrophils\u3002 (D)\u521d\u58d3(open pressure)350 mmH2O\u3002 (E)\u86cb\u767d\u8cea(total protein)250 mg/dL\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "56 \u6b72\u7537\u6027\u5de5\u5730\u5de5\u4eba\uf92d\u81ea\u53f0\u7063\u5357\u90e8\u6df9\u6c34\u5730\u5340\uff0c\u56e0\u767c\u71d2\u3001\u982d\u75db\u3001\u5614\u5410\u3001\u98df\u617e \uf967\u632f\u3001\u75b2\u5026\u3001\u5168\u8eab\u75e0\u75db\u7d04 3 \u65e5\uf92d\u6025\u8a3a\uff0c\u672c\u8eab\u6709\ufa03\uf9bd\u75c5\u3001\u814e\u81df\u75c5\u7b49\u75c5\u53f2\u3002 \u5230\u9662\u6642\u9ad4\u6eab 39.2 \u00b0C\uff0c\u5fc3\uf9db 120 \u6b21/\u5206\u9418\uff0c\u547c\u5438 22 \u6b21/\u5206\u9418\uff0c\u8840\u58d3 105/60 mmHg\uff0c\uf9e4\u5b78\u6aa2\u67e5\u7121\u7d50\u819c\u5145\u8840\u3001\u7121\u9ec3\u75b8\u3001\u7121\u76ae\u75b9\u3002\u8acb\u554f\u4e0b\uf99c\u4f55\u8005\u70ba\u53ef\u80fd\u4e4b \u8a3a\u65b7\uff1f", + "Options": "(A)Q \u71b1(Q fever)\u3002 (B)\u767b\u9769\u71b1(dengue fever)\u3002 (C)\u9264\u7aef\uf911\u65cb\u9ad4\u75c5(leptospirosis)\u3002 (D)\uf9d0\u9f3b\u75bd(melioidosis)\u3002 (E)\u4ee5\u4e0a\u7686\u662f\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "57 \u6b72\u7537\u6027\uff0c\u53e3\u670d\u542b\u6297\u51dd\u5291\u7684\uf970\u9f20\u5291\u81ea\uf970\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u73fe\u5728\u4f7f\u7528\u7684\uf970\u9f20\u5291\u591a\u70ba superwarfarin\u3002 (B)superwarfarin \u4f5c\u7528\u6a5f\u8f49\u548c warfarin \u4e00\u6a23\uff0c\u662f\u6291\u5236\u51dd\u8840\u56e0\u5b50 II\u3001 VII\u3001IX\u3001X \u7684\u5408\u6210\u3002 (C)superwarfarin \u4f5c\u7528\u958b\u59cb\u8f03\u6162\uff0c\u51dd\u8840\u529f\u80fd\uf962\u5e38\u53ef\u80fd\u5728 1\uff0d2 \u5929\u4ee5\u5f8c \u624d\u958b\u59cb\u51fa\u73fe\u3002 (D)\u5c0d\u53e3\u670d superwarfarin \u4e4b\u75c5\u4eba\uff0c\u5728\u51dd\u8840\u529f\u80fd\uf962\u5e38\u5c1a\u672a\u986f\u73fe\u6642\uff0c\u5373\u61c9 \u63d0\u65e9\u4f7f\u7528 vitamin K1 \u6cbb\uf9c1\u6548\u679c\u6bd4\u8f03\u597d\u3002 (E)\u75c5\u4eba\u5982\u56b4\u91cd\u51fa\u8840\uff0c\u4f7f\u7528 prothrombin complex concentrates \u6bd4\u7528\u65b0 \u9bae\uf92e\u51cd\u8840\u6f3f\u8f03\uf9e0\u6062\uf966\u51dd\u8840\u529f\u80fd\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "6 \u6b72\u7537\u7ae5\u7531\u7238\u7238\u7528\u8f4e\uf902\u8f09\u5230\u4e0a\u5b78\u9014\u4e2d\uff0c\u8f4e\uf902\u88ab\u8a08\u7a0b\uf902\u7531\u5de6\u5074\u4ee5\u6642\u901f 40 \u516c \uf9e9\u6514\u8170\u649e\u4e0a\uff0c\u5b69\u7ae5\u4e58\u5750\u5728\u526f\u99d5\u99db\u5ea7\uff0c\u6c92\u6709\u4f7f\u7528\u5b89\u5168\u5ea7\u6905\u3002\u6551\u8b77\uf902\u5230\u9054\u73fe\u5834 \u6642\uff0c\u7531\u6551\u8b77\u6280\u8853\u54e1\u521d\u6b65\u8a55\u4f30\uff0c\u4e0b\uf99c\u4f55\u9805\u689d\u4ef6\u6700\uf967\u9700\u8981\u8f49\u81f3\u5c0f\u5152\u5275\u50b7\u4e2d\u5fc3\uff1f", + "Options": "(A)\u7238\u7238\u7576\u5834\u6b7b\u4ea1\u3002 (B)\u53f3\u5074\u5927\u817f\u8b8a\u5f62\u3002 (C)\u53f3\u4e0b\u8179\u767c\u73fe\u73bb\u7483\u788e\u7247\u63d2\u5165\u3002 (D)\u5c0f\u5152\u5275\u50b7\u6307\uf969 pediatric trauma score \u70ba 7\u3002 (E)\uf9ea\uf902\u5b50\u7d04 1 \u516c\u5c3a\u8655\u767c\u73fe\u7537\u7ae5\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "60 \u6b72\u7537\u6027\u75c5\u60a3\u56e0\u767c\u71d2\u3001\u754f\u5bd2\u3001\u610f\uf9fc\u6539\u8b8a\u5df2\u4e00\u65e5\uff0c\u88ab\u9001\u5230\u6025\u8a3a\u3002\u75c5\u60a3\u6709\u9ad8 \u8840\u58d3\u3001\ufa03\uf9bd\u75c5\u3001\u53ca\u56e0\u4e2d\u98a8\u800c\u81e5\u5e8a\u4e4b\u75c5\u53f2\u3002\u5230\u9662\u6642\u9ad4\u6eab 39.3 \u00b0C\uff0c\u5fc3\uf9db 116 \u6b21 /\u5206\u9418\uff0c\u547c\u5438 24 \u6b21/\u5206\u9418\uff0c\u8840\u58d3 75/40 mmHg\u3002\uf9e4\u5b78\u6aa2\u67e5\u767c\u73fe\u9838\u90e8\u50f5\u786c\u3001 \u7121\u9ec3\u75b8\u3001\u8179\u90e8\u67d4\u8edf\u3001\u7121\u8925\u7621\u3002\u767d\u8840\u7403\u8a08\uf969 16800 /mm3\u3001Segment 78%\u3001 Band 10%\uff0cLactate 5.2 mmol/L\u3002\u8acb\u554f\u4e0b\uf99c\u6cbb\uf9c1\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u61c9\u5148\u8a55\u4f30\u547c\u5438\u9053\u662f\u5426\u901a\u66a2\u3001\u547c\u5438\u63db\u6c23\u662f\u5426\u9069\u7576\uff0c\u61c9\u5426\u63d2\u7ba1\u3002 (B)\u9700\u8fc5\u901f\u5efa\uf9f7\u4e2d\u592e\u975c\u8108\u7ba1\uf937\uff0c\u4ee5\u76e3\u6e2c\u4e2d\u592e\u975c\u8108\u58d3\u53ca\u4e2d\u5fc3\u975c\u8108\u6c27\u6c23\u98fd\u548c \ufa01(central venous oxygen saturation)\u3002 (C)\uf9f7\u5373\u7d66\u4e88 dopamine \u6216 norepinephrine \u7b49\u5347\u58d3\u5291\u975c\u8108\u6ef4\u6ce8\u3002 (D)\u65bc 1 \u5c0f\u6642\u5167\u7d66\u4e88\u5ee3\u6548\u6027\u6297\u751f\u7d20\u3002 (E)\u76e1\u53ef\u80fd\u65bc 6 \u5c0f\u6642\u5167\u67e5\u51fa\u53ef\u80fd\u4e4b\u611f\u67d3\u90e8\u4f4d\uff0c\u4e26\u9032\ufa08\u611f\u67d3\u6e90\u63a7\u5236(source control)\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "70 \u6b72\u7537\u6027\u75c5\u4eba\uff0c\u65e5\u524d\u525b\u63a5\u53d7\u5fc3\u81df\u51a0\uf9fa\u52d5\u8108\u7e5e\u9053\u624b\u8853\uff0c\u51fa\u9662\u5f8c 3 \u5929\u56e0\u665a\u4e0a \u7761\uf967\u8457\u89ba\u3001\u8a71\u591a\u3001\ufa08\u70ba\u6df7\uf91b\uff0c\u88ab\u9001\u56de\u6025\u8a3a\u3002\u5176\u5be6\u9a57\u5ba4\u6aa2\u67e5\u7d50\u679c\ufa26\u6b63\u5e38\uff0c\u50b7 \u53e3\u4e5f\u6c92\u6709\u611f\u67d3\u73fe\u8c61\uff0c\ufa19\u7d93\u5b78\u6aa2\u67e5\u4e5f\u6c92\u6709\u5c40\u90e8\ufa19\u7d93\u75c7\uf9fa\uff0c\u4f46\ufa1d\ufa19\uf9fa\u614b\u6aa2\u67e5\u767c \u73fe\u6709\u56b4\u91cd\u667a\u80fd\u969c\u7919\u3002\u5bb6\u5c6c\u8868\u793a\u75c5\u4eba\u5e7e\uf98e\u524d\u5c31\u6709\u667a\uf98a\u9000\u5316\u7684\u73fe\u8c61\uff0c\uf967\u8a18\u5f97\u5bb6 \u4eba\u3001\u66fe\u7d93\u81ea\ufa08\u5916\u51fa\u8d70\u5931\u904e\uff0c\u4f46\uf967\u6703\u6709\ufa08\u70ba\u6df7\uf91b\u7684\u73fe\u8c61\u3002\u4e0b\uf99c\u4f55\u9805\u8655\u7f6e\u6700\uf967 \u6070\u7576\uff1f", + "Options": "(A)\u61c9\u8003\u616e\u505a\u982d\u90e8\u96fb\u8166\u65b7\u5c64\u3002 (B)\u8acb\u75c5\u4eba\u767d\u5929\u76e1\uf97e\uf967\u8981\u7761\u89ba\u3002 (C)\u61c9\u9032\u4e00\u6b65\u8ffd\u8e64\u6aa2\u67e5\u3002 (D)\u8003\u616e\u7d66\u4e88\u6297\ufa1d\ufa19\u75c5\u85e5\u7269\u3002 (E)\u61c9\uf9f7\u5373\u8f49\u81f3\ufa1d\ufa19\u79d1\u75c5\u623f\u4f4f\u9662\u6cbb\uf9c1\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "72 \u6b72\u7537\u6027\u75c5\u4eba\uff0c\u56e0\u8179\u8139\u3001\u547c\u5438\u6025\u4fc3\u81f3\u6025\u8a3a\u6c42\u6cbb\u3002\uf9e4\u5b78\u6aa2\u67e5\u6709\u9838\u975c\u8108\uf960\u5f35\uff0c \u8179\u90e8\u6709 shifting dullness\uff0c\u8179\u6c34\u6aa2\u9a57\u7d50\u679c\u986f\u793a\u767d\u8840\u7403\u8a08\uf969 280 /mm3\uff0c 40\uff05 \u70ba\u591a\u6838\u7403\u3002\u8179\u6c34\u4e4b albumin \u70ba 1.3 g/dL\uff0ctriglyceride \u70ba 300 mg/dL\uff1b\u8840 \u4e2d\u4e4b albumin \u70ba 2.6 g/dL\u3002\u5176\u8179\u6c34\u4e4b\u6210\u56e0\uff0c\u4f55\u8005\u6700\u53ef\u80fd\uff1f", + "Options": "(A)\u8179\u819c\u6027\u7d50\u6838\u75c7\u3002 (B)\u7d30\u83cc\u6027\u8179\u819c\u708e\u3002 (C)\u8179\u5167\u6563\u5e03\u6027\u764c\u75c7\u3002 (D)\u5145\u8840\u6027\u5fc3\u8870\u7aed\u3002 (E)\u4e73\u7cdc\u8179\u6c34\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u4e00\u8f1b\u88dd\u8f09\u540c\u4f4d\u7d20\u4e4b\uf902\u8f1b\uf967\u614e\u7ffb\u8986\uff0c\u6551\u8b77\uf902\u5230\u9054\u5f8c\u767c\u73fe\u653e\u5c04\u540c\u4f4d\u7d20\u7269\u8cea\u5916 \u6d29\uff0c\u6709 1 \u540d\u7591\u4f3c\u906d\u540c\u4f4d\u7d20\u6c61\u67d3\u4e4b\u50b7\u60a3\u5f8c\u9001\u81f3\u67d0\u91ab\u9662\u6025\u8a3a\u90e8\u3002\u4e0b\uf99c\u6709\u95dc\u6025 \u8a3a\u61c9\u8b8a\u8655\uf9e4\u4e4b\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u6025\u8a3a\u61c9\u8a2d\u7f6e\u9664\u6c61\u5340\uff0c\u4e26\u52d5\u7dda\u7ba1\u5236\u5f15\u5c0e\u6b64\u75c5\u4eba\u5230\u9664\u6c61\u5340\u8655\uf9e4\u3002 (B)\u9664\u6c61\u5340\u5de5\u4f5c\u4eba\u54e1\u61c9\u7a7f\u8457\u9632\u6c34\u7684\u5168\u8eab\u9632\u8b77\u8863\uff0c\u624b\u6234\u96d9\u5c64\u5916\u79d1\u4e73\u81a0\u624b \u5957\uff0c\u53e3\u9f3b\u5e36\u5916\u79d1\u53e3\u7f69\u3002 (C)\u5fc5\u8981\u4e4b\u7dca\u6025\u91ab\uf9c1\u8655\uf9e4(\uf9b5\u5982\u58d3\u8feb\u6b62\u8840)\u8981\u6bd4\u9664\u6c61\u5148\u9032\ufa08\u3002 (D)\u75c5\u4eba\u5230\u9664\u6c61\u5340\u5f8c\uff0c\u61c9\u812b\u9664\u8863\u7269\u4ee5\u5927\uf97e\u6e05\u6c34\u5f37\uf98a\u6c96\u6d17\u5168\u8eab\u3002 (E)\u53d7\u6c61\u67d3\u4e4b\u7121\u50b7\u53e3\u76ae\u819a\uff0c\uf967\u61c9\u7528\uf98a\u5237\u6d17\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u4e0b\uf99c\u6709\u95dc\u6df1\u90e8\u975c\u8108\u6813\uf96c(deep vein thrombosis, DVT)\u7684\u6cbb\uf9c1\uff0c\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\uf974\u7121\u660e\u986f\u7528\u85e5\u7981\u5fcc\uff0c\u521d\u671f\u6cbb\uf9c1\u53ef\u4f7f\u7528\u4f4e\u5206\u5b50\uf97e\u809d\u7d20(low molecular weight heparin)\u3002 (B)\u814e\u81df\u529f\u80fd\uf967\uf97c\u8005(creatinine > 2 mg/dL)\uff0c\u4ecd\u53ef\u4f7f\u7528\u4f4e\u5206\u5b50\uf97e\u809d\u7d20\uff0c \u4f46\u9700\u8abf\u6574\u5291\uf97e\u3002 (C)\u5728\u4f7f\u7528\u809d\u7d20\u7684\u540c\u6642\uff0c\u5373\u53ef\u958b\u59cb\u53e3\u670d\u6297\u51dd\u8840\u5291 warfarin\u3002 (D)\u61f7\u5b55\u4e2d\u7684\u5a66\uf981\uff0c\u56e0\u4f4e\u5206\u5b50\uf97e\u809d\u7d20\u6709\u660e\u986f\u81f4\u7578\u80ce\u6027\uff0c\u6240\u4ee5\u53ea\u80fd\u53e3\u670d warfarin\u3002 (E)\uf974\u662f\u816b\u7624\u6240\u8a98\u767c\u7684 DVT\uff0c\u5efa\u8b70\u7d42\u751f\u4f7f\u7528\u6297\u51dd\u8840\u5291\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u4e0b\uf99c\u4f55\u7a2e\u75c7\uf9fa\u5c0d\u65bc\u5340\u5206\u6297\u4e59\u91af\u81bd\u9e7c\u6bd2\u6027(anticholinergic toxicity)\u548c\u4ea4\u611f \u8208\u596e\u6027\u6bd2\u6027(sympathomimetic toxicity)\u6700\u6709\u5e6b\u52a9\uff1f", + "Options": "(A)\u5fc3\u640f\u5feb\u901f\u3002 (B)\u76ae\u819a\u4e7e\u71e5\u3002 (C)\u610f\uf9fc\u6df7\uf91b\u3002 (D)\u77b3\u5b54\u653e\u5927\u3002 (E)\u9ad4\u6eab\u5347\u9ad8\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u4e0b\uf99c\u5c0d\u65bc\u9ad8\u8840\u9240\u4e4b\u654d\u8ff0\uff0c\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u767d\u8840\u7403\u589e\u591a\u53ef\u80fd\u6703\u5c0e\u81f4\u507d\u9ad8\u8840\u9240\u75c7(pseudohyperkalemia)\u3002 (B)\u5c0d\u65bc\u56b4\u91cd\u9ad8\u8840\u9240\u500b\u6848\u61c9\u7d66\u4e88\u6c2f\u5316\u9223(calcium chloride)\u3002 (C)\u4ee5\u80f0\u5cf6\u7d20\u6cbb\uf9c1\u9ad8\u8840\ufa03\u60a3\u8005\u6642\uff0c\u53ef\u80fd\u6703\u6709\u9ad8\u8840\u9240\u7684\u60c5\u5f62\u3002 (D)Kayexalate \u5c0d\u65bc\u66fe\u7d93\u63a5\u53d7\u7d50\u8178\ufa00\u9664\u8853\u7684\u75c5\u4eba\u53ef\u80fd\u7121\u6548\u3002 (E)\u5438\u5165 albuterol \u53ef\u6cbb\uf9c1\u9ad8\u8840\u9240\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u4e0b\uf99c\u95dc\u65bc\u53f3\u5fc3\u5ba4\u5fc3\u808c\u6897\uf96c\u7684\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u5927\u90e8\u5206\u70ba\u53f3\u51a0\uf9fa\u52d5\u8108\u4e4b\u75c5\u7076\u6240\u9020\u6210\uff0c\u56e0\u6b64\uf9f6\u5e8a\u4e0a\u7d93\u5e38\u5408\u4f75\u5728\u5de6\u5fc3\u5ba4 \u4e0b\u58c1\u5fc3\u808c\u6897\uf96c\u6642\u51fa\u73fe\u3002 (B)\u53f3\u5074\u5fc3\u96fb\u5716 V4R \u7684 ST \u6ce2\u6bb5\u4e0a\u5347\u70ba\u5176\u7279\u6b8a\u8b8a\u5316\uff0c\u4f46\uf967\ufa0a\u5f97\u4e00\u5b9a\u6703 \u51fa\u73fe\u3002 (C)\uf9f6\u5e8a\u8868\u73fe\u5e38\u5408\u4f75\u8840\u58d3\u504f\u4f4e\u53ca\u56b4\u91cd\u7684\u80ba\u6c34\u816b\u3002 (D)\u6cbb\uf9c1\u53ef\u63a1\u53d6\u8f38\u6db2\u704c\u6ce8\u4ee5\u63d0\u9ad8\u5de6\u5fc3\u5ba4\u524d\u8ca0\u8377\uff0c\u540c\u6642\u53ef\u8003\u616e\u7d66\u4e88\u9069\u7576\u7684 \u5f37\u5fc3\u85e5\u7269\u3002 (E)\uf974\u5728\u75c7\uf9fa\u767c\u4f5c 12 \u5c0f\u6642\u5167\uff0c\u61c9\u8003\u616e\u9032\ufa08 primary percutaneous coronary intervention\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u4e0b\uf99c\u95dc\u65bc\u6025\u6027\u80ba\u6813\uf96c\u7684\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u80f8\u90e8 X \u5149\u53ef\u80fd\u51fa\u73fe oligemia \u7684\u5340\u57df(Westermark's sign)\u3002 (B)\u5fc3\u96fb\u5716\u53ef\u80fd\u51fa\u73fe\u7ac7\u6027\u5fc3\u640f\u904e\u901f\u3001right bundle branch block \u6216 S1Q3T3 \u578b\u614b\u3002 (C)\u5fc3\u81df\u8d85\u97f3\u6ce2\u53ef\u80fd\ufa0a\u5230\u53f3\u5fc3\u623f\u3001\u53f3\u5fc3\u5ba4\u6216\u80ba\u52d5\u8108\u4e3b\u5e79\u64f4\u5927\uff0c\u5408\u4f75\u4e09\u5c16 \u74e3\u9589\u9396\uf967\u5168\u3002 (D)D-dimer \u5177\u6709\u9ad8\ufa01\u7279\uf962\u6027\uff0c\uf974\u5347\u9ad8\u5247\u5e7e\u4e4e\u53ef\u4ee5\u78ba\uf9f7\u8a3a\u65b7\u3002 (E)\uf974\u767c\u751f\u56b4\u91cd\u7f3a\u6c27\u6216\u4f11\u514b\uff0c\u61c9\u8003\u616e\u7d66\u4e88\u8840\u6813\u6eb6\u89e3\u6cbb\uf9c1\u4e26\u7167\u6703\u5916\u79d1\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u4e2d\u98a8\u81e5\u5e8a\u7b2c 3 \u5929\u7684\u9673\u5148\u751f\u51fa\u73fe\u9ad8\u71d2\u3001\u54b3\u55fd\u53ca\u547c\u5438\u6025\u4fc3\u7684\u75c7\uf9fa\uff0c\u80f8\u90e8 X \u5149 \u78ba\u8a3a\u70ba\u80ba\u708e\u3002\u95dc\u65bc\u5438\u5165\u6027\u80ba\u708e\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u8fd1\u671f\u7684\u7814\u7a76\u767c\u73fe\uff0c\u5438\u5165\u6027\u80ba\u708e\u6700\u4e3b\u8981\u7684\u81f4\u75c5\u83cc\u662f\u53ad\u6c27\u83cc\u3002 (B)Rapid sequence intubation \u662f\u5438\u5165\u6027\u80ba\u708e\u7684\u5371\u96aa\u56e0\u5b50\u4e4b\u4e00\u3002 (C)\u81e5\u5e8a\u75c5\u60a3\u767c\u751f\u5438\u5165\u6027\u80ba\u708e\u7684\u5178\u578b X \u5149\u5206\u4f48\u662f\u4e0a\u80ba\uf96e\u7684 posterior segments \u53ca\u4e0b\u80ba\uf96e\u7684 superior segments\u3002 (D)Pulmonary aspiration \u6240\u5f15\u8d77\u4e4b\u708e\u75c7\u53cd\u61c9\u6700\u9ad8\u5cf0\u767c\u751f\u5728\u7b2c 4 \u81f3 6 \u5c0f\u6642\u3002 (E)\u767c\u751f\u65bc\u5065\u5eb7\uf98e\u8f15\u4eba\u4e4b pulmonary aspiration\uff0c\uf974\u5438\u5165\uf97e\u5c0f\u53c8\u7121\u660e\u986f \u75c7\uf9fa\uff0c\uf967\u4e00\u5b9a\u8981\u4f7f\u7528\u6297\u751f\u7d20\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u4ee5\u4e0b\u95dc\u65bc\u5fc3\u5ba4\u983b\u8108(ventricular tachycardia, VT)\u8207\u4e0a\u5fc3\u5ba4\u983b\u8108 (supraventricular tachycardia, SVT)\u7684\u6558\u8ff0\uff0c\u4e0b\uf99c\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\uf9f6\u5e8a\u4e0a\uf974\u7121\u6cd5\u5340\u5225 VT \u6216 SVT with aberrancy\uff0c\u4e00\uf9d8\u7576\u4f5c VT \u8655 \u7f6e\u3002 (B)\uf974\u5fc3\u96fb\u5716\u4e0a\u51fa\u73fe atrioventricular dissociation\uff0c\u9700\u7576\u4f5c VT \u8655\u7f6e\u3002 (C)\uf974\u60a3\u8005\uf9fa\u6cc1\u7a69\u5b9a\uff0c\u53ef\u4ee5\u8003\u616e\u4f7f\u7528 adenosine \uf92d\u5340\u5206\uf978\u8005\u3002 (D)Wolff-Parkinson-White(WPW)syndrome \u4f34\u96a8 atrial fibrillation \u6642\uff0c\uf967\u53ef\u7d66\u4e88 \u03b2-blockers \u548c calcium channel blockers \uff0c\u6b64\u6642\u53ef\u4ee5 \u4f7f\u7528 digoxin \u6cbb\uf9c1\u3002 (E)WPW syndrome \u4f34\u96a8 narrow QRS tachycardia \u6642\uff0cadenosine \u975e \u7d55\u5c0d\u7981\u5fcc\u85e5\u7269\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u5916\u50b7\u75c5\u60a3\u5feb\u901f\u63d2\u7ba1(rapid sequence intubation)\u8655\u7f6e\u6240\u7528\u85e5\u7269\u7684\u9078\u64c7\uff0c\u4e0b \uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)Fentanyl \u4f7f\u7528\u65bc\u8840\u58d3\u4e0b\ufa09\u75c5\u60a3\u3002 (B)Ketamine \u4f7f\u7528\u65bc\u8166\u5916\u50b7\u75c5\u60a3\u3002 (C)Lidocaine \u4f7f\u7528\u65bc\u982d\u90e8\u5916\u50b7\u75c5\u60a3\u63d2\u7ba1\u524d\u7d66\u85e5\u3002 (D)Rocuronium \u4f7f\u7528\u65bc\u58d3\u7838\u50b7\u7684\u75c5\u60a3\u3002 (E)Succinylcholine \u7528\u65bc\u7591\u6709\u8166\u5916\u50b7\u7684\u75c5\u60a3\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u5728\u707d\u96e3\u73fe\u5834\u9644\u8fd1\u7684\u5340\u57df\u91ab\u9662\uff0c\u5df2\u6e67\u73fe\u904e\u591a\u75c5\u60a3\uff0c\u9060\u9060\u8d85\u904e\u8a72\u91ab\u9662\u53ef\u8ca0\u8377 \u6642\uff0c\u6b64\u6642\u9700\u9032\ufa08\u518d\u6b21\u7684\u6aa2\u50b7\u5206\uf9d0\uff0c\u4e0b\uf99c\u4f55\u7a2e\u65b9\u5f0f\u8f03\u9069\u5408\uff1f", + "Options": "(A)\uf967\u9700\u8981\u518d\u6b21\u6aa2\u50b7\u3002 (B)JumpSTART(simple triage and rapid treatment)\u3002 (C)PTT(pediatric triage tape)\u3002 (D)SAVE(secondary assessment of victim endpoint)\u3002 (E)START(simple triage and rapid treatment)\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u5728\u6025\u8a3a\u5ba4\uff0c\u7576\u61f7\u7591\u6d88\u5316\u6027\u6f70\u760d\u7a7f\u5b54\u6642\uff0c\u4e0b\uf99c\u8655\u7f6e\u4f55\u8005\u6700\uf967\u9069\u7576\uff1f", + "Options": "(A)\u7dca\u6025\u7167\u6703\u5916\u79d1\u91ab\u5e2b\u3002 (B)\uff38 \u5149\u7247\u4e0a\uf974\u770b\uf967\ufa0a\u8178\u8154\u5916\u7a7a\u6c23\u6642\uff0c\u61c9\u7d93\u9f3b\u80c3\u7ba1\u704c\u6ce8\u7a7a\u6c23\u9032\u5165\u80c3\u90e8 \u4ee5\u6aa2\u6e2c\u7a7f\u5b54\u3002 (C)\u653e\u7f6e\u9f3b\u80c3\u7ba1\u4f5c\u5f15\uf9ca\u3002 (D)\u7f6e\u5165\uf978\u689d\u5927\u53e3\u5f91\u4e4b\u7ba1\u7dda\u4f5c\u975c\u8108\u8f38\u6db2\u3002 (E)\u65bd\u6253\u5ee3\u6548\u6027\u6297\u751f\u7d20\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u5728\u6a5f\u5834\u5019\u6a5f\u6642\uff0c\u4e00\u4f4d\u4e2d\uf98e\u7537\u6027\u7a81\u7136\u5012\u5730\u5931\u53bb\u610f\uf9fc\uff0c\u4f60\u8acb\u822a\u7ad9\u4eba\u54e1\u901a\u77e5\u91ab\u52d9 \u5ba4\u5f8c\uff0c\uf9f7\u523b\u9032\ufa08\u5fc3\u80ba\uf966\u7526\u8853\u3002\u6a5f\u5834\u91ab\u52d9\u4eba\u54e1\u5e7e\u5206\u9418\u5f8c\uff0c\u5e36\u8457\u6025\u6551\u7bb1\u53ca\u81ea\u52d5 \u9ad4\u5916\u53bb\u986b\u5668(automatic external defibrillator, AED)\u5230\u9054\u73fe\u5834\uff0c\u6aa2\u67e5\u5f8c\u767c \u73fe\u75c5\u60a3\u4ecd\u7121\u8108\u640f\u3002\u4e0b\u4e00\u6b65\u6700\u9069\u7576\u7684\u8655\u7f6e\uff0c\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u5148\u505c\u6b62\u5fc3\u81df\u6309\u6469\uff0c\u7d66\u4e88\u75c5\u60a3\u4e00\u6b21\u80f8\u524d\u91cd\u64ca\uff0c\u555f\u52d5 AED \u96fb\u6e90\u4e26\u8cbc\u597d \u96fb\u64ca\u7247\uff0c\u5206\u6790\u5fc3\uf9d8\u3002 (B)\u5148\u6062\uf966\u5fc3\u81df\u6309\u6469\uff0c\u5728\uf967\u59a8\u7919\u5fc3\u81df\u6309\u6469\u7684\u60c5\u5f62\u4e0b\uff0c\u555f\u52d5 AED \u96fb\u6e90\u4e26 \u8cbc\u597d\u96fb\u64ca\u7247\uff0c\u518d\u505c\u6b62\u5fc3\u81df\u6309\u6469\uff0c\u5206\u6790\u5fc3\uf9d8\u3002 (C)\u5148\u505c\u6b62\u5fc3\u81df\u6309\u6469\uff0c\uf9f7\u5373\u5c07\u75c5\u60a3\u9001\u81f3\u6a5f\u5834\u91ab\u52d9\u5ba4\uff0c\u65bc\ufa08\u9032\u4e2d\uf9f7\u5373\u555f\u52d5 AED \u96fb\u6e90\u4e26\u8cbc\u597d\u96fb\u64ca\u7247\uff0c\u5206\u6790\u5fc3\uf9d8\u3002 (D)\u5148\u4ee5\u888b\u74e3\u7f69(bag-valve-mask)\u5354\u52a9\u7d66\u6c27 2 \u5206\u9418\u5f8c\uff0c\u555f\u52d5 AED \u96fb \u6e90\u4e26\u8cbc\u597d\u96fb\u64ca\u7247\uff0c\u5206\u6790\u5fc3\uf9d8\u3002 (E)\u5148\u4ee5\u5589\u7f69\u6c23\u9053(laryngeal mask airway)\u5efa\uf9f7\u547c\u5438\u9053\uff0c\u4e26\u7d66\u6c27 2 \u5206 \u9418\u5f8c\uff0c\u518d\u5c07\u75c5\u60a3\u9001\u81f3\u6a5f\u5834\u91ab\u52d9\u5ba4\uff0c\u65bc\ufa08\u9032\u4e2d\uf9f7\u5373\u555f\u52d5 AED \u96fb\u6e90\u4e26 \u8cbc\u597d\u96fb\u64ca\u7247\uff0c\u5206\u6790\u5fc3\uf9d8\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u4e00\u6c27\u5316\u78b3(carbon monoxide, CO)\u4e2d\u6bd2\u7684\u63cf\u8ff0\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u8840\u7d05\u7d20\u8207\u4e00\u6c27\u5316\u78b3\u7684\u7d50\u5408\u80fd\uf98a\u662f\u8207\u6c27\u6c23\u7d50\u5408\u80fd\uf98a\u7684 230\uff0d270 \u500d\uff0c \u800c\u808c\u7403\u86cb\u767d\u8207\u4e00\u6c27\u5316\u78b3\u7684\u7d50\u5408\u80fd\uf98a\u662f\u8207\u6c27\u6c23\u7d50\u5408\u80fd\uf98a\u7684 20\uff0d25 \u500d\u3002 (B)\u5982\u679c\u53d7\u5230\u4e2d\u7b49\u6216\u56b4\u91cd\u7684\u4e00\u6c27\u5316\u78b3\u66dd\uf938\uff0c\u5c31\u61c9\u62bd\u52d5\u8108\u8840\u6c27\u6fc3\ufa01\u3001\u6e2c carboxyhemoglobin(COHb)\u3001\u6e2c CK-MB \u53ca troponin-I\u3001 electrolytes\u3001lactate \u53ca\u7167\u80f8\u90e8 X \u5149\u7247\u3002 (C)Pulse oximetry \u53ef\u4ee5\u7528\uf92d\u8a55\u4f30\u4e00\u6c27\u5316\u78b3\u4e2d\u6bd2\u75c5\u4eba\u8840\u6c27\u6fc3\ufa01\u662f\u5426\u5145\u8db3\u3002 (D)\u75c5\u60a3\u5982\u679c\u53ea\u6709\u8f15\u5fae\u7684\u75c7\uf9fa\uff0c\u7121\u610f\uf9fc\u55aa\u5931\u3001\u7121\u5fc3\u80ba\u75c7\uf9fa\u3001\u6e05\u9192\u4e14\u5408\u4f5c\uff0c \u4ecd\u7136\u8981\uf9b5\ufa08\u6027\u5075\u6e2c COHb \u8207\u5fc3\u96fb\u5716\u6aa2\u67e5\uff0c\u4ee5\u627e\u51fa\u96b1\u85cf\u7684\u5fc3\u81df\u7f3a\u6c27\u3002 (E)\u4e00\u6c27\u5316\u78b3\u4e2d\u6bd2\u53ef\u80fd\u5f15\u8d77\u57fa\u5e95\u6838\u6216\u4e0b\u8996\u4e18\u75c5\u8b8a\uff0c\u9020\u6210 interval CO syndrome\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u5fc3\u640f\u904e\u7de9\u4e4b\uf9f6\u5e8a\u7279\u5fb5\u53ca\u76f8\u95dc\u8655\u7f6e\uff0c\u4e0b\uf99c\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)Type\u2161 second-degree atrioventricular(AV)block \u4e4b\u5fc3\u808c\u6897\uf96c\u75c5 \u4eba\uff0c\u4ee5\u524d\u58c1\u5fc3\u808c\u6897\uf96c\u5e38\ufa0a\uff0c\u800c\u4e14\uf9e0\u9032\u5c55\u81f3 complete AV block\u3002 (B)\u5c0d\u56b4\u91cd\u8840\uf9ca\u704c\u6ce8\uf967\uf97c\uff0c\u5b9c\u5148\u4f7f\u7528 transcutaneous pacing(TCP)\u53ca atropine\uff0c dopamine \u53ca epinephrine \uf967\u80fd\u8207\u5b83\u5011\u540c\u6642\u4f7f\u7528\u3002 (C)TCP \u4e4b\u4f7f\u7528\u6642\u6a5f\u70ba atropine \u4f7f\u7528\u7121\u6548\uff0c\u6216\u975c\u8108\u8f38\u6db2\u672a\u6253\u4e0a\u4e4b\uf967\u7a69 \u5b9a\u75c5\u60a3\u3002 (D)\u8840\uf9ca\u704c\u6ce8\uf967\u8db3\u7684 third-degree AV block\uff0c\u75c5\u4eba\u4f7f\u7528 TCP \u6cbb\uf9c1\u6548\u679c \u6bd4 atropine \u597d\u3002 (E)Isoproterenol \u4e26\u975e\u6cbb\uf9c1\u6709\u75c7\uf9fa\u5fc3\u640f\u904e\u7de9\u7684\u9996\u9078\u85e5\u7269\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u809d\u6027\u8166\u75c5\u8b8a(hepatoencephalopathy)\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u4f7f\u7528 flumazenil \u6cbb\uf9c1\u53ef\u80fd\u6709\u6548\u3002 (B)Asterixis \u5e38\u5728\u7b2c\u4e00\u968e\u6bb5\u809d\u6027\u8166\u75c5\u8b8a\u51fa\u73fe\u3002 (C)\u8840\u6c28\u6fc3\ufa01\u8207\u809d\u6027\u8166\u75c5\u8b8a\u56b4\u91cd\u7a0b\ufa01\u7121\u4e00\u81f4\u6027\u3002 (D)\u809d\u6027\u8166\u75c5\u8b8a\u56b4\u91cd\u7a0b\ufa01\u548c\u8166\u810a\u9ad3\u6db2\u4e2d glutamine \u6fc3\ufa01\u6709\u5bc6\ufa00\u76f8\u95dc\u3002 (E)\u8840\u6c28\u7a7f\u8d8a blood\uff0dbrain barrier \u5f8c\u5f62\u6210\u4e4b glutamine \u4ee5\u53ca tryptophan \u7b49\u7269\u8cea\uff0c\u5c0d\u65bc\u809d\u6027\u8166\u75c5\u8b8a\u4e4b\u8868\u73fe\u626e\u6f14\u91cd\u8981\u89d2\u8272\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u65bc\u5152\u7ae5\u7684\u8178\u5957\u758a(intussusception)\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u53ef\u4ee5\u56e0\u70ba Meckel diverticulum\u3001\u8178\u606f\u8089\u3001\uf9f5\u5df4\u7624\uff0c\u6216\uf962\u7269\u800c\u7522\u751f\u3002 (B)\u53ef\u4f7f\u7528\u92c7\u5291\u704c\u8178\u6cbb\uf9c1\uff0c\u6210\u529f\uf966\u4f4d\u4e4b\u5f8c\uff0c\u53ef\uf9f7\u5373\u51fa\u9662\u56de\u5bb6\u3002 (C)\u597d\u767c\uf98e\u9f61\u7d04\u70ba\u4e09\u500b\u6708\u81f3\uf9d1\u6b72\uff0c\u7537\uf981\u6bd4\u7d04\u70ba 4\uff1a1\u3002 (D)\u5e38\ufa0a\u7684\u75c7\uf9fa\u70ba\u9593\u6b47\u6027\u7684\u8179\u75db\uff0c\u51fa\u73fe currant jelly stool \u5df2\u662f\u5f8c\u671f\u7684 \u8868\u73fe\u3002 (E)\u6700\u5e38\ufa0a\u7684\u578b\u614b\u662f ileocolic intussusception\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u76f4\u817f\u64e1\u9ad8\u8a66\u9a57(straight leg raising test)\u7684\u6558\u8ff0\uff0c\u5176\u4e2d\uf967\u5305\u62ec\u4e0b\uf99c\u90a3 \u4e00\u9805\uff1f", + "Options": "(A)\u76f4\u817f\u64e1\u9ad8\u8a66\u9a57\u967d\u6027\u8868\u793a\ufa19\u7d93\u6839\u53d7\u5230\u58d3\u8feb\u3002 (B)\u76f4\u817f\u64e1\u9ad8\u53ea\u6709\u8907\u88fd\u51fa\u8170\u80cc\u75db\u548c\u5927\u817f\u5f8c\u5074\u75bc\u75db\uff0c\uf967\u8db3\u4ee5\u69cb\u6210\u8a72\u8a66\u9a57\u4e4b \u967d\u6027\u7d50\u679c\u3002 (C)\u60a3\u8005\u4ef0\u81e5\u3001\u4f38\u819d\u3001\u88ab\u52d5\u64e1\u9ad8\u60a3\u5074\u4e0b\u80a2\uff0c70\u00b0 \u5167\u51fa\u73fe\u5750\u9aa8\ufa19\u7d93\u75db\ufa07\u5c04 \u5230\u819d\u95dc\u7bc0\u4ee5\u4e0b\u7a31\u70ba\u540c\u5074\u76f4\u817f\u64e1\u9ad8\u8a66\u9a57\u967d\u6027\u3002 (D)\u5c0d\u5074\u76f4\u817f\u64e1\u9ad8\u8a66\u9a57\uff0c\u5c0d\u8a3a\u65b7\u690e\u9593\u76e4\u7a81\u51fa\u6240\u81f4\u4e4b\ufa19\u7d93\u6839\u53d7\u58d3\u7279\uf962\u6027\u8f03 \u9ad8\u3002 (E)\u5c0d\u5074\u76f4\u817f\u64e1\u9ad8\u8a66\u9a57\uff0c\u5c0d\u8a3a\u65b7\u690e\u9593\u76e4\u7a81\u51fa\u6240\u81f4\u4e4b\ufa19\u7d93\u6839\u53d7\u58d3\u654f\u611f\ufa01\u8f03 \u9ad8\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6bd2\u5316\u707d\u7684\u9632\u8b77\u88dd\u5099\uff0c\u4ee5\u4e0b\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)A \u7d1a\u9632\u8b77\u88dd\u5099\uff0c\u5305\u62ec\u81ea\u651c\u5f0f\u7a7a\u6c23\u74f6\u52a0\u4e0a\u5168\u8eab\u9632\u6f51\u6ffa\u7684\u5316\u5b78\u9632\u8b77\u8863\u3002 (B)B \u7d1a\u9632\u8b77\u88dd\u5099\u53ef\u4ee5\u4fdd\u8b77\u4eba\u54e1\u5728\u7f3a\u6c27\u4e4b\u74b0\u5883\u4e0b\u5de5\u4f5c\u3002 (C)C \u7d1a\u9632\u8b77\u88dd\u5099\uff0c\u5305\u62ec N95 \u9762\u7f69\u52a0\u4e0a\u5168\u8eab\u9632\u6f51\u6ffa\u7684\u5316\u5b78\u9632\u8b77\u8863\u3002 (D)B \u7d1a\u9632\u8b77\u88dd\u5099\u662f\u4e00\u822c\u91ab\uf9c1\u4eba\u54e1\u5c0d\u5316\u707d\u75c5\u4eba\u9032\ufa08\u91ab\uf9c1\u8a3a\u6cbb\ufa08\u70ba\u6642\uff0c\u61c9 \u7a7f\u8457\u4e4b\u88dd\u5099\u3002 (E)\u6d88\u9632\u8863\u52a0\u4e0a\u81ea\u651c\u5f0f\u7a7a\u6c23\u74f6\uff0c\u76f8\u7576\u65bc B \u7d1a\u7684\u9632\u8b77\u88dd\u5099\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6d88\u5316\u9053\u51fa\u8840\u6642\u4ee5\u9f3b\u80c3\u7ba1\u8655\u7f6e\u7684\u89c0\uf9a3\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u7591\u4f3c\u4e0b\u6d88\u5316\u9053\u51fa\u8840\u7684\u60a3\u8005\uf967\u5fc5\u653e\u7f6e\u9f3b\u80c3\u7ba1\u3002 (B)\u653e\u7f6e\u9f3b\u80c3\u7ba1\u5f88\u53ef\u80fd\u5f15\u8d77\u60a3\u8005\u975c\u8108\u66f2\u5f35\u7834\uf9a0\u51fa\u8840\uff0c\u61c9\u5118\u53ef\u80fd\u907f\u514d\u3002 (C)\u5f9e\u809b\u9580\u6392\u51fa\u9bae\u7d05\u8272\u8840\uf965\uff0c\u51fa\u8840\u6e90\u982d\u5fc5\u5b9a\u5728\u4e0b\u6d88\u5316\u9053\u3002 (D)\u9f3b\u80c3\u7ba1\u5f15\uf9ca\u7269\u4e26\u7121\uf962\u5e38\u6642\u4ecd\uf967\u80fd\u6392\u9664\u4e0a\u6d88\u5316\u9053\u51fa\u8840\u3002 (E)\u4e0a\u6d88\u5316\u9053\u51fa\u8840\u6642\u61c9\u4ee5\u51b0\u6c34\u4f5c\u9f3b\u80c3\u7ba1\u6c96\u6d17\uff0c\u56e0\u70ba\u5be6\u8b49\u91ab\u5b78\u986f\u793a\u4f4e\u6eab\u53ef \u6709\u52a9\u65bc\u6b62\u8840\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u9ad8\u6d77\u62d4\u75c7\u5019\u7fa4(high-altitude syndromes)\u7684\u63cf\u8ff0\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u9280\u674f\u53ef\u80fd\u53ef\u4ee5\u7528\uf92d\u9810\u9632\u6025\u6027\u9ad8\u5c71\u75c5\u3002 (B)\u6025\u6027\u9ad8\u5c71\u75c5\u6700\u4e3b\u8981\u7684\u6cbb\uf9c1\u662f\uf9f7\u5373\u4e0b\u5c71\u53ca\u7d66\u4e88\u6c27\u6c23\uff0c\u4e26\u7d66\u4e88\u53e3\u670d acetazolamide 125 mg \u4e00\u5929\uf978\u6b21\u3002 (C)\u9ad8\u6d77\u62d4\u80ba\u6c34\u816b(high-altitude pulmonary edema)\u662f\u5f88\u56b4\u91cd\u7684\u4f75\u767c \u75c7\uff0c\u61c9\uf9f7\u5373\u4e0b\u5c71\uff0c\u7d66\u6c27\u8207 nifedipine \u53e3\u670d\u6cbb\uf9c1\u3002 (D)\u5feb\u901f\u767b\u4e0a\u9ad8\u5c71\u6642\uff0c\uf974\u51fa\u73fe\u982d\u75db\u8207\u5614\u5410\uff0c\u61c9\u9ad8\ufa01\u61f7\u7591\u70ba\u6025\u6027\u9ad8\u5c71\u75c5\u3002 (E)\u9ad8\u6d77\u62d4\u75c7\u5019\u7fa4\u7684\u81f4\u75c5\u6a5f\u8f49\uff0c\u53ef\u80fd\u70ba\u9ad8\u5c71\u4f4e\u58d3\u8207\u4f4e\u8840\u6c27\uff0c\u7522\u751f\u8166\u90e8\u8840 \u7ba1\u6536\u7e2e\uff0c\u9032\u800c\u4f7f\u8166\u8840\uf9ca\u4e0b\ufa09\uff0c\u6700\u5f8c\u9020\u6210\u9ad8\u6d77\u62d4\u8166\u6c34\u816b(high-altitude cerebral edema)\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u96fb\u64ca\u50b7\u5bb3(electric injury)\u7684\u63cf\u8ff0\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u906d\u4ea4\uf9ca\u96fb\u64ca\u50b7\u6642\uff0c\u5982\u679c\u96fb\uf9ca\u9054 18\uff0d30 milliamperes (mA)\uff0c\u5373\u53ef\u80fd \u9020\u6210\u547c\u5438\u6291\u5236\u3002 (B)\u906d\u4ea4\uf9ca\u96fb\u64ca\u50b7\u6642\u5982\u679c\u96fb\uf9ca\u9054\u5230 70 mA \u4ee5\u4e0a\uff0c\u5373\u53ef\u80fd\u9020\u6210\u5fc3\u5ba4\u986b\u52d5\u3002 (C)\u906d\u9ad8\u58d3\u96fb(600\uff0d70,000 volts)\u7684\u4ea4\uf9ca\u96fb\u96fb\u64ca\u50b7\u6642\uff0c\u5fc3\u81df\u505c\u6b62\u7684\u6700 \u521d\u7684\u5fc3\uf9d8\u6bd4\u8f03\u5e38\ufa0a\u7684\u662f\u5fc3\u5ba4\u986b\u52d5\u3002 (D)\u906d\u9583\u96fb\u96fb\u64ca\u50b7\u6642\uff0c\u5fc3\u81df\u505c\u6b62\u7684\u6700\u521d\u5fc3\uf9d8\u6bd4\u8f03\u5e38\ufa0a\u7684\u662f asystole\u3002 (E)\u9ad8\u58d3\u96fb\u96fb\u64ca\u50b7\u6bd4\u9583\u96fb\u96fb\u64ca\u50b7\u8f03\u5e38\u9020\u6210\u808c\u7403\u86cb\u767d\uf9bd\u8207\u814e\u8870\u7aed\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u8f15\ufa01\u5275\u50b7\u6027\u8166\u640d\u50b7(traumatic brain injury)\u982d\u90e8\u96fb\u8166\u65b7\u5c64\u7684\u9069\u61c9\u75c7\uff0c \u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u5931\u61b6\u7684\u75c7\uf9fa\u3002 (B)\u5c40\u90e8\ufa19\u7d93\u5b78\uf962\u5e38\u5fb5\u5019\u3002 (C)\u610f\uf9fc\uf967\u6e05\u6216\u7672\u7647\u767c\u4f5c\u3002 (D)\u982d\uf9c5\u53ca\u5641\u5fc3\u3002 (E)\u51dd\u8840\u529f\u80fd\uf962\u5e38\u7684\u75c5\u53f2\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6f5b\u6c34\u6025\u75c7\u7684\u63cf\u8ff0\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u4e00\u822c\u800c\u8a00\u4f11\u9592\u6f5b\u6c34\u54e1\u80cc\u5f8c\u651c\u5e36\u7d14\u6c27\u7684\u6c23\u74f6\u4e0b\u6c34\u9032\ufa08\u6f5b\u6c34\uff0c\u7d71\u8a08\u4e0a\u55ae \u65e5\u591a\u6b21\u6f5b\u6c34\u9060\u6bd4\u55ae\u65e5\u55ae\u6b21\u6f5b\u6c34\u8f03\uf9e0\u7522\u751f\u6f5b\u6c34\u6025\u75c7\uff0c\u5982\uff1a\u6e1b\u58d3\u75c5 (decompression sickness)\u3002 (B)\u5982\u679c\u60a8\u6f5b\u6c34\u5f8c\u611f\u5230\u95dc\u7bc0\u75bc\u75db\uff0c\u81f3\u91ab\u9662\u6025\u8a3a\u5c31\u8a3a\uff0cX \u5149\u6aa2\u67e5\u7121\u95dc\u7bc0\u9aa8 \u6298\u6216\u75c5\u8b8a\uff0c\u5247\u60a8\u53ef\u80fd\u5f97\u5230\u7b2c\u4e8c\u578b\u6e1b\u58d3\u75c5\uff0c\u6b64\u6642\u6700\u91cd\u8981\u7684\u6cbb\uf9c1\u70ba\u9ad8\u58d3 \u6c27\u6cbb\uf9c1\u3002 (C)\u9032\ufa08\u55ae\u65e5\u55ae\u6b21\u4f11\u9592\u6f5b\u6c34\uff0c\u5728\u6700\u5f8c\u4e00\u6b21\u6f5b\u6c34\u5f8c\u81f3\u5c11\u8981\u9593\u9694 12 \u5c0f\u6642\u518d \u642d\u98db\u6a5f\u3002\u5982\u679c\u9032\ufa08\u4e00\u5929\u591a\u6b21\u7121\u9650\u5236\u6df1\ufa01\u7684\u6f5b\u6c34\uff0c\u6700\u597d\u5728\u6700\u5f8c\u4e00\u6b21\u6f5b \u6c34\u9593\u9694 24 \u5c0f\u6642\u5f8c\u518d\u642d\u98db\u6a5f\u3002 (D)\u7b2c\u4e00\u578b\u6e1b\u58d3\u75c5\u6bd4\u7b2c\u4e8c\u578b\u56b4\u91cd\uff0c\u5bb9\uf9e0\u9020\u6210\u810a\u9ad3\u8207\u8166\u90e8\u7684\u50b7\u5bb3\u3002 (E)\u6e1b\u58d3\u75c5\u7684\u81f4\u75c5\u6a5f\u8f49\uff0c\u4e3b\u8981\u662f\u7531\u65bc\u6c27\u6c23\u5806\u7a4d\u5728\u7d44\u7e54\u8207\u8840\u7ba1\u7cfb\u7d71\u4e2d\u9020\u6210 \u963b\uf96c\u8207\u767c\u708e\u53cd\u61c9\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u71b1\u4e2d\u6691(heatstroke)\u7684\u76f8\u95dc\u63cf\u8ff0\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u71b1\u4e2d\u6691\u7684\u5178\u578b\u5b9a\u7fa9\u70ba\u51fa\u73fe\u4e2d\u5fc3\u9ad4\u6eab\u9ad8\u65bc 39 \u2103\u3001\u4e2d\u6a1e\ufa19\u7d93\u7cfb\u7d71\u529f\u80fd \u5931\u8abf\u8207\u6c92\u6709\u51fa\u6c57(anhidrosis)\u3002 (B)\u71b1\u4e2d\u6691\u5f15\u8d77\u809d\u81df\u53d7\u50b7\u5f88\u5e38\ufa0a\uff0c\u809d\u81df\u9175\u7d20\u53ef\u80fd\u6703\u4e0a\u5347\uff0c\u53ef\u4ee5\u5354\u52a9\u9451\u5225 \u8a3a\u65b7\u71b1\u4e2d\u6691\u8207\u71b1\u8870\u7aed\u3002 (C)\u71b1\u4e2d\u6691\u75c5\u60a3\u901a\u5e38\u5728\u521d\u671f\u53ef\u5f15\u8d77\u9ad8\u8840\u9240\uff0c\u665a\u671f\u53ef\u51fa\u73fe\u4f4e\u8840\u9240\u3002 (D)\u71b1\u4e2d\u6691\u7684\u6cbb\uf9c1\uff0c\u53ef\u7528\u51b0\u6c34\u5feb\u901f\ufa09\u6eab\u3002 (E)\u904b\u52d5\u578b(exertional)\u8207\u975e\u904b\u52d5\u578b(nonexertional)\u71b1\u4e2d\u6691\u7684\uf9f6\u5e8a\u75c7 \uf9fa\u3001\u5fb5\u8c61\u8207\u6cbb\uf9c1\u5747\uf967\u540c\uff0c\u9ad4\u6eab\u8d8a\u9ad8\u7684\u71b1\u4e2d\u6691\u9020\u6210\u7684\u6b7b\u4ea1\uf9db\u8d8a\u9ad8\u3002", + "Answer": "B\u3001D" + }, + { + "\ufeffQuestion": "\uf953\u819c\u7a4d\u6c34\u7684\u6aa2\u67e5\uf969\u64da\u4e2d\uff0c\u4f55\u8005\u6700\u80fd\u652f\u6301 empyema \u7684\u8a3a\u65b7\uff1f", + "Options": "(A)\uf953\u819c\u7a4d\u6c34\u548c\u8840\u6e05\u7684\u5168\u86cb\u767d\u6fc3\ufa01\u6bd4\u503c\u70ba 0.6\u3002 (B)\uf953\u819c\u7a4d\u6c34\u548c\u8840\u6e05\u7684 lactate dehydrogenase \u6fc3\ufa01\u6bd4\u503c\u70ba 0.4\u3002 (C)\uf953\u819c\u7a4d\u6c34\u7684 pH \u70ba 6.5\u3002 (D)\uf953\u819c\u7a4d\u6c34\u7684\u767d\u8840\u7403\u8a08\uf969\u70ba 10000 /mm3\u3002 (E)\uf953\u819c\u7a4d\u6c34\u7684\u7d05\u8840\u7403\u8a08\uf969\u70ba 100000 /mm3\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u809d\u786c\u5316\u7684 65 \u6b72\u7537\u6027\u56e0\u80a2\u9ad4\u7d05\u816b\u3001\u75bc\u75db\u4e00\u5929\uf92d\u6025\u8a3a\u3002\u75c5\u4eba\uf978\u5929\u524d\u66fe\u98df\u7528\u751f \u9b5a\u7247\uff0c\u4e00\u5929\u5f8c\u51fa\u73fe\u8179\u7009\u3001\u5168\u8eab\u5026\u6020\u7b49\u75c7\uf9fa\uff0c\u4e4b\u5f8c\u53f3\u8173\u8e1d\u76ae\u819a\u51fa\u73fe\u7d05\u816b\uff0c\u4e26 \u8fc5\u901f\u64f4\u53ca\u5c0f\u817f\uff0c\u4f75\u6709\u6c34\u6ce1\u51fa\u73fe\u53ca\u7d44\u7e54\u58de\u6b7b\u73fe\u8c61\uff0c\u6b64\u6642\u6700\u53ef\u80fd\u4e4b\u81f4\u75c5\u83cc\u70ba \u4f55\uff1f", + "Options": "(A)Non-typhoid salmonella\u3002 (B)Pseudomonas aeruginosa\u3002 (C)Staphylococcus aureus\u3002 (D)Streptococcus pyogenes\u3002 (E)Vibrio vulnificus\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u4f9d\u64da\u300c\u7dca\u6025\u91ab\uf9c1\u6551\u8b77\u6cd5\u300d\uff0c\u6709\u95dc\u91ab\uf9c1\u6307\u5c0e\u91ab\u5e2b\u4e4b\u5de5\u4f5c\uff0c\u4e0b\uf99c\u654d\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u521d\u7d1a\u6551\u8b77\u6280\u8853\u54e1\u57f7\ufa08\u7dca\u6025\u6551\u8b77\u4e4b\u6559\u80b2\u3001\u8a13\uf996\u3001\u7763\u5c0e\u53ca\u8003\u6838\u3002 (B)\u8a02\u5b9a\u5404\u7d1a\u6551\u8b77\u6280\u8853\u54e1\u54c1\u8cea\u6307\u6a19\u3001\u57f7\ufa08\u54c1\u8cea\u76e3\u6e2c\u3002 (C)\u6838\u7c3d\u9ad8\u7d1a\u6551\u8b77\u6280\u8853\u54e1\u4f9d\u9810\uf9f7\u91ab\uf9c1\uf9ca\u7a0b\u65bd\ufa08\u6551\u8b77\u4e4b\u7d00\uf93f\u8868\u3002 (D)\u5e38\u898f\u7dda\u4e0a\u6307\u5c0e\u6551\u8b77\u6280\u8853\u54e1\u57f7\ufa08\u6551\u8b77\u5de5\u4f5c\u3002 (E)\u9ad8\u7d1a\u6551\u8b77\u6280\u8853\u54e1\u57f7\ufa08\u7dca\u6025\u6551\u8b77\u4e4b\u6559\u80b2\u3001\u8a13\uf996\u3001\u7763\u5c0e\u53ca\u8003\u6838\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u5152\u7ae5\u8650\u5f85\u7684\u75c5\u5fb5\uff0c\u6709\u6642\u5019\u6703\u8207\u5176\u4ed6\u7684\u75be\u75c5\u6df7\u6dc6\u3002\u95dc\u65bc\u975e\u5152\u8650\u7684\u60c5\u6cc1\uff0c\u4e0b\uf99c \u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u71d2\u71d9\u50b7\u53ef\u80fd\u662f\u4e8b\u6545\u50b7\u5bb3\u6240\u5f15\u8d77\uff0c\u5927\u90e8\u4efd\u662f\u71b1\u6c34\u6f51\u7051\u6240\u81f4\uff0c\uf967\u61c9\u8a72\u51fa \u73fe\uf9d0\u4f3c\u9999\u7159\u71d9\u50b7\u7684\u602a\uf962\u5f62\uf9fa\u3002 (B)\u8499\u53e4\u6591(Mongolian spots)\u70ba\uf9d0\u4f3c\u7600\u50b7\u7684\u9752\u7d2b\u6591\uff0c\u8207\u4e00\u822c\u7600\u50b7\u7684\u5dee \u5225\u5728\u65bc\u8499\u53e4\u6591\u6703\u96a8\u6642\u9593\u800c\u6709\u984f\u8272(\u7d2b\u3001\uf93d\u3001\uf923\u3001\u68d5)\u7684\u8b8a\u5316\u3002 (C)\u5e7c\u5152\u6216\u662f\u5b78\u9f61\u7684\u5152\u7ae5\uff0c\u5176\u975e\u5152\u8650\u4e4b\u7600\u50b7\uff0c\u4e00\u822c\u51fa\u73fe\u65bc\u9aa8\u982d\u7a81\u8d77\u4e4b\u8655\uff0c \u5982\uff1a\u5c0f\u817f\u3001\u524d\u984d\uff0c\u4e14\u5927\u90e8\u4efd\u662f\u55ae\u5074\u3002 (D)\u65b0\u751f\u5152\u975e\u5152\u8650\u4e4b\u9aa8\u6298\u5e38\u51fa\u73fe\u65bc\u9396\u9aa8\u3001\u80b1\u9aa8\u3002 (E)\u6210\u9aa8\uf967\u5168(osteogenesis imperfecta)\u662f\u57fa\u56e0\u7f3a\u9677\u6240\u9020\u6210\uff0c\u4e5f\u6642\u5e38\u88ab \u8aa4\u8a8d\u70ba\u5152\u8650\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u6025\u6027\u5fc3\u808c\u6897\uf96c\u4f75\u767c\u56b4\u91cd\u80ba\u6c34\u816b\uff0c\u4e0b\uf99c\u4f55\u8005\u4e4b\u53ef\u80fd\u6027\u6700\u4f4e\uff1f", + "Options": "(A)\u5de6\u5fc3\u5ba4\u524d\u58c1\u5927\u7247\u4e4b ST \u6ce2\u6bb5\u4e0a\u5347\u5fc3\u808c\u6897\uf96c\u3002 (B)\u5927\u7bc4\u570d\u4e4b\u975e ST \u6ce2\u6bb5\u4e0a\u5347\u5fc3\u808c\u6897\uf96c\u3002 (C)\u5de6\u5fc3\u5ba4\u4e0b\u58c1\u5fc3\u808c\u6897\uf96c\u4f75\u767c\u53f3\u5fc3\u5ba4\u6897\uf96c\u3002 (D)\u5de6\u5fc3\u5ba4\u524d\u58c1\u5fc3\u808c\u6897\uf96c\u4f75\u4e8c\u5c16\u74e3\u8171\uf96a\u6216\u4e73\u7a81\u808c\u65b7\uf9a0\u3002 (E)\u5de6\u5fc3\u5ba4\u524d\u58c1\u53ca\u4e2d\u8188\u6897\uf96c\u5c0e\u81f4\u5fc3\u5ba4\u4e2d\u8188\u7834\uf9a0\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u6025\u8a3a\u91ab\u5e2b\u5c0d\u65bc\u4e0b\uf99c\u61f7\u7591\u53d7\ufa06\u5c31\u8a3a\u4eba\u54e1\uff0c\u9664\u91ab\uf9c1\u7167\u8b77\u3001\u6cbb\uf9c1\u3001\u901a\u5831\u4ee5\u5916\uff0c\u4ea6 \u9700\u9a57\u50b7\u63a1\u8a3c\u8207\u958b\uf9f7\u5404\u7a2e\u7279\u6b8a\u8a3a\u65b7\u66f8\u3002\u4f46\u5982\u60a8\u50c5\u662f\u6025\u8a3a\u91ab\u5e2b\uff0c\uf967\u80fd\u8a3a\u65b7\u4f55\u7a2e \u53d7\ufa06\u4eba\u54e1\u548c\u958b\uf9f7\u7279\u6b8a\u8a3a\u65b7\u66f8\uff1f", + "Options": "(A)\u5bb6\u5ead\ufa06\uf98a\u88ab\u5bb3\u4eba\u3002 (B)\u53d7\u8650\u5152\u7ae5\u3002 (C)\u53d7\u8650\u6216\u5bb6\ufa06\u4e4b\uf934\u5148\u751f\u3002 (D)\u6027\ufa06\uf98a\u4fb5\u5bb3\u88ab\u5bb3\u4eba\u3002 (E)\u4ee5\u4e0a\u7686\u975e\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u6821\u5712\u767c\u751f\u706b\u707d\u4e8b\u4ef6\uff0c\u4f60\u662f\u7b2c\u4e00\u500b\u5230\u9054\u73fe\u5834\u7684\u4eba\u54e1\uff0c\u6839\u64da START(simple triage and rapid treatment)\uf9ca\u7a0b\uff0c\u8acb\u554f\u4ee5\u4e0b\u4f55\u8005\u6aa2\u50b7\u5206\uf9d0\u70ba\u9ec3\u8272\uff1f", + "Options": "(A)22 \u6b72\uf981\u6027\uff0c\u547c\u5438\u5feb\u901f\uff0c\u53e3\u9f3b\u6709\u9ed1\u8272\u78b3\uf9f9\u9644\u8457\uff0c\u610f\uf9fc\uf967\u6e05\u3002 (B)21 \u6b72\uf981\u6027\uff0c\u5de6\u5927\u817f\u9aa8\u6298\uff0c\u547c\u5438\u8108\u640f\u6b63\u5e38\uff0c\u610f\uf9fc\u6e05\u695a\u3002 (C)18 \u6b72\uf981\u6027\uff0c\u9a5a\u614c\u5931\u63aa\uff0c\u8dd1\uf92d\u8dd1\u53bb\uff0c\u4e00\u76f4\u54ed\u558a\u6709\u540c\u5b78\u9084\u5728\u6559\u5ba4\uf9e8\u9762\uff0c \u53f3\u624b\u8f15\ufa01\u71d2\u50b7\u3002 (D)25 \u6b72\uf981\u6027\uff0c\u7121\u547c\u5438\uff0c\u81c9\u90e8\u5927\u7247\u71d2\u50b7\u3002 (E)40 \u6b72\uf981\u6027\uff0c\u547c\u5438\u6bcf\u5206\u9418 25 \u4e0b\uff0c\u5fae\u8840\u7ba1\u5145\u586b\u6642\u9593 3 \u79d2\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u6839\u64da\u6c11\u570b 96 \uf98e 7 \u6708\u4fee\u8a02\u7684\ufa1d\ufa19\u885b\u751f\u6cd5\u6240\u5b9a\u7fa9\u7684\ufa1d\ufa19\u75be\u75c5\uff1a\u6307\u601d\u8003\u3001\u60c5 \u7dd2\u3001\u77e5\u89ba\u3001\u8a8d\u77e5\u3001\ufa08\u70ba\u7b49\ufa1d\ufa19\uf9fa\u614b\u8868\u73fe\uf962\u5e38\uff0c\u81f4\u5176\u9069\u61c9\u751f\u6d3b\u4e4b\u529f\u80fd\u767c\u751f\u969c \u7919\uff0c\u9700\u7d66\u4e88\u91ab\uf9c1\u53ca\u7167\u9867\u4e4b\u75be\u75c5\uff1b\u5176\u7bc4\u570d\uf967\u5305\u62ec\u4e0b\uf99c\u4f55\u8005\uff1f", + "Options": "(A)\ufa1d\ufa19\u75c5\u3002 (B)\ufa1d\ufa19\u5b98\u80fd\u75c7\u3002 (C)\u9152\u766e\u3002 (D)\u85e5\u766e\u3002 (E)\u53cd\u793e\u6703\u4eba\u683c\u9055\u5e38\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u75c5\u60a3\u4f7f\u7528\u6c27\u6c23\u7684\u6fc3\ufa01(FiO2)\u70ba 60%\uff0c\u800c\u5176 PaO2 \u70ba 280 mmHg\uff0cPaCO2 \u70ba 40 mmHg\uff0c\u5247\u4f30\u8a08\u75c5\u60a3\u7684 alveolar-arterial oxygen difference (A-a DO2)\u7d04\u70ba\u591a\u5c11 mmHg\uff1f", + "Options": "(A)50 (B)100 (C)150 (D)200 (E)250", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u75c5\u60a3\u8ec0\u5e79\u53ca\u56db\u80a2\ufa26\u6709\u7d05\u8272\u6591\u75b9\u3001\u4e18\u75b9\u53ca\u6c34\u75b1\u75b9\uff0c\u5176\u4e2d\u6709\u8a31\u591a\u76ae\u75b9\u70ba\u9776\uf9fa \u75b9\uff0c\u53c8\u5408\u4f75\u53e3\u8154\u6f70\u760d\u53ca\u773c\u7d50\u819c\u7d05\u816b\u3002\u4ee5\u4e0b\u8a3a\u65b7\u4f55\u8005\u6700\u6709\u53ef\u80fd\uff1f", + "Options": "(A)\u53f2\u5e1d\u6587\u5f37\u751f\u75c7\u5019\u7fa4(Stevens-Johnson syndrome)\u3002 (B)\uf9d0\u5929\u76b0\u7621(bullous pemphigoid)\u3002 (C)\u81bf\u75b1\u6027\u4e7e\u766c(pustular psoriasis)\u3002 (D)\u5c0b\u5e38\u5929\u76b0\u7621(pemphigus vulgaris)\u3002 (E)\u76b0\u75b9\u6027\u76ae\u819a\u708e(dermatitis herpertiformis)\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u7f3a\u8840\u6027\u8166\u4e2d\u98a8\u7684\u75c5\u60a3\u56e0\u8166\u90e8\u53d7\u5f71\u97ff\u7684\u5340\u57df\uf967\u540c\uff0c\u51fa\u73fe\u7684\uf9f6\u5e8a\u75c7\uf9fa\u4e5f\uf967\u76e1\u76f8 \u540c\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u5c0f\u8166\u6897\uf96c\u5e38\u6703\u9020\u6210\u7a81\u767c\u6027\u7121\u6cd5\u7ad9\uf9f7\u6216\u8d70\uf937\uff0c\u4f46\uf967\u6703\u51fa\u73fe\u8166\ufa19\u7d93\u7684\uf962 \u5e38\u3002 (B)\u4e2d\u5927\u8166\u52d5\u8108\u6897\uf96c\u6703\u9020\u6210\u5c0d\u5074\u80a2\u9ad4\u7121\uf98a(\u4e0a\u80a2\u8f03\u4e0b\u80a2\u56b4\u91cd)\u53ca\u9ebb\u6728\u611f\u3002 (C)\u524d\u5927\u8166\u52d5\u8108\u6897\uf96c\u9020\u6210\u5c0d\u5074\u80a2\u9ad4\u7121\uf98a(\u4e0b\u80a2\u8f03\u4e0a\u80a2\u56b4\u91cd)\u53ca\u8f15\u5fae\u7684\u611f \u89ba\u7f3a\u640d\u3002 (D)\u5f8c\u5927\u8166\u52d5\u8108\u6897\uf96c\u6703\u9020\u6210\u982d\uf9c5\u3001\u7729\uf9c5\u3001\u8907\u8996\u53ca\u904b\u52d5\u5931\u8abf\u7b49\u75c7\uf9fa\u3002 (E)\u57fa\u5e95\u52d5\u8108\u6897\uf96c\u6703\u9020\u6210\u56b4\u91cd\u7684\u56db\u80a2\u7671\u7613\u3001\u660f\u8ff7\u53ca\u9589\u9396\u75c7\u5019\u7fa4(locked-in syndrome)\uff0c\u9589\u9396\u75c7\u5019\u7fa4\u7684\u75c5\u60a3\u9664\uf9ba\u773c\u775b\u53ef\u4ee5\u5411\u4e0a\u79fb\u52d5\u4e4b\u5916\uff0c\u5168\u8eab \u808c\u8089\u7686\u7671\u7613\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u9aa8\u6298\u5f8c\u767c\u751f\u7f3a\u8840\u6027\u58de\u6b7b(avascular necrosis)\u7684\u597d\u767c\u4f4d\u7f6e\uff0c\u4e0b\uf99c\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u821f\uf9fa\u9aa8(scaphoid)\u9aa8\u6298\u3002 (B)\u80a1\u9aa8\u982d(femoral head)\u9aa8\u6298\u3002 (C)\u80a1\u9aa8\u9838(femoral neck)\u9aa8\u6298\u3002 (D)\u9ad5\u9aa8(patella)\u9aa8\u6298\u3002 (E)\u8ddd\u9aa8\u9838(talus neck)\u9aa8\u6298 Hawkins \u5206\uf9d0\u7b2c\u4e8c\u578b\u8207\u7b2c\u4e09\u578b\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u61f7\u5b55\u5a66\uf981\u767c\u751f\u8178\u963b\uf96c\u6642\uff0c\u6700\u5e38\ufa0a\u4e4b\u539f\u56e0\u70ba\u4e0b\uf99c\u4f55\u8005\uff1f", + "Options": "(A)\u8178\u5957\u758a(intussusception)\u3002 (B)\u76f2\u8178\u626d\u7d50(cecal volvulus)\u3002 (C)\u4e59\uf9fa\u7d50\u8178\u626d\u7d50(sigmoid volvulus)\u3002 (D)\u4e59\uf9fa\u7d50\u8178\u816b\u7624(sigmoid tumor)\u3002 (E)\u4e59\uf9fa\u7d50\u8178\u7cde\u77f3\u963b\uf96c(sigmoid bezoars)\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u61f7\u5b55\u9031\uf969 26 \u9031\u5a66\uf981\u5fc3\u81df\u505c\u6b62\u6642\uff0c\u95dc\u65bc\u6025\u6551\u7684\u6558\u8ff0\uff0c\u4e0b\uf99c\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u56e0\u5176\u6c23\u7ba1\u8f03\u70ba\u6c34\u816b\uff0c\u63d2\u7ba1\u8f03\u70ba\u56f0\u96e3\uff0c\u6240\u4ee5\u9700\u9078\u64c7\u5c0f\u534a\u865f\u7684\u6c23\u7ba1\u5167\u7ba1\u3002 (B)\u4f9d\u7167\u73fe\ufa08\u9ad8\u7d1a\u5fc3\u81df\u6551\u547d\u8853\u6307\u5f15\u9032\ufa08\u6025\u6551\u3002 (C)\u70ba\u907f\u514d\u5f71\u97ff\u5fc3\u81df\u6309\u58d3\u53ca\u547c\u5438\u9053\u5efa\uf9f7\uff0c\u53ef\u9078\u64c7\u7f6e\u653e\u80a1\u975c\u8108\u5c0e\u7ba1\uff0c\u7d66\u4e88 \u975c\u8108\u8f38\u6db2\u3002 (D)\u5c07\u75c5\u60a3\u53f3\u5074\u9ad6\u90e8\u53ca\u8170\u90e8\u588a\u9ad8\uff0c\u907f\u514d\u4e3b\u52d5\u8108\u53ca\u4e0b\u8154\u975c\u8108\u53d7\u5230\u58d3\u8feb\u3002 (E)\u9808\u7dca\u6025\u7167\u6703\u5a66\u7522\u79d1\u53ca\u65b0\u751f\u5152\u79d1\u91ab\u5e2b\uff0c\u5728\u6bcd\u89aa\u505c\u6b62\u5fc3\u8df3 5 \u5206\u9418\u5167\u57f7 \ufa08\u7dca\u6025\u5256\u8179\u7522\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u95dc\u65bc Boerhaave syndrome \u4e4b\u6558\u8ff0\u4e0b\uf99c\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u7672\u7647\u767c\u4f5c\u53ef\u8a98\u767c\u6b64\u75c7\u5019\u7fa4\u3002 (B)\u5e38\ufa0a\u4fb5\u72af\u65bc\u9060\u7aef\u98df\u9053\u3002 (C)\u5e38\u767c\u751f\u5728\u559d\u9152\u4e4b\u5f8c\u3002 (D)\u5e38\u5c0e\u81f4\u53f3\u5074\uf953\u819c\u7a4d\u6db2\u3002 (E)\u81f4\u75c5\u6a5f\u8f49\u70ba\u77ac\u9593\u98df\u9053\u5167\u9ad8\u58d3\u5c0e\u81f4\u98df\u9053\u5168\u5c64\u7834\uf9a0\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u95dc\u65bc end-tidal CO2 \u7684\uf969\u503c\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u9805\u932f\u8aa4\uff1f", + "Options": "(A)\u6162\u6027\u963b\uf96c\u6027\u80ba\u75c5\u8b8a\u7684\u75c5\u60a3\uff0c\u6b64\uf969\u503c\u548c PaCO2 \u7684\uf969\u503c\u5dee\uf962\u8b8a\u5927\u3002 (B)\u9032\ufa08\u5fc3\u80ba\uf966\u7526\u8853\u6642\uff0c\u75c5\u60a3\u6062\uf966\u8108\u640f\u524d\uff0c\u6b64\uf969\u503c\u5c31\u6703\u5148\u5347\u9ad8\u3002 (C)\u75c5\u60a3\u6ce8\u5c04 sodium bicarbonate \u5f8c\uff0c\u6b64\uf969\u503c\u6703\u77ed\u66ab\u5347\u9ad8\u3002 (D)\u6c23\u7ba1\u63d2\u7ba1\u6642\uf974\u8aa4\u63d2\u81f3\u98df\u9053\uff0c\u5247\u6b64\uf969\u503c\u504f\u4f4e\u3002 (E)\u6b63\u5e38\u4eba\u7684\uf969\u503c\u7d04\u548c PaCO2 \u76f8\u7b49\u4f46\u7a0d\u9ad8\u4e00\u9ede\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u95dc\u65bc hypertensive emergencies \u4e4b\u6558\u8ff0\uff0c\u4e0b\uf99c\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u9ad8\u8840\u58d3\u8166\u75c5\u8b8a(hypertensive encephalopathy)\u4fc2\u8840\u58d3\u8d85\u904e\u8166\u8840\u7ba1\u81ea \u6211\u8abf\u63a7\u4e4b\u4e0a\u9650\u6240\u5c0e\u81f4\u4e4b\u5927\u8166\u904e\ufa01\u704c\uf9ca(cerebral hyperperfusion)\u53ca \u8840\u8166\u5c4f\u969c\u5931\u8861(loss of the integrity of blood\uff0dbrain barrier)\uff0c\u7d50\u679c \u9020\u6210\u8166\u6c34\u816b\u53ca\u53b2\u5bb3\u7684\u8166\u8840\u7ba1\u6536\u7e2e\u3002 (B)\u9ad8\u8840\u58d3\u8166\u75c5\u8b8a\u4e4b\u6cbb\uf9c1\u61c9\u8a2d\u6cd5\u4ee5\u85e5\u7269\u5c07\u8840\u58d3\ufa09\u81f3 110/70 mmHg \u5de6\u53f3\u3002 (C)\u85e5\u7269\u4e4b\u9078\u64c7\u53ef\u4ee5\u975c\u8108\u6ef4\u6ce8 nitroprusside \u9054\u5230\u8f03\u5feb\u901f\ufa09\u58d3\u7684\u6548\u679c\u3002 (D)Angiotensin-converting enzyme inhibitor \u61c9\u907f\u514d\u4f7f\u7528\u65bc\u814e\u529f\u80fd\uf967\u4f73 \u4e4b\u75c5\u60a3\u53ca\u5b55\u5a66\u3002 (E)\uf974\u75c5\u60a3\u5408\u4f75\u6709\u4e3b\u52d5\u8108\u525d\uf9ea\uff0c\u6b32\u4f7f\u7528\u975c\u8108\u6ef4\u6ce8 nitroprusside \u6642\u61c9\u4f75 \u7528 \u03b2-blocker \u4ee5\u907f\u514d\u53cd\u5c04\u6027\u5fc3\u640f\u904e\u901f(reflex tachycardia)\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u95dc\u65bc neurogenic shock \u7684\u7279\u5fb5\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u5fc3\u8df3\uf967\u5feb\u3002 (B)\u76ae\u819a\u4e7e\u6eab\u3002 (C)\u8840\u58d3\ufa09\u4f4e\u3002 (D)\u80a2\u9ad4\u6eab\u6696\u3002 (E)\u8108\u58d3(pulse pressure)\u8b8a\u7a84\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u95dc\u65bc testicular torsion\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)Testicular torsion \uf967\u53ea\u767c\u751f\u65bc\u6709\u6fc0\uf99f\u6d3b\u52d5\u4e4b\u5f8c\uff0c\u5373\u4f7f\u65bc\u7761\u7720\u4e2d\u4ea6\u53ef \u80fd\u767c\u751f\u3002 (B)\u767c\u751f testicular torsion \u6642\uff0ccremasteric reflex \u61c9\u70ba\u9670\u6027\u3002 (C)\u53ef\u7528 Doppler ultrasound \uf92d\u78ba\u8a3a\uff0c\u53ef\ufa0a\u60a3\u5074\u8840\uf9ca\u6e1b\u5c11\u3002 (D)\u767c\u751f\u53f3\u5074 testicular torsion \u6642\uff0c\u5728\u958b\u5200\u524d\u53ef\u8003\u616e\u5f92\u624b\u56de\uf966\u60a3\u5074\u776a \u4e38\uff0c\u65b9\u6cd5\u70ba\u7ad9\u5728\u4ef0\u8eba\u7684\u75c5\u4eba\u8173\u524d\uff0c\u4ee5\u9806\u6642\u9418\u65b9\u5411\u626d\u8f49\u5176\u53f3\u5074\u776a\u4e38 540 \u3002\u3002 (E)\u767c\u751f testicular torsion \u6642\uff0c\u5176\u75bc\u75db\uf967\u6703\u96a8\u75c5\u4eba\u59ff\u52e2\u6539\u8b8a\u800c\u6709\u7a0b\ufa01\u4e0a \u7684\u5dee\uf962\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u4e59\uf9fa\u7d50\u8178\u626d\u7d50(sigmoid volvulus)\u7684\u8a3a\u65b7\u53ca\u6cbb\uf9c1\uff0c\u4e0b\uf99c\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u5927\u8178\u5167\u8996\u93e1\u53ef\u770b\u5230\u5728\u5927\u8178\u9ecf\u819c\u6709\uf911\u65cb\uf9fa\u62ec\u7d04\u808c\u4f3c\u7684\u626d\u8f49(spiral sphincter\uff0dlike twist)\u3002 (B)\u5728 barium enema study \u5178\u578b\u7279\u5fb5\u53ef\ufa0a\u9ce5\u5634(bird\u2019s beak)\u3002 (C)\u96fb\u8166\u65b7\u5c64\u8a3a\u65b7\u5177\u6709\u9ad8\ufa01\u6e96\u78ba\uf9db\uff0c\u5927\u90e8\u5206\u8a3a\u65b7\ufa26\u9700\u8981\u505a\u96fb\u8166\u65b7\u5c64\u3002 (D)\u5982\u679c\u8178\u9053\u662f\u5065\u5eb7\u7684\uff0c\u6c92\u6709\u58de\u6b7b\uff0c\u53ef\u4f7f\u7528 endoscopic decompression \uff0c \u8178\u9053\u53ef\u81ea\ufa08\u53bb\u626d\u8f49(self-detorsion)\u3002 (E)\u7d04\uf9d1\u6210\u6703\uf966\u767c\uff0c\u5efa\u8b70\u5728\u6025\u6027\u671f\u7de9\u89e3\u5f8c\uff0c\u5c07\u591a\u9918\u4e59\uf9fa\u7d50\u8178\u9078\u64c7\u6027\ufa00\u9664 (elective resection)\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u4e0b\uf99c\u81f4\u75c5\u83cc\u5f15\u8d77\u80ba\u708e\u7684\u6558\u8ff0\uff0c\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)Mycoplasma pneumoniae \u6703\u6709\u8178\u80c3\u75c7\uf9fa\u3002 (B)Pneumococcus \u4ecd\u662f\u6700\u5e38\ufa0a\u7684\u81f4\u75c5\u83cc\u3002 (C)Staphylococcus aureus \u597d\u767c\u5728\u6709\u6162\u6027\u80ba\u90e8\u75be\u75c5\u3002 (D)Streptococcus pneumoniae \u597d\u767c\u5728\uf934\uf98e\u4eba\u548c 2 \u6b72\u4ee5\u4e0b\u5b69\u7ae5\u3002 (E)Klebsiella \u6703\u5f62\u6210\u80ba\u7a7a\ufa05\u548c\u5927\uf96e\u6027\u6d78\u6f64\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u53e3\u670d\u6297\u51dd\u8840\u5291 warfarin \u7684\u8655\u7f6e\uff0c\u4e0b\uf99c\u4f55\u8005\u8f03\u6070\u7576\uff1f", + "Options": "(A)International normalized ratio(INR)2\uff0d3\uff0c\u7e7c\u7e8c\u76e3\u6e2c activated partial thromboplastin time \u5373\u53ef\u3002 (B)INR \uff1c 5\uff0c\u7121\u660e\u986f\u51fa\u8840\uff0c\u66ab\u505c warfarin \u7684\u4f7f\u7528\u81f3 INR \u56de\u5230\u6b63\u5e38 \u7bc4\u570d\u3002 (C)INR 5\uff0d9\uff0c\u7121\u660e\u986f\u51fa\u8840\uff0c\u8f38\u6ce8\u65b0\u9bae\uf92e\u51cd\u8840\u6f3f\u3002 (D)INR \uff1e 9\uff0c\u7121\u660e\u986f\u51fa\u8840\uff0c\u53cd\u8986\u975c\u8108\u6ce8\u5c04 vitamin K1\u3002 (E)INR \uff1e 20\uff0c\u7121\u660e\u986f\u51fa\u8840\uff0c\u66ab\u505c warfarin \u7684\u4f7f\u7528\u5373\u53ef\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u4e2d\u6a1e\u578b\u548c\u9031\u908a\u578b\u7729\uf9c5\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f ", + "Options": "(A)\u9031\u908a\u578b\u7729\uf9c5\u4e00\u822c\u6301\u7e8c\u6642\u9593\u8f03\u77ed\uff0c\u800c\u4e2d\u6a1e\u578b\u7684\u75c7\uf9fa\u53ef\u80fd\u9577\u9054\uf969\u9031\u81f3\uf969 \u6708\u3002 (B)\u4e00\u822c\u800c\u8a00\uff0c\u9031\u908a\u578b\u7729\uf9c5\u7684\u75c7\uf9fa\u6bd4\u8f03\u6703\u53d7\u982d\u90e8\u59ff\u52e2\u5f71\u97ff\uff0c\u800c\u4e2d\u6a1e\u578b\u8f03 \u5c11\u3002 (C)\u901a\u5e38\u9031\u908a\u578b\u7729\uf9c5\u7684\u75c7\uf9fa\u8f03\u8f15\u5fae\uff0c\u800c\u4e2d\u6a1e\u578b\u7684\u75c7\uf9fa\u8f03\u5f37\uf99f\u3002 (D)\u773c\u9707\u5728\u9031\u908a\u578b\u7729\uf9c5\u901a\u5e38\u662f\u55ae\u65b9\u5411\u7684\uff0c\u800c\u5728\u4e2d\u6a1e\u578b\u7729\uf9c5\u5247\u53ef\u80fd\u70ba\u6c34\u5e73\u3001 \u74b0\u578b\u6216\u5782\u76f4\u3002 (E)\u9031\u908a\u578b\u7729\uf9c5\uf967\u6703\u4f75\u6709\u5176\u4ed6\ufa19\u7d93\u75c7\uf9fa\uff0c\u4f46\u4e2d\u6a1e\u578b\u7684\u6709\u53ef\u80fd\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5fc3\u5305\u819c\u7a4d\u6db2\u7684\u6558\u8ff0\uff0c\u4e0b\uf99c\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u53ef\u80fd\u7684\u75c5\u56e0\u5305\u62ec\u5fc3\u5305\u819c\u708e\u3001\u7532\uf9fa\u817a\u529f\u80fd\u4f4e\u4e0b\u3001\u764c\u75c7\u3001\uf9bd\u6bd2\u75c7\u3001\u5fc3\u81df \u8154\u5ba4\u7834\uf9a0\u3001\u5275\u50b7\u7b49\u3002 (B)\u5178\u578b\u7684\uf9f6\u5e8a\u8868\u5fb5\u70ba\u4f4e\u8840\u58d3\u3001\u975c\u8108\uf960\u5f35\uff0c\u53ca\u9059\u9060\u3001\u4f4e\u6c89\u7684\u5fc3\u97f3(muffled heart sound)\uff0c\uf974\u6c92\u6709\u51fa\u73fe\u9019\u4e9b\u8868\u5fb5\uff0c\u5373\u53ef\u6392\u9664\u6025\u6027\u5fc3\u5305\u819c\u7a4d\u6db2\u3002 (C)\uf974\u6025\u6027\u80f8\u75db\u75c5\u60a3\u7a81\u7136\u660f\u53a5\u4e14\u8840\u58d3\u7a81\u7136\u6e2c\uf97e\uf967\u5230\uff0c\u5e8a\u908a\u8d85\u97f3\u6ce2\u767c\u73fe\u4e2d \uf97e\u4e4b\u5fc3\u5305\u819c\u7a4d\u6db2\uff0c\u61c9\u8003\u616e\u5fc3\u808c\u6897\uf96c\u4f75\u5fc3\u808c\u7834\uf9a0\u6216\u4e3b\u52d5\u8108\u525d\uf9ea\u3002 (D)\uf974\u8840\u58d3\u504f\u4f4e\uff0c\u6cbb\uf9c1\u4e0a\u9996\u5148\u61c9\u7d66\u4e88\u975c\u8108\u8f38\u6db2\u4ee5\u589e\u9032\u53f3\u5fc3\u7684\u58d3\uf98a\uff0c\u514b\u670d \u5fc3\u5305\u819c\u7a4d\u6db2\u7684\u58d3\u8feb\u3002 (E)\uf974\u5df2\u51fa\u73fe\u5fc3\u5305\u819c\u586b\uf96c\uff0c\u800c\u4ee5\u91dd\u62bd\u5438\u53c8\u7121\u6cd5\u5f15\uf9ca\u51fa\u7a4d\u6db2\uff0c\u5247\u61c9\u8003\u616e\u4ee5 \u624b\u8853\u65b9\u5f0f\u5c07\u5fc3\u5305\u819c\u6253\u958b(pericardiotomy)\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u4e3b\u52d5\u8108\u525d\uf9ea\u7684\u8a3a\u65b7\uff0c\u4e0b\uf99c\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u4e26\u975e\u6240\u6709\u75c5\u60a3\u5747\u4ee5\u80f8\u75db\u4e26\u8f49\u79fb\u81f3\u80cc\u90e8\u6b64\u4e00\u5178\u578b\u75c7\uf9fa\u8868\u73fe\u3002 (B)\uf98e\u7d00\u8f03\u5927\u4e4b\u9ad8\u8840\u58d3\u60a3\u8005\u5e38\u8207\u4e3b\u52d5\u8108\u7684\u7ca5\uf9fa\u52d5\u8108\u786c\u5316\u75c5\u7076\u76f8\u95dc\uff0c\uf974\uf98e \u7d00\u8f15\u8005\u61c9\u8003\u616e\u662f\u5426\u6709 Marfan syndrome \u3002 (C)\uf9e4\u5b78\u6aa2\u67e5\u4e0a\u61c9\u6ce8\u610f\u56db\u80a2\u8108\u640f\u5f37\u5f31\u662f\u5426\u5c0d\u7a31\uff0c\uf974\uf967\u78ba\u5b9a\u662f\u5426\u5c0d\u7a31\uff0c\u53ef \u9032\u4e00\u6b65\u6e2c\uf97e\u56db\u80a2\u8840\u58d3\u4ee5\u5224\u5225\u5de6\u53f3\u5074\u4e4b\u5dee\uf962\u3002 (D)\uf974\uf9e4\u5b78\u6aa2\u67e5\u65bc\u807d\u8a3a\u6642\uff0c\u5728\u80f8\u9aa8\u53f3\u5074\u4e0a\u65b9\u807d\u5230\u4e00\u8212\u5f35\u671f\u96dc\u97f3\uff0c\u61c9\u8003\u616e \u4e3b\u52d5\u8108\u525d\uf9ea\u81f3\u4e3b\u52d5\u8108\u57fa\u90e8\uff0c\u5c0e\u81f4\u4e3b\u52d5\u8108\u74e3\u9589\u5408\uf967\u5168\u3002 (E)\u80f8\u90e8 X \u5149\u6aa2\u67e5\u70ba\u6700\u91cd\u8981\u7684\u5224\u5b9a\u4f9d\u64da\uff0c\uf974\u80f8\u7e31\u8188\u8154\u7121\u64f4\u5927\u8b8a\u5bec\u4e4b\u60c5 \u5f62\uff0c\u5247\u53ef\u6392\u9664\u4e3b\u52d5\u8108\u525d\uf9ea\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5916\u50b7\u6027\u8840\u80f8(traumatic hemothorax)\uff0c\u4e0b\uf99c\u4f55\u8005\uf967\u662f\u7dca\u6025\u958b\u80f8\u624b\u8853 (urgent thoracotomy)\u7684\u9069\u61c9\u75c7\uff1f", + "Options": "(A)\u80f8\u7ba1\u5f15\uf9ca\u4e00\u6b21\u5f15\uf9ca\uf97e\u5927\u65bc 1500 \u6beb\u5347\u3002 (B)\u80f8\u7ba1\u5f15\uf9ca\uf97e\u6bcf\u5c0f\u6642\u5927\u65bc 200 \u6beb\u5347\uff0c\u4e14\u6301\u7e8c 3 \u5c0f\u6642\u4ee5\u4e0a\u3002 (C)\u75c5\u60a3\u7d93\u8f38\u6db2\u8f38\u8840\u6cbb\uf9c1\u5f8c\u4ecd\u6301\u7e8c\u6709\u4f11\u514b\u73fe\u8c61\uff0c\u4e14\u5df2\u6392\u9664\u5176\u4ed6\u90e8\u4f4d\u7684\u51fa \u8840\u3002 (D)\u75c5\u60a3\u80f8\u90e8 X \u5149\u5408\u4f75\u6709\u5927\uf97e\u6c23\u80f8\uff0c\u4e14\u53ef\u770b\u5230\u6c23\u7ba1\u504f\u79fb\u3002 (E)\u75c5\u60a3\u8ffd\u8e64\u7684\u80f8\u90e8 X \u5149\u5448\u73fe\u8840\u80f8\uf97e\u660e\u986f\u589e\u52a0\uff0c\u4e14\u75c5\u60a3\u5c0d\u8f38\u6db2\u6cbb\uf9c1\u53cd \u61c9\uf967\u4f73\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5916\u50b7\u75c5\u60a3\u7684\u521d\u7d1a\u8a55\u4f30\u53ca\u5176\u5c0d\u61c9\u7684\u8655\u7f6e\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u547c\u5438\u9053\u7684\u4fdd\u8b77\u5305\u62ec\u6253\u958b\u547c\u5438\u9053\u4f7f\u5176\u66a2\u901a\uff0c\u5982\u770b\u5f97\ufa0a\uf962\u7269\u5247\u5c07\u5176\u79fb \u9664\uff0c\uf967\u9700\u8003\u616e\u9838\u690e\u56fa\u5b9a\u3002 (B)\u610f\uf9fc\u6e05\u695a\u7684\u75c5\u60a3\uff0c\u61c9\u7d66\u4e88\u53e3\uf99e\u547c\u5438\u9053\uff0c\u4ee5\u907f\u514d\u820c\u982d\u5f8c\u5012\u3002 (C)\u75c5\u60a3\u6709\u5f35\uf98a\u6027\u6c23\u80f8\u7684\u8868\u73fe\uff0c\u61c9\u99ac\u4e0a needle decompression\uff0c\uf967\u53ef\u7b49 \u5f85\u3002 (D)\u75c5\u60a3\u6709\u5fc3\u5305\u819c\u586b\uf96c\u7684\u8868\u73fe\u6642\uff0c\u61c9\u5f85\u521d\u7d1a\u8a55\u4f30\u5f8c\uff0c\u65bc\u6b21\u7d1a\u8a55\u4f30\u6642\u518d\u7d66 \u4e88\u8655\u7f6e\u3002 (E)\u5faa\u74b0\uf967\u4f73\u7684\u75c5\u60a3\uff0c\u61c9\u5148\u5efa\uf9f7\u4e2d\u592e\u975c\u8108\u5c0e\u7ba1\u7d66\u4e88\u8f38\u6db2\uff0c\u5982\u6253\uf967\u4e0a\u518d\u7d66 \u4e88\uf978\u689d large-bore catheter \u9032\ufa08\u975c\u8108\u8f38\u6ce8\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5b55\u5a66\u5408\u4f75\u5176\u4ed6\u75be\u75c5\u7684\u6cbb\uf9c1\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u5b55\u5a66\u5408\u4f75\u7532\uf9fa\u817a\u4ea2\u9032\u6642\uff0c\u6703\u6709\u767c\u751f\u5b50\u7672\u524d\u75c7\u7684\u5371\u96aa\u3002 (B)\u5b55\u5a66\u4f75\u767c\u7532\uf9fa\u817a\u98a8\ufa06\u6642\uff0c\uf967\u53ef\u4f7f\u7528\u653e\u5c04\u6027\u7898\u6cbb\uf9c1\u3002 (C)\u5b55\u5a66\u767c\u751f\u9ad8\u8840\u58d3\u6025\u75c7\u6642\uff0c\u53ef\u4f7f\u7528 captopril \u53ca furosemide \u6cbb\uf9c1\u3002 (D)\u5b55\u5a66\u767c\u751f\u9663\u767c\u6027\u5fc3\u5ba4\u4e0a\u5fc3\u640f\u904e\u901f\u6642\uff0c\u53ef\u5b89\u5fc3\u4f7f\u7528 verapamil \u6cbb\uf9c1\u3002 (E)\u5b55\u5a66\u767c\u751f\u5fc3\u623f\u986b\u52d5\u6642\uff0c\u53ef\u7528\u4f4e\u5206\u5b50\uf97e\u809d\u7d20\u6cbb\uf9c1\u9632\u6b62\u8840\u6813\u5f62\u6210\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6b63\u5e38\u61f7\u5b55\u7684\u751f\uf9e4\u8b8a\u5316\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u767d\u8840\u7403\uf969\u76ee\u589e\u52a0\uff0c\u8840\u7d05\u7d20\u6fc3\ufa01\u6e1b\u5c11\u3002 (B)\u5168\u8eab\u8840\uf97e\u589e\u52a0\uff0c\u5fc3\u81df\u8f38\u51fa\u589e\u52a0\u3002 (C)\u6536\u7e2e\u58d3\u53ca\u8212\u5f35\u58d3\u7686\ufa09\u4f4e\uff0c\u4f46\u8212\u5f35\u58d3\ufa09\u4f4e\u8f03\u591a\u3002 (D)\u547c\u5438\u901f\ufa01\u8b8a\u5feb\uff0c\u6f6e\u6c23\u5bb9\u7a4d\u589e\u52a0\u3002 (E)\u8f03\u5927\u7684\u5931\u8840\uf97e\u624d\u6703\u51fa\u73fe\u9031\u908a\u704c\uf9ca\uf967\u8db3(\u4f11\u514b)\u7684\u5fb5\u8c61\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8840\u7ba1\u6813\uf96c(transarterial embolization)\u6cbb\uf9c1\u7684\u6642\u6a5f\uff0c\uf967\u5305\u62ec\u4e0b\uf99c\u4f55\u9805\uff1f", + "Options": "(A)\u4e0a\u80a2\u9aa8\u6298\u5408\u4f75\u8840\u7ba1\u50b7\u5bb3\u3002 (B)\u8179\u90e8\u920d\u632b\u50b7\uff0c\u8840\u58d3\uf967\u7a69\u5b9a\uff0c\u96fb\u8166\u65b7\u5c64\u767c\u73fe\u6709\u5927\u7bc4\u570d\u809d\u5be6\u8cea\u640d\u50b7\uff0c\u5408 \u4f75\u986f\u5f71\u5291\u5916\u6ef2\u3002 (C)\u8179\u90e8\u920d\u632b\u50b7\uff0c\u8840\u58d3\u7a69\u5b9a\uff0c\u96fb\u8166\u65b7\u5c64\u767c\u73fe\u6709\u813e\u81df\u986f\u5f71\u5291\u5916\u6ef2\u3002 (D)\u814e\u81df\u50b7\u5bb3\u6301\u7e8c\u51fa\u8840\u8207\u8840\uf9bd\uff0c\u8840\u816b\u53ea\u5c40\u9650\u5728 perirenal space\uff0c\u672a\u50b7\u53ca \u96c6\uf9bd\u7cfb\u7d71(collecting system)\u3002 (E)\u9aa8\u76c6\u9aa8\u6298\u75c5\u60a3\uff0c\u8840\u58d3\u975e\u5e38\uf967\u7a69\u5b9a\uff0c\u4e14\u5c40\u90e8\u8840\u816b\u8fc5\u901f\u64f4\u5927\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u4e8b\u6545\u6307\u63ee\u7cfb\u7d71(incident command system)\uff0c\u4ee5\u4e0b\u654d\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u6307\u63ee\u67b6\u69cb\u53ef\u5206\u6210\u4e94\u5927\u529f\u80fd\uff0c\u5305\u542b\u6307\u63ee\u3001\u5b89\u5168\u3001\u57f7\ufa08\u3001\u8a08\u5283\u4ee5\u53ca\u5f8c\u52e4\u3002 (B)\u76e3\u7763\u8005\u8207\u4e0b\u5c6c\u7684\u4eba\uf969\u6bd4\uf9b5\uff0c\u5efa\u8b70\u662f 1\uff1a8 \u8f03\u70ba\u5408\u9069\u3002 (C)\u5b89\u5168\u5b98\u9664\uf9ba\u8981\u78ba\u4fdd\u6551\u707d\u53ca\u707d\u96e3\u53d7\u5bb3\u8005\u4e4b\u5b89\u5168\u5916\uff0c\u540c\u6642\u8981\u5b9a\u671f\u5411\u5a92\u9ad4 \u767c\u4f48\u76f8\u95dc\u8a0a\u606f\u3002 (D)\u88fd\u4f5c\u50b7\u5bb3\u6216\u640d\u5bb3\u8a18\uf93f\uff0c\uf967\u662f\u5f8c\u52e4\u90e8\u9580\u7684\u4efb\u52d9\u3002 (E)\u6307\u63ee\u5b98\u5fc5\u9808\u5c0d\u6240\u6709\u707d\u96e3\ufa26\u6709\u975e\u5e38\u5c08\u696d\u7684\uf9ba\u89e3\uff0c\u5426\u5247\uf967\u80fd\u64d4\u4efb\u6307\u63ee\u5b98\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5152\u7ae5\u75c5\u6bd2\u6027\u54ee\u543c(viral croup)\u4e4b\u8655\u7f6e\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u60a3\u8005\uf974\u6709 idiopathic hypertrophic subaortic stenosis\uff0c\u4f7f\u7528 L-epinephrine \u5b89\u5168\u6027\u6709\u9867\u616e\u6642\uff0c\u9700\u4f7f\u7528 monitor \u76e3\u6e2c\u3002 (B)\u63a5\u53d7 epinephrine nebulization \u6cbb\uf9c1\u7684\u60a3\u8005\uff0c\u6cbb\uf9c1\u5f8c\u81f3\u5c11\u9700\u5728\u6025\u8a3a \u5ba4\u89c0\u5bdf 3 \u5c0f\u6642\u3002 (C)\u63a5\u53d7 epinephrine nebulization \u6cbb\uf9c1\u7684\u60a3\u8005\uff0c\u61c9\u540c\u6642\u63a5\u53d7\uf9d0\u56fa\u9187\u6cbb \uf9c1\u3002 (D)\u53e3\u670d dexamethasone \u4e26\uf967\u5efa\u8b70\u7528\u65bc croup \u7684\u6cbb\uf9c1\u3002 (E)\uf974\u60a3\u8005\u6574\u9ad4\u5916\u89c0\u8f15\u9b06\uff0c\u50c5\u6fc0\u52d5\u54ed\u9b27\u6642\u7522\u751f stridor \u8072\u97f3\uff0c\u53ef\u4ee5\uf967\u7528 epinephrine nebulization \u6cbb\uf9c1\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u80ba\u81bf\u760d(lung abscess)\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u53ad\u6c27\u83cc\u6240\u5f15\u8d77\u7684\u80ba\u81bf\u760d\u5e38\u5e38\u5305\u542b\u4e00\u7a2e\u4ee5\u4e0a\u7684\u83cc\u7a2e\u3002 (B)\u80ba\u81bf\u760d\u4e4b\u6cbb\uf9c1\u4ee5\u5916\u79d1\u624b\u8853\u70ba\u4e3b\uff0c\u76e1\u65e9\ufa00\u9664\u53ef\u6709\u6548\u7e2e\u77ed\u6297\u751f\u7d20\u4e4b\uf9c1\u7a0b\u3002 (C)\u6bd4\u8f03\u5bb9\uf9e0\u767c\u751f\u5728\u4e0b\u80ba\uf96e\u4e4b basal segments\u3002 (D)\u5bb9\uf9e0\u767c\u751f pulmonary aspiration \u7684\u60a3\u8005\u4e5f\u5bb9\uf9e0\u767c\u751f\u80ba\u81bf\u760d\u3002 (E)\u5927\u7d04 1/3 \u7684\u80ba\u81bf\u760d\u75c5\u60a3\u6703\u4f75\u767c\uf953\u819c\u8154\u7a4d\u81bf(empyema)\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6025\u6027\u80f0\u81df\u708e\u4e4b\u8a3a\u65b7\u548c\u6cbb\uf9c1\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)Amylase \u4e0a\u5347\u5feb\uff0c\u534a\u8870\u671f\u77ed\uff0c\u56e0\u6b64 36 \u5c0f\u6642\u5f8c\u654f\u611f\ufa01\u4e0b\ufa09\u3002 (B)Amylase \u548c lipase \u7684\uf969\u503c\u9ad8\u4f4e\u8ddf\u75be\u75c5\u7684\u56b4\u91cd\ufa01\u7121\u95dc\u3002 (C)\u5728 amylase \u6062\uf966\u81f3\u6b63\u5e38\u503c\u5f8c\uff0clipase \u5347\u9ad8\u4e4b\uf969\u503c\u4ecd\u53ef\u7dad\u6301\uf969\u5929\u3002 (D)\uf974 Ranson score \u2265 3 \u5206\uff0c\u6216 APACHE II \u2265 8 \u5206\uff0c\u4ee3\u8868\u56b4\u91cd \u7684\u6025\u6027\u80f0\u81df\u708e\uff0c\u9810\u5f8c\u8f03\u5dee\u3002 (E)\u8179\u90e8\u96fb\u8166\u65b7\u5c64\u53ef\u7528\uf92d\u8a55\u4f30\u56b4\u91cd\ufa01\uff0c\uf974\u96fb\u8166\u65b7\u5c64\u70ba\u6b63\u5e38\u53ef\u6392\u9664\u6025\u6027\u80f0 \u81df\u708e\u8a3a\u65b7\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6025\u6027\u75db\u98a8\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u662f\u4e00\u7a2e\u7d50\u6676\u8a98\u767c\u4e4b\uf904\u819c\u708e\u3002 (B)\u53ef\u8a98\u767c\u75db\u98a8\u7684\u85e5\u7269\u5305\u62ec\u963f\u65af\u5339\uf9b3\u3001\uf9dd\uf9bd\u5291\u3001\u74b0\u5b62\uf9b3\u7d20(cyclosporine)\u3002 (C)\u8840\u6e05\u4e2d\u9ad8\uf9bd\u9178\u6fc3\ufa01\u662f\u8a3a\u65b7\u75db\u98a8\u7684\u5fc5\u8981\u689d\u4ef6\u3002 (D)\u975e\uf9d0\u56fa\u9187\u6297\u708e\u85e5\u7269\u662f\u6cbb\uf9c1\u6025\u6027\u75db\u98a8\u7684\u9996\u9078\u7528\u85e5\u3002 (E)\u4e26\uf967\u9f13\uf97f\u4f7f\u7528\u975c\u8108\u6ce8\u5c04\u79cb\u6c34\u4ed9\u7d20\u6cbb\uf9c1\u75db\u98a8\uff0c\u5176\u56b4\u91cd\u526f\u4f5c\u7528\u5305\u62ec\u9aa8\u9ad3 \u6291\u5236\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6025\u6027\u6703\u53ad\u708e(epiglottitis)\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f ", + "Options": "(A)\u53ef\u80fd\u9020\u6210\u6025\u6027\u4e14\u7121\u6cd5\u9810\u671f\u4e4b\u547c\u5438\u9053\u963b\uf96c\u3002 (B)\uf974\u70ba\u7d30\u83cc\u9020\u6210\u8005\uff0c\u5e38\ufa0a\u7684\u83cc\u7a2e\u4e4b\u4e00\u70ba Haemophilus influenzae type A\u3002 (C)\u75c5\u4eba\u5e38\u6703\u5448\u73fe\u5411\u524d\u50be\u659c\uff0c\u5f35\u5634\uff0c\u982d\u90e8\u4f38\u5f35\u4e4b\u59ff\u52e2\u3002 (D)\u9838\u90e8\u5074\u9762 X \u5149\u53ef\ufa0a\u5230\u6703\u53ad\u816b\u5927\u5448\u59c6\u6307\u5370(thumbprinting)\u4e4b\u5f62\uf9fa\u3002 (E)\u53ef\u4f7f\u7528\uf9d0\u56fa\u9187\uf92d\u6e1b\u5c11\u547c\u5438\u9053\u767c\u708e\u53ca\u6c34\u816b\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6025\u6027\u8f38\u8840\u53cd\u61c9(acute transfusion reaction)\u7684\u8655\u7f6e\uff0c\u4e0b\uf99c\u4f55\u8005\u8f03\u6070\u7576\uff1f", + "Options": "(A)\uf974\u8f38\u8840\u6642\u767c\u751f\u8541\u9ebb\u75b9\uff0c\u7d55\uf967\u53ef\u518d\u7e7c\u7e8c\u8f38\u8840\u3002 (B)\uf974\u8f38\u8840\u6642\u767c\u71d2\uff0c\u5fc5\u662f\u8f38\u8840\u7684\u53cd\u61c9\uff0c\uf967\u6703\u662f\u611f\u67d3\u9020\u6210\u7684\u3002 (C)\u767c\u751f\u6025\u6027\u8840\u7ba1\u5167\u6eb6\u8840\u53cd\u61c9\u6642\uff0c\u7d55\uf967\u53ef\u518d\u7e7c\u7e8c\u8f38\u8840\u3002 (D)\u56e0\u8f38\u8840\u53cd\u61c9\uf967\u53ef\u9810\u671f\uff0c\u56e0\u6b64\u4e00\u958b\u59cb\u5373\u53ef\u4ee5\u6700\u5feb\u901f\ufa01\u8f38\u8840\u3002 (E)\uf974\u8f38\u8840\u6642\u767c\u71d2\u53ea\u9700\u4ee5 diphenhydramine \u6cbb\uf9c1\u5373\u53ef\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6025\u901f\u8996\uf98a\uf9b9\u5316\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u7db2\u819c\u4e2d\u592e\u52d5\u8108\u963b\uf96c\uff0c\u901a\u5e38\u6703\u4f34\u96a8\u773c\u775b\u75bc\u75db\u3002 (B)\u61f7\u7591\u8996\ufa19\u7d93\u708e\uff0c\u61c9\u7d66\u4e88\u53e3\u670d\uf9d0\u56fa\u9187\u6cbb\uf9c1\u3002 (C)\u6025\u6027\u9685\u89d2\u9589\u9396\u6027\u9752\u5149\u773c\uff0c\u5e38\ufa0a\u77b3\u5b54\u7e2e\u5c0f\uff0c\u5c0d\u5149\u7121\u53cd\u61c9\u3002 (D)\u773c\u5e95\u6aa2\u67e5\u767c\u73fe cherry-red spot\uff0c\u662f\u7db2\u819c\u4e2d\u592e\u975c\u8108\u963b\uf96c\u7684\u7279\u5fb5\u3002 (E)\uf974\u8996\uf98a\uf9b9\u5316\u8d77\u56e0\u65bc\u9873\u52d5\u8108\u708e\uff0c\u53e6\u4e00\u773c\u7684\u8996\uf98a\u4e5f\u53ef\u80fd\u5728\u5e7e\u5929\u5230\u5e7e\u661f\u671f \u9593\uf9b9\u5316\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6c23\u5598\u5728\u61f7\u5b55\u5a66\uf981\u7684\u63cf\u8ff0\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u5927\u7d04\u6709\u4e09\u5206\u4e4b\u3127\u7684\u6c23\u5598\u75c5\u60a3\uff0c\u5728\u61f7\u5b55\u6642\u6703\uf9b9\u5316\u3002 (B)\u5c16\u5cf0\u5410\u6c23\uf9ca\uf97e\uf969\u503c\u5728\u61f7\u5b55\u6642\u4e26\u6c92\u6709\u591a\u5927\u6539\u8b8a\uff0c\u53ef\u4ee5\u4f5c\u70ba\u75be\u75c5\u56b4\u91cd\ufa01 \u7684\u8a55\u4f30\u53ca\u6cbb\uf9c1\u6307\u5f15\u3002 (C)\u6025\u6027\u767c\u4f5c\u6642\uff0c\u5438\u5165\u6027\u4e59\u578b\u814e\u4e0a\u817a\u7d20\u63a5\u53d7\u5668\u4f5c\u7528\u5291\u70ba\u4e3b\u8981\u7684\u6cbb\uf9c1\u9078\u64c7\u3002 (D)\u63a7\u5236\uf97c\u597d\u7684\u6c23\u5598\uff0c\u5176\u6cbb\uf9c1\u9810\u5f8c\u548c\u4e00\u822c\u75c5\u60a3\u4e00\u6a23\uff0c\u4e5f\uf967\u6703\u589e\u52a0\u80ce\u5152\u7684 \u5371\u5bb3\u3002 (E)\u61f7\u5b55\u5a66\uf981\u53ef\u4ee5\u4f7f\u7528\u5438\u5165\u578b\uf9d0\u56fa\u9187\u88fd\u5291\uff0c\u4f46\uf967\u5b9c\u4f7f\u7528\u53e3\u670d\uf9d0\u56fa\u9187\u85e5\u7269\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6c23\u5598\u7684\u6cbb\uf9c1\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u4e59\u578b\u814e\u4e0a\u817a\u7d20\u63a5\u53d7\u5668\u4f5c\u7528\u5291\u6703\u4f7f\u652f\u6c23\u7ba1\u64f4\u5f35\u3002 (B)Theophylline \u662f\u6cbb\uf9c1\u6025\u6027\u6c23\u5598\u7684\u7b2c\u4e00\u7dda\u85e5\u7269\u3002 (C)\u5728\u5230\u9662 1 \u5c0f\u6642\u5167\u7d66\u8207\uf9d0\u56fa\u9187\u6cbb\uf9c1\uff0c\u53ef\u4ee5\u6e1b\u5c11\u4f4f\u9662\uf9db\u3002 (D)\u975c\u8108\u6ce8\u5c04\uf9ce\u9178\u9382\u53ef\u6cbb\uf9c1\u6025\u6027\u56b4\u91cd\u7684\u6c23\u5598\u3002 (E)\uf9d0\u56fa\u9187\u7684\u6297\u767c\u708e\u6548\u679c\u5728\u6cbb\uf9c1\u5f8c 4\uff0d8 \u5c0f\u6642\u51fa\u73fe\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u9152\ufa1d\u6212\u65b7\u75c7\u5019\u7fa4\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u75c7\uf9fa\u5728\u505c\u6b62\u559d\u9152\u4e4b\u5f8c 6\uff0d24 \u5c0f\u6642\u51fa\u73fe\u3002 (B)\u75c7\uf9fa\u53ef\u80fd\u6301\u7e8c 2\uff0d7 \u5929\u5de6\u53f3\u3002 (C)\u6703\u51fa\u73fe\u8996\u5e7b\u89ba\u53ca\u807d\u5e7b\u89ba\u3002 (D)\u8840\u58d3\u4e0a\u5347\u4e14\u5fc3\u8df3\u8b8a\u5feb\u3002 (E)\u610f\uf9fc\u6539\u8b8a\u4e3b\u8981\u662f\u4ee5\u55dc\u7761\u70ba\u4e3b\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5e38\ufa0a\u8fb2\u85e5\u4e2d\u6bd2\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u75c5\u4eba\u559d\u4e0b\uf967\u660e\u8fb2\u85e5\uff0c1\uff0d2 \u5929\u5f8c\u7522\u751f\u53e3\u8154\u7c98\u819c\u6f70\u760d\uff0c\u8981\u8003\u616e\u5df4\uf925\u5208 (paraquat)\u4e2d\u6bd2\u3002 (B)\u6c28\u57fa\u7532\u9178\u9e7d(carbamate)\u4e2d\u6bd2\uff0c\u56e0\u5176\u7121\u6cd5\u901a\u904e\u8840\u8166\u5c4f\u969c(blood-brain barrier)\uff0c\u6545\u5f88\u5c11\u767c\u751f seizure \u3002 (C)\u9664\u87f2\u83ca\ufa1d(pyrethrin)\u6703\u4f5c\u7528\u5728\ufa19\u7d93\u7d30\u80de\u819c\u4e0a\u9209\uf9ea\u5b50\u901a\u9053\uff0c\uf967\u65b7\u91cd \u8907\uf9ff\u6fc0\uff0c\u6700\u5f8c\u5c0e\u81f4\u5176\u50b3\u5c0e\u969c\u7919\u3002 (D)\u5609\u78f7\uf96c(glyphosate)\u7684\u6bd2\u6027\u4e3b\u8981\u662f\u8207\u5176\u6240\u542b\u7684\u8868\u9762\u64f4\u5f35\u5291 (surfactant)\u6709\u95dc\u3002 (E)\u5df4\uf925\u5208(paraquat)\u4e2d\u6bd2\uff0c\u65e9\u671f\u6642\u53ef\u4f7f\u7528\u8840\u6db2\u900f\u6790(hemodialysis) \u79fb\u9664\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u773c\u7403\u7834\uf9a0\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)BB \u5f48\u3001\u97ad\u70ae\u5c51\u6216\u5272\u8349\u6a5f\u5f48\u8d77\u7684\u5c0f\u6728\u584a\uff0c\u5747\u6709\u53ef\u80fd\u7a7f\u7834\u773c\u7403\u3002 (B)\u773c\u7403\u7834\uf9a0\u5e38\ufa0a\u7684\u8868\u73fe\uff0c\u5305\u62ec\u524d\u623f\u8b8a\u6dfa\u3001\u7a4d\u8840\u3001\u77b3\u5b54\u5f62\uf9fa\uf967\u898f\u5247\u3001\u8996 \uf98a\u660e\u986f\uf9b9\u5316\u7b49\u3002 (C)\u61f7\u7591\u773c\u7403\u7834\uf9a0\u6642\uff0c\u61c9\u6e2c\uf97e\u773c\u58d3\u3002 (D)\u61f7\u7591\u773c\u7403\u7834\uf9a0\u6642\uff0c\u61c9\u6ce8\u5c04\u7834\u50b7\u98a8\uf9d0\u6bd2\u7d20\u6216\u514d\u75ab\u7403\u86cb\u767d\uff0c\u548c\u975c\u8108\u6ce8\u5c04 \u6297\u751f\u7d20\u3002 (E)\u61f7\u7591\uf962\u7269\u7a7f\u7834\u773c\u7403\u6642\uff0c\u61c9\u7167 Water\u2019s view \u6216 orbital CT\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8f15\u5fae\u7684\u982d\u90e8\u5916\u50b7\u75c5\u60a3\uff0c\u4e0b\uf99c\u4f55\u8005\uf967\u7b26\u5408 Canadian CT head rule \u5efa\u8b70 \u9032\ufa08\u96fb\u8166\u65b7\u5c64\u7684\u9069\u61c9\u75c7\uff1f", + "Options": "(A)75 \u6b72\uf934\u5148\u751f\u9a0e\u8173\u8e0f\uf902\uff0c\u88ab\uf937\u4e0a\u7684\u77f3\u982d\u7d46\u5012\u5f8c\u8dcc\u5012\u649e\u5230\u982d\uff0c\u982d\u76ae\u6709 \u7d04 4 \u516c\u5206\u6495\uf9a0\u50b7\uff0c\u610f\uf9fc\u6e05\u695a\uff0cGCS 15\u3002 (B)22 \u6b72\u5927\u5b78\u751f\u6253\u6392\u7403\u6642\u88ab\u6253\u5230\u982d\uff0c\u982d\u76ae\u7121\u660e\u986f\u8840\u816b\uff0c\u610f\uf9fc\u6e05\u695a GCS 15\uff0c\u73fe\u89ba\u982d\uf9c5\uff0c\u6c92\u6709\u5614\u5410\u3002 (C)2 \u6b72\u5c0f\u5b69\u81ea\uf94c\u68af\u4e0b\u6efe\u4e0b\uf92d(\u7d04 60 \u516c\u5206\u9ad8)\uff0c\u982d\u76ae\u7121\u660e\u986f\u8840\u816b\uff0c\uf92d \u6025\u8a3a\u524d\u5728\u5bb6\u4e2d\u5410\uf9ba 5 \u6b21\uff0c\u73fe\u8f03\u55dc\u7761\u3002 (D)45 \u6b72\u7537\u6027\u9152\u5f8c\u9a0e\u6a5f\uf902\u81ea\u6454\uff0c\u6c92\u6709\u6234\u5b89\u5168\u5e3d\uff0c\u610f\uf9fc\u6e05\u695a GCS 15\uff0c\u53f3 \u773c\u660e\u986f\u718a\u8c93\u773c(raccoon eye)\u3002 (E)33 \u6b72\uf981\u6027\u6a5f\uf902\u4e58\u5ba2\uff0c\u6709\u6234\u5b89\u5168\u5e3d\uff0c\u88ab\u6642\u901f 80 \u516c\uf9e9\u7684\u8ca8\uf902\u5074\u649e\u5f8c \u98db\u51fa\u53bb\uff0c\u5168\u8eab\u591a\u8655\u64e6\u50b7\uff0c\u610f\uf9fc\u6e05\u695a GCS 15\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u92f0\u9e7d\u4e2d\u6bd2\u7684\u8655\uf9e4\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u53ef\u4f7f\u7528\u5f37\u8feb\uf9dd\uf9bd\u65b9\u6cd5\uf92d\u589e\u52a0\u92f0\u9e7d\u7684\u6392\u6cc4\u3002 (B)\u75c5\u60a3\u5982\u7522\u751f seizure \uff0c\u53ef\u4f7f\u7528 phenytoin \u6cbb\uf9c1\u3002 (C)\u6025\u6027\u4e2d\u6bd2\u6642\uff0c\u5982\u9700\u8840\u6db2\u900f\u6790(hemodialysis)\u6cbb\uf9c1\uff0c\u4f7f\u7528\u918b\u9178\u9e7d\u900f \u6790\u6db2\u6548\u679c\u8f03\u4f73\u3002 (D)\u4f7f\u7528\uf99a\u7e8c\u6027\u900f\u6790\u8f03\uf967\u6703\u6709\u92f0\u9e7d\u6fc3\ufa01\u53cd\u5f48\u56de\u5347\u7684\u554f\u984c\u3002 (E)\u65bd\u4e88\u80c3\u704c\u6d17\uff0c\u4e26\u4f7f\u7528\u6d3b\u6027\u78b3\u5e6b\u52a9\u5438\u9644\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u975c\u8108\u6ce8\u5c04\u986f\u5f71\u5291\u5f15\u8d77\u4e4b\u814e\u6bd2\u6027\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\ufa03\uf9bd\u75c5\u60a3\u8005\u3001\u63a7\u5236\u7a69\u5b9a\u7684\u9ad8\u8840\u58d3\u60a3\u8005\u3001\uf98e\u9f61\u5927\u65bc 70 \u6b72\u4ee5\u4e0a\u8005\uff0c\u5747 \u70ba\u9ad8\u5371\u96aa\u7fa4\u3002 (B)\u5177\u6709\u5371\u96aa\u56e0\u5b50\u8005\uff0c\u61c9\u4f7f\u7528\u975e\uf9ea\u5b50\u6027\u986f\u5f71\u5291\u3002 (C)\u6c23\u5598\u60a3\u8005\u3001\u5177\u6709\u56b4\u91cd\u5fc3\u80ba\u529f\u80fd\u5931\u5e38\u4e4b\u75c5\u4eba\u61c9\u4f7f\u7528\u975e\uf9ea\u5b50\u6027\u986f\u5f71\u5291\u3002 (D)\u8840\u4e2d creatinine \uff1e 3.0 mg/dL \u8005\uff0c\uf967\u5b9c\u4f7f\u7528\uf9ea\u5b50\u6027\u986f\u5f71\u5291\u3002 (E)Blood urea nitrogen 60 mg/dL\uff0c\u8840\u4e2d creatinine 1.55 mg/dL \u4e4b\u75c5\u4eba \uf967\u61c9\u4f7f\u7528\uf9ea\u5b50\u6027\u986f\u5f71\u5291\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u56b4\u91cd\u6c23\u5598\u7684\uf9f6\u5e8a\u8868\u73fe\uff0c\uf967\u5305\u62ec\u4e0b\uf99c\u4f55\u9805\uff1f", + "Options": "(A)\u767c\u7d3a\u3002 (B)Forced expiratory volume in the first second (FEV1)\u53ea\u6709\u9810\u671f\u503c \u7684 25%\u3002 (C)PaCO2 40 mmHg \u3002 (D)SpO2(\u6c27\u6c23\u98fd\u548c\ufa01)90%\u3002 (E)Wheezing \u8072\u97f3\u97ff\uf977\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u5728\u6025\u8a3a\u5ba4\u70ba 5 \u6b72\u5c0f\u5b69\u9032\u884c\u984d\u982d\u6495\u88c2\u50b7\u7e2b\u5408\u624b\u8853\u6642\uff0c\u5c0f\u5b69\u60c5\u7dd2\u6fc0\u52d5\u7121\u6cd5\u914d\u5408\uff0c \u7d93\u9069\u7576\u5b89\u64ab\u4ecd\u7121\u6cd5\u9032\u884c\uff0c\u4e0b\u5217\u6558\u8ff0\uff0c\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u53ef\u7d66\u4e88 midazolam \u56e0\u70ba\u5b89\u5168\u3001\u6709\u6548\uff0c\u4e14\u4f5c\u7528\u6642\u9593\u77ed\u3002 (B)\u53ef\u4f7f\u7528 chloral hydrate\uff0c\u4f46\u85e5\u6548\u7522\u751f\u6162\uff0c\u4e14\u4f5c\u7528\u6642\u9593\u9577\uff0c\u5c0d\u6025\u8a3a\u5ba4\u7684 \u4f7f\u7528\u800c\u8a00\uff0c\u4e26\u4e0d\u662f\u7406\u60f3\u7684\u85e5\u5291\u3002 (C)\u53ef\u4f7f\u7528 ketamine \u808c\u8089\u6ce8\u5c04\uff0c\u7522\u751f\u5408\u4f75\u93ae\u975c\u8207\u6b62\u75db\u7684\u6548\u679c\u3002 (D)ketamine \u4ea6\u53ef\u4f7f\u7528\u65bc 3 \u500b\u6708\u7684\u5b30\u5152\uff0c\u4f46\u8981\u6ce8\u610f\u553e\u6db2\u904e\u591a\uff0c\u9632\u6b62\u547c\u5438 \u9053\u7684\u963b\u585e\u3002 (E)ketamine \u53ef\u5408\u4f75 midazolam \u4f7f\u7528\uff0c\u4ee5\u6e1b\u5c11\u5e7b\u89ba\u7684\u7522\u751f\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u6cbb\u7642\u8178\u75c5\u6bd2\u6642\uff0c\u8981\u8b66\u89ba\u56b4\u91cd\u75c5\u5fb5\u7684\u51fa\u73fe\uff0c\u4ee5\u4e0b\u7684\u75c5\u7a0b\u6558\u8ff0\uff0c\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u8178\u75c5\u6bd2 71 \u578b\u6700\u5bb9\u6613\u5f15\u8d77\u795e\u7d93\u7cfb\u7d71\u7684\u4f75\u767c\u75c7\u3002 (B)\u56b4\u91cd\u75c5\u75c7\u5747\u65bc\u767c\u75c5\u5f8c 14 \u5929\u5167\u51fa\u73fe\uff0c\u5e73\u5747\u70ba\u767c\u75c5\u5f8c 7 \u5929\u5de6\u53f3\u3002 (C)\uf9e6\u60a3\u624b\u8db3\u53e3\u75c5\u4e4b 5 \u6b72\u4ee5\u4e0b\u5152\u7ae5\u5fc5\u9808\u7279\u5225\u6ce8\u610f\u3002 (D)\u300c\u808c\u8e8d\u578b\u62bd\u6410\u300d\u70ba\u91cd\u75c7\u524d\u5146\u4e4b\u4e00\u3002 (E)\u300c\u6301\u7e8c\u5614\u5410\u300d\u70ba\u91cd\u75c7\u524d\u5146\u4e4b\u4e00\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "5 \u6b72\u7537\u7ae5\u4e3b\u8a34\u8179\u75db\u3001\u767c\u71d2\u53ca\u8179\u7009\u5169\u5929\uff0c\u5bb6\u5c6c\u8868\u793a\u6d3b\u529b\u4e0d\u4f73\uff0c\u80c3\u53e3\u6975\u5dee\uff0c\u5c3f\u91cf \u4e5f\u6e1b\u5c11\u3002\u7406\u5b78\u6aa2\u67e5\u7d50\u679c\u4e26\u7121\u8179\u819c\u708e\u75c7\u72c0\uff0c\u4e5f\u7121\u8840\u4fbf\uff0c\u4f46\u6709\u8f15\u5ea6\u812b\u6c34\u73fe\u8c61\u3002 \u6025\u8a3a\u8840\u6db2\u6aa2\u9a57\u7d50\u679c\u5982\u4e0b\uff1aSugar 78 mg/dL\uff0c BUN 36 mg/dL\uff0ccreatinine 3.0 mg/dL\uff0c Amylase 71 U/L\uff0c AST 51 U/L\uff0c CRP 18 mg/L\uff0c WBC 13100/mm3\uff0c Hb 9.6 g/dL\uff0cPlatelet 89000/uL\uff0cHCO3 17 mmol/L\u3002\u6b64\u60a3\u8005\u6700\u53ef\u80fd\u8a3a\u65b7\u70ba\u4e0b \u5217\u4f55\u8005\u75be\u75c5\uff1f", + "Options": "(A)Ulcerative colitis\u3002 (B)Henoch-Schonlein purpura\u3002 (C)Hemolytic uremic syndrome\u3002 (D)Mesenteric lymphadenitis\u3002 (E)Salmonella enteritis\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u5c0d\u65bc\u9152\u766e\u6212\u65b7(alcohol withdrawal)\u7684\u6558\u8ff0\u4e0b\u5217\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u9152\u766e\u6212\u65b7(alcohol withdrawal)\u7684\u75c5\u60a3\u5e38\u6703\u6709\u5192\u6c57\u3001\u6b65\u614b\u4e0d\u7a69(ataxia) \u53ca\u5e7b\u89ba\u7522\u751f\u3002 (B)\u9152\u766e\u6212\u65b7(alcohol withdrawal)\u7684\u75c7\u72c0\u8207\u559d\u9152\u7684\u7a2e\u985e\u7121\u95dc\u3002 (C)\u9152\u766e\u6212\u65b7(alcohol withdrawal)\u7684\u75c7\u72c0\u53ef\u5206\u70ba\u56db\u671f\uff0c\u5206\u5225\u70ba autonomic hyperactivity\uff0challucination\uff0cdyskinesia and global confusion\u3002 (D)\u5728\u505c\u6b62\u559d\u9152\u5f8c\uff0c\u901a\u5e38\u5728 24 \u5c0f\u6642\u5167\u6703\u7522\u751f\u5192\u6c57\u3001\u5fc3\u60b8\u53ca\u5e7b\u89ba\u7684\u75c7\u72c0\u3002 (E)\u6cbb\u7642\u65b9\u5f0f\u4e3b\u8981\u4ee5\u652f\u6301\u6027\u7642\u6cd5\u70ba\u4e3b\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u5c0d\u65bc\u6297\u7cbe\u795e\u75c5\u85e5\u7269(antipsychotic drugs)\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u55ae\u80fa\u6c27\u5316\u9176\u6291\u5236\u5291(monoamine oxidase inhibitor\uff0cMAOI)\u7684\u4f5c\u7528\u662f \u589e\u52a0\u4e2d\u6a1e\u795e\u7d93\u4e2d\u7684\u6b63\u814e\u4e0a\u817a\u7d20(norepinephrine)\u53ca\u8840\u6e05\u7d20(serotonin) \u7684\u6fc3\u5ea6\u3002 (B)\u4f7f\u7528\u55ae\u80fa\u6c27\u5316\u9176\u6291\u5236\u5291(MAOI)\u985e\u7684\u85e5\u7269\u8981\u6ce8\u610f\u4e0d\u53ef\u8207\u542b\u6709\u916a\u80fa (tyramine)\u985e\u7684\u98df\u7269\u5408\u7528\uff0c\u5426\u5247\u6703\u9020\u6210\u8840\u58d3\u4e0b\u964d\u3002 (C)\u4e09\u74b0\u6297\u6182\u9b31(tricyclic antidepressant\uff0cTCA)\u985e\u7684\u85e5\u7269\u4f5c\u7528\u662f\u6291\u5236\u524d \u7a81\u89f8(presynap)\u5c0d norepinephrine \u53ca\u8840\u6e05\u7d20(serotonin)\u7684\u518d\u5229\u7528\u3002 (D)\u4e09\u74b0\u6297\u6182\u9b31(TCA)\u985e\u7684\u85e5\u7269\u526f\u4f5c\u7528\u6709\u6297\u4e59\u91af\u81bd\u9e7c\u4f5c\u7528(anticholinergic effect)\u53ca\u5fc3\u81df\u6bd2\u6027\u3002 (E)\u55ae\u80fa\u6c27\u5316\u9176\u6291\u5236\u5291(MAOI)\u53ca\u9078\u64c7\u6027\u8840\u6e05\u7d20\u56de\u6536\u6291\u5236\u5291(selective serotonin reuptake inhibitor)\u5169\u985e\u85e5\u7269\u5408\u7528\u6703\u7522\u751f\u8840\u6e05\u7d20\u75c7\u72c0 (serotonin syndrome)\uff0c\u6703\u7522\u751f\u4e2d\u6a1e\u795e\u7d93\u53ca\u8178\u80c3\u9053\u7684\u75c7\u72c0\uff0c\u6709\u53ef\u80fd\u6703 \u9020\u6210\u6b7b\u4ea1\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u6709\u95dc\u986f\u5f71\u5291(radiocontrast agents)\u5f15\u8d77\u4e4b\u6025\u6027\u814e\u8870\u7aed\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u986f\u5f71\u5291\u53ef\u4ee5\u76f4\u63a5\u9020\u6210\u814e\u5c0f\u7ba1\u6bd2\u6027(direct tubular toxicity) \u5f15\u8d77\u4e4b\u6025 \u6027\u814e\u8870\u7aed\u3002 (B)\u986f\u5f71\u5291\u53ef\u4ee5\u964d\u4f4e\u814e\u8840\u6d41(reduction in renal perfusion)\u5f15\u8d77\u4e4b\u6025\u6027\u814e \u8870\u7aed\u3002 (C)\u76ee\u524d\u7814\u7a76\u4e2d acetylcysteine \u5c0d\u65bc\u964d\u4f4e\u9ad8\u5371\u96aa\u7fa4\u75c5\u60a3\u56e0\u70ba\u4f7f\u7528\u986f\u5f71\u5291\u9020 \u6210\u6025\u6027\u814e\u8870\u7aed\u4e4b\u6a5f\u6703\uff0c\u7121\u4efb\u4f55\u6548\u679c\u3002 (D)\u6709\u4e9b\u7814\u7a76\u986f\u793a fenoldopam(selective dopamine-1 receptor agonist)\u53ef \u4ee5\u964d\u4f4e\u6162\u6027\u814e\u529f\u80fd\u4e0d\u5168(chronic renal insufficiency)\u7684\u75c5\u60a3\u9032\u884c\u8840\u7ba1 \u651d\u5f71\u8853\u9020\u6210\u6025\u6027\u814e\u8870\u7aed\u7684\u6a5f\u6703\u3002 (E)\u5c0d\u65bc\u4f7f\u7528\u986f\u5f71\u5291\u7684\u75c5\u60a3\u7d66\u4e88 crystalloid infusion \u53ef\u4ee5\u964d\u4f4e\u6025\u6027\u814e\u8870\u7aed \u7684\u6a5f\u6703\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u4e00\u4f4d 25 \u6b72\u7626\u9ad8\u7537\u6027\u56e0\u5728\u7dda\u4e0a\u904a\u6232\u6253\u602a\u7269\u6642\u7a81\u7136\u767c\u751f\u80f8\u75db\u5165\u6025\u8a3a\u6c42\u6cbb\uff0c\u75c5\u4eba \u81ea\u8ff0\u7121\u5916\u50b7\uff0c\u4ea6\u7121\u5176\u4ed6\u75be\u75c5\u53f2\uff0c\u5076\u800c\u6703\u62bd\u9ede\u7159\u3002\u6709\u95dc\u65bc\u6b64\u75c5\u4eba\u7684\u8a3a\u65b7\uff0c\u4e0b \u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u4e8c\u5c16\u74e3\u812b\u5782(mitral valve prolapse)\u53ef\u80fd\u6703\u4f34\u96a8\u6709\u982d\u6688\u3001\u904e\u5ea6\u63db\u6c23\u3001 \u7126\u616e\u8207\u5fc3\u60b8\u7684\u75c7\u72c0\u3002 (B)\u5410\u6c23\u7684\u80f8\u90e8 X \u5149(expiratory chest X-ray)\u5728\u8a3a\u65b7\u6c23\u80f8\u4e0a\u6bd4\u5438\u6c23\u7684\u80f8 \u90e8 X \u5149\u654f\u611f\u5ea6\u9ad8\u5f88\u591a\uff0c\u800c\u4e14\u5c0d\u80ba\u5be6\u8cea(lung parenchyma)\u53ef\u4ee5\u63d0\u4f9b \u8f03\u597d\u7684\u8a55\u4f30\u3002 (C)\u4f9d\u81e8\u5e8a\u5224\u65b7\uff0c\u82e5\u9700\u8981\u4ecd\u9808\u505a\u5fc3\u96fb\u5716\u4ee5\u6392\u9664\u6025\u6027\u51a0\u5fc3\u75c7\u3002 (D)\u80ba\u708e\u4e5f\u53ef\u80fd\u5f15\u8d77\u80f8\u75db\uff0c\u901a\u5e38\u6703\u4f34\u96a8\u767c\u71d2\u8207\u54b3\u55fd\u7684\u75c7\u72c0\uff0c\u7406\u5b78\u6aa2\u67e5\u53ef \u80fd\u807d\u5230\u56c9\u97f3(rales)\uff0c\u80f8\u90e8 X \u5149\u53ef\u5e6b\u5fd9\u78ba\u7acb\u8a3a\u65b7\u3002 (E)\u9760\u81e8\u5e8a\u75c7\u72c0\u8207\u5fb5\u8c61\u914d\u5408\u80f8\u90e8 X \u5149\u4ecd\u7121\u6cd5\u5b8c\u5168\u6392\u9664\u4e3b\u52d5\u8108\u525d\u96e2\uff0c\u82e5\u9700 \u8981\u4ecd\u9808\u505a\u9032\u4e00\u6b65\u7684\u5f71\u50cf\u5b78\u6aa2\u67e5\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u4e00\u4f4d 86 \u6b72\u7537\u6027\u56e0\u767c\u71d2\u88ab\u5bb6\u4eba\u9001\u81f3\u6025\u8a3a\uff0c\u64da\u770b\u8b77\u8868\u793a\u75c5\u4eba\u6700\u8fd1\u5403\u6771\u897f\u5e38\u55c6 \u5230\uff0c\u6709\u963f\u8332\u6d77\u9ed8\u75c7\u8207\u9ad8\u8840\u58d3\u75c5\u53f2\uff0c\u5e73\u5e38\u4f4f\u5bb6\u88e1\uff0c\u8fd1\u4e8c\u500b\u6708\u6c92\u4f86\u904e\u91ab\u9662\u3002\u4f60 \u6aa2\u67e5\u5f8c\u767c\u73fe\u53f3\u5074\u80ba\u90e8\u6709\u56c9\u97f3(rales)\uff0c\u80f8\u90e8 X \u5149\u53f3\u4e0b\u80ba\u8449\u6709\u6d78\u6f64\u3002\u4f60\u60f3\u7d66\u75c5 \u4eba\u7528\u55ae\u4e00\u7a2e\u6297\u751f\u7d20\u6cbb\u7642\u6642\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)Clindamycin\u3002 (B)Ceftriaxone\u3002 (C)Ceftazidime\u3002 (D)Levofloxacin\u3002 (E)Piperacillin-tazobactam\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u81ea\u767c\u6027\u6c23\u80f8(spontaneous pneumothorax)\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u5728\u65b0\u751f\u5152\u5e74\u9f61\u5c64\u5e38\u898b\u7684\u539f\u56e0\u70ba\u547c\u5438\u7a98\u8feb\u75c7\u5019\u7fa4(respiratory distress syndrome)\u3002 (B)\u572820\u81f340\u6b72\u5e74\u9f61\u5c64\u5e38\u898b\u7684\u539f\u56e0\u70ba\u80ba\u5c16\u90e8\u4f4d\u808b\u819c\u4e0b\u7684\u6c23\u6ce1\u7834\u88c2(rupture of subpleural bleb in the apex)\u3002 (C)\u5728\u5927\u65bc 40 \u6b72\u5e74\u9f61\u5c64\u6b21\u767c\u578b(secondary)\u81ea\u767c\u6027\u6c23\u80f8\u5e38\u898b\u7684\u539f\u56e0\u70ba\u80ba \u816b\u7624\u3002 (D)\u5728\u80f8\u90e8 X \u5149\u7247\u6709\u6642\u53ef\u770b\u5230\u6df1\u6e9d\u5fb5\u8c61(deep sulcus sign)\u3002 (E)\u7d66\u4e88\u75c5\u60a3 3-4 L/min \u6c27\u6c23\u53ef\u4ee5\u589e\u52a0\u808b\u819c\u7a7a\u6c23\u5438\u6536 3 \u81f3 4 \u500d\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u67d0\u5929\u4e0b\u5348\uff0c\u4e00\u4f4d 50 \u6b72\u5973\u6027\u88ab\u9001\u5230\u6025\u8a3a\u5ba4\uff0c\u5bb6\u5c6c\u8868\u793a\u75c5\u4eba\u6709\u6c23\u5598\u7684\u75c5\u53f2\uff0c\u65e9 \u4e0a\u559d\u4e86\u6628\u5929\u81ea\u884c\u5728\u5c71\u4e0a\u63a1\u6458\u7684\u6cbb\u6c23\u5598\u7684\u8349\u85e5\u6240\u71ac\u7684\u6e6f\u6c41\u5f8c\uff0c\u4e0b\u5348\u958b\u59cb\u80e1\u8a00 \u4e82\u8a9e\uff0c\u5168\u8eab\u6478\u8d77\u4f86\u53c8\u4e7e\u53c8\u71d9\u3002\u75c5\u60a3\u5230\u6025\u8a3a\u6642\u7684\u751f\u547d\u5fb5\u8c61\u5982\u4e0b\uff1a\u9ad4\u6eab 38.5\u2103\u3001 \u547c\u5438 19 \u6b21/min\u3001\u5fc3\u8df3 120 \u4e0b/min\u3001\u8840\u58d3 152/80 mmHg\uff0c\u610f\u8b58\u6df7\u4e82\uff0c\u8e81\u52d5\u4e0d \u5b89\uff0cE2V2M5\u3002\u5c0d\u65bc\u6b64\u4f4d\u75c5\u4eba\u7684\u8655\u7f6e\uff0c\u4f55\u8005\u6700\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u7d66\u4e88\u75c5\u4eba\u8db3\u5920\u7684\u8f38\u6db2\u88dc\u5145\u53ca\u9069\u7576\u7684\u76e3\u6e2c(monitor)\u3002 (B)\u7d66\u4e88\u75c5\u4eba\u7d04\u675f(physical restraints)\uff0c\u4f46\u6642\u9593\u4e0d\u5b9c\u904e\u4e45\u3002 (C)\u7d66\u4e88\u75c5\u4eba\u93ae\u975c\u7684\u85e5\u7269\uff0c\u5982 lorazepam \u6216 phenothiazines\u3002 (D)\u82e5\u75c5\u4eba\u7684\u5fc3\u96fb\u5716\u767c\u73fe\u6709 QRS \u8b8a\u5bec\uff0c\u53ef\u8003\u616e\u4f7f\u7528 sodium bicarbonate \u6cbb\u7642\u3002 (E)\u8003\u616e\u4f7f\u7528 physostigmine \u4f86\u6cbb\u7642\u75c5\u4eba\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u4e2d\u6bd2\u8655\u7406\u4e4b\u89e3\u6bd2\u5291\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u963f\u6258\u5e73(atropine)\u70ba\u6709\u6a5f\u78f7\u4e2d\u6bd2\u7684\u89e3\u6bd2\u5291\uff0c\u4e0d\u8ad6\u6709\u7121\u5fc3\u640f\u904e\u7de9\u3001\u652f \u6c23\u7ba1\u5206\u6ccc\u589e\u52a0\u6216\u75d9\u6523\u4e4b\u75c7\u72c0\u90fd\u8981\u7528\u3002 (B)Dimercaprol(BAL)\u70ba\u7837\u3001\u6c5e\u6216\u925b\u4e2d\u6bd2\u4e4b\u89e3\u6bd2\u5291\uff0c\u526f\u4f5c\u7528\u5177\u814e\u6bd2\u6027\uff0c \u7522\u751f\u5641\u5fc3\u3001\u5614\u5410\u53ca\u8541\u9ebb\u75b9\u3002 (C)Pralidoxime(PAM)\u70ba\u6709\u6a5f\u78f7\u4e2d\u6bd2\u89e3\u6bd2\u5291\uff0c\u4e0d\u4f7f\u7528\u65bc\u80fa\u57fa\u7532\u9178\u9e7d (carbamate)\u4e2d\u6bd2\u3002 (D)\u78fa\u91af\u8132(sulfonylurea)\u4e2d\u6bd2\u9020\u6210\u7684\u4f4e\u8840\u7cd6\u53ef\u7528 octreotide \u6cbb\u7642\u3002 (E)\u9223\u96e2\u5b50(CaCl2 \u6216 Ca gluconate)\u65bc\u6c2b\u6c1f\u9178\u3001\u9223\u96e2\u5b50\u963b\u65b7\u5291\u3001\u8349\u9178\u9e7d \u7b49\u4e2d\u6bd2\u4f7f\u7528\uff0c\u4e0d\u53ef\u7528\u65bc\u6bdb\u5730\u9ec3\u4e2d\u6bd2\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u6709\u4e00\u4f4d 25 \u6b72\u7537\u6027\uff0c\u6709\u8e81\u9b31\u75c7(bipolar disorder)\u4e4b\u75c5\u53f2\u3002\u6700\u8fd1\u56e0\u8178\u80c3\u708e\uff0c\u5df2 \u7d93\u8179\u7009 4 \u5929\u3002\u4eca\u56e0\u55dc\u7761\u53ca\u53e3\u9f52\u4e0d\u6e05\u88ab\u5bb6\u4eba\u5e36\u5230\u6025\u8a3a\u3002\u5bb6\u5c6c\u5e36\u4f86\u7684\u85e5\u888b\u542b\u6709 lithium\u3001valproate sodium \u53ca estazolam \u7684\u85e5\u7269\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u82e5\u75c5\u4eba\u7684\u8840\u4e2d lithium \u6fc3\u5ea6\u70ba 4 meq/L\uff0c\u61c9\u7528\u8840\u6db2\u900f\u6790\u4f86\u53bb\u9664 lithium\uff0c \u4e14\u5e38\u9700\u8981\u53cd\u8986\u591a\u6b21\u900f\u6790\u3002 (B)\u82e5\u75c5\u4eba\u51fa\u73fe seizure \u7684\u72c0\u6cc1\uff0c\u61c9\u4f7f\u7528 phenytoin \u6cbb\u7642\u3002 (C)\u61c9\u6aa2\u67e5 lithium\u3001valproic acid \u53ca benzodiazepine \u7684\u8840\u4e2d\u6fc3\u5ea6\u3002 (D)\u61c9\u8a62\u554f\u6709\u7121 polyuria \u7684\u72c0\u6cc1\uff0c\u6709\u52a9\u65bc\u9451\u5225\u8a3a\u65b7\u662f\u5426\u70ba lithium \u4e2d\u6bd2\u3002 (E)\u61c9\u7d66\u4e88\u75c5\u4eba\u8db3\u5920\u7684\u8f38\u6db2\u6cbb\u7642\uff0c\u9996\u9078\u7684\u8f38\u6db2\u70ba normal saline\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "21 \u6b72\u7537\u6027\uff0c\u56e0\u7a81\u767c\u6027\u53f3\u5074\u80f8\u75db\u81f3\u6025\u8a3a\uff0c\u80f8\u90e8 X \u5149\u6aa2\u67e5\u767c\u73fe\u53f3\u5074\u7d04\u6709 10% \u7684 \u6c23\u80f8\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u6b64\u75c5\u60a3\u61c9\u81f3\u5c11\u7559\u89c0 6 \u5c0f\u6642\uff0c\u4e4b\u5f8c\u7167 X \u5149\uff0c\u82e5 X \u5149\u6c92\u6709\u8b8a\u5316\uff0c\u53ef\u8003\u616e \u7d66\u4e88\u75c5\u60a3\u51fa\u9662\u4e26\u9810\u7d04 24 \u5c0f\u6642\u5f8c\u9580\u8a3a\u3002 (B)\u5728\u808b\u819c\u8154\u4e4b\u7a7a\u6c23\u7d66\u4ee5\u6bcf\u5929 1-2%\u4e4b\u901f\u7387\u5438\u6536\uff0c\u4f7f\u7528\u6c27\u6c23 3-4 L/min \u53ef \u4ee5\u589e\u52a0\u7d04 4 \u500d\u7684\u5438\u6536\u6bd4\u7387\u3002 (C)\u82e5\u7b2c\u4e00\u6b21\u767c\u4f5c\uff0c\u5176\u5f8c\u53ef\u80fd\u7684\u5f8c\u767c\u6bd4\u7387\u7d04\u70ba 3 \u6210\u3002 (D)\u4f7f\u7528\u5c0e\u7ba1\u9032\u884c\u62bd\u5438\u8207\u7f6e\u653e\u5c0f\u53e3\u5f91\u4e4b\u80f8\u7ba1\u7686\u5c6c\u65bc\u53ef\u63a5\u53d7\u7684\u6cbb\u7642\u65b9\u91dd\u3002 (E)\u82e5\u4f7f\u7528\u5c0e\u7ba1\u62bd\u5438\uff0c\u62bd\u5438\u91cf\u5927\u65bc 10 \u516c\u5347\u6642\u5373\u53ef\u80fd\u6709\u6301\u7e8c\u6f0f\u6c23\u4e4b\u60c5\u5f62\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "3 \u6b72\u534a\u5973\u7ae5\u7531\u5bb6\u5c6c\u9001\u5230\u6025\u8a3a\u5ba4\uff0c\u4e3b\u8a34\u4e94\u5929\u767c\u71d2\u53ca\u611f\u5192\u75c7\u72c0\uff0c\u7406\u5b78\u6aa2\u67e5\u767c\u73fe\u5973 \u7ae5\u6709\u5598\u9cf4\u8072\u97f3(stridor)\uff0c\u9838\u90e8\u50f5\u786c\uff0c\u6aa2\u50b7\u7ad9\u6e2c\u5f97 O2 saturation 96%\uff0c\u5224\u5b9a\u6aa2 \u50b7\u7d1a\u6578\u70ba\u4e09\u7d1a\uff0c\u5973\u7ae5\u986f\u5f97\u7126\u616e\uff0c\u5c1a\u53ef\u6d41\u66a2\u4f7f\u7528\u53e5\u5b50\u8868\u9054\uff0c\u4f46\u4e0d\u9858\u610f\u8eba\u4e0b\u63a5 \u53d7\u6aa2\u67e5\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u8f03\u70ba\u9069\u7576\uff1f", + "Options": "(A)\u7acb\u5373\u808c\u8089\u6ce8\u5c04\u985e\u56fa\u9187 dexamethasone 0.6mg/kg\u3002 (B)\u808c\u8089\u6ce8\u5c04 epinephrine\u3002 (C)\u9838\u90e8\u5074\u9762 X \u5149\u3002 (D)\u7acb\u5373\u6253\u4e0a\u9ede\u6ef4\uff0c\u88dc\u5145\u8f38\u6db2\u3002 (E)\u7acb\u5373\u6c23\u7ba1\u5167\u7ba1\u7f6e\u653e\uff0c\u7dad\u6301\u547c\u5438\u9053\u66a2\u901a\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u8178\u80c3\u9053\u51fa\u8840\uff0c\u4e0b\u5217\u654d\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)Proton-Pump inhibitor (PPI)\u53ef\u964d\u4f4e\u51fa\u8840\u6027\u80c3\u6f70\u760d\u7684\u518d\u51fa\u8840\u7387\uff0c\u4e5f \u53ef\u964d\u4f4e\u8f38\u8840\u53ca\u624b\u8853\u7684\u9700\u6c42\u3002 (B)Sengstaken-Blakemore tube (SB tube)\u56e0\u4f75\u767c\u75c7\u592a\u591a\uff0c\u76ee\u524d\u5df2\u4e0d\u5efa \u8b70\u4f7f\u7528\u65bc\u6cbb\u7642\u975c\u8108\u66f2\u5f35\u51fa\u8840\u3002 (C)\u4e0a\u8178\u80c3\u9053\u51fa\u8840\u5747\u53ef\u8003\u616e\u653e\u7f6e\u9f3b\u80c3\u7ba1\uff0c\u5373\u4f7f\u662f\u7591\u4f3c\u98df\u9053\u975c\u8108\u66f2\u5f35\u51fa\u8840 \u4ea6\u53ef\u9032\u884c\u3002 (D)\u8840\u7ba1\u651d\u5f71\u53ef\u70ba\u8a3a\u65b7\u5de5\u5177\uff0c\u4f46\u9700\u51fa\u8840\u901f\u7387\u8d85\u904e 0.5~2.0 ml/min \u624d\u53ef\u5075\u6e2c\u3002 (E)\u4e0b\u8178\u80c3\u9053\u51fa\u8840\u6700\u5e38\u898b\u7684\u539f\u56e0\u662f\u75d4\u7621\u51fa\u8840\uff0c\u5176\u6b21\u662f angiodysplasia \u548c\u61a9 \u5ba4\u75be\u75c5\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6c23\u816b\u6027\u81bd\u56ca\u708e(emphysematous cholecystitis)\uff0c\u4e0b\u5217\u654d\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u6c23\u816b\u6027\u81bd\u56ca\u708e\u767c\u751f\u5728\u5927\u7d04 1%\u7684\u6025\u6027\u81bd\u56ca\u708e\u60a3\u8005\u8eab\u4e0a\u3002 (B)\u6c23\u816b\u6027\u81bd\u56ca\u708e\u7684\u75c5\u4eba\u4e2d\u6709 30%\u81bd\u56ca\u4e26\u7121\u7d50\u77f3\u3002 (C)\u5efa\u8b70\u7528\u8179\u90e8\u65b7\u5c64\u6383\u63cf\u4f86\u78ba\u8a3a\u6c23\u816b\u6027\u81bd\u56ca\u708e\u3002 (D)\u6c23\u816b\u6027\u81bd\u56ca\u708e\u6bd4\u4e00\u822c\u6025\u6027\u81bd\u56ca\u708e\u7684\u6b7b\u4ea1\u7387\u9ad8\u3002 (E)\u6c23\u816b\u6027\u81bd\u56ca\u708e\u5927\u591a\u662f\u7531\u55ae\u4e00\u5fae\u751f\u7269\u611f\u67d3\u5f15\u8d77\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u6025\u6027\u80f0\u81df\u708e\u4e4b\u4f75\u767c\u75c7\uff0c\u4e0b\u5217\u654d\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u6025\u6027\u547c\u5438\u7a98\u8feb\u75c7\u5019\u7fa4(ARDS)\u3002 (B)\u5fc3\u5305\u819c\u7a4d\u6c34(pericardiac effusion)\u3002 (C)\u9580\u975c\u8108\u6813\u585e(portal vein thrombosis)\u3002 (D)\u7a81\u7136\u8996\u529b\u55aa\u5931(Purtscher\u2019s retinopathy)\u3002 (E)\u9ad8\u8840\u9223(hypercalcemia)\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u7121\u7d50\u77f3\u6027\u81bd\u56ca\u708e(acalculous cholecystitis)\u5e38\u898b\u5371\u96aa\u56e0\u5b50\uff0c\u4e0d\u5305\u62ec\uff1a", + "Options": "(A)\u591a\u91cd\u6027\u5916\u50b7 (B)\u5e74\u8f15\u80a5\u80d6\u5973\u6027\u3002 (C)\u81bd\u9053\u7d30\u83cc\u611f\u67d3\u3002 (D)\u81bd\u56ca\u626d\u8f49\u3002 (E)\u56b4\u91cd\u71d2\u71d9\u50b7\u75c5\u60a3\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "60 \u6b72\u7537\u6027\u904e\u53bb\u75c5\u53f2\u6709\u9ad8\u8840\u58d3\u8207\u7cd6\u5c3f\u75c5\uff0c\u672c\u6b21\u56e0\u70ba\u6025\u6027\u80f8\u75db\u5ef6\u4f38\u81f3\u80cc\u5f8c\u800c\u88ab \u9001\u81f3\u6025\u8a3a\u3002\u6c42\u8a3a\u6642\u8840\u58d3 220/110 mmHg\u3001\u5fc3\u8df3 98 \u6b21/min\u3001\u547c\u5438\u901f\u7387 20 \u6b21/min\uff0c \u80f8\u90e8 X \u5149\u770b\u5230\u7e31\u8188\u8154\u8b8a\u5bec(mediastinum widening)\uff0c\u5fc3\u96fb\u5716\u5448\u5de6\u5fc3\u5ba4\u80a5\u539a\u3002 \u95dc\u65bc\u6b64\u75c5\u60a3\u7684\u8a3a\u65b7\u8207\u81e8\u5e8a\u8655\u7f6e\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u81e8\u5e8a\u4e0a\u61c9\u8a72\u5f37\u70c8\u61f7\u7591\u4e3b\u52d5\u8108\u525d\u96e2(aortic dissection)\uff0c\u9700\u7acb\u5373\u5b89\u6392\u96fb \u8166\u65b7\u5c64\u6aa2\u67e5\u3002 (B)\u96d9\u5074\u80a2\u9ad4\u8840\u58d3\u6709\u5dee\u7570(pulse deficit)\u5c0d\u8a3a\u65b7\u6709\u5e6b\u52a9\u4f46\u53ea\u6709 15-30%\u7684 \u654f\u611f\u5ea6(sensitivity)\u3002 (C)\u4e3b\u52d5\u8108\u525d\u96e2\u7684\u60a3\u8005\u80f8\u90e8 X \u5149\u6709 63-88\uff05\u7570\u5e38\u8b8a\u5316\u3002 (D)\u4e3b\u52d5\u8108\u525d\u96e2\u6709\u6642\u6703\u525d\u96e2\u5230\u51a0\u72c0\u52d5\u8108\uff0c\u6700\u5e38\u88ab\u5f71\u97ff\u5230\u51a0\u72c0\u52d5\u8108\u662f\u53f3\u51a0 \u72c0\u52d5\u8108\uff0c\u6703\u9020\u6210\u4e0b\u58c1\u6216\u5f8c\u58c1\u6897\u585e\u3002 (E)\u95dc\u65bc\u6b64\u60a3\u8005\u7684\u8840\u58d3\u63a7\u5236\uff0c\u53ef\u4ee5\u8003\u616e\u55ae\u7368\u4f7f\u7528 nitroprusside\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u75c5\u60a3\u8ec0\u5e79\u53ca\u56db\u80a2\u90fd\u6709\u7d05\u8272\u6591\u75b9\u4e18\u75b9\u53ca\u6c34\u75b1\u75b9\uff0c\u5176\u4e2d\u6709\u8a31\u591a\u76ae\u75b9\u70ba\u9776\u72c0\u75b9\uff0c \u53c8\u5408\u4f75\u53e3\u8154\u6f70\u760d\u53ca\u773c\u7d50\u819c\u7d05\u816b\uff0c\u4ee5\u4e0b\u8a3a\u65b7\u4f55\u8005\u6700\u6709\u53ef\u80fd\uff1a", + "Options": "(A)\u53f2\u5e1d\u6587\u5f37\u751f\u75c7\u5019\u7fa4(Stevens-Johnson syndrome)\u3002 (B)\u985e\u5929\u76b0\u7621(Bullous pemphigoid)\u3002 (C)\u81bf\u75b1\u6027\u4e7e\u766c(Pustular psoriasis)\u3002 (D)\u5c0b\u5e38\u5929\u76b0\u7621(Pemphigus vulgaris)\u3002 (E)\u76b0\u75b9\u6027\u76ae\u819a\u708e(Dermatitis herpertiformis)\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "56 \u6b72\u5973\u6027\u56e0\u610f\u8b58\u4e0d\u6e05\u800c\u81f3\u6025\u8a3a\uff0c\u5728\u7be9\u6aa2\u6642\u767c\u73fe\u9ad4\u6eab 39.4\u2103\uff0c BP\uff1a 130/80 mmHg\uff0c \u5fc3\u8df3 100 \u6b21/\u5206\uff0c \u547c\u5438 16 \u6b21/\u5206\uff0c \u9031\u908a\u8840\u6c27\u6fc3\u5ea6(SPO2)\u70ba 98%\u3002 \u76ae\u819a\u767c\u73fe\u6709\u8a31\u591a\u5c0f\u51fa\u8840\u9ede(petechiae)\uff0c\u8840\u6db2\u4e2d\u767d\u8840\u7403\uff1a10000/mm3\uff0c\u8840\u8272 \u7d20\uff1a8.5 g/dL\uff0c\u8840\u5c0f\u677f 10000/ mm3\uff0cPT \u53ca PTT \u6b63\u5e38\uff0c\u8840\u6db2\u62b9\u7247\u767c\u73fe\u6709 schistocytes\uff0c\u808c\u9178\u9150\uff1a4.5 mg/dL\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u61c9\u7acb\u5373\u7d66\u4e88\u8840\u5c0f\u677f\uff0c\u4ee5\u907f\u514d\u81ea\u767c\u6027\u51fa\u8840\u3002 (B)\u61c9\u5b89\u6392\u9aa8\u9ad3\u62bd\u53d6\u53ca\u5207\u7247\u6aa2\u67e5\u3002 (C)\u75c5\u4eba\u7522\u751f\u5ee3\u6cdb\u6027\u8840\u7ba1\u5167\u51dd\u8840(disseminated intravascular coagulation)\u3002 (D)\u7d66\u4e88\u65b0\u9bae\u51b7\u51cd\u8840\u6f3f\u662f\u4e00\u6709\u6548\u4e4b\u6cbb\u7642\u3002 (E)\u813e\u81df\u5207\u9664\u662f\u4e00\u6709\u6548\u4e4b\u6cbb\u7642\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u75c5\u4eba\u51fa\u73fe\u4e0b\u5217\u4f55\u7a2e\u8868\u73fe\u6642\uff0c\u6700\u6709\u628a\u63e1\u8a8d\u5b9a\u4ed6\u662f\u9031\u908a\u578b\u6688\u7729(peripheral vertigo)\uff1f", + "Options": "(A)\u8033\u9cf4\u53ca\u807d\u529b\u55aa\u5931\u3002 (B)\u541e\u56a5\u56f0\u96e3\u3002 (C)\u7a81\u7136\u767c\u4f5c\u3002 (D)\u773c\u9707\u65b9\u5411\u4e0d\u5b9a\u3002 (E)\u8996\u89ba\u56fa\u5b9a(visual fixation)\u4e0d\u5f71\u97ff\u773c\u9707\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u4f55\u8005\u6700\u7b26\u5408\u776a\u4e38\u626d\u8f49(testicular torsion)\u4e4b\u5178\u578b\u8868\u73fe\uff1f", + "Options": "(A)\u59ff\u52e2\u6539\u8b8a\u53ef\u6e1b\u8f15\u75bc\u75db\u3002 (B)\u7ad9\u7acb\u6642\u60a3\u5074\u776a\u4e38\u5448\u6c34\u5e73\u8ef8\u5411\u3002 (C)\u8d77\u521d\u70ba\u4e0d\u660e\u986f\u4e4b\u8f15\u5ea6\u75bc\u75db\u3002 (D)\u75bc\u75db\u7bc4\u570d\u53ea\u6703\u5c40\u9650\u65bc\u9670\u56ca\u3002 (E)\u63d0\u776a\u808c\u53cd\u5c04(cremasteric reflex)\u6b63\u5e38\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u63a5\u53d7\u7f8e\u6c99\u51ac\u6cbb\u7642 29 \u6b72\u7537\u6027\uff0c\u5de6\u80f8\u4e2d\u69cd\uff0c\u88ab\u5bb6\u5c6c\u9001\u5165\u6025\u8a3a\uff0c\u547c\u5438\u6bcf\u5206\u9418\u7d04 30 \u6b21\u4ee5\u4e0a\uff0c\u9838\u52d5\u8108\u53ef\u6478\u5230\u5fae\u5f31\u640f\u52d5\uff0c\u610f\u8b58\u6fc0\u52d5\uff0c\u8eab\u9ad4\u6aa2\u67e5\u6642\u767c\u73fe\u5168\u8eab\u5192\u51b7\u6c57\u3001 \u9838\u975c\u8108\u6012\u5f35\u3001\u5de6\u80f8\u7121\u547c\u5438\u97f3\u3001\u6572\u8a3a\u70ba\u9f13\u97f3\uff0c\u5f48\u5b54\u5728\u5de6\u5074\u7b2c 6 \u808b\u9593\u8207\u9396\u9aa8\u4e2d \u7dda\u4ea4\u6703\u8655\u3002\u4e0b\u5217\u4f55\u8005\u8655\u7f6e\u6700\u70ba\u9069\u7576\uff1f", + "Options": "(A)\u7d66\u4e88\u6c23\u7ba1\u5167\u7ba1(endotracheal tube)\u63d2\u7ba1\uff0c\u540c\u6642\u4fdd\u8b77\u9838\u690e\u3002 (B)\u57f7\u884c\u8179\u90e8\u8d85\u97f3\u6ce2(FAST)\u6aa2\u67e5\uff0c\u5bdf\u770b\u8179\u5167\u662f\u5426\u5408\u4f75\u51fa\u8840\u3002 (C)\u76f4\u63a5\u7531\u5f48\u5b54\u8655\u653e\u7f6e\u80f8\u7ba1(chest tube)\uff0c\u5feb\u901f\u5f15\u6d41\u3002 (D)\u5feb\u901f\u7d66\u4e88\u8f38\u6db2 2 \u516c\u5347\u3002 (E)\u5728\u5de6\u5074\u9396\u9aa8\u4e2d\u7dda\u3001\u7b2c\u4e8c\u808b\u9593\u4ee5 14 \u865f\u7a7a\u91dd\u63d2\u5165\u6e1b\u58d3\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "21 \u6b72\u7537\u6027\u9a0e\uf902\u8207\u5c0f\u5ba2\uf902\u76f8\u649e\uff0c\u5230\u9662\u6642\u6709\u53f3\u5074\u8c93\u718a\u773c\u3001\u982d\u90e8\u5916\u50b7\uff0c\u610f\u8b58\u4e0d\u6e05\uff0c \u80f8\u90e8\u53ca\u4e0a\u8179\u90e8\u660e\u986f\u632b\u50b7\uff0c\u5de6\u80f8\u547c\u5438\u97f3\u8f03\u5c0f\uff0c\u8840\u58d3\uff1a90/50 mmHg\uff0c\u5fc3\u7387\uff1a140 /min\uff0c\u4e0b\u5217\u8655\u7f6e\u9806\u5e8f\u4f55\u8005\u6700\u70ba\u9069\u7576\uff1f 1. \u6c23\u7ba1\u5167\u7ba1(endotracheal tube)\u63d2\u5165\u3002 2. \u8166\u90e8\u96fb\u8166\u65b7\u5c64\u3002 3. \u5feb\u901f\u7d66\u4e88\u8f38 \u6db2 2 \u516c\u5347\u3002 4. \u8179\u90e8\u8d85\u97f3\u6ce2(FAST)\u3002 5. \u5de6\u5074\u80f8\u7ba1\u7f6e\u5165\u8853(tube thoracostomy)\u3002", + "Options": "(A)1->2->3->4->5\u3002 (B)1->3->5->4->2\u3002 (C)1->3->4->5->2\u3002 (D)5->1->3->2->4\u3002 (E)5->1->3->4->2\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u4e00\u4f4d 50 \u6b72\u5973\u6027\uff0c\u5f9e 3 \u6a13\u589c\u843d\uff0c\u88ab\u9001\u81f3\u6025\u8a3a\u5ba4\uff0c\u75c5\u4eba\u610f\u8b58\u6e05\u695a\uff0c\u751f\u547d\u5fb5\u8c61\u7a69 \u5b9a\uff0c\u4f46\u4e0b\u80cc\u90e8\u660e\u986f\u816b\u75db\uff0c\u4e0b\u80a2\u7671\u7613\u7121\u6cd5\u6d3b\u52d5\uff0c\u80f8\u8179\u90e8 X-ray \u767c\u73fe T12 fracture dislocation\uff0c\u5728\u7b2c\u4e00\u7dda\u7684\u8a55\u4f30\u548c\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u7acb\u5373\u7406\u5b78\u6aa2\u67e5 anus tone\u3002 (B)\u5118\u5feb\u5b89\u6392\u624b\u8853 reduction of dislocation\u3002 (C)Neurogenic shock \u5448\u73fe hypotension and tachycardia\u3002 (D)\u53ef\u8003\u616e\u4f7f\u7528 methylprednisolone\u3002 (E)\u7acb\u5373\u5b89\u6392 spine computer tomography \u6aa2\u67e5\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6a6b\u9694\u819c\u50b7\u5bb3(diaphragmatic injury)\uff0c\u4e0b\u5217\u63cf\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u9664\u975e\u8840\u58d3\u4e0b\u964d\uff0c\u901a\u5e38\u4e0d\u5fc5\u7dca\u6025\u624b\u8853\u3002 (B)\u901a\u5e38\u53f3\u5074\u6bd4\u5de6\u5074\u591a\u3002 (C)\u8f03\u5e38\u51fa\u73fe\u5728\u80f8\u8179\u90e8\u7684\u7a7f\u523a\u50b7\u3002 (D)\u5c0d\u751f\u547d\u5fb5\u8c61\u7684\u5371\u5bb3\u4e3b\u8981\u662f\u9020\u6210\u51fa\u8840\u6027\u4f11\u514b\u3002 (E)\u5c0d\u8f03\u5c0f\u7684\u6a6b\u9694\u819c\u50b7\u5bb3\uff0c\u7528\u96fb\u8166\u65b7\u5c64\u6383\u63cf(CT scan)\u7684\u8a3a\u65b7\u7387\u5f88\u9ad8\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u4f55\u7a2e\u72c0\u6cc1\u4e0d\u662f\u6210\u4eba\u8f15\u5ea6\u982d\u90e8\u5916\u50b7\u60a3\u8005\u65bd\u884c\u8166\u90e8\u96fb\u8166\u65b7\u5c64\u7684\u9069\u61c9\u75c7\uff1f", + "Options": "(A)\u718a\u8c93\u773c(raccoon\u2019s eyes)\u3002 (B)\u50b7\u5f8c\u5169\u5c0f\u6642\u660f\u8ff7\u6307\u6578(GCS)\u70ba 13 \u5206\u3002 (C)\u982d\u76ae\u6495\u88c2\u50b7\u7591\u9871\u9aa8\u958b\u653e\u6027\u9aa8\u6298\u3002 (D)\u5e74\u9f61 66 \u6b72\u3002 (E)\u50b7\u5f8c\u5614\u5410\u4e00\u6b21\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u4e00\u540d 8 \u6b72\u7537\u7ae5\uff0c\u65bc\u4e0a\u5b78\u9014\u4e2d\u88ab\u6a5f\uf902\u6514\u8170\u649e\u4e0a\uff0c\u7537\u7ae5\u7ffb\u6efe\u591a\u5708\u5f8c\u5012\u5730\u4e0d\u8d77\u3002 \u88ab\u6551\u8b77\uf902\u9001\u4f86\u6025\u8a3a\u6642\u751f\u547d\u8de1\u8c61\u9ad4\u6eab 36.7\u00b0C\uff0c\u547c\u5438 30 \u6b21/\u5206\u9418\uff0c\u5fc3\u8df3 125 \u6b21/ \u5206\u9418\uff0c\u8840\u58d3 82/65 mmHg\u3002\u75c5\u4eba\u610f\u8b58\u6a21\u7cca\u7121\u6cd5\u8868\u9054\uff0c\u4ee5\u4e0b\u95dc\u65bc\u5c0f\u5152\u5916\u50b7\u6025\u6551\uff0c \u4f55\u8005\u6700\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u82e5\u5468\u908a\u8840\u7ba1\u7121\u6cd5\u6253\u4e0a\uff0c\u65bc\u6b64\u75c5\u4eba\u53ef\u8003\u616e intraosseous \u7684\u65b9\u5f0f\uff0c\u82e5\u767c\u73fe \u811b\u9aa8\u9aa8\u6298\uff0c\u53ef\u4ee5\u6253\u540c\u908a\u7684\u672b\u7aef\u80a1\u9aa8\u3002 (B)\u7d66\u8207 crytalloid \u6bcf\u6b21 20ml/kg\uff0c\u76ee\u6a19\u70ba\u5c3f\u91cf 1.5ml/kg/hr\u3002 (C)\u7531\u65bc\u5152\u7ae5\u80f8\u58c1\u9aa8\u9abc\u8f03\u6709\u5f48\u6027\uff0c\u5c0e\u81f4\u80f8\u90e8\u632b\u50b7\u6642\uff0c\u8f03\u4e0d\u6613\u767c\u751f\u58d3\u529b\u6027 \u6c23\u80f8(tension pneumothorax)\u3002 (D)\u6309\u7167\u6b64\u75c5\u4eba\u7684\u751f\u547d\u8de1\u8c61\uff0c\u6d41\u5931\u8840\u91cf\u61c9\u6709\u5927\u65bc 30%\u3002 (E)\u9996\u8981\u4e4b\u52d9\u70ba\u4fdd\u8b77\u547c\u5438\u9053\uff0c\u82e5\u8981\u9078\u64c7\u6c23\u7ba1\u5167\u7ba1\uff0c\u5247\u53ef\u9078\u5927\u5c0f\u70ba 5~5.5 \u865f\uff0c\u6709 cuff \u7684\u6c23\u7ba1\u5167\u7ba1\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u8fd1\u5e74\u53f0\u7063\u9678\u7e8c\u8209\u8fa6\u4e86\u4e16\u754c\u904b\u52d5\u6703\u548c\u807d\u969c\u5967\u904b\u5169\u9805\u5927\u578b\u6d3b\u52d5\u8cfd\u4e8b\uff0e\u4e0b\u5217\u6709\u95dc \u5927\u578b\u6d3b\u52d5(mass gatherings)\u7dca\u6025\u91ab\u7642\u7684\u6558\u8ff0\uff0c\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u5b9a\u7fa9\uff1a\u70ba\u4e86\u540c\u4e00\u76ee\u7684\uff0c\u5728\u67d0\u4e00\u5730\u9ede\uff0c\u805a\u96c6\u7684\u4eba\u6578\u8d85\u904e 1000 \u4eba\u3002 (B)\u904b\u52d5\u578b\u96c6\u6703\u7522\u751f\u91ab\u7642\u9700\u6c42\u7684\u767c\u751f\u7387\u70ba 0.12-17 / 1000 \u4eba\u6b21\u3002 (C)\u904b\u52d5\u578b\u96c6\u6703\u7522\u751f\u5fc3\u8df3\u505c\u6b62\u7684\u767c\u751f\u7387\u70ba 3-40 / 1000000 \u4eba\u6b21\u3002 (D)\u7d50\u5408\u6025\u8a3a\u91ab\u5b78\uff0c\u516c\u5171\u885b\u751f\uff0c\u4ee5\u53ca\u516c\u5171\u5b89\u5168\u7b49\u4e09\u5927\u9818\u57df\u3002 (E)\u9700\u8981\u6709\u9069\u7576\u7684\u7dca\u6025\u91ab\u7642\u898f\u5283\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6211\u570b\u91ab\u7642\u6307\u5c0e\u5236\u5ea6\u8207\u91ab\u7642\u6307\u5c0e\u91ab\u5e2b\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u76f4\u8f44\u5e02\uff0c\u7e23(\u5e02)\u6d88\u9632\u4e3b\u7ba1\u6a5f\u95dc\u61c9\u6307\u5b9a\u91ab\u7642\u6307\u5c0e\u91ab\u5e2b\uff0c\u5efa\u7acb\u91ab\u7642\u6307 \u5c0e\u5236\u5ea6\u3002 (B)\u8ca0\u8cac\u5404\u7d1a\u6551\u8b77\u6280\u8853\u54e1\u57f7\u884c\u7dca\u6025\u6551\u8b77\u4e4b\u6559\u80b2\uff0c\u8a13\u7df4\uff0c\u7763\u5c0e\uff0c\u53ca\u8003\u6838\u3002 (C)\u8a02\u5b9a\u5404\u7d1a\u6551\u8b77\u6280\u8853\u54e1\u54c1\u8cea\u6307\u6a19\uff0c\u57f7\u884c\u54c1\u8cea\u76e3\u6e2c\u3002 (D)\u6838\u7c3d\u9ad8\u7d1a\u6551\u8b77\u6280\u8853\u54e1\u4f9d\u64da\u9810\u7acb\u91ab\u7642\u6d41\u7a0b\u65bd\u884c\u7dca\u6025\u6551\u8b77\u4e4b\u6551\u8b77\u7d00\u9304\u8868\u3002 (E)\u91ab\u7642\u6307\u5c0e\u91ab\u5e2b\u4e4b\u8cc7\u683c\u7531\u4e2d\u592e\u6d88\u9632\u6a5f\u95dc\u5b9a\u4e4b\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u7dca\u6025\u91ab\u7642\u6551\u8b77\u6cd5\u4e4b\u5340\u57df\u7dca\u6025\u91ab\u7642\u61c9\u8b8a\u4e2d\u5fc3\u4e4b\u7d44\u6210\u8207\u4efb\u52d9\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55 \u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u76ee\u524d\u5168\u570b\u5171\u8a2d\u7f6e 6 \u500b\u5340\u57df\u7dca\u6025\u61c9\u8b8a\u4e2d\u5fc3\u3002 (B)\u53ef\u4ee5\u59d4\u8a17\u91ab\u7642\u6a5f\u69cb\u8fa6\u7406\u5176\u696d\u52d9\u3002 (C)\u6025\u6551\u8cac\u4efb\u91ab\u9662\u9032\u884c\u6025\u91cd\u75c7\u75c5\u60a3\u8f49\u8a3a\u6642\uff0c\u9808\u5354\u52a9\u5e8a\u4f4d\u8abf\u5ea6\u4e26\u9032\u884c\u75c5\u60a3 \u8ffd\u8e64\u3002 (D)\u9808\u5b9a\u671f\u8fa6\u7406\u5e74\u5ea6\u91cd\u5927\u707d\u5bb3\u6709\u95dc\u7dca\u6025\u91ab\u7642\u4e4b\u6f14\u7df4\u3002 (E)\u9808\u638c\u63e1\u5340\u57df\u5167\u7dca\u6025\u91ab\u7642\u8cc7\u8a0a\u53ca\u8cc7\u6e90\u72c0\u6cc1\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u4f55\u8005\u4e0d\u662f\u7c98\u6db2\u6027\u6c34\u816b(myxedema)\u75c5\u4eba\u5e38\u898b\u7684\u7570\u5e38\u8868\u73fe\uff1f", + "Options": "(A)\u9ad8\u9209\u8840\u75c7(hypernatremia)\u548c\u6c34\u4efd\u5132\u7559(water retention)\u3002 (B)\u901a\u6c23\u4e0d\u8db3(hypoventilation)\u548c\u7f3a\u6c27(hypoxia)\u3002 (C)\u9ad4\u6eab\u904e\u4f4e(hypothermia)\u3002 (D)\u5fc3\u640f\u904e\u7de9(bradycardia)\u3002 (E)\u6df7\u4e82\uff0c\u751a\u81f3\u55dc\u7761\u6216\u660f\u8ff7\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6c34\u6bcd\u87ab\u50b7\u7684\u8655\u7f6e\uff0c\u4e0b\u5217\u4f55\u8005\u70ba\u932f\u8aa4\uff1f", + "Options": "(A)\u4e0d\u53ef\u4f7f\u7528\u6de1\u6c34\u6c96\u6d17\uff0c\u56e0\u6703\u523a\u6fc0\u76ae\u819a\u6b98\u9918\u523a\u7d30\u80de\u7684\u6bd2\u7d20\u91cb\u653e\u3002 (B)5\uff05\u918b\u9178\u662f\u6e1b\u5c11\u523a\u7d30\u80de\u6d3b\u6027\u7684\u9996\u9078\u3002 (C)\u7834\u50b7\u98a8\u75ab\u82d7\u6ce8\u5c04\u662f\u5fc5\u9808\u7684\u3002 (D)\u9810\u9632\u6027\u6297\u751f\u7d20\u4f7f\u7528\u662f\u4e0d\u5efa\u8b70\u7684\u3002 (E)\u5373\u4fbf\u672a\u51fa\u73fe\u5168\u8eab\u6027\u75c7\u72c0\uff0c\u60a3\u8005\u4ecd\u9700\u7559\u89c0 8 \u5c0f\u6642\uff0c\u907f\u514d\u9072\u767c\u6027\u53cd\u61c9\u7684 \u51fa\u73fe\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "25 \u6b72\u7537\u6027\uff0c\u56e0\u53f3\u773c\u88ab\u6253\u4e86\u4e00\u62f3\u800c\u81f3\u6025\u8a3a\u5c31\u8a3a\uff0c\u8eab\u9ad4\u6aa2\u67e5\u767c\u73fe\uff0c\u53f3\u773c\u7121\u6cd5\u5f80 \u4e0a\u770b\uff0c\u540c\u6642\u6709\u8907\u8996\uff0c\u61f7\u7591\u773c\u7736\u7206\u88c2\u6027\u9aa8\u6298(orbital blow out fractures)\uff0c\u4f60\u9810 \u671f\u9084\u6709\u54ea\u4e9b\u8eab\u9ad4\u6aa2\u67e5\u767c\u73fe\uff0c\u4e0d\u5305\u62ec\u4e0b\u5217\u4f55\u9805\uff1f", + "Options": "(A)\u53f3\u524d\u81c9\u9830\u611f\u89ba\u7570\u5e38\u3002 (B)\u773c\u7403\u5167\u9677\u3002 (C)\u773c\u7736\u5468\u570d\u76ae\u4e0b\u6c23\u816b\u3002 (D)\u7d50\u819c\u4e0b\u51fa\u8840\u3002 (E)\u8166\u810a\u9ad3\u6db2\u9f3b\u6f0f\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u4e00\u4f4d 65 \u6b72\u505c\u7d93\u5a66\u5973\uff0c\u904e\u53bb\u672a\u6709\u5168\u8eab\u6027\u75be\u75c5\uff0c\u534a\u5e74\u524d\u9ad4\u6aa2 CBC \u6b63\u5e38\uff0c\u6700\u8fd1 \u4e09\u5929\u9010\u6f38\u51fa\u73fe\u81c9\u8272\u84bc\u767d\u53ca\u904b\u52d5\u5f8c\u547c\u5438\u6025\u4fc3\u73fe\u8c61\uff0c\u4f46\u7121\u5176\u4ed6\u4e0d\u9069\uff0c\u5176 CBC \u5982 \u4e0b\uff1aHb 8.6 gm/dL\uff0cMCV 80 fL\uff0c\u767d\u8840\u7403 9950/mm3\uff0c\u5206\u985e\u6b63\u5e38\uff0c\u8840\u5c0f\u677f 145000 / mm3\uff0c\u4e0b\u5217\u4f55\u9805\u6aa2\u67e5\u5c0d\u8a3a\u65b7\u6700\u6709\u5e6b\u52a9\uff1f", + "Options": "(A)\u5c0f\u4fbf\u6aa2\u67e5\u3002 (B)\u809d\u529f\u80fd\u6aa2\u67e5\u3002 (C)\u814e\u529f\u80fd\u6aa2\u67e5\u3002 (D)\u5927\u4fbf\u6aa2\u67e5\u3002 (E)\u9aa8\u9ad3\u6aa2\u67e5\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6297\u78f7\u8102\u6297\u9ad4\u75c7(antiphospholipid antibody syndrome)\u7684\u6558\u8ff0\uff0c\u4f55\u8005\u70ba\u6b63 \u78ba\uff1f", + "Options": "(A)\u7570\u5e38\u7684\u51fa\u8840\u662f\u5e38\u898b\u7684\u81e8\u5e8a\u8868\u73fe\u3002 (B)\u4f4e\u65bc 3%\u7684\u7d05\u6591\u6027\u72fc\u7621(SLE)\u75c5\u4eba\u5408\u4f75\u6297\u78f7\u8102\u6297\u9ad4\u75c7\u3002 (C)\u81e8\u5e8a\u4e0a\u5f88\u5c11\u9020\u6210\u975c\u8108\u8840\u6813(venous thrombosis) \u3002 (D)\u8840\u4e2d\u51fa\u73fe\u6297\u78f7\u8102\u6297\u9ad4(antiphospholipid antibody)\u4e0d\u662f\u8a3a\u65b7\u7684\u5fc5\u8981\u689d \u4ef6\u3002 (E)\u53ef\u80fd\u9020\u6210\u61f7\u5b55\u5a66\u5973\u53cd\u8986\u6d41\u7522\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u8f38\u8840\u5f8c\u53cd\u61c9(acute transfusion reaction)\u7684\u8655\u7f6e\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u6070\u7576\uff1f", + "Options": "(A)\u82e5\u8f38\u8840\u6642\u767c\u751f\u8541\u9ebb\u75b9\uff0c\u4e0d\u53ef\u518d\u7e7c\u7e8c\u8f38\u8840\u3002 (B)\u82e5\u8f38\u8840\u6642\u767c\u71d2\uff0c\u5fc5\u662f\u8f38\u8840\u7684\u53cd\u61c9\uff0c\u4e0d\u6703\u662f\u611f\u67d3\u9020\u6210\u7684\u3002 (C)\u767c\u751f\u6025\u6027\u8840\u7ba1\u5167\u6eb6\u8840\u53cd\u61c9(acute intravascular hemolysis)\u6642\uff0c\u4e0d\u53ef\u518d \u7e7c\u7e8c\u8f38\u8840\u3002 (D)\u56e0\u8f38\u8840\u5f8c\u53cd\u61c9\u4e0d\u53ef\u9810\u671f\uff0c\u56e0\u6b64\u4e00\u958b\u59cb\u5373\u53ef\u4ee5\u6700\u5feb\u901f\u5ea6\u8f38\u8840\u3002 (E)\u82e5\u8f38\u8840\u6642\u767c\u71d2\uff0c\u53ea\u9700\u8981\u7528\u6297\u7d44\u7e54\u80fa\u85e5\u7269\u5982\uff1adiphenhydramine \u6cbb\u7642\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "78 \u6b72\u5973\u6027\u75c5\u60a3\uff0c\u60a3\u6709 40 \u5e74\u7cd6\u5c3f\u75c5\uff0c\u5e73\u6642\u8840\u7cd6\u63a7\u5236\u4e0d\u826f\u3002\u6b64\u6b21\u5230\u6025\u8a3a\u4e3b\u8a34\uff0c \u4e8c\u9031\u4ee5\u4f86\uff0c\u53f3\u8db3\u51fa\u73fe\u6f70\u721b\u6027\u50b7\u53e3\uff0c\u4e14\u60a3\u90e8\u7d05\u816b\u65e5\u6f38\u64f4\u5927\u3002\u611f\u67d3\u79d1\u91ab\u5e2b\u7684\u81e8 \u5e8a\u8a3a\u65b7\u70ba limb-threatening cellulitis\u3002\u8acb\u554f\uff1a\u9664\u4e86\u5916\u79d1\u6cbb\u7642\u5916\uff0c\u4ee5\u4e0b\u54ea\u4e00\u7a2e\u975c \u8108\u6ce8\u5c04\u6297\u751f\u7d20\uff0c\u6700\u4e0d\u9069\u7576\uff1f", + "Options": "(A)Ampicillin-sulbactam\u3002 (B)Aztreonam + clindamycin\u3002 (C)Cefoxitin\u3002 (D)Extended-spectrum fluroquinolone\u3002 (E)Piperacillin-tazobactam\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "32 \u6b72\u7537\u6027\u4e3b\u8a34\u56db\u80a2\u7121\u529b\uff0c\u610f\u8b58\u6e05\u695a\uff0c\u8fd1\u7aef\u80a2\u9ad4\u8f03\u9060\u7aef\u7121\u529b\uff0c\u773c\u7403\u6d3b\u52d5\u529b\u7570 \u5e38\uff0c\u77b3\u5b54\u5c0d\u5149\u53cd\u5c04\u4e0d\u826f\uff0c\u56db\u80a2\u611f\u89ba\u548c\u53cd\u5c04\u7686\u6b63\u5e38\uff0c\u4ee5\u4e0b\u8a3a\u65b7\u4f55\u8005\u6700\u70ba\u9069\u7576\uff1f", + "Options": "(A)\u8089\u6bd2\u687f\u83cc\u4e2d\u6bd2 botulism\u3002 (B)\u91cd\u75c7\u808c\u7121\u529b\u75c7 myasthemia gravis\u3002 (C)\u6025\u6027\u6f38\u6b47\u6027\u7d2b\u8cea\u75c7 acute intermittent porphyria\u3002 (D)\u925b\u4e2d\u6bd2 lead poisoning\u3002 (E)Guillain-Barr\u00e9 syndrome\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u95dc\u65bc Guillain-Barr\u00e9 syndrome(GBS)\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u662f\u6700\u5e38\u898b\u7684\u6025\u6027\u5168\u8eab\u6027\u795e\u7d93\u75c5\u8b8a\uff0c\u75c5\u60a3\u901a\u5e38\u4e4b\u524d\u6709\u904e\u75c5\u6bd2\u611f\u67d3\u75c5\u53f2\uff0c \u5982\u8178\u80c3\u708e\u3002 (B)\u4e3b\u8981\u5f71\u97ff\u7684\u662f\u904b\u52d5\u795e\u7d93\uff0c\u8868\u73fe\u70ba\u4e0d\u5c0d\u7a31\u7684\u80a2\u9ad4\u7121\u529b\uff0c\u901a\u5e38\u5148\u5f71\u97ff\u4e0b \u80a2\u7136\u5f8c\u662f\u4e0a\u80a2\u3002 (C)\u795e\u7d93\u5b78\u6aa2\u67e5\u6700\u660e\u986f\u7684\u5c31\u662f\u75c5\u60a3\u6703\u5931\u53bb\u6df1\u90e8\u808c\u8171\u53cd\u5c04(absence of deep tendon reflex)\u3002 (D)\u96d6\u7136\u75c5\u60a3\u6703\u6709\u4e00\u4e9b\u611f\u89ba\u7570\u5e38\u7684\u4e3b\u8a34\uff0c\u4f46\u662f\u795e\u7d93\u5b78\u6aa2\u67e5\u611f\u89ba\u795e\u7d93\u61c9\u8a72 \u662f\u6b63\u5e38\u7684\u3002 (E)Guillain-Barr\u00e9 syndrome \u7684\u767c\u751f\u548c\u6025\u6027 campylobacter jejuni \u611f\u67d3\u6709 \u95dc\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u3127\u540d 27 \u6b72\u5a66\u5973\uff0c\u56e0\u70ba\u7672\u7647\u767c\u4f5c\u88ab\u9001\u81f3\u6025\u8a3a\uff0c\u8840\u58d3 165/90 mmHg\u3001Glasgow coma scale(GCS)10 \u5206\uff0c\u4ee5\u524d\u6c92\u6709\u7672\u7647\u75c5\u53f2\uff0c\u61f7\u5b55 32 \u9031\uff0c\u7406\u5b78\u6aa2\u67e5\u767c\u73fe \u660e\u986f\u4e0b\u80a2\u6c34\u816b\uff0c\u4e0b\u5217\u95dc\u65bc\u6b64\u75c5\u60a3\u7684\u6cbb\u7642\u8207\u8655\u7f6e\uff0c\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u4e88\u4ee5\u975c\u8108\u6ce8\u5c04\u786b\u9178\u9382 6g\uff0c15 \u5206\u9418\u6ce8\u5c04\u5b8c\u7562\u3002 (B)\u5fc5\u9808\u6aa2\u9a57\u809d\u529f\u80fd\u3001\u814e\u529f\u80fd\u3001\u5168\u8840\u7403\u542b\u8840\u5c0f\u677f\u3002 (C)\u5fc5\u9808\u7acb\u5373\u5b89\u6392\u8166\u90e8\u96fb\u8166\u65b7\u5c64\u6383\u63cf\u6aa2\u67e5\u3002 (D)\u82e5\u7121\u660e\u986f\u51fa\u8840\uff0c\u61c9\u9650\u5236\u975c\u8108\u8f38\u6db2\u7684\u7d66\u4e88\u3002 (E)\u7d66\u4e88 furosemide \u5229\u5c3f\u5291\u4f7f\u7528\u4fc3\u9032\u5229\u5c3f\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u4e00\u4f4d 34 \u6b72\u5973\u6027\uff0c\u5728\u4e00\u5468\u524d\u7684\u4e0d\u5b55\u75c7\u9580\u8a3a\u63a5\u53d7\u4fc3\u6027\u817a\u6fc0\u7d20(gonadotropin)\u6cbb \u7642\u5f8c\uff0c\u8fd1\u65e5\u5167\u9010\u6f38\u81ea\u89ba\u547c\u5438\u6025\u4fc3\uff0c\u8179\u75db\u5408\u4f75\u5641\u5fc3\u5614\u5410\uff0c\u4ee5\u53ca\u8179\u570d\u53ca\u9ad4\u91cd\u589e \u52a0\uff0c\u5c31\u8a3a\u7576\u5929\u5c3f\u91cf\u660e\u986f\u6e1b\u5c11\u3002\u4e0b\u5217\u76f8\u95dc\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u4f7f\u7528\u4fc3\u6027\u817a\u6fc0\u7d20\u523a\u6fc0\u6392\u5375\u7684\u75c5\u60a3\u4e2d\uff0c\u7d04\u6709\u56db\u5206\u4e4b\u3127\u6703\u7522\u751f\u8f15\u5fae\u75c7\u72c0\uff0c \u50cf\u4e0a\u8ff0\u56b4\u91cd\u75c7\u72c0\u8005\uff0c\u7d04\u4e0d\u5230 2%\u3002 (B)\u9700\u6301\u7e8c\u8840\u6c27\u76e3\u6e2c\u4ee5\u53ca\u5fc3\u96fb\u5716\u76e3\u6e2c\u3002 (C)\u9700\u57f7\u884c\u8a73\u7d30\u7684\u8179\u90e8\u6aa2\u67e5\uff0c\u7279\u5225\u662f\u6df1\u89f8\u8a3a\u53ca\u9aa8\u76c6\u8154\u6aa2\u67e5(pelvic exam)\uff0c \u4ee5\u65e9\u671f\u8fa8\u8b58\u51fa\u56b4\u91cd\u75c5\u7076\u3002 (D)\u5be6\u9a57\u5ba4\u6aa2\u67e5\u5305\u62ec\u96fb\u89e3\u8cea\u3001\u814e\u529f\u80fd\u3001\u5168\u8840\u7403\u8a08\u6578(CBC)\u3001\u51dd\u8840\u529f\u80fd\u3001 \u4ee5\u53ca\u5099\u8840\u7b49\u3002 (E)\u56b4\u91cd\u7684\u4f75\u767c\u75c7\u5305\u62ec\u808b\u819c\u6216\u8179\u819c\u7a4d\u6c34\u3001\u814e\u8870\u7aed\u3001\u5375\u5de2\u626d\u8f49\u6216\u56ca\u816b\u7834\u88c2\u3001 \u4ee5\u53ca\u6210\u4eba\u547c\u5438\u7a98\u8feb\u75c7\u5019\u7fa4\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5152\u7ae5\u7672\u7647\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u5c07\u8fd1\u6709 50%\u5c6c\u539f\u56e0\u4e0d\u660e\u6027(idiopathic)\u7672\u7647\u3002 (B)\u56e0\u7672\u7647\u53ef\u80fd\u9020\u6210\u8166\u90e8\u50b7\u5bb3\uff0c\u7b2c\u4e00\u6b21\u767c\u4f5c\u61c9\u7acb\u5373\u7d66\u8207\u6297\u7672\u7647\u85e5\u7269\u3002 (C)\u5c0d\u65b0\u751f\u5152\u800c\u8a00\uff0c\u8166\u90e8\u8d85\u97f3\u6ce2\u53ef\u6392\u9664\u51fa\u8840\u6216\u6c34\u816b\u7b49\u72c0\u6cc1\u3002 (D)\u4f4e\u8840\u7cd6\u6216\u4f4e\u8840\u9223\u4e5f\u53ef\u80fd\u662f\u539f\u56e0\u3002 (E)\u767c\u71d2\u6027\u7672\u7647(febrile seizure)\u591a\u767c\u751f\u65bc 6 \u500b\u6708\u5230 5 \u6b72\u4e4b\u9593\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u5152\u7ae5\u51fa\u8840\u6027\u4f11\u514b\u6642\u8655\u7406\u6b65\u9a5f\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u5148\u7d66\u65bc 20ml/kg \u4e4b Ringer's lactate\u3002 (B)\u82e5\u8840\u58d3\u4ecd\u4e0d\u7a69\u5b9a\uff0c\u53ef\u4ee5\u91cd\u8907\u7d66\u65bc\u4e00\u81f3\u4e8c\u6b21 Ringer's lactate\u3002 (C)\u82e5\u8840\u58d3\u4ecd\u4e0d\u7a69\u5b9a\uff0c\u53ef\u7d66\u4e88 20 ml/kg \u7d05\u8840\u7403\u6fc3\u539a\u6db2(Packed RBC)\u3002 (D)\u7121\u6cd5\u5efa\u7acb\u975c\u8108\u6ef4\u6ce8\u6642\uff0c\u53ef\u4ee5\u9032\u884c venous cutdown \u6216 intraosseous injection\u3002 (E)\u5c3f\u91cf\u53ca\u5c3f\u6bd4\u91cd\u53ef\u4ee5\u63d0\u4f9b\u6025\u6551\u6642\u6db2\u9ad4\u7d66\u8db3\u8207\u5426\u4e4b\u91cd\u8981\u8cc7\u8a0a\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u4e00\u4f4d 76 \u6b72\u7537\u6027\u56e0\u547c\u5438\u6025\u4fc3\u9001\u4f86\u6025\u8a3a\uff0c\u75c5\u4eba\u9664\u9ad8\u8840\u58d3\u5916\u7121\u5176\u4ed6\u75be\u75c5\u53f2\u3002\u80f8\u90e8 X \u5149\u767c\u73fe\u6709\u808b\u819c\u7a4d\u6c34\uff0c\u808b\u819c\u6c34\u6aa2\u67e5\u7d50\u679c\u70ba\uff1a\u86cb\u767d\u8cea(protein)1.5 g/dL\uff0c\u4e73 \u9178\u812b\u6c2b\u9176(LDH)80 U/L\u3002\u8840\u4e2d\u7684\u86cb\u767d\u8cea 3.6 g/dL\uff0c\u4e73\u9178\u812b\u6c2b\u9176(LDH)201 U/L\u3002\u4f9d\u4e0a\u8ff0\u6aa2\u67e5\u7d50\u679c\uff0c\u6709\u95dc\u65bc\u6700\u53ef\u80fd\u7684\u539f\u56e0\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u81ea\u9ad4\u514d\u75ab\u75be\u75c5\u3002 (B)\u539f\u767c\u6216\u8f49\u79fb\u6027\u60e1\u6027\u816b\u7624\u3002 (C)\u7d30\u83cc\u6027\u80ba\u708e\u3002 (D)Amiodarone \u9020\u6210\u7684\u9593\u8cea\u6027\u80ba\u708e\u3002 (E)\u9b31\u8840\u6027\u5fc3\u8870\u7aed\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u4e00\u4f4d 90 \u6b72\u5973\u6027\u56e0\u767c\u71d2\u9001\u4f86\u6025\u8a3a\uff0c\u6b64\u75c5\u4eba\u9577\u671f\u4f4f\u5728\u5b89\u990a\u9662\uff0c\u6709\u5931\u667a\u75c7\u8207\u7cd6\u5c3f \u75c5\u75c5\u53f2\uff0c\u6700\u8fd1\u4e00\u500b\u6708\u5167\u6c92\u5230\u904e\u91ab\u9662\u3002\u7d93\u4f60\u6aa2\u67e5\u5f8c\u61f7\u7591\u662f\u80ba\u708e\uff0c\u6709\u95dc\u65bc\u6b64\u75c5 \u4eba\u80ba\u708e\u7684\u81f4\u75c5\u539f\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)Mycoplasma pneumoniae \u8207 Legionella \u662f\u9019\u4e9b\u4f4f\u5728\u5b89\u990a\u9662\u75c5\u4eba\u5e38\u898b\u7684 \u80ba\u708e\u81f4\u75c5\u539f\u3002 (B)\u56e0\u6b64\u985e\u75c5\u4eba\u6bd4\u8f03\u6c92\u6a5f\u6703\u51fa\u5916\u63a5\u89f8\u4eba\u7fa4\uff0c\u6240\u4ee5\u4e0d\u5bb9\u6613\u53d7\u5230\u6d41\u884c\u6027\u611f\u5192 \u75c5\u6bd2\u611f\u67d3\u3002 (C)\u5b89\u990a\u9662\u75c5\u4eba\u82e5\u5f97\u5230\u80ba\u708e\uff0c\u6700\u5e38\u898b\u7684\u81f4\u75c5\u539f\u70ba Pseudomonas aeruginosa\u3002 (D)\u70ba\u9019\u4e9b\u5b89\u990a\u9662\u8001\u4eba\u65bd\u6253\u6d41\u884c\u6027\u611f\u5192\u75ab\u82d7\uff0c\u9810\u9632\u6d41\u611f\u5f8c\u80ba\u708e (postinfluenzal pneumonia)\u7684\u6548\u679c\u53ef\u9054\u5230 80%\u3002 (E)\u6700\u5e38\u898b\u7684\u7d30\u83cc\u70ba Streptococcus pneumoniae\uff0cgram-negative bacilli \u4ee5\u53ca Haemophilius influenzae\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u4e00\u4f4d 55 \u6b72\u9577\u671f\u9152\u766e\u7684\u7537\u6027\u75c5\u4eba\u7531\u5bb6\u5c6c\u5e36\u4f86\u6025\u8a3a\uff0c\u4e3b\u8a34\u54b3\u55fd\u767c\u71d2\u5169\u500b\u661f\u671f\uff0c \u4e26\u6709\u9ad4\u91cd\u6e1b\u8f15\u4e14\u591c\u9593\u76dc\u6c57\u7684\u60c5\u5f62\uff0c\u62bd\u8840\u6aa2\u67e5\u767d\u8840\u7403\u4e0a\u5347\u53ca\u767c\u708e\u6307\u6578\u4e0a\u5347\uff0c \u80f8\u90e8 X \u5149\u986f\u793a\u5728\u5de6\u4e0b\u80ba\u6709\u4e00\u500b\u7d04\u4e94\u516c\u5206\u958b\u6d1e\u4e26\u6709 air-fluid level \u7684\u75c5\u7076\uff0c\u4e0b \u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u80ba\u90e8\u81bf\u760d\u5728\u514d\u75ab\u6b63\u5e38\u8005\u4e3b\u8981\u662f\u4ee5\u597d\u6c27\u83cc(aerobic)\u70ba\u4e3b\uff0c\u800c\u5728\u514d\u75ab \u4e0d\u5168\u8005\u4e3b\u8981\u662f\u4ee5\u53ad\u6c27\u83cc(anaerobic)\u7684\u611f\u67d3\u70ba\u4e3b\u3002 (B)\u6cbb\u7642\u4e0a\uff0c\u55ae\u7528\u6297\u751f\u7d20\u6cbb\u7642\u7684\u5931\u6557\u7387\u592a\u9ad8\uff0c\u61c9\u8a72\u8981\u914d\u5408\u59ff\u614b\u6027\u5f15\u6d41 (postural drainage)\u6216\u662f\u652f\u6c23\u7ba1\u93e1\u5f15\u6d41(bronchoscopic drainage)\u4ee5 \u52a0\u901f\u75ca\u7652 (C)\u5167\u79d1\u6cbb\u7642\u5931\u6557\u7684\u53ef\u80fd\u56e0\u7d20\u5305\u62ec\u5927\u7684\u7a7a\u6d1e\uff0c\u7a7a\u6d1e\u7684\u58c1\u5f88\u539a\uff0c\u81bf\u80f8\u7684\u7522 \u751f\uff0c\u4ee5\u53ca\u6709\u5835\u585e\u3002 (D)\u80f8\u90e8 X \u5149\u662f\u8ffd\u8e64\u81e8\u5e8a\u9032\u5c55\u5f88\u597d\u7684\u4f9d\u64da\u3002 (E)\u5927\u7d04 5 \u6210\u75c5\u60a3\u6700\u7d42\u9700\u8981\u5916\u79d1\u6cbb\u7642\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u5c0d\u65bc\u6c2b\u6c1f\u9178(HF)\u4e4b\u6cbb\u7642\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u53ef\u4f7f\u7528\u6700\u9ad8\u81f3 33%\u7684\u8461\u8404\u7cd6\u9178\u9223\u6eb6\u6db2\u5c40\u90e8\u6d78\u6ce1\u5230\u75bc\u75db\u964d\u4f4e\u3002 (B)\u53ef\u4f7f\u7528\u8461\u8404\u7cd6\u9178\u9223\u6eb6\u6db2\u6216\u6c2f\u5316\u9223\u6eb6\u6db2\u5728\u66b4\u9732\u90e8\u4f4d\u5c40\u90e8\u6ce8\u5c04\u3002 (C)\u53ef\u4f7f\u7528\u8461\u8404\u7cd6\u9178\u9223\u6eb6\u6db2\u52d5\u8108\u9023\u7e8c\u704c\u6ce8\u6216\u975c\u8108\u5c40\u90e8\u704c\u6ce8\u3002 (D)\u82e5\u98df\u5165 HF\uff0c\u53ef\u7d66\u4e88\u725b\u5976\u3001\u542b\u9223\u6eb6\u6db2\u3001\u542b\u9382\u80c3\u4e73\u3001\u9223\u7247\u6216\u542b\u9382\u80c3\u4e73\u7247\uff0c \u4ee5\u7d50\u5408\u6709\u6bd2\u6c1f\u96e2\u5b50\u3002 (E)\u82e5\u6709\u5168\u8eab\u6027\u75c7\u72c0\uff0c\u4e3b\u8981\u6cbb\u7642\u70ba\u77ef\u6b63\u4f4e\u8840\u9223\uff0c\u53ef\u6839\u64da\u8840\u4e2d\u6e38\u96e2\u9223\u503c\uff0c \u7528\u8461\u8404\u7cd6\u9178\u9223\u6216\u6c2f\u5316\u9223\u4f86\u52a0\u4ee5\u88dc\u5145\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u5c0d\u65bc\u8b8a\u6027\u8840\u7d05\u7d20\u8840\u75c7(methemoglobinemia)\u7684\u6558\u8ff0\uff0c\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u6709\u5f88\u591a\u56e0\u7d20\u6703\u9020\u6210\u8b8a\u6027\u8840\u7d05\u7d20\u8840\u75c7\uff0c\u5982\u5148\u5929\u6027\u56e0\u7d20\u6216\u67d0\u4e9b\u85e5\u7269\u5f15\u8d77\uff0c \u5982 nitrates\uff0clidocaine\uff0cacetaminophen \u7b49\u3002 (B)\u75c5\u4eba\u6703\u6709\u767c\u7d3a(cyanosis)\u7684\u73fe\u8c61\uff0c\u4f7f\u7528 pulse oxymeter \u6e2c\u91cf\u8840\u6c27\u6fc3 \u5ea6\u6642\uff0c\u53ef\u4ee5\u767c\u73fe\u8840\u6c27\u6fc3\u5ea6\u504f\u4f4e\u3002 (C)\u75c5\u4eba\u7684\u8840\u6db2\u5728\u8b8a\u6027\u8840\u7d05\u7d20\u5927\u65bc 10%\u6642\uff0c\u6703\u5448\u73fe\u5de7\u514b\u529b\u68d5\u8272 (chocolate-brown) \u3002 (D)\u6b64\u985e\u75c5\u4eba\u5176\u6c27\u5408\u8840\u7d05\u7d20\u5206\u96e2\u66f2\u7dda(oxyhemoglobin dissociation curve) \u6703\u5411\u5de6\u504f\u79fb(shift to left) \u3002 (E)\u56b4\u91cd G6PD \u7f3a\u4e4f\u75c7\u60a3\u8005\u4f7f\u7528\u7532\u57fa\u85cd(methylene blue)\u4f86\u6cbb\u7642\u8b8a\u6027\u8840 \u7d05\u7d20\u8840\u75c7\u6642\uff0c\u53ef\u80fd\u4f7f\u60a3\u8005\u7522\u751f\u6eb6\u8840\u6027\u8ca7\u8840\uff0c\u61c9\u5728\u4f7f\u7528\u524d\u5145\u5206\u544a\u77e5\u75c5 \u60a3\u53ca\u5bb6\u5c6c\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u5169\u4f4d\u56e0\u6e05\u6d17\u6eab\u6cc9\u6c34\u69fd\u800c\u660f\u8ff7\u7684\u75c5\u4eba\u88ab\u9001\u5230\u6025\u8a3a\u5ba4\uff0c\u64da EMT \u4eba\u54e1\u63cf\u8ff0\u73fe\u5834\u8ff7 \u6f2b\u8457\u81ed\u96de\u86cb\u7684\u5473\u9053\u3002\u5c0d\u65bc\u6b64\u5169\u4f4d\u75c5\u4eba\u7684\u6558\u8ff0\uff0c\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u5169\u4f4d\u75c5\u4eba\u53ef\u80fd\u662f\u786b\u5316\u6c2b(H2S)\u4e2d\u6bd2\u3002 (B)\u6551\u63f4\u4eba\u54e1\u6700\u597d\u651c\u5e36\u81ea\u651c\u5f0f\u547c\u5438\u8a2d\u5099(self-contained breathing apparatus) \u3002 (C)\u5728\u4e8b\u767c\u73fe\u5834\uff0c\u82e5\u75c5\u4eba\u6c92\u6709\u547c\u5438\uff0c\u5247\u7d66\u4e88\u75c5\u4eba\u53e3\u5c0d\u53e3\u4eba\u5de5\u547c\u5438\u3002 (D)\u89e3\u6bd2\u5291\u53ef\u8003\u616e\u7d66\u75c5\u60a3\u5438 amyl nitrite \u548c\u975c\u8108\u6ce8\u5c04 sodium nitrite\u3002 (E)\u75c5\u4eba\u53ef\u8003\u616e\u4f7f\u7528\u9ad8\u58d3\u6c27\u6cbb\u7642\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6709\u6a5f\u78f7\u4e2d\u6bd2\u7684\u6bd2\u6027\u75c7\u5019\u7fa4(toxidromes)\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u4e59\u70ef\u81bd\u9e7c(acetylcholine)\u63a5\u53d7\u5668\u6578\u91cf\u8207\u6d3b\u6027\u589e\u52a0\u6240\u5f15\u8d77\u3002 (B)\u8a18\u61b6\u53e3\u8a23\u70ba SLUDGE-BAM\uff0c\u5305\u62ec\u553e\u6db2\u589e\u52a0(salivation)\u3001\u6dda\u6db2\u589e\u52a0 (lacrimation)\u7b49\u3002 (C)\u8a18\u61b6\u53e3\u8a23\u70ba DUMBELS\uff0c\u5305\u62ec\u8179\u7009(diarrhea)\u3001\u589e\u52a0\u6392\u5c3f(urination)\u3001 \u7e2e\u77b3(miosis)\u7b49\u3002 (D)\u9020\u6210\u6240\u8b02\u7684\u81bd\u9e7c\u6027\u5371\u75c7(cholinergic crisis)\uff0c\u75c7\u72c0\u9084\u6709\u8179\u90e8\u4e0d\u9069 (abdominal discomfort)\u3001\u5614\u5410(emesis)\u7b49\u3002 (E)\u526f\u4ea4\u611f\u795e\u7d93\u8208\u596e\uff0c\u5176\u4e2d\u5fc3\u640f\u904e\u7de9\u3001\u652f\u6c23\u7ba1\u5206\u6ccc\u589e\u52a0\u3001\u547c\u5438\u56f0\u96e3\u70ba\u6700 \u5e38\u898b\u81f4\u6b7b\u539f\u56e0\uff0c\u7a31\u70ba\u300ckiller B's\u300d\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u4e00\u4f4d 35 \u6b72\u5973\u6027\uff0c\u56e0\u5148\u751f\u5916\u9047\u800c\u5728\u53e3\u89d2\u5f8c\u5fc3\u60c5\u4f4e\u843d\uff0c\u541e\u4e0b\u4e86 50 \u9846\u5f9e\u7f8e\u570b\u5e36 \u56de\u4f86\u7684 extra-strength Tylenol\u30023 \u500b\u5c0f\u6642\u5f8c\u5979\u88ab\u53cb\u4eba\u767c\u73fe\u800c\u9001\u4f86\u6025\u8a3a\u3002\u7d93\u62bd\u8840 \u6aa2\u67e5\uff0c\u5979 4 \u5c0f\u6642\u7684\u8840\u4e2d acetaminophen \u7684\u6fc3\u5ea6\u70ba 350 \u00b5g/mL\u3002\u5979\u4e3b\u8a34\u7121\u4efb\u4f55 \u4e0d\u8212\u670d\uff0c\u4e26\u4e14\u8981\u6c42\u8981\u56de\u5bb6\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u5728\u8a73\u7d30\u89e3\u91cb\u8fd4\u5bb6\u5f8c\u7684\u6ce8\u610f\u4e8b\u9805\uff0c\u4e26\u53ee\u5680\u75c5\u4eba\u5982\u6709\u4efb\u4f55\u4e0d\u9069\u5c31\u8981\u56de\u5230 \u6025\u8a3a\u5f8c\uff0c\u53ef\u8b93\u75c5\u4eba\u56de\u5bb6\u3002 (B)\u89c0\u5bdf 6 \u5c0f\u6642\uff0c\u5982\u75c5\u4eba\u4ecd\u7121\u4efb\u4f55\u4e0d\u9069\uff0c\u5247\u53ef\u8b93\u75c5\u4eba\u56de\u5bb6\u3002 (C)\u5b89\u6392\u75c5\u4eba\u4f4f\u9662\u89c0\u5bdf\uff0c\u56e0\u9577\u6548\u578b\u7684\u85e5\u7269\u6240\u5f15\u8d77\u7684\u75c7\u72c0\u53ef\u80fd\u6703\u5ef6\u9072\u8868\u73fe\u3002 (D)\u5b89\u6392\u4f4f\u9032\u7cbe\u795e\u79d1\u75c5\u623f\uff0c\u4ee5\u9810\u9632\u75c5\u4eba\u518d\u6b21\u81ea\u6bba\u3002 (E)\u958b\u59cb\u4f7f\u7528 N-acetylcysteine \u7684\u6cbb\u7642\uff0c\u4e26\u5b89\u6392\u75c5\u4eba\u4f4f\u9662\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u6709\u95dc\u88ab\u9396\u93c8\u86c7\u54ac\u50b7\u4e4b\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u50b7\u53e3\u5e38\u4e0d\u816b\u8139\uff0c\u6709\u9ebb\u75fa\u611f\u3002 (B)\u5f88\u65e9\u671f\u5373\u53ef\u80fd\u7522\u751f\u814e\u8870\u7aed\u3002 (C)\u6bd2\u6db2\u5982\u5674\u5230\u76ae\u819a\u6703\u5f15\u8d77\u76ae\u819a\u6f70\u760d\u3002 (D)\u5982\u4e0d\u5373\u6642\u6cbb\u7642\uff0c\u81f4\u6b7b\u539f\u56e0\u70ba\u547c\u5438\u8870\u7aed\u3002 (E)\u5982\u75c5\u4eba\u5c0d\u6297\u9396\u93c8\u86c7\u6297\u9ad4\u4e4b\u76ae\u819a\u8a66\u9a57\u70ba\u967d\u6027\u53cd\u61c9\uff0c\u4e0d\u53ef\u4f7f\u7528\u6297\u9396\u93c8\u86c7 \u6297\u9ad4\u6cbb\u7642\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u541e\u5165\u7570\u7269\u4e4b\u8655\u7f6e\uff0c\u4e0b\u5217\u654d\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u5152\u7ae5\u82e5\u541e\u4e0b\u9215\u6263\u578b\u96fb\u6c60\u5361\u4f4f\u98df\u9053\uff0c\u9700\u5118\u901f\u53d6\u51fa\uff0c\u5426\u5247\u5373\u4f7f\u5c0f\u65bc 6 \u5c0f \u6642\u4ea6\u53ef\u80fd\u9020\u6210\u98df\u9053\u7834\u88c2\u3002 (B)\u5152\u7ae5\u82e5\u541e\u4e0b\u9215\u6263\u578b\u96fb\u6c60\u5df2\u901a\u904e\u98df\u9053\u4e14\u7121\u75c7\u72c0\uff0c\u5247\u7121\u6025\u8feb\u6027\uff0c\u6bcf\u9031 X \u5149\u8ffd\u8e28\u6aa2\u67e5\u5373\u53ef\u3002 (C)\u82e5\u541e\u5165\u4fdd\u96aa\u5957\u5c01\u88dd\u7684\u53e4\u67ef\u9e7c\u5361\u4f4f\u98df\u9053\uff0c\u61c9\u5118\u5feb\u7167\u6703\u8178\u80c3\u79d1\u91ab\u5e2b\u9032\u884c \u5167\u8996\u93e1\u53d6\u51fa\u3002 (D)\u82e5\u541e\u5165\u5c16\u92b3\u7269\u54c1\u9577\u5ea6\u5927\u65bc 5cm\uff0c\u5bec\u5ea6\u5927\u65bc 2cm\uff0c\u5247\u901a\u904e\u80c3\u90e8\u7684\u6a5f\u7387 \u76f8\u7576\u4f4e \u3002 (E)\u5152\u7ae5\u82e5\u541e\u4e0b\u786c\u5e63\u5361\u4f4f\u98df\u9053\uff0c24 \u5c0f\u6642\u5167\u53ef\u8003\u616e\u4f7f\u7528 Foley \u5c0e\u7ba1\u79fb\u9664\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6d88\u5316\u9053\u51fa\u8840\u6642\u4ee5\u9f3b\u80c3\u7ba1\u8655\u7f6e\u7684\u89c0\u5ff5\uff0c\u4e0b\u5217\u654d\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u7591\u4f3c\u4e0b\u6d88\u5316\u9053\u51fa\u8840\u7684\u60a3\u8005\u4e0d\u5fc5\u653e\u7f6e\u9f3b\u80c3\u7ba1\u3002 (B)\u653e\u7f6e\u9f3b\u80c3\u7ba1\u5f88\u53ef\u80fd\u5f15\u8d77\u60a3\u8005\u975c\u8108\u66f2\u5f35\u7834\u88c2\u51fa\u8840\uff0c\u61c9\u76e1\u53ef\u80fd\u907f\u514d\u3002 (C)\u5f9e\u809b\u9580\u6392\u51fa\u9bae\u7d05\u8272\u8840\u4fbf\uff0c\u51fa\u8840\u6e90\u982d\u5fc5\u5b9a\u5728\u4e0b\u6d88\u5316\u9053\u3002 (D)\u9f3b\u80c3\u7ba1\u5f15\u6d41\u7269\u4e26\u7121\u7570\u5e38\u6642\u4ecd\u4e0d\u80fd\u6392\u9664\u4e0a\u6d88\u5316\u9053\u51fa\u8840\u3002 (E)\u4e0a\u6d88\u5316\u9053\u51fa\u8840\u6642\u61c9\u4ee5\u51b0\u6c34\u4f5c\u9f3b\u80c3\u7ba1\u6c96\u6d17\uff0c\u56e0\u70ba\u5be6\u8b49\u91ab\u5b78\u986f\u793a\u4f4e\u6eab\u53ef \u6709\u52a9\u65bc\u6b62\u8840\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u4e00\u540d 35 \u6b72\u9577\u671f\u9157\u9152\u7537\u6027\u75c5\u60a3\u56e0\u4e0a\u8179\u75db\u81f3\u6025\u8a3a\uff0c\u5176\u9ad4\u6eab\u70ba 37.8\u2103\uff0c\u5fc3\u8df3 120 \u6b21/\u5206\uff0c\u8840\u58d3 100/70 mmHg\uff0c\u5176\u767d\u8840\u7403\u70ba 13000/mm3\uff0csegment 80%\uff0c band 5%\uff0cAST 60 U/L\uff0clipase 1800 U/L\uff0c\u8acb\u554f\u4e0b\u5217\u4f55\u9805\u6cbb\u7642\u5c0d\u6b64\u75c5\u60a3\u76ee\u524d\u6700\u70ba\u91cd \u8981\uff1f", + "Options": "(A)\u7b2c\u4e00\u4ee3\u6216\u7b2c\u4e8c\u4ee3\u982d\u82bd\u80de\u83cc\u7d20\u7684\u7d66\u4e88(1st or 2nd generation of cephalosporins)\u3002 (B)\u8f38\u6db2\u7684\u88dc\u5145(fluid resuscitation)\u3002 (C)Gabexate mesilate(protease inhibitor)\u975c\u8108\u6ce8\u5c04\u3002 (D)\u55ce\u5561\u6b62\u75db\u5291\u975c\u8108\u6216\u808c\u8089\u6ce8\u5c04(narcotics)\u3002 (E)\u9f3b\u80c3\u7ba1\u5f15\u6d41(NG tube drainage)\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u4e00\u540d 5 \u6b72\u7537\u7ae5\u81ea\u8ff0\u534a\u5c0f\u6642\u524d\u541e\u5165 5 \u5143\u5927\u5c0f\u4e4b\u5851\u81a0\u73a9\u5177\u786c\u5e63\uff0c\u5176\u5bb6\u9577\u5e36\u81f3\u6025 \u8a3a\u6642\u8868\u793a\u6c92\u6709\u76ee\u64ca\u4e8b\u4ef6\u767c\u751f\uff0c\u75c5\u60a3\u547c\u5438\u5e73\u9806\u4e14\u7121\u80f8\u75db\u53ca\u8179\u75db\u60c5\u5f62\uff0c\u4f46\u75c5\u60a3 \u537b\u7121\u6cd5\u541e\u56a5\u53e3\u6c34\uff0c\u7d93 neck soft tissue\uff0c CXR \u53ca KUB \u6aa2\u67e5\u7121\u660e\u986f\u7570\u7269\u53ca\u7570\u5e38\uff0c \u8acb\u554f\u4ee5\u4e0b\u5217\u4f55\u8005\u8655\u7f6e\u6700\u9069\u7576\uff1f", + "Options": "(A)Chest computer tomography\u3002 (B)Endoscopic removal\u3002 (C)Foley catheter removal\u3002 (D)Intravenous glucagon administration\u3002 (E)Sublingually nifedipine use\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u8178\u5957\u758a\u662f\u5152\u7ae5\u5e38\u898b\u7684\u8179\u75db\u6025\u75c7\uff0c\u4e0b\u5217\u654d\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u767c\u75c5\u6642\uff0c\u75c5\u7ae5\u6703\u6709\u7a81\u7136\u7684\u6025\u6027\u8179\u75db\u3002 (B)\u8349\u8393\u91ac\u6a23\u4fbf(currant jelly stool)\u662f\u5178\u578b\u7684\u75c7\u72c0\u3002 (C)\u8d85\u97f3\u6ce2\u53ef\u767c\u73fe\u6709\u534a\u6708\u5fb5\u8c61(crescent sign)\u3002 (D)\u92c7\u5291\u704c\u8178\u662f\u8a3a\u65b7\u65b9\u5f0f\u4e4b\u4e00\u3002 (E)\u6700\u53ef\u80fd\u767c\u751f\u5728\u8ff4\u8178\u5957\u7d50\u8178\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u4e00\u540d 4 \u5929\u5927\u5973\u5b30\uff0c\u56e0\u8840\u4fbf\u53ca\u6301\u7e8c\u8179\u8139\u88ab\u9001\u81f3\u6025\u8a3a\uff0c\u96fb\u8166\u65b7\u5c64\u767c\u73fe pneumatosis intestinalis \u61f7\u7591\u662f\u58de\u6b7b\u6027\u8178\u708e(necrotizing enterocolitis)\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f \u8aa4\uff1f", + "Options": "(A)\u597d\u767c\u7684\u65cf\u7fa4\u662f\u65e9\u7522\u5152\u548c\u4f4e\u9ad4\u91cd\u7684\u65b0\u751f\u5152\u3002 (B)\u6bcd\u89aa\u4f7f\u7528\u53e4\u67ef\u9e7c\u662f\u8db3\u6708\u5b30\u5152\u767c\u751f\u58de\u6b7b\u6027\u8178\u708e\u7684\u5371\u96aa\u56e0\u5b50\u4e4b\u4e00\u3002 (C)\u5982\u679c\u592a\u665a\u8a3a\u65b7\u51fa\u4f86\u53ef\u80fd\u5c0e\u81f4\u8178\u7a7f\u5b54\uff0c\u6557\u8840\u6027\u4f11\u514b\u3002 (D)\u5be6\u9a57\u5ba4\u8a3a\u65b7\u5c0d\u65bc\u8a3a\u65b7\u58de\u6b7b\u6027\u8178\u708e\u4e26\u7121\u7279\u7570\u6027\u3002 (E)\u4e0d\u7ba1\u6709\u7121\u8178\u7a7f\u5b54\uff0c\u58de\u6b7b\u6027\u8178\u708e\u7684\u75c5\u4eba\u7686\u9808\u5916\u79d1\u624b\u8853\u6cbb\u7642\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u95dc\u65bc Boerhaave's syndrome \u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u7672\u7647\u767c\u4f5c\u53ef\u5c0e\u81f4\u3002 (B)\u5e38\u898b\u4fb5\u72af\u65bc\u9060\u7aef\u98df\u9053\u3002 (C)\u7537\u6027\u559d\u9152\u60c5\u5883\u70ba\u5371\u96aa\u56e0\u5b50\u3002 (D)\u5e38\u5c0e\u81f4\u53f3\u5074\u808b\u819c\u7a4d\u6db2\u3002 (E)\u81f4\u75c5\u6a5f\u8f49\u70ba\u77ac\u9593\u98df\u9053\u5167\u9ad8\u58d3\u5c0e\u81f4\u98df\u9053\u5168\u5c64\u7834\u88c2\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u5f8c\u5929\u514d\u75ab\u4e0d\u5168\u75c7\u5019\u7fa4(AIDS)\u60a3\u8005\u767c\u71d2\u53ca\u8179\u7009\u5e38\u898b\u4e4b\u81f4\u75c5\u83cc\uff0c\u4e0d\u5305\u62ec\u4e0b\u5217 \u4f55\u8005\uff1f", + "Options": "(A)\u5de8\u5927\u7d30\u80de\u75c5\u6bd2(Cytomegalovirus)\u3002 (B)\u6c99\u9580\u6c0f\u687f\u83cc(Salmonella species)\u3002 (C)\u91d1\u9ec3\u8272\u8461\u8404\u7403\u83cc(Staphylococcus aureus)\u3002 (D)\u55dc\u6c34\u7522\u6c23\u55ae\u5b62\u83cc\u5c6c(Aeromonas hydrophila)\u3002 (E)\u96b1\u5b62\u5b50\u87f2\u5c6c(Cryptosporidium)\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u6709\u95dc adenosine \u7684\u4f7f\u7528\u6642\u6a5f\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u53ef\u4ee5\u5728\u7a69\u5b9a WPW \u75c7\u5019\u7fa4\u5408\u4f75\u7a84 QRS \u6ce2\u898f\u5247\u983b\u8108(WPW syndrome with narrow QRS complex regular tachycardia)\u6642\u4f7f\u7528\u3002 (B)\u53ef\u4ee5\u5728\u7a69\u5b9a\u5fc3\u5ba4\u4e0a\u983b\u8108(supraventricular tachycardia)\u6642\u4f7f\u7528 (C)\u5c0d\u65bc\u4e0d\u7a69\u5b9a\u5fc3\u5ba4\u4e0a\u983b\u8108\uff0c\u53ef\u4ee5\u7d66\u4e88 adenosine \u4e00\u6b21\u3002 (D)\u5c0d\u65bc\u7a69\u5b9a\u5bec QRS \u6ce2\u898f\u5247\u983b\u8108(wide QRS complex regular tachycardia)\uff0c\u53ef\u4ee5\u7d66\u4e88 adenosine\u3002 (E)\u5c0d\u65bc\u4e0d\u7a69\u5b9a\u5bec QRS \u6ce2\u898f\u5247\u983b\u8108\uff0c\u53ef\u4ee5\u7d66\u4e88 adenosine\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u7528\u65bc\u5354\u52a9\u8a3a\u65b7\u80ba\u6813\u585e\u7684\u8a3a\u65b7\u5de5\u5177\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u5fc3\u96fb\u5716\u51fa\u73fe S1Q3T3 \u53ef\u78ba\u5b9a\u8a3a\u65b7\u80ba\u6813\u585e\u3002 (B)\u6b63\u5e38\u7684 D-Dimer \u503c\u53ef\u5b8c\u5168\u6392\u9664\u80ba\u6813\u585e\u3002 (C)\u5728\u7121\u7d66\u6c27\u72c0\u614b(room air)\uff0c\u52d5\u8108\u6c23\u9ad4\u5206\u6790 PaO2>80mmHg \u53ef\u5b8c\u5168\u6392\u9664 \u80ba\u6813\u585e\u3002 (D)\u75c5\u4eba\u4f11\u514b\u6703\u5f71\u97ff\u96fb\u8166\u65b7\u5c64\u5c0d\u80ba\u6813\u585e\u7684\u8a3a\u65b7\u7387\u3002 (E)\u80ba\u901a\u6c23\u704c\u6ce8\u6383\u63cf(ventilation-perfusion lung scan)\u53ef\u63d0\u4f9b\u6e96\u78ba\u8a3a\u65b7\uff0c \u662f\u80ba\u6813\u585e\u7684\u6025\u8a3a\u6a19\u6e96\u6aa2\u67e5\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u4e00\u4f4d 65 \u6b72\u7537\u6027\u56e0\u80f8\u60b6\u88ab\u8def\u4eba\u9001\u81f3\u91ab\u9662\u6025\u8a3a\u3002\u5728\u6025\u8a3a\uff0c\u75c5\u4eba\u4e3b\u8a34\u6709\u64e0\u58d3\u75bc\u75db \u611f\u81f3\u4e0b\u5df4\u53ca\u5de6\u80a9\u3002\u904e\u53bb\u8eab\u9ad4\u72c0\u6cc1\u826f\u597d\uff0c\u7121\u5fc3\u81df\u76f8\u95dc\u75c5\u53f2\uff0c\u76ee\u524d\u552f\u4e00\u670d\u7528\u7684 \u85e5\u70ba\u6a02\u5a01\u58ef(Levitra\uff0cVardenafil)\u3002\u5fc3\u96fb\u5716\u986f\u793a ST-segment elevation\uff0c\u62bd\u8840 \u5831\u544a\u986f\u793a troponin-I \u53ca CK-MB \u4e0a\u5347\uff0cD-Dimer \u6b63\u5e38\u503c\u3002\u7d93\u7531\u6025\u8a3a\u91ab\u5e2b\u521d\u6b65 \u5224\u65b7\u70ba\u6025\u6027\u51a0\u5fc3\u75c7(acute coronary syndrome)\uff0c\u63a5\u4e0b\u4f86\u7684\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55 \u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u7acb\u5373\u7d66\u4e88 nitroglycerin(0.4mg \u820c\u4e0b\u9320)\uff0c\u6700\u591a\u5291\u91cf\u53ef\u4ee5\u7d66\u5230\u4e09\u6b21(\u6bcf \u6b21\u9593\u9694\u4e94\u5206\u9418)\u3002 (B)\u9664\u975e\u6709\u8840\u58d3\u904e\u4f4e\u7b49\u7981\u5fcc\uff0c\u61c9\u4f8b\u884c\u6027\u7d66\u4e88 morphine(4mg\uff0cIVP)\u6e1b\u7de9 \u80f8\u60b6\u75c7\u72c0\u3002 (C)\u5373\u4f7f\u75c5\u4eba\u672c\u8eab\u5c0d\u65bc aspirin \u904e\u654f\uff0c\u4ecd\u61c9\u4f7f\u7528 clopidogrel(300mg)\u4ee3\u66ff\u3002 (D)ACE inhibitors \u4e0d\u61c9\u4f7f\u7528\u5728 LVEF(left ventricular ejection fraction)\u6b63 \u5e38\u7684\u75c5\u4eba\u3002 (E)\u5c0d\u65bc\u6b64\u985e\u75c5\u60a3\uff0c\u4e00\u5f8b\u7d66\u4e88\u6c27\u6c23\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u85e5\u7269\u5f15\u8d77\u5fc3\u81df\u8840\u7ba1\u6bd2\u6027\u7684\u6025\u6551\u53ca\u76f8\u5c0d\u61c9\u7684\u85e5\u7269\u8655\u7f6e\u914d\u5c0d\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55 \u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u6297\u7d44\u7e54\u80fa(antihistamine)\u5f15\u8d77\u7684\u591a\u578b\u6027\u5fc3\u5ba4\u5feb\u8df3(polymorphic VT)\uff0c \u4f7f\u7528 procainamide \u6cbb\u7642\u3002 (B)\u4e09\u74b0\u6297\u9b31\u5291\u5f15\u8d77\u7684\u5fc3\u5ba4\u6027\u5fc3\u5f8b\u4e0d\u6574(ventricular dysrhythmias)\uff0c\u4f7f\u7528 sodium bicarbonate \u6cbb\u7642\u3002 (C)\u5b89\u975e\u4ed6\u547d(amphetamine)\u5f15\u8d77\u9ad8\u8840\u58d3\u5371\u8c61(hypertensive crisis)\u4f7f\u7528 propranolol \u6cbb\u7642\u3002 (D)\u6025\u6027\u6bdb\u5730\u9ec3\u4e2d\u6bd2(acute digitalis intoxication)\u5f15\u8d77\u9ad8\u8840\u9240\u5c0e\u81f4 QRS \u8b8a\u5bec\uff0c\u4f7f\u7528 calcium chloride \u6cbb\u7642\u3002 (E)\u5728 acetylcholinesterase-inhibiting agents \u5f15\u8d77\u7684\u5fc3\u640f\u904e\u7de9\uff0c\u4f7f\u7528 isoproterenol \u6cbb\u7642\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "45 \u6b72\u5973\u6027\u6709\u4e73\u764c\u53ca\u80ba\u8f49\u79fb\u75c5\u53f2\uff0c\u5728\u5bb6\u5982\u5ec1\u5f8c\u660f\u5012\uff0c\u660f\u8ff7\u7d04 2 \u5206\u9418\uff0c\u81f3\u6025\u8a3a \u5ba4\u6642\u6709\u80f8\u60b6\u3001\u81c9\u84bc\u767d\u3001\u5192\u51b7\u6c57\u3001\u8840\u58d3\u4f4e\u73fe\u8c61\uff0c\u5176\u5fc3\u96fb\u5716\u5982\u4e0b\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55 \u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u75c5\u4eba\u5e38\u51fa\u73fe\u5947\u8108(pulsus paradoxus)\u3002 (B)\u70ba\u5fc3\u56e0\u6027\u4f11\u514b\uff0c\u9808\u9650\u5236\u6c34\u5206\uff0c\u4e0d\u53ef\u4f7f\u7528\u5927\u91cf\u8f38\u6db2\u3002 (C)\u8d85\u97f3\u6ce2\u5fc3\u5716\u662f\u826f\u597d\u7684\u8a3a\u65b7\u5de5\u5177\u3002 (D)\u5fc5\u8981\u6642\u9808\u65bd\u884c\u7dca\u6025\u5fc3\u5305\u819c\u7a7f\u523a\u8853(pericardiocentesis)\u3002 (E)X \u5149\u6aa2\u67e5\u53ef\u767c\u73fe\u5fc3\u81df\u5f71\u50cf\u8b8a\u5927\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u4f55\u8005\u70ba\u6025\u6027\u80ba\u52d5\u8108\u6813\u585e\uff0c\u65bd\u884c\u7e96\u7dad\u86cb\u767d\u6eb6\u89e3\u7642\u6cd5(fibrinolytic therapy) \u4e4b\u9069\u61c9\u75c7\uff1f", + "Options": "(A)\u80ba\u90e8 perfusion scan \u53ca ventilation scan \u51fa\u73fe mismatch \u73fe\u8c61\u3002 (B)\u610f\u8b58\u51fa\u73fe\u56b4\u91cd\u969c\u7919\u3002 (C)\u5fc3\u96fb\u5716\u51fa\u73fe S1Q3T3\u3002 (D)\u6025\u6027\u80f8\u75db\u767c\u751f 3 \u5c0f\u6642\u4ee5\u5167\u3002 (E)\u8840\u884c\u52d5\u529b\u5b78\u4e0d\u7a69\u5b9a\u4f75\u56b4\u91cd\u7f3a\u6c27\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "50 \u6b72\u7537\u6027\u56e0\u6025\u6027 ST \u6bb5\u4e0a\u5347\u5fc3\u808c\u6897\u585e\u65bc\u6025\u8a3a\u7b49\u5019\u9001\u5fc3\u5c0e\u7ba1\u5ba4\u6aa2\u67e5\u524d\uff0c\u5df2\u5efa \u7acb\u975c\u8108\u8f38\u6db2\u9014\u5f91\uff0c\u7a81\u7136\u767c\u751f\u610f\u8b58\u4e0d\u6e05\uff0c\u7121\u547c\u5438\u3001\u7121\u8108\u640f\uff0c\u5fc3\u96fb\u5716\u76e3\u8996\u5668\u5448 \u73fe\u5982\u4e0b\u5716\u6240\u793a\u3002\u4e0b\u5217\u7acb\u5373\u7684\u7dca\u6025\u8655\u7f6e\uff0c\u4f55\u8005\u6700\u6b63\u78ba\uff1f", + "Options": "(A)\u7acb\u523b\u7d66\u4e88\u4eba\u5de5\u547c\u5438\u6216\u6b63\u58d3\u7d66\u6c27\u3002 (B)\u7acb\u523b\u7d66\u4e88 epinephrine 1mg\u3002 (C)\u7acb\u523b\u7d66\u4e88\u53bb\u986b 1 \u6b21(\u53bb\u986b\u5668\u6e96\u5099\u904e\u7a0b\u4e2d\uff0c\u9808\u5be6\u65bd\u80f8\u90e8\u6309\u58d3)\u3002 (D)\u5148\u65bd\u884c\u5b8c\u6574\u7684 2 \u5206\u9418(\u6216 5 \u500b 30\uff1a2 \u5faa\u74b0 CPR)\uff0c\u518d\u65bd\u884c\u53bb\u986b\u3002 (E)\u5148\u65bd\u884c\u6c23\u7ba1\u63d2\u7ba1\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "30 \u6b72\u7537\u6027\u4e3b\u8a34\u6709\u6182\u9b31\u75c7\u75c5\u53f2\uff0c\u56e0\u670d\u7528\u4e09\u74b0\u6297\u6182\u9b31\u5291\u904e\u91cf\u9001\u81f3\u6025\u8a3a\u5ba4\u3002\u5230\u9662 \u6642\u9ad4\u6eab 37\u2103\u3001\u547c\u5438 26 \u6b21/min\u3001\u8840\u58d3 84/60 mmHg\uff0c\u610f\u8b58\u4e0d\u6e05(\u660f\u8ff7\u6307\u6578 E3M5V2)\u5fc3\u96fb\u5716\u76e3\u8996\u5668\u5448\u73fe\u5982\u4e0b\u5716\u6240\u793a\u3002\u7dca\u6025\u8655\u7f6e\u4ee5\u4f55\u8005\u6700\u512a\u5148\uff1f", + "Options": "(A)Amiodarone\u3002 (B)Lidocaine\u3002 (C)\u96d9\u76f8\u540c\u6b65\u96fb\u64ca(biphasic synchronized cardioversion)200 joules\u3002 (D)\u96d9\u76f8\u53bb\u986b(biphasic defibrillation)150-200 joules\u3002 (E)Sodium bicarbonate\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u6025\u6027\u5fc3\u808c\u6897\u585e\u4f75\u767c\u56b4\u91cd\u80ba\u6c34\u816b\uff0c\u4e0b\u5217\u4f55\u8005\u4e4b\u53ef\u80fd\u6027\u6700\u4f4e\uff1f", + "Options": "(A)\u5de6\u5fc3\u5ba4\u524d\u58c1\u5927\u7247\u4e4b ST \u6ce2\u6bb5\u4e0a\u5347\u5fc3\u808c\u6897\u585e(ST elevation myocardial infarction)\u3002 (B)\u591a\u51a0\u72c0\u52d5\u8108\u6d41\u57df\u3001\u7030\u6f2b\u6027ST\u6ce2\u6bb5\u4e0b\u964d\u4e4b\u975eST\u6ce2\u4e0a\u5347\u5fc3\u808c\u6897\u585e(non-ST elevation myocardial infarction)\u3002 (C)\u5de6\u5fc3\u5ba4\u4e0b\u58c1\u4e4b\u5fc3\u808c\u6897\u585e\u4f75\u767c\u53f3\u5fc3\u5ba4\u6897\u585e(right ventricular infarction)\u3002 (D)\u5de6\u5fc3\u5ba4\u524d\u58c1\u5fc3\u808c\u6897\u585e\u4f75\u4e8c\u5c16\u74e3\u8171\u7d22\u6216\u4e73\u7a81\u808c\u65b7\u88c2(chordae tendinae or papillary muscle rupture)\u3002 (E)\u5de6\u5fc3\u5ba4\u524d\u58c1\u53ca\u4e2d\u8188\u6897\u585e\u5c0e\u81f4\u5fc3\u5ba4\u4e2d\u8188\u7834\u88c2(septal rupture)\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u9ad8\u8840\u58d3\u5371\u75c7(hypertensive emergencies)\u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u9ad8\u8840\u58d3\u8166\u75c7(hypertensive encephalopathy)\u4fc2\u8840\u58d3\u8d85\u904e\u8166\u8840\u7ba1\u81ea\u6211\u8abf \u63a7\u4e4b\u4e0a\u9650\u6240\u5c0e\u81f4\u4e4b\u5927\u8166\u904e\u5ea6\u704c\u6d41(cerebral hyperperfusion)\u53ca\u8166\u8840\u5c4f \u969c\u5931\u8861(loss of the integrity of blood-brain barrier)\uff0c\u7d50\u679c\u9020\u6210\u8166\u6c34\u816b \u53ca\u53b2\u5bb3\u7684\u8166\u8840\u7ba1\u6536\u7e2e\u3002 (B)\u9ad8\u8840\u58d3\u8166\u75c7(hypertensive encephalopathy)\u4e4b\u6cbb\u7642\u61c9\u8a2d\u6cd5\u4ee5\u85e5\u7269\u5c07\u4e4b \u964d\u81f3\u6b63\u5e38\u8840\u58d3(110/70 mmHg \u5de6\u53f3)\u3002 (C)\u85e5\u7269\u4e4b\u9078\u64c7\u53ef\u4ee5\u975c\u8108\u6ef4\u6ce8 nitroprusside \u9054\u5230\u8f03\u5feb\u901f\u964d\u58d3\u7684\u76ee\u7684\u3002 (D)Angiotensin converting enzyme inhibitor(ACEI)\u61c9\u907f\u514d\u4f7f\u7528\u65bc\u814e\u529f\u80fd \u4e0d\u4f73\u4e4b\u75c5\u60a3\u53ca\u5b55\u5a66\u3002 (E)\u82e5\u75c5\u60a3\u5408\u4f75\u6709\u4e3b\u52d5\u8108\u525d\u96e2(aortic dissection)\uff0c\u6b32\u4f7f\u7528\u975c\u8108\u6ef4\u6ce8 nitroprusside \u6642\u61c9\u4f75\u7528 beta-blocker \u4ee5\u907f\u514d\u53cd\u5c04\u6027\u5fc3\u640f\u904e\u901f(reflex tachycardia)", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u4ee5\u4e0b\u95dc\u65bc\u5fc3\u5ba4\u5fc3\u5f8b\u4e0d\u6574(ventricular tachycardia\uff0cVT)\u8207\u5fc3\u5ba4\u4e0a\u5fc3\u5f8b\u4e0d\u6574 (supraventricular tachycardia\uff0cSVT)\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u81e8\u5e8a\u4e0a\u82e5\u7121\u6cd5\u5340\u5225 VT \u6216 SVT with aberrancy\uff0c\u53ef\u5148\u7576\u4f5c VT \u8655\u7f6e\u3002 (B)\u82e5\u5fc3\u96fb\u5716\u4e0a\u51fa\u73fe atrioventricular dissociation\uff0c\u61c9\u7576\u4f5c VT \u8655\u7f6e\u3002 (C)\u82e5\u5fc3\u96fb\u5716\u4e0a\u51fa\u73fe fusion beat\uff0c\u61c9\u7576\u4f5c VT \u8655\u7f6e\u3002 (D)WPW syndrome \u4f34\u96a8 atrial fibrillation \u6642\uff0c\u4e0d\u53ef\u7d66\u4e88\u4f5c\u7528\u5728 AV node \u7684\u85e5\u7269\uff0c\u5982\u4e59\u578b\u4ea4\u611f\u795e\u7d93\u963b\u65b7\u5291(beta blockers)\u548c\u9223\u96e2\u5b50\u963b\u65b7\u5291 (calcium channel blockers)\uff0c\u6b64\u6642\u53ef\u4ee5\u4f7f\u7528 digoxin \u6216 amiodarone\u3002 (E)WPW syndrome \u4f34\u96a8 narrow QRS tachycardia \u6642\uff0c\u53ef\u4ee5\u8003\u616e\u4f7f\u7528 adenosine\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u6709\u95dc staphylococcal scalded skin syndrome(SSSS)\u7684\u81e8\u5e8a\u8868\u73fe\uff0c\u4e0b\u5217\u654d\u8ff0\u4f55 \u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u901a\u5e38\u767c\u751f\u5728 6 \u6b72\u4ee5\u4e0b\u4e4b\u5152\u7ae5\u3002 (B)\u662f\u7531 phage group 2 serotoxin-producing staphylococci \u611f\u67d3\u5f15\u8d77\u7684\u3002 (C)\u75c5\u5146\u958b\u59cb\u65bc\u5634\u5df4\u5468\u570d\u7684\u7d05\u75b9\u53ca\u812b\u76ae\uff0c\u4e4b\u5f8c\u5f80\u4e0b\u64f4\u5c55\u5230\u8ec0\u5e79\u3002 (D)\u9ecf\u819c\u7d44\u7e54(mucous membranes)\u7d93\u5e38\u53d7\u5230\u4fb5\u72af\u3002 (E)\u76ae\u819a\u812b\u5c51\u5f8c 3~7 \u5929\u5167\u75c5\u5146\u5f88\u5feb\u5c31\u6703\u4e7e\u6389\u3001\u6d88\u5931\u6389\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6bd2\u6027\u4f11\u514b\u75c7\u5019\u7fa4(toxic shock syndrome)\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u81e8\u5e8a\u4e0a\u7684\u5fb5\u5146\u8868\u793a\u6b64\u75c5\u70ba\u591a\u91cd\u5668\u5b98\u4fb5\u72af\u3002 (B)\u76ae\u75b9\u901a\u5e38\u70ba\u5168\u8eab\u6027\u4e14\u5f8c\u671f\u6703\u812b\u76ae\uff0c\u7279\u5225\u662f\u624b\u638c\u3001\u8173\u638c\u3002 (C)\u4e0d\u6703\u51fa\u73fe\u7d50\u819c\u5145\u8840\u3002 (D)\u56e0\u5ddd\u5d0e\u6c0f\u75c7\u8f03\u5c11\u51fa\u73fe\u808c\u8089\u9178\u75db\u3001\u8179\u75db\u3001\u8179\u7009\u53ef\u4f5c\u70ba\u9451\u5225\u8a3a\u65b7\u7684\u6191\u85c9\u3002 (E)\u53ef\u80fd\u7684\u81f4\u75c5\u539f\u5305\u62ec Staphylococcus aureus \u548c Streptococcus pyogenes\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u7532\u72c0\u817a\u98a8\u66b4(thyroid storm)\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u57fa\u672c\u4e0a\u9019\u662f\u81e8\u5e8a\u7684\u8a3a\u65b7\uff0c\u901a\u5e38\u6703\u767c\u71d2\uff0c\u6709\u6642\u9ad4\u6eab\u53ef\u9054 40\u2103\u3002 (B)\u75c5\u4eba\u6703\u4ee5\u4e2d\u6a1e\u795e\u7d93\u7cfb\u7d71\u7684\u75c7\u72c0\u8868\u73fe\u3002 (C)\u9b31\u8840\u6027\u5fc3\u8870\u7aed\u662f\u5e38\u898b\u7684\u5fc3\u8840\u7ba1\u7cfb\u7d71\u7684\u7570\u5e38\u8868\u73fe\u3002 (D)\u8178\u80c3\u7cfb\u7d71\u7684\u75c7\u72c0\u5305\u62ec\u53ad\u98df\u3001\u9ec3\u75b8\u3001\u809d\u816b\u5927\u3002 (E)\u7532\u72c0\u817a\u529f\u80fd\u8a66\u9a57\u53ef\u4ee5\u6e05\u695a\u7684\u9451\u5225\u7121\u5408\u4f75\u75c7\u7684\u7532\u72c0\u817a\u4e2d\u6bd2\u75c7 (thyrotoxicosis)\u8207\u7532\u72c0\u817a\u98a8\u66b4\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u8acb\u554f\u6709\u95dc\u8089\u6bd2\u687f\u83cc\u6bd2\u7d20(botulism)\u6240\u5f15\u8d77\u7684\u6025\u6027\u75c7\u72c0\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u4e00\u822c\u98df\u7269\u6240\u5f15\u8d77\u7684\u6bd2\u6027\u75c7\u72c0\uff0c\u51fa\u73fe\u65bc 12 \u81f3 36 \u5c0f\u6642\u3002 (B)\u75c7\u72c0\u5927\u90e8\u5206\u5f9e\u4e0b\u80a2\u958b\u59cb\uff0c\u9010\u6f38\u5411\u8166\u90e8\u795e\u7d93\u8513\u5ef6\u3002 (C)\u901a\u5e38\u662f\u5c0d\u7a31\u7684\u3002 (D)\u81ea\u5f8b\u795e\u7d93\u5931\u8abf\u7684\u60c5\u5f62\u53ef\u80fd\u767c\u751f\uff0c\u4f46\u662f\u611f\u89ba\u795e\u7d93\u4e00\u822c\u6c92\u6709\u5f71\u97ff\u3002 (E)\u611f\u67d3\u6027\u50b7\u53e3\u6240\u5f15\u8d77\u7684\uff0c\u4e00\u822c\u6f5b\u4f0f\u671f\u8f03\u9577\uff0c\u800c\u4e14\u8178\u80c3\u9053\u75c7\u72c0\u6bd4\u8f03\u5c11\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u5c0d\u65bc\u6c30\u5316\u7269(cyanide)\u4e2d\u6bd2\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u6709\u53ef\u80fd\u51fa\u73fe\u674f\u4ec1\u5473\u3002 (B)\u6703\u51fa\u73fe\u4ee3\u8b1d\u6027\u9178\u4e2d\u6bd2\u7684\u73fe\u8c61\u3002 (C)\u75c7\u72c0\u51fa\u73fe\u7684\u5feb\u6162\uff0c\u8207\u66b4\u9732\u7684\u9014\u5f91\u3001\u6bd2\u7269\u7684\u5f62\u5f0f\u3001\u5291\u91cf\u6709\u95dc\uff0c\u5f9e\u5e7e\u79d2 \u9418\u5230\u5e7e\u5c0f\u6642\u90fd\u6709\u53ef\u80fd\u3002 (D)\u75c5\u4eba\u5373\u4f7f\u9084\u6c92\u6709\u547c\u5438\u8870\u7aed\uff0c\u4e00\u958b\u59cb\u5c31\u53ef\u4ee5\u770b\u5230\u660e\u986f\u7684\u767c\u7d3a\u7684\u73fe\u8c61\uff0c \u70ba\u9019\u985e\u4e2d\u6bd2\u7684\u7279\u5fb5\u3002 (E)\u670d\u7528\u785d\u5316\u7269\u85e5\u7269(nitrate)\uff0c\u6240\u51fa\u73fe\u7684\u8b8a\u6027\u8840\u7d05\u7d20\u8840\u75c7 (methemoglobinemia)\uff0c\u5176\u6cbb\u7642\u65b9\u5f0f\u8207\u6c30\u5316\u7269\u4e2d\u6bd2\u5927\u4e0d\u76f8\u540c\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u9ad4\u5167\u4e00\u6c27\u5316\u78b3\u7684\u6392\u9664\u8207\u75c5\u60a3\u6240\u547c\u5438\u7684\u6c27\u6c23\u6210\u5206\u6709\u5bc6\u5207\u95dc\u4fc2\u3002\u4e00\u822c\u7a7a\u6c23\u547c\u5438 \u6642\uff0c\u6392\u9664\u4e00\u534a\u7684\u4e00\u6c27\u5316\u78b3\u6240\u9700\u7684\u6642\u9593\u7d04\u70ba 5 \u5c0f\u6642\uff1b\u7d14\u6c27\u6c23\u547c\u5438\u5247\u53ef\u7e2e\u77ed\u6642 \u9593\u81f3\u7d04 80~90 \u5206\u9418\u3002\u82e5\u7d66\u4e88\u9ad8\u58d3\u6c27\u6cbb\u7642\uff0c\u5247\u53ef\u66f4\u52a0\u901f\u4e00\u6c27\u5316\u78b3\u4e4b\u6392\u9664\uff0c\u5c07 \u6642\u9593\u7e2e\u77ed\u81f3 20 \u5206\u9418\u3002\u95dc\u65bc\u9ad8\u58d3\u6c27\u6cbb\u7642\u4e4b\u9069\u61c9\u75c7\uff0c \u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u660f\u8ff7\u6216\u4efb\u4f55\u4e00\u6bb5\u6642\u9593\u610f\u8b58\u55aa\u5931\u3002 (B)\u51fa\u73fe\u5fc3\u808c\u7f3a\u8840\u5fb5\u5146\u6216\u5fc3\u5f8b\u4e0d\u6574\u3002 (C)\u4e00\u822c\u75c5\u4eba COHb > 40%\uff0c\u61f7\u5b55\u5a66\u5973 COHb > 15%\uff0c\u56e0\u70ba\u80ce\u5152\u8840\u7d05\u7d20 \u5c0d\u4e00\u6c27\u5316\u78b3\u7684\u654f\u611f\u5ea6\u6bd4\u6210\u4eba\u8840\u7d05\u7d20\u9ad8\uff0c\u66f4\u5bb9\u6613\u9020\u6210\u4e2d\u6bd2\u7f3a\u6c27\u3002 (D)\u51a0\u5fc3\u75c7\u75c5\u4eba COHb > 25%\u3002 (E)\u4ee5 100%\u7d14\u6c27\u6cbb\u7642\u4e0b\u75c7\u72c0\u7de9\u89e3\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u4ee5\u4e0b\u6709\u95dc\u6025\u6027\u58de\u6b7b\u6027\u7b4b\u819c\u708e\u4e4b\u6558\u8ff0\uff0c\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u65bc\u76ae\u819a\u8868\u9762\u51fa\u73fe\u7d05\u3001\u816b\u3001\u71b1\u5916\uff0c\u5e38\u6709\u4e0d\u6210\u6bd4\u4f8b\u7684\u9ebb\u3001\u75bc\u75db\uff0c\u53ca\u7cfb\u7d71 \u6027\u6bd2\u8840\u75c7\u7684\u5fb5\u5019\uff0c\u5982\u9ad8\u71d2\u3001\u5fc3\u640f\u904e\u901f\u3001\u610f\u8b58\u8b8a\u5316\uff0c\u4e43\u81f3\u4f11\u514b\u3002 (B)\u5e38\u767c\u751f\u65bc\u7cd6\u5c3f\u75c5\u3001\u809d\u786c\u5316\u3001\u9152\u766e\u53ca\u514d\u75ab\u529f\u80fd\u4e0d\u5168\u4e4b\u60a3\u8005\uff0c\u4f46\u4ea6\u53ef\u80fd \u51fa\u73fe\u65bc\u5065\u5eb7\u7684\u5e74\u8f15\u4eba\u3002 (C)\u767c\u751f\u65bc\u4e0b\u80a2\u8005\u591a\u70ba A \u5f62\u93c8\u7403\u83cc (group A \u03b2-hemolytic streptococci) \u611f\u67d3\uff0c\u4e14\u53ef\u80fd\u4f75\u767c\u6bd2\u8840\u4f11\u514b\u75c7\u5019\u7fa4(streptococcal toxic shock syndrome)\u3002 (D)\u82e5\u767c\u751f\u65bc\u6703\u9670\u90e8\u8005(Fournier's gangrene)\u5247\u591a\u70ba\u591a\u83cc\u7a2e\u611f\u67d3(\u5305\u62ec \u53ad\u6c27\u83cc)\uff0c\u5e38\u4f75\u767c\u65bc\u6703\u9670\u90e8\u5275\u50b7\u6216\u809b\u9580\u5468\u908a\u7684\u611f\u67d3\u3002 (E)\u61c9\u7acb\u5373\u958b\u59cb\u5ee3\u6548\u6027\u7684\u975c\u8108\u6297\u751f\u7d20\u6cbb\u7642\uff0c\u82e5\u65bc 72 \u5c0f\u6642\u5167\u672a\u898b\u660e\u986f\u6539\u5584\uff0c \u5247\u61c9\u7167\u6703\u5916\u79d1\u4f5c\u64f4\u5275\u624b\u8853(surgical debridement)\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u95dc\u65bc\u6557\u8840\u75c7(sepsis)\u6cbb\u7642\u4e4b\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u65e9\u671f\u76ee\u6a19\u5c0e\u5411\u6cbb\u7642 (early goal-directed therapy) \u70ba\u6557\u8840\u75c7\u6cbb\u7642\u7684\u91cd \u8981\u65b9\u5411\uff0c\u5728\u56b4\u91cd\u6557\u8840\u75c7\u53ca\u6557\u8840\u6027\u4f11\u514b\u60a3\u8005\u53ef\u964d\u4f4e 16%\u6b7b\u4ea1\u7387\uff0c\u61c9\u81ea \u6025\u8a3a\u5373\u958b\u59cb\u555f\u52d5\uff0c\u4e26\u5ef6\u7e8c\u81f3\u5f8c\u7e8c\u7684\u91cd\u75c7\u52a0\u8b77\u55ae\u4f4d\u3002 (B)\u4e2d\u5fc3\u975c\u8108\u7684\u6c27\u6c23\u98fd\u548c\u5ea6 (mixed venous saturation\uff0cScvo2) \u4fc2\u4ee3\u8868 \u7d44\u7e54\u704c\u6d41\u4e4b\u53c3\u6578\uff0c\u61c9\u4fdd\u6301 70%\u4ee5\u4e0a\u3002 (C)\u82e5\u5728\u8db3\u5920\u7684\u8f38\u6db2\u6cbb\u7642\u5f8c\u4ecd\u96e3\u4ee5\u7dad\u6301\u8840\u58d3\uff0c\u61c9\u52a0\u4e0a\u8840\u7ba1\u52a0\u58d3\u85e5\u7269 (vasopressors)\uff0c\u76ee\u6a19\u5728\u65bc\u7dad\u6301\u5e73\u5747\u8840\u58d3(mean arterial pressures) \u81f3 \u5c11 70 mmHg\u3002\u8b49\u64da\u986f\u793a\u7121\u8ad6\u4f7f\u7528 dopamine \u6216 norepinephrine\uff0c\u9054\u6210 \u4e0a\u8ff0\u76ee\u6a19\u5c07\u53ef\u986f\u8457\u6e1b\u5c11\u6b7b\u4ea1\u7387\u3002 (D)\u78b3\u9178\u6c2b\u9209(NaHCO3)\u53ef\u80fd\u9020\u6210\u5947\u7570\u6027\u7684\u7d30\u80de\u5167\u9178\u8840\u75c7\uff0c\u53ea\u6709\u5728\u56b4\u91cd \u9178\u8840\u75c7\u6642(pH <7.0-7.2)\u624d\u8003\u616e\u4f7f\u7528\u3002 (E)Activated protein C \u7d93\u5927\u898f\u6a21\u7814\u7a76\u8b49\u5be6\u5728\u56b4\u91cd\u6557\u8840\u75c7\u75c5\u60a3\u53ef\u6e1b\u5c11 6.1% \u7684\u6b7b\u4ea1\u7387\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "48 \u6b72\u7537\u6027\u65bc\u6d77\u908a\u91e3\u9b5a\uff0c\u4e0d\u614e\u88ab\u6240\u91e3\u7684\u9b5a\u523a\u50b7\u53f3\u8db3\uff0c\u65bc 12 \u5c0f\u6642\u5f8c\u53f3\u8db3\u816b\u8139\u4e26 \u6709\u51fa\u8840\u6027\u8840\u6ce1\u7522\u751f\uff0c\u9001\u91ab\u5f8c\u6709\u6557\u8840\u6027\u4f11\u514b\u73fe\u8c61\uff0c\u5c0d\u65bc\u8a72\u75c5\u60a3\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55 \u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u8a72\u75c5\u60a3\u53ef\u80fd\u70ba\u58de\u6b7b\u6027\u7b4b\u819c\u708e necrotizing fasciitis\u3002 (B)\u5728\u53f0\u7063\u6700\u6709\u53ef\u80fd\u662f\u5275\u50b7\u5f27\u83cc Vibrio vulnificus\uff0c\u8a72\u83cc\u70ba\u9769\u85cd\u6c0f\u967d\u6027\u83cc\u3002 (C)\u8a72\u75c5\u60a3\u53ef\u80fd\u5408\u4f75\u6709\u5176\u4ed6\u6162\u6027\u75c5\u3002 (D)\u5e38\u9700\u8981\u5f8c\u7dda\u7684\u6297\u751f\u7d20\u6cbb\u7642\uff0c\u4f8b\u5982\u7b2c\u4e09\u4ee3\u6216\u7b2c\u56db\u4ee3\u7684 cephalosporin\u3002 (E)\u5e38\u9700\u5916\u79d1\u4ecb\u5165\u6e05\u7406\u50b7\u53e3\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u9aa8\u5167\u91dd\u6ce8\u8f38\u6db2(intraosseous infusion)\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u5c0f\u5152\u6025\u6551\uff0c\u9aa8\u5167\u91dd\u7684\u6ce8\u5c04\u662f\u6700\u4f73\u7684\u8f38\u6db2\u9078\u64c7\u65b9\u5f0f\u3002 (B)\u5c0d\u65bc\u7d93\u9aa8\u5167\u91dd\u8f38\u6ce8\u6eb6\u6db2\uff0c\u50c5\u80fd\u4f7f\u7528\u6676\u9ad4\u6eb6\u6db2(crystalloid solution)\u3002 (C)\u9aa8\u5167\u6ce8\u5c04\u91dd\u7684\u4f7f\u7528\u50f9\u503c\uff0c\u76ee\u524d\u4ecd\u662f\u6a21\u7cca\u4e0d\u6e05\uff0c\u672a\u6709\u5b9a\u8ad6\u3002 (D)\u9aa8\u5167\u91dd\u6ce8\u5c04\u90e8\u4f4d\u8207\u5176\u6ce8\u5c04\u56db\u5468\u7684\u816b\u6f32\u6642\uff0c\u4ecd\u53ef\u7e7c\u7e8c\u4f7f\u7528\u505a\u70ba\u8f38\u6db2\u7684 \u8def\u5f91\u3002 (E)\u65bd\u6253\u9aa8\u5167\u6ce8\u5c04\u91dd\u6642\u53ef\u4ee5\u53cd\u62bd\u5f97\u51fa\u9aa8\u9ad3\uff0c\u800c\u78ba\u5b9a\u91dd\u982d\u4f4d\u7f6e\u6b63\u78ba\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "30 \u6b72\u5973\u6027\u75c5\u60a3\u56e0\u767c\u71d2\u3001\u5589\u56a8\u75db\u3001\u4ee5\u53ca\u5168\u8eab\u75e0\u75db\u4e00\u65e5\u81f3\u6025\u8a3a\uff0c\u524d\u591c\u767c\u751f\u4f34\u96a8 \u6d3b\u52d5\u60e1\u5316\u7684\u982d\u75db\u53ca\u5614\u5410\uff0c\u4e14\u6709\u9593\u6b47\u6027\u610f\u8b58\u6df7\u4e82\uff0c\u4f86\u9662\u524d\u51fa\u73fe\u904d\u4f48\u5168\u8eab\u7684\u7600 \u6591(petechiae)\uff0c\u75c5\u4eba\u7121\u65c5\u904a\u53f2\u3002\u5230\u9662\u6642\u9ad4\u6eab 38.3\u00b0C\uff0c\u8108\u640f 120/\u5206\u9418\uff0c\u547c\u5438 18/\u5206\u9418\uff0c\u8840\u58d3 80/60 mmHg\u3002\u5be6\u9a57\u5ba4\u6aa2\u67e5\u986f\u793a\uff1aWBC 17600/mm3 \u3001hemoglobin 13.6 g/dL\u3001platelet 54000/mm3\u3001BUN 57 mg/dL\u3001creatinine 3.3 mg/dL\u3001APTT \uff1e120 seconds\u3001INR 2.14\u3001D-Dimer \uff1e10 \u00b5g/mL\u3002\u8acb\u554f\u4e0b\u5217\u4f55\u8005\u70ba\u6700\u53ef\u80fd\u4e4b \u8a3a\u65b7\uff1f", + "Options": "(A)\u6bd2\u6027\u4f11\u514b\u75c7\u5019\u7fa4(toxic shock syndrome)\u3002 (B)\u6025\u6027\u6dcb\u75c5\u7403\u83cc\u83cc\u8840\u75c7(acute gonococcemia)\u3002 (C)\u6d1b\u78ef\u5c71\u6591\u75b9\u71b1(Rocky Mountain spotted fever)\u3002 (D)\u611f\u67d3\u6027\u5fc3\u5167\u819c\u708e(infective endocarditis)\u3002 (E)\u8166\u819c\u708e\u7403\u83cc\u83cc\u8840\u75c7(meningococcemia)\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u810a\u9ad3\u640d\u50b7\u7684\u524d\u810a\u9ad3\u75c7\u5019(anterior cord syndrome)\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4 \uff1f", + "Options": "(A)\u524d\u810a\u9ad3\u52d5\u8108\u7684\u6813\u585e(anterior spinal artery thrombosis)\u662f\u524d\u810a\u9ad3\u75c7\u5019 \u6210\u56e0\u4e4b\u4e00\u3002 (B)\u9838\u690e\u904e\u5ea6\u7684\u4f38\u5c55(hyper-extension)\u662f\u524d\u810a\u9ad3\u75c7\u5019\u6210\u56e0\u4e4b\u4e00\u3002 (C)\u9838\u690e\u9aa8\u6298\u58d3\u8feb\u81f3\u810a\u9ad3\u662f\u524d\u810a\u9ad3\u75c7\u5019\u6210\u56e0\u4e4b\u4e00\u3002 (D)\u524d\u810a\u9ad3(anterior spinal cord)\u56e0\u7a7f\u523a\u50b7\u9020\u6210\u7684\u76f4\u63a5\u50b7\u5bb3\u662f\u524d\u810a\u9ad3\u75c7\u5019 \u6210\u56e0\u4e4b\u4e00\u3002 (E)\u9838\u690e\u7684\u5f4e\u66f2(flexion)\u662f\u524d\u810a\u9ad3\u75c7\u5019\u6210\u56e0\u4e4b\u4e00\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u5916\u50b7\u75c5\u60a3\u5feb\u901f\u63d2\u7ba1(rapid sequence intubation)\u8655\u7f6e\u6240\u7528\u85e5\u7269\u7684\u6b63\u78ba\u9078\u64c7\uff0c \u4e0b\u5217\u4f55\u8005\u6700\u4e0d\u9069\u7576\uff1f", + "Options": "(A)Fentanyl \u4f7f\u7528\u65bc\u8840\u58d3\u4e0b\u964d\u75c5\u60a3\u3002 (B)Ketamine \u4f7f\u7528\u65bc\u8166\u5916\u50b7(traumatic brain injury)\u75c5\u60a3\u3002 (C)Lidocaine \u4f7f\u7528\u65bc\u982d\u90e8\u5916\u50b7\u75c5\u60a3\u63d2\u7ba1\u524d\u7d66\u85e5\u3002 (D)Rocuronium \u4f7f\u7528\u65bc\u5730\u9707\u5f8c\u58d3\u7838\u50b7\u7684\u75c5\u60a3\u3002 (E)Succinylcholine \u7528\u65bc\u7591\u6709\u8166\u5916\u50b7\u7684\u75c5\u60a3\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5916\u50b7\u6027\u7a92\u606f(traumatic asphyxia)\u7684\u81e8\u5e8a\u8868\u73fe\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u81c9\u90e8\u53ca\u9838\u90e8\u7684\u767c\u7d3a(craniocervical cyanosis)\u3002 (B)\u81c9\u90e8\u53ca\u9838\u90e8\u7684\u51fa\u8840\u9ede(craniocervical petechiae)\u3002 (C)\u7d50\u819c\u4e0b\u51fa\u8840(subconjunctival hemorrhage)\u3002 (D)\u80f8\u90e8\u920d\u6027\u50b7\u5bb3(thoracic crush injury)\u3002 (E)\u4e0b\u80a2\u6c34\u816b\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u4e00\u540d 45 \u6b72\u7537\u6027\u65bc\u9a0e\u4e58\u6469\u6258\uf902\u6642\u906d\u5f8c\u65b9\u6c7d\uf902\u8ffd\u649e\uff0c\u7576\u6642\u6642\u901f\u5927\u7d04 40 km/hr\u3002 \u75c5\u4eba\u88ab\u5f48\u5230\u96e2\u6a5f\uf902 10 \u516c\u5c3a\u9060\u7684\u5730\u65b9\u3002\u88ab\u6551\u8b77\uf902\u9001\u4f86\u6025\u8a3a\u6642\u751f\u547d\u8de1\u8c61\u9ad4\u6eab 36.7\u00b0C\uff0c\u547c\u5438 25 \u6b21/\u5206\u9418\uff0c\u5fc3\u8df3 135 \u6b21/\u5206\u9418\uff0c\u8840\u58d3 100/67 mmHg\u3002\u75c5\u4eba\u4e3b \u8a34\u5287\u70c8\u80f8\u75db\u53ca\u547c\u5438\u56f0\u96e3\u3002\u7406\u5b78\u6aa2\u67e5\u767c\u73fe\u53f3\u80f8\u6709\u660e\u986f\u64e6\u50b7\uff0c\u5c40\u90e8\u58d3\u75db\u4e14\u6709 crepitus \u4f34\u96a8\u547c\u5438\u97f3\u6e1b\u5f31 \u3002\u4ee5\u4e0b\u95dc\u65bc\u80f8\u90e8\u632b\u50b7\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u5916\u50b7\u5f15\u8d77\u4e3b\u52d5\u8108\u7834\u88c2\u7684\u75c5\u4eba\u5927\u90e8\u4efd\u90fd\u6b7b\u65bc\u6848\u767c\u73fe\u5834\uff0c\u5c11\u6578\u5b58\u6d3b\u8005\u53d7 \u50b7\u4f4d\u7f6e\u5927\u591a\u5728 ligamentum arteriosum\u3002 (B)\u58d3\u529b\u6027\u6c23\u80f8(tension pneumothorax)\u70ba\u81e8\u5e8a\u8a3a\u65b7\uff0c\u901a\u5e38\u6703\u5148\u51fa\u73fe\u4f4e \u8840\u58d3\uff0c\u7136\u5f8c\u624d\u6703\u51fa\u73fe\u767c\u7d3a\u3002 (C)\u82e5\u80f8\u90e8 X \u5149\u7247\u8a3a\u65b7\u7591\u4f3c\u53f3\u5074\u8840\u80f8\uff0c\u61c9\u4e88\u53f3\u5074\u80f8\u90e8\u653e\u7f6e\u80f8\u7ba1\u6cbb\u7642\uff0c\u82e5 \u99ac\u4e0a\u5f15\u6d41\u51fa\u5927\u65bc 1500 ml \u7684\u8840\uff0c\u5247\u9700\u8981\u5b89\u6392\u958b\u80f8\u624b\u8853\u6b62\u8840\u3002 (D)\u653e\u7f6e\u80f8\u7ba1\u5f8c\u82e5\u6301\u7e8c\u5f15\u6d41\u51fa\u7a7a\u6c23\uff0c\u5247\u8981\u8003\u616e\u652f\u6c23\u7ba1\u640d\u50b7\uff0c\u61c9\u5b89\u6392\u652f\u6c23 \u7ba1\u93e1\u8a3a\u65b7\uff0c\u6b64\u6642\u53ef\u5c07\u6c23\u7ba1\u5167\u7ba1\u653e\u7f6e\u53e6\u4e00\u5074\u4e3b\u652f\u6c23\u7ba1\u4e88\u4ee5\u55ae\u80ba\u547c\u5438\u4ee5 \u7dad\u6301\u901a\u6c23\u3002 (E)\u5c0d\u65bc\u5fc3\u81df\u632b\u50b7(blunt cardiac injury)\u7684\u75c5\u4eba\uff0ctroponins \u6bd4\u5fc3\u96fb\u5716\u5c0d\u81e8 \u5e8a\u4e0a\u7dca\u6025\u7684\u5224\u65b7\u548c\u6cbb\u7642\u66f4\u6709\u7528\u8655\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u4e00\u540d 45 \u6b72\u7537\u6027\u65bc\u5927\u6a13\u5de5\u5730\u7531\u5927\u7d04 3 \u516c\u5c3a\u8655\u8dcc\u843d\u5730\u9762\u3002\u76ee\u64ca\u8005\u767c\u73fe\u75c5\u4eba\u70ba\u982d \u90e8\u8457\u5730\u3002\u75c5\u4eba\u77ed\u66ab\u5931\u53bb\u610f\u8b58\u5f8c\u9192\u4f86\u5fd8\u8a18\u81ea\u5df1\u767c\u751f\u610f\u5916\u3002\u88ab\u6551\u8b77\uf902\u9001\u4f86\u6025\u8a3a \u6642\u751f\u547d\u8de1\u8c61\u9ad4\u6eab 36.7\u00b0C\uff0c\u547c\u5438 16 \u6b21/\u5206\u9418\uff0c\u5fc3\u8df3 102 \u6b21/\u5206\u9418\uff0c\u8840\u58d3 120/67 mmHg\u3002\u75c5\u4eba\u4e3b\u8a34\u56db\u80a2\u7121\u529b\u53ca\u611f\u89ba\u7570\u5e38\u3002\u4ee5\u4e0b\u95dc\u65bc\u75c5\u4eba\u53ef\u80fd\u767c\u751f\u7684\u810a\u9ad3\u640d \u50b7\uff0c\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)Anterior cord syndrome \u901a\u5e38\u7531\u65bc\u9838\u90e8 flexion \u5f15\u8d77\uff0c\u53d7\u50b7\u90e8\u4f4d\u4ee5\u4e0b\u50c5 \u4fdd\u7559\u672c\u9ad4\u611f\u89ba proprioception \u548c\u9707\u52d5\u611f\u89ba vibration\u3002 (B)Central cord syndrome \u5728\u5e74\u8f15\u4eba\u8f03\u6613\u767c\u751f\uff0c\u4e0b\u80a2\u7121\u529b\u6703\u5927\u65bc\u4e0a\u80a2\u7121\u529b\u3002 (C)Brown-Sequard syndrome \u70ba\u540c\u5074\u7121\u529b\uff0c\u540c\u5074\u5931\u53bb\u672c\u9ad4\u611f\u89ba\uff0c\u5408\u4f75\u5c0d\u5074 \u5931\u53bb\u75db\u89ba\u6eab\u89ba\u3002 (D)Cauda equina \u7684\u9810\u5f8c\u8f03\u597d\uff0c\u4e3b\u8981\u662f\u56e0\u70ba\u53d7\u50b7\u7684\u795e\u7d93\u70ba\u5468\u908a\u795e\u7d93 peripheral nerve\uff0c\u6709\u518d\u751f\u7684\u6a5f\u6703\u3002 (E)\u82e5\u78ba\u5b9a\u795e\u7d93\u640d\u50b7\u5728 C5 \u7684\u4f4d\u7f6e\uff0c\u5247\u9700\u8981\u8003\u616e\u9810\u5148\u63d2\u7ba1\u4ee5\u9632\u547c\u5438\u8870\u7aed\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u5728\u7a81\u767c\u706b\u707d\u4e8b\u4ef6\u4e2d\uff0c\u4f60\u662f\u7b2c\u4e00\u500b\u5230\u9054\u73fe\u5834\u7684\u91ab\u7642\u4eba\u54e1\uff0c\u6839\u64da START(Simple Triage And Rapid Treatment)\uff0c\u8acb\u554f\u4ee5\u4e0b\u4f55\u8005\u6aa2\u50b7\u5206\u985e\u70ba\u9ec3\u8272\uff1f", + "Options": "(A)22 \u6b72\u5973\u6027\uff0c\u547c\u5438\u5feb\u901f\uff0c\u53e3\u9f3b\u6709\u9ed1\u8272\u78b3\u7c92\u9644\u8457\uff0c\u610f\u8b58\u4e0d\u6e05\u3002 (B)21 \u6b72\u5973\u6027\uff0c\u5de6\u5927\u817f\u9aa8\u6298\uff0c\u547c\u5438\u8108\u640f\u6b63\u5e38\uff0c\u610f\u8b58\u6e05\u695a\u3002 (C)18 \u6b72\u5973\u6027\uff0c\u9a5a\u614c\u5931\u63aa\uff0c\u8dd1\u4f86\u8dd1\u53bb\uff0c\u4e00\u76f4\u54ed\u558a\u6709\u540c\u5b78\u9084\u5728\u6559\u5ba4\u88e1\u9762\uff0c \u53f3\u624b\u8f15\u5ea6\u71d2\u50b7\u3002 (D)25 \u6b72\u5973\u6027\uff0c\u7121\u547c\u5438\uff0c\u81c9\u90e8\u5927\u7247\u71d2\u50b7\u3002 (E)40 \u6b72\u5973\u6027\uff0c\u547c\u5438\u6bcf\u5206\u9418 25 \u4e0b\uff0c\u5fae\u8840\u7ba1\u5145\u586b\u6642\u9593 3 \u79d2\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u4e00\u4f4d\u6025\u8a3a\u75c5\u60a3\u62bd\u8840\u6aa2\u9a57\u7d50\u679c\u986f\u793a\uff0cpH 7.25\uff0c\u9209\u96e2\u5b50\u6fc3\u5ea6 138 mEq/L\uff0c\u9240\u96e2 \u5b50\u6fc3\u5ea6 3.4 mEq/L\uff0c\u6c2f\u96e2\u5b50\u6fc3\u5ea6 102 mEq/L\uff0cBicarbonate 16 mEq/L\uff0c\u4e0b\u5217\u4f55 \u7a2e\u72c0\u6cc1\u6700\u4e0d\u53ef\u80fd\uff1f", + "Options": "(A)\u9152\u7cbe\u6027\u916e\u9178\u8840\u75c7(alcohol ketoacidosis)\u3002 (B)\u7cd6\u5c3f\u75c5\u916e\u9178\u8840\u75c7(diabetic ketoacidosis)\u3002 (C)\u8179\u7009(diarrhea)\u3002 (D)\u7570\u4e19\u9187(isopropyl alcohol)\u4e2d\u6bd2\u3002 (E)\u6557\u8840\u75c7(sepsis)\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u9ad8\u5c71\u6025\u75c7(\u5982\u9ad8\u5c71\u75c7\u3001\u9ad8\u5c71\u8166\u6c34\u816b\u3001\u9ad8\u5c71\u80ba\u6c34\u816b)\u7684\u9810\u9632\uff0c\u4e0b\u5217\u85e5\u7269 \u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)Acetazolamide\u3002 (B)Dexamethasone\u3002 (C)Furosemide\u3002 (D)Nifedipine\u3002 (E)Sildenafil\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "25 \u6b72\u5973\u6027\u56e0\u6234\u4e86\u5c07\u8fd1 24 \u5c0f\u6642\u7684\u96b1\u5f62\u773c\u93e1\u5f8c\uff0c\u611f\u5230\u754f\u5149\u3001\u773c\u775b\u75bc\u75db\u3001\u8996\u529b\u6a21 \u7cca\uff0c\u4e14\u6709\u81bf\u72c0\u5206\u6ccc\u7269\u3002\u6aa2\u67e5\u767c\u73fe\u6709\u89d2\u819c\u6f70\u760d(corneal ulcer)\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u9664\u4e86\u4f7f\u7528\u6297\u751f\u7d20\u85e5\u6c34\u4e4b\u5916\uff0c\u5fc5\u9808\u4f7f\u7528\u773c\u7f69(eye patch)\u9810\u9632\u611f\u67d3\u3002 (B)\u82e5\u773c\u79d1\u91ab\u5e2b\u7121\u6cd5\u63d0\u4f9b\u7dca\u6025\u6703\u8a3a\uff0c\u53ef\u4ee5\u5148\u6295\u4e88 quinolone \u6297\u751f\u7d20\uff0c\u4e26\u52d9 \u5fc5\u5b89\u6392 24 \u5c0f\u6642\u5167\u773c\u79d1\u56de\u8a3a\u3002 (C)\u53ef\u6295\u4e88 cycloplegic agent \u5e6b\u52a9\u6e1b\u8f15\u75bc\u75db\u3002 (D)\u96b1\u5f62\u773c\u93e1\u76f8\u95dc\u7684\u89d2\u819c\u6f70\u760d\uff0c\u6700\u5e38\u898b\u70ba Pseudomonas \u7684\u611f\u67d3\u3002 (E)\u96d6\u7136\u9ebb\u9189\u85e5\u6c34\u6703\u4f7f\u75c5\u4eba\u611f\u5230\u5f88\u8212\u670d\uff0c\u4f46\u4e0d\u53ef\u7d66\u4e88\u56de\u5bb6\u4f7f\u7528\uff0c\u6703\u6709\u5931 \u660e\u4e4b\u865e\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "67 \u6b72\u7537\u6027\uff0c\u56e0\u8996\u529b\u6a21\u7cca\uff0c\u53f3\u5074\u982d\u90e8\u649e\u50b7\u800c\u81f3\u6025\u8a3a\uff0c\u8eab\u9ad4\u6aa2\u67e5\u767c\u73fe\u53f3\u984d-\u9873\u90e8 \u982d\u76ae\u53ca\u5916\u4e0a\u773c\u7736\u8840\u816b\uff0c\u5169\u5074\u77b3\u5b54\u7b49\u5927 2mm\uff0c\u5149\u53cd\u5c04\u6b63\u5e38\uff0c\u56db\u80a2\u6d3b\u52d5\u53ca\u6df1\u5c64 \u808c\u8171\u53cd\u5c04\u7686\u6b63\u5e38\uff0c\u6b65\u614b\u5e73\u7a69\uff0c\u4f46\u5bb9\u6613\u649e\u5230\u53f3\u5074\u7269\u9ad4\u3002\u8996\u91ce\u6aa2\u67e5\u767c\u73fe\u53f3\u5074\u540c \u5074\u504f\u76f2(homonymous hemianopsia)\uff0c\u6700\u6709\u53ef\u80fd\u7684\u8a3a\u65b7\u70ba\u4f55\uff1f", + "Options": "(A)\u53f3\u5074\u4e2d\u592e\u8996\u7db2\u819c\u52d5\u8108\u963b\u585e(central retinal artery occlusion)\u3002 (B)\u53f3\u5074\u786c\u8166\u819c\u4e0a\u51fa\u8840(epidural hemorrhage )\u3002 (C)\u5de6\u5074\u6795\u90e8\u6897\u585e\u6027\u4e2d\u98a8(occipital infarction)\u3002 (D)\u5de6\u5074\u786c\u8166\u819c\u4e0b\u51fa\u8840(subdural hemorrhage)\u3002 (E)\u8166\u4e0b\u5782\u9ad4\u816b\u7624(pituitary tumor)\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "45 \u6b72\u7537\u6027\uff0c\u6709 A \u578b\u8840\u53cb\u75c5\u53f2\uff0c\u6628\u5929\u4e0d\u5c0f\u5fc3\u8dcc\u5230\u649e\u5230\u53f3\u624b\u8098\uff0c\u4f86\u5230\u6025\u8a3a\u56e0\u53f3 \u624b\u524d\u81c2\u9010\u6f38\u816b\u8139\u75bc\u75db\u4e0d\u9069\u3002\u7406\u5b78\u6aa2\u67e5\u767c\u73fe\u53f3\u624b\u524d\u81c2\u591a\u8655\u7600\u9752\u4e14\u88ab\u52d5\u62c9\u626f\u52d5 \u4f5c(passive stretch)\u6642\uff0c\u75c5\u60a3\u8868\u60c5\u975e\u5e38\u75bc\u75db\u3002\u5e6b\u75c5\u60a3\u9032\u884c X \u5149\u6aa2\u67e5\u5f8c\u4e26\u7121 \u660e\u986f\u9aa8\u6298\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u5982\u679c\u6709\u4f34\u96a8\u9ebb\u6728\u611f\u53ef\u80fd\u662f compartment syndrome \u9700\u5b89\u6392\u4f4f\u9662\u3002 (B)\u53ef\u7d66\u4e88 Factor VIII 20-40U/Kg\u3002 (C)\u5373\u4f7f X \u5149\u6c92\u6709\u660e\u986f\u9aa8\u6298\uff0c\u56e0\u70ba\u60a3\u8655\u75bc\u75db\uff0c\u7576\u51fa\u8840\u5df2\u7d93\u63a7\u5236\uff0c\u4ecd\u53ef\u4ee5 \u8003\u616e\u526f\u6728\u56fa\u5b9a\u3002 (D)\u53ef\u4ee5\u88dc\u5145\u5b8c\u51dd\u8840\u56e0\u5b50\u5f8c\u518d\u6e2c\u91cf\u8154\u5ba4\u58d3\u529b\u3002 (E)\u5982\u9700\u7d66\u4e88\u6b62\u75db\u85e5\u6642\uff0c\u53ef\u7d93\u7531\u808c\u8089\u6ce8\u5c04\u6b62\u75db\u5291\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "70 \u6b72\u7537\u6027\uff0c\u904e\u53bb\u75c5\u53f2\u6709\u75db\u98a8\u8207\u7cd6\u5c3f\u75c5\uff0c\u4e3b\u8a34\u8f15\u5fae\u767c\u71d2\u8207\u53f3\u819d\u75bc\u75db\u4f86\u6025\u8a3a\u5c31 \u8a3a\u3002\u5728\u6025\u8a3a\u8840\u58d3 120/70 mmHg\u3001\u8108\u640f 80 \u6b21/min\u3001\u547c\u5438 16 \u6b21/min\u3001\u9ad4\u6eab 38.3\u2103\u3002 \u7406\u5b78\u6aa2\u67e5\u767c\u73fe\u53f3\u819d\u5c40\u90e8\u7d05\u816b\u3001\u6d3b\u52d5\u53d7\u9650\u3002\u95dc\u7bc0\u6db2\u6aa2\u67e5\u7d50\u679c\u984f\u8272\u7565\u5fae\u6df7\u6fc1\uff0c WBC 67000/ mm3 \u3001PMN 98%\u3002\u95dc\u65bc\u6b64\u75c5\u4eba\u7684\u6558\u8ff0\uff0c\u4ee5\u4e0b\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u5982\u95dc\u7bc0\u6db2\u986f\u5fae\u93e1\u93e1\u6aa2\u4e0b\u767c\u73fe crystal\uff0c\u5247\u53ef\u4ee5\u8a3a\u65b7\u70ba\u75db\u98a8\u6027\u95dc\u7bc0\u708e (gouty arthritis)\u3002 (B)\u61c9\u7acb\u5373\u65bc\u6025\u8a3a\u6aa2\u6e2c uric acid\uff0c\u5c0d\u8a3a\u65b7\u75db\u98a8\u6027\u6027\u95dc\u7bc0\u708e\u6709\u5f88\u5927\u7684\u5e6b\u52a9\u3002 (C)\u8a3a\u65b7\u82e5\u70ba\u75db\u98a8\u6027\u95dc\u7bc0\u708e\uff0c\u61c9\u7acb\u5373\u7d66\u4e88 allopurinol \u4f5c\u70ba\u6025\u6027\u767c\u4f5c\u7684\u6cbb \u7642\u3002 (D)\u5c0d\u65bc NSAIDs \u7981\u5fcc\u7684\u75c5\u4eba\u53ef\u4ee5\u7d66\u4e88\u53e3\u670d\u985e\u56fa\u9187\u3002 (E)\u7121\u8ad6\u662f\u75db\u98a8\u6027\u95dc\u7bc0\u708e\u6216\u611f\u67d3\u6027\u95dc\u7bc0\u708e\uff0c\u5176\u95dc\u7bc0\u6db2\u6aa2\u67e5\u7684 glucose \u503c\u7686 \u5c0f\u65bc\u8840\u6db2 glucose \u503c\u7684 50%\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u8155\u96a7\u9053\u75c7\u5019\u7fa4(carpal tunnel syndrome)\u7684\u6558\u8ff0\uff0c\u4e0d\u5305\u62ec\u4e0b\u5217\u90a3\u4e00\u9805\uff1f", + "Options": "(A)\u5176\u70ba\u9031\u908a\u795e\u7d93\u75c5\u8b8a\u3002 (B)\u8087\u56e0\u65bc\u6a48\u795e\u7d93\u53d7\u5230\u58d3\u8feb\u3002 (C)\u75c7\u72c0\u70ba\u5927\u62c7\u6307\u638c\u9762\u3001\u98df\u6307\u3001\u4e2d\u6307\u3001\u4ee5\u53ca\u7121\u540d\u6307\u6a48\u5074\u9ebb\u75db\u3002 (D)\u61f7\u5b55\u671f\u9593\u6703\u56e0\u6c34\u816b\u4f7f\u75c7\u72c0\u52a0\u5287\u3002 (E)\u81f4\u75c5\u56e0\u7d20\u70ba\u624b\u8155\u8655\u65bc\u4e0d\u65b7\u91cd\u8907\u5f4e\u66f2\u53ca\u4f38\u5c55\u4e4b\u904e\u5ea6\u4f7f\u7528\u72c0\u614b\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6025\u6027\u7f3a\u8840\u6027\u8166\u4e2d\u98a8\u75c5\u60a3\u4e4b\u6025\u6551\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4 \uff1f", + "Options": "(A)\u82e5\u662f\u6025\u6027\u7f3a\u8840\u6027\u8166\u4e2d\u98a8\u4e14\u7b26\u5408\u898f\u5b9a\uff0c\u53ef\u4f7f\u7528\u8840\u6813\u6eb6\u89e3\u5291(r-tPA)\u9032 \u884c\u8840\u6813\u6eb6\u89e3\u6cbb\u7642\uff0c\u4f7f\u7528\u5291\u91cf\u70ba 15 mg \u975c\u8108\u63a8\u6ce8 1 \u5206\u9418\uff0c50 mg \u975c\u8108 \u6ef4\u6ce8 30 \u5206\u9418\uff0c35 mg \u975c\u8108\u6ef4\u6ce8 30 \u5206\u9418\u3002 (B)\u65bd\u6253 r-tPA \u5f8c\uff0c\u65bc 24 \u5c0f\u6642\u5167\u4e0d\u8981\u540c\u6642\u7d66\u4e88\u6297\u8840\u6813\u85e5\u7269\u5982 heparin\u3002 (C)\u5efa\u7acb\u975c\u8108\u8def\u5f91\u6642\uff0c\u61c9\u5118\u91cf\u4f7f\u7528\u4e0d\u542b\u8461\u8404\u7cd6\u7684\u8f38\u6db2\u3002 (D)\u61c9\u5118\u901f\u5b8c\u6210\u7f8e\u570b\u570b\u5bb6\u885b\u751f\u9662\u8166\u4e2d\u98a8\u91cf\u8868(National Institutes of Health Stroke Scale, NIHSS)\u7684\u8a55\u4f30\u3002 (E)\u975c\u8108\u6ce8\u5c04\u8840\u6813\u6eb6\u89e3\u5291\u61c9\u65bc\u8166\u4e2d\u98a8\u75c7\u72c0\u767c\u4f5c 3 \u5c0f\u6642\u5167\u4f7f\u7528\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u4e0b\u5217\u75c5\u60a3\u61f7\u5b55\u6642\u5176\u4ed6\u5171\u5b58\u7684\u75be\u75c5\u7684\u6cbb\u7642\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u61f7\u5b55\u6642\u5408\u4f75\u7532\u72c0\u817a\u4ea2\u9032\u6703\u6709\u767c\u751f\u5b50\u7672\u524d\u75c7\u7684\u5371\u96aa\u3002 (B)\u5b55\u5a66\u4f75\u767c\u7532\u72c0\u817a\u98a8\u66b4(thyroid storm)\u6642\u4e0d\u53ef\u4f7f\u7528\u653e\u5c04\u6027\u7898\u7642\u6cd5 (radioactive iodine therapy)\u6cbb\u7642\u3002 (C)\u61f7\u5b55\u6642\u6cbb\u7642\u9ad8\u8840\u58d3\u6025\u75c7\u4f7f\u7528 captopril \u53ca lasix \u5feb\u901f\u6709\u6548\u3002 (D)\u5b55\u5a66\u767c\u751f\u9663\u767c\u6027\u5fc3\u5ba4\u4e0a\u5fc3\u640f\u904e\u901f\u53ef\u5b89\u5fc3\u4f7f\u7528 verapamil(isoptin)\u6cbb \u7642\u3002 (E)\u5b55\u5a66\u767c\u751f\u5fc3\u623f\u986b\u52d5\u6642\u53ef\u7528\u4f4e\u5206\u5b50\u91cf\u809d\u7d20\u6cbb\u7642\u9632\u6b62\u8840\u6813\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u4e00\u540d\u61f7\u5b55 28 \u9031\u4e14\u70ba\u96d9\u80de\u80ce\u7684 34 \u6b72\u5b55\u5a66\uff0c\u56e0\u53f3\u5074\u8170\u75db\u4f86\u6025\u8a3a\u5c31\u8a3a\uff0c\u751f\u547d\u8de1 \u8c61\u986f\u793a\uff1a\u8840\u58d3 138/73 mmHg\u3001\u5fc3\u8df3 101 \u6b21/\u5206\u9418\u3001\u547c\u5438\u901f\u7387 22 \u6b21/\u5206\u9418\u3001\u8033 \u6eab 36.8 \u2103\uff0c\u7406\u5b78\u6aa2\u67e5\u5448\u73fe\u53f3\u5074\u8179\u90e8\u8f15\u5fae\u58d3\u75db\u4f46\u7121\u53cd\u5f48\u75db\uff0c\u53f3\u5f8c\u5074\u8170\u5448\u73fe\u6572 \u75db\u3002\u6709\u95dc\u6b64\u75c5\u60a3\u7684\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u6b62\u75db\u85e5\u7684\u9078\u64c7\u4e0a\u4e0d\u53ef\u4f7f\u7528 narcotics\uff0c\u4ee5\u907f\u514d\u5f71\u97ff\u80ce\u5152\u3002 (B)\u53ef\u5b89\u6392\u8840\u6db2\u6aa2\u67e5\u3001\u4e00\u822c\u751f\u5316\u6aa2\u67e5\u53ca\u5c3f\u6db2\u5e38\u898f\u6aa2\u67e5\u3002 (C)\u82e5\u5c3f\u6db2\u6aa2\u67e5\u6b63\u5e38\uff0c\u4f46\u8d85\u97f3\u6ce2\u5448\u73fe\u53f3\u5074\u814e\u81df\u6c34\u816b\uff0c\u9700\u8003\u616e\u662f\u56e0\u80ce\u5152\u53ca \u5b50\u5bae\u58d3\u8feb\u8f38\u5c3f\u7ba1\u6240\u9020\u6210\u7684\u814e\u81df\u6c34\u816b\u6240\u5f15\u8d77\u7684\u75bc\u75db\u3002 (D)\u82e5\u5fc5\u8981\u6642\uff0c\u53ef\u4ee5\u5b89\u6392\u8179\u90e8 X \u5149\u6aa2\u67e5\u3002 (E)\u9700\u5c07\u6025\u6027\u95cc\u5c3e\u708e\u5217\u5165\u9451\u5225\u8a3a\u65b7\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6d88\u5316\u6027\u6f70\u760d\u7a7f\u5b54(Perforated peptic ulcer)\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u7ad9\u7acb\u80f8\u90e8 X \u5149\u672a\u770b\u5230\u6e38\u96e2\u6c23\u9ad4(free air)\u5373\u53ef\u6392\u9664\u7a7f\u5b54\u53ef\u80fd\u3002 (B)\u76ee\u524d\u4e0d\u5efa\u8b70\u65bd\u884c\u7d93\u9f3b\u80c3\u7ba1\u6253\u6c23\u5f8c\u7167 X \u5149\u3002 (C)\u8001\u5e74\u4eba\u53ef\u80fd\u4e0d\u6703\u6709\u7a81\u7136\u75bc\u75db\u75c7\u72c0\u6216\u660e\u986f\u8179\u819c\u708e\u5fb5\u5146\u3002 (D)\u75c7\u72c0\u5e38\u70ba\u7a81\u767c\u5287\u70c8\u4e0a\u8179\u75db\u3002 (E)\u75c5\u4eba\u53ef\u80fd\u7121\u6d88\u5316\u6027\u6f70\u760d\u75c5\u53f2\u6216\u6f70\u760d\u75c7\u72c0\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "30 \u6b72\u7537\u6027\u56e0\u70ba\u547c\u5438\u6025\u4fc3\u3001\u80f8\u75db\u81f3\u6025\u8a3a\u5ba4\uff0c\u6aa2\u50b7\u6642\u751f\u547d\u5fb5\u8c61\u70ba\uff0c\u8840\u58d3\uff1a160/80 mmHg\u3001\u5fc3\u8df3\uff1a89 \u4e0b/\u5206\u9418\u3001\u547c\u5438\uff1a30 \u4e0b/\u5206\u9418\u3001\u9ad4\u6eab\uff1a36.7\u2103\u3001pulse oximeter 99 %\uff1b\u554f\u8a3a\u6642\u958b\u59cb\u62b1\u6028\u8eab\u9ad4\u5de6\u534a\u908a\u9ebb\u9ebb\u7684\uff0cEKG \u70ba\u6b63\u5e38\u7ac7\u6027\u5fc3\u5f8b\uff0cCXR \u5728\u7e31\u8188\u8154\u6709\u6e38\u96e2\u6c23\u9ad4\uff0c\u518d\u8a73\u7d30\u8a62\u554f\u75c5\u53f2\u624d\u77e5\u662f\u5f9e\u6f5b\u6c34(Scuba diving)\u6d6e\u51fa\u5f8c\u9019\u5169\u5c0f\u6642\u624d\u767c\u751f\u7684\u3002\u4ee5\u4e0b\u8655\u7f6e\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u9ad8\u5ea6\u61f7\u7591\u70ba Acute coronary syndrome\uff0c\u7d66\u4e88 aspirin\u3001NTG\u3001\u6aa2\u67e5\u5fc3\u808c\u9175\u7d20\u3002 (B)\u9ad8\u5ea6\u61f7\u7591\u70ba Mediastinitis\u3001\u7d66\u4e88\u6297\u751f\u7d20\u3001\u7167\u6703\u80f8\u8154\u5916\u79d1\u3002 (C)\u9ad8\u5ea6\u61f7\u7591\u70ba Panic disorder\uff0c\u7d66\u4e88 Vena \u75c7\u72c0\u6cbb\u7642\uff0c\u89c0\u5bdf\u5373\u53ef\u3002 (D)\u9ad8\u5ea6\u61f7\u7591\u70ba Pulmonary barotrauma\uff0c\u7d66\u4e88\u75c7\u72c0\u6cbb\u7642\uff0c\u89c0\u5bdf\u5373\u53ef\u3002 (E)\u9ad8\u5ea6\u61f7\u7591\u70ba Pulmonary barotrauma \u5408\u4f75 arterial gas embolism\uff0c\u7d66\u4e88\u9ad8\u58d3\u6c27\u6cbb\u7642\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "38 \u6b72\u7537\u6027\uff0c\u56e0\u548c\u53cb\u4eba\u804a\u5929\u6642\u7a81\u7136\u5168\u8eab\u62bd\u6410\uff0c\u5931\u53bb\u610f\u8b58\u88ab\u9001\u81f3\u6025\u8a3a\u5ba4\uff0c\u5230\u9662\u6642\u5df2\u7121\u81ea\u767c\u6027\u547c\u5438\u5fc3\u8df3\uff0cEMT \u8868\u793a\u5230\u73fe\u5834\u6642\uff0cAED \u66fe\u7d93\u5efa\u8b70\u96fb\u64ca\u904e\u4e00\u6b21\uff0c\u96a8\u5f8c\u6301\u7e8c CPR \u5230\u8cb4\u9662\uff0c\u60a8\u5728\u5224\u5b9a\u7121\u9700\u518d\u6b21\u96fb\u64ca\u5f8c\uff0c\u8d95\u7dca\u653e\u4e0a\u6c23\u7ba1\u5167\u7ba1\uff0c\u7e7c\u7e8c\u7d66\u4e88 CPR \u6025\u6551\uff0c\u9019\u6642\u8b77\u7406\u5e2b\u5831\u544a\uff1a\u201cend-tidal CO2 45 mmHg\u201d\uff0c\u95dc\u65bc\u6025\u6551\u904e\u7a0b\u4e2d end-tidal CO2 \u7684\u4f7f\u7528\u53ca\u5224\u5b9a\uff0c\u4ee5\u4e0b\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u65bc CPR \u7684\u904e\u7a0b\u4e2d\uff0c\u61c9\u6301\u7e8c\u6e2c\u91cf end-tidal CO2\uff0c\u4ee5\u76e3\u6e2c CPR \u7684\u54c1\u8cea\u3002 (B)\u82e5\u662f end-tidal CO2 \u53ef\u4ee5\u91cf\u5230\u6578\u503c\uff0c\u6703\u96a8\u8457\u547c\u5438\u5468\u671f\u6709\u6240\u8b8a\u5316\uff0c\u4e14\u4e0d\u6703\u96a8\u8457 ambu bagging \u5f8c\u6e2c\u91cf\u4e0d\u5230\uff0c\u6c23\u7ba1\u5167\u7ba1\u61c9\u662f\u7f6e\u653e\u65bc\u6c23\u7ba1\u5167\u3002 (C)\u82e5\u662f end-tidal CO2 \u5c0f\u65bc 10 mmHg\uff0c\u61c9\u5617\u8a66\u6539\u5584 CPR \u54c1\u8cea\u3002 (D)\u82e5\u662f end-tidal CO2\u7a81\u7136\u6301\u7e8c\u589e\u52a0(\u901a\u5e38\u5927\u65bc\u6216\u7b49\u65bc 40 mmHg)\uff0c\u5247\u8868\u793a\u81ea\u767c\u6027\u5faa\u74b0\u6062\u5fa9(ROSC)\u3002 (E)\u807d\u8a3a\u53ca\u80f8\u90e8 X \u5149\u80fd\u8f03 end-tidal CO2 \u66f4\u6e96\u78ba\u7684\u78ba\u8a8d\u6c23\u7ba1\u5167\u7ba1\u662f\u5426\u7f6e\u653e\u65bc\u6c23\u7ba1\u5167\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "3 \u6b72\u7537\u7ae5\uff0c\u4e3b\u8a34 5 \u5929\u524d\u958b\u59cb\u6709\u611f\u5192\u75c7\u72c0\uff0c3 \u5929\u524d\u958b\u59cb\u8179\u90e8\u4e0d\u9069\uff0c\u56e0\u8179\u75db\u52a0\u5287\u7531\u5bb6\u5c6c\u9001\u5230\u6025\u8a3a\u5ba4\uff0c\u7576\u6642\u5169\u5074\u5c0f\u817f\u6709\u660e\u986f\u75bc\u75db\u73fe\u8c61\uff0c\u4e0b\u80a2\u76ae\u819a\u9678\u7e8c\u51fa\u73fe\u7d05\u8272\u6591\u9ede\u53ca\u985e\u4f3c\u7600\u9752\uff0c\u5bb6\u5c6c\u8868\u793a\u4e26\u7121\u5916\u50b7\u53f2\uff0c\u7121\u5614\u5410\uff0c\u904e\u53bb\u7121\u4efb\u4f55\u6162\u6027\u75be\u75c5\uff0c\u7121\u904e\u654f\u75c5\u53f2\u3002\u6025\u8a3a\u8840\u6db2\u6aa2\u9a57\u7d50\u679c\u5982\u4e0b\uff1aSugar 80 mg/dL\uff0c BUN 12 mg/dL\uff0c Amylase 50 U/L\uff0c AST 52 U/L\uff0c CRP 0.9 mg/L\uff0c WBC 11200/uL\uff0c Hb 12.6 g/dL\uff0c Hct 37.5 %\uff0c Platelet 300 k/uL\uff0c\u5c3f\u6db2\u6aa2\u67e5\u7d50\u679c\uff1aWBC 0/HPF, RBC 30/HPF\u3002\u6b64\u60a3\u8005\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\u70ba\u4e0b\u5217\u4f55\u8005\uff1a", + "Options": "(A)Von Willebrand disease\u3002 (B)Henoch-Schonlein purpura\u3002 (C)Meningocococemia\u3002 (D)Immune thrombocytopenic purpura(ITP)\u3002 (E)Hemophilia\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "40 \u6b72\u7537\u6027\u75c5\u4eba\u56e0\u660f\u5012\u9001\u91ab\uff0c\u7d93\u6025\u8a3a\u91ab\u5e2b\u8a3a\u6cbb\u5f8c\u767c\u73fe\u75c5\u4eba\u7f79\u60a3\u6025\u6027\u4e0b\u58c1 ST\u4e0a\u5347\u5fc3\u808c\u6897\u585e(STEMI)\u4f75\u4f11\u514b\uff0c\u6703\u8a3a\u5fc3\u81df\u79d1\u91ab\u5e2b\u8a55\u4f30\uff0c\u5efa\u8b70\u75c5\u4eba\u61c9\u63a5\u53d7\u7dca\u6025\u5fc3\u5c0e\u7ba1\u8655\u7f6e\uff0c\u82e5\u75c5\u4eba\u610f\u8b58\u6062\u5fa9\u6e05\u695a\uff0c\u8acb\u554f\u8ab0\u6700\u9069\u5408\u7c3d\u7acb\u5fc3\u5c0e\u7ba1\u540c\u610f\u66f8\uff1f", + "Options": "(A)\u75c5\u4eba\u81ea\u5df1\u3002 (B)\u75c5\u4eba\u592a\u592a\u3002 (C)\u672a\u8207\u75c5\u4eba\u540c\u4f4f\u7684\u5927\u5152\u5b50\u3002 (D)\u8207\u75c5\u4eba\u540c\u4f4f\u7684\u5973\u5152\u3002 (E)\u75c5\u4eba\u7684\u7236\u89aa\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "41 \u6b72\u7537\u6027\uff0c\u5e73\u6642\u898f\u5247\u670d\u7528\u78b3\u9178\u92f0(300 mg bid)10 \u5e74\uff0c\u7531\u5bb6\u5c6c\u9001\u4f86\u6025\u8a3a\uff0c\u4e3b\u8a34\u662f\u53ad\u98df\u3001\u5c0f\u4fbf\u4e0d\u8db3\u53ca\u610f\u8b58\u9010\u6f38\u6539\u8b8a\u7d04\u4e00\u661f\u671f\uff0c\u7121\u767c\u73fe\u85e5\u7269\u77ed\u5c11\u3002\u7406\u5b78\u6aa2\u67e5\u660f\u8ff7\u6307\u6578 E3V2M4\uff0c\u5169\u5074\u77b3\u5b54\u7b49\u5927\uff0c\u6709\u56b4\u91cd\u904b\u52d5\u5931\u8abf(ataxia)\u7684\u60c5\u5f62\uff0c\u8840\u58d3\uff1a72/48 mmHg\uff0c\u5fc3\u8df3\uff1a52 \u4e0b\u2044\u5206\u9418\uff0c\u547c\u5438\uff1a18 \u4e0b\u2044\u5206\u9418\uff0c\u9ad4\u6eab\uff1a37.2\u2103\u3002\u62bd\u8840\u5831\u544a\uff1aNa\uff1a 146 mEq/L\u3001K\uff1a 3.3 mEq/L\u3001Cl\uff1a 104 mEq/L\u3001glucose\uff1a 406 mg/dL\u3001BUN\uff1a 83.7 mg/dL\u3001Cr\uff1a 2.6 mg/dL\u3001\u92f0\u9e7d\u6fc3\u5ea6\u70ba 3.3 mEq/L\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u767c\u751f\u65bc\u6162\u6027\u670d\u7528\u92f0\u9e7d\u7684\u75c5\u4eba\u4f7f\u7528\u904e\u591a\u5291\u91cf\uff0c\u9019\u985e\u578b\u7684\u75c5\u4eba\u901a\u5e38\u6bd4\u6025\u6027\u4e2d\u6bd2\u7684\u75c5\u4eba\u56b4\u91cd\u3002 (B)\u7d66\u8207 Lasix \u7b49\u5229\u5c3f\u5291\u4ee5\u52a0\u901f\u92f0\u9e7d\u6392\u51fa\u3002 (C)\u63a5\u53d7\u8840\u6db2\u900f\u6790\u3002 (D)\u4e0d\u9700\u8981\u4f7f\u7528\u6d3b\u6027\u78b3\u3002 (E)\u7528 amiloride \u4f86\u6cbb\u7642\u92f0\u9e7d\u4e2d\u6bd2\u6240\u5f15\u8d77\u7684\u814e\u539f\u6027\u5c3f\u5d29\u75c7\u3002 ", + "Answer": "B " + }, + { + "\ufeffQuestion": "45 \u6b72\u7537\u6027\uff0c\u9152\u5f8c\u99d5\u99db\u5c0f\u5ba2\u8eca\u649e\u64ca\u8def\u908a\u8eca\u8f1b\u800c\u88ab\u9001\u5165\u6025\u8a3a\uff0cEMT \u4ee5\u9838\u5708\u3001\u982d \u90e8\u56fa\u5b9a\u5668\u8207\u9577\u80cc\u677f\u56fa\u5b9a\u3002\u75c5\u4eba\u64da\u8ff0\u6709\u7e6b\u5b89\u5168\u5e36\uff0c\u5b89\u5168\u6c23\u56ca\u4ea6\u7206\u958b\u3002\u5728\u73fe\u5834 \u6642\u80e1\u8a00\u4e82\u8a9e\u4e26\u6297\u62d2\u9001\u91ab\uff0c\u5230\u9662\u6642\u5247\u5448\u73fe\u534a\u7761\u534a\u9192\u72c0\u614b\uff0c\u9192\u6642\u4e00\u76f4\u5435\u9b27\u8981\u6c42 \u9664\u53bb\u9838\u5708\u8207\u56fa\u5b9a\uff0c\u4e0d\u904e\u96a8\u5373\u518d\u5ea6\u5165\u7761\u3002\u4f5c\u521d\u7d1a\u8a55\u4f30\u6642\uff0c\u5168\u8eab\u4e26\u7121\u660e\u986f\u5916\u50b7\uff0c \u547c\u5438\u5e73\u9806\uff0c\u5fc3\u8df3\uff1a105 \u4e0b/\u5206\u9418\uff0c\u8840\u58d3\uff1a148/85mmHg\uff0c\u5169\u908a\u77b3\u5b54\u7b49\u5927\u4e14\u5c0d\u5149\u6709\u53cd\u61c9\uff1b\u9838\u90e8\u4e2d\u7dda\u7121\u660e\u986f\u58d3\u75db\u611f\uff0c\u9b06\u958b\u9838\u5708\u4f5c\u6aa2\u67e5\u6642\u4e0d\u505c\u626d\u52d5\u9838\u90e8\uff0c\u56db\u80a2\u808c\u529b\u8207\u53cd\u5c04\u90fd\u6b63\u5e38\u3002\u6b64\u6642\u6700\u9069\u7576\u7684\u8655\u7f6e\u70ba\uff1a", + "Options": "(A)\u8a72\u75c5\u4eba\u7121\u660e\u986f\u9838\u690e\u53d7\u50b7\u8de1\u8c61\uff0c\u53ef\u76f4\u63a5\u79fb\u9664\u9838\u5708\u3002 (B)\u5148\u9001\u75c5\u4eba\u53bb\u7167\u5c04\u5b8c\u6574\u7684\u9838\u690e X-\u5149 (\u542b C-spine AP+Lat \u4ee5\u53ca Open mouth view)\uff0c\u5982\u5224\u8b80\u7d50\u679c\u6b63\u5e38\uff0c\u5247\u79fb\u9664\u9838\u5708\u3002 (C)\u76f4\u63a5\u958b\u7acb\u9838\u690e\u96fb\u8166\u65b7\u5c64\u651d\u5f71(CT Scan)\uff0c\u5982\u5224\u8b80\u7d50\u679c\u6b63\u5e38\uff0c\u5247\u79fb\u9664 \u9838\u5708\u3002 (D)\u66ab\u6642\u4e0d\u79fb\u9664\u9838\u5708\uff0c\u4f46\u5982\u679c\u5fc5\u9808\u5b89\u6392\u8166\u90e8\u96fb\u8166\u65b7\u5c64\u6642\uff0c\u53ef\u540c\u6642\u5b89\u6392\u9838 \u690e\u96fb\u8166\u65b7\u5c64\u6383\u63cf\u3002 (E)\u6703\u8a3a\u795e\u7d93\u5916\u79d1\u4f5c\u9032\u4e00\u6b65\u5efa\u8b70\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "45 \u6b72\u5973\u6027\u6a5f\u8eca\u9a0e\u58eb\u8207\u904a\u89bd\u8eca\u767c\u751f\u78b0\u649e\u4e8b\u6545\u5f8c\u5012\u5730\u3002EMT \u5230\u9054\u73fe\u5834\u5f8c\u767c\u73fe\u50b7\u60a3\u8eba\u5728\u904a\u89bd\u8eca\u53f3\u5f8c\u8f2a\u65c1\uff0c\u9664\u4e86\u5de6\u4e0b\u80a2\u5728\u8eca\u5e95\uff0c\u8eab\u9ad4\u5176\u9918\u90e8\u4f4d\u5747\u5728\u8eca\u5916\u3002\u73fe\u5834\u5b89\u5168\u7121\u865e\u4e14\u50b7\u60a3\u5b89\u5168\u5e3d\u672a\u812b\u843d\uff0c\u4e3b\u8a34\u5de6\u5927\u817f\u75bc\u75db\u7121\u6cd5\u884c\u52d5\u3002\u521d\u6b65\u8a55\u4f30\u986f\u793a\u50b7\u60a3\u610f\u8b58\u6e05\u9192\u3001\u547c\u5438\u6b63\u5e38\u3001\u5fc3\u8df3\uff1a120 \u4e0b/\u5206\u9418\u3001\u8840\u58d3\uff1a100/60 mmHg\u3001\u66b4\u9732\u8eab\u9ad4\u986f\u793a\u5de6\u5927\u817f\u7600\u9752\u816b\u8139\u3001\u9760\u8fd1\u9f20\u8e4a\u90e8\u6709\u4e00\u7d04 20 \u516c\u5206\u5bec\u4e4b\u8f2a\u80ce\u75d5\uff0c\u5176\u9918\u6aa2\u67e5\u4e26\u7121\u660e\u986f\u7570\u5e38\u3002\u8acb\u554f\u6709\u95dc\u5230\u9662\u524d\u7684\u56fa\u5b9a\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6700\u4e0d\u9069\u7576\uff1f", + "Options": "(A)EMT \u5c07\u50b7\u60a3\u79fb\u96e2\u8eca\u5e95\u524d\uff0c\u61c9\u5728\u4fdd\u8b77\u9838\u690e\u7684\u524d\u63d0\u4e0b\uff0c\u5c07\u50b7\u60a3\u7684\u5b89\u5168\u5e3d\u812b\u9664\u3002 (B)\u56e0\u50b7\u60a3\u53ef\u80fd\u9838\u690e\u53d7\u50b7\uff0c\u5728\u812b\u9664\u5b89\u5168\u5e3d\u5f8c\u61c9\u4ee4\u526f\u624b\u4ee5\u9069\u7576\u7684\u5f92\u624b\u65b9\u5f0f\u56fa\u5b9a\u9838\u690e\u3002 (C)\u521d\u6b65\u8a55\u4f30\u5f8c\uff0c\u50b7\u60a3\u53ef\u80fd\u6709\u5de6\u5074\u80a1\u9aa8\u9aa8\u6298\uff0c\u7121\u6cd5\u6392\u9664\u9838\u690e\u554f\u984c\uff0c\u56e0\u6b64\u9700\u8981\u4ee5\u9838\u5708\u56fa\u5b9a\u3002 (D)\u50b7\u60a3\u53ef\u80fd\u6709\u5de6\u5074\u80a1\u9aa8\u9aa8\u6298\uff0c\u6545\u521d\u6b65\u8a55\u4f30\u5f8c\u61c9\u4ee5\u727d\u5f15\u5f0f\u593e\u677f(Traction splint)\u56fa\u5b9a\u3002 (E)\u642c\u904b\u50b7\u60a3\u524d\u61c9\u5148\u4ee5\u9577\u80cc\u677f\u56fa\u5b9a\u5168\u8eab\uff0c\u4ee5\u907f\u514d\u4e8c\u6b21\u50b7\u5bb3\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "49 \u6b72\u7537\u6027\uff0c\u6709\u6182\u9b31\u75c7\uff0c\u67d0\u65e5\u51cc\u6668\u5fc3\u60c5\u4e0d\u597d\uff0c\u559d\u4e86\u4e00\u74f6\u706b\u934b\u7528\u7684\u9152\u7cbe\u71c8\u71c3\u6599\u81ea\u6bba\uff0c\u611f\u5230\u547c\u5438\u56f0\u96e3\u3001\u8996\u529b\u6a21\u7cca\u53ca\u8179\u75db\u73fe\u8c61\uff0c\u65bc\u662f\u88ab\u5bb6\u4eba\u9001\u81f3\u91ab\u9662\uff0c\u75c5\u4eba\u8e81\u52d5\u5f8c\u6f38\u6f38\u660f\u8ff7\u3002\u7d93\u8a62\u554f\u75c5\u53f2\u3001\u7406\u5b78\u6aa2\u67e5\u53ca\u5be6\u9a57\u5ba4\u5206\u6790\u5f8c\uff0c\u773c\u5e95\u986f\u793a\u8996\u76e4\u6c34\u816b\u4e14\u908a\u7de3\u4e0d\u6e05\u695a\uff0c\u52d5\u8108\u8840\u6db2\u6c23\u9ad4\u3008arterial blood gases\u3009\uff0c\u5728\u6c27\u6c23\u6bcf\u5206\u9418 2\u516c\u5347\u4e0b\uff0cpH \u70ba 7.092\u3001PaO2 110.5 mmHg\u3001PaCO2 20.9 mmHg\u3001HCO3- 6.1 mmol/l\u3001\u6c27\u6c23\u98fd\u548c\u5ea6\u70ba 100%\uff0c\u8840\u4e2d\u9670\u96e2\u5b50\u9593\u9699\u70ba 28.9\uff0c\u4e59\u9187\u6fc3\u5ea6\u6e2c\u4e0d\u5230\uff0c\u60a8\u6240\u7d66\u4e88\u7684\u6cbb\u7642\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)NaHCO3 \u6ce8\u5c04\u6cbb\u7642\u3002 (B)Fomepizole 10-20 mg/kg/day\u3002 (C)Ethanol \u6cbb\u7642\uff0c\u7d66\u4e88 1 g /kg loading dose\uff0c\u7136\u5f8c 66 mg/kg/hr\uff0c\u8840\u6db2\u900f\u6790\u6cbb\u7642\u6642\u7d66\u4e88 132 mg/kg/hr\u3002 (D)Folic acid \u6ce8\u5c04\u6cbb\u7642\u3002 (E)\u6709 Fomepizole \u89e3\u6bd2\u5291\u6642\uff0c\u4e0d\u5fc5\u8981\u7d66\u4e88\u8840\u6db2\u900f\u6790\u6cbb\u7642\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "5 \u540d\u6295\u5bbf\u65bc\u6c11\u5bbf\u4e4b\u65c5\u5ba2\uff0c\u6c11\u5bbf\u7f8e\u4f96\u7f8e\u5950\u901a\u98a8\u826f\u597d\uff0c\u7528\u5b8c\u665a\u9910\u5f8c 1 \u5c0f\u6642\uff0c\u5c1a\u672a\u6c90\u6d74\uff0c\u9678\u9678\u7e8c\u7e8c\u56e0\u70ba\u5fc3\u640f\u52a0\u901f\u3001\u547c\u5438\u6025\u4fc3\u53ca\u5168\u8eab\u767c\u7d3a\uff0c\u751a\u81f3\u795e\u667a\u4e0d\u6e05\u3001\u8840\u58d3\u4e0b\u964d\u53ca\u547c\u5438\u8870\u7aed\u6c42\u8a3a\uff0c\u96d6\u7136\u6301\u7e8c\u4f7f\u7528\u6c27\u6c23\u4ecd\u7121\u660e\u986f\u6548\u679c\uff0c\u52d5\u8108\u8840\u6c27\u6c23\u9ad4\u5206\u6790\u6c27\u6c23\u5206\u58d3 PaO2 95-100 mmHg\uff0c\u975c\u8108\u8840\u6c27\u6c23\u9ad4\u5206\u6790\u6c27\u6c23\u5206\u58d3 PvO2 38-42 mmHg\uff0c\u5168\u8eab\u767c\u7d3a\u672a\u898b\u6539\u5584\uff0c\u75c5\u4eba\u6cbb\u7642\u7528\u4f55\u7a2e antidote\uff1f", + "Options": "(A)Fomipezole \u3002 (B)Methylene blue\u3002 (C)Hydroxocobalamine \u3002 (D)Calcium gluconate \u3002 (E)Flumazenil \u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "70 \u6b72\u8001\u5148\u751f\u56e0\u70ba\u4f11\u514b\u9001\u81f3\u6025\u8a3a\u5c31\u8a3a\uff0c\u95dc\u65bc\u4f11\u514b\u75c5\u4eba\u7684\u8a55\u4f30\u8655\u7f6e\u3001\u8f38\u6db2\u6cbb\u7642\u53ca\u5347\u58d3\u85e5\u7269\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)Dopamine\uff0cEpinephrine\uff0cNorepinephrine \u4e09\u8005\u5c0d\u65bc \u03b1 \u63a5\u53d7\u5668\u523a\u6fc0\u5f37\u5ea6\u76f8\u7576\uff0c\u4f46 Norepinephrine \u5c0d\u65bc \u03b1 \u63a5\u53d7\u5668\u523a\u6fc0\u5f37\u5ea6\u6700\u5f37\uff0c\u5c0d\u65bc \u03b22 \u63a5\u53d7\u5668\u5247\u7121\u4f5c\u7528\u3002 (B)\u8840\u58d3\u662f\u6aa2\u6e2c\u7d44\u7e54\u704c\u6d41\u4e0d\u8db3\u7684\u654f\u611f\u6307\u6a19\uff0c\u4f11\u514b\u6642\u6703\u9020\u6210\u7d44\u7e54\u704c\u6d41\u53ca\u6c27\u6c23\u4e0d\u8db3\u3001\u56b4\u91cd\u7cfb\u7d71\u6027\u767c\u708e\u53cd\u61c9\u75c7\u5019\u7fa4(SIRS)\u3001\u591a\u91cd\u5668\u5b98\u8870\u7aed\u751a\u81f3\u6b7b\u4ea1\u3002 (C)\u6557\u8840\u6027\u4f11\u514b\u65bc\u6025\u8a3a\u6cbb\u7642\u7684\u65e9\u671f\u76ee\u6a19\uff0c\u4e2d\u5fc3\u975c\u8108\u7ba1(CVP)\u503c8~12mmHg\uff0c\u5e73\u5747\u52d5\u8108\u58d3(MAP) 65~90mmHg\uff0c\u4e2d\u5fc3\u975c\u8108\u6c27\u6c23\u98fd\u548c\u5ea6(Scvo2) >70%\uff0c\u53ef\u986f\u8457\u964d\u4f4e\u6b7b\u4ea1\u7387\u3002 (D)Dopamine \u548c Norepinephrine \u540c\u70ba\u6557\u8840\u6027\u4f11\u514b\u8003\u616e\u7684\u7b2c\u4e00\u7dda\u6cbb\u7642\u3002 (E)\u7b49\u5f35\u6676\u9ad4\u6db2(crystalloid fluids)\u8f38\u6db2\u5fa9\u7526\u4e4b 3\uff1a1 \u751f\u7406\u6cd5\u5247\uff0c\u4e3b\u8981\u662f\u56e0\u70ba\u7d04\u5269\u4e0b 30%\u7b49\u5f35\u6676\u9ad4\u6db2\u7559\u5728\u8840\u7ba1\u5167\uff0c\u6545\u88dc\u5145\u8840\u6db2\u6d41\u5931\u9700\u8981\u4e09\u500d\u91cf\u7684\u7b49\u5f35\u6676\u9ad4\u6db2\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "Magnesium sulfate \u53ef\u7528\u65bc\u8a31\u591a\u6025\u91cd\u75c7\u75c5\u4eba\uff0c\u4ee5\u4e0b\u4f55\u7a2e\u60c5\u5f62\u4e0d\u9069\u5408\u7d66\u4e88\uff1f", + "Options": "(A)\u591a\u5f62\u6027\u5fc3\u5ba4\u6027\u983b\u8108(Polymorphic ventricular tachycardia)\u61f7\u7591\u70ba Torsades de pointes\u3002 (B)\u598a\u5a20\u6027\u5b50\u9593\u75c7(Eclampsia)\u3002 (C)\u56b4\u91cd\u7684\u6c23\u5598\u3002 (D)\u4e09\u74b0\u578b\u6297\u6182\u9b31\u85e5\u7269(Tri-cyclic antidepressant)\u4e2d\u6bd2\u5f15\u8d77\u7684\u5fc3\u5ba4\u6027\u5fc3\u5f8b\u4e0d\u6574\u3002 (E)\u4ee5\u4e0a\u5747\u5408\u9069\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u75c5\u4eba\u70ba\u80ba\u764c\u5002\u8166\u3001\u809d\u3001\u9aa8\u982d\u591a\u8655\u8f49\u79fb\u7684\u672b\u671f\u7537\u6027\u60a3\u8005\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u82e5\u75c5\u4eba\u6b32\u7c3d\u7acb\u5b89\u5be7\u7de9\u548c\u91ab\u7642\u610f\u9858\u66f8\u6642\uff0c\u9700\u6709\u5177\u5b8c\u5168\u884c\u70ba\u80fd\u529b\u8005\u4e8c\u4eba\u4ee5\u4e0a\u5728\u5834\u898b\u8b49\uff0c\u5176\u4e2d\u4e0d\u5305\u62ec\u91ab\u8b77\u4eba\u54e1\u3002 (B)\u82e5\u75c5\u4eba\u5df2\u7c3d\u7acb\u5b89\u5be7\u7de9\u548c\u91ab\u7642\u610f\u9858\u66f8\uff0c\u75c5\u4eba\u4ecd\u96a8\u6642\u53ef\u64a4\u56de\u5176\u610f\u9858\u66f8\uff0c\u4f46\u9808\u4ee5\u66f8\u9762\u70ba\u4e4b\u3002 (C)\u5373\u4f7f\u75c5\u4eba\u5df2\u7c3d\u7f72\u5b89\u5be7\u7de9\u548c\u91ab\u7642\u610f\u9858\u66f8\uff0c\u4f46\u82e5\u75c5\u4eba\u81e8\u6642\u53cd\u6094\uff0c\u8981\u6c42\u63d2\u7ba1\u6025\u6551\uff0c\u91ab\u5e2b\u61c9\u4e88\u4ee5\u63d2\u7ba1\u6025\u6551\u3002 (D)\u82e5\u91ab\u5e2b\u5728\u5b8c\u6210\u63d2\u7ba1\u6025\u6551\u5f8c\u624d\u5f97\u77e5\u75c5\u4eba\u5df2\u9810\u7acb\u5b89\u5be7\u7de9\u548c\u91ab\u7642\u610f\u9858\u66f8 \uff0c\u6b64\u6642\u91ab\u5e2b\u4e0d\u5f97\u4f9d\u6b64\u610f\u9858\u66f8\u7acb\u5373\u64a4\u9664\u5176\u7dad\u751f\u8a2d\u5099\u3002 (E)\u82e5\u91ab\u5e2b\u5728\u5b8c\u6210\u63d2\u7ba1\u6025\u6551\u5f8c\uff0c\u75c5\u4eba\u4e4b\u59bb\u3001\u5152\u3001\u7236\u89aa\u6c7a\u5b9a\u7c3d\u7f72\u64a4\u9664\u5fc3\u80ba\u5fa9\u7526\u8853\u540c\u610f\u66f8\uff0c\u5247\u91ab\u5e2b\u5373\u53ef\u4f9d\u6b64\u540c\u610f\u66f8\u64a4\u9664\u5176\u7dad\u751f\u8a2d\u5099\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u99ac\u62c9\u677e\u8dd1\u8005\u5728\u6bd4\u8cfd\u6642\u7522\u751f\u4e86\u9ad8\u9ad4\u6eab\u8207\u610f\u8b58\u969c\u7919\u7684\u60c5\u5f62\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u71b1\u4e2d\u6691(heatstroke)\u5178\u578b\u7684\u75c7\u72c0\u70ba\u9ad8\u9ad4\u6eab(>40\u00b0C)\uff0c\u4e2d\u6a1e\u795e\u7d93\u7cfb\u7d71\u7570\u5e38\u8207\u6c92\u6709\u51fa\u6c57(anhidrosis)\u3002 (B)\u6b7b\u4ea1\u7387\u53ef\u9ad8\u9054 30%\u3002 (C)\u5c0f\u8166\u5c0d\u71b1\u50b7\u5bb3\u654f\u611f\uff0c\u53ef\u80fd\u5c0e\u81f4\u6b65\u4f10\u4e0d\u7a69\u3002 (D)\u5ef6\u9072\u964d\u6eab\u6703\u5c0e\u81f4\u6b7b\u4ea1\u7387\u4e0a\u5347\u3002 (E)\u6cbb\u7642\u71b1\u4e2d\u6691\u6642\uff0c\u8fc5\u901f\u964d\u6eab\u76ee\u6a19\u70ba\u4e2d\u5fc3\u9ad4\u6eab\u964d\u81f3 37\u00b0C\uff0c\u4ee5\u514d\u767c\u751f\u904e\u5ea6\u4f4e\u9ad4\u6eab(overshoot hypothermia)\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u5730\u9707\u707d\u96e3 1 \u81f3 3 \u5929\u5167\u767c\u751f\u7684\u6025\u6027\u75be\u75c5\uff0c\u4e0b\u5217\u4f55\u9805\u8f03\u4e0d\u5e38\u898b\uff1f", + "Options": "(A)\u58d3\u8feb\u75c7\u5019\u7fa4(Crush Syndrome)\u3002 (B)\u547c\u5438\u8870\u7aed(Respiratory Failure)\u3002 (C)\u814e\u8870\u7aed(Renal Failure)\u3002 (D)\u6182\u9b31\u75c7(Depression)\u3002 (E)\u71d9\u50b7(Burn)\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u55ae\u7d14\u71b1\u75d9\u6523(Simple febrile convulsion)\u7684\u7279\u5fb5\uff0c\u4e0d\u5305\u62ec\u4e0b\u5217\u4f55\u9805\uff1f", + "Options": "(A)24 \u5c0f\u6642\u5167\u50c5\u767c\u751f\u4e00\u6b21\u75d9\u6523\u3002 (B)\u5408\u4f75\u767c\u71d2 ( \u226738\u00baC )\u3002 (C)\u5c40\u90e8\u62bd\u6410\u767c\u4f5c( partial seizure)\u3002 (D)\u767c\u751f\u65bc 6 \u500b\u6708\u5230 5 \u6b72\u5927\u7684\u5152\u7ae5\u3002 (E)\u767c\u4f5c<15 \u5206\u9418\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u5c0d\u65bc\u98df\u9053\u7834\u88c2\u7684\u75c5\u4eba\u8655\u7f6e\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u5e03\u723e\u54c8\u592b\u75c7\u5019\u7fa4(Boerhaave syndrome)\u662f\u4e00\u7a2e\u56e0\u70ba\u6aa2\u67e5\u6240\u9020\u6210\u7684\u98df\u9053\u5167\u58d3\u529b\u4e0a\u5347\uff0c\u5c0e\u81f4\u98df\u9053\u7834\u88c2\u7684\u75be\u75c5\u3002 (B)\u7e31\u8188\u8154\u6c23\u816b(mediastinal emphysema)\u65bc\u98df\u9053\u7834\u88c2\u7684\u75c5\u4eba\u7684\u5f71\u50cf\u4e0a\u4e0d\u4e00\u5b9a\u770b\u7684\u5230\u3002 (C)\u98df\u9053\u7834\u88c2\u9020\u6210\u7684\u75bc\u75db\u5e38\u5e38\u662f\u6025\u6027\uff0c\u4e26\u4e14\u6703\u6295\u5c04\u5230\u80cc\u90e8\u3002 (D)\u541e\u56a5\u56f0\u96e3\u3001\u547c\u5438\u56f0\u96e3\u3001\u5410\u8840\u662f\u53ef\u80fd\u8868\u73fe\u7684\u75c7\u72c0\u3002 (E)\u98df\u9053\u7834\u88c2\u5230\u6cbb\u7642\u7684\u6642\u9593\u6703\u5f71\u97ff\u75c5\u4eba\u7684\u9810\u5f8c\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u5c0d\u65bc\u4e00\u500b\u6700\u8fd1\u7531\u570b\u5916\u65c5\u904a\u8fd4\u570b\u5f8c\u51fa\u73fe\u767c\u71d2\u7684\u75c5\u4eba\uff0c\u5728\u81e8\u5e8a\u8a3a\u65b7\u7684\u9451\u5225\u8a3a\u65b7\u4e0a\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u82e5\u75c5\u4eba\u662f\u5f9e\u71b1\u5e36\u5730\u5340\u65c5\u904a\u8fd4\u570b\uff0c\u5247\u7627\u75be(malaria)\u662f\u7b2c\u4e00\u500b\u5fc5\u9808\u512a\u5148\u6392\u9664\u7684\u9451\u5225\u8a3a\u65b7\uff0c\u5176\u5178\u578b\u7684\u81e8\u5e8a\u8868\u73fe\u70ba\u767c\u71d2(fever)\u3001\u813e\u81df\u816b\u5927(splenomegaly)\u3001\u53ca\u8840\u5c0f\u677f\u6578\u76ee\u4f4e\u4e0b(thrombocytopenia)\u3002 (B)\u7627\u75be\u75c5\u4eba\u5747\u6703\u51fa\u73fe\u9031\u671f\u6027(periodicity)\u767c\u71d2\u7684\u8868\u73fe\uff0c\u56e0\u6b64\u82e5\u75c5\u4eba\u6c92\u6709\u51fa\u73fe\u9031\u671f\u6027\u7684\u767c\u71d2\u578b\u614b\uff0c\u5247\u7627\u75be\u611f\u67d3\u7684\u53ef\u80fd\u6027\u53ef\u4ee5\u521d\u6b65\u6392\u9664\u3002 (C)\u82e5\u6392\u9664\u7627\u75be\u611f\u67d3\u7684\u53ef\u80fd\u6027\uff0c\u800c\u75c5\u4eba\u51fa\u73fe\u8840\u5c0f\u677f\u6578\u76ee\u4f4e\u4e0b(thrombocytopenia)\u5408\u4f75\u76ae\u819a\u9ede\u72c0\u51fa\u8840\u8868\u73fe\u6642(petechial hemo \u547c\u5438hage)\uff0c\u5247\u5fc5\u9808\u512a\u5148\u8003\u616e\u767b\u9769\u51fa\u8840\u71b1(dengue hemorrhagic fever)\u3001\u6d41\u884c\u6027\u8166\u810a\u9ad3\u819c\u708e\u96d9\u7403\u83cc\u83cc\u8840\u75c7(meningococcemia)\u3001\u53ca\u75c5\u6bd2\u6027\u51fa\u8840\u71b1(hemo \u547c\u5438 hagic fever)\u7684\u53ef\u80fd\u6027\u3002 (D)\u82e5\u75c5\u4eba\u5f9e\u5317\u7f8e\u6d32\u65c5\u904a\u56de\u570b\u51fa\u73fe\u767c\u71d2\u5408\u4f75\u8b6b\u5984\u610f\u8b58\u8b8a\u5316\uff0c\u5247\u5728\u6392\u9664\u4e00\u822c\u7684\u7d30\u83cc\u6027\u8166\u819c\u708e\u4e4b\u5916\uff0c\u5fc5\u9808\u8003\u616e\u897f\u5c3c\u7f85\u75c5\u6bd2(West Nile virus)\u611f\u67d3\u9020\u6210\u8166\u708e\u7684\u53ef\u80fd\u6027\u3002 (E)\u9664\u4e86\u7627\u75be\u4e4b\u5916\uff0c\u4e0a\u8ff0\u75be\u75c5\u7684\u6f5b\u4f0f\u671f\u5747\u5728\u4e09\u9031(\u2266 21 days)\u4e4b\u5167\uff0c\u82e5\u75c5\u4eba\u5728\u8fd4\u570b\u5f8c\u4e09\u9031\u4e4b\u5f8c\u624d\u51fa\u73fe\u611f\u67d3\u767c\u71d2\u7b49\u75c7\u72c0\uff0c\u5247\u9664\u4e86\u7627\u75be\u4e4b\u5916\uff0c\u5247\u5fc5\u9808\u8003\u616e\u75c5\u6bd2\u6027\u809d\u708e(viral hepatitis)\u3001\u6885\u6bd2(syphilis)\u3001\u6025\u6027\u4eba\u985e\u514d\u75ab\u4e0d\u5168\u75c5\u6bd2\u611f\u67d3(acute HIV infection)\u3001\u963f\u7c73\u5df4\u75e2\u75be\u809d\u81bf\u760d(amebic liver abscess)\u3001\u72c2\u72ac\u75c5(rabies)\u3001\u53ca\u5176\u4ed6\u5bc4\u751f\u87f2\u611f\u67d3\u7684\u53ef\u80fd\u6027\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u5152\u7ae5\u8eab\u9ad4\u8650\u5f85(Child Physical Abuse)\u5e38\u898b\u7684\u7279\u5fb5\uff0c\u4e0d\u5305\u62ec\u4e0b\u5217\u4f55\u9805\uff1f", + "Options": "(A)\u4e0d\u540c\u6642\u671f\u7684\u591a\u8655\u9aa8\u6298\u3002 (B)\u808b\u9aa8\u9aa8\u6298(Rib fracture)\u3002 (C)\u6d78\u6ce1\u71d9\u50b7(Immersion burns)\u3002 (D)\u8996\u7db2\u819c\u51fa\u8840(Retinal hemorrhage)\u3002 (E)\u8499\u53e4\u6591(Mongolian spots)\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u81e8\u5e8a\u4e0a\u75c5\u4eba\u5448\u73fe\u6025\u6027\u8179\u75db\u5408\u4f75\u8179\u90e8\u808c\u8089\u50f5\u786c\u72c0\u614b\u4e14\u5e38\u5f15\u8d77\u4f11\u514b\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u75c5\u4eba\u60a3\u6709\u6025\u6027\u6d88\u5316\u6027\u6f70\u760d\u7a7f\u5b54\u3002 (B)\u75c5\u4eba\u60a3\u6709\u98df\u9053\u7834\u88c2\u3002 (C)\u75c5\u4eba\u60a3\u6709\u813e\u81df\u7834\u88c2\u3002 (D)\u75c5\u4eba\u60a3\u6709\u8178\u626d\u8f49\u3002 (E)\u75c5\u4eba\u60a3\u6709\u6025\u6027\u51fa\u8840\u6027\u80f0\u81df\u708e\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u81e8\u5e8a\u4e0a\u6703\u5f71\u97ff\u5fc3\u96fb\u5716 ST \u6ce2\u6bb5\u5224\u8b80\u7684\u72c0\u6cc1\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u65e9\u671f\u518d\u6975\u5316\u53ca\u5de6\u5fc3\u5ba4\u80a5\u5927\uff0c\u5169\u8005\u7686\u53ef\u9020\u6210 ST \u6ce2\u6bb5\u7684\u4e0a\u5347\u6216\u4e0b\u964d\u3002 (B)\u5de6\u5074\u675f\u652f\u50b3\u5c0e\u963b\u65b7\u53ca\u5de6\u5fc3\u5ba4\u80a5\u5927\uff0c\u5169\u8005\u7686\u53ef\u9020\u6210 ST \u6ce2\u6bb5\u7684\u4e0a\u5347\u6216\u4e0b\u964d\u6216 T \u6ce2\u5012\u7f6e\u3002 (C)\u4f4e\u8840\u9240\u53ca\u6bdb\u5730\u9ec3\u4e2d\u6bd2\uff0c\u5169\u8005\u7686\u53ef\u9020\u6210 ST \u6ce2\u6bb5\u4e0b\u964d\u3002 (D)\u4e8c\u5c16\u74e3\u812b\u5782\u53ca\u80ba\u6813\u585e\u53ef\u9020\u6210 T \u6ce2\u5012\u7f6e\u3002 (E)\u81ea\u767c\u6027\u6c23\u80f8\u4e0d\u6703\u9020\u6210 T \u6ce2\u5012\u7f6e\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u525b\u51fa\u751f\u7684\u65b0\u751f\u5152\u7d93\u521d\u6b65\u4fdd\u6696\u64e6\u4e7e\u523a\u6fc0\u5f8c\uff0c\u6709\u547c\u5438\u56f0\u96e3\u53ca\u8f15\u5fae\u767c\u7d3a\u60c5\u5f62\uff0c\u5fc3\u8df3\uff1a80 \u4e0b/\u5206\u9418\uff0c\u63a5\u4e0b\u4f86\u7684\u8655\u7f6e\u70ba\uff1a", + "Options": "(A)\u4fdd\u6696\u4e26\u6301\u7e8c\u8a55\u4f30\u8eab\u9ad4\u72c0\u6cc1\u3002 (B)\u7d66\u4e88\u6025\u6551\u85e5\u7269 Epinephrine\u3002 (C)\u7d66\u4e88\u6b63\u58d3\u547c\u5438(Positive pressure ventilation)\u3002 (D)\u958b\u59cb\u58d3\u80f8(Chest compression)\u3002 (E)\u6e96\u5099\u63d2\u7ba1(Intubation)\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u95dc\u65bc wide QRS tachycardia \u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u82e5\u6709 ventriculo - atrial dissociation\uff0c\u8868\u793a\u70ba ventricular origin\u3002 (B)\u82e5\u70ba polymorphic ventricular tachycardia \u4e14\u5148\u524d EKG \u6709 QTc prolongation \u6216\u9382\u96e2\u5b50\u6fc3\u5ea6\u504f\u4f4e\u7684\u60c5\u5f62\uff0c\u53ef\u8003\u616e\u76f4\u63a5\u7d66\u4e88 MgSO4\u3002 (C)\u82e5\u6709\u9ad8\u5ea6\u4e00\u81f4\u6027\u4e4b QRS complex \u4f46\u898f\u5f8b\u6027\u6975\u4e0d\u898f\u5247\uff0c\u52a0\u4e0a\u9593\u6b47\u51fa\u73fe narrow QRS complexes\uff0c\u61c9\u8003\u616e\u70ba atrial fibrillation \u5408\u4f75 WPW syndrome\u3002 (D)\u82e5\u8840\u884c\u52d5\u529b\u5b78\u4e0d\u7a69\u5b9a\uff0c\u5247\u5b9c\u4ee5\u540c\u6b65\u96fb\u64ca\u6cbb\u7642\u3002 (E)\u82e5\u8840\u884c\u52d5\u529b\u5b78\u7a69\u5b9a\uff0c\u4e0d\u5b9c\u4f7f\u7528 adenosine \u6cbb\u7642\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6ccc\u5c3f\u7cfb\u7d71\u5275\u50b7\uff0c\u4e0b\u5217\u4f55\u8005\u53ef\u4ee5\u5e36\u85e5\u96e2\u958b\u6025\u8a3a\u56de\u5bb6\u89c0\u5bdf\uff1f", + "Options": "(A)10 \u6b72\u7537\u5b69\uff0c\u8170\u90e8\u632b\u50b7\u3001\u5c3f\u6db2\u6aa2\u67e5 RBC 25 / HPF\u3001\u7121\u8170\u90e8\u6572\u64ca\u75db\u3002 (B)75 \u6b72\u8001\u4eba\uff0c\u8eca\u798d\u8170\u75db\u3001\u6301\u7e8c\u8840\u5c3f (gross hematuria)\u3001\u8ca7\u8840\u3002 (C)16 \u6b72\u5973\u5b69\u9a0e\u8eca\u81ea\u6454\uff0c\u5c3f\u6db2\u6aa2\u67e5 RBC 90 / HPF\u3001\u4e0b\u8179\u75db\u3002 (D)40 \u6b72\u5361\u8eca\u53f8\u6a5f\uff0c\u8eca\u798d\u3001\u8840\u5c3f\u3001\u8179\u90e8\u808c\u8089\u50f5\u786c\u3002 (E)25 \u6b72\u5973\u6027\u505a\u5bb6\u4e8b\u6ed1\u5012\u3001\u4e0b\u8179\u75db\u3001\u8170\u75db\u3001\u5c3f\u6db2\u6aa2\u67e5 RBC 200 / HPF\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u75c5\u4eba\u767c\u751f\u5927\u91cf\u54b3\u8840\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u53ef\u80fd\uff1f", + "Options": "(A)\u75c5\u4eba\u60a3\u6709\u652f\u6c23\u7ba1\u64f4\u5f35\u75c7\u6025\u75c7\u3002 (B)\u75c5\u4eba\u60a3\u6709\u7a7a\u6d1e\u6027\u80ba\u7ed3\u6838\u75be\u75c5\u3002 (C)\u75c5\u4eba\u60a3\u6709\u80ba\u66f2\u83cc\u7403(Aspergilloma)\u75be\u75c5\u3002 (D)\u64cd\u4f5c\u80ba\u52d5\u8108\u5c0e\u7ba1\u5f15\u8d77\u80ba\u52d5\u8108\u7834\u88c2\u3002 (E)\u75c5\u4eba\u60a3\u6709\u50e7\u5e3d\u8fa6\u8fd4\u6d41(Mitral regurgitation)\u6025\u75c7\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5e03\u9b6f\u683c\u9054\u6c0f\u75c7\u5019\u7fa4(Brugada syndrome)\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u4e00\u7a2e\u9ad4\u67d3\u8272\u9ad4\u907a\u50b3\u57fa\u56e0\u7f3a\u9677(autosomal dominant genetic defect)\u3002 (B)\u9209\u96e2\u5b50\u901a\u9053(sodium channel)\u5b8c\u5168\u5931\u53bb\u529f\u80fd\u3002 (C)\u95dc\u9375\u5fc3\u96fb\u5716\u8868\u73fe\u51fa V2-V6 \u5c0e\u7a0b\u65e9\u671f\u518d\u6975\u5316\uff0c\u4e26\u6709\u6b63\u5411\u4e4b T \u6ce2\u8868\u73fe\u3002 (D)\u5728\u6771\u5357\u4e9e\u570b\u5bb6\u4e2d\uff0c\u4f54\u75c5\u4eba\u767c\u751f\u4e0d\u660e\u539f\u56e0\u7684\u5fc3\u5ba4\u986b\u52d5(VF)\u7684 40-50%\u3002 (E)\u6700\u6709\u6548\u7684\u6cbb\u7642\u70ba\u690d\u5165\u9ad4\u5167\u5fc3\u5f8b\u8f49\u8b8a\u9664\u986b\u5668(cardioverter- defibrillator)\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5e03\u723e\u54c8\u592b\u75c7\u5019\u7fa4(Boerhaave syndrome)\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u6703\u5f15\u8d77\u81f4\u547d\u7684\u80f8\u75db\u3002 (B)\u5e38\u767c\u751f\u5728\u4e00\u9663\u5287\u70c8\u5614\u5410\u4e4b\u5f8c\u3002 (C)\u6703\u5f15\u767c\u7e31\u8188\u8154\u6c23\u816b\u3002 (D)\u5f15\u767c\u81f4\u547d\u7684\u80c3\u7834\u88c2\u3002 (E)\u6703\u5408\u4f75\u6709\u6c23\u80f8\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u767c\u751f\u5fc3\u808c\u6897\u585e\u6642\u4f7f\u7528\u8840\u6813\u6eb6\u89e3\u5291\u7684\u7d55\u5c0d\u7981\u5fcc\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u75c5\u4eba\u4e4b\u524d\u6709\u767c\u751f\u904e\u8166\u90e8\u51fa\u8840\u75c5\u53f2\u3002 (B)\u75c5\u4eba\u4e4b\u524d\u6709\u767c\u751f\u904e\u8166\u90e8\u816b\u7624\u75c5\u53f2\u3002 (C)\u75c5\u4eba\u6709\u8166\u90e8\u8840\u7ba1\u75c5\u7076\u3002 (D)\u75c5\u4eba\u6b63\u9022\u6708\u7d93\u4f86\u6f6e\u3002 (E)\u61f7\u7591\u75c5\u4eba\u6709\u4e3b\u52d5\u8108\u525d\u96e2\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5152\u7ae5\u8178\u5957\u758a(Intussusception)\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u662f 3 \u500b\u6708\u5230 6 \u6b72\u7684\u5152\u7ae5\uff0c\u8178\u963b\u585e(Intestinal obstruction)\u6700\u5e38\u898b\u7684\u539f\u56e0\u3002 (B)\u6709\u6642\u53ef\u898b\u8349\u8393\u91ac\u4fbf(currant jelly stool)\u3002 (C)\u90e8\u5206\u75c5\u7ae5\u7684\u81e8\u5e8a\u75c7\u72c0\u70ba\u55dc\u7761(lethargy)\u3002 (D)\u8179\u90e8\u8d85\u97f3\u6ce2\u5448\u73fe target appearance \u3002 (E)\u8178\u5957\u758a\u82e5\u5fa9\u767c\uff0c\u61c9\u99ac\u4e0a\u624b\u8853\u6cbb\u7642\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u58de\u6b7b\u6027\u7b4b\u819c\u708e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u5927\u90e8\u5206\u75c5\u4eba\u4e0d\u9700\u624b\u8853\uff0c\u4ee5\u5f37\u6548\u6297\u751f\u7d20\u6cbb\u7642\u5373\u53ef\u3002 (B)\u6b7b\u4ea1\u7387\u7d04 25%\u81f3 35%\u3002 (C)\u75bc\u75db\u8d85\u904e\u8eab\u9ad4\u6aa2\u67e5\u8a55\u4f30\u53ef\u80fd\u662f\u65e9\u671f\u8a3a\u65b7\u91cd\u8981\u7279\u5fb5\u3002 (D)\u611f\u67d3\u7bc4\u570d\u64f4\u6563\u901f\u5ea6\u53ef\u9ad8\u9054\u6bcf\u5c0f\u6642 1 \u82f1\u540b\u3002 (E)\u5e38\u898b\u7684\u7f79\u75c5\u5371\u96aa\u56e0\u5b50\u70ba\u5e74\u7d00\u5927\u3001\u7cd6\u5c3f\u75c5\u3001\u9152\u766e\u60a3\u8005\u3001\u62b5\u6297\u529b\u5dee\u2026\u7b49\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u58de\u6b7b\u6027\u7b4b\u819c\u708e\u81e8\u5e8a\u8868\u73fe\u8207\u8a3a\u65b7\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u75be\u75c5\u521d\u671f\u4e0d\u6613\u8207\u4e00\u822c\u7684\u8702\u7aa9\u6027\u7d44\u7e54\u708e\u5340\u5206\uff0c\u56e0\u6b64\u5c0d\u65bc\u7cd6\u5c3f\u75c5\u3001\u809d\u786c\u5316\u3001\u8001\u5e74\u3001\u53ca\u514d\u75ab\u529f\u80fd\u4f4e\u4e0b\u5982\u8840\u6db2\u816b\u7624\u6216\u63a5\u53d7\u5316\u5b78\u6cbb\u7642\u75c5\u4eba\uff0c\u9700\u65e9\u671f\u9ad8\u5ea6\u8b66\u89ba\u6b64\u4e00\u75be\u75c5\u7684\u53ef\u80fd\u6027\u3002 (B)\u4e0d\u540c\u65bc\u4e00\u822c\u7684\u8702\u7aa9\u6027\u7d44\u7e54\u708e\uff0c\u58de\u6b7b\u6027\u7b4b\u819c\u708e\u5c6c\u65bc\u56b4\u91cd\u6df1\u90e8\u7d44\u7e54\u4e4b\u611f\u67d3\u5f15\u767c\u5168\u8eab\u6027\u708e\u75c7\u53cd\u61c9\uff0c\u56e0\u6b64\u6240\u6709\u75c5\u4eba\u5747\u6703\u51fa\u73fe\u767c\u71d2\u53ca\u5fc3\u640f\u904e\u901f\u4e4b\u73fe\u8c61\u3002 (C)\u7576\u60a3\u8005\u51fa\u73fe\u611f\u67d3\u90e8\u4f4d\u51fa\u73fe\u51fa\u8840\u6027\u6c34\u6ce1\u3001\u75c5\u7076\u8fc5\u901f\u64f4\u5c55\u5ef6\u4f38\u3001\u4e3b\u89c0\u75bc\u75db\u7a0b\u5ea6\u8207\u60a3\u90e8\u5916\u89c0\u8868\u73fe\u4e0d\u6210\u6bd4\u4f8b(\u5982\u5287\u70c8\u75bc\u75db\u4f46\u5916\u89c0\u53ea\u6709\u8f15\u5fae\u7d05\u816b)\u3001\u7121\u6cd5\u4ee5\u767c\u71d2\u89e3\u91cb\u7684\u7ac7\u6027\u5fc3\u640f\u904e\u901f\u6642\uff0c\u5747\u9700\u7acb\u5373\u6392\u9664\u58de\u6b7b\u6027\u7b4b\u819c\u708e\u8a3a\u65b7\u7684\u53ef\u80fd\u6027\u3002 (D)\u65bc\u8ec0\u5e79\u90e8\u4f4d\u6216\u982d\u9838\u90e8\u51fa\u73fe\u4e4b\u58de\u6b7b\u6027\u7b4b\u819c\u708e\uff0c\u591a\u70ba\u591a\u7a2e\u7d30\u83cc\u611f\u67d3(polymicrobial infection)\uff0c\u85e5\u7269\u6cbb\u7642\u7684\u8003\u91cf\u4e0a\u9700\u8981\u8003\u616e\u6709\u6548\u6db5\u84cb\u53ad\u6c27\u6027\u7d30\u83cc\u7684\u6297\u751f\u7d20\u3002\u5982\u6c23\u58de\u75bd(gas gangrene)\u3001\u5f17\u5c3c\u723e\u6c0f\u58de\u75bd(Fournier\u2019s gangrene)\u3001\u53ca\u9b6f\u7279\u7dad\u4ec0\u6c0f\u54bd\u550a\u708e(Ludwig\u2019s angina)\u5747\u5c6c\u6b64\u985e\u611f\u67d3\u3002 (E)\u7b4b\u819c\u5207\u958b\u8853\u9032\u884c\u58de\u6b7b\u7d44\u7e54\u6e05\u5275\u70ba\u6cbb\u7642\u6210\u529f\u8207\u5426\u7684\u6700\u91cd\u8981\u56e0\u7d20\u3002\u75c5\u4eba\u53ef\u80fd\u96a8\u75c5\u7a0b\u8207\u6cbb\u7642\u53cd\u61c9\u800c\u9700\u63a5\u53d7\u591a\u6b21\u7684\u624b\u8853\u6e05\u5275\u751a\u81f3\u622a\u80a2\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6703\u9020\u6210\u5bec\u7684\u9670\u96e2\u5b50\u9593\u9699\u9178\u4e2d\u6bd2(Wide Anion Gap Metabolic Acidosis)\u7684\u75c5\u56e0\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u60a3\u6709\u814e\u81df\u8870\u7aed\u75c5\u4eba\u3002 (B)\u60a3\u6709\u8b8a\u6027\u8840\u7d05\u7d20\u8840\u75c7(methemoglobinemia)\u75c5\u4eba\u3002 (C)\u60a3\u6709\u6c30\u5316\u7269(cyanide)\u4e2d\u6bd2\u75c5\u4eba\u3002 (D)\u60a3\u6709\u6ec5\u7cd6\u654f\u9320(metformin)\u4e2d\u6bd2\u75c5\u4eba\u3002 (E)\u670d\u7528\u4e59\u91af\u80fa\u915a(Acetaminophen)\u75c5\u4eba\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6025\u6027\u81bd\u56ca\u708e\u75c5\u4eba\u7684\u8655\u7f6e\uff0c\u4e0b\u5217\u4f55\u8005\u70ba\u932f\u8aa4\uff1f", + "Options": "(A)\u4e00\u65e6\u78ba\u5b9a\u8a3a\u65b7\u5c31\u9700\u8981\u7acb\u523b\u7d66\u4e88\u6297\u751f\u7d20\u6cbb\u7642\u3002 (B)\u6297\u751f\u7d20\u7684\u9078\u64c7\u53ef\u4ee5\u63a1\u7528 cephalosporin \u52a0\u4e0a metronidazole\u3002 (C)\u6297\u751f\u7d20\u7684\u9078\u64c7\u53ef\u4ee5\u63a1\u7528 fluoroquinolone \u52a0\u4e0a metronidazole\u3002 (D)\u5982\u679c\u6c92\u6709\u6cbb\u7642\u5c07\u5c0e\u81f4\u56b4\u91cd\u7684\u4f75\u767c\u75c7\u5982\u4e0a\u884c\u6027\u81bd\u7ba1\u708e(ascending cholangitis)\u3002 (E)Opioids \u985e\u7684\u6b62\u75db\u85e5\u6bd4 non-steroidal anti-inflammatory drug(NSAIDS)\u66f4\u9069\u5408\u7528\u65bc\u6025\u6027\u81bd\u56ca\u708e\u7684\u6b62\u75db\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6551\u8b77\u6280\u8853\u54e1\u7ba1\u7406\u8fa6\u6cd5\u898f\u5b9a\u4e2d\u7d1a\u6551\u8b77\u54e1\u5f97\u65bd\u884c\u4e4b\u6551\u8b77\u9805\u76ee\uff0c\u4e0b\u5217\u654d\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u8840\u7cd6\u76e3\u6e2c\u3002 (B)\u7d66\u4e88\u53e3\u670d\u8461\u8404\u7cd6\u3002 (C)\u7d66\u4e88\u5438\u5165\u652f\u6c23\u7ba1\u64f4\u5f35\u5291\u6216\u785d\u5316\u7518\u6cb9\u820c\u4e0b\u542b\u7247\u3002 (D)\u5468\u908a\u8840\u7ba1\u8def\u5f91\u4e4b\u8a2d\u7f6e\u53ca\u7dad\u6301\u3002 (E)\u7d66\u4e88\u8461\u8404\u7cd6(\u6c34)\u3001\u4e73\u9178\u6797\u683c\u6c0f\u6db2\u6216\u751f\u7406\u98df\u9e7d\u6c34\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6c23\u80f8(pneumothorax)\u7684\u8655\u7f6e\uff0c\u4e0b\u5217\u654d\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u5f35\u529b\u6027\u6c23\u80f8(tension pneumothorax)\u61c9\u8a72\u7acb\u5373\u91dd\u624e\u6e1b\u58d3(needle decompression)\u5f8c\uff0c\u63d2\u4e0a\u80f8\u7ba1\u5f15\u6d41\u3002 (B)\u6c27\u6c23\u7684\u7d66\u4e88\u6709\u52a9\u65bc\u808b\u819c\u8154\u6c23\u9ad4\u7684\u5438\u6536\u3002 (C)\u8d85\u97f3\u6ce2\u7121\u6cd5\u8a3a\u65b7\u6c23\u80f8\u3002 (D)\u96fb\u8166\u65b7\u5c64(CT scan)\u6709\u52a9\u65bc\u56b4\u91cd COPD \u5408\u4f75\u80ba\u90e8 Bullae \u7684\u75c5\u4eba\u8a3a\u65b7\u6c23\u80f8\u3002 (E)\u6b21\u7d1a\u7684\u81ea\u767c\u6027\u6c23\u80f8(Secondary spontaneous pneumothorax)\u901a\u5e38\u8207\u6162\u6027\u963b\u585e\u6027\u80ba\u75c5\u8b8a\u6709\u95dc\u4fc2\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5168\u8eab\u6027\u767c\u708e\u53cd\u61c9(Systemic Inflammatory Response Syndrome; SIRS)\u7684\u5b9a\u7fa9\uff0c\u4e0b\u5217\u54ea\u500b\u9805\u76ee\u4e0d\u7b26\u5408\uff1f", + "Options": "(A)\u767d\u8840\u7403\u6578\u503c\uff1a20,000/mm3\u3002 (B)\u9ad4\u6eab\uff1a40\u00b0\u2009C\u3002 (C)\u547c\u5438\u901f\u7387\uff1a25 \u4e0b/\u5206\u9418\u3002 (D)\u8840\u58d3\uff1a80/40 mmHg\u3002 (E)\u5fc3\u8df3\uff1a100 \u4e0b/\u5206\u9418\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u7d30\u83cc\u6027\u5fc3\u5167\u819c\u708e\u81e8\u5e8a\u8868\u73fe\u8207\u8a3a\u65b7\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u5df2\u77e5\u6709\u74e3\u819c\u6027\u5fc3\u81df\u75be\u75c5\u3001\u975c\u8108\u6210\u766e\u6027\u85e5\u7269\u6ce8\u5c04\u70ba\u91cd\u8981\u7684\u524d\u5c0e\u56e0\u7d20(predisposing factor)\uff0c\u56e0\u6b64\u82e5\u75c5\u53f2\u8a62\u554f\u6642\u6c92\u6709\u767c\u73fe\u75c5\u4eba\u6709\u4e0a\u8ff0\u524d\u5c0e\u56e0\u7d20\u6642\uff0c\u5247\u53ef\u4ee5\u6392\u9664\u7d30\u83cc\u6027\u5fc3\u5167\u819c\u708e\u8a3a\u65b7\u4e4b\u53ef\u80fd\u6027\u3002 (B)\u56e0\u70ba\u7d30\u83cc\u9644\u8457\u65bc\u74e3\u819c\u9020\u6210\u50b7\u5bb3\u6216\u9020\u6210\u4e8c\u5c16\u74e3\u4e73\u982d\u808c\u65b7\u88c2\uff0c\u5c0e\u81f4\u6025\u6027\u74e3\u819c\u9006\u6d41(regurgitation)\uff0c\u56e0\u6b64\u6240\u6709\u7d30\u83cc\u6027\u5fc3\u5167\u819c\u708e\u7684\u75c5\u4eba\u5728\u7406\u5b78\u6aa2\u67e5\u4e0a\u5747\u53ef\u7531\u807d\u8a3a\u767c\u73fe\u5fc3\u96dc\u97f3(heart murmur)\u3002 (C)\u767c\u71d2\u70ba\u6700\u5e38\u898b\u81e8\u5e8a\u5fb5\u5019(sign)\uff0c\u800c\u53ea\u6709\u4e0d\u5230 50%\u7684\u75c5\u4eba\u53ef\u4ee5\u5728\u7406\u5b78\u6aa2\u67e5\u6642\u767c\u73fe\u7d30\u83cc\u6027\u5fc3\u5167\u819c\u708e\u7684\u76ae\u819a\u8868\u73fe\u3002 (D)\u5728\u6c92\u6709\u63a5\u53d7\u904e\u4eba\u5de5\u74e3\u819c\u7f6e\u63db(prosthetic valve replacement)\u7684\u75c5\u4eba\u4e2d\uff0c\u6240\u6709\u81f4\u75c5\u83cc\u7684\u76db\u884c\u7387\u4e2d\u4ee5\u8349\u7da0\u8272\u93c8\u7403\u83cc(Viridans group streptococci)\u70ba\u7b2c\u4e00\u4f4d\uff0c\u5176\u6b21\u70ba\u91d1\u9ec3\u8272\u8461\u8404\u7403\u83cc(Staphylococcus aureus)\u53ca\u8178\u7403\u83cc\u5c6c(Enterococcus species)\u3002 (E)\u7d93\u80f8\u5fc3\u81df\u8d85\u97f3\u6ce2(transthoracic echocardiography )\u5c0d\u65bc\u7d30\u83cc\u6027\u5fc3\u5167\u819c\u708e\u6709\u6975\u9ad8\u7684\u8a3a\u65b7\u654f\u611f\u5ea6(sensitivity)\u8207\u7279\u7570\u6027(specificity)\uff0c\u56e0\u6b64\u82e5\u7d93\u80f8\u5fc3\u81df\u8d85\u97f3\u6ce2\u6c92\u6709\u767c\u73fe\u74e3\u819c\u8d05\u751f\u7269(vegetation)\u6642\uff0c\u5247\u53ef\u4ee5\u5b8c\u5168\u6392\u9664\u7d30\u83cc\u6027\u5fc3\u5167\u819c\u708e\u7684\u8a3a\u65b7\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8840\u6db2\u6210\u5206\u53ca\u8f38\u8840\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u6fc3\u7e2e\u7d05\u8840\u7403\u4fdd\u5b58\u7d04 21~42 \u5929\uff0c\u901a\u5e38\u8f38\u8840\u4e00\u6b21\u81f3\u5c11 2 \u55ae\u4f4d\uff0c\u53ef\u5347\u9ad8\u8840\u7403\u6bd4\u5bb9 6%\u53ca\u8840\u7d05\u7d20 2 g/dL\u3002 (B)\u8840\u5c0f\u677f\u6578\u5c0f\u65bc 10,000/mm3\u7121\u75c7\u72c0\u8005(\u5982\uff1aITP\u3001TTP)\u3001\u5c0f\u65bc 20,000/mm3\u6709\u51dd\u8840\u75be\u75c5\u6216\u5c0f\u51fa\u8840\u3001\u5c0f\u65bc 30,000/mm3\u6709\u5927\u51fa\u8840\u3001\u5c0f\u65bc 50,000/mm3\u6b32\u884c\u4fb5\u5165\u6027\u6cbb\u7642\u6216\u4e00\u822c\u624b\u8853\uff0c\u8003\u616e\u8f38\u8840\u5c0f\u677f\u3002 (C)\u8f38\u8840\u5f8c\u767c\u71d2\u3001\u5bd2\u986b\u3001\u81c9\u8272\u6f6e\u7d05\u3001\u4f11\u514b\u3001\u8840\u7d05\u7d20\u5c3f\uff0c\u70ba\u6025\u6027\u8840\u7ba1\u5167\u6eb6\u8840\u4e4b\u56b4\u91cd\u8f38\u8840\u53cd\u61c9\uff0c\u9700\u5373\u523b\u505c\u6b62\u8f38\u8840\uff0c\u8f38\u6db2\u88dc\u5145\u53ca\u5fc3\u80ba\u652f\u6301\u6cbb\u7642\uff0c\u53ef\u80fd\u6703\u81f4\u547d\u3002 (D)\u627f\u4e0a\uff0c\u9808\u91cd\u65b0\u6aa2\u9a57\u8840\u578b\u53ca\u4ea4\u53c9\u8a66\u9a57\u3001\u76f4\u63a5\u53ca\u9593\u63a5 Coombs \u8a66\u9a57\u3001\u5168\u8840\u6aa2\u67e5(CBC)\u3001\u808c\u9178\u9150(Creatinine)\u3001PT&APTT\u3001Haptoglobin\u3001LDH\u7b49\u3002 (E)\u8f15\u5fae\u8f38\u8840\u53cd\u61c9\uff0c\u76ae\u819a\u7662\u3001\u8541\u9ebb\u75b9\uff0c\u66ab\u505c\u8f38\u8840\u7d66\u4e88\u6297\u7d44\u7e54\u80fa\u6cbb\u7642\uff0c\u75c7\u72c0\u6539\u5584\u53ef\u7e7c\u7e8c\u8f38\u8840\uff0c\u53ea\u9700\u901a\u77e5\u8840\u5eab\uff0c\u4e0d\u9700\u8981\u9032\u4e00\u6b65\u62bd\u8840\u6aa2\u9a57\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6d88\u5316\u9053\u51fa\u8840(gastrointestinal bleeding)\u4e4b\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)Proton pump inhibitor \u53ef\u964d\u4f4e\u51fa\u8840\u6027\u80c3\u6f70\u760d\u7684\u518d\u51fa\u8840\u7387\uff0c\u4e5f\u53ef\u964d\u4f4e\u8f38\u8840\u53ca\u624b\u8853\u7684\u9700\u6c42\u3002 (B)\u5982\u679c\u6709\u660e\u986f\u6216\u5927\u91cf\u7684\u8840\u4fbf\uff0c\u5247\u61c9\u653e\u7f6e\u9f3b\u80c3\u7ba1\u4f86\u6392\u9664\u4e0a\u6d88\u5316\u9053\u51fa\u8840\u3002 (C)\u8840\u7ba1\u651d\u5f71\u53ef\u70ba\u8a3a\u65b7\u5de5\u5177\uff0c\u4f46\u51fa\u8840\u901f\u7387\u6700\u5c11\u9808\u9054 0.5 ml/\u5206\u9418 \u4ee5\u4e0a\u624d\u53ef\u5075\u6e2c\u5230\u3002 (D)\u82e5\u61f7\u7591\u70ba\u98df\u9053\u975c\u8108\u66f2\u5f35\u9020\u6210\u7684\u6d88\u5316\u9053\u51fa\u8840\uff0c\u5247\u4e0d\u5efa\u8b70\u7f6e\u653e\u9f3b\u80c3\u7ba1\uff0c\u4ee5\u514d\u9020\u6210\u98df\u9053\u975c\u8108\u66f2\u5f35\u7834\u88c2\u51fa\u8840\u3002 (E)\u80c3\u93e1(UGI endoscopy) \u5c0d\u4e0a\u6d88\u5316\u9053\u51fa\u8840\u7684\u8a3a\u65b7\u662f\u6700\u7cbe\u78ba\u7684\uff0c\u4e14\u5c0d\u6709\u660e\u986f\u51fa\u8840\u7684\u60a3\u8005\u53ef\u7d66\u4e88\u5118\u65e9\u6cbb\u7642\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5c0f\u5152\u5438\u5165\u7570\u7269(Foreign Body Aspiration)\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u80f8\u90e8 X \u5149\u5e7e\u4e4e\u90fd\u770b\u5f97\u5230\u660e\u986f\u8b8a\u5316\u3002 (B)\u652f\u6c23\u7ba1\u93e1\u70ba\u8a3a\u65b7\u8207\u6cbb\u7642\u7684\u9ec3\u91d1\u6e96\u5247(golden standard)\u3002 (C)\u98df\u7269(\u5982\u82b1\u751f)\u8207\u5c0f\u73a9\u5177\u70ba\u5e38\u898b\u7684\u7570\u7269\u3002 (D)\u55c6\u5230\u75c5\u53f2(choking history)\u70ba\u91cd\u8981\u7684\u8a3a\u65b7\u4f9d\u64da\u3002 (E)\u5b30\u5e7c\u5152\u5e38\u898b\u6b7b\u4ea1\u539f\u56e0\u4e4b\u4e00\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u816b\u7624\u6025\u75c7\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u4e0a\u8154\u975c\u8108\u75c7\u5019\u7fa4 (superior vena cava syndrome)\u5f88\u5c11\u4ee5\u547c\u5438\u56f0\u96e3\u6216\u54b3\u55fd\u4f5c\u8868\u73fe\u3002 (B)\u60e1\u6027\u816b\u7624\u6240\u5f15\u8d77\u7684\u9ad8\u8840\u9223\u5728\u6025\u8a3a\u7684\u8655\u7406\u6700\u512a\u5148\u662f calcitonin \u7684\u7d66\u4e88\u3002 (C)\u60e1\u6027\u816b\u7624\u6240\u5f15\u8d77\u7684\u9ad8\u8840\u9223\u75c7\u72c0\u7684\u8868\u73fe\u53d6\u6c7a\u65bc\u8840\u9223\u7684\u6578\u503c\uff0c\u800c\u975e\u8840\u9223\u589e\u52a0\u7684\u901f\u5ea6\u3002 (D)\u6700\u5e38\u898b\u5f15\u8d77\u9ad8\u8840\u9223\u7684\u60e1\u6027\u816b\u7624\u662f\uff1a\u4e73\u764c\u3001\u80ba\u764c\u53ca\u591a\u767c\u6027\u9aa8\u9ad3\u7624\u3002 (E)\u6700\u5e38\u5f15\u8d77\u4e0a\u8154\u975c\u8108\u75c7\u5019\u7fa4(superior vena cava syndrome) \u7684\u60e1\u6027\u816b\u7624\u70ba\u6dcb\u5df4\u7624 (lymphoma) \u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8f38\u8840\u76f8\u95dc\u7684\u6025\u6027\u80ba\u50b7\u5bb3(transfusion-related acute lung injury)\uff0c\u4e0b\u5217\u654d\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u5927\u591a\u8ddf\u65b0\u9bae\u51b7\u51cd\u8840\u6f3f\u53ca\u8840\u5c0f\u677f\u7684\u8f38\u8840\u76f8\u95dc\u3002 (B)\u55ae\u7368\u8f38\u6fc3\u7e2e\u7d05\u8840\u7403(Packed RBC)\u4e5f\u5e38\u767c\u751f\u3002 (C)\u5e38\u5e38\u9020\u6210\u5169\u908a\u80ba\u6d78\u6f64(infiltrate)\u3002 (D)\u5e38\u5e38\u5728\u8f38\u8840\u5f8c 6 \u5c0f\u6642\u5167\u767c\u751f\u3002 (E)\u6cbb\u7642\u65b9\u5f0f\u70ba\u652f\u6301\u6027\u7642\u6cd5(supportive care)\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8edf\u7d44\u7e54\u7570\u7269(Soft tissue foreign body)\u8a3a\u65b7\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)X \u5149\u6aa2\u67e5(Plain Radiography)\u53ef\u8a3a\u65b7 3mm \u5927\u5c0f\u73bb\u7483\u788e\u7247\u3002 (B)X \u5149\u6aa2\u67e5\u5c0d\u65bc\u6728\u6750\u7570\u7269\u8a3a\u65b7\u7387\u4f4e\u3002 (C)\u8d85\u97f3\u6ce2\u7121\u6cd5\u8a3a\u65b7\u662f\u5426\u6709\u5851\u81a0\u7570\u7269\u3002 (D)\u50b7\u53e3\u63a2\u67e5\u5f8c\u7121\u767c\u73fe\u7570\u7269\u4f46\u4ecd\u61f7\u7591\u6709\u7570\u7269\u7559\u7f6e\u6642\uff0c\u53ef\u8003\u616e\u5f71\u50cf\u6aa2\u67e5\u3002 (E)\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5(CT)\u6709\u53ef\u80fd\u5c07\u6728\u6750\u7570\u7269\u8aa4\u5224\u6210\u6c23\u6ce1\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u56b4\u91cd\u6557\u8840\u75c7 6 \u5c0f\u6642\u5167\u6cbb\u7642\u76ee\u6a19(Stop Sepsis Bundle)\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u9700\u4f7f\u7528\u751f\u7406\u98df\u9e7d\u6c34\u5c07 CVP \u7dad\u6301\u5728 8-12 mmH2O\u3002 (B)\u9700\u5c07 ScvO2\u7dad\u6301\u5728 >80% \u4ee5\u4e0a\u3002 (C)\u5982\u679c ScvO2\u4e0d\u8db3\uff0c\u9700\u5c07\u8840\u7d05\u7d20 Hb \u7dad\u6301\u5728 10 g/dL \u4ee5\u4e0a\u3002 (D)\u5982\u679c Hb \u5df2\u8db3\u5920\u4f46 ScvO2 \u4e0d\u8db3\uff0c\u5247\u9700\u4f7f\u7528 Dopamine\uff0cDobutamine\u3002 (E)\u5982\u679c Hb \u5df2\u8db3\u5920\u4f46 ScvO2 \u4e0d\u8db3\uff0c\u6700\u5f8c\u53ef\u4ee5\u4f7f\u7528\u547c\u5438\u5668\u4f86\u8abf\u9ad8 ScvO2\u3002", + "Answer": "A\u3001B" + }, + { + "\ufeffQuestion": "\u5de5\u5ee0\u5de5\u4eba\u4e0d\u614e\u89f8\u96fb\uff0c\u7576\u60a8\u9032\u884c\u91ab\u7642\u8655\u7f6e\u6642\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u96fb\u58d3\u6108\u9ad8\uff0c\u5247\u7522\u751f\u7684\u50b7\u5bb3\u6108\u5927\u3002 (B)\u5230\u9662\u524d\u6b7b\u56e0\u591a\u70ba\u5fc3\u8df3\u505c\u6b62\u6216\u5fc3\u5ba4\u986b\u52d5\u3002 (C)\u96fb\u50b7\u5bb3\u5f8c\uff0c\u9700\u6ce8\u610f\u662f\u5426\u6709\u6a6b\u7d0b\u808c\u6eb6\u89e3(rhabdomyolysis)\u6216\u6025\u6027\u814e\u8870\u7aed\u7684\u7522\u751f\u3002 (D)\u9700\u9577\u6642\u9593\u66dd\u9732\u65bc\u9ad8\u58d3\u96fb\u50b7\u5bb3\uff0c\u624d\u6703\u7522\u751f\u8154\u5ba4\u75c7\u5019\u7fa4(compartment syndrome)\u3002 (E)\u982d\u9838\u90e8\u96fb\u50b7\u5bb3\u7684\u75c5\u4eba\uff0c\u53ef\u80fd\u5728\u672a\u4f86\u6703\u7522\u751f\u767d\u5167\u969c\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u6025\u6027\u4e2d\u98a8\u6642\u7684\u9ad8\u8840\u58d3\u8655\u7f6e\uff0c\u4e0b\u5217\u654d\u8ff0\u4f55\u8005\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u7f3a\u8840\u6027\u4e2d\u98a8\u82e5\u6536\u7e2e\u58d3\u672a\u8d85\u904e 220 mmHg\u3001\u8212\u5f35\u58d3\u672a\u8d85\u904e 120 mmHg \u6642\uff0c\u4e0d\u9700\u7279\u5225\u964d\u8840\u58d3\u3002 (B)\u82e5\u70ba\u51fa\u8840\u6027\u4e2d\u98a8\u61c9\u9069\u7576\u5c07\u6536\u7e2e\u58d3\u964d\u81f3 160 mmHg \u5de6\u53f3\u3002 (C)\u7f3a\u8840\u6027\u4e2d\u98a8\u5728\u9ec3\u91d1\u6642\u9593 3 \u5c0f\u6642\u5167\u62b5\u9662\u4e14\u7121\u5176\u4ed6\u7981\u5fcc\u75c7\uff0c\u82e5\u80fd\u5c07\u8840\u58d3\u964d\u81f3 185/110 mmHg \u4ee5\u4e0b\uff0c\u4ecd\u53ef\u8003\u616e\u65bd\u4e88\u8840\u6813\u6eb6\u89e3\u6cbb\u7642\u3002 (D)\u964d\u8840\u58d3\u85e5\u7269\u7684\u9078\u64c7\u5305\u62ec Labetalol\u3001 Nicardipine \u6216 Nitroglycerine \u6ef4\u6ce8\u4e26\u96a8\u6642\u8abf\u6574\u3002 (E)\u4ee5\u4e0a\u5747\u9069\u7576\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u5047\u8a2d\u60a8\u6b63\u5728\u6025\u8a3a\u5ba4\u7576\u73ed\uff0c\u6025\u8a3a\u89c0\u5bdf\u5340\u6709\u591a\u4f4d\u7b49\u5f85\u4f4f\u9662\u7684\u5152\u7ae5\uff0c\u56e0\u75c5\u623f\u7121\u5e8a\u800c\u6eef\u7559\u6025\u8a3a\uff0c\u60a8\u9032\u5165\u89c0\u5bdf\u5ba4\u6642\u6b63\u597d\u591a\u4f4d\u5bb6\u9577\u56e0\u5b69\u7ae5\u767c\u71d2\uff0c\u975e\u5e38\u64d4\u5fc3\u5c0f\u670b\u53cb\u8166\u90e8\u6703\u56e0\u800c\u53d7\u640d\u800c\u4e0d\u77e5\u6240\u63aa\uff0c\u5411\u60a8\u8acb\u6559\u5982\u4f55\u9762\u5c0d\u5152\u7ae5\u767c\u71d2\uff0c\u95dc\u65bc\u4e0b\u5217\u885b\u6559\u5167\u5bb9\uff0c\u4e0b\u5217\u4f55\u8005\u6700\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u5b30\u5152\u9ad4\u6eab\u6e2c\u91cf\u7d50\u679c\u4f9d\u9ad8\u4f4e\u9806\u5e8f\u70ba\u809b\u6eab\uff1e\u53e3\u6eab\uff1e\u814b\u6eab\uff0c\u6bcf\u500b\u5dee\u8ddd\u7d040.6\u2103(1\u2109)\u3002 (B)3 \u500b\u6708\u4ee5\u4e0b\u5b30\u5152\u9ad4\u6eab\u82e5\u8d85\u904e 38\u2103\uff0c\u7d04\u6709 3-4%\u53ef\u80fd\u6703\u6709\u56b4\u91cd\u7d30\u83cc\u611f\u67d3\uff0c\u9700\u8981\u6aa2\u67e5\u767c\u71d2\u539f\u56e0\u3002 (C)3-36 \u500b\u6708\u5927\u7684\u5b30\u5e7c\u5152\uff0c\u9ad4\u6eab\u82e5\u8d85\u904e 39.5\u2103\uff0c\u6703\u6709\u8f03\u9ad8\u7684\u83cc\u8840\u75c7\u767c\u751f\u7387\uff0c\u82e5\u8d85\u904e 40\u2103\uff0c\u5247\u80ba\u708e\u7403\u83cc\u83cc\u8840\u75c7\u767c\u751f\u7387\u4e5f\u6703\u9010\u6f38\u4e0a\u5347\u3002 (D)\u8840\u6db2\u4e2d\u767d\u8840\u7403(WBC)\u82e5\u8d85\u904e 15,000/uL\uff0c\u662f\u83cc\u8840\u75c7\u53ef\u80fd\u767c\u751f\u7684\u6307\u6a19\u4e4b\u4e00\u3002 (E)3-36 \u500b\u6708\u5927\u7684\u5b30\u5e7c\u5152\uff0c\u9ad4\u6eab\u4e26\u4e0d\u9069\u5408\u505a\u70ba\u6c7a\u5b9a\u62bd\u8840\u6aa2\u67e5\u8207\u5426\u7684\u53c3\u8003\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u654d\u8ff0\u4f55\u8005\u6bd4\u8f03\u4e0d\u6703\u662f\u5916\u79d1\u624b\u8853\u5f8c\u75c5\u4eba\u8178\u80c3\u529f\u80fd\u6062\u5fa9\u9072\u5ef6\u7684\u539f\u56e0\uff1f", + "Options": "(A)\u96fb\u89e3\u8cea\u5931\u8861\u3002 (B)\u8179\u5167\u767c\u708e\u6216\u611f\u67d3\u3002 (C)\u80f0\u81df\u708e\u3002 (D)\u8ca7\u8840\u3002 (E)\u85e5\u7269(\u5982\uff1a\u55ce\u5561\u985e\u6b62\u75db\u85e5 Opioids\u3001Phenothiazides)\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)Tension pneumothorax \u70ba\u4e00 life threatening \u6025\u75c7, \u9700\u7d93\u7167 X \u5149\u78ba\u8a8d\u4ee5\u5f8c,\u518d\u505a\u7dca\u6025\u8655\u7f6e\u3002 (B)\u5927\u91cf\u8840\u80f8\uff0cThoracotomy \u9808\u7531\u5408\u683c\u8a13\u7df4\u6709\u7d93\u9a57\u7684 surgeon \u70ba\u4e4b\u3002 (C)\u82e5\u80f8\u7ba1\u4e00\u958b\u59cb 1500 ml \u8840\u91cf\u5f15\u6d41\u51fa\u4f86 \u6216 \u6bcf 2~4 hour 200 ml \u8840\u5f15\u6d41\u51fa\u4f86\uff0c\u9700\u8981\u8003\u616e\u8acb\u80f8\u8154\u5916\u79d1\u958b\u80f8\u624b\u8853\u3002 (D)\u80f8\u7ba1\u7f6e\u653e\u4e00\u822c\u4f4d\u65bc\u7b2c\u56db\u7b2c\u4e94\u808b\u9593\uff0c\u814b\u4e2d\u7dda\u3002 (E)\u7d04\u6709 15~ 30%\u7684\u80f8\u90e8\u7a7f\u523a\u50b7\u9700\u958b\u80f8\u624b\u8853\u6cbb\u7642\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u5fc3\u80ba\u505c\u6b62\u75c5\u4eba\u7d93\u6025\u6551\u5fa9\u7526\u8853\uff0c\u6062\u5fa9\u81ea\u767c\u6027\u5faa\u74b0\u5f8c\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u61c9\u8a2d\u6cd5\u7dad\u6301\u8840\u884c\u52d5\u529b\u5faa\u74b0\u7a69\u5b9a\u4e26\u907f\u514d\u4f4e\u8840\u58d3\u3002 (B)\u61c9\u907f\u514d\u904e\u5ea6\u63db\u6c23\uff0c\u4ee5\u514d\u4e8c\u6c27\u5316\u78b3\u6fc3\u5ea6\u904e\u4f4e\u9020\u6210\u8166\u8840\u7ba1\u6536\u7e2e\u800c\u5f71\u97ff\u8166\u7d44\u7e54\u704c\u6d41\u3002 (C)\u5fa9\u7526\u5f8c\u4e00\u5929\u5167\u61c9\u8a2d\u6cd5\u7dad\u6301\u9ad8\u6fc3\u5ea6\u6c27\u6c23\uff0c\u4ee5\u6539\u5584\u5404\u5668\u5b98\u7d44\u7e54\u7684\u7f3a\u6c27\u60c5\u6cc1\u3002 (D)\u82e5\u75c5\u4eba\u672a\u7acb\u5373\u7526\u9192\u4e14\u7121\u7279\u6b8a\u7981\u5fcc\u75c7\uff0c\u61c9\u5118\u65e9\u958b\u59cb\u7d66\u4e88\u4f4e\u6eab\u6cbb\u7642\u4ee5\u8a2d\u6cd5\u6539\u5584\u9810\u5f8c\u3002 (E)\u82e5\u6025\u6027\u51a0\u5fc3\u75c7\u70ba\u9020\u6210\u5fc3\u80ba\u505c\u6b62\u4e4b\u539f\u56e0\uff0c\u61c9\u9032\u884c\u5fc3\u5c0e\u7ba1\u6aa2\u67e5\u53ca\u4ecb\u5165\u6027\u6cbb\u7642\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u91dd\u5c0d\u51cd\u50b7(frostbite)\u7684\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u9700\u8003\u616e\u6ce8\u5c04\u7834\u50b7\u98a8\u985e\u6bd2\u7d20\u3002 (B)\u82e5\u76ae\u819a\u51fa\u73fe\u6c34\u6ce1\uff0c\u5247\u8868\u793a\u7b2c\u4e8c\u5ea6\u51cd\u50b7\u3002 (C)\u51cd\u50b7\u8655\u7f6e\u9700\u65e9\u671f\u5927\u7bc4\u570d\u6e05\u7621\uff0c\u4ee5\u9632\u5f8c\u7e8c\u7684\u611f\u67d3\u3002 (D)\u7d66\u4e88\u6b62\u75db\u5291\uff0c\u5982\u975e\u985e\u56fa\u9187\u6d88\u708e\u6b62\u75db\u85e5(NSAID)\u3002 (E)\u4ee5\u4e7e\u71b1\u6696\u6c23\u56de\u6eab\u51cd\u80a2\uff0c\u53ef\u80fd\u6703\u9020\u6210\u50b7\u5bb3\u52a0\u5287\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u4e3b\u52d5\u8108\u525d\u96e2\u8207\u6025\u6027\u51a0\u5fc3\u75c7\u96e8\u8005\u5e38\u4ee5\u80f8\u75db\u8868\u73fe\uff0c\u4ee5\u4e0b\u6558\u8ff0\u4f55\u8005\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u4e3b\u52d5\u8108\u525d\u96e2\u53ca\u5074\u3001\u5f8c\u58c1\u5fc3\u808c\u6897\u585e\uff0c\u5176\u81e8\u5e8a\u75c7\u72c0\u4e4b\u80f8\u75db\u5747\u53ef\u80fd\u8f49\u79fb\u81f3\u80cc\u5f8c\u3002 (B)\u7406\u5b78\u6aa2\u67e5\u9664\u6ce8\u610f\u56db\u80a2\u8840\u58d3\u6709\u7121\u660e\u986f\u5dee\u7570\u5916\uff0c\u82e5\u807d\u5230\u65b0\u51fa\u73fe\u7684\u4e3b\u52d5\u8108\u74e3\u9006\u6d41\u96dc\u97f3\uff0c\u9700\u8003\u616e\u4e3b\u52d5\u8108\u525d\u96e2\u5f71\u97ff\u81f3\u4e3b\u52d5\u8108\u57fa\u90e8\u6240\u9020\u6210\u3002 (C)\u5fc3\u96fb\u5716\u5448\u73fe ST \u6ce2\u4e0a\u5347\u78ba\u8a3a\u70ba\u5fc3\u808c\u6897\u585e\u8005\uff0c\u4ecd\u6709\u5c11\u6578\u53ef\u80fd\u70ba\u4e3b\u52d5\u8108\u525d\u96e2\u53ca\u51a0\u72c0\u52d5\u8108\u6240\u9020\u6210\u3002 (D)\u6025\u6027\u51a0\u5fc3\u75c7\u75c5\u4eba\u5728\u7d66\u4e88 heparin \u6216 fibrinolytic therapy \u524d\uff0c\u52d9\u5fc5\u5148\u4ed4\u7d30\u56de\u9867\u80f8\u90e8 X \u5149\u7247\u6709\u7121\u80f8\u4e2d\u7e31\u8188\u6709\u7121\u8b8a\u5bec\u6216\u4e3b\u52d5\u8108\u7684\u5916\u89c0\u6709\u7121\u4e0d\u6b63\u5e38\u9f13\u8d77\u3002 (E)\u70ba\u6c42\u5b89\u5168\u8d77\u898b\uff0cST \u6ce2\u4e0a\u5347\u578b\u5fc3\u808c\u6897\u585e\u5728\u9001\u5fc3\u5c0e\u7ba1\u4ecb\u5165\u6cbb\u7642\u524d\u5b9c\u5e38\u898f\u9032\u884c\u96fb\u8166\u65b7\u5c64\u4ee5\u6392\u9664\u4e3b\u52d5\u8108\u525d\u96e2\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u4e2d\u5e74\u7537\u6027\u7cd6\u5c3f\u75c5\u4eba\u56e0\u610f\u8b58\u4e0d\u6e05\u88ab\u9001\u81f3\u6025\u8a3a\u5ba4\u5c31\u8a3a\uff0c\u624b\u6307\u8840\u7cd6\u6aa2\u6e2c\u767c\u73fe\u8840\u7cd6\u904e\u9ad8\u7121\u6cd5\u6e2c\uff0c\u95dc\u65bc\u9ad8\u8840\u7cd6\u5371\u75c7\u4e4b\u8a55\u4f30\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u9ad8\u6ef2\u900f\u6027\u9ad8\u8840\u7cd6\u72c0\u614b(HHS)\u8840\u7cd6\u5e38\u9ad8\u65bc 600 mg/dL\u3001\u6709\u6548\u8840\u6e05\u6ef2\u900f\u5ea6\u5927\u65bc 320 mOsm/L\u3001\u52d5\u8108 pH \u503c>7.3\u3001HCO3- >15 mEq/L\u3001\u8840\u4e2d\u7121\u916e\u9ad4\u6216\u5c11\u91cf\uff0c\u4f46\u9808\u6ce8\u610f\u662f\u5426\u6709\u6df7\u5408\u578b\u9178\u9e7c\u5e73\u8861\u7570\u5e38\u3002 (B)\u6d88\u5316\u9053\u51fa\u8840\u3001\u611f\u67d3\u3001\u814e\u529f\u80fd\u4e0d\u5168\u3001\u8840\u6db2\u900f\u6790\u53ca\u80ba\u6813\u585e\u7b49\u7686\u53ef\u4fc3\u767c HHS\uff0c\u4f7f\u7528\u92f0\u9e7d\u3001\u5229\u5c3f\u5291\u3001\u985e\u56fa\u9187\u4e5f\u53ef\u3002 (C)HHS \u5e73\u5747\u9ad4\u6db2\u4e0d\u8db3\u7d04\u70ba\u9ad4\u91cd\u7684 20~25%\u6216 8~12 \u5347\uff0c\u534a\u6578\u9808\u65bc\u524d 12\u5c0f\u6642\u88dc\u5145\u5b8c\u7562\uff0c\u5118\u53ef\u80fd\u65bc\u4e00\u5929\u5167\u5e73\u8861\u3002\u958b\u59cb\u8f38\u6db2\u5efa\u8b70\u4ee5\u751f\u7406\u9e7d\u6c3415~20 ml/kg/hr(\u7b2c\u4e00\u5c0f\u6642)\u88dc\u5145\uff0c\u4e4b\u5f8c 4~14 ml/kg/hr \u88dc\u5145\u4e14\u96a8\u9ad4\u6db2\u72c0\u614b\u6c7a\u5b9a\u3002 (D)\u627f\u4e0a\uff0c\u80f0\u5cf6\u7d20\u6cbb\u7642\u958b\u59cb\u4ee5 0.1 units/kg/hr\uff0c\u6bcf\u5c0f\u6642\u6e2c\u8840\u7cd6\uff0c\u82e5\u7b2c\u4e00\u5c0f\u6642\u964d\u4f4e\u5c11\u65bc 50mg/dL\uff0c\u5247\u52a0\u500d\u6bcf\u5c0f\u6642\u80f0\u5cf6\u7d20\u5291\u91cf\u76f4\u5230\u6bcf\u5c0f\u6642\u8840\u7cd6\u7a69\u5b9a\u964d\u4f4e 50~70 mg/dL\u3002 (E)\u627f\u4e0a\uff0c\u7576\u8840\u7cd6\u964d\u81f3 250mg/dL\uff0c\u6539\u7528\u542b 5%\u7cd6\u6c34\u4e4b\u751f\u7406\u9e7d\u6c34\u8f38\u6db2\uff0c\u7dad\u6301\u8840\u7cd6\u65bc 150~200 mg/dL\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u4e2d\u5e74\u7537\u6027\u56e0\u56b4\u91cd\u8179\u75db\u81f3\u6025\u8a3a\u5ba4\u5c31\u8a3a\uff0c\u95dc\u65bc\u6025\u6027\u8179\u75db\u4e4b\u8a55\u4f30\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u95cc\u5c3e\u708e\u5e38\u898b\u75c7\u72c0\u70ba\u53f3\u4e0b\u8179\u75db\uff0c\u800c\u76f2\u8178\u5f8c(retrocecal)\u95cc\u5c3e\u708e\u75c7\u72c0\u53ef\u81f4\u53f3\u4e0a\u8179\u75db\uff0c\u65e9\u671f\u95cc\u5c3e\u708e\u53ef\u81f4\u5ee3\u6cdb\u6027\u8179\u75db\u3002 (B)\u6d88\u5316\u6027\u6f70\u760d\u5e38\u5448\u73fe\u6301\u7e8c\u56b4\u91cd\u4e0a\u8179\u75db\uff0c\u800c\u80c3\u6f70\u760d\u53ca\u80c3\u708e\u5e38\u70ba\u5de6\u4e0a\u8179\u75db\uff0c\u5341\u4e8c\u6307\u8178\u6f70\u760d\u7a7f\u5b54\u70ba\u53f3\u4e0a\u8179\u75db\u3002 (C)\u8178\u7a7f\u5b54\u75c5\u4eba\u7684 X \u5149\u8868\u73fe\uff0c\u5927\u7d04 40%\u53ef\u770b\u5230\u6e38\u96e2\u6c23\u9ad4(free air)\u3002 (D)\u6025\u6027\u8179\u75db\u75c5\u4eba\u7b2c\u4e00\u6b21\u8840\u6db2\u5e38\u898f\u6aa2\u67e5\uff0c\u5373\u4f7f\u767d\u8840\u7403\u6578\u76ee\u6b63\u5e38\uff0c\u7121\u6cd5\u6392\u9664\u662f\u5426\u9700\u8981\u624b\u8853\u3002 (E)\u4ee3\u8b1d\u6027\u75be\u75c5(\u5982\uff1a\u611b\u8fea\u751f\u5371\u75c7 Addisonian crisis \u53ca\u5c3f\u6bd2\u75c7)\u53ef\u8868\u73fe\u5ee3\u6cdb\u6027\u8179\u75db\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u4e2d\u5e74\u7537\u6027\u56e0\u56b4\u91cd\u80f8\u75db\u81f3\u6025\u8a3a\u5ba4\u5c31\u8a3a\uff0c\u95dc\u65bc\u81f4\u547d\u6027\u80f8\u75db\u5e38\u898b\u539f\u56e0\u7684\u5178\u578b\u75c7\u72c0\u53ca\u6025\u6027\u51a0\u5fc3\u75c7\u8a55\u4f30\u7684\u6bd4\u8f03\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u5fc3\u7d5e\u75db\u75bc\u75db\u90e8\u4f4d\u65bc\u80f8\u9aa8\u5f8c\u6216\u4e0a\u8179\u90e8\uff0c\u60b6\u75db\u6216\u58d3\u8feb\u611f\uff1b\u5927\u9762\u7a4d\u80ba\u6813\u585e\u70ba\u6574\u500b\u80f8\u90e8\u7684\u539a\u91cd\u7dca\u8feb\u611f\u3002 (B)\u4e3b\u52d5\u8108\u525d\u96e2\u53ca\u98df\u9053\u7834\u88c2\u75bc\u75db\u90e8\u4f4d\u4e3b\u8981\u65bc\u80f8\u9aa8\u4e0b\uff0c\u524d\u8005\u5e38\u70ba\u6495\u88c2\u75db\u4e14\u8f49\u79fb\u81f3\u80cc\u5074\u80a9\u80db\u9593\uff0c\u5f8c\u8005\u5e38\u70ba\u5287\u70c8\u5614\u5410\u5f8c\u7a81\u7136\u5c16\u92b3\u75db\u4e14\u8f49\u79fb\u81f3\u80cc\u90e8\u3002 (C)\u9664\u4e86\u5fc3\u808c\u708e\u3001\u5fc3\u5305\u819c\u708e\u3001\u4e3b\u52d5\u8108\u525d\u96e2\u53ef\u80fd\u9020\u6210 Troponin \u4e0a\u5347\uff0c\u547c\u5438\u8870\u7aed\u3001\u6557\u8840\u75c7\u53ca\u71d2\u71d9\u50b7\u4e5f\u6709\u95dc\u3002 (D)\u6025\u6027\u4e2d\u98a8\u6216\u8718\u86db\u819c\u4e0b\u8154\u51fa\u8840\uff0c\u4e26\u4e0d\u6703\u9020\u6210 Troponin \u4e0a\u5347\u3002 (E)\u9664\u4e86\u6025\u6027\u51a0\u5fc3\u75c7\u5916\uff0c\u6162\u6027\u9152\u7cbe\u4e2d\u6bd2\u3001\u651d\u8b77\u817a\u764c\u3001\u4e00\u6c27\u5316\u78b3\u4e2d\u6bd2\u90fd\u8207CK-MB \u5347\u9ad8\u6709\u95dc\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u5275\u50b7\u5408\u4f75\u810a\u9ad3\u640d\u50b7\uff0c\u767c\u751f\u8179\u5f0f\u547c\u5438\uff0c\u53d7\u50b7\u7684\u4f4d\u7f6e\u61c9\u70ba\u61c9\u70ba\u61c9\u70ba\u61c9\u70ba\u4f55\u8655\uff1f", + "Options": "(A)\u7b2c\u56db\u9838\u690e\u3002 (B)\u7b2c\u4e03\u9838\u690e\u3002 (C)\u7b2c\u5341\u4e8c\u80f8\u690e\u3002 (D)\u7b2c\u4e00\u8170\u690e\u3002 (E)\u7b2c\u4e94\u8170\u690e\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u82e5\u88ab\u6c34\u6bcd(Jellyfish)\u54ac\u50b7\uff0c\u4e0b\u5217\u7684\u8655\u7406\u65b9\u6cd5\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u4ee5\u5927\u91cf\u6e05\u6c34\u6c96\u6d17\u50b7\u53e3\u3002 (B)\u4ee5\u9152\u7cbe( 40% ~ 70 % isopropyl alcohol)\u6f51\u7051\u5728\u50b7\u53e3\u3002 (C)\u8981\u907f\u514d\u6c34\u6bcd\u54ac\u50b7\uff0c\u7a7f\u6f5b\u6c34\u8863\u6e38\u6cf3\u662f\u4e00\u500b\u597d\u65b9\u6cd5\u3002 (D)\u64e6\u62ed\u918b (5% acetic acid)\u6709\u7de9\u548c\u7684\u6548\u679c\u3002 (E)\u61c9\u7acb\u5373\u7528\u5927\u91cf\u9e7d\u6c34\u6c96\u6d17\u50b7\u53e3\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u5728 2010 \u5e74\u7f8e\u570b\u5fc3\u81df\u5354\u6703(AHA)\u7684\u6025\u6551\u6e96\u5247\u4e2d\uff0c\u95dc\u65bc\u63d0\u5347\u71b1\u5fc3\u6551\u52a9\u8005(bystander)\u7684\u65bd\u6551\u610f\u9858\uff0c\u4e0b\u5217\u654d\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u5e38\u898b\u7684\u5be6\u65bd\u5fc3\u80ba\u5fa9\u7526\u8853(CPR)\u7684\u969c\u7919\u5305\u62ec\u4e86\uff0c\u5bb3\u6015\u50b7\u5230\u75c5\u4eba\uff0c\u5bb3\u6015\u64cd\u4f5c\u932f\u8aa4\uff0c\u9ad4\u80fd\u4e0d\u8db3\uff0c\u64d4\u5fc3\u6cd5\u5f8b\u8cac\u4efb\uff0c\u64d4\u5fc3\u53d7\u5230\u611f\u67d3\u3002 (B)\u5728\u6c11\u773e\u6025\u6551\u6559\u80b2\u7684\u8ab2\u5802\u4e0a\uff0c\u8981\u63d0\u5230\u5982\u4f55\u514b\u670d\u9762\u81e8\u9700\u8981\u6025\u6551\u72c0\u6cc1\u6642\u7684\u6050\u614c\u53cd\u61c9\uff0c\u662f\u57fa\u65bc\u5be6\u8b49\u91ab\u5b78 Class I \u7684\u5efa\u8b70\u3002 (C)\u7576\u65bd\u6551\u8005\u6c92\u6709\u610f\u9858\u6216\u8005\u662f\u4e0d\u80fd\u5be6\u65bd\u5b8c\u6574\u7684 CPR\uff0c\u6211\u5011\u53ef\u4ee5\u6559\u4ed6\u5011\u53ea\u58d3\u80f8\u7684 CPR (Hands-only CPR)\u4f5c\u70ba\u4ee3\u66ff\u3002 (D)\u6559\u65bd\u6551\u8005\u958b\u59cb CPR \u7684\u6642\u6a5f\u662f\uff1a\u75c5\u4eba\u6c92\u6709\u610f\u8b58\u800c\u4e14\u6c92\u6709\u547c\u5438\uff0c\u6216\u662f\u6c92\u6709\u6b63\u5e38\u547c\u5438(\u5982\u5598\u606f\u5f0f\u547c\u5438 gasping)\u3002 (E)\u7576\u6c42\u6551\u8005\u767c\u73fe\u75c5\u4eba\u6c92\u6709\u610f\u8b58\u800c\u4e14\u6c92\u6709\u547c\u5438\uff0c\u6216\u662f\u6c92\u6709\u6b63\u5e38\u547c\u5438\uff0c\u5982\u5598\u606f\u5f0f\u547c\u5438(gasping)\u6642\uff0c\u7dca\u6025\u6551\u8b77\u670d\u52d9(EMS)\u7684\u6d3e\u9063\u4eba\u54e1(Dispatcher)\u61c9\u8a72\u63d0\u4f9b\u7dda\u4e0a CPR \u6307\u5c0e\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u5728 2010 \u5e74\u7f8e\u570b\u5fc3\u81df\u5354\u6703(AHA)\u7684\u6025\u6551\u6e96\u5247\u4e2d\uff0c\u95dc\u65bc\u6025\u6551\u6559\u80b2\u8ab2\u7a0b\u7684\u8a2d\u8a08\uff0c\u4e0b\u5217\u4f55\u8005\u4e0d\u662f\u57fa\u65bc\u5be6\u8b49\u91ab\u5b78 Class I \u7684\u5efa\u8b70\uff1f", + "Options": "(A)\u6211\u5011\u61c9\u8a72\u8981\u8a55\u4f30\u6025\u6551\u6559\u80b2\u8ab2\u7a0b\u7684\u6709\u6548\u6027\uff0c\u4e26\u4e14\u8981\u900f\u904e\u6a19\u6e96\u7684\u65b9\u5f0f\u9032\u884c\u4e0a\u8ff0\u8a55\u4f30\u3002 (B)\u95dc\u65bc\u57fa\u672c\u6025\u6551\u8853(BLS)\u7684\u6559\u80b2\uff0c\u5229\u7528\u77ed\u7684\u5f71\u5e36\u6559\u5b78\u914d\u5408\u540c\u6b65\u52d5\u624b\u7684\u7df4\u7fd2\uff0c\u662f\u6709\u6548\u800c\u53ef\u4ee5\u53d6\u4ee3\u50b3\u7d71\u7531\u6307\u5c0e\u54e1\u4e3b\u5c0e\u7684\u6559\u5b78\u65b9\u5f0f\u3002 (C)\u6211\u5011\u61c9\u8a72\u8981\u8b93\u6c92\u6709\u53d7\u904e\u8a13\u7684\u71b1\u5fc3\u6551\u52a9\u8005(bystanders)\u4f7f\u7528 AED\u3002 (D)\u6211\u5011\u61c9\u8a72\u8981\u898f\u5283\u6c11\u773e\u4f7f\u7528 AED \u7684\u8a13\u7df4\u8ab2\u7a0b\uff0c\u4e26\u4e14\u4fc3\u9032\u6c11\u773e\u4f86\u4e0a\u8ab2\u3002 (E)\u9ad8\u7d1a\u5fc3\u81df\u6551\u547d\u8853(ACLS)\u7684\u6559\u80b2\u8ab2\u7a0b\u61c9\u8a72\u5305\u542b\u5718\u968a\u5408\u4f5c\u548c\u9818\u5c0e\u7684\u8a13\u7df4\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u5728\u4e8b\u6545\u6307\u63ee\u7cfb\u7d71\u4e2d(Incident Command System, ICS)\uff0c\u5b89\u5168\u5b98(safety officer)\u662f\u5c6c\u65bc\u4e0b\u5217\u4f55\u8005\u90e8\u9580\u7ba1\u8f44\uff1f", + "Options": "(A)\u6307\u63ee\u90e8\u9580(Command)\u3002 (B)\u8ca1\u52d9\u90e8\u9580(Finance)\u3002 (C)\u8a08\u5283\u90e8\u9580(Planning)\u3002 (D)\u5f8c\u52e4\u90e8\u9580(Logistics)\u3002 (E)\u57f7\u884c\u90e8\u9580(Operation)\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u5728\u5b89\u5be7\u7de9\u548c\u91ab\u7642\u689d\u4f8b\u4e2d\uff0c\u82e5\u4e0d\u65bd\u884c\u5fc3\u80ba\u5fa9\u7526\u8853\uff0c\u9808\u7b26\u5408\u76f8\u95dc\u898f\u5b9a\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u75c5\u4eba\u9700\u70ba\u672b\u671f\u75c5\u4eba\u3002 (B)\u9700\u7d93 2 \u4f4d\u91ab\u5e2b\u8a3a\u65b7\u78ba\u70ba\u672b\u671f\u75c5\u4eba\uff0c\u53ea\u9808 1 \u4f4d\u70ba\u76f8\u95dc\u5c08\u79d1\u91ab\u5e2b\u3002 (C)\u9700\u6709\u610f\u9858\u66f8\u7684\u7c3d\u7acb\u3002 (D)\u82e5\u75c5\u4eba\u672a\u6eff 20 \u6b72\uff0c\u7c3d\u7f72\u610f\u9858\u66f8\u6642\uff0c\u61c9\u5f97\u5176\u6cd5\u5b9a\u4ee3\u7406\u4eba\u4e4b\u540c\u610f\u3002 (E)\u82e5\u75c5\u4eba\u610f\u8b58\u660f\u8ff7\u6216\u7121\u6cd5\u6e05\u695a\u8868\u9054\u4e0d\u65bd\u884c\u5fc3\u80ba\u5fa9\u7526\u8853\u7684\u610f\u9858\u6642\uff0c\u53ef\u7531\u5176\u6700\u8fd1\u89aa\u5c6c\u51fa\u5177\u540c\u610f\u66f8\u4ee3\u66ff\u4e4b\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u5728\u7389\u5c71\u9802\u4e0a\u8fce\u63a5 2012 \u5e74\u7b2c\u4e00\u9053\u66d9\u5149\uff0c\u7576\u665a\u5929\u6c23\u975e\u5e38\u5bd2\u51b7\uff0c\u6709\u4f4d 70 \u6b72\u7684\u8001\u5148\u751f\u7a81\u7136\u610f\u8b58\u6539\u8b8a\uff0c\u5168\u8eab\u51b0\u51b7\u986b\u6296\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u53ef\u80fd\u767c\u751f\u7684\u6025\u75c7\u70ba\u4f4e\u9ad4\u6eab\u75c7\u3002 (B)\u5178\u578b\u7684\u4f4e\u9ad4\u6eab\u75c7\u70ba\u610f\u8b58\u6539\u8b8a\uff0c\u5fc3\u8df3\u7de9\u6162\u3002 (C)\u73fe\u5834\u8655\u7f6e\u61c9\u6e1b\u4f4e\u9032\u4e00\u6b65\u71b1\u91cf\u7684\u6563\u5931\u3002 (D)\u53bb\u9664\u8eab\u4e0a\u6f6e\u6fd5\u7684\u8863\u7269\uff0c\u4f7f\u7528\u6bdb\u6bef\u6216\u7761\u888b\u52a0\u4ee5\u4fdd\u6eab\u3002 (E)\u9700\u7e2e\u77ed\u8a55\u4f30\u547c\u5438\u3001\u8108\u640f\u7684\u6642\u9593\uff0c\u82e5 10 \u79d2\u5167\u7121\u547c\u5438\u8108\u640f\uff0c\u7acb\u5373\u7d66\u4e88CPR\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u9020\u6210\u95cc\u5c3e\u51fa\u53e3\u963b\u585e\u7684\u539f\u56e0(luminal obstruction of appendix)\uff0c\u4e0b\u5217\u4f55\u8005\u6700\u4e0d\u53ef\u80fd\uff1f", + "Options": "(A)\u6dcb\u5df4\u7d44\u7e54(lymphatic tissue)\u3002 (B)\u816b\u7624(tumor)\u3002 (C)\u5bc4\u751f\u87f2(parasites)\u3002 (D)\u7cde\u77f3(fecalith)\u3002 (E)\u7cde\u4fbf(feces)\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "41 \u6b72\u7537\u6027\u75c5\u4eba\uff0c\u6709\u9577\u671f\u98f2\u9152\u5c0e\u81f4\u9152\u7cbe\u6027\u809d\u708e\u53ca\u809d\u786c\u5316\u4e4b\u75c5\u53f2\uff0c\u4e3b\u8a34\u4eca\u5929\u4e0a\u5348\u5de6\u4e0b\u80a2\u958b\u59cb\u51fa\u73fe\u7d05\u816b\u71b1\u75db\u7684\u73fe\u8c61\uff0c\u8a3a\u6240\u91ab\u5e2b\u8a3a\u65b7\u70ba\u8702\u7aa9\u6027\u7d44\u7e54\u708e\u4e26\u958b\u7acb\u53e3\u670d\u6297\u751f\u7d20\u6cbb\u7642\uff0c\u56e0\u70ba\u75c7\u72c0\u6301\u7e8c\u7121\u6539\u5584\u540c\u6642\u4e0b\u5348\u958b\u59cb\u51fa\u73fe\u9ad8\u71d2\u5bd2\u986b\u7684\u73fe\u8c61\uff0c\u56e0\u800c\u7531\u5bb6\u5c6c\u966a\u540c\u5230\u6025\u8a3a\u6c42\u8a3a\u3002\u6025\u8a3a\u7576\u6642\u4e4b\u751f\u547d\u5fb5\u8c61\u70ba\uff1a\u8840\u58d3 86/58 mmHg\u3001\u9ad4\u6eab 35.8\u2103\u3001\u8108\u640f\u6bcf\u5206\u9418 128 \u4e0b\u3001\u547c\u5438\u6bcf\u5206\u9418 20 \u4e0b\u3001\u6307\u7aef\u8840\u6c27\u6fc3\u5ea6\u70ba 94%\uff0c\u4e3b\u8981\u7684\u7406\u5b78\u6aa2\u67e5\u986f\u793a\u75c5\u4eba\u6709\u8f15\u5fae\u9ec3\u75b8\u3001\u80f8\u58c1\u86db\u72c0\u75e3(spider angioma)\u3001\u79fb\u52d5\u6027\u6fc1\u97f3(shifting dullness)\u3002\u8840\u6db2\u6aa2\u67e5\u767c\u73fe\u767d\u8840\u7403\u7e3d\u6578\u70ba9680/\u00b5L\uff0c\u5206\u7bc0\u578b\u55dc\u4e2d\u6027\u767d\u8840\u7403(segment form WBC)\u6bd4\u7387\u70ba 92%\uff0c\u751f\u5316\u6aa2\u9a57\u986f\u793a\u809d\u529f\u80fd\u53ca\u814e\u529f\u80fd\u6307\u6578\u7570\u5e38\u3002\u95dc\u65bc\u9019\u4f4d\u75c5\u4eba\u7684\u8a3a\u65b7\u8207\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u6b64\u75c5\u4eba\u8a3a\u65b7\u70ba\u8702\u7aa9\u6027\u7d44\u7e54\u708e\uff0c\u4e00\u822c\u6297\u751f\u7d20\u6cbb\u7642\u9810\u5f8c\u826f\u597d\u3002 (B)\u5728\u53f0\u7063\uff0c\u6700\u5e38\u898b\u7684\u81f4\u75c5\u83cc\u70ba\u6297\u7532\u6c27\u82ef\u9752\u9ef4\u7d20\u91d1\u9ec3\u8272\u8461\u8404\u7403\u83cc(methicillin-resistant Staphylococcus aureus)\u3002 (C)\u5275\u50b7\u5f27\u83cc(Vibrio vulnificus )\u53ca\u55dc\u6c34\u7522\u6c23\u55ae\u80de\u83cc(Aeromonas hydrophila)\u4e26\u975e\u6b64\u75c5\u4eba\u7684\u9700\u8981\u8003\u616e\u7684\u5e38\u898b\u81f4\u75c5\u83cc\u3002 (D)\u6b64\u985e\u578b\u7684\u611f\u67d3\u5982\u679c\u767c\u751f\u7684\u90e8\u4f4d\u4f4d\u65bc\u6703\u9670\u90e8\u6642\uff0c\u5247\u7a31\u70ba\u5f17\u5c3c\u723e\u6c0f\u58de\u75bd(Fournier\u2019s gangrene)\uff0c\u5169\u8005\u9664\u975c\u8108\u6297\u751f\u7d20\u4e4b\u5916\uff0c\u5747\u9700\u8981\u7acb\u5373\u65bd\u4e88fasciotomy \u9032\u884c\u50b7\u53e3\u6e05\u5275\u3002 (E)\u6297\u751f\u7d20\u9078\u64c7\u4ee5\u6297\u683c\u862d\u6c0f\u967d\u6027\u83cc\u4e4b\u6297\u751f\u7d20\u70ba\u9996\u9078\uff0c\u5982 oxacillin \u6297\u751f\u7d20\u3002\u4f46\u5982\u679c\u61f7\u7591\u70ba\u6297\u7532\u6c27\u82ef\u9752\u9ef4\u7d20\u91d1\u9ec3\u8272\u8461\u8404\u7403\u83cc(MRSA)\u611f\u67d3\u6642\uff0c\u5247\u4ee5 vancomycin \u70ba\u6297\u751f\u7d20\u6cbb\u7642\u7684\u9996\u9078\u7528\u85e5\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u6240\u8b02\u5927\u91cf\u50b7\u60a3\u4e8b\u4ef6(Mass Casualty Incident)\uff0c\u4e0b\u5217\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u4e00\u500b\u4e8b\u4ef6\u7522\u751f 15 \u500b\u4ee5\u4e0a\u7684\u50b7\u60a3\uff0c\u5c31\u7a31\u4e4b\u3002 (B)\u901a\u5e38\u662f\u6307\u5275\u50b7\u6240\u5f15\u8d77\u7684\uff0c\u5176\u4ed6\u75be\u75c5\u5f15\u8d77\u7684\u4e00\u822c\u4e0d\u7b97\u3002 (C)\u56e0\u70ba\u5404\u5730\u5340\u7684\u8cc7\u6e90\u591a\u5be1\uff0c\u4e5f\u56e0\u50b7\u75c5\u56b4\u91cd\u5ea6\u7684\u4e0d\u540c\uff0c\u6a19\u6e96\u53ef\u80fd\u56e0\u5730\u56e0\u793e\u5340\u800c\u7570\u3002 (D)\u73fe\u5834\u7ba1\u5236\u7684\u90e8\u5206\uff0c\u7531\u6d88\u9632\u5c40\u8ca0\u8cac\uff0c\u800c\u91ab\u7642\u6551\u8b77\u7531\u885b\u751f\u5c40\u8ca0\u8cac\u3002 (E)\u73fe\u5834\u7684\u8655\u7406\u9806\u5e8f\uff0c\u4e00\u822c\u5148\u8655\u7406\u80fd\u8fc5\u901f\u96e2\u958b\u73fe\u5834\u7684\uff0c\u4e0d\u80fd\u79fb\u52d5\u7684\u5f8c\u4f86\u624d\u6551\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u4e00\u540d 12 \u6b72\u7684\u7537\u5b69\u56e0\u70ba\u809b\u9580\u51fa\u8840\u88ab\u5e36\u81f3\u6025\u8a3a\u6c42\u8a3a\u3002\u8a62\u554f\u75c5\u53f2\u767c\u73fe\u6b64\u73fe\u8c61\u5df2\u7d93\u6301\u7e8c\u7d04\u6578\u500b\u6708\u3002\u6b64\u5916\uff0c\u75c5\u4eba\u6709\u4fbf\u79d8\u7684\u7fd2\u6163\u548c\u5076\u723e\u6703\u6709\u5927\u4fbf\u5931\u7981\u7684\u73fe\u8c61\uff0c\u4ed6\u5426\u8a8d\u6709\u4efb\u4f55\u4eba\u66fe\u7d93\u4e0d\u9069\u7576\u5730\u89f8\u6478\u4ed6\u7684\u79c1\u5bc6\u8655\u3002\u7406\u5b78\u6aa2\u67e5\u767c\u73fe\u809b\u9580\u5f35\u529b\u964d\u4f4e\uff0c\u6709 3 \u8655\u809b\u88c2(anal fissures)\uff0c\u4e14\u5728 8 \u9ede\u9418\u65b9\u5411\u6709\u7d50\u75a4(scar)\u3002\u8a66\u554f\uff0c\u9019\u540d\u75c5\u4eba\u81e8\u5e8a\u75c7\u72c0\u548c\u7406\u5b78\u6aa2\u67e5\u7d50\u679c\u6700\u53ef\u80fd\u662f\u4e0b\u5217\u4f55\u8005\u6240\u9020\u6210\u7684\uff1f", + "Options": "(A)\u5148\u5929\u6027\u5de8\u7d50\u8178\u75c7(Hirschsprung disease) (B)\u4fbf\u79d8(Constipation) (C)\u809b\u9580\u7a7f\u523a\u50b7(Penetrating anal trauma) (D)\u75d4\u7621(Hemorrhoids) (E)\u6fd5\u75b9(Eczama)", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u4e00\u540d 26 \u6b72\u6709\u53e4\u67ef\u9e7c (Cocaine) \u6feb\u7528\u75c5\u53f2\u7684\u7537\u6027\u75c5\u4eba\u56e0\u80f8\u75db\u800c\u81f3\u6025\u8a3a\u5c31\u91ab\uff0c\u5fc3\u96fb\u5716\u5448\u73fe\u7f3a\u8840\u6027\u8b8a\u5316\uff0c\u8acb\u554f\u4e0b\u5217\u4f55\u8005\u70ba\u7b2c\u4e00\u7dda\u6cbb\u7642\u7684\u9996\u9078\u85e5\u7269\uff1f", + "Options": "(A)Phetolamine\u3002 (B)Labetalol\u3002 (C)Diazepam\u3002 (D)Verapamil\u3002 (E)Propanolol\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u4e00\u540d 32 \u6b72\u5973\u6027\uff0c4 \u5c0f\u6642\u524d\u5728\u5de5\u4f5c\u4e2d\u88ab\u4e0d\u614e\u5f15\u71c3\u7684\u706b\u85e5\u70b8\u50b7\uff0c\u80cc\u90e8\u7126\u9ed1\u6216\u8d77\u6c34\u6ce1\uff0c\u5168\u8eab\u7d04 50%\u9ad4\u8868\u9762\u7a4d\u8d77\u6c34\u6ce1\u6216\u7126\u9ed1\u3002\u5979\u9ad4\u91cd 50 kg\uff0c\u8840\u58d3 110/89 mmHg\uff0c\u5fc3\u8df3 120 \u4e0b/\u5206\uff0c\u7559\u7f6e\u5c0e\u5c3f\u7ba1\u6709 100 ml \u5c3f\u6db2\uff0c\u5f9e\u53d7\u50b7\u5230\u73fe\u5728\u5df2\u7d66\u4e861000 ml \u4e73\u9178\u6797\u683c\u6c0f\u6db2\uff0c\u8acb\u554f\u82e5\u6839\u64da Parkland formula\uff0c\u63a5\u4e0b\u4f86 4 \u5c0f\u6642\u7684\u8f38\u6db2\uff0c\u6bcf\u5c0f\u6642\u8a72\u7d66\u591a\u5c11 ml\uff1f", + "Options": "(A)10000 ml\u3002 (B)5000 ml\u3002 (C)250 ml\u3002 (D)1000 ml\u3002 (E)500 ml\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u4e00\u540d 32 \u6b72\u5973\u6027\uff0c\u591a\u91cd\u5275\u50b7\u88ab\u9001\u81f3\u5730\u5340\u91ab\u9662\u6025\u8a3a\u3002\u5979\u7684\u8840\u58d3\u5fc3\u8df3\u7a69\u5b9a\uff0c\u845b\u6c0f\u660f\u8ff7\u6307\u6578(Glasgow Coma Score) \u70ba 7\uff0c\u984f\u9762\u9aa8\u6298\u5408\u4f75\u591a\u8655\u6495\u88c2\u50b7\uff0c\u80f8\u90e8 X\u5149\u5448\u73fe\u7e31\u8188\u8154\u5bec\u5927\uff0c\u547c\u5438\u72c0\u614b\u826f\u597d\uff0c\u8179\u90e8\u5e73\u8edf\uff0c\u8178\u97f3\u6b63\u5e38\u3002\u8a72\u9662\u5916\u79d1\u91ab\u5e2b\u4f11\u5047\uff0c\u91ab\u9662\u7121\u624b\u8853\u80fd\u529b\uff0c\u6700\u8fd1\u6709\u80fd\u529b\u8655\u7406\u7684\u91ab\u5b78\u4e2d\u5fc3\u5728 40 \u516c\u91cc\u5916\u3002\u8acb\u554f\u4e0b\u4e00\u500b\u6b65\u9a5f\uff0c\u6700\u5408\u9069\u7684\u8655\u7f6e\u662f\uff1f", + "Options": "(A)\u7dca\u6025\u8f38\u6db2\u6025\u6551\u3002 (B)\u653e\u7f6e\u6c23\u7ba1\u5167\u7ba1\u3002 (C)\u9032\u884c\u80f8\u90e8\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u3002 (D)\u7dca\u6025\u653e\u7f6e\u80f8\u7ba1\u3002 (E)\u7acb\u523b\u8f49\u9662\u81f3\u91ab\u5b78\u4e2d\u5fc3\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u4e00\u540d 60 \u516c\u65a4\u7537\u6027\uff0c\u53d7\u5230 2 \u5230 3 \u5ea6\u71d2\u50b7\uff0c\u7d04 30%\u7684\u9ad4\u8868\u9762\u7a4d\uff0c\u6b64\u75c5\u4eba\u9664\u4e86\u5e73\u5e38\u9700\u6c42\u7684\u6db2\u9ad4\u91cf\uff0c\u5728 24 \u5c0f\u6642\u5167\u9084\u9700\u8981\u7d66\u65bc\u591a\u5c11\u91cf\u7684\u4e73\u9178\u6797\u683c\u6db2(Ringer's lactate)\uff1f", + "Options": "(A)1.8 liter\u3002 (B)3.6 liter\u3002 (C)5.4 liter\u3002 (D)7.2 liter\u3002 (E)9.0 liter\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u4e00\u540d\u61f7\u5b55 38 \u9031\u7684\u5b55\u5a66\u5728\u6025\u8a3a\u751f\u4e0b\u4e86\u4e00\u540d\u7537\u5b30\u3002\u4f60\u6b63\u5728\u5354\u52a9\u8655\u7f6e\u9019\u540d\u65b0\u751f\u5152\uff0c\u7406\u5b78\u6aa2\u67e5\u767c\u73fe\u7537\u5b30\u5448\u73fe\u55dc\u7761\uff0c\u767c\u7d3a\u548c\u6d3b\u529b\u4e0d\u4f73\u7684\u5916\u89c0\uff0c\u4ee5\u53ca\u5fc3\u640f\u7de9\u6162\u3002\u5728\u4f7f\u7528\u888b\u8fa6\u7f69\u7d66\u4e88\u6b63\u58d3\u547c\u5438\u548c\u6c27\u6c23\u4e4b\u5f8c\uff0c\u4ed6\u7684\u5fc3\u8df3\u4ecd\u7136\u53ea\u6709\u6bcf\u5206\u9418 40 \u4e0b\uff0c\u4f60\u7684\u53e6\u4e00\u4f4d\u540c\u4e8b\u6b63\u5728\u6e96\u5099\u9032\u884c\u6c23\u7ba1\u63d2\u7ba1\uff1b\u8a66\u554f\u63a5\u4e0b\u4f86\u6700\u9069\u7576\u7684\u8655\u7f6e\u70ba\u4f55\uff1f", + "Options": "(A)\u5efa\u7acb\u975c\u8108\u901a\u8def\uff0c\u4e26\u7d66\u4e88\u78b3\u9178\u6c2b\u9209(sodium bicarbonate)\u3002 (B)\u5efa\u7acb\u975c\u8108\u901a\u8def\uff0c\u4e26\u7d66\u4e88\u814e\u4e0a\u817a\u7d20\u3002 (C)\u5efa\u7acb\u9aa8\u5167\u6ce8\u5c04\uff0c\u4e26\u7d66\u4e88\u814e\u4e0a\u817a\u7d20\u3002 (D)\u5efa\u7acb\u975c\u8108\u901a\u8def\uff0c\u4e26\u7d66\u4e88\u6bcf\u516c\u65a4 10 \u6beb\u5347\u751f\u7406\u98df\u9e7d\u6c34\u7684\u8f38\u6db2\u6cbb\u7642\u3002 (E)\u958b\u59cb\u80f8\u5916\u6309\u58d3(chest compression)\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u4e00\u540d\u51fa\u751f\u4e0d\u6eff 24 \u5c0f\u6642\u7684\u8db3\u6708\u65b0\u751f\u5152\uff0c\u88ab\u767c\u73fe\u9ec3\u81bd\u800c\u5f9e\u5a66\u7522\u79d1\u8a3a\u6240\uff0c\u8f49\u8a3a\u5230\u91ab\u9662\u6025\u8a3a\u6c42\u8a3a\u3002\u8a66\u554f\uff0c\u9020\u6210\u8a72\u540d\u65b0\u751f\u5152\u9ec3\u81bd\u539f\u56e0\uff0c\u4e0b\u5217\u4f55\u8005\u6700\u4e0d\u53ef\u80fd\uff1f", + "Options": "(A)\u56e0\u751f\u7522\u5275\u50b7\u6240\u5f15\u8d77\u4e4b\u982d\u8840\u816b(cephalohematoma)\u3002 (B)\u8840\u578b\u4e0d\u76f8\u5bb9\u5f15\u8d77\u4e4b\u6eb6\u8840\u3002 (C)\u7532\u72c0\u817a\u529f\u80fd\u4f4e\u4e0b\u3002 (D)\u6557\u8840\u75c7\u3002 (E)\u5148\u5929\u6027\u611f\u67d3(congenital infection)\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u4e00\u4f4d 28 \u6b72\u5973\u6027\u56e0\u61f7\u7591\u5b50\u5bae\u5916\u5b55\uff0c\u5728 5 \u5929\u524d\u81f3\u5a66\u7522\u79d1\u9580\u8a3a\u5c31\u8a3a\uff0c\u8981\u6c42\u81f3\u6025\u8a3a\u770b\u5831\u544a\uff0c\u7b2c\u4e00\u5929\u7684 hCG\uff1a800 IU/L\uff0c72 \u5c0f\u6642\u5f8c\u70ba 850 IU/L \uff0c\u7d93\u9670\u9053\u8d85\u97f3\u6ce2\uff0c\u7b2c\u4e00\u5929\u548c 72 \u5c0f\u6642\u5f8c\u7686\u7121\u5b50\u5bae\u5167\u80da\u80ce\uff1b\u4e0b\u5217\u8a3a\u65b7\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u56e0 hCG \u6fc3\u5ea6\u9806\u5229\u4e0a\u5347\uff0c\u96d6\u8d85\u97f3\u6ce2\u4e0d\u898b\u5b50\u5bae\u5167\u80da\u80ce\uff0c\u4ecd\u9ad8\u5ea6\u61f7\u7591\u70ba\u6b63\u5e38\u5b50\u5bae\u5167\u61f7\u5b55\u3002 (B)\u56e0 hCG \u6fc3\u5ea6\u9806\u5229\u4e0a\u5347\uff0c\u52a0\u4e0a\u8d85\u97f3\u6ce2\u4e0d\u898b\u5b50\u5bae\u5167\u80da\u80ce\uff0c\u9ad8\u5ea6\u61f7\u7591\u70ba\u5b50\u5bae\u5916\u5b55\u3002 (C)\u56e0 hCG \u6fc3\u5ea6\u672a\u9054\u4e0a\u5347\u901f\u7387\uff0c\u52a0\u4e0a\u8d85\u97f3\u6ce2\u4e0d\u898b\u5b50\u5bae\u5167\u80da\u80ce\uff0c\u9ad8\u5ea6\u61f7\u7591\u5df2\u6d41\u7522\u3002 (D)\u56e0 hCG \u6fc3\u5ea6\u672a\u9054\u4e0a\u5347\u901f\u7387\uff0c\u52a0\u4e0a\u8d85\u97f3\u6ce2\u4e0d\u898b\u5b50\u5bae\u5167\u80da\u80ce\uff0c\u9ad8\u5ea6\u61f7\u7591\u70ba\u5b50\u5bae\u5916\u5b55\u3002 (E)\u56e0 hCG \u6fc3\u5ea6\u96d6\u672a\u9054\u4e0a\u5347\u901f\u7387\uff0c\u96d6\u8d85\u97f3\u6ce2\u4e0d\u898b\u5b50\u5bae\u5167\u80da\u80ce\uff0c\u4ecd\u9ad8\u5ea6\u61f7\u7591\u70ba\u6b63\u5e38\u5b50\u5bae\u5167\u61f7\u5b55\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u4e00\u4f4d 30 \u6b72\u7537\u6027\u81f3\u6025\u8a3a\uff0c\u56e0\u70ba\u6628\u65e5\u5728\u9f8d\u6d1e\u9644\u8fd1\u885d\u6d6a\uff0c\u53f3\u8173\u8e1d\u88ab\u7901\u77f3\u5272\u51fa\u7d04 6\u516c\u5206\u7684\u6495\u88c2\u50b7\u3002\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5c0f\u5fc3\u6e05\u5275\uff0c\u79fb\u9664\u53ef\u80fd\u7684\u7570\u7269\uff0c\u7e2b\u5408\u6cbb\u7642\uff0c\u5916\u79d1\u9580\u8a3a\u8ffd\u8e64\u3002 (B)\u5c0f\u5fc3\u6e05\u5275\uff0c\u79fb\u9664\u53ef\u80fd\u7684\u7570\u7269\uff0c\u4e0d\u7e2b\u5408\uff0c\u5916\u79d1\u9580\u8a3a\u8ffd\u8e64\u3002 (C)\u5c0f\u5fc3\u6e05\u5275\uff0c\u79fb\u9664\u53ef\u80fd\u7684\u7570\u7269\uff0c\u4e0d\u7e2b\u5408\uff0c\u7d66\u4e88 Augmentin \u9810\u9632\u6027\u6297\u751f\u7d20\u5916\u79d1\u9580\u8a3a\u8ffd\u8e64\u3002 (D)\u5c0f\u5fc3\u6e05\u5275\uff0c\u79fb\u9664\u53ef\u80fd\u7684\u7570\u7269\uff0c\u4e0d\u7e2b\u5408\uff0c\u61f7\u7591\u53ef\u80fd Vibrio species \u611f\u67d3\uff0c\u7d66\u4e88 ciprofloxacin \u9810\u9632\u6027\u6297\u751f\u7d20\u5916\u79d1\u9580\u8a3a\u8ffd\u8e64\u3002 (E)\u5c0f\u5fc3\u6e05\u5275\uff0c\u79fb\u9664\u53ef\u80fd\u7684\u7570\u7269\uff0c\u4e0d\u7e2b\u5408\uff0c\u61f7\u7591\u53ef\u80fd Aeromonas species\u611f\u67d3\uff0c\u7d66\u4e88 trimethoprim-sulfamethoxazole \u9810\u9632\u6027\u6297\u751f\u7d20\u5916\u79d1\u9580\u8a3a\u8ffd\u8e64\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u4e00\u4f4d 32 \u6b72\u5a66\u5973\u5728\u6025\u8a3a\u6025\u7522\u751f\u4e0b\u4e00\u8db3\u6708\u65b0\u751f\u5152\u3002\u65b0\u751f\u5152\u525b\u51fa\u751f\u6642\u767c\u73fe\u6709\u767c\u7d3a\u53ca\u547c\u5438\u7a98\u8feb\u7684\u73fe\u8c61\u3002\u7406\u5b78\u6aa2\u67e5\u767c\u73fe\u53f3\u5074\u80f8\u90e8\u7121\u6cd5\u807d\u5230\u5fc3\u97f3\uff0c\u5de6\u5074\u547c\u5438\u97f3\u660e\u986f\u8f03\u5c0f\u8072\uff0c\u4e14\u8179\u90e8\u51f9\u9677\u985e\u4f3c\u821f\u72c0(scaphoid abdomen)\u3002\u8a66\u554f\uff0c\u63a5\u4e0b\u4f86\u6700\u9069\u7576\u7684\u8655\u7f6e\u70ba\u4f55\uff1f", + "Options": "(A)\u7d66\u4e88\u888b\u8fa6\u7f69(BVM)\u6b63\u58d3\u547c\u5438\u3002 (B)\u6c23\u7ba1\u5167\u7ba1\u63d2\u7ba1\u5efa\u7acb\u3002 (C)\u5efa\u7acb\u975c\u8108\u6ce8\u5c04\u4e26\u7d66\u4e88 naloxone\u3002 (D)\u958b\u59cb\u80f8\u5916\u6309\u58d3(chest compression)\u3002 (E)\u5efa\u7acb\u9aa8\u5167\u6ce8\u5c04(intraosseous)\u4e26\u7d66\u4e88\u814e\u4e0a\u817a\u7d20\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u4e00\u4f4d 32 \u6b72\u5973\u6027\u7cbe\u795e\u75c5\u4eba\uff0c\u670d\u7528\u904e\u91cf\u7cbe\u795e\u79d1\u85e5\u7269\u5f8c\uff0c\u5bb6\u5c6c\u767c\u73fe\u75c5\u4eba\u660f\u8ff7\u53ca\u6d41\u6c57\uff0c\u9001\u81f3\u6025\u8a3a\uff0c\u6aa2\u50b7\u5206\u985e\u4e00\u7d1a\uff0c\u8840\u58d3\uff1a170/100 mmHg\u3001\u5fc3\u8df3\uff1a142 \u4e0b/\u5206\u9418\uff0c\u9ad4\u6eab 41.2\u2103\uff0c\u8108\u885d\u5f0f\u8840\u6c27 SpO2 95%\uff0c\u660f\u8ff7\u6307\u6578 E1M2V2\u3001\u81c9\u90e8\u6f6e\u7d05\u3001\u77b3\u5b54\u64f4\u5927\u3001\u773c\u7403\u9663\u6523\u3001\u808c\u8df3\u8e8d(myoclonus)\u53ca\u53cd\u5c04\u589e\u5f37(\u4e0b\u80a2>\u4e0a\u80a2)\uff0cEKG \u986f\u793a QRS \u6ce2\u53ca QTc \u5ef6\u9577\uff0c\u6b64\u75c5\u4eba\u70ba\u4f55\u7a2e\u75c7\u5019\u7fa4\uff1f", + "Options": "(A)\u6297\u7cbe\u795e\u75c5\u85e5\u7269\u60e1\u6027\u75c7\u5019\u7fa4 (neuroleptic malignant syndrome)\u3002 (B)\u60e1\u6027\u9ad8\u6eab(malignant hyperthermia)\u3002 (C)\u795e\u7d93\u6fc0\u80fa\u75c7\u5019\u7fa4 (serotonin syndrome)\u3002 (D)\u526f\u4ea4\u611f\u795e\u7d93\u8208\u596e\u75c7\u5019\u7fa4(anticholinergic syndrome)\u3002 (E)\u4ea4\u611f\u795e\u7d93\u8208\u596e\u75c7\u5019\u7fa4(sympathomimetic syndrome)\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u4e00\u4f4d 48 \u6b72\u7537\u6027\u75c5\u4eba\u81f3\u6025\u8a3a\u5c31\u91ab\uff0c\u5176\u6aa2\u67e5\u5831\u544a\u6578\u503c\u5982\u4e0b\uff1aNa+ 147 mEq/L, K+ 4.7 mEq/L, Cl- 101 mEq/L, pH 7.126, HCO3- 15.5 mEq/L, BUN 42 mg/dL, Cr 1.7 mg/dL, Glucose 207 mg/dL \u548c Ethanol 6.9 mg/dL\u3002\u5c31\u4ee5\u4e0a\u6578\u503c\uff0c\u8acb\u554f\u9670\u96e2\u5b50\u9593\u9699 (Anion gap)\u548c\u8a08\u7b97\u6ef2\u900f\u58d3(Calculated osmolarity)\u5404\u662f\u591a\u5c11\uff1f", + "Options": "(A)27.5 \u53ca 320.0 mOsm/L\u3002 (B)30.5 \u53ca 321.5 mOsm/L\u3002 (C)33.5 \u53ca 323.0 mOsm/L\u3002 (D)36.5 \u53ca 324.5 mOsm/L\u3002 (E)24.5 \u53ca 318.5 mOsm/L\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u4e00\u4f4d 6 \u6b72\u7537\u7ae5\u6c92\u6709\u4efb\u4f55\u751f\u547d\u5fb5\u8c61\uff0c\u88ab\u9001\u81f3\u6025\u8a3a\uff0c\u56e0\u7121\u53cd\u61c9\u548c\u751f\u547d\u5fb5\u8c61\uff0c\u4f60\u958b\u59cb\u57f7\u884c\u6c23\u7ba1\u63d2\u7ba1\uff0c\u4f60\u7684\u540c\u4e8b\u4e5f\u540c\u6642\u958b\u59cb\u80f8\u90e8\u6309\u58d3\u3002\u7576\u4f60\u5b8c\u6210\u63d2\u7ba1\u4e5f\u78ba\u8a8d\u4f4d\u7f6e\u7121\u8aa4\u6642\uff0c\u5728\u65c1\u5354\u52a9\u6025\u6551\u7684\u8b77\u58eb\u767c\u73fe\u5fc3\u96fb\u5716\u76e3\u8996\u5668\u5448\u73fe\u51fa\u5fc3\u5ba4\u9707\u986b(ventricular fibrillation)\u3002\u6b64\u6642\uff0c\u4f60\u8a72\u63a1\u53d6\u6700\u9069\u7576\u7684\u8655\u7f6e\u70ba\u4f55\uff1f", + "Options": "(A)\u5efa\u7acb\u975c\u8108\u901a\u8def\uff0c\u4e26\u7d66\u4e88 amiodarone 5 mg/kg\u3002 (B)\u5efa\u7acb\u975c\u8108\u901a\u8def\uff0c\u4e26\u7d66\u4e88 epinephrine 0.1 mg/kg\u3002 (C)\u5efa\u7acb\u975c\u8108\u901a\u8def\uff0c\u4e26\u7d66\u4e88 epinephrine 0.01 mg/kg\u3002 (D)\u7d66\u4e88\u53bb\u986b\u96fb\u64ca(defibrillation )\uff0c\u96fb\u91cf\u4ee5 4 J/kg \u958b\u59cb\u3002 (E)\u7d66\u4e88\u53bb\u986b\u96fb\u64ca(defibrillation )\uff0c\u96fb\u91cf\u4ee5 2 J/kg \u958b\u59cb\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u4e00\u4f4d\u5973\u6027 62 \u6b72\u5973\u6027\uff0c\u5728\u5bb6\u88e1\u88ab\u52d5\u7269\u54ac\u50b7\u5de6\u8173\u80cc\u4e0a\uff0c\u5169\u500b\u54ac\u75d5\u6e05\u6670\u53ef\u898b\uff0c\u50b7\u53e3\u51fa\u8840\uff0c\u96a8\u5373\u51fa\u73fe\u7d05\u3001\u816b\u53ca\u75db\u65bc\u50b7\u53e3\u5468\u570d\uff0c\u4e26\u4e14\u6709\u8840\u5c3f\u3001\u8179\u75db\u53ca\u8170\u75db\u3002\u7d93\u904e 3 \u6642 15 \u5206\u5f8c\u9001\u81f3\u6025\u8a3a\uff0c\u75c5\u4eba\u672c\u8eab\u6709\u9ad8\u8840\u58d3\u75c5\u53f2\u3002\u7406\u5b78\u6aa2\u67e5\uff1a\u8840\u58d3\uff1a212/113 mm/Hg\uff0c\u5fc3\u8df3 60 \u4e0b/\u5206\u9418\uff0c\u547c\u5438 16 \u4e0b/\u5206\u9418\u53ca\u9ad4\u6eab 35.8\u2103\u3002\u9664\u4e86\u5de6\u8173\u4e0a\u50b7\u53e3\u5468\u570d\u8f15\u5fae\u7d05\u816b\u8139\uff0c\u8179\u90e8\u53ca\u8170\u90e8\u5747\u6709\u58d3\u75db\uff0c\u4f46\u4e26\u7121\u53cd\u5f48\u75db\uff0c\u5be6\u9a57\u5ba4\u6aa2\u67e5 PT p\uff1a >100\"\uff0c PT c\uff1a 11.7\"\uff0caPTT p\uff1a>150\"\uff0caPTT c\uff1a 32.3\"\uff0c\u4e0b\u5217\u6cbb\u7642\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u9f9c\u6bbc\u82b1\u53ca\u8d64\u5c3e\u9752\u7af9\u7d72\u6297\u6bd2\u86c7\u8840\u6e05\u3002 (B)\u9396\u93c8\u86c7\u6297\u6bd2\u86c7\u8840\u6e05\u3002 (C)\u96e8\u5098\u7bc0\u53ca\u773c\u93e1\u86c7\u6297\u6bd2\u86c7\u8840\u6e05\u3002 (D)\u72c2\u72ac\u75c5\u75ab\u82d7\u3002 (E)\u4e0d\u9700\u6253\u4efb\u4f55\u75ab\u82d7\u6216\u8840\u6e05\uff0c\u6301\u7e8c\u89c0\u5bdf\u5373\u53ef\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u4f9d\u64da 96 \u5e74 7 \u6708 11 \u65e5\u516c\u544a\u4fee\u6b63\u4e4b\u7dca\u6025\u91ab\u7642\u6551\u8b77\u6cd5\u7b2c 25 \u689d\u7684\u898f\u5b9a\uff0c\u91ab\u7642\u6307\u5c0e\u91ab\u5e2b\u8ca0\u8cac\u4e4b\u5de5\u4f5c\u5167\u5bb9\u4e0d\u5305\u62ec\u4e0b\u5217\u4f55\u9805\uff1f", + "Options": "(A)\u5404\u7d1a\u6551\u8b77\u6280\u8853\u54e1\u57f7\u884c\u7dca\u6025\u6551\u8b77\u4e4b\u6559\u80b2\u8207\u8a13\u7df4\u3002 (B)\u5404\u7d1a\u6551\u8b77\u6280\u8853\u54e1\u57f7\u884c\u7dca\u6025\u6551\u8b77\u4e4b\u7763\u5c0e\u53ca\u8003\u6838\u3002 (C)\u8a02\u5b9a\u5404\u7d1a\u6551\u8b77\u6280\u8853\u54e1\u54c1\u8cea\u6307\u6a19\u3001\u57f7\u884c\u54c1\u8cea\u76e3\u6e2c\u3002 (D)\u6838\u7c3d\u9ad8\u7d1a\u6551\u8b77\u54e1\u4f9d\u64da\u9810\u7acb\u91ab\u7642\u6d41\u7a0b\u65bd\u884c\u7dca\u6025\u6551\u8b77\u4e4b\u6551\u8b77\u7d00\u9304\u8868\u3002 (E)\u9ad8\u7d1a\u6551\u8b77\u6280\u8853\u54e1\u5728\u73fe\u5834\u57f7\u884c\u4fb5\u5165\u6027\u6551\u8b77\u8655\u7f6e\u4e4b\u7dda\u4e0a\u91ab\u7642\u6307\u5c0e\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u4f9d\u64da\u885b\u751f\u7f72\u6240\u516c\u5e03\uff0c101-102 \u5e74\u5ea6\u91ab\u7642\u54c1\u8cea\u53ca\u75c5\u4eba\u5b89\u5168\u5de5\u4f5c\u76ee\u6a19\u4e8c\uff1a\u300c\u843d\u5be6\u611f\u67d3\u7ba1\u5236\u300d\u4e4b\u57f7\u884c\u7b56\u7565\u4e2d\uff0c\u5efa\u8b70\u843d\u5be6\u7d44\u5408\u5f0f\u7167\u8b77(bundle care)\u7684\u6982\u5ff5\uff0c\u5c0d\u65bc\u7f6e\u653e\u4e2d\u592e\u5c0e\u7ba1\u7684\u75c5\u4eba\uff0c\u61c9\u540c\u6642\u63a1\u53d6\u591a\u9805\u63aa\u65bd\uff0c\u4ee5\u964d\u4f4e\u4e2d\u592e\u5c0e\u7ba1\u76f8\u95dc\u8840\u6d41\u611f\u67d3(CLA-BSI, Central Line Associated Blood Stream Infection)\uff0c\u4e0b\u5217\u654d\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u4f8b\u884c\u6027\u8a55\u4f30\u4e2d\u592e\u5c0e\u7ba1\u4e0d\u518d\u9700\u8981\u6642\u61c9\u7acb\u5373\u62d4\u9664\u3002 (B)\u7f6e\u653e\u4e2d\u592e\u5c0e\u7ba1\u6642\uff0c\u57f7\u884c\u8005\u8207\u75c5\u4eba\u7686\u9700\u4f7f\u7528\u6700\u5927\u9762\u7a4d\u7684\u8986\u84cb\u9632\u8b77\u3002 (C)\u7f6e\u653e\u4e2d\u592e\u5c0e\u7ba1\u9700\u5fb9\u5e95\u9032\u884c\u76ae\u819a\u6d88\u6bd2\uff0c\u6d88\u6bd2\u6db2\u63a1\u7528 2% chlorhexidine \u70ba\u4f73\u3002 (D)\u614e\u9078\u7f6e\u653e\u4e2d\u592e\u5c0e\u7ba1\u7684\u4f4d\u7f6e\uff0c\u5118\u53ef\u80fd\u4f7f\u7528\u9f20\u8e4a\u90e8\u70ba\u7f6e\u653e\u90e8\u4f4d\u3002 (E)\u78ba\u5be6\u57f7\u884c\u624b\u90e8\u885b\u751f\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u4f9d\u4e16\u754c\u885b\u751f\u7d44\u7e54(World Health Organization, WHO)\u5b9a\u7fa9\u707d\u96e3(Disaster)\u7684\u4e8b\u6545\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u4e0d\u7b26\u5408\u707d\u96e3\u5b9a\u7fa9\u7684\u689d\u4ef6\uff1f", + "Options": "(A)\u6838\u96fb\u5ee0\u610f\u5916\u4e8b\u6545\uff0c\u9020\u6210\u96fb\u5ee0 30 \u516c\u91cc\u5167\u7684\u5c45\u6c11\u9700\u7dca\u6025\u64a4\u96e2\uff0c\u4f46\u7121\u4eba\u7acb\u5373\u50b7\u4ea1\u3002 (B)\u4eba\u53e3\u7d04 1000 \u4eba\u7684\u5c0f\u93ae\uff0c\u8ddd\u96e2\u5927\u57ce\u5e02\u7d04 80 \u516c\u91cc\uff0c\u5c0f\u93ae\u4e0a\u53ea\u6709 2 \u9593\u79c1\u4eba\u8a3a\u6240\uff0c\u767c\u751f\u7d04 25 \u4eba\u6b7b\u50b7\u7684\u904a\u89bd\u8eca\u610f\u5916\u3002 (C)\u56e0\u904b\u6cb9\u8239\u6f0f\u6cb9\uff0c\u9020\u6210\u8d85\u904e 1000 \u516c\u91cc\u6d77\u5cb8\u7dda\u53d7\u5230\u56b4\u91cd\u6c59\u67d3\uff0c\u81f4\u6355\u9b5a\u4f5c\u696d\u9700\u505c\u6b62\u3002 (D)\u707d\u96e3\u5c0d\u751f\u547d\u6216\u751f\u614b\u50b7\u5bb3\u7684\u7a0b\u5ea6\uff0c\u6703\u8d85\u51fa\u707d\u5340\u5167\u57fa\u672c\u7d50\u69cb(infrastructure)\u80fd\u5920\u8655\u7406\u7684\u7bc4\u570d\u3002 (E)\u5728\u5317\u7f8e\u7684\u67d0\u500b\u5927\u57ce\u5e02\uff0c\u767c\u751f\u6821\u5712\u69cd\u64ca\u4e8b\u4ef6\uff0c\u9020\u6210 10 \u591a\u540d\u5b78\u751f\u6b7b\u4ea1\uff0c5 \u540d\u91cd\u50b7\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u4f9d\u885b\u751f\u7f72\u300c101 \u5e74\u5ea6\u91ab\u9662\u7dca\u6025\u91ab\u7642\u80fd\u529b\u5206\u7d1a\u8a55\u5b9a\u57fa\u6e96\u300d\u5c0d\u5916\u50b7\u8655\u7f6e\u54c1\u8cea\u7684\u8981\u6c42\uff0c\u4e0b\u5217\u654d\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u91cd\u5ea6\u7d1a\u6025\u6551\u8cac\u4efb\u91ab\u9662\u5916\u50b7\u5c0f\u7d44\u555f\u52d5\u5f8c\uff0c\u81f3\u5230\u9054\u6642\u9593\u61c9\u5c0f\u65bc 10 \u5206\u9418\u3002 (B)\u91cd\u5ea6\u7d1a\u6025\u6551\u8cac\u4efb\u91ab\u9662\u5916\u50b7\u5c0f\u7d44\u555f\u52d5\u5f8c\uff0c\u81f3\u5230\u9054\u6642\u9593\u61c9\u5c0f\u65bc 30 \u5206\u9418\u3002 (C)\u4e2d\u5ea6\u7d1a\u6025\u6551\u8cac\u4efb\u91ab\u9662\u5916\u50b7\u5c0f\u7d44\u555f\u52d5\u5f8c\uff0c\u81f3\u5230\u9054\u6642\u9593\u61c9\u5c0f\u65bc 60 \u5206\u9418\u3002 (D)\u4e2d\u5ea6\u7d1a\u6025\u6551\u8cac\u4efb\u91ab\u9662\u6aa2\u50b7\u4e00\u7d1a\u5916\u50b7\u75c5\u4eba\u61c9\u555f\u52d5\u5916\u50b7\u5c0f\u7d44\u3002 (E)\u91cd\u5ea6\u7d1a\u6025\u6551\u8cac\u4efb\u91ab\u9662\u6aa2\u50b7\u4e00\u7d1a\u5916\u50b7\u75c5\u4eba\u61c9\u555f\u52d5\u5916\u50b7\u5c0f\u7d44\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u91ab\u5e2b\u958b\u7acb\u5404\u9805\u8a3a\u65b7\u66f8\u6642\uff0c\u61c9\u529b\u6c42\u614e\u91cd\uff0c\u5c24\u5176\u662f\u6709\u95dc\u6b7b\u4ea1\u4e4b\u539f\u56e0\u3002\u95dc\u65bc\u8a3a\u65b7\u66f8\u958b\u7acb\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u5c0d\u65bc\u975e\u75c5\u6b7b\u7684\u75c5\u4eba\u4e0d\u5b9c\u958b\u7acb\u6b7b\u4ea1\u8a3a\u65b7\u66f8\u3002 (B)\u5c0d\u65bc\u8f49\u8a3a\u9014\u4e2d\u6b7b\u4ea1\u7684\u75c5\u4eba\uff0c\u56e0\u5230\u63a5\u53d7\u91ab\u9662(receiving hospital)\u6642\u5df2\u7121\u751f\u547d\u5fb5\u8c61\uff0c\u6545\u4f9d\u91ab\u7642\u6cd5\u65bd\u884c\u7d30\u5247\u898f\u5b9a\uff0c\u63a5\u53d7\u91ab\u9662\u4e0d\u5f97\u958b\u7acb\u6b7b\u4ea1\u8a3a\u65b7\u66f8\u3002 (C)\u6839\u64da\u91ab\u5e2b\u6cd5\u898f\u5b9a\uff0c\u91ab\u5e2b\u975e\u89aa\u81ea\u8a3a\u5bdf\uff0c\u4e0d\u5f97\u4ea4\u4ed8\u8a3a\u65b7\u66f8\u3002 (D)\u5c0d\u65bc\u6027\u4fb5\u3001\u5bb6\u66b4\u53d7\u5bb3\u4eba\uff0c\u91ab\u5e2b\u9700\u958b\u7acb\u9a57\u50b7\u8a3a\u65b7\u66f8\uff0c\u4e0d\u5f97\u7121\u6545\u62d2\u7d55\u3002 (E)\u91ab\u5e2b\u975e\u89aa\u81ea\u6aa2\u8996\u5c4d\u9ad4\uff0c\u4e0d\u5f97\u4ea4\u4ed8\u6b7b\u4ea1\u8b49\u660e\u66f8\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u4ee5\u4e0b\u54ea\u4e00\u9805\u6307\u6a19\u6700\u9069\u5408\u7528\u4f86\u8a55\u4f30\u4e00\u500b\u5230\u9662\u524d\u6551\u8b77\u7cfb\u7d71\u5c0d\u5230\u9662\u524d\u7121\u5fc3\u8df3\u75c5\u4eba(OHCA)\u7684\u6025\u6551\u6210\u6548\uff1f", + "Options": "(A)OHCA \u500b\u6848\u7684\u5e73\u5747\u53cd\u61c9\u6642\u9593\u3002 (B)OHCA \u500b\u6848\u7531\u9ad8\u7d1a\u6551\u8b77\u6280\u8853\u54e1\u51fa\u52e4\u7684\u6bd4\u7387\u3002 (C)OHCA \u500b\u6848\u5b58\u6d3b\u5230\u4f4f\u9662\u7684\u6bd4\u7387\u3002 (D)OHCA \u500b\u6848\u5b58\u6d3b\u51fa\u9662\u7684\u6bd4\u7387\u3002 (E)OHCA \u500b\u6848\uff0c\u5176\u4e2d\u70ba\u6709\u65c1\u89c0\u8005\u76ee\u64ca\uff0c\u4e00\u958b\u59cb\u76e3\u6e2c\u5230\u7684\u5fc3\u5f8b\u662f\u5fc3\u5ba4\u986b\u52d5\uff0c\u5176\u5b58\u6d3b\u51fa\u9662\u7684\u6bd4\u7387\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u4f55\u8005\u662f\u6210\u4eba\u5916\u50b7\u521d\u7d1a\u8a55\u4f30(primary survey)\u6642\uff0c\u9808\u7acb\u523b\u8655\u7406\u7684\uff1f", + "Options": "(A)\u53f3\u638c 4 \u516c\u5206\u50b7\u53e3\u958b\u653e\u6027\u9aa8\u6298\u3002 (B)\u547c\u5438\u6025\u4fc3\uff0c\u6bcf\u5206\u9418 38 \u4e0b\u3002 (C)\u5fc3\u8df3\u5feb\u901f\uff0c\u6bcf\u5206\u9418 108 \u4e0b\u3002 (D)\u767c\u71d2\uff0c39.5oC\u3002 (E)\u845b\u6c0f\u660f\u8ff7\u6307\u6578(Glasgow Coma Score) E2V3M5\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u6709 15 \u4f4d\u75c5\u4eba\uff0c\u5728\u5403\u904e\u5348\u9910\u5f8c 20 \u5206\u9418\u5f8c\u5614\u5410\u3001\u8179\u7009\u3001\u6d41\u53e3\u6c34\u53ca\u6d41\u6c57\uff0c\u7dca\u63a5\u8457\u6709\u5169\u4f4d\u610f\u8b58\u55aa\u5931\uff0c\u75c5\u4eba\u5927\u591a\u5448\u73fe\u5169\u5074\u91dd\u72c0\u77b3\u5b54\uff0c\u5169\u5074\u80ba\u90e8\u6709\u56c9\u97f3\uff0c\u76ae\u819a\u6fd5\u51b7\uff0c\u4e0b\u5217\u90a3\u9805\u7269\u8cea\u4e2d\u6bd2\u70ba\u6700\u4e0d\u53ef\u80fd\uff1f", + "Options": "(A)\u6709\u6a5f\u78f7\u4e2d\u6bd2\u3002 (B)\u6c28\u57fa\u7532\u9178\u9e7d\u4e2d\u6bd2\u3002 (C)Amanita muscaria \u6bd2\u83c7\u4e2d\u6bd2\u3002 (D)\u9bd6\u9b5a\u4e2d\u6bd2\u3002 (E)Bethanechol \u4e2d\u6bd2\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u6709\u95dc Acetaminophen \u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u654d\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)Acetaminophen \u4e2d\u6bd2\u7684\u89e3\u6bd2\u5291\u70ba N-acetylcysteine\u3002 (B)\u6025\u6027\u809d\u81df\u8870\u7aed\u70ba Acetaminophen \u4e2d\u6bd2\u6700\u5e38\u898b\u7684\u6b7b\u4ea1\u539f\u56e0\u3002 (C)\u4e00\u822c Acetaminophen \u7d04\u6709 5%\u7d93\u7531 Cytochrome P450 \u4ee3\u8b1d\u3002 (D)Asparate aminotransferase \u5728 24~72 \u5c0f\u6642\u958b\u59cb\u4e0a\u5347\uff0c\u5728 72~96 \u5c0f\u6642\u6703\u9054\u5230\u6700\u9ad8\u5cf0\u3002 (E)\u75c5\u4eba\u65bc\u98df\u5165 Acetaminophen \u5f8c 6 \u5c0f\u6642\u7684\u8840\u4e2d\u6fc3\u5ea6\u70ba 200 \u00b5g/ml\uff0c\u53ef\u5148\u89c0\u5bdf\uff0c\u4e0d\u5fc5\u7d66\u89e3\u6bd2\u5291\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u80ba\u5916\u7d50\u6838\u75c5(extrapulmonary tuberculosis)\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u5c0f\u65bc 4 \u6b72\u7684\u5152\u7ae5\u7d04 10%\u4ee5\u6b64\u80ba\u5916\u7d50\u6838\u75c5\u4f86\u8868\u73fe\u3002 (B)\u767c\u751f\u4f4d\u7f6e\u7684\u6a5f\u7387\u70ba\u751f\u6b96\u6ccc\u5c3f\u7cfb\u7d71\u591a\u65bc\u9aa8\u9abc\u7cfb\u7d71\u3002 (C)\u808b\u819c\u80ba\u5916\u7d50\u6838\u75c5\u901a\u5e38\u7121\u75c7\u72c0\uff0c\u6c92\u6709\u63a5\u53d7\u6cbb\u7642\u7684\u75c5\u4eba\u5fa9\u767c\u7387\u7d04 65%\u3002 (D)\u5e73\u9762 X \u5149\u7247\u8a3a\u65b7\u810a\u690e\u80ba\u5916\u7d50\u6838\u75c5\u8207\u51b7\u81bf\u760d(cold abscess)\u76f8\u7576\u654f\u611f\u3002 (E)\u4e2d\u6a1e\u795e\u7d93\u7cfb\u7d71\u7684\u80ba\u5916\u7d50\u6838\u75c5\u6703\u5408\u4f75\u8840\u7ba1\u708e\uff0c\u4ee5\u4e2d\u8166\u52d5\u8108(middle cerebral artery)\u6700\u5e38\u53d7\u5230\u4fb5\u72af\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u8f3b\u5c04\u50b7\u5bb3\u6558\u8ff0\u53ca\u75c5\u4eba\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u03b1 \u5c04\u7dda\u4e0d\u80fd\u7a7f\u8d8a\u76ae\u819a\uff0c\u56e0\u6b64\u53ea\u6709\u9032\u5230\u4eba\u9ad4\u5167\u8f03\u6703\u9020\u6210\u50b7\u5bb3\u3002 (B)\u53f0\u7063\u6838\u80fd\u96fb\u5ee0\u82e5\u767c\u751f\u610f\u5916\u3001\u6838\u707d\u6025\u6551\u8cac\u4efb\u91ab\u9662\u5206\u4e09\u7d1a\uff0c\u7b2c\u4e00\u7d1a\u70ba\u6838\u80fd\u96fb\u5ee0\u9644\u8a2d\u54e1\u5de5\u8a3a\u6240\u6216\u91ab\u52d9\u5ba4\u3002 (C)\u6025\u6027\u8f3b\u50b7\u75c7\u5019\u7fa4\u7684\u60a3\u8005\uff0c\u7576\u63a5\u89f8\u5291\u91cf\u8d8a\u5927\uff0c\u6f5b\u4f0f\u671f\u6642\u9593\u8d8a\u77ed\uff0c\u8868\u73fe\u75c7\u72c0\u4e5f\u8d8a\u56b4\u91cd\u3002 (D)\u5c0d\u65bc\u53d7\u6c61\u67d3\u7684\u91cd\u75c7\u60a3\u8005\uff0c\u61c9\u8b8a\u6642\u9700\u512a\u5148\u9664\u6c61\u3001\u624d\u9032\u884c\u6025\u6551\u63aa\u65bd\u3002 (E)\u8f3b\u5c04\u6c61\u67d3\u53ef\u5206\u6210\u66b4\u9732\u53ca\u9ad4\u5167\u3001\u5916\u6c61\u67d3\uff0c\u81e8\u5e8a\u4e0a\u82e5\u53ea\u6709\u66b4\u9732\uff0c\u4e0d\u9700\u4f5c\u4eba\u9ad4\u9664\u6c61\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u8f3b\u50b7\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u654d\u8ff0\u4f55\u8005\u4e0d\u6b63\u78ba\uff1f", + "Options": "(A)\u8f3b\u5c04\u5438\u6536\u5291\u91cf\u4e58\u4ee5\u54c1\u8cea\u56e0\u7d20(quality factor)\uff0c\u7a31\u4e4b\u70ba\u8f3b\u5c04\u7b49\u6548\u5291\u91cf(radiation equivalent)\uff0c\u570b\u969b\u6a19\u6e96 MKS \u5236\u4e4b\u4e0b\uff0c\u55ae\u4f4d\u70ba Sievert(Sv)\u3002 (B)\u8f3b\u5c04\u9632\u8b77\u7684\u4e09\u9805\u8981\u7d20\uff0c\u662f\u6642\u9593\u3001\u8ddd\u96e2\u53ca\u5c4f\u853d\u7269\u3002 (C)\u8f3b\u5c04\u7269\u5c0d\u65bc\u4eba\u9ad4\u7684\u5f71\u97ff\uff0c\u5927\u81f4\u4e0a\u53ef\u4ee5\u5206\u5916\u90e8\u7167\u5c04\u3001\u9ad4\u8868\u6c61\u67d3\u53ca\u5167\u90e8\u651d\u5165\u7b49\u4e09\u7a2e\u60c5\u6cc1\u3002 (D)\u521d\u6b65\u8a55\u4f30\u8f3b\u5c04\u50b7\u5bb3\u7684\u7a0b\u5ea6\uff0c\u53ef\u4ee5\u62bd\u8840\u6aa2\u9a57\u8840\u7403\u4e2d\u7684\u591a\u6838\u7403(PMN)\u4f86\u5224\u5b9a\u3002 (E)\u5982\u679c\u8f3b\u5c04\u50b7\u5bb3\u5408\u4f75\u91cd\u5927\u5275\u50b7\u6642\uff0c\u61c9\u8a72\u512a\u5148\u8655\u7406\u5275\u50b7\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u8179\u4e3b\u52d5\u8108\u7834\u88c2(Ruptured abdominal aortic aneurysm)\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u53ef\u80fd\u4f34\u96a8\u5641\u5fc3\u548c\u5614\u5410\u75c7\u72c0\u3002 (B)\u53ef\u80fd\u767c\u751f\u660f\u53a5(Syncope)\u5f8c\uff0c\u91cf\u6e2c\u8840\u58d3\u70ba\u6b63\u5e38\u3002 (C)\u5178\u578b\u75c7\u72c0\u70ba\u75bc\u75db\u3001\u4f4e\u8840\u58d3\u53ca\u640f\u52d5\u6027\u8179\u90e8\u816b\u584a(Pulsatile abdominal mass)\u3002 (D)\u75bc\u75db\u90e8\u4f4d\u53ef\u80fd\u70ba\u8179\u75db\u3001\u8170\u75db\u6216\u80cc\u75db\u3002 (E)\u8d85\u904e\u4e00\u500b\u6708\u7684\u8179\u75db\uff0c\u53ef\u6392\u9664\u8179\u4e3b\u52d5\u8108\u7834\u88c2\u53ef\u80fd\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u8907\u5408\u5f0f\u7dca\u6025\u72c0\u6cc1(Complex Emergencies, CE)\u7684\u7279\u8272\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u70ba\u6700\u8fd1 20 \u5e74\u5167\uff0c\u6700\u5e38\u898b\u7684\u4eba\u70ba\u707d\u96e3\u3002 (B)\u5340\u57df\u5167\u653f\u6cbb\u4e0d\u7a69\u5b9a\uff0c\u5c0e\u81f4\u66b4\u529b\u8207\u885d\u7a81\u7684\u767c\u751f\uff0c\u662f\u5f15\u767c CE \u7684\u4e3b\u8981\u539f\u56e0\u3002 (C)\u662f\u6307 2 \u7a2e\u4ee5\u4e0a\u5929\u7136\u707d\u96e3\u540c\u6642\u767c\u751f\u6240\u81f4\u3002 (D)\u5b97\u6559\u3001\u7a2e\u65cf\u53ca\u793e\u6703\u554f\u984c\u7684\u885d\u7a81\uff0c\u8b93\u707d\u96e3\u8655\u7406\u66f4\u70ba\u56f0\u96e3\u8207\u5371\u96aa\u3002 (E)\u5e73\u6c11\u3001\u5a66\u5e7c\u8207\u8001\u4eba\u70ba\u6700\u5bb9\u6613\u53d7\u50b7\u5bb3\u7684\u65cf\u7fa4\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u5927\u578b\u6d3b\u52d5(Mass Gathering)\u7684\u89c0\u5ff5\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u4e00\u822c\u800c\u8a00\uff0c\u5927\u578b\u6d3b\u52d5\u662f\u6307\u7fa4\u773e\u805a\u96c6\u4eba\u6578\u8d85\u904e 500 \u4eba\u7684\u6d3b\u52d5\u3002 (B)\u5728 1999 \u5e74\u7684\u82f1\u502b\u91ab\u5b78\u96dc\u8a8c\u5efa\u8b70\uff0c\u6bcf 1000 \u4eba\u9700\u6709\u4e00\u4f4d\u6025\u6551\u4eba\u54e1\uff0c\u6bcf2000 \u4eba\u9700\u6709\u4e00\u8f1b\u6709\u9ad8\u7d1a\u6551\u8b77\u6280\u8853\u54e1\u7684\u6551\u8b77\u8eca\uff0c\u6bcf 5000 \u4eba\u5247\u9700\u4e00\u4f4d\u6025\u8a3a\u91ab\u5e2b\u3002 (C)\u5982\u73fe\u5834\u7121\u6cd5\u5728 5 \u5206\u9418\u5167\u63d0\u4f9b\u9ad8\u7d1a\u5fc3\u81df\u6551\u547d\u8853\u7684\u91ab\u7642\u7167\u9867\uff0c\u73fe\u5834\u5c31\u5fc5\u9808\u6e96\u5099\u81ea\u52d5\u9ad4\u5916\u96fb\u64ca\u5668\u3002 (D)\u6bcf\u6b21\u91ab\u7642\u7167\u8b77\uff0c\u7121\u8ad6\u662f\u8f15\u5fae\u7684\u9084\u662f\u56b4\u91cd\u7684\u6848\u4f8b\uff0c\u6700\u597d\u90fd\u80fd\u78ba\u5be6\u586b\u5beb\u4e00\u4efd\u91ab\u7642\u6551\u8b77\u7d00\u9304\u55ae\u3002 (E)\u6839\u64da\u5be6\u8b49\u91ab\u5b78\uff0c\u5927\u578b\u7fa4\u773e\u805a\u96c6\u6d3b\u52d5\uff0c\u5fc3\u81df\u505c\u6b62\u7684\u6551\u6d3b\u7387\u7d04\u5728 20-80%\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u4f4e\u9ad4\u6eab(Hypothermia)\u7684\u63cf\u8ff0\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u4f4e\u9ad4\u6eab\u7684\u5fc3\u96fb\u5716\u4e2d\uff0c\u53ef\u80fd\u6703\u51fa\u73fe Osborn (J) wave\uff0c\u662f\u5728 QRS complex\u672b\u7aef\u51fa\u73fe\u8ca0\u5411\u6ce2(negative deflection)\u3002 (B)\u4f4e\u9ad4\u6eab\u53ef\u80fd\u6703\u5f15\u8d77\u986b\u6296(shivering)\uff0c\u53ef\u589e\u52a0\u57fa\u790e\u4ee3\u8b1d\u7387 2 \u5230 5 \u500d\uff0c\u5728\u810a\u9ad3\u8207\u4e0b\u8996\u4e18\u524d\u8449\u53d7\u5230\u8abf\u63a7\u3002 (C)\u6eab\u5ea6\u7684\u8abf\u63a7\u4e2d\u4ee5\u4e0b\u8996\u4e18\u5f8c\u8449(posterior hypothalamus)\u8ca0\u8cac\u975e\u986b\u6296\u6027\u7684\u6eab\u5ea6\u4fdd\u7559\u8207\u6d88\u6563\u3002 (D)\u7576\u9ad4\u6eab\u4f4e\u5230\u651d\u6c0f 25 \u5ea6\u4ee5\u4e0b\u53ef\u80fd\u51fa\u73fe VF\uff0c\u4e3b\u8981\u539f\u56e0\u662f\u7a7f\u8d8a\u7d30\u80de\u819c\u975c\u6b62\u96fb\u4f4d(transmembrane resting potential)\u589e\u52a0\uff0c\u9020\u6210 VF \u7684\u95be\u503c(threshold)\u964d\u4f4e\u3002 (E)\u7576\u9ad4\u6eab\u4f4e\u5230\u651d\u6c0f 33.5 \u5ea6\u4ee5\u4e0b\u6642\u6703\u660e\u986f\u964d\u4f4e\u8166\u6ce2\uff0c\u7576\u9ad4\u6eab\u9054\u5230\u651d\u6c0f 19\u5230 20 \u5ea6\u6642\u8166\u6ce2\u6703\u505c\u6b62\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6bd2\u86c7\u8207\u6606\u87f2\u54ac\u50b7\u7684\u63cf\u8ff0\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u5728\u53f0\u7063\u5982\u679c\u88ab\u6bd2\u86c7\u54ac\u50b7\uff0c\u4f46\u4e0d\u77e5\u662f\u4f55\u7a2e\u6bd2\u86c7\u6839\u64da\u6587\u737b\u7d71\u8a08\uff0c\u5efa\u8b70\u4ee5\u65bd\u6253\u591a\u7a2e\u8840\u6e05\u4ee5\u722d\u53d6\u7642\u6548\u3002 (B)\u88ab\u80e1\u8702\u53ee\u50b7\u9020\u6210\u7684\u6025\u6027\u904e\u654f\u53cd\u61c9\uff0c\u5728\u6210\u4eba\u53ef\u7528 1\uff1a10000 \u7684 epinephrine 0.3 \u5230 0.5 mL \u808c\u8089\u6ce8\u5c04\u3002 (C)\u88ab\u6bd2\u86c7\u54ac\u50b7\uff0c\u5982\u679c\u5230\u6025\u8a3a\u6642\u6c92\u6709\u75c7\u72c0\uff0c\u5373\u53ef\u5efa\u8b70\u96e2\u9662\u65bc\u9580\u8a3a\u8ffd\u8e64\uff0c\u4e0d\u5fc5\u65bd\u6253\u8840\u6e05\u3002 (D)\u6839\u64da\u6587\u737b\u7d71\u8a08\uff0c\u6bd2\u86c7\u54ac\u50b7\u75c5\u4f8b\u5728\u53f0\u7063\u4ee5\u88ab\u9396\u93c8\u86c7\u54ac\u50b7\u9020\u6210\u6025\u6027\u814e\u640d\u50b7\u7684\u6bd4\u4f8b\u6700\u9ad8\u3002 (E)\u6839\u64da\u6587\u737b\u7d71\u8a08\uff0c\u6bd2\u86c7\u54ac\u50b7\u75c5\u4f8b\u5728\u53f0\u7063\u4ee5\u88ab\u4f4f\u5bb6\u9644\u8fd1\u88ab\u9f9c\u6bbc\u82b1\u54ac\u50b7\u7684\u6bd4\u4f8b\u6700\u9ad8\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u7cd6\u5c3f\u75c5\u916e\u9178\u4e2d\u6bd2(diabetic ketoacidosis)\u7684\u63cf\u8ff0\uff0c\u4e0b\u5217\u654d\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u5176\u81e8\u5e8a\u75c7\u72c0\u4e3b\u8981\u662f\u5c0e\u56e0\u65bc\u8840\u7cd6\u904e\u9ad8\u3001\u9ad4\u6db2\u4e0d\u8db3\u53ca\u9178\u8840\u75c7\u3002 (B)\u6cbb\u7642\u9996\u8981\u662f\u88dc\u5145\u6c34\u5206\u3002 (C)\u6cbb\u7642\u904e\u7a0b\u4e2d\u6709\u53ef\u80fd\u7522\u751f\u81f4\u547d\u6027\u7684\u4f4e\u8840\u9240\u3002 (D)\u610f\u8b58\u6539\u8b8a\u4e3b\u8981\u662f\u8087\u56e0\u65bc\u4ee3\u8b1d\u6027\u9178\u8840\u75c7\u3002 (E)\u9451\u5225\u8a3a\u65b7\u5305\u542b\u9152\u7cbe\u6027\u916e\u9178\u4e2d\u6bd2(alcoholic ketoacidosis)\u3001\u4e73\u9178\u4e2d\u6bd2\u3001\u814e\u8870\u7aed\u53ca\u6c34\u694a\u9178\u4e2d\u6bd2\u7b49\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u5152\u7ae5\u6025\u6027\u95cc\u5c3e\u708e(Acute appendicitis)\u7684\u654d\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u975e\u7834\u88c2\u6027\u95cc\u5c3e\u708e\u75c5\u7ae5\u4e2d\u7537\u7ae5\u8f03\u591a\uff0c\u9ad8\u5cf0\u671f\u70ba 9 \u81f3 12 \u6b72\uff0c2 \u6b72\u4ee5\u4e0b\u8f03\u5c11\u767c\u751f\u3002 (B)\u5728\u8179\u90e8 X \u5149\u4e0a\u51fa\u73fe\u7cde\u77f3(fecalith)\u7684\u5f71\u50cf\uff0c\u5176\u6bd4\u4f8b\u7d04\u70ba 30%\u3002 (C)\u6025\u6027\u95cc\u5c3e\u708e\u53ef\u80fd\u6703\u51fa\u73fe\u5c40\u90e8\u8179\u819c\u708e\u5fb5\u72c0(local peritonitis sign)\uff0c\u4f46\u5982\u95cc\u5c3e\u4f4d\u65bc\u9aa8\u76c6\u8154\u5167\uff0c\u5247\u4e0d\u6703\u51fa\u73fe\u6b64\u5fb5\u72c0\u3002 (D)\u75c5\u4eba\u6703\u51fa\u73fe\u53ad\u98df\u3001\u5614\u5410\u3001\u53f3\u4e0b\u8179\u75bc\u75db\uff0c\u975e\u7834\u88c2\u6027\u95cc\u5c3e\u708e\u75c5\u7ae5\u53ef\u80fd\u6709\u767c\u71d2\uff0c\u4f46\u8f03\u7834\u88c2\u6027\u95cc\u5c3e\u708e\u75c5\u7ae5\u767c\u71d2\u7684\u6eab\u5ea6\u4f4e\u3002 (E)\u975e\u7834\u88c2\u6027\u95cc\u5c3e\u708e\u65bc\u75c7\u72c0\u51fa\u73fe\u4e4b 8 \u81f3 24 \u5c0f\u6642\u5167\u5373\u53ef\u4ee5\u9032\u5c55\u5230\u7834\u88c2\u6027\u95cc\u5c3e\uff0c\u6545\u9808\u5118\u65e9\u7167\u6703\u5916\u79d1\u91ab\u5e2b\u8655\u7f6e\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u9ad8\u6d77\u62d4\u80ba\u6c34\u816b( High-altitude pulmonary edema)\u7684\u6cbb\u7642\uff0c\u5728\u5be6\u8b49\u91ab\u5b78\u4e2d\u7684\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)Labetalol 25mg \u53e3\u670d\u6bcf\u5929\u5169\u6b21\u3002 (B)Sildenafil 50 mg \u53e3\u670d\u6bcf\u5929\u4e09\u6b21\u3002 (C)Tadalafil 10 mg \u53e3\u670d\u6bcf\u5929\u5169\u6b21\u3002 (D)\u7d66\u4e88 4L/\u5206\u9418 \u6c27\u6c23\u3002 (E)\u7acb\u5373\u4e0b\u964d\u9ad8\u5ea6\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6a6b\u7d0b\u808c\u6eb6\u89e3\u75c7(Rhabdomyolysis)\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u6210\u4eba\u767c\u751f\u6a6b\u7d0b\u808c\u6eb6\u89e3\u75c7\u7684\u539f\u56e0\u6709\u85e5\u7269\u6feb\u7528\u3001\u5916\u50b7\u3001\u904b\u52d5\u904e\u5ea6\u53ca\u611f\u67d3\u7b49\u3002 (B)\u9664\u4e86\u7a4d\u6975\u7d66\u4e88\u8f38\u6db2\u6cbb\u7642\u5916\uff0cloop diuretic \u985e\u5229\u5c3f\u5291(\u5982 furosemide)\u7684\u7d66\u4e88\u4e5f\u662f\u6a19\u6e96\u6cbb\u7642\u3002 (C)\u6d41\u611f\u75c5\u6bd2\u53ca Legionella \u662f\u56e0\u611f\u67d3\u800c\u5c0e\u81f4\u6a6b\u7d0b\u808c\u6eb6\u89e3\u75c7\u6700\u5e38\u898b\u7684\u611f\u67d3\u6e90\u3002 (D)\u6a6b\u7d0b\u808c\u6eb6\u89e3\u75c7\u53ef\u80fd\u7684\u4f75\u767c\u75c7\u6709\u6025\u6027\u814e\u8870\u7aed\u3001\u4ee3\u8b1d\u6027\u5931\u8abf\u3001\u8154\u5ba4\u75c7\u5019\u7fa4\u53ca\u795e\u7d93\u75c5\u8b8a\u7b49\u3002 (E)\u56b4\u91cd\u6a6b\u7d0b\u808c\u6eb6\u89e3\u75c7\u7684\u60a3\u8005\u53ef\u80fd\u6703\u51fa\u73fe\u5641\u5fc3\u3001\u5614\u5410\u3001\u8179\u75db\u53ca\u5fc3\u5f8b\u4e0d\u6574\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6025\u6027\u80ba\u6c34\u816b\u7684\u7dca\u6025\u8655\u7f6e\uff0c\u4e0b\u5217\u654d\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u61c9\u8a2d\u6cd5\u8b93\u75c5\u4eba\u5e73\u8eba\u4e26\u5c07\u8173\u62ac\u9ad8\u3002 (B)\u7b2c\u4e00\u7dda\u85e5\u7269\u6cbb\u7642\u5305\u62ec furosemide \u5229\u5c3f\u5291\u3002 (C)\u82e5\u8840\u58d3\u8a31\u53ef\uff0c\u975c\u8108\u8f38\u6ce8 nitroglycerine \u53ef\u6e1b\u5c11\u975c\u8108\u8840\u6db2\u56de\u6d41\u53ca\u964d\u4f4e\u80ba\u52d5\u8108\u58d3\uff0c\u5c0d\u7de9\u89e3\u80ba\u6c34\u816b\u6709\u76f8\u7576\u5e6b\u52a9\u3002 (D)\u82e5\u70ba\u6025\u6027\u4e8c\u5c16\u74e3\u6216\u4e3b\u52d5\u8108\u74e3\u9589\u9396\u4e0d\u5168\u6240\u81f4\uff0c\u9664\u85e5\u7269\u6cbb\u7642\u5916\u5e38\u9700\u5916\u79d1\u624b\u8853\u77ef\u6b63\u624d\u80fd\u5b8c\u5168\u89e3\u6c7a\u3002 (E)\u82e5\u7528\u85e5\u7269\u6cbb\u7642\u7121\u6548\uff0c\u5247\u9700\u8003\u616e\u4ecb\u5165\u6027\u6cbb\u7642(interventional therapy)\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6025\u6027\u80ba\u6813\u585e(pulmonary embolism)\u7684\u8655\u7406\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)warfarin \u53ef\u7528\u65bc\u6cbb\u7642\u4efb\u4f55\u539f\u56e0\u5f15\u8d77\u7684\u6025\u6027\u80ba\u6813\u585e\u3002 (B)\u53ef\u4f9d\u7167\u5de6\u5fc3\u5ba4\u529f\u80fd\u8207\u8840\u884c\u52d5\u529b\u7684\u8b8a\u5316\u8a55\u4f30\u75c5\u4eba\u5371\u96aa\u7a0b\u5ea6\u3002 (C)\u6297\u8840\u6813\u85e5\u7269\u6cbb\u7642(antithrombotic therapy)\uff0c\u53ef\u8003\u616e heparin \u6216 Low Molecular Weight Heparin\u3002 (D)\u61c9\u8a72\u4e00\u5f8b\u7d66\u4e88 fibrinolysis therapy\u3002 (E)\u5c0d\u65bc\u5927\u7247\u80ba\u6813\u585e\u5408\u4f75\u4f4e\u8840\u58d3\u7684\u5e74\u8f15\u60a3\u8005\uff0c\u4e0d\u5efa\u8b70\u63a5\u53d7 surgical embolectomy\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6025\u6027\u5fc3\u808c\u708e\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u654d\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u9664\u4e86\u75c5\u6cc1\u56b4\u91cd\u51fa\u73fe\u5fc3\u81df\u8870\u7aed\u5fb5\u5019\u7684\u75c5\u4f8b\u5916\uff0c\u81e8\u5e8a\u8868\u73fe\u5e38\u4ee5\u767c\u71d2\u3001\u808c\u8089\u9178\u75db\u3001\u982d\u75db\u7b49\u7121\u7279\u7570\u6027\u75c7\u72c0\u8868\u73fe\u3002 (B)\u5fc3\u96fb\u5716\u6700\u5e38\u898b\u7684\u7570\u5e38\u70ba\u8d85\u5c80\u5176\u767c\u71d2\u7a0b\u5ea6\u4e4b\u7ac7\u6027\u5fc3\u640f\u904e\u901f(sinus tachycardia out of proportion to the extent of fever)\u3002 (C)\u5408\u4f75\u5fc3\u5305\u819c\u767c\u708e\u6642\u8f03\u6613\u51fa\u73fe\u80f8\u75db\u75c7\u72c0\uff0c\u5fc3\u96fb\u5716\u4ea6\u53ef\u5448\u73fe\u5c40\u90e8\u6216\u5ee3\u6cdb\u6027\u7684 ST \u6ce2\u6bb5\u4e0a\u5347\u3002 (D)\u75c5\u7406\u53ef\u898b\u5c40\u90e8 lymphocyte\u3001plasma cell \u53ca histiocyte \u6d78\u6f64\uff0c\u5408\u4f75\u4e0d\u7b49\u7a0b\u5ea6\u4e4b\u5fc3\u808c\u7834\u58de\u6216\u6eb6\u89e3\uff0c\u5fc3\u81df\u9175\u7d20\u5e7e\u4e4e\u5747\u6703\u7570\u5e38\u5730\u5347\u9ad8\u3002 (E)\u6cbb\u7642\u4ee5\u652f\u6301\u7642\u6cd5\u70ba\u4e3b\uff0c\u56b4\u91cd\u75c5\u4f8b\u53ef\u80fd\u8003\u616e\u4f7f\u7528 immuno-suppressive therapy\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u5fc3\u81df\u5fa9\u7526\u5f8c\u4e4b\u4f4e\u6eab\u7642\u6cd5\uff0c\u6839\u64da\u5be6\u8b49\u91ab\u5b78\u4e4b\u7814\u7a76\u7d50\u679c\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u5728\u9001\u53bb\u4f5c\u5fc3\u5c0e\u7ba1\u4e4b\u524d\uff0c\u4e0d\u53ef\u4ee5\u9032\u884c\u964d\u6eab\uff0c\u4ee5\u514d\u7522\u751f\u5fc3\u7387\u4e0d\u6574\u7684\u98a8\u96aa\u3002 (B)\u53ef\u4ee5\u7531\u80a1\u975c\u8108\u4e2d\u592e\u975c\u8108\u5c0e\u7ba1\u7d66\u4e88 4\u2103\u7684\u751f\u7406\u98df\u9e7d\u6c34\u4f7f\u75c5\u4eba\u8fc5\u901f\u964d\u6eab\u3002 (C)\u55ae\u7368\u7d66\u4e88 4\u2103\u7684\u751f\u7406\u98df\u9e7d\u6c34\u7121\u6cd5\u7dad\u6301\u5fc3\u81df\u5fa9\u7526\u5f8c\u4e4b\u8f15\u5ea6\u4f4e\u9ad4\u6eab\u7642\u6cd5\u3002 (D)\u4f4e\u9ad4\u6eab\u6703\u6709\u5229\u5c3f\u4f5c\u7528\uff0c\u6545\u5fc5\u9808\u76e3\u6e2c\u4e2d\u592e\u975c\u8108\u58d3\u529b\uff0c\u4e26\u9069\u7576\u88dc\u5145\u8f38\u6db2\u3002 (E)\u57f7\u884c\u8f15\u5ea6\u4f4e\u9ad4\u6eab\u7642\u6cd5\u6642\u6700\u5e38\u898b\u7684\u5fc3\u5f8b\u4e0d\u6574\u662f\u5fc3\u640f\u904e\u7de9(Bradycardia)\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u7729\u6688\u75c7(vertigo)\u7684\u9451\u5225\u8a3a\u65b7\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u5167\u8033\u8ff7\u8def\u708e(labyrinthitis)\u901a\u5e38\u6703\u5408\u4f75\u55ae\u5074\u984f\u9762\u795e\u7d93\u9ebb\u75fa\u3002 (B)\u826f\u6027\u9663\u767c\u59ff\u52e2\u6027\u7729\u6688\u75c7(benign paroxysmal positional vertigo)\u7684\u75c7\u72c0\u4e0d\u6703\u96a8\u8457\u53cd\u8986\u7684\u8a98\u767c\u800c\u6e1b\u7de9\u3002 (C)\u82e5\u540c\u6642\u5408\u4f75\u6b65\u614b\u5931\u8abf\u3001\u807d\u529b\u5c1a\u5931\u53ca\u55ae\u5074\u8996\u529b\u4e0d\u826f\u5247\u8981\u8003\u616e\u5c0f\u8166\u6a4b\u8166\u89d2(cerebellopontine angle)\u816b\u7624\u3002 (D)\u524d\u5ead\u795e\u7d93\u708e(vestibular neuritis)\u901a\u5e38\u6301\u7e8c\u6578\u5929\u3002 (E)\u6885\u5c3c\u723e\u6c0f\u75c7(M\u00e9ni\u00e8re disease)\u7b2c\u4e00\u6b21\u767c\u4f5c\u7684\u5e74\u9f61\uff0c\u901a\u5e38\u5728 60 \u6b72\u4ee5\u4e0b\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u4e2d\u592e\u975c\u8108\u5c0e\u7ba1\u4e4b\u5be6\u8b49\u91ab\u5b78\u7814\u7a76\u7d50\u679c\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u5857\u85e5\u7684\u4e2d\u592e\u975c\u8108\u5c0e\u7ba1\uff0c\u96d6\u7136\u6bd4\u8f03\u8cb4\uff0c\u4f46\u53ef\u4ee5\u9810\u9632\u8840\u6d41\u611f\u67d3\u3002 (B)\u80a1\u975c\u8108\u4e2d\u592e\u975c\u8108\u5c0e\u7ba1\u6700\u6613\u767c\u751f\u8840\u6d41\u611f\u67d3\uff0c\u9396\u9aa8\u4e0b\u975c\u8108\u6700\u5c11\u3002 (C)\u57f7\u884c Central Line Bundle \u4e4b\u7121\u83cc\u63aa\u65bd\uff0c\u53ef\u4ee5\u9810\u9632\u8840\u6d41\u611f\u67d3\u3002 (D)\u6253\u4e2d\u592e\u975c\u8108\u5c0e\u7ba1\u6642\u4f7f\u7528\u512a\u7898\u6d88\u6bd2\u6bd4 Chlorhexidine \u611f\u67d3\u5c11\u3002 (E)\u4e2d\u592e\u975c\u8108\u5c0e\u7ba1\u5f15\u767c\u4e4b\u8840\u6d41\u611f\u67d3\u5927\u591a\u662f\u845b\u862d\u6c0f\u967d\u6027 G(+)\u7d30\u83cc\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u624b\u8853\u5f8c\u767c\u71d2\u7684\u539f\u56e0\uff0c\u53ef\u8003\u616e\u201dFive Ws\u201d\uff0c\u8acb\u554f\u4e0b\u5217\u5c0d\u65bc\u201dFive Ws\u201d\u7684\u654d\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)Wind\uff1a\u80ba\u64f4\u5f35 Atelectasis \u6216\u80ba\u708e Pneumonia\u3002 (B)Water\uff1a\u812b\u6c34 Dehydration\u3002 (C)Wound\uff1a\u50b7\u53e3\u611f\u67d3\u3002 (D)Walking\uff1a\u6df1\u90e8\u975c\u8108\u8840\u6813 Deep Vein Thrombosis\u3002 (E)Wrong Drug\uff1a\u85e5\u7269\u71b1 Drug fever \u6216\u507d\u819c\u6027\u8178\u708e Pseudomembrane colitis\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u71b1\u62bd\u6410(Febrile seizure)\u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u654d\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u71b1\u62bd\u6410\u70ba\u5e74\u5e7c\u5152\u7ae5\u6700\u5e38\u898b\u7684\u62bd\u6410\u6027\u75be\u60a3\uff0c\u7d04\u4f54\u5152\u7ae5\u7684 2~5%\u3002 (B)\u4e0d\u9650\u5b9a\u4efb\u4f55\u62bd\u6410\u5f62\u5f0f\u3002 (C)\u75be\u75c5\u5bb6\u65cf\u53f2\uff1a\u5bb6\u65cf\u6210\u54e1\u7d04 10~15%\u6709\u71b1\u62bd\u6410\u3002 (D)\u591a\u8207\u75c5\u6bd2\u611f\u67d3\u6709\u95dc\uff0c\u5c24\u5176\u662f human herpesvirus \u5e38\u88ab\u8a8d\u70ba\u6709\u76f8\u95dc\u6027\u3002 (E)\u9808\u6392\u9664\u4e2d\u6a1e\u795e\u7d93\u611f\u67d3\u4e4b\u6025\u75c7\uff0c\u8b6c\u5982\u7d30\u83cc\u6027\u8166\u819c\u708e\u6216\u6025\u6027\u75c5\u6bd2\u6027\u8166\u708e\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u91ab\u9662\u7684\u707d\u5bb3\u7dca\u6025\u61c9\u8b8a\uff0c\u6839\u64da\u7dca\u6025\u61c9\u8b8a\u7ba1\u7406\u7684\u539f\u7406\uff0c\u53ca\u885b\u751f\u7f72\u7684\u6cd5\u898f\u898f\u5b9a\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u91ab\u9662\u7dca\u6025\u61c9\u8b8a\u6642\uff0c\u5fc5\u9808\u8a2d\u7f6e\u6307\u63ee\u7d44\u3001\u8b66\u6212\u7d44\u3001\u758f\u6563\u7d44\u3001\u6551\u8b77\u7d44\u3001\u901a\u5831\u7d44\u53ca\u6ec5\u706b\u7d44\u7b49\u516d\u7d44\u4f86\u9032\u884c\u6551\u707d\uff0c\u6b64\u7a31\u4e4b\u70ba\u91ab\u9662\u7dca\u6025\u61c9\u8b8a\u6307\u63ee\u9ad4\u7cfb(Hospital Incident Command System\uff0cHICS)\u3002 (B)\u91ab\u9662\u65bc\u7dca\u6025\u707d\u5bb3\u4e8b\u4ef6\u4e2d\uff0c\u9664\u4e86\u7167\u9867\u56e0\u70ba\u707d\u96e3\u800c\u7522\u751f\u7684\u50b7\u75c5\u4eba\u4e4b\u5916\uff0c\u61c9\u7e7c\u7e8c\u63d0\u4f9b\u5fc5\u8981\u4e4b\u91ab\u7642\u7167\u9867\u8207\u9069\u7576\u4e4b\u8f49\u8a3a\u5f8c\u9001\u8655\u7406\uff0c\u7a31\u4e4b\u70ba\u6301\u7e8c\u904b\u4f5c(continuity of operation)\u3002 (C)\u684c\u4e0a\u6a21\u64ec\u6f14\u7df4\uff0c\u4e0d\u53ef\u4ee5\u8996\u70ba\u6b63\u898f\u7684\u6f14\u7fd2\uff0c\u53ea\u80fd\u7b97\u70ba\u6f14\u7fd2\u4e4b\u524d\u7684\u9810\u6f14\u3002 (D)\u91ab\u9662\u7dca\u6025\u707d\u5bb3\u61c9\u8b8a\u63aa\u65bd\u8a08\u756b\uff0c\u6839\u64da\u7dca\u6025\u61c9\u8b8a\u7ba1\u7406\u7684\u539f\u5247\uff0c\u5167\u5bb9\u61c9\u5305\u62ec\u56e0\u61c9\u707d\u5bb3\u4e4b\u9810\u9632(prevention)\u3001\u6e1b\u707d(mitigation)\u3001\u61c9\u8b8a(response)\u8207\u5fa9\u539f(recovery)\u5404\u968e\u6bb5\u4e4b\u61c9\u8b8a\u9ad4\u7cfb\u3001\u61c9\u8b8a\u7d44\u7e54\u8207\u5de5\u4f5c\u8077\u8cac\u3002 (E)\u91ab\u9662\u7684\u7dca\u6025\u4e8b\u4ef6\uff0c\u9664\u4e86\u706b\u707d\u4e4b\u5916\uff0c\u5176\u4ed6\u901a\u7a31\u70ba\u5927\u91cf\u50b7\u60a3\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u4e59\u72c0\u7d50\u8178\u626d\u7d50(Sigmoid volvulus)\u7684\u6558\u8ff0\uff0c\u8acb\u9078\u51fa\u6bd4\u8f03\u6b63\u78ba\u8005\uff1f", + "Options": "(A)\u70ba\u5c0f\u5152\u8178\u963b\u585e\u6700\u5e38\u898b\u7684\u539f\u56e0\u4e4b\u4e00\u3002 (B)\u5176\u5728\u6210\u4eba\u5927\u8178\u90e8\u4f4d\u5f15\u767c\u8178\u963b\u585e\u7684\u767c\u751f\u6a5f\u7387\uff0c\u9ad8\u904e\u60e1\u6027\u816b\u7624\u8207\u61a9\u5ba4\u708e\u3002 (C)\u8179\u90e8 X \u5149(Plain Abdomen)\u4e0a\u53ef\u898b\u5178\u578b\u7684\u300cCoffee Bean Sign\u300d\u3002 (D)\u591a\u70ba\u6025\u6027\u767c\u4f5c\uff0c\u5c11\u898b\u6162\u6027\u4fbf\u79d8\u75c5\u53f2\u3002 (E)\u7cbe\u795e\u75c5\u4eba\u56e0\u8178\u8815\u52d5\u4e00\u822c\u76f8\u5c0d\u4e0a\u8f03\u5feb\uff0c\u56e0\u6b64\u5373\u4f7f\u670d\u7528\u6297\u81bd\u9e7c\u88fd\u5291(Anticholenergic agents)\uff0c\u4e5f\u6bd4\u8f03\u4e0d\u5bb9\u6613\u767c\u751f\u6b64\u75c7\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6688\u53a5(syncope)\u7684\u81e8\u5e8a\u75c7\u5019\u3001\u9451\u5225\u8a3a\u65b7\u8207\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u5fc3\u56e0\u6027\u7684\u6688\u53a5\u5f8c\u7e8c\u8ffd\u8e64\u516d\u500b\u6708\u7684\u6b7b\u4ea1\u7387\u751a\u4f4e(\u5c0f\u65bc\u767e\u5206\u4e4b\u4e00)\uff0c\u56e0\u6b64\u4e0d\u9700\u8981\u5b89\u6392\u9032\u4e00\u6b65\u7684\u6aa2\u67e5\u3002 (B)\u8001\u5e74\u4eba\u767c\u751f\u6688\u53a5\uff0c\u4e0d\u9808\u6392\u9664 aortic stenosis \u7684\u53ef\u80fd\u6027\u3002 (C)\u56e0\u70ba\u5fc3\u5f8b\u4e0d\u6574\u6240\u5c0e\u81f4\u7684\u6688\u53a5\u901a\u5e38\u6703\u6709\u524d\u5146\u75c7\u72c0(prodromal symptoms)\u3002 (D)\u8ff7\u8d70\u795e\u7d93\u6027\u6688\u53a5(vasovagal syncope)\u901a\u5e38\u6703\u6709\u524d\u5146\u75c7\u72c0(prodromal symptoms)\u3002 (E)\u7d93\u5e38\u6027\u767c\u751f\u6688\u53a5\u7684\u5e74\u8001\u75c5\u4eba\uff0c\u4e0d\u9808\u6392\u9664 carotid sinus hypersensitivity\u7684\u53ef\u80fd\u6027\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u65bc\u8166\u819c\u708e\u83cc\u8840\u75c7(meningococcemia)\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u7d55\u5927\u90e8\u5206\u7684\u5b30\u5152\u75c5\u4f8b\u662f C \u578b\u8840\u6e05\u578b\u6240\u5f15\u8d77\u7684\u3002 (B)\u5176\u5408\u4f75\u6557\u8840\u75c7\u4f46\u672a\u6709\u8166\u819c\u708e\u8005\u4e4b\u6b7b\u4ea1\u7387\u4ea6\u53ef\u9ad8\u9054 70%\u3002 (C)\u731b\u7206\u6027\u7d2b\u6591(purpura fulminas)\u591a\u767c\u751f\u65bc\u6210\u4eba\u4e14\u591a\u5408\u4f75\u7030\u6f2b\u6027\u8840\u7ba1\u5167\u51dd\u96c6(DIC)\u3002 (D)\u6700\u5e38\u898b\u7684\u4f75\u767c\u75c7\u70ba\u80ba\u708e\u8207\u547c\u5438\u7a98\u8feb\u75c7\u5019\u7fa4\u3002 (E)\u78ba\u8a8d\u611f\u67d3\u4e4b\u75c5\u4eba\u81f3\u5c11\u9700\u547c\u5438\u9053\u9694\u96e2 12 \u5c0f\u6642\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u65bc\u91d1\u9ec3\u8272\u8461\u8404\u7403\u83cc(Staphylococcus aureus)\u8207 A \u578b\u93c8\u7403\u83cc(Streptococcus pyogenes)\u5f15\u8d77\u7684\u6bd2\u6027\u4f11\u514b\u75c7\u5019\u7fa4(toxic shock syndrome)\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)A \u578b\u93c8\u7403\u83cc\u7684\u6bd2\u6027\u4f11\u514b\u75c7\u5019\u7fa4\u7d55\u5927\u90e8\u5206\u767c\u751f\u65bc\u5973\u6027\u3002 (B)\u91d1\u9ec3\u8272\u8461\u8404\u7403\u83cc\u7684\u6bd2\u6027\u4f11\u514b\u75c7\u5019\u7fa4\u83cc\u8840\u75c7\u7d04 60%\u3002 (C)\u91d1\u9ec3\u8272\u8461\u8404\u7403\u83cc\u7684\u6bd2\u6027\u4f11\u514b\u75c7\u5019\u7fa4\u7d44\u7e54\u58de\u6b7b\u5f88\u5e38\u898b\u3002 (D)A \u578b\u93c8\u7403\u83cc\u7684\u6bd2\u6027\u4f11\u514b\u75c7\u5019\u7fa4\u6b7b\u4ea1\u7387\u7d04 3%\u3002 (E)\u91d1\u9ec3\u8272\u8461\u8404\u7403\u83cc\u7684\u6bd2\u6027\u4f11\u514b\u75c7\u5019\u7fa4\u8f03\u5e38\u51fa\u73fe\u76ae\u75b9(Erythroderma rash) \u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6025\u6027\u5fc3\u808c\u6897\u585e\u5408\u4f75\u5fc3\u56e0\u6027\u4f11\u514b\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u4e0d\u9069\u7576\uff1f", + "Options": "(A)Aspirin \u53ca plavix \u4ecd\u53ef\u7d66\u4e88\uff0c\u4f46 nitroglycerine \u53ca morphine \u5247\u4e0d\u5408\u9069\u3002 (B)\u82e5\u8d85\u904e\u9ec3\u91d1\u6cbb\u7642\u6642\u9593 (12 \u5c0f\u6642)\uff0c\u5247\u61c9\u5165\u4f4f\u52a0\u8b77\u75c5\u623f\u4ee5\u85e5\u7269\u6cbb\u7642\uff0c\u800c\u4e0d\u61c9\u9032\u884c\u5fc3\u5c0e\u7ba1\u4ecb\u5165\u6cbb\u7642\u3002 (C)\u82e5\u7121\u5fc3\u5c0e\u7ba1\u4ecb\u5165\u8655\u7f6e\u7684\u8a2d\u65bd\u6216\u4eba\u529b\uff0c\u53ef\u8003\u616e\u7d66\u4e88\u8840\u6813\u6eb6\u89e3\u6cbb\u7642\u3002 (fibrinnolytic therapy) \uff0c\u4e4b\u5f8c\u5118\u5feb (< 30 \u5206\u9418) \u8f49\u81f3\u6709\u5fc3\u5c0e\u7ba1\u5ba4\u7684\u91ab\u9662\u9032\u4e00\u6b65\u8655\u7f6e\u3002 (D)\u4e3b\u52d5\u8108\u5167\u6c23\u7403\u5e6b\u6d66 (intra-aortic balloon counterpulsation) \u53ef\u6539\u5584\u5fc3\u808c\u53ca\u91cd\u8981\u5668\u5b98\u4e4b\u704c\u6ce8\uff0c\u6bd4\u4f7f\u7528\u5927\u91cf\u8840\u7ba1\u52a0\u58d3\u7d20 (vasopressors) \u70ba\u4f73\u3002 (E)\u82e5\u70ba\u5de6\u5fc3\u5ba4\u4e0b\u58c1\u6897\u585e\u52a0\u4e0a\u53f3\u5fc3\u5ba4\u6897\u585e\u800c\u4f75\u767c\u4f11\u514b\uff0c\u61c9\u7d66\u4e88\u9069\u7576\u8f38\u6db2\u6cbb\u7642\u4ee5\u6539\u5584\u524d\u8ca0\u8377 (preload) \u4e0d\u8db3\u7684\u60c5\u5f62\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u70ba\u4fc3\u9032\u75c5\u4eba\u5b89\u5168\u800c\u9032\u884c\u4e4b\u63aa\u65bd\uff0c\u4e0b\u5217\u654d\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u5371\u6025\u72c0\u6cc1\u4e4b\u96fb\u8a71\u91ab\u56d1\uff0c\u7d93\u8986\u8aa6\u5f8c\u5373\u53ef\u7acb\u523b\u57f7\u884c\u3002 (B)\u4f7f\u7528\u5169\u7a2e\u4ee5\u4e0a\u4e4b\u4e0d\u540c\u65b9\u6cd5\u9032\u884c\u75c5\u4eba\u7684\u8fa8\u8b58\u3002 (C)\u4f7f\u7528\u6a19\u6e96\u5316\u4e4b\u7e2e\u5beb\u3002 (D)\u4fb5\u5165\u6027\u6aa2\u67e5\u6216\u6cbb\u7642\u524d\uff0c\u518d\u5ea6\u9032\u884c\u75c5\u4eba\u7684\u8fa8\u8b58\u3002 (E)\u61c9\u9032\u884c\u624b\u8853\u90e8\u4f4d\u6a19\u8a18\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u70ba\u7dad\u8b77\u91ab\u8b77\u4eba\u54e1\u8207\u75c5\u4eba\u5b89\u5168\uff0c\u9810\u9632\u91ab\u9662\u6025\u8a3a\u5ba4\u4e4b\u66b4\u529b\u4e8b\u4ef6\uff0c\u885b\u751f\u7f72\u767c\u51fd\u6307\u793a\u91ab\u9662\u6025\u8a3a\u5ba4\u9032\u884c\u76f8\u95dc\u63aa\u65bd\uff0c\u4e0d\u5305\u542b\u4e0b\u5217\u4f55\u8005\uff1f", + "Options": "(A)\u5efa\u7acb\u6025\u8a3a\u5ba4\u4e4b\u9580\u7981\u7ba1\u5236 \u3002 (B)\u914d\u7f6e 24 \u5c0f\u6642\u8b66\u5bdf\u4eba\u54e1\u3002 (C)\u88dd\u8a2d\u8b66\u6c11\u9023\u7dda\u96fb\u8a71\u3002 (D)\u5f35\u8cbc\u53cd\u66b4\u529b\u6d77\u5831\u3002 (E)\u8a3a\u7642\u5340\u8207\u5019\u8a3a\u5340\u660e\u986f\u5340\u9694\u5404\u6709\u7368\u7acb\u7a7a\u9593\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u6eab\u6cc9\u98ef\u5e97\u767c\u751f 3 \u540d\u5de5\u4eba\u6aa2\u4fee\u786b\u78fa\u6cc9\u6eab\u6cc9\u84c4\u6c34\u5854\u6642\u4e0d\u614e\u4e2d\u6bd2\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u70ba\u932f\u8aa4\uff1f", + "Options": "(A)\u73fe\u5834\u6436\u6551\u50b7\u60a3\u6642\uff0c\u65bd\u6551\u8005\u61c9\u651c\u5e36\u81ea\u651c\u5f0f\u547c\u5438\u8a2d\u5099\u3002 (B)\u5c0d\u9ecf\u819c\u6709\u5f37\u70c8\u523a\u6fc0\u4f5c\u7528\u3002 (C)\u5fc5\u8981\u6642\u5148\u6234\u6297\u5316\u5b78\u7269\u8cea\u624b\u5957\u6216\u5176\u4ed6\u9632\u8b77\u8863\u5177\uff0c\u5fc3\u80ba\u5fa9\u7526\u8853(CPR)\u6642\uff0c\u5efa\u8b70\u5fc3\u81df\u6309\u58d3\uff0c\u4e0d\u4f5c\u53e3\u5c0d\u53e3\u4eba\u5de5\u547c\u5438\u3002 (D)\u4f7f\u7528 Cyanide antidote kit \u70ba\u89e3\u6bd2\u5291\u3002 (E)\u4e3b\u8981\u4e2d\u6bd2\u6a5f\u8f49\u70ba\u9ebb\u75fa\u547c\u5438\u4e2d\u6a1e\u53ca\u6291\u5236\u7d30\u80de\u93c8\u4e2d\u8272\u7d20\u6c27\u5316\u9175\u7d20\uff0c\u4f7f\u7d30\u80de\u547c\u5438\u53d7\u5230\u6291\u5236\u800c\u5f15\u8d77\u7d44\u7e54\u7f3a\u6c27\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u9810\u6e2c\u50b7\u53e3\u662f\u5426\u6703\u611f\u67d3\u7684\u56e0\u7d20\uff0c\u4e0d\u5305\u62ec\u4e0b\u5217\u4f55\u9805\uff1f", + "Options": "(A)\u6297\u751f\u7d20\u4f7f\u7528\u8207\u5426\u3002 (B)\u75c5\u4eba\u7684\u5e74\u7d00\u3002 (C)\u50b7\u53e3\u6df1\u5ea6\u3002 (D)\u50b7\u53e3\u662f\u5426\u6709\u6c61\u67d3\u3002 (E)\u50b7\u53e3\u4f4d\u7f6e\u3002 \u8a3b\u8a3b\u8a3b\u8a3b\uff1a\uff1a\uff1a\uff1a\u6b64\u7248\u672c\u70ba\u8003\u8a66\u73fe\u5834\u4fee\u6b63\u5f8c\u7248\u672c\u6b64\u7248\u672c\u70ba\u8003\u8a66\u73fe\u5834\u4fee\u6b63\u5f8c\u7248\u672c\u6b64\u7248\u672c\u70ba\u8003\u8a66\u73fe\u5834\u4fee\u6b63\u5f8c\u7248\u672c\u6b64\u7248\u672c\u70ba\u8003\u8a66\u73fe\u5834\u4fee\u6b63\u5f8c\u7248\u672c\u3002\u3002\u3002\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "10 \u6b72\u5152\u7ae5\u906d\u4e0d\u660e\u86c7\u985e\u54ac\u50b7\u5c0f\u817f \uff0c\u5169\u500b\u54ac\u75d5\u6e05\u6670\u53ef\u898b \uff0c\u50b7\u53e3\u6709\u8840\u75b1\u53ca\u7d05\u816b\u60c5\u5f62\u3002\u9001\u5230\u6025\u8a3a\u5ba4\u6642\u6709\u8840\u5c3f \u3002\u5be6\u9a57\u5ba4\u6aa2\u67e5\u8840\u5c0f\u677f\u6e1b\u5c11 \uff0cPT \u53caaPTT \u7570\u5e38\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u96e8\u5098\u7bc0\u5c6c\u65bc\u51fa\u8840\u6027\u6bd2\u86c7 \u3002 (B)\u4f9d\u64da\u81e8\u5e8a\u75c7\u72c0 \uff0c\u5fc5\u9808\u8003\u616e\u88ab\u9f9c\u6bbc\u82b1\u6bd2\u86c7\u6216\u9396\u93c8\u86c7\u54ac\u50b7 \u3002 (C)\u61c9\u5118\u65e9\u4f7f\u7528\u6297\u751f\u7d20\u6cbb\u7642 \uff0c\u4ee5\u9810\u9632\u50b7\u53e3\u611f\u67d3 \u3002 (D)\u6839\u64da\u6587\u737b\u7d71\u8a08 \uff0c\u6bd2\u86c7\u54ac\u50b7\u75c5\u4f8b\u5728\u53f0\u7063\u4ee5\u88ab\u9f9c\u6bbc\u82b1\u54ac\u50b7\u9020\u6210\u6025\u6027\u814e\u640d\u50b7\u6bd4\u4f8b\u6700\u9ad8 \u3002 (E)\u5152\u7ae5\u4f7f\u7528\u6297\u86c7\u6bd2\u8840\u6e05\u6cbb\u7642 \uff0c\u6ce8\u5c04\u5291\u91cf\u5b8c\u5168\u662f\u4f9d\u7167\u9ad4\u91cd\u6c7a\u5b9a \uff0c\u8207\u86c7\u9ad4\u5927\u5c0f\u53ca\u81e8\u5e8a\u75c7\u72c0\u7121\u95dc \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "1\u6b72\u534a\u7537\u7ae5 \uff0c\u56e0\u70ba\u54b3\u55fd\u8072\u5982\u72d7\u5420 \ufe59barking cough \ufe5a\uff0c\u547c\u5438\u6025\u4fc3\u800c\u9001\u81f3\u6025\u8a3a\u5c31\u91ab\u3002\u751f\u547d\u5fb5\u8c61\u5982\u4e0b \uff1a\u5fc3\u8df3 140 \u6b21/min \uff0c\u547c\u5438 40 \u6b21/min \uff0c\u8840\u6c27\u98fd\u548c\u5ea6 90% \uff0c \u9ad4\u6eab 38 \u2103\uff0c\u9ad4\u91cd 12 kg \uff0c\u6709\u95dc\u8a72\u75c5\u7ae5\u56b4\u91cd\u5ea6 \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u6700\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u4f9d\u64da Westley score \u76845\u500b\u9805\u76ee\u8a08\u5206 \uff0c\u4ee5\u5224\u65b7\u547c\u5438\u9053\u963b\u585e\u7684\u56b4\u91cd\u5ea6 \u3002 (B)\u70ba\u8a55\u4f30\u547c\u5438\u9053\u72f9\u7a84\u6216\u963b\u585e\u7684\u56b4\u91cd\u5ea6 \uff0c\u61c9\u4f8b\u884c\u6027\u7167\u9838\u90e8\u6b63\u9762 X\u5149\u3002 (C)\u5728\u6025\u8a3a\u4f7f\u7528 epinephrine \u5438\u5165\u6cbb\u7642\u9054\u5169\u6b21\u4ee5\u4e0a\u6642 \uff0c\u61c9\u5b89\u6392\u4f4f\u9662 \u3002 (D)\u8840\u6c27\u98fd\u548c\u5ea6\u6301\u7e8c\u4f4e\u65bc 92% \uff0c\u70ba\u56b4\u91cd\u60c5\u5f62 \uff0c\u61c9\u5b89\u6392\u4f4f\u9662 \u3002 (E)\u82e5\u540c\u6642\u70ba\u5510\u6c0f\u75c7\u6642 \uff0c\u56e0\u4f7f\u7528\u547c\u5438\u5668\u5c0e\u81f4\u8072\u9580\u4e0b\u72f9\u7a84 \uff0c\u70ba\u767c\u751f\u56b4\u91cd\u547c\u5438\u9053\u963b\u585e\u7684\u9ad8\u5371\u96aa\u7fa4 \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "20 \u6b72\u7537\u6027\u6709\u6182\u9b31\u75c5\u53f2 \uff0c\u56e0\u70ba\u670d\u85e5\u904e\u91cf (overdose )\u88ab\u9001\u81f3\u6025\u8a3a\u5ba4 \uff0c\u6709\u95dc\u4e09\u74b0\u6297\u6182\u9b31\u5291\u4e2d\u6bd2 \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u61c9\u6ce8\u610f\u5fc3\u5f8b\u4e0d\u6574\u53ef\u80fd\u6703\u5408\u4f75 prolonged QT \u3002 (B)\u82e5\u767c\u751f wide QRS complex \u5fc3\u5f8b\u4e0d\u6574 \uff0c\u85e5\u7269\u6cbb\u7642\u9996\u9078\u70ba amiodarone \u3002 (C)\u6bd2\u6027\u4f5c\u7528\u5305\u62ec anticholinergic \u53ca\u03b1-adrenergic blockade effects \u3002 (D)\u7d66\u4e88 sodium bicarbonate (NaHCO 3-)\u9e7c\u5316\u5c3f\u6db2 \uff0c\u8840\u6db2 pH\u76ee\u6a19\u503c\u70ba7.45~7.55 \u3002 (E)\u5e38\u5408\u4f75\u8840\u6db2\u751f\u5316\u96fb\u89e3\u8cea\u4e0d\u5e73\u8861\u5305\u62ec\u4f4e\u8840\u9240\u53ca\u4f4e\u8840\u9382 \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "25 \u6b72\u5973\u6027\u56e0\u610f\u8b58\u6df7\u4e82\u53ca\u62bd\u6410 (convulsion )\uff0c\u88ab\u670b\u53cb\u7531\u591c\u5e97\u9001\u5230\u6025\u8a3a\u5ba4 \u3002\u6709\u95dc\u7532\u57fa\u5b89\u975e\u4ed6\u547d (methamphetamine )\u4e2d\u6bd2\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u4f75\u767c\u75c7\u5305\u62ec\u8166\u51fa\u8840 \u3002 (B)\u75c5\u4eba\u901a\u5e38\u6709\u9ad4\u6eab\u904e\u9ad8\u60c5\u5f62\u61c9\u7d66\u4e88\u964d\u6eab \uff0c\u4f46\u9ad4\u6eab\u9ad8\u4f4e\u8207\u9810\u5f8c\u7121\u95dc \u3002 (C)\u56b4\u91cd\u75c5\u4eba\u53ef\u80fd\u6703\u51fa\u73fe\u4f11\u514b\u53ca\u814e\u8870\u7aed\u75c7\u72c0 \u3002 (D)\u6709\u4e9b\u75c5\u4eba\u6703\u6709\u5fc3\u808c\u7f3a\u8840\u6216\u5fc3\u808c\u6897\u585e\u60c5\u5f62 \u3002 (E)\u5047\u5982\u75c5\u4eba\u6709\u62bd\u6410\u60c5\u5f62 \uff0c\u61c9\u4fdd\u8b77\u75c5\u4eba\u547c\u5438\u9053 \uff0c\u7dad\u6301\u9069\u7576\u6c27\u6c23\u6fc3\u5ea6\u53ca\u63db\u6c23\u529f\u80fd\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "25 \u6b72\u5973\u6027\u61f7\u5b55 28 \u9031\uff0c\u56e0\u4e0b\u6a13\u68af\u6454\u5012\u626d\u50b7\u53f3\u8db3\u8e1d \uff0c\u75c5\u4eba\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a (\u8f15\u5fae\u8179\u75db\u53ca\u53f3\u8170\u90e8\u632b\u50b7 )\uff0c\u7121\u7834\u6c34\u6216\u9670\u9053\u51fa\u8840 \u3002\u63a5\u4e0b\u4f86\u4f55\u8005\u8655\u7406 \u6700\u9069\u7576\ufe56", + "Options": "(A)\u51fa\u9662\u56de\u5bb6\u89c0\u5bdf \uff0c\u7d66\u4e88\u885b\u6559 \uff0c\u5b89\u6392\u9580\u8a3a\u8ffd\u8e64 \u3002 (B)\u5b89\u6392\u8d85\u97f3\u6ce2\u6aa2\u67e5 \uff0c\u8d85\u97f3\u6ce2\u6aa2\u67e5\u7121\u7570\u5e38\u5247\u51fa\u9662\u56de\u5bb6\u89c0\u5bdf \u3002 (C)\u5b89\u6392\u8179\u90e8\u6838\u78c1\u5171\u632f\u6383\u63cf \u3002 (D)\u7167\u6703\u5a66\u7522\u79d1\u91ab\u5e2b \uff0c\u5b89\u6392 fetal monitoring \u81f3\u5c11 4\u5c0f\u6642\u3002 (E)\u5b89\u6392\u8179\u90e8\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5 \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "25 \u6b72\u7537\u6027\u7531\u81fa\u5317\u5750\u8eca\u5230\u7389\u5c71\u5854\u5854\u52a0\u767b\u5c71\u53e3 \uff0c\u518d\u8d70\u8def\u5230\u6392\u96f2\u5c71\u838a (\u6d77\u62d4 3,402 \u516c\u5c3a)\uff0c\u7576\u5929\u665a\u4e0a\u6709\u982d\u75db \u3001\u982d\u6688\u3001\u5641\u5fc3\u3001\u5614\u5410\u3001\u547c\u5438\u56f0\u96e3 \u3001\u7121\u6cd5\u5e73\u8eba\u53ca\u54b3\u55fd\u6709\u8840\u75f0 \uff0c\u4f9d\u64da\u76ee\u524d\u5efa\u8b70 \uff0c\u4e0b\u5217\u4f55\u7a2e\u8655\u7f6e \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u7d66\u4e88\u6c27\u6c23\u6cbb\u7642 \u3002 (B)\u53ef\u8b93\u75c5\u4eba\u8eba\u9032\u52a0\u58d3\u888b (hyperbaric bag )\u4e2d\u6cbb\u7642 \u3002 (C)\u7d66\u4e88 nifedipine \u6cbb\u7642\u3002 (D)\u8003\u616e\u9023\u591c\u5118\u901f\u5c07\u75c5\u4eba\u5e36\u4e0b\u5c71 \u3002 (E)\u5efa\u8b70\u4f7f\u7528 furosemide \u6cbb\u7642\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "25 \u6b72\u7537\u6027\u5176\u5de6\u908a\u7b2c 3\u808b\u9593\u9396\u9aa8\u6b63\u4e2d\u7dda\u8655\u6709\u4e00\u5200\u50b7 \uff0c\u5200\u5b50\u4ecd\u63d2\u5728\u8eab\u9ad4\u4e0a \uff0c\u5176\u751f\u547d\u5fb5\u8c61\u662f\u8840\u58d3 120/70 mmHg \uff0c\u5fc3\u8df3 120 \u6b21/min \uff0c\u8840\u6c27\u98fd\u548c\u5ea6 99% \u3002\u5df2\u653e\u7f6e\u5de6\u5074\u80f8\u7ba1 (tube thoracostomy )\uff0c\u4e26\u6d41\u51fa 2,000 ml \u9bae\u8840\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005 \u6700\u9069\u7576\uff1f", + "Options": "(A)\u62d4\u6389\u5200\u5b50\u7559\u4f5c\u8b49\u7269 \uff0c\u9032\u884c\u50b7\u53e3\u7e2b\u5408 \u3002 (B)\u5728\u76f8\u540c\u90e8\u4f4d\u653e\u7b2c 2\u6839\u80f8\u7ba1\u3002 (C)\u5728\u6025\u8a3a\u4f5c\u7dca\u6025\u80f8\u5ed3\u5207\u958b\u8853 (ED thoracotomy )\u3002 (D)\u5230\u624b\u8853\u5ba4\u88e1\u4f5c\u7dca\u6025\u80f8\u5ed3\u5207\u958b\u8853 \u3002 (E)\u80f8\u90e8\u96fb\u8166\u65b7\u5c64 \u6aa2\u67e5\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "26 \u6b72\u5973\u6027\u75c5\u4eba\u56e0\u547c\u5438\u56f0\u96e3\u81f3\u6025\u8a3a\u5c31\u91ab \uff0c3 \u5929\u524d\u5c31\u611f\u89ba\u547c\u5438\u6bd4\u8f03\u8cbb\u529b \uff0c\u60c5\u6cc1\u65e5\u8da8\u56b4\u91cd \u3002\u81ea\u89ba\u6700\u8fd1\u8b8a\u5f97\u865b\u5f31 \uff0c\u96d9\u624b\u7121\u529b\u68b3\u982d\u9aee \uff0c\u800c\u4e14\u770b\u6771\u897f\u6703\u6709\u96d9\u5f71\u7684\u60c5\u5f62\u3002\u795e\u7d93\u5b78\u6aa2\u67e5\u70ba\u8fd1\u7aef\u80a2\u9ad4\u8f03\u9060\u7aef\u7121\u529b \uff0c\u773c\u7403\u6d3b\u52d5\u529b\u7570\u5e38 \uff0c\u56db\u80a2\u611f\u89ba\u548c\u53cd\u5c04\u7686\u6b63\u5e38 \u3002\u8acb\u554f\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\u662f \uff1f", + "Options": "(A)Amyotrophic lateral sclerosis \u3002 (B)Myasthenia gravis \u3002 (C)Acute intermittent porphoria \u3002 (D)Duchenne muscular dystrophy \u3002 (E)Guillain-Barre syndrome \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "26 \u6b72\u52de\u5de5\u56e0\u610f\u8b58\u4e0d\u6e05\u548c\u547c\u5438\u6025\u4fc3\u88ab\u9001\u5230\u6025\u8a3a\u5ba4 \uff0c\u6709\u95dc\u71b1\u50b7\u5bb3 (heat injury ) \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u71b1\u4e2d\u6691\u75c5\u4eba\u7684\u76ae\u819a\u901a\u5e38\u662f\u4e7e\u71e5\u7121\u6c57 \uff0c\u4f46\u6709\u4e9b\u904b\u52d5\u578b\u71b1\u50b7\u5bb3\u75c5\u4eba\u4ecd\u53ef\u5448\u73fe\u76ae\u819a\u6fd5\u71b1\u7684\u73fe\u8c61 \u3002 (B)\u7dca\u6025\u964d\u4f4e\u9ad4\u6eab\u662f\u6c7a\u5b9a\u75c5\u4eba\u9810\u5f8c\u7684\u91cd\u5927\u56e0\u7d20 \u3002 (C)\u4e00\u822c\u964d\u6eab\u81f3 37 \u2103\u7b26\u5408\u6b63\u5e38\u4eba\u7684\u9ad4\u6eab\u6a19\u6e96 \u3002 (D)\u71b1\u4e2d\u6691\u7684\u81e8\u5e8a\u75c7\u72c0\u901a\u5e38\u6703\u8d85\u904e 40 \u2103\u3002 (E)\u71b1\u4e2d\u6691\u75c5\u4eba\u7684\u9ad4\u6db2\u61c9\u4ee5\u4e2d\u5fc3\u975c\u8108\u5c0e\u7ba1\u58d3\u529b\u53ca\u5c3f\u6db2\u91cf\u4f86\u88dc\u5145 \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "27 \u6b72\u7684\u5916\u7c4d\u52de\u5de5 \uff0c\u88ab\u9001\u81f3\u6025\u8a3a\u4e3b\u8a34\u6fc0\u52d5 \u3001\u7126\u8e81\u3001\u808c\u8089\u62bd \u6410\uff0c\u5408\u4f75\u4f4e\u5ea6\u767c\u71d2\u53ca\u610f\u8b58\u4e0d\u6e05 \u3002\u75c5\u4eba 1\u500b\u6708\u524d\u5728\u570b\u5916\u88ab\u91ce\u72d7\u54ac\u50b7\u53f3\u624b\u548c\u53f3\u5927\u817f \u3002\u67d0\u4f4d\u624b\u90e8\u76ae\u819a\u7834\u640d\u7684\u91ab\u8b77\u4eba\u54e1 \uff0c\u5728\u672a\u6234\u624b\u5957\u7684\u60c5\u6cc1\u4e0b\u63a5\u89f8\u5230\u75c5\u4eba\u7684\u553e\u6db2 \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u61c9\u8a72\u7acb\u5373\u4f7f\u7528\u80a5\u7682\u6c34 \u3001\u5fb9\u5e95\u5730\u6e05\u6d17\u50b7\u53e3 \uff0c\u4e5f\u53ef\u4ee5\u4f7f\u7528\u916e\u7898\u6eb6\u6db2(povidone-iodine )\u704c\u6d17\u50b7\u53e3 \u3002 (B)\u8a72\u91ab\u8b77\u4eba\u54e1\u61c9\u7acb\u5373\u63a5\u53d7 20 IU /kg \u7684\u7279\u7570\u6027\u514d\u75ab\u7403\u86cb\u767d \uff0c\u5305\u62ec\u50b7\u53e3\u5468\u570d\u6ce8\u5c04\u3002 (C)\u8a72\u91ab\u8b77\u4eba\u54e1\u9084\u9700\u8981\u63a5\u53d7\u5168\u7a0b\u7684\u75ab\u82d7 \uff0c\u63a1\u81c0\u90e8\u7684\u808c\u8089\u6ce8\u5c04 \u3002 (D)\u5373\u4f7f\u8a72\u91ab\u8b77\u4eba\u54e1\u61f7\u5b55 \uff0c\u4e5f\u4ecd\u9700\u8981\u6ce8\u5c04\u7279\u7570\u6027\u514d\u75ab\u7403\u86cb\u767d\u53ca\u75ab\u82d7 \u3002 (E)\u7531\u65bc\u75ab\u82d7\u662f\u5229\u7528\u53bb\u6bd2\u6027\u7684\u75c5\u6bd2\u5099\u88fd \uff0c\u5b83\u53ef\u7528\u65bc\u514d\u75ab\u529f\u80fd\u4f4e\u4e0b\u8005 \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "28 \u6b72\u5e74\u8f15\u5973\u6027 \uff0c\u88ab\u9001\u81f3\u6025\u8a3a \uff0c\u4e3b\u8a34\u6700\u8fd1 4\u5929\u56db\u80a2\u9010\u6f38\u7121\u529b \uff0c\u808c\u8089\u7121\u529b\u60c5\u5f62\u81ea\u80a2\u9ad4\u672b\u7aef\u5411\u8fd1\u7aef\u9032\u5c55 \uff0c\u75c5\u4eba\u610f\u8b58\u6e05\u695a \uff0c\u795e\u7d93\u5b78\u6aa2\u67e5\u986f\u793a\u9871\u795e\u7d93\u529f\u80fd \u6b63\u5e38\uff0c\u56db\u80a2\u808c\u529b\u4e0b\u964d\u7121\u6cd5\u62b5\u6297\u91cd\u529b \uff0c\u80a2\u9ad4\u7121\u529b\u767c\u751f\u524d 2\u9031\u6709\u8179\u7009 \u3001\u8179\u75db\u7b49\u8178\u80c3\u708e\u7684\u75c7\u72c0\u3002\u6709\u95dc Guillain-Barr\u00e9 syndrome (GBS )\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u6b64\u75c5\u662f\u6700\u5e38\u898b\u7684\u6025\u6027\u5168\u8eab\u6027\u795e\u7d93\u75c5\u8b8a \uff0c\u53ef\u80fd\u548c\u6025\u6027 campylobacter jejuni \u611f\u67d3\u6709\u95dc \u3002 (B)\u4e3b\u8981\u5f71\u97ff\u7684\u662f\u904b\u52d5\u795e\u7d93 \uff0c\u8868\u73fe\u70ba\u5c0d\u7a31\u7684\u80a2\u9ad4\u7121\u529b \uff0c\u901a\u5e38\u5148\u5f71\u97ff\u4e0b\u80a2\u7136\u5f8c\u662f\u4e0a\u80a2 \u3002 (C)\u795e\u7d93\u5b78\u6aa2\u67e5\u6700\u660e\u986f\u7684\u5c31\u662f\u75c5\u4eba\u6703\u5931\u53bb\u6df1\u90e8\u808c\u8171\u53cd\u5c04 \u3002 (D)\u75c5\u4eba\u6703\u6709\u4e00\u4e9b\u611f\u89ba\u7570\u5e38\u7684\u4e3b\u8a34\u53ca\u7570\u5e38\u7684\u611f\u89ba\u795e\u7d93\u5b78\u6aa2\u67e5 \u3002 (E)\u53ef\u8003\u616e\u7528\u8840\u6f3f\u7f6e\u63db (plasmapheresis )\u6cbb\u7642\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "29 \u6b72\u5065\u5eb7\u7537\u6027\u7121\u4efb\u4f55\u75be\u75c5\u53f2 \uff0c2\u5929\u524d\u5728\u4ed6\u9662\u7be9\u6aa2 A\u578b\u6d41\u611f\u5448\u967d\u6027 \uff0c\u4e26\u958b\u59cb\u670d\u7528\u514b\u6d41\u611f \uff0c\u4eca\u56e0\u9ad8\u71d2\u4e0d\u9000 \u3001\u547c\u5438\u56f0\u96e3\u4f86\u5c31\u8a3a \u3002\u80f8\u90e8 X\u5149\u5448\u73fe\u96d9\u5074\u6027\u80ba\u90e8\u6d78\u6f64\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u61c9\u5411\u75be\u75c5\u7ba1\u5236\u7f72\u901a\u5831\u70ba\u6d41\u611f\u91cd\u75c7\u75c5\u4eba \uff0c\u6709\u6a5f\u6703\u60e1\u5316\u70ba\u547c\u5438\u8870\u7aed\u751a\u81f3\u6b7b\u4ea1\uff0c\u4f4f\u9662\u6cbb\u7642\u662f\u5fc5\u9808\u7684 \u3002 (B)\u82e5\u8840\u6c27\u98fd\u548c\u5ea6 < 95% \u5c31\u5fc5\u9808\u7d66\u6c27 \uff0c\u7d66\u6c27\u6642 \u61c9\u4f7f\u7528\u6f6e\u6fd5\u74f6 \uff0c\u4e26\u7d66\u8207\u652f\u6c23\u7ba1\u64f4\u5f35\u5291 \uff0c\u4f7f\u75f0\u5bb9\u6613\u54b3\u51fa \u3002 (C)\u82e5\u7121\u5408\u4f75\u7d30\u83cc\u611f\u67d3\u7684\u75c7\u72c0 \uff0c\u4e0d\u61c9\u4f7f\u7528\u975c\u8108\u6ce8\u5c04\u7684\u6297\u751f\u7d20 \u3002 (D)\u82e5\u6301\u7e8c\u7f3a\u6c27 (PaO 2/FiO 2 < 200 \u4e14PaCO 2 > 50 mmHg \u6216\u662f pH < 7.25 )\uff0c\u5fc5\u9808\u8003\u616e\u63d2\u7ba1\u4f7f\u7528\u547c\u5438\u5668\u6cbb\u7642 \uff0c\u975e\u4fb5\u8972\u6027\u547c\u5438\u5668 (\u5982 BiPAP \u3001CPAP \u7b49)\u56e0\u53ef\u80fd\u6703\u589e\u52a0\u75c5\u6bd2\u6563\u4f48 \uff0c\u4e0d\u5efa\u8b70\u4f7f\u7528 \u3002 (E)\u672c\u5730\u5c1a\u975e\u6297\u85e5\u6027\u75c5\u6bd2\u7684\u6d41\u884c\u5340 \uff0c\u4e0d\u9f13\u52f5\u5e38\u898f\u52a0\u7528\u6216\u6539\u7528 zanamivir \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "30 \u6b72\u5973\u6027\u6709\u7126\u616e\u75c7\u75c5\u53f2 \uff0c\u56e0\u70ba\u610f\u8b58\u4e0d\u6e05\u9001\u5230\u6025\u8a3a\u5ba4 \uff0cEMT \u5728\u73fe\u5834\u767c\u73fe\u5b89\u7720\u85e5lorazepam \u85e5\u888b\u3002\u5230\u9662\u6642\u5fc3\u8df3 130 \u6b21/min \u3001\u6536\u7e2e\u8840\u58d3 80 mmHg \u3001\u547c\u5438 8\u6b21/min \u3001\u9ad4\u6eab 36.5 \u2103\u3002\u4e0b\u5217\u6025\u8a3a\u8655\u7f6e\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u7dca\u6025\u8655\u7f6e\u61c9\u512a\u5148\u8655\u7406\u547c\u5438\u9053\u53ca\u8a55\u4f30\u63db\u6c23\u662f\u5426\u8db3\u5920 \u3002 (B)\u61c9\u4f7f\u7528\u5347\u58d3\u5291 (vasopressor )\u7a69\u5b9a\u8840\u58d3\u53ca\u7dad\u6301\u5468\u908a\u7d44\u7e54\u704c\u6d41 \u3002 (C)\u4efb\u4f55\u610f\u8b58\u4e0d\u6e05\u75c5\u4eba \uff0c\u61c9\u5118\u901f\u7d66\u4e88\u89e3\u6bd2\u5291 flumazenil \u3002 (D)\u53ef\u5148\u5617\u8a66\u7d66\u4e88\u660f\u8ff7\u96de\u5c3e\u9152\u6cbb\u7642 (DONT \uff1aD50W \u3001Oxygen \u3001Narcan \u3001Thiamine )\u3002 (E)\u7a69\u5b9a\u751f\u547d\u5fb5\u8c61\u5f8c \uff0c\u61c9\u8a73\u7d30\u8a62\u554f\u75c5\u53f2 \uff0c\u5fc5\u8981\u6642\u53ef\u7d66\u4e88\u6d17\u80c3\u6cbb\u7642 \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "30 \u6b72\u7537\u6027\u56e0\u65e9\u4e0a\u8d77\u5e8a\u6642\u767c\u73fe\u5168\u8eab\u7121\u529b \u3001\u52d5\u5f48\u4e0d\u5f97\u800c\u81f3\u6025\u8a3a \u3002\u75c5\u4eba\u6558\u8ff0 3\u500b\u6708\u524d\u4ea6\u6709\u4e00\u6b21\u985e\u4f3c\u767c\u4f5c \u3002\u9019\u534a\u5e74\u4f86\u75c5\u4eba\u6709\u5fc3\u60b8\u53ca\u9ad4\u91cd\u4e0b\u964d\u7b49\u75c7\u72c0 \u3002\u5230\u9662\u6642\u8840\u58d3 120/70 mmHg \u3001\u5fc3\u8df3 110 \u6b21/min \u3001\u547c\u5438 20 \u6b21/min \u3001\u9ad4\u6eab 37 \u2103\uff0c\u5176\u4ed6\u8eab\u9ad4\u6aa2\u67e5\u9664\u56db\u80a2\u5c0d\u7a31\u7121\u529b\u5916 \uff0c\u4e26\u7121\u7570\u5e38 \u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u751f\u5316\u6aa2\u67e5\u9700\u6aa2\u9a57\u9240\u96e2\u5b50 \u3001\u9382\u96e2\u5b50 \u3001\u9223\u96e2\u5b50\u7b49\u8b8a\u5316 \u3002 (B)\u8a3a\u65b7\u53ef\u80fd\u70ba\u7532\u72c0\u817a\u6a5f\u80fd\u4ea2\u9032\u5408\u4f75\u9663\u767c\u6027\u80a2\u9ad4\u7121\u529b (periodic paralysis ) \u3002 (C)\u5f71\u97ff\u7684\u808c\u7fa4\u5927\u591a\u662f\u9060\u7aef\u808c\u8089 \uff0c\u4e0b\u80a2\u6bd4\u4e0a\u80a2\u6613\u53d7\u5230\u5f71\u97ff \uff0c\u6709\u5c0d\u7a31\u6027 \uff0c\u591a\u5408\u4f75\u611f\u89ba\u7570\u5e38 \u3002 (D)\u8a72\u75c5\u4eba\u98df\u7528\u6fb1\u7c89\u53ca\u9e7d\u5206\u591a\u4e4b\u98df\u7269\u8f03\u6613\u767c\u4f5c \u3002 (E)\u4e0d\u53ef\u7d66\u4e88\u75c5\u4eba dextrose \u6eb6\u6db2\u52a0 KCL \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "32 \u6b72\u5973\u6027\u6a5f\u8eca\u8eca\u798d \uff0c\u81ea\u6454\u5f8c\u9001\u81f3\u6025\u8a3a \uff0c\u53f3\u5927\u817f\u8b8a\u5f62 \u3002\u75c5\u4eba\u5df2\u88ab\u653e\u7f6e\u6c23\u7ba1\u5167\u7ba1\uff0c\u4f7f\u7528\u547c\u5438\u5668\u8f14\u52a9\u547c\u5438 \uff0c\u5728\u6025\u8a3a\u521d\u59cb\u8840\u58d3 80/60 mmHg \uff0c\u5fc3\u8df3 120 \u6b21/min \uff0c\u5728\u8f38\u6db2\u5fa9\u7526\u6025\u6551\u5f8c \uff0c\u8840\u58d3\u56de\u5347\u5230 120/80 mmHg \u30021\u5c0f\u6642\u5f8c\uff0c\u8840\u58d3\u53c8\u964d\u5230 90/75 mmHg \uff0c\u5fc3\u8df3 130 \u6b21/min \uff0c\u8acb\u554f\u6b64\u6642 \u6700\u512a\u5148\u7684\u8655\u7f6e\u662f \uff1f", + "Options": "(A)\u7dca\u6025\u653e\u7f6e\u80f8\u7ba1 \u3002 (B)\u5408\u9069\u7684\u8f38\u6db2\u6cbb\u7642 \uff0c\u627e\u51fa\u51fa\u8840\u9ede\u4e26\u4e88\u6b62\u8840 \u3002 (C)\u7d66\u4e88\u5927\u91cf\u8f38\u6db2\u6436\u6551 \u3002 (D)\u9032\u884c\u5f9e\u982d\u5230\u8173\u7684\u6b21\u7d1a\u8a55\u4f30 (secondary survey )\u3002 (E)\u91cd\u65b0\u9032\u884c\u521d\u7d1a\u8a55\u4f30 (repeated primary survey )\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "38 \u6b72\u7537\u6027\u9152\u5f8c\u8207\u4ed6\u4eba\u4e92\u6bc6 \uff0c\u7d93\u7531 EMT \u9001\u81f3\u6025\u8a3a \u5ba4\u3002\u767c\u73fe\u982d\u76ae\u6495\u88c2\u50b7\u6d41\u8840\u5df2\u6b62\u4f4f\uff0c\u81c9\u90e8\u53ca\u4e0b\u5df4\u8b8a\u5f62\u816b\u8139 \uff0c\u8840\u58d3 86/56 mmHg \u3001\u5fc3\u8df3 126 \u6b21/min \u3001\u547c\u5438 24 \u6b21/min \uff0c\u610f\u8b58\u4e0d\u6e05 \uff0c\u4e0b\u5217\u4f55\u7a2e\u8655\u7f6e \u512a\u5148\u57f7\u884c\uff1f", + "Options": "(A)\u9f3b\u54bd\u7ba1\u7f6e\u653e \u3002 (B)\u6797\u683c\u6c0f\u6db2 2,000 ml \u8f38\u6db2\u6cbb\u7642 \u3002 (C)\u8840\u7ba1\u6813\u585e\u6cbb\u7642 \u3002 (D)\u8166\u90e8\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5 \u3002 (E)\u74b0\u72c0\u8edf\u9aa8\u5207\u958b\u8853 (cricothyroidotomy )\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "3\u6b72\u5973\u7ae5\u88ab\u5abd\u5abd\u5e36\u81f3\u6025\u8a3a\u5c31\u91ab \uff0c\u4e3b\u8a34\u767c\u71d2 1\u5929\u3002\u7d93\u904e\u8a3a\u8996\u76ae\u819a\u53ca\u53e3\u8154 \uff0c\u521d\u6b65\u8a3a\u65b7\u70ba\u624b\u8db3\u53e3\u75c5 \u3002\u5973\u7ae5\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a \uff0c\u7121\u9808\u7acb\u5373\u4f4f\u9662 \u3002\u885b\u6559\u6642\u61c9\u544a\u77e5\u5abd\u5abd\u6709\u54ea\u4e9b\u91cd\u75c7\u60c5\u6cc1\u9808\u8fc5\u901f\u5c31\u91ab \uff0c\u4e0d\u5305\u62ec \u4e0b\u5217\u4f55\u8005 \uff1f", + "Options": "(A)\u808c\u8e8d\u578b\u62bd\u6410 (myoclonic jerk )\u3002 (B)\u6301\u7e8c\u5614\u5410 \u3002 (C)\u6301\u7e8c\u660f\u7761 \u3002 (D)\u6301\u7e8c\u8179\u7009 \u3002 (E)\u547c\u5438\u6025\u4fc3 \u3001\u5fc3\u8df3\u52a0\u5feb \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "40 \u6b72\u5973\u6027 5\u5929\u524d\u611f\u5230\u982d\u75db\u5641\u5fc3\u53ca\u767c\u71d2 \uff0c3\u5929\u524d\u958b\u59cb\u610f\u8b58\u4e0d\u6e05 \u3001\u8b6b\u5984\uff0c\u6628\u65e5\u8d77\u55dc\u7761\uff0c\u4eca\u5929\u767c\u751f\u75d9\u6523\u4f86\u9662 \uff0c\u4f4f\u9662\u6642\u9ad4\u6eab 38.5 \u2103\uff0c\u80f8\u8179\u90e8\u7121\u7570\u5e38 \uff0c\u9838\u90e8\u50f5\u76f4\u3001\u8166\u795e\u7d93\u6aa2\u67e5\u7121\u7570\u5e38 \uff0c\u808c\u8171\u53cd\u5c04\u6b63\u5e38 \uff0cBabinski sign \u5448\u9670\u6027\uff0cWBC 9,000/mm 3\uff0c\u8170\u690e\u7a7f\u523a \u7684\u521d\u59cb\u58d3\u529b 180 mmH 2O\uff0c\u8166\u810a\u9ad3\u6db2\u6aa2\u67e5\u7d50\u679c \u70ba\u767d\u8840\u7403193/mm 3(\u591a\u6838\u7403 12 \uff0c\u6dcb\u5df4\u7403 141 \uff0c\u55ae\u6838\u7403 40 )\uff0c\u7d05\u8840\u7403 6,500/mm 3\uff0c\u86cb\u767d\u8cea 92 mg/dL \uff0cglucose 40 mg/dL \uff0c\u6700\u53ef\u80fd \u7684\u8a3a\u65b7\u662f\u4e0b\u5217\u4f55\u8005 \uff1f", + "Options": "(A)\u8718\u86db\u819c\u4e0b\u8154\u51fa\u8840 \u3002 (B)\u55ae\u7d14\u76b0\u75b9\u75c5\u6bd2\u8166\u708e \u3002 (C)\u6025\u6027\u5316\u81bf\u6027\u8166\u819c\u708e \u3002 (D)\u7d50\u6838\u6027\u8166\u819c\u708e \u3002 (E)\u5bc4\u751f\u87f2\u5f15\u8d77\u8166\u819c\u708e \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "40 \u6b72\u7537\u6027\u5728\u9ad8\u723e\u592b\u7403\u5834\u88ab\u9583\u96fb\u64ca\u50b7 (lightning injury ) \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u9583\u96fb\u50b7\u56e0\u4f0f\u7279\u96fb\u58d3\u6975\u9ad8 \uff0c\u6613\u5f15\u8d77\u5fc3\u5ba4\u7e96\u7dad\u986b\u52d5 (ventricular fibrillation )\u3002 (B)\u9583\u96fb\u50b7\u82e5\u75c5\u4eba\u80fd\u5b58\u6d3b\u4e0b\u4f86 \uff0c\u5bb9\u6613\u767c\u751f\u795e\u7d93\u7cbe\u795e\u4f75\u767c\u75c7 \uff0c\u5305\u62ec\u7cbe\u795e\u5206\u88c2 \u3002 (C)\u9583\u96fb\u50b7\u9020\u6210\u5927\u91cf\u50b7\u60a3\u73fe\u5834\u8655\u7406 \uff0c\u4ee5\u6aa2\u50b7\u5206\u985e\u7d05\u8272\u6a19\u7c64\u75c5\u4eba\u70ba\u7b2c\u4e00\u512a\u5148 \u3002 (D)\u8c6a\u96e8\u5408\u4f75\u9583\u96fb\u4f86\u8972 \uff0c\u61c9\u5f80\u7a7a\u66e0\u8655\u758f\u6563 \uff0c\u4ee5\u907f\u514d\u88ab\u5012\u584c\u5efa\u7bc9\u7269\u58d3\u50b7 \u3002 (E)\u975c\u8108\u8f38\u6db2\u88dc\u5145\u4e4b\u539f\u5247 \uff0c\u5c0d\u65bc\u96fb\u64ca\u50b7\u53ca\u9583\u96fb\u50b7\u7684\u75c5\u4eba\u662f\u76f8\u540c\u7684 \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "45 \u6b72\u809d\u786c\u5316\u75c5\u4eba\u56e0\u767c\u71d2\u53ca\u8179\u8139\u800c\u4f4f\u9662 \uff0c\u8eab\u9ad4\u6aa2\u67e5\u767c\u73fe\u6709\u8179\u6c34 \uff0c\u4e14\u8179\u90e8\u6709\u58d3\u75db\u53ca\u53cd\u5f48\u75db\u4e4b\u73fe\u8c61 \uff0c\u6709\u95dc\u81ea\u767c\u6027\u7d30\u83cc\u6027\u7684\u8179\u819c\u708e \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u7d93\u5e38\u5177\u6709\u767c\u71d2 \u3001\u8179\u75db\u8207\u767d\u8840\u7403\u589e\u52a0\u7684\u75c7\u72c0 \u3002 (B)\u8179\u6c34\u4e2d\u7684\u767d\u8840\u7403 >1,000/mm 3\u53ca\u55dc\u4e2d\u6027\u7403 >250/mm 3\u70ba\u78ba\u7acb\u8a3a\u65b7 \u3002 (C)\u5efa\u8b70\u4f7f\u7528\u7b2c\u4e09\u4ee3\u6297\u751f\u7d20 \u3002 (D)\u61c9\u6e2c lactic acid \uff0c\u82e5\u662f\u56b4\u91cd\u6557\u8840\u75c7\u61c9\u7d66\u4e88 crystalloid 20 ml/kg \u3002 (E)\u570b\u5167\u6700\u5e38\u898b\u83cc\u7a2e\u662f\u9769\u862d\u6c0f\u9670\u6027\u83cc \uff0c\u5982 Escherichia coli \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "45 \u6b72\u7537\u6027\u4e00\u65e9\u7761\u9192\u56e0\u773c\u6b6a\u5634\u659c\u4f86 \u6025\u8a3a\u5c31\u91ab \uff0c\u7d93\u6aa2\u67e5\u70ba\u53f3\u5074\u5468\u908a\u578b\u984f\u9762\u795e\u7d93\u9ebb\u75fa(peripheral type facial palsy )\uff0c\u4ed4\u7d30\u6aa2\u67e5\u767c\u73fe\u75c5\u4eba\u5408\u4f75\u6709\u53f3\u5074\u8033\u75db\u53ca\u53f3\u5916\u8033\u6c34\u6ce1\u6027\u7d05\u75b9 \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u6b64\u70ba Ramsay Hunt Syndrome \uff0c\u800c\u975e Bell\u2019s palsy \u3002 (B)\u6b64\u70ba\u6c34\u75d8 -\u5e36\u72c0\u76b0\u75b9\u75c5\u6bd2 (Varicella-Zoster virus \uff0cVZV )\u4e4b\u611f\u67d3 \u3002 (C)Ramsay Hunt Syndrome \u4e00\u958b\u59cb\u7684\u81e8\u5e8a\u8868\u73fe\u4e5f\u53ef\u4ee5\u6c92\u6709\u7d05\u75b9 \u3002 (D)\u53ef\u5118\u65e9\u4f7f\u7528\u6297\u75c5\u6bd2\u85e5\u7269 acyclovir \u8207\u985e\u56fa\u9187 \u3002 (E)Ramsay Hunt Syndrome \u984f\u9762\u795e\u7d93\u9ebb\u75fa\u6062\u5fa9\u60c5\u6cc1\u6bd4 Bell\u2019s palsy \u597d\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "48 \u6b72\u5973\u6027\u75c5\u4eba\u7d93\u904e 16 \u5c0f\u6642\u7684\u98db\u884c \uff0c\u56e0\u7a81\u7136\u611f\u5230\u547c\u5438\u56f0\u96e3 \u3001\u80f8\u75db\u3001\u76dc\u6c57\uff0c\u7531\u6a5f\u5834\u76f4\u5165\u6025\u8a3a \u5ba4\uff0c\u5230\u9054\u6025\u8a3a \u5ba4\u6642\u5df2\u5448\u660f\u8ff7\u72c0\u614b \uff0c\u75c5\u4eba\u5728\u534a\u500b\u6708\u524d\u624d\u56e0\u5de6\u80a1\u9aa8( left femur )\u9aa8\u6298\u800c\u51fa\u9662 \uff0c\u4e26\u6c92\u6709\u9ad8\u8840\u58d3 \u3001\u5fc3\u81df\u75c5\u7684\u75c5\u53f2 \u3002\u7d93\u8a55\u4f30\u5f8c \uff0c\u8840\u58d3 80/44 mmHg \u3001\u5fc3\u8df3 120 \u6b21/min \u3001\u547c\u5438 22 \u6b21/min \uff0c\u8840\u6c27\u98fd\u548c\u5ea6 88% \uff0c\u5fc3\u96fb\u5716\u76e3\u8996\u5668\u5448\u73fe sinus tachycardia \uff0c\u8eab\u9ad4\u6aa2\u67e5\u5448\u73fe\u6e05\u6f88\u547c\u5438\u97f3 \u3002\u6709\u95dc\u9019\u4f4d\u75c5\u4eba\u7684\u76f8\u95dc\u6558\u8ff0 \uff0c\u4e0b\u5217\u4f55\u8005\u6700\u4e0d\u9069\u7576 \ufe56", + "Options": "(A)\u5fc3\u96fb\u5716\u82e5\u6709\u51fa\u73fe S1Q3T3 \u53ef\u652f\u6301\u80ba\u6813\u585e\u7684\u8a3a\u65b7 \u3002 (B)\u56e0\u8840\u884c\u52d5\u529b\u4e0d\u7a69 \uff0c\u4e0d\u5b9c\u4f7f\u7528 fibrinolytic agent \u3002 (C)\u80ba\u901a\u6c23\u704c\u6ce8\u6383\u63cf (ventilation-perfusion lung scan )\u7de9\u4e0d\u6fdf\u6025 \uff0c\u5728\u6025\u8a3a\u81e8\u5e8a\u50f9\u503c\u4f4e \u3002 (D)\u61c9\u8003\u616e\u7acb\u5373\u505a\u80f8\u90e8\u87ba\u65cb\u5f62\u65b7\u5c64\u6aa2\u67e5 (spiral chest CT )\u3002 (E)\u75c5\u4eba\u4f11\u514b\u6703\u5f71\u97ff\u96fb\u8166\u65b7\u5c64\u5c0d\u80ba\u6813\u585e\u7684\u8a3a\u65b7\u7387 \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "4\u500b\u6708\u5927\u7537\u5b30\u56e0\u547c\u5438\u56f0\u96e3\u88ab\u6bcd\u89aa\u5e36\u81f3\u6025\u8a3a \uff0c\u4e3b\u8a34 3\u5929\u4f86\u547c\u5438\u51fa\u73fe\u96dc\u97f3 \uff0c\u4e14\u98df\u617e\u4e0b\u964d\uff0c\u7cbe\u795e\u8b8a\u5dee \u3002\u8eab\u9ad4\u6aa2\u67e5\u6642 \uff0c\u7537\u5b30\u547c\u5438\u6025\u4fc3 \uff0c\u5169\u5074\u6709\u5598\u9cf4\u8072 (wheezing ) \uff0c\u672a\u4f9b\u7d66\u6c27\u6c23\u60c5\u6cc1\u4e0b \uff0c\u8840\u6c27\u98fd\u548c\u5ea6\u70ba 94% \uff0c\u4e14\u6709\u660e\u986f\u7684\u808b\u9593\u5167\u51f9 (intercostal retraction )\u3002\u4e0b\u5217\u4f55\u7a2e\u75c5\u6bd2 \u6700\u53ef\u80fd\u5c0e\u81f4\u6b64\u75be\u75c5 \uff1f", + "Options": "(A)Influenza virus (B)Parainfluenza virus (C)Rhinovirus (D)Respiratory syncytial virus (E)Enterovirus", + "Answer": "D" + }, + { + "\ufeffQuestion": "4\u6b72\u5973\u7ae5\u88ab\u7238\u7238\u5e36\u5230\u6025\u8a3a\u5ba4 \uff0c\u4e3b\u8a34\u80c3\u53e3\u4e0d\u597d\u53ca\u767c\u71d2 1\u5929\u3002\u5230\u9662\u6642\u547c\u5438 32 \u6b21/min \uff0c\u5fc3\u8df3 148 \u6b21/min \uff0c\u9ad4\u6eab 39 \u2103\u3002\u5973\u7ae5\u4e0d\u592a\u9858\u610f\u8b1b\u8a71 \uff0c\u52c9\u5f37\u958b\u53e3\u4e5f\u807d\u4e0d\u61c2\u5979\u8aaa\u4ec0\u9ebc \uff0c\u4f46\u78ba\u5b9a\u6c92\u6709\u6d41\u9f3b\u6c34 \u3001\u54b3\u55fd\u3002\u8eab\u9ad4\u6aa2\u67e5\u6642\u5916\u89c0\u770b\u8d77\u4f86\u5f88\u865b\u5f31 \uff0c\u537b\u4e0d\u9858\u610f\u5e73\u8eba \uff0c\u547c\u5438\u56f0\u96e3\u4e14\u6709\u553e\u6db2\u81ea\u5634\u89d2\u6d41\u51fa \uff0c\u5438\u6c23\u6642\u65bc\u9838\u90e8\u53ef\u4ee5\u807d\u5230stridor \u96dc\u97f3\u3002\u4e0b\u5217\u6558\u8ff0\u8207\u8655\u7f6e\u4f55\u8005 \u6700\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u7576\u5973\u7ae5\u6e05\u9192\u6642 \uff0c\u4e0d\u8981\u5f37\u8feb\u5979\u8eba\u4e0b \u3002 (B)\u7d66\u4e88\u6c27\u6c23 \u3001\u4e26\u76e3\u6e2c\u8840\u6c27\u98fd\u548c\u5ea6 \u3002 (C)\u61c9\u907f\u514d\u6aa2\u67e5\u5589\u56a8 \uff0c\u4ee5\u514d\u9020\u6210\u6025\u6027\u547c\u5438\u9053\u963b\u585e \u3002 (D)\u82e5\u53ef\u884c \uff0c\u9838\u90e8\u53ef\u5074\u7167 X\u5149\uff0c\u7136\u800c\u5fc5\u9808\u6e96\u5099\u96a8\u6642\u53ef\u63d2\u6c23\u7ba1\u5167\u7ba1\u6025\u6551 \u3002 (E)\u7576 X\u5149\u6216\u5167\u8996\u93e1\u78ba\u5b9a\u6703\u53ad\u986f\u8457\u816b\u5927\u6642 \uff0c\u4f7f\u7528\u6297\u751f\u7d20\u61c9\u8003\u616e\u6700\u5e38\u898b\u7684\u81f4\u75c5\u83cc\u70ba Hemophilus influenzae type A \u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "4\u6b72\u7537\u7ae5\u9ad8\u71d2 5\u5929\u4e0d\u9000\uff0c\u91ab\u5e2b\u61f7\u7591\u70ba\u5ddd\u5d0e\u75c5 (Kawasaki disease )\u3002\u6709\u95dc\u8a72\u75c5\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u4e3b\u8981\u75c7\u72c0\u5305\u62ec\u5634\u5507\u7d05\u88c2 (red and cracked lips )\u548c\u8349\u8393\u820c (strawberry tongue )\u3002 (B)\u55ae\u5074\u975e\u5316\u81bf\u6027\u9838\u90e8\u6dcb\u5df4\u817a\u816b\u5927 \u3002 (C)\u76ae\u819a\u6709\u591a\u6a23\u6027\u7d05\u6591 (polymorphous exanthem )\u3002 (D)\u809b\u9580\u9644\u8fd1\u6709\u812b\u76ae\u73fe\u8c61 (desquamation )\u3002 (E)NSAID \u53ca aspirin \u7686\u70ba\u85e5\u7269\u9996\u9078 \u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "50 \u6b72\u7537\u6027\uff0c5\u5929\u524d\u9152\u5f8c\u8207\u4ed6\u4eba\u722d\u57f7\u4e92\u6bc6 \uff0c\u56e0\u9838\u90e8\u75bc\u75db\u816b\u8139\u800c\u5c31\u91ab \uff0c\u6aa2\u67e5\u6642\u767c\u73fe\u74b0\u72c0\u8edf\u9aa8\u4e0b\u7aef\u816b\u8139 \uff0c\u8aaa\u8a71\u8072\u97f3\u6b63\u5e38 \uff0c\u53f3\u5074\u77b3\u5b54\u7e2e\u5c0f \uff0c\u773c\u77bc\u4e0b\u5782 \u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u51fa\u73fe\u4ea4\u611f\u8166\u795e\u7d93\u50b7\u5bb3\u7684\u75c7\u72c0 \u3002 (B)\u53ef\u5b89\u6392\u982d\u90e8\u96fb\u8166\u65b7\u5c64\u6383\u63cf \u3002 (C)\u5b89\u6392\u52d5\u8108\u8840\u7ba1\u651d\u5f71\u6aa2\u67e5 \u3002 (D)\u5982\u679c\u8a3a\u65b7\u70ba\u9838\u52d5\u8108\u53d7\u5275 \uff0c\u53ef\u8003\u616e\u4f7f\u7528\u6297\u51dd\u8840\u5291 \u3002 (E)\u505a\u652f\u6c23\u7ba1\u93e1\u6aa2\u67e5 \u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "50 \u6b72\u7537\u6027\u4f86\u5230\u6025\u8a3a \uff0c30 \u5206\u9418\u524d\u670d\u7528 amlodipine (Norvasc 5 mg/tab ) 40 \u9846\uff0c\u610f\u8b58\u4e0d\u6e05 \uff0c\u8840\u58d3 60/30 mmHg \uff0c\u5fc3\u8df3 40 \u6b21/min \uff0c\u547c\u5438 20 \u6b21/min \uff0c\u9ad4\u6eab 37 \u2103\u3002\u4f9d\u76ee\u524d\u4e4b\u7814\u7a76\u8b49\u64da \uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u7642\u6548 \u6700\u4f73\uff1f", + "Options": "(A)\u7d66\u4e88 10% Ca gluconate 0.6 ml/kg \u3002 (B)\u5b89\u6392\u8840\u6db2\u900f\u6790 \uff0c\u52a0\u5f37\u6392\u9664 \u3002 (C)\u5118\u5feb\u6d17\u80c3 \uff0c\u4e26\u7d66\u4e88\u4f7f\u7528\u6d3b\u6027\u78b3 \u3002 (D)\u7d66\u4e88 1.0 U/kg/hr insulin \u3002 (E)\u7d66\u4e88 glucagon 5 mg \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "50 \u6b72\u7537\u6027\u75c5\u4eba\u56e0\u80f8\u90e8\u4e0d\u9069 \uff0c\u81f3\u6025\u8a3a\u5c31\u91ab \u3002\u5230\u9662\u6642\u751f\u547d\u5fb5\u8c61\u8840\u58d3 102/60 mmHg \uff0c\u5fc3\u8df3 56 \u6b21/min \uff0c\u547c\u5438 22 \u6b21/min \uff0c\u8840\u6c27\u98fd\u548c\u5ea6 95% \u3002\u5fc3\u96fb\u5716\u986f\u793a \uff0cLead II \u3001III \u53caaVF \u7686\u6709\u660e\u986f\u4e4b ST elevation \u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u61c9\u8003\u616e\u505a\u53f3\u5074 EKG\u3002 (B)\u53f3\u5074 EKG\u4e2d\u82e5 V4R \u4e26\u7121\u660e\u986f\u4e4b ST elevation \uff0c\u5373\u53ef\u6392\u9664\u53f3\u5fc3\u5ba4\u5fc3\u808c\u6897\u585e\u3002 (C)\u53f3\u5074 EKG\u4e2dV4R \u7121\u8ad6\u6709\u7121\u660e\u986f\u4e4b ST elevation \uff0c\u90fd\u4e0d\u5b9c\u7d66\u4e88nitroglycerin \u53camorphine \u3002 (D)\u53f3\u5fc3\u5ba4\u5fc3\u808c\u6897\u585e\u81e8\u5e8a\u8868\u73fe\u70ba\u4f4e\u8840\u58d3 \u3001\u9838\u975c\u8108\u6012\u5f35\u53ca\u7121\u80ba\u6c34\u816b\u73fe\u8c61 \u3002 (E)\u7591\u4f3c\u53f3\u5fc3\u5ba4\u5fc3\u808c\u6897\u585e\u4f75\u767c\u4f4e\u8840\u58d3 \uff0c\u800c\u9700\u7d66\u4e88\u9069\u7576\u7684\u975c\u8108\u8f38\u6db2\u6642 \uff0c\u4e0d\u5b9c\u4ee5\u4e2d\u5fc3\u975c\u8108\u58d3\u6578\u503c\u70ba\u53c3\u8003\u6578\u64da \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "50 \u6b72\u5a66\u5973\u4f86\u6025\u8a3a\u5c31\u91ab \uff0c\u7d93\u6aa2\u67e5\u8a3a\u65b7\u70ba\u5375\u5de2\u764c\u672b\u671f \uff0c\u4f60\u6c7a\u5b9a\u61c9\u7528 \u201dSPIKE\u201d \u544a\u77e5\u58de\u6d88\u606f\u7684\u6280\u5de7 \uff0c\u8acb\u554f\u95dc\u65bc \u201dSPIKE\u201d \u544a\u77e5\u58de\u6d88\u606f\u7684\u6280\u5de7 \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u201cS\u201d \u6307\u7684\u662f\u5efa\u7acb\u9069\u7576\u7684\u6e9d\u901a\u74b0\u5883 (setting up the interview )\u3002 (B)\u201dP\u201d \u6307\u7684\u662f\u8a55\u4f30\u75c5\u4eba\u7684\u8a8d\u77e5\u8207\u611f\u53d7 (perception )\u3002 (C)\u201dI\u201d \u6307\u7684\u662f\u8a55\u4f30\u75c5\u4eba\u81ea\u5df1\u5c0d\u75be\u75c5\u7684\u4e86\u89e3\u7a0b\u5ea6 (insight )\u3002 (D)\u201dK\u201d \u6307\u7684\u662f\u7d66\u4e88\u75c5\u4eba\u76f8\u95dc\u77e5\u8b58\u8207\u8a0a\u606f (knowledge )\u3002 (E)\u201dE\u201d \u6307\u7684\u662f\u61c9\u7528\u540c\u7406\u5fc3\u9867\u53ca\u75c5\u4eba\u7684\u60c5\u7dd2\u8207\u611f\u53d7 (empathy )\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "50 \u6b72\u8fb2\u592b\u5674\u7051\u8fb2\u85e5\u5f8c \uff0c\u5012\u81e5\u65bc\u7530\u908a \u3002\u88ab EMT \u9001\u5230\u6025\u8a3a\u5ba4 \uff0c\u5230\u9662\u6642\u9ad4\u6eab 38.5 \u2103\u3001\u8840\u58d3 100/70 mmHg \u3001\u547c\u5438 30 \u6b21/min \u3001\u8840\u6c27\u98fd\u548c\u5ea6 88% \uff0c\u6709\u95dc\u6709\u6a5f\u78f7\u4e2d\u6bd2( organophosphate intoxication )\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u6709\u6a5f\u78f7\u8fb2\u85e5\u662f\u5e38\u7528\u7684\u9664\u8349\u5291 \uff0c\u6703\u5f15\u8d77\u6c23\u7ba1\u5206\u6ccc\u7269\u904e\u591a \uff0c\u7d93\u5e38\u9020\u6210\u547c\u5438\u8870\u7aed\u3002 (B)\u89e3\u6bd2\u5291\u963f\u6258\u5e73 (atropine )\u4e3b\u8981\u662f\u62ee\u6297 nicotinic toxidromes \u3002 (C)\u75c5\u4eba\u6709\u62bd\u6410 (convulsions )\u53ef\u7528 diazepam \u6cbb\u7642\uff0c\u540c\u6642\u5fc5\u9808\u6ce8\u610f\u75c5\u4eba\u547c\u5438\u9053\u66a2\u901a \u3002 (D)\u6709\u6a5f\u78f7\u4e2d\u6bd2\u7684\u81f4\u6bd2\u6a5f\u8f49\u4e3b\u8981\u662f\u5f15\u8d77\u795e\u7d93\u672b\u7aef acetylcholine \u5206\u6ccc\u6e1b\u5c11 \u3002 (E)\u6709\u6a5f\u78f7\u4e2d\u6bd2\u75c5\u4eba\u7684\u77b3\u5b54\u5927\u5c0f\u70ba\u7e2e\u77b3 (miosis )\uff0c\u540c\u6642\u76ae\u819a\u70ba\u6eab\u71b1\u4e14\u4e7e\u71e5\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "52 \u6b72\u5973\u6027\u56e0\u8fd1\u65e5\u4f86\u5c0f\u817f\u4e0a\u7a81\u7136\u51fa\u73fe\u8f15\u5fae\u7600\u9752\u800c\u524d\u4f86\u6025\u8a3a \u3002\u62bd\u8840\u6aa2\u67e5\u6642\u767c\u73fe\u8840\u5c0f\u677f\u70ba 52,000/ \u00b5L\uff0c\u8840\u7d05\u7d20\u53ca\u767d\u8840\u7403\u6b63\u5e38 \u3002\u8eab\u9ad4\u6aa2\u67e5\u767c\u73fe\u9664\u5c0f\u817f\u5916\u7121\u5176\u4ed6\u51fa\u8840\u8655\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)Sulfa-containing antibiotic \u6216aspirin \u7b49\u53ef\u80fd\u9020\u6210\u8840\u5c0f\u677f\u6578\u76ee\u964d\u4f4e \uff0c\u6b64\u7a2e\u60c5\u5f62\u5927\u90e8\u5206\u53ef\u5728\u505c\u85e5 7\u81f310 \u5929\u5f8c\u9010\u6f38\u56de\u5fa9 \u3002 (B)\u809d\u786c\u5316\u75c5\u4eba\u6703\u56e0\u70ba\u813e\u81df\u816b\u5927\u9020\u6210 splenic sequestration \uff0c\u5c0e\u81f4\u8840\u5c0f\u677f\u6578\u76ee\u964d\u4f4e\u3002 (C)\u6b64\u5a66\u4eba\u8840\u5c0f\u677f\u904e\u4f4e\u6709\u81ea\u767c\u6027\u5167\u51fa\u8840\u7684\u5371\u96aa \uff0c\u61c9\u8a72\u8981\u8f38\u6ce8\u8840\u5c0f\u677f\u6fc3\u7e2e\u6db2 \u3002 (D)\u82e5\u9700\u8981\u8f38\u6ce8\u8840\u5c0f\u677f \uff0c\u6700\u597d\u9078\u64c7 ABO \u8840\u578b\u76f8\u7b26\u7684\u8840\u5c0f\u677f \u3002 (E)\u82e5\u8f38\u5165\u7684\u65b0\u9bae\u8840\u5c0f\u677f\u6c92\u6709\u906d\u5230\u7834\u58de \uff0c\u4e00\u822c\u53ef\u5b58\u6d3b 3\u81f35\u5929\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "55 \u6b72\u9577\u671f\u9152\u766e\u7684\u7537\u6027\u75c5\u4eba\u7531\u5bb6\u5c6c\u5e36\u4f86\u6025\u8a3a \uff0c\u4e3b\u8a34\u54b3\u55fd\u767c\u71d2\u5169\u500b\u661f\u671f \uff0c\u4e26\u6709\u9ad4\u91cd\u6e1b\u8f15\u4e14\u591c\u9593\u76dc\u6c57\u7684\u60c5\u5f62 \uff0c\u62bd\u8840\u6aa2\u67e5\u767d\u8840\u7403\u4e0a\u5347\u53ca\u767c\u708e\u6307\u6578\u4e0a\u5347 \uff0c\u80f8\u90e8 X\u5149\u986f\u793a\u5728\u5de6\u4e0b\u80ba\u6709 1\u500b\u7d04 5\u516c\u5206\u958b\u6d1e\u4e26\u6709 air-fluid level \u7684\u75c5\u7076\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u80ba\u81bf\u760d\u5728\u514d\u75ab\u6b63\u5e38\u8005\u4e3b\u8981\u662f\u4ee5\u597d\u6c27\u83cc (aerobic )\u70ba\u4e3b\uff0c\u800c\u5728\u514d\u75ab\u4e0d\u5168\u8005\u4e3b\u8981\u662f\u4ee5\u53ad\u6c27\u83cc (anaerobic )\u7684\u611f\u67d3\u70ba\u4e3b \u3002 (B)\u80ba\u81bf\u75ec\u7684\u6cbb\u7642 \uff0c\u55ae\u7528\u6297\u751f\u7d20\u6cbb\u7642\u7684\u5931\u6557\u7387\u592a\u9ad8 \uff0c\u61c9\u8a72\u8981\u914d\u5408\u59ff\u614b\u6027\u5f15\u6d41( postural drainage )\u6216\u662f\u652f\u6c23\u7ba1\u93e1\u5f15\u6d41 (bronchoscopic drainage )\u4ee5\u52a0\u901f\u75ca\u7652 \u3002 (C)\u80ba\u81bf\u760d\u7684\u6cbb\u7642 \uff0c\u5927\u65bc 50% \u7684\u75c5\u4eba\u9808\u63a5\u53d7\u624b\u8853\u6cbb\u7642 \uff0c\u4ee5\u6709\u6548\u7e2e\u77ed\u6297\u751f\u7d20\u4e4b\u7642\u7a0b\u3002 (D)\u80f8\u90e8 X\u5149\u662f\u8ffd\u8e64\u81e8\u5e8a\u9032\u5c55\u6700\u4f73\u7684\u4f9d\u64da \u3002 (E)\u597d\u6c27\u83cc\u901a\u5e38\u8207\u9662\u5167\u611f\u67d3\u7684\u80ba\u81bf\u75ec\u6709\u95dc \uff0c\u4e14\u6709\u8f03\u9ad8\u7684\u6b7b\u4ea1\u7387 \u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "56 \u6b72\u5973\u6027\u56e0\u610f\u8b58\u4e0d\u6e05\u800c\u81f3\u6025\u8a3a \uff0c\u5728\u6aa2\u50b7 \u6642\u767c\u73fe\u9ad4\u6eab 39.4 \u2103\uff0c\u8840\u58d3 130/80 mmHg \uff0c \u5fc3\u8df3 100 \u6b21/min \uff0c \u547c\u5438 16 \u6b21/min \uff0c\u8840\u6c27\u98fd\u548c\u5ea6 98% \u3002\u76ae\u819a\u767c\u73fe\u6709\u8a31\u591a\u5c0f\u51fa\u8840\u9ede (petechiae ) \uff0c\u8840\u6db2\u4e2d\u767d\u8840\u7403 10,000/mm 3\uff0c\u8840\u8272\u7d20 8.5 g/dL \uff0c\u8840\u5c0f\u677f 10,000/mm 3\uff0cPT \u53caaPTT \u6b63\u5e38\uff0c\u8840\u6db2\u62b9\u7247\u767c\u73fe\u6709 schistocytes \uff0c\u808c\u9178\u91504.5 mg/dL \u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u6b64\u75be\u75c5\u8f03\u5e38\u767c\u751f\u65bc\u5973\u6027\u53ca 30-50 \u6b72\u7684\u6210\u4eba \u3002 (B)\u75c5\u4eba\u7522\u751f\u5ee3\u6cdb\u6027\u8840\u7ba1\u5167\u51dd\u8840 (disseminated intravascular coagulation )\u3002 (C)\u56de\u5fa9\u6b63\u5e38\u8840\u5c0f\u677f\u6578\u76ee\u662f\u6cbb\u7642\u7684\u76ee\u6a19 \u3002 (D)\u61c9\u5118\u91cf\u907f\u514d\u8f38\u8840\u5c0f\u677f \u3002 (E)\u8840\u6f3f\u7f6e\u63db (plasma exchange )\u53ef\u6cbb\u7642\u5927\u90e8\u5206\u75c5\u4eba \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "5\u6b72\u7537\u7ae5\u88ab\u4f11\u65c5\u8eca\u5012\u8eca\u6642\u649e\u64ca \uff0c\u9001\u4f86\u6025\u8a3a\u6642\u767c\u73fe\u610f\u8b58\u4e0d\u6e05 \uff0c\u76ae\u819a\u51b0\u51b7 \uff0c\u80a2\u9ad4\u8edf\u5f31\u7121\u5f35\u529b \uff0c\u8840\u58d3 74/52 mmHg \uff0c\u5fc3\u8df3 142 \u6b21/min \uff0c\u547c\u5438 36 \u6b21/ min \uff0c\u8840\u6c27\u98fd\u548c\u5ea6 88% \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u7f6e\u5165\u6c23\u7ba1\u5167\u7ba1\u53ef\u9078\u7528 4.5 \u865f\u3002 (B)\u7d66\u4e88\u8f38\u6db2\u76ee\u6a19\u70ba\u5c3f\u91cf 1 ml/kg/hr \u3002 (C)\u6b64\u75c5\u4eba\u4f30\u8a08\u51fa\u8840\u91cf\u61c9\u5927\u65bc 20% \u3002 (D)\u5152\u7ae5\u56e0\u9aa8\u9abc\u8f03\u67d4\u8edf\u6709\u5f48\u6027 \uff0c\u80f8\u90e8\u53d7\u50b7\u6642 \uff0c\u4e0d\u6613\u767c\u751f\u5275\u50b7\u6027\u7a92\u606f(traumatic asphyxia )\u3002 (E)\u653e\u7f6e\u9f3b\u80c3\u7ba1\u53ca\u5c0e\u5c3f\u7ba1\u4e4b\u5f8c \uff0c\u6709\u52a9\u65bc\u8179\u90e8\u50b7\u5bb3\u7684\u8a55\u4f30 \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "60 \u6b72\u5973\u6027\u56e0\u70ba\u6628\u65e5\u5403\u904e\u7f50\u88dd\u9183\u86b5\u5f8c \uff0c\u767c\u751f\u8996\u529b\u6a21\u7cca\u53ca\u56db\u80a2\u9ebb\u75fa\u60c5\u5f62 \uff0c\u8840\u58d390/60mm Hg \uff0c\u5fc3\u8df3 110 \u6b21/min \uff0c\u8840\u6c27\u98fd\u548c\u5ea6 85% \uff0c\u4e0b\u5217\u6709\u95dc\u8089\u6bd2\u687f\u83cc\u4e2d\u6bd2(botulism )\u7684\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u77b3\u5b54\u4e4b\u5149\u53cd\u61c9\u6b63\u5e38 (normal light reflex )\u3002 (B)\u9ad4\u6eab\u901a\u5e38\u9ad8\u65bc 38.5 \u2103\u3002 (C)\u4e0b\u964d\u578b\u80a2\u9ad4\u7121\u529b (descending paralysis )\u3002 (D)\u610f\u8b58\u6e05\u695a (normal mental status )\u3002 (E)\u6bd2\u7d20\u5305\u62ec A\u548cB chains \uff0c\u4e3b\u8981\u662f A chain \u5f15\u8d77\u8ef8\u7a81\u795e\u7d93\u50b3\u5c0e\u7570\u5e38 \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "63 \u6b72\u7537\u6027\u904e\u53bb\u75c5\u53f2\u6709\u9ad8\u8840\u58d3\u8207\u7cd6\u5c3f\u75c5 \uff0c\u672c\u6b21\u56e0\u70ba\u6025\u6027\u80f8\u75db\u5ef6\u4f38\u81f3\u80cc\u5f8c\u800c\u88ab\u9001\u81f3\u6025\u8a3a \u3002\u6c42\u8a3a\u6642\u8840\u58d3 220/110 mmHg \u3001\u5fc3\u8df3 102 \u6b21/min \u3001\u547c\u5438 22 \u6b21/min \uff0c\u80f8\u90e8 X\u5149\u770b\u5230\u7e31\u8188\u8154\u8b8a\u5bec (mediastinum widening ) \uff0c\u5fc3\u96fb\u5716\u5448\u5de6\u5fc3\u5ba4\u80a5\u539a \u3002\u95dc\u65bc\u6b64\u75c5\u4eba\u7684\u8a3a\u65b7\u8207\u81e8\u5e8a\u8655\u7f6e \uff0c\u4e0b\u5217\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u81e8\u5e8a\u4e0a\u61c9\u8a72\u5f37\u70c8\u61f7\u7591\u4e3b\u52d5\u8108\u525d\u96e2 (aortic dissection )\uff0c\u9700\u7acb\u5373\u5b89\u6392\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5 \u3002 (B)\u96d9\u5074\u80a2\u9ad4\u8840\u58d3\u6709\u5dee\u7570 (pulse deficit )\u5c0d\u8a3a\u65b7\u6709\u5e6b\u52a9 \uff0c\u4f46\u654f\u611f\u5ea6(sensitivity )\u4f4e\u3002 (C)\u4e3b\u52d5\u8108\u525d\u96e2\u7684\u75c5\u4eba\u80f8\u90e8 X\u5149\u6709 calcium sign \u7684\u4e0d\u5230\u4e00\u534a \u3002 (D)\u4e3b\u52d5\u8108\u525d\u96e2\u901a\u5e38\u6703\u5f15\u8d77\u5fc3\u5305\u819c\u586b\u585e \uff0c\u81f4\u6b7b\u7387\u76f8\u7576\u9ad8 \u3002 (E)\u95dc\u65bc\u6b64\u75c5\u4eba\u7684\u8840\u58d3\u63a7\u5236 \uff0c\u4e0d\u53ef\u4ee5\u55ae\u7368\u4f7f\u7528 nitroprusside \uff0c\u4ee5\u514d\u9020\u6210 reflex tachycardia \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "67 \u6b72\u7537\u6027\uff0c\u56e0\u4e0d\u614e\u5de6\u5074\u982d\u90e8\u649e\u50b7\u800c\u81f3\u6025\u8a3a \uff0c\u8eab\u9ad4\u6aa2\u67e5\u767c\u73fe\u5de6\u984d -\u9873\u90e8\u982d\u76ae\u6495\u88c2\u50b7\u53ca\u5de6\u773c\u7736\u8840\u816b \uff0c\u5169\u5074\u77b3\u5b54\u7b49\u5927 2 mm \uff0c\u5149\u53cd\u5c04\u6b63\u5e38 \uff0c\u75c5\u4eba\u610f\u8b58\u6e05\u695a \uff0c\u4e3b\u8a34\u8996\u529b\u6a21\u7cca\u5df2\u6709 3\u500b\u6708\u3002\u8996\u91ce\u6aa2\u67e5\u767c\u73fe\u5de6\u5074\u540c\u5074\u504f\u76f2 \uff0c\u6700\u6709\u53ef\u80fd \u7684\u8a3a\u65b7\u70ba\u4f55\uff1f", + "Options": "(A)\u5de6\u5074\u786c\u8166\u819c\u4e0a\u51fa\u8840 \u3002 (B)\u9871\u5e95\u9aa8\u6298\u53ca\u9871\u5167\u51fa\u8840 \u3002 (C)\u53f3\u5074\u6795\u90e8\u6897\u585e\u6027\u4e2d\u98a8 \u3002 (D)\u5de6\u5074\u5c0f\u8166\u51fa\u8840 \u3002 (E)\u8166\u4e0b\u5782\u9ad4\u816b\u7624 \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "68 \u6b72\u7537\u6027\u56e0\u70ba\u6700\u8fd1\u5e7e\u5929\u5168\u8eab\u7121\u529b \u3001\u5641\u5fc3\u3001\u5614\u5410\uff0c\u800c\u88ab\u5e36\u81f3\u91ab\u9662\u6c42\u8a3a \uff0c\u75c5\u4eba\u75c5\u53f2\u6709\u5fc3\u81df\u75c5 \uff0c\u814e\u81df\u75c5 \uff0c\u9577\u671f\u670d\u7528\u7684\u85e5\u7269\u77e5\u9053\u540d\u5b57\u7684\u6709\u6bdb\u5730\u9ec3 \uff0c\u963f\u65af\u5339\u9748 \uff0c\u5229\u5c3f\u5291\uff0c\u7d93\u62bd\u8840\u6aa2\u67e5\u767c\u73fe \uff0cWBC 4,800/mm 3(band:0%, seg:70% ) \uff0c BUN 53 mg/dL \uff0cCreatinine 4.2 mg/dL \uff0cK+ 7.3 mEq/L \uff0cDigoxin level 1.75 ng/ \u00b5L\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)Digoxin level 1.75 ng/ \u00b5L\u7121\u6cd5\u6392\u9664\u75c7\u72c0\u662f\u6bdb\u5730\u9ec3\u4e2d\u6bd2\u5f15\u8d77 \u3002 (B)\u7dca\u6025\u8840\u6db2\u900f\u6790 (hemodialysis )\u7121\u6cd5\u8fc5\u901f\u6539\u5584\u75c5\u6cc1 \u3002 (C)\u82e5\u51fa\u73fe\u4e0d\u7a69\u5b9a VT \uff0c\u53ef\u4f7f\u7528\u540c\u6b65\u6574\u6d41\u8853 (synchronized cardioversion )\uff0c\u7531\u96d9\u5411 100 \u7126\u8033\u958b\u59cb\u96fb\u64ca \u3002 (D)\u82e5 digoxin level \u5927\u65bc 2.5 ng/ \u00b5L\u5247\u4e00\u5b9a\u9700\u8981\u4f7f\u7528 digoxin- specific Fab antibody \u6cbb\u7642 (E)\u4f7f\u7528 digoxin-specific Fab antibody \uff0c\u82e5\u80fd\u5c07 digoxin level \u964d\u81f3\u5c0f\u65bc 0.5 ng/ \u00b5L\uff0c\u5c0d\u75c5\u4eba\u6700\u6709\u5229 \u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "74 \u6b72\u5973\u6027\u75c5\u4eba\u7a81 \u7136\u8aaa\u8a71\u56f0\u96e3 \u3001\u541e\u56a5\u4e0d\u9806 \uff0c\u8eab\u9ad4\u6aa2\u67e5\u986f\u793a\u767c\u97f3\u969c\u7919 \uff0c\u820c\u982d\u504f\u5411\u53f3\u5074\uff0c\u53f3\u81c9\u4e0b\u5782 \uff0c\u53f3\u5074\u9762\u90e8\u611f\u89ba\u55aa\u5931 \uff0c\u53f3\u81c2\u7121\u529b\u53ca\u5931\u8a9e\u75c7 \uff0c\u4ee5\u4e0a\u8868\u5fb5 \u6700\u53ef\u80fd\u70ba\u4f55\u8655\u4e4b\u75c5\u8b8a \uff1f", + "Options": "(A)\u5de6\u5074\u8166\u5e79 \u3002 (B)\u5c0f\u8166\u3002 (C)\u5de6\u5074\u5927\u8166 \u3002 (D)\u6a4b\u8166\u3002 (E)\u53f3\u5074\u4e2d\u8166 \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4e59\u91af\u6c28\u915a (acetaminophen )\u4e2d\u6bd2\u7684\u75c7\u72c0\u5206\u671f \uff0c\u4e0b\u5217\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u7b2c\u4e00\u671f (0-24 \u5c0f\u6642)\uff0c\u53ef\u80fd\u7522\u751f\u53cd\u80c3 \u3001\u5614\u5410\u3001\u5026\u6020\u7b49\u75c7\u72c0 \uff0c\u6703\u6709\u4f4e\u8840\u9240\u73fe\u8c61\u3002 (B)\u7b2c\u4e8c\u671f (24-48 \u5c0f\u6642)\uff0c\u6b64\u671f\u75c7\u72c0\u901a\u5e38\u6703\u60e1\u5316 \uff0c\u7522\u751f\u53f3\u4e0a\u8179\u75db \uff0c\u4f46\u809d\u529f\u80fd\u53ca prothrombin time \u4ecd\u672a\u7522\u751f\u7570\u5e38 \u3002 (C)\u7b2c\u4e09\u671f (72-96 \u5c0f\u6642)\uff0c\u6703\u6709\u660e\u986f\u7684\u809d\u7d30\u80de\u58de\u6b7b \uff0c\u7522\u751f\u9ec3\u75b8 \u3001\u5614\u5410\u3001\u660e\u986f\u809d\u529f\u80fd \u3001bilirubin \u53caPT \u4e4b\u7570\u5e38\u3002\u56b4\u91cd\u6642\u53ef\u80fd\u7522\u751f\u6025\u6027\u809d\u814e\u8870\u7aed \u3001\u809d\u8166\u75c7\u3001\u809d\u660f\u8ff7 \u3001\u51fa\u8840\u7b49\u73fe\u8c61 \u3002 (D)\u7b2c\u56db\u671f (5-14 \u5929)\u5167\uff0c\u82e5\u4e2d\u6bd2\u4e0d\u6df1 \uff0c\u809d\u529f\u80fd\u53ef\u80fd\u5b8c\u5168\u5fa9\u539f \u3002 (E)\u4e59\u91af\u6c28 \u915a( acetaminophen )\u4e2d\u6bd2\u7684\u89e3\u6bd2\u5291\u70ba N-acetylcysteine \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4e2d\u5e74\u7537\u6027\u7cd6\u5c3f\u75c5\u4eba\u56e0\u610f\u8b58\u4e0d\u6e05\u88ab\u9001\u81f3\u6025\u8a3a\u5ba4 \uff0c\u624b\u6307\u8840\u7cd6\u6aa2\u6e2c\u767c\u73fe\u8840\u7cd6\u904e\u9ad8\u7121\u6cd5\u6e2c\uff0c\u95dc\u65bc\u9ad8\u8840\u7cd6 \u6025\u75c7\u4e4b\u8a55\u4f30\u8655\u7f6e \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u611f\u67d3\u75c7\u662f\u8a98\u767c\u9ad8\u6ef2\u900f\u6027\u9ad8\u8840\u7cd6\u72c0\u614b (HHS )\u7684\u6700\u5e38\u898b\u6025\u6027\u75be\u75c5 \uff0c\u7279\u5225\u662f\u80ba\u708e\u548c\u6ccc\u5c3f\u9053\u611f\u67d3 \u3002 (B)\u5229\u5c3f\u5291 \u3001\u4f7f\u7528\u92f0\u9e7d \u3001\u4e59\u578b\u963b\u65b7\u5291 \u3001\u985e\u56fa\u9187 \u3001\u9223\u96e2\u5b50\u963b\u65b7\u5291\u7b49\u85e5\u7269\u53ef\u80fd\u8b93\u75c5\u4eba\u66f4\u5bb9\u6613\u7522\u751f HHS \u3002 (C)HHS \u75c5\u4eba\u7684\u8840\u7cd6\u5e38\u9ad8\u65bc 600 mg/dL \u3001\u6709\u6548\u8840\u6e05\u6ef2\u900f\u5ea6\u5927\u65bc 315 mOsm/L \u3001\u52d5\u8108 pH \u503c>7.3 \u3001HCO 3- >15 mEq/L \u3001\u8840\u4e2d\u7121\u916e\u9ad4\u6216\u5c11\u91cf \uff0c\u4f46\u9808\u6ce8\u610f\u662f\u5426\u6709\u6df7\u5408\u578b\u9178\u9e7c\u5e73\u8861\u7570\u5e38 \u3002 (D)HHS \u5e73\u5747\u9ad4\u6db2\u4e0d\u8db3\u7d04\u70ba\u9ad4\u91cd\u7684 20~25% \u62168~12 \u516c\u5347\uff0c\u534a\u6578\u9808\u65bc\u524d 12 \u5c0f\u6642\u88dc\u5145\u5b8c\u7562 \uff0c\u5118\u53ef\u80fd\u65bc\u4e00\u5929\u5167\u5e73\u8861 \u3002\u958b\u59cb\u8f38\u6db2\u5efa\u8b70\u4ee5\u751f\u7406\u98df\u9e7d\u6c3415~20 ml/kg/hr (\u7b2c 1\u5c0f\u6642)\u88dc\u5145\uff0c\u4e4b\u5f8c 4~14 ml/kg/hr \u88dc\u5145\u3002 (E)HHS \u7684\u80f0\u5cf6\u7d20\u6cbb\u7642\u958b\u59cb\u4ee5 0.1 units/kg/hr \uff0c\u6bcf\u5c0f\u6642\u6e2c\u8840\u7cd6 \uff0c\u82e5\u7576\u8840\u7cd6\u964d\u81f3 250 mg/dL \uff0c\u6539\u7528\u542b 5% \u7cd6\u6c34\u4e4b\u751f\u7406\u98df\u9e7d\u6c34\u8f38\u6db2 \uff0c\u7dad\u6301\u8840\u7cd6\u65bc150~200 mg/dL \u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u5728\u6025\u8a3a\u5ba4\u70ba 4\u6b72\u7537\u7ae5\u9032\u884c\u984d\u982d\u6495\u88c2\u50b7\u7e2b\u5408\u624b\u8853\u6642 \uff0c\u7537\u7ae5\u8e81\u52d5\u7121\u6cd5\u914d\u5408\u7e2b\u5408 \u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u4f7f\u7528 ketamine \u808c\u8089\u6ce8\u5c04 \uff0c\u53ef\u7522\u751f\u5408\u4f75\u93ae\u975c\u8207\u6b62\u75db\u7684\u6548\u679c \u3002 (B)\u53ef\u7d66\u4e88 midazolam \u56e0\u70ba\u5b89\u5168 \u3001\u6709\u6548\uff0c\u4e14\u4f5c\u7528\u6642\u9593\u77ed \u3002 (C)Ketamine \u53ef\u5408\u4f75 midazolam \u4f7f\u7528\uff0c\u4ee5\u6e1b\u5c11\u5e7b\u89ba\u7684\u7522\u751f \u3002 (D)Ketamine \u53ef\u4f7f\u7528\u65bc 3\u500b\u6708\u7684\u5b30\u5152 \uff0c\u4f46\u8981\u6ce8\u610f\u553e\u6db2\u904e\u591a \uff0c\u9632\u6b62\u547c\u5438\u9053\u7684\u963b\u585e\u3002 (E)\u53ef\u4f7f\u7528 chloral hydrate \uff0c\u4f46\u85e5\u6548\u7522\u751f\u6162 \uff0c\u4e14\u4f5c\u7528\u6642\u9593\u9577 \u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u5728\u7406\u60f3\u60c5\u6cc1\u4e0b \uff0c\u5316\u707d\u53d7 \u6c61\u67d3\u75c5\u4eba\u7684\u53bb\u6c61\u6b65\u9a5f\u61c9\u8a72\u5728\u91ab\u9662\u5916\u57f7\u884c \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u707d\u5bb3\u73fe\u5834\u61c9\u5efa\u7acb\u71b1 \u3001\u6eab\u3001\u51b7\u5340\u548c\u4e26\u5c01\u9396\u73fe\u5834\u9032\u884c\u7ba1\u5236 \u3002 (B)\u5728\u71b1\u5340\u88e1\u4e3b\u8981\u662f\u5c07\u53d7\u6c61\u67d3\u75c5\u4eba\u76e1\u901f\u6551\u96e2 \uff0c\u907f\u514d\u9032\u4e00\u6b65\u52a0\u91cd\u6c59\u67d3\u66b4\u9732 \u3002 (C)\u5728\u6696\u5340\u88e1\u53d7\u6c61\u67d3\u75c5\u4eba\u61c9\u5fb9\u5e95\u9664\u6c61\u548c\u91ab\u7642\u8655\u7f6e\u4ee5\u7a69\u5b9a\u75c5\u60c5 \u3002 (D)\u5728\u51b7\u5340\u5c07\u88ab\u8f49\u51fa\u7684\u75c5\u4eba\u662f\u5df2\u5b8c\u5168\u9664\u6c61\u7684\u72c0\u614b \u3002 (E)\u6696\u5340\u8207\u51b7\u5340\u4e4b\u9593\u7684\u4eba\u54e1 \uff0c\u53ef\u4ee5\u76f8\u4e92\u652f\u63f4\u6551\u8b77\u5de5\u4f5c \u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u5730\u9707\u50b7\u8005\u88ab\u623f\u5b50\u5012\u584c\u58d3\u50b7 \uff0c\u7d93 8\u5c0f\u6642\u5f8c\u624d\u7372\u812b\u56f0\u5f8c\u9001\u81f3\u91ab\u9662 \uff0c\u6b64\u6642\u6700\u4e0d\u53ef\u80fd\u767c\u751f\u7684\u50b7\u5bb3\u70ba \uff1f", + "Options": "(A)\u4f4e\u9ad4\u6eab \u3002 (B)\u6a6b\u7d0b\u808c\u6eb6\u89e3\u75c7 \u3002 (C)\u5916\u50b7\u6027\u7a92\u606f \u3002 (D)\u56e0\u7d44\u7e54 \u518d\u704c\u6d41\u9020\u6210\u5fc3\u5f8b\u4e0d\u6574\u53ca\u731d\u6b7b \u3002 (E)\u50b7\u53e3\u56b4\u91cd\u611f\u67d3\u5c0e\u81f4\u6557\u8840\u75c7 \u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u6709\u4e00\u706b\u707d\u73fe\u5834\u51fa\u73fe\u5927\u91cf\u50b7\u60a3 \uff0c\u73fe\u5834\u6aa2\u50b7\u4eba\u54e1\u767c\u73fe\u4e00\u4f4d\u75c5\u4eba\u5012\u81e5\u5728\u5730\u6c92\u6709\u547c\u5438\uff0c\u6253\u958b\u547c\u5438\u9053\u4e4b\u5f8c\u4ecd\u7121\u6cd5\u81ea\u884c\u547c\u5438 \u3002\u4f9d START (Simple Triage and Rapid Treatment )\u6aa2\u50b7\u539f\u5247 \uff0c\u4e0b\u4e00\u6b65\u8655\u7f6e\u4f55\u8005 \u6700\u9069\u7576\uff1f", + "Options": "(A)\u7d66\u4e88\u53e3\u5c0d\u53e3\u4eba\u5de5\u547c\u5438 \u3002 (B)\u63d2\u4e0a\u5589\u7f69\u5f0f\u547c\u5438\u9053 \u3002 (C)\u6aa2\u67e5\u6709\u7121\u8108\u640f \u3002 (D)\u7d66\u4e88\u5fc3\u5916\u6309\u6469 \u3002 (E)\u653e\u68c4\u6025\u6551 \u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u6709\u95dc pediatric trauma \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u70ba\u9054\u5230 sniffing position \uff0c\u63d2\u7ba1\u6642\u61c9\u5c07\u982d\u6795\u90e8 (occiput )\u588a\u9ad8\u3002 (B)\u56e0\u70ba\u653e\u7f6e intraosseous needle \u53ef\u80fd\u6703\u50b7\u5bb3\u751f\u9577\u677f \uff0c\u6240\u4ee5\u5c0f\u65bc 6\u6b72\u5152\u7ae5\u61c9\u5728\u975c\u8108\u5c0e\u7ba1\u53ca\u4e2d\u5fc3\u975c\u8108\u5c0e\u7ba1\u5747\u7121\u6cd5\u5efa\u7acb\u6642\u624d\u5efa\u8b70\u65bd\u884c \u3002 (C)6\u6b72\u5152\u7ae5\u82e5\u6709\u56b4\u91cd\u51fa\u8840 \uff0c\u7d66\u4e88\u8f38\u6db2\u6cbb\u7642 10 ml/kg \u3002 (D)\u82e5\u80f8\u90e8 X\u5149\u6c92\u6709\u986f\u793a\u808b\u9aa8\u9aa8\u6298 \uff0c\u6c23\u80f8\u6216\u8840\u80f8\u6642 \uff0c\u5247 pulmonary contusion \u7684\u6a5f\u6703\u6975\u4f4e \u3002 (E)\u5c0f\u65bc 1\u6b72\u4ee5\u4e0b\u7684\u5b30\u5152\u5176\u6b63\u5e38\u5c3f\u91cf\u61c9\u5927\u65bc 2 ml/kg/hr \u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u4e2d\u6bd2\u75c5\u4eba\uff0c\u81e8\u5e8a\u4f7f\u7528\u89e3\u6bd2\u5291\uff0c\u4e0b\u5217\u914d\u5c0d\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u4e09\u74b0\u6297\u6182\u9b31\u5291(TCA)--sodium bicarbonate\u3002 (B)\u82ef\u91cd\u6c2e\u57fa\u9e7d(benzodiazepine)--flumazenil\u3002(C)\u758a\u6c2e\u5316\u7269(azide)--amyl & sodium nitrite\uff0c sodium thiosulfate (\u4e9e\u785d\u9178\u620a\u916f\u3001\u4e9e\u785d\u9178\u9209\u3001\u786b\u4ee3\u786b\u9178\u9209)\u3002(D)\u8b8a\u6027\u8840\u7d05\u7d20\u8840\u75c7(methemoglobinemia)--methylene blue(\u7532\u57fa\u85cd)\u3002(E)\u7532\u9187(methanol)--fomepizole\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u5916\u50b7\u6027\u4e3b\u52d5\u8108\u7834\u88c2 \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u53ef\u80fd\u5728\u5165\u9662\u5f8c\u7a81\u7136\u60e1\u5316\u800c\u6b7b\u4ea1 \u3002 (B)\u5178\u578b\u80f8\u90e8 X\u5149\u7684\u8868\u73fe\u5305\u542b\u9f3b\u80c3\u7ba1\u7684\u4f4d\u7f6e\u504f\u5411\u5de6\u5074 \u3002 (C)\u87ba\u65cb\u5f0f\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u6c92\u6709\u767c\u73fe\u8840\u80f8\u53ca\u4e3b\u52d5\u8108\u7684\u554f\u984c \uff0c\u4ecd\u61c9\u5bc6\u5207\u89c0\u5bdf\u75c5\u4eba\u751f\u547d\u5fb5\u8c61 \u3002 (D)\u82e5\u540c\u6642\u767c\u73fe\u51fa\u8840\u6d41\u5165\u5de6\u5074\u80f8\u90e8\u7684\u60c5\u5f62 \uff0c\u9808\u7acb\u5373\u5b89\u6392\u624b\u8853 \u3002 (E)\u56b4\u683c\u7684\u85e5\u7269\u63a7\u5236\u6536\u7e2e\u58d3\u5728 100 - 120 mmHg \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u5b55\u5a66\u5b50\u764e\u75c7 (eclampsia )\u4e4b\u6558\u8ff0\u53ca\u8655\u7f6e \uff0c\u4e0b\u5217\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u63a7\u5236 seizure \u6700\u6709\u6548\u85e5\u7269\u70ba MgSO 4\uff0cloading dose \u70ba6 gm \u3002 (B)\u61c9\u7a4d\u6975\u7d66\u4e88\u5229\u5c3f\u5291 diuretics \uff0c\u63a7\u5236\u8212\u5f35\u58d3 < 105 mmg/Hg \u53ca\u5c3f\u91cf > 30 ml/hr \uff0c\u4ee5\u6e1b\u8f15\u6c34\u816b\u73fe\u8c61 \u3002 (C)\u82e5\u75c5\u4eba\u6301\u7e8c seizure \uff0c\u4ecd\u9700\u57f7\u884c\u982d\u90e8\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5 \u3002 (D)\u75c5\u4eba\u9808\u5408\u4f75\u6709\u86cb\u767d\u5c3f \uff0c\u624d\u7b26\u5408\u8a3a\u65b7 \u3002 (E)\u61c9\u5118\u5feb\u5b89\u6392\u5f15\u7522 \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u5b55\u5a66\u6025\u6027\u8179\u75db\u7684\u6558\u8ff0 \uff0c\u4e0b\u5217\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u61f7\u5b55\u524d\u671f\u6700\u5e38\u898b\u5b50\u5bae\u5916\u5b55\u53ca\u5148\u5146\u6027\u6d41\u7522 \u3002 (B)\u61f7\u5b55\u5f8c\u671f\u6700\u5e38\u898b\u5b50\u5bae\u65e9\u671f\u5bae\u7e2e\u53ca \u80ce\u76e4\u5265\u96e2\u3002 (C)\u81bd\u7d50\u77f3\u5728\u61f7\u5b55\u6642\u671f \uff0c\u6a5f\u7387\u589e\u9ad8 \uff0c\u70ba\u5b55\u5a66\u6700\u5e38\u9700\u7dca\u6025\u624b\u8853\u7684\u75be\u75c5 \u3002 (D)\u6025\u6027\u95cc\u5c3e\u708e\u767c\u751f\u7387\u5728\u5b55\u5a66\u4e0d\u8b8a \uff0c\u4f46 delayed diagnosis \u6bd4\u4f8b\u8f03\u9ad8 \u3002 (E)\u8d85\u97f3\u6ce2\u662f\u5728\u5b55\u5a66\u6025\u6027\u8179\u75db\u512a\u5148\u4f7f\u7528\u4e4b\u8a3a\u65b7\u5de5\u5177 \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6c11\u570b 102 \u5e74\u885b\u751f\u798f\u5229\u90e8\u516c\u4f48\u4e4b \u300e\u61c9\u7f6e\u6709\u81ea\u52d5\u9ad4\u5916\u5fc3\u81df\u96fb\u64ca\u53bb\u986b\u5668\u4e4b\u516c\u5171\u5834\u6240\u300f\uff0c\u4e0b\u5217\u4f55\u8005 \u4e0d\u5c6c\u65bc\u898f\u5b9a\u4e2d\u4e4b\u516b\u5927\u985e\u516c\u5171\u5834\u6240 \uff1f", + "Options": "(A)\u4e8c\u7b49\u7ad9\u4ee5\u4e0a\u4e4b\u53f0\u9435\u8eca\u7ad9 \u3002 (B)\u5ea7\u4f4d\u6578\u8d85\u904e 19 \u4eba\u5ea7\u4e14\u6d3e\u9063\u5ba2\u8259\u7d44\u54e1\u4e4b\u8f09\u5ba2\u98db\u6a5f \u3002 (C)\u5e73\u5747\u55ae\u65e5\u6709 3,000 \u540d\u6c11\u773e\u51fa\u5165\u4e4b\u96fb\u5f71\u7247\u6620\u6f14\u5834\u6240 \u3002 (D)\u570b\u4e2d\u4ee5\u4e0a\u4e4b\u5b78\u6821 \u3002 (E)\u5ba2\u623f\u623f\u9593\u8d85\u904e 250 \u9593\u4e4b\u65c5\u9928 \u3001\u98ef\u5e97\u3001\u62db\u5f85\u6240 (\u9650\u6709\u5be2\u5ba4\u5ba2\u623f\u8005 )\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u5152\u7ae5\u6025\u6027\u95cc\u5c3e\u708e (acute appendicitis )\uff0c\u4e0b\u5217\u654d\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u975e\u7834\u88c2\u6027\u95cc\u5c3e\u708e\u4ee5\u7537\u7ae5\u8f03\u591a \uff0c\u9ad8\u5cf0\u671f\u70ba 9\u81f312 \u6b72\uff0c 2\u6b72\u4ee5\u4e0b\u8f03\u5c11\u767c\u751f\u3002 (B)\u6025\u6027\u95cc\u5c3e\u708e\u53ef\u80fd\u6703\u51fa\u73fe\u5c40\u90e8\u8179\u819c\u708e\u5fb5\u72c0 (local peritoneal sign )\uff0c\u4f46\u5982\u95cc\u5c3e\u4f4d\u65bc\u9aa8\u76c6\u8154\u5167 \uff0c\u5247\u4e0d\u6613\u51fa\u73fe\u6b64\u5fb5\u72c0 \u3002 (C)\u75c5\u7ae5\u6703\u51fa\u73fe\u53ad\u98df \u3001\u5614\u5410\u3001\u53f3\u4e0b\u8179\u75bc\u75db \uff0c\u975e\u7834\u88c2\u6027\u95cc\u5c3e\u708e\u75c5\u7ae5\u53ef\u80fd\u6709\u767c\u71d2\uff0c\u4f46\u7834\u88c2\u6027\u95cc\u5c3e\u708e\u75c5\u7ae5\u767c\u71d2\u7684\u6eab\u5ea6\u8f03\u9ad8 \u3002 (D)10 \u6b72\u4ee5\u4e0a\u95cc\u5c3e\u708e\u75c5\u7ae5\u767c\u751f\u7834\u88c2\u7684\u6a5f\u7387 \uff0c\u6bd4 3\u6b72\u4ee5\u4e0b\u9ad8 \u3002 (E)\u975e\u7834\u88c2\u6027\u95cc\u5c3e\u708e\u65bc\u75c7\u72c0\u51fa\u73fe\u4e4b 8\u81f324 \u5c0f\u6642\u5167\u5373\u53ef\u4ee5\u9032\u5c55\u5230\u7834\u88c2\u6027\u95cc\u5c3e\u708e\uff0c\u6545\u9808\u5118\u65e9 \u6703\u8a3a\u5916\u79d1\u91ab\u5e2b\u8655\u7f6e \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u73ab\u7470\u75b9 (roseola infantum )\u7684\u8a3a\u65b7 \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u4e3b\u8981\u662f\u7531\u4eba\u985e\u76b0\u75b9\u75c5\u6bd2\u7b2c\u516d\u578b (human herpes virus 6 )\u6240\u5f15\u8d77 \u3002 (B)\u597d\u767c\u7684\u5e74\u7d00\u662f 6\u500b\u6708\u5230 3\u6b72\u3002 (C)\u51fa\u75b9\u5f8c\u4e0d\u4e45\u5c31\u51fa\u73fe\u9000\u71d2 \u3002 (D)\u75b9\u5b50\u4e3b\u8981\u51fa\u73fe\u5728\u9838\u90e8 \u3001\u8ec0\u5e79\u3001\u81c0\u90e8\u53ca\u53e3\u8154\u9ecf\u819c \u3002 (E)\u767c\u751f\u71b1\u75d9\u6523\u7684\u6a5f\u7387\u9ad8 \u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u7f8e\u570b\u5fc3\u81df\u5354\u6703 (AHA )\u6025\u6027\u7f3a\u8840\u6027\u8166\u4e2d\u98a8\u75c5\u4eba\u4e4b\u6025\u6551\u8655\u7f6e \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u61c9\u5118\u901f\u5b8c\u6210\u7f8e\u570b\u570b\u5bb6\u885b\u751f\u9662\u8166\u4e2d\u98a8\u91cf\u8868 (National Institutes of Health Stroke Scale, NIHSS )\u7684\u8a55\u4f30 \u3002 (B)\u82e5\u75c5\u4eba\u6c92\u6709\u4f7f\u7528\u53e3\u670d\u6297\u51dd\u8840\u5291 \uff0c\u5047\u5982\u6642\u9593\u7dca\u8feb \uff0c\u51dd\u8840\u6aa2\u9a57\u7d50\u679c\u5c1a\u672a\u51fa\u4f86\u4e4b\u524d\u53ef\u5148\u7d66\u4e88 r-tPA \u6cbb\u7642\u3002\u4f46\u82e5\u5f8c\u4f86\u6aa2\u9a57\u7d50\u679c\u51fa\u4f86\u986f\u793a INR > 1.7 \u6216aPTT \u6642\u9593\u5ef6\u9577\u6642\u5247\u9808\u505c\u6b62\u6cbb\u7642 \u3002 (C)\u82e5\u7b26\u5408\u898f\u5b9a\u53ca\u9069\u61c9\u75c7 \uff0c\u53ef\u4f7f\u7528\u8840\u6813\u6eb6\u89e3\u5291 (r-tPA ) \u9032\u884c\u8840\u6813\u6eb6\u89e3\u6cbb\u7642 \uff0c\u5efa\u8b70\u5291\u91cf\u70ba 0.9 mg/kg \uff0c10% \u975c\u8108\u63a8\u6ce8 1\u5206\u9418\uff0c\u5176\u9918 90% \u975c\u8108\u6ef4\u6ce8 1\u5c0f\u6642\u3002 (D)\u65bd\u6253 r-tPA \u6642\uff0c\u61c9\u540c\u6642\u5118\u5feb\u7d66\u4e88 aspirin \u3002 (E)\u5982\u5df2\u65bd\u6253 r-tPA \uff0c\u4e0d\u5efa\u8b70\u518d\u7d66\u4e88\u6297\u51dd\u8840\u85e5\u7269\u5982 heparin \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u7f8e\u570b\u570b\u5bb6\u885b\u751f\u9662\u8166\u4e2d\u98a8\u91cf\u8868 (National Institutes of Health Stroke Scale \uff0cNIHSS )\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u6db5\u84cb\u8a55\u4f30\u6025\u6027 \u8166\u4e2d\u98a8\u75c5\u4eba\u7684\u5b8c\u6574\u795e\u7d93\u5b78\u6aa2\u67e5 \u3002 (B)\u53ef\u8a55\u4f30\u8166\u4e2d\u98a8\u75c5\u4eba \u7684\u81e8\u5e8a\u56b4\u91cd\u5ea6 \u3002 (C)\u5206\u6578\u7531 0\u5206\u81f3 42 \u5206\u3002 (D)\u5206\u6578\u8d8a\u9ad8\u4ee3\u8868\u75c5\u6cc1\u8d8a\u56b4\u91cd \u3002 (E)\u4e00\u822c\u800c\u8a00 \uff0c\u5927\u65bc 25 \u5206\u7684\u75c5\u4eba\u4e0d\u5efa\u8b70\u65bd\u6253\u8840\u6813\u6eb6\u89e3\u5291 \u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u7729\u6688\u75c7 (vertigo )\u7684\u9451\u5225\u8a3a\u65b7 \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u826f\u6027\u9663\u767c\u59ff\u52e2\u6027\u7729\u6688\u75c7 (benign paroxysmal positional vertigo )\u7684\u75c7\u72c0\u6703\u96a8\u8457\u53cd\u8986\u7684\u8a98\u767c\u800c\u6e1b\u7de9 \u3002 (B)\u6885\u5c3c\u723e\u6c0f\u75c7 (M\u00e9ni\u00e8re disease ) \u7b2c\u4e00\u6b21\u767c\u4f5c\u7684\u5e74\u9f61 \uff0c\u901a\u5e38\u5728 65 \u6b72\u4ee5\u4e0b\u3002 (C)\u82e5\u540c\u6642\u5408\u4f75\u6b65\u614b\u5931\u8abf \u3001\u807d\u529b\u55aa\u5931\u53ca\u55ae\u5074\u8996\u529b\u4e0d\u826f\u5247\u8981\u8003\u616e\u5c0f\u8166\u6a4b\u8166\u89d2(cerebellopontine angle )\u816b\u7624\u3002 (D)\u524d\u5ead\u795e\u7d93\u708e (vestibular neuronitis )\u901a\u5e38\u6301\u7e8c\u6578\u5929 \uff0c\u4e14\u901a\u5e38\u4e0d\u6703\u5fa9\u767c \u3002 (E)\u5167\u8033\u8ff7\u8def\u708e (labyrinthitis )\u901a\u5e38\u6703\u5408\u4f75\u807d\u529b\u55aa\u5931 \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u9662\u5916\u707d\u5bb3\u73fe\u5834\u7dca\u6025\u61c9\u8b8a\u4f5c\u696d \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u4ee5\u7c21\u6613\u6aa2\u50b7\u53ca\u5feb\u901f\u6cbb\u7642\u6cd5\u5247 (simple triage and rapid treatment \uff0cSTART )\u505a\u6aa2\u50b7\u5206\u985e \u3002 (B)\u5728\u707d\u5bb3\u73fe\u5834\u82e5\u6709\u5371\u53ca\u6551\u8b77\u4eba\u54e1\u7684\u60c5\u6cc1 \uff0c\u61c9\u4ee5\u6e1b\u5c11\u73fe\u5834\u8655\u7f6e\u5feb\u901f\u8f49\u9001\u70ba\u539f\u5247\u3002 (C)\u53ef\u5c07\u8f15\u50b7\u75c5\u4eba\u9001\u5f80\u8f03\u9060\u7684\u91ab\u9662 \uff0c\u4ee5\u514d\u9020\u6210\u7576\u5730\u91ab\u9662\u6025\u8a3a\u58c5\u585e \uff0c\u800c\u7121\u6cd5\u6709\u6548\u8655\u7406\u91cd\u75c7\u75c5\u4eba \u3002 (D)\u70ba\u4e86\u5118\u901f\u6551\u707d \uff0c\u6307\u63ee\u5b98\u61c9\u8981\u6c42\u6700\u8fd1\u6025\u6551\u8cac\u4efb\u91ab\u9662\u6d3e\u51fa\u91ab\u7642\u4eba\u54e1\u7d44\u6210\u6551\u8b77\u968a\u524d\u5f80\u6551\u63f4 \u3002 (E)\u61c9\u8b8a\u6307\u63ee\u4e2d\u5fc3\u9700\u8981\u8207\u7576\u5730\u91ab\u9662\u5bc6\u5207\u806f\u7d61 \uff0c\u6e9d\u901a\u9700\u8981\u8f49\u9001\u91ab\u9662\u7684\u75c5\u4eba\u72c0\u6cc1\u4ee5\u6c42\u5b8c\u7f8e\u914d\u5408 \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6557\u8840\u6027\u4f11\u514b \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u6557\u8840\u6027\u4f11\u514b\u5c31\u662f\u6557\u8840\u75c7\u4f75\u767c\u5e73\u5747\u52d5\u8108\u58d3\u5c0f\u65bc 65 mmHg \uff0c\u4e14\u7d93\u5feb\u901f\u8f38\u6db2 30 ml/kg \u5f8c\u4ecd\u70ba\u4f4e\u8840\u58d3 \u3002 (B)\u61c9\u7f6e\u653e\u4e2d \u5fc3\u975c\u8108\u5c0e\u7ba1 (CVP )\uff0c\u4e26\u7dad\u6301 CVP level \u65bc8-12 mmHg \u5de6\u53f3\u3002 (C)\u5927\u591a\u7684\u793e\u5340\u6027\u8166\u819c\u708e\u4f75\u6557\u8840\u6027\u4f11\u514b\u662f\u7531 S. pneumoniae \u6216 N. meningitidis \u5f15\u8d77\u3002 (D)\u82e5\u8003\u616e\u7d66\u4e88 \u5347\u58d3\u5291\uff0c\u61c9\u512a\u5148\u4f7f\u7528 dopamine \u3002 (E)\u8edf\u7d44\u7e54\u611f\u67d3\u5f15\u8d77\u7684\u6557\u8840\u6027\u4f11\u514b \uff0c\u591a\u6578\u6703\u6709\u83cc\u8840\u75c7 \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u814e\u4e0a\u817a\u529f\u80fd\u4e0d\u8db3 (adrenal insufficiency )\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)Addison disease \u76ee\u524d\u88ab\u8a8d\u70ba\u5927\u90e8\u5206\u548c\u514d\u75ab\u75be\u75c5\u4eba\u6709\u95dc \u3002 (B)\u5c31\u5168\u4e16\u754c\u7684\u7d71\u8a08\u4f86\u770b \uff0c\u5f15\u8d77\u814e\u4e0a\u817a\u529f\u80fd\u4e0d\u8db3\u7684\u539f\u56e0\u4e2d \uff0c\u6700\u5e38\u898b\u7684\u611f\u67d3\u75c7\u662f\u7d50\u6838\u75c5 \u3002 (C)\u8166\u4e0b\u5782\u9ad4\u8853\u5f8c \uff0c\u75c5\u4eba\u6709\u53ef\u80fd\u767c\u751f\u7684\u4f75\u767c\u75c7\u4e4b\u4e00 \u3002 (D)HIV \u6703\u76f4\u63a5\u7834\u58de\u814e\u4e0a\u817a\u800c\u5f15\u8d77\u814e\u4e0a\u817a\u529f\u80fd\u4e0d\u8db3 \u3002 (E)Sheehan syndrome \u662f\u4e00\u7a2e\u7522\u5f8c\u5927\u5931\u8840\u9020\u6210\u8166\u4e0b\u5782\u9ad4\u524d\u8449\u7684\u58de\u6b7b \uff0c\u5c0e\u81f4\u5167\u5206\u6ccc\u5931\u8abf \uff0c\u5305\u62ec\u814e\u4e0a\u817a\u6a5f\u80fd\u4f4e\u4e0b \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u816b\u7624\u6eb6\u89e3\u75c7\u5019\u7fa4 (tumor lysis syndrome )\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u4e3b\u8981\u662f\u767c\u751f\u5728\u8840\u6db2\u65b9\u9762\u7684\u60e1\u6027\u816b\u7624 \u3002 (B)\u816b\u7624\u6eb6\u89e3\u75c7\u5019\u7fa4\u4e2d\u6700\u6613\u9020\u6210\u81f4\u547d\u7684\u96e2\u5b50\u4e0d\u5e73\u8861\u662f\u9ad8\u8840\u9240 \u3002 (C)\u9ad8\u8840\u9223\u4e5f\u5e38\u898b\u65bc\u816b\u7624\u6eb6\u89e3\u75c7\u5019\u7fa4 \u3002 (D)\u9ad8\u5c3f\u9178\u8840\u75c7\u6cbb\u7642\u5305\u62ec\u9e7c\u5316\u5c3f\u6db2 \uff0c\u975c\u8108\u8f38\u6db2\u4ee5\u53ca\u7d66\u4e88 acetazolamide \u3002 (E)\u975c\u8108\u8f38\u6db2\u53ca\u4f7f\u7528\u964d\u5c3f\u9178\u85e5 allopurinol \uff0c\u53ef\u4ee5\u964d\u4f4e\u816b\u7624\u6eb6\u89e3\u75c7\u7684\u767c \u751f\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u7dca\u6025\u80f8\u5ed3\u5207\u958b\u8853 (emergent thoracotomy )\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u920d\u50b7\uff0c\u7121\u8108\u640f \uff0cEKG \u70baasystole \u3002 (B)\u920d\u50b7\uff0c\u7121\u8108\u640f \uff0cEKG \u70bapulseless electrical activity (PEA )\u3002 (C)\u7a7f\u523a\u50b7 \uff0c\u7121\u8108\u640f \uff0cEKG \u70baasystole \u3002 (D)\u7a7f\u523a\u50b7 \uff0c\u7121\u8108\u640f \uff0cEKG \u70baPEA \u3002 (E)\u7a7f\u523a\u50b7 \uff0c\u6709\u8108\u640f \uff0c\u660e\u986f\u4f11\u514b \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6f5b\u6c34\u5f15\u8d77\u4e4b\u6e1b\u58d3\u75c5 (decompression sickness )\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u53c3\u52a0\u6f5b\u6c34\u6d3b\u52d5\u6f5b\u81f3 30 \u7c73\u6df1\u4e0a\u5347\u5f8c \uff0c\u9020\u6210\u80a2\u9ad4\u8207\u95dc\u7bc0\u75bc\u75db \uff0c\u662f\u7b2c\u4e8c\u578b\u6e1b\u58d3\u75c5(Type II DCS )\u3002 (B)\u53c3\u52a0\u6f5b\u6c34\u65c5\u904a\u6d3b\u52d5\u5f8c \uff0c\u6b32\u642d\u4e58\u98db\u6a5f\u8fd4\u56de\u53f0\u7063\u81f3\u5c11\u9700\u6f5b\u6c34\u6d3b\u52d5\u7d50\u675f 6\u5c0f\u6642\u5f8c\u624d\u80fd\u642d\u4e58 \uff0c\u4ee5\u907f\u514d\u6e1b\u58d3\u75c5\u767c\u751f \u3002 (C)\u6e1b\u58d3\u75c5\u6700\u6709\u6548\u4e4b\u6cbb\u7642\u662f\u76f4\u63a5\u4ee5\u52a0\u58d3\u8259 3ATA \u9032\u884c\u9ad8\u58d3\u6c27 (HBO ) \u6cbb\u7642\u3002 (D)\u5c0d\u65bc\u6e1b\u58d3\u75c5\u4e4b\u8f14\u52a9\u6cbb\u7642 \uff0cheparin \u5728\u5be6\u8b49\u91ab\u5b78\u7814\u7a76\u65bc\u4eba\u985e\u4e26\u672a\u6709\u6548 \u3002 (E)\u6f5b\u6c34\u5f15\u8d77\u6e1b\u58d3\u75c5\u4e4b\u75c5\u7406\u6a5f\u8f49\u662f\u7531\u65bc\u6c26\u6c23\u8d85\u98fd\u548c\u5806\u7a4d\u65bc\u9ad4\u5167\u6240\u81f4 \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6a6b\u9694\u819c\u53d7\u50b7 \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u7a7f\u523a\u50b7\u6240\u81f4\u8005 \uff0c\u6bd4\u920d\u632b\u50b7\u8f03\u5e38\u51fa\u73fe \u3002 (B)\u920d\u632b\u50b7\u6240\u81f4\u8005 \uff0c\u591a\u51fa\u73fe\u5728\u5de6\u5074 \u3002 (C)\u8f15\u5fae\u6a6b\u9694\u819c\u50b7\u5bb3 \uff0c\u96fb\u8166\u65b7\u5c64\u7684\u6a6b\u65b7\u9762\u6aa2\u67e5\u4e0d\u6613\u767c\u73fe \u3002 (D)\u5bb9\u6613\u8aa4\u8a3a\u70ba\u55ae\u5074\u8840\u80f8 \u3002 (E)\u4e3b\u8981\u81e8\u5e8a\u8868\u73fe\u70ba\u51fa\u8840\u6027\u4f11\u514b \u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u7672\u7647\u91cd\u7a4d\u72c0\u614b (status epilepticus )\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u7672\u7647\u91cd\u7a4d\u72c0\u614b \u7684\u5b9a\u7fa9\u662f\u6307\u7672\u7647\u9023\u7e8c\u767c\u4f5c\u6216\u9593\u6b47\u6027\u767c\u4f5c\u8d85\u904e 30 \u5206\u9418\uff0c\u800c\u6c92\u6709\u6062\u5fa9\u610f\u8b58 \u3002 (B)\u6709\u670d\u7528\u7672\u7647\u85e5\u7269\u75c5\u4eba \uff0c\u901a\u5e38\u9700\u76e3\u6e2c\u7672\u7647\u85e5\u7269\u6fc3\u5ea6 \u3002 (C)\u8001\u5e74\u4eba\u7b2c\u4e00\u6b21\u7672\u7647\u767c\u4f5c \uff0c\u5e38\u898b\u539f\u56e0\u70ba\u8166\u4e2d\u98a8 \u3002 (D)Depakine \u8f03 phenytoin \u66f4\u9069\u5408\u4f7f\u7528\u5728\u5fc3\u5f8b\u4e0d\u6574\u7684\u7672\u7647\u91cd\u7a4d\u72c0\u614b\u75c5\u4eba \u3002 (E)Phenytoin \u7684\u5efa\u8b70\u5291\u91cf\u70ba 20 mg/kg \uff0c\u4e0d\u61c9\u52a0\u5728 \u542b\u6709\u8461\u8404\u7cd6\u7684 \u8f38\u6db2\uff0c\u4e14\u901f\u5ea6\u4e0d\u61c9\u8d85\u904e 50 mg/min \u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u4f60\u6b63\u5728\u8655\u7406\u4e00\u540d 3 \u500b\u6708\u5927\u5230\u9662\u524d\u5fc3\u8df3\u505c\u6b62(OHCA)\u7684\u7537\u5b30\uff0c\u8acb\u554f\u5c0d\u65bc\u5354\u52a9\u4f60\u5224\u65b7\u75c5\u5b30\u662f\u5426\u70ba\u5b30\u5152\u731d\u6b7b\u75c7(sudden infant death syndrome)\u7684\u9ad8\u5371\u96aa\u65cf\u7fa4\uff0c\u6700\u7121\u52a9\u76ca\u7684\u75c5\u53f2\u70ba\u4e0b\u5217\u4f55\u8005\uff1f ", + "Options": "(A)\u7236\u6bcd\u8b93\u7537\u5b30\u8db4\u7761\u3002(B)\u7537\u5b30\u662f\u65e9\u7522\u5152\u3002(C)\u7537\u5b30\u548c\u7236\u6bcd\u4e00\u8d77\u7761\u5728\u540c\u4e00\u500b\u623f\u9593\u7684\u7368\u7acb\u5b30\u5152\u5e8a\u3002(D)\u7236\u6bcd\u8b93\u5b30\u5152\u7761\u5728\u9b06\u8edf\u7684\u5e8a\u588a\u4e0a\u3002(E)\u7236\u89aa\u6709\u62bd\u83f8\u7684\u7fd2\u6163\u3002 ", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u4f60\u6b63\u5728\u8655\u7406\u4e00\u540d 5\u5929\u5927\u7684\u65b0\u751f\u5152 \uff0c\u6bcd\u89aa\u8aaa\u5973\u5b30\u5728\u66f4\u63db\u5c3f\u5e03\u6642\u767c\u73fe\u6cbe\u6709\u8840\u8de1 \uff0c\u56e0\u70ba\u5df2\u7d93\u767c\u73fe 3-4\u6b21\u985e\u4f3c\u73fe\u8c61 \uff0c\u6bcd\u89aa\u975e\u5e38\u64d4\u5fc3\u800c\u5e36\u5230\u6025\u8a3a\u6c42\u8a3a \u3002\u5973\u5b30\u6d3b\u529b\u6975\u4f73\uff0c\u9032\u98df\u72c0\u6cc1\u4e5f\u8207\u5728\u5b30\u5152\u5ba4\u6642\u76f8\u4eff \u3002\u8eab\u9ad4\u6aa2\u67e5\u4e26\u7121\u7570\u5e38\u767c\u73fe \u3002\u8acb\u554f\u4e0b\u5217\u8a3a\u65b7\u4f55\u8005\u6700\u9069\u7576\uff1f", + "Options": "(A)\u5047\u6027\u6708\u7d93\u8207\u65b0\u751f\u5152\u9670\u9053\u5206\u6ccc\u7269 \u3002 (B)\u611f\u67d3\u6027\u8178\u708e (infectious colitis ) \u3002 (C)\u6ccc\u5c3f\u9053\u611f\u67d3 \u3002 (D)\u5c3f\u5e03\u75b9 \u3002 (E)\u809b\u88c2\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u4f60\u6b63\u5728\u8655\u7406\u4e00\u540d 6 \u500b\u6708\u5927\u7684\u767c\u71d2\u5973\u5b30\uff0c\u6bcd\u89aa\u8aaa\u5973\u5b30\u60a3\u6709\u6cd5\u6d1b\u6c0f\u56db\u91cd\u75c7(Tetralogy of Fallot)\u5c1a\u672a\u63a5\u53d7\u5b8c\u5168\u77ef\u6b63\u624b\u8853\u3002\u8eab\u9ad4\u6aa2\u67e5\u6642\uff0c\u4f60\u767c\u73fe\u5973\u5b30\u7a81\u7136\u8e81\u52d5\u3001\u547c\u5438\u6025\u4fc3\u4e14\u767c\u7d3a\u3002\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u6700\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u63d0\u4f9b\u6c27\u6c23\uff0c\u63a1\u66f2\u819d\u62b1\u80f8\u59ff\u52e2\u3002(B)\u53ef\u7d66\u4e88 digoxin(\u5291\u91cf\u70ba\u6bcf\u516c\u65a4 30-50 \u5fae\u514b)\u3002(C)\u53ef\u7d66\u4e88 propranolol(\u5291\u91cf\u70ba\u6bcf\u516c\u65a4 0.2 \u6beb\u514b) \u3002(D)\u53ef\u7d66\u4e88 morphine (\u5291\u91cf\u70ba\u6bcf\u516c\u65a4 0.1-0.2 \u6beb\u514b) \u3002(E)\u53ef\u7d66\u4e88\u751f\u7406\u98df\u9e7d\u6c34\u8f38\u6db2\u6cbb\u7642(\u5291\u91cf\u70ba\u6bcf\u516c\u65a4 20 \u6beb\u5347) \u3002 ", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u4f9d\u64da\u53f0\u7063\u73fe\u884c\u5be6\u65bd\u6aa2\u50b7\u5206\u7d1a\u5236\u5ea6 (Taiwan Triage & Acuity Scale, TTAS )\u4e4b\u67b6\u69cb\u8207\u5167\u5bb9 \uff0c\u95dc\u65bc\u5152\u7ae5\u6aa2\u50b7 \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u6aa2\u50b7\u4e09\u7d1a\u75c5\u7ae5\u82e5\u5019\u8a3a\u6642\u9593\u8d85\u904e 30 \u5206\u9418\uff0c\u6aa2\u50b7\u4eba\u54e1\u9700 \u518d\u6b21\u8a55\u4f30 \u75c5\u7ae5\u75c5\u60c5\u6025\u8feb\u5ea6 \u3002 (B)\u6aa2\u50b7\u4eba\u54e1\u82e5\u4f9d\u4e0d\u540c\u5e74\u9f61\u7684\u5fc3\u8df3\u7d55\u5c0d\u503c\u5224\u5b9a\u6025\u8feb\u5ea6 \uff0c\u6bd4\u8f03\u5bb9\u6613\u9020\u6210overtriage \u73fe\u8c61\u3002 (C)\u75bc\u75db\u5340\u5206\u70ba\u5468\u908a\u578b\u75bc\u75db\u53ca\u4e2d\u6a1e\u578b\u75bc\u75db \u3002 (D)\u4e26\u672a\u5c07\u51dd\u8840\u7570\u5e38\u5217\u5165\u5224\u5b9a\u4f9d\u64da \u3002 (E)\u5df2\u5c07\u9ad8\u5371\u96aa\u53d7\u50b7\u6a5f\u8f49\u5217\u5165\u5224\u5b9a\u4f9d\u64da \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u5152\u7ae5\u8eab\u9ad4\u8650\u5f85 (child physical abuse )\u5e38\u898b\u7684\u7279\u5fb5 \uff0c\u4e0d\u5305\u62ec \u4e0b\u5217\u4f55\u9805 \uff1f", + "Options": "(A)\u87ba\u65cb\u5f0f\u9aa8\u6298 (spiral fracture )\u3002 (B)\u65b0\u751f\u5152\u9396\u9aa8\u9aa8\u6298 (clavicle fracture )\u3002 (C)\u6d78\u6ce1\u71d2\u50b7 (immersion burn )\u3002 (D)\u8996\u7db2\u819c\u51fa\u8840 (retinal hemorrhage )\u3002 (E)\u53d7\u50b7\u6a5f\u8f49\u8207\u75c5\u53f2\u7684\u63cf\u8ff0\u4e0d\u76f8\u543b\u5408 \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u67d0\u77f3\u5316\u5de5\u5ee0\u7206\u70b8\u5f15\u8d77\u6709\u6bd2\u5316\u5b78\u7269\u8cea\u5916\u6f0f \uff0c\u9020\u6210\u4eba\u54e1\u50b7\u4ea1 \uff0c\u7d93\u67e5\u6709\u6bd2\u5316\u5b78\u7269\u8cea\u70ba\u4e19\u70ef\u8148 \u3002\u4e0b\u5217\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u4e19\u70ef\u8148\u5c6c\u65bc\u9ad8\u5ea6\u6613\u71c3\u7684\u6709\u6bd2\u5316\u5b78\u7269\u8cea \uff0c\u5f88\u5bb9\u6613\u88ab\u706b\u82b1\u9ede\u71c3\u4e14\u71c3\u71d2\u4e2d\u7684\u4e19\u70ef\u8148\u6703\u91cb\u51fa\u6c2e\u6c27\u5316\u7269\u548c\u6c2b\u6c30\u9178 \u3002 (B)\u5c07\u5438\u5165\u6027\u66b4\u9732\u7684\u75c5\u4eba\u6551\u96e2\u66b4\u9732\u6e90 \uff0c\u7d66\u4e88\u9069\u7576\u63db\u6c23\u548c\u6c27\u6c23\u4f9b\u7d66 \uff1b\u76ae\u819a\u906d\u53d7\u4e19\u70ef\u8148\u66b4\u9732\u7684\u75c5\u4eba \uff0c\u4ea6\u6703\u9020\u6210\u4e2d\u6bd2 \uff0c\u6240\u4ee5\u8981\u78ba\u5b9a\u5df2\u5728\u9664\u6c61\u5340\u5b8c\u6210\u9069\u7576\u7684\u9664\u6c61 \u3002 (C)\u4e19\u70ef\u8148\u4e2d\u6bd2\u7d66\u4e88\u89e3\u6bd2\u5291 cyanide antidote \u5957\u7d44\u6216 cyanokit (hydroxocobalamin )\u3002 (D)\u89e3\u6bd2\u5291 cyanide antidote \u5957\u7d44\u7684\u89e3\u6bd2\u4f5c\u7528\u6a5f\u8f49\u70ba\u7522\u751f\u932f\u5408\u7269(complex )\uff0c\u964d\u4f4e\u6c30\u5316\u7269\u7684\u6bd2\u6027\u4f5c\u7528 \u3002 (E)\u4e19\u70ef\u8148\u5c6c\u65bc\u7cfb\u7d71\u6027\u7a92\u606f\u5291 \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6838\u751f\u5316\u4e8b\u4ef6\u7684\u61c9\u8b8a\u4e2d \uff0c\u6709\u95dc\u61c9\u8b8a\u4eba\u54e1\u7684\u9632\u8b77\u8863 \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u6bd2\u6027\u5316\u5b78\u7269\u8cea\u7528\u7684 A\u7d1a\u9632\u8b77\u8863 \uff0c\u5305\u62ec\u81ea\u651c\u5f0f\u7a7a\u6c23\u74f6 (SCBA )\u52a0\u4e0a\u5168\u8eab\u6c23\u5bc6\u5f0f\u7684\u9632\u8b77\u8863 \uff0c\u63d0\u4f9b\u6700\u9ad8\u7b49\u7d1a\u9632\u8b77 \u3002 (B)\u6bd2\u6027\u5316\u5b78\u7269\u8cea\u7528\u7684 C\u7d1a\u9632\u8b77\u8863 \uff0c\u5305\u62ec\u5168\u9762\u5f0f\u9762\u7f69\u52a0\u4e0a\u9069\u7576\u7684\u6ffe\u6bd2\u7f50 \uff0c\u53ca\u5168\u8eab\u9632\u6f51\u6ffa\u7684\u9632\u8b77\u8863 \u3002 (C)\u5728\u91ab\u9662\u6025\u8a3a\u63a5\u89f8\u8655\u7406\u5316\u707d\u75c5\u4eba\u4e4b\u91ab\u8b77\u4eba\u54e1 \uff0c\u8981\u7a7f\u6234 B\u7d1a\u9632\u8b77\u8863 \u3002 (D)\u9019\u4e9b\u9632\u8b77\u8863 \uff0c\u5c0d\u65bc\u7a7f\u900f\u5f0f\u7684\u8f3b\u5c04\u7dda\u6c92\u6709\u9632\u8b77\u4f5c\u7528 \u3002 (E)\u8f3b\u5c04\u707d\u5bb3\u5e38\u7528\u7684\u9632\u8b77\u8863 \uff0c\u4e3b\u8981\u662f\u7528\u65bc\u9632\u7bc4\u8f3b\u5c04\u5875\u5c0d\u65bc\u4eba\u54e1\u7684\u6c61\u67d3 \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6839\u64da 2010 \u5e74ILCOR \u53caAHA/ACC \u7684ACLS \u6e96\u5247\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u5c0d\u65bc ventricular fibrillation \u7684\u75c5\u4eba\u6025\u6551 \uff0c\u7b2c 1\u6b21epinephrine \u61c9\u65bc\u7b2c 2\u6b21\u53bb\u986b\u4e4b\u5f8c\u7d66\u4e88 \u3002 (B)\u5c0d\u65bc\u4e0d\u7a69\u5b9a\u7684 PSVT \uff0c\u53ef\u4ee5\u5617\u8a66\u7d66\u4e88 adenosine 6 mg \u4e00\u6b21\uff1b\u82e5\u5931\u6557 \uff0c\u5247\u540c\u6b65\u96fb\u64ca \u3002 (C)\u5c0d\u65bc\u7a69\u5b9a\u800c\u4e0d\u78ba\u5b9a\u662f VT \u7684wide QRS complex tachycardia \uff0c\u53ef\u4ee5\u5617\u8a66\u7d66\u4e88 adenosine 6 mg \u4e00\u6b21\uff1b \u82e5\u5931\u6557\uff0c\u518d\u6539\u7528 amiodarone \u6216procainamide \u3002 (D)\u4e0d\u7a69\u5b9a\u7684 atrial fibrillation \u5408\u4f75 WPW\uff0c\u61c9\u7528\u540c\u6b65\u96fb\u64ca \u3002 (E)\u4e0d\u7a69\u5b9a\u7684 torsades de pointes \uff0c\u61c9\u7528\u53bb\u986b\u96fb\u64ca \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6839\u64da\u65b0\u7248\u5b89\u5be7\u7de9\u548c\u689d\u4f8b\u898f\u5b9a \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u75c5\u4eba\u7c3d\u7f72\u610f\u9858\u66f8 \uff0c\u9808\u6709\u5169\u4f4d\u898b\u8b49\u4eba \uff0c\u7dca\u6025\u6642\u82e5\u5bb6\u5c6c\u672a\u5230 \uff0c\u91ab\u9662\u91ab\u5e2b \u3001\u8b77\u7406\u5e2b\u53ca\u793e\u5de5\u5e2b\u7b49\u53ef\u7576\u898b\u8b49\u4eba \u3002 (B)\u764c\u672b\u75c5\u4eba\u56e0\u660f\u8ff7\u53ca\u547c\u5438\u8870\u7aed \uff0c\u5728\u6025\u8a3a\u63d2\u7ba1\u6025\u6551 \uff0c\u96d6\u672c\u4eba\u672a\u7c3d\u7f72\u653e\u68c4\u6025\u6551\u610f\u9858\u66f8 \uff0c\u4f46\u5728\u914d\u5076\u8d95\u5230\u5f8c\u7c3d\u7f72\u540c\u610f\u66f8 \uff0c\u4ecd\u53ef\u64a4\u9664\u7dad\u751f\u8a2d\u5099 \u3002 (C)\u8a3a\u65b7\u672b\u671f\u75c5\u4eba\u9808\u5169\u4f4d\u91ab\u5e2b\u5224\u65b7\u7c3d\u540d \uff0c\u5176\u4e2d\u81f3\u5c11\u4e00\u4f4d\u9808\u70ba\u76f8\u95dc\u5c08\u79d1\u91ab\u5e2b \u3002 (D)\u82e5\u55aa\u5076\u4e4b\u764c\u672b\u75c5\u4eba\u9677\u5165\u660f\u8ff7 \uff0c\u5176\u7236\u89aa\u8207\u5176\u6210\u5e74\u5152\u5b50\u5c0d\u662f\u5426\u63d2\u7ba1\u6025\u6551 \u610f\u898b\u4e0d\u540c\uff0c\u4f9d\u6cd5\u4ee5\u5176\u7236\u89aa\u610f\u898b\u70ba\u6e96 \u3002 (E)\u764c\u672b\u75c5\u4eba\u7d93\u7c3d\u7f72\u610f\u9858\u66f8\u5f8c \uff0c\u624d\u53ef\u8a3b\u8a18\u65bc\u91ab\u7642\u6a5f\u69cb\u75c5\u6b77\u8cc7\u6599\u4e2d \uff0c\u4f46\u56e0\u500b\u8cc7\u6cd5\u898f\u5b9a\u4e0d\u5f97\u8a3b\u8a18\u65bc\u5065\u4fdd\u5361 \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u75c5\u4eba\u4f7f\u7528\u6c27\u6c23\u7684\u6fc3\u5ea6 (FiO 2)\u70ba 40% \uff0c\u800c\u5176 PaO 2 185 mmHg \uff0cPaCO 2 40 mmHg \uff0c\u5247\u4f30\u8a08\u75c5\u4eba\u7684 alveolar-arterial oxygen difference (A-a DO 2)\u7d04\u70ba\u591a\u5c11mmHg \uff1f", + "Options": "(A)50 \u3002 (B)100 \u3002 (C)150 \u3002 (D)200 \u3002 (E)250 \u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u75c5\u4eba\u7684\u904e\u53bb\u75c5\u53f2\u8207\u5176\u5e38\u898b\u7684\u80ba\u708e\u81f4\u75c5\u83cc\u7684\u76f8\u95dc\u6027 \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u5065\u5eb7\u7684\u6210\u5e74\u4eba\u5f97\u6d41\u884c\u6027\u611f\u5192\u5f8c \uff0c\u80ba\u708e\u5e38\u898b\u7684\u81f4\u75c5\u83cc\u70ba Legionella species \u3002 (B)COPD \u7684\u75c5\u4eba\uff0c\u80ba\u708e\u5e38\u898b\u7684\u81f4\u75c5\u83cc\u70ba Haemophilus influenzae \u3002 (C)\u9152\u766e\u7684\u75c5\u4eba \uff0c\u80ba\u708e\u5e38\u898b\u7684\u81f4\u75c5\u83cc\u70ba Klebsiella pneumoniae \u3002 (D)\u525b\u5f9e\u91ab\u9662\u51fa\u9662\u7684\u75c5\u4eba \uff0c\u80ba\u708e\u5e38\u898b\u7684\u81f4\u75c5\u83cc\u70ba Pseudomonas aeruginosa \u3002 (E)AIDS \u7684\u75c5\u4eba\uff0c\u80ba\u708e\u5e38\u898b\u7684\u81f4\u75c5\u83cc\u70ba Pneumocystis carinii \u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u8178\u5957\u758a(intussusception )\u662f\u5152\u7ae5\u5e38\u898b\u7684\u8179\u75db\u6025\u75c7 \uff0c\u4e0b\u5217\u654d\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u92c7\u5291\u704c\u8178 (barium enema )\u662f\u8a3a\u65b7\u65b9\u5f0f\u4e4b\u4e00 \u3002 (B)\u8349\u8393\u91ac\u6a23\u4fbf (currant jelly stool )\u662f\u65e9\u671f\u7684\u5178\u578b\u75c7\u72c0 \u3002 (C)\u8d85\u97f3\u6ce2\u53ef\u767c\u73fe\u6709\u6a19\u9776\u5fb5\u8c61 (target sign )\u3002 (D)\u82e5\u6709\u8b49\u64da\u986f\u793a\u5df2\u6709\u8178\u7a7f\u5b54 \uff0c\u61c9\u5efa\u8b70\u958b\u5200 \u3002 (E)\u6700\u5e38\u898b\u70ba\u8ff4\u8178\u5957\u7d50\u8178 (ileo-colic type )\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u7591\u6709\u80f8\u690e\u9aa8\u6298\u53ca\u79fb\u4f4d\u7684\u75c5\u4eba \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u7acb\u5373\u5b89\u6392 spine CT \u6aa2\u67e5\u3002 (B)\u7acb\u5373\u8eab\u9ad4\u6aa2\u67e5\u809b\u9580\u5f35\u529b (anal tone )\u3002 (C)\u7121\u8db3\u5920\u6587\u737b\u5be6\u8b49\u652f\u6301\u4f8b\u884c\u4f7f\u7528\u985e\u56fa\u9187 \u3002 (D)\u82e5\u6709\u4f4e\u8840\u58d3\u53ca\u5fc3\u640f\u904e\u901f \uff0c\u61c9\u8003\u616e\u795e\u7d93\u6027\u4f11\u514b \u3002 (E)\u5118\u5feb\u5b89\u6392\u624b\u8853 \uff0c\u9032\u884c\u5fa9\u4f4d\u53ca\u56fa\u5b9a \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u885b\u751f\u798f\u5229\u90e8\u65bc\u4eca\u5e74\u57f7\u884c \u300c\u63d0\u5347\u6025\u8a3a\u66a8\u8f49\u8a3a\u54c1\u8cea\u8a08\u756b \u300d\u3002\u95dc\u65bc\u8f49\u8a3a \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u91ab\u9662\u8fa6\u7406\u8f49\u8a3a \uff0c\u61c9\u5c07\u5176\u539f\u56e0\u8207\u98a8\u96aa\u544a\u77e5\u50b7\u75c5 \u672c\u4eba\u6216\u5176\u89aa\u5c6c \uff0c\u4e26\u8a18\u8f09\u65bc\u75c5\u6b77\u3002 (B)\u91ab\u9662\u8fa6\u7406\u8f49\u8a3a\u61c9\u5354\u52a9\u75c5\u4eba\u9078\u64c7\u53ca\u5b89\u6392\u9069\u7576\u4e4b\u6551\u8b77\u904b\u8f38\u5de5\u5177 \u3001\u6551\u8b77\u4eba\u54e1\uff0c\u4e26\u63d0\u4f9b\u9069\u7576\u4e4b\u7dad\u751f\u8a2d\u5099\u53ca\u85e5\u54c1 \u3001\u91ab\u6750\u3002 (C)\u91ab\u9662\u8fa6\u7406\u8f49\u8a3a (\u542b\u81ea\u52d5\u51fa\u9662 )\u61c9\u586b\u5177\u8f49\u8a3a\u55ae \uff0c\u4f75\u540c\u75c5\u6b77\u6458\u8981\u4ea4\u4ed8\u96a8\u884c\u6551\u8b77\u4eba\u54e1 \uff1b\u5fc5\u8981\u6642\u5f97\u5148\u4ee5\u50b3\u771f\u6216\u96fb\u5b50\u6587\u4ef6\u65b9\u5f0f\u9001\u9054\u63a5\u53d7\u8f49\u8a3a\u4e4b\u91ab\u9662 \u3002 (D)\u91ab\u9662\u8fa6\u7406\u8f49\u8a3a \uff0c\u61c9\u5148\u806f\u7e6b\u5f8c\u9001\u91ab\u9662 \uff0c\u5f8c\u9001\u57fa\u5730\u91ab\u9662\u53ef\u56e0\u6eff\u5e8a\u62d2\u7d55\u63a5\u53d7\u5176\u8f49\u8a3a\u3002 (E)\u75c5\u4eba\u7d93\u8655\u7f6e\u75c5\u6cc1\u82e5\u4ecd\u672a\u7a69\u5b9a \uff0c\u4f46\u75c5\u4eba\u672c\u4eba\u6216\u5bb6\u5c6c\u8981\u6c42\u81ea\u52d5\u51fa\u9662 \uff0c\u6b64\u6642\u4ecd\u61c9\u4ea4\u4ed8\u51fa\u9662\u75c5\u6458\u53ca\u8f49\u8a3a\u55ae \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u982d\u90e8\u5916\u50b7\u7684\u75c5\u4eba \uff0c\u660f\u8ff7\u6307\u6578 14 \u5206\uff0c\u982d\u90e8\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u7684\u9069\u61c9\u75c7 \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u53ea\u6709\u982d\u6688\u53ca\u5641\u5fc3 \u3002 (B)\u5931\u61b6\u7684\u75c7\u72c0 \u3002 (C)\u5c40\u90e8\u795e\u7d93\u5b78\u7570\u5e38\u5fb5\u5019 \u3002 (D)\u610f\u8b58\u4e0d\u6e05\u6216\u7672\u7647\u767c\u4f5c \u3002 (E)\u51dd\u8840\u529f\u80fd\u7570\u5e38\u7684\u75c5\u53f2 \u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc testicular torsion \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)Testicular torsion \u591a\u767c\u751f\u65bc\u6fc0\u70c8\u904b\u52d5\u4e4b\u5f8c \u3002 (B)\u55ae\u5074\u63d0\u776a\u808c\u53cd\u5c04 (cremasteric reflex )\u6d88\u5931\u7684\u8a3a\u65b7\u7387\u53ef\u9054 99% \u3002 (C)\u53ef\u7528 doppler ultrasound \u4f86\u78ba\u8a3a\uff0c\u53ef\u898b\u60a3\u5074\u8840\u6d41\u6e1b\u5c11 \u3002 (D)\u5982\u70ba\u776a\u4e38\u626d\u8f49\u6642\u6574\u500b\u776a\u4e38\u75bc\u75db\u53ca\u816b\u8139 \uff0c\u4ee5\u624b\u6258\u8457\u6703\u6e1b\u8f15\u776a\u4e38\u75bc\u75db \u3002 (E)\u767c\u4f5c 6\u5c0f\u6642\u5167\u662f\u9ec3\u91d1\u6cbb\u7642\u671f \u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc bystander CPR \u53capublic access defibrillation (PAD )\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u75c5\u4eba\u767c\u751f ventricular fibrillation (VF )\uff0c\u82e5\u672a\u80fd\u53ca\u6642\u96fb\u64ca\u53bb\u986b \uff0c\u5247\u5b58\u6d3b\u7387\u6bcf\u5206\u9418\u4e0b\u964d 7~10% \u3002 (B)\u6211\u570b\u7dca\u6025\u91ab\u7642\u6551\u8b77\u6cd5\u65bc\u4eca\u5e74\u4fee\u8a02\u5f8c \uff0c\u898f\u5b9a\u516b\u5927\u985e\u516c\u5171\u5834\u6240\u61c9\u8a2d\u7f6e\u81ea\u52d5\u9ad4\u5916\u53bb\u986b\u5668 (automated external defibrillator \uff0cAED )\u6216\u5176\u4ed6\u5fc5\u8981\u4e4b\u7dca\u6025\u6551\u8b77\u8a2d\u5099 \u3002 (C)PAD \u9700\u914d\u5408 bystander CPR \u624d\u80fd\u6709\u6548\u9054\u5230\u7b2c\u4e00\u6642\u9593\u6551\u8b77\u7684\u76ee\u7684 \u3002 (D)\u524d\u8ff0\u589e\u4fee\u689d\u6587\u4e2d\u898f\u5b9a\u6551\u8b77\u4eba\u54e1\u4ee5\u5916\u7684\u4eba \uff0c\u70ba\u514d\u9664\u4ed6\u4eba\u751f\u547d\u4e4b\u6025\u8feb\u5371\u96aa\uff0c\u4f7f\u7528\u7dca\u6025\u6551\u8b77\u8a2d\u5099\u6216\u65bd\u4e88\u6025\u6551\u63aa\u65bd\u8005 \uff0c\u9069\u7528\u6c11\u6cd5 \u3001\u5211\u6cd5\u4e2d\u7dca\u6025\u907f\u96e3\u514d\u8cac\u4e4b\u898f\u5b9a \u3002 (E)\u4e0d\u8ad6\u75c5\u4eba\u767c\u751f VF \u5012\u4e0b\u6642\u662f\u5426\u5728\u91ab\u9662\u5167 \uff0c\u6216 AED/ \u96fb\u64ca\u53bb\u986b\u5668\u662f\u5426\u5728\u5834\uff0c\u5747\u61c9\u5148\u4e88\u4ee5 CPR 1.5~3 \u5206\u9418\u4e4b\u5f8c\u518d\u884c\u96fb\u64ca \uff0c\u5982\u6b64\u75c5\u4eba\u5b58\u6d3b\u7684\u6a5f\u6703\u53ca\u9810\u5f8c\u8f03\u4f73 \u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u95dc\u65bc H7N9 \u6d41\u611f\u81e8\u5e8a\u8a3a\u7642 \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u76ee\u524d\u5c1a\u7121\u6301\u7e8c\u6027\u4eba\u50b3\u4eba\u7684\u73fe\u8c61 \uff0c\u4f46\u4e0d\u6392\u9664\u6709\u4fb7\u9650\u6027\u4eba\u50b3\u4eba\u7684\u60c5\u5f62 \u3002 (B)\u53f0\u7063\u5df2\u5c07\u6b64\u75c5\u4f8b\u5217\u70ba\u7b2c\u4e94\u985e\u50b3\u67d3\u75c5 \u3002 (C)\u53ef\u50b3\u67d3\u671f\u70ba\u767c\u75c5\u5f8c 7\u65e5\u5167\u3002 (D)\u6025\u6027\u547c\u5438\u9053\u611f\u67d3 \uff0c\u81e8\u5e8a\u75c7\u72c0\u81f3\u5c11\u5305\u62ec\u767c\u71d2 (\u226738 \u2103)\u53ca\u54b3\u55fd\u70ba\u81e8\u5e8a\u689d\u4ef6\u4e4b\u4e00\u3002 (E)\u81e8\u5e8a\u6aa2\u9ad4\u57f9\u990a\u5206\u96e2\u53ca\u9451\u5b9a\u51fa H7N9 \u6d41\u611f\u75c5\u6bd2\u70ba\u6aa2\u9a57\u689d\u4ef6\u4e4b\u4e00 \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc head trauma \uff0c\u82e5\u4ee5 hyperventilation \u4f86\u9054\u5230\u77ed\u66ab\u6027\u7684\u964d\u4f4e\u8166\u58d3 \uff0c\u61c9\u7dad\u6301PaCO 2\u65bc\u4f55\u7a2e\u7bc4\u570d \uff1f", + "Options": "(A)35 mmHg \u4ee5\u4e0a\u3002 (B)30~35 mmHg \u3002 (C)25~30 mmHg \u3002 (D)20~25 mmHg \u3002 (E)< 20 mmHg \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5fc3\u5305\u819c\u586b\u585e (cardiac tamponade )\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u53ef\u80fd\u7684\u75c5\u56e0\u5305\u62ec\u5fc3\u5305\u819c\u708e \u3001\u7532\u72c0\u817a\u529f\u80fd\u4f4e\u4e0b \u3001\u764c\u75c7\u3001\u5c3f\u6bd2\u75c7 \u3001\u5fc3\u81df\u8154\u5ba4\u7834\u88c2\u3001\u5275\u50b7\u7b49 \u3002 (B)\u5178\u578b\u7684\u81e8\u5e8a\u8868\u5fb5\u70ba\u4f4e\u8840\u58d3 \u3001\u9838\u975c\u8108\u6012\u5f35 \uff0c\u53ca\u9059\u9060 \u3001\u4f4e\u6c89\u5fc3\u97f3 (muffled heart sounds )\u3002\u4f46\u5275\u50b7\u6240\u9020\u6210\u6216\u5408\u4f75\u51fa\u8840\u8005 \uff0c\u7d93\u5e38\u6c92\u6709\u9019\u4e9b\u8868\u5fb5 \u3002 (C)\u82e5\u6025\u6027\u80f8\u75db\u75c5\u4eba\u7a81\u7136\u660f\u53a5\u4e14\u91cf\u4e0d\u5230\u8840\u58d3 \uff0c\u5e8a\u908a\u8d85\u97f3\u6ce2\u767c\u73fe\u4e2d\u91cf\u4e4b\u5fc3\u5305\u819c\u7a4d\u6db2\uff0c\u61c9\u8003\u616e\u5fc3\u808c\u6897\u585e\u4f75\u5fc3\u808c\u7834\u88c2\u6216\u4e3b\u52d5\u8108\u525d\u96e2 \u3002 (D)\u5c0d\u65bc\u975e\u5275\u50b7\u6027\u6216\u975e\u6a5f\u68b0\u6027\u5fc3\u5305\u819c\u586b\u585e \uff0c\u6cbb\u7642\u4e0a\u9996\u5148\u61c9\u8003\u616e\u4f7f\u7528norepinephrine \u3002 (E)\u5c0d\u65bc\u5275\u50b7\u6027\u6216\u975e\u6a5f\u68b0\u6027\u5fc3\u5305\u819c\u586b\u585e \uff0c\u901a\u5e38\u61c9\u8003\u616e\u4ee5\u624b\u8853\u65b9\u5f0f\u5c07\u5fc3\u5305\u819c\u6253\u958b(pericardiotomy )\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6c34\u75d8\u5e36\u72c0\u75b1\u75b9\u75c5\u6bd2 (Varicella-Zoster virus )\u7684\u81e8\u5e8a\u8868\u73fe\u8207\u8655\u7f6e \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u6c34\u75d8\u76ae\u75b9\u7531\u81c9 \u3001\u982d\u76ae\u5f80\u8ec0\u5e79\u53ca\u56db\u80a2\u5ef6\u4f38 \uff0c\u9ad4\u8868\u6709\u906e\u84cb\u8655\u8f03\u66b4\u9732\u8655\u75c5\u7076\u70ba\u591a\uff0c\u4e14\u53ef\u540c\u6642\u770b\u5230\u5404\u968e\u6bb5\u7684\u76ae\u75b9\u8b8a\u5316 \u3002\u5929\u82b1\u76ae\u75b9\u5247\u5448\u96e2\u5fc3\u72c0\u5206\u5e03 \uff0c\u4e14\u76ae\u75b9\u6f14\u8b8a\u898f\u5f8b\u4e14\u6574\u9f4a\u4e00\u81f4 \u3002 (B)\u5152\u7ae5\u611f\u67d3\u6c34\u75d8\u9808\u907f\u514d\u4f7f\u7528 acetaminophen \u4f5c\u70ba\u9000\u71d2\u85e5\u7269 \uff0c\u4ee5\u514d\u5c0e\u81f4 Reye syndrome \u7684\u7522\u751f\u3002 (C)\u81e8\u5e8a\u611f\u67d3\u591a\u70ba\u81ea\u9650\u6027\u75c5\u7a0b \uff0c\u52a0\u4e0a\u6297\u75c5\u6bd2\u85e5\u7269 acyclovir \u53ef\u80fd\u6709\u81f4\u7578\u578b\u80ce\u7684\u98a8\u96aa\uff0c\u56e0\u6b64\u5b55\u5a66\u767c\u751f\u6c34\u75d8\u611f\u67d3\u4e0d\u5efa\u8b70\u7d66\u4e88\u6297\u75c5\u6bd2\u85e5\u7269 acyclovir \u6cbb\u7642\u3002 (D)\u6210\u4eba\u4e3b\u8981\u7684\u81f4\u6b7b\u539f\u56e0\u4ee5\u5fc3\u808c\u708e\u53ca\u75c5\u6bd2\u6027\u8166\u708e\u70ba\u4e3b \uff0c\u5152\u7ae5\u5247\u4ee5\u6557\u8840\u75c7\u53ca\u539f\u767c\u75c5\u6bd2\u6027\u80ba\u708e\u70ba\u4e3b \u3002 (E)\u50b3\u67d3\u65b9\u5f0f\u70ba\u76ae\u819a\u76f4\u63a5\u63a5\u89f8\u6c34\u75d8\u6216\u5e36\u72c0\u75b1\u75b9\u75c2\u76ae \u3001\u547c\u5438\u9053\u98db\u6cab\u6216\u7a7a\u6c23\u50b3\u67d3\uff0c\u8207\u958b\u653e\u6027\u80ba\u7d50\u6838\u53ca\u9ebb\u75b9\u540c\u70ba\u6700\u5177\u50b3\u67d3\u6027\u7684\u75be\u75c5\u4e4b\u4e00 \u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5916\u50b7\u51fa\u8840\u6027\u4f11\u514b\u53ca\u8f38\u6db2\u7684\u89c0\u5ff5 \uff0c\u4e0b\u5217\u4f55\u8005 \u6700\u9069\u7576\uff1f", + "Options": "(A)\u5927\u91cf\u8f38\u8840 (massive transfusion )\u901a\u5e38\u662f\u6307 12 \u5c0f\u6642\u5167\u7d66\u4e88\u6fc3\u7e2e\u7d05\u8840\u7403(PRBC )5\u55ae\u4f4d\u4ee5\u4e0a \u3002 (B)\u9700\u8981\u5927\u91cf\u8f38\u6db2\u6642 \uff0c\u61c9\u5118\u65e9\u7d66\u4e88\u7d05\u8840\u7403 \u3001\u8840\u6f3f\u3001\u8840\u5c0f\u677f \uff0c\u4e26\u907f\u514d\u5927\u91cf\u7684\u6676\u8cea\u6db2(crystalloid )\u8f38\u6ce8\u3002 (C)\u7d66\u4e88\u5e38\u6eab\u8f38\u8840\u6642 \uff0c\u53ef\u63d0\u9ad8\u5b58\u6d3b\u6a5f\u6703 \u3002 (D)\u5c0d\u8f38\u6db2\u6025\u6551\u53cd\u61c9\u4e0d\u4f73 \uff0c\u6700\u5e38\u898b\u7684\u539f\u56e0\u662f\u7121\u6cd5\u63a7\u5236\u7684\u51fa\u8840 \u3002 (E)\u8f38\u6db2\u904e\u91cf\u4e26\u4e0d\u6703\u9020\u6210\u51dd\u8840\u7570\u5e38 \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u7532\u72c0\u817a\u98a8\u66b4 (thyroid storm )\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u5c0d\u7532\u72c0\u817a\u6a5f\u80fd\u4ea2\u9032\u75c5\u4eba \uff0c\u7532\u72c0\u817a\u98a8\u66b4\u662f\u500b\u81e8\u5e8a\u8a3a\u65b7 \u3002 (B)\u6700\u5e38\u898b\u7684\u8a98\u767c\u539f\u56e0\u70ba\u611f\u67d3\u75c7 \u3002 (C)\u5f9e\u7121\u5408\u4f75\u75c7\u7684\u7532\u72c0\u817a\u6a5f\u80fd\u4ea2\u9032\u8f49\u8b8a\u70ba\u7532\u72c0\u817a\u98a8\u66b4 \uff0cfree T4 \u3001T4 \u53caT3 \u90fd\u6703\u660e\u986f\u4e0a\u5347 \u3002 (D)\u75c5\u4eba\u53ef\u80fd\u51fa\u73fe\u55dc\u7761 \u3001\u62bd\u6410\u3001\u660f\u8ff7\u7b49\u4e2d\u6a1e\u795e\u7d93\u7cfb\u7d71\u7684\u75c7\u72c0 \u3002 (E)\u75c5\u4eba\u53ef\u80fd\u51fa\u73fe\u53ad\u98df \u3001\u9ec3\u75b8\u3001\u809d\u816b\u5927\u7b49\u8178\u80c3\u7cfb\u7d71\u7684\u75c7\u72c0 \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8001\u4eba\u5916\u50b7 \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u51fa\u8840\u6027\u4f11\u514b\u901a\u5e38\u4e0d\u5bb9\u6613\u770b\u5230\u5fc3\u8df3\u52a0\u5feb \u3002 (B)\u4f4e\u8840\u58d3\u6642\u53ef\u5148\u4ee5 crystalloid \u7d66\u4e88 1\u6b211~2 \u516c\u5347\uff0c\u5728\u8001\u5e74\u4eba\u61c9\u6bd4\u4e00\u822c\u4eba\u65e9\u9ede\u7d66\u4e88\u8f38\u8840 \u3002 (C)\u982d\u90e8\u5916\u50b7 \uff0c\u8001\u5e74\u4eba\u786c\u819c\u5916\u51fa\u8840\u7684\u6a5f\u6703\u8f03\u4e00\u822c\u4eba\u9ad8 \u3002 (D)\u9838\u690e\u9aa8\u6298 \uff0c\u5728\u8001\u5e74\u4eba\u767c\u751f\u7684\u6a5f\u7387\u8f03\u9ad8 \uff0c\u4e14\u66f4\u4e0d\u6613\u8a3a\u65b7 \u3002 (E)\u8001\u5e74\u4eba\u9aa8\u6298\u597d\u767c\u4f4d\u7f6e\u70ba\u9ad6\u90e8 (hip )\u3001\u80b1\u9aa8(humerus )\u53ca\u624b\u8155 \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6d88\u5316\u9053\u51fa\u8840 (gastrointestinal bleeding )\u4e4b\u8655\u7f6e \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)Proton pump inhibitor \u53ef\u964d\u4f4e\u51fa\u8840\u6027\u80c3\u6f70\u760d\u7684\u518d\u51fa\u8840\u7387 \uff0c\u4e5f\u53ef\u964d\u4f4e\u8f38\u8840\u53ca\u624b\u8853\u7684\u9700\u6c42 \u3002 (B)\u5982\u679c\u6709\u660e\u986f\u6216\u5927\u91cf\u7684\u8840\u4fbf \uff0c\u5247\u61c9\u653e\u7f6e\u9f3b\u80c3\u7ba1\u4f86\u6392\u9664\u4e0a\u6d88\u5316\u9053\u51fa\u8840 \u3002 (C)\u8840\u7ba1\u651d\u5f71\u53ef\u70ba\u8a3a\u65b7\u5de5\u5177 \uff0c\u4f46\u51fa\u8840\u901f\u7387\u6700\u5c11\u9808\u9054 0.5 ml/min \u4ee5\u4e0a\u624d\u53ef\u5075\u6e2c\u5230\u3002 (D)Sengstaken-Blakemore tube (SB tube )\u56e0\u4f75\u767c\u75c7\u592a\u591a \uff0c\u76ee\u524d\u5df2\u4e0d\u5efa\u8b70\u4f7f\u7528\u65bc\u6cbb\u7642\u98df\u9053\u975c\u8108\u66f2\u5f35\u51fa\u8840 \u3002 (E)\u4e0a\u8178\u80c3\u9053\u51fa\u8840\u5747\u53ef\u8003\u616e\u653e\u7f6e\u9f3b\u80c3\u7ba1 \uff0c\u5373\u4f7f\u662f\u7591\u4f3c\u98df\u9053\u975c\u8108\u66f2\u5f35\u51fa\u8840\u4ea6\u53ef\u9032\u884c\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u80f8\u90e8\u5916\u50b7 \uff0c\u808b\u9aa8\u8207\u80a9\u80db\u9aa8\u9aa8\u6298 \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u80a9\u80db\u9aa8\u9aa8\u6298 \uff0c\u901a\u5e38\u4e0d\u9700\u624b\u8853\u6cbb\u7642 \u3002 (B)1\u52303\u808b\u9aa8\u9aa8\u6298 \uff0c\u56e0\u70ba\u5bb9\u6613\u5408\u4f75\u5927\u8840\u7ba1\u6216\u80f8\u8154\u810a\u9ad3\u53d7\u50b7 \uff0c\u6b7b\u4ea1\u7387\u7d04 10% \u3002 (C)\u80f8\u9aa8\u6216\u80a9\u80db\u9aa8\u9aa8\u6298\u5e38\u898b\u65bc\u76f4\u63a5\u7684\u649e\u64ca \u3002 (D)10 \u523012 \u808b\u9aa8\u9aa8\u6298\u901a\u5e38\u5bb9\u6613\u5408\u4f75\u809d\u813e\u640d\u50b7 \u3002 (E)\u808b\u9aa8\u9aa8\u6298\u9700\u6ce8\u610f\u6709\u7121\u6c23\u80f8 \u3001\u8840\u80f8\u4ee5\u53ca\u5f8c\u7e8c\u80ba\u708e\u7684\u554f\u984c \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u9152\u7cbe\u6212\u65b7 (alcohol withdrawal )\u75c7\u5019\u7fa4 \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u75c7\u72c0\u5728\u505c\u6b62\u559d\u9152\u4e4b\u5f8c 6\uff0d24 \u5c0f\u6642\u51fa\u73fe \u3002 (B)\u75c7\u72c0\u53ef\u80fd\u6301\u7e8c 2\uff0d7 \u5929\u5de6\u53f3\u3002 (C)\u9152\u7cbe\u6212\u65b7\u7684\u75c5\u4eba\u5e38\u6703\u6709\u5192\u6c57 \u3001\u6b65\u614b\u4e0d\u7a69 (ataxia )\u53ca\u5e7b\u89ba\u7522\u751f \u3002 (D)\u8840\u58d3\u4e0a\u5347\u4e14\u5fc3\u8df3\u8b8a\u5feb \u3002 (E)\u610f\u8b58\u6539\u8b8a\u4e3b\u8981\u662f\u4ee5\u55dc\u7761\u70ba\u4e3b \u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u9663\u767c\u6027\u4e0a\u5fc3\u5ba4\u5fc3\u640f\u904e\u901f (paroxysmal supraventricular tachycardia )\u4e4b\u8655\u7f6e\uff0c\u4e0b\u5217\u654d\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)PSVT \u7d55\u5927\u591a\u6578\u662f narrow QRS complex \uff0c\u4f46\u4e5f\u6709\u5c11\u6578\u662f wide QRS complex \u3002 (B)\u5728\u91ab\u9662\u6025\u8a3a\u6cbb\u7642 PSVT \uff0c \u4e0d\u5fc5\u5148\u505a\u9838\u52d5\u8108\u7ac7\u6309\u6469 \uff0c\u53ef\u76f4\u63a5\u4f7f\u7528 adenosine \u3002 (C)\u5728\u6c92\u6709\u85e5\u7269\u53ef\u4f7f\u7528\u7684\u5730\u65b9 \uff0c\u5c0d PSVT \u75c5\u4eba\u505a\u9838\u52d5\u8108\u7ac7\u6309\u6469\u61c9\u505a\u53f3\u908a \uff0c\u4ee5\u514d\u842c\u4e00\u75c5\u4eba\u8166\u4e2d\u98a8 \uff0c\u6703\u9020\u6210\u8f03\u70ba\u56b4\u91cd\u7684\u53f3\u5074\u504f\u7671 \u3002 (D)Adenosine \u53ef\u7528\u65bc\u6cbb\u7642\u61f7\u5b55\u5a66\u5973\u4e4b PSVT \u3002 (E)Adenosine \u53ef\u4ee5\u7528\u65bc WPW syndrome \u6240\u5f15\u8d77\u4e4b PSVT \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6c2b\u6c1f\u9178\u7684\u654d\u8ff0 \uff0c\u4e0b\u5217\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u6c2b\u6c1f\u9178\u76f8\u8f03\u4e4b\u4e0b\u662f\u5f31\u9178 \uff0c\u5b83\u6bd4\u5f37\u9178\u5982\u9e7d\u9178\u89e3\u96e2\u6c2b\u96e2\u5b50\u7684\u901f\u5ea6\u7d04\u6162 1000 \u500d\uff0c\u6240\u4ee5\u4e0d\u5bb9\u6613\u9020\u6210\u5316\u5b78\u6027\u707c\u50b7 \u3002 (B)\u50b7\u5bb3\u56b4\u91cd\u5ea6\u6c7a\u5b9a\u65bc\u6c2b\u6c1f\u9178\u7684\u6fc3\u5ea6\u548c\u66b4\u9732\u7684\u6642\u9593 \u3002 (C)\u7834\u58de\u6c27\u5316\u78f7\u9178\u5316 \u3001\u91a3\u9175\u89e3\u548c\u5176\u5b83\u7d30\u80de\u7684\u4ee3\u8b1d \u3002 (D)\u9020\u6210\u8840\u9223\u904e\u4f4e \u3001\u8840\u9382\u904e\u4f4e \u3001\u8840\u9240\u904e\u9ad8 \u3002 (E)\u6700\u4e3b\u8981\u6bd2\u6027\u662f\u4f86\u81ea\u65bc\u6c1f\u96e2\u5b50 \u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u773c\u79d1\u6025\u75c7 \uff0c\u4e0b\u5217\u6558\u8ff0 \u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u5927\u90e8\u4efd\u7d2b\u5916\u7dda\u89d2\u819c\u708e (ultraviolet keratitis )\u9020\u6210\u7684\u50b7\u5bb3\u662f\u4e0d\u53ef\u9006\u7684 \u3002 (B)\u70ba\u4e86\u7f8e\u89c0 \uff0c\u6240\u6709\u773c\u77bc\u7684\u6495\u88c2\u50b7\u90fd\u9700\u8981\u7e2b\u5408 \u3002 (C)\u6700\u5e38\u898b\u773c\u7aa9\u9aa8\u6298 (orbital blow-out fracture )\u7684\u4f4d\u7f6e\u662f\u773c\u7aa9\u5e95\u90e8 (orbital floor )\u3002 (D)\u9694\u819c\u524d\u8702\u7aa9\u6027\u7d44\u7e54\u708e (preseptal cellulitis )\u5e38\u6703\u5f71\u97ff \u75c5\u4eba\u7684\u8996\u529b \uff0c\u6545\u9700\u7a4d\u6975\u6cbb\u7642 \u3002 (E)\u5c0d\u65bc\u56b4\u91cd\u7d50\u819c\u64e6\u50b7 \uff0c\u53ef\u958b\u7acb\u5c40\u90e8\u9ebb\u9189\u773c\u85e5\u6c34\u8b93\u75c5\u4eba\u5e36\u56de\u5bb6\u4f7f\u7528 \uff0c\u7de9\u89e3\u773c\u775b\u5c40\u90e8\u7684\u4e0d\u9069 \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u767b\u9769\u71b1\u7684\u8a3a\u65b7\u8207\u8655\u7f6e \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u57c3\u53ca\u6591\u868a\u53ca\u767d\u7dda\u6591\u868a\u5747\u70ba\u5176\u5a92\u4ecb\u6606\u87f2 \uff0c\u5176\u4e2d\u524d\u8005\u559c\u6b61\u68f2\u606f\u65bc\u5ba4 \u5167\uff0c\u5f8c\u8005\u5247\u591a\u68f2\u606f \u65bc\u5ba4\u5916\u3002 (B)\u70ba\u53f0\u7063\u5730\u5340\u6cd5\u5b9a\u50b3\u67d3\u75c5\u5883\u5916\u79fb\u5165\u78ba\u5b9a\u75c5\u4f8b\u7d71\u8a08\u6578\u4e4b\u7b2c 2\u4f4d\uff0c\u7e3d\u75c5\u4f8b\u6578\u50c5\u6b21\u65bc\u963f\u7c73\u5df4\u6027\u75e2\u75be \u3002 (C)\u5883\u5916\u79fb\u5165\u6848\u4f8b\u6578\u591a\u65bc\u672c\u571f\u6848\u4f8b\u6578 \uff0c\u7279\u5225\u662f\u6771\u5357\u4e9e\u53ca\u4e2d\u5357\u7f8e\u6d32\u5730\u5340\u70ba\u9ad8\u6d41\u884c\u75c5\u5b78\u98a8\u96aa\u5730\u5340 \u3002\u800c\u672c\u571f\u75c5\u4f8b\u76ee\u524d\u50c5\u4fb7\u9650\u65bc\u53f0\u5357 \u3001\u9ad8\u96c4\u53ca\u5c4f\u6771\u4e09\u7e23\u5e02\u3002 (D)\u767c\u75c5\u524d 1\u65e5\u81f3\u767c\u75c5\u5f8c 10 \u65e5\u70ba\u300c\u53ef\u611f\u67d3\u671f \u300d\u6216\u7a31\u70ba \u300c\u75c5\u6bd2\u8840\u75c7\u671f \u300d\uff0c\u6b64\u6642\u671f\u611f\u67d3\u8005\u82e5\u88ab\u6591\u868a\u53ee\u54ac \uff0c\u5247\u6b64\u6591\u868a\u5c07\u611f\u67d3\u767b\u9769\u75c5\u6bd2\u4e26\u5177\u6709\u9032\u4e00\u6b65\u50b3\u67d3\u4e4b\u80fd\u529b \uff0c\u6545\u7591\u4f3c\u767b\u9769\u71b1\u75c5\u4eba\u65bc\u6b64\u6642\u671f\u5167\u9700\u65bc\u61f8\u639b\u868a\u5e33\u5167\u6cbb\u7642\u89c0\u5bdf\uff0c\u9632\u6b62\u75ab\u60c5\u4e4b\u64f4\u6563 \u3002 (E)\u767b\u9769\u51fa\u8840\u71b1\u75c5\u4eba\u9664\u8840\u5c0f\u677f\u4e0b\u964d\u5c0f\u65bc 10 \u842c\u4ee5\u4e0b\u4e4b\u5916 \uff0c\u540c\u6642\u6703\u56e0\u5fae\u8840\u7ba1\u6ef2\u900f\u6027\u589e\u52a0\u9020\u6210\u8840\u6f3f\u6ef2\u6f0f (plasma leakage )\u73fe\u8c61\uff0c\u5f62\u6210\u76f8\u5c0d\u6027\u7684\u8840\u6db2\u6fc3\u7e2e\u6548\u679c \uff0c\u4f7f\u5f97\u75c5\u4eba\u51fa\u73fe\u8840\u6bd4\u5bb9\u4e0a\u5347 20% \u53ca\u8840\u6e05\u86cb\u767d\u6578\u503c\u4e0a\u5347\u7684\u73fe\u8c61\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8179\u4e3b\u52d5\u8108\u7624 \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u5c0f\u65bc 4\u516c\u5206\u4e4b\u8179\u4e3b\u52d5\u8108\u7624 \uff0c\u7834\u88c2\u7684\u6a5f\u6703\u4e0d\u9ad8 \u3002 (B)\u5927\u90e8\u5206\u5b8c\u6574\u7684\u8179\u4e3b\u52d5\u8108\u7624 \u4e26\u4e0d\u6703\u75db \uff0c\u7576\u75bc\u75db\u6642\u6697\u793a\u52d5\u8108\u7624\u53ef\u80fd\u5df2\u7834\u88c2 \u3002 (C)\u662f\u5426\u51fa\u73fe\u4f4e\u8840\u58d3\u662f\u5f71\u97ff\u7834\u88c2\u4e4b\u8179\u4e3b\u52d5\u8108\u7624\u9810\u5f8c\u7684\u91cd\u8981\u56e0\u7d20 \u3002 (D)\u82e5\u4e3b\u52d5\u8108\u7834\u88c2\u5408\u4f75\u4f4e\u8840\u58d3 \uff0c\u8981\u7a4d\u6975\u5927\u91cf\u8f38\u8840 \u3001\u8f38\u6db2\uff0c\u8b93\u8840\u58d3\u6062\u5fa9\u6b63\u5e38 \uff0c\u624b\u8853\u9810\u5f8c\u8f03\u4f73 \u3002 (E)\u82e5\u8840\u884c\u52d5\u529b\u5b78\u4e0d\u7a69\u5b9a\u8207\u9ad8\u5ea6\u61f7\u7591\u70ba\u8179\u4e3b\u52d5\u8108\u7834\u88c2\u6642 \uff0c\u61c9\u7acb\u5373\u63a5\u53d7\u624b\u8853\u6cbb\u7642\uff0c\u4e0d\u61c9\u70ba\u4e86\u7b49\u5f85\u96fb\u8166\u65b7\u5c64\u52d5\u8108\u651d\u5f71\u800c\u5ef6\u9072 \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8179\u90e8\u920d\u50b7\u6642 \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u6700\u5e38\u53d7\u640d\u7684\u5668\u5b98\u70ba\u813e\u81df\u8207\u809d\u81df \u3002 (B)\u809d\u3001\u813e\u4e4b\u640d\u50b7\u82e5\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a \uff0c\u53ef\u63a1\u975e\u624b\u8853\u6cbb\u7642 \u3002 (C)\u82e5\u751f\u547d\u5fb5\u8c61\u4e0d\u7a69\u5b9a \uff0c\u4e14\u8d85\u97f3\u6ce2\u767c\u73fe\u5927\u91cf\u8179\u8154\u51fa\u8840 \uff0c\u53ef\u4ee5\u76f4\u63a5\u9032\u884c\u624b\u8853 \u3002 (D)\u8178\u640d\u50b7\u5728\u8179\u90e8\u5916\u50b7\u521d\u671f\u5e38\u6c92\u6709\u75c7\u72c0 \uff0c\u9700\u6301\u7e8c\u89c0\u5bdf\u75c5\u4eba\u75c7\u72c0\u53ca\u8eab\u9ad4\u6aa2\u67e5 \u3002 (E)\u6a6b\u9694\u819c\u640d\u50b7\u4ee5\u53f3\u5074\u8f03\u70ba\u5e38\u898b \u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u81bf\u80f8 (empyema )\u7684\u808b\u819c\u6db2\u6aa2\u67e5 \uff0c\u6700\u80fd\u652f\u6301\u7684\u5be6\u9a57\u5ba4\u6578\u64da \uff0c\u4e0b\u5217\u4f55\u8005 \u9664\u5916\uff1f", + "Options": "(A)\u808b\u819c\u6db2\u7684\u7d30\u83cc\u57f9\u990a\u967d\u6027 \u3002 (B)\u808b\u819c\u6db2\u7684 lactate dehydrogenase \u5927\u65bc 1,000 IU/L \u3002 (C)\u808b\u819c\u6db2\u7684 pH\u5c0f\u65bc 7.1 \u3002 (D)\u808b\u819c\u6db2\u7684\u767d\u8840\u7403\u8a08\u6578\u5927\u65bc 10,000/mm 3\u3002 (E)\u808b\u819c\u6db2\u7684\u8461\u8404\u7cd6\u5c0f\u65bc 40 mg/dL \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u9ad4\u91cd\u7d04 30 \u516c\u65a4\u7684 6\u6b72\u5973\u7ae5\uff0c\u7531\u5bb6\u5c6c\u9001\u9054\u6025\u8a3a\u5ba4\u6642\u5448\u73fe\u55dc\u7761 \uff0c\u547c\u5438\u6025\u4fc3 \u3002\u8840\u58d380/40 mmHg \uff0c\u5fc3\u8df3 130 \u6b21/min \uff0c\u8840\u7cd6 500 mg/dL \uff0c\u6025\u8a3a\u91ab\u5e2b\u8a55\u4f30\u6709 10% \u812b\u6c34\u60c5\u5f62 \uff0c\u95dc\u65bc\u6cbb\u7642\u53ca\u5176\u9810\u5f8c \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u53ef\u8003\u616e\u512a\u5148\u7d66\u4e88 0.9% \u751f\u7406\u98df\u9e7d\u6c34 600 ml \u704c\u6ce8\uff0c\u4ee5\u63d0\u5347\u8840\u58d3 \u3002 (B)\u82e5\u7d66\u4e88 0.9% \u751f\u7406\u98df\u9e7d\u6c34 600ml \u704c\u6ce8\u4e00\u6b21\u5f8c \uff0c\u82e5\u75c5\u7ae5\u610f\u8b58\u8f49\u597d\u4e14\u704c\u6d41(perfusion )\u4e5f\u5df2\u9069\u7576 \uff0c48 \u5c0f\u6642\u5167\u8f38\u6db2\u88dc\u5145\u4ee5\u4e0d\u8d85\u904e\u7dad\u6301\u8f38\u6db2 1.5 \u500d\u70ba\u539f\u5247\u3002 (C)\u7d66\u4e88\u751f\u7406\u98df\u9e7d\u6c34\u704c\u6ce8\u5f8c \uff0c\u7acb\u5373\u7d66\u4e88 regular insulin 0.1unit/kg/hr \u6301\u7e8c\u975c\u6ce8\u3002 (D)\u82e5\u8840\u7cd6\u77ef\u6b63\u5f8c \uff0c\u4f4e\u8840\u9209\u60c5\u5f62\u4ecd\u7121\u6cd5\u7a69\u5b9a\u56de\u5347 \uff0c\u88ab\u8a8d\u70ba\u662f\u767c\u751f\u8166\u6c34\u816b\u7684\u98a8\u96aa\u4e4b\u4e00 \u3002 (E)\u9069\u5ea6\u7684\u98df\u9e7d\u6c34\u704c\u6ce8 \u3001\u88dc\u5145 bicarbonate \u53caregular insulin \u53ef\u4ee5\u6e1b\u5c11\u8166\u6c34\u816b\u7684\u767c\u751f \u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u5b55\u5a66\u5916\u50b7\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u5c0d\u65bc\u80ce\u5152\u521d\u6b65\u6700\u597d\u7684\u6cbb\u7642\uff0c\u662f\u5c0d\u5176\u6bcd\u89aa\u50b7\u52e2\u505a\u6700\u597d\u7684\u6cbb\u7642\u53ca\u5c0d\u80ce\u5152\u505a\u65e9\u671f\u8a55\u4f30\u3002 (B)\u4e00\u822c\u6cbb\u7642\u7684\u512a\u5148\u9806\u5e8f\u8207\u672a\u61f7\u5b55\u8005\u76f8\u540c\u3002 (C)\u5b55\u5a66\u81e5\u59ff\u4e00\u822c\u63a1\u5de6\u5074\u62ac\u9ad8\u70ba\u5b9c\u3002 (D)\u7576\u8840\u6db2\u6c23\u9ad4\u5206\u6790 PaCO2\u70ba 40 mmHg \u8981\u8003\u616e\u7015\u81e8\u547c\u5438\u8870\u7aed\u3002 (E)Tetanus toxoid \u5728\u61f7\u5b55\u521d\u671f\u53ef\u4ee5\u4f7f\u7528\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u5916\u50b7\u9020\u6210\u6a6b\u8188\u7834\u88c2(traumatic diaphragmatic rupture)\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u591a\u534a\u51fa\u73fe\u5728\u5de6\u5074\u3002 (B)\u920d\u50b7\u8f03\u6613\u9020\u6210\u6a6b\u8188\u5927\u578b\u653e\u5c04\u72c0\u7684\u88c2\u50b7\uff0c\u7a7f\u523a\u50b7\u5247\u662f\u9020\u6210\u5c0f\u7684\u7834\u6d1e\u3002 (C)\u53d7\u50b7\u65e9\u671f\u7684 X \u5149\u5e38\u88ab\u8aa4\u8a8d\u70ba\u6a6b\u8188\u4e0a\u5347\u6216\u5c40\u90e8\u8840\u6c23\u80f8\u3002 (D)\u7576\u61f7\u7591\u5de6\u5074\u6a6b\u8188\u7834\u88c2\u6642\uff0c\u53ef\u653e\u7f6e\u80c3\u7ba1\uff0c\u82e5\u80f8\u90e8 X \u5149\u767c\u73fe\u80c3\u7ba1\u51fa\u73fe\u5728\u80f8\u8154\u5167\u5247\u53ef\u78ba\u8a3a\u3002 (E)\u5c0d\u8f03\u5c0f\u7684\u6a6b\u8188\u819c\u50b7\u5bb3\uff0c\u7528\u96fb\u8166\u65b7\u5c64\u6383\u63cf\u7684\u8a3a\u65b7\u7387\u5f88\u9ad8\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u7591\u4f3c\u72c2\u72ac\u75c5\u52d5\u7269\u6293\u54ac\u50b7\uff0c\u4e0b\u5217\u654d\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u5982\u679c\u53ef\u80fd\u7684\u8a71\uff0c\u907f\u514d\u7e2b\u5408\u50b7\u53e3\uff0c\u5982\u9808\u7e2b\u5408\u50b7\u53e3\u61c9\u5118\u53ef\u80fd\u5730\u5bec\u9b06\u3002 (B)\u6297\u751f\u7d20\u3001\u7834\u50b7\u98a8\u75ab\u82d7\u6216\u7834\u50b7\u98a8\u514d\u75ab\u7403\u86cb\u767d\u7684\u7d66\u4e88\uff0c\u61c9\u5982\u540c\u5176\u4ed6\u6293\u54ac\u50b7\u53e3\u7684\u8655\uf9e4\u4e00\u6a23\u3002 (C)\u5bb6\u72ac\u8c93\u6293\u54ac\u50b7\u66ab\uf967\u7d66\u4e88\ufa06\uf938\u5f8c\u75ab\u82d7\u9810\u9632\u63a5\u7a2e\u3002 (D)\uf9ca\uf92a\u72ac\u8c93\u5982\ufa06\uf938\u7b49\u7d1a\u70ba\u7b2c\u4e8c\uf9d0(\u542b)\u4ee5\u4e0a\uff0c\u5efa\u8b70\u63a5\u7a2e\u75ab\u82d7\u3002 (E)\u5c0d\u65bc\u975e\u514d\u75ab\u529f\u80fd\uf967\u5168\u8005\uff0c\ufa06\uf938\u7b49\u7d1a\u70ba\u7b2c\u4e8c\uf9d0\u6642\u7d66\u4e88\u72c2\u72ac\u75c5\u514d\u75ab\u7403\u86cb\u767d\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u4f11\u514b\uff0c\u4eba\u9ad4\u85c9\u7531\u81ea\u5f8b\u795e\u7d93\u53cd\u61c9(autonomic response)\u6240\u5f62\u6210\u7684\u4ee3\u511f\u6a5f\u5236(compensatory mechanism)\uff0c\u4f86\u589e\u52a0\u91cd\u8981\u5668\u5b98\u8840\uf9ca\u91cf\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u4f4d\u65bc\u76ae\u819a\u3001\u808c\u8089\u3001\u814e\u81df\u548c\u813e\u81df\u7684\u5c0f\u52d5\u8108\u6536\u7e2e\u3002 (B)\u5fc3\u8df3\u548c\u5fc3\u81df\u6536\u7e2e\u529b\u589e\u52a0\uff0c\u4ee5\u589e\u52a0\u5fc3\u8f38\u51fa\u91cf\u3002 (C)\u4fc3\u9032\u6297\u5229\u5c3f\u6fc0\u7d20\u91cb\u653e\uff0c\u4ee5\u4fdd\u7559\u9ad4\u5167\u6c34\u5206\u548c\u9e7d\u5206\uff0c\u589e\u52a0\u8840\u7ba1\u5167\u5bb9\u7a4d\u3002 (D)\u6e1b\u5c11 vasoactive hormones \u7684\u91cb\u653e\uff0c\u5982 dopamine\u3001epinephrine \u7b49\u3002 (E)\u975c\u8108\u6536\u7e2e\uff0c\u589e\u52a0\u8840\u6db2\u56de\uf9ca\u91cf\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u7a7a\u4e2d\u50b7\u75c5\u60a3\u904b\u9001(Aeromedical Transportation)\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u4ee5\u76f4\u6607\u6a5f\u7a7a\u4e2d\u904b\u9001\u75c5\u4eba\uff0c\u610f\u8b58\uf967\u597d\u7684\u75c5\u4eba\u61c9\u8003\u616e\u653e\u7f6e\u9f3b\u80c3\u7ba1\uff0c\u4ee5\u6e1b\u5c11\u5438\u5165\u6027\u80ba\u708e\u7684\u98a8\u96aa\uff1b\u82e5\u5df2\u6c23\u7ba1\u63d2\u7ba1\uff0c\u767b\u6a5f\u524d\u6c23\u56ca\u58d3\u529b(cuff pressure)\uff0c\u4fdd\u6301\u6700\u9ad8\u4e0a\u9650\u3002 (B)\u5c31\u75c5\u4eba\u5b89\u5168\u800c\u8a00\uff0c\u56fa\u5b9a\u7ffc\u98db\u6a5f\u662f\u6bd4\u76f4\u6607\u6a5f\u66f4\u597d\u7684\u9078\u64c7\u3002 (C)\u7206\u70b8\u50b7\u50b7\u60a3\u9808\u7279\u5225\u5c0f\u5fc3\u6c23\u80f8\u3001\u4e2d\u7a7a\u5668\u5b98\u7834\u88c2\uff0c\u53ca\u52d5\u8108\u7a7a\u6c23\u6813\u585e\u7684\u60e1\u5316\u3002 (D)\u7a7a\u4e2d\u8f49\u8a3a\uff0c\u9664\u61c9\u7b26\u5408\u7a7a\u4e2d\u6551\u8b77\u9069\u61c9\u75c7\u5916\uff0c\u4ee5\u8a72\u5730\u5340\u4e4b\u91ab\u9662\u4f9d\u5176\u8a2d\u5099\u53ca\u5c08\u9577\u7121\u6cd5\u63d0\u4f9b\u5b8c\u6574\u6cbb\u7642\uff0c\u4e14\u975e\u7d93\u7a7a\u4e2d\u8f49\u8a3a\u5c07\u5f71\u97ff\u7dca\u6025\u91ab\u7642\u6551\u8b77\u6642\u6548\u8005\u70ba\u9650\u3002 (E)\u6211\u570b\u6709\u5168\u570b\u7a7a\u4e2d\u7dca\u6025\u91ab\u7642\u6551\u8b77\u8aee\u8a62\u4e2d\u5fc3(National Aeromedical Counseling Center\uff0c\u7c21\u7a31 NACC)\uff0c\u8ca0\u8cac\u5c0d\u65bc\u6211\u570b\u4f7f\u7528\u516c\u8cbb\u7a7a\u4e2d\u8f49\u8a3a\u904b\u9001\u50b7\u75c5\u60a3\u7533\u8acb\u6848\u7684\u5be9\u6838\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u4ee3\u8b1d\u6027\u9178\u4e2d\u6bd2(metabolic acidosis)\u7d66\u4e88\u78b3\u9178\u6c2b\u9e7d(HCO3-)\u6cbb\u7642\u7684\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u4ee3\u8b1d\u6027\u9178\u4e2d\u6bd2\u5408\u4f75\u547c\u5438\u4ee3\u511f\uf967\u826f\uff0c\u9996\u5148\u8981\u5148\u6539\u5584\u547c\u5438\u63db\u6c23\uff0c\u800c\u975e\u7d66\u4e88\u78b3\u9178\u6c2b\u9e7d(HCO3-)\u3002 (B)\u6cbb\u7642\u76ee\u6a19\u70ba\u7dad\u6301\u9ad4\u5167 HCO3- > 15 mEq/L\u3002 (C)\u7d66\u4e88\u5291\u91cf\u70ba 0.5 mEq/kg\u3002 (D)\u8f15\u5230\u4e2d\u5ea6\u7684\u4ee3\u8b1d\u6027\u9178\u4e2d\u6bd2\uff0c\u7d66\u4e88\u78b3\u9178\u6c2b\u9e7d(HCO3-)\u6cbb\u7642\u53cd\u800c\u53ef\u80fd\u6709\u5bb3\u3002 (E)\u56b4\u91cd\u4ee3\u8b1d\u6027\u9178\u4e2d\u6bd2\u4e14\u9020\u6210\u5fc3\u5f8b\uf967\u7a69(myocardial irritability)\u7684\u75c5\u4eba\uff0c\u53ef\u4ee5\u7d66\u4e88\u78b3\u9178\u6c2b\u9e7d(HCO3-)\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6ccc\u5c3f\u7cfb\u7d71\u5916\u50b7(genitourinary trauma)\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u8840\u5c3f\u7684\u7a0b\u5ea6\u8207\u640d\u50b7\u56b4\u91cd\u7a0b\u5ea6\u6210\u6b63\u6bd4\u3002 (B)\u5c3f\u9053\u53e3\u6709\u8840\u6642\uff0c\u61c9\u907f\u514d\u76f4\u63a5\u653e\u7f6e\u5c3f\u7ba1\u3002 (C)\u5728 renal pedicle \u7684\u640d\u50b7\uf967\u4e00\u5b9a\u6703\u6709\u8840\u5c3f\u3002 (D)\u5c0f\u5152\u8170\u90e8\u920d\u50b7\uff0c\u5c3f\u6db2\u6aa2\u67e5\u767c\u73fe> 50 RBCs/HPF\uff0c\u53ef\u8003\u616e\u5b89\u6392\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u8a55\u4f30\u6709\u7121\u814e\u81df\u640d\u50b7\u3002 (E)\u8180\u80f1\u7834\u88c2\u5728\u6210\u4eba\u4ee5\u8179\u819c\u5916(extraperitoneal)\u5916\u6f0f\u8f03\u5e38\u898b\uff0cextraperitoneal\u7684\u8180\u80f1\u640d\u50b7\u5927\u591a\uf967\u9700\u624b\u8853\uff0c\u50c5\u9808\u653e\u7f6e\u5c0e\u5c3f\u7ba1\u5f15\uf9ca\u5373\u53ef\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u6709\u95dc spontaneous tendon rupture\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u9577\u671f\u4f7f\u7528\uf9d0\u56fa\u9187\u8207 fluoroquinolone \u662f\u91cd\u8981\u7684\u5371\u96aa\u56e0\u5b50\u3002 (B)Thompson test \u53ef\u7528\u4f86\u5e6b\u52a9\u8a3a\u65b7 Achilles tendon rupture\u3002 (C)Achilles tendon rupture \u7684\u75c5\u4eba\u7686\u9700\u8981\u958b\u5200\u6cbb\u7642\u3002 (D)Ruptures of the anterior tibialis tendon \u7684\u75c5\u4eba\u5927\u90e8\u4efd\uf967\u9700\u8981\u958b\u5200\u6cbb\u7642\u3002 (E)Ruptures of the posterior tibialis tendon \u597d\u767c\u5728\u5973\u6027\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u6709\u95dc amiodarone \u85e5\u7269\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u7531\u809d\u81df\u4ee3\u8b1d\uff0c\u7d93\u7531\u814e\u81df\u6392\u6cc4\u3002 (B)\u88ab\u5206\uf9d0\u65bc class III antiarrhythmic drugs\u3002 (C)\u542b\u6709 37.3%\u7684 iodine\uff0c\u56e0\u6b64\u5c0d\u65bc iodine \u6216\u662f\u7532\u6bbc\uf9d0(shellfish)\u6703\u904e\u654f\u7684\u4eba\u7981\u7528\u3002 (D)\u8ddf simvastatin \u4f75\u7528\u6703\u589e\u52a0\u6a6b\u7d0b\u808c\u6eb6\u89e3(rhabdomyolysis)\u7684\u98a8\u96aa\u3002 (E)\u9577\u671f\u53e3\u670d\u4f7f\u7528\u53ef\u80fd\u5f71\u97ff\u7532\u72c0\u817a\u548c\u809d\u81df\u529f\u80fd\uff0c\u5f15\u8d77\u80ba\u90e8\u7e96\u7dad\u5316\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u6709\u570b\u5916\u65c5\u904a\u53f2\u7684\u75c5\u4eba\uff0c\u51fa\u73fe\u767c\u71d2\u4f86\u5230\u6025\u8a3a\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u53f0\u7063\u5730\u5340\u5883\u5916\u79fb\u5165\u91cd\u8981\u50b3\u67d3\u75c5\u78ba\u5b9a\u75c5\u4f8b\u4e2d\uff0c\u4ee5\u7627\u75be\u5360\u6700\u9ad8\u7684\u6bd4\u4f8b\u3002 (B)\u767b\u9769\u71b1\u3001\u5c48\u516c\u75c5\u3001\u6591\u75b9\u50b7\u5bd2\u3001\u6885\u6bd2\u53ca\u4f0a\u6ce2\u62c9\u75c5\u6bd2\u611f\u67d3\u5747\u53ef\u80fd\u5408\u4f75\u76ae\u75b9(rash)\u8868\u73fe\u3002 (C)\u75c5\u6bd2\u6027\u809d\u708e(\u5982\u6025\u6027 A \u578b\u809d\u708e)\u3001\u7627\u75be\u3001\u9264\u7aef\u87ba\u65cb\u9ad4\u75c5\u53ca\u9ec3\u71b1\u75c5\u7b49\u5747\u53ef\u80fd\u51fa\u73fe\u9ec3\u75b8(jaundice)\u3002 (D)\u9664\u65c5\u904a\u5730\u5340\u5916\uff0c\uf967\u540c\u75be\u75c5\u7684\u6f5b\u4f0f\u671f\u3001\u75c5\u4eba\u56de\u570b\u65e5\u671f\u3001\u75c5\u4eba\u51fa\u73fe\u75c7\u72c0\u4e4b\u65e5\u671f\uff0c\u5747\u662f\u9451\u5225\u8a3a\u65b7\u6642\u7684\u91cd\u8981\u8003\u91cf\u3002 (E)\u5c0d\u65bc\u525b\u7531\u4e2d\u6771\u5730\u5340\u56de\u570b\uf967\u5230 2 \u9031\u4e4b\u75c5\u4eba\uff0c\uf9ca\u884c\u6027\u8166\u810a\u9ad3\u819c\u708e\u611f\u67d3\u3001\u7627\u75be\u3001\u70ad\u75bd\u71b1\u3001\u5e03\u6c0f\u687f\u83cc\u75c5(Brucellosis)\u53ca\u4e2d\u6771\u547c\u5438\u75c7\u5019\u7fa4\u51a0\u72c0\u75c5\u6bd2\u611f\u67d3\u75c7(MERS-CoV)\u5747\u70ba\u53ef\u80fd\u4e4b\u9451\u5225\u8a3a\u65b7\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u4ee5\u4e0b\u54ea\u4e00\u9805\u6307\u6a19\u6700\u9069\u5408\u7528\u4f86\u8a55\u4f30\u4e00\u500b\u5230\u9662\u524d\u6551\u8b77\u7cfb\u7d71\u5c0d\u5230\u9662\u524d\u5fc3\u8df3\u505c\u6b62\u7684\u75c5\u4eba(Out-of-Hospital Cardiac Arrest\uff0cOHCA)\u4e4b\u6025\u6551\u6210\u6548?", + "Options": "(A)OHCA \u500b\u6848\u7684\u5e73\u5747\u53cd\u61c9\u6642\u9593\u3002 (B)OHCA \u500b\u6848\u7531\u9ad8\u7d1a\u6551\u8b77\u6280\u8853\u54e1\u51fa\u52e4\u7684\u6bd4\u7387\u3002 (C)OHCA \u500b\u6848\u5b58\u6d3b\u5230\u4f4f\u9662\u7684\u6bd4\u7387\u3002 (D)OHCA \u500b\u6848\u5b58\u6d3b\u51fa\u9662\u7684\u6bd4\u7387\u3002 (E)OHCA \u500b\u6848\uff0c\u5176\u4e2d\u70ba\u6709\u65c1\u89c0\u8005\u76ee\u64ca\uff0c\u4e00\u958b\u59cb\u76e3\u6e2c\u5230\u7684\u5fc3\u5f8b\u662f\u5fc3\u5ba4\u986b\u52d5\uff0c\u5176\u5b58\u6d3b\u51fa\u9662\u7684\u6bd4\u7387\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u4f9d\u64da 2013 \u5e74\u65b0\u82f1\u683c\u862d\u91ab\u5b78\u96dc\u8a8c\u53ca 2014 \u5e74\u7f8e\u570b\u75be\u75c5\u7ba1\u5236\u5c40(CDC)\u65c5\u904a\u8005\u5065\u5eb7\u9ec3\u76ae\u66f8\u7684\u5efa\u8b70\uff0c\u95dc\u65bc\u9ad8\u5c71\u75be\u75c5(high altitude illness)\u6cbb\u7642\u4e0b\u5217\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u5982\u767c\u751f\u9ad8\u5c71\u80ba\u6c34\u816b(high altitude pulmonary edema)\uff0c\u61c9\u81f3\u5c11\u964d\u4f4e\u9ad8\u5ea6 1,000 \u516c\u5c3a\u4ee5\u4e0a\u3002 (B)\u5982\u767c\u751f\u9ad8\u5c71\u8166\u6c34\u816b(high altitude cerebral edema)\uff0c\u61c9\u81f3\u5c11\u964d\u4f4e\u9ad8\u5ea61,000 \u516c\u5c3a\u4ee5\u4e0a\u3002 (C)\u651c\u5e36\u5f0f\u52a0\u58d3\u888b(portable hyperbaric chamber)\u53ef\u7528\u65bc\u6cbb\u7642\u9ad8\u5c71\u80ba\u6c34\u816b\u53ca\u9ad8\u5c71\u8166\u6c34\u816b\u3002 (D)\u5a01\u800c\u92fc(Sildenafil\uff0cViagra)\u53ca Nifedipine(Calcium channel blockade)\uf967\u5efa\u8b70\u540c\u6642\u4f7f\u7528\u3002 (E)\u5c3f\u6bd2\u75c7\u4e4b\u75c5\u4eba\u4f7f\u7528\u4e39\u6728\u65af(Acetazolamide\uff0cDiamox)\u53ef\uf967\u9700\u8abf\u6574\u5291\u91cf\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u4e00\u5c0d\u6bcd\u5973\u5e74\u9f61\u5206\u5225\u70ba 44 \u6b72\u53ca 15 \u6b72\uff0c\u7686\u65bc 2 \u5929\u524d\u958b\u59cb\u51fa\u73fe\u5614\u5410\u3001\u8179\u7009\u3001\u982d\u6688\u3001\u773c\u77bc\u4e0b\u5782\u3001\u808c\u8089\u7121\u529b\u3001\u541e\u56a5\u53ca\u547c\u5438\u56f0\u96e3\u7b49\u75c7\u72c0\u3002\u5169\u8005\u90fd\u56e0\u547c\u5438\u8870\u7aed\u800c\u4f4f\u9032\u52a0\u8b77\u75c5\u623f\u63a5\u53d7\u9032\u4e00\u6b65\u7684\u6cbb\u7642\u3002\u8a66\u554f\uff0c\u6700\u7b26\u5408\u9019\u5c0d\u6bcd\u5973\u81e8\u5e8a\u8868\u73fe\u7684\u8a3a\u65b7\u70ba\u4e0b\u5217\u4f55\u8005?", + "Options": "(A)\u5409\u862d-\u5df4\u96f7\u6c0f\u75c7\u5019\u7fa4(Guillain-Barre syndrome)\u3002 (B)\u91cd\u75c7\u808c\u7121\u529b(Myasthenia Gravis )\u3002 (C)\u808c\u8089\u5931\u990a\u75c7(Muscular dystrophy)\u3002 (D)\u8089\u6bd2\u687f\u83cc\u4e2d\u6bd2(Botulism)\u3002 (E)\u4e00\u6c27\u5316\u78b3\u4e2d\u6bd2(CO intoxication)\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u5728\u4e00\u5834\u7a81\u767c\u7684\u74e6\u65af\u6c23\u7206\u4e8b\u4ef6\u4e2d\uff0c\u6aa2\u50b7\u4eba\u54e1\u5df2\u7d93\u505a\u597d\u521d\u6b21\u6aa2\u50b7\uff0c\u4f60(\u59b3)\u662f\u7b2c\u4e00\u500b\u5230\u9054\u73fe\u5834\u652f\u63f4\u7684\u91ab\u7642\u4eba\u54e1\uff0c\u88ab\u6307\u6d3e\u4efb\u52d9\u70ba\u9032\u884c\u4e8c\u6b21\u6aa2\u50b7\uff0c\u8acb\u554f\u6839\u64daSTART(Simple Triage And Rapid Treatment)\uff0c\u4e0b\u5217\u75c5\u4eba\u4e4b\u6aa2\u50b7\u5206\uf9d0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)34 \u6b72\u5973\u6027\uff0c\u547c\u5438\u6025\u4fc3\uff0c\u53e3\u9f3b\u6709\u9ed1\u8272\u78b3\u7c92\u9644\u8457\uff0c\u610f\u8b58\uf967\u6e05\uff1a\u9ec3\u8272\u3002 (B)25 \u6b72\u7537\u6027\uff0c\u6253\u958b\u547c\u5438\u9053\u5f8c\u4ecd\u7121\u547c\u5438\uff0c\u81c9\u90e8\u53ca\u8ec0\u5e79\u5927\u7247\u71d2\u50b7\uff1a\u9ed1\u8272\u3002 (C)60 \u6b72\u5973\u6027\uff0c\u547c\u5438 25 \u6b21/min\uff0c\u5fae\u8840\u7ba1\u586b\u5145\u6642\u9593\u5927\u65bc 3 \u79d2\uff1a\u7d05\u8272\u3002 (D)18 \u6b72\u7537\u6027\uff0c\u96d9\u5074\u524d\u81c2\u64e6\u50b7\uff0c\u56db\u8655\u5954\u8dd1\uff0c\u54ed\u558a\u8457\u670b\u53cb\u5728\u74e6\u792b\u5806\u4e2d\uff1a\u7da0\u8272\u3002 (E)32 \u6b72\u5973\u6027\uff0c\u610f\u8b58\u6e05\u695a\uff0c\u547c\u5438\u8108\u640f\u6b63\u5e38\uff0c\u53f3\u4e0b\u80a2\u816b\u8139\u8b8a\u5f62\uff1a\u9ec3\u8272\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u598a\u5a20\u7b2c\u4e00\u671f(first trimester)\u5e38\u898b\u7684\u9670\u9053\u51fa\u8840\u539f\u56e0\uff0c\uf967\u5305\u62ec\u4e0b\u5217\u4f55\u8005?", + "Options": "(A)\u5b50\u5bae\u5916\u5b55(ectopic pregnancy)\u3002 (B)\u598a\u5a20\u6ecb\u990a\u5c64\u75be\u75c5(gestational trophoblastic disease)\u3002 (C)\uf9ca\u7522(abortion)\u3002 (D)\u524d\u7f6e\u80ce\u76e4(placenta previa)\u3002 (E)\u8457\u5e8a\u51fa\u8840(implantation bleeding)\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u7269\u8cea\u4e2d\u6bd2\u6642\uff0c\u6240\u4f7f\u7528\u7684\u89e3\u6bd2\u5291\u914d\u5c0d\uff0c\u4f55\u8005\u6700\uf967\u9069\u7576?", + "Options": "(A)\u55ae\u7d14\u6027\u7a92\u606f\u5291(Simple asphyxiant)\uff1a100%\u6c27\u6c23\u3002 (B)\u4e00\u6c27\u5316\u78b3(CO)\uff1a100%\u6c27\u6c23\u3002 (C)\u758a\u6c2e\u5316\u7269(Azide)\uff1a\u786b\u4ee3\u786b\u9178\u9209(Sodium thiosulfate)\u3002 (D)\u82ef\u80fa(Aniline)\uff1a\u7532\u57fa\u85cd(Methylene blue)\u3002 (E)\u5927\u82b1\u66fc\u9640\u7f85(Datura)\uff1aPhysostigmine\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u6709\u95dc\u885b\u751f\u798f\u5229\u90e8\u516c\u4f48\u4e4b\u516c\u5171\u5834\u6240\u6c11\u773e\u7248 CPR+AED \u6559\u6750\u4e4b\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u5206\u70ba\u7c21\u6613\u7248\u3001\u5b8c\u6574\u7248\u3001\u4ee5\u53ca AED \u7ba1\uf9e4\u54e1\u7248\u4e09\u500b\u968e\u5c64\u3002 (B)\u4e09\u500b\u968e\u5c64\u6559\u6750\u6559\u5b78\u7684\uf9ca\u7a0b\u548c\u5c08\u696d\u4eba\u54e1\u7248\u6700\u5927\u7684\uf967\u540c\u5728\u65bc\uf967\u6559\u5c0e\u4eba\u5de5\u547c\u5438\u3002 (C)\u6559\u6750\u4e2d\u6709\u7279\u5225\u5f37\u8abf\u6cd5\u5f8b\u4fdd\u8b77\u5584\u5fc3\u6551\u52a9\u8005\u7684\u6bb5\u843d\u3002 (D)AED \u7ba1\uf9e4\u54e1\u8ab2\u7a0b\u5373\u70ba\u5b8c\u6574\u7248\u7684\u8ab2\u7a0b\u518d\u52a0\u4e0a AED \u8a2d\u7f6e\uf9ca\u7a0b\u3002 (E)\u4e09\u500b\u968e\u5c64\u7684\u6559\u6750\u90fd\u6709\u6559\u5c0e\u6c11\u773e\u5982\u4f55\u8fa8\u8b58\u7015\u6b7b\u5f0f\u547c\u5438\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u6709\u95dc\u764c\u75c7\u75c5\u4eba\u5316\u7642\u5f8c\u7522\u751f febrile neutropenia\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u53ef\u80fd\u70ba\u611f\u67d3\u75c7\uff0c\u9700\u9032\u884c\u8a73\u7d30\u75c5\u53f2\u8a62\u554f\u548c\uf9e4\u5b78\u6aa2\u67e5\u3002 (B)\u5373\u4f7f\u75c5\u4eba\u5c3f\u6db2\u6aa2\u67e5\u7d50\u679c\u6c92\u6709\u51fa\u73fe\u81bf\u5c3f(pyuria)\uff0c\u4ecd\u9700\u9032\u884c\u5c3f\u6db2\u57f9\u990a(urine culture)\u3002 (C)\u75c5\u4eba\u8eab\u4e0a\u7684\u7559\u7f6e\u5c0e\u7ba1\u4ea6\u9700\u8a55\u4f30\u6709\u7121\u611f\u67d3\u4e4b\u53ef\u80fd\u6027\u3002 (D)\uf9e4\u5b78\u6aa2\u67e5\u61c9\u5305\u62ec\u75c5\u4eba\u53e3\u8154\u53ca\u809b\u9580\u5468\u570d\u5340\u57df\uff0c\u5728\u4f7f\u7528\u6297\u751f\u7d20\u524d\u61c9\u5148\u9032\u884c\u809b\u9580\u6307\u8a3a\u3002 (E)\u5efa\u8b70\u505a\u5169\u5957\u8840\u6db2\u57f9\u990a\u6aa2\u67e5\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u4f55\u8005\u662f\u6613\u611f\u67d3\u7834\u50b7\u98a8(Tetanus-prone)\u7684\u50b7\u53e3?", + "Options": "(A)\u4e8c\u5ea6\u71d9\u50b7\u3002 (B)\u6df1\u5ea6 0.5 \u516c\u5206\u3002 (C)\u73bb\u7483\u5272\u50b7\u3002 (D)\u53d7\u50b7 4 \u5c0f\u6642\u5167\u3002 (E)\u7dda\u72c0\u50b7\u53e3\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u4f55\u8005\uf967\u662f\u570b\u969b\u516c\u8a8d\u7684\u751f\u7269\u6050\u6016\u653b\u64ca(Bioterrorism)A \uf9d0\u751f\u7269\u6230\u5291?", + "Options": "(A)\u5929\u82b1(Smallpox)\u3002 (B)\u70ad\u75bd\u75c5(Anthrax)\u3002 (C)\u6f22\u4ed6\u75c5\u6bd2(Hanta virus)\u3002 (D)\u4f0a\u6ce2\u62c9\u75c5\u6bd2(Ebola virus)\u3002 (E)\u8089\u6bd2\u687f\u83cc\u6bd2\u7d20(Botulinum Toxin)\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u4f55\u8005\uf967\u6703\u6709\u4eba\u50b3\u4eba\u7684\u60c5\u5f62\u767c\u751f?", + "Options": "(A)\u80ba\u708e\u578b\u9f20\u75ab(Pneumonic Plague)\u3002 (B)\u5929\u82b1(Smallpox)\u3002 (C)\u75c5\u6bd2\u6027\u51fa\u8840\u71b1(Viral Hemorrhagic Fever)\u3002 (D)\u5438\u5165\u6027\u70ad\u75bd\u75c5(Inhalational Anthrax)\u3002 (E)\u51a0\u72c0\u75c5\u6bd2(Coronavirus)\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u95dc\u65bc\u5404\u7a2e\u58de\u6b7b\u6027\u7b4b\u819c\u708e(necrotizing fasciitis)\u7684\u6558\u8ff0\uff0c\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u60e1\u6027\u5916\u8033\u708e(malignant otitis externa)\u70ba\u767c\u751f\u65bc\u5916\u8033\u9053\u3001\u9873\u9aa8\u4e73\u7a81(mastoid)\u53ca\u9871\u5e95\u9aa8\u90e8\u4f4d\u4e4b\u58de\u6b7b\u6027\u611f\u67d3\uff0c\u4e3b\u8981\u81f4\u75c5\u83cc\u70ba\u80ba\u708e\u96d9\u7403\u83cc(Streptococcus pneumoniae)\u3002 (B)\u798f\u5c3c\u723e\u6c0f\u58de\u75bd(Fournier gangrene)\u70ba\u4e00\u7a2e\u767c\u751f\u65bc\u6703\u9670\u90e8\u4f4d\u4e4b\u58de\u6b7b\u6027\u7b4b\u819c\u708e\uff0c\u5927\u591a\u662f\u591a\u91cd\u5fae\u751f\u7269\u611f\u67d3(polymicrobial infection)\uff0c\u4e14\u4ee5\u5927\u8178\u687f\u83cc(Escherichia coli)\u70ba\u6700\u5e38\u5206\u96e2\u51fa\u4e4b\u7d30\u83cc\u3002 (C)\u7b2c\u4e8c\u578b\u58de\u6b7b\u6027\u7b4b\u819c\u708e\u591a\u767c\u751f\u65bc\u904e\u53bb\u5927\u81f4\u5065\u5eb7\u7684\u75c5\u4eba\uff0c\u597d\u767c\u90e8\u4f4d\u70ba\u56db\u80a2\uff0c\u800c\u4ee5 A \u578b\u93c8\u7403\u83cc(Group A streptococcus)\u70ba\u6700\u4e3b\u8981\u7684\u81f4\u75c5\u83cc\u3002 (D)\u809d\u786c\u5316\u75c5\u4eba\u767c\u751f\u80a2\u9ad4\u4e4b\u58de\u6b7b\u6027\u7b4b\u819c\u708e\u6642\uff0c\u5fc5\u9808\u8003\u616e\u6d77\u6d0b\u5f27\u83cc(Vibrio vulnificus)\u53ca\u89aa\u6c34\u6027\u7522\u6c23\u55ae\u80de\u83cc(Aeromonas hydrophilia)\u70ba\u81f4\u75c5\u83cc\u4e4b\u53ef\u80fd\u6027\u3002 (E)\u5728\u53f0\u7063\u5730\u5340\uff0c\u514b\u96f7\u4f2f\u6c0f\u83cc(Klebsiella pneumoniae)\u4e5f\u662f\u9020\u6210\u58de\u6b7b\u6027\u8edf\u7d44\u7e54\u611f\u67d3\u7684\u53ef\u80fd\u81f4\u75c5\u83cc\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u95dc\u65bc\u80ba\u708e\u8207\u81f4\u75c5\u83cc\u7684\u6558\u8ff0\uff0c\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)MRSA\u3001Mycoplasma pneumoniae \u53ca Legionella \u540c\u70ba\u5b89\u990a\u9662\u4f4f\u6c11\u5e38\u898b\u4e4b\u80ba\u708e\u81f4\u75c5\u83cc\u3002 (B)Legionella pneumophila \u81e8\u5e8a\u4e0a\u9664\u4e86\u767c\u71d2\u3001\u4e7e\u54b3\u4e4b\u5916\u540c\u6642\u5e38\u898b\u8179\u7009\u3001\u5614\u5410\u7b49\u8178\u80c3\u9053\u75c7\u72c0\u3002 (C)Pseudomonas aeruginosa \u70ba\u6700\u8fd1\u6709\u4f4f\u9662\u53f2\u53ca\u514d\u75ab\u529f\u80fd\uf967\u5168\u7684\u75c5\u4eba\u5e38\u898b\u4e4b\u80ba\u708e\u81f4\u75c5\u83cc\u3002 (D)Staphylococcus aureus \u662f\u75c5\u6bd2\u611f\u67d3\u5f8c\u7e8c\u767c\u7d30\u83cc\u6027\u80ba\u708e\u4e4b\u5e38\u898b\u81f4\u75c5\u83cc\u3002 (E)Klebsiella pneumoniae \u662f\u9152\u766e\u8005\u91cd\u8981\u4e4b\u80ba\u708e\u81f4\u75c5\u83cc\uff0c\u80f8\u90e8 X \u5149\u51fa\u73febulging fissure sign \u662f\u7279\u9ede\u4e4b\u4e00\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u90a3\u4e00\u500b\u767c\u71d2(\u9ad4\u6eab\u226738\u2103)\u7684\u75c5\u7ae5\u7f79\u60a3\u56b4\u91cd\u7d30\u83cc\u611f\u67d3(severe bacterial infection)\u7684\u6a5f\u6703\u6700\u9ad8?", + "Options": "(A)2 \u500b\u6708\u5927\u7121\u5176\u4ed6\u76f8\u95dc\u75c7\u72c0\u7684\u7537\u5b30\uff0c\u767d\u8840\u7403 20,000/\u00b5L\u3002 (B)4 \u500b\u6708\u5927\u7121\u5176\u4ed6\u76f8\u95dc\u75c7\u72c0\u7684\u7537\u5b30\uff0c\u5c3f\u6db2\u6aa2\u67e5\u4e26\u7121\u7570\u5e38\u767c\u73fe\u3002 (C)2 \u500b\u6708\u5927\u7121\u5176\u4ed6\u76f8\u95dc\u75c7\u72c0\u7684\u5973\u5b30\uff0c\u767d\u8840\u7403 8,200/\u00b5L\u3002 (D)4 \u500b\u6708\u5927\u8179\u7009\u7684\u5973\u5b30\uff0c\u7cde\u4fbf\u6aa2\u67e5\u4e26\u7121\u7570\u5e38\u767c\u73fe\u3002 (E)6 \u500b\u6708\u5927\u7121\u5176\u4ed6\u76f8\u95dc\u75c7\u72c0\u7684\u7537\u5b30\uff0c\u5c3f\u6db2\u6aa2\u67e5\u4e26\u7121\u7570\u5e38\u767c\u73fe\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u6025\u6027\u5fc3\u808c\u6897\u585e\u5408\u4f75\u5fc3\u56e0\u6027\u4f11\u514b\uff0c\u4e0b\u5217\u8655\u7f6e\u6216\u85e5\u7269\u4f55\u8005\uf967\u9069\u7576?", + "Options": "(A)Aspirin 300 mg \u53e3\u670d\u3002 (B)Captopril 25 mg \u53e3\u670d\u3002 (C)Dopamine 5 mcg/kg/min \u975c\u8108\u6ef4\u6ce8\u3002 (D)Intra-Aortic Balloon Counterpulsation\u3002 (E)\u7167\u6703\u5fc3\u81df\u79d1\u91ab\u5e2b\u9032\u884c percutaneous coronary intervention\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u6025\u6027\u8166\u4e2d\u98a8\u7684\u8655\u7f6e\uff0c\u4e0b\u5217\u654d\u8ff0\u4f55\u8005\uf967\u9069\u7576?", + "Options": "(A)\u7f3a\u8840\u6027\u8166\u4e2d\u98a8\u82e5\uf967\u8003\u616e\u8840\u6813\u6eb6\u89e3\u6cbb\u7642\uff0c\u6536\u7e2e\u58d3\u672a\u8d85\u904e 220 mmHg\u3001\u8212\u5f35\u58d3\u672a\u8d85\u904e 120 mmHg \u6642\uff0c\uf967\u9700\u7279\u5225\u964d\u8840\u58d3\u3002 (B)\u7f3a\u8840\u6027\u8166\u4e2d\u98a8\u82e5\u80fd\u5c07\u8840\u58d3\u964d\u81f3 185/110 mmHg \u4ee5\u4e0b\uff0c\u4ecd\u53ef\u8003\u616e\u65bd\u4e88\u8840\u6813\u6eb6\u89e3\u6cbb\u7642\u3002 (C)\u82e5\u70ba\u51fa\u8840\u6027\u8166\u4e2d\u98a8\u61c9\u9069\u7576\u5c07\u6536\u7e2e\u58d3\u964d\u81f3 160 mmHg \u5de6\u53f3\u3002 (D)\u964d\u8840\u58d3\u85e5\u7269\u7684\u9078\u64c7\u5305\u62ec Labetalol\u3001Nicardipine \u6216 Nitroglycerine \u6ef4\u6ce8\u4e26\u96a8\u6642\u8abf\u6574\u3002 (E)\u4f9d\u76ee\u524d\u570b\u5167\u8655\u7f6e\uf9ca\u7a0b\uff0c\u5efa\u8b70\u65bc\u5230\u9054\u6025\u8a3a 30 \u5206\u9418\u5167\u505a\u96fb\u8166\u65b7\u5c64\u6383\u63cf\u300145 \u5206\u9418\u5167\u5224\u8b80 CT \u7d50\u679c\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u61f7\u5b55 26 \u5468\u6709\u6c23\u5598\u75c5\u53f2\u4e4b\u5b55\u5a66\u56e0\u547c\u5438\u56f0\u96e3\u81f3\u6025\u8a3a\u5c31\u8a3a\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u5373\u4f7f\u807d\u8a3a\u6c92\u6709\u5598\u9cf4\u8072(wheezing)\u4e5f\uf967\u80fd\u6392\u9664\u6c23\u5598\u6025\u6027\u767c\u4f5c\u7684\u53ef\u80fd\u3002 (B)\u80ba\u529f\u80fd\u91cf\u8a08(spirometry)\u53ef\u7528\u4f86\u8a55\u4f30\u6c23\u5598\u6025\u6027\u767c\u4f5c\u4e4b\u56b4\u91cd\u5ea6\u53ca\u6cbb\u7642\u6548\u679c\u3002 (C)\u61c9\u7d66\u4e88\u6c27\u6c23\u7dad\u6301\u8840\u6c27\u6fc3\u5ea6> 95%\uff0c\u540c\u6642\u88dd\u4e0a\u80ce\u5152\u76e3\u8996\u5668\u5bc6\u5207\u89c0\u5bdf\u662f\u5426\u6709\u80ce\u5152\u7a98\u8feb\u3002 (D)\u5438\u5165\u578b\u4e59\u4e8c\u578b\u4ea4\u611f\u795e\u7d93\u8208\u596e\u5291(\u03b22 agonists)\u662f\u6c23\u5598\u6025\u6027\u767c\u4f5c\u4e4b\u5b55\u5a66\u7684\u7b2c\u4e00\u7dda\u6cbb\u7642\u3002 (E)\u5168\u8eab\u6027\uf9d0\u56fa\u9187(systemic corticosteroids)\u4e26\uf967\u5efa\u8b70\u4f7f\u7528\u65bc\u6c23\u5598\u6025\u6027\u767c\u4f5c\u4e4b\u5b55\u5a66\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6709\u6a5f\u78f7\u8fb2\u85e5\u88fd\u5291\u4e4b\u7279\u6027\uff0c\u4e0b\u5217\u654d\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u6b64\uf9d0\u542b\u78f7\u6709\u6a5f\u5316\u5408\u7269\uff0c\u7a2e\uf9d0\u7e41\u591a\uff0c\u5728\u8fb2\u696d\u4e0a\u88ab\u5ee3\u6cdb\u7684\u7528\u4f86\u6bba\u87f2\u3001\u6bba\u83cc\u53ca\u6bba\u87ce\u3002 (B)\u6b64\uf9d0\u6709\u6a5f\u78f7\u6bba\u87f2\u5291\u4e4b\u8102\u6eb6\u6027\u8f03\u4f4e\uff0c\u5177\u849c\u81ed\u5473\u3002 (C)\u6613\u5f9e\u4eba\u9ad4\u7684\u80c3\u8178\u9053\u3001\u76ae\u819a\u3001\u773c\u775b\u6216\u547c\u5438\u9053\u5438\u6536\uff0c\u9020\u6210\u5c40\u90e8\u6216\u5168\u8eab\u6027\u7684\u5f71\u97ff\u3002 (D)\u4e2d\u6bd2\u7684\u56b4\u91cd\u5ea6\u8207\u4e2d\u6bd2\u5291\u91cf\u53ca\u4eba\u9ad4\u5c0d\u6bd2\u7269\u7684\u5438\u6536\u53ca\u6392\u9664\u901f\u7387\u6709\u95dc\u3002 (E)\u4e2d\u6bd2\u4e4b Muscarinic \u7279\u6b8a\u75c7\u72c0\u70ba\u817a\u9ad4\u5206\u6ccc\u589e\u52a0\u3001\u5fc3\u8df3\u7de9\u6162\u3001\u77b3\u5b54\u7e2e\u5c0f\u7b49\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5b50\u5bae\u5916\u5b55(ectopic pregnancy)\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u5b50\u5bae\u5916\u5b55\u75c5\u4eba\u7684\u5178\u578b\u8868\u73fe\u70ba\u7a81\u7136\u767c\u751f\u56b4\u91cd\u7684\u55ae\u5074\u6216\u96d9\u5074\u8179\u75db\uff0c\u4f46\u901a\u5e38\uf967\u592a\u6709\u9670\u9053\u51fa\u8840\u7684\u60c5\u5f62\u3002 (B)\u5b50\u5bae\u5916\u5b55\u75c5\u4eba\u5728\u75be\u60a3\u767c\u751f\u6642\uff0c\u4ecd\u7136\u6709\u53ef\u80fd\u4e4b\u524d\u7684\u6708\u7d93\u7686\u6b63\u5e38\u3002 (C)\u53ea\u6709\u6aa2\u9a57\u4e00\u6b21 \u03b2-hCG \u7121\u6cd5\u660e\u78ba\u5206\u8fa8\u75c5\u4eba\u767c\u751f\u5b50\u5bae\u5916\u5b55\u6216\u6b63\u5e38\u61f7\u5b55\u3002 (D)\u5982\u75c5\u4eba\u5148\u524d\u70ba\u4e86\u7d55\u80b2\u800c\u63a5\u53d7\u8f38\u5375\u7ba1\u624b\u8853\uff0c\u7576\u6709\u61f7\u5b55\u60c5\u5f62\u6642\u61c9\u512a\u5148\u8003\u616e\u662f\u5426\u767c\u751f\u5b50\u5bae\u5916\u5b55\u3002 (E)\u8d85\u904e\u4e00\u534a\u4ee5\u4e0a\u7684\u5b50\u5bae\u5916\u5b55\u75c5\u4eba\u4e26\u7121\u767c\u73fe\u660e\u78ba\u7684\u98a8\u96aa\u56e0\u5b50\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6c34\u694a\u9178(Salicylate)\u4e2d\u6bd2\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u8981\u7cbe\u78ba\u8a55\u4f30\u56b4\u91cd\u7a0b\u5ea6\uff0c\u5efa\u8b70\u6e2c\u91cf\u8840\u4e2d\u6fc3\u5ea6\uff0c\u5c0d\u7167\u670d\u7528\u6642\u9593\uff0c\u4f7f\u7528 Done nomogram \u53bb\u5224\u65b7\u3002 (B)\u6162\u6027\u670d\u7528\u6c34\u694a\u9178\u85e5\u7269\u6cbb\u7642\u75c5\u4eba\uff0c\u82e5\u62b1\u6028\u8033\u9cf4\uff0c\u5373\u8981\u8003\u616e\u662f\u5426\u6709\u4e2d\u6bd2\u53ef\u80fd\u3002 (C)\u6210\u5e74\u4eba\u6025\u6027\u904e\u91cf\uff0c\u56b4\u91cd\u7a0b\u5ea6\u548c\u85e5\u7269\u670d\u7528\u5291\u91cf\u6709\u76f8\u7576\u5927\u7684\u95dc\u4fc2\u3002 (D)\u6c34\u694a\u9178\u4e2d\u6bd2\u4e3b\u8981\u8868\u73fe\u70ba High anion gap metabolic acidosis\uff0c\u4f46\u82e5\u62bd\u8840\u70ba normal anion gap metabolic acidosis\uff0c\u4ea6\uf967\u80fd\u5b8c\u5168\u6392\u9664\u53ef\u80fd\u6027\u3002 (E)\u82e5\u75c5\u4eba\u814e\u8870\u7aed\u3001\u610f\u8b58\u6539\u8b8a\u3001\u6025\u6027\u80ba\u640d\u50b7\uff0c\u9700\u8003\u616e\u7dca\u6025\u8840\u6db2\u900f\u6790\u6cbb\u7642\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8f38\u8840\u76f8\u95dc\u6025\u6027\u80ba\u640d\u50b7(transfusion-related acute lung injury\uff0cTRALI)\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u662f\u8f38\u8840\u76f8\u95dc\u6b7b\u4ea1\u7684\u4e3b\u8981\u539f\u56e0\u4e4b\u4e00\u3002 (B)\u901a\u5e38\u767c\u751f\u65bc\u8f38\u8840\u4e2d\u6216\u8f38\u8840\u5f8c 6 \u5c0f\u6642\u4ee5\u5167\u3002 (C)\u8f03\u5e38\u767c\u751f\u65bc FFP \u6216 platelet transfusion\uff0c\u8f03\u5c11\u767c\u751f\u5728\u55ae\u7368\u7d66\u4e88 packed RBC transfusion \u4e4b\u5f8c\u3002 (D)TRALI \u56e0\u70ba\u6709\u80ba\u6c34\u816b\uff0c\u6240\u4ee5\u61c9\u8a72\u7a4d\u6975\u7d66\u4e88\u5229\u5c3f\u5291\u3002 (E)\u5927\u90e8\u5206\u7684\u75c5\u4eba\uff0c\u5728\u63a5\u53d7\u652f\u6301\u6027\u7684\u6cbb\u7642\u5f8c\uff0c\u80ba\u640d\u50b7\u6703\u81ea\u884c\u9010\u6f38\u6539\u5584\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6210\u4eba\u80f8\u90e8\u920d\u50b7\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u5916\u50b7\u5f15\u8d77\u4e3b\u52d5\u8108\u7834\u88c2\u7684\u75c5\u4eba\u5927\u90fd\u6b7b\u65bc\u6848\u767c\u73fe\u5834\uff0c\u5c11\u6578\u5b58\u6d3b\u8005\u53d7\u50b7\u4f4d\u7f6e\u5927\u591a\u5728 ligamentum arteriosum\u3002 (B)\u5f35\u529b\u6027\u6c23\u80f8(tension pneumothorax)\u70ba\u81e8\u5e8a\u8a3a\u65b7\uff0c\u901a\u5e38\u6703\u5148\u51fa\u73fe\u4f4e\u8840\u58d3\uff0c\u7136\u5f8c\u624d\u6703\u51fa\u73fe\u767c\u7d3a\u60c5\u5f62\u3002 (C)\u82e5\u80f8\u90e8 X \u5149\u53ca\u8d85\u97f3\u6ce2\u8a3a\u65b7\u8840\u80f8\uff0c\u61c9\u653e\u7f6e\u80f8\u7ba1\uff0c\u82e5\u99ac\u4e0a\u5f15\uf9ca\u51fa\u5927\u65bc 1,500 ml \u7684\u8840\uff0c\u5247\u9808\u5b89\u6392\u958b\u80f8\u624b\u8853\u6b62\u8840\u3002 (D)\u653e\u7f6e\u80f8\u7ba1\u5f8c\u82e5\u6301\u7e8c\u5f15\uf9ca\u51fa\u7a7a\u6c23\uff0c\u5247\u8981\u8003\u616e\u6c23\u7ba1\u652f\u6c23\u7ba1\u640d\u50b7\uff0c\u61c9\u5b89\u6392\u652f\u6c23\u7ba1\u93e1\u8a3a\u65b7\u3002 (E)\u5c0d\u65bc\u5fc3\u81df\u632b\u50b7(blunt cardiac injury)\u7684\u75c5\u4eba\uff0c\u62bd\u8840\u9a57 Troponin I \u6bd4\u8d77\u5fc3\u96fb\u5716\u5c0d\u81e8\u5e8a\u4e0a\u7dca\u6025\u7684\u5224\u65b7\u548c\u6cbb\u7642\u66f4\u6709\u7528\u8655\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6210\u4eba\u810a\u9ad3\u640d\u50b7(Spinal cord injury)\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)Anterior cord syndrome \u53d7\u50b7\u90e8\u4f4d\u4ee5\u4e0b\u6703\u55aa\u5931\u672c\u9ad4\u611f\u89ba(proprioception)\u548c\u9707\u52d5\u611f\u89ba(vibration)\u3002 (B)Central cord syndrome \u5728\u8001\u4eba\u5bb6\u8f03\u6613\u767c\u751f\uff0c\u53d7\u50b7\u6a5f\u8f49\u901a\u5e38\u70bahyperextension\uff0c\u4e0a\u80a2\u7121\u529b\u6703\u5927\u65bc\u4e0b\u80a2\u7121\u529b\u3002 (C)Cauda equina syndrome \u7684\u9810\u5f8c\u8f03\u597d\uff0c\u4e3b\u8981\u56e0\u70ba\u53d7\u50b7\u7684\u795e\u7d93\u70ba\u5468\u908a\u795e\u7d93\uff0c\u6709\u518d\u751f\u7684\u6a5f\u6703\u3002 (D)Brown-Sequard syndrome \u70ba\u540c\u5074\u7121\u529b\uff0c\u540c\u5074\u5931\u53bb\u672c\u9ad4\u611f\u89ba\uff0c\u5408\u4f75\u5c0d\u5074\u5931\u53bb\u75db\u89ba\u6eab\u89ba\u3002 (E)\u810a\u9ad3\u640d\u50b7\u9020\u6210\u795e\u7d93\u6027\u4f11\u514b(neurogenic shock)\uff0c\u901a\u5e38\u80a2\u9ad4\u5448\u73fe\u6eab\u6696\uff0c\u8840\u58d3\u4f4e\u4f46\u5fc3\u8df3\u76f8\u5c0d\uf967\u5feb(relative bradycardia)\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u4e2d\u6a1e\u795e\u7d93\u611f\u67d3\u7684\u6558\u8ff0\uff0c\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)Streptococcus pneumoniae\u3001Neisseria meningitidis \u70ba\u5e38\u898b\u7684\u75c5\u539f\u83cc\u3002 (B)Listeria monocytogenes \u9020\u6210\u7684\u4e2d\u6a1e\u795e\u7d93\u611f\u67d3\u5728\u8001\u5e74\u4eba\u8f03\u5e38\u898b\u3002 (C)\u5373\u4f7f\u75c5\u4eba\u6c92\u6709\u51fa\u73fe\u767c\u71d2\u3001\u9838\u90e8\u50f5\u786c\u3001\u610f\u8b58\u8b8a\u5316\u7b49\u5178\u578b\u75c7\u72c0\uff0c\u4e5f\uf967\u80fd\u6392\u9664\u8166\u819c\u708e\u7684\u53ef\u80fd\u6027\u3002 (D)\u82e5\u61f7\u7591\u7d30\u83cc\u6027\u8166\u819c\u708e\uff0c\u61c9\u7b49\u8170\u690e\u7a7f\u523a\u5b8c\u6210\uff0c\u6536\u96c6\u5230\u8166\u810a\u9ad3\u6db2\u6aa2\u9ad4\u5f8c\uff0c\u518d\u958b\u59cb\u7d66\u4e88\u6297\u751f\u7d20\u6cbb\u7642\u3002 (E)\u75c5\u4eba\u767c\u751f\u610f\u8b58\u8b8a\u5316\u3001\u5c40\u90e8\u795e\u7d93\u5b78\u7f3a\u9677\u6216\u7672\u7647\u767c\u4f5c\u7b49\u60c5\u5f62\uff0c\u9032\u884c\u8170\u690e\u7a7f\u523a\u524d\u61c9\u5148\u5b89\u6392\u982d\u90e8\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u81f4\u547d\u6027\u80f8\u75db\u5e38\u898b\u539f\u56e0\u7684\u5178\u578b\u75c7\u72c0\u53ca\u6025\u6027\u51a0\u5fc3\u75c7\u8a55\u4f30\u7684\u6bd4\u8f03\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u5fc3\u7d5e\u75db\u75bc\u75db\u90e8\u4f4d\u65bc\u80f8\u9aa8\u5f8c\u6216\u4e0a\u8179\u90e8\uff0c\u60b6\u75db\u6216\u58d3\u8feb\u611f\uff1b\u5927\u9762\u7a4d\u80ba\u6813\u585e\u70ba\u6574\u500b\u80f8\u90e8\u7684\u539a\u91cd\u7dca\u8feb\u611f\u3002 (B)\u4e3b\u52d5\u8108\u525d\u96e2\u53ca\u98df\u9053\u7834\u88c2\u75bc\u75db\u90e8\u4f4d\u4e3b\u8981\u65bc\u80f8\u9aa8\u4e0b\uff0c\u524d\u8005\u5e38\u70ba\u6495\u88c2\u75db\u4e14\u8f49\u79fb\u81f3\u80cc\u5074\u80a9\u80db\u9593\uff0c\u5f8c\u8005\u5e38\u70ba\u5287\u70c8\u5614\u5410\u5f8c\u7a81\u7136\u5c16\u92b3\u75db\u4e14\u8f49\u79fb\u81f3\u80cc\u90e8\u3002 (C)\u4e3b\u52d5\u8108\u525d\u96e2\u3001\u547c\u5438\u8870\u7aed\u3001\u6557\u8840\u75c7\u53ca\u71d2\u71d9\u50b7\u53ef\u80fd\u9020\u6210 Troponin \u4e0a\u5347\u3002 (D)\u6025\u6027\u4e2d\u98a8\u6216\u8718\u86db\u819c\u4e0b\u8154\u51fa\u8840\uff0c\u4e26\uf967\u6703\u9020\u6210 Troponin \u4e0a\u5347\u3002 (E)\u9664\u4e86\u6025\u6027\u51a0\u5fc3\u75c7\u5916\uff0c\u6162\u6027\u9152\u7cbe\u4e2d\u6bd2\u3001\u651d\u8b77\u817a\u764c\u3001\u4e00\u6c27\u5316\u78b3\u4e2d\u6bd2\u90fd\u8207CK-MB \u5347\u9ad8\u6709\u95dc\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8154\u5ba4\u75c7\u5019\u7fa4(Compartment Syndrome)\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba?", + "Options": "(A)\u811b\u9aa8\u9aa8\u6298\u662f\u597d\u767c\u90e8\u4f4d\uff0c\u624b\u90e8\u4e5f\u53ef\u767c\u751f\u8154\u5ba4\u75c7\u5019\u7fa4\u3002 (B)\u7576\u8154\u5ba4\u58d3\u529b\u8d85\u904e 45 mmHg\uff0c\u7d44\u7e54\u7684\u7f3a\u8840\u624d\u6703\u767c\u751f\u3002 (C)\u6478\uf967\u5230\u80a2\u9ad4\u8fd1\u7aef\u52d5\u8108\u640f\u52d5\uff0c\u70ba\u65e9\u671f\u4e4b\u8154\u5ba4\u75c7\u5019\u7fa4\u5fb5\u5019\u3002 (D)\u53ef\u5efa\u8b70\u75c5\u4eba\u62ac\u9ad8\u60a3\u80a2\uff0c\u6e1b\u5c11\u8154\u5ba4\u58d3\u529b\u3002 (E)\u90fd\u666e\u52d2(Doppler)\u8d85\u97f3\u6ce2\u662f\u8a3a\u65b7\u7684\u597d\u5de5\u5177\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u9838\u90e8\u5916\u50b7(Neck injury)\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u5c0d\u65bc\u9838\u90e8\u5275\u50b7\u7684\uf9e4\u5b78\u6aa2\u67e5\uff0cHard signs \u76f8\u5c0d\u65bc Soft signs \u901a\u5e38\u4ee3\u8868\u8f03\u56b4\u91cd\u7684\u50b7\u5bb3\u3002 (B)\uf9e4\u5b78\u6aa2\u67e5\u767c\u73fe expanding hematoma \u53ca Stridor/Hoarseness\uff0c\u7686\u70ba\u9838\u90e8\u5916\u50b7\u7684 Hard signs\u3002 (C)\u9838\u90e8\u7a7f\u523a\u50b7\u4e2d Zone II injuries \u76f8\u5c0d\u65bc Zone I \u53ca III\uff0c\u82e5\u6709\u5fc5\u8981\u53ef\u8003\u616e\u76f4\u63a5\u65bd\u4e88\u624b\u8853\u63a2\u67e5\uff0c\uf967\u4e00\u5b9a\u8981\u5b89\u6392\u50b3\u7d71\u8840\u7ba1\u651d\u5f71\u6aa2\u67e5(conventional angiography)\u3002 (D)\u9838\u90e8\u7a7f\u523a\u50b7\u60a3\u8005\u82e5\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\uff0c\u53ef\u5148\u5b89\u6392 CTA(CT angiography)\u6aa2\u67e5\u6709\u7121\u8840\u7ba1\u640d\u50b7\u3002 (E)\u9838\u90e8\u920d\u50b7\u9020\u6210\u9838\u52d5\u8108\u525d\u96e2(carotid artery dissection)\uff0c\u8a3a\u65b7\u78ba\u5b9a\u5f8c\u61c9\u7d66\u4e88\u6297\u51dd\u8840\u5291\u6cbb\u7642\uff0c\u4f86\u9810\u9632\u4e2d\u98a8\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u907f\u514d\u6e1b\u58d3\u75be\u75c5(Decompression illness)\u4e4b\u767c\u751f\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba?", + "Options": "(A)\u6f5b\u5230\u6df1\u6d77\u5f8c\u5feb\u901f\u4e0a\u5347\u3002 (B)\u6f5b\u6c34\u5f8c 12 \u5c0f\u6642\u5167\u642d\u98db\u6a5f\u3002 (C)\u6f5b\u6c34\u5f8c\u505a\u5287\u70c8\u904b\u52d5\u3002 (D)\u6f5b\u6c34\u5f8c\u591a\u88dc\u5145\u6c34\u5206\u3002 (E)\u6f5b\u6c34\u5f8c\u5750\u8eca\u4e0a\u5c71\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5609\u78f7\u585e\u7570\u4e19\u80fa\u9e7d(Glyphosate)\u8fb2\u85e5\u4e2d\u6bd2\u7684\u654d\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u662f\u4e00\u7a2e\u9664\u8349\u5291\uff0c\u5e02\u552e\u5e38\u898b\u7684\u5e74\u5e74\u6625\u5373\u5c6c\u6b64\uf9d0\u3002 (B)\u4e3b\u8981\u6210\u4efd\u70ba\u91a3\u78f7\uf9d0\u4f54 41%\u548c\u975e\u96e2\u5b50\u6027\u4e4b\u8868\u9762\u64f4\u5f35\u5291(surfactant polyoxyethyleneamine)\u4f54 15%\u3002 (C)\u6703\u6709\u8150\u8755\u7684\u4f5c\u7528\uff0c\u6240\u4ee5\u98df\u5165\u6642\uff0c\u53ef\u80fd\u9020\u6210\u80c3\u8178\u9053\u53ca\u4e0a\u547c\u5438\u9053\u9ecf\u819c\u523a\u6fc0\u548c\u7cdc\u721b\u3002 (D)\u4e3b\u8981\u6bd2\u6027\u6a5f\u8f49\u8207\u5176\u6240\u542b\u4e4b\u91a3\u78f7\uf9d0\u6709\u95dc\u3002 (E)\u56b4\u91cd\u4e2d\u6bd2\u6642\uff0c\u6703\u9020\u6210\u5fc3\u81df\u6bd2\u6027\u3001\u4ee3\u8b1d\u6027\u9178\u4e2d\u6bd2\u3001\u9ad8\u8840\u9240\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u61f7\u5b55\u6642\u7684\u6025\u75c7\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)HELLP syndrome \u53ef\u80fd\u6703\u767c\u751f\u88ab\u819c\u4e0b\u809d\u8840\u816b(subcapsular liver hematoma)\u7684\u81f4\u547d\u4f75\u767c\u75c7\u3002 (B)\u5728\u9760\u8fd1\u9810\u7522\u671f\u7684\u61f7\u5b55\u5a66\u5973\u5982\u767c\u751f\u75bc\u75db\u7684\u9670\u9053\u51fa\u8840\uff0c\u5247\u61c9\u8003\u616e\u662f\u5426\u767c\u751f\u80ce\u76e4\u65e9\u671f\u525d\u96e2(abruptio placentae)\u3002 (C)\u7522\u5f8c\u51fa\u8840(postpartum hemorrhage)\u7684\u6cbb\u7642\u8457\u91cd\u65bc\u4fc3\u9032\u5b50\u5bae\u6536\u7e2e\u8207\u77ef\u6b63\u51dd\u8840\u529f\u80fd\u7570\u5e38\u3002 (D)\u61f7\u5b55\u5a66\u5973\u767c\u751f\u5b50\u7647\u75c7(eclampsia)\u6642\u61c9\u7acb\u5373\u4f7f\u7528 benzodiazepine \uf9d0\u7684\u85e5\u7269\u4f86\u63a7\u5236 seizure\u3002 (E)\u61f7\u5b55\u5a66\u5973\u767c\u751f HELLP syndrome \u6642\uff0c\u9382\u96e2\u5b50\u7684\u7d66\u4e88\u3001\u8840\u58d3\u7684\u63a7\u5236\u8207\u7a69\u5b9a\u751f\u547d\u5fb5\u8c61\u662f\u975e\u5e38\u91cd\u8981\u7684\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6a6b\u7d0b\u808c\u6eb6\u89e3\u75c7(rhabdomyolysis)\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u5728\u6a6b\u7d0b\u808c\u6eb6\u89e3\u75c7\u767c\u751f\u6642\uff0c\u61c9\u8a72\u907f\u514d NSAID \u7684\u4f7f\u7528\u3002 (B)\u7576\u5c3f\u6db2\u8a66\u7d19\u8a66\u9a57(urine dipstick test)\u986f\u793a\u8840\u5c3f\uff0c\u4f46\u986f\u5fae\u93e1\u6aa2\u4e0b\u537b\u767c\u73fe\u5c3f\u6db2\u4e2d\u7121\u7d05\u8840\u7403\u7684\u5b58\u5728\uff0c\u6b64\u6642\u61c9\u8003\u616e\u75c5\u4eba\u53ef\u80fd\u767c\u751f myoglobinuria\u3002 (C)\u6a6b\u7d0b\u808c\u6eb6\u89e3\u75c7\u6240\u9020\u6210\u6025\u6027\u814e\u8870\u7aed\u70ba\u814e\u5167\u578b\u6025\u6027\u814e\u8870\u7aed(intrinsic acute renal failure)\u3002 (D)\u6a6b\u7d0b\u808c\u6eb6\u89e3\u75c7\u6240\u53ef\u80fd\u9020\u6210\u7684\u8840\u4e2d\u96fb\u89e3\u8cea\u7570\u5e38\u5305\u62ec\u9ad8\u8840\u9240\u75c7\u3001\u4f4e\u8840\u9223\u75c7\u8207\u9ad8\u78f7\u9178\u8840\u75c7\u3002 (E)\u6a6b\u7d0b\u808c\u6eb6\u89e3\u75c7\u7684\u8a3a\u65b7\u6a19\u6e96\u70ba\uff0c\u5728\u78ba\u5b9a\u7121\u5fc3\u81df\u548c\u8166\u90e8\u7684\u50b7\u5bb3\u5f8c\uff0c\u8840\u6f3f\u4e2d CK \u503c\u5927\u65bc\u6b63\u5e38\u503c\u4e0a\u9650\u7684 10 \u500d\u4ee5\u4e0a\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u7a7a\u4e2d\u91ab\u7642\u4e4b\u60a3\u8005\u9078\u64c7\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u5916\u50b7\u75c5\u4eba\u82e5\u7a0b\u5ea6\u6108\u56b4\u91cd(\u4f46\u975e\u6b7b\u4ea1)\u4e14\u6108\u504f\u9060\uff0c\u5247\u7a7a\u4e2d\u5f8c\u9001\u6548\u76ca\u6bd4\u5730\u9762\u904b\u9001\u66f4\u986f\u8457\u3002 (B)\u9700\u8981\u7dca\u6025 bypass surgery \u6216 balloon pump support \u4e4b\u5fc3\u81df\u75c5\u7684\u75c5\u4eba\uff0c\u53ef\u8003\u616e\u5b89\u6392\u7a7a\u4e2d\u91ab\u7642\u8f49\u9001\u3002 (C)\u91dd\u5c0d\u6709\u5fc3\u81df\u75c5\u4e4b\u5b55\u5a66\u767c\u751f\u65e9\u7522\u6216\u65e9\u671f\u7834\u6c34\uf967\u9069\u5408\u7528\u7a7a\u4e2d\u91ab\u7642\u8f49\u9001\u3002 (D)\u6025\u6027\u7f3a\u8840\u6027\u8166\u4e2d\u98a8\u75c5\u4eba\uff0c\u662f\u7a7a\u4e2d\u91ab\u7642\u8f49\u9001\u7684\u9069\u61c9\u75c7\u3002 (E)\u65e9\u7522\u4e4b\u65b0\u751f\u5152\u4ecd\u53ef\u900f\u904e\u5c08\u696d\u4eba\u54e1\u9032\u884c\u7a7a\u4e2d\u91ab\u7642\u904b\u9001\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u9aa8\u76c6\u9aa8\u6298\u7684\u63cf\u8ff0\u8207\u8655\u7f6e\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u4e00\u65e6\u78ba\u5b9a\u9aa8\u76c6\u9aa8\u6298\uff0c\u5247\u9808\u6392\u9664\u8179\u8154\u3001\u5f8c\u8179\u8154\u3001\u751f\u6b96\u7cfb\u7d71\u53ca\u6ccc\u5c3f\u7cfb\u7d71\u640d\u50b7\u4e4b\u53ef\u80fd\u3002 (B)\u8840\u884c\u52d5\u529b\u5b78\uf967\u7a69\u5b9a\u4e4b\u9aa8\u76c6\u9aa8\u6298\u50b7\u60a3\uff0c\u61c9\u5118\u901f\u5b89\u6392\u8840\u7ba1\u651d\u5f71\u6aa2\u67e5\uff0c\u9032\u884c\u6813\u585e\u6cbb\u7642\u3002 (C)\u9aa8\u76c6\u9aa8\u6298\u7684\u6a5f\u8f49\u5305\u62ec\uff1aanterior posterior compression\u3001lateral compression \u53ca vertical shear\uff0c\u5176\u4e2d\u4ee5 lateral compression \u6700\u5e38\u898b\u3002 (D)\u9aa8\u76c6\u9aa8\u6298\u5c0e\u81f4\u5f8c\u8179\u8154\u51fa\u8840\uff0c\u4e3b\u8981\u4f86\u6e90\u70ba\u975c\u8108\u53ca\u9aa8\u6298\u908a\u7de3\u51fa\u8840\uff0c\u52d5\u8108\u51fa\u8840\u50c5\u4f54 10~15%\u3002 (E)\u9664\u4e86\u6813\u585e\u6cbb\u7642\u5916\uff0c\u56fa\u5b9a\u9aa8\u76c6\u4ea6\u53ef\u63a7\u5236\u5f8c\u8179\u8154\u51fa\u8840\uff0c\u4f46\u5c0d\u975c\u8108\u53ca\u9aa8\u6298\u908a\u7de3\u51fa\u8840\u6548\u679c\u8f03\u4f73\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u611f\u67d3\u6027\u5fc3\u5167\u819c\u708e(Infective endocarditis)\u7684\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u611f\u67d3\u6027\u5fc3\u5167\u819c\u708e\u6700\u5e38\u767c\u751f\u5728\u4e8c\u5c16\u74e3(mitral valve)\u3002 (B)\u63a5\u53d7\u74e3\u819c\u7f6e\u63db\u624b\u8853 2 \u500b\u6708\u5167\u88ab\u8a3a\u65b7\u51fa\u611f\u67d3\u6027\u5fc3\u5167\u819c\u708e\uff0c\u8f03\u53ef\u80fd\u70ba\u9662\u5167\u611f\u67d3(hospital-acquired)\u3002 (C)\u91d1\u9ec3\u8272\u8461\u8404\u7403\u83cc\u4fb5\u72af\u529b\u5f37\uff0c\u53ef\u80fd\u76f4\u63a5\u4fb5\u72af\u6c92\u6709\u8d05\u751f\u7269\u7684\u74e3\u819c\u3002 (D)\u611f\u67d3\u6027\u5fc3\u5167\u819c\u708e\u7684\u75c5\u4eba\u90fd\u9808\u63a5\u53d7\u6297\u51dd\u8840\u5291\u6cbb\u7642\u3002 (E)\u6297\u751f\u7d20\u6cbb\u7642\u4e00\u822c\u9700 4~6 \u5468\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u92f0\u9e7d(Lithium)\u4e2d\u6bd2\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u82e5\u5f15\u8d77\u7672\u7647\uff0c\u7528 phenytoin \u6cbb\u7642\u6548\u679c\uf967\u4f73\u3002 (B)\u6025\u6027\u92f0\u9e7d\u4e2d\u6bd2\u6642\uff0c\u75c5\u4eba\u4e3b\u8981\u5148\u4ee5\u795e\u7d93\u5b78\u75c7\u72c0\u8868\u73fe\uff0c\u5176\u6b21\u624d\u662f\u8178\u80c3\u9053\u75c7\u72c0\u3002 (C)\u9577\u671f\u670d\u7528\uff0c\u5e38\u9020\u6210\u591a\u5c3f\u3001\u5641\u5fc3\u3001\u76ae\u819a\u75b9\u3001\u624b\u6296\u7b49\u526f\u4f5c\u7528\u3002 (D)\u814e\u8870\u7aed\u3001\u809d\u786c\u5316\u3001\u9ad4\u6db2\u6c34\u5206\u7f3a\u4e4f\u3001\u611f\u67d3\uff0c\u7686\u662f\u5c0e\u81f4\u92f0\u9e7d\u4e2d\u6bd2\u4e4b\u4fc3\u767c\u56e0\u5b50(precipitating factors)\u3002 (E)\u6025\u6027\u670d\u7528\u92f0\u9e7d\u75c5\u4eba\uff0c\u82e5\u8840\u6e05\u6fc3\u5ea6\u5927\u65bc 1.5 mEq/L\uff0c\u5373\u4f7f\u7121\u75c7\u72c0\uff0c\u4e5f\u61c9\u5efa\u8b70\u75c5\u4eba\u4f4f\u9662\u89c0\u5bdf\u8207\u6cbb\u7642\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8001\u4eba\u5916\u50b7\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u51fa\u8840\u6027\u4f11\u514b\u901a\u5e38\uf967\u5bb9\u6613\u770b\u5230\u5fc3\u8df3\u52a0\u5feb\u3002 (B)\u4f4e\u8840\u58d3\u6642\u53ef\u5148\u4ee5 crystalloid \u7d66\u4e88 1 \u6b21 250~500 ml \u7684\u8f38\u6db2\uff0c\u4e26\u5bc6\u5207\u8a55\u4f30\uff0c\u5fc5\u8981\u7684\u8a71\u53ef\u91cd\u8986\u7d66\u4e88\u3002 (C)\u982d\u90e8\u5916\u50b7\uff0c\u8001\u5e74\u4eba\u786c\u8166\u819c\u5916\u51fa\u8840\u7684\u6a5f\u6703\u6bd4\u4e00\u822c\u4eba\u9ad8\u3002 (D)\u9838\u690e\u9aa8\u6298\uff0c\u5728\u8001\u5e74\u4eba\u767c\u751f\u7684\u6a5f\u7387\u8f03\u9ad8\uff0c\u4e14\u66f4\uf967\u6613\u8a3a\u65b7\u3002 (E)\u8001\u5e74\u4eba\u9aa8\u6298\u597d\u767c\u4f4d\u7f6e\u70ba\u9aa8\u76c6\u3001\u9ad6\u90e8\u3001\u80b1\u9aa8\u53ca\u624b\u8155\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u7672\u7647\u53ca\u7672\u7647\u91cd\u7a4d\u72c0\u614b\u7684\u6558\u8ff0\uff0c\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u6709\u7672\u7647\u75c5\u53f2\uff0c\u7d93\u85e5\u7269\u898f\u5247\u63a7\u5236\uff0c\u9020\u6210\u7672\u7647\u5fa9\u767c\u7684\u539f\u56e0\u5e38\u70ba\u5fd8\u8a18\u5403\u85e5\u3001\u559d\u9152\u6216\u7761\u7720\uf967\u8db3\u3002 (B)\u6709\u7672\u7647\u904e\u53bb\u75c5\u53f2\uff0c\u5076\u767c\u7672\u7647\u6642\uff0c\u6700\u91cd\u8981\u7684\u6aa2\u67e5\u70ba\u8840\u7cd6\u53ca\u8840\u4e2d\u6297\u7672\u7647\u85e5\u7269\u6fc3\u5ea6\u3002 (C)\u5b55\u5a66\u61f7\u7591\u5b50\u7672\u75c7(eclampsia)\u9020\u6210\u7672\u7647\u767c\u4f5c\uff0c\u53ef\u5148\u7d66\u4e88\u786b\u9178\u9382(Magnesium sulfate)4~6 g IV\uff0c\u4e4b\u5f8c 1~2 g/hr\u3002 (D)\u7672\u7647\u91cd\u7a4d\u72c0\u614b\u662f\u6307\u7672\u7647\u9023\u7e8c\u767c\u4f5c\u6216\u9593\u65b7\u767c\u4f5c\u8d85\u904e 5 \u5206\u9418\u4ee5\u4e0a\u4e14\u672a\u56de\u5fa9\u610f\u8b58\u3002 (E)\u6297\u7672\u7647\u85e5\u7269 Phenytoin \u53ef\u4ee5\u5408\u4f75\u7531\u542b\u7cd6\u9ede\u6ef4\u6216\u808c\u8089\u6ce8\u5c04\u7d66\u4e88\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u55ae\u7d14\u6ce1\u75b9\u6027\u8166\u708e(Herpes simplex encephalitis)\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u597d\u767c\u65bc\u5c0f\u65bc 20 \u6b72\u53ca\u5927\u65bc 50 \u6b72\u5e74\u9f61\u5c64\u3002 (B)\u82e5\u672a\u6cbb\u7642\u6b7b\u4ea1\u7387\u9ad8\u9054 70%\u3002 (C)\u5b58\u6d3b\u8005\u53ef\u80fd\u9577\u671f\u4f34\u6709\u795e\u7d93\u5f8c\u907a\u75c7\u3002 (D)CT \u6216 MRI \u5f71\u50cf\u6aa2\u67e5\u5e38\u8868\u73fe\u51fa\u984d\u8449\u75c5\u8b8a\u3002 (E)\u82e5\u81e8\u5e8a\u75c7\u72c0\u548c\u7d30\u83cc\u6027\u8166\u819c\u708e\u96e3\u4ee5\u5340\u5206\u6642\u9700\u7d66\u4e88\u7d93\u9a57\u6027\u6297\u751f\u7d20\u53ca\u6297\u75c5\u6bd2\u85e5\u7269\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u504f\u982d\u75db(migraine)\u7684\u6cbb\u7642\u85e5\u7269\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)Dihydroergotamine(DHE)\u53ef\u80fd\u9020\u6210\u5641\u5fc3\u3001\u5614\u5410\u3001\u8179\u7009\u7684\u75c7\u72c0\u3002 (B)Ketorolac \uf967\u9069\u5408\u7528\u65bc\u598a\u5a20\u7b2c\u4e09\u671f\u3002 (C)Opioids \u6700\u9069\u5408\u7528\u5728\u6162\u6027\u548c\u5fa9\u767c\u7684\u504f\u982d\u75db\u60a3\u8005\u3002 (D)Olanzapine \u6703\u9020\u6210\u5fc3\u96fb\u5716\u4e0a QT \u6ce2\u6bb5\u5ef6\u9577\u3002 (E)Prochlorperazine \u540c\u6642\u6709\u6b62\u5410\u7684\u6548\u679c\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u7834\u50b7\u98a8(Tetanus)\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u75c5\u539f\u70ba\u9769\u862d\u6c0f\u967d\u6027\u687f\u83cc Clostridium tetani\u3002 (B)\u7522\u751f\u6bd2\u7d20 Tetanospasmin \u53ef\u4f5c\u7528\u65bc\u9aa8\u9abc\u808c\u3001\u810a\u9ad3\u3001\u8166\u90e8\u53ca\u4ea4\u611f\u795e\u7d93\u7cfb\u7d71\u3002 (C)\u8a3a\u65b7\u4ee5\u81e8\u5e8a\u75c7\u72c0\u70ba\u4e3b\u3002 (D)\u82e5\u8981\u57f7\u884c\u50b7\u53e3\u6e05\u5275\uff0c\u4e00\u5f8b\u5148\u7d66\u4e88\u7834\u50b7\u98a8\u514d\u75ab\u7403\u86cb\u767d(Tetanus immune globulin)\u3002 (E)\u6e05\u5275\u5f8c\u5efa\u8b70\u6ce8\u5c04 Penicillin \u6cbb\u7642\u5168\u8eab\u6027\u7684\u7834\u50b7\u98a8\u611f\u67d3\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u95dc\u65bc Neuroleptic malignant syndrome \u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u5f62\u6210\u539f\u56e0\u548c\u6297\u7cbe\u795e\u75c5\u85e5\u7269\u904e\u91cf\u7121\u592a\u5927\u95dc\u4fc2\uff0c\u901a\u5e38\u767c\u751f\u5728\u85e5\u7269\u958b\u59cb\u4f7f\u7528\u6216\u8abf\u6574\u5291\u91cf\u6642\u3002 (B)\u8981\u8a3a\u65b7 Neuroleptic malignant syndrome\uff0c\u4e00\u5b9a\u8981\u6709\u767c\u71d2\u548c\u808c\u8089\u5f37\u76f4(Muscular rigidity)\u3002 (C)\u56b4\u91cd\u75c5\u4eba\u4e14\u6709\u986f\u8457\u808c\u8089\u5f37\u76f4\u500b\u6848\uff0c\u9700\u4f7f\u7528 Dantrolene \u6cbb\u7642\u3002 (D)\u82e5\u75c5\u4eba\u767c\u71d2\u4e14\u808c\u8089\u5f37\u76f4\uff0c\u5f37\u70c8\u5efa\u8b70\u63d2\u7ba1\u7d66\u4e88\u808c\u8089\u9b06\u5f1b\u5291\u964d\u4f4e\u75c5\u4eba\u9ad4\u6eab\u3002 (E)\u82e5\u75c5\u4eba\u5df2\u63d2\u7ba1\u9700\u808c\u8089\u9b06\u5f1b\u5291\uff0c\u53bb\u6975\u5316\u808c\u8089\u9b06\u5f1b\u5291\u8f03\u975e\u53bb\u6975\u5316\u808c\u8089\u9b06\u5f1b\u5291\u70ba\u4f73\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u6703\u5f15\u8d77\u9031\u908a\u578b\u7729\u6688(Peripheral vertigo)\u7684\u539f\u56e0\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u826f\u6027\u9663\u767c\u578b\u59ff\u52e2\u6027\u7729\u6688(Benign paroxysmal positional vertigo)\u3002 (B)\u5185\u8033\u8ff7\u8def\u708e(Labyrinthitis)\u3002 (C)\u524d\u5ead\u795e\u7d93\u708e(Vestibular neuritis)\u3002 (D)\u504f\u982d\u75db(Migraine)\u3002 (E)\u6885\u5c3c\u723e\u6c0f\u75c7(Meniere disease)\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u6839\u64da CURB-65 \u8a55\u5206\uff0c\u4e0b\u5217\u4f55\u8005\uf967\u662f\u56b4\u91cd\u793e\u5340\u578b\u80ba\u708e\u7684\u5371\u96aa\u56e0\u5b50\uff1f", + "Options": "(A)\u65b0\u767c\u751f\u7684\u610f\u8b58\u6df7\u4e82\u3002 (B)\u8840\u4e2d\u5c3f\u7d20\u6c2e(BUN)\u2265 7 mmol/l(19 mg/dL)\u3002 (C)\u547c\u5438\u901f\u7387\u2265 30 \u6b21/min\u3002 (D)\u9ad4\u6eab\u2265 39 \u2103\u3002 (E)\u5e74\u9f61\u2265 65 \u6b72\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u6839\u64da American College of Emergency Physicians guidelines \u4ee5\u53ca The San Francisco Syncope Rule\uff0c\u4e0b\u5217 5 \u4f4d\u521d\u6b65\u539f\u56e0\uf967\u660e\u7684 syncope \u75c5\u4eba\uff0c\u54ea\u4f4d\u6bd4\u8f03\uf967\u9700\u8981\u4f4f\u9662?", + "Options": "(A)Blood creatinine 5 mg/dl\u3002 (B)Hematocrit 28%\u3002 (C)\u5fc3\u96fb\u5716\u70ba\u65b0\u767c\u751f\u7684 atrioventricular block\u3002 (D)\u6709 sudden cardiac death \u5bb6\u65cf\u53f2\u3002 (E)\u5e74\u9f61 85 \u6b72\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u6839\u64da 2012 \u5317\u7f8e\u7dca\u6025\u61c9\u8b8a\u6307\u5357(2012 Emergency Response Guidebook)\uff0c\u6709\u95dc\u5316\u5b78\u707d\u5bb3\u4e8b\u4ef6\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u5f9e\u4e0a\u98a8\u8655\u63a5\u8fd1\u4e8b\u767c\u5730\u9ede\uff0c\u4ee5\u7dad\u8b77\u81ea\u8eab\u5b89\u5168\u3002 (B)\u5176\u4e2d\u63d0\u5230\u5371\u5bb3\u5206\uf9d0\u7cfb\u7d71(Hazard Classification System)\uff0c\u5c07\u5371\u5bb3\u6027\u5316\u5b78\u7269\u8cea\u5206\u70ba\u4e5d\uf9d0(\u4f8b\u5982\uff0c\u7b2c\u4e00\uf9d0\uff1a\u5177\u7206\u70b8\u6027\u7269\u8cea\uff1b\u7b2c\u4e8c\uf9d0\uff1a\u6c23\u9ad4\uf9d0\u7b49)\u3002 (C)\u6a19\u793a\u5371\u5bb3\u6027\u5316\u5b78\u7269\u8cea\u7684\u544a\u793a\u724c\uff0c\u82e5\u5448\u73fe\u7d05\u8272\uff0c\u662f\u8868\u793a\u53ef\u71c3\u6027(flammability)\u3002 (D)\u6240\u8b02\u521d\u671f\u9694\u96e2\u5340\u57df(Initial Isolation Zone)\uff0c\u662f\u6307\u5728\u8a72\u5340\u57df\u5167\u4e0a\u98a8\u8655\u4e4b\u4eba\u6709\u53ef\u80fd\ufa06\uf938\u65bc\u81f4\u547d\u6fc3\u5ea6\u7684\u5371\u5bb3\u6027\u5316\u5b78\u7269\u8cea\u3002 (E)\u6240\u8b02 Toxic Inhalation Hazard(TIH)\u7269\u8cea\uff0c\u662f\u6307\u8207\u6c34\u63a5\u89f8\uff0c\u80fd\u7522\u751f\u6709\u6bd2\u6c23\u9ad4\uff0c\u9020\u6210\u5438\u5165\u6027\u5371\u5bb3\u7684\u5316\u5b78\u7269\u8cea\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u6839\u64da 2010 AHA guidelines for CPR and ECC\uff0cST-segment elevation \u7b26\u5408STEMI \u7684\u6a19\u6e96\uff0c\u4e0b\u5217\u4f55\u8005\u9664\u5916?", + "Options": "(A)\u5973\u6027\u75c5\u4eba\uff0cJ-point elevation \u5728 leads V2 \u53ca V3 \u4ee5\u5916\u7684 lead \u8d85\u904e 0.1 mV (1 mm)\u3002 (B)\u5e74\u9f61\u5927\u65bc 40 \u6b72\u4ee5\u4e0a\u7537\u6027\uff0cJ-point elevation \u5728 leads V2 and V3 \u8d85\u904e 0.2 mV(2 mm)\u3002 (C)\u5e74\u9f61\u5927\u65bc 40 \u6b72\u4ee5\u4e0a\u7537\u6027\uff0cJ-point elevation \u5728 leads V2 \u53ca V3 \u4ee5\u5916\u7684lead \u8d85\u904e 0.1 mV(1 mm)\u3002 (D)\u5e74\u9f61\u5c0f\u65bc 40 \u6b72\u4ee5\u4e0b\u7537\u6027\uff0cJ-point elevation \u5728 leads V2 and V3 \u8d85\u904e 0.15 mV(1.5 mm)\u3002 (E)\u5e74\u9f61\u5c0f\u65bc 40 \u6b72\u4ee5\u4e0b\u7537\u6027\uff0cJ-point elevation \u5728 leads V2 \u53ca V3 \u4ee5\u5916\u7684lead \u8d85\u904e 0.1 mV(1 mm)\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u5c0d\u65bc\u56b4\u91cd\u6557\u8840\u75c7\u53ca\u6557\u8840\u6027\u4f11\u514b\u75c5\u4eba\u7684\u8655\u7f6e\uff0c\u6839\u64da\u6700\u65b0 2012 \u570b\u969b\u6557\u8840\u75c7\u6cbb\u7642\u6307\u5f15(International Guidelines for Management of Severe Sepsis and Septic Shock\uff1a2012)\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba?", + "Options": "(A)\u5ee3\u6548\u6027\u6297\u751f\u7d20\u61c9\u8a72\u5728\u81e8\u5e8a\u8a3a\u65b7\u6557\u8840\u6027\u4f11\u514b\u6216\u56b4\u91cd\u6557\u8840\u75c7\u5f8c\u7684 2 \u5c0f\u6642\u5167\u7d66\u4e88\u3002 (B)\u56b4\u91cd\u6557\u8840\u75c7\u6307\u7684\u662f\u81e8\u5e8a\u4e0a\u7591\u4f3c\u611f\u67d3\u7684\u60c5\u6cc1\u4e0b\u51fa\u73fe\u7d44\u7e54\u704c\uf9ca\uf967\u8db3(tissue hypoperfusion)\u6216\u5668\u5b98\u529f\u80fd\u5931\u5e38(organ dysfunction)\u3002\u5176\u4e2d\u5c0d\u65bc\u5668\u5b98\u529f\u80fd\u5931\u5e38\u4e2d\u95dc\u65bc\u6025\u6027\u80ba\u640d\u50b7\u7684\u5b9a\u7fa9\uff0c\u5728\u6c92\u6709\u80ba\u708e\u7684\u60c5\u6cc1\u4e0b\uff0c\u75c5\u4eba\u7684PaO2/FiO2 < 200 mmHg \u8b02\u4e4b\u3002 (C)\u521d\u671f\u524d 6 \u5c0f\u6642\u6025\u6551\u7684\u76ee\u6a19\uff0c\u5e0c\u671b\u7dad\u6301\u4e2d\u592e\u975c\u8108\u58d3(CVP)\u4ecb\u65bc 8~12 mmHg\uff0c\u5e73\u5747\u52d5\u8108\u58d3(MAP)\u2267 65 mmHg\uff0c\u5c3f\u91cf\u8f38\u51fa\u2265 0.5 mL/kg/hr\uff0c\u4e0a\u8154\u975c\u8108\u6c27\u6c23\u5206\u58d3(ScvO2)> 70 mmHg \u6216\u6df7\u5408\u975c\u8108\u8840\u6c27\u98fd\u548c\u5ea6(Sv O2)> 65 mmHg\uff0c\u5f85\u6025\u8a3a\u9054\u5230\u4e0a\u8ff0\u76ee\u6a19\u5f8c\uff0c\u59cb\u5f97\u8f49\u5230\u52a0\u8b77\u75c5\u623f\u7e7c\u7e8c\u6cbb\u7642\u3002 (D)\u5c0d\u65bc\u4f11\u514b\u4e14\u5c0d\u4e00\u958b\u59cb\u7684\u8f38\u6db2\u6cbb\u7642\u6c92\u6709\u53cd\u61c9\u7684\u75c5\u4eba\uff0c\u61c9\u9996\u9078\u4f7f\u7528\u6607\u58d3\u5291\u591a\u5df4\u80fa(dopamine)\uff0c\u63d0\u5347\u5e73\u5747\u52d5\u8108\u58d3(MAP)\u5230\u9054 65 mmHg \u70ba\u76ee\u6a19\u3002 (E)\u5c0d\u65bc\u7d93\u904e\u8f38\u6db2\u6cbb\u7642\u5f8c\u6c92\u6709\u7d44\u7e54\u704c\uf9ca\uf967\u8db3\uff0c\u4e14\u6c92\u6709\u56b4\u91cd\u7f3a\u6c27\u3001\u6025\u6027\u51fa\u8840\u6216\u5fc3\u808c\u7f3a\u6c27\u6897\u585e\u7684\u60c5\u5f62\u4e0b\uff0c\u75c5\u4eba\u8840\u7d05\u7d20\u7684\u5efa\u8b70\u70ba\u7dad\u6301\u5728 7~9 g/dL\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "\u5c0d\u65bc\u80ba\u6813\u585e\u75c5\u4eba\uff0c\u4e0b\u5217\u4f55\u8005\u70ba\u5efa\u8b70\u6ce8\u5c04 fibrinolytic agents \u7684\u9069\u61c9\u75c7?", + "Options": "(A)\u96fb\u8166\u65b7\u5c64\u767c\u73fe\u5169\u5074\u90fd\u6709 pulmonary emboli\u3002 (B)O2 \u9700\u4f7f\u7528 6 L/min \u4ee5\u4e0a\u4ee5\u7dad\u6301 SaO2 \u5927\u65bc 90%\u3002 (C)\u5408\u4f75\u6709\u4e0b\u80a2\u7684 deep vein thrombosis\u3002 (D)\u6536\u7e2e\u58d3\u5c0f\u65bc 90 mmHg\u3002 (E)\u80f8\u75db\u4e26\u4e14 12 leads EKG \u6709 S1Q3T3 pattern \u8b8a\u5316\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u8179\u90e8\u920d\u50b7\u7684 10 \u6b72\u5973\u5b69\uff0c\u96fb\u8166\u65b7\u5c64\u8a3a\u65b7\u70ba Grade III \u7684\u813e\u81df\u6495\u88c2\u50b7\uff0c\u56e0\u6b64\u6536\u6cbb\u5c0f\u5152\u52a0\u8b77\u75c5\u623f\u5bc6\u5207\u89c0\u5bdf\uff0c\u76ee\u524d\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\uff0c\u4e0b\u5217\u4f55\u7a2e\u60c5\u6cc1\u61c9\u7acb\u5373\u5256\u8179\u624b\u8853\u63a2\u67e5?", + "Options": "(A)\u62bd\u8840\u8ffd\u8e64 Amylase \u70ba 400 U/L\u3002 (B)\u62bd\u8840\u767c\u73fe\u767d\u8840\u7403 16,000/mm\u3002 (C)\u8179\u819c\u5916(extraperitoneal)\u7684\u8180\u80f1\u7834\u88c2\u3002 (D)\u56e0\u8179\u75db\u8ffd\u8e64\u96fb\u8166\u65b7\u5c64\u767c\u73fe\u6709\u8179\u8154\u5167\u6e38\u96e2\u7a7a\u6c23(intraperitoneal free air)\u3002 (E)24 \u5c0f\u6642\u5f8c\u8ffd\u8e64 hemoglobin \u5f9e 11 g/dL \u6389\u5230 8.5 g/dL\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "\u76ee\u524d\u570b\u5167\u7591\u4f3c\u611f\u67d3\u4f0a\u6ce2\u62c9\u75c5\u6bd2(Ebola)\u75c5\u4eba\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u8acb\u75c5\u4eba\u81ea\u884c\u81f3\u6700\u8fd1\u7684\u9632\u75ab\u91ab\u9662\u5c31\u91ab\u3002 (B)\u8acb\u75c5\u4eba\u6253 1922 \u96fb\u8a71\uff0c\u7531\u5c08\u4eba\u5354\u52a9\u5c31\u91ab\u3002 (C)\u4f0a\u6ce2\u62c9\u75c5\u6bd2\u611f\u67d3\u7684\u75c5\u4eba\u5e38\u6709\u808c\u8089\u75db\u3001\u982d\u75db\u3001\u5614\u5410\u3001\u8179\u7009\u7b49\u75c7\u72c0\u3002 (D)\u4f0a\u6ce2\u62c9\u75c5\u6bd2\u662f\u7dda\u72c0\u75c5\u6bd2\u79d1(Filoviridae)\u7684\u6210\u54e1\u3002 (E)\u4f0a\u6ce2\u62c9\u75c5\u6bd2\u611f\u67d3\u7684\u75c5\u4eba\u5176\u6b7b\u4ea1\u7387\u53ef\u4ee5\u9ad8\u9054 90%\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "\u75c5\u4eba\u56e0\u80f8\u75db\u5c31\u8a3a\u6642\uff0c\u8840\u58d3 155/95 mmHg\uff0c\u5fc3\u8df3 65 \u6b21/min\uff0c\u5fc3\u96fb\u5716\u767c\u73fe lead V1-V3 \u7684 ST-segment elevation\uff0c\u5728\u6025\u8a3a\u6301\u7e8c\u80f8\u75db\uff0c\u6b64\u6642\u53ef\u7d66\u4e88\u4ee5\u4e0b\u8655\u7f6e\uff0c\u4e0b\u5217\u4f55\u8005\u6700\uf967\u9069\u7576?", + "Options": "(A)Atenolol 25 mg \u53e3\u670d\u3002 (B)Dobutamine 5 mcg/kg/min \u975c\u8108\u6ef4\u6ce8\u3002 (C)Morphine 3 mg \u975c\u8108\u6ce8\u5c04\u3002 (D)NTG 0.6 mg \u820c\u4e0b\u7d66\u4e88\u3002 (E)\u7167\u6703\u5fc3\u81df\u5167\u79d1\u91ab\u5e2b\u8003\u616e percutaneous coronary intervention\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "\u75c5\u4eba\u6709 Hypertrophic cardiomyopathy \u75c5\u53f2\uff0c\u5230\u6025\u8a3a\u6642\u4e3b\u8a34\u80f8\u75db\uff0c\u4e0b\u5217\u6cbb\u7642\u61c9\u5148\u8003\u616e\u7d66\u4e88?", + "Options": "(A)Clopidogrel 300 mg \u53e3\u670d\u3002 (B)Dobutamine 5 mcg/kg/min\u3002 (C)Nitroglycerin 5 mcg/min\u3002 (D)Norepinephrine 2 mcg/min\u3002 (E)Propanolol 10 mg \u53e3\u670d\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "8 \u6b72\u7537\u5b69 3 \u500b\u5c0f\u6642\u524d\u8aa4\u98df\u5168\u65b0\u9215\u6263\u96fb\u6c60 1 \u9846\uff0c\u7531\u5abd\u5abd\u966a\u540c\u81f3\u6025\u8a3a\uff0c\u8acb\u554f\u4ee5\u4e0b\u8655\u7f6e\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u82e5\u9215\u6263\u96fb\u6c60\u5361\u5728\u98df\u9053\uff0c\u53ef\u80fd\u5728 6 \u5c0f\u6642\u5167\u9020\u6210\u98df\u9053\u7834\u88c2\u3002 (B)\u82e5 X \u5149\u7247\u986f\u793a\u9215\u6263\u96fb\u6c60\u5361\u5728\u98df\u9053\uff0c\u61c9\u512a\u5148\u5617\u8a66\u5c3f\u7ba1\u6c23\u7403\u79fb\u9664\u8853(foley balloon catheter technique)\u79fb\u9664\u7570\u7269\u3002 (C)\u5c0d\u65bc\u5c0f\u65bc 6 \u6b72\u7684\u5152\u7ae5\uff0c\u9700\u5728 48 \u5c0f\u6642\u8ffd\u8e64 X \u5149\u6aa2\u67e5\u78ba\u5b9a\u96fb\u6c60\u5df2\u901a\u904e\u80c3\u5e7d\u9580\u3002 (D)\u82e5\u7121\u75c7\u72c0\uff0c\u5927\u90e8\u5206 48~72 \u5c0f\u6642\u5f8c\u9215\u6263\u96fb\u6c60\u53ef\u81ea\u884c\u6392\u51fa\u3002 (E)\u82e5\u96fb\u6c60\u5df2\u901a\u904e\u98df\u9053\u8207\u80c3\uff0c\u4f46\u6709\u8178\u80c3\u9053\u75bc\u75db\u75c7\u72c0\uff0c\u4ecd\u9700\u8981\u5916\u79d1\u91ab\u5e2b\u8a55\u4f30\u662f\u5426\u9700\u8981\u624b\u8853\u6392\u9664\u7570\u7269\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "80 \u6b72\u7537\u6027\u8b77\uf9e4\u4e4b\u5bb6\u4f4f\u6c11\uff0c\u7531\u7167\u670d\u54e1\u966a\u4f34\u9001\u81f3\u6025\u8a3a\uff0c\u4e3b\u8a34\u534a\u591c\u5168\u8eab\u6414\u7662\u96e3\u8010\uff0c\u8033\u6eab\u70ba 37.0\u2103\uff0c\uf9e4\u5b78\u6aa2\u67e5\u767c\u73fe\u4e0b\u8179\u90e8\u3001\u96d9\u5074\u9f20\u8e4a\u90e8\u8207\u80cc\u90e8\u6709\u591a\u767c\u6027\u7d05\u75b9\u8207\u6307\u7532\u6293\u75d5\uff0c\u4ee5\u4e0b\u75be\u75c5\u4f55\u8005\u662f\u6700\u53ef\u80fd\u7684\u539f\u56e0?", + "Options": "(A)\u8541\u9ebb\u75b9(urticaria)\u3002 (B)\u75a5\u7621(scabies)\u3002 (C)\u63a5\u89f8\u6027\u76ae\u819a\u708e(contact dermatitis)\u3002 (D)\u6fd5\u75b9(eczema)\u3002 (E)\u4e7e\u766c(psoriasis)\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "8 \u6b72\u7537\u7ae5\uff0c\u8d70\u8def\u4e0a\u5b78\u9014\u4e2d\u88ab\u6c7d\u8eca\u5074\u649e\uff0c\u7ffb\u6efe\u591a\u5708\u5f8c\u5012\u5730\uf967\u8d77\uff0c\u6551\u8b77\u8eca\u9001\u81f3\u6025\u8a3a\uff0c\u9ad4\u6eab 36.7 \u2103\u3001\u547c\u5438 30 \u6b21/min\u3001\u5fc3\u8df3 130 \u6b21/min\u3001\u8840\u58d3 80/65 mmHg\uff0c\u75c5\u4eba\u610f\u8b58\u6a21\u7cca\u7121\u6cd5\u8868\u9054\uff0c\u4e0b\u5217\u95dc\u65bc\u5c0f\u5152\u5916\u50b7\u6025\u6551\u4e4b\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u9996\u8981\u4e4b\u52d9\u70ba\u4fdd\u8b77\u547c\u5438\u9053\uff0c\u82e5\u8981\u9078\u64c7\u6c23\u7ba1\u5167\u7ba1\uff0c\u53ef\u9078\u64c7\u5927\u5c0f\u70ba 6 \u865f\u6709cuff \u7684\u6c23\u7ba1\u5167\u7ba1\u3002 (B)\u82e5\u5468\u908a\u8840\u7ba1\u7121\u6cd5\u6253\u4e0a\uff0c\u6b64\u75c5\u4eba\u53ef\u8003\u616e\u65bc\u8fd1\u7aef\u811b\u9aa8\u653e\u7f6e\u9aa8\u91dd(intraosseous injection)\u3002 (C)\u7d66\u4e88 crystalloid \u6bcf\u6b21 20 ml/kg\uff0c\u76ee\u6a19\u70ba\u5c3f\u91cf 1 ml/kg/hr\u3002 (D)\u7531\u65bc\u5152\u7ae5\u80f8\u58c1\u9aa8\u9abc\u8f03\u6709\u5f48\u6027\uff0c\u56e0\u6b64\u80f8\u90e8\u632b\u50b7\u6642\u8f03\uf967\u6613\u767c\u751f\u5f35\u529b\u6027\u6c23\u80f8(tension pneumothorax)\u3002 (E)\u4f9d\u7167\u6b64\u75c5\u4eba\u7684\u751f\u547d\u5fb5\u8c61\uff0c\uf9ca\u5931\u8840\u91cf\u61c9\u6709\u5927\u65bc\u5168\u8eab\u8840\u91cf\u7684 30%\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "78 \u6b72\u75c5\u4eba\u56e0\u6162\u6027\u963b\u585e\u6027\u80ba\u75c5(COPD)\u6025\u6027\u767c\u4f5c\u81f3\u6025\u8a3a\u5c31\u8a3a\u3002\u4ee5\u4e0b\u6558\u8ff0\u95dc\u65bc\u4f7f\u7528\u975e\u4fb5\u8972\u6027\u6b63\u58d3\u547c\u5438\u5668(noninvasive positive pressure ventilation\uff0cNPPV)\u4e4b\u7981\u5fcc\u75c7\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u547c\u5438\u901f\u7387> 25 \u6b21/min \u4e14\u4f7f\u7528\u8f14\u52a9\u547c\u5438\u808c\u3002 (B)\u7121\u6cd5\u7dad\u6301\u547c\u5438\u9053\u901a\u66a2\u3002 (C)\u610f\u8b58\uf967\u6e05\u3002 (D)\u8840\u884c\u52d5\u529b\u5b78\uf967\u7a69\u5b9a\u3002 (E)\u6975\u5ea6\u80a5\u80d6\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "70 \u6b72\u9577\u671f\u5438\u7159\u7537\u6027\uff0c\u56e0\u767c\u71d2\u3001\u54b3\u55fd\u53ca\u547c\u5438\u56f0\u96e3\u81f3\u6025\u8a3a\u5c31\u8a3a\uff0c\u75c5\u4eba\u540c\u6642\u6709\u5168\u8eab\u75e0\u75db\u3001\u8179\u75db\u53ca\u8179\u7009\u75c7\u72c0\u3002\u751f\u547d\u5fb5\u8c61\u70ba\u8840\u58d3 90/60 mmHg\u3001\u547c\u5438 30 \u6b21/min\u3001\u5fc3\u8df3 130 \u6b21/min\u3001\u9ad4\u6eab 39 \u2103\u3001\u8840\u6c27\u98fd\u548c\u5ea6 90%\u3002\u80f8\u90e8 X \u5149\u986f\u793a\u96d9\u5074\u80ba\u708e\uff0c\u5c3f\u6db2 Legionella \u6297\u539f\u6e2c\u8a66\u70ba\u967d\u6027\u3002\u95dc\u65bc\u6b64\u75be\u75c5\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u53ef\u80fd\u6703\u4f75\u767c\u80f0\u81df\u708e\u3002 (B)\u6b64\u7a2e\u75be\u75c5\uf967\u6703\u4eba\u50b3\u4eba\u3002 (C)\u4f4e\u8840\u9209\u70ba\u5e38\u898b\u6aa2\u9a57\u7570\u5e38\u3002 (D)\u6cbb\u7642\u9996\u9078\u70ba\u7b2c\u4e09\u4ee3 Cephalosporin \u6216 Carbapenem \uf9d0\u6297\u751f\u7d20\u3002 (E)\u75f0\u6db2\u57f9\u990a\u5e38\u7121\u6cd5\u57f9\u990a\u51fa\u81f4\u75c5\u83cc\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "65 \u6b72\u5973\u6027\u75c5\u4eba\u88ab\u9001\u5165\u6025\u8a3a\uff0c\u4e3b\u8a34\u7a81\u767c\u6027\u547c\u5438\u56f0\u96e3\u3001\u5598\u3001\u80f8\u60b6\u3002\uf9e4\u5b78\u6aa2\u67e5\u547c\u5438\u97f3\u96d9\u5074\u5c0d\u7a31\u7121\u56c9\u97f3\uff1b\u96d9\u4e0b\u80a2\u7121\u6c34\u816b\u3002\u5fc3\u8df3 120 \u6b21/min\uff0croom air SpO2 93%\u3002\u904e\u53bb\u75c5\u53f2\u70ba\u4e73\u764c\u3001\u63a5\u53d7\u904e\u624b\u8853\u53ca\u5316\u7642\uff1b2 \u661f\u671f\u524d\u624d\u56e0\u53f3\u5074\u9ad6\u95dc\u7bc0\u9aa8\u6298\u958b\u5200\u51fa\u9662\u3002\u60a8\u61f7\u7591\u6b64\u75c5\u4eba\u6700\u53ef\u80fd\u767c\u751f\u80ba\u52d5\u8108\u6813\u585e\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u6b64\u75c5\u4eba\u7684 AaDO2(Alveolar-arterial gradient)\u53ef\u80fd\u6703\u4e0b\u964d\u3002 (B)\u6b64\u75c5\u4eba\u7684 Well\u2019s score \u70ba 7 \u5206\u3002 (C)\u5fc3\u96fb\u5716\u53ef\u80fd\u51fa\u73fe sinus tachycardia \u53ca S1Q3T3 pattern\u3002 (D)\u82e5\u75c5\u4eba\u51fa\u73fe\u7a81\u767c\u6027\u7684\u5fc3\u8df3\u505c\u6b62\uff0c\u53ef\u8003\u616e\u8840\u6813\u6eb6\u89e3\u5291(Fibrinolysis)\uff0c\u5982 tPA\u3002 (E)\u4ecd\u9700\u5b89\u6392 EKG \u53ca\u5fc3\u808c\u9175\u7d20\u6aa2\u67e5\uff0c\u6392\u9664\u6025\u6027\u51a0\u5fc3\u75c7\u7684\u53ef\u80fd\u6027\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "65 \u6b72\u5973\u6027\uff0c\u6709\u80f0\u81df\u764c\u75c5\u53f2\uff0c\u53f3\u8173\u816b\u7d04 1 \u9031\u3002\u8acb\u554f\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u7531\u7d93\u9a57\u8c50\u5bcc\u7684\u6383\u63cf\u8005\u9032\u884c\u6383\u63cf\uff0c\u8840\u7ba1\u8d85\u97f3\u6ce2\u7528\u4f86\u8a3a\u65b7\u6df1\u90e8\u975c\u8108\u6813\u585e\u7684\u654f\u611f\u6027\u548c\u7279\u7570\u6027\u53ef\u9054 90%\u4ee5\u4e0a\u3002 (B)\u60a3\u8005\u6108\u80a5\u80d6\uff0c\u6108\uf967\u5bb9\u6613\u7d93\u7531\u8840\u7ba1\u8d85\u97f3\u6ce2\u6b63\u78ba\u8a3a\u65b7\u6df1\u90e8\u975c\u8108\u6813\u585e\u3002 (C)\u5148\u524d\u66fe\u6709\u6df1\u90e8\u975c\u8108\u6813\u585e\u7684\u75c5\u53f2\uff0c\uf967\u5bb9\u6613\u5229\u7528\u8d85\u97f3\u6ce2\u7684\u58d3\u8feb\u6027\u4f86\u5340\u5206\u65b0\u7684\u6216\u820a\u7684\u8840\u6813\u3002 (D)\u5982\u679c\u6b64\u60a3\u8005\u7684\u975c\u8108\u7d93\u8d85\u97f3\u6ce2\u6383\u63cf\u7121\u6cd5\u58d3\u6241\uff0c\u53ef\u8a3a\u65b7\u70ba\u6df1\u90e8\u975c\u8108\u6813\u585e\u3002 (E)\u8d85\u97f3\u6ce2\u4e0b\u8981\u770b\u5230\u8840\u6813\u624d\u80fd\u8a3a\u65b7\u6df1\u90e8\u975c\u8108\u6813\u585e\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "65 \u6b72\u7537\u6027\u8dcc\u5012\u88ab\u82b1\u5712\u788e\u6389\u7684\u73bb\u7483\u5272\u50b7\uff0c\u4e26\u8dcc\u5750\u6a39\u679d\u6ce5\u571f\u5806\u88e1\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba?", + "Options": "(A)\u81c9\u90e8\u50b7\u53e3 5 \u516c\u5206\u53d7\u50b7\u5df2\u7d93\u8d85\u904e 12 \u5c0f\u6642\uff0c\u8003\u91cf\u611f\u67d3\uf967\u5efa\u8b70\u7f1d\u5408\u3002 (B)\u4f4d\u65bc\u5927\u817f\u7684\u50b7\u53e3\u6bd4\u4f4d\u65bc\u982d\u76ae\u7684\u50b7\u53e3\u6709\u66f4\u9ad8\u7684\u50b7\u53e3\u611f\u67d3\u98a8\u96aa\u3002 (C)\u4f7f\u7528 X \u5149\u6aa2\u67e5\u53ef\u4ee5\u5075\u6e2c\u8d85\u904e 90%\u85cf\u5728\u76ae\u4e0b\u7684\u788e\u73bb\u7483\u6216\u65b7\u6389\u7684\u6a39\u679d\u3002 (D)\u5c0f\u817f\u50b7\u53e3\u8f03\u6df1\uff0c\u5efa\u8b70\u63a1\u7528\u76ae\u4e0b\u7e2b\u5408\u3002 (E)\u9078\u64c7\uf967\u542b\u9152\u7cbe\u4e4b\u512a\u7898(10% povidone-iodine solution)\u6e05\u6d17\u50b7\u53e3\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "65 \u6b72\u7537\u6027\uff0c\u5e73\u6642\u62bd\u83f8\uff0c\u6709\u9ad8\u8840\u58d3\u75c5\u53f2\u3002\u4f86\u6025\u8a3a\u4e3b\u8a34\u504f\u5074\u982d\u75db\uff0c\u6aa2\u50b7\u9ad4\u6eab 37\u2103\uff0c\u5fc3\u8df3 84 \u6b21/min\uff0c\u547c\u5438 16 \u6b21/min\uff0c\u8840\u58d3 142/84 mmHg\uff0c\u4e0b\u5217\u95dc\u65bc\u6025\u8a3a\u982d\u75db\u9451\u5225\u8a3a\u65b7\u6558\u8ff0\u4f55\u8005\u6b63\u78ba?", + "Options": "(A)\u82e5\u75c5\u4eba\u55ae\u5074\u982d\u75db\u77ed\u6642\u9593\u5167\u5bc6\u96c6\u767c\u4f5c\uff0c\u5408\u4f75\u55ae\u5074\uf9ca\u6dda\u3001\uf9ca\u9f3b\u6c34\uff0c\u61c9\u61f7\u7591\u662f\u53e2\u96c6\u6027\u982d\u75db(cluster headache)\uff0c\u6b64\uf9d0\u75c5\u4eba\u53ef\u80fd\u51fa\u73fe\u540c\u5074\u773c\u77bc\u4e0b\u5782(ptosis)\u3001\u7e2e\u77b3(miosis)\u7b49\u795e\u7d93\u5b78\u75c7\u72c0\u3002 (B)\u82e5\u75c5\u4eba\u51fa\u73fe\u55ae\u5074\u3001\u8108\u52d5\u5f0f(pulsatile)\u56b4\u91cd\u982d\u75db\u3001\u904b\u52d5\u6642\u66f4\u75db\u3001\u5408\u4f75\u5641\u5fc3\u5614\u5410\u3001\u754f\u5149\uff0c\u61c9\u61f7\u7591\u662f\u504f\u982d\u75db(migraine)\u3002\u504f\u982d\u75db\uf967\u6703\u4ee5\u96d9\u5074\u982d\u75db\u4f86\u8868\u73fe\u3002 (C)\u82e5\u75c5\u4eba\u55ae\u5074\u982d\u75db\uff0c\u9873\u52d5\u8108(temporal artery)\u58d3\u75db\u4e14 pulse \u589e\u5f37\uff0c\u8840\u6db2\u6c88\u964d\u901f\u5ea6(ESR)\u6b63\u5e38\uff0c\u540c\u5074\u773c\u77bc\u4e0b\u5782(ptosis)\u3001\u7e2e\u77b3(miosis)\uff0c\u5247\u53ef\u80fd\u662f\u9873\u52d5\u8108\u8166\u8840\u7ba1\u708e(temporal arteritis)\uff0c\u540c\u6642\u9808\u6ce8\u610f\u75c5\u4eba\u6709\u7121\u8996\u529b\u964d\u4f4e\u72c0\u6cc1\uff0c\u9808\u5118\u5feb\u4ee5\uf9d0\u56fa\u9187\u6cbb\u7642\u3002 (D)\u7f3a\u8840\u6027\u4e2d\u98a8\u4e5f\u53ef\u80fd\u4ee5\u982d\u75db\u8868\u73fe\uff0c\u5c24\u4ee5\u524d\u5927\u8166\u52d5\u8108(anterior cerebral artery)\u4e2d\u98a8\u8f03\u5e38\u8868\u73fe\u3002 (E)\u75c5\u4eba\u82e5\u6709\u5728\u670d\u7528\u6297\u51dd\u8840\u5291\uff0c\u61c9\u5c07\u8166\u51fa\u8840\u5217\u70ba\u9451\u5225\u8a3a\u65b7\u3002\u82e5\u96fb\u8166\u65b7\u5c64\u986f\u793a\u7121\u51fa\u8840\uff0c\u81e8\u5e8a\u4e0a\u4ecd\u5f37\u70c8\u61f7\u7591\u8718\u86db\u819c\u4e0b\u8154\u51fa\u8840(SAH)\u61c9\u5b89\u6392\u8166\u90e8\u6838\u78c1\u5171\u632f(MRI)\u6392\u9664\u4e4b\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "60 \u6b72\u7537\u6027\u56e0\u547c\u5438\u56f0\u96e3\u81f3\u6025\u8a3a\u5c31\u8a3a\uff0c\u5176\u80f8\u8154 X \u5149\u986f\u793a\u96d9\u5074\u808b\u819c\u7a4d\u6c34\u3002\u7d93\u9032\u884c\u8a3a\u65b7\u6027\u808b\u819c\u7a7f\u523a\u5f8c\u80f8\u6c34\u4e4b\u5be6\u9a57\u5ba4\u5206\u6790\u7d50\u679c\u5982\u4e0b\uff1a\u9178\u9e7c\u503c pH 7.57\uff0c\u80f8\u6c34/\u8840\u6e05\u4e73\u9178\u812b\u6c2b\u9176\u6bd4\u503c(LDH ratio)0.4\uff0c\u80f8\u6c34/\u8840\u6e05\u86cb\u767d\u8cea\u6bd4\u503c(Protein ratio)0.2\uff0c\u7d30\u80de\u5206\uf9d0\u8a08\u6578 WBC 133 cells/\u00b5L(\u5176\u4e2d 65%\u70ba lymphocyte)\u3002\u4e0b\u5217\u8a3a\u65b7\u4f55\u8005\u6700\u9069\u7576?", + "Options": "(A)\u5fc3\u8870\u7aed\u3002 (B)\u7d30\u83cc\u6027\u80ba\u708e\u3002 (C)\u6dcb\u5df4\u764c\u3002 (D)\u80ba\u7d50\u6838\u3002 (E)\u7d05\u6591\u6027\u72fc\u7621\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "5 \u6b72\u5152\u7ae5\u9ad4\u91cd 20 \u516c\u65a4\uff0c\u56e0\u7672\u7647\u91cd\u7a4d\u72c0\u614b(Status Epilepticus)\u5728\u6bcd\u89aa\u966a\u540c\u4e0b\u7531\u6551\u8b77\u8eca\u9001\u9054\u6025\u8a3a\u6cbb\u7642\uff0c\u4e3b\u8a34\u62bd\u6410\u5df2\u7d93 30 \u5206\u9418\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u78ba\u4fdd\u547c\u5438\u9053\u66a2\u901a\uff0c\u7a69\u5b9a\u751f\u547d\u5fb5\u8c61\u662f\u7b2c\u4e00\u8981\u52d9\u3002 (B)\u5982\u679c\u7dca\u6025\u6aa2\u6e2c\u767c\u73fe\u4f4e\u8840\u7cd6\uff0c\u61c9\u7acb\u5373\u4f7f\u7528 10% G/W 100 ml \u975c\u8108\u6ce8\u5165\u3002 (C)\u82e5\u62bd\u6410\u6301\u7e8c\uff0c\u61c9\u7d66\u4e88\u975c\u6ce8 Lorazepam 2 mg\uff0c\u53ef\u91cd\u8907\u7d66\u3002 (D)\u82e5\u62bd\u6410\u6301\u7e8c\uff0c\u9ede\u6ef4\u6253\uf967\u4e0a\uff0c\u61c9\u7d93\u7531\u809b\u9580\u7d66\u85e5 Diazepam 2 mg\u3002 (E)\u82e5\u62bd\u6410\u6301\u7e8c\uff0c\u53ef\u8003\u616e\u975c\u6ce8 Midazolam 2 mg\uff0c\u518d\u52a0\u4e0a Midazolam 1 mcg/kg/min \u9023\u7e8c\u975c\u6ce8\u7d66\u85e5\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "50 \u6b72\u7537\u6027\u56e0\u5348\u9910\u904e\u5f8c\u53f3\u4e0a\u8179\u75bc\u75db\u81f3\u6025\u8a3a\u5c31\u8a3a\uff0c\u904e\u53bb\u75c5\u53f2\u6709\u7cd6\u5c3f\u75c5\u8207\u9ad8\u8840\u58d3\uff0c\u95dc\u65bc\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u81bd\u77f3\u7d5e\u75db(biliary colic pain)\uff0c\u5927\u90e8\u5206\u65bc 1~5 \u500b\u5c0f\u6642\u5167\u6703\u7de9\u89e3\u3002 (B)\u6025\u8a3a\u8d85\u97f3\u6ce2\u904b\u7528\u65bc\u8a3a\u65b7\u6025\u6027\u81bd\u56ca\u708e\u654f\u611f\u5ea6(sensitivity)\u8207\u5c08\u4e00\u6027(specificity)\u90fd\u50c5\u7d04 70%\u3002 (C)\u6b64\u75c5\u4eba\u7684\u8179\u90e8\u8d85\u97f3\u6ce2\u81bd\u56ca\u539a\u5ea6\uff0c\u5927\u65bc 3 mm \u5247\u8981\u61f7\u7591\u6025\u6027\u81bd\u56ca\u708e\u3002 (D)\u82e5\u6b64\u75c5\u4eba\u6709\u81bd\u56ca\u708e\uff0c\u8d85\u97f3\u6ce2\u53ef\u80fd\u6c92\u6709 sonographic Murphy\u2019s sign\u3002 (E)\u55ce\u5561\uf9d0\u7684\u6b62\u75db\u85e5\u7269\u4f7f\u7528\u65bc\u6b64\u75c5\u4eba\u4e0a\u53ef\u80fd\u6703\u589e\u52a0\u81bd\u9053\u58d3\u529b\u8207\u8a98\u767cSphincter of Oddi \u7684\u6536\u7e2e\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "50 \u6b72\u7537\u6027\u56e0\u54b3\u8840\u81f3\u6025\u8a3a\u5c31\u8a3a\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u61c9\u512a\u5148\u8a55\u4f30\u547c\u5438\u9053\u662f\u5426\u901a\u66a2\u53ca\u8840\u6c27\u6fc3\u5ea6\u662f\u5426\u8db3\u5920\u3002 (B)\u53ef\u4f9d\u64da 24 \u5c0f\u6642\u5167\u4e4b\u54b3\u8840\u91cf\u5340\u5206\u56b4\u91cd\u5ea6\uff0c\u5176\u4e2d\u5927\u91cf\u54b3\u8840\u4e4b\u5b9a\u7fa9\u70ba 24\u5c0f\u6642\u5167\u4e4b\u54b3\u8840\u91cf> 600 ml\u3002 (C)\u80ba\u6813\u585e\u5e38\u5e38\u5f15\u8d77\u5927\u91cf\u54b3\u8840\u3002 (D)\u80f8\u90e8 X \u5149\u662f\u5fc5\u8981\u4e4b\u6aa2\u67e5\uff0c\u4f46\u6709 15~30%\u4e4b\u6a5f\u6703\u70ba\u6b63\u5e38\u3002 (E)\u82e5\u54b3\u8840\u4e4b\u984f\u8272\u70ba\u6697\u7d05\u8272\uff0c\u5247\u61c9\u6ce8\u610f\u51fa\u8840\u53ef\u80fd\u4f86\u81ea\u65bc\u8178\u80c3\u9053\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "48 \u6b72\u5973\u6027\u56e0\u6df1\u90e8\u975c\u8108\u6813\u585e\u6b63\u4f7f\u7528 Warfarin \u6cbb\u7642\uff0c1 \u5c0f\u6642\u524d\u958b\u59cb\u51fa\u73fe\u96d9\u5074\u5927\u91cf\u9f3b\u51fa\u8840\u4e14\u7121\u6cd5\u4ee5\u76f4\u63a5\u52a0\u58d3\u6cd5\u6b62\u8840\uff0c\u76ee\u524d\u8840\u58d3\u70ba 136/82 mmHg\uff0c\u5fc3\u8df3 110\u6b21/min\uff0c\u62bd\u8840\u7d50\u679c\u767c\u73fe platelets 170,000 /\u00b5L\uff0c Hb 8 g/dL\uff0cHct 23 %\uff0cINR 8\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u6700\uf967\u9069\u5408?", + "Options": "(A)\u7d66\u4e88 desmopressin acetate(ddAVP)\u3002 (B)\u7d66\u4e88\u65b0\u9bae\u51b7\u51cd\u8840\u6f3f(fresh frozen plasma)\u3002 (C)\u7d66\u4e88 prothrombin complex concentrate\u3002 (D)\u7d66\u4e88 vitamin K\u3002 (E)\u505c\u6b62 Warfarin \u4f7f\u7528\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "47 \u6b72\u7537\u6027\u75c5\u4eba\uff0c\u524d\u5929\u98f2\u9152\u72c2\u6b61\u5f8c\uff0c\u56e0\u5641\u5fc3\u5614\u5410\u4f34\u96a8\u547c\u5438\u5598\u88ab\u5e36\u5165\u6025\u8a3a\uff0c\u751f\u547d\u5fb5\u8c61\uff1a\u9ad4\u6eab 36.5 \u2103\uff0c\u8108\u640f 124 \u6b21/min\uff0c\u547c\u5438 26 \u6b21/min\uff0c\u8840\u58d3 103/61 mmHg\uff0cSpO2 100%\uff0c\u6aa2\u9a57\u5831\u544a\uff1a\u52d5\u8108\u8840\u6db2\u6c23\u9ad4\u5206\u6790\uff1apH \u503c 7.27\u3001pCO2 25 mmHg\u3001HCO3- 11 mmol/L\uff0c\u8840\u7cd6\u503c 102 mg/dL\uff0c\u8840\u9209\u6fc3\u5ea6 142 mmol/L\uff0c\u8840\u9240\u6fc3\u5ea6 3.5 mmol/L\uff0c\u8840\u6c2f\u6fc3\u5ea6 106 mmol/L\uff0c\u8840\u6e05\u916e\u9ad4(serum ketones)\u5448\u967d\u6027\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u6b64\u75c5\u4eba\u70ba\u9670\u96e2\u5b50\u9593\u9699\u589e\u52a0\u4e4b\u4ee3\u8b1d\u6027\u9178\u8840\u75c7(high anion gap metabolic acidosis)\u3002 (B)\u82e5\u61f7\u7591\u70ba\u9152\u7cbe\u6027\u916e\u9178\u4e2d\u6bd2\uff0c\u9700\u5148\u6392\u9664\u611f\u67d3\u6216\u85e5\u7269\u9020\u6210\u7684\u4e73\u9178\u4e2d\u6bd2(lactic acidosis)\u3002 (C)\u53ef\u4ee5\u6aa2\u9a57\u8840\u6db2\u6ef2\u900f\u58d3\u53ca\u7532\u9187(Methanol)\u6fc3\u5ea6\uff0c\u4ee5\u6392\u9664\u7532\u9187\u6216\u5176\u4ed6\u6709\u6a5f\u9178\u4e2d\u6bd2\u3002 (D)\u82e5\u70ba\u9152\u7cbe\u6027\u916e\u9178\u4e2d\u6bd2\uff0c\u53ef\u7d66\u4e88\u75c5\u4eba\u542b\u7cd6\u6eb6\u6db2\uff0c\u589e\u52a0\u9ad4\u5167\u8461\u8404\u7cd6\u6fc3\u5ea6\u4e26\u88dc\u5145\u9ad4\u6db2\u7684\uf967\u8db3\u3002 (E)\u5728\u9152\u7cbe\u6027\u916e\u9178\u4e2d\u6bd2\uff0c\u70ba\u4fc3\u9032\u8461\u8404\u7cd6\u5229\u7528\uff0c\u6e1b\u5c11\u8102\u80aa\u5206\u89e3\u7522\u751f\u916e\u9178\uff0c\u9700\u7d66\u4e88\u80f0\u5cf6\u7d20\u88dc\u5145\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "40 \u6b72\u5973\u6027\u60a3\u6709\u7532\u72c0\u817a\u75be\u75c5\u4f46\u672a\u898f\u5247\u670d\u85e5\u8ffd\u8e64\uff0c\u56e0\u76ae\u819a\u504f\u9ec3\u3001\u55dc\u7761\u53ca\u547c\u5438\u56f0\u96e3\u9001\u5165\u6025\u8a3a\uff0c\u7d93\u6aa2\u67e5\u767c\u73fe\uff1a\u9ad4\u6eab 39.2 \u2103\uff0c\u8840\u58d3 145/75 mmHg\uff0c\u8108\u640f\uf967\u898f\u5247\uff0c\u7d04 145 \u6b21/min\uff0c\u5fc3\u96fb\u5716\u986f\u793a\u5fc3\u623f\u7e96\u7dad\u986b\u52d5\u5408\u4f75\u5feb\u901f\u5fc3\u5ba4\u901f\u7387(atrial fibrillation with rapid ventricular rate)\uff0c\u80f8\u90e8 X \u5149\u6aa2\u67e5\u767c\u73fe\u5169\u5074\u80ba\u7a4d\u6c34(pulmonary edema)\u3002\u4f9d\u64da\u81e8\u5e8a\u8868\u73fe\uff0c\u4e0b\u5217\u6cbb\u7642\u6558\u8ff0\u4f55\u8005\u6b63\u78ba?", + "Options": "(A)\u4ee5\u652f\u6301\u6027\u6cbb\u7642\uff0c\u5305\u62ec\u7d66\u4e88\u6c27\u6c23\u548c\u9ad4\u6db2\u88dc\u5145\u70ba\u4e3b\uff0c\u91dd\u5c0d\u767c\u71d2\uff0c\u53ef\u4ee5\u7d66\u4e88 Acetaminophen \u6216 Aspirin \u5354\u52a9\u9000\u71d2\u3002 (B)\u56e0\u75c5\u4eba\u6709\u5fc3\u623f\u7e96\u7dad\u986b\u52d5\u5408\u4f75\u5feb\u901f\u5fc3\u5ba4\u901f\u7387(atrial fibrillation with rapid ventricular rate)\uff0c\u53ef\u4ee5\u5148\u7d66\u4e88 Amiodarone \u63a7\u5236\u5fc3\u8df3\u901f\u7387\uff0c\u907f\u514d\u5fc3\u8870\u7aed\u75c7\u72c0\u60e1\u5316\u3002 (C)Propylthiouracil(PTU)\u548c Methimazole \u90fd\u53ef\u4ee5\u7528\u4f86\u6291\u5236\u7532\u72c0\u817a\u7d20\u5408\u6210\u548c\u6291\u5236 T4 \u8f49\u63db\u70ba T3\u3002 (D)\u7898\u7518\u6cb9(Lugol`s solution)\u542b\u6709\u7898\u96e2\u5b50\uff0c\u9808\u548c PTU \u540c\u6642\u4e00\u8d77\u4f7f\u7528\uff0c\u624d\u80fd\u6291\u5236\u7532\u72c0\u817a\u7d20\u7684\u751f\u6210\u3002 (E)\u8461\u8404\u7cd6\u76ae\u8cea\u7d20(glucocorticoids)\u53ef\u4ee5\u6291\u5236 T4 \u8f49\u63db\u70ba T3\uff0c\u80fd\u6539\u5584\u7532\u72c0\u817a\u98a8\ufa06(thyroid storm)\u75c5\u4eba\u7684\u5b58\u6d3b\u7387\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "3 \u6b72\u5c0f\u670b\u53cb\uff0c\u904e\u53bb\u8eab\u9ad4\u5065\u5eb7\uff0c\u5bb6\u5c6c\u4ee3\u70ba\u4e3b\u8a34\u5169\u5929\u524d\u958b\u59cb\u8179\u7009\u53ca\u9593\u6b47\u6027\u8179\u75db\uff0c\u5728\u793e\u5340\u578b\u91ab\u9662\u6025\u8a3a\u63a5\u53d7\u975c\u8108\u8f38\u6db2\u6cbb\u7642\uff0c\u60c5\u5f62\u4e26\u672a\u6539\u5584\uff0c\u751a\u81f3\u958b\u59cb\u6709\u8840\u4fbf\u60c5\u6cc1\uff0c\u5bb6\u9577\u89c0\u5bdf\u5c0f\u670b\u53cb\u54ed\u9b27\u60c5\u5f62\u983b\u7e41\uff0c\u8981\u6c42\u8f49\u5230\u5f8c\u9001\u91ab\u9662\u6025\u8a3a\u6cbb\u7642\uff0c\u8840\u6db2\u6aa2\u67e5\u5982\u4e0b\uff1aWBC: 12,000/ uL\uff0cHb: 9 g/dL\uff0cPLT: 19,000/uL\uff0cglucose 75 mg/dL\uff0cBUN 50 mg/dL\uff0cCreatinine 5.5 mg/dL\uff0cAST 60 U/L\uff0cNa 125 mEq/L\uff0cK 4.8 mEq/L\uff0c\u4e0b\u5217\u4f55\u8005\u6b63\u78ba?", + "Options": "(A)\u5c0f\u670b\u53cb\u61c9\u8a72\u662f\u662f\u8178\u5957\u758a\u5f15\u8d77\u3002 (B)\u8840\u6db2\u62b9\u7247(Blood smear)\u5c0d\u8a3a\u65b7\u6c92\u6709\u5e6b\u52a9\u3002 (C)\u5c0f\u670b\u53cb\u5c3f\u5c11\u60c5\u6cc1\u5f88\u5c11\u6703\u6301\u7e8c\u4e00\u9031\u3002 (D)\u6297\u751f\u7d20\u5c0d\u9019\u6a23\u7684\u60c5\u6cc1\u5f88\u6709\u5e6b\u52a9\u3002 (E)\u8f03\u53ef\u80fd\u662f\u6bd2\u7d20(toxin)\u7834\u58de\u5927\u8178\u9ecf\u819c\u8868\u76ae\u9032\u5165\u8840\u6db2\u9020\u6210\u5f71\u97ff\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "38 \u6b72\u6709\u7532\u72c0\u817a\u4ea2\u9032\u75c5\u53f2\u7684\u5973\u6027\uff0c\u56e0\u767c\u71d2\u5408\u4f75\u547c\u5438\u5598\u9001\u5165\u6025\u8a3a\uff0c\u6aa2\u50b7\u6642\u751f\u547d\u5fb5\u8c61\uff1a\u9ad4\u6eab 39.5 \u2103\uff0c\u8108\u640f 143 \u6b21/min\uff0c\u547c\u5438 24 \u6b21 /min\uff0c\u8840\u58d3 108/59 mmHg\uff0c SpO2 98%\u3002\uf9e4\u5b78\u6aa2\u67e5\u767c\u73fe\uff1a\u60a3\u8005\u5448\u7aef\u5750\u547c\u5438(orthopnea)\u4f34\u96a8\u96d9\u4e0b\u80a2\u6c34\u816b(pedal edema)\uff0c\u5169\u5074\u547c\u5438\u97f3\u6709\u6fd5\u56c9\u97f3(rales)\uff0c\u5fc3\u96fb\u5716\u986f\u793a\u7ac7\u6027\u5fc3\u640f\u904e\u901f(sinus tachycardia)\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u9700\u8a55\u4f30\u75c5\u4eba\u610f\u8b58\u72c0\u614b\u662f\u5426\u6709\u55dc\u7761\u3001\u62bd\u6410\u3001\u660f\u8ff7\u7b49\u75c7\u72c0\u4ee5\u53ca\u662f\u5426\u6709\u53ad\u98df\u3001\u8179\u75db\u3001\u9ec3\u75b8\u7b49\u809d\u81bd\u80c3\u8178\u7cfb\u7d71\u529f\u80fd\u969c\u7919\u7684\u8868\u73fe\u3002 (B)\u4f9d\u64da\u75c5\u4eba\u904e\u53bb\u7532\u72c0\u817a\u4ea2\u9032\u4e4b\u75c5\u53f2\uff0c\u52a0\u4e0a\u9ad4\u6eab\u4e0a\u5347\u4ee5\u53ca\u5fc3\u640f\u904e\u901f\u4f34\u96a8\u5fc3\u8870\u7aed\uff0c\u82e5\u6709\u4e2d\u6a1e\u795e\u7d93\u548c\u809d\u81bd\u80c3\u8178\u529f\u80fd\u969c\u7919\u7b49\u81e8\u5e8a\u75c7\u72c0\uff0c\u53ef\u4ee5\u61f7\u7591\u662f\u5426\u70ba\u7532\u72c0\u817a\u98a8\ufa06(thyroid storm)\u3002 (C)\u53ef\u4ee5\u6aa2\u9a57\u75c5\u4eba\u7684\u7532\u72c0\u817a\u529f\u80fd\uff0c\u4f86\u5224\u65b7\u662f\u7532\u72c0\u817a\u4e2d\u6bd2\u75c7(thyrotoxicosis)\u6216\u662f\u7532\u72c0\u817a\u98a8\ufa06(thyroid storm)\u3002 (D)\u9020\u6210\u7532\u72c0\u817a\u98a8\ufa06(thyroid storm)\u7684\u53ef\u80fd\u539f\u56e0\uff0c\u5305\u62ec\u611f\u67d3\u3001\u7cd6\u5c3f\u75c5\u916e\u9178\u8840\u75c7(diabetic ketoacidosis)\u6216\u505c\u7528\u6297\u7532\u72c0\u817a\u85e5\u7269\u3002 (E)\u9700\u8981\u8003\u616e\u662f\u5426\u6709\u611f\u67d3\u3001\u71b1\u6025\u75c7\u6216\u4f7f\u7528\u4ea4\u611f\u795e\u7d93\u8208\u596e\u85e5\u7269(sympathomimetic agents)\u7b49\u5176\u4ed6\u53ef\u80fd\u7684\u9451\u5225\u8a3a\u65b7\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "35 \u6b72\u7537\u6027\u75c5\u4eba\uff0c\u56e0\u4eca\u5929\u65e9\u6668\u6709\u89e3 1 \u6b21\u5c11\u91cf\u8840\u4fbf\u81f3\u6025\u8a3a\u5c31\u8a3a\uff0c\u7d93\u8a62\u554f\u7121\u8179\u75db\u6216\u6688\u53a5\u75c5\u53f2\uff0c\u95dc\u65bc\u4e0b\u6d88\u5316\u9053\u51fa\u8840\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u78ba\u8a3a\u7684\u4e0b\u6d88\u5316\u9053\u51fa\u8840\u4e2d\u6700\u5e38\u898b\u5f15\u8d77\u7684\u75c5\u56e0\u70ba\u61a9\u5ba4\u75be\u75c5\u3002 (B)\u6709 10~14%\u7684\u8840\u4fbf\u75c5\u4eba\u51fa\u8840\u9ede\u4f86\u81ea\u65bc\u4e0a\u6d88\u5316\u9053\u3002 (C)\u7121\u8179\u90e8\u58d3\u75db\u7684\u4e0b\u6d88\u5316\u9053\u51fa\u8840\u75c5\u4eba\u6703\u6709\u8f03\u9ad8\u7684\u7f79\u75c5\u7387(morbidity rate)\u3002 (D)\u7d04 80%\u7684\u4e0b\u6d88\u5316\u9053\u51fa\u8840\u75c5\u4eba\u51fa\u8840\u6703\u81ea\u884c\u7de9\u89e3\u3002 (E)Glasgow-Blatchford Bleeding score \u80fd\u505a\u70ba\u4e0b\u6d88\u5316\u9053\u51fa\u8840\u75c5\u4eba\uff0c\u53ef\u4ee5\u51fa\u9662\u9580\u8a3a\u8ffd\u8e64\u6cbb\u7642\u7684\u552f\u4e00\u6a19\u6e96\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "32 \u6b72\u5973\u6027\u56e0\u70ba\u6162\u6027\u6708\u7d93\u904e\u591a\u75c7\u9020\u6210\u8ca7\u8840\uff0c\u56e0\u6b64\u66fe\u63a5\u53d7\u904e\u591a\u6b21 packed RBC \u8f38\u8840\uff0c\u6700\u8fd1\u5169\u6b21\u8f38\u8840\u6642\u51fa\u73fe febrile nonhemolytic transfusion reaction\uff0c\u76ee\u524d\u5979\u7684Hb 6.0 g/dL\uff0c\u7d93\u904e\u8f38\u8840\u6bd4\u5c0d(type and cross-match)\u5f8c\uff0c\u4f7f\u7528\u4e0b\u5217\u4f55\u7a2e\u65b9\u6cd5\u53ef\u4ee5\u964d\u4f4e\u518d\u6b21\u51fa\u73fe febrile nonhemolytic transfusion reaction \u7684\u53ef\u80fd\u6027?", + "Options": "(A)\u5168\u8840\u8f38\u8840(Whole blood transfusion)\u3002 (B)\u653e\u5c04\u7dda\u7167\u5c04\u4e4b\u8840\u54c1\u8f38\u8840(Irradiated red blood cell transfusion)\u3002 (C)\u964d\u4f4e\u8f38\u8840\u901f\u5ea6\uff0c\u4f7f\u8f38\u8840\u6642\u9593\u8d85\u904e 4 \u5c0f\u6642\u3002 (D)\u6e1b\u5bb9\u4e4b\u8840\u54c1\u8f38\u8840(Volume-reduced red cell transfusion)\u3002 (E)\u6e1b\u9664\u767d\u8840\u7403\u4e4b\u8840\u54c1\u8f38\u8840(Leukocyte-reduced red blood cell transfusion)\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "32 \u6b72\u5973\u6027\uff0c4 \u5c0f\u6642\u524d\u5728\u89c0\u8cde\u570b\u6176\u7159\u706b\u6642\uf967\u614e\u88ab\u5f15\u71c3\u7684\u706b\u85e5\u70b8\u50b7\uff0c\u5168\u8eab\u7d04 50%\u9ad4\u8868\u9762\u7a4d\u8d77\u6c34\u6ce1\u6216\u7126\u9ed1\u3002\u75c5\u4eba\u9ad4\u91cd 50 kgw\uff0c\u8840\u58d3 110/89 mmHg\uff0c\u5fc3\u8df3 120\u6b21/min\uff0c\u7559\u7f6e\u5c0e\u5c3f\u7ba1\u5df2\u6709 100 ml \u5c3f\u6db2\uff0c\u5f9e\u53d7\u50b7\u5230\u73fe\u5728\u5df2\u7d66\u4e86 1,000 ml \u4e73\u9178\u6797\u683c\u6c0f\u6db2\uff0c\u8acb\u554f\u82e5\u6839\u64da Parkland formula\uff0c\u63a5\u4e0b\u4f86 4 \u5c0f\u6642\u7684\u8f38\u6db2\uff0c\u6bcf\u5c0f\u6642\u8a72\u7d66\u591a\u5c11 ml?", + "Options": "(A)8,000 ml\u3002 (B)5,000 ml\u3002 (C)625 ml\u3002 (D)1,000 ml\u3002 (E)975 ml\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "32 \u6b72\u7537\u6027\u81f3\u6025\u8a3a\u5c31\u8a3a\uff0c\u4e3b\u8a34\u70ba\u96d9\u773c\u75bc\u75db\u754f\u5149\u3001\u6dda\uf9ca\uf967\u6b62\u3001\u5408\u4f75\u8996\u529b\u6a21\u7cca\u75c7\u72c0\u3002\u4ed6\u5f9e\u4e8b\u96fb\u92b2\u5de5\u4f5c\uff0c\u4eca\u5929\u6c92\u6234\u8b77\u76ee\u93e1\u5de5\u4f5c 8 \u5c0f\u6642\u5f8c\u5c31\u51fa\u73fe\u9019\u75c7\u72c0\uff0c\u8acb\u554f\u4ee5\u4e0b\u4f55\u8005\u662f\u6700\u9069\u5408\u7528\u4f86\u66ab\u6642\u7de9\u89e3\u75bc\u75db\u7684\u85e5\u7269?", + "Options": "(A)Nonsteroidal anti-inflammatory drug eye drop\u3002 (B)Steroid eye drop\u3002 (C)Decongestant eye drop\u3002 (D)Topical anesthetics\u3002 (E)Antihistamine eye drop\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "30 \u6b72\u5973\u6027\u61f7\u5b55 12 \u9031\uff0c\u56e0\u504f\u982d\u75db\u5408\u4f75\u5641\u5fc3\u5614\u5410\u524d\u4f86\u6c42\u8a3a\uff0c\u53ef\u8003\u616e\u7d66\u4e88\u4e0b\u5217\u54ea\u4e00\u7a2e\u85e5\u7269\u6700\u9069\u7576\uff1f", + "Options": "(A)Chlorpromazine\u3002 (B)Dihydroergotamine\u3002 (C)Metoclopramide\u3002 (D)Prochlorperazine\u3002 (E)Sumatriptan\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "30 \u6b72\u7537\u6027\u8eca\u798d\u5230\u9662\u6642\u6709\u80f8\u524d\u64e6\u632b\u50b7\u75d5\u8de1\uff0c\u610f\u8b58\u6e05\u695a\uff0c\u8840\u58d3 145/75 mmHg\uff0c\u5fc3\u8df3 115 \u6b21/min\uff0c\u547c\u5438 30 \u6b21/min\uff0c\u53f3\u5074\u547c\u5438\u97f3\u6fc1\uff0c\u80f8\u58c1\u547c\u6c23\u6642\u80f8\u58c1\u51f8\u51fa\uff0c\u800c\u5438\u6c23\u6642\u80f8\u58c1\u51f9\u9677\uff0c\u95dc\u65bc\u6b64\u75c5\u4eba\u6025\u6551\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u53f3\u5074\u80f8\u90e8\u7d93\u6aa2\u67e5\u767c\u73fe\u6709\u6c23\u8840\u80f8\uff0c\u9808\u7f6e\u5165\u80f8\u7ba1\u5f15\uf9ca\u3002 (B)\u6b64\u547c\u5438\u578b\u614b\u9808\u61f7\u7591\u9023\u67b7\u80f8(flail chest)\u7684\u8a3a\u65b7\u3002 (C)\u5224\u65b7\u6b64\u75c5\u4eba\u53ef\u80fd\u4f75\u6709\u4f11\u514b\u73fe\u8c61\u3002 (D)\u6aa2\u67e5\u5efa\u8b70\u5305\u62ec\u5341\u4e8c\u5c0e\u7a0b\u5fc3\u96fb\u5716\u53ca\u5fc3\u808c\u9175\u7d20\u6aa2\u9a57\u3002 (E)\u5178\u578b\u7684\u80ba\u632b\u50b7\u5728\u653e\u5c04\u7dda\u6aa2\u67e5\u7684\u8b8a\u5316\u4e0a\u5e38\u51fa\u73fe\u5728\u53d7\u50b7 6 \u5c0f\u6642\u4e4b\u5f8c\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "30 \u6b72\u7537\u6027\uff0c\u5168\u8eab\u7121\u529b\u5169\u5929\uff0c\u4eca\u5929\u6e05\u6668\u767c\u73fe\u56db\u80a2\u7121\u529b\u52a0\u5287\u5408\u4f75\u5fc3\u60b8\uff0c\u88ab\u5bb6\u4eba\u9001\u5165\u6025\u8a3a\u5ba4\u3002\u75c5\u4eba\u81ea\u8a34\u5e73\u6642\u5e38\u6709\u624b\u6296\u3001\u76dc\u6c57\u7b49\u75c7\u72c0\uff0c\u904e\u53bb\u4e5f\u66fe\u6709\u56db\u80a2\u7121\u529b\u7684\u72c0\u6cc1\u3002\u6aa2\u67e5\u6642\u9ad4\u6eab 36.2 \u2103\uff0c\u8108\u640f 65 \u6b21/min\uff0c\u8840\u58d3 128/79 mmHg\uff0c\u547c\u543816 \u6b21/min\uff0c\u9664\u56db\u80a2\u5c0d\u7a31\u7121\u529b\u5916\uff0c\u7121\u5176\u4ed6\u7570\u5e38\u767c\u73fe\u3002\u62bd\u8840\u6aa2\u9a57\u767c\u73fe\u8840\u4e2d\u9240\u96e2\u5b50\u6fc3\u5ea6\u70ba 1.6 mmol/L\u3001TSH \u504f\u4f4e\u3001T3 \u548c Free T4 \u504f\u9ad8\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u6b64\u75c5\u4eba\u53ef\u61f7\u7591\u70ba\u7532\u72c0\u817a\u6a5f\u80fd\u4ea2\u9032\u6240\u5c0e\u81f4\u7684\u4f4e\u8840\u9240\u5468\u671f\u6027\u9ebb\u75fa\u75c7\u3002 (B)\u75c5\u4eba\u53ef\u80fd\u5728\u98f2\u9152\u6216\u5927\u91cf\u98df\u7528\u751c\u98df\u5f8c\u767c\u4f5c\uff0c\u75c7\u72c0\u4ee5\u80a2\u9ad4\u5c0d\u7a31\u6027\u9060\u7aef\u7121\u529b\u70ba\u4e3b\u3002 (C)\u5fc3\u96fb\u5716\u4e0a\u53ef\u80fd\u767c\u73fe T \u6ce2\u8b8a\u5e73\uff0cST \u6bb5\u4e0b\u964d\u548c U \u6ce2\u51fa\u73fe\u7684\u73fe\u8c61\u3002 (D)\u7531\u5468\u908a\u975c\u8108\u8def\u5f91\u7d66\u4e88\u6c2f\u5316\u9240(KCl)\u91dd\u5291\u88dc\u5145\u6642\uff0c\u9240\u96e2\u5b50\u6fc3\u5ea6\uf967\u61c9\u8d85\u904e 40 mEq/L\u3002 (E)\u7531\u5468\u908a\u975c\u8108\u7d66\u4e88\u9240\u96e2\u5b50\u6642\uff0c\u88dc\u5145\u901f\u5ea6\uf967\u61c9\u8d85\u904e 40 mEq/hr\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "28 \u6b72\u7537\u6027 1 \u5c0f\u6642\u524d\u767c\u751f\u8eca\u798d\uff0c\u8179\u90e8\u920d\u50b7\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u5230\u6025\u8a3a\u99ac\u4e0a\u6aa2\u67e5 amylase\u3001lipase \u5747\u6b63\u5e38\uff0c\u4e26\uf967\u80fd\u6392\u9664(exclude)\u80f0\u81df\u640d\u50b7\u3002 (B)\u5230\u6025\u8a3a\u99ac\u4e0a\u505a\u8179\u8154\u704c\u6d17(DPL)\uff0c\u53ef\u6392\u9664\u80f0\u81df\u640d\u50b7\u3002 (C)\u5230\u6025\u8a3a\u99ac\u4e0a\u505a\u8179\u90e8\u96fb\u8166\u65b7\u5c64\uff0c\uf967\u53ef\u4ee5\u6392\u9664\u8178\u5b50\u640d\u50b7\u3002 (D)\u8179\u90e8\u920d\u50b7\u5de6\u5074\u6a6b\u8188\u819c\u53d7\u640d\u7834\u88c2\u6bd4\u53f3\u5074\u66f4\u5e38\u767c\u751f\u3002 (E)\u82e5\u60a3\u8005\u50c5\u6709\u55ae\u7d14\u809d\u81df\u6495\u88c2\u50b7\uff0c\u8996\u7a0b\u5ea6\u53ef\u63a1\u53d6\u975e\u624b\u8853\u6cbb\u7642\u3002", + "Answer": "B " + }, + { + "\ufeffQuestion": "26 \u6b72\u5973\u6027\u61f7\u5b55 32 \u9031\u3001\u9ad4\u91cd 65 \u516c\u65a4\uff0c\u5728\u904e\u6591\u99ac\u7dda\u6642\u88ab\u6a5f\u8eca\u649e\u5230\uff0c\u6551\u8b77\u8eca\u9001\u4f86\u6025\u8a3a\u6642\uff0c\u610f\u8b58\u6e05\u9192\u3001\u547c\u5438 24 \u6b21/min\u3001\u8108\u640f 112 \u6b21/min\u3001\u8840\u58d3 118/76 mmHg\u3001\u9ad4\u6eab 36.5 \u2103\u3002\u50b7\u60a3\u4e3b\u8a34\u4e0b\u8179\u75db\u5408\u4f75\u9670\u9053\u5c11\u91cf\u51fa\u8840\uff0c\uf9e4\u5b78\u6aa2\u67e5\u767c\u73fe\u4e0b\u8179\u58d3\u75db\u4f46\u7121\u53cd\u5f48\u75db\uff0c\u4ee5\u4e0b\u95dc\u65bc\u6b64\u5b55\u5a66\u6558\u8ff0\uff0c\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u5b55\u5a66\u7684\u8840\u58d3\u96d6\u7136\u5728\u6b63\u5e38\u7bc4\u570d\uff0c\u4f46\u5176\u51fa\u8840\u91cf\u4ecd\u6709\u53ef\u80fd\u8d85\u904e 1,500 ml\uff0c\u6240\u4ee5\u8981\u7d66\u4e88 crystalloid fluid \u8f38\u6db2\u6cbb\u7642\uff0c\u4e26\u8003\u616e\u8f38\u8840\u3002 (B)\u5b55\u5a66\u96d6\uf967\u77e5\u81ea\u5df1\u7684\u8840\u578b\uff0c\u4f46\u5df2\u77e5\u80ce\u5152\u7684\u8840\u578b\u70ba type O Rh(-)\uff0c\u56e0\u6b64\uf967\uf941\u9a57\u51fa\u7522\u5a66\u7684\u8840\u578b\u70ba\u4f55\uff0c\u90fd\uf967\u9700\u8981\u7d66\u4e88 RhO(D)immunoglobulin\u3002 (C)\u5b55\u5a66\u61c9\u63a1\u5de6\u5074\u8eba\u59ff\u52e2\uff0c\u4ee5\u907f\u514d\u5b50\u5bae\u58d3\u8feb\u4e0b\u8154\u975c\u8108\u3002 (D)\u9670\u9053\u5206\u6ccc\u7269\u4e4b pH \u503c\u5728 5 \u5de6\u53f3\u6642\uff0c\u4ee3\u8868\u7f8a\u819c\u7834\u88c2(amniotic membrane rupture)\u3002 (E)\u82e5\u6b64\u5b55\u5a66\u5728\u6025\u8a3a\u8655\u7f6e\u5f8c\u4ecd\uf967\u5e78\u5fc3\u8df3\u505c\u6b62\uff0c\u53ef\u8003\u616e\u7dca\u6025\u5256\u8179\u751f\u7522\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "26 \u6b72\u7537\u6027\uff0c\u5728\u53c3\u52a0\u99ac\u62c9\u677e\u8def\u8dd1\u5927\u91cf\uf9ca\u6c57\u5f8c\uff0c\u559d\u4e86\u8a31\u591a\u7684\u7926\u6cc9\u6c34\u548c\u98f2\u6599\u88dc\u5145\u6c34\u5206\u3002\u7d93\u904e\u4f11\u606f\u5f8c\u4ecd\u611f\u982d\u6688\u3001\u982d\u75db\uff0c\u56e0\u6b64\u7e7c\u7e8c\u5927\u91cf\u559d\u6c34\u3002\u5f8c\u4f86\u56e0\u70ba\u75c7\u72c0\u52a0\u5287\uff0c\u88ab\u670b\u53cb\u9001\u5165\u6025\u8a3a\u3002\u6aa2\u50b7\u6642\u9ad4\u6eab 36.5\u2103\uff0c\u8108\u640f 61 \u6b21/min\uff0c\u8840\u58d3 110/75 mmHg\uff0c\u547c\u5438 19 \u6b21/min\uff0c\u610f\u8b58\u72c0\u614b E3V4M5\u3002\u7d93\u62bd\u8840\u6aa2\u67e5\u767c\u73fe\uff0c\u8840\u9209\u6fc3\u5ea6 128 mmol/L\uff0c\u8840\u6f3f\u6ef2\u900f\u58d3(plasma osmolality)266 mOsm/L\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u8a55\u4f30\u4f4e\u8840\u9209\u75c5\u4eba\u6642\uff0c\u9996\u5148\u5fc5\u9808\u8a55\u4f30\u7d30\u80de\u5916\u6db2(extracellular fluid)\u72c0\u614b\u3002 (B)\u9ad8\u8840\u7cd6\u75c5\u4eba\u53ef\u80fd\u56e0\u70ba\u8840\u7cd6\u904e\u9ad8\u9020\u6210\u5047\u6027\u4f4e\u8840\u9209\u3002 (C)\u6b64\u75c5\u4eba\u53ef\u80fd\u662f\u904e\u91cf\u98f2\u6c34\u9020\u6210\u7684\u4f4e\u6ef2\u900f\u58d3\u6027\u4f4e\u8840\u9209(hypotonic hyponatremia)\u3002 (D)\u4f4e\u8840\u9209\u77ef\u6b63\u7684\u901f\u5ea6\uff0c\u4ee5\u6bcf\u5c0f\u6642\u589e\u52a0\uf967\u8d85\u904e 0.5~1.0 mEq/L \u70ba\u539f\u5247\u3002\u82e5\u75c5\u4eba\u767c\u751f\u7672\u7647\uff0c\u901f\u5ea6\u53ef\u4ee5\u52a0\u500d\u3002 (E)\u77ef\u6b63\u8840\u9209\u901f\u5ea6\u904e\u5feb\uff0c\u53ef\u80fd\u9020\u6210\u8166\u6c34\u816b(cerebral edema)\uff0c\u56b4\u91cd\u8005\u6703\u81f4\u6b7b\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "25 \u6b72\u5973\u6027\u56e0\u6234\u96b1\u5f62\u773c\u93e1\u5f8c\u51fa\u73fe\u53f3\u773c\u77bc\u7d05\u4e26\uf9ca\u51fa\u9ecf\u6db2\u81bf\u6027\u5206\u6ccc\u7269(mucopurulent discharge)\u4f86\u6025\u8a3a\uff0c\u773c\u775b\uf967\u6703\u75bc\u75db\uff0c\u4ee5\u4e0b\u4f55\u7a2e\u85e5\u7269\u6700\u9069\u5408\u7528\u4f86\u6cbb\u7642\u6b64\u75c5\u4eba?", + "Options": "(A)Gentamicin/Betamethasone \u773c\u6ef4\u5291\u3002 (B)Tetracycline HCl \u773c\u85e5\u818f\u3002 (C)Rinderon-A \u773c\u85e5\u818f\u3002 (D)Erythromycin \u773c\u85e5\u818f\u3002 (E)Ciprofloxacin \u773c\u6ef4\u5291\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "25 \u6b72\u7537\u6027\u9a0e\u8eca\u88ab\u8ca8\u8eca\u58d3\u904e\u8179\u90e8\uff0c\u5230\u9662\u6642\u6709\u8179\u90e8\u53ca\u9aa8\u76c6\u9aa8\u6298\u8b8a\u5f62\uff0c\u53f3\u5927\u817f\u8b8a\u5f62\uff0c\u610f\u8b58\u6e05\u695a\uff0c\u8840\u58d3 80/45 mmHg\uff0c\u5fc3\u8df3 145 \u6b21/min\uff0c\u547c\u5438\u97f3\u6e05\u695a\u5c0d\u7a31\uff0c\u4e0a\u8179\u90e8\u6709\uf9d7\u80ce\u58d3\u75d5\uff0c\u95dc\u65bc\u6b64\u75c5\u4eba\u6025\u6551\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba?", + "Options": "(A)\u512a\u5148\u9078\u64c7\u5169\u689d 22-Gauge \u53e3\u5f91\u975c\u8108\u7559\u7f6e\u91dd\u65bc\u96d9\u5074\u524d\u81c2\u975c\u8108\uff0c\u7d66\u4e88\u9ede\u6ef4\u53ca\u8f38\u8840\u6cbb\u7642\u3002 (B)\u4f7f\u7528 FAST(Focused Assessment Sonography in Trauma)\u8d85\u97f3\u6ce2\u6aa2\u67e5\u5f8c\u8179\u8154\u7684\u6f5b\u5728\u51fa\u8840\u3002 (C)FAST \u8d85\u97f3\u6ce2\u6aa2\u67e5\u9670\u6027\u6642\uff0c\u53ef\u6392\u9664\u9808\u624b\u8853\u7684\u60c5\u6cc1\u3002 (D)\u5feb\u901f\u7f6e\u5165\u5927\u53e3\u5f91\u975c\u8108\u5c0e\u7ba1\u7d66\u4e88\u8f38\u8840\uff0c\u9078\u64c7\u5f9e\u80a1\u975c\u8108\u6bd4\u5f9e\u9396\u9aa8\u4e0b\u975c\u8108\u597d\u3002 (E)FAST \u8d85\u97f3\u6ce2\u6aa2\u67e5\u9670\u6027\u6642\uff0c\u61c9\u8003\u616e\u7d66\u4e88\u9aa8\u76c6\u56fa\u5b9a\u53ca\u5b89\u6392\u7dca\u6025\u8840\u7ba1\u651d\u5f71\u6aa2\u67e5\u3002", + "Answer": "E " + }, + { + "\ufeffQuestion": "25 \u6b72\u7537\u6027\u642d\u6377\u904b\u6642\u88ab\u4eba\u7528\u5200\u96a8\u6a5f\u523a\u50b7\uff0c\u50b7\u53e3\u4f4d\u65bc\u5de6\u524d\u80f8\u7b2c 4 \u808b\u9593\u8655\u3002\u5230\u9662\u524d 1 \u5206\u9418\u50b7\u60a3\u5fc3\u80ba\u529f\u80fd\u505c\u6b62\uff0cEMT \u7acb\u5373\u65bd\u884c\u5fc3\u80ba\u5fa9\u7526\u8853\u3002\u5230\u9662\u5f8c\u91ab\u8b77\u4eba\u54e1\u63a5\u624b\u6025\u6551\uff0c\u6b64\u6642\u4ecd\u6478\uf967\u5230\u9838\u52d5\u8108\u8108\u640f\uff0c\u4f46 EKG monitor \u4e0a\u5448\u73fe\u5feb\u800c\u7a84\u7684 QRS\u6ce2\u578b\u3002\u7dca\u6025\u9032\u884c\u5fc3\u80ba\u5fa9\u7526\u8853\u53ca\u6c23\u7ba1\u5167\u7ba1\u63d2\u7ba1\u5f8c\uff0c\u767c\u73fe\u5169\u5074\u547c\u5438\u97f3\u7b49\u5927\u3001\u6c92\u6709\u6e1b\u5f31\u3002\u8acb\u554f\u4e0b\u4e00\u6b65\u8655\u7f6e\u4f55\u8005\u6700\u9069\u7576?", + "Options": "(A)\u7acb\u5373\u7d66\u4e88\u5927\u91cf\u8f38\u6db2\u5373\u53ef\u3002 (B)\u7acb\u5373\u5728\u5169\u5074\u80f8\u90e8\u63d2\u5165\u80f8\u7ba1\u3002 (C)\u7acb\u5373\u9032\u884c\u5fc3\u5305\u819c\u7a7f\u523a\u8853\u3002 (D)\u7acb\u5373\u5728\u6025\u8a3a\u9032\u884c\u7dca\u6025\u80f8\ufa0b\u5207\u958b\u8853(ED thoracotomy)\u3002 (E)\u7acb\u5373\u7d66\u4e88 ACLS \u6025\u6551\uff0c\u540c\u6642\u9001\u53bb\u958b\u5200\u623f\u9032\u884c\u958b\u80f8\u624b\u8853\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "1 \u6b72\u5152\u7ae5\u89e3\u9ecf\u6db2\u72c0\u8840\u4fbf\uff0c\u6301\u7e8c\u6709\u9663\u767c\u6027\u8179\u75db\u54ed\u9b27\u60c5\u5f62\uff0c\u6025\u8a3a\u7dca\u6025\u5b89\u6392\u8179\u90e8 X\u5149\u53ca\u8179\u90e8\u8d85\u97f3\u6ce2\u6aa2\u67e5\uff0c\u767c\u73fe\u6709\u8178\u963b\u585e\u60c5\u6cc1\uff0c\u60a8\u5224\u65b7\u662f\u8178\u5957\u758a\u53ef\u80fd\u6027\u6975\u9ad8\uff0c\u6b63\u5411\u5bb6\u5c6c\u8aaa\u660e\u7a7a\u6c23\u5fa9\u4f4d(air reduction)\u5fc5\u8981\u6027\uff0c\u5bb6\u5c6c\u8a62\u554f\u6b64\u6280\u8853\u662f\u5426\u6709\u7981\u5fcc\u60c5\u6cc1(contraindication)\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u6709\u8840\u4fbf\u6642\uf967\u53ef\u9032\u884c\uff0c\u6015\u58d3\u529b\u5c0e\u81f4\u8178\u7a7f\u5b54\u3002 (B)\u82e5\u6709\u8178\u7a7f\u5b54\u6216\u8179\u819c\u708e\u8de1\u8c61\u6642\uff0c\u61c9\u63a1\u53d6\u624b\u8853\u65b9\u5f0f\u70ba\u5b9c\u3002 (C)\u4f4e\u8840\u5bb9\u6216\u6557\u8840\u6027\u4f11\u514b\u8005\u9700\u8981\u6703\u8a3a\u5916\u79d1\u91ab\u5e2b\u63a1\u53d6\u624b\u8853\u65b9\u5f0f\u3002 (D)\u82e5\u662f lymphoma \u5f15\u8d77\u8178\u5957\u758a\uff0c\u4e5f\uf967\u5b9c\u7528\u975e\u624b\u8853\u65b9\u5f0f(nonsurgical reduction)\u3002 (E)\u75c7\u72c0\u8d85\u904e 24 \u5c0f\u6642\u4e5f\uf967\u5b9c\u63a1\u7528\u975e\u624b\u8853\u65b9\u5f0f\u3002", + "Answer": "A " + }, + { + "\ufeffQuestion": "1 \u6b72\u534a\u53ca 3 \u6b72\u5144\u5f1f\uff0c\u7531\u7236\u89aa\u64d4\u4efb\u6469\u6258\u8eca\u99d5\u99db\uff0c\u6bcd\u89aa\u5f9e\u5f8c\u5ea7\u74b0\u62b1\u56fa\u5b9a\u5c0f\u670b\u53cb\uff0c\u6c92\u6709\u6234\u5b89\u5168\u5e3d\uff0c\u8f49\u5f4e\u6642\uf967\u614e\u6454\u8eca\uff0c\u5169\u4f4d\u5c0f\u670b\u53cb GCS \u6eff\u5206\uff0c\u4f46\u5f1f\u5f1f\u5916\u89c0\u4e0a\u53ef\u898b\u5de6\u9873\u5074(left temporal)\u6709\u8840\u816b\uff0c\u54e5\u54e5\u5247\u5f8c\u9871\u90e8(occipital)\u6709\u8840\u816b\uff0c\u7531\u6551\u8b77\u8eca\u9001\u62b5\u6025\u8a3a\uff0c\u7576\u6642\u6c92\u6709\u5614\u5410\uff0c\u4e5f\u80fd\u5b89\u64ab\uff0c\u4ed4\u7d30\u8a62\u554f\u4e8b\u6545\u904e\u7a0b\u5f8c\u56e0\u8eca\u901f\u6162\uff0c\u4e26\u975e\u9ad8\u5371\u96aa\u53d7\u50b7\u6a5f\u8f49\uff0c\u4f9d\u64da Pediatric Emergency Care Applied Research Network(PECARN)\u5c0d\u8166\u90e8\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u5efa\u8b70\uff0c\u8acb\u554f\u4e0b\u5217\u4f55\u8005\u6b63\u78ba?", + "Options": "(A)\u96d6\u7136\u5c0f\u670b\u53cb\u610f\u8b58\u6e05\u695a\uff0c\u4f46\u90fd\u6709\u5f8c\u9871\u90e8\u8840\u816b\uff0c\u5169\u4f4d\u90fd\u61c9\u8a72\u9032\u884c\u8166\u90e8\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u3002 (B)\u54e5\u54e5\u53d7\u50b7\u4f4d\u7f6e\u98a8\u96aa\u9ad8\uff0c\u61c9\u8a72\u63a5\u53d7\u8166\u90e8\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u3002 (C)\u5169\u4f4d\u610f\u8b58\u6e05\u695a\uff0c\u5373\u4f7f\u7576\u6642\u6709\u610f\u8b58\u55aa\u5931\u5e7e\u79d2\u9418\uff0c\u4e5f\u61c9\u8a72\u89c0\u5bdf\u5373\u53ef\u3002 (D)\u5f1f\u5f1f\u672a\u6eff 2 \u6b72\u5e74\u7d00\u8f03\u5c0f\uff0c\u82e5\u7236\u6bcd\u64d4\u5fc3\uff0c\u53ef\u4ee5\u5b89\u6392\u8166\u90e8\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u3002 (E)\u54e5\u54e5\u53ca\u5f1f\u5f1f\u6c7a\u5b9a\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u539f\u5247\u662f\u76f8\u540c\u7684\u3002", + "Answer": "D " + }, + { + "\ufeffQuestion": "10 \u6b72\u7684\u7537\u7ae5\uff0c\u9ad4\u91cd 20 \u516c\u65a4\uff0c\u610f\u8b58\u6e05\u9192\u4f46\u662f\u547c\u5438\u5fae\u5598\uff0c\u5bb6\u4eba\u8868\u793a\u5c0f\u670b\u53cb\u6700\u8fd1\u5e38\u60f3\u559d\u6c34\uff0c\u6709\u9593\u6b47\u6027\u8179\u75db\u53ca\u5614\u5410\u3002\u8840\u6db2\u6aa2\u67e5\u5448\u73fe\u9178\u8840\u75c7(pH=7.10)\uff0cketone body 2+\uff0cblood sugar 911 mg/dL\uff0c\u5224\u65b7\u662f diabetic ketoacidosis\uff0c\u8acb\u554f\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u932f\u8aa4?", + "Options": "(A)\u61c9\u8a72\u5728 1~2 \u5c0f\u6642\u5167\u7d66\u4e88 0.9 % Normal Saline 200~400 ml\u3002 (B)\u82e5\u8840\u6db2 pH < 6.9\uff0c\u5408\u4f75\u9ad8\u8840\u9240\uff0c\u61c9\u53ef\u4ee5\u7d66 bicarbonate \u6cbb\u7642\u3002 (C)\u7acb\u5373\u7d66\u4e88\u80f0\u5cf6\u7d20\u6bcf\u5c0f\u6642 4U\u3002 (D)\u8840\u7cd6\u964d\u81f3 300 mg/dL \u5f8c\u8981\u958b\u59cb\u7d66\u4e88 5% G/W \u3002 (E)\u88dc\u5145 bicarbonate \u5176\u5be6\u6703\u589e\u52a0\u8166\u6c34\u816b\u98a8\u96aa\u3002", + "Answer": "C " + }, + { + "\ufeffQuestion": "18\u6b72\u5a66\u5973 6\u5929\u524d\u63a5\u53d7\u5256\u8179\u751f\u7522\uff0c\u5230\u6025\u8a3a\u4e3b\u8a34\u8179\u75db\u53ca\u6709\u60e1\u81ed\u5e36\u8840\u7684\u9670\u9053\u5206\u6ccc\u7269\u3002\u7406\u5b78\u6aa2\u67e5\u986f\u793a\u660e\u986f\u7684\u4e0b\u8179\u58d3\u75db\uff0c\u624b\u8853\u50b7\u53e3\u4e7e\u6de8\u5b8c\u6574\uff0c\u5169\u5074\u4e73\u623f\u8f15\u5fae\u816b\u8139\u53ca\u58d3\u75db\u4f46\u7121\u767c\u71b1\uff0c\u751f\u547d\u5fb5\u8c61\uff1a \u8840\u58d3 155/79 mmHg \uff0c\u5fc3\u8df3 110\u6b21/min\uff0c\u547c\u543820\u6b21/min\uff0c\u9ad4\u6eab 39\u2103\uff0c\u4ee5\u4e0b\u8a3a\u65b7 \u6700\u80fd\u89e3\u91cb \u6b64\u767c\u71d2\u539f\u56e0\uff1f", + "Options": "(A)\u5b50\u5bae\u5167\u819c\u708e (Endometritis )\u3002 (B)\u4e73\u817a\u708e( Mastitis)\u3002 (C)\u814e\u76c2\u814e\u708e( Pyelonephritis )\u3002 (D)\u8179\u5167\u7d17\u5e03\u6eef\u7559\u3002 (E)\u95cc\u5c3e\u708e( Appendicitis )\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "20\u6b7250\u516c\u65a4\u5973\u6027\u60a3\u8005\u5f9e\u6c23\u7206\u73fe\u5834\u5e36\u5230\u6025\u8a3a\u5c31\u91ab\uff0c\u5230\u9662\u6642 GCS E4M6V5 \uff0c\u9ad4\u6eab\uff1a 36oC\uff0c\u5fc3\u8df3 120\u6b21/min\uff0c\u547c\u5438\u901f\u7387 20\u6b21/min\uff0c\u8840\u58d3 150/88mmHg \u3002 \u81c9\u90e8\u3001\u524d\u80f8\u3001\u80cc\u90e8\u53ca\u96d9\u4e0a\u80a2\u6709 2\uff5e3\u5ea6\u71d2\u707c\u50b7\u7d0440%TBSA \u3002\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u8f03 \u9069\u5b9c\uff1f", + "Options": "(A)\u82e5\u60a3\u8005\u75bc\u75db\u53ef\u4ee5\u6253\u6b62\u75db\u91dd\u3002 (B)\u5e38\u898f\u4f7f\u7528\u9810\u9632\u6027\u6297\u751f\u7d20\u6cbb\u7642\u662f\u5fc5\u8981\u7684\u3002 (C)\u80f8\u90e8 X\u5149\u82e5\u6b63\u5e38\u53ef\u4ee5\u5148\u89c0\u5bdf\u4e0d\u6025\u8457\u63d2\u6c23\u7ba1\u5167\u7ba1\u3002 (D)\u53ef\u4f7f\u7528\u51b0\u584a\u53ca\u51b0\u6c34\u6577\u50b7\u53e3\u4ee5\u6e1b\u7de9\u7d44\u7e54\u9032\u4e00\u6b65\u50b7\u5bb3\u3002 (E)\u4f9d\u64da Modified Parkland Formula \u524d24\u5c0f\u6642\u9700\u7d66 Ringer\u2019s lactate 4,000ml\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "23\u6b72\u7537\u6027\u5230\u7da0\u5cf6\u6f5b\u6c34\uff0c\u4e0a\u5cb8 20\u5206\u9418\u5f8c\u7a81\u7136\u89ba\u5f97\u53f3\u8173\u7121\u529b\uff0c\u7d93\u521d\u6b65\u8a55\u4f30\u75c5\u4eba\u610f\u8b58\u6e05\u9192\uff0c\u8840\u58d3 130/80 mmHg \uff0c\u5fc3\u8df3 100\u6b21/min\uff0c\u547c\u5438 18\u6b21/min\uff0c\u53f3\u8173\u80a2\u9ad4\u529b\u91cf 3\u5206\uff0c\u5176\u4ed6\u80a2\u9ad4\u529b\u91cf\u6b63\u5e38\u3002\u6b64\u6642\u5982\u6b32\u5c07\u75c5\u4eba\u8f49\u81f3\u53f0\u7063\u897f\u90e8\u4e4b\u91ab\u9662\uff0c\u4e0b\u5217\u4f55 \u7a2e\u65b9\u5f0f\u6700\u4f73\uff1f", + "Options": "(A)\u5148\u642d\u8239\u81f3\u53f0\u6771\uff0c\u518d\u5750\u6551\u8b77\u8eca\u7d93\u5357\u90e8\u6a6b\u8cab\u516c\u8def\u81f3\u897f\u90e8\u3002 (B)\u5750\u76f4\u5347\u6a5f\u76f4\u63a5\u98db\u904e\u5357\u90e8\u6a6b\u8cab\u516c\u8def\u81f3\u897f\u90e8\u3002 (C)\u5148\u642d\u8239\u81f3\u53f0\u6771\uff0c\u518d\u7531\u53f0\u6771\u6a5f\u5834\u642d\u4e00\u822c\u5546\u7528\u5ba2\u6a5f\u81f3\u897f\u90e8\u3002 (D)\u5750\u76f4\u5347\u6a5f\u4f4e\u98db(\u4f4e\u65bc 300\u516c\u5c3a)\u7e5e\u904e\u53f0\u7063\u5357\u7aef\u81f3\u897f\u90e8\u3002 (E)\u5750\u76f4\u5347\u6a5f\u76f4\u63a5\u98db\u904e\u4e2d\u592e\u5c71\u8108\u81f3\u53f0\u5317\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "26\u6b72\u5973\u6027\u61f7\u5b55 25\u9031\uff0c\u99d5\u99db\u6c7d\u8eca\u5728\u570b\u9053\u4e0a\u767c\u751f\u8eca\u798d\uff0c\u6551\u8b77\u4eba\u54e1\u767c\u73fe\u73fe\u5834\u5b89\u5168\u6c23\u56ca\u6709\u6253\u958b\uff0c\u8f49\u9001\u5230\u91ab\u9662\u6642\u610f\u8b58\u6e05\u695a\u4f46\u4e3b\u8a34\u4e0b\u8179\u90e8\u75bc\u75db\uff0c\u81f3\u6025\u8a3a \u6642\u751f\u547d\u5fb5\u8c61\uff1a\u5fc3\u8df3 88\u6b21/min\uff0c\u8840\u58d3 105/70 mmHg \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u5b55\u5a66\u61f7\u5b55\u671f\u6703\u589e\u52a0\u6bcd\u89aa\u4e4b\u5168\u8eab\u8840\u5bb9\u91cf\uff0c\u6545\u6703\u5448\u73fe Hypervolemic \uff0c\u6545\u6709\u53ef\u80fd\u5931\u8840\u5927\u65bc 30%\u624d\u6703\u6709\u751f\u547d\u5fb5\u8c61\u4e4b\u7570\u5e38\u3002 (B)\u7576\u61f7\u5b55 12\u9031\u6642\u5b50\u5bae\u5e95\u9ad8\u5ea6\u7d04\u5728\u6065\u9aa8\u806f\u5408\u8655\uff0c\u7576 20\u9031\u6642\u5927\u7d04\u5728\u809a\u81cd\u9ad8\u5ea6\uff0c\u4e4b\u5f8c\u6bcf\u589e\u52a0\u4e00 \u9031\u5b50\u5bae\u5e95\u7d04\u4e0a\u5347 1\u516c\u5206\u3002 (C)\u70ba\u907f\u514d\u5f71\u97ff\u975c\u8108\u4e4b\u56de\u6d41\uff0c\u5efa\u8b70\u53ef\u5de6\u5074\u8eba\uff0c\u82e5\u6709\u4f7f\u7528\u9577\u80cc\u677f\uff0c\u653e\u7f6e\u6771\u897f\u65bc\u9577\u80cc\u677f\u4e0b\u65b9\u53f3\u81c0\u5340\u57df\u8655\uff0c\u4f7f\u60a3\u8005\u5448\u73fe\u5de6\u4f4e\u53f3\u9ad8\u7d04\u50be\u659c 30\u00b0\u3002 (D)\u8179\u90e8\u632b\u50b7\u5e38\u5c0e\u81f4\u80ce\u5152\u6b7b\u4ea1\u7684\u539f\u56e0\u70ba\u5b50\u5bae\u7834\u88c2\u53ca\u80ce\u76e4\u7834\u88c2\u3002 (E)\u82e5\u6b64\u5b55\u5a66\u7d93\u6aa2\u67e5\u5f8c\u6709\u53f3\u5074\u8840\u80f8\uff0c\u5247\u80f8\u7ba1\u653e\u7f6e\u7684\u4f4d\u7f6e\u548c\u4e00\u822c\u6210\u4eba\u7121\u7570\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "28\u6b72\u5973\u6027\uff0c\u88ab\u5bb6\u5c6c\u767c\u73fe\u660f\u5012\u5728\u5bb6\u4e2d\u800c\u9001\u6025\u8a3a\uff0c\u5176\u8868\u73fe\u70ba\u77b3\u5b54\u653e\u5927\u3001\u773c\u7403\u9663\u6523\u3001\u795e\u7d93\u808c\u8089\u7684\u53cd\u5c04\u589e\u5f37\u3001\u808c\u9663\u6523\uff0c\u8840\u58d3 190/108mmHg \uff0c\u5fc3\u8df3 126\u6b21/min\uff0c\u547c\u5438 32\u6b21/min\uff0c\u9ad4\u6eab 39.5\u2103\uff0c\u8acb\u554f\u75c5\u4eba\u7684\u8a3a\u65b7 \u6700\u4e0d\u53ef\u80fd \u70ba\u4e0b\u5217\u4f55\u8005\uff1f", + "Options": "(A)\u5b89\u975e\u4ed6\u547d\u3002 (B)\u4e09\u74b0\u6297\u6182\u9b31\u5291\u3002 (C)\u795e\u7d93\u6fc0\u80fa\u75c7\u5019\u7fa4( Serotonin syndrome )\u3002 (D)\u6709\u6a5f\u78f7\u8fb2\u85e5\u4e2d\u6bd2\u3002 (E)\u6297\u7cbe\u795e\u75c5\u85e5\u7269\u4e4b\u60e1\u6027\u75c7\u5019\u7fa4\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "28\u6b72\u5b55\u5a66\uff0c\u61f7\u5b55 35\u9031\uff0c\u81ea\u884c\u958b\u8eca\u524d\u5f80\u7522\u6aa2\u6642\uff0c\u56e0\u70ba\u524d\u8eca\u6025\u715e\u53cd\u61c9\u4e0d\u53ca\u649e\u4e0a\u524d\u8eca\uff0c\u5230\u9662\u6642\u610f\u8b58\u6e05\u9192\uff0c\u8840\u58d3 130/80mmHg \uff0c\u5fc3\u8df3 100\u6b21/min\uff0c\u547c\u5438 20\u6b21/min\uff0c\u7406\u5b78\u6aa2\u67e5\u767c\u73fe\u809a\u81cd\u4e0b\u6709\u4e00\u660e\u986f\u5b89\u5168\u5e36\u52d2\u75d5\u3002\u8acb\u554f\u5c0d\u65bc\u6b64\u4f4d\u60a3\u8005\u7684\u8a55\u4f30\u53ca\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u5b50\u5bae\u7834\u88c2\u662f\u76f8\u5c0d\u5c11\u898b\u7684\u4f75\u767c\u75c7\u3002\u7576\u5b50\u5bae\u7834\u88c2\u767c\u751f\u6642\uff0c\u80ce\u5152\u7684\u6b7b\u4ea1\u7387\u5927\u65bc\u6bcd\u89aa\u3002 (B)\u8d85\u97f3\u6ce2\u6aa2\u67e5\u6bd4\u80ce\u5152\u76e3\u6e2c\u66f4\u80fd\u5075\u6e2c\u80ce\u76e4\u525d\u96e2\u3002 (C)\u80ce\u76e4\u525d\u96e2\u662f\u50c5\u6b21\u65bc\u6bcd\u89aa\u6b7b\u4ea1\u9020\u6210\u80ce\u5152\u6b7b\u4ea1\u7684\u6700\u5e38\u898b\u539f\u56e0\u3002 (D)\u5728\u6bcd\u89aa\u72c0\u6cc1\u7a69\u5b9a\u5f8c\uff0c\u61c9\u76e1\u901f\u6703\u8a3a\u5a66\u7522\u79d1\u4ee5\u8a55\u4f30\u80ce\u5152\u72c0\u6cc1\uff0c\u7121\u8ad6\u662f\u5426\u6709\u7834\u6c34\u6216\u662f\u9670\u9053\u51fa\u8840\u7684\u60c5\u5f62\u3002 (E)\u5927\u90e8\u5206\u7684\u5a66\u7522\u79d1\u91ab\u5e2b\u8a8d\u70ba\uff0c\u524d 4\u500b\u5c0f\u6642\u7684\u76e3\u6e2c\u82e5\u662f\u6bcf\u500b\u5c0f\u6642\u7684\u5bae\u7e2e\u6b21\u6578\u5c0f\u65bc 3\u6b21\uff0c\u5b55\u5a66\u662f\u53ef\u4ee5\u51fa\u9662\u8fd4\u5bb6\u7684\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "29\u6b72\u5973\u6027\u61f7\u5b55 20\u9031\uff0c\u4f86\u6025\u8a3a\u4e3b\u8a34\u53f3\u4e0b\u8179\u75db\u5df2 2\u5929\u6642\u9593\uff0c\u4f86\u8a3a\u4e4b\u524d\u98df\u617e\u4e0d\u4f73\u3001\u5614\u5410\u6578\u6b21\uff0c\u5c1a\u7121\u8179\u7009\u3002\u751f\u547d\u5fb5\u8c61\u9ad4\u6eab 37\u2103\u3001\u5fc3\u8df3 108\u6b21/min\uff0c\u547c\u5438 20\u6b21/min\uff0c\u8840\u58d3 112/76mmHg \u3002\u7406\u5b78\u6aa2\u67e5\u767c\u73fe\u53f3\u4e0b\u8179\u6709\u660e\u986f\u58d3\u75db\uff0c\u4e14\u6709\u53cd\u5f48\u75db( rebound tenderness ) \u3002\u5be6\u9a57\u5ba4\u6aa2\u67e5\u767c\u73fe WBC 7,800/\u03bcL \uff0cNeutrophil 78%\uff0cHb 13 g/dL \uff0cPLT 242,000/\u03bcL \u3002Sugar 102mg/dL \uff0cCreatinine 0.8 mg/dL\uff0cAST 38 U/L \u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u6839\u64da modified Alvarado score \u53ef\u63a8\u4f30\u60a3\u8005\u7f79\u60a3\u95cc\u5c3e\u708e\u7684\u6a5f\u7387\u5c0f\u65bc10%\u3002 (B)\u8d85\u97f3\u6ce2\u6aa2\u67e5\u82e5\u767c\u73fe\u95cc\u5c3e\u7121\u6cd5\u58d3\u6241( non-compressible ) \uff0c\u4e14\u76f4\u5f91\u5927\u65bc3mm\u5247\u53ef\u78ba\u8a3a\u70ba\u95cc\u5c3e\u708e\u3002 (C)\u82e5\u5c0d\u5b55\u5a66\u9032\u884c\u8179\u90e8\u96fb\u8166\u65b7\u5c64\uff0c\u63a8\u4f30\u80ce\u5152\u7684\u8f3b\u5c04\u7dda\u5438\u6536\u5291\u91cf\u7d04\u70ba20~30\u96f7\u5f97( rad)\u3002 (D)\u6b64\u4f4d \u75c5\u4eba\u53ef\u4ee5\u9078\u64c7\u8179\u90e8\u78c1\u632f\u9020\u5f71( MRI)\u5e6b\u52a9\u8a3a\u65b7\u3002 (E)\u904e\u591a\u7684\u5f71\u50cf\u6aa2\u67e5\u6703\u5927\u5e45\u63d0\u5347\u95cc\u5c3e\u708e\u7a7f\u5b54\u7684\u6a5f\u6703\uff0c\u61c9\u65e9\u671f\u6703\u8a3a\u5916\u79d1\u91ab\u5e2b\u9032\u884c\u624b\u8853\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "2\u6b72\u5973\u7ae5\u767c\u71d2 5\u5929\uff0c\u6d41\u53e3\u6c34 \u3001\u820c\u982d\u3001\u7259\u9f66\u3001\u5634\u5507\u6709\u6f70\u760d \u3001\u53e3\u81ed\u3001\u9838\u90e8\u6dcb\u5df4\u7d50\u816b\u5927\u3001\u53f3\u624b\u62c7\u6307\u7d05\u816b\u6709\u6c34\u6ce1\uff0c\u8eab\u9ad4\u5176\u4ed6\u90e8\u4f4d\u6aa2\u67e5\u6b63\u5e38\uff0c\u8a3a\u6240\u7d66\u4e88\u53e3\u670dAmoxicillin \u5f8c\u4ecd\u767c\u71d2\u3002\u8acb\u554f \u6700\u53ef\u80fd\u7684\u75c5\u539f\u9ad4\u70ba\u4f55\uff1f", + "Options": "(A)\uff21\u7fa4\u93c8\u7403\u83cc( Group A streptococcus )\u3002 (B)\u514b\u6c99\u5947\u75c5\u6bd2( Coxsackievirus )\u3002 (C)\u91d1\u9ec3\u8272\u8461\u8404\u7403\u83cc( Staphylococcus aureus )\u3002 (D)\u55ae\u7d14\u75b1\u75b9\u75c5\u6bd2( Herpes simplex virus )\u3002 (E)\u817a\u75c5\u6bd2( Adenovirus )\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "30\u6b72\u5973\u6027\u88ab\u6d41\u6d6a\u8c93\u54ac\u50b7\u5f8c\u7531\u5bb6\u4eba\u966a\u540c\u5230\u6025\u8a3a\u8a3a\u6cbb\u3002 \u75c5\u4eba\u81ea\u8ff0\u570b\u5c0f\u7562\u696d\u4ee5\u5f8c\u5373\u4e0d\u66fe\u63a5\u53d7\u904e\u7834\u50b7\u98a8\u75ab\u82d7\u6ce8\u5c04\uff0c\u4ea6\u4e0d\u66fe\u63a5\u53d7\u72c2\u72ac\u75c5\u75ab\u82d7\u6ce8\u5c04\u3002\u50b7\u53e3\u6aa2\u8996\u767c\u73fe\u53f3\u524d\u81c2\u6709\u4e00\u8655 3\u516c\u5206\u6495\u88c2\u50b7\u3002\u6709\u95dc\u8c93\u54ac\u50b7\u4e4b\u8655\u7f6e\uff0c\u4e0b\u5217\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u521d\u7d1a\u7e2b\u5408\u6703\u589e\u52a0\u611f\u67d3\u6a5f\u6703\uff0c\u56e0\u6b64\u61c9\u9810\u9632\u6027\u4f7f\u7528\u6297\u751f\u7d20\u6cbb\u7642\u3002 (B)\u56e0\u5c6c\u7834\u50b7\u98a8\u611f\u67d3\u9ad8\u5371\u96aa\u50b7\u53e3\uff0c\u6545\u61c9\u65bd\u6253\u7834\u50b7\u98a8\u514d\u75ab\u7403\u86cb\u767d\u3002 (C)\u56e0\u53ef\u80fd\u611f\u67d3\u72c2\u72ac\u75c5\uff0c\u6545\u61c9\u65bd\u6253\u72c2\u72ac\u75c5\u75ab\u82d7\u81f3\u5c11 3\u5291\u3002 (D)\u5c6c\u9ad8\u611f\u67d3\u50b7\u53e3\uff0c\u5efa\u8b70\u4f7f\u7528\u6297\u751f\u7d20\uff0c\u9996\u9078\u85e5\u7269\u70ba Moxifloxacin \u3002 (E)\u50b7\u53e3\u8655\u7406\u5b8c\u5f8c\uff0c\u82e5\u672a\u5b89\u6392\u4f4f\u9662\uff0c\u5efa\u8b70\u61c9\u65bc 72\u5c0f\u6642\u5167\u56de\u9580\u8a3a\u8ffd\u8e64\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "35\u6b72\u7537\u6027\u75c5 \u4ebaHIV\u967d\u6027\uff0c\u6700\u8fd1 3\u500b\u6708\u672a\u4f9d\u91ab\u56d1\u670d\u85e5\uff0c\u4f86\u6025\u8a3a\u639b\u865f\u4e3b\u8a34\u6700\u8fd12\u9031\u6709\u767c\u71d2\u548c\u547c\u5438\u8d8a\u4f86\u8d8a\u5598\u7684\u75c7\u72c0\uff0c\u7576\u4ed6\u5230\u9054\u6025\u8a3a\u6642\uff0c\u751f\u547d\u5fb5\u8c61\uff1a\u5fc3\u8df3110\u6b21/min\uff0c\u8840\u58d3 135/75 mmHg\uff0c\u547c\u5438 22\u6b21/min\uff0c\u8840\u6c27\u6fc3\u5ea6 92%(room air) \uff0c\u73fe\u5728\u9ad4\u6eab\u6b63\u5e38\uff1b\u62bd\u8840\u5831\u544a\u5982\u4e0b\uff1a WBC 2,000/uL \uff1b\u80f8\u90e8 X\u5149\u767c\u73fe\u5169\u5074\u7030\u6f2b\u6027\u9593\u8cea\u6027\u6d78\u6f64( interstitial infiltrates ) \uff0c\u4e0b\u5217\u85e5\u7269\u4f55\u8005 \u4e0d\u9069\u5408\u7528\u65bc\u76ee\u524d\u75c5\u6cc1\u7684\u6cbb\u7642\uff1f", + "Options": "(A)Pentamidine \u3002 (B)Prednisone \u3002 (C)Pyrimethamine \u3002 (D)Sulfamethoxazole \u3002 (E)Trimethoprim \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "37\u6b72\u7537\u6027\u5728\u9580\u8a3a\u5c31\u91ab\uff0c\u6cbb\u7642\u601d\u89ba\u5931\u8abf\u75c7( Schizophrenia ) \uff0c\u670d\u7528\u85e5\u7269\u70baSeroquel 100mg \u8207Lexotan(bromazepam )3mg(\u7761\u524d\u670d\u7528\u5404 1\u9846) \uff0c\u5e7e\u65e5\u5f8c\u610f\u8b58\u4e0d\u6e05\uff0c\u5168\u8eab\u50f5\u786c\u800c\u9001\u91ab\u3002\u91cf\u6e2c\u7684\u751f\u547d\u5fb5\u8c61\u5982 \u4e0b\uff1a GCS E4M4V1 \u3001\u8840\u58d3 85/51 mmHg \u3001\u5fc3\u8df3 168\u6b21/min\u3001\u9ad4\u6eab 40.2\u2103\u3001\u547c\u5438 22\u6b21/min\u3001SpO 2 94%\u3002\u4e24\u5074\u77b3\u5b54\u7686\u70ba 3.5mm\u3002\u5176\u4ed6\u8eab\u9ad4\u6aa2\u67e5\u767c\u73fe\uff0c DTR\uff1ahyporeflexia, Babinski sign (-)\u3001Rigidity\uff1a(+)\u56db\u80a2\u5747\u76f8\u4f3c\u3001\u76dc\u6c57\u3002\u96fb\u8166\u65b7\u5c64\u7121\u660e\u986f\u7570\u5e38\uff0c\u5fc3\u96fb\u5716\u70ba\u7ac7\u6027\u983b\u8108\u3002\u62bd\u8840\u6aa2\u9a57\u53c3\u8003 \uff1aCK 319 U/L \u3001Cr 1.3 mg/dL \u3001Na 122 mEq/L \u3001AST 94 U/L \u3001ALT 126 U/L \u3002\u5728\u7591\u4f3c\u4e2d\u6bd2\u7684\u60c5\u6cc1\u4e0b\uff0c\u4e0b\u5217\u4f55\u7a2e\u8a3a\u65b7\u6b63\u78ba\uff1f", + "Options": "(A)Cholinergic toxidrome \u3002 (B)Anticholinergic toxidrome \u3002 (C)Sympathomimetics \u3002 (D)Serotonin syndrome \u3002 (E)Neuroleptic malignant syndrome \u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "38\u6b72\u5973\u6027\u75c5\u4eba\u56e0\u610f\u8b58\u969c\u7919\uff0c\u88ab\u5bb6\u4eba\u9001\u81f3\u6025\u8a3a\u3002\u75c5\u4eba\u5448\u73fe\u55dc\u7761\u3002\u8840\u7cd6\u6b63\u5e38\uff0c\u7121\u85e5\u7269\u53f2\u3002\u64da\u5bb6\u4eba\u63cf\u8ff0\uff0c\u75c5\u4eba 6\u5e74\u524d\u751f\u7b2c\u4e8c\u80ce\u6642\u7121\u6cd5\u54fa\u4e73\u3002\u7406\u5b78\u6aa2\u67e5\u767c\u73fe\u81c9\u8272\u84bc\u767d\uff0c\u8840\u58d3 90/60 mmHg, \u5fc3\u8df3 64\u6b21/min\uff0c\u547c\u5438 14\u6b21/min\u3002\u9ad4\u6bdb\u6e1b\u5c11\u3002\u5be6\u9a57\u5ba4\u6aa2\u67e5\u767c\u73fe Hb 8.8 g/dl \uff0cNa 124 mEq/L \u3002\u4ee5\u4e0b\u8655\u7f6e\uff0c\u4f55\u8005\u6700\u70ba \u9069\u7576\uff1f", + "Options": "(A)\u7d66\u4e88 3% NaCl \u9ede\u6ef4\u5f8c\uff0c\u82e5\u8840\u9209\u6b63\u5e38\uff0c\u610f\u8b58\u6e05\u9192\uff0c\u53ef\u51fa\u9662\u56de\u5bb6\u3002\u4e26\u9f13\u52f5\u75c5\u4eba\u591a\u651d\u53d6\u9e7d\u4efd\u3002 (B)\u7d66\u4e88\u8f38\u8840 packed RBC\u4e8c\u55ae\u4f4d\uff0c\u82e5\u7121\u660e\u986f\u51fa\u8840\u6e90\uff0c\u4e14\u8840\u7d05\u7d20\u6539\u5584\uff0c\u53ef\u51fa\u9662\u56de\u5bb6\u3002 (C)\u75c5 \u4eba\u6240\u6709\u8868\u73fe\u53ef\u7528\u814e\u4e0a\u817a\u4f4e\u80fd\u75c7\u4f86\u89e3\u91cb\uff0c\u7d66\u4e88\u814e\u4e0a\u817a\u76ae\u9187\u5f8c\uff0c\u53ef\u51fa\u9662\u56de\u5bb6\u3002 (D)\u6b64\u75c5 \u4eba\u53ef\u80fd\u70ba Sheehan's syndrome \uff0c\u9808\u505a\u8166\u5782\u9ad4\u4f4e\u80fd\u75c7\u6aa2\u67e5\u53ca\u6cbb\u7642\u3002 (E)\u6b64\u75c5 \u4eba\u56e0\u5448\u73fe\u4f11\u514b\uff0c\u61c9\u5148\u7d66\u4e88 Dopamine \u6cbb\u7642\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "39\u6b72\u7537\u6027\uff0c\u904e\u53bb\u6709\u9577\u671f \u7672\u7647\u75c5\u53f2 \uff0c\u4eca\u65e5\u5728\u5bb6\u4e2d\u88ab\u5bb6\u5c6c\u767c\u73fe\u6709\u7672\u7647\u767c\u4f5c\uff0c\u7576\u75c5\u4eba\u88ab\u5e36\u81f3\u6025\u8a3a\u6642\u610f\u8b58\u5df2\u5b8c\u5168\u6e05\u9192\uff0c\u95dc\u65bc\u6b64\u75c5\u4eba\u4e4b\u8655\u7f6e\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u985e\u4f3c\u6b64\u75c5\u4eba\u5f88\u591a\u662f\u56e0\u70ba\u672a\u898f\u5247\u670d\u7528\u6297\u7672\u7647\u85e5\u7269\u6240\u81f4\u3002 (B)\u61f7\u7591\u75c5\u4eba\u662f\u56e0\u672a\u898f\u5247\u670d\u7528\u6297\u7672\u7647\u85e5\u7269\uff0c\u5728\u6295\u4e88\u6297\u7672\u7647\u85e5\u7269\u8d77\u59cb\u5291\u91cf(loading dose )\u524d\uff0c\u9700\u6aa2\u6e2c\u8840\u6e05\u4e2d\u6297\u7672\u7647\u85e5\u7269\u4e4b\u6fc3\u5ea6\u3002 (C)\u82e5\u75c5\u4eba\u8840\u6e05\u4e2d\u6297\u7672\u7647\u85e5\u7269\u4e4b\u6fc3\u5ea6\u9069\u7576\uff0c\u9700\u8003\u91cf\u7d66\u4e88\u88dc\u5145\u5291\u91cf(supplemental dose )\u4ee5\u907f\u514d\u7672\u7647\u518d\u6b21\u767c\u4f5c\u3002 (D)\u7e31\u4f7f\u662f\u4f7f\u7528\u6297\u7672\u7647\u85e5\u7269\u63a7\u5236\u826f\u597d\u4e4b\u7672\u7647\u75c5\u4eba\uff0c\u9084\u662f\u6703\u6709\u5076\u767c\u6027\u7684\u7672\u7647\u767c\u4f5c\u3002 (E)\u76ee\u524d\u7121\u5be6\u8b49\u7684\u6e96\u5247\u4f86\u6c7a\u5b9a\u8a72\u75c5\u4eba\u9700\u65bc\u6025\u8a3a\u7559\u89c0\u6642\u9593\u7684\u9577\u77ed\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "40\u6b72\u5973\u6027\u7591\u4f3c\u670d\u7528\u85e5\u7269\u5f8c\u4e0a\u540a\uff0c\u9001\u81f3\u6025\u8a3a\u6642\u5df2\u7121\u751f\u547d\u5fb5\u8c61\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u4f9d\u7167\u4e0a\u540a\u4e4b\u65b9\u5f0f\uff0c\u82e5\u8eab\u9ad4\u9a30\u7a7a\u4e14\u8173\u6c92\u6709\u89f8\u5730\u7a31\u70ba complete\uff0c\u5176\u4ed6\u7a2e\u5747\u7a31\u70ba incomplete \u3002 (B)\u9020\u6210\u6b7b\u4ea1\u901a\u5e38\u662f 3\u7a2e\u56e0\u7d20\uff1a\u810a\u9ad3\u6216\u8166\u5e79\u53d7\u640d\u3001\u9838\u90e8\u69cb\u9020\u53d7\u5230\u58d3\u8feb\u6216\u5fc3\u640f\u904e\u6162\u5c0e\u81f4\u5fc3\u8df3\u505c\u6b62\u3002 (C)\u82e5\u4e0a\u540a\u4e4b\u9ad8\u5ea6\u5927\u65bc\u6216\u7b49\u65bc\u60a3\u8005\u4e4b\u8eab\u9ad8\uff0c\u6b7b\u4ea1\u4e4b\u539f\u56e0\u61c9\u70ba\u58d3\u8feb\u4e4b\u58d3\u529b\u904e\u5927\uff0c\u5c0e\u81f4\u9838\u90e8\u5167\u90e8\u8840\u7ba1\u58d3\u8feb\u56e0\u800c\u8166\u6b7b\u3002 (D)\u5fc3\u640f\u904e\u6162\u662f\u56e0\u70ba\u4e0a\u540a\u4e4b\u58d3\u529b\u523a\u6fc0 carotid sinus \u5c0e\u81f4 vagal tone \u589e\u52a0\u6240\u81f4\u3002 (E)\u82e5\u7121\u6cd5\u6392\u9664\u9838\u690e\u640d\u50b7\uff0c\u6700\u597d\u4f7f\u7528\u9838\u5708\u56fa\u5b9a\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "50\u6b72\u7537\u6027\uff0c\u56e0\u70ba\u5de6\u819d\u95dc\u7bc0\u75bc\u75db\u81f3\u6025\u8a3a\u6c42\u8a3a\uff0c\u819d\u95dc\u7bc0\u62bd\u5438\u6642\u767c\u73fe\u984f\u8272\u9ec3\u6fc1\u4e14\u5be6\u9a57\u5ba4\u5206\u6790\u70ba\uff1a WBC 15,000/\u03bcL \uff0cPMN 70% \u3002\u91dd\u5c0d\u6b64\u75c5\u4eba\uff0c\u4ee5\u4e0b\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u6b64\u75c5\u4eba\u53ef\u80fd\u70ba\u6557\u8840\u6027\u95dc\u7bc0\u708e\uff0c\u6700\u5e38\u898b\u7684\u81f4\u75c5\u83cc\u70ba\u6dcb\u75c5\u96d9\u7403\u83cc\u3002 (B)\u6b64\u75c5\u4eba\u53ef\u80fd\u70ba\u840a\u59c6\u75c5( Lyme disease ) \uff0c\u5e38\u5408\u4f75\u8868\u73fe\u5c3f\u9053\u708e\u53ca\u7d50\u819c\u708e\u3002 (C)\u975e\u985e\u56fa\u9187\u6027\u6297\u767c\u708e\u85e5\u7269\u91dd\u5c0d\u95dc\u7bc0\u75bc\u75db\u6709\u5f88\u597d\u7684\u7642\u6548\uff0c\u61c9\u5e38\u898f\u4f7f\u7528\u3002 (D)\u82e5\u75c5\u4eba\u525b\u5f9e\u71b1\u5e36\u5730\u5340\u65c5\u904a\u56de\u4f86\u4e14\u5408\u4f75\u8768\u5b50\u53ee\u54ac\u7684\u75c5\u53f2\uff0c\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\u662f\u53cd\u61c9\u6027\u95dc\u7bc0\u708e\u3002 (E)\u8a72\u75c5\u4eba\u53ef\u80fd\u70ba\u6025\u6027\u75db\u98a8\u767c\u4f5c\uff0c\u7d04\u6709\u4e09\u6210\u7684\u75c5\u4eba\u5176\u8840\u4e2d\u5c3f\u9178\u503c\u843d\u65bc\u6b63\u5e38\u7bc4\u570d\u5167\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "58\u6b72\u7537\u6027\u5f9e 3\u6a13\u9ad8\u8dcc\u843d\uff0c\u5728\u6025\u8a3a\u7684\u8840\u58d3 80/40mmHg \u3001\u5fc3\u8df3 120\u6b21/min\u3001\u547c\u543820\u6b21/min\u3001O2\u98fd\u548c\u6fc3\u5ea6\uff1a 88%\u3001GCS E1M4V1 \uff0c\u8166\u90e8\u96fb\u8166\u65b7\u5c64\u5448\u73fe\u53f3\u5074\u9871\u5167\u51fa\u8840\u4e26\u4e2d\u7dda\u504f\u79fb( right intraparenchymal hemorrhage with right to left midline shift ) \uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005 \u4e0d\u5b9c\uff1f", + "Options": "(A)\u6c23\u7ba1\u5167\u7ba1\u63d2\u7ba1\u3002 (B)\u904e\u5ea6\u901a\u6c23( PaCO 2 35mmHg )\u4e0d\u5b9c\u7dad\u6301\u592a\u4e45\u3002 (C)\u4f7f\u7528 mannitol \u964d\u8166\u58d3( intracranial pressure )\u3002 (D)\u53ef\u8003\u616e\u4f7f\u7528\u9ad8\u5f35\u529b\u8f38\u6db2( hypertonic saline )\u964d\u8166\u58d3\u3002 (E)\u4e0d\u4f7f\u7528 barbiturates \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "6\u6b72\u5c0f\u7ae5\u56e0\u8179\u75db\u3001\u8179\u7009 1\u9031\u7121\u767c\u71d2\u800c\u4f86\u5230\u6025\u8a3a\u6c42\u8a3a\uff0c\u5be6\u9a57\u5ba4\u6aa2\u67e5\uff1a WBC 3,000/\u03bcL(4,000\uff5e10,000)\uff0cHb 6.0 g/dL(12\uff5e16)\uff0cPLT 100K/\u03bcL (150K\uff5e400K)\uff0cBUN 235mg/dL \uff0cCr 20.0mg/dL \uff0c\u8a3a\u65b7\u70ba\u611f\u67d3\u6027\u8179\u7009\uff0c\u6709\u95dc\u6b64\u75be\u75c5\u4e4b\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u611f\u67d3\u6027\u8179\u7009\u901a\u5e38\u5e36\u6709\u8840\u7d72\u3002 (B)\u6b64\u75be\u75c5\u75c5\u539f\u9ad4\u4ee5 Shiga toxin -producing E.coli \u6700\u5e38\u898b\u3002 (C)\u6b64\u75c5\u4eba\u9700\u88dc\u5145\u7d05\u8840\u7403\u6fc3\u539a\u7e2e\u6db2\u53ca\u8840\u5c0f\u677f\u3002 (D)\u75c5\u4eba\u63a5\u53d7\u8840\u6db2\u900f\u6790( hemodialysis )\u75be\u75c5\u5f97\u4ee5\u6539\u5584\u3002 (E)\u6b64\u75be\u75c5\u9808\u9810\u9632\u6027\u6295\u4e88\u6297\u751f\u7d20\u6cbb\u7642\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "70 \u6b72\u7537\u6027\u75c5\u4eba\u56e0\u6025\u6027\u5fc3\u808c\u6897\u585e\u5165\u9662\u63a5\u53d7\u8840\u6813\u6eb6\u89e3\u6cbb\u7642\uff0c\u4f4f\u9662\u7b2c 5\u5929\u51fa\u73fe\u767c\u71d2\u3001\u80f8\u53e3\u60b6\u75db\u3001\u547c\u5438\u4e0d\u9806\u66a2\u4e14\u4e0b\u80a2\u51fa\u73fe\u6df1\u975c\u8108\u8840\u6813\u3002\u8840\u58d3 170/90 mmHg\u3001\u5fc3\u8df3 120\u6b21/min\u3001\u547c\u5438 26\u6b21/min\u3001\u9ad4\u6eab 38.0\u2103\u3002\u6709\u95dc\u6b64\u75c5\u4eba\u53ef\u80fd\u51fa\u73fe\u7684\u75c7\u72c0\u53ca\u5fb5\u5019\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u6b64\u75c5\u4eba\u4f7f\u7528 heparin\u7b2c5\u5929\uff0c\u8840\u5c0f\u677f\u8a08\u6578\u53ef\u80fd\u5728 50,000\u81f360,000/\u03bcL \u3002 (B)\u6b64\u75c5\u8f03\u5e38\u767c\u751f\u5728\u4f7f\u7528\u4f4e\u5206\u5b50\u91cf\u809d\u7d20( low-molecular -weight heparin )\u7684\u75c5\u4eba\u3002 (C)\u505c\u7528\u6297\u51dd\u8840\u5291 heparin 1\u9031\u5f8c\uff0c\u8840\u5c0f\u677f\u53ef\u6062\u5fa9\u6b63\u5e38\u8a08\u6578\u3002 (D)\u505c\u7528\u6297\u51dd\u8840\u5291 heparin\uff0c\u53ef\u6539\u7528\u9078\u64c7\u6027\u7b2c Xa\u56e0\u5b50\u6291\u5236\u5291Fondaparinux \u3002 (E)\u6b64\u75c5\u767c\u751f\u7387 0.5\uff5e5.0%\uff0c1\u500b\u6708\u5167\u7684\u6b7b\u4ea1\u7387\u53ef\u9054 20\uff5e30%\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "70\u6b72\u5931\u667a\u7537\u6027\uff0c\u4e4b\u524d\u66fe\u5fc3\u5f8b\u4e0d\u6574\u4f75\u6709\u5fc3\u96fb\u5716 QTc\u5ef6\u9577\u73fe\u8c61\uff0c\u56e0\u5728\u5bb6\u4e2d\u7a81\u7136\u8e81\u52d5\u88ab\u5e36\u5165\u6025\u8a3a\u5ba4\uff0c\u7d93\u81e8\u5e8a\u8a55\u4f30\u5f8c\u60a3\u8005\u9700\u4f7f\u7528\u93ae\u975c\u85e5\u7269\uff0c\u8acb\u554f\u4e0b\u5217\u85e5\u7269\u9078\u64c7\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)Loraxepam (Ativan)1\uff5e2 mg IM/IV \u3002 (B)Halperidol (Holdol)2\uff5e5 mg IM/IV \u3002 (C)Droperidol (Inapsine)2.5 mg IM/IV \u3002 (D)Olanzapine (Zyprexa)10 mg IM \u3002 (E)Ziprasidone (Geodon)20 mg IM \u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "70\u6b72\u7537\u6027\uff0c\u904e\u53bb\u7121\u5438\u83f8\u53f2\uff0c\u6b64\u6b21\u56e0\u54b3\u55fd 1\u500b\u6708\u90fd\u6c92\u6539\u5584\u4e14\u6709\u904b\u52d5\u5f8c\u547c\u5438\u56f0\u96e3( exertional dyspnea )\u72c0\u6cc1\uff0c\u6545\u81f3\u6025\u8a3a\u5c31\u91ab\uff0c\u80f8\u90e8 X\u5149\u6aa2\u67e5\u986f\u793a\u53f3\u5074\u6709\u4e2d\u91cf\u808b\u819c\u7a4d\u6db2\uff0c\u4ee5\u7d30\u91dd\u62bd\u5438\u5f8c\u6aa2\u9a57\u767c\u73fe\u808b\u819c\u7a4d\u6db2\u7684 total protein \u70ba4.8 g/dL\uff0cLDH\u70ba228 U/L\uff0c\u540c\u6642\u75c5\u4eba\u8840\u6db2\u4e2d\u7684 total protein \u70ba5.8 g/dL(\u6b63\u5e38\u7bc4\u570d\u70ba 6.4\uff5e8.4 g/dL)\uff0cLDH\u70ba273 U/L(\u6b63\u5e38\u7bc4\u570d\u70ba 131\uff5e250 U/L) \uff0c\u6709\u95dc\u53ef\u80fd\u75be\u75c5\u7684\u9451\u5225\u8a3a\u65b7\uff0c\u4e0b\u5217\u9451\u5225\u8a3a\u65b7\u4f55\u8005 \u53ef\u80fd\u6027\u6700\u4f4e\uff1f", + "Options": "(A)\u80ba\u708e\u3002 (B)\u5fc3\u81df\u8870\u7aed\u3002 (C)\u80ba\u90e8\u60e1\u6027\u816b\u7624\u3002 (D)\u80ba\u7d50\u6838\u75c5\u808b\u819c\u7a4d\u6c34\u3002 (E)\u81bf\u80f8\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "77\u6b72\u7537\u6027\u5728\u9580\u8a3a\u5c31\u91ab\uff0c\u6cbb\u7642\u5df4\u91d1\u68ee\u6c0f\u75c7( Parkisonism ) \uff0c\u670d\u7528\u85e5\u7269\u70baMadopar (levodopa)250mg 1# tid, Enzil (amantadine )100mg \u00bd # bid \u3002\u904e\u53bb\u75c5\u53f2\uff1a\u5c3f\u6bd2\u75c7\u63a5\u53d7\u8840\u6db2\u900f\u6790\uff0c\u5fc3\u81df\u66fe\u63a5\u53d7\u7e5e\u9053\u624b\u8853\u3002\u75c5\u4eba\u56e0\u610f\u8b58\u4e0d\u6e05\u767c\u71d2\uff0c\u5168\u8eab\u50f5\u786c\u800c\u9001\u91ab\u3002\u91cf\u6e2c\u7684\u751f\u547d\u5fb5\u8c61\u5982\u5217\uff0c GCS E4M6V5 (\u4f46\u662f\u7121\u6cd5\u8aaa\u51fa\u6b63\u78ba\u5730\u9ede\u5224\u65b7) \uff0c\u8840\u58d3 162/76 mmHg \uff0c \u5fc3\u8df3 84\u6b21/min\uff0c\u9ad4\u6eab 39.2\u2103\uff0c\u547c\u543816\u6b21/min\uff0cSpO 2 96%\u3002\u77b3\u5b54\u5927\u5c0f\u5de6\u53f3\u5074\u7686\u70ba 3.0mm\u3002Babinski sign(-)\uff0cRigidity\uff1a(+)\u56db\u80a2\u5747\u76f8\u4f3c\u3002\u6c92\u6709\u660e\u986f\u611f\u67d3\u5fb5\u8c61\uff0c\u96fb\u8166\u65b7\u5c64\u7121\u660e\u986f\u7570\u5e38\uff0c\u5fc3\u96fb\u5716\u7121\u660e\u986f\u7570\u5e38\u3002\u62bd\u8840\u6aa2\u9a57\u53c3\u8003\uff1a CK 319U/L \uff1bCr 1.3mg/dL \uff1bNa 142mEq/L \uff1bAST 20U/L \uff1bWBC 9,450 \u00b5/L\u3002\u5728\u7591\u4f3c\u4e2d\u6bd2\u7684\u60c5\u6cc1\u4e0b\uff0c\u4e0b\u5217\u4f55\u7a2e\u8a3a\u65b7\u6b63\u78ba\uff1f", + "Options": "(A)Cholinergic toxidrome \u3002 (B)Anticholinergic toxidrome \u3002 (C)Sympathomimetics \u3002 (D)Serotonin syndrome \u3002 (E)Neuroleptic malignant syndrome \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "9\u500b\u6708\u5973\u7ae5(\u9ad4\u91cd 10\u516c\u65a4)\u5728\u5bb6\u6301\u7e8c\u6709\u9663\u767c\u6027\u8179\u75db\u54ed\u9b27\u60c5\u5f62\uff0c\u56e0\u767c\u751f\u8840\u4fbf\u88ab\u9001\u4f86\u6025\u8a3a\uff0c\u7dca\u6025\u5b89\u6392\u8179\u90e8 X\u5149\u53ca\u8179\u90e8\u8d85\u97f3\u6ce2\u6aa2\u67e5\uff0c\u7591\u4f3c\u6709\u8178\u963b\u585e\u60c5\u6cc1\uff0c\u60a8\u5224\u65b7\u662f\u8178\u5957\u758a\u53ef\u80fd\u6027\u6975\u9ad8\uff0c\u4e0b\u5217\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u75c7\u72c0\u82e5\u70ba 24\u5c0f\u6642\u4ee5\u5167\uff0c\u5efa\u8b70\u512a\u5148\u63a1\u7528\u975e\u624b\u8853\u65b9\u5f0f\u3002 (B)\u6709\u8179\u819c\u708e\u8de1\u8c61\u6642\u4e0d\u53ef\u9032\u884c\u7a7a\u6c23\u5fa9\u4f4d( air reduction ) \uff0c\u6015\u58d3\u529b\u5c0e\u81f4\u8178\u7a7f\u5b54\u3002 (C)\u51fa\u8840\u91cf\u591a\u4e14\u6709\u5faa\u74b0\u4e0d\u8db3\u75c7\u72c0\u6642\uff0c\u8981\u5118\u901f\u7d66\u4e88 Normal Saline 200 mL\uff0c\u4e26\u6e96\u5099\u8f38\u8840\u3002 (D)\u8840\u4fbf\u662f\u8178\u5957\u758a\u4e4b\u665a\u671f\u75c7\u72c0\uff0c\u4e5f\u662f\u63a1\u53d6\u7a7a\u6c23\u5fa9\u4f4d( air reduction )\u4e4b\u7981\u5fcc\u75c7( contraindication )\u3002 (E)\u82e5\u7a7a\u6c23\u5fa9\u4f4d( air reduction )\u5931\u6557\uff0c\u9700\u8981\u91cd\u65b0\u8a55\u4f30\u662f\u5426\u70ba incarcerated hernia\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "EMT\u5c071\u540d\u56b4\u91cd\u71d9\u50b7\u75c5\u4eba\u5f9e\u706b\u5834\u6551\u51fa\uff0c\u5c31\u8fd1\u9001\u81f3\u67d0\u91cd\u5ea6\u7d1a\u6025\u6551\u8cac\u4efb\u91ab\u9662\u6025\u8a3a\uff0c\u7d93\u6025\u6551\u5f8c\uff0c\u56e0\u8a72\u9662\u7121\u71d2\u50b7\u52a0\u8b77\u75c5\u623f\uff0c\u6025\u8a3a\u91ab\u5e2b\u64ec\u5c07\u75c5\u4eba\u8f49\u51fa\uff0c\u537b\u627e\u4e0d\u5230\u9130\u8fd1\u91ab\u9662\u6709\u71d2\u50b7\u52a0\u8b77\u75c5\u623f\u53ef\u7528\uff0c\u5f8c\u5bb6\u5c6c\u5805\u6301\u8f49\u81f3 A\u91ab\u5b78\u4e2d\u5fc3\u6025\u8a3a\uff0c\u8acb\u554f\u4e0b\u5217\u4f55\u8005\u70ba \u6b63\u78ba\uff1f", + "Options": "(A)\u6025\u8a3a\u91ab\u5e2b\u61c9\u53bb\u96fb\u8a72\u5340\u5340\u57df\u7dca\u6025\u91ab\u7642\u61c9\u8b8a\u4e2d\u5fc3( rROC) \uff0c\u8981\u6c42\u5354\u52a9\u8f49\u8a3a\u3002 (B)\u8f49\u51fa\u524d\uff0c\u91ab\u5e2b\u61c9\u586b\u5177\u7dca\u6025\u50b7\u75c5\u8f49\u8a3a\u55ae\u3002 (C)\u6b64\u6848\u4f8b\u61c9\u5c6c\u81ea\u52d5\u51fa\u9662\uff0c\u91ab\u5e2b\u7121\u9808\u806f\u7e6b A\u91ab\u5b78\u4e2d\u5fc3\u6025\u8a3a\u3002 (D)\u5371\u6025\u500b\u6848\uff0c\u8a72\u9662\u70ba\u91cd\u5ea6\u7d1a\u6025\u6551\u8cac\u4efb\u91ab\u9662\uff0c\u8f49\u9662\u5be6\u5c6c\u4e0d\u7576\u3002 (E)\u8a72\u6848\u70ba\u5bb6\u5c6c\u5805\u6301\u8f49\u9662\uff0c\u4e0d\u5c6c\u65bc\u7dca\u6025\u91ab\u7642\u6551\u8b77\u6cd5\u898f\u7bc4\u500b\u6848\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4e00\u4f4d\u9152\u766e\u5408\u4f75\u809d\u786c\u5316 \u75c5\u4eba\uff0c\u56e0\u70ba\u98df\u9053\u66f2\u5f35\u51fa\u8840\u800c\u5165\u6025\u8a3a\uff0c\u6b63\u5728\u7981\u98df\u8207\u63a5\u53d7\u85e5\u7269\u6cbb\u7642\uff0c\u65bc\u5165\u6025\u8a3a\u7b2c 24\u5c0f\u6642\u51fa\u73fe\u60c5\u7dd2\u6fc0\u52d5\u3001\u76dc\u6c57\u3001\u624b\u6296\u3001\u982d\u75bc\u3001\u8840\u58d3\u4e0a\u5347\u3001\u7672\u7647\u3001\u4ee5\u53ca\u8996\u5e7b\u89ba (visual hallucination ) \uff0c\u6b64\u75c5\u4eba\u4e4b\u8655\u7f6e\uff0c\u4ee5\u4e0b\u6558\u8ff0\u4f55\u8005\u70ba \u932f\u8aa4\uff1f", + "Options": "(A)\u7b26\u5408\u9152\u7cbe\u6212\u65b7\u75c7\u72c0\u5408\u4f75\u7672\u7647\u7684\u8a3a\u65b7\uff0c\u4f46\u4ecd\u9700\u9032\u884c\u8a73\u76e1\u4e4b\u8eab\u9ad4\u6aa2\u67e5\u53ca\u9451\u5225\u8a3a\u65b7\u3002 (B)\u9152\u7cbe\u6212\u65b7\u75c7\u72c0\u5408\u4f75\u7672\u7647\u8655\u7f6e\u4ee5 Benzodiazepines \u70ba\u9996\u9078\u3002 (C)\u53ef\u4f7f\u7528 Haloperidol \u4f86\u6cbb\u7642\u9152\u7cbe\u6212\u65b7\u5408\u4f75\u7684\u5e7b\u89ba( hallucination )\u3002 (D)\u53ef\u4f7f\u7528\u6297\u7672\u7647\u85e5(\u5982 phenytoin )\u4f86\u9810\u9632\u518d\u6b21\u51fa\u73fe\u9152\u7cbe\u6212\u65b7\u7684\u7672\u7647\u3002 (E)Benzodiazepines \u7684\u4f7f\u7528\u53ef\u964d\u4f4e\u9152\u7cbe\u6212\u65b7\u5408\u4f75\u77bb\u5984( Delirium)\u7684\u767c\u751f\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u6709\u95dc\u8179\u7009\u7684\u8aaa\u660e\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u5927\u90e8\u5206\u8179\u7009\u5c6c\u65bc\u975e\u611f\u67d3\u6027\u8179\u7009\uff0c\u611f\u67d3\u6027\u8179\u7009\u75c5\u539f\u5247\u591a\u70ba\u75c5\u6bd2\u6240\u5f15\u8d77\u3002 (B)\u8001\u5e74\u4eba\u8178\u7cfb\u819c\u7f3a\u8840\u5c11\u65bc 10%\u4ee5\u8179\u7009\u8868\u73fe\uff0c\u5e74\u8f15\u4eba\u6301\u7e8c\u6027\u8179\u7009\u5247\u9808\u8003\u616e\u6027\u884c\u70ba\u611f\u67d3\u3002 (C)\u8840\u6db2\u751f\u5316\u6aa2\u67e5\u548c\u5168\u8840\u7403\u8a08\u6578\u5c0d\u65bc\u8179\u7009\u8a3a\u65b7\u5e38\u6709\u5e6b\u52a9\u3002 (D)Wright stain \u7528\u4f86\u6aa2\u6e2c\u7cde\u4fbf\u4e2d\u7684\u767d\u8840\u7403\uff0c\u5176\u967d\u6027\u53cd\u61c9\u6642\u7d04\u6709 8\u6210\u80fd\u57f9\u990a\u51fa\u75c5\u539f\u83cc\u3002 (E)\u7cde\u4fbf\u82e5\u5e36\u8840\uff0c\u901a\u5e38\u4e0d\u9700\u8981\u518d\u505a\u7cde\u4fbf\u7d30\u83cc\u57f9\u990a\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u4f55\u7a2e\u65b9\u5f0f\u5230\u7389\u5c71\u5317\u5cf0(\u9ad8\u5ea6 3,850\u516c\u5c3a) \uff0c\u7576\u665a\u4f4f\u7389\u5c71\u5317\u5cf0\uff0c\u767c\u751f\u56b4\u91cd\u9ad8\u6d77\u62d4\u75be\u75c5( high altitude illness )\u4e4b\u98a8\u96aa \u6700\u9ad8\uff1f", + "Options": "(A)\u7531\u5e73\u5730\u5750\u76f4\u5347\u6a5f\u76f4\u63a5\u5230\u7389\u5c71\u5317\u5cf0\u3002 (B)\u7531\u5357\u6295\u7e23\u6771\u57d4\u6eab\u6cc9(\u9ad8\u5ea6 1,100\u516c\u5c3a) \uff0c\u7d93\u516b\u901a\u95dc\u53e4\u9053\u8d70\u5230\u89c0\u9ad8(\u9ad8\u5ea62,800\u516c\u5c3a) \uff0c\u7b2c 1\u665a\u4f4f\u89c0\u9ad8\uff0c\u7b2c 2\u5929\u518d\u7531\u89c0\u9ad8\u8d70\u5230\u7389\u5c71\u5317\u5cf0\u3002 (C)\u7531\u53f0\u5317\u51fa\u767c\uff0c\u5750\u591c\u8eca\u5230\u7389\u5c71\u570b\u5bb6\u516c\u5712\u5854\u5854\u52a0\uff0c\u6e05\u6668\u7531\u5854\u5854\u52a0\u767b\u5c71\u53e3(\u9ad8\u5ea6 2,600\u516c\u5c3a) \uff0c\u8d70\u5230\u6392\u96f2\u5c71\u838a(\u9ad8\u5ea6 3,402\u516c\u5c3a) \uff0c\u7b2c 3\u5929\u518d\u7531\u6392\u96f2\u5c71\u838a\u8d70\u5230\u7389\u5c71\u5317\u5cf0\u3002 (D)\u7531\u53f0\u5317\u51fa\u767c\uff0c\u5750\u8eca\u7b2c 1\u665a\u4f4f\u5728\u963f\u91cc\u5c71\u9752\u5e74\u6d3b\u52d5\u4e2d\u5fc3(\u9ad8\u5ea6 2,000\u516c\u5c3a) \uff0c\u6e05\u6668\u7531\u5854\u5854\u52a0\u767b\u5c71\u53e3\uff0c\u8d70\u5230\u6392\u96f2\u5c71\u838a\uff0c\u7b2c 3\u5929\u518d\u7531\u6392\u96f2\u5c71\u838a\u8d70\u5230\u7389\u5c71\u5317\u5cf0\u3002 (E)\u7531\u53f0\u4e2d\u51fa\u767c\uff0c\u5750\u8eca\u7b2c 1\u665a\u4f4f\u5728\u6771\u57d4\u5c71\u838a(\u9ad8\u5ea6 2,500\u516c\u5c3a) \uff0c\u6e05\u6668\u7531\u5854\u5854\u52a0\u767b\u5c71\u53e3\uff0c\u8d70\u5230\u6392\u96f2\u5c71\u838a\uff0c\u7b2c 3\u5929\u518d\u7531\u6392\u96f2\u5c71\u838a\u8d70\u5230\u7389\u5c71\u5317\u5cf0\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u4f55\u7a2e\u96fb\u89e3\u8cea\u7570\u5e38 \u4e0d\u6703\u51fa\u73fe\u5728\u4e2d\u6691( heat stroke )\u75c5\u4eba\uff1f ", + "Options": "(A)\u9ad8\u8840\u9209\u3002 (B)\u9ad8\u8840\u9240\u3002 (C)\u9ad8\u8840\u9223\u3002 (D)\u4f4e\u8840\u9209\u3002 (E)\u4f4e\u8840\u9240\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u4f55\u7a2e\u9178\u6027\u6db2\u9ad4\u707c\u50b7 \u9700\u8003\u616e\u6ce8\u5c04\u9223\u96e2\u5b50\u6eb6\u6db2\u4f86\u6cbb\u7642\uff1f", + "Options": "(A)Acetic acid (\u918b\u9178) \u3002 (B)Chromic acid (\u927b\u9178) \u3002 (C)Formic acid (\u7532\u9178) \u3002 (D)Nitric acid (\u785d\u9178) \u3002 (E)Oxalic acid(\u8349\u9178) \u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u4f55\u7a2e\u85e5\u7269\u4e2d\u6bd2\u75c5\u4eba \u4e0d\u9069\u5408\u591a\u5291\u91cf\u7684\u6d3b\u6027\u78b3\u6cbb\u7642( multidose activated charcoal)\uff1f", + "Options": "(A)Theophylline \u3002 (B)Carbamazepine \u3002 (C)Phenobarbital \u3002 (D)Quinine\u3002 (E)Acetaminophen \u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u6297\u751f\u7d20\u4f7f\u7528\uff0c\u4f55\u8005\u8f03\u70ba \u6b63\u78ba\uff1f", + "Options": "(A)33\u6b72\u9152\u766e\u7537\u6027\u80ba\u708e\uff0c\u7d66\u4e88 ceftriaxone 1g \u9759\u8108\u6ce8\u5c04 1\u59291\uff5e2\u6b21\u3002 (B)7\u6b72\u7537\u5b69\u6025\u6027\u54bd\u5589\u708e\uff0c\u7d66\u4e88 tetracyclines \u6bcf\u5929\u6bcf\u516c\u65a4 50mg\u53e3\u670d\u3002 (C)5\u6b72\u5973\u7ae5\u6025\u6027\u8166\u819c\u708e\uff0c\u7d66\u4e88 azithromycin \u6bcf\u5929\u6bcf\u516c\u65a4 10mg\u975c\u8108\u6ce8\u5c04\u3002 (D)26\u6b72\u7537\u6027\u7c43\u7403\u904b\u52d5\u54e1\u8f15\u5fae\u80ba\u708e\uff0c\u7d66\u4e88 moxifloxacin 400mg \u53e3\u670d 1\u59291\u6b21\u3002 (E)28\u6b72\u5b55\u5a66\u6ccc\u5c3f\u9053\u611f\u67d3\uff0c\u7d66\u4e88 ciprofloxacin 500 mg \u53e3\u670d 1\u5929\u5169\u6b21\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u95dc\u65bc\u4f4e\u8840\u9209( hyponatremia )\uff0c\u4f55\u8005\u6558\u8ff0 \u932f\u8aa4\uff1f", + "Options": "(A)\u4f4e\u8840\u9209\u5c0d\u65bc\u60a3\u8005\u7684\u808c\u8089\u5f35\u529b\u548c\u529f\u80fd\u4e0d\u6703\u6709\u7279\u5225\u8868\u73fe\u6216\u5f71\u97ff\u3002 (B)\u5728\u6c92\u6709\u51fa\u73fe\u62bd\u6410( seizure)\u4f75\u767c\u75c7\u7684\u75c5\u4eba\uff0c\u8840\u9209\u77ef\u6b63\u4e0a\u5347\u7684\u901f\u5ea6\u4e0d\u61c9\u8d85\u904e\u6bcf\u5c0f\u6642 0.5\uff5e1 mEq/L\u3002 (C)\u82e5\u60a3\u8005\u5df2\u6709\u7672\u7647\u767c\u4f5c\uff0c\u8840\u9209\u77ef\u6b63\u4e0a\u5347\u7684\u901f\u5ea6\u53ef\u589e\u52a0\u81f3\u6bcf\u5c0f\u6642 1\uff5e2 mEq/L\u3002 (D)\u6cbb\u7642\u6162\u6027\u4f4e\u8840\u9209\u60a3\u8005\uff0c\u82e5\u4e0a\u5347\u901f\u5ea6\u5927\u65bc\u6bcf\u5c0f\u6642 0.5 mEq/L \uff0c\u5bb9\u6613\u767c\u751fcentral putamen myelinolysis \u800c\u6709\u795e\u7d93\u529f\u80fd\u969c\u7919\u3002 (E)\u901a\u5e38\u5728 Na\u5c0f\u65bc 120 mEq/L \u6642\u6613\u958b\u59cb\u51fa\u73fe\u81e8\u5e8a\u75c7\u72c0\uff0c\u800c\u4f4e\u65bc 113 mEq/L \u5bb9\u6613\u767c\u751f\u7672\u7647\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u95dc\u65bc\u6025\u6027\u4e2d\u8033\u708e\u7684\u6558\u8ff0\uff0c\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u5e38\u898b\u7684\u81f4\u75c5\u83cc\u70ba Streptococcus pneumoniae \u3001Haemophilus influenzae (nontypeable )\u53ca Moraxella catarrhalis \u3002 (B)\u8a3a\u65b7\u6a19\u6e96\u70ba\u8eab\u9ad4\u6aa2\u67e5\u770b\u5230\u8033\u819c\u767c\u7d05( erythema)\u3002 (C)\u5c0d\u65bc\u5169\u6b72\u4ee5\u4e0a\u6025\u6027\u4e2d\u8033\u708e\u60a3\u7ae5\uff0c\u82e5\u672a\u5408\u4f75\u56b4\u91cd\u75c7\u72c0\uff0c\u53ef\u8003\u616e\u89c0\u5bdf 48\u5c0f\u6642\u5f8c\u518d\u6c7a\u5b9a\u662f\u5426\u7d66\u4e88\u6297\u751f\u7d20\u6cbb\u7642\u3002 (D)\u6297\u751f\u7d20\u6cbb\u7642\u5305\u62ec amoxicillin \u6216\u662f amoxicillin -clavulanate \u7b49\u3002 (E)\u5927\u7d04\u6709\u4e00\u534a\u7684\u60a3\u8005\u5728\u6cbb\u7642\u5b8c\u7562\u5f8c\u4ecd\u53ef\u80fd\u6709\u4e2d\u8033\u7a4d\u6c34( OME)\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u95dc\u65bc\u9f3b\u8154\u51fa\u8840( Epistaxis)\u7684\u6558\u8ff0\uff0c\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u6700\u5e38\u898b\u7684\u51fa\u8840\u90e8\u4f4d\u70ba\u9f3b\u4e2d\u8188\u524d\u4e0b\u5074 Kiesselbach's plexus (\u6216\u7a31Little\u2019s area )\u3002 (B)\u5152\u7ae5\u7684\u9f3b\u8154\u51fa\u8840\u4ea6\u597d\u767c\u65bc Kiesselbach's plexus (\u6216\u7a31 Little\u2019s area )\u3002 (C)\u9ad8\u8840\u58d3\u662f\u9020\u6210 epistaxis\u7684\u91cd\u8981\u539f\u56e0\uff0c\u9f3b\u8154\u51fa\u8840\u75c5\u4eba\u540c\u6642\u91cf\u6e2c\u5230\u6709\u504f\u9ad8\u7684\u8840\u58d3\u503c\u6642\uff0c\u7b2c\u4e00\u6642\u9593\u61c9\u5118\u901f\u964d\u4f4e\u8840\u58d3\u3002 (D)\u53ef\u7528\u7684\u6cbb\u7642\u5305\u62ec oxymetazoline spray \u4ee5\u53ca\u6b62\u8840\u68c9( pledgets)\u3002 (E)\u785d\u9178\u9280\u5316\u5b78\u71d2\u707c\u6cd5( silver nitrate chemically cauterizes )\u4e0d\u5efa\u8b70\u540c\u6642\u7528\u65bc\u96d9\u5074\u9f3b\u8154\u524d\u5074\u51fa\u8840\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4e0b\u80cc\u75db\u662f\u5e38\u898b\u7684\u6025\u8a3a\u4e3b\u8a34\uff0c\u95dc\u65bc\u5e38\u898b\u7684\u4e0b\u80cc\u75db\u75c5\u56e0\uff0c\u4ee5\u4e0b\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u795e\u7d93\u6027\u8ddb\u884c( neurogenic claudication )\u53ef\u56e0\u4f11\u606f\u800c\u7de9\u89e3\uff0c\u4f46\u56e0\u810a\u67f1\u5411\u524d\u5f4e\u66f2\u800c\u52a0\u5287\u3002 (B)\u99ac\u5c3e\u75c7\u5019\u7fa4( cauda equina syndrome )\u6700\u5e38\u898b\u7684\u75c7\u72c0\u662f\u809b\u9580\u62ec\u7d04\u808c\u7684\u5f35\u529b\u6e1b\u5c11\uff0c\u800c\u975e\u5c3f\u6eef\u7559\u3002 (C)\u7576\u61f7\u7591\u786c\u819c\u5916\u58d3\u8feb\u75c7\u5019\u7fa4( epidural compression syndrome )\u662f\u56e0\u70ba\u816b\u7624\u9020\u6210\u6642\uff0c\u9700\u5728\u6838\u78c1\u5171\u632f\u78ba\u8a3a\u524d\uff0c\u5148\u7d66\u4e88\u985e\u56fa\u9187\u6cbb\u7642\u3002 (D)\u8a3a\u65b7\u786c\u810a\u819c\u5916\u81bf\u760d( spinal epidural abscess ) \uff0c\u9700\u540c\u6642\u8868\u73fe\u51fa\u56b4\u91cd\u80cc\u75db\uff0c\u767c\u71d2\u53ca\u795e\u7d93\u5b78\u7f3a\u9677\u7b49 3\u7a2e\u75c7\u72c0\u3002 (E)\u810a\u690e\u9aa8\u9ad3\u708e\u7684\uff38\u5149\u8868\u73fe\uff0c\u5e38\u898b\u9aa8\u982d\u7684\u589e\u751f\u53ca\u690e\u9593\u76e4\u72f9\u7a84\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u5f15\u8d77\u6025\u6027\u814e\u8870\u7aed\u7684\u5404\u9805\u5167\u6e90\u6027\u56e0\u7d20( intrinsic renal failure )\u4e4b\u4e2d\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)Acute interstitial nephritis \u3002 (B)Hemorrhagic shock \u3002 (C)Ischemic acute tubular necrosis (ATN)\u3002 (D)Rapid progressive glomerulonephritis \u3002 (E)Rhabdomyolysis \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u5b55\u5a66\u731d\u6b7b\u9700\u65bd\u884c\u5fc3\u80ba\u5fa9\u7526\u8853\u6642\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u4f7f\u7528\u9762\u7f69\u901a\u6c23\u6642\uff0c\u82e5\u963b\u529b\u5927\u4ee5\u81f4\u6f6e\u6c23\u5bb9\u7a4d\u4e0d\u8db3\uff0c\u53ef\u589e\u52a0\u901a\u6c23\u901f\u5ea6\u4f86\u5f4c\u88dc\u3002 (B)\u65bd\u884c\u5feb\u901f\u9806\u5e8f\u6027\u63d2\u7ba1\u6642( rapid sequence intubation ) \uff0c\u4f7f\u7528\u808c\u8089\u9b06\u5f1b\u5291\u61c9\u907f\u514d succinylcholine \u3002 (C)\u80ce\u5152 28\u9031\u4ee5\u4e0b\u4e0d\u9700\u8003\u616e\u7dca\u6025\u5256\u8179\u7522\u3002 (D)\u58d3\u80f8\u6642\u61c9\u512a\u5148\u9078\u64c7\u8179\u80a1\u6e9d\u7f6e\u5165\u4e2d\u592e\u975c\u8108\u5c0e\u7ba1\u3002 (E)Amiodarone \u5c0d\u80ce\u5152\u6703\u7522\u751f\u56b4\u91cd\u4e0d\u826f\u5f71\u97ff\uff0c\u61c9\u907f\u514d\u4f7f\u7528\u65bc\u5b55\u5a66\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u5e7c\u7ae5\u56e0\u5916\u50b7\u800c\u81f3\u6025\u8a3a\u6c42\u8a3a\uff0c\u8a66\u554f\u4e0b\u5217\u4f55\u8005\u53d7\u50b7\u90e8\u4f4d\u8f03\u7b26\u5408\u610f\u5916\u53d7\u50b7\u3001\u5152\u8650\u7684\u53ef\u80fd\u6027 \u6700\u4f4e\uff1f", + "Options": "(A)\u7167\u9867\u8005\u4ee3\u8a34 1\u6b72\u534a\u7684\u5e7c\u7ae5\u81ea\u5df1\u73a9\u5f04\u751f\u6b96\u5668\u9020\u6210\u88c2\u50b7\u3002 (B)\u7167\u9867\u8005\u4ee3\u8a34 1\u6b72\u534a\u7684\u5e7c\u7ae5\u8dd1\u6b65\u8dcc\u5012\uff0c\u6aa2\u67e5\u767c\u73fe\u9396\u9aa8\u9aa8\u6298\u3002 (C)\u7167\u9867\u8005\u4ee3\u8a34 2\u6b72\u7684\u5b69\u7ae5\u8dd1\u6b65\u8dcc\u5012\uff0c\u6aa2\u67e5\u767c\u73fe\u4e0b\u5df4\u88c2\u50b7\u3002 (D)\u7167\u9867\u8005\u4ee3\u8a34 10\u500b\u6708\u5927\u7684\u5e7c\u5152\u56e0\u5b78\u6b65\u6454\u5012\uff0c\u6aa2\u67e5\u767c\u73fe\u5927\u817f\u9aa8\u6298\u3002 (E)\u7167\u9867\u8005\u4ee3\u8a34 10\u500b\u6708\u5927\u5e7c\u7ae5\u5f9e\u5e8a\u4e0a\u6454\u843d\uff0c\u6aa2\u67e5\u767c\u73fe\u591a\u8655\u808b\u9aa8\u9aa8\u6298\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u5728\u6025\u8a3a\u5ba4\u70ba 5\u6b72\u5e7c\u5152\u9032\u884c\u984d\u982d\u6495\u88c2\u50b7\u7e2b\u5408\u624b\u8853\u6642\uff0c\u5c0f\u5b69\u60c5\u7dd2\u6fc0\u52d5\u7121\u6cd5\u914d\u5408\uff0c\u7d93\u9069\u7576\u5b89\u64ab\u4ecd\u7121\u6cd5\u9032\u884c\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1a", + "Options": "(A)\u53ef\u4f7f\u7528 chloral hydrate \uff0c\u4f46\u85e5\u6548\u7522\u751f\u6162\uff0c\u4e14\u4f5c\u7528\u6642\u9593\u9577\uff0c\u4e26\u4e0d\u662f\u7406\u60f3\u7684\u6025\u8a3a\u4fb5\u8972\u6cbb\u7642 \u93ae\u975c\u85e5\u5291\u3002 (B)\u53ef\u4f7f\u7528 ketamine \u808c\u8089\u6ce8\u5c04\uff0c\u7522\u751f\u5408\u4f75\u93ae\u975c\u8207\u6b62\u75db\u7684\u6548\u679c\u3002 (C)\u53ef\u7d66\u4e88 midazolam \u56e0\u70ba\u5b89\u5168\u3001\u6709\u6548\u4e14\u4f5c\u7528\u6642\u9593\u77ed\u3002 (D)ketamine \u53ef\u5408\u4f75 midazolam \u4f7f\u7528\uff0c\u4ee5\u6e1b\u5c11\u5e7b\u89ba\u7684\u7522\u751f\u3002 (E)ketamine \u4ea6\u53ef\u4f7f\u7528\u65bc 3\u500b\u6708\u7684\u5b30\u5152\uff0c\u4f46\u8981\u6ce8\u610f\u553e\u6db2\u904e\u591a\uff0c\u9632\u6b62\u547c\u5438\u9053\u963b\u585e\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u5728\u8a55\u4f30\u6c23\u80f8\u6642\uff0c\u4e0b\u5217\u90a3\u4e00\u500b\u8d85\u97f3\u6ce2\u5fb5\u8c61( sign)\u6709\u6700\u9ad8\u7684\u7279\u7570\u6027(specificity ) \uff0c\u53ef\u7528\u4f86\u78ba\u8a3a\u6c23\u80f8\uff1f", + "Options": "(A)Comet -tail artifacts \u3002 (B)Lung point sign \u3002 (C)Lung pulse sign \u3002 (D)Seashore sign \u3002 (E)Stratosphere sign \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u4e00\u611b\u6ecb\u75c5( AIDS)\u4eba\u4f86\u9662\u6025\u8a3a\u4e3b\u8a34\u5168\u8eab\u7121\u529b\uff0c\u9ad4\u91cd\u6e1b\u8f15\uff0c\u98df\u617e\u4e0d\u4f73\uff0c\u8272\u7d20\u6c88\u8457\u65bc\u9f52\u9f66\uff0c\u9ad4\u6aa2\u767c\u73fe\u4f4e\u8840\u58d3\uff0c\u8acb\u554f\u61c9\u9ad8\u5ea6\u61f7\u7591\u8a72\u75c5\u4eba\u60a3\u6709\u4f55\u7a2e\u4f75\u767c\u75c7\uff1f ", + "Options": "(A)\u6557\u8840\u75c5\u3002 (B)\u814e\u4e0a\u817a\u6a5f\u80fd\u4f4e\u4e0b\u3002 (C)\u767c\u751f Kaposi's sarcoma \u3002 (D)\u5fc3\u81df\u8870\u7aed\u3002 (E)\u71df\u990a\u4e0d\u826f\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u5fc3\u5305\u819c\u586b\u585e( cardiac tamponade ) \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u5fc3\u96fb\u5716\u53ef\u80fd\u6703\u51fa\u73fe electrical alternans \u7684\u8b8a\u5316\u3002 (B)\u53ef\u80fd\u7684\u75c5\u56e0\u5305\u62ec\u5fc3\u5305\u819c\u708e\uff0c\u7532\u72c0\u817a\u529f\u80fd\u4f4e\u4e0b\uff0c\u764c\u75c7\uff0c\u5c3f\u6bd2\u75c7\uff0c\u5275\u50b7\u7b49\u3002 (C)\u53ef\u80fd\u6703\u6709 Kussmaul signs \uff0c\u75c5\u4eba\u6df1\u5410\u6c23\u6642\u9838\u975c\u8108\u6703\u66f4\u52a0\u64f4\u5f35\u3002 (D)\u5178\u578b\u7684\u81e8\u5e8a\u8868\u5fb5\u70ba Beck triad \u5305\u62ec\uff1a\u4f4e\u8840\u58d3\uff0c\u975c\u8108\u6012\u5f35\uff0c\u53ca\u9059\u9060\uff0c\u4f4e\u6c89\u7684\u5fc3\u97f3( muffled heart sound )\u3002 (E)\u8212\u5f35\u672b\u671f\u6642\uff0c\u53f3\u5fc3\u623f\u53ca\u5de6\u5fc3\u623f\u58d3\u529b\u76f8\u8fd1\u6216\u76f8\u7b49\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u53f0\u7063\u5e38\u898b\u6bd2\u86c7\u54ac\u50b7\u7684\u81e8\u5e8a\u8868\u73fe\u4e4b\u6558\u8ff0\uff0c\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u51fa\u8840\u6027\u6bd2\u86c7\u54ac\u50b7\u6703\u51fa\u73fe\u7259\u75d5\u548c\u5c40\u90e8\u816b\u8139\u53ca\u75bc\u75db\uff0c\u53ef\u898b\u76ae\u4e0b\u6de4\u8840\u3001\u6c34\u6ce1\u6216\u8840\u6ce1\u3002 (B)\u51fa\u8840\u6027\u6bd2\u86c7\u54ac\u50b7\u53ef\u80fd\u4f75\u767c\u75c7\u5982\u6eb6\u8840\u3001\u6a6b\u7d0b\u808c\u6eb6\u89e3\u3001\u7030\u6f2b\u6027\u8840\u7ba1\u5167\u51dd\u7d50( DIC)\u3002 (C)\u96e8\u5098\u7bc0\u54ac\u50b7\u6642\uff0c\u4e0d\u6613\u767c\u73fe\u9f52\u75d5(\u5c0f\u7259\u75d5) \u3002 (D)\u773c\u93e1\u86c7\u86c7\u6bd2\u5177\u6709\u7d30\u80de\u6bd2\u7d20\uff0c\u6703\u9020\u6210\u5c40\u90e8\u816b\u8139\u53ca\u75bc\u75db\u3001\u51fa\u8840\u6027\u7684\u76ae\u4e0b\u6de4\u8840\u3001\u6c34\u6ce1\u6216\u8840\u6ce1\uff0c\u56b4\u91cd\u8005\u6703\u9020\u6210\u76ae\u819a\u58de\u6b7b\u3002 (E)\u88ab\u773c\u93e1\u86c7\u54ac\u50b7\uff0c\u75c5\u4eba\u6703\u5641\u5fc3\u3001\u5614\u5410\u3001\u8179\u75db\u3001\u8179\u7009\uff0c \u4e14\u6709\u56b4\u91cd\u795e\u7d93\u808c\u8089\u50b3\u5c0e\u963b\u65b7\u75c7\u72c0\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u8089\u6bd2\u687f\u83cc\u4e2d\u6bd2( botulism) \uff0c\u4e0b\u5217\u63cf\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u7531\u8089\u6bd2\u687f\u83cc( Clostridium botulinum )\u5206\u6ccc\u7684\u6bd2\u7d20\u6240\u5f15\u767c\uff0c\u75c7\u72c0\u767c\u751f\u5728\u98df\u5165\u5f8c 6\uff5e48\u5c0f\u6642\u3002 (B)\u5148\u767c\u751f\u8907\u8996\u3001\u773c\u77bc\u4e0b\u5782\u3001\u773c\u7403\u8f49\u52d5\u969c\u7919\u3001\u53e3\u9f52\u4e0d\u6e05\u3001\u541e\u56a5\u56f0\u96e3\u3002 (C)\u63a5\u8457\u767c\u751f\u81ea\u4e0a\u80a2\u5230\u4e0b\u80a2\u7684\u808c\u529b\u4e0b\u964d\uff0c\u9010\u6f38\u547c\u5438\u7a98\u8feb\uff0c\u6700\u5f8c\u547c\u5438\u8870\u7aed\u3002 (D)\u6703\u7522\u751f\u611f\u89ba\u529f\u80fd\u8207\u808c\u8171\u53cd\u5c04\u529f\u80fd\u7570\u5e38\u3002 (E)\u901a\u5e38\u6703\u51fa\u73fe\u5c3f\u6db2\u7f6e\u7559\uff0c\u8996\u529b\u6a21\u7cca\uff0c\u76ae\u819a\u53ca\u773c\u775b\u4e7e\u71e5\u7b49\u75c7\u72c0\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u65bc\u7532\u9187\u4e2d\u6bd2\u4e4b\u6558\u8ff0\u3001\u89e3\u6bd2\u5291\u4f7f\u7528\u53ca\u6cbb\u7642\uff0c\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u4e3b\u8981\u6709\u6bd2\u4ee3\u8b1d\u7269\u7532\u9178\u4e4b\u534a\u8870\u671f\uff0c\u7d04 20\u5c0f\u6642\u3002 (B)\u665a\u671f\u75c7\u72c0\u4e3b\u8981\u662f\u4ee3\u8b1d\u6027\u9178\u4e2d\u6bd2\u548c\u8996\u795e\u7d93\u6c34\u816b\uff0c\u7522\u751f\u6c38\u4e45\u7684\u795e\u7d93\u6027\u5f8c\u907a\u75c7\u3002 (C)\u4ee5 Fomepizole \u4f5c\u70ba\u7532\u9187\u4e2d\u6bd2\u7684\u89e3\u6bd2\u5291\u4e4b\u6cbb\u7642\u76ee\u6a19\u662f\u9054\u5230\u7532\u9187\u6fc3\u5ea6\u5c0f\u65bc20mg/dL\u3002 (D)\u4f7f\u7528\u4e59\u9187\u6cbb\u7642\u7532\u9187\u4e2d\u6bd2\uff0c\u53e3\u670d\u6216\u975c\u8108\u6ce8\u5c04\u7684\u8ca0\u8377\u5291\u91cf\u70ba\u6bcf\u516c\u65a4\u9ad4\u91cd1g\u3002 (E)\u4f7f\u7528\u4e59\u9187\u6cbb\u7642\u7532\u9187\u4e2d\u6bd2\uff0c\u5982\u9700\u8840\u6db2\u900f\u6790\u6642\uff0c\u61c9\u6e1b\u5c11\u7d66\u4e88\u7684\u4e59\u9187\u91cf\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u7a7a\u4e2d\u91ab\u7642\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u5b89\u5168\u662f\u7a7a\u4e2d\u91ab\u7642\u7684\u9996\u8981\u6307\u5c0e\u539f\u5247\u3002 (B)\u6a5f\u9577\u65bc\u51fa\u767c\u524d\u9700\u5145\u5206\u638c\u63e1\u98db\u6a5f\u72c0\u6cc1\u3001\u5929\u6c23\u72c0\u6cc1\uff0c\u540c\u6a23\u8981\u4e86\u89e3\u75c5\u4eba\u4e4b\u8cc7\u6599\u53ca\u72c0\u6cc1\u3002 (C)\u7a7a\u4e2d\u91ab\u7642\u4e4b\u8b77\u7406\u4eba\u54e1\u901a\u5e38\u90fd\u5177\u5099\u52a0\u8b77\u75c5\u623f\u6216\u6025\u8a3a\u91ab\u7642\u7167\u8b77\u4e4b\u7d93\u9a57\u3002 (D)\u7a7a\u4e2d\u91ab\u7642\u4e4b\u91ab\u7642\u6307\u5c0e\u54e1\u7d04 50%\u5177\u5099\u6709\u6025\u8a3a\u4e4b\u80cc\u666f\u3002 (E)\u6a5f\u7d44\u54e1\u7684\u8eab\u9ad4\u72c0\u6cc1\u548c\u58d3\u529b\u90fd\u6703\u5f71\u97ff\u98db\u884c\u5b89\u5168\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6025\u6027\u5fc3\u81df\u8870\u7aed\u5408\u4f75\u80ba\u6c34\u816b\u7684\u75c5\u4eba\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u5fc3\u623f\u6392\u9209\u80dc\u80bd( Natriuretic peptide )\u5efa\u8b70\u7528\u4f86\u8a3a\u65b7\u6216\u662f\u6392\u9664\u5fc3\u81df\u8870\u7aed\uff0c\u4f46\u662f\u5e38\u898f\u6aa2\u9a57\u4ecd\u662f\u6709\u722d\u8b70\u7684\u3002 (B)\u5982\u679c\u75c5\u4eba\u8840\u58d3\u5927\u65bc 150/100 mmHg \uff0c\u53ef\u4f7f\u7528\u785d\u9178\u7518\u6cb9(Nitroglycerin ) \uff0c\u6700\u5927\u5291\u91cf\u662f 100 mg/min \uff0c\u8abf\u6574\u5291\u91cf\u7684\u7d42\u9ede\u662f\u4ee5\u8840\u58d3\u6216\u662f\u75c7\u72c0\u6539\u5584\u3002 (C)\u5229\u5c3f\u5291\u9808\u5408\u4f75\u8840\u7ba1\u64f4\u5f35\u5291\u540c\u6642\u4f7f\u7528\uff0c\u5229\u5c3f\u5291\u82e5\u55ae\u7368\u4f7f\u7528\u53ef\u80fd\u6703\u589e\u52a0\u6b7b\u4ea1\u7387\u3002 (D)\u975e\u4fb5\u8972\u6027\u547c\u5438\u5668\u53ef\u4ee5\u4f7f\u7528\u5728\u6025\u6027\u5fc3\u81df\u8870\u7aed\u6216\u662f\u80ba\u6c34\u816b\u7684\u75c5\u4eba\u3002 (E)\u975e\u4fb5\u8972\u6027\u547c\u5438\u5668\u53ef\u4ee5\u7528\u5728\u4e2d\u7b49\u81f3\u56b4\u91cd\u7684\u6025\u6027\u5fc3\u81df\u8870\u7aed\u547c\u5438\u8870\u7aed\u75c5\u4eba\uff0c\u9700\u8981\u914d\u5408\u8840\u6db2\u5faa\u74b0\u7a69\u5b9a\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6d77\u6d0b\u751f\u7269\u6bd2\u7d20\u4e4b\u654d\u8ff0\uff0c\u4f55\u8005\u70ba \u6b63\u78ba\uff1f", + "Options": "(A)\u6cb3\u8c5a\u6bd2\u7d20\u7528\u7092\u3001\u9183\u3001\u70f9\u716e\uff0c\u5c31\u53ef\u4ee5\u7834\u58de\u3002 (B)\u6cb3\u8c5a\u4e2d\u6bd2\u75c7\u72c0\u5728\u5403\u4e0b\u5f8c\u591a\u6578\u5728 24\u5c0f\u6642\u5f8c\u7522\u751f\u3002 (C)\u73ca\u745a\u7901\u9b5a\u985e\u6bd2\u7d20\u7684\u5f62\u6210\u8207\u751f\u7269\u93c8\u6709\u95dc\u3002 (D)\u7d44\u7e54\u80fa\u9b5a\u985e\uff0c\u7d44\u7e54\u80fa\u6703\u56e0\u70f9\u716e\u7684\u904e\u7a0b\u800c\u53d7\u5230\u7834\u58de\uff0c\u53ea\u8981\u719f\u98df\u5c31\u4e0d\u6703\u4e2d\u6bd2\u3002 (E)\u6c34\u6bcd\u7684\u87ab\u50b7\uff0c\u5e38\u65bc\u76ae\u819a\u4e0a\u5448\u73fe\u7279\u6b8a\u5448\u6dcb\u5df4\u5206\u4f48\u7684\u7d05\u7dda\uff0c\u5927\u91cf\u6e05\u6c34\u6c96\u6d17\u53ef\u4f7f\u523a\u7d72\u80de\u5931\u53bb\u6d3b\u6027\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u690e\u52d5\u8108\u525d\u96e2( vertebral artery dissection )\u7684\u767c\u751f\u8207\u75c7\u72c0\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u901a\u5e38\u597d\u767c\u65bc\u5e74\u7d00\u5927\u65bc 65\u6b72\u3002 (B)\u901a\u5e38\u5408\u4f75\u5f8c\u9838\u90e8\u55ae\u5074\u56b4\u91cd\u982d\u75db\u3002 (C)\u51fa\u73fe\u7684\u795e\u7d93\u75c7\u72c0\u901a\u5e38\u6db5\u84cb\u8166\u5e79\u8207\u5c0f\u8166\u3002 (D)\u75c5\u4eba\u6703\u51fa\u73fe\u9838\u90e8\u75bc\u75db\u3001\u81c9\u8207\u80a2\u9ad4\u9ebb\u6728\u3001\u7729\u6688\u3001\u80a2\u9ad4\u5931\u8abf( Ataxia)\u8207\u69cb\u97f3\u56f0\u96e3( dysarthria )\u3002 (E)\u690e\u52d5\u8108\u525d\u96e2( vertebral artery dissection )\u53ef\u56e0\u9838\u90e8\u53d7\u50b7\u800c\u5f15\u767c \u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u5875\u7206\u53d7\u50b7\u75c5\u4eba\u7684\u5fa9\u7526\u6cbb\u7642\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)60\u516c\u65a4\u6210\u4eba\u5168\u8eab\u8a08\u6709 40% \u9ad4\u8868\u9762\u7a4d\u7684\u4e8c\u7d1a\u548c\u4e09\u7d1a\u7684\u71d2\u50b7\uff0c\u9700 8\u5c0f\u6642\u8f38\u5165 3,600 ml \u4e73\u9178\u6797\u683c\u5f0f\u6db2\u3002 (B)\u81c9\u90e8\u6709\u5168\u5c64\u71d2\u50b7\u7684\u75c5\u4eba\u9700\u7acb\u5373\u6c23\u7ba1\u5167\u63d2\u7ba1\u3002 (C)\u7159\u9727\u4e2d\u542b\u6709\u7684\u9846\u7c92\u7269\u8cea\uff0c\u901a\u5e38\u70ba\u5c0f\u65bc 0.5 micrometer \u7684\u5927\u5c0f\uff0c\u9019\u662f\u7531\u6709\u6a5f\u6750\u6599\u7684\u4e0d\u5b8c\u5168\u71c3\u71d2\u800c\u5f62\u6210\u7684\u3002 (D)\u7159\u9727\u4e2d\u7684\u5c0f\u9846\u7c92\u53ef\u4ee5\u5230\u9054\u7d42\u7aef\u7d30\u652f\u6c23\u7ba1( Terminal bronchioles ) \uff0c\u5f15\u8d77\u708e\u75c7\u53cd\u61c9\uff0c\u4e14\u5c0e\u81f4\u652f\u6c23\u7ba1\u75d9\u6523\u548c\u6c34\u816b\u3002 (E)\u7576\u5438\u5165\u6027\u640d\u50b7\u5b58\u5728\uff0c\u8f38\u6db2\u5fa9\u7526\u61c9\u8a72\u5c0f\u5fc3\u64cd\u4f5c\uff0c\u4ee5\u514d\u52a0\u91cd\u80ba\u6c34\u816b\u548c\u6025\u6027\u547c\u5438\u7a98\u8feb\u75c7\u5019\u7fa4\uff0c\u5efa\u8b70\u65e9\u671f\u5c31\u61c9\u5efa\u7acb\u8840\u6d41\u52d5\u529b\u5b78\u7684\u76e3\u6e2c\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u56b4\u91cd\u54b3\u8840( Life-threatening hemoptysis )\u7684\u7dca\u6025\u81e8\u5e8a\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u81e8\u5e8a\u4e0a\u7d93\u5e38\u4f7f\u7528 Bleeding lung down \u7684\u64fa\u4f4d\u65b9\u5f0f\uff0c\u6709\u53ef\u80fd\u6703\u9020\u6210\u66f4\u56b4\u91cd\u7684 Ventilation -perfusion mismatch \u3002 (B)\u75c5\u4eba\u5982\u51fa\u73fe\u547c\u5438\u8870\u7aed\u6216\u751f\u547d\u5fb5\u8c61\u4e0d\u7a69\uff0c\u9808\u7acb\u5373\u7d66\u4e88\u63d2\u7ba1\u6cbb\u7642\uff0cEndotracheal tube \u7ba1\u5f91\u9078\u64c7\u8d8a\u5927\u8d8a\u597d\uff0c\u6700\u597d\u662f 8mm\u4ee5\u4e0a\u3002 (C)\u82e5\u75c5\u4eba\u6709\u5408\u4f75\u4f7f\u7528 wafarin\uff0c\u9808\u6aa2\u6e2c\u51dd\u8840\u529f\u80fd\uff0c\u5f85\u5831\u544a\u51fa\u4f86\u5f8c\u518d\u6c7a\u5b9a\u662f\u5426\u8f38\u6ce8\u65b0\u9bae\u51b7\u51cd\u8840\u6f3f( FFP\uff0cFresh frozen plasma )\u3002 (D)\u76e1\u65e9\u505a Emergency bronchoscopy \uff0c\u662f\u8a3a\u65b7\u8207\u6cbb\u7642\u7684\u7b2c\u4e00\u7dda\u9078\u64c7\u3002 (E)\u82e5\u51fa\u8840\u6301\u7e8c\u7121\u6cd5\u63a7\u5236\uff0c\u9700\u8003\u616e BAE(bronchial artery angiography and embolization )\u6216\u5916\u79d1\u624b\u8853\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4f60\u6b63\u5728\u8655\u7f6e 1\u540d\u5de6\u819d\u75bc\u75db\u4e14\u767c\u71d2 3\u5929\u7684 8\u6b72\u7537\u7ae5\uff0c\u7d93\u904e\u521d\u6b65\u8a55\u4f30\u5f8c\uff0c\u4f60\u9ad8\u5ea6\u61f7\u7591\u7537\u7ae5\u7f79\u60a3\u6025\u6027\u5316\u81bf\u6027\u95dc\u7bc0\u708e( acute septic arthritis ) \u3002\u4e0b\u5217\u4f55\u8005 \u6700\u4e0d\u53ef\u80fd\u662f\u9020\u6210\u8a72\u7537\u7ae5\u5316\u81bf\u6027\u95dc\u7bc0\u708e\u7684\u81f4\u75c5\u83cc\uff1f", + "Options": "(A)Methicillin -resistant Staphylococcus aureus \u3002 (B)Methicillin -sensitive Staphylococcus aureus \u3002 (C)Streptococcus sepcies \u3002 (D)H. Influenzae \u3002 (E)Gram -negative bacilli \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4f60\u6b63\u8655\u7f6e 1\u540d7\u6b72\u7591\u4f3c\u4e0b\u6d88\u5316\u9053\u51fa\u8840\u7684\u7537\u7ae5\uff0c\u809b\u8a3a\u767c\u73fe\u624b\u5957\u4e0a\u78ba\u5be6\u6709\u9bae\u8840\uff0c\u5176\u4ed6\u7406\u5b78\u6aa2\u67e5\u7121\u660e\u986f\u7570\u5e38\u3002\u4e0b\u5217\u4f55\u8005\u662f\u9020\u6210\u6b64\u7537\u7ae5\u6d88\u5316\u9053\u51fa\u8840 \u6700\u53ef\u80fd\u7684\u539f\u56e0\uff1f", + "Options": "(A)\u904e\u654f\u6027\u7d2b\u6591( Henoch -Schonlein purpura )\u3002 (B)\u8178\u5957\u758a( intussusception )\u3002 (C)\u606f\u8089( Polyp)\u3002 (D)\u725b\u5976\u86cb\u767d\u904e\u654f (Milk protein allergy )\u3002 (E)\u6885\u514b\u723e\u61a9\u5ba4( Meckel's diverticulum )\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u7cfb\u7d71\u6027\u81ea\u9ad4\u514d\u75ab\u75be\u75c5\u5e38\u4f34\u96a8\u6709\u5404\u7a2e\u4f75\u767c\u75c7\uff0c\u4ee5\u4e0b\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u8c9d\u585e\u7279\u58eb\u75c5( Behcet's disease )\u7684\u75c5\u4eba\u6bd4\u8f03\u5bb9\u6613\u6709\u6df1\u5c64\u975c\u8108\u8840\u6813\u554f\u984c\u3002 (B)\u9873\u52d5\u8108\u708e\u7684\u75c5\u4eba( temporal arteritis )\u8f03\u5bb9\u6613\u6709\u8996\u795e\u7d93\u7684\u50b7\u5bb3\u554f\u984c\u3002 (C)\u98a8\u6fd5\u6027\u95dc\u7bc0\u708e\u7684\u75c5\u4eba\uff0c\u6bd4\u8f03\u5bb9\u6613\u56e0\u8f15\u5fae\u5916\u50b7\u9020\u6210\u5bf0\u690e\u8207\u6a1e\u690e\u7684\u534a\u812b\u4f4d( atlantoaxial subluxation )\u3002 (D)\u50f5\u76f4\u6027\u810a\u690e\u708e\u7684\u75c5\u4eba\u7d93\u5e38\u4f34\u96a8\u6709\u99ac\u5c3e\u75c7\u5019\u7fa4( Cauda equina syndrome )\u3002 (E)\u7cfb\u7d71\u6027\u786c\u5316\u75c7( systemic sclerosis )\u6703\u589e\u52a0\u5fc3\u5f8b\u4e0d\u6574\u7684\u98a8\u96aa\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u5169\u90e8\u6469\u6258\u8eca\u8eca\u798d\uff0c EMT\u6536\u5230\u901a\u5831\u8d95\u62b5\u73fe\u5834\uff0c\u6551\u8b77\u8eca\u4e0a\u6709 EMT -P\uff0cEMT -II\u54041\u540d\uff0c\u53e6\u6709\u9cf3\u51f0\u5fd7\u5de5 EMT -I 1\u540d\u3002 1\u540d\u60a3\u8005\u73fe\u5834\u5df2\u7121\u547c\u5438\u3001\u7121\u5fc3\u8df3\uff0c\u7d93\u904e\u7684\u8def\u4eba\u6b63\u898b\u7fa9\u52c7\u70ba\uff0c\u7d66\u4e88 CPR\u4e2d\u3002\u9cf3\u51f0\u5fd7\u5de5\u7acb\u523b\u7d66\u4e88\u75c5\u4eba\u63d2\u4e0a\u5589\u7f69\u5f0f\u6c23\u7ba1\uff0c EMT -P\u5e6b\u60a3\u8005\u6253\u4e0a\u9ede\u6ef4\uff0c EMT -II\u63a5\u4e0a AED\u5f8c\uff0c AED\u8a9e\u97f3\u767c\u51fa\uff1a\u5efa\u8b70\u96fb\u64ca\u3002\u8acb\u554f\u9019\u500b\u904e\u7a0b\u4e2d\uff0c\u8ab0\u9055\u53cd\u4e86\u73fe\u884c\u7684\u6551\u8b77\u6280\u8853\u54e1\u7ba1\u7406\u8fa6\u6cd5\u4e4b\u898f\u7bc4\uff1f", + "Options": "(A)\u7121\u4eba\u9055\u53cd\u898f\u5b9a \u3002 (B)\u9cf3\u51f0\u5fd7\u5de5 EMT -I\u3002 (C)EMT -II\u3002 (D)EMT -P\u3002 (E)\u8def\u4eba \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u7a7a\u4e2d\u91ab\u7642\u8f49\u9001\u7684\u64cd\u4f5c\u8207\u9ad8\u5ea6( altitude)\u6709\u95dc\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u6ce2\u4ee5\u8033\u5b9a\u5f8b( Boyle\u2019s Law ) \uff1a\u8d8a\u9ad8\u7a7a \u2192\u58d3\u529b\u8d8a\u5c0f \u2192\u6c23\u6ce1\u9ad4\u7a4d\u8b8a\u5927\u3002 (B)\u4ea8\u5229\u5b9a\u5f8b( Henry\u2019s Law ) \uff1a\u5728\u5b9a\u6eab\u4e0b\uff0c\u6eb6\u89e3\u5728\u6db2\u9ad4\u4e2d\u6c23\u9ad4\u7684\u91cf\u53cd\u6bd4\u65bc\u6db2\u9ad4\u4e0a\u65b9\u6c23\u9ad4\u7684\u5206\u58d3\u3002 (C)\u75c5\u4eba\u5df2\u4f7f\u7528\u6c23\u7ba1\u5167\u7ba1\uff0c\u6c23\u56ca( cuff)\u4e0d\u9700\u8981\u6539\u70ba\u6ce8\u5165\u6db2\u9ad4\uff0c\u5982\u751f\u7406\u98df\u9e7d\u6c34\u3002 (D)\u75c5\u4eba\u5df2\u4f7f\u7528\u5c0e\u5c3f\u7ba1\uff0c\u6c23\u56ca( balloon)\u4e2d\u6db2\u9ad4\u61c9\u6539\u70ba\u6c23\u9ad4\u3002 (E)10%\u4e4b\u6c23\u80f8\uff0c\u7a7a\u4e2d\u8f49\u9001\u524d\u4e0d\u9700\u8981\u63d2\u5165\u80f8\u7ba1\u6e1b\u58d3\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u6025\u6027\u80f0\u81df\u708e\u7684\u56b4\u91cd\u5ea6\u5224\u65b7\u5c0d\u5f8c\u7e8c\u75c5\u4eba\u7684\u8655\u7f6e\u548c\u9810\u5f8c\u76f8\u7576\u91cd\u8981\uff0c\u4f9d\u64da\u4e9e\u7279\u862d\u5927\u5206\u985e\u6e96\u5247( Atlanta criteria ) \uff0c\u4e0b\u5217\u5747\u53ef\u9810\u6e2c\u56b4\u91cd\u80f0\u81df\u708e\u7684\u6307\u6a19\uff0c\u4f55\u8005 \u9664\u5916\uff1f", + "Options": "(A)APACHE II score \u2264 8\u3002 (B)Ranson score \u2267 3 \u3002 (C)Serum creatinine > 2mg/dL \uff0cbefore fluid resuscitation \u3002 (D)Serum calcium \u2266 7.5 mg/dL \u3002 (E)Presence of pancreatic pseudocyst \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6839\u64da\u4e16\u754c\u885b\u751f\u7d44\u7e54 WHO2009 \u5e74\u767b\u9769\u71b1\u75c5\u4f8b\u5206\u985e\u65b9\u5f0f\uff0c\u4e0b\u5217\u4f55\u8005 \u4e0d\u662f\u767b\u9769\u71b1\u91cd\u75c7\u7684\u8a3a\u65b7\u689d\u4ef6\uff1f", + "Options": "(A)\u56b4\u91cd\u51fa\u8840\u3002 (B)\u56b4\u91cd\u8840\u6f3f\u6ef2\u6f0f\u5c0e\u81f4\u4f11\u514b\u3002 (C)GOT\u6216GPT\u22671000 IU/L \u3002 (D)\u56b4\u91cd\u8840\u6f3f\u6ef2\u6f0f\u5c0e\u81f4\u9ad4\u6db2\u84c4\u7a4d\u53ca\u547c\u5438\u7a98\u8feb\u3002 (E)\u809d\u81df\u816b\u5927\u8d85\u904e\u808b\u9aa8\u4e0b\u7de3 2\u516c\u5206\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u75c5\u4eba\u4e3b\u8a34\u54b3\u8840\u81f3\u6025\u8a3a\u5c31\u8a3a\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)24\u5c0f\u6642\u5167\u54b3\u8840\u8d85\u904e 600 mL\u7a31\u70ba\u5927\u91cf\u54b3\u8840( Massive hemoptysis )\u3002 (B)\u652f\u6c23\u7ba1\u52d5\u8108\u6813\u585e\u8853( Bronchial artery embolization )\u6709 1.4\uff5e6.5\uff05 \u7684\u98a8\u96aa\u53ef\u80fd\u4f75\u767c\u810a\u690e\u52d5\u8108( Spinal artery )\u963b\u585e\uff0c\u5c0e\u81f4\u55ae\u5074\u504f\u7671\u3002 (C)\u542b\u986f\u5f71\u5291\u4e4b\u96fb\u8166\u65b7\u5c64\u651d\u5f71\u8207\u652f\u6c23\u7ba1\u93e1\u6aa2\u67e5\uff0c\u8a3a\u65b7\u51fa\u8840\u9ede\u7684\u6b63\u78ba\u7387\u76f8\u7576\u3002 (D)\u6709 15\uff5e30\uff05\u54b3\u8840\u75c5\u4eba\u7684\u80f8\u90e8 X\u5149\u6b63\u5e38\u3002 (E)\u80ba\u90e8\u8840\u6d41\u6709\u5169\u5957\u8840\u7ba1\u7cfb\u7d71\u4f9b\u61c9( Bronchial and pulmonary vessels )\uff0c\u9700\u8981\u7dca\u6025\u8655\u7406\u7684\u54b3\u8840\u591a\u70ba Bronchial vessels \u51fa\u8840\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u91dd\u5c0d\u5c0f\u5152\u5275\u50b7\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u5c0f\u5152\u5275\u50b7\u6025\u6551\u8655\u7f6e\u539f\u5247\u548c\u5927\u4eba\u76f8\u540c\u3002 (B)\u5c0f\u5152\u5275\u50b7\u6027\u5927\u91cf\u8840\u80f8\uff0c\u5efa\u8b70\u624b\u8853\u4e4b\u5b9a\u7fa9\u70ba\u80f8\u7ba1\u7f6e\u653e\u5f8c\u7684\u7acb\u5373\u51fa\u8840\u91cf\u5927\u65bc 15mL/kg \u6216\u5927\u65bc 4mL/kg/h \u3002 (C)\u82e5\u51fa\u73fe\u4f11\u514b\u5fb5\u5146\uff0c\u53ef\u7d66\u4e88\u751f\u7406\u98df\u9e7d\u6c34 20mL/kg 3 \u6b21\uff0c\u82e5\u4ecd\u7121\u6cd5\u6539\u5584\u4f11\u514b\u5fb5\u5146\uff0c\u53ef\u7d66\u4e88\u8f38\u8840 10mL/kg\u3002 (D)\u82e5\u6709\u8166\u51fa\u8840\u4f75\u61f7\u7591\u6709\u9871\u5167\u58d3\u5347\u9ad8\u4e4b\u5916\u50b7\u60a3\u8005\uff0c\u53ef\u9069\u5ea6\u7d66\u4e88\u904e\u5ea6\u63db\u6c23\uff0c\u7406\u60f3\u4e2d\u63a7\u5236 PaCO 2\u4ecb\u65bc 30\uff5e34mmHg \u3002 (E)\u5728\u5c0f\u5152\u5275\u50b7\u4e2d\uff0c\u82e5\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\uff0c\u7591\u4f3c\u6709\u814e\u81df\u920d\u632b\u50b7\u53ef\u9a57\u5c3f\u6db2\u6aa2\u67e5\uff0c\u82e5\u5927\u65bc 5 RBCs/HPF \u61c9\u5b89\u6392\u9032\u4e00\u6b65\u6aa2\u67e5\u53ca\u8655\u7f6e\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u91dd\u5c0d\u4e0d\u5b8c\u5168\u810a\u9ad3\u640d\u50b7\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)Central cord syndrome \u6703\u51fa\u73fe\u75c5\u7076\u8655\u4ee5\u4e0b\u5b8c\u5168\u7671\u7613\u53ca\u5931\u53bb\u75bc\u75db\u548c\u6eab\u5ea6\u611f\u89ba\u3002 (B)Anterior cord syndrome \u6703\u51fa\u73fe\u56db\u80a2\u7671\u7613\uff0c\u90e8\u5206\u53ef\u80fd\u5c0e\u81f4\u75db\u53ca\u6eab\u5ea6\u611f\u89ba\u4e0b\u964d\uff0c\u4e14\u4e0a\u80a2\u75c7\u72c0\u5927\u65bc\u4e0b\u80a2\u3002 (C)Brown -sequard syndrome \u6703\u51fa\u73fe\u75c5\u7076\u8655\u4ee5\u4e0b\u540c\u5074\u80a2\u9ad4\u7121\u529b\uff0c\u672c\u9ad4\u611f\u89ba\u6d88\u5931\uff0c\u4e14\u5c0d\u5074\u75db\u89ba\u53ca\u6eab\u5ea6\u611f\u89ba\u6d88\u5931\u3002 (D)Cauda equina \u662fcentral nerve injury \uff0c\u6703\u4f34\u96a8\u5927\u5c0f\u4fbf\u5931\u7981\u3002 (E)\u4ee5\u4e0a 4\u7a2e\u9810\u5f8c\u6700\u5dee\u7684\u662f Brown -sequard syndrome \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u91dd\u5c0d\u6025\u6027\u95cc\u5c3e\u708e( Acute appendicitis )\u7684\u6aa2\u67e5\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)CRP\u6bcf8\u5c0f\u6642\u4e0a\u5347 1\u500d\uff0c\u5728 36\uff5e50\u5c0f\u6642\u5230\u5dd4\u5cf0\u3002 (B)modified Alvarado score \u5927\u65bc 6\u5206\u4e0d\u7528\u5f71\u50cf\u5b78\u6aa2\u67e5\u5373\u53ef\u76f4\u63a5\u6703\u8a3a\u5916\u79d1\u91ab\u5e2b\u3002 (C)\u8d85\u97f3\u6ce2\u6aa2\u67e5\u82e5\u9670\u6027( negative)\u4e5f\u7121\u6cd5\u6392\u9664\u662f\u6025\u6027\u95cc\u5c3e\u708e\u3002 (D)\u8179\u90e8\u96fb\u8166\u65b7\u5c64\u662f\u9670\u6027( negative) \uff0c\u61c9\u53ef\u6392\u9664\u662f\u6025\u6027\u95cc\u5c3e\u708e\u3002 (E)Laparoscopy \u53ef\u7528\u4ee5\u8a3a\u65b7\u53ca\u6cbb\u7642\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6557\u8840\u6027\u95dc\u7bc0\u708e\u662f\u6025\u6027\u95dc\u7bc0\u75bc\u75db\u9700\u6392\u9664\u7684\u554f\u984c\uff0c\u5728\u9752\u5c11\u5e74\u65cf\u7fa4\u53c8\u4ee5\u6dcb\u75c5\u96d9\u7403\u83cc\u70ba\u6700\u5e38\u898b\u7684\u81f4\u75c5\u83cc\u3002\u4ee5\u4e0b\u91dd\u5c0d\u6dcb\u75c5\u96d9\u7403\u83cc\u9020\u6210\u7684\u6557\u8840\u6027\u95dc\u7bc0\u708e(gonococcal septic arthritis) \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u53cd\u8986\u62bd\u5438\u95dc\u7bc0\u6db2\u6703\u589e\u52a0\u611f\u67d3\u6a5f\u6703\uff0c\u4e0d\u5efa\u8b70\u6bcf\u65e5\u62bd\u5438\u95dc\u7bc0\u6db2\u3002 (B)\u53ef\u4ee5\u7528\u7b2c\u4e09\u4ee3\u982d\u5b62\u9ef4\u7d20\u6cbb\u7642\u6dcb\u75c5\u96d9\u7403\u83cc\u5c0e\u81f4\u7684\u6557\u8840\u6027\u95dc\u7bc0\u708e\u3002 (C)\u5728\u95dc\u7bc0\u708e\u767c\u75c5\u4e4b\u5f8c\u75c5\u4eba\u5e38\u6709\u8171\u9798\u708e( tenosynovitis )\u7684\u75c5\u7a0b\u9032\u5c55\u3002 (D)\u98a8\u6fd5\u6027\u95dc\u7bc0\u708e \u3001\u9152\u7cbe\u6feb\u7528 \u3001\u985e\u56fa\u9187\u6cbb\u7642\u7686\u70ba\u5e38\u898b\u7684\u5371\u96aa\u56e0\u5b50\u3002 (E)\u95dc\u7bc0\u6db2\u7684\u7d30\u83cc\u57f9\u990a\u5e38\u70ba\u967d\u6027\uff0c\u4e0d\u9700\u63a1\u6aa2\u5b50\u5bae\u9838\u6216\u5c3f\u9053\u7684\u7d30\u83cc\u57f9\u990a\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6df1\u90e8\u975c\u8108\u6813\u585e( Deep Vein Thrombosis \uff0cDVT)\u662f\u6307\u6df1\u90e8\u975c\u8108\u7684\u8840\u6db2\u963b\u585e\u56de\u6d41\u4e0d\u826f\u7522\u751f\u60a3\u80a2\u7684\u75c7\u72c0\uff0c\u4e0b\u5217\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u6b64\u75be\u75c5\u8f03\u5e38\u767c\u751f\u5728\u4e0b\u80a2\uff0c\u5927\u65bc 50%\u75c5\u4eba\u7684\u60a3\u80a2\u6703\u51fa\u73fe\u7d05\u816b\u3001\u75bc\u75db\u53ca\u6eab\u5ea6\u4e0a\u5347\u7b49\u75c7\u72c0\u3002 (B)\u56b4\u91cd\u6642\u6703\u9020\u6210\u85cd\u8272\u975c\u8108\u708e( Phlegmasia cerulea dolens )\u53ef\u80fd\u5f15\u8d77\u8840\u6db2\u5faa\u74b0\u53d7\u963b\uff0c\u9020\u6210\u8154\u5ba4\u75c7\u5019\u7fa4\u4f7f\u60a3\u80a2\u7f3a\u8840\u58de\u6b7b\uff0c\u82e5\u518d\u4e0d\u53ca\u6642\u8655\u7406\u751a\u81f3\u6703\u5c0e\u81f4\u622a\u80a2\u3002 (C)Homan sign \u5373\u8db3\u80cc\u7528\u529b\u5c48\u66f2\u6642\u5c0f\u817f\u6703\u611f\u5230\u6975\u5ea6\u75bc\u75db\uff0c\u5c0d\u65bc\u8a3a\u65b7\u6df1\u90e8\u975c\u8108\u6813\u585e\u7684\u654f\u611f\u5ea6\u4f73\u3002 (D)\u7531\u65bc\u8d85\u97f3\u6ce2\u6aa2\u67e5( Duplex ultrasonography )\u53d7\u5230\u6aa2\u67e5\u8005\u7684\u6280\u8853\u5f71\u97ff\u5f88\u5927\uff0c\u4e26\u975e\u4e0b\u80a2\u6df1\u90e8\u975c\u8108\u6813\u585e\u6aa2\u67e5\u7684\u5efa\u8b70\u9078\u9805\u3002 (E)\u9580\u8a3a\u75c5\u4eba\u670d\u7528\u6297\u51dd\u8840\u85e5\u7269 Warfarin\uff0c\u8981\u7d93\u5e38\u76e3\u6e2c\u570b\u969b\u6a19\u6e96\u5316\u6bd4\u503cINR(international normalized ratio )\u503c\uff0c\u5efa\u8b70\u4fdd\u6301\u5728 1.0\uff5e2.0\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u86c7\u54ac\u50b7\u7684\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f ", + "Options": "(A)\u5207\u958b\u50b7\u53e3\uff0c\u5438\u542e\u6bd2\u7d20\u3002 (B)\u52a0\u58d3\u5e36( tourniquet )\u52a0\u58d3\u4f7f\u52d5\u8108\u584c\u9677\uff0c\u4e0d\u8b93\u52d5\u8108\u904b\u9001\u6bd2\u7d20\u5230\u5168\u8eab\u3002 (C)\u4ee5\u75c5\u4eba\u6240\u8fa8\u8b58\u7684\u86c7\u7a2e\u9015\u884c\u6297\u6bd2\u86c7\u8840\u6e05\u6ce8\u5c04\u3002 (D)\u7981\u6b62\u6d78\u6ce1\u51b0\u6c34\u3002 (E)\u5728\u60a3\u80a2\u5efa\u7acb\u975c\u8108\u7ba1\u9053\uff0c\u4ee5\u4fbf\u7a0d\u5f8c\u53ef\u6ce8\u5c04\u6297\u6bd2\u86c7\u8840\u6e05\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u8a31\u591a\u75be\u75c5\u4ee5\u80a9\u9838\u75bc\u75db\u70ba\u81e8\u5e8a\u75c7\u72c0\uff0c\u4ee5\u4e0b\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u7576\u9838\u90e8\u75bc\u75db\u5408\u4f75\u6709\u795e\u7d93\u5b78\u75c7\u72c0\uff0c\u82e5\uff38\u5149\u7121\u7570\u72c0\uff0c\u5247\u9808\u5b89\u6392\u808c\u96fb\u5716\u6216\u795e\u7d93\u50b3\u5c0e\u6aa2\u67e5\uff0c\u800c\u975e\u6838\u78c1\u5171\u632f\u3002 (B)\u4e2d\u5fc3\u810a\u9ad3\u75c7\u5019\u7fa4( central cord syndrome ) \uff0c\u6703\u9020\u6210\u4e0b\u80a2\u8f03\u4e0a\u80a2\u7121\u529b\u3002 (C)\u9838\u690e\u7684\u764c\u8f49\u79fb\u6700\u5e38\u898b\u7684\u70ba\u80c3\u764c\u53ca\u5927\u8178\u764c \u3002 (D)\u80f8\u5ed3\u51fa\u53e3\u75c7\u5019\u7fa4( thoracic outlet syndrome )\u597d\u767c\u65bc\u5b55\u9f61\u5a66\u5973\u3002 (E)\u80a9\u8180\u8f49\u79fb\u75db\u6700\u5e38\u898b\u7684\u539f\u56e0\u662f\u5fc3\u808c\u6897\u585e\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u611f\u67d3\u75c7\u7684\u9451\u5225\u8a3a\u65b7\u5f80\u5f80\u9700\u8981\u8003\u91cf\u6709\u7121\u7279\u5b9a\u6d41\u884c\u75c5\u5b78\u5371\u96aa\u56e0\u5b50\u7684\u66b4\u9732\uff0c\u8acb\u554f\u4e0b\u5217\u611f\u67d3\u75c7\u76f8\u95dc\u6d41\u884c\u75c5\u5b78\u5371\u96aa\u56e0\u5b50\u7684\u6558\u8ff0\uff0c\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u897f\u5c3c\u7f85\u71b1\u8166\u708e( West Nile encephalitis )\u2190\u2192\u6771\u6b50\u3001\u54c8\u85a9\u514b\u3001\u4fc4\u7f85\u65af\u3002 (B)\u4f0a\u6ce2\u62c9\u75c5\u6bd2\u611f\u67d3( Ebola virus infection )\u2190\u2192\u897f\u975e\u5730\u5340\u570b\u5bb6\u65c5\u904a\u53f2\u3002 (C)\u9264\u7aef\u87ba\u65cb\u9ad4\u75c5( Leptospirosis )\u2190\u2192\u53f0\u7063\u672c\u5730\u98b1\u98a8\u904e\u5f8c\u6216\u6d2a\u6c34\u6c3e\u6feb\u5f8c\u5730\u5340\u3002 (D)\u6d41\u884c\u6027\u8166\u810a\u9ad3\u819c\u708e( Meningococcal Meningitis )\u2190\u2192\u6492\u54c8\u62c9\u6c99\u6f20\u4ee5\u5357\u7684\u975e\u6d32\u5730\u5340\u570b\u5bb6\u3002 (E)\u7627\u75be( Malaria)\u2190\u2192\u6771\u5357\u4e9e\u5730\u5340\u3001\u975e\u6d32\u53ca\u5927\u6d0b\u6d32\u65c5\u904a\u53f2\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u5c0d\u65bc\u8001\u5e74\u4eba\u5916\u50b7\u5f8c\u5faa\u74b0\u7684\u8a55\u4f30\u8207\u8003\u91cf\uff0c\u8acb\u554f\u4ee5\u4e0b\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u5728\u8001\u5e74\u4eba\u8eab\u4e0a\u770b\u5230 100/60 mmHg\u7684\u8840\u58d3\uff0c\u6709\u53ef\u80fd\u5df2\u7d93\u662f\u4f11\u514b\u7684\u60c5\u5f62\u3002 (B)\u56e0\u70ba\u5e74\u7d00\u8001\u5316\uff0c\u5fc3\u81df\u8f38\u51fa( cardiac index )\u53ca\u6700\u5927\u53ef\u9054\u5fc3\u8df3(maximal heart rate )\u6703\u4e0b\u964d\u3002 (C)\u82e5\u662f\u56b4\u91cd\u5916\u50b7\u7684\u8001\u5e74\u5916\u50b7\u60a3\u8005\u51fa\u73fe\u4f4e\u8840\u58d3\u53ca\u4ee3\u8b1d\u6027\u9178\u8840\u75c7\u60a3\u8005\u6b7b\u4ea1\u7387\u6975\u9ad8\u3002 (D)\u56e0\u70ba\u8001\u5e74\u5916\u50b7\u60a3\u8005\u5fc3\u81df\u529f\u80fd\u964d\u4f4e\uff0c\u56e0\u6b64\u61c9\u8a72\u964d\u4f4e\u8f38\u6ce8 pRBC\u7684\u9580\u6abb\u3002 (E)\u8001\u5e74\u5916\u50b7\u60a3\u8005\u8179\u8154\u5167\u5be6\u8cea\u81df\u5668\u920d\u50b7\uff0c\u65e9\u671f\u958b\u5200\u6cbb\u7642\u8f03\u5148\u63a1\u4fdd\u5b88\u6027\u6cbb\u7642\u98a8\u96aa\u70ba\u4f4e\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u5c0d\u65bc\u773c\u90e8\u75bc\u75db\u6216\u7d05\u773c\u60a3\u8005\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u6301\u7e8c\u6027\u8996\u529b\u6a21\u7cca\u9700\u7acb\u5373\u8f49\u4ecb\u773c\u79d1\u91ab\u5e2b\u3002 (B)\u53ef\u5148\u7d66\u4e88\u5c40\u90e8\u6b62\u75db\u8207\u985e\u56fa\u9187\u88fd\u5291\uff0c\u82e5\u8d85\u904e 48\u5c0f\u6642\u75c7\u72c0\u7121\u6cd5\u6539\u5584\u518d\u8f49\u4ecb\u7d66\u773c\u79d1\u91ab\u5e2b\u3002 (C)\u975e\u5275\u50b7\u6027\u7684\u7d05\u773c\u60a3\u8005\u6c92\u6709\u8996\u529b\u8b8a\u5316\u6216\u56b4\u91cd\u75bc\u75db\u53ef\u5148\u7d66\u4e88\u85e5\u7269\u6cbb\u7642\uff0c\u4e26\u89c0\u5bdf 48\u5c0f\u6642\u3002 (D)\u82e5\u70ba\u55ae\u5074\u7d05\u773c\u53ca\u75bc\u75db\u4f75\u6709\u982d\u75db\u5614\u5410\u75c7\u72c0\uff0c\u5373\u4fbf\u6c92\u6709\u8996\u529b\u8b8a\u5316\u4ecd\u9700\u8003\u616e\u9752\u5149\u773c\u3002 (E)\u6709\u914d\u6234\u96b1\u5f62\u773c\u93e1\u7684\u60a3\u8005\u61c9\u8f49\u4ecb\u773c\u79d1\u91ab\u5e2b\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6f5b\u5728\u751f\u547d\u5371\u96aa\u80f8\u75db\u5e38\u898b\u539f\u56e0\u7684\u5178\u578b\u75c7\u72c0\u8a55\u4f30\u8207\u6bd4\u8f03\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u4e3b\u52d5\u8108\u525d\u96e2\u4e3b\u8981\u65bc\u80f8\u9aa8\u4e0b\u56b4\u91cd\u6495\u88c2\u75db\u4e14\u8f49\u79fb\u81f3\u80cc\u5074\u80a9\u80db\u9593\uff0c\u80f8\u90e8 X\u5149\u7247\u6709\u6a5f\u6703\u770b\u5230\u7e31\u8188\u8154\u8b8a\u5bec\u53ca Calcium sign\u3002 (B)\u5e74\u8f15\u7537\u6027\u56e0\u7a81\u767c\u4e4b\u56b4\u91cd pleuritic chest pain \u4f86\u8a3a\uff0c\u5408\u4f75\u51fa\u73fe\u547c\u5438\u7a98\u8feb\u53ca\u4f11\u514b\uff0c\u8eab\u9ad4\u6aa2\u67e5\u767c\u73fe\u55ae\u5074\u9838\u975c\u8108\u6012\u5f35\u53ca\u55ae\u5074\u547c\u5438\u97f3\u8b8a\u5c0f\uff0c\u6b64\u6642\u9808\u8003\u616e needle decompression \u3002 (C)\u82e5\u75c5\u4eba\u4f86\u8a3a\u70ba 30\u5206\u9418\u524d\u559d\u9152\u5f8c\u5287\u70c8\u5614\u5410\u5f8c\u7a81\u7136\u5c16\u92b3\u75db\u4e14\u8f49\u79fb\u81f3\u80cc\u90e8\uff0c\u81e8\u5e8a\u4e0a\u9808\u61f7\u7591\u98df\u9053\u7834\u88c2\u3002\u82e5\u4e0a\u6bb5\u98df\u9053\u7834\u88c2( upper esophageal perforation )\u8f03\u5c11\u7528\u80f8\u90e8 X\u5149\u7247\u770b\u5230\u7e31\u8188\u8154\u6c23\u816b\u3002 (D)\u81e8\u5e8a\u4e0a\u80ba\u6813\u585e\u5728\u80f8\u90e8 X\u5149\u7247\u4e0a\u5076\u800c\u53ef\u898b\u5230 Westermark's sign \u6216\u662fHampton hump \u3002 (E)\u5178\u578b\u6025\u6027\u51a0\u5fc3\u75c7\u70ba\u4f4d\u65bc\u80f8\u9aa8\u5f8c\u6216\u4e0a\u8179\u90e8\u60b6\u75db\u6216\u58d3\u8feb\u611f\uff0c\u53ef\u80fd\u5408\u4f75\u51fa\u73fe\u5641\u5fc3\u3001\u5614\u5410\u3001\u5192\u51b7\u6c57\u3001\u5598\u7b49\u75c7\u72c0\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u61f7\u5b55\u9031\u6578 26\u9031\u5a66\u5973\u9a0e\u6a5f\u8eca\u8207\u5c0f\u5ba2\u8eca\u767c\u751f\u78b0\u649e\u4e8b\u6545\u5f8c\u88ab 119\u4eba\u54e1\u9001\u81f3\u6025\u8a3a\u3002\u6709\u95dc\u5b55\u5a66\u5916\u50b7\u4e4b\u8a55\u4f30\u8207\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u5373\u4f7f\u662f\u8f15\u5fae\u5916\u50b7\u4ea6\u53ef\u80fd\u5c0d\u80ce\u5152\u6709\u6975\u5927\u5f71\u97ff\uff0c\u6545\u61c9\u5148\u6cbb\u7642\u80ce\u5152\uff0c\u518d\u5c0d\u5b55\u5a66\u7684\u50b7\u52e2\u9032\u884c\u8a55\u4f30\u3002 (B)\u9670\u9053\u5206\u6ccc\u7269\u4e4b pH\u503c\u5728 5\u5de6\u53f3\u6642\uff0c\u4ee3\u8868\u7f8a\u819c\u7834\u88c2( Amniotic membrane rupture )\u3002 (C)\u80ce\u5152\u6b7b\u4ea1\u6700\u5e38\u898b\u7684\u539f\u56e0\u662f\u80ce\u76e4\u525d\u96e2( abruptio placentae ) \uff0c\u6b7b\u4ea1\u7387\u9ad8\u905450\uff5e80%\u3002 (D)\u4e0d\u8ad6\u50b7\u52e2\u5982\u4f55\uff0c\u5b55\u5a66\u90fd\u662f X\u5149\u53ca\u96fb\u8166\u65b7\u5c64\u7b49\u653e\u5c04\u7dda\u6aa2\u67e5\u7684\u7d55\u5c0d\u7981\u5fcc\u75c7\u3002 (E)\u61c9\u5b89\u6392 fetal monitoring \u81f3\u5c11 4\uff5e6\u5c0f\u6642\uff0c\u82e5\u60a3\u8005\u6709\u9670\u9053\u51fa\u8840\u53ca\u5bae\u7e2e\u7b49\u75c7\u72c0\uff0c\u66f4\u61c9 monitor 24 \u5c0f\u6642\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u95dc\u65bc Alcoholic Ketoacidosis \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u75c5\u4eba\u6709 large anion gap \u56e0\u70ba\u6709\u9ad8\u7684 serum ketones \u3002 (B)\u75c5\u4eba\u8840\u6db2 alcohol levels \u901a\u5e38\u6703\u5f88\u9ad8\u3002 (C)\u75c5\u4eba\u662f\u5728 starvation \u53cadehydration \u72c0\u614b\u3002 (D)\u6cbb\u7642\u53ef\u7d66\u4e88 glucose\u8ddfsaline\u8f38\u6db2\u3002 (E)\u61c9\u5728\u7d66\u4e88 glucose\u4e4b\u524d\u5148\u7d66\u4e88 Thiamine 50 \uff5e100 mg\u4ee5\u9810\u9632\u8a98\u767cWernicke\u2019s disease \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc Nerve gases (\u795e\u7d93\u6bd2\u6c23) \uff0c\u4e0b\u5217\u6558\u8ff0\u8207\u8655\u7406\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)2-PAM\u53ef\u7528\u4f86\u62b5\u6d88\u795e\u7d93\u6bd2\u6c23\u9020\u6210 muscarinic effects (\u6bd2\u8548\u9e7c\u4f5c\u7528) \u3002 (B)Atropine \u53ef\u7528\u4f86\u62b5\u6d88\u795e\u7d93\u6bd2\u6c23\u9020\u6210 nicotinic effects (\u83f8\u9e7c\u4f5c\u7528) \u3002 (C)Benzodiazepines \u53ef\u7528\u4f86\u6cbb\u7642 seizure\u3002 (D)GA\u3001GB\u3001GD\u3001VF\u7686\u5c6c\u8f03\u51fa\u540d\u7684\u795e\u7d93\u6bd2\u6c23\uff0c\u70ba\u6709\u6a5f\u78f7\u6bd2\u7269\u3002 (E)\u7522\u751f SLUD syndrome \uff0c\u662f\u6307\u6709 salivation \u3001lacrimation \u3001urination\u3001desaturation \u7684\u75c7\u72c0\u7fa4\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc Thyroid Storm \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u53ef\u4ee5\u7d66\u4e88\u6bcf\u65e5 300mg\u5291\u91cf\u7684 hydrocortisone \u985e\u56fa\u9187\u88dc\u5145\u3002 (B)\u610f\u8b58\u8e81\u52d5\u53ca\u809d\u529f\u80fd\u7570\u5e38\uff0c\u975e\u7532\u72c0\u817a\u98a8\u66b4\u4e4b\u5e38\u898b\u8868\u73fe\u3002 (C)Thyroid storm \u53ef\u80fd\u5f15\u767c\u9ad8\u9ad4\u6eab\uff0c\u5fc5\u9808\u7d66\u4e88 acetaminophen \u6216salicylate (\u6c34\u694a\u9178)\u5118\u901f\u964d\u4f4e\u9ad4\u6eab\u3002 (D)Iodine \u662f\u7528\u4f86\u6e1b\u5c11\u5468\u908a\u8840\u6db2\u4e2d\u7684 thyroid hormone T4 \uff0c\u8f49\u8b8a\u6210\u66f4\u5177\u6d3b\u6027\u7684 T3\u5f62\u5f0f\u3002 (E)Propranolol \u9664\u53ef\u63a7\u5236\u5fc3\u640f\u904e\u901f\uff0c\u4e5f\u53ef\u4ee5\u6e1b\u5c11 thyroid hormone \u5f9e\u7532\u72c0\u817a\u9ad4\u7684\u91cb\u51fa\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u4e0b\u6d88\u5316\u9053\u51fa\u8840\u7684\u8a3a\u65b7\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u8840\u7ba1\u651d\u5f71( angiography )\u9700\u5728\u6d41\u8840\u91cf\u5927\u65bc 0.5mL/min \u7684\u60c5\u5f62\u4e0b\u624d\u80fd\u8a3a\u65b7\u51fa\u8840\u3002 (B)\u939d 99m\u6a19\u5e5f\u7d05\u8840\u7403\u8178\u80c3\u9053\u9583\u720d\u9020\u5f71( Tc-99m-labeled RBC Scintigraphy )\u53ea\u8981\u6d41\u8840\u91cf\u5927\u65bc 0.1mL/min \u5c31\u80fd\u8a3a\u65b7\u51fa\u8840\u3002 (C)\u96fb\u8166\u65b7\u5c64\u5c0d\u65bc\u4e0b\u6d88\u5316\u9053\u51fa\u8840\u7684\u8a3a\u65b7\u6c92\u6709\u5e6b\u52a9\u3002 (D)\u4e00\u822c\u800c\u8a00\uff0c\u5167\u8996\u93e1\u7684\u8a3a\u65b7\u7387\u6bd4\u8840\u7ba1\u651d\u5f71\u53ca\u9583\u720d\u9020\u5f71\u90fd\u9ad8\u3002 (E)\u82e5\u61f7\u7591\u5c0f\u8178\u51fa\u8840\uff0c\u53ef\u4ee5\u5efa\u8b70\u75c5\u4eba\u8f49\u8a3a\u81f3\u914d\u5099\u81a0\u56ca\u5167\u8996\u93e1\u7684\u91ab\u9662\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5b50\u7647\u524d\u75c7( preeclampsia )\u7684\u5404\u7a2e\u5371\u96aa\u56e0\u5b50\uff0c\u4e0b\u5217\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u6162\u6027\u814e\u75c5\u3002 (B)\u591a\u80ce\u598a\u5a20\u3002 (C)\u7d93\u7522\u5a66\u3002 (D)\u6162\u6027\u9ad8\u8840\u58d3\u3002 (E)\u61f7\u5b55\u524d\u7cd6\u5c3f\u75c5\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5316\u5b78\u85e5\u5291\u6ffa\u5165\u773c\u775b\u7684\u8655\u7406\u65b9\u5f0f\uff0c\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u9e7c\u6027\u85e5\u5291\u9020\u6210\u7684\u50b7\u5bb3\u5f80\u5f80\u8f03\u9178\u6027\u85e5\u5291\u4f86\u5f97\u56b4\u91cd\u3002 (B)\u81ea\u7b2c\u4e00\u6642\u9593\u5c31\u61c9\u5927\u91cf\u6c96\u6c34\u76f4\u5230 pH\u503c\u56de\u5fa9\u6b63\u5e38\u3002 (C)\u6c96\u6d17\u904e\u7a0b\u61c9\u907f\u514d\u4f7f\u7528\u9ebb\u9189\u6b62\u75db\u85e5\u7269\uff0c\u4ee5\u514d\u5f71\u97ff\u50b7\u52e2\u7684\u8a55\u4f30\u3002 (D)\u82e5\u906d 3\u79d2\u81a0\u5674\u6ffa\u5c0e\u81f4\u773c\u76ae\u5728\u6b63\u5e38\u4f4d\u7f6e\u88ab\u9ecf\u8457\uff0c\u53ef\u8003\u616e\u89c0\u5bdf\u6cbb\u7642\u3002 (E)\u5c0d\u65bc\u6240\u6709\u4e0d\u77e5\u540d\u7684\u6eb6\u5291\u90fd\u61c9\u7576\u505a\u9178\u9e7c\u5674\u6ffa\u8655\u7406\uff0c\u4ee5\u5927\u91cf\u7684\u6c34\u6c96\u6d17\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5929\u7136\u707d\u96e3\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u5730\u9707\u707d\u5bb3\u5f8c\u91ab\u9662\u7684\u5927\u91cf\u50b7\u60a3\u591a\u662f\u9aa8\u6298\u6216\u58d3\u788e\u50b7\u7684\u50b7\u60a3\u3002 (B)\u6025\u6027\u58d3\u529b\u7cbe\u795e\u7570\u5e38( Acute stress disorder )\u591a\u767c\u751f\u65bc\u707d\u96e3\u5fa9\u539f\u671f\u3002 (C)\u707d\u96e3\u5f8c\uff0c\u901a\u5e38\u5916\u50b7\u50b7\u60a3\u6c42\u8a3a\u591a\u767c\u751f\u5728\u707d\u96e3\u6025\u6027\u671f\u53ca\u5fa9\u539f\u671f\u3002 (D)\u707d\u96e3\u5f8c\uff0c\u901a\u5e38 vector -borne disease (\u5982\u767b\u9769\u71b1)\u4e3b\u8981\u767c\u751f\u5728\u707d\u96e3\u5fa9\u539f\u671f\u3002 (E)\u901a\u5e38\u65bc\u5927\u5730\u9707\u707d\u5bb3\u5f8c\uff0c\u524d 3\u5c0f\u6642\u5373\u6709\u5927\u91cf\u6b7b\u4ea1\u8005\u767c\u751f\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5fc3\u81df\u920d\u50b7( Blunt cardiac trauma ) \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u82e5\u5fc3\u96fb\u5716\u4e0a\u51fa\u73fe ST-T\u6bb5\u4e0a\u5347\uff0c\u9700\u8003\u616e\u51a0\u72c0\u52d5\u8108\u525d\u96e2( coronary artery dissection )\u3002 (B)\u5fc3\u81df\u9175\u7d20\u6b63\u5e38\u6642\uff0c\u7121\u6cd5\u6392\u9664\u5fc3\u81df\u920d\u50b7\u3002 (C)\u7d93\u80f8\u5fc3\u81df\u8d85\u97f3\u6ce2( transthoracic echocardiography )\u8a3a\u65b7\u5fc3\u81df\u920d\u50b7\u7684\u654f\u611f\u5ea6\u8f03\u7d93\u98df\u9053\u5fc3\u81df\u8d85\u97f3\u6ce2( Transesophageal echocardiography \uff0cTEE)\u4f73\u3002 (D)\u5fc3\u81df\u920d\u50b7 24\u5c0f\u6642\u5167\u6700\u5bb9\u6613\u767c\u751f\u7a81\u767c\u6027\u7684\u5fc3\u5f8b\u4e0d\u6574\u3002 (E)\u82e5\u75c5\u4eba\u767c\u751f\u5fc3\u56e0\u6027\u4f11\u514b\uff0c\u9700\u8003\u616e\u75c5\u4eba\u5fc3\u81df\u69cb\u9020\u662f\u5426\u53d7\u640d\uff0c\u5fc5\u8981\u6642\u9700\u624b\u8853\u6cbb\u7642\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u4e3b\u52d5\u8108\u525d\u96e2\u7684\u6cbb\u7642\uff0c\u4e0b\u5217\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u61c9\u7acb\u5373\u5efa\u7acb\u975c\u8108\u7ba1\u9053\u4e26\u56b4\u5bc6\u76e3\u6e2c\u8840\u58d3\u3001\u8108\u640f\u3001\u5fc3\u5f8b\u7b49\u751f\u547d\u5fb5\u8c61\u3002 (B)\u75c5\u4eba\u8840\u58d3\u901a\u5e38\u5f88\u9ad8\uff0c\u5118\u901f\u4ee5 labetalol\u7b49\u964d\u58d3\u85e5\u7269\u964d\u8840\u58d3\u70ba\u9996\u8981\u4efb\u52d9\uff0c\u61c9\u8a72\u5728\u9001\u75c5\u4eba\u9032\u884c\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u524d\u5373\u5118\u5feb\u7d66\u4e88\u3002 (C)\u82e5\u75c5\u4eba\u8840\u58d3\u504f\u4f4e\uff0c\u61c9\u9032\u884c\u5fc5\u8981\u7684\u8f38\u6db2\u751a\u81f3\u8f38\u8840\u6cbb\u7642\uff0c\u4e26\u4ee5\u5e8a\u908a\u8d85\u97f3\u6ce2\u78ba\u8a8d\u5fc3\u5305\u586b\u585e\u6216\u8840\u80f8\u7b49\u4f75\u767c\u75c7\u4e4b\u53ef\u80fd\u3002 (D)\u82e5 Stanford type B \u4e4b\u4e3b\u52d5\u8108\u525d\u96e2\u9020\u6210\u91cd\u8981\u5167\u81df\u8840\u7ba1\u963b\u585e\u800c\u56b4\u91cd\u7f3a\u8840\uff0c\u4ecd\u61c9\u8003\u616e\u9032\u884c\u624b\u8853\u6cbb\u7642\u3002 (E)\u82e5\u75c5\u4eba\u8840\u58d3\u5df2\u6e2c\u4e0d\u5230\u800c\u5448\u73fe pulseless electrical activity (PEA) \uff0c\u61c9\u53ef\u616e intra-aortic balloon pump (IABP)\u6216 extracorporeal membrane oxygenation (ECMO)\u7b49\u6a5f\u68b0\u6027\u8f14\u52a9\u6cbb\u7642\uff0c\u4e26\u8fc5\u901f\u929c\u63a5\u81f3\u624b\u8853\u6cbb\u7642\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8033\u90e8\u75c5\u75c7\u53ca\u8655\u7406\uff0c\u4ee5\u4e0b\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)Aminoglycoside \u96d6\u6709\u8033\u6bd2\u6027\uff0c\u4f46\u505a\u70ba\u5916\u8033\u708e\u7684\u5c40\u90e8\u6cbb\u7642\u7528\u85e5\uff0c\u5438\u6536\u9020\u6210\u7cfb\u7d71\u6027\u6216\u5c40\u90e8\u526f\u4f5c\u7528\u7684\u6a5f\u6703\u6975\u4f4e\uff0c\u662f\u4fbf\u5b9c\u5b89\u5168\u7684\u7528\u85e5\u3002 (B)Ramsay Hunt syndrome \u4e3b\u8981\u81e8\u5e8a\u8868\u73fe\u70ba\u8033\u75db( otalgia) \u3001\u8033\u9cf4(tinnitus)\u4ee5\u53ca\u8033\u6bbc\u6ce1\u75b9\uff0c\u4ea6\u5e38\u5408\u4f75 facial palsy \u3002 (C)\u8033\u75db( otalgia)\u767c\u751f\u6642\uff0c\u4e0b\u984e\u963b\u751f\u81fc\u9f52\u6216\u81fc\u9f52\u81bf\u760d\u4ea6\u61c9\u5217\u5165\u5e38\u898b\u7684\u9451\u5225\u8a3a\u65b7\u3002 (D)\u5305\u542b Aspirin\u7684NSAID\u985e\u85e5\u7269\u662f\u9020\u6210\u7684\u85e5\u7269\u6027\u8033\u9cf4\u5e38\u898b\u7684\u81f4\u75c5\u56e0\u3002 (E)\u816e\u817a\u708e\u611f\u67d3\u5f8c\u6709\u53ef\u80fd\u6703\u51fa\u73fe hearing loss \u7684\u4f75\u767c\u75c7\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8840\u58d3\u5e36\u8a66\u9a57( Tourniquet Test )\u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u4ee5\u6536\u7e2e\u58d3\u53ca\u8212\u5f35\u58d3\u5169\u8005\u5e73\u5747\u503c\u7684\u58d3\u529b\uff0c\u70ba\u8840\u58d3\u5e36\u4e4b\u58d3\u529b\u3002 (B)\u7528\u8840\u58d3\u5e36\u7d81\u4e0a\u81c2 10\u5206\u9418\uff0c\u89c0\u5bdf\u524d\u81c2\u908a\u9577\u70ba 1\u82f1\u540b\u7684\u6b63\u65b9\u5f62\u5167\u7684\u9ede\u72c0\u51fa\u8840\u6578\u76ee\u3002 (C)\u82e5\u6bcf\u5e73\u65b9\u82f1\u540b( 6.25\u5e73\u65b9\u516c\u5206)\u51fa\u73fe\u5927\u65bc\u6216\u7b49\u65bc 20\u500b\u9ede\u72c0\u51fa\u8840\uff0c\u5373\u70ba\u967d\u6027\u53cd\u61c9\u3002 (D)\u82e5\u5148\u524d\u6e2c\u8a66\u70ba\u9670\u6027\u6216\u7121\u51fa\u8840\u8868\u73fe\uff0c\u53ef\u518d\u91cd\u8907\u6e2c\u8a66\u3002 (E)\u8a72\u8a66\u9a57\u6709\u52a9\u65bc\u81e8\u5e8a\u8a3a\u65b7\u767b\u9769\u71b1\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5feb\u901f\u6b21\u5e8f\u63d2\u7ba1( rapid sequence intubation )\u4e2d\u7528\u85e5\u7684\u8003\u91cf\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)fentanyl\u4e0d\u53ef\u7528\u5728\u6709\u51a0\u72c0\u52d5\u8108\u75be\u75c5\u7684\u75c5\u4eba\u3002 (B)lidocaine \u4e0d\u53ef\u7528\u5728\u6c23\u5598\u767c\u4f5c\u7684\u75c5\u4eba\u3002 (C)ketamine \u53ef\u7528\u5728\u8840\u58d3\u4f4e\u7684\u75c5\u4eba\u3002 (D)diazepam \u9069\u5408\u7528\u65bc\u8a98\u5c0e( induction )\u3002 (E)rocuronium \u6709\u93ae\u5b9a\u6548\u679c\uff0c\u53ef\u4e0d\u5fc5\u4f75\u7528\u8a98\u5c0e\u85e5\u7269\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u72c2\u72ac\u75c5\u53ca\u72c2\u72ac\u75c5\u75ab\u82d7\u6ce8\u5c04\uff0c\u4e0b\u5217\u654d\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u72c2\u72ac\u75c5\u5c6c\u65bc\u7b2c\u4e00\u985e\u6cd5\u5b9a\u50b3\u67d3\u75c5\u3002 (B)\u88ab\u5bb6\u72ac\u54ac\u50b7\uff0c\u53ef\u66ab\u4e0d\u7528\u7d66\u4e88\u72c2\u72ac\u75c5\u75ab\u82d7\u3002 (C)\u88ab\u91ce\u72d7\u54ac\u50b7\uff0c\u61c9\u7acb\u5373\u6ce8\u5c04\u7b2c\u4e00\u5291\u72c2\u72ac\u75c5\u75ab\u82d7\uff0c\u53ef\u80fd\u7684\u8a71\u89c0\u5bdf\u8a72\u91ce\u72d710\u65e5\uff0c\u5982\u7121\u75c7\u72c0\uff0c\u53ef\u505c\u6b62\u63a5\u7a2e\u75ab\u82d7\u3002 (D)\u88ab\u91ce\u72d7\u54ac\u50b7\uff0c\u5982\u50b7\u53e3\u66b4\u9732\u7b49\u7d1a\u70ba\u7b2c\u4e8c\u985e\uff0c\u5efa\u8b70\u540c\u6642\u6ce8\u5c04\u72c2\u72ac\u75c5\u514d\u75ab\u7403\u86cb\u767d\u3002 (E)\u7b2c\u4e00\u6b21\u66b4\u9732\u5f8c\u72c2\u72ac\u75c5\u75ab\u82d7\u6ce8\u5c04\u4e4b\u5291\u6b21\u70ba 5\u6b21\uff0c\u7b2c\u4e8c\u5291\u75ab\u82d7\u6ce8\u5c04\u65e5\u70ba\u7b2c\u4e00\u5291\u6ce8\u5c04\u5f8c\u7b2c 3\u5929\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5152\u7ae5\u51fa\u75b9\u6027\u75be\u75c5\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba \uff1f", + "Options": "(A)\u65b0\u751f\u5152\u7570\u4f4d\u6027\u76ae\u819a\u708e( atopic dermatitis ) \uff0c\u70ba\u907f\u514d\u4f75\u767c\u7d30\u83cc\u611f\u67d3\uff0c\u61c9\u907f\u514d\u4f7f\u7528\u5c40\u90e8\u985e\u56fa\u9187\u6cbb\u7642\u3002 (B)\u5152\u7ae5\u60a3\u6c34\u75d8( Varicella)\u5982\u9ad8\u71d2\u4e0d\u9000\uff0c\u53ef\u8003\u616e\u4ea4\u66ff\u4f7f\u7528Acetaminophen \u53caAspirin\u4ee5\u52a0\u5f37\u9000\u71d2\u6548\u679c\u3002 (C)\u9ebb\u75b9( Measles) \u3001\u8178\u75c5\u6bd2( Enterovirus )\u53ca\u55ae\u7d14\u76b0\u75b9\u75c5\u6bd2( Herpes simplex virus )\u5747\u6709\u53ef\u80fd\u5f15\u767c\u9ecf\u819c\u8655\u7684\u75c5\u7076\u3002 (D)12\u6b72\u5152\u7ae5\uff0c\u65bc\u982d\u75db\u3001\u767c\u71d2 3\u5929\u5f8c\u51fa\u73fe\u5168\u8eab\u7d05\u75b9\uff0c\u58d3\u8108\u5e36\u6e2c\u8a66\u967d\u6027\uff0c\u61c9\u65bc 1\u9031\u5167\u5411\u75be\u7ba1\u7f72\u901a\u5831\u767b\u9769\u71b1\u3002 (E)\u7329\u7d05\u71b1( Scarlet fever )\u70ba\u5b78\u9f61\u5152\u7ae5\u5e38\u898b\u4e4b\u91d1\u9ec3\u8272\u8461\u8404\u7403\u83cc\u611f\u67d3(Staphylococcus aureus ) \uff0c\u53ef\u9078\u7528 Oxacillin \u6cbb\u7642\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5152\u7ae5\u541e\u98df\u7570\u7269\u7684\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u541e\u98df\u9215\u6263\u96fb\u6c60\u82e5\u7d93 X\u5149\u78ba\u8a8d\u5df2\u5728\u80c3\u90e8\u3001\u82e5\u75c5\u7ae5\u6c92\u6709\u75c7\u72c0\uff0c\u53ef\u4ee5\u5148\u8fd4\u5bb6\u89c0\u5bdf\u5b89\u6392\u9580\u8a3a\u8ffd\u8e64\u3002 (B)\u541e\u98df\u5c16\u92b3\u7269\u82e5\u5df2\u901a\u904e\u5341\u4e8c\u6307\u8178\uff0c\u6700\u5e38\u9020\u6210\u8178\u7a7f\u5b54\u7684\u4f4d\u7f6e\u662f\u5728\u8ff4\u8178\u76f2\u8178\u74e3( ileocecal valve )\u3002 (C)\u5451\u98df\u920d\u7269(\u5982\u786c\u5e63)\u5361\u5728\u98df\u9053\uff0c\u7121\u75c7\u72c0\u8005\u53ef\u4ee5\u5148\u89c0\u5bdf 48\u5c0f\u6642\uff0c\u82e5\u4ecd\u5728\u98df\u9053\u624d\u9808\u79fb\u9664\u3002 (D)\u82e5\u9215\u6263\u96fb\u6c60\u5361\u5728\u98df\u9053\uff0c\u5728 6\u5c0f\u6642\u5167\u53ef\u80fd\u9020\u6210\u98df\u9053\u7a7f\u5b54\u3001\u56e0\u6b64\u9808\u5118\u901f\u79fb\u9664\u3002 (E)\u8aa4\u541e\u5c16\u92b3\u7269\u82e5\u7d93 X\u5149\u78ba\u8a8d\u5df2\u5728\u80c3\u90e8\u3001\u82e5\u75c5\u4eba\u6c92\u6709\u75c7\u72c0\uff0c\u4ecd\u9808\u5118\u901f\u53d6\u51fa\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u660f\u53a5( Syncope) \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u66ab\u6642\u6027\u7684\u610f\u8b58\u53ca\u808c\u8089\u5f35\u529b\u55aa\u5931\u4e4b\u72c0\u614b\uff0c\u5230\u9054\u6025\u8a3a\u6642\uff0c\u5e38\u53ef\u81ea\u767c\u6027\u56de\u5fa9\uff0c\u53ef\u80fd\u6709\u4e00\u534a\u627e\u4e0d\u5230\u539f\u56e0\u3002 (B)\u539f\u56e0\u90fd\u662f\u826f\u6027\u7684\uff0c\u4f8b\u5982\u8840\u7ba1\u8ff7\u8d70\u795e\u7d93\u6027\u6688\u53a5( vasovagal event ) \uff0c\u6240\u4ee5\u8acb\u75c5\u4eba\u4e0d\u5fc5\u64d4\u5fc3\u3002 (C)\u8840\u7ba1\u8ff7\u8d70\u795e\u7d93\u6027\u6688\u53a5( vasovagal event )\u539f\u56e0\u662f\u4ea4\u611f\u795e\u7d93\u592a\u904e\u8208\u596e\uff0c\u5c0e\u81f4\u904e\u5ea6\u5fc3\u8df3\u52a0\u901f\u9020\u6210\u3002 (D)\u9838\u52d5\u8108\u7ac7\u654f\u611f\u75c7( Carotid sinus hypersensitivity )\u5e38\u898b\u7684\u539f\u56e0\u6709\uff1a\u7537\u751f\u522e\u9b0d\u5b50\u3001\u8863\u9818\u592a\u7dca\u3001\u8f49\u982d\u52d5\u4f5c\u3002\u5e38\u898b\u65bc\u5e74\u8f15\u60a3\u8005\u3002 (E)\u820a\u91d1\u5c71\u6688\u53a5\u898f\u5247( San Francisco Syncope Rule)\u53ef\u4ee5\u7be9\u9078\u51fa\u6688\u53a5\u5f8c\u77ed\u6642\u9593\u5167\u5bb9\u6613\u767c\u751f\u4f75\u767c\u75c7\u3001\u9700\u4f4f\u9662\u7684\u60a3\u8005\uff0c\u800c\u4e14\u63a5\u4e0b\u4f86\u7684\u6aa2\u67e5\u5fc5\u9808\u8457\u91cd\u5728\u795e\u7d93\u5b78\u65b9\u9762\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6025\u6027\u51a0\u5fc3\u75c7\u4e4b\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u6839\u64da\u7f8e\u570b\u5fc3\u81df\u5b78\u6703\u6cbb\u7642\u6307\u5f15\u5efa\u8b70\uff0c\u767c\u4f5c\u6642\u9593 \u5c0f\u65bc 12\u5c0f\u6642\u8005\uff0c\u5fc3\u96fb\u5716\u4e0a\u80f8\u524d\u5c0e\u7a0b V1\uff5eV5\u51fa\u73fe ST\u6ce2\u6bb5\u4e0b\u964d 3mm\uff0c\u800c\u50c5 aVR\u4e00\u500b\u5c0e\u7a0b\u51fa\u73fe ST\u6ce2\u6bb5\u4e0a\u5347 \u5927\u65bc 1mm\uff0c\u4ea6\u61c9\u8003\u616e\u7acb\u5373\u9032\u884c\u5fc3\u5c0e\u7ba1\u6aa2\u67e5\u4e26\u65bd\u884c\u51a0\u72c0\u52d5\u8108\u4ecb\u5165\u6cbb\u7642\u3002 (B)\u82e5 V1\uff5eV4\u51fa\u73fe ST\u6ce2\u4e0a\u5347 3mm\uff0c\u75c5\u4eba\u4ecd\u6709\u5287\u70c8\u80f8\u75db\uff0c\u4f46\u8ddd\u96e2\u767c\u4f5c\u6642\u9593\u5df2\u6709 14\u5c0f\u6642\u8005\uff0c\u5247\u4e0d\u8003\u616e\u9032\u884c\u51a0\u72c0\u52d5\u8108\u4ecb\u5165\u6cbb\u7642\u3002 (C)\u82e5\u75c5\u4eba\u5408\u4f75\u56b4\u91cd\u6025\u6027\u80ba\u6c34\u816b\uff0c\u5373\u4f7f\u8ddd\u96e2\u767c\u4f5c\u6642\u9593\u5df2\u8d85\u904e 12\u5c0f\u6642\u4e5f\u61c9\u9032\u884c\u7dca\u6025\u5fc3\u5c0e\u7ba1\u624b\u8853\u6cbb\u7642\u3002 (D)\u82e5\u75c5\u4eba\u5448\u73fe\u56b4\u91cd\u5fc3\u56e0\u6027\u4f11\u514b\uff0c\u5247\u4e0d\u8ad6\u8ddd\u96e2\u767c\u4f5c\u6642\u9593\u591a\u4e45\u7686\u61c9\u8003\u616e\u9032\u884c\u7dca\u6025\u5fc3\u5c0e\u7ba1\u624b\u8853\u6cbb\u7642\u3002 (E)\u82e5\u75c5\u4eba\u70ba\u767c\u4f5c\u5728 12\u5c0f\u6642\u5167\u4e4b ST\u6bb5\u4e0a\u5347\u5fc3\u808c\u6897\u585e( STEMI) \uff0c\u4f60\u7684\u91ab\u9662\u7121\u6cd5\u9032\u884c\u51a0\u72c0\u52d5\u8108\u4ecb\u5165\u6cbb\u7642\uff0c\u800c\u75c5\u4eba\u56e0\u904e\u53bb\u66fe\u6709\u8166\u51fa\u8840\u75c5\u53f2\u800c\u4e0d\u9069\u5408\u9032\u884c\u8840\u6813\u6eb6\u89e3\u6cbb\u7642\uff0c\u5247\u5373\u4f7f\u8f49\u9662\u8eca\u7a0b\u9700\u82b1\u8cbb 1\u500b\u5c0f\u6642\uff0c\u4ea6\u61c9\u8a2d\u6cd5\u8f49\u9662\u9032\u884c\u51a0\u72c0\u52d5\u8108\u4ecb\u5165\u6cbb\u7642\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6025\u6027\u6c23\u5598( asthma)\u4e4b\u6025\u8a3a\u8a55\u4f30\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)FEV1\u5c0f\u65bc 40%\u70ba\u56b4\u91cd\u6c23\u5598\u767c\u4f5c\u3002 (B)\u7d66\u4e88\u6c27\u6c23\u6cbb\u7642\u7dad\u6301 SaO 2\u2267 90%\u3002 (C)\u7d93\u6cbb\u7642\u5f8c FEV1 \u5df2\u9054 50%\u8868\u793a\u6cbb\u7642\u6548\u679c\u597d\uff0c\u53ef\u8003\u616e\u56de\u5bb6\u800c\u4e0d\u9808\u4f4f\u9662\u3002 (D)\u4f4e\u793e\u6703\u7d93\u6fdf\u968e\u5c64\u6216\u6162\u6027\u7cbe\u795e\u75c5\u53f2\u662f\u6c23\u5598\u6b7b\u4ea1\u7684\u5371\u96aa\u56e0\u5b50\u3002 (E)\u6c23\u5598\u5b55\u5a66\u7684\u52d5\u8108\u8840\u6db2\u6c23\u9ad4\u5206\u6790 PaCO 2\u6b63\u5e38\u7bc4\u570d\uff0c\u5e38\u8868\u793a\u8840\u4e2d\u4e8c\u6c27\u5316\u78b3\u5df2\u958b\u59cb\u5806\u7a4d\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6025\u6027\u8179\u75db\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u6025\u6027\u8179\u75db\u75c5\u4eba\u62bd\u8840\u6aa2\u67e5\u767c\u73fe\u767d\u8840\u7403\u6578\u76ee\u6b63\u5e38\uff0c\u7121\u6cd5\u6392\u9664\u662f\u5426\u9700\u8981\u624b\u8853\u3002 (B)\u5e74\u8f15\u5973\u6027\u4e0b\u8179\u75db\u4f86\u8a3a\uff0c\u904e\u53bb\u66fe\u6709\u9aa8\u76c6\u8154\u767c\u708e\u7684\u75c5\u53f2\uff0c\u9700\u8003\u616e\u662f\u5426\u6709\u5b50\u5bae\u5916\u5b55\u4e4b\u53ef\u80fd\u6027\u3002 (C)\u61a9\u5ba4\u708e\u597d\u767c\u65bc\u7537\u6027\u4e14\u96a8\u8457\u5e74\u7d00\u5176\u767c\u751f\u7387\u6703\u96a8\u4e4b\u589e\u52a0\uff0c\u4f4d\u7f6e\u5e38\u898b\u65bc\u4e59\u72c0\u7d50\u8178\u3002 (D)\u5287\u70c8\u4e0a\u8179\u75db\u5408\u4f75\u5641\u5fc3\u3001\u5614\u5410\u3001\u5192\u51b7\u6c57\uff0c\u9808\u8003\u616e\u57f7\u884c\u5fc3\u96fb\u5716\u6aa2\u67e5\u3002 (E)\u8178\u7a7f\u5b54\u75c5\u4eba\u7684\uff38\u5149\u8868\u73fe\uff0c\u9664\u4e86\u5c11\u6578 5%\u75c5\u4eba\u5916\uff0c\u591a\u53ef\u770b\u5230\u6e38\u96e2\u6c23\u9ad4(free air)\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5275\u50b7\u6027\u4e3b\u52d5\u8108\u640d\u50b7\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u6700\u5e38\u767c\u751f\u640d\u50b7\u7684\u90e8\u4f4d\u70ba\u8fd1\u7aef\u964d\u4e3b\u52d5\u8108( proximal descending aorta )\u3002 (B)\u91cf\u6e2c\u56db\u80a2\u8840\u58d3\u53ef\u80fd\u767c\u73fe\u4e0a\u80a2\u9ad8\u8840\u58d3\uff0c\u800c\u4e0b\u80a2\u4f4e\u8840\u58d3\u7684\u73fe\u8c61\u3002 (C)\u5178\u578b\u80f8\u90e8 X\u5149\u7684\u8868\u73fe\u5305\u542b\u9f3b\u80c3\u7ba1\u7684\u4f4d\u7f6e\u504f\u5411\u5de6\u5074\u3002 (D)\u5178\u578b\u80f8\u90e8 X\u5149\u7684\u8868\u73fe\u70ba\u7e31\u8188\u8154\u8b8a\u5bec\uff0c\u5bec\u5ea6\u5927\u65bc 8\u516c\u5206\u3002 (E)\u82e5\u540c\u6642\u51fa\u73fe\u5de6\u5074\u660e\u986f\u8840\u80f8\uff0c\u9700\u7acb\u5373\u5b89\u6392\u624b\u8853\u6cbb\u7642\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8a3a\u65b7\u5fc3\u808c\u6897\u585e\u4e0b\u5217\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)ST\u6bb5\u4e0a\u5347\u5fc3\u808c\u6897\u585e( STEMI)\u5b9a\u7fa9\u70ba\u6709\u5fc3\u808c\u7f3a\u6c27\u7684\u81e8\u5e8a\u75c7\u72c0\uff0c\u540c\u6642\u5fc3\u96fb\u5716\u5448\u73fe ST\u6bb5\u6301\u7e8c\u4e0a\u5347\uff0c\u63a5\u7e8c\u91cb\u653e\u51fa\u5fc3\u808c\u58de\u6b7b\u4e4b\u751f\u7269\u6307\u6a19(biomarker )\u3002 (B)V4\uff5eV6\u7684\u80f8\u524d\u5c0e\u6975\u6709\u9023\u7e8c\u5169\u500b\u4ee5\u4e0a\u7684 ST\u6bb5\u4e0b\u964d\uff0c\u53ef\u80fd\u986f\u793a\u5f8c\u58c1\u5168\u58c1\u5f0f\u640d\u50b7( transmural posterior injury )\u3002 (C)\u75c5\u4eba\u51a0\u72c0\u52d5\u8108\u5de6\u524d\u964d\u652f\u963b\u585e\uff0c\u6703\u770b\u5230\u5fc3\u96fb\u5716\u591a\u500b\u5c0e\u6975 ST\u6bb5\u4e0b\u964d\u5408\u4f75aVR ST\u6bb5\u4e0a\u5347\uff0c\u5fc5\u9808\u8996\u70ba ST\u6bb5\u4e0a\u5347\u5fc3\u808c\u6897\u585e( STEMI)\u7a4d\u6975\u91cd\u65b0\u704c\u6d41\u51a0\u72c0\u52d5\u8108\u3002 (D)\u7d93\u80f8\u58c1\u5fc3\u81df\u8d85\u97f3\u6ce2( Transthoracic echocardiography )\u6703\u770b\u5230\u5c40\u90e8\u5fc3\u5ba4\u58c1\u6d3b\u52d5\u5f62\u6cc1\u4e0d\u4f73\uff0c\u56e0\u6b64\u53ef\u7528\u65bc\u8f14\u52a9\u8a3a\u65b7\u3002 (E)\u5fc3\u808c\u91cb\u653e\u7684 Troponin(Cardiac Troponin \uff0ccTn)\u662f\u8a3a\u65b7\u5fc3\u808c\u6897\u585e\u9996\u9078\u7684\u751f\u7269\u6027\u6307\u6a19\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8178\u75c5\u6bd2\u91cd\u75c7\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u53f0\u7063\u5730\u5340\u4e3b\u8981\u7531\u8178\u75c5\u6bd2 71\u578b\u5f15\u8d77\u3002 (B)\u76f4\u63a5\u81f4\u6b7b\u539f\u56e0\u70ba\u814e\u8870\u7aed\u3002 (C)\u4f75\u767c\u91cd\u75c7\u7684\u60a3\u8005\u5927\u90e8\u5206\u5747\u6709\u8166\u5e79\u8166\u708e( brain stem encephalitis )\u3002 (D)\u6301\u7e8c\u660f\u7761\u3001\u6301\u7e8c\u5614\u5410\u53ca\u808c\u8e8d\u578b\u62bd\u6410( myoclonic jerks )\u70ba\u91cd\u75c7\u4e09\u5927\u524d\u5146\u3002 (E)\u91cd\u75c7\u75c5\u4eba\u7684\u81f4\u6b7b\u7387\u7d04 3\uff5e20\uff05\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8179\u819c\u900f\u6790( peritoneal dialysis )\u7684\u8179\u819c\u708e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u6297\u751f\u7d20\u53ef\u5148\u7d66\u4e88\u7b2c\u4e00\u4ee3\u7684 cephalosporin \u3002 (B)\u6cbb\u7642\u65b9\u9762\u53ef\u4ee5\u5c07\u6297\u751f\u7d20\u52a0\u5165\u900f\u6790\u6db2\u4e2d\uff0c\u4e0d\u9808\u4f7f\u7528\u975c\u8108\u7d66\u4e88\u3002 (C)\u9020\u6210\u8179\u819c\u708e\u6700\u5e38\u898b\u7684\u83cc\u7a2e\u662f Staphylococcus aureus \uff0c\u7d04\u4f54 40%\u3002 (D)\u5efa\u8b70\u6cbb\u7642\u7684\u671f\u9593\u70ba 7\uff5e10\u5929\u3002 (E)\u900f\u6790\u6db2\u5167\u767d\u8840\u7403\u7d30\u80de\u6578\u901a\u5e38\u5927\u65bc 100/mm3\uff0c\u55dc\u4e2d\u6027\u767d\u8840\u7403\u5927\u65bc50%\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8180\u80f1\u7834\u88c2( bladder rupture ) \uff0c\u4e0b\u5217\u63cf\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u8179\u819c\u5916\u7834\u88c2( Extraperitoneal rupture )\u8f03\u8179\u819c\u5167\u7834\u88c2( Intraperitoneal rupture)\u6613\u6709\u611f\u67d3\u53ca\u8179\u5167\u81bf\u760d\u5f62\u6210\u7684\u98a8\u96aa\u3002 (B)\u8179\u819c\u5916\u7834\u88c2\u8f03\u8179\u819c\u5167\u7834\u88c2\u5e38\u898b\u3002 (C)\u8180\u80f1\u8179\u819c\u5916\u7834\u88c2\u7684\u6cbb\u7642\u70ba\u63d2\u5c3f\u7ba1\u5f15\u6d41\u3002 (D)\u8180\u80f1\u8179\u819c\u5167\u7834\u88c2\u9700\u624b\u8853\u63a2\u67e5\u53ca\u8180\u80f1\u4fee\u88dc\u3002 (E)\u8a3a\u65b7\u7684\u9ec3\u91d1\u6a19\u6e96\u70ba\u9006\u884c\u6027\u8180\u80f1\u651d\u5f71( retrograde cystogram )\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u7cd6\u5c3f\u75c5\u916e\u9178\u4e2d\u6bd2( Diabetic Ketoacidosis ) \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u53ea\u767c\u751f\u65bc\u80f0\u5cf6\u7d20\u4f9d\u8cf4\u578b\u7684\u60a3\u8005\u3002 (B)\u62bd\u8840\u6578\u503c\u8840\u7cd6 \u5927\u65bc 400mg/dl \uff0canion gap \u5927\u65bc 10\uff0cbicaronate \u5c0f\u65bc 15 mEq/L\uff0cpH\u5c0f\u65bc 7.3\u70ba\u5176\u8a3a\u65b7\u6a19\u6e96\u3002 (C)\u6cbb\u7642\u4e0a\u7531\u65bc\u75c5\u4eba\u7f3a\u5c11\u6c34\u4efd \uff0c\u5efa\u8b70\u5148\u5f9e 0.45% normal saline \u958b\u59cb\u7d66\u3002 (D)\u75c5\u7a0b\u767c\u5c55\u6642\u9593\u901a\u5e38\u6bd4\u9ad8\u6ef2\u900f\u58d3\u975e\u916e\u9178\u660f\u8ff7\u4f86\u5f97\u4e45\u3002 (E)\u60a3\u8005\u5927\u7d04\u7f3a\u5c11 5\uff5e10\u516c\u5347\u7684\u6c34\u4efd\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8f3b\u5c04\u50b7\u5bb3\uff0c\u4e0b\u5217\u6558\u8ff0\u8207\u8655\u7406\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u5168\u8eab\u6027\u8f3b\u5c04\u50b7\u5bb3\u8981\u6536\u96c6\u75c5\u4eba\u8eab\u9ad4\u7684\u6392\u51fa\u7269\uff0c\u542b\u75f0\u6db2\u3001\u5c3f\u6db2\u3001\u7cde\u4fbf\u3001\u5614\u5410\u7269\u4f5c\u653e\u5c04\u6027\u540c\u4f4d\u7d20\u5206\u6790\u3002 (B)\u53ea\u6709\u8f3b\u5c04\u9ad4\u5167\u6c61\u67d3\u75c5 \u4eba\u61c9\u8207\u5168\u8eab\u6027\u8f3b\u5c04\u50b7\u5bb3\u75c5\u4eba\u4e00\u6a23\u8a18\u9304\u4e0b\u6240\u6709\u75c7\u72c0\u767c\u751f\u7684\u8d77\u59cb\u6642\u9593\u3002 (C)\u75c5\u4eba\u5373\u4f7f\u53ea\u662f\u9ad4\u5916\u6c61\u67d3\uff0c\u4ecd\u61c9\u53d6\u5f97\u75c5 \u4eba\u7684CBC/DC \u548curinalysis \u3002 (D)\u75c5\u4eba\u5168\u8eab\u5728 30Gy\u9ad8\u66b4\u9732\u5291\u91cf\u4e0b\uff0c\u5728 3\u65e5\u5f8c\u767c\u751f\u56b4\u91cd\u4f11\u514b\u3001\u5faa\u74b0\u7cfb\u7d71\u5d29\u6f70\u800c\u6b7b\u4ea1\u3002 (E)\u75c5\u4eba\u5168\u8eab\u5728 4Gy\u66b4\u9732\u5291\u91cf\u4e0b\uff0c\u7d93\u904e 3\u661f\u671f\u6f5b\u4f0f\u671f\u5f8c\u767c\u751f\u6025\u6027Hematopoietic syndrome (\u9aa8\u9ad3\u9020\u8840\u75c7\u5019\u7fa4) \uff0c\u53ef\u80fd\u767c\u751f\u611f\u67d3\u53ca\u51fa\u8840\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u95cc\u5c3e\u708e( Appendicitis )\u7684\u8d85\u97f3\u6ce2\u8a3a\u65b7\uff0c\u4ee5\u4e0b\u8005\u70ba \u932f\u8aa4\uff1f", + "Options": "(A)\u8d85\u97f3\u6ce2\u4e0b\u70ba\u4e00\u7ba1\u72c0\u69cb\u9020\uff0c\u5927\u591a\u6c92\u6709\u8178\u8815\u52d5\u4e5f\u7121\u6cd5\u58d3\u6241\u3002 (B)\u7ba1\u72c0\u69cb\u9020\u4e4b\u6a6b\u65b7\u9762\u76f4\u5f91\u5927\u65bc 3mm\u5373\u53ef\u4ee5\u78ba\u5b9a\u8a3a\u65b7\u3002 (C)\u95cc\u5c3e\u4e2d\u6709\u6642\u53ef\u898b\u5230\u7cde\u77f3( faecoliths )\u3002 (D)\u82e5\u7ba1\u72c0\u69cb\u9020\u5468\u570d\u6709\u6db2\u9ad4\u7a4d\u7559\u6216\u81bf\u760d\u5f62\u6210\u5247\u53ef\u80fd\u70ba\u95cc\u5c3e\u708e\u7834\u88c2\u3002 (E)\u6a6b\u65b7\u9762\u901a\u5e38\u53ef\u898b\u8f03\u9ad8\u8ff4\u97f3( Echogenic )\u7684\u9ecf\u819c\u5c64\u53ca\u5916\u570d\u8f03\u4f4e\u8ff4\u97f3(Hypoechoic )\u7684\u6c34\u816b\u808c\u8089\u5c64\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u7206\u70b8\u50b7\u5bb3( Blast injuries) \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u53ef\u80fd\u6703\u9020\u6210\u52d5\u8108\u6c23\u9ad4\u6813\u585e\u800c\u7522\u751f\u795e\u7d93\u5b78\u75c7\u72c0\u3002 (B)\u521d\u7d1a\u7206\u70b8\u50b7\u5bb3\u7684\u50b7\u60a3\u6b7b\u4ea1\u6700\u5e38\u898b\u539f\u56e0\u4f86\u81ea\u8179\u8154\u5167\u51fa\u8840\u3002 (C)\u521d\u7d1a\u7206\u70b8\u50b7\u5bb3\u5bb9\u6613\u5f71\u97ff\u5230\u65bc\u50b7\u60a3\u7684\u807d\u529b\u7cfb\u7d71\u3001\u547c\u5438\u7cfb\u7d71\u53ca\u8178\u80c3\u7cfb\u7d71\u3002 (D)\u521d\u7d1a\u7206\u70b8\u50b7\u5bb3\u53ef\u80fd\u6703\u9020\u6210\u50b7\u60a3\u5ef6\u9072\u6027\u8178\u80c3\u9053\u7834\u88c2\uff0c\u6240\u4ee5\u50b7\u60a3\u751a\u81f3\u8981\u89c0\u5bdf\u5230 48\u5c0f\u6642\u4f86\u78ba\u8a8d\u3002 (E)\u50b7\u60a3\u56e0\u7206\u70b8\u800c\u9020\u6210\u55ae\u7368\u7684\u8033\u819c\u7834\u88c2\u50b7\u5bb3\uff0c\u901a\u5e38\u4ecd\u61c9\u63a5\u53d7 \u80f8\u90e8 X\u5149\u7684\u6aa2\u67e5\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u7672\u7647\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u7672\u7647\u91cd\u7a4d\u72c0\u614b( status epilepticus )\u662f\u6301\u7e8c\u6216\u9593\u6b47\u7672\u7647\u767c\u4f5c\u8d85\u904e 5\u5206\u9418\u4e14\u7121\u610f\u8b58\u56de\u5fa9\u3002(B)\u9152\u7cbe\u6212\u65b7\u5f15\u8d77\u4e4b\u7672\u7647\u901a\u5e38\u4e0d\u9700\u8981\u9577\u671f\u7684\u6297\u7672\u7647\u85e5\u7269\u6cbb\u7642\u3002(C)\u6297\u7672\u7647\u85e5\u7269\u6709\u81f4\u7578\u80ce\u6027\uff0c\u4e0d\u5efa\u8b70\u6301\u7e8c\u4f7f\u7528\u65bc\u7672\u7647\u75c5\u53f2\u8207\u7672\u7647\u75c7\u72c0\u7684\u5b55\u5a66\u3002(D)\u7672\u7647\u60a3\u8005\u4f7f\u7528 lorazepam \u8207phenytoin \u6cbb\u7642\u53cd\u61c9\u4e0d\u4f73\u6642\uff0c\u4f7f\u7528barbiturates \u53ef\u80fd\u4e5f\u7121\u53cd\u61c9\u3002(E)\u61f7\u7591\u7d30\u83cc\u6027\u8166\u819c\u708e\u7684\u60a3\u8005\uff0c\u5373\u9700\u958b\u59cb\u4f7f\u7528\u7d93\u9a57\u6027( empiric)\u6297\u751f\u7d20\u6cbb\u7642\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "18\u6b72\u5973\u6027\u6709\u81ea\u9ad4\u514d\u75ab\u6eb6\u8840\u6027\u8ca7\u8840 (Autoimmune Hemolyti c Anemia)\u75c5\u53f2\uff0c5\u5929\u5167\u81c9\u8272\u84bc\u767d\u4e26\u6709\u547c\u5438\u6025\u4fc3\u800c\u6c42\u8a3a\u3002\u6709\u95dc\u6b64\u75c5\u4eba\u4e4b\u8655\u7f6e\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u7b2c\u4e00\u7dda\u6cbb\u7642\u662f\u7528\u9ad8\u5291\u91cf\u76ae\u8cea\u985e\u56fa\u9187\u3002 (B)\u53ef\u4f7f\u7528 azathioprine 2~4mg/kg/day \u6216cyclosporine \u7b49\u6297\u514d\u75ab\u85e5\u7269\u4f86\u6e1b\u5c11\u985e\u56fa\u9187\u5291\u91cf\u3002 (C)\u63a5\u53d7\u813e \u5207\u9664(Splenectomy )\u5f8c\uff0c\u53ef\u75ca\u7652\u6c38\u9060\u4e0d\u518d\u5fa9\u767c\u3002 (D)\u813e\u5207\u9664\u5f8c\u70ba\u9810\u9632\u7522\u751f overwhelming post -splenectomy infection \uff0c\u75c5\u4eba\u61c9\u6ce8\u5c04\u93c8\u7403\u83cc\u75ab\u82d7\u3002 (E)\u6025\u6027\u671f\u9664\u88dc\u5145\u7d05\u8840\u7403\u6fc3\u539a\u6db2 (PRBC)\u5916\uff0c\u8840\u6f3f\u900f\u6790\u6216\u63db\u8840\u4e5f\u80fd\u6709\u6548\u79fb\u9664\u81ea\u9ad4\u6297\u9ad4\u6fc3\u5ea6\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "1\u6b72\u5b30\u5152\u767c\u71d2\uff0c\u7121\u660e\u986f\u611f\u67d3\u6e90\uff0c\u4e0b\uf99c\u8aaa\u660e\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u4e0d\u9808\u4f8b\u884c\u6027\u505a\u5c3f\u6db2\u5206\u6790\u3002 (B)\u6709\u6ccc\u5c3f\u9053\u611f\u67d3\u98a8\u96aa\u8005\uff0c\u82e5\u5c3f\u6db2\u5206\u6790\u70ba\u9670\u6027\u5247\u4e0d\u9808\u505a\u7d30\u83cc\u57f9\u990a\u3002 (C)\u5c3f\u6db2\u683c\u862d\u6c0f\u67d3\u8272\u9032\u884c\u7d30\u83cc\u9451\u5b9a\uff0c\u8a3a\u65b7\u6ccc\u5c3f\u9053\u611f\u67d3\u4e4b\u654f\u611f\u6027\u8207\u5c08\u4e00\u6027\u5c0f\u65bc60%\u3002 (D)\u5c3f\u888b\u6536\u96c6\u6aa2\u9ad4 (bag collection specimen )\u5224\u65b7\u6ccc\u5c3f\u9053\u611f\u67d3\u7684\u6b63\u78ba\u6027\u5f88\u4f4e\u3002 (E)\u61c9\u7acb\u5373\u4f7f\u7528\u6297\u751f\u7d20\uff0c\u4e0d\u9808\u7b49\u6536\u5230\u5c3f\u6db2\u6aa2\u9ad4\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "23\u6b72\u7537\u6027\u4e00\u9031\u524d\u81ea\u975e\u6d32\u8056\u591a\u7f8e\u666e\u6797\u897f\u6bd4\u8fd4\u56de\u53f0\u7063\u3002\u5230\u6025\u8a3a\u4e3b\u8a34\u9ad8\u71d2 40.2\u2103\u3001\u986b\u6296\u3001\u5168\u8eab\u7121\u529b\u4ee5\u53ca\u8179\u75db\u3002\u8108\u640f 122\u4e0b/min\u3001\u547c\u5438 24\u6b21/min\u3002\u8eab\u4e0a\u6c92\u6709\u660e\u986f\u7d05\u75b9\uff0c\u4e5f\u6c92\u6709\u95dc\u7bc0\u75bc\u75db\u3002\u5be6\u9a57\u5ba4\u6aa2\u67e5\u767c\u73fe total bilirubin 4.9mg/dL \u3001direct bilirubin 1.1mg/dL \u3001SGPT(ALT) 247 U/L\u3001SGOT(AST)236 U/L\u3002\u8d85\u97f3\u6ce2\u6aa2\u67e5\u767c\u73fe\u809d\u81df\u816b\u5927\uff0c\u6c92\u6709\u81bd\u7d50\u77f3\u6216\u81bd\u7ba1\u64f4\u5927\uff0c\u4e5f\u6c92\u6709\u767c\u73fe\u809d\u81bf\u760d\u3002\u4e0b\uf99c\u4f55\u8005\u6aa2\u67e5\u6700\u6709\u52a9\u65bc \u8a3a\u65b7\uff1f", + "Options": "(A)\u8840\u6db2\u62b9\u7247 (blood smear )\u3002 (B)\u809d\u708e\u6a19\u8a18 (hepatitis markers )\u3002 (C)\u9264\u7aef\u87ba\u65cb\u9ad4\u986f\u5fae\u51dd\u96c6\u6e2c\u8a66 (Leptospiral microscopic agglutination test )\u3002 (D)\u8179\u90e8\u96fb\u8166\u65b7\u5c64\u3002 (E)\u7cde\u4fbf\u6aa2\u67e5\u5bc4\u751f\u87f2\u53ca\u87f2\u5375\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "27\u6b72\u7537\u6027\uff0c\u6f5b\u6c34\u6642\u88ab\u77f3\u72d7\u516c (stonefish)\u523a\u50b7\u5de6\u624b\u638c\uff0c\u5c40\u90e8\u7d05\u816b\uff0c\u4e26\u9010\u6f38\u5411\u624b\u81c2\u5ef6\u4f38\u816b\u8139\uff0c\u75bc\u75db\u4e0d\u582a\uff0c\u56e0\u800c\u5c31\u91ab\u3002\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\uff0c\u7121\u547c\u5438\u5598\u6216\u662f\u5fc3\u81df\u4e0d\u9069\u4e4b\u611f\u3002\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u5c40\u90e8\u6d78\u6ce1\u71b1\u6c34\u3002 (B)\u8981\u4f7f\u7528\u89e3\u6bd2\u8840\u6e05 (antivenom )\u3002 (C)\u8981\u6ce8\u5c04\u6297\u751f\u7d20\u3002 (D)\u5e38\u898b\u51fa\u8840\u6027\u4e2d\u6bd2\u53cd\u61c9\u3002 (E)\u4f7f\u7528\u5927\u91cf\u975c\u8108\u8f38\u6db2\u6cbb\u7642\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "28\u6b72\u5973\u6027\u61f7\u5b55 26\u9031\uff0c\u904e\u99ac\u8def\u6642\u88ab\u516c\u8eca\u649e\u5230\uff0c\u6551\u8b77\u8eca\u9001\u81f3\u6025\u8a3a\u6642\u610f\u8b58\u6e05\u695a\uff0c\u547c\u5438 26\u6b21/min\u3001\u8108\u640f 140\u4e0b/min\u3001\u8840\u58d3 80/50mmHg \u3001\u9ad4\u6eab 36\u2103\u3002\u75c5\u4eba\u4e3b\u8a34\u8179\u75db\u4f75\u5c11\u91cf\u9670\u9053\u51fa\u8840\u3002\u95dc\u65bc\u9019\u4f4d\u75c5\u4eba\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u53ef\u63a1 \u5de6\u5074\u8eba\u59ff\u52e2\uff0c\u907f\u514d\u5b50\u5bae\u58d3\u8feb\u4e0b\u8154\u975c\u8108\u3002 (B)\u6b64 \u75c5\u4eba\u5b50\u5bae\u5e95\u7684\u9ad8\u5ea6\uff0c\u61c9\u8a72\u5728\u809a\u81cd\u7684\u9ad8\u5ea6\u4ee5\u4e0a\u3002 (C)\u6b64 \u75c5\u4eba\u5931\u8840\u91cf\u53ef\u80fd\u5df2\u7d93\u9054\u7e3d\u8840\u91cf\u7684 30%\u4ee5\u4e0a\u3002 (D)\u6aa2\u6e2c\u9670\u9053\u5206\u6ccc\u7269\u4e4b pH\u70ba7.0\uff0c\u9700\u9ad8\u5ea6\u61f7\u7591\u7f8a\u819c\u7834\u88c2 (amniotic membrane rupture)\u3002 (E)\u6b64 \u75c5\u4eba\u8840\u578b\u70ba Rh\u9670\u6027\uff0c\u80ce\u5152\u7236\u89aa\u8840\u578b\u4ea6\u70ba Rh\u9670\u6027\uff0c\u5247 Rh0(D) immunoglobulin \u5291\u91cf\u9700\u52a0\u500d\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "28\u6b72\u7537\u6027\u96fb\u8166\u7dad\u4fee\u54e1\uff0c\u5de5\u4f5c\u6642\u4e0d\u614e\u88ab\u6c2b\u6c1f\u9178\u5674\u6ffa \u5230\u624b\u80cc\u548c\u624b\u81c2\uff0c\u5c40\u90e8\u7d05\u816b\u5287\u75db\uff0c\u6c96\u6d17\u5f8c\u7acb\u5373\u5c31\u91ab\u3002\u8a3a\u5bdf\u5f8c\uff0c\u624b\u80cc\u8207\u624b\u81c2\u51fa\u73fe\u5c40\u90e8\u8150\u8755\u6027\u5916\u89c0\uff0c\u75bc\u75db\u96e3\u8010\uff0c\u6e2c\u5f97\u751f\u547d\u5fb5\u8c61\uff1a\u8840\u58d3 127/51 mmHg \uff0c\u547c\u5438 16\u6b21/min\uff0c\u8108\u640f 52\u4e0b/min\uff0c\u9ad4\u6eab 36.2\u2103\uff0c\u610f\u8b58\u6e05\u695a\u3002\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u4f7f\u7528\u5927\u91cf\u6e05\u6c34\u6c96\u6d17\uff0c\u76f4\u5230\u75bc\u75db\u6d88\u5931\u3002 (B)\u4f7f\u7528\u6c27\u5316\u9382\u8edf\u818f\u5c40\u90e8\u5857\u62b9\uff0c\u4e26\u6ce8\u5c04\u8461\u8404\u7cd6\u9178\u9223 (Calcium Gluconate )\u6eb6\u6db2\u3002 (C)\u816b\u75db\u56b4\u91cd\uff0c\u65bd\u884c\u7b4b\u819c\u5207\u958b\u8853 (fasciotomy )\u3002 (D)\u4f7f\u7528\u9810\u9632\u6027\u6297\u751f\u7d20\u3002 (E)\u51fa\u73fe\u9ad8\u8840\u9223\uff0c\u9ad8\u8840\u9382\uff0c\u4f4e\u8840\u9240\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "30\u6b72\u5973\u6027\u56e0\u9ad8\u71d2\u3001\u54b3\u55fd\u53ca\u865b\u5f31\u7121\u529b\u9001\u5165\u6025\u8a3a\uff0c\u5728\u6025\u8a3a\u9ad4\u6eab 38.5\u2103\u3001\u8840\u58d3110/70mmHg \u3001\u8108\u640f 105\u4e0b/min\u3001\u8840\u6c27\u6fc3\u5ea6\u70ba 95%\u3002\u7406\u5b78\u6aa2\u67e5\u767c\u73fe\u75c5\u4eba\u624b\u81c2\u6709\u591a\u8655\u91dd\u5b54\uff0c\u4e26\u6709\u5fc3\u96dc\u97f3\u3002\u80ba\u90e8 X\u5149\u53ca\u5c3f\u6db2\u6aa2\u67e5\u5747\u7121\u7570\u5e38\u3002\u5247\u4ee5\u4e0b\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u6b64\u60a3\u8005\u9700\u6703\u8a3a\u5fc3\u81df\u79d1\u5b89\u6392\u5fc3\u81df\u8d85\u97f3\u6ce2\u3002 (B)\u82e5\u5169\u6b21\u8840\u6db2\u57f9\u990a\u51fa\u7d30\u83cc\u53ef\u8996\u70ba\u8a3a\u65b7\u611f\u67d3\u6027\u5fc3\u5167\u819c\u708e\u7684\u4e3b\u8981\u8981\u4ef6 (major criteria)\u3002 (C)\u767c\u71d2\u8d85\u904e 38\u2103\u4e5f\u662f\u8a3a\u65b7\u7684\u4e3b\u8981\u8981\u4ef6\u4e4b\u4e00\u3002 (D)\u4f7f\u7528 Vancomycin + Gentamicin + Nafcillin \u6cbb\u7642\u3002 (E)\u6709\u4e00\u90e8\u5206\u75c5\u4eba \u53ef\u4ee5\u5728\u624b\u638c\u53ca\u8173\u638c\u770b\u5230\u7121\u75db\u6027\u7684\u51fa\u8840\u9ede\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "32\u6b72\u5973\u6027\u56e0\u670d\u7528\u8fb2\u85e5\u81ea\u6bba\u9001\u91ab\u3002\u75c5\u4eba\u72c0\u4f3c\u75db\u82e6\uff0c\u5614\u5410\uff0c\u53e3\u5410\u6de1\u85cd\u7da0\u8272\u6ce1\u6cab\uff0c\u547c\u5438\u5598\u3002\u8840\u58d3 92/60 mmHg \uff0c \u547c\u5438 26\u6b21/min\uff0c\u8108\u640f 114\u4e0b/min\uff0c\u9ad4\u6eab 36\u2103\uff0c\u8840\u6c27\u6fc3\u5ea6\u70ba 88%\uff0c\u75c5\u4eba\u53e3\u5167\u9ecf\u819c\u6709\u71d2\u707c\u75d5\u8de1\u3002\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u6700 \u9069\u7576\uff1f", + "Options": "(A)\u5728\u5118\u5feb\u7684\u6642\u9593\uff0c\u7d66\u4e88\u6c27\u6c23\uff0c\u6e1b\u5c11\u80ba\u6ce1\u7e96\u7dad\u7522\u751f\u3002 (B)6\u5c0f\u6642\u5167\u8840\u6db2\u900f\u6790( Hemodialysis )\u6709\u5e6b\u52a9\u3002 (C)\u7d93\u6b63\u5e38\u76ae\u819a\u5438\u6536\u826f\u597d\uff0c\u76ae\u819a\u63a5\u89f8\u5f8c\u5f88\u5bb9\u6613\u4e2d\u6bd2\u3002 (D)\u8840\u6db2\u4e2d\u6fc3\u5ea6\u70ba\u5224\u65b7\u9810\u5f8c\u91cd\u8981\u4f9d\u64da\u3002 (E)\u7d66\u4e88\u6297\u6c27\u5316\u5291\uff0c\u5982 superoxide dismutase \u53ef\u4ee5\u6291\u5236\u7269\u8cea\u9032\u5165\u80ba\u6ce1\u7d30\u80de\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "36\u6b72\u6709\u7cd6\u5c3f\u75c5\u53f2\u61f7\u5b55 8\u500b\u6708\u7684\u5b55\u5a66\uff0c\u7b49\u5019\u7522\u6aa2\u6642\u88ab\u76ee\u64ca\u5012\u4e0b\uff0c\u4f60\u662f\u7b2c\u4e00\u4f4d\u5230\u5834\u7684\u91ab\u8b77\u4eba\u54e1\uff0c\u4f9d\u64da 2015\u5e74AHA\u4e4bACLS\u6307\u5f15\u958b\u59cb\u9032\u884c\u6025\u6551\uff0c\u4ee5\u4e0b\u54ea\u500b\u8655\u7f6e\u932f\u8aa4\uff1f", + "Options": "(A)\u767c\u73fe\u60a3\u8005\u6c92\u6709\u53cd\u61c9 \u8207\u547c\u5438\uff0c\u7acb\u523b\u8acb\u8a3a\u9593\u8b77\u58eb\u555f\u52d5\u9662\u5167\u7dca\u6025\u61c9\u8b8a\u7cfb\u7d71\u53d6\u5f97\u96fb\u64ca\u5668\u8207\u652f\u63f4 \u3002 (B)\u5c07\u60a3\u8005\u5074\u50be 27~30\u5ea6\u6703\u6709\u5229\u65bc\u9ad8\u54c1\u8cea CPR\u7684\u9032\u884c\u3002 (C)\u7576\u60a3\u8005\u5fc3\u8df3\u505c\u6b62 4\u5206\u9418\u5f8c\uff0c\u61c9\u8003\u616e\u9032\u884c\u7015\u6b7b\u5256\u8179\u751f\u7522 (Perimortem Cesarean Delivery \uff0cPMCD)\u3002 (D)\u4e0d\u9700\u4f7f\u7528 Vasopressin \u66ff\u4ee3\u7b2c\u4e8c\u5291\u7684 Epinephrine \u3002 (E)\u5982\u679c\u60a3\u8005\u6062\u5fa9\u5fc3\u8df3\u547c\u5438\u53ef\u4ee5\u8003\u616e\u5c07\u60a3\u8005\u57f7\u884c\u4f4e\u6eab\u6cbb\u7642\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "38\u6b72\u7537\u6027\u8eca\u798d\u5f8c\u4e3b\u8a34\u56db\u80a2\u9ebb\u4e14\u7121\u529b\uff0c\u751f\u547d\u5fb5\u8c61\u5982\u4e0b\uff1a\u8108\u640f 88\u4e0b/min\uff0c\u8840\u58d370/40mmHg \uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u9700\u5148\u6392\u9664\u5176\u4ed6\u53ef\u80fd\u5c0e\u81f4\u4f11\u514b\u7684\u539f\u56e0\u5f8c\u624d\u61f7\u7591\u662f\u795e\u7d93\u6027\u4f11\u514b\u3002 (B)\u795e\u7d93\u6027\u4f11\u514b\u4e4b\u81e8\u5e8a\u8868\u5fb5\u70ba\u4f4e\u8840\u58d3\u3001\u8108\u640f\u6162\u53ca\u56db\u80a2\u51b0\u51b7\u3002 (C)\u82e5\u61f7\u7591\u795e\u7d93\u6027\u4f11\u514b\u7576\u7d66\u4e88\u9069\u7576\u4e4b\u6c34\u5206\u5f8c\u53ef\u4f7f\u7528\u5347\u58d3\u5291\u3002 (D)\u7b2c\u4e94\u9838\u690e\u4ee5\u4e0a\u4e4b\u810a\u9ad3\u640d\u50b7\u53ef\u80fd\u9020\u6210\u75c5\u4eba\u8188\u795e\u7d93\u640d\u50b7\u3002 (E)\u5c0d\u65bc\u632b\u50b7\u5c0e\u81f4\u4e4b\u810a\u9ad3\u640d\u50b7\u4f7f\u7528\u9ad8\u5291\u91cf\u985e\u56fa\u9187\u4ecd\u6709\u722d\u8b70\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "39\u9031\u81ea\u7136\u7522\u5973\u5b30\u51fa\u751f\u6642\u5448\u73fe\u767c\u7d3a\uff0c\u6d3b\u52d5\u529b\u4e0d\u4f73\uff0c\u8108\u640f 40\u4e0b/min\uff0c\u4f7f\u7528\u888b\u74e3\u7f69\u6b63\u58d3\u901a\u6c23\u8207\u80f8\u90e8\u6309\u58d3 60\u79d2\u5f8c\uff0c\u8108\u640f\u4ecd\u5c0f\u65bc 60\u4e0b/min\uff0c\u8acb\u554f\u63a5\u4e0b\u4f86\u8655\u7f6e\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5efa\u7acb\u6c23\u7ba1\u5167\u7ba1\uff0c\u975c\u8108\u6ce8\u5c04 Epinephrine \u3002 (B)\u6301\u7e8c 30\uff1a2\u7684\u80f8\u90e8\u6309\u58d3\u8207\u901a\u6c23 1\u5206\u9418\u3002 (C)\u5efa\u7acb\u6c23\u7ba1\u5167\u7ba1\uff0c\u975c\u8108\u6ce8\u5c04 Atropine\u3002 (D)\u505c\u6b62\u58d3\u80f8\uff0c\u958b\u59cb\u4ee5\u6c27\u6c23\u901a\u6c23\u3002 (E)\u505c\u6b62\u58d3\u80f8\uff0c\u5efa\u7acb\u6c23\u7ba1\u5167\u7ba1\u4ee5\u7a7a\u6c23\u901a\u6c23\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "40\u6b72\u7537\u6027\u56e0\u70ba\u4e0d\u660e\u539f\u56e0\u5598\u4e86\u5169\u5929\u800c\u88ab\u9001\u9032\u6025\u8a3a\u5ba4\uff0c\u5f8c\u4f86\u8a3a\u65b7\u70ba\u80ba\u6813\u585e\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u80ba\u6813\u585e\u5e38\u898b\u75c7\u72c0\u70ba\u4f4e\u8840\u6c27\u3001\u5fc3\u8df3\u5feb\u3001\u547c\u5438\u5feb\u3001\u54b3\u8840\u3001\u5192\u51b7\u6c57\u53ca\u767c\u71d2\u3002 (B)\u7d04\u6709 50%\u6a5f\u6703\u5728\u60a3\u8005\u8eab\u4e0a\u767c\u73fe\u6df1\u90e8\u975c\u8108\u6813\u585e (Deep Vein Thrombosis \uff0cDVT)\u3002 (C)\u5982\u679c\u8ca0\u8cac\u8a3a\u65b7\u7684\u6025\u8a3a\u91ab\u5e2b\u8a8d\u70ba\u75c5\u4eba\u5f97\u5230\u80ba\u6813\u585e\u7684\u98a8\u96aa\u6975\u4f4e\uff0c\u800c\u4e14Pulmonary Embolism Rule -Out Criteria (PERC Rule )\u6bcf\u4e00\u9805\u90fd\u7b26\u5408\uff0c\u4e0d\u518d\u5b89\u6392\u95dc\u65bc\u80ba\u6813\u585e\u7684\u6aa2\u67e5\u662f\u5408\u7406\u7684\u3002 (D)\u75c7\u72c0\u7684\u56b4\u91cd\u7a0b\u5ea6\u8207\u5728\u80ba\u52d5\u8108\u5167\u7684\u6813\u585e\u5927\u5c0f\u6709\u95dc\u3002 (E)\u75c5\u4eba\u8840\u58d3\u4e0b\u964d\u5230 80/50 mmHg \uff0c\u6b64\u6642\u53ef\u5b9a\u7fa9\u70ba\u5927\u91cf\u80ba\u6813\u585e (massive PE)\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "42\u6b72\u7537\u6027\uff0c\u56e0\u70ba\u6025\u6027\u75c5\u75c7\uff0c\u5728\u4e2d\u570b\u5927\u9678\u91ab\u9662\u63a5\u53d7\u6cbb\u7642 3\u65e5\uff0c\u76ee\u524d\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\u3002\u4ee5\u4e0b\u4f55\u7a2e\u60c5\u6cc1 \u8f03\u9069\u5408\u7d93\u7a7a\u4e2d\u8f49\u8a3a\u56de\u53f0\u7063\u6cbb\u7642 \uff1f", + "Options": "(A)\u5341\u4e8c\u6307\u8178\u7a7f\u5b54\uff0c\u624b\u8853\u5f8c\u3002 (B)\u8996\u7db2\u819c\u525d\u96e2\uff0c\u96f7\u5c04\u624b\u8853\u5f8c\u3002 (C)\u8840\u4fbf\uff0c\u5168\u5927\u8178\u93e1\u5408\u4f75\u606f\u8089\u5207\u9664\u8853\u3002 (D)\u5927\u817f\u9aa8\u9aa8\u6298\u624b\u8853\u3002 (E)10%\u6c23\u8840\u80f8\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "45\u6b72\u5973\u6027\uff0c\u5230\u897f\u85cf\u65c5\u904a\uff0c\u5728\u73e0\u5cf0\u5927\u672c\u71df (\u9ad8\u5ea6 5,200\u516c\u5c3a)\uff0c\u767c\u751f\u547c\u5438\u56f0\u96e3\uff0c\u4e26\u54b3\u51fa\u6ce1\u6cab\u5e36\u8840\u4e4b\u75f0\u6db2\uff0c\u4e0b\uf99c\u6cbb\u7642\u4f55\u8005\u6700 \u4e0d\u5efa\u8b70\uff1f", + "Options": "(A)\u7d66\u4e88\u6c27\u6c23\u3002 (B)\u4e0b\u964d\u9ad8\u5ea6\u3002 (C)\u4f7f\u7528\u5a01\u800c\u92fc (Sildenafil \uff0cViagra)\u6cbb\u7642\u3002 (D)\u4f7f\u7528 Nifedipine \u6cbb\u7642\u3002 (E)\u4f7f\u7528\u5229\u5c3f\u5291 Lasix\u6cbb\u7642\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "45\u6b72\u7537\u6027\uff0c\u7cd6\u5c3f\u75c5\u75c5\u53f2\u3002\u4e00\u500b\u6708\u524d\u63a5\u53d7\u6e1b\u91cd\u624b\u8853(\u80c3\u7e5e\u9053\u624b\u8853\uff0c Roux -en-Y gastric bypass )\uff0c\u4e3b\u8ff0\u525b\u624d\u548c\u670b\u53cb\u805a\u9910\uff0c\u5403\u5b8c\u6771\u897f\u4e00\u5c0f\u6642\u5f8c\u4fbf\u767c\u751f\u5641\u5fc3\u3001\u5614\u5410\u3001\u8179\u7d5e\u75db\u3001\u8179\u8139\u53ca\u8179\u7009\uff0c\u5408\u4f75\u5192\u51b7\u6c57\uff0c\u6aa2\u50b7\u8840\u58d3 95/62mmHg \uff0c\u8108\u640f 106\u4e0b/min\uff0c\u547c\u5438 18\u6b21/min\uff0c\u9ad4\u6eab 36.5\u00b0C\uff0c\u6307\u5c16\u8840\u7cd6( finger -stick blood glucose )45mg/dL\uff0c\u8acb\u554f\u6700 \u6709\u53ef\u80fd\u662f\u4e0b\uf99c\u4f55\u7a2e\u8853\u5f8c\u4f75\u767c\u75c7\uff1f", + "Options": "(A)\u8178\u963b\u585e( bowel obstruction )\u3002 (B)\u543b\u5408\u53e3\u6ef2\u6f0f( anastomotic leakage )\u3002 (C)\u8178\u6f0f( enteric leak )\u3002 (D)\u81bd\u77f3\u75c7( cholelithiasis )\u3002 (E)\u50be\u98df\u75c7\u5019\u7fa4( dumping syndrome )\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "45\u6b72\u7537\u6027\u9577\u671f\u9157\u9152\u4e14\u6709\u5408\u4f75\u9ec3\u75b8\u8207\u8179\u6c34\uff0c\u56e0\u8840\u58d3\u4f4e\u8207\u5168\u8eab\u7121\u529b\u81f3\u6025\u8a3a\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u82e5\u7121\u767c\u71d2\u548c\u8179\u75db\u75c7\u72c0\uff0c\u5927\u90e8\u4efd\u80fd\u6392\u9664\u81ea\u767c\u6027\u8179\u819c\u708e\u7522\u751f\u3002 (B)\u6709\u8179\u6c34\u75c5\u4eba\uff0c\u81ea\u767c\u6027\u8179\u819c\u708e\u7684\u5e74\u767c\u751f\u7387\u7d04\u70ba 70%\u3002 (C)\u7b2c\u4e00\u6b21\u81ea\u767c\u6027\u8179\u819c\u708e\u534a\u5e74\u5b58\u6d3b\u7387\u7d04\u70ba 70%\u3002 (D)\u5927\u90e8\u5206\u7684\u75c5\u539f\u83cc\u662f\u70ba Enterobacteriaceae \u3002 (E)\u8179\u6c34\u5206\u6790\u767d\u8840\u7403\u6578 \uff1e250/mm3 \u53ef\u4ee5\u8a3a\u65b7\u81ea\u767c\u6027\u8179\u819c\u708e\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "47\u6b72\u7537\u6027\uff0c\u9580\u8a3a\u958b\u7acb Seroquel(Quetiapine )\u53caLexotan(Bromazepam )\u6cbb\u7642\u5176\u7cbe\u795e\u75be\u75c5\uff0c\u56e0\u5bb6\u4eba\u767c\u73fe\u75c5\u4eba\u660f\u8ff7 \u4e0d\u9192\uff0c\u56db\u80a2\u50f5\u786c\u6296\u52d5\u9001\u91ab\u3002\u6e2c\u5f97\u751f\u547d\u5fb5\u8c61\uff1a \u8840\u58d3 147/51 mmHg \uff0c\u547c\u5438 21\u6b21/min\uff0c\u8108\u640f 162\u4e0b/min\uff0c\u660f\u8ff7\u6307\u6578\uff1aE4M1V1\uff0c\u9ad4\u6eab 39.2\u2103\uff0c\u8eab\u9ad4\u6aa2\u67e5\u767c\u73fe\u75c5\u4eba\u51fa\u6c57\uff0c\u5169\u5074\u77b3\u5b54\u7b49\u5927\u6709\u5149\u53cd\u61c9\uff0c\u80a2\u9ad4\u50f5\u786c\u3002\u62bd\u8840\u7d50\u679c\u809d\u814e\u529f\u80fd\u7121\u660e\u986f\u7570\u5e38\u3002\u75c5\u4eba\u6700 \u6709\u53ef\u80fd\u662f\u4f55\u7a2e\u75c7\u5019\u7fa4\uff1f", + "Options": "(A)Cholinergic toxidrome \u3002 (B)Anticholinergic toxidrome \u3002 (C)Sympathomimetics \u3002 (D)Serotonin syndrome \u3002 (E)Neuroleptic malignant syndrome \u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "4\u6b72\u5973\u7ae5\u4e0d\u5c0f\u5fc3\u541e\u4e0b\u4e0d\u660e\u7269\u54c1\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u82e5 X\u5149\u767c\u73fe\u80c3\u88e1\u6709\u6253\u958b\u7684\u8ff4\u7d0b\u91dd\uff0c\u4e0d\u8ad6\u9577\u5ea6\u5927\u5c0f\uff0c\u61c9\u8a72\u6703\u8a3a\u5152\u7ae5\u8178\u80c3\u79d1\u7acb\u5373\u79fb\u9664\u3002 (B)\u82e5\u5abd\u5abd\u56de\u60f3\u8d77\u684c\u4e0a\u5c11\u4e86\u4e00\u500b\u9215\u6263\u96fb\u6c60\uff0c\u61c9\u8a72\u99ac\u4e0a\u7167 X\u5149\u3002 (C)\u5047\u5982\u5c0f\u670b\u53cb\u6709\u5148\u5929\u6027\u98df\u9053\u9589\u9396\uff0c\u66fe\u958b\u904e\u5200\uff0c\u4e00\u65e6\u6709\u4e0d\u9069 \uff0c\u61c9\u9032\u884c\u98df\u9053\u651d\u5f71( esophagogram )\u6216\u5167\u8996\u93e1\u3002 (D)\u82e5\u662f\u5e73\u6ed1\u3001\u5713\u5f62\u4e14\u4e0d\u5177\u8150\u8755\u6027\u7684\u5c0f\u6771\u897f\u505c\u7559\u5728\u98df\u9053\u4e2d\u9593\uff0c\u53ef\u5bb9\u8a31\u89c0\u5bdf36\u5c0f\u6642\u3002 (E)\u5982\u679c\u4e0d\u653e\u5fc3\u80c3\u4e2d\u7570\u7269\u662f\u5426\u6392\u51fa\u9ad4\u5916\uff0c\u53ef\u4ee5\u6bcf 3~5\u65e5\u7167 1\u5f35X\u5149\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "50\u6b72\u5973\u6027\uff0c \u81f3\u8d8a\u5357\u65c5\u904a\uff0c\u4e14\u6709\u63a5\u89f8\u79bd\u9ce5\u53f2\uff0c\u8fd4\u570b\u5f8c\u767c\u71d2 (\u8d85\u904e 38\u2103) \u3001\u5589\u56a8\u75db\u3001\u808c\u8089\u75e0\u75db\u3001\u982d\u75db\u3001\u54b3\u55fd\u548c\u5168\u8eab\u5026\u6020\u7121\u529b\u7b49\u985e\u6d41\u611f\u75c7\u72c0\u81f3\u6025\u8a3a\u5c31\u8a3a\u3002\u95dc\u65bc\u7591\u4f3c\u65b0\u578b A\u578b\u6d41\u611f\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u76ee\u524d\u78ba\u5b9a\u66fe\u7d93\u611f\u67d3\u4eba\u985e\u7684\u65b0\u578b A\u578b\u6d41\u611f\u4e9e\u578b\u5305\u62ec H5N1\u3001H6N1\u3001H7N2\u3001H7N9\u3001H9N2\u3001H10N7\u3001H10N8\u7b49\u3002 (B)H7N9 \u70ba\u79bd\u6d41\u611f\u75c5\u6bd2\uff0c\u5c6c\u6b63\u9ecf\u6db2\u75c5\u6bd2\u79d1( Orthomyxoviridae )\u7684 A \u578b\u6d41\u611f\u75c5\u6bd2\u5c6c( Influenza virus A )\u3002 (C)\u76ee\u524d\u91dd\u5c0d H5N1\u6d41\u611f\u5df2\u6709\u75ab\u82d7\u53ef\u4f9b\u9810\u9632\u3002 (D)\u6297\u75c5\u6bd2\u85e5\u7269 amantadine \u6216rimantadine \u5c0d\u65b0\u578b A\u578b\u6d41\u611f\u75c5\u6bd2\u6cbb\u7642\u6548\u679c\u597d\uff0c\u5efa\u8b70\u4f7f\u7528\u3002 (E)\u65b0\u578b A\u578b\u6d41\u611f\u70ba\u7b2c\u4e94\u985e\u50b3\u67d3\u75c5\uff0c 24\u5c0f\u6642\u5167\u901a\u5831\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "50\u6b72\u7537\u6027\u56e0\u5de6\u4e0a\u8179\u90e8\u7a81\u767c\u75bc\u75db\uff0c\u5408\u4f75\u5614\u5410\u81f3\u6025\u8a3a\u6c42\u8a3a\u3002\u904e\u53bb\u75c5\u53f2\u6709\u6a6b\u8188\u819c\u759d\u6c23(hiatal hernia )\u53ca\u80c3\u98df\u9053\u9006\u6d41 (gastroesophageal reflux disease )\u3002\u6aa2\u50b7\u751f\u547d\u5fb5\u8c61\u70ba\u8840\u58d3 86/40 mmHg \u3001\u8108\u640f 121\u6b21/min\u3001\u9ad4\u6eab 37\u2103\u3001\u547c\u5438 20\u6b21/min\u3001\u8840\u6c27\u6fc3\u5ea6 98%\u3002\u7406\u5b78\u6aa2\u67e5\u4e3b\u8981\u7570\u5e38\u70ba\u4e0a\u8179\u8139\u75db\uff0c\u53e9\u8a3a\u70ba\u9f13\u97f3 (tympanic)\uff0c\u4e14\u5de6\u4e0b\u80ba\u547c\u5438\u97f3\u6e1b\u5c11\u3002 \u8a66\u8457\u7f6e\u5165\u9f3b\u80c3\u7ba1\u537b\u4e00\u76f4\u5931\u6557\u3001\u7121\u6cd5\u63d2\u5165\u3002\u5be6\u9a57\u5ba4\u5831\u544a\u767c\u73fe lactate 28mg/dL \u3001pH 7.13\u3001HCO 3- 8.1\u3001Hb 12 g/dL \u3002\u80f8\u90e8 X\u5149\u767c\u73fe\u80c3\u8139\u5927\uff0c\u4e14\u4f4d\u5728\u6a6b\u8188\u819c\u4ee5\u4e0a\u3002\u9664\u4e86\u9069\u7576\u7684\u8f38\u6db2\u6cbb\u7642\u4e4b\u5916\uff0c\u4e0b\uf99c\u4f55\u8005\u8f03 \u9069\u7576\uff1f", + "Options": "(A)\u6703\u8a3a\u5916\u79d1\u958b\u5200\u6cbb\u7642\u3002 (B)\u5b89\u6392\u80c3\u93e1\u3002 (C)\u8f38\u7d05\u8840\u7403\u6fc3\u7e2e\u6db2 (PRBC)\u3002 (D)\u975c\u8108\u6ce8\u5c04 Sodium bicarbonate \u3002 (E)\u6539\u63d2\u53e3\u80c3\u7ba1 (orogastric tube )\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "55\u6b72\u5973\u6027\uff0c\u7121\u51fa\u570b\u65c5\u904a\u53f2\uff0c\u4e3b\u8a34\u6f38\u9032\u6027\u55ae\u5074\u982d\u75db\u3001\u5026\u6020\uff0c\u7a81\u767c\u5de6\u5074\u8996\u529b\u55aa\u5931\uff0c\u6aa2\u67e5\u986f\u793a\u70ba\u8996\u795e\u7d93\u708e\uff0c\u4e0b\uf99c\u8a3a\u65b7\u4f55\u8005\u53ef\u80fd\u6027 \u8f03\u9ad8\uff1f", + "Options": "(A)Lyme disease \u3002 (B)Carotid dissection \u3002 (C)Giant cell arteritis \u3002 (D)Cerebral sinus thrombosis \u3002 (E)Antiphospholipid syndrome \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "5\u6b7220\u516c\u65a4\u7537\u7ae5\u5728\u904e\u99ac\u8def\u6642\u88ab\u95d6\u7d05\u71c8\u6c7d\u8eca\u649e\u64ca\uff0c\u7531\u6551\u8b77\u8eca\u9001\u81f3\u6025\u8a3a\uff0c\u9ad4\u6eab35\u2103\u3001\u547c\u5438 30\u6b21/min\u3001\u8108\u640f 160\u4e0b/min\u3001\u8840\u58d3 70/40mmHg \uff0cGCS\uff1aE1V2M4\uff0c\u5e8a\u908a\u8d85\u97f3\u6ce2\u767c\u73fe\u6709\u8840\u80f8\u53ca\u5c11\u91cf\u8179\u8154\u5167\u51fa\u8840\u3002\u95dc\u65bc\u6b64 \u75c5\u4eba\u6025\u6551\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u8003\u616e\u6c23\u7ba1\u63d2\u7ba1\u4fdd\u8b77\u547c\u5438\u9053\uff0c\u53ef\u9078\u7528 5\u865f\u6709 Cuff\u7684\u6c23\u7ba1\u5167\u7ba1\u3002 (B)\u653e\u7f6e\u53f3\u5074\u80f8\u7ba1\u5f8c\uff0c\u7acb\u523b\u5f15\u6d41\u51fa 150ml\u9bae\u8840\uff0c\u9700\u7acb\u5373\u9032\u884c\u958b\u80f8\u624b\u8853 (operative thoracotomy )\u3002 (C)\u4ee5\u751f\u7406\u98df\u9e7d\u6c34\u5feb\u901f\u8f38\u6db2\u53ef\u91cd\u8907 3\u6b21\uff0c\u6bcf\u6b21 400ml\uff0c\u82e5\u8840\u58d3\u4ecd\u4f4e\uff0c\u53ef\u518d\u8f38PRBC 200 ml \u3002 (D)\u82e5\u5468\u908a\u8840\u7ba1\u7121\u6cd5\u6253\u4e0a\uff0c\u53ef\u8003\u616e\u65bc\u8fd1\u7aef\u811b\u9aa8\u653e\u7f6e\u9aa8\u5167\u91dd (intraosseous injection)\uff0c\u4e26\u7531\u9aa8\u91dd\u62bd\u8840\u9032\u884c\u5099\u8840\u3002 (E)\u6b64 \u75c5\u4eba\u8f38\u6db2\u9700\u5148\u52a0\u6eab\uff0c\u4e26\u907f\u514d\u5931\u6eab\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "5\u6b72\u5152\u7ae5 1\u5c0f\u6642\u524d\u5f9e\u7d04 60\u516c\u5206\u9ad8\u5ea6\u8dcc\u843d\uff0c\u982d\u76ae\u6709 2\uff0a2\u516c\u5206\u8840\u816b\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u6700\u9069\u7576\uff1f", + "Options": "(A)\u82e5\u7121\u795e\u7d93\u5b78\u7570\u5e38\uff0c\u4ecd\u61c9\u5be6\u65bd\u982d\u90e8\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\uff0c\u4ee5\u6392\u9664\u9871\u5167\u51fa\u8840\u3002 (B)5\u6b72\u5152\u7ae5\u82e5\u6709\u982d\u76ae\u8840\u816b\uff0c\u9aa8\u6298\u6216\u9871\u5167\u51fa\u8840\u7684\u98a8\u96aa\u8f03 2\u6b72\u4ee5\u4e0b\u5152\u7ae5\u70ba\u9ad8\u3002 (C)\u82e5\u7121\u795e\u7d93\u5b78\u75c7\u72c0\uff0c\u4e0d\u9808\u5f71\u50cf\u6aa2\u67e5\uff0c\u53ef\u7acb\u5373\u8b93\u75c5\u4eba\u56de\u5bb6\u3002 (D)\u65bc\u6025\u8a3a\u89c0\u5bdf 4\u5c0f\u6642\u5f8c\uff0c\u82e5\u7121\u4efb\u4f55\u795e\u7d93\u5b78\u75c7\u72c0\u53ef\u8b93\u75c5\u4eba\u8fd4\u5bb6\uff0c\u4e0d\u9808\u5f71\u50cf\u6aa2\u67e5\u3002 (E)\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u7d50\u679c\u6b63\u5e38\uff0c 20%\u7684\u75c5\u4eba\u6703\u7522\u751f\u9072\u767c\u6027\u795e\u7d93\u75c7\u72c0\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "60\u6b72\u7537\u6027\u7a81\u767c\u80f8\u75db\uff0c\u5982\u5200\u5272\u822c\u524d\u80f8\u75db\u5230\u5f8c\u80cc\u5192\u51b7\u6c57\uff0c\u8840\u58d3 200/100 mmHg \uff0c\u8108\u640f 100\u4e0b/min\uff0c\u8d85\u97f3\u6ce2\u986f\u793a\u4e3b\u52d5\u8108\u5f13\u8655\u6709\u525d\u96e2\u7684\u5167\u819c\u74e3 (dissection flap )\u3002\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u5e74\u8f15\u4eba\u88ab\u8a3a\u65b7\u51fa\u6b64\u75be\u75c5\u6642\uff0c\u8981\u5c0b\u627e\u5176\u4ed6\u539f\u56e0\uff0c\u4f8b\u5982\u5148\u5929\u6027\u5fc3\u8840\u7ba1\u75be\u75c5\uff0c\u5916\u50b7\u6216\u662f\u61f7\u5b55\u3002 (B)\u4ee5 Stanford\u5206\u985e\u7cfb\u7d71 (Stanford classification system )\u5340\u5206\u70ba A\u578b\u53caB\u578b\uff0c\u4ee5\u982d\u81c2\u52d5\u8108 (brachiocephalic artery )\u70ba\u5206\u578b\u4f9d\u64da\u3002 (C)\u901a\u5e38\u75bc\u75db\u7684\u4f4d\u7f6e\u7121\u6cd5\u53cd\u6620\u75c5\u7076\u7684\u90e8\u4f4d\uff0c\u4e14\u75bc\u75db\u4f4d\u7f6e\u6703\u6539\u8b8a\u3002 (D)\u5e38\u4ee5\u9ad8\u8840\u58d3\u8868\u73fe\uff0c\u7576\u51fa\u73fe\u4f4e\u8840\u58d3\u6216\u4f11\u514b\uff0c\u8981\u8003\u616e\u5fc3\u5305\u819c\u586b\u585e\u3001\u4e3b\u52d5\u8108\u51fa\u8840\u3001\u56b4\u91cd\u4e3b\u52d5\u8108\u74e3\u9589\u9396\u4e0d\u5168\u6216\u5fc3\u808c\u6897\u585e\u7b49\u3002 (E)\u63a7\u5236\u8840\u58d3\u6700\u4f73\u9078\u64c7\u662f\u4e59\u578b\u963b\u65b7\u5291 (\u03b2-blockers)\uff0c\u76ee\u6a19\u662f\u5c07\u5fc3\u8df3\u964d\u523060~70\u4e0b/min\u3002", + "Answer": "A\u3001B\u3001C\u3001D\u3001E" + }, + { + "\ufeffQuestion": "60\u6b72\u7537\u6027\u5230\u9662\u524d\u5fc3\u81df\u505c\u6b62 (OHCA)\uff0c\u5fc3\u96fb\u5716\u986f\u793a PEA(pulseless electrical activity)\uff0c\u91cd\u9ede\u5f0f\u6025\u8a3a\u5fc3\u81df\u8d85\u97f3\u6ce2\u767c\u73fe\u75c5\u4eba\u53f3\u5fc3\u5ba4\u660e\u986f\u64f4\u5927\uff0c\u4e0b\uf99c\u4f55\u7a2e\u8a3a\u65b7\u6700\u6709\u53ef\u80fd\uff1f", + "Options": "(A)\u5fc3\u5305\u819c\u586b\u585e\u3002 (B)\u4f4e\u8840\u5bb9\u3002 (C)\u6025\u6027\u5fc3\u808c\u6897\u585e\u3002 (D)\u80ba\u52d5\u8108\u6813\u585e\u3002 (E)\u5f35\u529b\u6027\u6c23\u80f8\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "60\u6b72\u9577\u671f\u9157\u9152\u75c5\u4eba\u65e9\u4e0a\u958b\u59cb\u6c92\u559d\u9152\uff0c\u665a\u4e0a\u81f3\u6025\u8a3a\u4e3b\u8a34\u5fc3\u60b8\u3001\u5641\u5fc3\u3001\u5614\u5410\uff0c\u8840\u6db2\u6aa2\u67e5\u986f\u793a\uff1a pH 7.2\uff0c\u78b3\u9178\u6c2b\u9209\uff1a 6 mmol/L \uff0c\u9209\uff1a 135 mmol/L \uff0c\u9240\uff1a 4.0 mmol/L\uff0c\u6c2f\uff1a 105 mmol/L \uff0c\u916e\u9ad4\u967d\u6027\u53cd\u61c9\uff0c \u8840\u7cd6\uff1a 110 mg/dL \uff0c\u4e73\u9178\uff1a 2.0 mmol/L\u3002\u4ee5\u4e0b\u63cf\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u7532\u9187\u4e2d\u6bd2\u4e0d\u6703\u7522\u751f\u916e\u9ad4\uff0c\u4e14\u7532\u9187\u4e2d\u6bd2\u5f15\u767c\u4e4b\u9178\u4e2d\u6bd2\u8f03\u56b4\u91cd\u3002 (B)\u5927\u91cf\u8f38\u6db2\u6cbb\u7642\u6b64\u75c5\u5f8c\uff0c\u6700\u5e38\u898b\u7684\u4f75\u767c\u75c7\u662f\u8166\u6c34\u816b\u3002 (C)\u6cbb\u7642\u6b64\u75c5\u7684\u8f38\u6db2\u4e0d\u61c9\u9078\u64c7\u542b\u7cd6\u5206\u9ede\u6ef4\u3002 (D)\u80f0\u5cf6\u7d20\u53ef\u6e1b\u5c11\u916e\u9ad4\u7684\u7522\u751f\uff0c\u5c0d\u65bc\u6cbb\u7642\u6b64\u75c5\u5f88\u6709\u76ca\u8655\u3002 (E)\u82e5\u8840\u6db2 pH\u503c\u5c0f\u65bc 7.2\u6642\u61c9\u5e38\u898f\u7d66\u4e88\u78b3\u9178\u6c2b\u9209\u6cbb\u7642\u9178\u4e2d\u6bd2\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "62\u6b72\u7537\u6027\u7f79\u60a3\u651d\u8b77\u817a\u764c\u6b63\u5728\u63a5\u53d7\u653e\u5c04\u7dda\u6cbb\u7642 (radiation therapy )\uff0c\u904e\u53bb 3\u5929\u5076\u723e\u6703\u6392\u4fbf\u5931\u7981\u3001\u88e1\u6025\u5f8c\u91cd (tenesmus)\uff0c\u4eca\u5929\u958b\u59cb\u8179\u7009\u4e26\u6709\u8840 \u4fbf\u3002\u751f\u547d\u5fb5\u8c61\u70ba\u8840\u58d3 136/78 mmHg \u3001\u8108\u640f 84\u4e0b/min\u3001\u9ad4\u6eab 37.2\u2103\u3002\u7406\u5b78\u6aa2\u67e5\u8179\u90e8\u89f8\u8a3a\u662f\u67d4\u8edf\u7684\u3002\u809b\u9580\u6307\u8a3a\u767c\u73fe\u6709\u7030\u6f2b\u6027\u58d3\u75db (diffuse tenderness )\u3001\u5e36\u6709\u9bae\u8840\u3001\u800canal tone\u5b8c\u597d\u3002\u96d9\u4e0b\u80a2\u7684\u808c\u8089\u5f37\u5ea6\u3001\u6df1\u8171\u53cd\u5c04\u53ca\u611f\u89ba\u7686\u5c0d\u7a31\u4e14\u5b8c\u6574\u3002\u8acb\u554f\u4e0b\uf99c\u6cbb\u7642\u4f55\u8005\u70ba \u6700\u9069\u7576\uff1f", + "Options": "(A)\u7d93\u9a57\u6027\u7d66\u4e88 ceftriaxone \u53cadoxycycline \u3002 (B)\u6b62\u75db\u5291\u53ca\u53e3\u670d sucralfate \u3002 (C)\u975c\u8108\u6ce8\u5c04 pantoprazole \u3002 (D)\u6703\u8a3a\u5916\u79d1\u9032\u884c\u624b\u8853\u3002 (E)\u7f6e\u5165\u809b\u7ba1\u6e1b\u58d3\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "64\u6b72\u5973\u6027\uff0c\u904e\u53bb\u7d93\u5e38\u670d\u7528\u4e0d\u660e\u6cbb\u7642\u75e0\u75db\u85e5\u7269\uff0c\u8fd1\u65e5\u98df\u617e\u4e0d\u632f\u5168\u8eab\u7121\u529b\u4f86\u8a3a\uff0c\u751f\u547d\u5fb5\u8c61\u70ba\uff1a\u9ad4\u6eab 36.9\u2103\uff0c\u8108\u640f 68\u4e0b/min\uff0c\u547c\u5438 14\u6b21/min\uff0c\u8840\u58d3 86/54mmHg \uff0cSpO 2\uff1a98%\uff0c\u8840\u7cd6\u503c 126mg/dL \uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u814e\u4e0a\u817a\u5371\u8c61( adrenal crisis )\u5076\u723e\u4e5f\u6703\u4ee5\u6025\u6027\u8179\u75db\u4f86\u505a\u70ba\u81e8\u5e8a\u8868\u73fe\u3002 (B)\u814e\u4e0a\u817a\u6a5f\u80fd\u4e0d\u8db3\u4e5f\u53ef\u80fd\u6703\u767c\u751f\u982d\u75db\uff0c\u610f\u8b58\u4e0d\u6e05\uff0c\u8996\u529b\u6539\u8b8a\u6216\u8178\u80c3\u9053\u75c7\u72c0\u7b49\u81e8\u5e8a\u75c7\u72c0\u3002 (C)\u8840\u6e05\u76ae\u8cea\u9187( serum cortisol )\u82e5\u5927\u65bc 18mg/dL\uff0c\u4e00\u822c\u53ef\u6392\u9664\u814e\u4e0a\u817a\u76ae\u8cea\u529f\u80fd\u4e0d\u5168\u3002 (D)\u521d\u7d1a\u814e\u4e0a\u817a\u6a5f\u80fd\u4e0d\u8db3\uff0c\u5728\u62bd\u8840\u6aa2\u67e5\u4e0a\u5bb9\u6613\u767c\u73fe\u6709\u4f4e\u8840\u9240\u548c\u4f4e\u8840\u9209\u3002 (E)\u75c5\u4eba\u82e5\u6709\u4f4e\u8840\u58d3\u7684\u60c5\u5f62\u53ef\u5148\u6309\u7167\u4f11\u514b\u6025\u6551\u6d41\u7a0b\u5148\u7d66\u4e88\u6db2\u9ad4\u88dc\u5145\uff0c\u82e5\u7121\u53cd\u61c9\u518d\u8003\u616e\u7d66\u4e88 hydrocortisone (100mg iv bolus )\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "65\u6b72\u5973\u6027\uff0c\u6709\u9ad8\u8840\u58d3\u8207\u5fc3\u623f\u986b\u52d5 (atrial fibrillation )\u75c5\u53f2\uff0c\u56e0\u81ea\u89ba\u5929\u65cb\u5730\u8f49\u5408\u4f75\u5614\u5410\u81f3\u6025\u8a3a\u3002\u6709\u95dc\u6b64\u500b\u6848\u4e4b\u6558\u8ff0\u4e0b\uf99c\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u6709\u6b65\u614b\u4e0d\u7a69\uff0c\u540c\u5074\u984f\u9762\u808c\u8089\u7121\u529b\u8207\u89d2\u819c\u53cd\u5c04\u6d88\u5931\uff0c\u8981\u8003\u616e\u5c0f\u8166\u6a4b\u8166\u89d2\u816b\u7624(cerebellopontine angle tumor )\u3002 (B)\u82e5\u70ba\u7a81\u767c\u6027\u7729\u6688\u4f75\u6709\u807d\u529b\u55aa\u5931\u6642\uff0c\u8981\u8003\u616e\u5167\u8033\u8ff7\u8def\u708e (labyrinthitis )\u3002 (C)\u82e5\u70ba\u6885\u5c3c\u723e\u6c0f\u75c7 (Meniere's Disease )\uff0c\u5176\u75c7\u72c0\u767c\u751f\u6642\u9593\u53ef\u9577\u9054 12\u5c0f\u6642\uff0c\u983b\u7387\u53ef\u80fd\u5f9e 1\u5468\u6578\u6b21\u81f3 1\u500b\u6708\u6578\u6b21\u3002 (D)\u9031\u908a\u6027 \u7729\u6688(peripheral vertigo )\u7684\u81e8\u5e8a\u75c7\u72c0\u4e3b\u8981\u4ee5 H2 antihistamines\u85e5\u7269\u6cbb\u7642\u70ba\u4e3b\u3002 (E)\u4f7f\u7528\u9223\u96e2\u5b50\u963b\u65b7\u5291 (calcium channel blockers )\u53ef\u4ee5\u7de9\u89e3\u9031\u908a\u6027\u7729\u6688\u7684\u81e8\u5e8a\u75c7\u72c0\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "70\u6b72\u7537\u6027\uff0c 10\u5929\u524d\u56e0\u80a1\u9aa8\u9838\u9aa8\u6298\u63a5\u53d7\u5168\u8eab\u9ebb\u9189\u53ca\u624b\u8853\uff0c\u73fe\u56e0\u55ae\u5074\u8173\u816b\u75db\u53ca\u547c\u5438\u56f0\u96e3\u5230\u6025\u8a3a\u5c31\u91ab\uff0c\u751f\u547d\u5fb5\u8c61\u70ba\u8840\u58d3 110/60mmHg \uff0c\u8108\u640f 130\u4e0b/min\uff0c\u547c\u543830\u6b21/min\uff0c\u9ad4\u6eab 37\u00b0C\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u80f8\u90e8 X\u5149Westermark sign \u6216Hampton hump \u8a3a\u65b7\u80ba\u6813\u585e\u4e4b\u7279\u7570\u6027(specificity )\u9ad8\u3002 (B)\u7576\u53f3\u5fc3\u5ba4\u58d3\u529b\u5927\u65bc 40mmHg \u6642\uff0c\u5fc3\u96fb\u5716\u5728 V5\uff0cV6\u53ef\u767c\u73fe T\u6ce2\u5012\u7f6e (C)D-dimer\u53ef\u56e0\u9ad8\u8840\u8102\u6216\u8005\u75c7\u72c0\u8d85\u904e\u4e94\u5929\u800c\u5448\u73fe\u8f03\u9ad8\u7684\u6578\u503c\u3002 (D)\u52d5\u8108\u8840\u6db2\u6c23\u9ad4\u5206\u6790\uff0c\u53ef\u767c\u73fe\u80ba\u6ce1 -\u52d5\u8108\u6c27\u6c23\u58d3\u529b\u5dee( Alveolar -arterial oxygen tension gradient )\u964d\u4f4e\u3002 (E)\u6b64\u6642\u75c5\u4eba\u4ee5\u8840\u6813\u6eb6\u89e3\u5291\u6cbb\u7642\u6bd4\u809d\u7d20 (Heparin)\u7642\u6548\u66f4\u597d\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "70\u6b72\u7537\u6027\uff0c\u56e0\u8996\u529b\u6a21\u7cca\uff0c\u5de6\u5074\u982d\u90e8\u649e\u50b7\u81f3\u6025\u8a3a\uff0c\u7406\u5b78\u6aa2\u67e5\u767c\u73fe\u5de6\u984d -\u9873\u90e8\u982d\u76ae\u53ca\u773c\u7736\u8840\u816b\uff0c\u5169\u5074\u77b3\u5b54\u7b49\u5927\u70ba 3mm\uff0c\u5747\u5c0d\u5149\u53cd\u5c04\u6b63\u5e38\uff0c\u56db\u80a2\u6d3b\u52d5\u53ca\u6df1\u5c64\u808c\u8171\u53cd\u5c04\u7686\u6b63\u5e38\uff0c\u6b65\u614b\u5e73\u7a69\uff0c\u4f46\u5bb9\u6613\u649e\u5230\u5de6\u5074\u7269\u9ad4\u3002\u8996\u91ce\u6aa2\u67e5\u767c\u73fe\u5de6\u5074\u540c\u5074\u504f\u76f2(homonymous hemianopsia )\uff0c\u4e0b\uf99c\u4f55\u8005\u70ba \u6700\u53ef\u80fd\u7684\u8a3a\u65b7\uff1f", + "Options": "(A)\u8166\u4e0b\u5782\u9ad4\u816b\u7624( pituitary tumor )\u3002 (B)\u53f3\u5074\u786c\u8166\u819c\u4e0a\u51fa\u8840( epidural hemorrhage )\u3002 (C)\u5de6\u5074\u786c\u8166\u819c\u4e0b\u51fa\u8840( subdural hemorrhage )\u3002 (D)\u53f3\u5074\u6795\u90e8\u6897\u585e\u6027\u4e2d\u98a8( occipital infarction )\u3002 (E)\u53f3\u5074\u4e2d\u592e\u8996\u7db2\u819c\u52d5 \u8108\u963b\u585e( central retinal artery occlusion )\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "74\u6b72\u7684\u8001\u5148\u751f\u5e7e\u5929\u524d\u958b\u59cb\u6709\u776a\u4e38\u75db\uff0c\u4e14\u8d8a\u4f86\u8d8a\u75db\uff0c\u5728\u6025\u8a3a\u7406\u5b78\u6aa2\u67e5\u986f\u793a\u776a\u4e38\u58d3\u75db\uff0c\u4f46\u9670\u56ca\u5916\u89c0\u6b63\u5e38\uff0c\u4e14\u7121\u5206\u6ccc\u7269\u5f9e\u5c3f\u9053\u6d41\u51fa\u3002\u4e0b\uf99c\u4f55\u8005\u6cbb\u7642\u70ba \u6700\u9069\u7576\uff1f", + "Options": "(A)Ceftriaxone \u3002 (B)Cephalexin \u3002 (C)Doxycycline \u3002 (D)Levofloxacin \u3002 (E)Amoxicillin \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "75\u6b72\u5973\u6027\uff0c\u904e\u53bb\u56e0\u8166\u4e2d\u98a8\u9577\u671f\u81e5\u5e8a\uff0c\u5e73\u5e38\u5728\u5b89\u990a\u4e2d\u5fc3\u7167\u9867\uff0c\u6709\u9f3b\u80c3\u7ba1\u7559\u7f6e\uff0c\u4e2d\u5348\u704c\u98df\u5f8c\u5614\u5410\u53ca\u55c6\u54b3\uff0c\u591c\u9593\u767c\u751f\u547c\u5438\u5598 (dyspnea)\u53ca\u6301\u7e8c\u54b3\u55fd\u72c0\u6cc1\uff0c\u6545\u7531\u5b89\u990a\u4e2d\u5fc3\u9001\u81f3\u6025\u8a3a\u5c31\u91ab \u3002\u6709\u95dc\u75c5\u4eba\u7684\u81e8\u5e8a\u8655\u7f6e\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u53ea\u8981\u6709\u55c6\u54b3\u7684\u72c0\u6cc1\uff0c\u5c31\u61c9\u8a72\u9810\u9632\u6027\u4f7f\u7528\u6297\u751f\u7d20\u3002 (B)\u4f7f\u7528\u985e\u56fa\u9187 (steroid)\u53ef\u4ee5\u907f\u514d\u80ba\u640d\u50b7 (lung injury )\u3002 (C)\u5982\u679c\u7522\u751f\u5438\u5165\u6027\u80ba\u708e\u6642\uff0c\u6700\u5e38\u898b\u75c5\u83cc\u70ba S. aureus\u3002 (D)\u6297\u751f\u7d20\u53ef\u9078\u64c7\u4f7f\u7528\u5ee3\u6548\u578b\u7684 Levofloxacin \u5373\u53ef\u3002 (E)\u91dd\u5c0d\u72c0\u6cc1\u7a69\u5b9a\u7684\u75c5\u4eba\uff0c\u89c0\u5bdf 24\u5c0f\u6642\u5f8c\u6301\u7e8c\u7a69\u5b9a\uff0c\u53ef\u4ee5\u8f49\u56de\u5b89\u990a\u4e2d\u5fc3\u7167\u9867\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "76\u6b72\u7537\u6027\uff0c\u56e0\u610f\u8b58\u4e0d\u6e05\u6c42\u8a3a\u3002\u6700\u8fd1\u5e38\u62b1\u6028\u8179\u7009\u548c\u8179\u75db\u3002\u751f\u547d\u5fb5\u8c61\u70ba\uff1a\u9ad4\u6eab 39\u2103\uff0c\u8108\u640f 140\u4e0b/min\uff0c\u547c\u5438\u901f\u7387 20\u6b21/min\uff0c\u8840\u58d3 148/98mmHg \uff0cSpO 2\uff1a 92%\u3002\u807d\u8a3a\u6642\u547c\u5438\u97f3\u5448\u6fd5\u56c9\u97f3\uff0c\u62bd\u8840\u6aa2\u9a57\u767c\u73fe\u60a3\u8005\u6709\u7532\u72c0\u817a\u529f\u80fd\u4ea2\u9032\u3002\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u5728\u9451\u5225\u8a3a\u65b7\u4e0a\uff0c\u9664\u4e86\u611f\u67d3\u75c7\u5916\u61c9\u8003\u616e\u85e5\u7269\u3001\u7532\u72c0\u817a\u75be\u75c5\u3001\u6297\u7cbe\u795e\u85e5\u7269\u60e1\u6027\u75c7\u5019\u7fa4 (malignant neuroleptic syndrome )\u6216\u55dc\u927b\u7d30\u80de\u7624(pheochromocytoma )\u7b49\u5176\u4ed6\u75be\u75c5\u3002 (B)\u7532\u72c0\u817a\u98a8\u66b4 (thyroid storm )\u4e3b\u8981\u662f\u7d93\u7531\u81e8\u5e8a\u75c7\u72c0\u5224\u65b7\uff0c\u4ea6\u53ef\u4f7f\u7528 Burch and Wartofsky\u2019s Diagnostic Parameters and Scoring Points \u4f86\u505a\u70ba\u8a3a\u65b7\u4f9d\u64da\u3002 (C)\u5fc3\u8870\u7aed\u75c7\u72c0\u53ef\u898b\u65bc\u7532\u72c0\u817a\u98a8\u66b4\u3002 (D)\u7532\u72c0\u817a\u98a8\u66b4\u9ad8\u71d2\u7684 \u75c5\u4eba\u61c9\u7981\u6b62\u4f7f\u7528 aspirin\u9000\u71d2\uff0c\u4ee5\u907f\u514d\u96f7\u6c0f\u75c7\u5019\u7fa4(Reye syndrome )\u3002 (E)\u6b64\u60a3\u8005\u7684\u6cbb\u7642\u61c9\u8a72\u5148\u7d66\u4e88 methimazole \uff0c1~2\u500b\u5c0f\u6642\u5f8c\u518d\u7d66\u4e88 Iodine\u5982Lugol solution \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "88\u6b72\u7537\u6027\u904e\u99ac\u8def\u906d\u6c7d\u8eca\u64e6\u649e\uff0c\u5bb6\u5c6c\u8aaa\u5e73\u5e38\u60a3\u8005\u6709\u8f15\u5ea6\u5931\u667a\u75c7\u670d\u7528\u85e5\u7269\uff0c\u56e0\u70ba\u5fc3\u81df\u74e3\u819c\u624b\u8853\u6709\u5403\u6297\u51dd\u8840\u85e5\u7269\uff0c\u9001\u81f3\u6025\u8a3a\u5ba4\u6642\u81c9\u90e8\uff0c\u80f8\u8179\u90e8\u64e6\u632b\u50b7\u53ca\u5f8c\u8166\u8840\u816b\uff0c\u751f\u547d\u5fb5\u8c61\u5982\u4e0b\uff1a\u8108\u640f 88\u4e0b/min\uff0c\u8840\u58d3 105/70mmHg \uff0c\u8a62\u554f\u60a3\u8005\u554f\u984c\u7121\u6cd5\u6b63\u78ba\u56de\u7b54\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u96d6\u7136\u6c92\u6709\u51fa\u73fe\u5fc3\u8df3\u52a0\u5feb\uff0c\u4f46\u6b64\u8840\u58d3\u4ecd\u6709\u53ef\u80fd\u6bd4\u5e73\u5e38\u4f4e\uff0c\u61c9\u4ed4\u7d30\u8a62\u554f\u3002 (B)\u5bb6\u5c6c\u8868\u660e\u610f\u8b58\u8ddf\u5e73\u5e38\u6c92\u6709\u592a\u5927\u4e0d\u540c\uff0c\u6240\u4ee5\u6c92\u6709\u8166\u51fa\u8840\u4e4b\u7591\u616e\u3002 (C)\u5728\u4f11\u514b\u7684\u75c5\u4eba\u5229\u7528\u8840\u6db2\u6c23\u9ad4\u548c\u4e73\u9178\u53ef\u8a55\u4f30\u75c5\u4eba\u7684\u9810\u5f8c\u3002 (D)\u5728\u4f11\u514b\u7684\u8001\u4eba\u4f7f\u7528\u986f\u5f71\u5291\u6aa2\u67e5\u8981\u5f88\u5c0f\u5fc3\uff0c\u6709\u53ef\u80fd\u6703\u60e1\u5316\u75c5\u4eba\u4e4b\u814e\u529f\u80fd\u3002 (E)\u8001\u4eba\u982d\u90e8\u5916\u50b7\u51fa\u73fe\u786c\u8166\u819c\u4e0b\u51fa\u8840 (SDH)\u4e4b\u6a5f\u7387\u9ad8\u65bc\u786c\u8166\u819c\u4e0a\u51fa\u8840(EDH)\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "8\u500b\u6708\u5927\u7f79\u60a3\u6cd5\u6d1b\u6c0f\u56db\u91cd\u75c7( Tetralogy of Fallot )\u4e4b\u5b30\u5152\uff0c\u56e0\u5728\u4e00\u9663\u54ed\u9b27\u5f8c\u767c\u751f\u5168\u8eab\u767c\u7d3a\u800c\u88ab\u6bcd\u89aa\u9001\u81f3\u6025\u8a3a\u6c42\u8a3a\u3002\u5728\u91ab\u5e2b\u8a55\u4f30\u5f8c\u8a8d\u70ba\u662f\u7f3a\u6c27\u767c\u4f5c (blue spell)\uff0c\u958b\u7acb\u91ab\u56d1\u7d66\u4e88\u975c\u6ce8\u55ce\u5561 (morphine )\uff0c\u4f46\u7531\u65bc\u60c5\u6cc1\u7dca\u6025\uff0c\u8b77\u58eb\u7d66\u4e86 10\u500d\u7684\u6cbb\u7642\u5291\u91cf\u3002\u8a66\u554f\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u6700 \u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u91dd\u5c0d\u6b64\u75c5\u4eba\u7684\u8655\u7f6e\u4e3b\u8981\u662f\u4f9d\u64da\u4e0b\uf99c\u4e94\u9805\u539f\u5247 \uff1a \u7d66\u4e88\u652f\u6301\u6027\u7684\u6cbb\u7642\u3001\u9632\u6b62\u6216\u6e1b\u5c11\u6bd2\u7269\u7684\u5438\u6536\u3001\u589e\u52a0\u6bd2\u7269\u7684\u6392\u6cc4\u3001\u53ef\u8003\u616e\u7d66\u4e88\u89e3\u6bd2\u5291\u548c\u9810\u5f8c\u8a55\u4f30\u3002 (B)\u53ef\u767c\u73fe\u77b3\u5b54\u6536\u7e2e\u81f3\u5982\u91dd\u5b54\u5927\u5c0f\u822c (pinpoint size )\u3002 (C)\u82e5\u75c5\u5b30\u51fa\u73fe\u610f\u8b58\u969c\u7919\uff0c\u53ef\u8003\u616e\u7d66\u4e88\u975c\u8108\u6ce8\u5c04 flumazenil \u3002\u53ef\u6539\u5584\u75c5\u5b30\u7684\u610f\u8b58\u72c0\u614b\u3002 (D)\u82e5\u75c5\u5b30\u51fa\u73fe\u660f\u8ff7\u53ca\u547c\u5438\u6291\u5236\u7b49\u75c7\u72c0\uff0c\u53ef\u7d66\u4e88\u975c\u8108\u6ce8\u5c04 naloxone \u89e3\u6bd2\u5291\u4ee5\u6539\u5584\u75c5\u5b30\u7684\u75c7\u72c0\u3002 (E)\u7576\u6025\u6027\u55ce\u5561\u4e2d\u6bd2\u800c\u9020\u6210\u547c\u5438\u6291\u5236\u6642\uff0c\u53ef\u8003\u616e\u6c23\u7ba1\u63d2\u7ba1\u4e26\u4f7f\u7528\u547c\u5438\u5668\u4ee5\u7dad\u6301\u547c\u5438\u9053\u66a2\u901a\u548c\u547c\u5438\u529f\u80fd\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "Cricothyroidotomy \u8f03emergency tracheostomy \u4e4b\u512a\u9ede\uff0c\u4e0b\uf99c\u4f55\u8005\u70ba \u932f\u8aa4\uff1f", + "Options": "(A)\u5bb9\u6613\u64cd\u4f5c\u3002 (B)\u8f03\u4e0d\u6613\u51fa\u8840\u3002 (C)\u8f03\u9069\u5408\u63d0\u4f9b\u7dca\u6025\u5916\u79d1\u6c23\u9053 (surgical airway )\u3002 (D)\u53ef\u7528\u65bc 12\u6b72\u4ee5\u4e0b\u5c0f\u5b69\u3002 (E)\u64cd\u4f5c\u6642\u9593\u8f03\u77ed\u5373\u53ef\u5b8c\u6210\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e00\u4f4d\u6210\u5e74\u75c5\u4eba\u5728\u6578\u5929\u5167\u51fa\u73fe\u4e00\u5074\u81c9\u90e8\u7121\u6cd5\u6d3b\u52d5\u3001\u53e3\u89d2\u4e0b\u5782\u3001\u984d\u982d\u76ba\u7d0b\u6d88\u5931\uff0c\u4f46\u80a2\u9ad4\u6d3b\u52d5\u8207\u611f\u89ba\u6b63\u5e38\u7684\u60c5\u6cc1\uff0c\u4ee5\u4e0b\u8655\u7f6e\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u4e00\u822c\u8a8d\u70ba\u662f\u75c5\u6bd2\u611f\u67d3\u6240\u81f4\uff0c\u6240\u4ee5\u61c9\u7d66\u4e88\u6297\u75c5\u6bd2\u85e5\u7269\u6cbb\u7642\u3002(B)\u82e5\u5408\u4f75\u6709\u56b4\u91cd\u8033\u6735\u75bc\u75db\u6642\uff0c\u61c9\u8003\u616e\u7d66\u4e88\u6297\u75c5\u6bd2\u85e5\u7269\u3002(C)\u82e5\u51fa\u73fe\u773c\u89d2\u819c\u53d7\u640d\u6642\uff0c\u61c9\u8003\u616e\u7d66\u4e88\u6297\u751f\u7d20\u85e5\u7269\u6cbb\u7642\u3002(D)\u5408\u4f75\u4f7f\u7528\u985e\u56fa\u9187\u8207\u6297\u75c5\u6bd2\u85e5\u7269\u6bd4\u55ae\u7368\u4f7f\u7528\u985e\u56fa\u9187\u6709\u8f03\u597d\u7684\u7642\u6548\u4e14\u6e1b\u5c11\u4f75\u767c\u75c7\u3002(E)\u61c9\u5b89\u6392\u96fb\u8166\u65b7\u5c64\u6216\u6838\u78c1\u5171\u632f\u6392\u9664\u8166\u4e2d\u98a8\u7684\u53ef\u80fd\u3002", + "Answer": "B\u3001C" + }, + { + "\ufeffQuestion": "\u4e0b\uf99c\u4f55\u8005\u6700 \u9700\u8981\u5728\u6025\u8a3a\u9032\u884c\u7dca\u6025\u80f8\u5ed3\u5207\u958b\u8853( resuscitative t horacotomy )\uff1f", + "Options": "(A)25\u6b72\u7537\u6027\u6c7d\u8eca\u99d5\u99db\u672a\u7e6b\u5b89\u5168\u5e36\u649e\u4e0a\u8def\u71c8\uff0c\u65b9\u5411\u76e4\u8b8a\u5f62\uff0c\u5230\u9662\u6642\u5448\u73fe\u5fc3\u80ba\u529f\u80fd\u505c\u6b62\uff0c\u5fc3\u96fb\u5716\u5448\u73fe Pulseless Electrical Activity (PEA)\u3002 (B)60\u6b72\u7537\u6027\u88ab\u5c16\u5200\u523a\u50b7\u5de6\u524d\u80f8\u90e8\uff0c\u5230\u9662\u6642\u5448\u73fe\u5fc3\u80ba\u529f\u80fd\u505c\u6b62\uff0c\u5fc3\u96fb\u5716\u5448\u73fe PEA\u3002 (C)16\u6b72\u7537\u6027\u5f9e\u6a39\u4e0a\u6389\u843d\uff0c\u88ab\u6a39\u679d\u63d2\u7a7f\u80f8\u53e3\uff0c\u5230\u9662\u6642\u8840\u58d3 80/40mmHg \u3002 (D)40\u6b72\u5973\u6027\u906d\u5c16\u5200\u523a\u50b7\u5de6\u524d\u80f8\uff0c\u5230\u9662\u524d\u6642\u73fe\u5fc3\u80ba\u529f\u80fd\u505c\u6b62\uff0c\u77b3\u5b54\u7121\u5149\u53cd\u5c04\u3002 (E)20\u6b72\u7537\u6027\u88ab\u68d2\u7403\u64ca\u4e2d\u80f8\u90e8\u5f8c\u5012\u5730\u4e0d\u8d77\uff0c\u5230\u9662\u6642\u5448\u73fe\u5fc3\u80ba\u529f\u80fd\u505c\u6b62\uff0c\u5fc3\u96fb\u5716\u5448\u73fe ventricular f ibrillation \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4e0b\uf99c\u75c5\u4eba\uff0c\u4f55\u8005 \u4e0d\u662f\u9838\u690e\u53d7\u50b7\u7684\u9ad8\u5371\u96aa\u7fa4 \uff1f", + "Options": "(A)30\u6b72\u7537\u6027\u5c0f\u8ca8\u8eca\u99d5\u99db\uff0c\u5728\u9ad8\u901f\u516c\u8def\u4e0a\u7ffb\u8eca\uff0c\u6e05\u9192\u53ef\u884c\u8d70\uff0c\u540c\u8eca\u4e58\u5ba21\u4eba\u6b7b\u4ea1\u3002 (B)35\u6b72\u5973\u6027\u884c\u4eba\uff0c\u904e\u99ac\u8def\u6642\u88ab\u95d6\u7d05\u71c8\u6c7d\u8eca\u9ad8\u901f\u649e\u64ca\uff0c\u73fe\u5728\u9838\u90e8\u75e0\u75db\u3002 (C)40\u6b72\u7537\u6027\u5de5\u4eba\uff0c\u7531 6\u516c\u5c3a\u9ad8\u9df9\u67b6\u8dcc\u843d\uff0c\u7121\u660e\u986f\u795e\u7d93\u5b78\u75c7\u72c0\u3002 (D)50\u6b72\u7537\u6027\u6c7d\u8eca\u99d5\u99db\uff0c 1\u5929\u524d\u505c\u7d05\u71c8\u6642\u88ab\u5f8c\u8eca\u8ffd\u649e\uff0c\u73fe\u5728\u958b\u59cb\u5f8c\u9838\u90e8\u75bc\u75db\u3002 (E)80\u6b72\u7537\u6027\u8d70\u8def\u8dcc\u5012\u649e\u5230\u982d\uff0c\u610f\u8b58\u6e05\u9192\uff0c\u982d\u90e8\u96fb\u8166\u65b7\u5c64\u6383\u63cf\u767c\u73fe\u786c\u8166\u819c\u4e0b\u51fa\u8840\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e0b\uf99c\u95dc\u65bc\u9aa8\u76c6\u9aa8\u6298\u7684\u63cf\u8ff0\u8207\u8655\u7f6e\uff0c\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u4e00\u65e6\u78ba\u5b9a\u9aa8\u76c6\u9aa8\u6298\uff0c\u5247\u9808\u6392\u9664\u8179\u8154\u3001\u5f8c\u8179\u8154\u3001\u751f\u6b96\u7cfb\u7d71\u53ca\u6ccc\u5c3f\u7cfb\u7d71\u640d\u50b7\u4e4b\u53ef\u80fd\u3002 (B)\u8840\u884c\u52d5\u529b\u5b78\u4e0d\u7a69\u5b9a\u4e4b\u9aa8\u76c6\u9aa8\u6298\u50b7\u60a3\uff0c\u5747\u61c9\u5118\u901f\u5b89\u6392\u8840\u7ba1\u651d\u5f71\u6aa2\u67e5\uff0c\u9032\u884c\u6813\u585e\u6cbb\u7642\u3002 (C)\u5c0e\u81f4\u9aa8\u76c6\u9aa8\u6298\u7684\u6a5f\u8f49\u4e2d\uff0c\u4ee5 Lateral Compression \u7684\u6a5f\u8f49\u6700\u5e38\u898b\u3002 (D)\u9aa8\u76c6\u9aa8\u6298\u5c0e\u81f4\u5f8c\u8179\u8154\u51fa\u8840\uff0c\u4e3b\u8981\u4f86\u6e90\u70ba\u975c\u8108\u53ca\u9aa8\u6298\u908a\u7de3\u51fa\u8840\uff0c\u52d5\u8108\u51fa\u8840\u50c5\u4f54 10\u301c15%\u3002 (E)\u9664\u4e86\u6813\u585e\u6cbb\u7642\u5916\uff0c\u56fa\u5b9a\u9aa8\u76c6\u4ea6\u53ef\u63a7\u5236\u5f8c\u8179\u8154\u51fa\u8840\uff0c\u4f46\u5c0d\u975c\u8108\u53ca\u9aa8\u6298\u908a\u7de3\u51fa\u8840\u6548\u679c\u8f03\u4f73\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4e0b\uf99c\u95dc\u65bc\u8178\u963b\u585e( intestinal obstruction )\u4e4b\u6558\u8ff0\uff0c\u4e0b\uf99c\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u5728\u958b\u767c\u570b\u5bb6\uff0c\u9020\u6210\u7684\u539f\u56e0\u6700\u591a\u70ba\u624b\u8853\u5f8c\u7c98\u9ecf\uff0c\u5176\u6b21\u70ba\u816b\u7624\uff0c\u7b2c\u4e09\u70ba\u759d\u6c23( hernia)\u3002 (B)\u5728\u5e74\u7d00\u70ba 6\u81f336\u500b\u6708\u7684\u5c0f\u5b69\uff0c\u8178\u5957\u758a( intussusception )\u662f\u6700\u5e38\u5f15\u8d77\u963b\u585e\u7684\u539f\u56e0\u3002 (C)\u5148\u524d\u56e0\u624b\u8853\u5f8c\u7c98\u9ecf\u5f15\u8d77\u5c0f\u8178\u963b\u585e\u7684\u6b21\u6578\u589e\u52a0\uff0c\u4e4b\u5f8c\u5fa9\u767c( recurrence )\u963b\u585e\u7684\u6a5f\u6703\u4e5f\u589e\u52a0\u3002 (D)\u9589\u74b0( Close -loop)\u8178\u963b\u585e\u6709\u66f4\u9ad8\u5f15\u8d77\u8178\u7d5e\u7d50( strangulation )\u7684\u5371\u96aa\u3002 (E)\u7d30\u83cc\u79fb\u4f4d( bacterial translocation )\u5728\u55ae\u7d14\u8178\u963b\u585e\u5e38\u898b\uff0c\u5c0d\u4fdd\u5b88\u6cbb\u7642\u7684\u75c5\u4eba\uff0c\u5efa\u8b70\u4f8b\u884c\u4f7f\u7528\u6297\u751f\u7d20\u6cbb\u7642\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u4e0b\uf99c\u95dc\u65bc\u91ab\u9662\u7dca\u6025\u61c9\u8b8a\u53ca\u7dca\u6025\u707d\u5bb3\u7684\u5371\u5bb3\u8106\u5f31\u5ea6\u5206\u6790 (Hazard Vulnerability Analysis)\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u53ea\u6709\u5340\u57df\u91ab\u9662\u53ca\u5730\u5340\u91ab\u9662\u9700\u8981\u5728\u91ab\u9662\u7dca\u6025\u61c9\u8b8a\u8a08\u5283\u66f8\u5167\u505a\u7dca\u6025\u707d\u5bb3\u7684\u5371\u5bb3\u8106\u5f31\u5ea6\u5206\u6790\u3002 (B)\u4f9d\u73fe\u4eca\u570b\u969b\u60c5\u52e2\uff0c\u7121\u8ad6\u91ab\u9662\u7b49\u7d1a\u53ca\u5730\u7406\u4f4d\u7f6e\uff0c\u6050\u6016\u653b\u64ca\u76f8\u95dc\u707d\u96e3\u90fd\u662f\u91ab\u9662\u7dca\u6025\u61c9\u8b8a\u8a08\u5283\u66f8\u5167\u9996\u512a\u5148\u8981\u898f\u5283\u3002 (C)\u91ab\u9662\u9762\u5c0d\u5316\u5b78\u707d\u5bb3\uff0c\u9700\u6709\u6e96\u5099\u9664\u6c61\u8a2d\u5099\u53ca\u89e3\u6bd2\u5291\u898f\u5283\uff0c\u5176\u5b83\u8a2d\u5099\u5c1a\u4e0d\u9700\u8003\u616e\u3002 (D)\u90fd\u6703\u5340\u91ab\u9662\u9762\u5c0d\u5730\u9707\u5371\u5bb3\uff0c\u61c9\u8003\u616e\u56b4\u91cd\u75c5\u60c5 \u75c5\u4eba\u7a81\u6e67\u5bb9\u91cf\u53ca\u8840\u6db2\u900f\u6790\u589e\u591a\u7684\u9700\u6c42\u3002 (E)\u91ab\u5b78\u4e2d\u5fc3\u4e4b\u91ab\u9662\u7dca\u6025\u61c9\u8b8a\u8a08\u5283\u91dd\u5c0d\u6240\u6709\u7dca\u6025\u707d\u5bb3\u61c9\u8b8a\u5747\u61c9\u505a\u898f\u5283\uff0c\u6545\u4e0d\u9700\u8981\u505a\u7dca\u6025\u707d\u5bb3\u5371\u5bb3\u8106\u5f31\u5ea6\u5206\u6790\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u5927\u91cf\u50b7\u60a3\u6642\uff0c\u6839\u64da simple triage and rapid treatment \u7684\u6aa2\u50b7\u539f\u5247\uff0c\u8a55\u4f30 \u75c5\u4eba\u7684\u9806\u5e8f\u662f\uff1a", + "Options": "(A)\u547c\u5438 \u2192 \u5faa\u74b0 \u2192 \u610f\u8b58\u3002 (B)\u547c\u5438 \u2192 \u610f\u8b58 \u2192 \u5faa\u74b0\u3002 (C)\u5faa\u74b0 \u2192 \u547c\u5438 \u2192 \u610f\u8b58\u3002 (D)\u5faa\u74b0 \u2192 \u610f\u8b58 \u2192 \u547c\u5438\u3002 (E)\u610f\u8b58 \u2192 \u547c\u5438 \u2192 \u5faa\u74b0\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u5927\u8178\u7f3a\u8840\u75c7( colonic ischemia )\u597d\u767c\u5728\u5927\u65bc 60\u6b72\u4ee5\u4e0a\u7684\u65cf\u7fa4\uff0c\u4e0b\uf99c\u76f8\u95dc\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u5927\u90e8\u5206\u75c5\u4eba\u5927\u8178\u7f3a\u8840\u60c5\u6cc1\u70ba\u81ea\u9650\u6027( self-limited) \uff0c\u96a8\u8457\u4fdd\u5b88(conservative )\u6cbb\u7642\u800c\u6539\u5584\u3002 (B)\u5178\u578b\u8868\u73fe\u75c7\u72c0\u70ba\u5de6\u4e0b\u8179\u7d5e\u75db\u3001\u8179\u8139\uff0c\u5927\u90e8\u5206\u75c5\u4eba\u51fa\u73fe\u8840\u4fbf\u60c5\u5f62\u3002 (C)\u50c5\u90e8\u5206\u75c5\u4eba\u5728 plain radiographs \u51fa\u73fe thumbprinting \uff0c\u4f46\u4e0d\u5177\u8a3a\u65b7\u7684\u7279\u7570\u6027\u3002 (D)\u5927\u8178\u93e1\u6aa2\u67e5\u80fd\u63d0\u4f9b\u76f4\u63a5\u89c0\u5bdf\u9ecf\u819c\u7f3a\u8840\u7684\u60c5\u5f62\uff0c\u5fc5\u8981\u6642\u5f97\u9032\u884c\u5207\u7247\u8207\u5176\u4ed6\u75c5\u56e0\u9451\u5225\u3002 (E)\u96fb\u8166\u65b7\u5c64\u8840\u7ba1\u651d\u5f71( CT angiography )\u6aa2\u67e5\u80fd\u63d0\u4f9b\u78ba\u5207\u5927\u8178\u7f3a\u8840\u75c7\u7684\u8a3a\u65b7\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u4e2d\u5e74\u7537\u6027\u56e0\u5927\u91cf\u9157\u9152\u5f8c\u8179\u75db\u6c42\u8a3a\uff0c\u6aa2\u67e5\u767c\u73fe\u8840\u58d3\u504f\u4f4e\u53ca\u9ad8\u9670\u96e2\u5b50\u9593\u9699( high anion gap )\u4ee3\u8b1d\u6027\u9178\u4e2d\u6bd2\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u8840\u4e2d\u6c92\u6709\u6aa2\u67e5\u5230 ketone\u4e0d\u80fd\u6392\u9664\u9152\u7cbe\u6027\u916e\u9178\u4e2d\u6bd2\u7684\u8a3a\u65b7\u3002 (B)\u5148\u88dc\u5145\u542b 5%\u7cd6\u6c34\u4e4b\u751f\u7406\u98df\u9e7d\u6c34\u8f38\u6db2\uff0c\u518d\u6539\u70ba\u542b 5%\u7cd6\u6c34\u4e4b half saline\u4f5c\u70ba\u7dad\u6301\u8f38\u6db2\uff0c\u76f4\u5230\u53e3\u670d\u6062\u5fa9\uff0c\u4e26\u88dc\u5145\u9240\u548c\u9382\u3002 (C)\u9152\u7cbe\u6027\u916e\u9178\u4e2d\u6bd2\u60a3\u8005\u8840\u7cd6\u53ef\u7565\u9ad8\u65bc\u6b63\u5e38\u503c\u6216\u4f4e\u65bc\u6b63\u5e38\u503c\u3002 (D)\u60a3\u8005\u52d5\u8108\u8840\u82e5 PH\u4f4e\u65bc 7.2\uff0c\u9700\u8003\u616e\u88dc\u5145 sodium bicarbonate \u4ee5\u514d\u56e0\u9178\u8840\u75c7\u9020\u6210\u81f4\u547d\u6027\u7684\u5fc3\u5f8b\u4e0d\u6574\u3002 (E)\u61c9\u88dc\u5145\u5927\u91cf\u8f38\u6db2\u53ca\u5e38\u898f\u4f7f\u7528\u7dad\u4ed6\u547d B1(thiamine)\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e2d\u5e74\u7537\u6027\u56e0\u767c\u71d2\u54b3\u55fd\u591a\u65e5\u81f3\u6025\u8a3a\u6c42\u8a3a\uff0c\u80f8\u90e8 X\u5149\u986f\u793a\u80ba\u81bf\u760d\uff0c\u4ee5\u4e0b\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)Lemierre\u2019s syndrome \u53ef\u7e8c\u767c\u65bc\u6241\u6843\u817a\u708e\u4e4b\u5f8c\u3002 (B)\u591a\u767c\u6027\u7684\u80ba\u81bf\u760d\u5f88\u5e38\u898b\uff0c\u4e14\u591a\u7531\u8840\u884c\u6027\u611f\u67d3\u9020\u6210\u3002 (C)\u514d\u75ab\u529b\u6b63\u5e38\u7684 \u75c5\u4eba\u5e38\u898b\u7684\u81f4\u75c5\u83cc\u662f\u55dc\u6c27\u83cc\uff0c\u514d\u75ab\u529b\u4f4e\u4e0b\u7684 \u75c5\u4eba\u5247\u70ba\u53ad\u6c27\u83cc\u3002 (D)\u4e03\u6210\u7684\u75c5\u4eba\u9700\u624b\u8853\u5f15\u6d41\u3002 (E)\u8fd1 40\u5e74\u6b64\u75c5\u7684\u767c\u751f\u7387\u5287\u589e\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u6c34\u6bcd\u87ab\u50b7\u6642\u9700\u6e05\u6f54\u50b7\u53e3\uff0c\u5efa\u8b70\u7684\u50b7\u53e3\u8655\u7406\u65b9\u5f0f\uff0c\u4e0b\uf99c\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u6e05\u6c34\u3002 (B)\u6d77\u6c34\u3002 (C)\u6d78\u6ce1 45\u2103\u71b1\u6c34\u3002 (D)5%\u918b\u9178(acetic acid )\u3002 (E)\u5857\u62b9\u5229\u591a\u5361\u56e0 (lidocaine)\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u4ee5\u4e0b\u4e00\u6c27\u5316\u78b3\u4e2d\u6bd2\u75c5\u4eba\u4f55\u8005\u6700 \u9700\u8981\u63a5\u53d7\u9ad8\u58d3\u6c27\u6cbb\u7642 \uff1f", + "Options": "(A)\u5b55\u5a66\u8840\u4e2d\u4e00\u6c27\u5316\u78b3\u6fc3\u5ea6 (carboxyhemoglobin level )\u70ba5%\u3002 (B)\u4e00\u822c\u4eba\u8840\u4e2d\u4e00\u6c27\u5316\u78b3\u6fc3\u5ea6 (carboxyhemoglobin level )\u70ba15%\u3002 (C)\u66fe\u7d93\u767c\u751f\u6688\u53a5 (syncope)\u6216\u610f\u8b58\u55aa\u5931\u3002 (D)\u75c5\u4eba\u6709\u982d\u6688( dizziness)\u7684\u75c7\u72c0\u3002 (E)\u4e2d\u6bd2\u5f8c\u51fa\u73fe\u81c9\u9ebb\u53ca\u624b\u9ebb\u7684\u72c0\u6cc1\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u5916\u50b7\u6027\u4e3b\u52d5\u8108\u640d\u50b7( Traumatic aortic injury )\u662f\u6025\u8a3a\u56f0\u96e3\u8a3a\u65b7\u4e14\u81f4\u547d\u7684\u5916\u50b7\u4e4b\u4e00\uff0c\u95dc\u65bc\u8a72\u5916\u50b7\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u5927\u90e8\u5206\u662f\u56e0\u7a7f\u523a\u50b7\u6216\u662f\u6e1b\u901f (deceleration )\u50b7\u5bb3\u6240\u9020\u6210\u3002 (B)90%\u4e3b\u52d5\u8108\u920d\u50b7\u60a3\u8005\u6703\u5728\u7576\u5834\u6b7b\u4ea1\uff0c\u4f86\u4e0d\u53ca\u9001\u91ab\u3002 (C)\u9ad8\u4f4d\u808b\u9aa8\u9aa8\u6298\u3001\u4e0d\u5c0d\u7a31\u7684\u96d9\u4e0a\u80a2\u8840\u58d3\u3001\u53ca\u4e0b\u80a2\u8108\u640f\u8b8a\u5f31\u7b49\u60c5\u6cc1\u90fd\u61c9\u5c0f\u5fc3\u662f\u5426\u6709\u4e3b\u52d5\u8108\u640d\u50b7\u3002 (D)\u5927\u90e8\u5206\u75c5\u4eba\u7684\u80f8\u90e8 X\u5149\u53ef\u80fd\u770b\u5230\u7e31\u8188\u8154\u8b8a\u5bec\u53ca\u5de6\u5074\u6c23\u7ba1\u504f\u79fb\u3002 (E)\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\u7684\u50b7\u60a3\uff0c\u4e00\u65e6\u61f7\u7591\u4e3b\u52d5\u8108\u640d\u50b7\uff0c\u90fd\u61c9\u5b89\u6392 CT angiogram with contrast \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u56e0\u53e4\u67ef\u9e7c (Cocaine)\u6feb\u7528\u800c\u5f15\u8d77\u7684\u80f8\u75db\u53ca acute coronary syndrome \uff0c\u75c5\u4eba\u8108\u640f120\u4e0b/min\uff0c\u8840\u58d3 168/96 mmHg \uff0c\u9ad4\u6eab 37.2\u2103\uff0c\u6cbb\u7642\u6b64\u75c5\u4eba\u4e4b \u9996\u9078\u85e5\u7269\u70ba\u4f55\u8005\uff1f", + "Options": "(A)Diazepam \u3002 (B)Labetolol \u3002 (C)Phetolamine \u3002 (D)Tissue plasminogen activator (t-PA)\u3002 (E)Verapamil \u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u56e0\u767c\u751f\u5927\u5730\u9707\uff0c\u591a\u8655\u623f\u5c4b\u5012\u584c\u4e26\u6709\u5927\u91cf\u50b7 \u75c5\u4eba\uff0c\u885b\u751f\u5c40\u6d3e\u9063\u8cb4\u9662\u51fa\u52e4\u7dca\u6025\u91ab\u7642\u6551\u8b77\u4efb\u52d9\uff0c\u4f60\u5728\u73fe\u5834\u8ca0\u8cac\u75c5\u4eba\u6aa2\u50b7\u5206\u985e\uff0c\u6839\u64da Simple Triage and Rapid Treatment (START)\u6aa2\u50b7\u539f\u5247\uff0c\u4ee5\u4e0b\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u7121\u540d\u6c0f\uff0c\u7537\u6027\uff0c\u7121\u547c\u5438\u8108\u640f\uff0c\u982d\u9838\u5206\u96e2\u70ba\u9ed1\u8272\u3002 (B)50\u6b72\u7121\u547c\u5438\u7537\u6027\uff0c\u6253\u958b\u547c\u5438\u9053\u5f8c\u6709\u547c\u5438\u70ba\u7d05\u8272\u3002 (C)30\u6b72\u5973\u6027\uff0c\u547c\u5438\u5927\u7d04 25\u6b21/min\uff0c\u6a48\u52d5\u8108\u6478\u4e0d\u5230\uff0c\u53f3\u5074\u5927\u817f\u8b8a\u578b\u5408\u4f75\u50b7\u53e3\u5927\u91cf\u51fa\u8840\u70ba\u9ec3\u8272\u3002 (D)18\u6b72\u7537\u6027\uff0c\u73fe\u5834\u8dd1\u4f86\u8dd1\u53bb\uff0c\u53f3\u624b\u53ca\u96d9\u8173\u591a\u8655\u64e6\u50b7\u70ba\u7da0\u8272\u3002 (E)21\u6b72\u5973\u6027\uff0c\u5de6\u5074\u5927\u817f\u9aa8\u6298\uff0c\u547c\u5438\u8108\u640f\u6b63\u5e38\uff0c\u610f\u8b58\u6e05\u9192\u70ba\u9ec3\u8272\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u5728\u6025\u8a3a\u5c0d\u65bc\u5d4c\u9813\u6027\u759d\u6c23 (Incarcerated Hernia )\u7684\u8655\u7406\u4f55\u8005\u8f03 \u4e0d\u9069\u5b9c\uff1f", + "Options": "(A)\u5fa9\u4f4d (reduction )\u82e5\u4e0d\u6210\u529f\u8005\u9700\u7981\u98df\u3002 (B)\u7d66\u4e88 \u975c\u8108\u6ce8\u5c04\u6b62\u75db\u85e5\u3002 (C)\u5c0d\u65bc\u759d\u6c23\u8655\u7d66\u4e88\u71b1\u6577\u8b93\u5fa9\u4f4d\u66f4\u5bb9\u6613\u3002 (D)\u5fa9\u4f4d 1~2\u6b21\u5931\u6557\u5373\u8003\u616e\u627e\u5916\u79d1\u91ab\u5e2b\u8655\u7406\u3002 (E)\u5fa9\u4f4d\u6210\u529f\u5f8c\u4ecd\u9700\u89c0\u5bdf\u4e00\u6bb5\u6642\u9593\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u5728\u91ab\u9662\u707d \u5bb3\u6307\u63ee\u7cfb\u7d71( Hospital Incident Command System )\u67b6\u69cb\u4e0b\uff0c\u4e0b\uf99c\u54ea\u500b\u90e8\u9580\u4e0d\u5c6c\u65bc\u57f7\u884c\u90e8\u9580( Operation section )\uff1f", + "Options": "(A)\u5371\u5bb3\u7269\u8cea\u8ab2( Hazmat Branch )\u3002 (B)\u57fa\u790e\u8a2d\u65bd\u8ab2( Infrastructure Branch )\u3002 (C)\u91ab\u7642\u7167\u8b77\u8ab2( Medical Care Branch )\u3002 (D)\u8b66\u6212\u7ba1\u5236\u8ab2( Security Branch )\u3002 (E)\u72c0\u6cc1\u5206\u6790\u8ab2( Situation Branch )\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u5730\u9707\u707d\u96e3\u4e2d\uff0c 60\u6b72\u7537\u6027\u75c5\u4eba\u88ab\u8863\u6ac3\u58d3\u4f4f\u96d9\u4e0b\u80a2 10\u5c0f\u6642\u624d\u88ab\u6551\u51fa\uff0c\u5728\u6025\u8a3a\u7684\u6cbb\u7642\u4e2d\u54ea\u500b\u61c9\u8a72\u662f \u6709\u5bb3\u7684\uff1f", + "Options": "(A)\u5927\u91cf\u751f\u7406\u98df\u9e7d\u6c34\u975c\u6ce8\u3002 (B)\u88dc\u5145\u9240\u96e2\u5b50 \u3002 (C)\u88dc\u5145\u78b3\u9178\u6c2b\u9209 (Sodium Bicarbonate )\u3002 (D)\u88dc\u5145\u9223\u96e2\u5b50\u3002 (E)\u88dc\u5145\u7518\u9732\u9187(Mannitol)\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u5e74\u8f15\u7537\u6027\u7121\u904e\u53bb\u75c5\u53f2\uff0c\u53c3\u52a0\u99ac\u62c9\u677e\u7af6\u8cfd\u6642\uff0c\u56e0\u610f\u8b58\u6539\u8b8a\u88ab\u9001\u9032\u6025\u8a3a\uff0c\u5230\u9662\u6642\u610f\u8b58\u4e0d\u6e05\uff0c\u9ad4\u6eab 42\u00b0C\uff0c\u76ae\u819a\u4e7e\u71b1\uff0c\u62bd\u8840\u6aa2\u9a57\u767d\u8840\u7403\u53ca CRP\u7686\u5728\u6b63\u5e38\u7bc4\u570d\uff0c\u7121\u8166\u819c\u708e\u8b49\u64da\uff0c\u96fb\u8166\u65b7\u5c64\u53ca\u80f8\u90e8 X\u5149\u4ea6\u7121\u7570\u5e38\u3002\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u75c5\u4eba\u82e5\u6709\u526f\u4ea4\u611f\u795e\u7d93\u8208\u596e\u5291\u904e\u91cf\u4ea6\u6709\u985e\u4f3c\u7684\u81e8\u5e8a\u8868\u73fe\u3002 (B)\u61c9\u8a72\u5feb\u901f\u964d\u6eab\u5230 37\u2103\u4ee5\u4e0b\uff0c\u4ee5\u6e1b\u5c11\u9ad8\u9ad4\u6eab\u5c0d\u65bc\u795e\u7d93\u7684\u50b7\u5bb3\u3002 (C)\u5728\u964d\u6eab\u904e\u7a0b\u4e2d\uff0c\u82e5 \u75c5\u4eba\u986b\u6296(shivering)\u53ef\u7528\u77ed\u6548\u6027 Benzodiazepine\u6cbb\u7642\u3002 (D)\u7576\u8db3\u5920\u7684\u8f38\u6db2\u6cbb\u7642\u5f8c\uff0c\u82e5\u6301\u7e8c\u4f4e\u8840\u58d3\u61c9\u7528 Norepinephrine \u4f5c\u70ba\u5347\u58d3\u5291\u3002 (E)\u56e0\u70ba \u75c5\u4eba\u5448\u73fe\u812b\u6c34\u72c0\u614b\uff0c\u62bd\u8840\u53ef\u898b\u5178\u578b\u7684\u9ad8\u8840\u9240\u53ca\u9ad8\u8840\u9209\u8868\u73fe\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "35\u6b72\u7537\u6027\u5728\u96a7\u9053\u5de5\u4f5c\uff0c\u5927\u91cf\u5192\u6c57\u5f8c\u795e\u667a\u4e0d\u6e05\uff0c\u73fe\u5834\u74b0\u5883\u5ba4\u6eab 40\u2103\u6563\u71b1\u4e0d\u826f\u3002\u8acb\u554f\u4ee5\u4e0b\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u71b1\u4e2d\u6691 (Heat Stroke )\u7684\u60a3\u8005\u9664\u4e86\u9ad4\u6eab\u5347\u9ad8\u5916\uff0c\u6700\u4e3b\u8981\u6703\u6709\u7672\u7647\u6216\u795e\u667a\u4e0d\u6e05\u7b49\u4e2d\u6a1e\u795e\u7d93\u65b9\u9762\u7684\u75c7\u72c0\u3002 (B)\u71b1\u8870\u7aed (Heat Exhaustion )\u7684\u75c5\u4eba\u9ad4\u6eab\u53ef\u80fd\u4e0d\u6703\u8d85\u904e 40\u2103\u3002 (C)\u6cbb\u7642\u71b1\u4e2d\u6691\u6642\uff0c\u5982\u679c\u75c5\u4eba\u7684\u8eab\u9ad4\u60c5\u6cc1\u8a31\u53ef\u8f38\u6db2\u901f\u7387\u53ef\u4ee5\u7531 250 ml/hr\u958b\u59cb\u3002 (D)\u4f7f\u7528 4\u2103\u7684\u751f\u7406\u98df\u9e7d\u6c34\u8f38\u6db2\u964d\u6eab\u7684\u6548\u679c\u662f\u6bd4\u51b0\u6795\u9084\u8981\u597d\u7684\u8f14\u52a9\u964d\u6eab \u6cbb\u7642\u3002 (E)\u71b1\u4e2d\u6691\u964d\u6eab\u7684\u9996\u8981\u76ee\u6a19\u662f\u628a\u4e2d\u5fc3\u9ad4\u6eab\u964d\u5230 39\u2103\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u4e0b\u80a2\u97cc\u5e36\u50b7\u5bb3\u7684\u6558\u8ff0\uff0c\u4e0b\uf99c\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u7576\u61f7\u7591\u75c5\u4eba\u6709\u524d\u5341\u5b57\u97cc\u5e36\u65b7\u88c2\u6642\uff0c\u5176\u7406\u5b78\u6aa2\u67e5 Lachman test \u7684\u654f\u611f\u5ea6\u8f03anterior drawer sign \u9ad8\u3002 (B)\u5f8c\u5341\u5b57\u97cc\u5e36\u65b7\u88c2\u8f03\u524d\u5341\u5b57\u97cc\u5e36\u65b7\u88c2\u66f4\u5bb9\u6613\u767c\u751f\u3002 (C)\u9577\u671f\u985e\u56fa\u9187\u6216\u7b2c\u4e09\u4ee3\u982d\u5b62\u5b50\u83cc\u7d20 (cephalosporins )\u7684\u4f7f\u7528\uff0c\u7686\u662f\u81ea\u767c\u6027\u808c\u8171\u65b7\u88c2\u7684\u5371\u96aa\u56e0\u5b50\u3002 (D)\u81ea\u767c\u6027\u811b\u5f8c\u808c\u8171( posterior tibialis tendon )\u65b7\u88c2\u591a\u767c\u751f\u65bc\u5287\u70c8\u904b\u52d5\u6642\uff0c\u6545\u5e74\u8f15\u7537\u6027 \u75c5\u4eba\u8f03\u591a\u3002 (E)\u7576\u6709\u95dc\u7bc0\u8840\u816b\u7522\u751f\u6642\uff0c\u5f8c\u5341\u5b57\u97cc\u5e36\u65b7\u88c2\u8f03\u524d\u5341\u5b57\u97cc\u5e36\u65b7\u88c2\u6a5f\u7387\u8f03\u9ad8\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u81ea\u767c\u6027\u6c23\u80f8\u7684\u8a3a\u65b7\u53ca\u8655\u7f6e\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u539f\u767c\u6027\u6c23\u80f8\u7684\u5371\u96aa\u56e0\u5b50\u5305\u62ec\u62bd\u83f8\u3001\u7537\u6027\u3001\u4e8c\u5c16\u74e3\u812b\u5782\u53ca\u907a\u50b3\u3002 (B)\u8a3a\u65b7\u53ef\u4ee5\u85c9\u7531\u80f8\u90e8 X\u5149\u3001\u80f8\u90e8\u96fb\u8166\u65b7\u5c64\u6216\u8d85\u97f3\u6ce2\uff0c\u4e09\u8005\u654f\u611f\u6027\u53ca\u7279\u7570\u6027\u5747\u9ad8\u65bc 90%\u4ee5\u4e0a\u3002 (C)Room air \u4e0b\uff0c\u8840\u6c27\u6fc3\u5ea6 (Oxygen saturation ) 91%\uff0c\u7b26\u5408\u7a69\u5b9a\u6c23\u80f8\u75c5\u4eba(Stable patient )\u7684\u689d\u4ef6(Criteria)\u3002 (D)\u81e8\u5e8a\u4e0a\u4e00\u65e6\u9ad8\u5ea6\u61f7\u7591\u5f35\u529b\u6027\u6c23\u80f8\uff0c\u9808\u7acb\u5373\u8655\u7f6e\uff0c\u4e0d\u80fd\u518d\u7b49\u80f8\u90e8 X\u5149\u78ba\u8a8d\u8a3a\u65b7\u3002 (E)\u81ea\u767c\u6027\u6c23\u80f8\u7bc4\u570d\u5982\u679c\u5c0f\u65bc 20%\uff0c\u5728\u7a69\u5b9a\u7684\u5065\u5eb7\u6210\u4eba\u53ef\u4ee5\u7528\u6c27\u6c23\u6cbb\u7642\u53ca\u89c0\u5bdf\uff0c\u4e0d\u7528 \u7acb\u5373\u65bd\u884c\u80f8\u7ba1\u653e\u7f6e\u8853\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u8840\u54c1\u6cbb\u7642\u5c0d\u6539\u5584 von Willebrand factor \u56e0\u5b50\u7f3a\u4e4f\uff0c\u4e0b\uf99c\u4f55\u8005\u5177\u6709 \u6700\u4f73\u6548\u679c\uff1f", + "Options": "(A)\u5168\u8840( Whole blood )\u3002 (B)\u5206\u96e2\u8853\u8840\u5c0f\u677f( platelet phoresis )\u3002 (C)\u6d17\u6ecc\u7d05\u8840\u7403 (Washed Red Blood Cells )\u3002 (D)\u65b0\u9bae\u51b7\u51cd\u8840\u6f3f (fresh -frozen plasma )\u3002 (E)\u51b7\u51dd\u6c89\u6fb1\u54c1 (cryoprecipitate )\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6297\u78f7\u8102\u8cea\u75c7\u4faf\u7fa4 (Antiphospholipid Syndrome )\u4e4b\u654d\u8ff0\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u597d\u767c\u65bc\u5973\u6027\u3002 (B)\u61f7\u7591\u6025\u6027\u8840\u6813\u5f62\u6210\u6642\uff0c D-dimer\u662f\u5224\u65b7\u6b64\u75be\u75c5\u5371\u96aa\u6027\u9ad8\u4f4e\u7684\u91cd\u8981\u6aa2\u67e5\u3002 (C)\u72fc\u7621\u6297\u51dd\u56e0\u5b50 (Lupus anticoagulant )\u967d\u6027\u53cd\u61c9\u4e4b \u75c5\u4eba\uff0c20\u5e74\u5167\u670950%\u6a5f\u7387\u767c\u751f\u52d5\u975c\u8108\u6813\u585e\u3002 (D)\u6b64\u75be\u75c5\u4ee5 Warfarin\u6cbb\u7642\uff0c International normalized ratio (INR)\u61c9\u7dad\u6301\u57283\u3002 (E)\u6297\u78f7\u8102\u8cea\u75c7\u4faf\u7fa4\u4e4b\u5b55\u5a66\uff0c\u53ef \u7528\u4f4e\u5206\u5b50\u91cf\u809d\u7d20\u6216\u4f4e\u5291\u91cf\u963f\u65af\u5339\u6797\u6cbb\u7642\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u65bc Gout\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u597d\u767c\u65bc\u5927\u8173\u8dbe\u7684 first metatarsophalangeal joint \uff0c\u4f46\u5168\u8eab\u5404\u8655\u95dc\u7bc0\u5747\u6709\u53ef\u80fd\u767c\u751f\u3002 (B)\u78ba\u5b9a\u8a3a\u65b7\u9700\u6aa2\u9a57\u95dc\u7bc0\u6db2\u7684\u7d50\u6676\u6210\u4efd\u3002 (C)\u82e5\u7121\u6cd5\u8207\u6557\u8840\u6027\u95dc\u7bc0\u708e\u9451\u5225\u6642\uff0c\u5247\u4f4f\u9662\u6cbb\u7642\u662f\u6700\u5b89\u5168\u7684\u505a\u6cd5\u3002 (D)\u4e00\u822c\u800c\u8a00\uff0c\u6295\u8207 NSAID\u985e\u85e5\u7269\uff0c\u75bc\u75db\u7d04\u5728 2\u5929\u5f97\u5230\u7de9\u89e3\u3002 (E)\u975c\u8108\u6ce8\u5c04 colchicine \u5e38\u5408\u4f75\u56b4\u91cd\u526f\u4f5c\u7528\uff0c\u5982 bone marrow suppression \uff0c\u6545\u6975\u5c11\u4f7f\u7528\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6025\u6027\u9f3b\u7ac7\u708e\u7684\u6558\u8ff0\uff0c\u4e0b\uf99c\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u5e38\u898b\u7684\u524d\u4e09\u5927\u81f4\u75c5\u539f\u8207\u4e2d\u8033\u708e\u4e4b\u5e38\u898b\u81f4\u75c5\u539f\u76f8\u540c\u3002 (B)\u81e8\u5e8a\u8868\u73fe\u70ba\u9ec3\u7da0\u8272\u7684\u6fc3\u9f3b\u6d95\uff0c\u9f3b\u585e\u3001 \u9f3b\u984f\u90e8\u98fd\u8139\u611f\uff0c\u751a\u81f3\u55c5\u89ba\u964d\u4f4e\u3002 (C)\u5c0d\u65bc\u51fa\u73fe\u9ec3\u7da0\u8272\u6fc3\u9f3b\u6d95\u7684\u75c5\u4eba\uff0c\u5fc5\u9808\u9ad8\u5ea6\u61f7\u7591\u51fa\u73fe\u7d30\u83cc\u6027\u611f\u67d3\u4e4b\u53ef\u80fd\u6027\uff0c\u4e00\u5f8b\u7d66\u4e88\u6297\u751f\u7d20\u6cbb\u7642\u3002 (D)\u76e4\u5c3c\u897f\u6797\u985e\u904e\u654f\u8005\uff0c Cefuroxime \u662f\u5408\u7406\u7684\u6297\u751f\u7d20\u66ff\u4ee3\u7528\u85e5\u3002 (E)X\u5149\u6aa2\u67e5\u7684\u8a3a\u65b7\u50f9\u503c\u4e0d\u9ad8\uff0c\u4e0d\u5e38\u898f\u5efa\u8b70\u65bc\u6240\u6709\u6025\u6027\u9f3b\u7ac7\u708e\u75c5\u4eba\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6025\u8a3a\u6240\u898b\u5927\u8178\u61a9\u5ba4\u708e( diverticulitis )\u75c5\u4eba\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u767c\u751f\u7387\u96a8\u5e74\u7d00\u589e\u52a0\u800c\u589e\u52a0\uff0c\u5728 40\u6b72\u4ee5\u4e0b\uff0c\u7537\u6027\u6bd4\u5973\u6027\u5bb9\u6613\u767c\u751f\u3002 (B)\u6709\u4e00\u534a\u7684\u75c5\u4eba\uff0c\u8868\u9054\u904e\u53bb\u66fe\u7d93\u51fa\u73fe\u76f8\u4f3c\u7684\u8179\u75db\u3002 (C)\u597d\u767c\u90e8\u4f4d\u4f9d\u5e8f\u70ba\u6a6b\u7d50\u8178\u3001\u4e59\u72c0\u7d50\u8178\u3001 \u5347\u7d50\u8178\u3002 (D)\u8179\u90e8\u96fb\u8166\u65b7\u5c64\u662f\u9996\u9078\u78ba\u5b9a\u8a3a\u65b7\u7684\u6aa2\u67e5\u5de5\u5177\u3002 (E)\u5927\u8178\u7a7f\u5b54\u3001\u5f62\u6210\u81bf\u760d\u6216\u5927\u8178\u963b\u585e\u70ba\u53ef\u80fd\u7684\u5408\u4f75\u75c7\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u91cd\u75c7\u808c\u7121\u529b (myasthenia gravis )\u4e4b\u6558\u8ff0\uff0c\u4e0b\uf99c\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u591a\u6578\u60a3\u8005\u4ee5\u5168\u8eab\u7121\u529b\u8868\u73fe\uff0c\u5c24\u5176\u662f\u8fd1\u7aef \u80a2\u9ad4\u808c\u8089\u7fa4\u3002 (B)\u8001\u4eba\u60a3\u8005\u56e0\u65b0\u767c\u751f\u7684\u984f\u9762\u808c\u8089\u7121\u529b\u6613\u88ab\u8aa4\u8a3a\u70ba\u4e2d\u98a8\u3002 (C)\u60a3\u8005\u5e38\u56e0\u611f\u67d3\u3001\u624b\u8853\u6216\u505c\u7528\u85e5\u7269\u800c\u52a0\u91cd\u547c\u5438\u8870\u7aed\u7684\u72c0\u6cc1\u3002 (D)\u60a3\u8005\u82e5\u56e0\u547c\u5438\u8870\u7aed\u9700\u63d2\u7ba1\u6cbb\u7642\u6642\uff0c\u512a\u5148\u9078\u64c7 pancuronium \u3002 (E)\u60a3\u8005\u4f75\u6709\u5fc3 \u81df\u75c5\uff0c\u4f7f\u7528 edrophonium \u6cbb\u7642\u6642\uff0c\u53ef\u80fd\u5c0e\u81f4\u5fc3\u640f\u904e\u7de9\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u63a5\u53d7\u8840\u6813\u6eb6\u89e3\u6cbb\u7642 Fibrinolytic therapy \u5f8c\u7522\u751f\u4f75\u767c\u75c7\u4e4b\u8655\u7f6e\uff0c\u8acb\u554f\u4e0b\uf99c\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u958b\u59cb\u8840\u6813\u6eb6\u89e3\u6cbb\u7642\u5f8c\u6bcf 4~6\u5c0f\u6642\u6aa2\u67e5\u8840\u7d05\u7d20\uff0c\u7576\u8840\u7d05\u7d20\u964d\uff1e 1~2 g/dL\uff0c\u61c9\u61f7\u7591\u6709\u51fa\u8840\u73fe\u8c61\u3002 (B)\u75c5\u4eba\u767c\u751f\u8179\u5167\u6216\u9871\u5167\u51fa\u8840\u6642\uff0c\u61c9\u99ac\u4e0a\u505c\u6b62\u8840\u6813\u6eb6\u89e3\u85e5\u7269\u3001\u6297\u8840\u5c0f\u677f\u85e5\u7269\u53ca heparin\u7b49\u6cbb\u7642\u3002 (C)\u75c5\u4eba\u6ce8\u5c04\u90e8\u4f4d\u51fa\u8840\uff0c\u61c9\u99ac\u4e0a\u6ce8\u5c04 Protamine \u6cbb\u7642\u3002 (D)\u63a5\u53d7 Heparin\u85e5\u7269\u5f8c\u767c\u751f\u51fa\u8840\uff0c\u53ef\u6ce8\u5c04 Protamine \u6cbb\u7642\u3002 (E)\u5927\u91cf\u51fa\u8840\u6642\uff0c\u61c9\u8f38\u6ce8\u8840\u6db2\u51dd\u56fa\u56e0\u5b50 cryoprecipitate \u6216FFP\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u8a98\u767c acute angle -closure glaucoma \u7684\u56e0\u5b50\uff0c\u4e0b\uf99c\u4f55\u8005 \u8f03\u7121\u76f8\u95dc \uff1f", + "Options": "(A)\u4f7f\u7528\u773c\u90e8\u6297\u7d44\u7e54\u80fa\u85e5\u7269\u3002 (B)\u9f3b\u585e\u75c5\u4eba\u4f7f\u7528\u507d\u9ebb\u9ec3\u7d20 (Pseudoephedrine )\u3002 (C)\u6c23\u5598\u75c5\u4eba\u4f7f\u7528\u5438\u5165\u6027\u4e59\u4e8c\u578b\u4ea4\u611f\u795e\u7d93\u8208\u596e\u5291\u3002 (D)\u5f37\u5149\u74b0\u5883\u3002 (E)\u60c5\u7dd2\u58d3\u529b\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6bcf\u5e74 12\u6708\u5230\u6b21\u5e74\u7684 3\u6708\u662f\u6d41\u611f\u6d41\u884c\u671f\uff0c\u5404\u5927\u91ab\u9662\u6025\u8a3a\u5ba4\u64e0\u6eff\u4e86\u767c\u71d2\u7684\u75c5\u4eba\uff0c\u4ee5\u4e0b\u95dc\u65bc\u6d41\u611f\u4f75\u767c\u91cd\u75c7\u7684\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u901a\u5831\u689d\u4ef6\u70ba\u51fa\u73fe\u985e\u6d41\u611f\u75c7\u72c0\u4e00\u5468\u5167\u56e0\u70ba\u4f75\u767c\u75c7\u5982\u80ba\u708e\u7b49\u9700\u8981\u4f4f\u52a0\u8b77\u75c5\u623f\u6cbb\u7642\u6216\u6b7b\u4ea1\u8005\u3002 (B)\u76ee\u524d\u70ba\u7b2c\u56db\u985e\u50b3\u67d3\u75c5\uff0c\u9700\u65bc\u4e00\u5468\u5167\u901a\u5831\u3002 (C)A\u578b\u53ca B\u578b\u6d41\u611f\u90fd\u53ef\u4ee5\u7d66\u4e88 Zanamivir \u6cbb\u7642\u3002 (D)Zanamivir \u4e3b\u8981\u662f\u7d93\u7531\u6291\u5236\u795e\u7d93\u80fa\u9178\u9176 (neuraminidase )\u4f86\u964d\u4f4e\u611f\u67d3\u7684\u56b4\u91cd\u6027\u3002 (E)105\u5e74\u5ea6\u4ee5\u4f86\u53f0\u7063\u5730\u5340\u5b63\u7bc0\u6027\u6d41\u611f A\u578b\u4e3b\u8981\u662f H1N1\u53caH3N2\u5169\u7a2e\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u4f9d\u7167\u516c\u5171\u5834\u6240\u5fc5\u8981\u7dca\u6025\u6551\u8b77\u8a2d\u5099\u7ba1\u7406\u8fa6\u6cd5\uff0c\u6709\u95dc\u516c\u5171\u5834\u6240\u81ea\u52d5\u9ad4\u5916\u5fc3\u81df\u96fb\u64ca\u53bb\u986b\u5668( Automated External Defibrillator \uff0cAED) \uff0c\u4e0b\uf99c\u4f55\u8005 \u4e0d\u5c6c\u65bc\u898f\u5b9a\u4e2d\u4e4b\u516b\u5927\u985e\u516c\u5171\u5834\u6240 \uff1f", + "Options": "(A)\u6843\u5712\u4e2d\u6b63\u570b\u969b\u6a5f\u5834\u3002 (B)\u5317\u4e8c\u9ad8\u95dc\u897f\u4f11\u606f\u5340\u3002 (C)\u4e8c\u7b49\u7ad9\u4ee5\u4e0a\u4e4b\u53f0\u9435\u8eca\u7ad9\u3002 (D)\u9ad8\u4e2d\u4ee5\u4e0a\u4e4b\u5b78\u6821\u3002 (E)\u6de1\u6c34\u5f80\u8fd4\u516b\u91cc\u6bcf\u8258\u53ef\u642d\u8f09 90\u4eba\u4e4b\u4ea4\u901a\u8239\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u4f9d\u7dca\u6025\u91ab\u7642\u6551\u8b77\u6cd5\u898f\u5b9a\u4e2d\uff0c\u6709\u95dc\u7dca\u6025\u91ab\u7642\u6551\u8b77\u8cc7\u8a0a\u901a\u5831\u8fa6\u6cd5\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u7576\u5730\u65b9\u6551\u707d\u6551\u8b77\u6307\u63ee\u4e2d\u5fc3\u63a5\u7372\u5831\u6848\uff0c\u7d93\u521d\u6b65\u5224\u5b9a\u4fc2\u5927\u91cf\u50b7 \u75c5\u4eba\u4e8b\u4ef6\uff0c\u61c9\u901a\u77e5\u7576\u5730\u885b\u751f\u3001\u6d88\u9632\u4e3b\u7ba1\u6a5f\u95dc\u53ca\u76f8\u95dc\u6a5f\u95dc(\u69cb) \u3002\u61c9\u65bc\u7dca\u6025\u91ab\u7642\u7ba1\u7406\u7cfb\u7d71\u5167\u5efa\u7acb\u300c\u707d\u5bb3\u4e8b\u4ef6\u6a94\u300d \u3002 (B)\u9047\u975e\u5927\u91cf\u50b7 \u75c5\u4eba\u4e8b\u4ef6\u6642\uff0c\u5730\u65b9\u885b\u751f\u4e3b\u7ba1\u6a5f\u95dc\u77e5\u6089\u4e26\u5224\u5b9a\u70ba\u300c\u7279\u6b8a\u4e8b\u4ef6\u300d\u5f8c\uff0c\u5f97\u65bc\u7dca\u6025\u91ab\u7642\u7ba1\u7406\u7cfb\u7d71\u5efa\u7acb\u300c\u707d\u5bb3\u4e8b\u4ef6\u6a94\u300d \u3002 (C)\u5340\u57df\u7dca\u6025\u91ab\u7642\u61c9\u8b8a\u4e2d\u5fc3\u5f97\u5354\u52a9\u5730\u65b9\u885b\u751f\u4e3b\u7ba1\u6a5f\u95dc\u53ca\u6025\u6551\u8cac\u4efb\u91ab\u9662\u9032\u884c\u76f8\u95dc\u8cc7\u6599\u8490\u96c6\u53ca\u767b\u9304\u3002 (D)\u6025\u6551\u8cac\u4efb\u91ab\u9662\u61c9\u65bc 60\u5206\u9418\u5167\u63d0\u4f9b\u7576\u6642\u4e8b\u4ef6\u76f8\u95dc\u4e4b\u6536\u6cbb\u50b7 \u75c5\u4eba\u521d\u6b65\u6aa2\u50b7\u4eba\u6578\u8cc7\u6599\uff0c\u4e26\u63d0\u4f9b\u806f\u7d61\u4e4b\u55ae\u4e00\u7a97\u53e3\u8207\u96fb\u8a71\uff0c\u8ca0\u8cac\u8207\u885b\u751f\u3001\u6d88\u9632\u4e3b\u7ba1\u6a5f\u95dc\u806f\u7e6b\u53ca\u66f4\u65b0\u50b7 \u75c5\u4eba\u8655\u7f6e\u8cc7\u6599\u81f3\u5b8c\u6210\u50b7 \u75c5\u4eba\u91ab\u7642\u7dca\u6025\u8655\u7f6e\u70ba\u6b62\u3002 (E)\u7dca\u6025\u91ab\u7642\u6551\u8b77\u8cc7\u8a0a\u901a\u5831\u4f5c\u696d\uff0c\u5982\u9047\u901a\u8a0a\u50b3\u8f38\u6545\u969c\u4e2d\u65b7\uff0c\u5f97\u4ee5\u5176\u4ed6\u65b9\u5f0f\u5148\u884c\u901a\u5831\uff0c\u4e26\u65bc\u6545\u969c\u6392\u9664\u5f8c 24\u5c0f\u6642\u5167\u5b8c\u6210\u901a\u5831\u8cc7\u8a0a\u767b\u9304\u4f5c\u696d\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4f9d\u64da 2014\u5e7412\u6708\u7f8e\u570b\u91ce\u5916\u91ab\u5b78\u6703 (Wilderness Medical Society )\u7684Guideline\uff0c\u95dc\u65bc\u51cd\u7621 (frostbite)\u7684\u6025\u8a3a\u8655\u7f6e\uff0c\u4e0b\uf99c\u4f55\u8005 \u4e0d\u5efa\u8b70\uff1f", + "Options": "(A)\u5feb\u901f\u4ee5 37~39\u2103\u7684\u6eab\u6c34\uff0c\u5c07\u51cd\u7621\u7684\u80a2\u9ad4\u56de\u6eab\u3002 (B)\u542b\u6e05\u6f88\u6db2\u9ad4\u7684\u6c34\u6ce1\uff0c\u53ef\u8003\u616e\u4ee5\u91dd\u5c07\u6c34\u6ce1\u5167\u6db2\u9ad4\u62bd\u51fa\u3002 (C)\u51fa\u8840\u6027\u6c34\u6ce1\uff0c\u61c9\u7528\u91dd\u5c07\u6c34\u6ce1\u5167\u6db2\u9ad4\u62bd\u51fa\u3002 (D)\u5c0d\u65bc\u6709\u622a\u80a2\u98a8\u96aa\u8005\uff0c\u8003\u616e\u7d66\u4e88 thrombolytic agent (tPA)\u6cbb\u7642\u3002 (E)\u61c9\u8003\u616e\u7d66\u4e88\u7834\u50b7\u98a8 (tetanus)\u9810\u9632\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4f9d\u64da 2015\u5e74\u65b0\u7248 AHA ACLS \u6307\u5c0e\u539f\u5247\u7684\u5fc3\u640f\u904e\u901f (\u2265150\u4e0b/min)\u6d41\u7a0b\uff0c50\u6b72\u7537\u6027\uff0c\u7a81\u7136\u5fc3\u60b8\uff0c\u7121\u80f8\u60b6\u75db\u6216\u5641\u5fc3\u611f\uff0c\u5fc3\u96fb\u5716\u70ba\u898f\u5247\u55ae\u578b\u5bec QRS\u6ce2\u5fc3\u640f\u904e\u901f\uff0c\u7121\u6cd5\u78ba\u5b9a\u662f\u5426\u70ba VT\uff0c\u8108\u640f\u7d04 180\u4e0b/min\uff0c\u8840\u58d3 106/76mmHg \uff0c\u6c92\u6709\u4f4e\u8840\u58d3\u3001\u4f11\u514b\u3001\u7f3a\u8840\u80f8\u75db\u7b49\u75c7\u72c0\uff0c\u4e0b\uf99c\u6cbb\u7642\u4f55\u8005 \u512a\u5148\uff1f", + "Options": "(A)Adenosine \uff0c\u521d\u59cb\u5291\u91cf 6mg\u975c\u8108\u63a8\u6ce8 1~3\u79d2\uff0c\u518d\u52a0\u4e0a 20ml\u751f\u7406\u9e7d\u6c34\u5feb\u901f\u7d66\u4e88\u3002 (B)Amiodarone \uff0c\u521d\u59cb\u5291\u91cf 300mg\u975c\u8108\u63a8\u6ce8\u3002 (C)\u540c\u6b65\u6574\u6d41 100J\u3002 (D)\u540c\u6b65\u6574\u6d41\uff0c\u96d9\u76f8\u6ce2 120~200 J \u6216\u55ae\u76f8\u6ce2 200J\u3002 (E)\u540c\u6b65\u6574\u6d41 50J\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u4f9d\u64da 2015\u5e74\u65b0\u7248 AHA ACLS \u6307\u5c0e\u539f\u5247\u7684\u5fc3\u640f\u904e\u901f (\u2265150\u4e0b/min)\u6d41\u7a0b\uff0c\u5c0d\u65bc\u6709\u4f4e\u8840\u58d3\u3001\u4f11\u514b\u3001\u7f3a\u8840\u80f8\u75db\u7b49\u75c7\u72c0\u4e4b\u8655\u7f6e\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u7a84\u7684\u3001\u898f\u5247\u7684 QRS\u6ce2\uff0c\u5291\u91cf\u70ba 50~100J\u540c\u6b65\u6574\u6d41\u3002 (B)\u7a84\u7684\u3001\u4e0d\u898f\u5247\u7684 QRS\u6ce2\uff0c\u5291\u91cf\u70ba 120~200J(\u96d9\u76f8)\u6216200J(\u55ae\u76f8)\u540c\u6b65\u6574\u6d41\u3002 (C)\u5bec\u7684\u3001\u898f\u5247\u7684 QRS\u6ce2\uff0c\u5291\u91cf\u70ba 100J\u540c\u6b65\u6574\u6d41\u3002 (D)\u5bec\u7684\u3001\u4e0d\u898f\u5247\u7684 QRS\u6ce2\uff0c\u5291\u91cf\u70ba 120~200J(\u96d9\u76f8)\u6216200J(\u55ae\u76f8)\u540c\u6b65\u6574\u6d41\u3002 (E)\u9663\u767c\u6027\u5fc3\u5ba4\u4e0a\u5fc3\u640f\u904e\u901f (PSVT)\uff0c\u53ef\u5148\u7d66 Adenosine 6mg \u5feb\u901f\u975c\u8108\u63a8\u6ce8\u6cbb\u7642\uff0c\u82e5\u6709\u6548\u5247\u4e0d\u7528\u96fb\u64ca\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4f9d\u64da\u6211\u570b\u6cd5\u5b9a\u53ca\u65b0\u8208\u50b3\u67d3\u75c5\u500b\u6848(\u542b\u7591\u4f3c\u75c5\u4f8b)\u5206\u985e\u53ca\u901a\u5831\u898f\u5b9a\uff0c 24\u5c0f\u6642\u5167\u901a\u5831\u8005\uff0c \u4e0d\u5305\u62ec\u4e0b\uf99c\u4f55\u9805\uff1f", + "Options": "(A)\u6025\u6027\u75c5\u6bd2\u6027 A\u578b\u809d\u708e\u3002 (B)\u6d41\u611f\u4f75\u767c\u91cd\u75c7\u3002 (C)\u4eba\u985e\u514d\u75ab\u7f3a\u4e4f\u75c5\u6bd2\u611f\u67d3\u3002 (D)\u72c2\u72ac\u75c5\u3002 (E)\u4e2d\u6771\u547c\u5438\u75c7\u5019\u7fa4\u51a0\u72c0\u75c5\u6bd2\u611f\u67d3\u75c7\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u521d\u59cb\u5fc3\u5f8b\u70ba\u7121\u8108\u640f\u96fb\u6c23\u6d3b\u52d5 (pulseless electrical activity )\u4e4b\u5fc3\u80ba\u505c\u6b62 \u75c5\u4eba\u5728\u6025\u6551 10\u5206\u9418\u5f8c\u4ecd\u672a\u898b\u6548\u679c\uff0c\u4ee5\u4e0b\u8655\u7f6e\u4f55\u8005 \u6700\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u62bd\u52d5\u8108\u8840\u6aa2\u9a57\u53ef\u5340\u5206 hypoxia\u3001acidosis\u53cahyperkalemia/hypokalemia \u3002 (B)\u75c5\u53f2\u8207 \u75c5\u4eba\u88ab\u767c\u73fe\u7684\u73fe\u5834\u74b0\u5883\uff0c\u6216\u6e2c\u91cf\u9ad4\u6eab\u53ef\u5354\u52a9 \u5224\u65b7 hypothermia\u4e4b\u53ef\u80fd\u6027\u3002 (C)\u5e8a\u908a\u8d85\u97f3\u6ce2\u53ef\u5354\u52a9\u5224\u65b7 cardiac tamponade \u3001acute pulmonary embolism \u3001tension pneumothorax \u53cahypovolemia \u7b49\u3002 (D)\u75c5\u53f2\u3001 \u75c5\u4eba\u7528\u85e5\u53f2\uff0c\u6216 \u75c5\u4eba\u88ab\u767c\u73fe\u7684\u73fe\u5834\uff0c\u53ef\u5354\u52a9\u5224\u65b7\u85e5\u7269\u6216\u6bd2\u7269\u4e2d\u6bd2\u4e4b\u53ef\u80fd\u6027\u3002 (E)\u5e8a\u908a X\u5149\u651d\u5f71\u53ef\u5354\u52a9\u5224\u5b9a\u5f35\u529b\u6027\u6c23\u80f8\u4e4b\u53ef\u80fd\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u6025\u6027\u7f3a\u8840\u6027\u8166\u6897\u585e\u4e2d\u98a8\u60a3\u8005\uff0c\u767c \u75c5\u5c0f\u65bc 3\u5c0f\u6642\u5167\uff0c NIHSS\u70ba20\uff0c\u4e0b\uf99c\u4f55\u7a2e\u60c5\u6cc1\uff0c\u4ecd\u53ef\u4f7f\u7528 \u975c\u8108\u8840\u6813\u6eb6\u89e3\u85e5\u7269( tissue plasminogen activators \uff0ctPA)\uff1f", + "Options": "(A)\u8840\u7cd6\u503c 460mg/dL \u3002 (B)\u6b63\u5728\u4f7f\u7528\u53e3\u670d\u6297\u51dd\u8840\u5291 Warfarin\uff0cINR\u70ba2.0\u3002 (C)\u8840\u5c0f\u677f\u503c 110,000 /mm3\u3002 (D)\u4e2d\u98a8\u767c\u751f\u6642\u6709\u7672\u7647\u767c\u4f5c\u3002 (E)\u7576\u6642\u8840\u58d3\u70ba 210/115 mmHg \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u8a08\u7a0b\u8eca\u5c0d\u649e\u8eca\u798d\uff0c\u5c0e\u81f4\u8a08\u7a0b\u8eca\u5f8c\u5ea7 3\u6b72\u5e7c\u5152\u4e58\u5ba2\u53d7\u50b7\uff0c\u96a8\u5f8c\u7531\u6551\u8b77\u8eca\u9001\u81f3\u6025\u8a3a\u3002\u5c0f\u5152\u524d\u984d \u6709\u6495\u88c2\u50b7\u53e3\uff0c\u8108\u640f 120\u4e0b/min\uff0c\u8840\u58d3 86/48mmHg \uff0c\u7dca\u62b1\u6bcd\u89aa\u3002\u82e5\u9010\u6f38\u51fa\u73fe\u547c\u5438\u7a98\u8feb\u3001\u795e\u667a\u660f\u7761\u6642\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005 \u6700\u9069\u7576\uff1a", + "Options": "(A)\u5e7c\u5152\u547c\u5438\u9760\u6a6b\u8188\u904b\u52d5\u70ba\u4e3b\uff0c\u4e0d\u8003\u616e\u4f7f\u7528\u85e5\u7269\u5f15\u5c0e( drug-assisted)\u63d2\u7ba1\u3002 (B)\u5e7c\u5152\u6c23\u7ba1\u5167\u7ba1\u63d2\u7ba1\uff0c\u512a\u5148\u8003\u616e\u7d93\u53e3\u63d2\u7ba1( oral intubation )\u3002 (C)\u5e7c\u5152\u5c0d\u5f35\u529b\u6027\u6c23\u80f8\u5177\u8010\u53d7\u6027( tolerable) \uff0c\u4e0d\u6613\u7522\u751f\u4f11\u514b\u3002 (D)\u5e7c\u5152\u5c0d\u7526\u9192\u7403\u547c\u5438( bag-mask ventilation )\u6548\u679c\u4e0d\u4f73\uff0c\u8003\u616e\u5916\u79d1\u6c23\u9053\u5207\u958b\u8853\u3002 (E)\u5e7c\u5152\u547c\u5438\u9053\u7d50\u69cb\u8207\u6210\u4eba\u4e0d\u540c\uff0c\u4ef0\u81e5\u6642\u61c9\u4fdd\u6301\u5f8c\u4ef0( hyperextension )\u4ee5\u9632\u547c\u5438\u9053\u963b\u585e\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u9762\u5c0d\u9662\u5167\u4e0d\u9810\u671f\u5fc3\u8df3\u505c\u6b62\u75c5\u4eba (In-hospital cardiac arrest \uff0c IHCA)\uff0c\u9996\u8981\u5de5\u4f5c\u662f\u9810\u9632\u5b83\u7684\u767c\u751f\uff0c\u56e0\u6b64\u6211\u5011\u63d0\u5021\u4e86\u5feb\u901f\u53cd\u61c9\u5718\u968a (Rapid response teams \uff0cRRTs)\u6216\u662f\u91ab\u7642\u6025\u6551\u5718\u968a (Medical emergency teams \uff0c METs)\u7684\u8a2d\u7acb\uff0c\u6709\u95dcRRTs/METs \u7684\u63cf\u8ff0\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)RRTs/METs \u7684\u8a2d\u7acb\uff0c\u4e3b\u8981\u662f\u75c5\u4eba\u5728\u767c\u751f IHCA\u5f8c\uff0c\u53ef\u4ee5\u6709\u5718\u968a\u4e00\u8d77\u53bb\u6025\u6551\uff0c\u4ee5\u589e\u52a0\u75c5\u4eba\u5fa9\u7526\u7684\u6a5f\u6703\u3002 (B)RRTs/METs \u7684\u8a2d\u7acb\uff0c\u53ef\u4ee5\u6539\u5584\u4f4f\u9662\u75c5\u4eba\u7684\u5b58\u6d3b\u7387\u3002 (C)\u85c9\u7531 Early Warning Sign Systems \uff0c\u6211\u5011\u53ef\u4ee5\u8fa8\u5225\u51fa\u5371\u96aa\u7684\u4f4f\u9662\u75c5\u4eba\uff0c\u9032\u800c\u9810\u9632 IHCA\u7684\u767c\u751f\u3002 (D)RRTs/METs \u7684\u8a13\u7df4\u9664\u4e86\u6025\u6551\u6280\u80fd\u5916\uff0c\u9084\u5305\u62ec\u5718\u968a\u5408\u4f5c\u7684\u89c0\u5ff5\u5efa\u7acb\u3002 (E)RRTs/METs \u7684\u8a2d\u7acb\u9664\u4e86\u5c0d\u6210\u4eba\u75c5\u4eba\u6709\u5e6b\u52a9\u5916\uff0c\u5c0d\u5c0f\u5152\u75c5\u4eba\u53ef\u80fd\u4e5f\u6709\u52a9\u76ca\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u6839\u64da\u53f0\u7063\u75be\u7ba1\u5c40\u7d71\u8a08 \u7684\u5152\u7ae5\u8178\u75c5\u6bd2\u6bcf\u5e74\u7684\u6d41\u884c\u671f\u548c\u91cd\u75c7\u8cc7\u6599\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u5e38\u898b\u7684\u8178\u75c5\u6bd2\u91cd\u75c7\u70ba 5\u6b72\u4ee5\u4e0a\u5b69\u7ae5\u3002 (B)\u514b\u6c99\u5947\u75c5\u6bd2\u4e0d\u6703\u5f15\u8d77\u624b\u8db3\u53e3\u75c5\u3002 (C)\u6bcf\u5e74\u6d41\u884c\u671f\uff0c\u5171\u6709 2\u500b\u9ad8\u5cf0\uff0c\u5206\u5225\u70ba 4~6\u6708\uff0c 9~10\u6708\u3002 (D)\u8a98\u767c\u5b30\u5152\u6025\u6027\u5fc3\u808c\u708e\uff0c\u5e38\u898b\u70ba\u8178\u75c5\u6bd2 71\u578b\u3002 (E)\u8178\u75c5\u6bd2\u91cd\u75c7\u70ba\u7b2c\u4e94\u985e\u50b3\u67d3\u75c5\uff0c\u9808\u9032\u884c\u901a\u5831\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6839\u64da\u6551\u8b77\u6280\u8853\u54e1\u7ba1\u7406\u8fa6\u6cd5\uff0c\u4e2d\u7d1a\u6551\u8b77\u54e1\u53ef\u65bd\u884c\u4e4b\u6551\u8b77\u9805\u76ee\uff0c \u4e0d\u5305\u62ec\u90a3\u9805\uff1a", + "Options": "(A)\u64cd\u4f5c\u624b\u52d5\u96fb\u64ca\u5668\u3002 (B)\u7d66\u4e88\u9ede\u6ef4\u6ce8\u5c04\u3002 (C)\u6025\u7522\u63a5\u751f\u3002 (D)\u5354\u52a9\u4f7f\u7528\u5438\u5165\u652f\u6c23\u7ba1\u64f4\u5f35\u5291\u3002 (E)\u4f7f\u7528\u5589\u7f69\u547c\u5438\u9053 (LMA)\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u6839\u64da\u885b\u751f\u798f\u5229\u90e8\u75be\u75c5\u7ba1\u5236\u7f72\u5efa\u8b70\uff0c\u88ab\u52d5\u7269\u6293\u54ac\u50b7\u6709\u76ae\u819a\u50b7\u53e3\u553e\u6db2\u63a5\u89f8\uff0c\u95dc\u65bc\u7591\u4f3c\u72c2\u72ac\u75c5\u8655\u7f6e\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u82e5\u88ab\u6d41\u6d6a\u72ac\u8c93\u6293\u54ac\u50b7\u66b4\u9732\uff0c\u7acb\u5373\u5c31\u91ab\u4e26\u63a5\u7a2e\u75ab\u82d7\uff0c\u82e5\u6d41\u6d6a\u72ac\u8c93\u89c0\u5bdf 7\u5929\u7121\u75c7\u72c0\uff0c\u5373\u53ef\u505c\u6b62\u63a5\u7a2e\u75ab\u82d7\u3002 (B)\u82e5\u88ab\u5bb6\u72ac\u8c93\u6293\u54ac\u50b7\u66b4\u9732\uff0c\u66ab\u4e0d\u7d66\u4e88\u75ab\u82d7\uff0c\u89c0\u5bdf\u5bb6\u72ac\u8c93\uff0c\u82e5\u4e00\u500b\u6708\u5f8c\u51fa\u73fe\u7591\u4f3c\u72c2\u72ac\u75c5\u75c7\u72c0\uff0c\u5247\u7d66\u4e88\u75ab\u82d7\u3002 (C)\u7576\u50b7\u53e3\u9700\u540c\u6642\u65bd\u4e88\u514d\u75ab\u7403\u86cb\u767d\u6d78\u6f64\u6ce8\u5c04\u6642\uff0c\u5efa\u8b70\u5728\u6578\u5c0f\u6642\u5f8c (\u22672\u5c0f\u6642)\u518d\u9032\u884c\u7e2b\u5408\u3002 (D)\u9700\u72c2\u72ac\u75c5\u514d\u75ab\u7403\u86cb\u767d\u4f7f\u7528\u6642\uff0c\u975c\u8108\u6ce8\u5c04\u512a\u65bc\u50b7\u53e3\u6d78\u6f64\u6ce8\u5c04\uff0c\u514d\u75ab\u7403\u86cb\u767d\u53ef\u8207\u66b4\u9732\u5f8c\u9996\u5291\u75ab\u82d7\u540c\u6642\u65bd\u6253\u3002 (E)\u4eba\u985e\u72c2\u72ac\u75c5\u514d\u75ab\u7403\u86cb\u767d (HRIG)\u4e4b\u4f7f\u7528\u5291\u91cf\u70ba 20 IU/kg\uff0c\u7d66\u4e88\u524d\u9032\u884c\u76ae\u819a\u654f\u611f\u6027\u6e2c\u8a66\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u8655\u7f6e 1\u6b72\u5b30\u5152\u547c\u5438\u8870\u7aed\uff0c\u4e0b\uf99c\u8aaa\u660e\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u8072\u5e36 (vocal cord )\u662f\u547c\u5438\u9053\u6700\u72f9\u7a84\u8655\u3002 (B)\u4e0b\u547c\u5438\u9053\u963b\u585e\u7684\u611f\u67d3\u539f\u56e0\u662f\u54ee\u543c (Croup)\u3002 (C)\u9032\u884c Rapid -sequence intubation \u61c9\u5148\u884c\u7d66\u4e88\u975e\u53bb\u6975\u5316\u795e\u7d93\u808c\u8089\u963b\u65b7\u5291\u3002 (D)\u63d2\u7ba1\u524d\u5b9c\u5c07\u982d\u6795\u90e8\u588a\u9ad8\uff0c\u4ee5\u5229\u64fa\u6210\u55c5\u59ff (sniffing position)\u3002 (E)\u63d2\u7ba1\u6642\uff0c\u5589\u7247\u9577\u5ea6\u4e4b\u9078\u64c7\u61c9\u6e2c\u91cf\u4e0a\u9580\u9f52\u81f3\u4e0b\u9837\u89d2 (angle of mandible )\u8ddd\u96e2\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u9023\u74b0\u5927\u8eca\u798d\u6709\u6578\u540d\u50b7\u8005\uff0c\u7576\u91ab\u7642\u8cc7\u6e90\u6709\u9650\u60c5\u6cc1\u4e0b\uff0c\u6700\u8fd1\u4e4b\u91cd\u5ea6\u5275\u50b7\u91ab\u9662\u50c5\u80fd\u540c\u6642\u6536\u6cbb 4\u540d\u60a3\u8005\uff0c\u4e0b\uf99c\u54ea\u4f4d\u60a3\u8005\u60a8 \u6703\u5efa\u8b70\u5148\u9001\u81f3\u5c31\u8fd1\u4e4b\u975e\u91cd\u5ea6\u6025\u6551\u91ab\u9662\u8a55\u4f30\uff1f", + "Options": "(A)55\u6b72\u7537\u6027\u6c7d\u8eca\u99d5\u99db\u984f\u9762\u90e8\u632b\u50b7\u5408\u4f75\u80f8\u90e8\u7a7f\u523a\u50b7\uff0c\u73fe\u5834\u547c\u5438 30\u6b21/min\u3002 (B)30\u6b72\u7537\u6027\u6a5f\u8eca\u99d5\u99db\uff0c\u4e8b\u6545\u73fe\u5834\u4eba\u88ab\u649e\u98db 3\u516c\u5c3a\u9060\uff0c\u53f3\u624b\u4e0a\u81c2\u53ca\u53f3\u5927\u817f\u5916\u89c0\u8b8a\u5f62\uff0c\u610f\u8b58\u6e05\u695a\u7121\u982d\u90e8\u5916\u50b7\uff0c\u8108\u640f 80\u4e0b/min\uff0c\u8840\u58d3 120/80 mmHg\u3002 (C)40\u6b72\u5973\u6027\u4e58\u65bc\u6c7d\u8eca\u526f\u5ea7\uff0c\u5b89\u5168\u6c23\u56ca\u70b8\u958b\uff0c\u8eab\u4e0a\u7d04 25%\u71d2\u50b7\uff0c\u4e3b\u8a34\u56db\u80a2\u9ebb\u53ca\u7121\u529b\uff0c\u610f\u8b58\u6e05\u9192\uff0c\u8108\u640f 70\u4e0b/min\uff0c\u8840\u58d3 80/40 mmHg \u3002 (D)25\u6b72\u61f7\u5b55\u884c\u4eba\uff0c\u906d\u6a5f\u8eca\u4ee5 60km/hr\u6642\u901f\u649e\u64ca\uff0c\u610f\u8b58\u6e05\u695a\uff0c\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\uff0c\u50c5\u56db\u80a2\u6709\u64e6\u50b7\uff0c\u4e3b\u8a34\u8179\u75db\u3002 (E)40\u6b72\u7537\u6027\u9a0e\u8173\u8e0f\u8eca\uff0c\u906d\u6c7d\u8eca\u4ee5 20km/hr\u6642\u901f\u649e\u64ca\uff0c\u610f\u8b58\u6e05\u695a\uff0c\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\uff0c\u53f3\u624b\u524d\u81c2\u8b8a\u5f62\u5408\u4f75\u958b\u653e\u6027\u50b7\u53e3\uff0c\u672b\u68a2\u5faa\u74b0\u6b63\u5e38\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u5c0d\u65bc\u5916\u50b7\u6027\u4f11\u514b\u60a3\u8005\u7684\u8655\u7f6e\uff0c\u4ee5\u4e0b\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u76ee\u6a19\u662f\u63a7\u5236\u51fa\u8840\u53ca\u56de\u5fa9\u8db3\u5920\u7684\u5faa\u74b0\u5bb9\u7a4d\u3002 (B)\u81e8\u5e8a\u8a55\u4f30\u51fa\u8840\u91cf\u9054\u5168\u8eab\u8840\u91cf\u7684 30%\u4ee5\u4e0a\u6642\uff0c\u61c9\u5118\u901f\u7d66\u4e88 crystalloid fluid\u53ca\u8f38\u6ce8\u8840\u6db2\u88fd\u54c1\u3002 (C)\u5728\u7d66\u4e88 crystalloid fluid \u53ca\u8840\u6db2\u88fd\u54c1\u6cbb\u7642\u60a3\u8005\u6642\uff0c\u61c9\u5c0f\u5fc3\u76e3\u6e2c\u4f4e\u9ad4\u6eab\u53cacoagulopathy \u3002 (D)\u5728\u6cbb\u7642\u5916\u50b7\u6027\u4f4e\u8840\u5bb9\u4f11\u514b\u60a3\u8005\uff0c\u70ba\u4e86\u63d0\u4f9b\u8db3\u5920\u7684\u8840\u58d3\u4ee5\u9054\u5230\u8db3\u5920\u7684\u5468\u908a\u7d44\u7e54\u704c\u6ce8\uff0c\u61c9\u8a72\u5118\u901f\u7d66\u4e88\u5347\u58d3\u5291\u3002 (E)\u9664\u4e86\u5118\u901f\u7684\u7d66\u4e88\u8f38\u6db2\u6cbb\u7642\uff0c\u4e5f\u61c9\u5118\u901f\u627e\u51fa\u51fa\u8840\u90e8\u4f4d\uff0c\u4ee5\u9054\u5230\u65e9\u671f\u63a7\u5236\u51fa\u8840\u7684\u76ee\u7684\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u8acb\u554f\u4e0b\uf99c\u8840\u7ba1\u6025\u75c7\u4e2d\uff0c\u54ea\u4e00\u7a2e\u75be\u75c5 \u6700\u5bb9\u6613\u7528\u8d85\u97f3\u6ce2\u4f5c\u8a3a\u65b7\uff1f", + "Options": "(A)\u80ba\u52d5\u8108\u6813\u585e( pulmonary embolism )\u3002 (B)\u6df1\u5c64\u975c\u8108\u6813\u585e( deep vein thrombosis )\u3002 (C)\u57fa\u5e95\u52d5\u8108\u6813\u585e( basilar artery thrombosis )\u3002 (D)\u4e3b\u52d5\u8108\u525d\u96e2( aortic dissectio n)\u3002 (E)\u4e0a\u8154\u975c\u8108\u75c7\u5019\u7fa4( superior vena cava syndrome \uff0cSVCS)\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5316\u5b78\u707d\u5bb3\u73fe\u5834\u53ca\u8655\u7406\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u5728\u51b7\u5340\u5c0d\u50b7\u60a3\u662f\u53ef\u4ee5\u505a\u7a69\u5b9a\u6027\u6cbb\u7642 (primary stabilization )\u3002 (B)\u5728\u6696\u5340\u57f7\u884c\u9664\u6c59\uff0c\u4e26\u6c7a\u5b9a\u5f8c\u9001\u5148\u5f8c\u9806\u5e8f\u3002 (C)\u5728\u71b1\u5340\u61c9\u8a72 \u53ea\u57f7\u884c\u50b7\u60a3\u7684\u641c\u6551\u53ca\u5c07\u5176\u79fb\u8f49\u51fa\u6c61\u67d3\u5340\u3002 (D)\u901a\u5e38 cyanide antidote kit \u5728\u73fe\u5834\u7d66\u4e88\u6709\u5176\u91ab\u7642\u6548\u7528\u3002 (E)\u73fe\u5834\u61c9\u5efa\u7acb\u4e8b\u4ef6\u6307\u63ee\u7cfb\u7d71\uff0c\u4e26\u5340\u5283\u51fa\u71b1\u3001\u6696\u3001\u51b7\u5340\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6210\u4eba\u810a\u9ad3\u640d\u50b7 (Spinal Cord injury )\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)Anterior cord syndrome \u7684\u9810\u5f8c\u8f03\u5176\u5b83\u810a\u9ad3\u75c7\u5019\u7fa4 (spinal cord syndrome )\u70ba\u4f73\u3002 (B)Central cord syndrome \u4e0a\u80a2\u7121\u529b\u6703\u8f03\u4e0b\u80a2\u56b4\u91cd\u3002 (C)Cauda equina syndrome \u53ef\u80fd\u6703\u6709\u5927\u5c0f\u4fbf\u529f\u80fd\u7570\u5e38\u53ca\u6703\u9670\u90e8\u75db\u89ba\u6d88\u5931\u7684\u75c7\u72c0\u3002 (D)\u810a\u524d\u52d5\u8108\u6813\u585e (thrombosis of anterior spinal artery ) \u53ef\u80fd\u9020\u6210 Anterior cord syndrome \u3002 (E)\u6700\u5e38\u9020\u6210 Brown -Sequard syndrome \u7684\u539f\u56e0\u70ba\u810a\u9ad3\u7a7f\u523a\u50b7\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5152\u7ae5\u810a\u690e\u5275\u50b7 (spinal trauma )\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)X\u5149\u82e5\u7121\u6cd5\u6392\u9664\u9838\u690e\u50b7\u5bb3\u6642\uff0c\u53ef\u8003\u616e\u5b89\u6392\u65b7\u5c64\u6383\u63cf\u6aa2\u67e5\u3002 (B)X\u5149\u5efa\u8b70\u81f3\u5c11\u8981\u7167 3\u500b\u65b9\u5411\uff1a\u524d\u5f8c\u3001\u5074\u9762\u53ca\u5f35\u53e3 (odontoid view )\u3002 (C)\u5927\u90e8\u4efd\u767c\u751f SCIWORA (spinal cord injury without radiographic abnormality )\u7684\u5152\u7ae5\uff0c\u5728\u50b7\u5bb3\u767c\u751f\u6642\u5373\u9020\u6210\u7671\u7613\u3002 (D)\u591a\u91cd\u5275\u50b7\u5152\u7ae5\uff0c\u7686\u9700\u61f7\u7591\u810a\u690e\u5275\u50b7\u3002 (E)12\u6b72\u4ee5\u4e0b\u5152\u7ae5\uff0c\u9838\u690e\u50b7\u5bb3\u5927\u591a\u767c\u751f\u5728\u6795\u90e8 (Occiput)\u81f3\u7b2c\u4e8c\u9838\u690e\u4e4b\u9593\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6bd2\u5316\u707d\u8655\u7f6e\u6c30\u5316\u7269 (cyanide)\u4e2d\u6bd2\uff0c\u4ee5\u4e0b\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u6bd2\u5316\u707d\u73fe\u5834\u56e0\u70ba\u8981\u7a4d\u6975\u7d66\u4e88\u89e3\u6bd2\u5291\uff0c\u4e00\u5b9a\u8981\u70ba \u75c5\u4eba\u5efa\u7acb\u975c\u8108\u7ba1\u8def\u3002 (B)\u5373\u4f7f\u4e9e\u785d\u9178\u9209 (sodium nitrite )\u53ef\u4ee5\u7acb\u5373\u7d93\u975c\u8108\u7d66\u4e88\uff0c\u4ecd\u9700\u8981\u4f7f\u7528\u5438\u5165\u578b\u4e9e\u785d\u9178\u7570\u620a\u916f (amyl nitrite )\u3002 (C)\u5728\u6c30\u5316\u7269\u4f34\u96a8\u4e00\u6c27\u5316\u78b3\u4e2d\u6bd2\u7684\u60a3\u8005\u4f7f\u7528\u4e9e\u785d\u9178\u9e7d (nitrites)\u662f\u76f8\u5c0d\u7981\u5fcc\u75c7\uff0c\u56e0\u70ba\u6703\u7522\u751f\u8b8a\u6027\u8840\u7d05\u7d20\u8840\u75c7 (methemoglobinemia )\u4e14\u9032\u4e00\u6b65\u964d\u4f4e\u6c27\u6c23\u8f38\u9001\u3002 (D)\u8a3a\u65b7\u4e0d\u660e\u78ba\u6642\uff0c\u4e9e\u785d\u9178\u9e7d\u548c\u786b\u4ee3\u786b\u9178\u9209 (sodium thiosulfate )\u56e0\u5177\u6709\u76f8\u5c0d\u8f03\u4f4e\u7684\u6bd2\u6027\uff0c\u662f\u4e00\u7a2e\u66f4\u5b89\u5168\u7684\u7d93\u9a57\u6cbb\u7642\u7528\u85e5\u3002 (E)\u5728\u91ab\u9662\u8655\u7406\u73fe\u5834\u5df2\u9664\u6c59\u904e\u7684\u6bd2\u5316\u707d \u75c5\u4eba\uff0c\u70ba\u907f\u514d\u73fe\u5834\u9664\u6c59\u4e0d\u5b8c\u6574\uff0c\u9808\u7a7f\u6234 B\u7d1a\u9632\u8b77\u8863\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6d41\u884c\u6027\u611f\u5192\uff0c\u67d0\u4e9b\u75c5\u4eba\u6709\u8f03\u9ad8\u98a8\u96aa\u7522\u751f\u4f75\u767c\u75c7\uff0c \u4e0d\u5305\u62ec\u4e0b\uf99c\u4f55\u8005 \uff1f", + "Options": "(A)3\u6b72\u7684\u5c0f\u5b69\u3002 (B)\u7cd6\u5c3f \u75c5\u4eba\u8005\u3002 (C)28\u6b72\u5a66\u5973\u751f\u7522\u5f8c\u4e00\u9031\u3002 (D)16\u6b72\u7537\u6027\uff0c\u9577\u671f\u670d\u7528 Aspirin\u3002 (E)50\u6b72\u7537\u6027\uff0c BMI(body mass index )\u70ba29\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u7279\u6b8a\u65cf\u7fa4\u7684\u80ba\u708e\u8a3a\u65b7\u53ca\u8655\u7f6e\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u9152\u766e\u8005\u80ba\u708e\u5e38\u898b\u7684\u81f4\u75c5\u83cc\u70ba P . aeruginosa \u3002 (B)\u7cd6\u5c3f \u75c5\u4eba\u8005\u5e38\u898b\u7684\u81f4\u75c5\u83cc\u70ba H. influenzae \u3002 (C)\u5b55\u5a66\u5982\u6709\u547c\u5438\u9053\u611f\u67d3\u75c7\u72c0\u5408\u4f75 varicella\u66b4\u9732\u53f2\uff0c\u61c9\u7167\u80f8\u90e8 X\u5149\u4ee5\u6392\u9664\u80ba\u708e\u7684\u53ef\u80fd\u3002 (D)\u8001\u5e74\u4eba\u7684\u6d41\u611f\u4f75\u7d30\u83cc\u6027\u80ba\u708e\u5e38\u898b\u7684\u75c5\u83cc\u70ba P . aeruginosa \u3002 (E)\u5b89\u990a\u9662\u4f4f\u6c11\u80ba\u708e\u5e38\u898b\u7684\u75c5\u83cc\u70ba S. aureus\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u773c\u7736\u9aa8\u6298 (orbital fracture )\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u773c\u90e8\u920d\u50b7\u6700\u5e38\u898b\u7684\u773c\u7736\u9aa8\u6298\u662f\u4e0b\u58c1\u53ca\u5167\u5074\u58c1\u9aa8\u6298\u3002 (B)\u5373\u4f7f\u672a\u9020\u6210\u808c\u8089\u904b\u52d5\u53d7\u9650\u6216\u8907\u8996\uff0c\u4ecd\u9700\u7167\u6703\u773c\u79d1\u8a55\u4f30\u773c\u7403\u50b7\u5bb3\u3002 (C)Blow -out fracture \u82e5\u9020\u6210\u773c\u7403\u808c\u8089\u904b\u52d5\u53d7\u9650\uff0c\u6700\u5e38\u898b\u70ba\u4e0b\u76f4\u808c\u3002 (D)\u53ef\u8003\u616e\u7d66\u4e88\u6297\u751f\u7d20\u3002 (E)Blow -out fracture \u75c5\u4eba\u5e38\u5728\u773c\u775b\u5411\u4e0b\u770b\u6642\u9020\u6210\u8907\u8996\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u814e\u4e0a\u817a\u6a5f\u80fd\u4e0d\u8db3 (Adrenal Insufficiency \uff0cAI)\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u5e2d\u6f22\u6c0f\u75c7(Sheehan\u2019s syndrome ) \uff0c\u5c6c\u65bc\u521d\u7d1a\u814e\u4e0a\u817a\u6a5f\u80fd\u4e0d\u8db3 (primary AI)\uff0c\u591a\u767c\u751f\u65bc\u5927\u91cf\u5931\u8840\u9020\u6210\u8166\u4e0b\u5782\u9ad4\u524d\u8449\u7684\u58de\u6b7b\uff0c\u5c0e\u81f4\u5167\u5206\u6ccc\u5931\u8abf\u3002 (B)\u611f\u67d3\u75c7\u53ea\u6703\u5c0e\u81f4\u6b21\u7d1a\u814e\u4e0a\u817a\u6a5f\u80fd\u4e0d\u8db3 (secondary AI )\u3002 (C)\u6c83\u7279\u8c6a\u65af -\u5f17\u91cc\u5fb7\u91cc\u514b\u68ee\u4e8c\u6c0f\u75c7\u5019\u7fa4 (Waterhouse -Friderichsen syndrome )\u662f\u4e00\u7a2e\u56e0\u7a81\u7136\u7684\u611f\u67d3\u800c\u5f15\u81f4\u5927\u91cf \u53ca\u96d9\u5074\u7684\u814e\u4e0a\u817a\u51fa\u8840\u3002\u4e3b\u8981\u662f\u7531\u7d50\u6838\u6027\u8166\u819c\u708e\u6240\u5c0e\u81f4\u3002 (D)\u814e\u4e0a\u817a\u6a5f\u80fd\u4e0d\u8db3\u6240\u5c0e\u81f4\u7684\u8840\u58d3\u4e0d\u7a69\uff0c\u521d\u6b65\u8655\u7406\u4e3b\u8981\u662f\u5148\u7d66\u4e88\u985e\u56fa\u9187\u88dc\u5145\uff0c\u82e5\u81e8\u5e8a\u53cd\u61c9\u4e0d\u4f73\u518d\u8003\u616e\u7d66\u4e88\u751f\u7406\u98df\u9e7d\u6eb6\u6db2 (N/S)\u6216\u5347\u58d3\u5291\uff0c\u82e5\u6301\u7e8c\u4f4e\u8840\u58d3\u53ef\u8003\u616e\u7e7c\u7e8c\u88dc\u5145\u9069\u91cf\u985e\u56fa\u9187\u3002 (E)Etomidate \uff0cAminoglutethimide \uff0cMitotane \u548cKetoconazole \u4e5f\u53ef\u80fd\u5c0e\u81f4\u814e\u4e0a\u817a\u6a5f\u80fd\u4e0d\u8db3\u767c\u751f\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u7cd6\u5c3f\u75c5\u75c5\u4eba\u5728\u6025\u8a3a\u7684\u8a3a\u65b7\u8207\u8655\u7f6e\uff0c\u4e0b\uf99c\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u7a7a\u8179 8\u5c0f\u6642\u8840\u7cd6\u5927\u65bc 126 mg/dL (7.0 mmol/L )\u6216\u4efb\u4e00\u8840\u7cd6\u5927\u65bc 200 mg/dL(11.1 mmol/L )\u5373\u53ef\u78ba\u8a3a\u7cd6\u5c3f\u75c5\u3002 (B)\u7cd6\u5c3f \u75c5\u4eba\u8005\u8f03\u6613\u51fa\u73fe\u975e\u5178\u578b\u7684\u80f8\u75db\uff0c\u751a\u81f3\u6709\u53ef\u80fd\u6c92\u6709\u80f8\u75db\u5c31\u51fa\u73fe\u5fc3\u808c\u6897\u585e\u7684\u72c0\u6cc1\u3002 (C)\u7cd6\u5c3f \u75c5\u4eba\u8005\u5408\u4f75\u9ad8\u8840\u58d3\uff0c\u61c9\u8a72\u512a\u5148\u4f7f\u7528 Angiotensin II receptor blockers \u6216 Angiotensin -converting enzyme inhibitors \u4f86\u63a7\u5236\u8840\u58d3\u3002 (D)\u5373\u4f7f\u6c92\u6709\u9ad8\u8840\u58d3\uff0c Angiotensin -converting enzyme inhibitors \u53ef\u4ee5\u9810\u9632\u6216\u6e1b\u7de9\u7cd6\u5c3f\u75c5\u9020\u6210\u7684\u814e\u81df\u75c5\u8b8a (diabetic nephropat hy)\u3002 (E)\u5982\u60a3\u8005\u7684\u814e\u529f\u80fd\u4e0d\u7406\u60f3\uff0c\u4e0d\u61c9\u8a72\u4f7f\u7528 Metformin\u4f5c\u70ba\u7b2c\u4e00\u7dda\u964d\u8840\u7cd6\u7684\u85e5\u7269\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u982d\u90e8\u5916\u50b7 \u75c5\u4eba\u9871\u5167\u58d3\u4e0a \u5347(Increased Intracranial Pressure \uff0cIICP)\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u9871\u5167\u58d3\u5927\u65bc 20mmHg \u6703\u589e\u52a0\u6b7b\u4ea1\u7387\u3002 (B)\u82e5\u767c\u751f\u9264\u56de\u759d\u812b (Uncal transtentorial herniation )\uff0c\u53ef\u80fd\u6703\u9020\u6210 \u75c5\u4eba\u540c\u5074\u77b3\u5b54\u64f4\u5f35\u53ca\u5c0d\u5074\u80a2\u9ad4\u7121\u529b\u3002 (C)\u5efa\u8b70\u7dad\u6301 PaCO 2\u572825~30 mmHg \uff0cPaCO 2\u592a\u4f4e\u53ef\u80fd\u9020\u6210\u8166\u90e8\u7f3a\u8840\u3002 (D)\u75c5\u4eba\u5e8a\u982d\u62ac\u9ad8 30\u5ea6\u53ef\u4fc3\u9032\u8166\u810a\u9ad3\u6db2\u6d41\u51fa\u9871\u5167\uff0c\u85c9\u6b64\u964d\u4f4e\u8166\u58d3\u3002 (E)Mannitol \u9664\u4e86\u53ef\u964d\u4f4e\u8166\u58d3\u5916\uff0c\u4e5f\u53ef\u5e6b\u52a9\u6e05\u9664\u81ea\u7531\u57fa (free radical )\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u58d3\u788e\u50b7\u5bb3 (crush injury )\uff0c\u4e0b\uf99c\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u53ef\u80fd\u6703\u9020\u6210\u50b7\u5bb3\u90e8\u4f4d\u7684 compartment syndrome \uff0c\u901a\u5e38\u8154\u5ba4\u58d3\u529b\u5927\u65bc 30 mmHg \u3002 (B)\u53ef\u80fd\u6703\u9020\u6210\u50b7\u60a3\u51fa\u73fe\u4f4e\u8840\u5bb9\u3001\u9ad8\u8840\u9240\u3001\u9ad8\u8840\u9223\u3001\u9178\u8840\u75c7\u3002 (C)\u53ef\u80fd\u6703\u9020\u6210\u50b7\u60a3\u51fa\u73fe disseminated intravascular coagulation \u3001\u814e\u529f\u80fd\u8870\u7aed\u56b4\u91cd\u4f75\u767c\u75c7\u3002 (D)\u88ab \u812b\u56f0\u524d\u53ef\u5148\u7d66\u4e88 1~2 L\u751f\u7406\u98df\u9e7d\u6c34\u53ca bicarbonate \u6cbb\u7642\u3002 (E)\u50b7\u60a3\u53ef\u80fd\u63a5\u53d7\u7b4b\u819c\u5207\u958b\u8853 (fasciotomy )\u6216\u9ad8\u58d3\u6c27 (hyperbaric oxygen )\u6cbb\u7642\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "35\u6b72\u5973\u6027\uff0c\u56e0\u767c\u71d2\u53ca\u5168\u8eab\u9178\u75db 5\u65e5\u81f3\u6025\u8a3a\u5c31\u8a3a\uff0c\u6709\u4e0a\u8179\u75db\u3001\u5641\u5fc3\u53ca\u98df\u617e\u4e0d\u632f\u75c7\u72c0\uff0c\u8eab\u9ad4\u6aa2\u67e5\u6709\u8179\u90e8\u58d3\u75db\uff0c\u7d93\u8840\u6db2\u6aa2\u9a57\u767d\u8840\u7403 2,500/mm3\uff0c\u8840\u6bd4\u5bb915.6 g/dL\uff0c\u8840\u5c0f\u677f 45,000/mm3\uff0cGOT 176 IU/L \uff0cGPT 180 IU/L\uff0c\u4e0b\u5217\u654d\u8ff0\u4f55\u8005\u6b63\u78ba \uff1f", + "Options": "(A)\u53ef\u4f7f\u7528\u767b\u9769\u71b1 NS1\u5feb\u901f\u6aa2\u9a57\u8a66\u9a57\u5e6b\u52a9\u8a3a\u65b7\uff0c\u8a66\u9a57\u6aa2\u6e2c\u8840\u4e2d IgM\u6297\u9ad4\uff0c\u4f46\u5176\u654f\u611f\u6027\u53ca\u7279\u7570\u6027\u90fd\u4e0d\u9ad8\u3002 (B)\u767b\u9769\u71b1\u53ef\u80fd\u4f75\u767c\u6025\u6027\u81bd\u56ca\u708e\uff0c\u8655\u7f6e\u4ecd\u61c9\u9032\u884c\u624b\u8853\u6216\u884c\u7d93\u76ae\u7a7f\u809d\u81bd\u56ca\u5f15\u6d41\u8853\u3002 (C)\u75c5\u4eba\u6b64\u6642\u61c9\u7d66\u4e88\u8840\u5c0f\u677f\u8f38\u8840\u4ee5\u907f\u514d\u51fa\u8840\u3002 (D)\u767c\u71d2\u7d66\u4e88 acetaminophen \u6cbb\u7642\uff0c\u5982\u5641\u5fc3\u7121\u6cd5\u9032\u98df\u5247\u6539\u7528 ketoprofen \u6ce8\u5c04\u3002 (E)\u6b64\u75c5\u4eba\u5982\u751f\u547d\u5fb4\u8c61\u7a69\u5b9a\uff0c\u7121\u660e\u986f\u51fa\u8840\uff0c\u5c6c group B\u75c5\u4eba\uff0c\u61c9\u5b89\u6392\u4f4f\u9662\u89c0\u5bdf\u6cbb\u7642\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u4f55\u7a2e\u75c5\u6cc1\uff0c\u5728\u9ad8\u5c71\u4e0a\u6703 \u6bd4\u5728\u5e73\u5730\u589e\u52a0\u767c\u75c5\u6216\u52a0\u91cd\u7684\u98a8\u96aa\uff0c\u4e0d\u5305\u62ec \u4e0b\u5217\u4f55\u8005\uff1f", + "Options": "(A)\u6162\u6027\u814e\u75be\u75c5 (chronic kidney disease )\u3002 (B)\u5fc3\u81df\u8870\u7aed (heart failure)\u3002 (C)\u6c23\u5598(asth ma)\u3002 (D)\u8178\u80c3\u9053\u51fa\u8840 (GI bleeding) \u3002 (E)\u7672\u7647(epilepsy )\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6a6b\u8188\u819c\u640d\u50b7( diaphragmatic injury )\u5e38\u898b\u7684\u5f71\u50cf\u5b78\u8868\u73fe\uff0c\u4e0b\u5217\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u80f8\u90e8\u96fb\u8166\u65b7\u5c64\u5f71\u50cf\u51fa\u73fe collar sign\u3002 (B)\u80f8\u90e8 X\u5149\u5f71\u50cf\u767c\u73fe\u60a3\u5074\u6a6b\u8188\u5347\u9ad8\u3002 (C)\u80f8\u90e8 X\u5149\u5f71\u50cf\u767c\u73fe\u7e31\u8188\u8154\u671d\u60a3\u5074\u504f\u79fb\u3002 (D)\u80f8\u90e8 X\u5149\u5f71\u50cf\u898b\u5230\u80f8\u8154\u6709 air-fluid level \u3002 (E)\u80f8\u90e8 X\u5149\u5f71\u50cf\u898b\u5230\u9f3b\u80c3\u7ba1\u8737\u7e5e\u5728\u80f8\u8154\u5167\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u6703\u9020\u6210\u6025\u6027\u8996\u529b\u6e1b\u640d\u6216\u8996\u529b\u55aa\u5931( visual loss )\u7684\u75be\u75c5\u4e2d\uff0c\u54ea\u4e00\u7a2e \u6703\u5f15\u767c\u773c\u775b\u75bc\u75db\uff1f", + "Options": "(A)\u4e2d\u5fc3\u8996\u7db2\u819c\u52d5\u8108\u963b\u585e(Central retinal artery occlusion )\u3002 (B)\u4e2d\u5fc3\u8996\u7db2\u819c\u975c\u8108\u963b\u585e(Central retinal vein occlusion )\u3002 (C)\u5de8\u7d30\u80de\u75c5\u6bd2\u8996\u7db2\u819c\u708e(Cytomegalovirus retinitis )\u3002 (D)\u7532\u9187\u4e2d\u6bd2( Methanol intoxication)\u3002 (E)\u8996\u795e\u7d93\u708e( Optic neuritis)\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u9ad8\u8840\u58d3\u6027\u6025\u6027\u5fc3\u81df\u8870\u7aed\u75c5\u4eba\u7684\u6cbb\u7642\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u82e5\u75c5\u4eba\u4f7f\u7528 Nitroglycerin \u4e4b\u5f8c\u7522\u751f\u4f4e\u8840\u58d3\uff0c\u9700\u7acb\u5373\u8f38\u6db2\u6cbb\u7642\u3002 (B)\u975e\u4fb5\u8972\u6027\u547c\u5438\u5668\u53ef\u8003\u616e\u4f7f\u7528\u65bc\u6b64\u985e\u8840\u6db2\u5faa\u74b0\u7a69\u5b9a\u7684\u75c5\u4eba\u3002 (C)\u5229\u5c3f\u5291\u9700\u8207\u8840\u7ba1\u64f4\u5f35\u5291\u5408\u4f75\u4f7f\u7528\uff0c\u82e5\u55ae\u7368\u4f7f\u7528\u5229\u5c3f\u5291\u53ef\u80fd\u589e\u52a0\u6b7b\u4ea1\u7387\u3002 (D)\u9577\u671f\u4f7f\u7528 Nitroprusside \u6cbb\u7642\uff0c\u53ef\u80fd\u7522\u751f cyanide toxicity\u3002 (E)\u5728\u6025\u6027\u671f\u6642\uff0c\u82e5\u8840\u58d3\u5927\u65bc 150/100 mmHg \uff0c\u53ef\u4f7f\u7528\u9ad8\u5291\u91cfNitroglycerin \uff0c\u4e26\u4f9d\u75c7\u72c0\u53ca\u8840\u58d3\u9032\u884c\u8abf\u6574\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u6025\u8a3a\u5ba4\u6709\u5b55\u5a66\u8db3\u6708\u6025\u7522\uff0c\u904e\u53bb\u7522\u6aa2\u767c\u73fe\u7f8a\u6c34\u904e\u591a\uff0c\u5b30\u5152\u65bc\u6025\u8a3a\u5ba4\u51fa\u751f\u5f8c\uff0c\u6025\u8a3a\u91ab\u5e2b\u7576\u6642\u6aa2\u67e5\u767c\u73fe\u8eab\u9ad4\u7d05\u6f64\u4f46\u56db\u80a2\u5747\u5448\u73fe\u767c\u7d3a\u60c5\u6cc1\uff0c\u56db\u80a2\u7671\u8edf\u7121\u529b\uff0c\u62bd\u5438\u547c\u5438\u9053\u5206\u6ccc\u7269\u6642\u81c9\u90e8\u6709\u53cd\u61c9\uff0c\u547c\u5438\u5fae\u5f31\uff0c\u5fc3\u8df3 90\u6b21/min\uff0c\u8acb\u554fAPGAR score \u8a08\u7b97\u7d50\u679c\u70ba\u4f55 \uff1f", + "Options": "(A)3\u3002 (B)4\u3002 (C)5\u3002 (D)6\u3002 (E)7\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6839\u64da 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care \u6700\u65b0\u5efa\u8b70\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u8db3\u6708\u65b0\u751f\u5152\u6216\u65e9\u7522\u5152\uff0c\u5982\u679c\u4e0d\u9700\u8981\u6025\u6551\u8655\u7f6e\u8005\uff0c\u51fa\u751f\u5f8c\u5ef6\u5f8c 30\u79d2\u518d\u9257\u593e\u81cd\u5e36\u5c0d\u65b0\u751f\u5152\u53ef\u80fd\u662f\u6709\u76ca\u8655\u7684\u3002 (B)Preterm newborn \u7d66\u4e88\u6025\u6551\u8655\u7f6e\uff0c\u6c27\u6c23\u5efa\u8b70\u5148\u7528 100%\uff0c\u518d\u8996\u60c5\u6cc1\u8abf\u964d\u3002 (C)Atropine \u4f7f\u7528\u5728\u5fc3\u640f\u904e\u6162\u7684\u5efa\u8b70\u4e0d\u8b8a\u3002 (D)\u65b0\u751f\u5152\u5fc3\u80ba\u5fa9\u7526\u8853\u58d3\u5439\u6bd4\u70ba 3\uff1a1\uff0c\u5982\u679c\u662f\u5fc3\u56e0\u6027( cardiac origin )\uff0c\u58d3\u5439\u6bd4\u53ef\u4ee5\u4f7f\u7528 15\uff1a2\u3002 (E)\u7576 tracheal intubation \u7121\u6cd5\u6210\u529f\u5efa\u7acb\u6642\uff0claryngeal mask \u53ef\u4ee5\u4f7f\u7528\u5728\u8db3\u6708\u65b0\u751f\u5152\u6216 34\u9031\u4ee5\u4e0a\u65e9\u7522\u5152\uff0c\u6b64\u5efa\u8b70\u70ba Class I\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4e00\u540d\u65bc\u5b89\u990a\u9662\u9577\u5e74\u81e5\u5e8a\u75c5\u4eba\u88ab\u9001\u81f3\u6025\u8a3a\u5c31\u91ab\u6642\uff0c\u91ab\u5e2b\u767c \u73fe\u75c5\u4eba\u8eab\u9ad4\u6709\u591a\u8655\u7662\u75b9\uff0c\u5c24\u5176\u662f\u5728\u809a\u81cd\u3001\u814b\u4e0b \u53ca\u9670\u90e8\u7b49\u8655\uff0c\u7d93\u8a3a\u65b7\u70ba\u75a5\u7621 (Scabies)\u3002\u95dc\u65bc\u75a5\u7621\u7684\u6cbb\u7642\uff0c\u4e0b\u5217\u5efa\u8b70\u4f55\u8005 \u6700\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u4f7f\u7528 Ivermectin \u6cbb\u7642\u3002 (B)\u4f7f\u7528 Lindane\u6cbb\u7642\u3002 (C)\u4f7f\u7528 Permethrin \u6cbb\u7642\u3002 (D)\u63a5\u89f8\u8005\u9700\u4e00\u8d77\u63a5\u53d7\u6cbb\u7642\u3002 (E)\u6bba\u87f2\u5f8c\u4f7f\u7528 Cortisone \u5857\u62b9\u53ef\u6539\u5584\u76ae\u819a\u7662\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "70\u6b72\u5973\u6027\u88ab\u9001\u81f3\u6025\u8a3a\uff0c\u8eab\u9ad4\u6aa2\u67e5\u767c\u73fe\u55ae\u5074\u773c\u76ae\u4e0b\u5782( ptosis)\uff0c\u77b3\u5b54\u7e2e\u5c0f(miosis)\u53ca\u540c\u5074\u81c9\u90e8\u7121\u6c57(anhydrosis )\uff0c\u81e8\u5e8a\u9451\u5225\u8a3a\u65b7\uff0c \u4e0d\u5305\u62ec\u4e0b\u5217\u4f55\u9805\uff1f", + "Options": "(A)\u75b1\u75b9\u611f\u67d3 (herpes zoster )\u3002 (B)\u7b2c\u4e09\u5c0d\u9871\u795e\u7d93\u9ebb\u75fa(CN3 palsy )\u3002 (C)\u5167\u9838\u52d5\u8108\u525d\u96e2(internal carotid artery dissection )\u3002 (D)\u4e2d\u98a8(cerebral infarction )\u3002 (E)\u80ba\u764c\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "75\u6b72\u5973\u6027\u6709 cervical spondylosis \u904e\u53bb\u75c5\u53f2\uff0c\u56e0\u8eca\u798d\u53d7\u50b7\u9020\u6210\u9838\u90e8\u75bc\u75db\u88ab\u9001\u81f3\u6025\u8a3a\u5c31\u91ab\uff0c\u6025\u8a3a\u6aa2\u67e5\u767c\u73fe\u75c5\u4eba\u660e\u986f\u96d9\u5074\u4e0a\u80a2\u7121\u529b\u5408\u4f75\u5931\u53bb\u75db\u89ba\u548c\u6eab\u5ea6\u611f\u89ba\uff0c\u8acb\u554f\u9019\u4f4d\u75c5\u4eba\u53ef\u80fd\u7684\u8a3a\u65b7\u662f\uff1f", + "Options": "(A)Brown -S\u00e9quard syndrome \u3002 (B)Carotid dissection \u3002 (C)Central cord syndrome \u3002 (D)Posterior cord syndrome \u3002 (E)Vertebral artery dissection \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5fc3\u808c\u6897\u585e\u7684\u6558\u8ff0\uff0c\u4e0b\u5217 \u4f55\u8005\u932f\u8aa4 \uff1f", + "Options": "(A)\u5408\u4f75\u5fc3\u56e0\u6027\u4f11\u514b\u7684\u6b7b\u4ea1\u7387\u53ef\u9054 80%\u3002 (B)Dressler\u2019s syndrome \u53ef\u5728\u5fc3\u808c\u6897\u585e\u5f8c 2-10\u9031\u5167\u767c\u751f\u3002 (C)\u6301\u7e8c\u7ac7\u6027\u5fc3\u640f\u904e\u901f(sinus tachycardia )\u75c5\u4eba\u7684\u9810\u5f8c\u8f03\u5dee\u3002 (D)\u521d\u671f\u6700\u5e38\u898b\u7684\u5fc3\u5f8b\u4e0d\u6574\u70ba VPCs(ventricular premature contractions) \u3002 (E)\u75c5\u4eba\u51fa\u73fe AIVR(accelerated idioventricular rhythms)\u4ee3\u8868\u9810\u5f8c\u8f03\u5dee\uff0c\u9700\u7a4d\u6975\u6cbb\u7642\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6025\u6027\u8179\u75db\u6642\u4f7f\u7528\u6b62\u75db\u85e5\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4 \uff1f", + "Options": "(A)Opioids \u93ae\u75db\u6e1b\u8f15\u75bc\u75db\uff0c\u4e0d\u6703\u5f71\u97ff\u8179\u90e8\u8eab\u9ad4\u6aa2\u67e5\uff0c\u5ef6\u9072\u8a3a\u65b7\u6216\u5c0e\u81f4\u767c\u75c5\u7387\u3001 \u6b7b\u4ea1\u7387\u5347\u9ad8\u3002 (B)Ketorolac \u5c6c\u65bc NSAID\uff0c\u662f\u7d14\u7cb9\u7684\u6b62\u75db\u5291\uff0c\u4e0d\u6703\u63a9\u84cb\u65e9\u671f\u7684\u8179\u819c\u708e\u75c7\u72c0\u3002 (C)\u9f3b\u80c3\u7ba1\u62bd\u5438\u53ef\u4ee5\u5e6b\u52a9 \u4e0a\u6d88\u5316\u9053\u51fa\u8840\u8a3a\u65b7 \uff0c\u8178\u963b\u585e \u6642\u4e5f\u53ef\u4ee5\u4f7f\u7528\u9f3b\u80c3\u7ba1\u5f15\u6d41\u4f86\u6e1b\u58d3\u3002 (D)\u7d66\u4e88\u6b62\u5410\u85e5\u5982 Metoclopramide \u53ef\u4ee5\u6539\u5584\u8853\u5f8c\u5614\u5410\u5f15\u8d77\u4e4b\u8179\u75db\uff0c\u4f46\u982d\u75db\u70ba\u53ef\u80fd\u7684\u526f\u4f5c\u7528\u3002 (E)\u975c\u8108\u6ce8\u5c04 Metoclopramide \u7684\u5291\u91cf\u70ba 10 mg\uff0c\u7de9\u6162\u7d66\u4e88\u53ef\u4ee5\u6e1b\u5c11\u9310\u9ad4 \u5916( Extra pyramidal )\u7684\u526f\u4f5c\u7528\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "46\u6b72\u5973\u6027\uff0c\u56e0\u5de6\u534a\u908a\u81c9\u7a81\u7136\u50f5\u786c\u3001\u81c9\u6b6a\u5634\u659c\uff0c\u81ea\u89ba\u984f\u9762\u795e\u7d93\u9ebb\u75fa\u81f3\u6025\u8a3a\u5c31\u8a3a\uff0c\u4e0b\u5217\u4f55\u7a2e\u75c7\u72c0 \u4e0d\u9700\u8981\u5b89\u6392\u8166\u90e8\u5f71\u50cf\u6aa2\u67e5\uff1f", + "Options": "(A)\u80a2\u9ad4\u7121\u529b\u3002 (B)\u524d\u984d\u76ba\u7d0b\u4e0d\u53d7\u5f71\u97ff(facial plegia sparing the forehead) \u3002 (C)\u773c\u775b\u7121\u6cd5\u5411\u5916\u770b\u3002 (D)\u541e\u56a5\u56f0\u96e3\u3001\u6d41\u53e3\u6c34\u3002 (E)\u820c\u982d\u524d\u4e09\u5206\u4e4b\u4e8c \u5473\u89ba\u7570\u5e38\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "47\u6b72\u5de1\u5c71\u54e1\u65bc\u81fa\u6771\u5c71\u5340\u906d\u9f2c\u737e\u54ac\u50b7\uff0c\u53f3\u5c0f\u817f\u6709 2\u516c\u5206\u6495\u88c2\u50b7\u4f75\u51fa\u8840\uff0c\u81f3\u6025\u8a3a\u5ba4\u5f8c\u7684\u8655\u7f6e\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u61c9\u8a62\u554f\u904e\u53bb\u662f\u5426\u66fe\u63a5\u53d7\u72c2\u72ac\u75c5\u75ab\u82d7\u6ce8\u5c04\uff0c\u5982\u75c5\u4eba\u672a\u66fe\u63a5\u53d7\u6ce8\u5c04\uff0c\u6b64\u6b21\u61c9\u7d66\u4e88\u72c2\u72ac\u75c5\u75ab\u82d7\u53ca\u514d\u75ab\u7403\u86cb\u767d\u6ce8\u5c04\u3002 (B)\u72c2\u72ac\u75c5\u514d\u75ab\u7403\u86cb\u767d\u5728\u50b7\u53e3\u5468\u908a\u6d78\u6f64\u65bd\u6253\uff0c\u907f\u514d\u6ce8\u5165\u975c\u8108\u3002 (C)\u75c5\u4eba\u4e09\u5e74\u524d\u66fe\u6253\u904e\u72c2\u72ac\u75c5\u75ab\u82d7\uff0c\u5247\u6b64\u6b21\u4e0d\u5fc5\u7d66\u4e88\u72c2\u72ac\u75c5\u75ab\u82d7\u6ce8\u5c04\u3002 (D)\u61c9\u8a62\u554f\u904e\u53bb\u662f\u5426\u66fe\u63a5\u53d7\u7834\u50b7\u98a8\u75ab\u82d7\u6ce8\u5c04\uff0c\u5982\u75c5\u60a3\u672a\u66fe\u63a5\u53d7\u6ce8\u5c04\uff0c\u6b64\u6b21\u61c9\u7d66\u4e88\u7834\u50b7\u98a8\u75ab\u82d7\u6ce8\u5c04\u3002 (E)\u75c5\u4eba\u4e09\u5e74\u524d\u66fe\u6253\u904e\u7834\u50b7\u98a8\u75ab\u82d7\uff0c\u5247\u6b64\u6b21\u4e0d\u5fc5\u7d66\u4e88\u7834\u50b7\u98a8\u75ab\u82d7\u6ce8\u5c04\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6a6b\u7d0b\u808c\u6eb6\u89e3\u75c7 (rhabdomyolysis )\u65e9\u671f\u53ef\u80fd\u5f15\u8d77\u7684\u4f75\u767c\u75c7\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)Acute renal failure \u3002 (B)Disseminated intravascular coagulation \u3002 (C)Hypercalcemia \u3002 (D)Hyperkalemia \u3002 (E)Hyperuricemia \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u504f\u982d\u75db\u75c5\u4eba\u4e4b\u81e8\u5e8a\u8868\u73fe \uff0c\u4f55\u9805\u6558\u8ff0 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u982d\u75db\u5f37\u5ea6\u5e38\u9054\u5230\u75bc\u75db\u91cf\u8868\u4e2d\u5ea6\u4ee5\u4e0a\u3002 (B)\u5176\u75c7\u72c0\u4e00\u822c\u53ef\u4ee5\u6301\u7e8c\u5230 72\u5c0f\u6642(\u5e73\u5747\u7d04 4-72\u5c0f\u6642)\u3002 (C)\u6700\u5e38\u898b\u7684\u5148\u5146\u70ba\u982d\u6688 (lightheadedness)\u53ca\u8996\u89ba\u76f2\u9ede (scotoma )\u3002 (D)\u5176\u7279\u5fb5\u70ba\u55ae\u5074\uff0c\u8108\u640f\u5f0f(pulsatile )\u982d\u75db\u4e14\u96a8\u6d3b\u52d5\u52a0\u5287\u3002 (E)\u75c7\u72c0 \u5f88\u5c11\u767c\u751f\u65bc\u5b69\u7ae5\u671f\uff0c\u591a\u65bc 40\u6b72\u5de6\u53f3\u9054\u9ad8\u5cf0\u671f\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "50\u6b72\u5973\u6027\u88ab\u9001\u81f3\u6025\u8a3a\uff0c\u4e3b\u8ff0\u865b\u5f31\u7121\u529b\uff0c\u8840\u9209 126 meq/L\uff0c\u75c5\u4eba\u6c92\u6709\u660e\u986f\u6c34\u816b\uff0c\u5f8c\u7e8c\u6aa2\u67e5\u767c\u73fe\u5c3f\u6db2\u9209\u96e2\u5b50 30 (\u6b63\u5e38\u503c \uff1a27 -287) meq/L\uff0c\u4e0b\u5217\u54ea\u500b\u75be\u75c5\u662f\u6700\u6709\u53ef\u80fd \u7684\u8a3a\u65b7\uff1f", + "Options": "(A)\u809d\u786c\u5316(liver cirrhosis )\u3002 (B)\u6297\u5229\u5c3f\u5206\u6ccc\u7570\u5e38\u75c7(SIADH) \u3002 (C)\u5fc3\u81df\u8870\u7aed (heart failure )\u3002 (D)\u814e\u75c5\u75c7\u5019\u7fa4 (nephrotic syndrome )\u3002 (E)\u56b4\u91cd\u8178\u80c3\u6d41\u5931(severe GI loss )\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u98df\u9053\u8150\u8755\u6027\u50b7\u5bb3( corrosive injury )\u4e4b\u63cf\u8ff0\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4 \uff1f", + "Options": "(A)\u5167\u8996\u93e1\u6aa2\u67e5\u61c9\u5118\u65e9\u9032 \u884c\uff0c\u4ee5\u8a55\u4f30\u9ecf\u819c\u53d7\u640d\u7a0b\u5ea6 \u3002 (B)\u5f37\u9178\u9020\u6210\u8f03\u6dfa\u7684 coagulation necrosis\uff0c\u80c3\u640d\u50b7\u8f03\u91cd\uff0c\u524d\u5ead\u5e7d\u9580\u90e8\uf9e0\u72f9\u7a84\uff0c\uf9e0\u9178\u4e2d\u6bd2\uff0c\u6b7b\u4ea1\u7387\u8f03\u5f37\u9e7c\u4f4e\u3002 (C)\u5f37\u9e7c\u9020\u6210\u8f03\u6df1\u7684 liquefaction necrosis \uff0c\u98df\u9053\u640d\u50b7\u8f03\u91cd\uff0c\u98df\u9053\uf9e0\u72f9\u7a84\u3002 (D)\u5152\u7ae5\u8aa4\u541e\u9215\u6263\u578b\u96fb\u6c60\uff0c\u82e5\u61f7\u7591\u5361\u5728\u98df\u9053\uff0c\u5167\u8996\u93e1\u6aa2\u67e5\u61c9\u5118\u65e9\u65bc 6\u5c0f\u6642\u5167\u5b8c\u6210\u3002 (E)\u5152\u7ae5\u8aa4\u541e\u9215\u6263\u578b\u96fb\u6c60\uff0c\u82e5\u61f7\u7591\u5361\u5728\u98df\u9053\uff0c\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\uff0c\u4f46\u5167\u8996\u93e1\u6aa2\u67e5\u7121\u6cd5\u99ac\u4e0a\u505a\uff0c\u78ba\u8a8d\u662f\u5169\u5c0f\u6642\u5167\u98df\u5165\u53ef\u4ee5\u8003\u616e Foley Balloon catheter technique \u79fb\u9664\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u767c\u73fe\u5371\u5bb3\u7269\u8cea\u6642\uff0c\u8eab\u70ba\u6025\u8a3a\u91ab\u7642\u4eba\u54e1\uff0c\u61c9\u8a72\u505a\u51fa\u76f8\u95dc\u61c9\u8b8a\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u5371\u5bb3\u7269\u8cea\u5c0d\u65bc\u793e\u5340\u5b89\u5168\u7684\u5371\u5bb3\u8a55\u4f30(community risk assessment )\u3002 (B)\u78ba\u8a8d\u767c\u751f\u7684\u5371\u5bb3\u7269\u8cea\u4e8b\u4ef6(recognition of an event )\u3002 (C)\u5206\u8fa8\u6b64\u6b21\u4e8b\u4ef6\u4e2d\u5305\u542b\u6709\u54ea\u7a2e\u5371\u5bb3\u7269\u8cea(identification of the substances involved )\u3002 (D)\u9694\u96e2\u4e26\u505a\u73fe\u5834\u5371\u5bb3\u7269\u8cea\u7ba1\u5236 (isolation and scene control )\u3002 (E)\u9664\u6c59\u4e26\u4e88\u7a69\u5b9a\u75c5\u4eba\u751f\u547d\u5fb5\u8c61\u548c\u5efa\u7acb\u6aa2\u50b7 (decontamination \u3001stabilization and triage )\uff0c\u9664\u6c59\u7b2c\u4e00\u6b65\u9a5f\u662f\u65bc\u71b1\u5340 (hot zone )\u7acb\u5373\u65bd\u4e88\u5927\u91cf\u6e05\u6c34\u6c96\u6d17\u60a3\u8005\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6025\u6027\u5fc3\u5305\u819c\u708e (acute pericarditis )\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u80f8\u75db\u75c7\u72c0\u56b4\u91cd\u5ea6\u901a\u5e38\u8207\u59ff\u52e2\u7121\u95dc\u3002 (B)\u82e5\u4f75\u767c\u5927\u91cf\u5fc3\u5305\u819c\u7a4d\u6db2\uff0c\u5fc3\u96fb\u5716\u53ef\u80fd\u5448\u73fe electrical alternans \u3002 (C)\u91dd\u5c0d\u8a3a\u65b7\u5fc3\u5305\u819c\u7a4d\u6db2\uff0c\u96fb\u8166\u65b7\u5c64\u6383\u63cf\u8f03\u8d85\u97f3\u6ce2\u7684\u654f\u611f\u5ea6\u9ad8\u3002 (D)\u5fc3\u96fb\u5716\u8868\u73fe\u53ef\u80fd\u51fa\u73fe PR elevation \u3002 (E)\u75c5\u6bd2\u6027\u5fc3\u5305\u819c\u708e\u5e38\u9700\u8981\u4f4f\u9662\u4ee5\u62bd\u5fc3\u5305\u819c\u7a4d\u6c34\u3002", + "Answer": "B\u3001D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u5728\u6025\u8a3a\u5c0d\u65bc\u95dc\u7bc0\u708e\u75c5\u4eba \u7684\u9451\u5225\u8a3a\u65b7\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u5e38\u4ee5\u55ae\u95dc\u7bc0(monoarticular )\u65b9\u5f0f\u8868\u73fe\uff1f", + "Options": "(A)Gonococcal arthritis\u3002 (B)Lyme disease \u3002 (C)Gout\u3002 (D)Reactive arthritis \u3002 (E)Viral arthritis \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "30\u6b72\u5973\u6027\u61f7\u5b55 36\u9031( G4P1AA0SA2 )\uff0c\u81e8\u5e8a\u61f7\u7591\u6025\u6027\u80ba\u6813\u585e\uff0c\u8acb\u554f\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u6b63\u78ba \uff1f", + "Options": "(A)r -tPA\u6703\u901a\u904e\u80ce\u76e4\uff0c\u61f7\u5b55\u7981\u6b62\u4f7f\u7528\u3002 (B)\u82e5\u4e0d\u9069\u5408\u80ba\u90e8\u8840\u7ba1\u96fb\u8166\u65b7\u5c64\u651d\u5f71(CT -PA)\uff0c\u53ef\u8003\u616e\u6838\u78c1\u5171\u632f(MRI)\u3002 (C)\u53ef\u7528 Wells' Criteria \u4f86\u9810\u6e2c\u5b55\u5a66\u80ba\u6813\u585e\u7684\u53ef\u80fd\u6027\u3002 (D)\u82e5\u8d85\u97f3\u6ce2\u767c\u73fe\u6709 DVT\uff0c\u53ef\u4ee5\u76f4\u63a5\u958b\u59cb\u7528 Unfractionated heparin \u6216low-molecular -weight heparin \u4f5c\u6297\u51dd\u8840\u6cbb\u7642\u3002 (E)\u61c9\u5b89\u6392 V/Q scan\uff0c\u5c0d\u80ce\u5152\u8f3b\u5c04\u5291\u91cf\u8f03\u5c11\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6c23\u5598\u91cd\u7a4d( Status asthmaticus )\u767c\u4f5c\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u901a\u5e38\u5438\u5165\u652f\u6c23\u7ba1\u64f4\u5f35\u5291\u548c\u985e\u56fa\u9187\u7121\u6cd5\u6539\u5584\u3002 (B)\u91dd\u5291\u6216\u662f\u5438\u5165\u786b\u9178\u9382\u53ef\u4ee5\u7576\u4f5c\u56b4\u91cd\u6c23\u5598\u7684\u8f14\u52a9\u6cbb\u7642\uff0c\u4f46\u5bb9 \uf9e0\u5f15\u767c\u4f4e\u8840\u58d3\u53ca\u795e\u7d93\u808c\u8089\u963b\u65b7\u73fe\u8c61\u3002 (C)\u5982\u679c\u9700\u8981\u63d2\u7ba1\uff0c Ketamine \u662f\u904e\u7a0b\u4e2d\u53ca\u901a\u6c23\u958b\u59cb\u5f8c\u7684\u826f\u597d\u8f14\u52a9\u85e5\u7269\u3002 (D)\u96e3\u6cbb\u60c5\u6cc1 (refractory situations )\u4e0b\uff0c\u6210\u4eba\u53ef\u4ee5\u7d66\u4e88\u814e\u4e0a\u817a\u7d20(epinephrine )SC\u6216IM\uff0c0.5\u6beb\u514b\u3002 (E)\u4f7f\u7528\u547c\u5438\u5668\u4e26\u4e0d\u80fd\u6e1b\u8f15\u6c23\u5598\u9020\u6210\u7684\u6c23\u9053\u963b\u585e\uff0c\u53ea\u662f\u8b93\u75c5\u4eba\u6e1b\u5c11\u547c\u5438\u4f5c\u529f\u3001\u6539\u5584\u6c27\u5408\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "32\u6b72\u7537\u6027\u4fee\u8eca\u5ee0\u5de5\u4eba\u559d\u4e86 100 mL\u96fb\u934d\u6db2( plating solution )\u81ea\u6bba\uff0c\u56e0\u5589\u56a8\u75db\u548c\u8179\u75db\u81f3\u6025\u8a3a\u5c31\u91ab\uff0c\u75c5\u4eba\u81ea\u8ff0\u96fb\u934d\u6db2\u542b\u9ad8\u6fc3\u5ea6\u927b\u9178(Chromic acid )\uff0c \u8acb\u554f\u4e0b\u5217\u4f55\u7a2e\u6cbb\u7642\u8207\u8655\u7f6e\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u5b89\u6392\u7dca\u6025\u80c3\u93e1\u6aa2\u67e5\u3002 (B)\u7d66\u4e88 succimer(DMSA)\u87af\u5408\u5291\u6cbb\u7642\u3002 (C)\u7d66\u4e88 Vitamin C \u3002 (D)\u7d66\u4e88 Acetylcysteine \u3002 (E)\u5be6\u65bd\u6c23\u7ba1\u5167\u7ba1\u7f6e\u5165(endotracheal intubation)\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "23\u6b72\u5973\u6027\u88ab\u9001\u81f3\u6025\u8a3a\uff0c\u4e3b\u8a34\u70ba\u767c\u71d2\u53ca\u610f\u8b58\u4e0d\u6e05\uff0c\u904e\u53bb\u75c5\u53f2\u4e0d\u8a73\u3002 \u8840\u6db2\u6aa2\u9a57\u7d50\u679c\uff0c\u52d5\u8108\u8840\u6c23\u9ad4\u5206\u6790 (ABG)\uff1apH 7.39\uff0cPCO 2 24 mmHg \uff0cPaO 2 89 mmHg\uff0cHCO 3 14 meq/L \uff1bNa 130 meq/L \uff0cK 5.0 meq/L \uff0cCl 96 meq/L \uff0cBUN 20 mg/dL \uff0cCr 1.3 mg/dL \uff0cGlucose 300 mg/dL \u3002\u75c5\u4eba\u9178\u4e2d\u6bd2\u7684\u9451\u5225\u8a3a\u65b7\uff0c\u4e0d\u5305\u62ec\u54ea\u9805 \uff1f", + "Options": "(A)\u916e\u9178\u8840\u75c7 (ketoacidosis) \u3002 (B)\u814e\u5c0f\u7ba1\u9178\u8840\u75c7(renal tubular acidosis )\u3002 (C)Metformin \u4e2d\u6bd2\u3002 (D)\u6c34\u694a\u9178(salicylates )\u4e2d\u6bd2\u3002 (E)\u4e73\u9178\u8840\u75c7 (lactic acid acidosis) \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6297\u78f7\u8102\u8cea\u75c7\u5019\u7fa4( Antiphospholipid syndrome, APS)\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u597d\u767c\u65bc\u5973\u6027\uff0c\u81e8\u5e8a\u4e0a\u5e38\u9020\u6210\u975c\u8108\u8840\u6813\u3002 (B)Catastrophic APS\u6703\u9020\u6210\u591a\u91cd\u5668\u5b98\u7684\u5c0f\u8840\u7ba1\u963b\u585e\u3002 (C)Catastrophic APS\u7684\u81e8\u5e8a\u75c5\u7a0b\u9032\u5c55\u5feb\u901f\uff0c\u81f4\u6b7b\u7387\u53ef\u9ad8\u9054 50%\u3002 (D)\u8003\u91cf\u53ef\u80fd\u9020\u6210\u6d41\u7522\uff0c\u60a3\u6709\u6297\u78f7\u8102\u8cea\u75c7\u5019\u7fa4\u7684\u5b55\u5a66\u61c9\u907f\u514d\u4f7f\u7528\u4f4e\u5206\u5b50\u91cf\u809d\u7d20\u6216\u963f\u65af\u5339\u6797\u6cbb\u7642\u3002 (E)\u7121\u8840\u6813\u76f8\u95dc\u75c5\u53f2\u4e14\u5065\u5eb7\u7684 antiphospholipid antibodies \u967d\u6027\u75c5\u60a3\uff0c\u4e0d\u9700\u7d66\u4e88\u9810\u9632\u6027\u6297\u8840\u6813\u6cbb\u7642\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "54\u6b72\u7537\u6027\uff0c\u6709\u9152\ufa1d\u6027\u809d\u786c\u5316\u4e4b\u75c5\u53f2\uff0c\u4e3b\u8a34\u5927\u91cf \u5614\u5410\u9bae\u8840\u81f3\u6025\u8a3a\u5ba4\u6c42\u8a3a\uff0c\u8a55\u4f30\u70ba\u6025\u6027\u98df\u9053\u975c\u8108\u7624\u51fa\u8840\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4 \uff1f", + "Options": "(A)\u56e0\u61f7\u7591\u98df\u9053\u975c\u8108\u7624\u51fa\u8840\uff0c\u6545\u4e0d\u61c9\u653e\u7f6e\u9f3b\u80c3\u7ba1\u3002 (B)\u6b64\u6642\u61c9\u9996\u91cd\u7a69\u5b9a\u751f\u547d\u5fb5\u8c61\uff0c\u4e26\u61c9\u5118\u65e9\u5b89\u6392\u5167\u8996\u93e1\u6cbb\u7642\u3002 (C)\u8840\u7ba1\u6d3b\u6027(vasoactive )\u85e5\u7269\u53ef\u4ee5\u6e1b\u5c11\u9580\u8108\u8840\u6d41\u5f9e\u800c \u964d\u4f4e\u9580\u8108\u58d3\uff0c\u9054\u5230\u6b62\u8840\u7684\u6548\u679c\u3002 (D)\u809d\u786c\u5316\u75c5\u4eba\u98df\u9053\u975c\u8108\u7624\u51fa\u8840\u6642\uff0c\u53ef\u4ee5\u4f7f\u7528 quinolone \u6216ceftriaxone \u4f86\u9810\u9632\u611f\u67d3\u3002 (E)\u75c5\u4eba\u751f\u547d\u5fb5\u8c61\u4e0d\u7a69\u5b9a\uff0c\u82e5\u7121\u6cd5\u53ca\u6642\u63d0\u4f9b\u5167\u8996\u93e1\u6cbb\u7642\u6642\uff0c\u4ecd\u61c9\u8003\u616e\u653e\u7f6eSengstaken -Blakemore tube\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5ef6\u4f38\u6027\u5275\u50b7\u8d85\u97f3\u6ce2( Extended Focused Assessment with Sonogra phy for Trauma, E -FAST)\uff0c\u4e0b\u5217\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)FAST \u53ef\u4ee5\u5075\u6e2c\u8179\u8154\u5167\u51fa\u8840\u3002 (B)E -FAST\u53ef\u4ee5\u5075\u6e2c\u662f\u5426\u6709\u8840\u80f8 (hemothorax )\u3002 (C)E -FAST\u53ef\u4ee5\u5075\u6e2c\u662f\u5426\u6709\u6c23\u80f8 (pneumothorax )\u3002 (D)FAST \u53ef\u4ee5\u5075\u6e2c\u5fc3\u5305\u7a4d\u6db2\u3002 (E)E -FAST\u53ef\u5075\u6e2c\u4e3b\u52d5\u8108\u7624\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u8fa6\u7406\u6551\u8b77\u6280\u8853\u54e1\u4e4b\u8a13\u7df4\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4 \uff1f", + "Options": "(A)\u5404\u7d1a\u5225\u6551\u8b77\u54e1\u8a13\u7df4\u53ca\u7e7c\u7e8c\u6559\u80b2\u8ab2\u7a0b\u4e4b\u5e2b\u8cc7\uff0c\u4ee5\u5be6\u969b\u5f9e\u4e8b\u7dca\u6025\u91ab\u7642\u6551\u8b77\u5de5\u4f5c\u4e09\u5e74\u4ee5\u4e0a\u4e4b\u91ab\u5e2b\u3001\u8b77\u7406\u4eba\u54e1\u6216\u9ad8\u7d1a\u3001\u4e2d\u7d1a\u6551\u8b77\u54e1\u70ba\u9650\u3002 (B)\u8a2d\u7acb\u4e3b\u65e8\u8207\u7dca\u6025\u91ab\u7642\u6551\u8b77\u76f8\u95dc\u4e4b\u4eba\u6c11\u5718\u9ad4\u6216\u885b\u751f\u798f\u5229\u90e8\u4e3b\u7ba1\u4e4b\u57fa\u91d1\u6703\uff0c\u5176\u7406\u4e8b\u3001\u8463\u4e8b\u6703\u4e4b\u6210\u54e1\u8cc7\u683c\u7b26\u5408\u898f\u5b9a\u8005\uff0c\u5f97\u7d93\u7533\u8acb\u8a31\u53ef\u5f8c\u8fa6\u7406\u521d\u3001\u4e2d\u7d1a\u6551\u8b77\u6280\u8853\u54e1\u8a13\u7df4\u3002 (C)\u4e00\u822c\u7d1a\u4ee5\u4e0a\u6025\u6551\u8cac\u4efb\u91ab\u9662\uff0c\u5f97\u7d93\u7533\u8acb\u8a31\u53ef\u5f8c\u8fa6\u7406\u521d\u7d1a\u6551\u8b77\u6280\u8853\u54e1\u8a13\u7df4\u3002 (D)\u4e2d\u5ea6\u7d1a\u4ee5\u4e0a\u6025\u6551\u8cac\u4efb\u91ab\u9662\uff0c\u5f97\u7d93\u7533\u8acb\u8a31\u53ef\u5f8c\u8fa6\u7406\u4e2d\u7d1a\u6551\u8b77\u6280\u8853\u54e1\u8a13\u7df4\u3002 (E)\u53ea\u8a31\u53ef\u91cd\u5ea6\u7d1a\u6025\u6551\u8cac\u4efb\u91ab\u9662\uff0c\u5f97\u7d93\u7533\u8acb\u8a31\u53ef\u5f8c\u8fa6\u7406\u9ad8\u7d1a\u6551\u8b77\u6280\u8853\u54e1\u8a13\u7df4\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u300e\u7dca\u6025\u91ab\u7642\u6551\u8b77\u6cd5\u300f\u4e2d\u898f\u5b9a\u5f97\u8a2d\u7f6e\u6551\u8b77\u8eca\u4e4b\u6a5f\u95dc(\u69cb) \uff0c\u4e0b\u5217\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u6d88\u9632\u6a5f\u95dc\u3002 (B)\u885b\u751f\u6a5f\u95dc\u3002 (C)\u8ecd\u4e8b\u6a5f\u95dc\u3002 (D)\u5b97\u6559\u6a5f\u69cb\u3002 (E)\u6551\u8b77\u8eca\u71df\u696d\u6a5f\u69cb\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u507d\u819c\u6027\u7d50\u8178\u708e (pseudomembranous colitis )\u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u5927\u90e8\u5206\u767c\u751f\u65bc\u5927\u8178\uff0c\u5167\u8996\u93e1\u53ef \u898b\u9ec3\u8272\u507d\u819c\u3002 (B)\u8a3a\u65b7\u5305\u62ec\uff1a\u7cde\uf965\u57f9\u990a\u3001\u7cde\uf965\u6bd2\u7d20\u548c\u5927\u8178\u93e1\u6aa2\u67e5\u3002 (C)\u7b2c\u4e09\u4ee3 cephalosporins \u6297\u751f\u7d20\u5c0d\u6b64\u75c5\u6700\u6709\u6548\uff0c\u7d04\u4e00\u661f\u671f\u53ef\u75ca\u7652\u3002 (D)\u6700\u5e38\u898b\u4e4b \u81e8\u5e8a\u8868\u73fe\u5305\u62ec\uff1a\u8179\u7009\u3001\u767c\u71d2\u3001\u767d\u8840\u7403\u4e0a\u5347\u548c\u8179\u75db\u3002 (E)\u6700\u5e38\u898b\u5f15\u767c\u6b64\u75c5\u4e4b\u7d30\u83cc\u70ba Clostridium difficile \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "20\u6b72\u7537\u6027\u5728\u7389\u5c71\u4e4b\u6392\u96f2\u5c71\u838a (3,402\u516c\u5c3a)\uff0c\u665a\u4e0a 10\u9ede\uff0c\u767c\u751f\u6b65\u614b\u4e0d\u7a69\u53ca\u795e\u667a\u6539\u8b8a (GCS E3V4M6) \uff0c\u4e0b\u5217\u4f55\u8005\u8655\u7f6e \u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u8003\u616e\u7acb\u5373\u4e0b\u5c71\u3002 (B)\u7d66\u4e88\u6c27\u6c23\u3002 (C)\u4f7f\u7528\u52a0\u58d3\u888b (hyperbaric bag )\u3002 (D)\u7d66\u4e88\u6ce8\u5c04 dexamethasone \u3002 (E)\u7d66\u4e88\u670d\u7528\u5a01\u800c\u92fc(Viagra, Sildenafil )\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u9f3b\u7ac7\u708e\u7684\u6558\u8ff0\u4e0b\u5217\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u5927\u591a\u6578\u7684\u611f\u67d3\u6e90\u662f\u7d30\u83cc\u3002 (B)\u4f7f\u7528\u76ae\u8cea\u985e\u56fa\u9187\u9f3b\u5167\u5674\u5291\u53ef\u80fd\u5ef6\u9577\u75c5\u7a0b\u3002 (C)\u9996\u9078\u6cbb\u7642\u6297\u751f\u7d20\u662f\u78fa\u80fa\u985e\u3002 (D)\u773c\u7736\u8702\u7aa9\u7d44\u7e54\u708e(orbital cellulitis)\u6700\u5e38\u7531\u7be9\u7ac7(Ethmoid Sinus )\u611f\u67d3\u5f15\u767c\u3002 (E)\u975e\u8907\u96dc\u6027\u9f3b\u7ac7\u708e\u78ba\u8a3a\u9700\u8981\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u80f8\u90e8\u5916\u50b7\u75c5\u4eba\uff0c\u4f55\u8005\u8f03 \u4e0d\u53ef\u80fd\u9700\u8981\u624b\u8853\uff1f", + "Options": "(A)\u9023\u7e8c\u4e09\u6839\u808b\u9aa8\u7686\u6709\u5169\u8655\u9aa8\u6298\u3002 (B)\u5de6\u5074\u8840\u6c23\u80f8\u537b\u672a\u5408\u4f75\u808b\u9aa8\u9aa8\u6298\u3002 (C)X \u5149\u767c\u73fe\u9f3b\u80c3\u7ba1\u51fa\u73fe\u5728\u80f8\u8154\u5167\u3002 (D)\u80f8\u7ba1\u653e\u7f6e\u5f8c\u51fa\u4f86\u8d85\u904e 1,500 mL\u8840\u6db2\u3002 (E)\u6c23\u80f8\u7d93\u80f8\u7ba1\u5f15\u6d41\u5f8c\uff0c\u4ecd\u6301\u7e8c\u6709\u5927\u91cf\u6c23\u9ad4\u6ea2\u51fa\u6642\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "65\u6b72\u5973\u6027\u6709\u5fc3\u81df\u8870\u7aed\u3001\u6162\u6027\u814e\u8870\u7aed\u53ca\u8e81\u9b31\u75c7\u75c5\u53f2\uff0c\u56e0\u610f\u8b58\u6a21\u7cca\u53ca\u624b\u4e0d\u81ea\u4e3b\u6296\u52d5\u88ab\u5bb6\u4eba\u9001\u81f3\u6025\u8a3a\u5c31\u91ab\uff0c\u8840\u58d3 150/75 mmHg \uff0c\u5fc3\u8df3 88\u6b21/min\uff0c\u547c\u5438 25\u6b21/min\uff0c\u9ad4\u6eab 36.5\u00b0C\uff0c\u660f\u8ff7\u6307\u6578 E3V3M5\uff0c\u8840\u6db2\u6aa2\u9a57 creatinine 5.6mg/dL \uff0c\u92f0\u9e7d(lithium )\u6fc3\u5ea6 3.5 mEq/L\uff0c\u4e0b\u5217\u4f55\u8005\u70ba\u6700\u597d \u7684\u6cbb\u7642\u8207\u8655\u7f6e\uff1f", + "Options": "(A)\u8840\u6db2\u900f\u6790(hemodialysis )\u3002 (B)\u975c\u8108\u7d66\u4e88\u5927\u91cf\u751f\u7406\u98df\u9e7d\u6c34\u3002 (C)\u975c\u8108\u6ce8\u5c04\u5229\u5c3f\u5291\u3002 (D)\u6d17\u80c3\u3002 (E)\u975c\u8108\u7d66\u4e88\u78b3\u9178\u6c2b\u9209(sodium bicarbonate )\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u4ee5\u4e0b\u91dd\u5c0d\u808b\u819c\u7a4d\u6db2\u7684\u5224\u8b80\uff0c\u4f55\u8005\u932f\u8aa4 \uff1f", + "Options": "(A)\u98df\u9053\u7834\u88c2\u53ef\u80fd\u9020\u6210\u808b\u819c\u7a4d\u6db2\u7684 amylase\u5347\u9ad8\u3002 (B)\u80ba\u6813\u585e\u6240\u9020\u6210\u7684\u808b\u819c\u7a4d\u6db2\u6709\u53ef\u80fd\u662f transudates \u3002 (C)\u98a8\u6fd5\u6027\u95dc\u7bc0\u708e\u9020\u6210\u7684\u808b\u819c\u7a4d\u6db2\u5176\u8461\u8404\u7cd6\u6703\u4e0a\u5347\u3002 (D)\u7576 pH\u503c\u5c0f\u65bc 7.1\uff0c\u53ef\u8a3a\u65b7\u81bf\u80f8\uff0c\u4e26\u4e14\u662f\u80f8\u7ba1\u5f15\u6d41\u7684\u9069\u61c9\u75c7\u3002 (E)\u764c\u75c7\u6240\u9020\u6210\u7684\u808b\u819c\u7a4d\u6db2\uff0c\u5176\u767d\u8840\u7403\u5206\u985e\u6703\u4ee5\u6dcb\u5df4\u7403\u70ba\u4e3b\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "82\u6b72\u7537\u6027\u6709\u9ad8\u8840\u58d3\u3001\u5fc3\u81df\u75c5\u3001\u651d\u8b77\u817a\u80a5\u5927\u75c5\u53f2 \uff0c\u4e3b\u8a34\u6392 \uf965\u6392\u5c3f\u4e0d\u9806\uff0c\u5168\u8eab\u4e0d\u8212\u670d\u81f3\u6025\u8a3a\u5ba4\u5c31\u8a3a\u3002\u8eab\u9ad4\u6aa2\u67e5\u767c\u73fe\u4e0b\u8179\u90e8\u6709\u500b\u816b\u584a \uff0c\u62bd\u8840\u6aa2\u9a57\uff1a BUN 30 mg/dL\uff0cCreatinine 2.0 mg/dL \uff1b\u5e38\u898f\u5c3f\u6db2\u6aa2\u67e5 WBC/PUS \uff1a3-5/HPF\uff0cRBC\uff1a15- 20/HPF\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4 \uff1f", + "Options": "(A)\u5c3f\u6eef\u7559\u5f8c\u5f15\u8d77 BUN\u6216Creatinine \u660e\u986f\u5347\u9ad8\u7684\u60a3\u8005\u53ef\u4ee5\u8003\u616e\u6536\u4f4f\u9662\u3002 (B)\u5efa\u8b70\u5e38\u898f\u4f7f\u7528\u6297\u751f\u7d20\u9810\u9632\u6ccc\u5c3f\u9053\u611f\u67d3 \u3002 (C)\u5e8a\u908a\u8d85\u97f3\u6ce2\u53ef\u4ee5\u8a3a\u65b7\u662f\u5426\u6709\u6025\u6027\u5c3f\u6eef\u7559\u3002 (D)\u5c0e\u5c3f\u7ba1\u7684\u4fdd\u7559\u6c23\u56ca\u5728\u5c3f\u9053\u5167\u81a8\u8139\uff0c\u53ef\u80fd \u5f15\u8d77\u5c3f\u9053 \u50b7\u5bb3\u3002 (E)\u6025\u6027\u5c3f\u6eef\u7559\u5f15\u8d77\u75bc\u75db\uff0c\u82e5\u5617\u8a66\u5e7e\u6b21\u5c0e\u5c3f\u5931\u6557\u5f8c\uff0c\u53ea\u8981\u4e0b\u8179\u90e8\u6c92\u6709\u660e\u986f\u7684\u9aa8\u76c6\u8154\u5275\u50b7\u6216\u7570\u5e38\u89e3\u5256\u7d50\u69cb\uff0c\u53ef\u4ee5\u9032\u884c\u6065\u9aa8\u4e0a\u5c0e\u7ba1\u63d2\u5165\u8853\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "2\u500b\u534a\u6708\u5927\u7537\u5b30\uff0c\u8db3\u6708\u7522\uff0c\u56e0\u5614\u5410\u56db\u5929\uff0c\u7531\u5bb6\u9577\u5e36\u5230\u6025\u8a3a\u6c42\u8a3a\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba \uff1f", + "Options": "(A)\u61c9\u8a72\u662f\u80c3\u98df\u9053\u9006\u6d41\uff0c\u4e0d\u5fc5\u9032\u4e00\u6b65\u6aa2\u67e5\uff0c\u7d66\u4e88\u6b62\u5410\u85e5\u3002 (B)\u8179\u90e8\u4e0a\u6d88\u5316\u9053\u651d\u5f71\u6aa2\u67e5(upper GI tract contrast study )\u53ef\u5e6b\u52a9\u9451\u5225\u8a3a\u65b7\u3002 (C)\u82e5\u5614\u5410\u7269\u6709\u81bd\u6c41\u984f\u8272\uff0c\u61c9\u8003\u616e\u5148\u5929\u6027\u5e7d\u9580\u72f9\u7a84\u3002 (D)\u82e5\u662f\u5148\u5929\u6027\u5e7d\u9580\u72f9\u7a84\uff0c\u75c5\u4eba\u5bb9 \uf9e0\u812b\u6c34\uff0c\u75be\u75c5\u65e9\u671f\u5bb9\uf9e0\u5408\u4f75\u9178\u8840\u75c7\u3002 (E)\u82e5\u8179\u90e8\u8d85\u97f3\u6ce2\u767c\u73fe\u662f\u5148\u5929\u6027\u5e7d\u9580\u72f9\u7a84\uff0c\u61c9\u8a72\u7dca\u6025\u6703\u8a3a\u5916\u79d1\u9032\u884c\u624b\u8853\u6cbb\u7642\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u5e74\u8f15\u7537\u6027\u906d\u4eba\u7528\u7403\u68d2\u6bc6\u6253\u88ab\u9001\u81f3\u6025\u8a3a\u3002\u8eab\u9ad4\u6aa2\u67e5\u767c\u73fe : \u4e0b\u80a2\u7121\u529b\uff0c\u4e0a\u80a2\u9664\u5c0f\u6307\u5916\u5c55 (abduction)\u6709\u554f\u984c\u5916\u5176\u9918\u808c\u8089\u529b\u91cf\u6b63\u5e38\uff1b\u80f8\u90e8\u5927\u7d04\u9396\u9aa8\u4ee5\u4e0b\u53ca\u4e0a\u81c2\u5167\u5074\u6703\u9ebb\u6728\u3002\u81e8\u5e8a\u9808\u61f7\u7591\u810a\u9ad3 \u54ea\u4e00\u7bc0\u53d7\u640d\uff1f", + "Options": "(A)C4 \u3002 (B)T1\u3002 (C)T4\u3002 (D)T8\u3002 (E)L3\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "28\u6b72HIV\u967d\u6027\u75c5\u4eba\uff0c\u4e3b\u8a34\u6700\u8fd1\u534a\u5e74\u672a\u898f\u5247\u8ffd\u8e64\u670d\u85e5\uff0c\u8fd1\u4e00\u5468\u89ba\u5f97\u8d8a\u4f86\u8d8a\u5598\u5408\u4f75\u767c\u71d2\uff0c\u5230\u9054\u6025\u8a3a\u6642\u751f\u547d\u5fb5\u8c61\uff1a\u8840\u58d3 105/75 mmHg \uff0c\u547c\u5438 32\u6b21/min\uff0c\u5fc3\u8df3 120\u6b21/min\uff0c\u8840\u6c27\u6fc3\u5ea6 89%\uff0c\u80f8\u90e8 X\u5149\u767c\u73fe\u5169\u5074\u7030\u6f2b\u6027\u9593\u8cea\u6027\u6d78\u6f64(interstitial infiltrates) \uff0c\u61f7\u7591\u80ba\u56ca\u87f2\u80ba\u708e(pneumocystis pneumonia )\u611f\u67d3\uff0c\u4e0b\u5217\u654d\u8ff0\u53ca\u6cbb\u7642\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u80ba\u56ca\u87f2\u80ba\u708e(pneumocystis pneumonia )\u70ba AIDS\u60a3\u8005\u6700\u5e38\u898b\u4f3a\u6a5f\u6027\u611f\u67d3\u3002 (B)\u53ef\u7d66\u4e88 Trimethoprim -sulfamethoxazole \u6297\u751f\u7d20\u6cbb\u7642\u3002 (C)\u6cbb\u7642\u85e5\u7269\u4ea6\u53ef\u8003\u616e Pentamidine \u3002 (D)\u6b64\u6642\u61c9\u907f\u514d\u7d66\u4e88\u985e\u56fa\u9187\uff0c\u4ee5\u907f\u514d\u589e\u52a0\u7cfb\u7d71\u6027\u611f\u67d3\u98a8\u96aa\u3002 (E)\u5c0d\u65bc CD4+ T -cell counts \u5c0f\u65bc 200 cells/mm3\u7684\u60a3\u8005\uff0c\u9700\u9810\u9632\u6027\u7d66\u4e88\u6297\u751f\u7d20\uff0c\u4ee5\u9632\u6b62\u5fa9\u767c\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc quick sepsis -related organ failure assessment score (qSOFA)\u7528\u65bc\u8a55\u4f30\u611f\u67d3\u75c7\u75c5\u4eba\uff0c\u9010\u6f38\u53d7\u5230\u91cd\u8996\uff0c\u6709\u95dc qSOFA\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)qSOFA \u8a55\u4f30\u9805\u76ee\u7e3d\u5171\u6709\u4e09\u9805\uff0c\u53ea\u8981\u7b26\u5408\u5169\u9805\uff0c\u5c31\u53ef\u4ee5\u8a3a\u65b7\u75c5\u4eba\u6709\u6557\u8840\u75c7\u3002 (B)\u8840\u4e2d\u7e3d\u81bd\u7d05\u7d20 (T-bilirubin)\u5927\u65bc 2.0 mg/dL\u70baqSOFA\u8a55\u4f30\u9805\u76ee\u4e4b\u4e00\u3002 (C)\u8840\u5c0f\u677f\u5c0f\u65bc 10,000/mm3\u70baqSOFA\u8a55\u4f30\u9805\u76ee\u4e4b\u4e00\u3002 (D)\u547c\u5438\u6b21\u6578 \u226720\u6b21/min\u70baqSOFA\u8a55\u4f30\u9805\u76ee\u4e4b\u4e00\u3002 (E)\u6536\u7e2e\u8840\u58d3\u5c0f\u65bc\u7b49\u65bc 100 mmHg \u70baqSOFA\u8a55\u4f30\u9805\u76ee\u4e4b\u4e00\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u906d\u53d7\u6c99\u6797 (sarin)\u6bd2\u6c23\u6050\u6016\u653b\u64ca\u6642\uff0c\u4e00\u4f4d\u5e74\u7d04 70\u6b72\u5973\u6027\u61f7\u7591\u4e2d\u6bd2\u88ab\u9001\u81f3\u6025\u8a3a\uff0c\u5979\u53ef\u80fd\u767c\u751f\u7684\u75c7\u72c0\uff0c \u4e0d\u5305\u62ec\u4e0b\u5217\u4f55\u9805 :", + "Options": "(A)\u6d41\u6dda(lacrimation) \u3002 (B)\u808c\u8089\u986b\u52d5 (muscle fasciculations )\u3002 (C)\u5fc3\u8df3\u6162(bradycardia )\u3002 (D)\u62bd\u6410(seizures )\u3002 (E)\u7121\u6c57(anhidrosis )\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6eba\u6c34 (submersion injury )\u7684\u6cbb\u7642\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba \uff1f", + "Options": "(A)\u4f7f\u7528\u985e\u56fa\u9187 (corticosteroid )\u53ef\u6539\u5584\u9810\u5f8c\u3002 (B)\u4f7f\u7528\u54c8\u59c6\u7acb\u514b\u6cd5\u6709\u52a9\u65bc\u5c07\u6c34\u5206 \u81ea\u80ba\u90e8\u6392\u51fa\u3002 (C)\u61c9\u9032\u884c\u4f8b\u884c\u6027\u9838\u690e\u56fa\u5b9a(routine cervical spine immobilization )\u3002 (D)\u7d93\u9a57\u6027\u4f7f\u7528\u6297\u751f\u7d20(empirical antibiotics )\u6709\u52a9\u65bc\u75c5\u60a3\u9810\u5f8c\u3002 (E)\u5c0d\u65bc Glasgow Coma Scale \u5927\u65bc 13\u4e14\u8840\u6c27\u98fd\u548c\u5ea6\u226795%\u7684\u6eba\u6c34\u75c5\u4eba\uff0c\u80f8\u90e8 X\u5149\u70ba\u975e\u5fc5\u8981\u6aa2\u67e5\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u4f9d\u6211\u570b\u5b89\u5be7\u7de9\u548c\u91ab\u7642\u689d\u4f8b\u898f\u7bc4\uff0c\u6c11\u773e\u53ef\u7c3d\u7f72\u300c\u9810\u7acb\u9078\u64c7\u5b89\u5be7\u7de9\u548c\u91ab\u7642\u610f\u9858\u66f8\u300d \u3001 \u300c\u9810\u7acb\u4e0d\u65bd\u884c\u5fc3\u80ba\u5fa9\u7526\u610f\u9858\u66f8\u300d \u3001 \u300c\u4e0d\u65bd\u884c\u7dad\u751f\u91ab\u7642\u540c\u610f\u66f8\u300d\u7b49\u91ab\u7642\u9810\u7acb\u6307\u793a\uff0c\u4e0b\u5217\u4f55\u9805\u662f\u7c3d\u7f72\u8005\u4e4b\u5fc5\u8981\u689d\u4ef6\uff1f", + "Options": "(A)\u5e74\u6eff 18\u6b72\u4ee5\u4e0a\u3002 (B)\u5177\u6709\u5b8c\u5168\u884c\u70ba\u80fd\u529b\u8005\u3002 (C)\u91ab\u7642\u6a5f\u69cb\u3002 (D)\u75be\u75c5\u672b\u671f\u3002 (E)\u59d4\u4efb\u4ee3\u7406\u4eba\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u773c\u58d3 (Intraocular pressure )\u548c\u773c\u775b\u76f8\u95dc\u6025\u75c7\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4 \uff1f", + "Options": "(A)\u5df2\u61f7\u7591\u6709\u773c\u7403\u7834\u88c2\u6642\u4e0d\u61c9\u91cf\u6e2c\u773c\u58d3\u3002 (B)\u6b63\u5e38\u7684\u773c\u58d3\u4ecb\u65bc 10~20 mmHg \u3002 (C)\u524d\u623f\u7a4d\u8840\u6642(hyphema )\u4e00\u822c\u6703\u9020\u6210\u773c\u58d3\u4e0a\u5347\u3002 (D)\u773c\u7403\u7834\u88c2\u6642\u4e00\u822c\u6703\u9020\u6210\u773c\u58d3\u964d\u4f4e\u3002 (E)\u8461\u8404\u819c\u708e(uveitis)\u4e00\u822c\u6703\u9020\u6210\u773c\u58d3\u4e0a\u5347\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "65\u6b72\u7537\u6027\u906d\u4ed6\u4eba\u68cd\u68d2\u8972\u64ca\u5f8c\u88ab\u9001\u5230\u6025\u8a3a\u5ba4\uff0c\u4e0b\u5217\u72c0\u6cc1\u6709\u53ef\u80fd\u6703\u5f71\u97ff\u5275\u50b7\u8d85\u97f3\u6ce2(Focused Assessment with Sonogra phy for Trauma, FAST)\u7684\u57f7\u884c\u6216\u5224\u65b7\uff0c\u4f55\u8005 \u9664\u5916\uff1f", + "Options": "(A)\u76ae\u4e0b\u6c23\u816b (subcutaneous emphysema )\u3002 (B)\u9577\u671f\u8179\u819c\u900f\u6790\u3002 (C)\u6700\u8fd1\u63a5\u53d7\u904e\u8179\u90e8\u624b\u8853(prior abdominal surgery )\u3002 (D)\u80a5\u80d6 (obesity )\u3002 (E)\u7121\u8179\u6c34\u4e4b\u809d\u786c\u5316\u75c5\u4eba\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u61f7\u5b55\u75c5\u4eba\u7684\u547c\u5438\u9053\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4 \uff1f", + "Options": "(A)Preoxygenation \u6642\uff0c\u4ee5\u9f3b\u7ba1\u6301\u7e8c\u7d66\u4e88\u9ad8\u6d41\u91cf\u6c27\u6c23 15 L/min \u76f4\u5230paralysis\uff0c\u53ef\u907f\u514d\u75c5\u4eba \u7f3a\u6c27\u3002 (B)\u82e5\u63d2\u7ba1\u5931\u6557\u61c9\u8003\u616e\u652f\u6c23\u7ba1\u93e1\u63d2\u7ba1\uff0c\u56e0\u5b55\u5a66\u4e0d\u9069\u7528 laryngeal mask airway\u3002 (C)\u4f7f\u7528 video laryngoscope \u53ef\u589e\u52a0 first-pass\u7684\u6210\u529f\u7387\u3002 (D)\u5b55\u5a66\u4ee5\u5e73\u8eba\u7684\u59ff\u52e2\u63d2\u7ba1\uff0c\u53e6\u8acb\u52a9\u624b\u5c07\u61f7\u5b55\u7684\u5b50\u5bae\u63a8\u5411\u5de6\u5074\u3002 (E)\u61c9\u4f7f\u7528\u6a19\u6e96\u5291\u91cf\u7684 RSI\u85e5\u7269\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "58\u6b72\u7537\u6027\u6709\u9f3b\u54bd\u764c\u75c5\u53f2\uff0c\u76ee\u524d\u4ecd\u5728\u63a5\u53d7\u653e\u5c04\u6cbb\u7642\u4e2d\uff0c\u8fd1\u4e00\u500b\u661f\u671f\u98df\u617e\u4e0d\u632f\u4e14\u5168\u8eab\u7121\u529b\uff0c\u62bd\u8840\u767c\u73fe Ca2+ 15.5 mg/dL \u3001Albumin 3.0 g/dL \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)Corrected Ca2+ = 16.3 mg/dL \u3002 (B)\u5fc3\u96fb\u5716\u53ef\u80fd\u51fa\u73fe ST\u6bb5\u4e0b\u964d\u3001QT \u6bb5\u7e2e\u77ed\u3002 (C)\u53ef\u7d66\u4e88\u751f\u7406\u98df\u9e7d\u6c34 1,000 mL\uff0c\u6ef4\u6ce8\u5169\u5c0f\u6642\u3002 (D)\u8840\u6db2\u900f\u6790\u53ef\u6709\u6548\u964d\u4f4e\u8840\u4e2d\u9223\u96e2\u5b50\u3002 (E)Bi sphospho nates\u8f03Calcitonin \u6548\u679c\u66f4\u4f73\u66f4\u5feb\uff0c\u70ba\u9996\u9078\u7528\u85e5\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u76f4\u5347\u6a5f\u8d77\u964d\u4e4b\u8d77\u964d\u5340( Landing zone )\u4f55\u8005\u932f\u8aa4 \uff1f", + "Options": "(A)\u76f4\u5347\u6a5f\u8d77\u964d\u6642 Landing zone \u662f\u5371\u96aa\u7684\u5340\u57df\uff0c\u5c0e\u56e0\u65bc\u6b64\u6642\u76f4\u5347\u6a5f\u8449\u7247\u4e0b\u5782\u4f46\u4ecd\u6709\u6700\u4f4e\u8f49\u901f\u3002 (B)\u6a5f\u7d44\u54e1\u5728\u76f4\u5347\u6a5f\u8d77\u964d\u671f\u9593\u61c9\u8ddd\u96e2 Landing zone 100ft \u4ee5\u4e0a\uff0c\u91ab\u7642\u4eba\u54e1\u61c9\u8ddd\u96e2 200ft\u4ee5\u4e0a\uff0c\u4e14\u5169\u8005\u61c9\u6709\u9069\u7576\u4e4b\u773c\u775b\u53ca\u8033\u6735\u4e4b\u4fdd\u8b77\u3002 (C)\u6240\u6709\u91ab\u7642\u7269\u54c1(\u9ede\u6ef4\u67b6\u7b49) \u5747\u61c9\u7dad\u6301\u4f4e\u65bc\u80a9\u8180\u4e4b\u9ad8\u5ea6\u3002 (D)\u76f4\u5347\u6a5f\u4e4b\u958b\u95dc\u9580\u61c9\u7531\u5730\u9762\u5de5\u4f5c\u4eba\u54e1\u64cd\u4f5c\u8f03\u70ba\u5b89\u5168\u3002 (E)\u4e0d\u53ef\u5f9e\u76f4\u5347\u6a5f\u4e4b\u5f8c\u65b9\u63a5\u8fd1\u6216\u96e2\u958b\uff0c\u7576\u9760\u8fd1\u6216\u96e2\u53bb\u6642\u9700\u4ee5\u8e72\u4f0f\u4e4b\u59ff\u52e2\u9762\u5c0d\u76f4\u5347\u6a5f\u5f8c\u8259\u9580\u4e14\u5c07\u982d\u653e\u4f4e\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u5728\u5927\u91cf\u50b7\u60a3\u4e8b\u4ef6\u4e2d\uff0c\u5c0d\u5c0f\u5152\u75c5\u60a3\u4e4b\u6aa2\u50b7\u5206\u985e\uff0c\u76ee\u524d\u63a1\u7528 JumpSTART \u5c0f\u5152\u5927\u91cf\u50b7\u60a3\u6aa2\u50b7\u7cfb\u7d71 (JumpSTART Pediatric MCI Triage\u00a9 )\uff0c\u6709\u95dc\u6b64\u7cfb\u7d71\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4 \uff1f", + "Options": "(A)\u8a55\u4f30\u70ba\uff1a\u80fd\u5426\u884c\u52d5\u6216\u8d70\u8def\u2192 \u6709\u7121\u547c\u5438\u2192 \u547c\u5438\u901f\u7387 \u2192\u6709\u7121\u8108\u640f\u2192 \u610f\u8b58\u72c0\u614b\u3002 (B)\u6aa2\u50b7\u5206\u985e\u5206\u70ba\u6b7b\u4ea1\u3001\u7acb\u5373\u5f8c\u9001\u3001\u5ef6\u5f8c\u5f8c\u9001\u3001\u8f15\u75c7\u56db\u985e\u3002 (C)\u610f\u8b58\u72c0\u614b\u63a1\u7528 modified Glasgow Coma Scale \u3002 (D)\u6bcf\u4f4d\u50b7\u60a3\u7686\u61c9\u63a5\u53d7\u8a73\u7d30\u7684\u4e8c\u6b21\u8a55\u4f30\u3002 (E)\u5927\u91cf\u50b7\u60a3\u4e8b\u4ef6\u6aa2\u50b7\u5206\u985e\u904e\u7a0b\u4e2d\uff0c\u539f\u5247\u4e0a\u4e0d\u5c0d\u5fc3\u8df3\u505c\u6b62\u8005\u65bd\u884c\u5fc3\u81df\u6309\u58d3\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "30\u6b72\u5973\u6027\u5f9e\u706b\u5834\u6551\u51fa\uff0c\u9ad4\u91cd 60\u516c\u65a4\uff0c\u71d2\u50b7\u9762\u7a4d\u70ba 40%\u9ad4\u8868\u9762\u7a4d\uff0c\u53e3\u54bd\u90e8\u6709\u78b3\u7c92\u6c88\u7a4d\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)SpO 2 98%\uff0c\u547c\u5438\u6b63\u5e38\uff0c\u4e0d\u9808\u63d2\u7ba1\u6cbb\u7642\u3002 (B)\u653e\u7f6e\u9f3b\u80c3\u7ba1\u6e1b\u58d3\uff0c\u4f46\u4e00\u822c\u524d 24\u5c0f\u6642\u4e0d\u9700\u8981\u8461\u8404\u7cd6\u8f38\u6db2\u3002 (C)\u7d66\u4e88\u55ce\u5561\u6b62\u75db\uff0c\u70ba\u964d\u4f4e\u547c\u5438\u6291\u5236\u98a8\u96aa\uff0c\u808c\u8089\u6ce8\u5c04\u8f03\u975c\u8108\u6ce8\u5c04\u4f73\u3002 (D)\u7d66\u4e88\u985e\u56fa\u9187\u964d\u4f4e\u5589\u982d\u6c34\u816b\uff0cHydrocortisone 100mg STAT+Q8H IV \u3002 (E)\u6839\u64da Parkland Formula \uff0c\u524d 8\u5c0f\u6642\u6ef4\u6ce8\u6797\u683c\u6c0f\u6db2\u6bcf\u5c0f\u6642 150\u6beb\u5347\uff0c\u5f8c16\u5c0f\u6642\u6bcf\u5c0f\u6642 75\u6beb\u5347\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "5\u6b72\u6709\u938c\u5200\u578b\u8ca7\u8840\u75c7( sickle cell anemia )\u4e4b\u7537\u7ae5\uff0c\u56e0\u9ad8\u71d2\u53ca\u7121\u6cd5\u8d70\u52d5\u7531\u4fdd\u6bcd\u9001\u81f3\u6025\u8a3a\u3002\u8eab\u9ad4\u6aa2\u67e5\u767c\u73fe\u5de6\u819d\u7d05\u71b1\u4e14\u816b\u75db\uff0c\u7121\u5176\u4ed6\u547c\u5438\u9053\u53ca\u6ccc\u5c3f\u9053\u4e4b\u76f8\u95dc\u75c7\u72c0\uff0c\u95dc\u65bc\u5c0f\u5152\u4e4b\u6557\u8840\u6027\u95dc\u7bc0\u708e (septic arthritis) \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba \uff1f", + "Options": "(A)\u4f9d\u75c5\u4eba\u5e74\u9f61\uff0c\u5316\u81bf\u6027\u95dc\u7bc0\u708e\u6700\u5e38\u898b\u83cc\u7a2e\u9664 MSSA\u53caMRSA\u5916\uff0cHaemophilus influenzae \u4e4b\u611f\u67d3\u4e5f\u6392\u524d\u4e09 \u540d\u3002 (B)\u819d\u84cb\u7684 X\u5149\u65bc\u521d\u671f\u7121 \u6cd5\u8a3a\u65b7\u6557\u8840\u6027\u95dc\u7bc0\u708e\uff0c\u56e0\u6b64\u4e0d\u9700\u8981\u7167\u3002 (C)\u65bc\u81e8\u5e8a\u8a3a\u65b7\u4e2d\u61f7\u7591\u6557\u8840\u6027\u95dc\u7bc0\u708e\uff0c\u5fc5\u9808\u8981\u7b49\u62bd\u8840\u7d50\u679c\u51fa\u4f86\u518d\u505a\u95dc\u7bc0\u7a7f\u523a\u62bd\u6db2 (arthrocentesis )\u8a3a\u65b7\u3002 (D)\u56e0\u70ba \u95dc\u7bc0\u6db2\u4e4b\u7d30\u83cc\u57f9\u990a\u6709\u4e09\u5206\u4e4b\u4e00\u662f\u9670\u6027\uff0c\u7576\u81e8\u5e8a\u4e0a\u9ad8\u5ea6\u61f7\u7591\u6642\uff0c\u6df7\u6fc1\u7684\u95dc\u7bc0\u6db2\u53ef\u4ee5\u5e6b\u52a9\u8a3a\u65b7 \u7591\u4f3c\u75c5\u4f8b \u3002 (E)\u6b64\u75c5\u4eba\u7121\u5176\u4ed6\u75c7\u72c0\uff0c\u6240\u4ee5\u4e0d\u7528\u6536\u53d6\u5c3f\u6db2\uff0c\u76ae\u819a\u50b7\u53e3\u3001\u54bd\u5589 \u3001\u76f4\u8178\u8655\u4e4b\u7d30\u83cc\u57f9\u990a\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6b32\u9451\u5225 Anticholinergic toxidromes \u548c Sympathomimetic toxidromes \u5169\u7a2e\u4e2d\u6bd2\u75c7\u5019\u7fa4\uff0c\u8acb\u554f\u4e0b\u5217\u4f55\u7a2e\u81e8\u5e8a\u75c7\u72c0\u6700\u5bb9\uf9e0\u5340\u5206\u5169\u8005\u5dee\u7570 \uff1f", + "Options": "(A)\u610f\u8b58\u4e0d\u6e05\u3002 (B)\u5fc3\u8df3\u5feb\u3002 (C)\u9ad8\u8840\u58d3\u3002 (D)\u9ad8\u9ad4\u6eab\u3002 (E)\u5192\u6c57\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "37\u6b72\u7537\u6027\u559d\u4e86\u5927\u91cf\u5316\u5b78\u6db2\u9ad4\uff0c\u56e0\u610f\u8b58\u4e0d\u6e05\u88ab\u5bb6\u4eba\u9001\u81f3\u6025\u8a3a\u5c31\u91ab\uff0c\u8acb\u554f\u4e0b\u5217\u4f55\u7a2e\u60c5\u5f62 \u4e0d\u5efa\u8b70\u4f7f\u7528 Fomepizole \u6cbb\u7642\uff1f", + "Options": "(A)\u8840\u6e05\u7532\u9187\u6fc3\u5ea6\u5927\u65bc 20 mg/dL \u3002 (B)\u7121\u6cd5\u89e3\u91cb osmolar gap \u5927\u65bc 10 mOsm/L \u3002 (C)\u8840\u6e05\u4e19\u9187 (isopropyl alcohol )\u6fc3\u5ea6\u5927\u65bc 100 mg/dL \u3002 (D)\u7121\u6cd5\u89e3\u91cb \u7684\u4ee3\u8b1d\u6027\u9178 \u4e2d\u6bd2(pH \u5c0f\u65bc 7.3)\u3002 (E)\u8840\u6e05\u4e59\u4e8c\u9187\u6fc3\u5ea6\u5927\u65bc 20 mg/dL \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "42\u6b72\u5973\u6027\u767c\u71d2 3\u65e5\u81f3\u6025\u8a3a\u5c31\u8a3a\uff0c\u8eab\u9ad4\u6aa2\u67e5\u767c\u73fe\u5927\u817f\u8655\u6709\u4e00\u7126\u75c2( eschar)\uff0c\u61f7\u7591\u6059\u87f2\u75c5(scrub typhus )\uff0c \u4e0b \u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba \uff1f", + "Options": "(A)\u6297\u751f\u7d20\u4ee5 ciprofloxacin \u70ba\u9996\u9078\u3002 (B)\u70ba\u7b2c\u56db\u985e\u50b3\u67d3\u75c5\uff0c\u9700\u9032\u884c\u50b3\u67d3\u75c5\u901a\u5831\u4e26\u4f4f\u9662\u9032\u884c\u9694\u96e2\u3002 (C)\u75c5\u4eba\u591a\u6578\u6709\u65c5\u904a\u53f2\uff0c\u5728\u570b\u5916\u5f97\u5230\u611f\u67d3\u3002 (D)\u75c5\u539f\u70ba Orientia tsutsugamushi \uff0c\u6f5b\u4f0f\u671f\u901a\u5e38\u70ba 9\u523012\u5929\u3002 (E)\u5982\u4e0d\u9032\u884c\u6cbb\u7642\uff0c\u6b7b\u4ea1\u7387\u53ef\u9054\u5230 80%\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u810a\u9ad3\u640d\u50b7\u75c7\u5019\u7fa4\u4e4b\u75c7\u72c0\uff0c\u4e0b\u5217\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u810a\u9ad3\u4f11\u514b (Spinal shock )\uff1a\u4f4e\u8840\u58d3\uff0c\u4f46\u56db\u80a2\u672b\u68a2\u6eab\u6696\uff0c\u5fc3\u8df3\u8f03\u6162\u3002 (B)\u4e2d\u5fc3\u810a\u9ad3\u75c7\u5019\u7fa4(Central cord syndrome )\uff1a\u80a2\u9ad4\u7121\u529b\u4f34\u96a8\u90e8\u5206\u75db\u89ba\u53ca\u6eab\u5ea6\u611f\u89ba\u4e0b\u964d\uff0c\u4e0b\u80a2\u8f03\u4e0a\u80a2\u56b4\u91cd\u3002 (C)Brown - S\u00e9quard syndrome \uff1a\u53d7\u50b7\u90e8\u4f4d\u540c\u5074\u80a2\u9ad4\u7121\u529b\u3001\u672c\u9ad4\u611f\u89ba\u53ca\u9707\u52d5\u611f\u89ba\u6d88\u5931\uff0c\u5c0d\u5074\u75db\u89ba\u53ca\u6eab\u5ea6\u611f\u89ba\u6d88\u5931\u3002 (D)\u810a\u9ad3\u524d\u67f1\u75c7\u5019\u7fa4(Anterior cord syndrome )\uff1a\u53d7\u50b7\u90e8\u4f4d\u4ee5\u4e0b\u672c\u9ad4\u611f\u89ba\u53ca\u9707\u52d5\u611f\u89ba\u6d88\u5931\uff0c\u4f46\u75db\u89ba\u53ca\u6eab\u5ea6\u611f\u89ba\u4ecd\u4fdd\u7559\u3002 (E)\u99ac\u5c3e\u75c7\u5019\u7fa4 (Cauda equina syndrome )\uff1a\u5927\u5c0f\uf965 \u529f\u80fd\u55aa\u5931\uff0c\u4e0b\u534a\u8eab\u7121\u529b\uff0c\u50c5\u7559\u6703\u9670\u3001\u81c0\u90e8\u53ca\u5927\u817f\u5167\u5074\u611f\u89ba\u6b63\u5e38\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8f38\u8840\u76f8\u95dc\u4f75\u767c\u75c7\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u82e5\u75c5\u4eba\u6700\u8fd1\u6578\u6b21\u8f38\u8840\u51fa\u73fe febrile transfusion reaction \uff0c\u6b64\u6b21\u8f38\u8840\u5b9c\u4f7f\u7528irradiated blood \u3002 (B)\u82e5\u75c5\u4eba\u8f38\u8840\u6642\u51fa\u73fe\u904e\u654f\u6027\u8f38\u8840\u53cd\u61c9(allergic transfusion reactions) \uff0c\u53ef\u7d66\u4e88 diphenhydramine \u6cbb\u7642\uff0c\u4e4b\u5f8c\u7d93\u8a55\u4f30\u53ef\u7e7c\u7e8c\u8f38\u8840\u3002 (C)\u8f38\u8840\u76f8\u95dc\u6025\u6027\u80ba\u640d\u50b7 (Transfusion- related acute lung injury \uff0cTRALI)\u5e38\u767c\u751f\u65bc PRBC\u8f38\u8840\u5f8c\uff0c\u8f03\u5c11\u767c\u751f\u65bc FFP\u6216Platelet\u8f38\u6ce8\u3002 (D)\u8f38\u8840\u76f8\u95dc\u6025\u6027\u80ba\u640d\u50b7 (Transfusion- related acute lung injury \uff0cTRALI)\u6703\u9020\u6210\u80ba\u6c34\u816b(pulmonary edema )\uff0c\u5b9c\u5118\u901f\u7d66\u4e88\u5229\u5c3f\u5291\u6cbb\u7642\u3002 (E)\u95dc\u65bc\u8840\u7ba1\u5916\u6eb6\u8840\u6027\u8f38\u8840\u53cd\u61c9 (Extravascular hemolytic transfusion reaction)\uff0c\u6eb6\u8840(hemolysis )\u901a\u5e38\u767c\u751f\u65bc\u809d\u81df\u548c\u9aa8\u9ad3\uff0c\u8f03\u5c11\u767c\u751f\u65bc\u813e\u81df\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "77\u6b72\u7537\u6027\u559d\u4e86\u5927\u91cf\u5927\u6ec5\u677e( Dimethoate 44% )\u81ea\u6bba\uff0c\u56e0\u5614\u5410\u610f\u8b58\u660f\u8ff7\u4e14\u7672\u7647\u88ab\u5bb6\u4eba\u9001\u81f3\u6025\u8a3a\u5c31\u91ab\uff0c\u8acb\u554f\u4e0b\u5217\u4f55\u7a2e\u6cbb\u7642\u6700\u53ef\u80fd \u6539\u5584\u75c5\u4eba\u7684\u9810\u5f8c\uff1f", + "Options": "(A)\u6d17\u80c3(Gastric lavage )\u3002 (B)\u7d66\u4e88\u6d3b\u6027\u78b3 (Activated charcoal )\u3002 (C)\u9e7c\u5316\u5c3f\u6db2 (Urinary alkalinization )\u3002 (D)\u7d66\u4e88 Atropine\u3002 (E)\u7d66\u4e88 Pralidoxime \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "60\u6b72\u7537\u6027\u81f3\u6025\u8a3a\u5c31\u91ab\u4e3b\u8a34\u53f3\u81c9\u90e8\u75bc\u75db\u4e8c\u65e5\u4e26\u51fa\u73fe\u75b1\u75b9\u3001\u548c\u53f3\u773c\u767c\u7d05\u75bc\u75db\u754f\u5149\u3002\u7d93\u8a3a\u65b7\u70ba\u773c\u90e8\u5e36\u72c0\u75b1\u75b9 (Herpes Zoster Ophthalmicus )\u3002\u95dc\u65bc\u6b64\u75be\u75c5\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4 \uff1f", + "Options": "(A)\u5927\u90e8\u5206\u4fb5\u72af\u5230\u540c\u5074\u4e0a\u773c\u76ae\u3002 (B)\u6709\u4e9b\u75c5\u4eba \u6703\u4f75\u767c\u8996\u795e\u7d93\u708e\u3002 (C)\u6297\u75c5\u6bd2\u85e5\u9700\u4f9d\u75c5\u4eba\u814e\u529f\u80fd\u8abf\u6574\u5291\u91cf\u3002 (D)\u6cbb\u7642\u53ef\u8003\u616e\u53e3\u670d valacyclovir \u3002 (E)\u82e5\u75b1\u75b9\u51fa\u73fe\u5728\u9f3b\u982d\u7a31\u70ba Hutchinson sign\uff0c\u9810\u5f8c\u8f03\u4f73\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "65\u6b72\u5973\u6027\u56e0\u8eca\u798d\u53d7\u50b7\u88ab\u9001\u81f3\u6025\u8a3a\uff0c\u8eca\u798d\u7576\u6642\u5979\u5750\u5728\u6c7d\u8eca\u526f\u99d5\u99db\u5ea7\u4e26\u5df2\u7e6b\u4e0a\u5b89\u5168\u5e36\uff0c\u8eab\u9ad4\u6aa2\u67e5\u767c\u73fe\u8179\u90e8\u51fa\u73fe seat belt sign \u4e14\u62b1\u6028\u6709\u5de6\u80a9\u75bc\u75db\u7684\u60c5\u6cc1\uff0c\u7136\u800c\u75c5\u4eba\u5de6\u80a9\u7684\u95dc\u7bc0\u6d3b\u52d5\u6b63\u5e38\uff0c\u6839\u64da\u4e0a\u8ff0\u75c7\u72c0\uff0c\u75c5\u4eba\u6700\u53ef\u80fd\u767c\u751f\u4e0b\u5217\u4f55\u8005\u640d\u50b7\uff1f", + "Options": "(A)T12 Chance fracture \u3002 (B)T10 compression fracture \u3002 (C)\u813e\u81df\u7834\u88c2 (splenic rupture )\u3002 (D)\u809d\u81df\u6495\u88c2\u50b7 (liver laceration )\u3002 (E)\u5341\u4e8c\u6307\u8178\u8840\u816b( duodenum hematoma )\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "2\u6b72\u5973\u7ae5\u6025\u8a3a\u5c31\u91ab\uff0c\u6bcd\u89aa\u8868\u793a\u5973\u7ae5\u6709\u547c\u5438\u9053\u5148\u5929\u6027\u75be\u75c5\uff0c\u525b\u525b\u5ffd\u7136\u547c\u5438\u5598\uff0c\u53cd\u61c9\u4e0d\u4f73\u3002\u65bc\u6025\u8a3a\u521d\u6b65\u8a55\u4f30\uff0c\u547c\u5438\u8cbb\u529b\uff0c\u819a\u8272\u84bc\u767d\uff0c\u7d66\u4e88\u6c23\u9053\u62bd\u5438\u4e26\u4f7f\u7528\u7526\u9192\u7403\u7d66\u6c27\u5f8c\uff0c\u751f\u547d\u5fb5\u8c61\u5982\u4e0b\uff1a\u8840\u58d3 55/32 mmHg \uff0c\u547c\u5438 42\u6b21/min\uff0c\u5fc3\u8df3 56\u6b21/min(\u898f\u5247 )\uff0c\u9ad4\u6eab35\u2103\u3002\u521d\u6b65\u7dca\u6025\u8655\u7f6e\uff0c \u4e0d\u5305\u62ec\u4e0b\u5217\u4f55\u8005\uff1f", + "Options": "(A)\u4f7f\u7528\u652f\u6c23\u7ba1\u64f4\u5f35\u5291\u6cbb\u7642\u3002 (B)\u4f7f\u7528 epinephrine \u5438\u5165\u6cbb\u7642\u3002 (C)\u63d2\u7ba1\u6642\uff0c\u4f7f\u7528\u93ae\u975c\u5291\u6700\u597d\u7684\u9078\u64c7\u70ba ketamine\u3002 (D)\u4f7f\u7528\u985e\u56fa\u9187\u6ce8\u5c04\u3002 (E)\u9032\u884c\u58d3\u80f8\u7d66\u6c27 15:2\u6025\u6551\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "10\u6b72\u7537\u7ae5\uff0c\u9ad4\u91cd 25\u516c\u65a4\uff0c\ufa1d \u795e\u4e0d\u4f73\uff0c\u53cd\u61c9\u9072\u920d\uff0c BT 38\u2103\uff0cHR 140\u6b21/min\uff0cRR 32\u6b21/min\uff0cBP 80/50 mmHg \uff0cO 2 Sat 96%\u3002\u8840\u6db2\u6aa2 \u9a57\u7d50\u679c\uff1aGlucose\u5927\u65bc 500 mg/dL\uff0c\u4e0b\u5217\u6558\u8ff0 \u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)\u61c9\u8a72\u958b\u7acb ABG\u53ca\u6aa2\u9a57\u8840\u4e2d ketone body \u6fc3\u5ea6\u3002 (B)\u56e0\u70ba\u4f11\u514b\u75c7\u72c0\u660e\u986f\uff0c\u512a\u5148\u7d66\u4e88 IV 250 -500 mL normal saline \uff0c\u4f7fcapillary refilling time \u6062\u5fa9\u6b63\u5e38\u3002 (C)\u5118\u901f IV bolus insulin 2.5 IU \u3002 (D)\u6301\u7e8c\u7dad\u6301 IV infusion 2.5 IU/hr \u3002 (E)\u8840\u7cd6\u964d\u4f4e\u901f\u5ea6\u61c9\u8a72\u4f4e\u65bc\u6bcf\u5c0f\u6642 50-100 mg/dL \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4ee5\u7121\u6ce8\u5c04\u986f\u5f71\u5291\u4e4b\u96fb\u8166\u65b7\u5c64\u8a3a\u65b7\u982d\u90e8\u8718\u86db\u819c\u4e0b\u8154\u51fa\u8840 (subarachnoid hemorrhage )\u5177\u6709\u8f03\u9ad8\u9748\u654f\u5ea6\u7684\u6642\u9593\u70ba\u75c7\u72c0\u767c\u751f\u5f8c\uff1a", + "Options": "(A)6 -12\u5c0f\u6642\u3002 (B)12 \u81f323\u5c0f\u6642\u3002 (C)24 \u81f347\u5c0f\u6642\u3002 (D)48 \u5c0f\u6642\u81f3 71\u5c0f\u6642\u3002 (E)\u5927\u65bc 72\u5c0f\u6642\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u4e00\u4f4d\u75c5\u4eba\u56e0\u7a81\u7136\u7684\u53f3\u5074\u80f8\u75db\u53ca\u547c\u5438\u6025\u4fc3\u81f3\u6025\u8a3a\uff0c\u8eab\u9ad4\u6aa2\u67e5\u986f\u793a\u53f3\u5074\u547c\u5438\u97f3\u6e1b\u4f4e\u4e14\u5728\u53e9\u8a3a\u6642\u70ba\u9f13\u97f3\uff0c\u91dd\u5c0d\u6b64\u75be\u75c5\u4ee5\u4e0b\u6558\u8ff0\u4f55\u8005\u932f\u8aa4 \uff1f", + "Options": "(A)\u6162\u6027\u963b\u585e\u6027\u80ba\u75c5\u662f\u6b21 \u767c\u6027(secondary )\u81ea\u767c\u6027\u6c23\u80f8\u6700\u5e38\u898b\u7684\u539f\u56e0\u3002 (B)\u8d85\u97f3\u6ce2\u662f\u5f88\u597d\u7684\u6c23\u80f8\u8a3a\u65b7\u5de5\u5177\uff0c\u6c23\u80f8\u75c5\u4eba\u8d85\u97f3\u6ce2\u4e0b\u6703\u6709 sea-shore sign\u3002 (C)\u9ad8\u6d77\u62d4\u98db\u884c\u6703\u589e\u52a0\u58d3\u529b\u6027\u6c23\u80f8\u7684\u98a8\u96aa\uff0c\u6545\u6c23\u80f8\u7de9\u89e3\u7684\u4e03\u65e5\u5167\u4e0d\u5efa\u8b70\u9ad8\u6d77\u62d4\u98db\u884c\u3002 (D)\u58d3\u529b\u6027\u6c23\u80f8\u70ba\u81e8\u5e8a\u8a3a\u65b7\uff0c\u61c9\u5728\u57f7\u884c\u80f8\u90e8 X\u5149\u4e4b\u524d\uff0c\u65bc\u60a3\u5074\u9396\u9aa8\u4e2d\u7dda\u7b2c\u4e8c\u808b\u9593\u9032\u884c\u91dd\u523a\u6e1b\u58d3(needle thoracostomy )\u3002 (E)\u7ad9\u7acb\u7684\u80f8\u90e8 X\u5149\uff0c\u5f9e\u80f8\u8154\u9802\u90e8\u91cf\u6e2c\u5230\u80ba\u9802\u90e8(Apex -cupola)\u7684\u8ddd\u96e2\u82e5\u5c0f\u65bc 3\u516c\u5206\u53ef\u6b78\u985e\u65bc\u5c0f\u578b\u6c23\u80f8\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "40\u6b72\u7537\u6027\u88ab\u8f49\u8a3a\u81f3\u6025\u8a3a\uff0c\u81c6\u65b7\u662f\u8840\u6813\u6027\u8840\u5c0f\u677f\u4f4e\u4e0b\u6027\u7d2b\u6591\u75c7( thrombotic thrombocytopenic purpura )\uff0c\u81e8\u5e8a\u8868\u5fb5\u4e0d\u5305\u62ec \u54ea\u9805\uff1f", + "Options": "(A)\u767c\u71d2(fever) \u3002 (B)\u51dd\u8840\u8122\u539f\u6642\u9593(prothrombin time )\u5ef6\u9577\u3002 (C)\u8840\u5c0f\u677f\u4f4e\u4e0b (thrombocytopenia )\u3002 (D)\u795e\u7d93\u75c7\u72c0 (neurologic findings) \u3002 (E)\u6eb6\u8840\u6027\u8ca7\u8840 (hemolytic anemia )\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "48\u6b72\u7537\u6027 A\u578b\u8840\u53cb\u75c5( hemophilia )\u75c5\u4eba\uff0c\u6628\u5929\u8dcc\u5012\u5f8c\uff0c\u5de6\u8098\u95dc\u7bc0\u51fa\u73fe\u660e\u986f\u95dc\u7bc0\u8840\u816b\uff0c\u5de6\u524d\u81c2\u816b\u8139\u75bc\u75db\uff0cX \u5149\u6aa2\u67e5\u4e26\u7121\u660e\u986f\u9aa8\u6298\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u53ef\u7d66\u4e88 factor VIII 15 -30 IU/ kg\u6cbb\u7642\u3002 (B)\u8840\u53cb\u75c5\u60a3\u81e8\u5e8a\u6aa2\u9a57\u53ef\u898b APTT(activated partial thromboplastin time)\u7570\u5e38\u3002 (C)\u5982\u75c5\u4eba\u5de6\u524d\u81c2\u816b\u8139\u5408\u4f75\u56b4\u91cd\u75bc\u75db\u53ca\u9ebb\u6728\u611f\uff0c\u9700\u8003\u616e\u8154\u5ba4\u75c7\u5019\u7fa4(compartment syndrome )\uff0c\u65bc\u88dc\u5145\u51dd\u8840\u56e0\u5b50\u5f8c\uff0c\u53ef\u6e2c\u91cf\u8154\u5ba4\u58d3\u529b\u3002 (D)\u70ba\u907f\u514d\u975c\u8108\u6ce8\u5c04\u9020\u6210\u8840\u816b\uff0c\u53ef\u5148\u7d66\u4e88 NSAID\u808c\u8089\u6ce8\u5c04\u4e88\u4ee5\u6b62\u75db\u3002 (E)\u56b4\u91cd\u8840\u53cb\u75c5 \u75c5\u4eba\u81e8\u5e8a\u5e38\u4ee5\u81ea\u767c\u6027\u51fa\u8840\u6216\u5275\u50b7\u5f8c\u96e3\u4ee5\u63a7\u5236\u7684\u51fa\u8840\u70ba\u8868\u73fe\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u4e0d\u660e\u539f\u56e0\u6688\u53a5 (syncope)\uff0c\u4e0b\u5217\u4f55\u8005 \u4e0d\u662f\u9700\u4f4f\u9662\u8a55\u4f30\u6aa2\u67e5\u7684\u5371\u96aa\u56e0\u5b50\uff1f", + "Options": "(A)\u6709\u5fc3\u81df\u8870\u7aed\u75c5\u53f2\u3002 (B)\u8840\u6bd4\u5bb9(hematocrit )\u5c0f\u65bc 30%\u3002 (C)\u6709\u5fc3\u56e0\u6027\u731d\u6b7b\u7684\u5bb6\u65cf\u53f2\u3002 (D)\u75c5\u4eba\u70ba 40\u6b72\u3002 (E)\u52d5\u8108\u6536\u7e2e\u58d3\u5c0f\u65bc 90 mmHg \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u9762\u5c0d\u9662\u5167\u4e0d\u9810\u671f\u5fc3\u8df3\u505c\u6b62\u75c5\u4eba( In-hospital cardiac arrest, IHCA )\uff0c\u9996\u8981\u5de5\u4f5c\u662f\u9810\u9632\u5b83\u7684\u767c\u751f\uff0c\u56e0\u6b64\u6211\u5011\u63d0\u5021\u4e86\u5feb\u901f\u53cd\u61c9\u5718\u968a(Rapid response teams\uff0cRRTs)\u6216\u662f\u91ab\u7642\u6025\u6551\u5718\u968a(Medical emergency teams, METs )\u7684\u8a2d\u7acb\uff0c\u6709\u95dcRRTs/METs \u7684\u63cf\u8ff0\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)RRTs/METs \u7684\u8a2d\u7acb\uff0c\u4e3b\u8981\u662f\u75c5\u4eba\u5728\u767c\u751f IHCA\u5f8c\uff0c\u53ef\u4ee5\u6709\u5718\u968a\u4e00\u8d77\u53bb\u6025\u6551\uff0c\u4ee5\u589e\u52a0\u75c5\u4eba\u5fa9\u7526\u7684\u6a5f\u6703\u3002 (B)RRTs/METs \u7684\u8a2d\u7acb\uff0c\u53ef\u4ee5\u6539\u5584\u4f4f\u9662\u75c5\u4eba\u7684\u5b58\u6d3b\u7387\u3002 (C)\u85c9\u7531 Early Warning Sign Systems\uff0c\u6211\u5011\u53ef\u4ee5\u8fa8\u5225\u51fa\u5371\u96aa\u7684\u4f4f\u9662\u75c5\u4eba\uff0c\u9032\u800c\u9810\u9632 IHCA\u7684\u767c\u751f\u3002 (D)RRTs/METs \u7684\u8a13\u7df4\u9664\u4e86\u6025\u6551\u6280\u80fd\u5916\uff0c\u9084\u5305\u62ec\u5718\u968a\u5408\u4f5c\u7684\u89c0\u5ff5\u5efa\u7acb\u3002 (E)\u76ee\u524d\u7684\u7814\u7a76\u986f\u793a\uff0cRRTs/METs \u7684\u8a2d\u7acb\u9664\u4e86\u5c0d\u6210\u4eba\u6709\u5e6b\u52a9\u5916\uff0c\u5c0d\u5c0f\u5152\u75c5\u4eba\u53ef\u80fd\u4e5f\u6709\u52a9\u76ca\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u9152\ufa1d\u6212\u65b7\u5f8c\u5f15\u767c\u4e4b\u7672\u7647\u75c7\uff0c\u4e0b\u5217\u4f55\u9805\u6558\u8ff0\u6700\u70ba\u9069\u7576\uff1f", + "Options": "(A)\u5c40\u90e8\u6027\u7672\u7647\u767c\u4f5c\u8f03\u70ba\u5e38\u898b\u3002(B)\u5927\u591a\u6578\u75c5\u4eba\u50c5\u6703\u6709\u4e00\u6b21\u767c\u4f5c\u3002(C)\u7d04\u4e09\u5206\u4e4b\u4e8c\u75c5\u4eba\u7672\u7647\u767c\u4f5c\u5f8c\u6703\u4f34\u96a8\u8457\u8b6b\u5984(delirium)\u767c\u751f\u3002(D)\u7d04\u4e5d\u6210\u75c5\u4eba\u505c\u6b62\u559d\u9152\u5f8c48\u5c0f\u6642\u5167\u767c\u4f5c\u3002(E)\u5c11\u6578\u4e4b\u591a\u6b21\u767c\u4f5c\u75c5\u4eba\u6703\u65bc12\u5c0f\u6642\u5167\u591a\u6b21\u767c\u4f5c\uff0c\u4f46\u96a8\u5f8c\u5c31\u4e0d\u518d\u767c\u4f5c\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "35\u6b72\u7537\u6027\u5728\u8dd1\u8d85\u7d1a\u99ac\u62c9\u677e\u9014\u4e2d\u88ab\u767c\u73fe\u795e\u667a\u4e0d\u6e05\u9001\u5230\u6025\u8a3a\u5ba4\uff0c\u5728\u6025\u8a3a GCS E3V3M5\uff0c\u8840\u58d3 100/50 mmHg \uff0c\u8108\u640f 110 \u6b21/min\uff0c\u547c\u5438 22 \u6b21/min\uff0c\u9ad4\u6eab 37\u2103\uff0c\u8840\u7cd6 100 mg/dL \uff0c\u8166\u90e8\u96fb\u8166\u65b7\u5c64\u7121\u7570\u5e38\uff0c\u8840\u9209 115 meq/L \uff0c\u5c0d\u65bc\u6b64\u4f4e\u8840\u9209\u4e4b\u8655\u7f6e\uff0c\u4e0b\u5217\u4f55\u8005\u6700\u70ba \u9069\u7576\uff1f", + "Options": "(A)\u4ee5 3% NaCl 500 m L\u975c\u8108\u6ef4\u6ce8(IV drip ) 24\u5c0f\u6642\u3002 (B)\u4ee5 3% NaCl 500 m L\u975c\u8108\u6ef4\u6ce8(IV drip ) 48\u5c0f\u6642\u3002 (C)\u4ee5 3% NaCl 100 m L\u975c\u8108\u63a8\u6ce8(IV bolus) \u3002 (D)\u4ee5 3% NaCl 500 mL \u975c\u8108\u63a8\u6ce8(IV bolus) \u3002 (E)\u4ee5 0.9% NaCl 500 m L\u975c\u8108\u63a8\u6ce8( IV bolus) \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u7d50\u6676\u6027\u6ed1\u819c\u708e (crystal induced synovitis )\u4e4b\u75db\u98a8( gout)\u8207\u507d\u75db\u98a8(pseudogout \u6216\u7a31 calcium pyrophosphate deposition )\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u75db\u98a8\u8207\u507d\u75db\u98a8\u548c\u5927\u90e8\u5206\u7684 septic arthritis \u4e00\u6a23\u662f\u5c6c\u65bc monoarthritis \u3002 (B)\u6025\u6027\u75db\u98a8\u7684\u767c\u4f5c\u5e38\u898b\u65bc 40\u6b72\u4ee5\u4e0a\u4e4b\u4e2d\u5e74\u7537\u6027\uff0c\u80b2\u9f61\u5973\u6027\u7684\u767c\u4f5c\u53ef\u80fd\u8207\u598a\u5a20\u7cd6\u5c3f\u75c5\u6709\u95dc\u3002 (C)Gout \u7684\u62bd\u5438\u95dc\u7bc0\u6db2\u65bc\u504f\u5149\u986f\u5fae\u93e1\u4e0b\u53ef\u898b\u9ec3\u8272\u5c3f\u9178\u7d50\u6676\uff0c\u800c\u507d\u75db\u98a8\u7684calcium pyrophosphate \u5247\u70ba\u85cd\u8272\u3002 (D)\u8840\u6db2\u4e2d\u7684 uric acid\u8207\u9223\u3001\u78f7\u4e0d\u80fd\u7576\u4f5c\u8a3a\u65b7\u75db\u98a8\u6216\u507d\u75db\u98a8\u7684\u4f9d\u64da\u3002 (E)\u79cb\u6c34\u4ed9\u7d20 (colchicine )\u53ef\u6cbb\u7642\u6025\u6027\u7684\u75db\u98a8\u8207\u507d\u75db\u98a8\u767c\u4f5c\uff0c\u4f46\u4ee5\u975c\u8108\u6ce8\u5c04\u53ef\u80fd\u5c0e\u81f4\u9aa8\u9ad3\u6291\u5236\u8207\u6b7b\u4ea1\u7b49\u56b4\u91cd\u526f\u4f5c\u7528\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u91dd\u5c0d\u80ba\u708e\u7684\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u9000\u4f0d\u8ecd\u4eba\u75c7\u7684\u5b63\u7bc0\u6027\u5f88\u660e\u986f\uff0c\u591a\u597d\u767c\u65bc\u590f\u5929\u3002 (B)Streptococcus pneumoniae \u6700\u5e38\u7e8c\u767c\u65bc\u75c5\u6bd2\u611f\u67d3\u4e4b\u5f8c\u3002 (C)Staphylococcus aureus \u662f\u9152\u766e\u75c5\u4eba\u6700\u5e38\u898b\u7684\u80ba\u708e\u81f4\u75c5\u83cc\u3002 (D)Mycoplasma pneumoniae \u5e38\u6709\u80ba\u5916\u75c7\u72c0\uff0c\u50cf\u662f\u76ae\u819a\u75b9\u6216\u662f\u8178\u80c3\u9053\u75c7\u72c0\u3002 (E)\u82e5\u70ba\u51fa\u9662\u4e03\u5929\u5167\u7684\u75c5\u4eba\uff0c\u6240\u9078\u64c7\u7684\u6297\u751f\u7d20\u9700\u8981\u80fd\u6db5\u84cb Pseudomonas aeruginosa \u7684\u6cbb\u7642\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u80ba\u81bf\u760d( lung abscess )\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4 \uff1f", + "Options": "(A)\u6b64\u75c5\u6b21\u767c\u6027\u7684\u6b7b\u4ea1\u7387\u8f03\u539f\u767c\u6027\u7684\u6b7b\u4ea1\u7387\u9ad8\u3002 (B)\u6b64\u75c5\u6709\u516b\u6210\u5c6c\u65bc\u6b21\u767c\u6027\uff0c\u597d\u767c\u65bc\u764c\u75c7\u6216\u514d\u75ab\u529b\u4f4e\u4e0b\u4e4b\u75c5\u4eba\u3002 (C)\u591a\u767c\u75c5\u7076\u4e26\u4e0d\u5e38\u898b\uff0c\u4f46 Lemierre\u2019s syndrome \u5728\u80ba\u90e8\u53ef\u898b\u591a\u500b\u75c5\u7076\u3002 (D)\u81f4\u75c5\u83cc\u70ba\u53ad\u6c27\u83cc\u6642\uff0c\u611f\u67d3\u9014\u5f91\u591a\u70ba\u5438\u5165\u6027\u3002 (E)\u4e00\u822c\u4f86\u8aaa\u85e5\u7269\u6cbb\u7642\u53ef\u4ee5\u63a7\u5236\u6b64\u75c5\uff0c\u85e5\u7269\u6cbb\u7642\u5931\u6557\u7684\u539f\u56e0\u6709\u652f\u6c23\u7ba1\u963b\u585e\u6216\u662f\u975e\u7d30\u83cc\u6027\u7684 \u611f\u67d3\u6e90\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "29\u6b72\u6182\u9b31\u75c7\u7537\u6027\u75c5\u4eba\uff0c\u6839\u64da\u53cb\u4eba\u8868\u793a\u75c5\u4eba\u4f86\u9662\u524d 1\u500b\u5c0f\u6642\uff0c\u5403\u4e0b\u4e0d\u660e\u7a2e\u985e\u7684\u5b89\u7720\u85e5 (Benzodiazepine )\u548c\u4e09\u74b0\u6297\u6182\u9b31\u5291(Tricyclic antidepressants, TCA)\u5171 40\u5e7e\u9846\uff0c\u5230\u9662\u6642\u660f\u8ff7\u6307\u6578\u70ba E2V2M4\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4 \uff1f", + "Options": "(A)\u4e09\u74b0\u6297\u6182\u9b31\u5291\u4e2d\u6bd2\u8005\u5176\u76ae\u819a\u8868\u73fe\u70ba\u4e7e\u71e5\u3002 (B)\u8003\u616e\u4fdd\u8b77\u547c\u5438\u9053\uff0c\u7d66\u4e88\u6c23\u7ba1\u5167\u7ba1\u63d2\u7ba1\u5f8c\uff0c\u9032\u884c\u6d17\u80c3\u4e26\u7d66\u4e88\u6d3b\u6027\u78b3\u3002 (C)\u5fc3\u96fb\u5716\u5728 aVR\u6709\u9ad8\u7684 R\u6ce2(\u5373\u6700\u5f8c 40\u6beb\u79d2\u6709\u53f3\u8ef8\u504f\u7684\u60c5\u5f62 )\uff0c\u4ee3\u8868TCA\u4e2d\u6bd2\u3002 (D)\u53ef\u4ee5\u7d66\u4e88 Flumazenil (Anexate)\u505a\u70ba\u6b64\u75c5\u4eba Benzodiazepine \u4e2d\u6bd2\u7684\u89e3\u6bd2\u5291\u3002 (E)\u53ef\u4ee5\u7d66\u4e88 1 mEq/kg \u7684NaHCO 3\u505a\u70ba\u6b64\u75c5\u4eba TCA\u4e2d\u6bd2\u7684\u89e3\u6bd2\u5291\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "11\u500b\u6708\u7537\u7ae5\uff0c\u9ad4\u91cd\u7d04 10\u516c\u65a4\uff0c\u5728\u5bb6\u6301\u7e8c\u6709\u9663\u767c\u6027\u8179\u75db\u54ed\u9b27\u60c5\u5f62\uff0c\u7236\u6bcd\u662f\u4e3b\u8981\u7167\u9867\u8005\uff0c\u5c3f\u5e03\u767c\u73fe\u6709\u8840 \uf965\uff0c\u5e8a\u908a\u8179\u90e8\u8d85\u97f3\u6ce2\u5f71\u50cf\u5224\u65b7\u662f\u8178\u5957\u758a\u53ef\u80fd\u6027\u6975\u9ad8\uff0c\u4e0b\u5217\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u9019\u5e74\u7d00\u7684\u5152\u7ae5\u901a\u5e38\u627e\u4e0d\u5230\u5f15\u5c0e\u9ede (leading point )\u3002 (B)\u6709\u8179\u819c\u708e\u8de1\u8c61\u6642\uff0c\u7a7a\u6c23\u5fa9\u4f4d (air reduction)\u7684\u58d3\u529b\u5fc5\u9808\u964d\u4f4e\uff0c\u4ee5\u514d\u5c0e\u81f4\u8178\u7a7f\u5b54\u3002 (C)\u8840 \uf965\u7684\u51fa\u73fe\uff0c\u4e26\u975e\u662f\u63a1\u53d6\u7a7a\u6c23\u5fa9\u4f4d(air reduction)\u4e4b\u7981\u5fcc\u75c7\u3002 (D)\u4e0d\u540c \u5b63\u7bc0\u767c\u751f\u7387\u4e5f\u4e0d\u540c\uff0c\u53ef\u80fd\u548c\u75c5\u6bd2\u611f\u67d3\u6709\u95dc\u3002 (E)\u82e5\u7a7a\u6c23\u5fa9\u4f4d (air reduction )\u5931\u6557\uff0c\u9700\u8981\u91cd\u65b0\u8a55\u4f30\u662f\u5426\u70ba incarcerated hernia\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "25\u6b72\u601d\u89ba\u5931\u8abf\u75c7\u7537\u6027\u75c5\u4eba 30\u5206\u9418\u524d\u56e0\u547c\u5438\u56f0\u96e3\uff0c\u9838\u90e8\u8207\u4e0b\u5df4\u50f5\u786c\u81f3\u6025\u8a3a\u5ba4\uff0c\u540c\u884c\u53cb\u4eba\u8aaa 2\u5929\u524d\u4ed6\u7684 \ufa1d\u795e\u79d1\u91ab\u5e2b\u5e6b\u4ed6\u63db\u4e86\u65b0\u7684\u8655\u65b9\uff0c\u751f\u547d\u5fb5\u8c61\u4e26\u7121\u7279\u6b8a\u7570\u5e38\uff0c\u8eab\u9ad4\u6aa2\u67e5\u767c\u73fe\u4e0b\u984e\u8207\u9838\u90e8\u5f37\u76f4\u4e26\u65bc\u4e0a\u547c\u5438\u9053\u807d\u898b\u5598\u9cf4\u8072(stridor)\uff0c\u75c5\u4eba\u4e26\u7121\u5408\u4f75\u76ae\u819a\u7d05\u75b9\u3001\u7121\u820c\u982d\u816b\u8139\u3001\u7121\u54ee\u5598\u8072(wheezing )\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u8f03\u70ba\u9069\u7576 \uff1f", + "Options": "(A)Diazepam 5 mg \u975c\u8108\u6ce8\u5c04\u3002 (B)Diphenhydramine 50 mg\u975c\u8108\u6ce8\u5c04\u3002 (C)\u7d93\u7531\u5149\u675f\u7e96\u7dad\u5167\u8996\u93e1\u76f4\u8996\u547c\u5438\u9053\u5f8c\uff0c\u4e88\u4ee5\u63d2\u7ba1\u6cbb\u7642\u3002 (D)Methylprednisolone 125 mg \u975c\u8108\u6ce8\u5c04\u3002 (E)\u4ee5\u5feb\u901f\u6c23\u7ba1\u63d2\u7ba1\u6b65\u9a5f (Rapid sequence intubation) \u7d93\u7531\u53e3\u8154\u65bd\u4ee5\u6c23\u7ba1\u5167\u7ba1\u63d2\u7ba1\u6cbb\u7642\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "42\u6b72\u5973\u6027\u6709\u7532\u72c0\u817a\u4ea2\u9032\u75c5\u53f2\uff0c\u76ee\u524d\u6c92\u6709\u5e38\u898f\u9580\u8a3a\u8ffd\u8e64\uff0c\u5df2\u767c\u71d2\u5408\u4f75\u5598\u5169\u5929\uff0c\u9001\u81f3\u6025\u8a3a\u6642\u660f\u8ff7\u6307\u6578 E2V2M4\uff0c\u9ad4\u6eab42.1\u2103\uff0c\u5fc3\u8df3 180\u6b21/min\uff0c\u5fc3\u96fb\u5716\u5448\u73fe\u5fc3\u623f\u986b\u52d5\uff0c\u8840\u6c27\u98fd\u548c\u6fc3\u5ea6 76%\uff0c\u80ba\u90e8\u807d\u8a3a\u96d9\u5074\u56c9\u97f3\uff0c\u80ba\u90e8\u8d85\u97f3\u6ce2\u6709\u5ee3\u6cdb\u6027\u5927\u91cf B Lines\uff0c\u8840\u58d3 70/40 mmHg \uff0c\u95dc\u65bc\u6b64\u75c5\u4eba\u8655\u7f6e\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u7b49 TSH\u548cFree T4\u6aa2\u9a57\u503c\u78ba\u8a3a\u5f8c\u518d\u7d66\u4e88 Methimazole \u6216Propythiouracil \u3002 (B)\u7d66\u4e88 Amiodarone 150 mg \u77ef\u6b63\u5fc3\u5f8b\u4e0d\u6574\u3002 (C)\u7d66\u4e88 Acetylsalicylic acid \u964d\u6eab\u3002 (D)\u7d66\u4e88 NTG \u6ef4\u6ce8\u964d\u4f4e\u524d\u8ca0\u8377 (preload ) \u3002 (E)\u7d66\u4e88 Propylthiouracil 600 mg \u53e3\u670d\uff0c\u4e00\u5c0f\u6642\u5f8c\u518d\u7d66\u4e88 Lugol solution 10 drops\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "1\u6b72\u5e7c\u5152\u65bc\u4e2d\u570b\u5ee3\u6771\u51fa\u73fe\u767c\u71d2\u53ca\u5168\u8eab\u76ae\u75b9\u75c7\u72c0\u5f8c\u8fd4\u53f0\u5c31\u91ab\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", + "Options": "(A)\u53e3\u8154\u6aa2\u67e5\u5982\u51fa\u73fe\u67ef\u6c0f\u6591(koplik spots)\uff0c\u61c9\u5efa\u8b70\u75c5\u4eba\u4f4f\u9662\u8ca0\u58d3\u9694\u96e2\u75c5\u623f\u3002 (B)\u9451\u5225\u8a3a\u65b7\u4e2d\uff0c\u9ebb\u75b9\u901a\u5e38\u71d2\u9000\u5f8c\u9694\u5929\u624d\u6703\u51fa\u75b9\uff0c\u7d05\u75b9\u901a\u5e38\u5148\u51fa\u73fe\u5728\u624b\u8173\uff0c\u4e4b\u5f8c\u8513\u5ef6\u5230\u8ec0\u5e79\u53ca\u81c9\u90e8\uff0c\u53e3\u8154\u9ecf\u819c\u901a\u5e38\u4e0d\u53d7\u5f71\u97ff\u3002 (C)\u9451\u5225\u8a3a\u65b7\u4e2d\uff0c\u5fb7\u570b\u9ebb\u75b9\u4e26\u975e\u6cd5\u5b9a\u50b3\u67d3\u75c5\uff0c\u75c7\u72c0\u8f15\u5fae\u8005\u53ef\u51fa\u9662\u56de\u5bb6\u89c0\u5bdf\u5373\u53ef\u3002 (D)\u7329\u7d05\u71b1\u75c5\u6e90\u70ba\u55ae\u80a1 DNA\u75c5\u6bd2\uff0c\u53ef\u7d93\u7531\u98db \u6cab\u50b3\u67d3\uff0c\u5efa\u8b70\u55ae\u4eba\u75c5\u623f\u4f4f\u9662\u3002 (E)\u5b30\u5152\u73ab\u7470\u75b9 \u7684\u76ae\u75b9\u548c\u767c\u71d2\u4e00\u8d77\u51fa\u73fe\uff0c\u9000\u71d2\u5f8c\u76ae\u75b9\u5373\u6d88\u5931\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "30\u6b72\u7537\u6027\u5728\u8dd1\u99ac\u62c9\u677e\u9014\u4e2d\u88ab\u767c\u73fe\u795e\u667a\u4e0d\u6e05\u9001\u5230\u6025\u8a3a\u5ba4\uff0c\u5728\u6025\u8a3a GCS E3V3M5\uff0c\u8840\u58d3 100/50 mmHg \uff0c\u8108\u640f 120 \u6b21/min\uff0c\u547c\u5438 22 \u6b21/min\uff0c\u9ad4\u6eab 41\u2103\uff0c\u8840\u7cd6 100 mg/dL \uff0c\u4e0b\u5217\u4f55\u8005\u8655\u7f6e\u6700\u9069\u7576\uff1f", + "Options": "(A)\u61c9\u5148\u5c07\u75c5\u4eba\u8eab\u4e0a\u4ee5\u51b7\u7684\u81ea\u4f86\u6c34\u7051\u6fd5\uff0c\u4e26\u7d66\u4e88\u5439\u96fb\u98a8\u6247\u3002 (B)\u61c9\u5148\u5118\u5feb\u5c07\u75c5\u4eba\u5168\u8eab\u7684\u6c57\u6c34\u64e6\u4e7e\u3002 (C)\u61c9\u5148\u5118\u5feb\u5c07\u75c5\u4eba\u9ad4\u6eab\u964d\u81f3 37\u2103\u4ee5\u4e0b\u3002 (D)\u61c9\u5148\u8b93\u75c5\u4eba\u53bb\u505a\u8166\u90e8\u96fb\u8166\u65b7\u5c64\u3002 (E)\u61c9\u5148\u7d66\u75c5\u4eba\u559d\u904b\u52d5\u98f2\u6599\u88dc\u5145\u6c34\u5206\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u4ee3\u8b1d\u6027\u9178\u4e2d\u6bd2\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u53ef\u56e0\u5927\u91cf\u5feb\u901f\u8f38\u6ce8\u751f\u7406\u98df\u9e7d\u6c34\u5f8c\u9020\u6210\u3002 (B)\u5728\u8840\u6db2 pH\u503c\u4f4e\u65bc 7.1\u6642\uff0c\u547c\u5438\u6027\u751f\u7406\u4ee3\u511f\u529f\u80fd\u6703\u8b8a\u5dee\u3002 (C)\u82e5\u8840\u9240\u6fc3\u5ea6\u6b63\u5e38\u6642\uff0c\u7d30\u80de\u5167\u9240\u96e2\u5b50\u53ef\u80fd\u56b4\u91cd\u504f\u4f4e\u3002 (D)\u4e59\u9187\u5e38\u662f\u9020\u6210\u56b4\u91cd\u4ee3\u8b1d\u6027\u9178\u4e2d\u6bd2\u7684\u4e3b\u56e0\u3002 (E)\u4fdd\u9240\u5229\u5c3f\u5291\u53ef\u9020\u6210\u6b63\u5e38\u9670\u96e2\u5b50\u9593\u9699(anion gap )\u4ee3\u8b1d\u6027\u9178\u4e2d\u6bd2\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u95dc\u65bc\u786c\u819c\u5916\u8840\u816b( Epidural hematoma )\u7684\u63cf\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u786c\u819c\u5916\u8840\u816b\u5728\u8001\u4eba\u53ca\u5c0f\u65bc 2\u6b72\u5152\u7ae5\u8f03\u70ba\u5e38\u898b\u3002 (B)\u786c\u819c\u5916\u8840\u816b\u6700\u5e38\u51fa\u73fe\u7684\u5340\u57df\u5728\u524d\u984d\u8449( frontal region) \u3002 (C)\u82e5\u786c\u819c\u5916\u8840\u816b\u75c5\u4eba\u5408\u4f75\u610f\u8b58\u660f\u8ff7\uff0c\u5176\u6b7b\u4ea1\u7387\u504f\u9ad8\uff0c\u53ef\u9054 80%\u3002 (D)\u786c\u819c\u5916\u8840\u816b\u5728\u8166\u90e8\u96fb\u8166\u65b7\u5c64\u5f71\u50cf\u4e0a\u770b\u8d77\u4f86\u901a\u5e38\u5982\u5f4e\u6708\u5f62( crescent -shaped)\u3002 (E)\u5728\u8166\u90e8\u96fb\u8166\u65b7\u5c64\u5f71\u50cf\u4e0a\uff0c\u786c\u819c\u5916\u8840\u816b\u7bc4\u570d\u901a\u5e38\u4e0d\u6703\u5ef6\u4f38\u8d85\u904e\u9871\u9aa8\u7e2b(suture line )\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u6839\u64da 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care \u6700\u65b0\u5efa\u8b70\uff0c\u4e0b\u5217\u6558\u8ff0 \u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)Atropine \u4e26\u4e0d\u5efa\u8b70\u5e38\u898f\u4f7f\u7528\u5728\u5371\u6025\u5152\u7ae5\u53ca\u65b0\u751f\u5152\u63d2\u7ba1\u524d\u6e96\u5099(preintubation) \uff0c\u4f86\u9632\u6b62\u7dca\u6025\u63d2\u7ba1\u6642\u5f15\u8d77\u7684\u5fc3\u8df3\u904e\u6162\u3002 (B)Atropine \u5291\u91cf\u70ba 0.02 mg/kg\uff0c\u6bcf\u6b21\u4f7f\u7528\u7684\u6700\u4f4e\u5291\u91cf\u70ba 0.1 mg\u3002 (C)\u5be6\u8b49\u91ab\u5b78\u986f\u793a\uff0c Atropine \u53ef\u7528\u65bc\u5fc3\u640f\u904e\u6162\u7684\u75c5\u4eba\u3002 (D)\u4e0d\u8ad6 amiodarone \u6216lidocaine \u90fd\u53ef\u4ee5\u7528\u65bc shock -refractory VF \u6216pulseless VT\u3002 (E)\u5728\u91cd\u75c7\u6cbb\u7642\u8cc7\u6e90(\u5982\u547c\u5438\u5668\u3001\u5347\u58d3\u5291)\u4e0d\uf9e0\u53d6\u5f97\u7684\u81e8\u5e8a\u5834\u57df\uff0c\u91dd\u5c0d\u6557\u8840\u6027\u4f11\u514b\u7684\u5152\u7ae5\u7d66\u4e88\u5927\u5291\u91cf\u7684\u8f38\u6db2\u53ef\u80fd\u662f\u6709\u5bb3\u7684\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "5\u6b72\u5973\u7ae5\u6025\u8a3a\u5c31\u91ab\uff0c\u6bcd\u89aa\u8868\u793a\u5973\u7ae5\u6709\u547c\u5438\u9053\u5148\u5929\u6027\u75be\u75c5\uff0c\u525b\u525b\u767c\u751f 3\u6b21\u62bd\u6410\uff0c\u6bcf\u6b21\u7d04 5\u5206\u9418\uff0c\u5408\u4f75\u6703\u767c\u7d3a\uff0c\u7d93\u6551\u8b77\u8eca\u9001\u81f3\u91ab\u9662\u5c31\u91ab\u3002\u62b5\u9054\u6025\u8a3a\u6642\uff0c\u5973\u7ae5\u4f9d\u7136\u5448\u73fe\u89d2\u5f13\u53cd\u5f35\uff0c\u773c\u775b\u4e0a\u540a\uff0c\u7259\u95dc\u7dca\u9589\uff0c\u5634\u5507\u767c\u7d3a\u3002\u7dca\u6025\u8655\u7f6e\u547c\u5438\u9053\u63d2\u7ba1\u548c\u7672\u7647\u8655\u7406\uff0c\u4f55\u8005\u6b63\u78ba \uff1f", + "Options": "(A)Ketamine 4 mg/kg IM injection \u3002 (B)Midazolam 0.1 mg/kg IM injection \u3002 (C)Phenytoin 20 mg/kg IM infusion \u3002 (D)Succinylcholine 1.5 mg/kg IM injection\u3002 (E)Valium 5 mg IM injection \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u91dd\u5c0d\u5404\u7a2e\u6025\u6027\u4e2d\u6bd2\u5f15\u8d77\u7684\u5fc3\u81df\u505c\u6b62( cardiac arrest ) \uff0c\u9664\u4e86\u7d66\u4e88 ACLS\u6025\u6551\u5916\uff0c\u8acb\u554f\u4e0b\u5217\u54ea\u4e00\u7a2e\u89e3\u6bd2\u5291\u6cbb\u7642\u6548\u76ca\u8f03\u5c0f \uff1f", + "Options": "(A)Digoxin \u4e2d\u6bd2\u7528 Digoxin Fab \u6cbb\u7642\u3002 (B)Organophosphates \u4e2d\u6bd2\u7528 Atropine \u6cbb\u7642\u3002 (C)Sodium channel blocker \u4e2d\u6bd2\u7528 Sodium bicarbonate \u6cbb\u7642\u3002 (D)Calcium channel blocker \u4e2d\u6bd2\u7528 Glucagon \u6cbb\u7642\u3002 (E)Local anesthetic agents \u4e2d\u6bd2\u7528 IV lipid emulsion \u6cbb\u7642\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4f9d\u64da\u7f8e\u570b\u71d2\u71d9\u50b7\u5b78\u6703(AmericanBurnAssociation)\u5efa\u8b70\uff0c\u56b4\u91cd\u71d2\u71d9\u50b7(Majorburn)\u61c9\u5165\u4f4f\u71d2\u50b7\u4e2d\u5fc3\uff0c\u4e0b\u5217\u4f55\u8005\u4e0d\u9808\u5165\u4f4f\u71d2\u50b7\u4e2d\u5fc3\uff1f", + "Options": "(A)40\u6b72\u7537\u6027\uff0c\u7121\u904e\u53bb\u75c5\u53f2\uff0c\u56db\u80a2\u4e8c\u5ea6\u71d2\u50b729%\u9ad4\u8868\u9762\u7a4d\u3002(B)40\u6b72\u7537\u6027\uff0c\u7121\u904e\u53bb\u75c5\u53f2\uff0c\u80cc\u90e8\u4e09\u5ea6\u71d2\u50b711%\u9ad4\u8868\u9762\u7a4d\u3002(C)70\u6b72\u7537\u6027\uff0c\u7121\u904e\u53bb\u75c5\u53f2\uff0c\u56db\u80a2\u4e8c\u5ea6\u71d2\u50b717%\u9ad4\u8868\u9762\u7a4d\u3002(D)4\u6b72\u5973\u7ae5\uff0c\u7121\u904e\u53bb\u75c5\u53f2\uff0c\u6703\u9670\u53ca\u81c0\u90e8\u4e09\u5ea6\u71d2\u50b73%\u9ad4\u8868\u9762\u7a4d\u3002(E)30\u6b72\u5973\u6027\uff0c\u7121\u904e\u53bb\u75c5\u53f2\uff0c\u524d\u80f8\u4e8c\u5ea6\u71d2\u50b74%\u9ad4\u8868\u9762\u7a4d\uff0c\u5408\u4f75\u53e3\u54bd\u90e8\u6709\u78b3\u7c92\u6c89\u7a4d\u53ca\u8072\u97f3\u9010\u6f38\u6c99\u555e\u3002", + "Answer": "A\u3001B\u3001C\u3001D\u3001E" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8840\u6c27\u4e0d\u8db3( hypoxemia )\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u53f3\u5411\u5de6\u5206\u6d41 (right -to-left shunt)\u6642\uff0c\u53ea\u8981\u589e\u52a0\u6c27\u6c23\u7684\u4f9b\u61c9\uff0c\u52d5\u8108\u4e2d\u7684\u6c27(PaO 2)\u5c31\u6703\u986f\u8457\u4e0a\u5347\u3002 (B)\u55ae\u7368\u901a\u6c23\u4e0d\u8db3(hypoventilation )\u53ea\u6703\u589e\u52a0 PaCO 2\uff0c\u4f46\u662f A-a O 2\u68af\u5ea6\u6b63\u5e38\uff0c\u8ddf\u6c27\u6c23\u7684\u4f9b\u61c9\u7121\u95dc\u3002 (C)\u901a\u6c23\u8207\u704c\u6d41\u5dee\u7570(ventilation -perfusion mismatch ) \u6642\uff0c\u5373\u4f7f\u589e\u52a0\u6c27\u6c23\u7684\u4f9b\u61c9\uff0c\u52d5\u8108\u4e2d\u7684\u6c27(PaO 2)\u7121\u6cd5\u660e\u986f\u4e0a\u5347\uff0c\u4f46 A-a O 2\u68af\u5ea6\u6703\u589e\u52a0\u3002 (D)\u64f4\u6563\u80fd\u529b\u4e0b\u964d(diffusion impairment )\u6642\uff0c\u589e\u52a0\u6c27\u6c23\u7684\u4f9b\u61c9\uff0c\u52d5\u8108\u4e2d\u7684\u6c27(PaO 2)\u5c31\u6703\u4e0a\u5347\uff0c\u4f46 A-a O 2\u68af\u5ea6\u4e0d\u6703\u660e\u986f\u8b8a\u5316\u3002 (E)\u5927\u6c23\u4e2d\u6c27\u5206\u58d3\u4e0b\u964d\u6642\uff0c\u53ea\u8981\u589e\u52a0\u6c27\u6c23\u7684\u4f9b\u61c9\uff0c\u52d5\u8108\u4e2d\u7684\u6c27 (PaO 2)\u5c31\u6703\u986f\u8457\u4e0a\u5347\uff0c\u4f46 A-a O 2\u68af\u5ea6\u6703\u4e0b\u964d\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "28\u6b72\u7537\u6027\u70ba\u7b2c\u4e00\u578b\u7cd6\u5c3f\u75c5\u75c5\u4eba \uff0c\u76ee\u524d\u4f7f\u7528\u80f0\u5cf6\u7d20\u5e6b\u6d66\u63a7\u5236\u8840\u7cd6\uff0c\u81ea\u524d\u5929\u958b\u59cb\u4e0a\u5410\u4e0b\u7009\u3001\u98df\u617e\u4e0d\u632f\uff0c\u4eca\u5929\u65e9\u4e0a\u7a81\u7136\u767c\u751f\u53e3\u9f52\u4e0d\u6e05\uff0c\u81ea\u89ba\u53f3\u5074\u80a2\u9ad4\u8f03\u70ba\u7121\u529b\uff0c\u5230\u6025\u8a3a\u6642\u8840\u7cd6 40 mg/dL \uff0c\u95dc\u65bc\u6b64\u75c5\u4eba\u8655\u7f6e\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4 \uff1f", + "Options": "(A)\u4f4e\u8840\u7cd6\u53ef\u5c0e\u81f4\u7591\u4f3c\u4e2d\u98a8\u75c7\u72c0\uff0c\u56e0\u6b64\u5148\u6cbb\u7642\u4f4e\u8840\u7cd6\u70ba\u4f73\u3002 (B)\u542b\u7cd6\u8f38\u6db2\u8f03\u6607\u7cd6\u7d20(Glucagon)\u6cbb\u7642\u6548\u679c\u66f4\u5feb\uff0c\u61c9\u512a\u5148\u4f7f\u7528\u3002 (C)\u66ab\u6642\u505c\u7528\u80f0\u5cf6\u7d20\u5e6b\u6d66\u81f3\u5c11 24\u5c0f\u6642\u3002 (D)\u611f\u67d3\u3001\u814e\u529f\u80fd\u60e1\u5316\u3001\u6025\u6027\u51a0\u5fc3\u75c7\u90fd\u6709\u53ef\u80fd\u5c0e\u81f4\u4f4e\u8840\u7cd6\u3002 (E)\u8179\u819c\u900f\u6790\u60a3\u8005\u8840\u7cd6\u8a66\u7d19\u53ef\u80fd\u4e0d\u6e96\uff0c\u61c9\u518d\u62bd\u8840\u78ba\u8a8d\u8840\u7cd6\u503c\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u77ed\u66ab\u6027\u8166\u7f3a\u8840\u767c\u4f5c (transient ischemic attack )\u60a3\u8005\u4f9d\u64da 2007\u5e74ABCD2 score\uff0c\u5982\u6709\u4e0b\u5217\u54ea\u9805\u56e0\u5b50\u6700\u5bb9 \uf9e0\u7e8c\u767c\u4e2d\u98a8\uff1f", + "Options": "(A)\u5e74\u9f61\u5c0f\u65bc 60\u6b72\u3002 (B)\u8ca7\u8840\u3002 (C)\u767c\u4f5c\u6642\u9593\u5927\u65bc 10\u5206\u9418\u3002 (D)\u6709\u51a0\u5fc3\u75c5\u5bb6\u65cf\u53f2\u3002 (E)\u767c\u4f5c\u6642\u5408\u4f75\u6709\u8996\u529b\u65b9\u9762\u7684\u75c7\u72c0\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u4f55\u8005 \u975e\u70ba\u5275\u50b7\u8d85\u97f3\u6ce2( Focused Assessment with Sonogra phy for Trauma, FAST)\u6240\u6383\u63cf\u4e4b\u4f4d\u7f6e\uff1f", + "Options": "(A)\u809d\u81df\u8207\u53f3\u814e\u4ea4\u754c (hepatorenal recess )\u3002 (B)\u813e\u81df\u8207\u5de6\u814e\u4ea4\u754c (splenorenal recess)\u3002 (C)\u4e3b\u52d5\u8108 (aorta)\u3002 (D)\u9aa8\u76c6\u8154 (pelvic view )\u3002 (E)\u528d\u7a81\u4e0b (subxiphoid view )\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u95dc\u65bc Fresh frozen plasma (FFP)\u7684\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)AB\u578b\u53ef\u4f5c\u70ba\u5168\u9069\u4f9b\u8840\u8005(universal donor )\u3002 (B)\u9700\u6025\u4f5c\u80c3\u93e1\u7684\u75c5\u4eba\uff0c\u5982\u6709\u51dd\u8840\u529f\u80fd\u969c\u7919 (coagulopathy )\uff0c\u9700\u5148\u8f38FFP\u3002 (C)\u4f7f\u7528 FFP\u53ef\u6cbb\u7642\u56e0 Dabigatran \u5f15\u8d77\u7684\u51dd\u8840\u529f\u80fd\u969c\u7919\u3002 (D)\u75c5\u4eba\u63a5\u53d7 FFP\u8f38\u6ce8\u524d\u9700\u5148\u505a ABO\u548cRh\u914d\u5c0d( ABO -type and Rh compatible )\u3002 (E)\u89e3\u51cd\u5f8c\u7684 FFP\uff0c\u9700\u5728 48\u5c0f\u6642\u5167\u4f7f\u7528\u5b8c\u7562\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "60\u6b72\u7537\u6027\u75c5\u4eba\uff0c\u9ad4\u91cd 60\u516c\u65a4\uff0c\u4e3b\u8a34\u6d41\u9f3b\u8840\u4e00\u9031\uff0c\u547c\u5438 21\u6b21/min\uff0c\u8108\u640f 74\u6b21/min\uff0c\u8840\u58d3 158/90 mmHg \uff0c\u9ad4\u6eab36.7\u2103\uff0c\u8840\u6c27 98%\uff0c\u904e\u53bb\u6709\u6162\u6027\u814e\u81df\u75c5\u75c5\u53f2\uff0c\u4e14\u5728\u4e00\u9031\u524d\u5df2\u5efa\u7acb\u597d\u5de6\u524d\u81c2\u52d5\u975c\u8108\u763b\u7ba1\uff0c\u8840\u6db2\u6aa2 \u9a57\u70ba BUN 280 mg/dL\uff0cCr 23.5 mg/dL \uff0cHCO 3- 11.4 mEq/L \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)desmopressin 0.3 mg SC \u6216IV\uff0c\u53ef\u589e\u52a0 von Willebrand factor \u6539\u5584\u75c7\u72c0\u3002 (B)\u53ef\u80fd\u56e0\u5c3f\u6bd2\u75c7\u6bd2\u7d20\u7684\u76f4\u63a5\u4f5c\u7528\u800c\u9020\u6210\uf9e0 \u51fa\u8840\u50be\u5411\u3002 (C)\u82e5\u6301\u7e8c\u5927\u91cf\u51fa\u8840\u61c9\u8003\u616e\u7d66\u4e88 cryoprecipitate \u3002 (D)\u61c9\u4f8b\u884c\u8f38\u8840\u5c0f\u677f\u6cbb\u7642\u3002 (E)\u62bd\u8840\u6aa2\u9a57 bleeding time \u6703\u5ef6\u9577\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u80a5\u80d6\u75c5\u4eba\u63a5\u53d7\u80c3\u7e5e\u9053\u6e1b\u80a5\u624b\u8853( laparoscopic Roux -en-Y gastric bypass )\u5f8c\uff0c\u53ef\u80fd\u51fa\u73fe\u7684\u526f\u4f5c\u7528\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", + "Options": "(A)Fentanyl \u548cBenzodiazepines \u85e5\u7269\u662f\u89aa\u8102\u6027\uff0c\u5728\u80a5\u80d6\u60a3\u8005\u4e2d\uff0c \u534a\u8870\u671f\u6703\u5ef6\u9577\u3002 (B)\u80c3\u7e5e\u9053\u6e1b\u80a5\u624b\u8853\u8853\u5f8c\u99ac\u4e0a\u767c\u751f\u7684\u6025\u6027\u8178\u963b\u585e\u70ba\u5916\u79d1\u6025\u75c7\uff0c\u9808\u7acb\u5373\u8655\u7406\u3002 (C)\u80c3\u7e5e\u9053\u6e1b\u80a5\u624b\u8853\u8853\u5f8c\u8178\u963b\u585e\uff0c\u5305\u62ec\u5167\u759d\u548c Roux\u7aef\u7684\u65cb\u8f49\u3002 (D)\u80c3\u7e5e\u9053\u6e1b\u80a5\u624b\u8853\u8853\u5f8c\u6025\u6027\u8178\u963b\u585e\uff0c\u4e0d\u6703\u51fa\u73fe\u81bd\u6c41\u5614\u5410\u7269\u3002 (E)\u50be\u98df\u75c7\u5019 \u7fa4(Dumping syndrome )\u662f\u9910\u5f8c\u80c3\u6392\u7a7a\u5feb\uff0c\u80c3\u6fc0\u7d20\u91cb\u653e\u548c\u5167\u81df\u8840\u7ba1\u64f4\u5f35\u5f15\u8d77\u7684\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "4\u6b72\u5973\u7ae5\uff0c\u9ad4\u91cd 20\u516c\u65a4\uff0c\u6709\u611f\u5192\u75c7\u72c0\uff0c\u55dc\u7761\u767c\u71d2\u5026\u6020\u98df\u617e\u4e0d\u632f\u591a\u65e5\uff0c\u8840\u58d370/40 mmHg \uff0c\u5fc3\u8df3 120\u6b21/min\uff0cO2 Sat 95%\uff0c\u547c\u5438\u7d04 24\u6b21/min\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4 \uff1f ", + "Options": "(A)\u75c5\u7ae5\u53ef\u4ee5\u512a\u5148\u7d66\u4e88 0.9%\u751f\u7406\u98df\u9e7d\u6c34\u6216\u4e73\u9178\u6797\u683c\u6c0f\u6db2 400 mL\u704c\u6ce8\uff0c\u6642\u9593 5-10\u5206\u9418\u3002 (B)\u5982\u679c\u61f7\u7591\u662f\u5fc3\u808c\u708e\u6216\u5fc3\u56e0\u6027\u4f11\u514b\uff0c\u53ef\u4ee5\u7d66\u4e88 0.9%\u751f\u7406\u98df\u9e7d\u6c34\u6216\u4e73\u9178\u6797\u683c\u6c0f\u6db2 100-200 mL\u704c\u6ce8\uff0c\u6642\u9593 10-20\u5206\u9418\u3002 (C)\u6cbb\u7642\u6548\u679c\u4e0d\u7406\u60f3\u6642\u53ef\u4ee5\u8003\u616e\u6703\u8a3a\u5c08\u5bb6\u3002 (D)\u82e5\u5c0f\u670b\u53cb\u7684 urine output \u6bcf\u5c0f\u6642 20 mL\u8868\u793a\u6cbb\u7642\u53cd\u61c9\u9084\u4e0d\u7406\u60f3\u3002 (E)\u6cbb\u7642\u671f\u9593\u82e5\u5c0f\u670b\u53cb\u7684\u8840\u58d3\u9054\u5230 80/50 mmHg \uff0c\uf965\u61c9\u8a72\u505c\u6b62\u88dc\u5145\u8f38\u6db2\uff0c\u4ee5\u514d\u904e\u5ea6\u7d66\u4e88\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "28\u6b72\u61f7\u5b55\u5a66\u5973\u8eca\u798d\u9001\u81f3\u6025\u8a3a\u5ba4\uff0c\u610f\u8b58\u6a21\u7cca\uff0c\u660f\u8ff7\u6307\u6578 E3V4M5\uff0c\u5fc3\u8df3 110\u6b21/min\uff0c\u8840\u58d3 80/50 mmHg \uff0c\u4e3b\u8a34\u8179\u75db\u53ca\u53f3\u5927\u817f\u75bc\u75db\uff0c\u8eab\u9ad4\u6aa2\u67e5\u767c\u73fe\u4e0b\u8179\u6309\u58d3\u6709\u53cd\u5f48\u75db\u3001\u5b50\u5bae\u5e95\u7d04\u5728\u809a\u81cd\u9644\u8fd1\u3001\u9670\u9053\u6709\u900f\u660e\u6db2\u9ad4\u5206\u6ccc\u7269\u3001\u53f3\u5927\u817f\u8b8a\u5f62\u4ee5\u53ca\u7d04 15\u516c\u5206\u6495\u88c2\u50b7\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u6b63\u78ba\uff1f", + "Options": "(A)\u61f7\u5b55\u75c5\u4eba\uff0c\u4e0d\u5efa\u8b70\u65bd\u6253\u7834\u50b7\u98a8\u3002 (B)\u4e0d\u53ef\u7167 X\u5149\u4f86\u78ba\u8a8d\u53f3\u5927\u817f\u662f\u5426\u9aa8\u6298\u3002 (C)\u7531\u751f\u547d\u5fb5\u8c61\u5224\u65b7\u51fa\u8840\u91cf\u7d04\u70ba\u5168\u8eab\u8840\u91cf 15-30%\u3002 (D)\u82e5\u9670\u9053\u5206\u6ccc\u7269 pH\u503c\u70ba 7\uff0c\u53ef\u80fd\u662f\u7f8a\u819c\u7834\u88c2\u6d41\u51fa\u7684\u7f8a\u6c34\u3002 (E)\u521d\u6b65\u5224\u65b7\u80ce\u5152\u9031\u6578\u7d04 12\u9031\uff0c\u5c1a\u7121\u6cd5\u4f7f\u7528\u80ce\u5fc3\u97f3\u53ca\u5bae\u7e2e\u76e3\u8996\u5668(cardiotochodynamometry )\uff0c\u50c5\u80fd\u4ee5\u90fd\u535c\u52d2(Doppler )\u8d85\u97f3\u6ce2\u8a55\u4f30\u80ce\u5fc3\u97f3\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "55\u6b72\u5973\u6027\u75c5\u4eba\u7d93\u904e 16\u5c0f\u6642\u7684\u98db\u884c\uff0c\u56e0\u7a81\u7136\u611f\u5230\u547c\u5438\u56f0\u96e3\u3001\u80f8\u75db\u3001\u76dc\u6c57\uff0c\u7531\u6a5f\u5834\u76f4\u5165\u6025\u8a3a\u5ba4\u3002\u5230\u9662\u6642\u8840\u58d3 80/44 mm/Hg \u3001\u5fc3\u8df3 120\u6b21/min\u3001\u547c\u5438 22\u6b21/min\uff0c\u8840\u6c27\u98fd\u548c\u5ea6 88%\uff0c\u5fc3\u96fb\u5716\u76e3\u8996\u5668\u5448\u73fe sinus tachycardia \u3002\u75c5\u4eba\u7121\u9ad8\u8840\u58d3\u3001\u5fc3\u81df\u75c5\u7684\u75c5\u53f2\uff0c\u7d93\u8a55\u4f30\u5f8c\u9ad8\u5ea6\u61f7\u7591\u80ba\u6813\u585e\u3002\u6709\u95dc\u9019\u4f4d\u75c5\u4eba\u7684\u76f8\u95dc\u6aa2\u67e5\uff0c\u4e0b\u5217\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u6b64\u75c5\u4eba\u80f8\u90e8 X\u5149\u53ef\u80fd\u5b8c\u5168\u6b63\u5e38\u3002 (B)\u4e0b\u80a2\u975c\u8108\u8d85\u97f3\u6ce2\u53ef\u80fd\u767c\u73fe\u6df1\u5c64\u975c\u8108\u6813\u585e\u3002 (C)\u80ba\u6813\u585e\u7684\u75c5\u4eba ECG\u53ef\u80fd\u51fa\u73fe V1-V4\u7684T\u6ce2\u5012\u7f6e( T wave inversion)\u3002 (D)\u6709\u75c7\u72c0\u7684\u80ba\u6813\u585e\u75c5\u4eba\uff0c\u5176 D-dimer\u6578\u503c\u7570\u5e38\u4e0d\u6703\u8d85\u904e 3\u5929\u3002 (E)\u80f8\u90e8\u96fb\u8166\u65b7\u5c64\u8840\u7ba1\u651d\u5f71(CT angiography )\u5728\u80a5\u80d6\u6216\u547c\u5438\u6975\u5feb\u901f\u75c5\u4eba\u8f03\u96e3\u8a3a\u65b7\u80ba\u6813\u585e\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "1\u6b72\u5973\u7ae5\u6025\u8a3a\u5c31\u91ab\uff0c\u7236\u6bcd\u89aa\u8868\u793a\u5973\u7ae5\u767c\u80b2\u6b63\u5e38\uff0c 2\u5929\u4f86\u767c\u71d2\uff0c\u54b3\u55fd\u8072\u97f3\u7c97\u800c\u8aaa\u8a71\u6c99\u555e\uff0c\u547c\u5438\u6709\u9ede\u5598\uff0c\u98df\u617e\u4e0d\u4f73\uff0c\u53cd\u61c9\u7565\u4e0d\u4f73\u3002\u521d\u6b65\u8a55\u4f30\uff0c\u547c\u5438\u6dfa\u5feb\uff0c\u819a\u8272\u6b63\u5e38\uff0c\u6709\u80f8\u9aa8\u4e0a\u51f9\u9677(retraction )\uff0c\u751f\u547d\u5fb5\u8c61\u5982\u4e0b\uff1a\u8840\u58d3 96/58 mmHg\uff0c\u547c\u5438 34\u6b21/min\uff0c\u5fc3\u8df3 116\u6b21/min\uff0c\u9ad4\u6eab38\u2103\uff0c\u8840\u6c27 92%\u3002\u4e0b\u5217\u63cf\u8ff0\u548c\u8655\u7f6e\uff0c\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)epinephrine \u5438\u5165\u6cbb\u7642\u3002 (B)Heliox \u5438\u5165\u6cbb\u7642\u3002 (C)\u62bd\u8840\uff0c\u4e26\u4e14\u5b89\u6392\u7167\u5c04\u9838\u90e8\u548c\u80f8\u90e8\uff38\u5149\u3002 (D)\u6ce8\u5c04\u985e\u56fa\u9187\u3002 (E)\u6b64\u75c5\u4eba\u70ba\u4e0a\u547c\u5438\u9053\u963b\u585e\uff0c\u61c9\u7acb\u5373\u63d2\u7ba1\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u814e\u4e0a\u817a\u6a5f\u80fd\u4f4e\u4e0b( adrenal insufficiency )\u6558\u8ff0\u4f55\u8005 \u932f\u8aa4\uff1f", + "Options": "(A)\u5e38\u898b\u65bc\u6162\u6027\u985e\u56fa\u9187\u4f7f\u7528\u8005\u505c\u85e5\u5f8c\u6216\u816b\u7624\u75c5\u4eba\u3002 (B)\u53ef\u56e0\u8166\u819c\u8166\u708e\u7403\u83cc\u611f\u67d3\u9020\u6210\u814e\u4e0a\u817a\u51fa\u8840\u3002 (C)CMV \u611f\u67d3\u662f\u9020\u6210 HIV\u75c5\u4eba\u814e\u4e0a\u817a\u4f4e\u4e0b\u7684\u4e3b\u8981\u539f\u56e0\u3002 (D)\u8178\u80c3\u9053\u611f\u67d3\u662f\u9020\u6210\u814e\u4e0a\u817a\u5371\u8c61 (adrenal crisis )\u5e38\u898b\u539f\u56e0\u4e4b\u4e00\u3002 (E)\u6b21\u767c\u6027\u814e\u4e0a\u817a\u6a5f\u80fd\u4f4e\u4e0b\u4e0d\u6703\u9020\u6210\u8840\u6db2\u4e2d Cortisol\u7f3a\u4e4f\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u95dc\u65bc NOAC(novel oral anticoagulants )\u7684\u6558\u8ff0\u4f55\u8005\u932f\u8aa4 \uff1f", + "Options": "(A)Dabigatran \u5c6c\u65bc direct thrombin inhibitor \u3002 (B)Rivaroxaban \u5c6c\u65bc direct Factor Xa inhibitor \u3002 (C)\u5373\u4f7f Thrombin clotting time \u6b63\u5e38\uff0c\u4ecd\u7121\u6cd5\u6392\u9664\u75c5\u4eba\u76ee\u524d\u7684\u51dd\u8840\u529f\u80fd\u7570\u5e38\u6e90\u81ea\u65bc Dabigatran \u7684\u53ef\u80fd\u6027\u3002 (D)\u8840\u6db2\u900f\u6790 (Hemodialysis )\u53ef\u79fb\u9664\u8840\u4e2d\u7684 Dabigatran \u3002 (E)\u7576\u4f7f\u7528 Rivaroxaban \u7684\u75c5\u4eba\u51fa\u73fe\u91cd\u5927\u51fa\u8840 (major bleeding )\u4e8b\u4ef6\u6642\uff0c\u53ef\u7d66\u4e88 antifibrinolytic agent (\u5982 tranexamic acid )\u6cbb\u7642\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4e00\u540d 6\u6b72\u7684\u5973\u5b69\u56e0\u76ae\u819a\u51fa\u73fe\u767c\u7662\u7684\u6591\u4e18\u75b9\u548c\u767c\u71d2\u5168\u8eab\u5026\u6020\u800c\u81f3\u6025\u8a3a\u5c31\u91ab\uff0c\u6aa2\u67e5\u767c\u73fe\u6241\u6843\u817a\u51fa\u73fe\u767d\u8272\u5206\u6ccc\u7269\u3001\u9838\u90e8\u6dcb\u5df4\u817a\u816b\u5927\u3001\u809d\u813e\u816b\u5927\u3002\u8acb\u554f\u4ee5\u4e0b\u4f55\u8005\u662f\u6700\u53ef\u80fd \u7684\u81f4\u75c5\u75c5\u539f\u9ad4\uff1f", + "Options": "(A)A \u578b\u93c8\u7403\u83cc( Group A Streptococcus)\u3002 (B)EB \u75c5\u6bd2( Epstein -Barr virus )\u3002 (C)\u514b\u6c99\u5947\u75c5\u6bd2(Coxsackie virus )\u3002 (D)\u91d1\u9ec3\u8272\u8461\u8404\u7403\u83cc(Staphylococcus aureus )\u3002 (E)\u6d41\u611f\u75c5\u6bd2(Influenza virus )\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u60e1\u6027\u5916\u8033\u708e( malignant external otitis ) \uff0c\u6703\u9020\u6210\u9871\u5e95\u9aa8\u9ad3\u708e( skull base osteomyelitis )\u800c\u5371\u53ca\u751f\u547d\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5927\u90e8\u4efd\u500b\u6848\u4f7f\u7528\u6297\u751f\u7d20\u6cbb\u7642\u5373\u53ef\u3002 (B)\u53ef\u7531\u982d\u9871\u5074\u9762 X\u5149\u6c7a\u5b9a\u81e8\u5e8a\u5206\u671f\u3002 (C)\u5fc5\u9808\u6709\u4e0a\u5347\u7684\u767c\u708e\u6307\u6578\u5982 C\u53cd\u61c9\u86cb\u767d(C -reactive protein )\u624d\u53ef\u78ba\u8a3a\u3002 (D)\u6700\u5e38\u5f15\u767c\u7684\u81f4\u75c5\u83cc\u662f\u80ba\u708e\u93c8\u7403\u83cc\u3002 (E)\u6700\u5e38\u9020\u6210\u7b2c\u4e94\u5c0d\u8166\u795e\u7d93\u75c5\u8b8a\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6025\u6027\u6703\u53ad\u708e( Acute epiglottitis ) \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u4e0d\u53ef\u7d66\u4e88\u6ce8\u5c04\u985e\u56fa\u9187(steroids)\u4ee5\u514d\u52a0\u91cd\u611f\u67d3\u3002 (B)\u6297\u751f\u7d20\u53ef\u9078\u64c7 cefotaxime \u52a0\u4e0a vancomycin\u3002 (C)\u5e38\u898b\u81f4\u75c5\u83cc\u5305\u542b\u93c8\u7403\u83cc(Streptococcus)\u53ca\u8461\u8404\u7403\u83cc(Staphylococcus) \uff0c\u4f46\u4e5f\u53ef\u80fd\u57f9\u990a\u70ba\u9670\u6027\u3002 (D)\u5178\u578b\u81e8\u5e8a\u75c7\u72c0\u6709\u6240\u8b02\u7684\u4e09\u500b D\uff0c\u5373 Drooling\u3001 Dysphagia \u3001Distress\u3002 (E)\u78ba\u5b9a\u8a3a\u65b7\u4e0d\u9700\u8981\u96fb\u8166\u65b7\u5c64\u5f71\u50cf\u6aa2\u67e5\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "22\u6b72\u5973\u6027\u75c5\u4eba\u56e0\u914d\u8f09\u96b1\u5f62\u773c\u93e1\u5165\u7761\u5f8c\u96d9\u773c\u7d05\u816b\u75bc\u75db\u81f3\u6025\u8a3a\u5c31\u91ab\u3001\u6aa2\u67e5\u767c\u73fe\u89d2\u819c\u6f70\u760d\uff0c\u8acb\u554f \u6700\u6709\u53ef\u80fd\u5f15\u767c\u611f\u67d3\u7684\u75c5\u539f\u9ad4\u70ba\u4f55\uff1f", + "Options": "(A)\u6c34\u75d8\u5e36\u72c0\u75b1\u75b9\u75c5\u6bd2(Varicella zoster virus )\u3002 (B)\u91d1\u9ec3\u8272\u8461\u8404\u7403\u83cc(Staphylococcus aureus )\u3002 (C)\u80ba\u708e\u93c8\u7403\u83cc(Streptococcus pneumoniae )\u3002 (D)\u55ae\u7d14\u75b1\u75b9\u75c5\u6bd2( Herpes simplex virus )\u3002 (E)\u7da0\u81bf\u687f\u83cc( Pseudomonas aeruginosa)\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u4f7f\u7528\u6297\u8840\u6813\u85e5\u7269( antithrombotics )\u6cbb\u7642\u975c\u8108\u6813\u585e\u5408\u4f75\u80ba\u6813\u585e\u7684\u63cf\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u53e3\u670d NOAC(novel oral anticoagulant )\u5982 rivaroxaban \u53ef\u7528\u65bc\u6cbb\u7642\u6d17\u814e\u60a3\u8005\u7684\u975c\u8108\u6813\u585e\uff0c\u8f03\u50b3\u7d71\u6cbb\u7642\u65b9\u4fbf\u4e14\u5b89\u5168\u3002 (B)\u8840\u5c0f\u677f\u6578\u76ee\u4f4e\u65bc 100,000/mm3\u662f\u4f7f\u7528 fibrinolytic therapy \u7684\u7d55\u5c0d\u7981\u5fcc\u75c7\u3002 (C)\u6297\u51dd\u8840\u85e5\u7269(anticoagulant )\u6bd4\u6297\u8840\u5c0f\u677f\u85e5\u7269(antiplatelet )\u66f4\u80fd\u6709\u6548\u9810\u9632\u975c\u8108\u6813\u585e(venous thromboembolism )\u3002 (D)\u82e5\u60a3\u8005\u8840\u58d3\u4e0b\u964d\u81f3 75/55 mmHg\uff0c\u53ef\u8003\u616e\u4f7f\u7528 fibrinolytic therapy \u3002 (E)Warfarin \u6cbb\u7642\u521d\u671f 24-36\u5c0f\u6642\u53ef\u80fd\u589e\u52a0\u8840\u6813\u7522\u751f(thrombogenesis ) \uff0c\u5408\u4f75\u975c\u8108\u6ce8\u5c04 heparin\u6cbb\u7642 3-5\u5929\u53ef\u6e1b\u8f15\u6b64\u73fe\u8c61\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5927\u91cf\u8f38\u8840( massive transfusion )\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)24 \u5c0f\u6642\u5167\u7d66\u4e88\u81f3\u5c11 10\u55ae\u4f4d PRBCs(packed red blood cells )\u53ef\u7a31\u70ba\u5927\u91cf\u8f38\u8840\u3002 (B)\u5927\u91cf\u8f38\u8840\u60a3\u8005\uff0c\u8f38\u6ce8 FFP(fresh frozen plasma )\uff1aplatelets\uff1aPRBCs\u5e38\u7528\u5efa\u8b70\u6bd4\u4f8b\u70ba 2\uff1a1\uff1a1\u3002 (C)\u5927\u91cf\u8f38\u8840\u6642\uff0c\u82e5\u8840\u5c0f\u677f\u5c0f\u65bc 50,000/mm3\uff0c\u5efa\u8b70\u8f38\u6ce8\u8840\u5c0f\u677f\u3002 (D)\u5927\u91cf\u8f38\u8840\u6642\uff0c\u82e5\u76e3\u6e2c INR\u5927\u65bc 1.5\uff0c\u5efa\u8b70\u8f38\u6ce8 FFP(fresh frozen plasma)\u3002 (E)\u5927\u91cf\u8f38\u8840\u6642\uff0c\u82e5 fibrinogen level \u5c0f\u65bc 1g/L\u6216100 mg/dL\uff0c\u53ef\u7d66\u4e88cryoprecipitate \u6216fibrinogen concentrate \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u7d05\u6591\u6027\u72fc\u7621( systemic lupus erythematosus, SLE )\u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u51fa\u73fe\u5fc3\u5305\u819c\u7a4d\u6db2(p ericardial effusion )\u6642\uff0c\u9ad8\u5291\u91cf glucocorticoid \u53ef\u6e1b\u5c11\u5fc3\u5305\u7a7f\u523a\u8853(pericardiocentesis )\u4e4b\u9700\u8981\u3002 (B)\u4f75\u767c\u5fc3\u5305\u819c\u708e(pericarditis)\u6642\uff0c\u61c9\u907f\u514d\u4f7f\u7528 NSAIDs (non -steroidal anti- inflammatory drugs )\u6cbb\u7642\u3002 (C)\u9577\u671f\u4f7f\u7528 glucocorticoid \u7684SLE\u60a3\u8005\u767c\u751f\u80ba\u708e\u6642\uff0c\u6cbb\u7642\u4ee5\u7b2c\u4e8c\u4ee3\u982d\u5b62\u83cc\u7d20(cephalosporins)\u70ba\u9996\u9078\u3002 (D)SLE \u60a3\u8005\u5f97\u5230\u51a0\u72c0\u52d5\u8108\u75be\u75c5(coronary artery disease )\u7684\u98a8\u96aa\u4e26\u7121\u660e\u986f\u63d0\u9ad8\u3002 (E)Erythrocyte sedimentation rate (ESR)\u53ef\u7528\u4f86\u9451\u5225\u8a3a\u65b7\u72fc\u7621\u6027\u8178\u708e(lupus enteritis )\u548c\u5176\u4ed6\u539f\u56e0\u8179\u75db\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u6709\u95dc Toxic epidermal necrolysis \u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)Toxic epidermal necrolysis \u6b7b\u4ea1\u7387\u53ef\u80fd\u9ad8\u9054 30%\u3002 (B)Toxic epidermal necrolysis \u5f71\u97ff\u5927\u65bc\u767e\u5206\u4e4b\u4e09\u5341\u9ad4\u8868\u9762\u7a4d(BSA )\u6642\uff0c\u7a31\u70ba Stevens- Johnson syndrome \u3002 (C)\u6cbb\u7642\u4e3b\u8981\u4ee5 hydration \uff0c\u9810\u9632\u4e8c\u5ea6\u611f\u67d3\u53ca\u50b7\u53e3\u7167\u8b77\u70ba\u4e3b\u3002 (D)\u5e38\u4ee5\u767c\u71b1\u3001\u5589\u56a8\u75db\u3001\u808c\u8089\u75db\u70ba\u521d\u671f\u8868\u5fb5\u3002 (E)\u5168\u8eab\u90fd\u53ef\u80fd\u51fa\u73fe\u76ae\u819a\u7d05\u75b9\uff0c\u5c24\u5176\u4ee5\u56db\u80a2\u6700\u70ba\u5e38\u898b\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6839\u64da\u6211\u570b\u75be\u75c5\u7ba1\u5236\u7f72\u5c0d\u6c11\u773e\u7684\u5ba3\u5c0e\uff0c\u7576\u51fa\u73fe\u4e0b\u5217\u75c7\u5019\u6642\u4ee3\u8868\u53ef\u80fd\u662f\u8178\u75c5\u6bd2\u91cd\u75c7\uff0c\u9664\u4e86\u54ea\u4e00\u9805 \uff1f", + "Options": "(A)\u54ed\u9b27\u4e0d\u4f11\u3002 (B)\u5fc3\u8df3\u52a0\u5feb\u3002 (C)\u6301\u7e8c\u5614\u5410\u3002 (D)\u55dc\u7761\u3002 (E)\u808c\u8e8d\u578b\u62bd\u6410\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u4e00\u4f4d 60\u6b72\u7537\u6027\u75c5\u4eba\u88ab\u9001\u81f3\u6025\u8a3a\uff0c\u4ed6\u7684\u610f\u8b58\u4f3c\u4e4e\u660f\u8ff7\uff0c\u795e\u7d93\u6aa2\u67e5\u767c\u73fe\u56db\u80a2\u5c0d\u4efb\u4f55\u523a\u6fc0\u90fd\u7121\u4efb\u4f55\u52d5\u4f5c\uff0c\u4ea6\u7121\u6cd5\u767c\u51fa\u4efb\u4f55\u8072\u97f3\uff0c\u4f46\u4f60\u89c0\u5bdf\u5230\u75c5\u4eba\u773c\u775b\u5076\u723e\u6703\u81ea\u884c\u5f35\u958b\u9589\u5408\uff0c\u4ed6\u7684\u75c5\u8b8a\u4f4d\u7f6e \u6700\u53ef\u80fd\u5728\uff1f", + "Options": "(A)\u6a4b\u8166( pons)\u3002 (B)\u5c0f\u8166(cerebellum )\u3002 (C)\u4e0b\u8996\u4e18(hypothalamus )\u3002 (D)\u4e2d\u8166( mid-brain)\u3002 (E)\u5ef6\u8166( medulla)\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u5275\u50b7\u75c5\u4eba\u5e8a\u65c1\u8d85\u97f3\u6ce2\u6aa2\u67e5\u7684\u5fb5\u8c61\uff0c \u54ea\u4e00\u7a2e\u6703\u8b93\u4f60\u61f7\u7591\u75c5\u4eba\u6709\u6c23\u80f8(pneumothorax )\uff1f", + "Options": "(A)A -lines\u3002 (B)B- lines\u3002 (C)Lung point sign\u3002 (D)Lung sliding\u3002 (E)Tissue -like sign\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4e00\u540d 21\u6b72\u7537\u6027\u9a0e\u8eca\u81ea\u6454\u7d50\u679c\u547c\u5438\u56f0\u96e3\u88ab\u9001\u5230\u6025\u8a3a\uff0c\u975e\u5e38\u8e81\u52d5\u4e14\u6293\u8457\u9838\u90e8\u9396\u9aa8\u90e8\u4f4d\uff0cBP \uff1a170/92 mmHg \uff0cHR\uff1a140\u6b21/min\uff0cRR\uff1a31\u6b21/min\uff0c\u521d\u6b65\u8a55\u4f30\u767c\u73fe\u547c\u5438\u6025\u4fc3\u6709 stridor\uff0ctrachea\u6c92\u6709\u504f\u79fb\uff0c\u5169\u5074\u547c\u5438\u97f3\u6e1b\u5f31\u4e14\u5c0d\u7a31\u8d77\u4f0f\uff0c\u8acb\u554f\u4e0b\u5217\u8a3a\u65b7\u4f55\u8005\u6700\u6709\u53ef\u80fd\uff1f", + "Options": "(A)Tension pneumothorax \u3002 (B)Flail chest \u3002 (C)Posterior dislocation of clavicular head \u3002 (D)Massive hemothorax \u3002 (E)Hyperventilation\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4ee5\u4e0b\u54ea\u4e00\u4f4d\u75c5\u4eba\u53ef\u8003\u616e\u5728\u6025\u8a3a\u9032\u884c\u7dca\u6025\u958b\u80f8\u624b\u8853( resuscitative thoracotomy )\uff1f", + "Options": "(A)35 \u6b72\u7537\u6027\u9ad8\u8655\u589c\u843d\u5f8c\u53f3\u5074\u80f8\u90e8\u7121\u547c\u5438\u97f3\uff0c\u5230\u9662\u5448\u73fe asystole\u3002 (B)20 \u6b72\u7537\u6027\u8207\u4eba\u6253\u9b25\u5f8c\u5de6\u80f8\u88ab\u5200\u523a\u5165\uff0c\u7121\u547c\u5438\u5fc3\u8df3\uff0c\u5230\u9662\u5448\u73feasystole\u3002 (C)19 \u6b72\u5973\u6027\u958b\u8eca\u8eca\u798d\u5f8c\u524d\u80f8\u649e\u64ca\u65b9\u5411\u76e4\uff0c\u5230\u9662\u7121\u547c\u5438\u5fc3\u8df3\uff0c\u5448\u73fe pulseless electrical activity (PEA)\u3002 (D)25 \u6b72\u7537\u6027\u5de6\u80f8\u906d\u53d7\u69cd\u50b7\uff0c\u5230\u9662\u7121\u547c\u5438\u5fc3\u8df3\uff0c\u5448\u73fe PEA\u3002 (E)30 \u6b72\u7537\u6027\u5f9e\u9df9\u67b6\u8dcc\u843d\uff0c\u80f8\u90e8\u8b8a\u5f62\uff0c\u5230\u9662\u7121\u547c\u5438\u5fc3\u8df3\uff0c\u5448\u73feasystole\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u5916\u50b7\u75c5\u4eba\u5e38\u6703\u9047\u5230\u56f0\u96e3\u63d2\u7ba1\uff0c\u75c5\u4eba\u662f\u5426\u53ef\u80fd\u70ba\u56f0\u96e3\u63d2\u7ba1\u53ef\u7528 LEMON \u7e2e\u5beb\u8a55\u4f30\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)L\uff1aLook externally \uff0c\u76f4\u63a5\u8089\u773c\u8a55\u4f30\u75c5\u4eba\u5916\u89c0\u662f\u5426\u56f0\u96e3\u63d2\u7ba1\u3002 (B)E\uff1aEvaluate the 3-3 -2 rules\uff0c\u4f7f\u7528\u624b\u6307\u6307\u5e45\u8a55\u4f30\u75c5 \u4eba\uff0c\u5f35\u5634\u9700\u9054\u4e09\u6307\u5e45\uff0c\u820c\u9aa8\u81f3\u4e0b\u5df4\u9700\u9054\u4e09\u6307\u5e45\uff0c\u7532\u72c0\u8edf\u9aa8\u81f3\u820c\u9aa8\u9700\u9054\u5169\u6307\u5e45\u3002 (C)M \uff1aMallampati \uff0c\u75c5\u4eba\u5f35\u5634\u5f8c\u5229\u7528\u61f8\u58c5\u5782\u8a55\u4f30\u3002 (D)O\uff1aObstruction\uff0c\u662f\u5426\u6709 airway\u963b\u585e\u73fe\u8c61\u3002 (E)N\uff1aNeck mobility\u3002 ", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5c0f\u5152\u5916\u50b7\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f ", + "Options": "(A)\u5c0f\u5152\u80f8\u90e8\u5275\u50b7\uff0c\u808b\u9aa8\u9aa8\u6298\u8f03\u80ba\u632b\u50b7\u5e38\u898b\u3002 (B)\u5c0f\u5152\u8179\u90e8\u920d\u50b7\u6700\u5e38\u898b\u70ba\u813e\u81df\u88c2\u50b7\uff0c\u5927\u591a\u6578\u4e0d\u9700\u8981\u8840\u7ba1\u6813\u585e\u6216\u624b\u8853\u6cbb\u7642\u3002 (C)\u74b0\u7532\u819c\u5207\u958b\u8853\u53ef\u5728 12\u6b72\u4ee5\u4e0a\u4e4b\u5152\u7ae5\u57f7\u884c\u3002 (D)\u82e5\u9700\u8981\u8f38\u8840\uff0c\u6bcf\u516c\u65a4\u9700 20mL\u7684pRBC\u3002 (E)\u7dca\u6025\u8655\u7f6e\u6642\u82e5\u6253\u4e0d\u4e0a\u975c\u8108\u91dd\uff0c\u53ef\u8003\u616e\u9aa8\u91dd\u3002", + "Answer": "A\u3001D" + }, + { + "\ufeffQuestion": "\u4f9d\u64da\u707d\u5bb3\u9632\u6551\u6cd5\u7b2c\u4e03\u689d\uff0c\u4e0b\u5217\u4f55\u55ae\u4f4d\u8ca0\u8cac\u57f7\u884c\u4e2d\u592e\u707d\u5bb3\u9632\u6551\u696d\u52d9\uff1f", + "Options": "(A)\u884c\u653f\u9662\u570b\u5bb6\u641c\u6551\u6307\u63ee\u4e2d\u5fc3\u3002 (B)\u884c\u653f\u9662\u4e2d\u592e\u707d\u5bb3\u9632\u6551\u59d4\u54e1\u6703\u3002 (C)\u885b\u751f\u798f\u5229\u90e8\u5340\u57df\u7dca\u6025\u91ab\u7642\u61c9\u8b8a\u4e2d\u5fc3\u3002 (D)\u5167\u653f\u90e8\u6d88\u9632\u7f72\u3002 (E)\u884c\u653f\u9662\u707d\u5bb3\u9632\u6551\u8fa6\u516c\u5ba4\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u5ddd\u5d0e\u6c0f\u75c7( Kawasaki's Disease )\u662f\u9020\u6210\u5152\u7ae5\u5f8c\u5929\u5fc3\u81df\u75c5\u7684\u4e3b\u8981\u539f\u56e0\u4e4b\u4e00\uff0c\u5178\u578b\u75c7\u72c0\u9664\u4e86\u9ad8\u71d2\u4e94\u5929\u5916\uff0c\u4e0b\u5217\u75c7\u72c0\u7684\u63cf\u8ff0\u4f55\u8005\u6700\u4e0d\u7b26\u5408 \u5178\u578b\u5ddd\u5d0e\u6c0f\u75c7\u7684\u81e8\u5e8a\u8a3a\u65b7\u8981\u4ef6\uff1f", + "Options": "(A)\u96d9\u773c\u7d50\u819c\u7d05\u816b\u4f75\u6709\u9ec3\u8272\u5206\u6ccc\u7269\u3002 (B)\u5634\u5507\u767c\u7d05\u4e7e\u88c2\u3002 (C)\u8eab\u4e0a\u5ee3\u5e03\u6027\u7d05\u8272\u6591\u75b9\u3002 (D)\u624b\u638c\u8173\u638c\u6c34\u816b\u3002 (E)\u9838\u90e8\u55ae\u5074\u7d04 2\u516c\u5206\u5927\u7684\u6dcb\u5df4\u7d50\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u6839\u64da\u7f8e\u570b\u5fc3\u81df\u5b78\u6703\u8207\u7f8e\u570b\u5152\u79d1\u91ab\u5b78\u6703\u5728 2016\u5e74\u5171\u540c\u63a8\u51fa\u7684\u6700\u65b0\u7248\u65b0\u751f\u5152\u6025\u6551\u5efa\u8b70(n eonatal resuscitation ) \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u6025\u6551\u904e\u7a0b\u7576\u4e2d\uff0c\u8840\u6c27\u6fc3\u5ea6\u7684\u91cf\u6e2c\u90e8\u4f4d\uff0c\u5efa\u8b70\u70ba\u65b0\u751f\u5152\u7684\u5de6\u4e0a\u80a2\u3002 (B)\u5728\u6e05\u7406\u547c\u5438\u9053\u3001\u7d66\u4e88\u6b63\u58d3\u547c\u5438 30\u79d2\u5f8c\uff0c\u82e5\u5fc3\u8df3\u91cf\u6e2c\u70ba\u6bcf\u5206\u9418 50\u4e0b\uff0c\u6b64\u6642\u5efa\u8b70\u57f7\u884c\u901a\u6c23\u6821\u6b63\u6b65\u9a5f\uff0c\u5305\u62ec\u8abf\u6574\u9762\u7f69\u3001\u91cd\u65b0\u64fa\u4f4d\u3001\u62bd\u5438\u53e3\u9f3b\u3001\u6253\u958b\u53e3\u8154\u3001\u589e\u52a0\u901a\u6c23\u58d3\u529b\u3001\u4ee5\u53ca\u8003\u616e\u66ff\u4ee3\u7684\u547c\u5438\u9053\u3002 (C)\u5728\u6b63\u58d3\u901a\u6c23(\u5c1a\u672a\u58d3\u80f8)\u6642\uff0c\u7528\u4ee5\u901a\u6c23\u7684\u6c27\u6c23\u6fc3\u5ea6\u5207\u52ff\u9078\u7528\u7d14\u6c27\uff1b\u572835\u9031\u4ee5\u4e0a\u61c9\u8a2d\u5b9a\u70ba 21-30%\uff0c35\u9031\u4ee5\u4e0b\u5247\u5efa\u8b70\u8a2d\u5b9a\u70ba 21%\u3002 (D)\u5728\u4e00\u958b\u59cb\u7684\u9ec3\u91d1 1\u5206\u9418\u5167\uff0c\u65bd\u6551\u9806\u5e8f\u70ba\u7dad\u6301\u9ad4\u6eab\uff0c\u75c5\u53f2\u8a55\u4f30\uff0c\u66a2\u901a\u547c\u5438\u9053\u3002 (E)\u80f8\u90e8\u6309\u58d3\u5efa\u8b70\u6bcf\u5faa\u74b0 3\u79d2\u9418\u9808\u58d3\u80f8 3\u4e0b\u5439\u4e00\u53e3\u6c23\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u9ebb\u75b9\u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u521d\u671f\u75c7\u72c0\u9664\u767c\u71d2\u5916\uff0c\u5e38\u5408\u4f75\u6709\u5641\u5fc3\u3001\u5614\u5410\u3001\u8179\u75db\u3001\u8179\u7009\u548c\u98df\u617e\u4e0d\u632f\u3002 (B)\u8eab\u4e0a\u76ae\u75b9\u9577\u51fa\u4f86\u7684\u9806\u5e8f\u7531\u8eab\u9ad4\u958b\u59cb\uff0c\u7136\u5f8c\u5f80\u4e0a\u8513\u5ef6\u81f3\u9838\u90e8\u8207\u982d\u90e8\uff0c\u6700\u5f8c\u5230\u56db\u80a2\u3001\u624b\u638c\u8207\u8173\u638c\u3002 (C)\u76ae\u75b9\u9577\u51fa\u4f86\u4e4b\u524d\u4e26\u4e0d\u6703\u50b3\u67d3\u7d66\u5176\u4ed6\u4eba\u3002 (D)\u6b64\u75be\u75c5\u5c6c\u65bc\u7b2c\u4e8c\u985e\u6cd5\u5b9a\u50b3\u67d3\u6027\u75be\u75c5\uff0c\u9700\u65bc 24\u5c0f\u6642\u5167\u5b8c\u6210\u901a\u5831\u3002 (E)\u53ef\u7d93\u7531\u98db\u6cab\u8207\u53e3\u9f3b\u5206\u6ccc\u7269\u50b3\u67d3\uff0c\u4f46\u4e0d\u6703\u7d93\u7531\u7a7a\u6c23\u50b3\u67d3\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "3\u6b72\u7537\u7ae5\u4e3b\u8a34\u8179\u75db\u4e00\u5929\u591a\uff0c\u5bb6\u5c6c\u8868\u793a\u6d3b\u529b\u4e0d\u4f73\u3001\u80c3\u53e3\u6975\u5dee\u3002\u53ea\u8981\u4e00\u63a5\u8fd1\u6b64\u5b69\u7ae5\u5c31\u54ed\u9b27\u4e0d\u5b89\uff0c\u6839\u672c\u7121\u6cd5\u914d\u5408\u8eab\u9ad4 \u6aa2\u67e5\u3002\u6709\u95dc\u5c0f\u5152\u8179\u75db\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u4efb\u4f55\u6d3b\u529b\u4e0d\u4f73\u3001\u98df\u617e\u4e0d\u597d\u7684\u5b69\u7ae5\u8a55\u4f30\u6aa2\u67e5\u7684\u7b2c\u4e00\u6b65\u9a5f\uff0c\u662f\u78ba\u8a8d\u5e8a\u908a\u8840\u7cd6(b edside glucose )\u3002 (B)\u82e5\u6b64\u75c5\u7ae5\u6700\u5f8c\u8a3a\u65b7\u70ba\u95cc\u5c3e\u708e\uff0c\u53ef\u80fd\u5df2\u7d93\u7834\u88c2\u4e26\u5408\u4f75\u8179\u819c\u708e\u3002 (C)\u82e5\u6709\u95dc\u7bc0\u708e\u5408\u4f75\u5168\u8eab\u76ae\u75b9\uff0c\u4f46\u76ae\u75b9\u5206\u5e03\u4e0d\u5747\uff0c\u5c24\u5176\u4e0b\u80a2\u8207\u81c0\u90e8\u51fa\u73fe\u7684\u7d05\u75b9\u6bd4\u4e0a\u80a2\u8207\u80f8\u8179\u90e8\u4f86\u7684\u53c8\u591a\u53c8\u65e9\uff0c\u5247\u9700\u512a\u5148\u8003\u616e\u904e\u654f\u6027\u7d2b\u6591\u75c7(Henoch-Scholein purpura)\u3002 (D)\u82e5\u6b64\u75c5\u7ae5\u6301\u7e8c\u6709\u5287\u70c8\u5614\u5410\u3001\u9ad4\u91cd\u6e1b\u8f15\u8207\u812b\u6c34\u5fb5\u72c0\uff0c\u5247\u9700\u512a\u5148\u8003\u616e\u5e7d\u9580\u72f9\u7a84\u75c7(p yloric stenosis )\u3002 (E)\u6b64\u75c5\u7ae5\u4e5f\u53ef\u80fd\u662f\u8178\u5957\u758a\uff0c\u4e14\u61c9\u540c\u6642\u6aa2\u67e5\u662f\u5426\u5408\u4f75\u6709\u6dcb\u5df4\u764c(lymphoma )\u6216\u6885\u514b\u723e\u61a9\u5ba4(Meckel's diverticulum )\u7b49\u5176\u4ed6\u75c5\u7076\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5c0f\u5152\u62bd\u6410( seizure) \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u71b1\u75d9\u6523(febrile convulsion )\u70ba\u5c0f\u5152\u62bd\u6410\u6700\u5e38\u898b\u7684\u539f\u56e0\u3002 (B)\u8b49\u64da\u986f\u793a\u71b1\u75d9\u6523\u7684\u5b69\u7ae5\u4e0d\u5efa\u8b70\u7d66\u4e88\u6297\u7672\u7647\u85e5\u7269\u3002 (C)\u71b1\u75d9\u6523\u7684\u5b69\u7ae5\u7a4d\u6975\u7d66\u4e88\u9000\u71d2\u85e5\u7269\u53ef\u6e1b\u5c11\u518d\u6b21\u767c\u4f5c\u7684\u6a5f\u6703\u3002 (D)3\u6b72\u4ee5\u4e0b\u7b2c\u4e00\u6b21\u767c\u751f\u7121\u767c\u71d2\u75d9\u6523(afebrile seizure )\u7684\u75c5\u7ae5\uff0c\u5efa\u8b70\u65bd\u884c\u8166\u90e8\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u3002 (E)\u82e5\u91cd\u7a4d\u7672\u7647\u75c7(status epilepticus )\u7684\u75c5\u7ae5\u6700\u5f8c\u4f7f\u7528 propofol\u6301\u7e8c\u6ef4\u6ce8\u6cbb\u7642\uff0c\u9700\u6ce8\u610f\u4ee3\u8b1d\u6027\u9178\u8840\u75c7\u3001\u6a6b\u7d0b\u808c\u6eb6\u89e3\u75c7\u3001\u814e\u8870\u7aed\u6216\u5fc3\u8870\u7aed\u7b49\u5408\u4f75\u75c7\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5152\u7ae5\u6025\u6027\u5fc3\u5305\u819c\u708e\u7684\u63cf\u8ff0\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u6700\u5e38\u898b\u7684\u75c5\u56e0\u662f\u611f\u67d3\u9020\u6210\u7684\uff0c\u5176\u4e2d\u6700\u5e38\u898b\u7684\u75c5\u6bd2\u70ba\u514b\u6c99\u5947\u75c5\u6bd2(Coxsackie virus)\u3002 (B)\u5178\u578b\u7684\u75c7\u72c0\u662f\u80f8\u75db\u8207\u547c\u5438\u7a98\u8feb\u3002 (C)\u8eab\u9ad4 \u6aa2\u67e5\u53ef\u80fd\u767c\u73fe\u9838\u975c\u8108\u6012\u5f35\u3001\u80a2\u9ad4\u6c34\u816b\u3001\u809d\u813e\u816b\u5927\u3001\u51fa\u73fe\u5947\u8108(pulsus paradoxus )\u548c\u807d\u8a3a\u767c\u73fe\u6469\u64e6\u97f3(pericardial friction rub )\u3002 (D)\u78ba\u5b9a\u8a3a\u65b7\u7684\u9ec3\u91d1\u6e96\u5247(gold standard )\u70ba\u4e0b\u5217\u4e09\u9805\u689d\u4ef6\u81f3\u5c11\u51fa\u73fe\u5169\u9805\uff1a12\u5c0e\u7a0b\u5fc3\u96fb\u5716 \u51fa\u73fe\u591a\u5c0e\u7a0b ST\u7bc0\u6bb5\u4e0a\u5347\u3001\u80f8\u90e8 X\u5149\u51fa\u73fe\u5fc3\u81df\u80a5\u5927(cardiomegaly )\u4ee5\u53ca\u8840\u4e2d troponin -I\u4e0a\u5347\u3002 (E)\u5b58\u6d3b\u4e0b\u4f86\u7684\u75c5\u7ae5\uff0c\u6709\u4e9b\u5f8c\u4f86\u6703\u56e0\u5fc3\u5305\u819c\u8b8a\u539a\u800c\u767c\u5c55\u6210\u7e2e\u7a84\u6027\u5fc3\u5305\u819c\u708e(constrictive peri carditis)\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u6b62\u6688\u3001\u6b62\u5410\u85e5\u5e38\u898b\u7684\u526f\u4f5c\u7528\uff0c\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)antihistamines (\u5982\uff1adiphenhydramine )\u5e38\u898b\u7684\u526f\u4f5c\u7528\u70ba\u55dc\u7761(drowsiness )\u3002 (B)benzodiazepines(\u5982\uff1alorazepam )\u5e38\u898b\u7684\u526f\u4f5c\u7528\u70ba\u93ae\u975c(sedation )\u3002 (C)benzamides (\u5982\uff1a metoclopramide )\u5e38\u898b\u7684\u526f\u4f5c\u7528\u70ba\u9310\u9ad4\u5916\u75c7\u5019\u7fa4(extrapyramidal symptoms )\u3002 (D)phenothiazines(\u5982\uff1aprochlorperazine )\u5e38\u898b\u7684\u526f\u4f5c\u7528\u70ba\u9310\u9ad4\u5916\u75c7\u5019\u7fa4(extrapyramidal symptoms)\u3002 (E)serotonin antagonists (\u5982\uff1aondansetron, granisetron)\u5e38\u898b\u7684\u526f\u4f5c\u7528\u70ba\u9310\u9ad4\u5916\u75c7\u5019\u7fa4(extrapyramidal symptoms )\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u5c0d\u65bc\u6025\u6027\u8179\u7009\u7684\u75c5\u4eba\uff0c\u9032\u884c\u7cde\u4fbf\u6aa2\u67e5\u7684\u8655\u7f6e\uff0c\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u6025\u6027\u8179\u7009\u8d85\u904e 3\u5929\u7684\u75c5\u4eba\uff0c\u61c9\u8a72\u9032\u884c\u7cde\u4fbf\u7d30\u83cc\u57f9\u990a\u3002 (B)\u514d\u75ab\u4e0d\u5168\u7684\u75c5\u4eba\u6709\u6025\u6027\u8179\u7009\u6642\uff0c\u61c9\u8a72\u9032\u884c\u7cde\u4fbf\u7d30\u83cc\u57f9\u990a\u3002 (C)\u6025\u6027\u8179\u7009\u75c5\u4eba\u6240\u9032\u884c\u7684\u7cde\u4fbf\u7d30\u83cc\u57f9\u990a\uff0c\u5e38\u5e38\u80fd\u57f9\u990a\u51fa\u75c5\u539f\u83cc\u3002 (D)\u5c0d\u65bc\u61f7\u7591\u8207\u4f7f\u7528\u6297\u751f\u7d20\u76f8\u95dc\u7684\u8179\u7009\u6642\uff0c\u61c9\u8a72\u9032\u884c Clostridium difficile toxin\u7684\u6aa2\u9a57\u3002 (E)\u5c0d\u65bc Reiter \u2019s syndrome \u7684\u75c5\u4eba\u6709\u6025\u6027\u8179\u7009\u6642\uff0c\u9700\u8003\u616e\u9032\u884cSalmonella \u7684\u7cde\u4fbf\u7d30\u83cc\u57f9\u990a\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u5c0d\u65bc\u541e\u98df\u7570\u7269\u7684\u8655\u7f6e\uff0c\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u5c0d\u65bc\u8aa4\u98df\u786c\u5e63\u7684\u5152\u7ae5\uff0c\u53ef\u4ee5\u4f7f\u7528\u5167\u8996\u93e1\u6216\u5c3f\u7ba1\u9032\u884c\u79fb\u9664\u3002 (B)\u5c0d\u65bc\u8aa4\u98df\u6210\u5305\u7684\u55ce\u5561\u6bd2\u54c1\u4e4b\u72c0\u6cc1\uff0c\u4e0d\u9069\u5408\u4ee5\u5167\u8996\u93e1\u9032\u884c\u79fb\u9664\u3002 (C)\u8aa4\u98df\u7684\u9215\u6263\u96fb\u6c60\u5982\u679c\u4ecd\u5728\u98df\u9053\u4e2d\uff0c\u61c9\u76e1\u901f\u4ee5\u5167\u8996\u93e1\u7684\u65b9\u5f0f\u79fb\u9664\u3002 (D)\u5c0d\u65bc\u8aa4\u98df\u9215\u6263\u96fb\u6c60\u5df2\u7d93\u8d85\u904e 2\u5c0f\u6642\uff0c\u4ecd\u5361\u5728\u98df\u9053\u4e2d\uff0c\u5247\u4e0d\u9069\u5408\u4ee5\u5c3f\u7ba1\u9032\u884c\u79fb\u9664\u3002 (E)\u5982\u679c\u540c\u6642\u8aa4\u98df\u9215\u6263\u96fb\u6c60\u548c\u78c1\u9435\u4e14\u7570\u7269\u5df2\u7d93\u901a\u904e\u98df\u9053\uff0c\u53ef\u4ee5\u7b49\u6709\u8178\u80c3\u9053\u75c7\u72c0\u6642\uff0c\u9032\u884c\u5167\u8996\u93e1\u79fb\u9664\u8655\u7f6e\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "52\u6b72\u5973\u6027\u6709\u7532\u72c0\u817a\u4ea2\u9032\u75c5\u53f2\uff0c\u81ea\u884c\u505c\u85e5\u8fd1\u5169\u5e74\uff0c\u9019\u4e09\u5929\u6301\u7e8c\u767c\u71d2\u5408\u4f75\u547c\u5438\u5598\u81f3\u6025\u8a3a\u6c42\u6cbb\uff0c\u5230\u9662\u6642\u610f\u8b58\u660f\u8ff7 E1V2M4\uff0c\u9ad4\u6eab 40\u2103\uff0c\u5fc3\u8df3\u7d04 160-200\u6b21/min\uff0c\u547c\u5438\u901f\u5ea6 32\u6b21/min\uff0c\u8840\u58d3 160/90mmHg \uff0c\u8840\u6c27\u98fd\u548c\u5ea6 76%\uff0c\u5fc3\u96fb\u5716\u76e3\u8996\u5668\u5448\u73fe\u5fc3\u623f\u986b\u52d5\uff0c\u80ba\u90e8\u807d\u8a3a\u96d9\u5074\u56c9\u97f3\uff0c\u96d9\u4e0b\u80a2\u6c34\u816b\uff0c\u95dc\u65bc\u8a72\u75c5\u4eba\u4e4b\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u7d66\u4e88 amiodarone 150 mg \u77ef\u6b63\u5fc3\u5f8b\u4e0d\u6574\u3002 (B)\u5148\u7d66\u4e88 Lugol\u2019s solution\uff0c\u4e00\u5c0f\u6642\u518d\u7d66 propythiouracil \u3002 (C)Acetaminophen \u53ef\u80fd\u60e1\u5316\u809d\u529f\u80fd\uff0c\u6539\u7d66\u4e88 acetylsalicylic acid \u964d\u6eab\u3002 (D)\u75c5\u4eba\u82e5\u70ba\u9ad8\u8f38\u51fa\u6027\u5fc3\u8870\u7aed(high output heart failure ) \uff0c\u53ef\u7d66\u4e88propranolol \u63a7\u5236\u5fc3\u8df3\u901f\u7387\u3002 (E)\u7531\u65bc propythiouracil \u809d\u6bd2\u6027\u5927\uff0c\u4e14\u53ef\u80fd\u5c0e\u81f4\u7121\u9846\u7c92\u6027\u767d\u8840\u7403\u75c7(agranulocytosis ) \uff0c\u9808\u7b49 TSH\u548cfree T4\u5831\u544a\u78ba\u8a8d\u5f8c\u624d\u53ef\u7d66\u4e88\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "88\u6b72\u7537\u6027\u70ba\u7b2c\u4e8c\u578b\u7cd6\u5c3f\u75c5\u8005\uff0c\u76ee\u524d\u4f7f\u7528 metformin\u4ee5\u53ca glypizide\u63a7\u5236\u8840\u7cd6\uff0c\u65e9\u4e0a\u88ab\u5bb6\u4eba\u767c\u73fe\u610f\u8b58\u4e0d\u6e05\uff0c\u5230\u6025\u8a3a\u6642\u8840\u7cd6 36 mg/dL \uff0c\u7d66\u4e88 D50W 80mL\u5f8c\u5373\u6062\u5fa9\u610f\u8b58\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u82e5\u75c5\u4eba\u814e\u529f\u80fd\u60e1\u5316\uff0c\u9808\u6ce8\u610f\u662f\u5426\u6709\u4e73\u9178\u4e2d\u6bd2\u3002 (B)\u5982\u679c\u65bd\u6253\u96fb\u8166\u65b7\u5c64\u4e4b\u986f\u5f71\u5291\uff0c metformin \u61c9\u505c\u7528 48\u5c0f\u6642\u3002 (C)\u75c5\u4eba\u7559\u9662\u89c0\u5bdf\u81f3\u8840\u7cd6\u7a69\u5b9a\u4e14\u7121\u5176\u4ed6\u9700\u6cbb\u7642\u7684\u539f\u56e0\uff0c\u9808\u5148\u78ba\u8a8d\u53ef\u9032\u98df\u518d\u96e2\u9662\u3002 (D)Metformin \u8f03glypizide \u66f4\u5bb9\u6613\u9020\u6210\u4f4e\u8840\u7cd6\uff0c\u8001\u5e74\u75c5\u4eba\u4e0d\u5efa\u8b70\u4f7f\u7528metformin \u3002 (E)\u7531\u65bc glypizide \u70ba\u9577\u6548\u6027\u85e5\u7269\uff0c\u53ef\u80fd\u6703\u518d\u5ea6\u4f4e\u8840\u7cd6\uff0c\u5efa\u8b70\u5728\u6025\u8a3a\u89c0\u5bdf\u8f03\u9577\u6642\u9593\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6a6b\u7d0b\u808c\u6eb6\u89e3\u75c7( rhabdomyolysis )\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u8a3a\u65b7\u6a19\u6e96\u70ba\u8840\u6f3f\u4e2d creatine kinase (CK)\u503c\u5927\u65bc\u6b63\u5e38\u503c\u4e0a\u9650\u7684 5\u500d\u4ee5\u4e0a\uff0c\u4f46\u9808\u5148\u6392\u9664\u5fc3\u81df\u53ca\u8166\u90e8\u75be\u75c5\u3002 (B)\u8840\u6db2 CK\u503c\u80fd\u6709\u6548\u9810\u6e2c\u6025\u6027\u814e\u81df\u640d\u50b7\u7684\u98a8\u96aa\u3002 (C)\u53ef \u5408\u4f75\u9ad8\u8840\u9240\uff0c\u9ad8\u8840\u78f7\u53ca\u4f4e\u8840\u9223\u7b49\u96fb\u89e3\u8cea\u7570\u5e38\u3002 (D)\u6cbb\u7642\u9700\u7d66\u4e88\u5927\u91cf\u8f38\u6db2\u53ca\u9e7c\u5316\u5c3f\u6db2\uff0c\u6700\u597d\u53ef\u7dad\u6301\u5c3f\u91cf\u5927\u65bc 300 mL/hr\u3002 (E)\u8840\u6db2 myoglobin \u534a\u8870\u671f\u8f03 CK\u77ed\uff0c24\u5c0f\u6642\u5f8c\u4e0d\u5efa\u8b70\u62ff\u4f86\u8a3a\u65b7\u6a6b\u7d0b\u808c\u6eb6\u89e3\u75c7\u3002", + "Answer": "B\u3001D" + }, + { + "\ufeffQuestion": "\u7dca\u6025\u7522\u4e0b\u7684\u65b0\u751f\u5152\uff0c\u9ad4\u91cd\u7d04 2\u516c\u65a4\uff0c\u7d93\u521d\u6b65\u4fdd\u6696\u64e6\u4e7e\u523a\u6fc0\u5f8c\uff0c\u6709 \u547c\u5438\u56f0\u96e3\u53ca\u8f15\u5fae\u767c\u7d3a(cyanosis)\u60c5\u5f62\uff0c\u5fc3\u8df3 80\u6b21/min\uff0c\u63a5\u4e0b\u4f86\u7684\u8655\u7f6e\uff0c\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u7e7c\u7e8c\u4fdd\u6696\uff0c\u8a55\u4f30\u8840\u7cd6\u3002 (B)\u6ce8\u5c04 epinephrine \u3002 (C)\u7d66\u4e88\u6b63\u58d3\u547c\u5438(p ositive pressure ventilation )\u3002 (D)\u63d2\u7ba1(intubation)\uff0c \u4f7f \u7528 laryngeal mask airway (LMA)\u3002 (E)\u958b\u59cb\u58d3\u80f8(chest compre ssion) \uff0c\u7d66\u4e88\u901a\u6c23\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "40\u6b72\u7537\u6027\uff0c\u767c\u751f\u4e0d\u660e\u539f\u56e0\u7684\u6688\u53a5( syncope) \u3002\u8acb\u554f\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u662f \u5c6c\u65bc\u9700\u8981\u4f4f\u9662\u7684\u9ad8\u5371\u96aa\u7fa4\uff1f", + "Options": "(A)\u5fc3\u96fb\u5716\u51fa\u73fe\u5de6\u675f\u652f\u50b3\u5c0e\u963b\u65b7(left bundle branch block )\u3002 (B)\u5fc3\u81df\u8870\u7aed\u75c5\u53f2\u3002 (C)\u4e3b\u8a34\u547c\u5438\u56f0\u96e3\u3002 (D)\u6536\u7e2e\u58d3\u5c0f\u65bc 90 mmHg \u3002 (E)\u9838\u52d5\u8108\u6309\u6469(carotid massage )\u5f8c\u767c\u751f\u5927\u65bc 3\u79d2\u7684\u5fc3\u640f\u505c\u6b62(asystole )\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u80a5\u539a\u6027\u5fc3\u808c\u75c7( hypertrophic cardiomyopathy )\u7684\u81e8\u5e8a\u8868\u73fe\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)Nitroglycerin \u5c0d\u80f8\u75db\u7684\u6539\u5584\u6548\u679c\u4e0d\u4f73\u3002 (B)\u5fc3\u623f\u9707\u986b(atrial fibrillation)\u53ef\u4f7f\u75c7\u72c0\u52a0\u5287\u3002 (C)\u4f10\u6c0f\u64cd\u4f5c( Valsalva maneuver )\u53ef\u4f7f\u5fc3\u96dc\u97f3\u6e1b\u5f31\u3002 (D)\u75c7\u72c0\u56b4\u91cd\u5ea6\u548c\u5e74\u7d00\u76f8\u95dc\u3002 (E)\u904b\u52d5\u6027\u547c\u5438\u56f0\u96e3(dyspnea on exertion )\u662f\u6700\u5e38\u898b\u65e9\u671f\u75c7\u72c0\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u4e3b\u52d5\u8108\u525d\u96e2( aortic dissection )\u7684\u6cbb\u7642\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)Standford type B \u7684\u75c5\u4eba\uff0c\u82e5\u6301\u7e8c\u56b4\u91cd\u80f8\u75db\u53ef\u9032\u884c\u624b\u8853\u6cbb\u7642\u3002 (B)\u4f7f\u7528\u8840\u7ba1\u64f4\u5f35\u5291\u524d\u61c9\u5148\u4f7f\u7528\u85e5\u7269\u63a7\u5236\u5fc3\u5f8b\u3002 (C)\u8d85\u97f3\u6ce2\u53ef\u8a55\u4f30\u6709\u7121\u5fc3\u5305\u819c\u586b\u585e(cardiac tamponade ) \uff0c\u4ee5\u9032\u884c\u65e9\u671f\u6cbb\u7642\u3002 (D)\u9223\u96e2\u5b50\u963b\u65b7\u5291\u70ba\u964d\u8840\u58d3\u9996\u9078\u3002 (E)\u7a4d\u6975\u63a7\u5236\u6536\u7e2e\u58d3\u81f3 100-120 mmHg\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5fc3\u808c\u6897\u585e\u6240\u4f7f\u7528\u6297\u8840\u5c0f\u677f\u85e5\u7269\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)Aspirin \u53ef\u6e1b\u5c11 ST\u6bb5\u4e0a\u5347\u5fc3\u808c\u6897\u585e\u75c5\u4eba\u7684\u6b7b\u4ea1\u7387\u9054 20%\u4ee5\u4e0a\u3002 (B)Abciximab \u4e0d\u5efa\u8b70\u4f7f\u7528\u65bc\u4e0d\u63a1\u7528\u7d93\u76ae\u51a0\u72c0\u52d5\u8108\u4ecb\u5165\u6027\u6cbb\u7642(percutaneous coronary intervention )\u7684\u51a0\u5fc3\u75c7\u75c5\u4eba\u3002 (C)Clopidogrel \u548comeprazole \u5408\u4f75\u4f7f\u7528\u53ef\u589e\u5f37\u6548\u679c\u3002 (D)Prasugrel \u4e0d\u53ef\u7528\u65bc\u6709\u66ab\u6642\u6027\u8166\u7f3a\u8840\u767c\u4f5c(transient ischemic attack )\u75c5\u53f2\u7684\u75c5\u4eba\u3002 (E)\u4f7f\u7528 ticagrelor \u75c5\u4eba\uff0c\u9032\u884c\u624b\u8853\u524d\u5efa\u8b70\u81f3\u5c11\u505c\u85e5 3\u5929\u4ee5\u4e0a\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8170\u5927\u808c\u81bf\u760d( psoas muscle abscess )\u63cf\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u75c7\u72c0\u5e38\u4ee5\u6f5b\u5728\u767c\u71d2\u3001\u8179\u75db\u8207\u8ddb\u884c\u8868\u73fe\u3002 (B)\u75c5\u539f\u5bb9\u6613\u7d93\u7531\u8840\u884c\u9014\u5f91\u5f9e\u9060\u8655\u50b3\u905e\u611f\u67d3\u3002 (C)\u6309\u58d3\u75c5\u4eba\u60a3\u5074\u5927\u817f\uff0c\u8acb\u75c5\u4eba\u7528\u529b\u62ac\u817f\u6642\uff0c\u80fd\u8a98\u767c\u75bc\u75db\u3002 (D)\u6700\u5e38\u7531\u93c8\u7403\u83cc\u611f\u67d3\u9020\u6210\u3002 (E)\u4ee5\u6297\u751f\u7d20\u53ca\u7d93\u76ae\u7a7f\u523a\u5f15\u6d41\u624b\u8853\u6cbb\u7642\u70ba\u539f\u5247\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6025\u8a3a\u4e0b\u80cc\u75db\u75c5\u4eba\u4e4b\u6aa2\u67e5\u8207\u8655\u7f6e\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u975e\u75c7\u72c0\u5074\u7684\u4e0b\u80a2\u76f4\u817f\u62ac\u9ad8\u8a66\u9a57(crossed straight leg raise test )\u967d\u6027\uff0c\u5c0d\u65bc\u690e\u9593\u76e4\u7a81\u51fa\u75c7\u8a3a\u65b7\u5177\u6709\u9ad8\u5ea6\u7279\u7570\u6027(specificity)\u4f46\u4f4e\u654f\u611f\u5ea6(sensitivity )\u3002 (B)\u5c0d\u65bc\u7591\u4f3c\u816b\u7624\u9020\u6210\u786c\u819c\u58d3\u8feb\u75c7\uff0cdexamethasone \u61c9\u5728\u78ba\u5b9a\u6027\u6aa2\u67e5\u78ba\u8a8d\u524d\u4f7f\u7528\u3002 (C)\u8170\u690e\u810a\u67f1\u72f9\u7a84(spinal stenosis )\u6240\u7522\u751f\u795e\u7d93\u6027\u9593\u6b47\u8ddb\u884c\uff0c\u5728\u810a\u690e\u524d\u5c48\u6642\u75c7\u72c0\u52a0\u91cd\uff0c\u800c\u810a\u690e\u4f38\u5c55\u6642\u8f03\u6e1b\u7de9\u3002 (D)\u6a6b\u8cab\u6027\u810a\u9ad3\u708e(transverse myelitis )\u7684\u8166\u810a\u9ad3\u6db2\u6aa2\u67e5\u7d93\u5e38\u5448\u73fe\u6dcb\u5df4\u7403\u6dcb\u5df4\u7ec6\u80de\u589e\u591a(lymphocytosis )\u548c\u86cb\u767d\u8cea\u5347\u9ad8\u3002 (E)\u810a\u690e\u9aa8\u9ad3\u708e(vertebral osteomyelitis )\u8840\u6db2\u6aa2\u67e5\u4e2d\uff0c\u767d\u8840\u7403\u53ef\u80fd\u70ba\u6b63\u5e38\uff0c\u800c\u7d05\u8840\u7403\u6c89\u964d\u7387(er ythrocyte sedimentation rate )\u548c C\u53cd\u61c9\u86cb\u767d\u5e7e\u4e4e\u90fd\u6703\u4e0a\u5347\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u75c5\u4eba\u53f3\u819d\u819d\u84cb\u9aa8\u524d\u6ed1\u6db2\u56ca( prepatellar bursa )\u816b\u75db\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u6ed1\u6db2\u56ca\u708e\u6700\u5e38\u767c\u751f\u65bc\u8098\u90e8\u548c\u819d\u90e8\u3002 (B)\u53ef\u80fd\u56e0\u70ba\u53cd\u8986\u5275\u50b7\u6216\u75db\u98a8\u9020\u6210\u3002 (C)\u5316\u81bf\u6027\u6ed1\u6db2\u56ca\u708e(septic bursitis) \u6700\u5e38\u898b\u65bc\u819d\u84cb\u9aa8\u524d\u6ed1\u6db2\u56ca\u8207\u9df9\u5634\u7a81\u6ed1\u6db2\u56ca\u3002 (D)\u6ed1\u6db2\u56ca\u6db2\u8840\u7cd6\u76f8\u5c0d\u65bc\u8840\u6e05\u8840\u7cd6\u6bd4\u4f8b\u5927\u65bc 50%\uff0c\u53ef\u8a3a\u65b7\u5316\u81bf\u6027\u6ed1\u6db2\u56ca\u708e\u3002 (E)\u91d1\u9ec3\u8272\u8461\u8404\u7403\u83cc\u662f\u6700\u5e38\u898b\u6ed1\u6db2\u56ca\u708e\u611f\u67d3\u7684\u83cc\u7a2e\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "45\u6b72\u7537\u6027\u7121\u5916\u50b7\u75c5\u53f2\uff0c\u6578\u5c0f\u6642\u524d\u53f3\u819d\u95dc\u7bc0\u9010\u6f38\u7522\u751f\u75bc\u75db\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u75db\u98a8\u767c\u4f5c\u4ee5\u591a\u8655\u95dc\u7bc0\u708e\u8868\u73fe\u70ba\u4e3b\u3002 (B)\u507d\u75db\u98a8(pseudogout )\u662f\u8349\u9178\u9223(calcium oxalate )\u6c89\u7a4d\u95dc\u7bc0\u6ed1\u6db2\u56ca\u9020\u6210\u3002 (C)\u6025\u6027\u75db\u98a8\u767c\u4f5c\u6642\uff0c\u75c5\u4eba\u8840\u6db2\u5c3f\u9178\u503c\u90fd\u6703\u4e0a\u5347\u3002 (D)\u82e5\u95dc\u7bc0\u62bd\u5438\u6db2\u65bc\u504f\u5149\u986f\u5fae\u93e1\u4e0b\u898b\u5230\u85cd\u8272\u91dd\u72c0\u7d50\u6676\u9ad4\u53ef\u8a3a\u65b7\u75db\u98a8\u3002 (E)\u814e\u529f\u80fd\u4e0d\u826f\u75c5\u4eba\u61c9\u8003\u616e\u4ee5\u79cb\u6c34\u4ed9\u7d20(colchicine )\u6cbb\u7642\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u7dca\u6025\u6551\u8b77\u6280\u8853\u54e1\u81ea\u5b78\u6821\u9001\u4f86\u4e00\u4f4d 19\u6b72\u5b78\u751f\uff0c\u96a8\u540c\u6821\u8b77\u8207\u8001\u5e2b\u8aaa\u8ab2\u5802\u4e0a\u7672\u7647\u767c\u4f5c\uff0c\u4e0a\u6551\u8b77\u8eca\u524d\u505c\u6b62\uff0c\u65bc\u5c31\u91ab\u9014\u4e2d\u53c8\u518d\u5ea6\u767c\u4f5c\u4e26\u6301\u7e8c\u81f3\u73fe\u5728\uff0c\u9019\u6b21\u767c\u4f5c\u6301\u7e8c\u8d85\u904e\u4e94\u5206\u9418\u3002\u6551\u8b77\u6280\u8853\u54e1\u8aaa\u8eca\u4e0a\u6e2c\u91cf\u8840\u7cd6\u503c\u70ba 102 mg/dL \uff0c\u4e26\u8d81\u672a\u767c\u4f5c\u6642\u5df2\u5c07\u975c\u8108\u7ba1\u8def\u5efa\u7acb\u5b8c\u6210\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005 \u6700\u70ba\u9069\u7576\ufe56", + "Options": "(A)\u7dca\u6025\u6c23\u7ba1\u5167\u7ba1\u7f6e\u5165\u3002 (B)\u975c\u8108\u6ce8\u5c04 lorazepam \u3002 (C)\u975c\u8108\u6ce8\u5c04 phenobarbital\u3002 (D)\u975c\u8108\u6ce8\u5c04 propofol\u3002 (E)\u975c\u8108\u6ce8\u5c04 fentanyl\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "72\u6b72\u5973\u6027\u65bc\u6e05\u6668 6\u9ede20\u5206\u88ab\u4e08\u592b\u5e36\u4f86\u6025\u8a3a\uff0c\u5148\u751f\u8aaa\u6628\u665a\u5c31\u5be2\u6642\u4e00\u5207\u6b63\u5e38\uff0c\u4eca\u5929\u65e9\u4e0a 6\u9ede\u5de6\u53f3\u8d77\u5e8a\u6642\u767c\u73fe\u592a\u592a\u53f3\u908a\u884c\u52d5\u4e0d\u4fbf\u3001\u8b1b\u8a71\u4e0d\u6e05\u695a\u3002\u8eab\u9ad4\u6aa2\u67e5\u767c\u73fe\u53f3\u5074\u80a2\u9ad4\u7121\u529b\u4f34\u96a8\u5931\u8a9e\u75c7\u8207\u9ad4\u611f\u7570\u5e38\uff0c\u8840\u58d3 170/100 mmHg\uff0c\u8840\u6db2\u6aa2\u67e5\u7121\u7570\u5e38\u767c\u73fe\uff0c\u4e26\u7121\u4efb\u4f55\u51fa\u8840\u5371\u96aa\u56e0\u7d20\uff0c\u982d\u90e8\u96fb\u8166\u65b7\u5c64\u4e26\u7121\u8166\u51fa\u8840\u4e4b\u73fe\u8c61\u4f46\u5de6\u5074\u4e2d\u5927\u8166\u52d5\u8108\u6d41\u57df\u7070\u8cea\u8207\u767d\u8cea\u4e4b\u754c\u7dda\u4e0d\u6e05\uff0c\u73fe\u5728\u6642\u9593\u70ba 7\u9ede15\u5206\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005 \u6700\u70ba\u9069\u7576 \uff1f", + "Options": "(A)Aspirin\u3002 (B)Heparin \u3002 (C)Labetalol \u3002 (D)Nimodipine \u3002 (E)Thrombolysis \u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "35\u6b72\u5973\u6027\u4e3b\u8a34\u4eca\u5929\u770b\u6771\u897f\u6709\u5169\u500b\u5f71\u5b50\u81f3\u6025\u8a3a\uff0c\u75c5\u53f2\u8a62\u554f\u767c\u73fe 3\u5468\u524d\u8179\u7009\u767c\u71d2\u5f8c\uff0c\u6700\u8fd1\u4e00\u500b\u661f\u671f\u8d70\u8def\u6709\u56f0\u96e3\u800c\u4e14\u75c7\u72c0\u8d8a\u4f86\u8d8a\u660e\u986f\u3002\u7121\u904e\u53bb\u75c5\u53f2 \uff0c\u7121\u7269\u8cea\u6feb\u7528\uff0c\u75c5\u4eba\u610f\u8b58\u6b63\u5e38\uff0c\u81e8\u5e8a\u6aa2\u67e5 \u767c\u73fe\u773c\u808c\u9ebb\u75fa\u8207\u80a2\u9ad4\u904b\u52d5\u5931\u8abf\uff0c\u4e0b\u80a2\u5c0d\u7a31\u6027\u7121\u529b\u53ca\u611f\u89ba\u7f3a\u5931\uff0c\u4e14\u6709\u808c\u8171\u53cd\u5c04\u6e1b\u5f31\u7684\u60c5\u5f62\uff0c\u76ae\u819a\u7121\u6606\u87f2\u54ac\u50b7\u7684\u75d5\u8de1\u3002\u8166\u810a\u9ad3\u6db2\u6aa2\u67e5\u86cb\u767d\u8cea\u542b\u91cf 75mg/dL\uff0c\u767d\u8840\u7403\u6bcf\u7acb\u65b9\u6beb\u7c73\u5c11\u65bc 10\u500b\u7d30\u80de\u5916\u7121\u5176\u4ed6\u767c\u73fe\uff0c\u4e0b\u5217\u8a3a\u65b7\u4f55\u8005\u6700\u70ba\u9069 \u7576\uff1f", + "Options": "(A)\u683c\u6797 -\u5df4\u5229\u75c7\u5019\u7fa4(Guillian -Barre syndrome )\u3002 (B)\u91cd\u75c7\u808c\u7121\u529b\u75c7( myasthenia gravis )\u3002 (C)\u591a\u767c\u6027\u786c\u5316\u75c7( multiple sclerosis )\u3002 (D)\u58c1\u8768\u9ebb\u75fa\u75c7(t ick paralysis )\u3002 (E)\u97cb\u5c3c\u514b\u6c0f\u8166\u75c5( Wernicke\u2019s encephalopathy )\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u4e00\u540d 25\u6b72\u5973\u6027\u60a3\u6709\u81ea\u9ad4\u514d\u75ab\u75be\u75c5\u81f3\u6025\u8a3a\u6c42\u8a3a\uff0c\u4e3b\u8a34\u6700\u8fd1\u7121\u529b\u611f\u8d8a\u4f86\u8d8a\u660e\u986f\uff0c\u4f60\u61f7\u7591\u6709\u91cd\u75c7\u808c\u7121\u529b\u4e4b\u53ef\u80fd\uff0c\u4e0b\u5217\u795e\u7d93\u5b78\u6aa2\u67e5\uff0c\u4f55\u8005\u6700\u6709\u52a9\u65bc\u5efa\u7acb\u8a3a\u65b7\uff1f", + "Options": "(A)\u8173\u8dbe\u529b\u91cf\u3002 (B)\u773c\u76ae\u6d3b\u52d5\u3002 (C)\u884c\u8d70\u6b65\u614b\u3002 (D)\u95dc\u7bc0\u53cd\u5c04\u3002 (E)\u9707\u52d5\u611f\u89ba\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "46\u6b72\u7537\u6027\u88ab\u6551\u8b77\u8eca\u9001\u4f86\u6025\u8a3a\uff0c\u5bb6\u4eba\u4ee3\u8a34\u75c5\u4eba\u4e00\u5929\u5167\u767c\u71d2\u3001\u982d\u75db\u3001\u795e\u667a\u4e0d\u6e05\uff0c\u6551\u8b77\u6280\u8853\u54e1\u8aaa\u75c5\u4eba\u65bc\u904b\u9001\u904e\u7a0b\u4e2d\u610f\u8b58\u72c0\u614b\u5c31\u6709\u660e\u986f\u7684\u60e1\u5316\uff0c\u5230\u9054\u6025\u8a3a\u6642\uff0c\u9ad4\u6eab 40\u2103\uff0c\u5fc3\u8df3 130\u6b21/min\uff0c\u8840\u58d3 110/60 mmHg\uff0c\u547c\u5438 20\u6b21/min\uff0c\u8840\u6c27\u6fc3\u5ea6 95%\u3002\u9838\u90e8\u7565\u70ba\u50f5\u786c\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005 \u6700\u70ba\u512a\u5148 \uff1f", + "Options": "(A)\u8840\u6db2\u57f9\u990a\u4e26\u7d66\u4e88\u6297\u751f\u7d20\u6cbb\u7642\u3002 (B)\u5b89\u6392\u986f\u5f71\u5291\u982d\u90e8\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u3002 (C)\u7d93\u975c\u8108\u7d66\u4e88 dexamethasone 10mg\u3002 (D)\u8170\u690e\u7a7f\u523a\u62bd\u53d6\u8166\u810a\u9ad3\u6db2\u6aa2\u67e5\u3002 (E)\u5b89\u6392\u7dca\u6025\u6838\u78c1\u5171\u632f\u6383\u63cf\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u4f7f\u7528 succinylcholine \u7576\u4f5c\u808c\u8089\u9b06\u5f1b\u5291\u4f86\u5e6b\u52a9\u63d2\u7ba1\u6642\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u4f7f\u7528 succinylcholine \u53ef\u80fd\u6703\u9020\u6210\u75c5\u4eba\u5fc3\u640f\u904e\u7de9\u3002 (B)\u4f7f\u7528 succinylcholine \u53ef\u80fd\u6703\u9020\u6210\u75c5\u4eba\u80c3\u5167\u58d3\u53ca\u9871\u5167\u58d3\u5347\u9ad8\u3002 (C)\u5728\u5148\u884c\u85e5\u7269 (premedication )\uff0c\u5efa\u8b70\u4f7f\u7528\u4f4e\u5291\u91cf\u975e\u53bb\u6975\u5316\u808c\u8089\u9b06\u5f1b\u5291\u4ee5\u907f\u514d\u808c\u8089\u986b\u6296\u3002 (D)S uccinylcholine \u4e0d\u53ef\u7528\u65bc\u5df2\u77e5\u9ad8\u8840\u9240\u3001\u795e\u7d93\u808c\u8089\u75c5\u8b8a\u6216\u91cd\u75c7\u808c\u7121\u529b\u7684\u75c5\u4eba\u8eab\u4e0a\u3002 (E)\u5982\u679c\u7d66\u4e86 succinylcholine \u5f8c\uff0c\u75c5\u4eba\u767c\u751f\u7121\u6cd5\u89e3\u91cb\u7684\u767c\u71d2\u53ca\u808c\u8089\u50f5\u786c\uff0c\u9808\u8003\u616e\u7d66\u4e88 dantrolene sodium \u6cbb\u7642\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u91dd\u5c0d\u6c23\u5598\u91cd\u7a4d\u75c7\u7684\u6cbb\u7642\uff0c\u4e0b\u5217\u63cf\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u6c23\u7ba1\u63d2\u7ba1\u4e26\u4e0d\u80fd\u7de9\u89e3\u652f\u6c23\u7ba1\u6536\u7e2e\u3002 (B)\u7576\u75c5\u4eba\u9700\u63d2\u7ba1\u6642\uff0cketamine \u6703\u5347\u9ad8\u80f8\u5167\u58d3\u662f\u7981\u5fcc\u85e5\u7269\u3002 (C)\u63d2\u7ba1\u5f8c\u7684\u75c5\u4eba\uff0c\u76ee\u6a19\u662f\u7acb\u5373\u6821\u6b63\u547c\u5438\u9178\u8840\u75c7\u81f3\u6b63\u5e38\u7bc4\u570d\u3002 (D)\u7d66\u4e88 Heliox\u53ef\u4ee5\u6e1b\u5c11\u63d2\u7ba1\u7387\u3001\u6e1b\u5c11\u52a0\u8b77\u75c5\u623f\u4f4f\u9662\u7387\u53ca\u4f4f\u9662\u5929\u6578\u3002 (E)\u53ef\u975c\u8108\u6ce8\u5c04 magnesium sulfate \u6cbb\u7642\uff0c\u4f46\u9808\u6ce8\u610f\u9ad8\u8840\u58d3\u53ca\u795e\u7d93\u808c\u8089\u963b\u65b7\u7684\u526f\u4f5c\u7528\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u6709\u95dc\u7279\u5b9a\u65cf\u7fa4\u75c5\u4eba\u80ba\u708e\u7684\u654d\u8ff0\uff0c\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u5b89\u990a\u9662(nursing home )\u4f4f\u6c11\uff0cM. pneumoniae \u548cLegionella \u662f\u8f03\u5e38\u898b\u4e4b\u81f4\u75c5\u83cc\u3002 (B)\u809d\u79fb\u690d\u8853\u5f8c\u60a3\u8005\uff0c\u524d\u4e09\u500b\u6708 Gram -negative bacilli(P. aeruginosa)\uff0c S. aureus\u548cLegionella \u70ba\u5e38\u898b\u83cc\u7a2e\u3002 (C)\u5b55\u5a66\u6709\u6c34\u75d8\u63a5\u89f8\u66b4\u9732\uff0c\u51fa\u73fe\u54b3\u55fd\u547c\u5438\u9053\u75c7\u72c0\uff0c\u61c9\u5efa\u8b70\u7167\u80f8\u90e8 X\u5149\u3002 (D)\u9152\u7cbe\u6210\u766e\u8005\u6700\u5e38\u898b\u81f4\u75c5\u83cc\u70ba S. pneumoniae \uff0c\u7136\u800c Klebsiella species\u4e5f\u662f\u91cd\u8981\u81f4\u75c5\u83cc\u3002 (E)\u975e\u5178\u578b\u80ba\u708e\u8f03\u5e38\u51fa\u73fe\u65bc\u5e74\u8f15\u65cf\u7fa4\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u81ea\u767c\u6027\u6c23\u80f8\u7684\u8a3a\u65b7\u4ee5\u53ca\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5982\u75c5\u4eba\u51fa\u73fe\u6c23\u7ba1\u504f\u79fb\uff0c\u8840\u58d3\u53ca\u8840\u6c27\u964d\u4f4e\uff0c\u55ae\u5074\u547c\u5438\u97f3\u6e1b\u4f4e\uff0c\u61c9\u512a\u5148\u9032\u884c\u80f8\u90e8 X\u5149\u78ba\u8a3a\u3002 (B)\u75c5\u4eba\u80f8\u90e8\u8d85\u97f3\u6ce2\u51fa\u73fe comet tail sign\u6642\uff0c\u53ef\u4ee5\u5e6b\u52a9\u8a3a\u65b7\u6c23\u80f8\u3002 (C)\u4f9d American College of Chest Physicians \u898b\u89e3\uff0c\u7ad9\u7acb\u7684\u80f8\u90e8 X\u5149\uff0c\u5f9e\u80f8\u8154\u9802\u90e8\u91cf\u6e2c\u5230\u80ba\u9802\u90e8(a pex-cupola)\u7684\u8ddd\u96e2\u82e5\u5c0f\u65bc 5\u516c\u5206\u53ef\u4ee5\u6b78\u985e\u65bc\u5c11\u91cf\u6c23\u80f8\uff0c\u53ef\u8003\u616e\u89c0\u5bdf\u6cbb\u7642\u3002 (D)\u53ef\u7d66\u75c5\u4eba\u6c27\u6c23\uff0c\u5c0d\u6c23\u80f8\u5438\u6536\u6709\u5e6b\u52a9\u3002 (E)\u5982\u75c5\u4eba\u6c23\u80f8\u91cf\u9700\u5f15\u6d41\u6642\uff0c\u5f15\u6d41\u65b9\u5f0f\u53ea\u6709\u80f8\u7ba1\u7f6e\u653e\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "77\u6b72\u7537\u6027\u4e2d\u98a8\u9577\u671f\u81e5\u5e8a\uff0c\u56e0\u767c\u71d2\u53ca\u547c\u5438\u5598\u9001\u81f3\u6025\u8a3a\uff0c\u62bd\u8840\u6aa2\u67e5\u767d\u8840\u7403\u53ca C\u53cd\u61c9\u86cb\u767d\u4e0a\u5347\uff0c\u80f8\u90e8 X\u5149\u986f\u793a\u53f3\u4e0b\u80ba\u6709\u4e00\u7d04 5\u516c\u5206\u958b\u6d1e\u75c5\u7076(cavitary lesion) \u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u80ba\u81bf\u760d\u548c\u5438\u5165\u6027\u80ba\u708e\u76f8\u95dc\u3002 (B)\u80ba\u81bf\u760d\u4ee5\u53ad\u6c27\u83cc\u611f\u67d3\u8f03\u5e38\u898b \u3002 (C)\u80ba\u81bf\u760d\u591a\u534a\u4e0d\u5fc5\u5f15\u6d41 \u3002 (D)\u53ad\u6c27\u83cc\u611f\u67d3\u6bd4\u55dc\u6c27\u83cc\u611f\u67d3\u9810\u5f8c\u4e0d\u826f\u3002 (E)\u6297\u751f\u7d20 ampicillin- sulbactam \u662f\u5408\u7406\u7684\u4e00\u958b\u59cb\u7d93\u9a57\u7528\u85e5\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u75c5\u4eba\u767c\u751f\u54b3\u8840\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5c11\u91cf\u54b3\u8840\uff0c\u56e0\u5927\u591a\u662f\u6025\u6027\u652f\u6c23\u7ba1\u708e\u5f15\u8d77\uff0c\u53ef\u4e0d\u5fc5\u7167 X\u5149\u3002 (B)\u54b3\u8840\u90fd\u61c9\u5b89\u6392\u4f4f\u9662\u89c0\u5bdf\u53ca\u6aa2\u67e5\u3002 (C)\u5927\u91cf\u54b3\u8840\uff0c\u751f\u547d\u73fe\u8c61\u7a69\u5b9a\uff0c\u56e0 X\u5149\u8a3a\u65b7\u7387\u4e0d\u9ad8\uff0c\u61c9\u76f4\u63a5\u5b89\u6392\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u3002 (D)\u5927\u91cf\u54b3\u8840\uff0c\u8981\u7dad\u6301\u547c\u5438\u9053\uff0c\u63d2\u7ba1\u6642\u907f\u514d\u4f7f\u7528 rapid sequence intubation\u3002 (E)\u5927\u91cf\u54b3\u8840\uff0c\u751f\u547d\u73fe\u8c61\u4e0d\u7a69\u5b9a\uff0c\u61c9\u8003\u616e\u76f4\u63a5\u63d2\u7ba1\u4e26\u9032\u884c\u652f\u6c23\u7ba1\u93e1\u6aa2\u67e5\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u4e00\u4f4d 75\u6b72\u7537\u6027\u75c5\u4eba\u56e0\u70ba\u60c5\u7dd2\u6fc0\u52d5\u4e14\u5408\u4f75\u66b4\u529b\u8209\u52d5\u88ab\u9001\u5230\u6025\u8a3a\u5ba4\uff0c\u5728\u6aa2\u50b7\u6642\u8840\u58d3 165/104mmHg\uff0c\u547c\u5438 16\u6b21/min\uff0c\u5fc3\u8df3 105\u6b21/min\uff0c\u9ad4\u6eab 37.2\u2103\u3002\u75c5\u4eba\u904e\u53bb\u6709\u9ad8\u8840\u58d3\u8207\u5931\u667a\u75c7\u75c5\u53f2\uff0c\u65bc\u795e\u7d93\u5167\u79d1\u9580\u8a3a\u8ffd\u8e64\u3002\u6700\u8fd1\u5e7e\u5929\u75c5\u4eba\u958b\u59cb\u61f7\u7591\u5bb6\u5c6c\u5077\u4ed6\u7684\u9322\u6216\u6709\u4eba\u8981\u50b7\u5bb3\u4ed6\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u9451\u5225\u8a3a\u65b7\u61c9\u5305\u62ec\u8b6b\u5984\u3002 (B)\u8b6b\u5984\u7684\u539f\u56e0\u5305\u542b\u85e5\u7269\u3001\u96fb\u89e3\u8cea\u4e0d\u5e73\u8861\u3001\u611f\u67d3\u7b49\u3002 (C)\u82e5\u75c5\u4eba\u6fc0\u52d5\uff0c\u80a2\u9ad4\u7d04\u675f\u901a\u5e38\u70ba\u512a\u5148\u9078\u64c7\u3002 (D)\u82e5\u75c5\u4eba\u6fc0\u52d5\uff0c\u975e\u85e5\u7269\u7684\u6cbb\u7642\u53ef\u4ee5\u5305\u542b\u63d0\u4f9b\u5b89\u975c\u8212\u9069\u7684\u74b0\u5883\u8207\u5bb6\u5c6c\u7684\u966a\u4f34\u3002 (E)\u82e5\u75c5\u4eba\u6fc0\u52d5\uff0c\u975e\u85e5\u7269\u7684\u6cbb\u7642\u5931\u6557\uff0c\u53ef\u4ee5\u8003\u616e\u53e3\u670d risperidone \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4e00\u4f4d 35\u6b72\u7537\u6027\u56e0\u70ba\u6d41\u9f3b\u6c34\u3001\u6d41\u773c\u6dda\u3001\u5641\u5fc3\u3001\u5614\u5410\u3001\u8179\u7009\u548c\u809a\u5b50\u7d5e\u75db\u4f86\u6025\u8a3a\uff0c\u75c5\u53f2\u8a62\u554f\u6642\u5426\u8a8d\u904e\u53bb\u6709\u4efb\u4f55\u75be\u75c5\uff0c\u4f46\u662f\u75c5\u6b77\u4e0a\u986f\u793a\u75c5\u4eba\u6709\u6d77\u6d1b\u56e0(heroin)\u6feb\u7528\u7684\u75c5\u53f2\uff0c\u8eab\u9ad4\u6aa2\u67e5\u767c\u73fe\u75c5\u4eba\u77b3\u5b54\u653e\u5927\u8207\u76ae\u819a\u8d77\u96de\u76ae\u7599\u7629(goosebump )\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u6b64\u75c5\u4eba\u53ef\u80fd\u662f\u6d77\u6d1b\u56e0\u6212\u65b7\u75c7\u5019\u7fa4\u3002 (B)\u5927\u591a\u6578\u6d77\u6d1b\u56e0\u6212\u65b7\u75c7\u5019\u7fa4\u5728\u505c\u85e5 36-72\u5c0f\u6642\u5f8c\u51fa\u73fe\uff0c\u53ef\u6301\u7e8c 7-10\u5929\u3002 (C)\u9d09\u7247\u985e\u85e5\u7269\u6212\u65b7\u75c7\u5019\u7fa4\u75c7\u72c0\u6301\u7e8c\u6700\u4e45\u7684\u662f\u7f8e\u6c99\u51ac( methadone )\u3002 (D)\u9d09\u7247\u985e\u85e5\u7269\u6212\u65b7\u75c7\u5019\u7fa4\u75c7\u72c0\u6700\u56b4\u91cd\u7684\u662f\u6d77\u6d1b\u56e0\u3002 (E)\u82e5\u662f\u8f15\u5ea6\u9d09\u7247\u985e\u85e5\u7269\u6212\u65b7\u75c7\u5019\u7fa4\uff0c\u53ef\u4ee5\u8003\u616e\u4f7f\u7528 buprenorphine \u6216naloxone\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "30\u6b72\u7537\u6027\u56e0\u5168\u8eab\u50f5\u786c\u3001\u610f\u8b58\u4e0d\u6e05\u53ca\u9ad8\u71d2\u4e0d\u9000\u88ab\u9001\u81f3\u6025\u8a3a\uff0c\u75c5\u4eba\u65bc\u7cbe\u795e\u79d1\u9580\u8a3a\u898f\u5247\u670d\u7528\u6297\u7cbe\u795e\u75c5\u85e5\u7269(antipsychotics ) \uff0c\u521d\u6b65\u8a3a\u65b7\u70ba\u6297\u7cbe\u795e\u75c5\u85e5\u7269\u60e1\u6027\u75c7\u5019\u7fa4( neuroleptic malignant syndrome , NMS) \uff0c\u4e0b\u5217\u6709\u95dc\u6297\u7cbe\u795e\u75c5\u85e5\u7269\u60e1\u6027\u75c7\u5019\u7fa4\u4e4b\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u53ef\u7528 dentrolene sodium \u6216bromocriptine \u6cbb\u7642\u5168\u8eab\u50f5\u786c\u3002 (B)\u53ef\u80fd\u6703\u6709\u81ea\u5f8b\u795e\u7d93\u529f\u80fd\u5931\u8abf(autonomic dysfunction ) \uff0c\u5982\u5fc3\u8df3\u5feb\u3001\u767c\u6c57\u53ca\u8840\u58d3\u7570\u5e38\u3002 (C)\u6b7b\u4ea1\u7387\u53ef\u9ad8\u9054 20%\u3002 (D)\u5fc5\u9808\u505c\u7528\u6297\u7cbe\u795e\u75c5\u85e5\u7269(antipsychotics )\u3002 (E)\u6297\u81bd\u9e7c\u85e5\u7269(anticholinergic medications)\u901a\u5e38\u6709\u5e6b\u52a9\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u5c0d\u65bc\u9152\u7cbe\u6212\u65b7\u75c7\u5019\u7fa4( alcohol withdrawal syndrome ) \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u9152\u7cbe\u6212\u65b7\u6027\u7672\u7647(alcohol withdrawl seizures ) \uff0c\u901a\u5e38\u70ba diffuse tonic -clonic seizures \u3002 (B)\u9152\u7cbe\u6212\u65b7\u6027\u7672\u7647\uff0c\u85e5\u7269\u6cbb\u7642\u9996\u9078\u70ba benzodiazepines \u3002 (C)\u9152\u7cbe\u6212\u65b7\u6027\u7672\u7647\uff0cphenytoin \u4ea6\u70ba\u5e38\u7528\u85e5\u7269\uff0c\u91cd\u8907\u7d66\u4e88\u521d\u59cb\u5291\u91cf(repeated loading)\u53ef\u63d0\u9ad8\u7672\u7647\u95be\u503c(seizure threshold)\u3002 (D)\u9152\u7cbe\u6212\u65b7\u6027\u8b6b\u5984(alcohol withdrawl delirium ) \uff0c\u5e38\u767c\u751f\u5728\u6700\u5f8c\u4e00\u6b21\u559d\u9152\u5f8c\u7684 3\u81f35\u5929\u5167\uff0c\u53ef\u6301\u7e8c 48\u81f372\u5c0f\u6642\uff0c\u751a\u81f3\u66f4\u4e45\u3002 (E)\u9152\u7cbe\u6212\u65b7\u6027\u5e7b\u89ba\u75c7(alcohol withdrawl hallucinosis) \uff0c\u5e38\u4ee5\u6297\u7cbe\u795e\u75c5(antipsychotics )\u85e5\u7269\u6cbb\u7642\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8179\u819c\u900f\u6790\u5c0e\u7ba1( PD catheter )\u611f\u67d3\uff0c\u4e0b\u5217\u6558\u8ff0\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u901a\u5e38\u6703\u767c\u71d2\uff0c\u4f46\u5c0e\u7ba1\u51fa\u53e3\u8655(catheter exit site )\u5c11\u6709\u5c40\u90e8\u7d05\u816b\u6216\u75bc\u75db\u3002 (B)\u4ee5 Streptococcus viridans \u70ba\u6700\u5e38\u898b\u83cc\u7a2e\u3002 (C)\u82e5\u75c5\u4eba\u53ef\u65bc\u9580\u8a3a\u8ffd\u8e64\u6cbb\u7642\uff0c\u53ef\u4f7f\u7528\u7b2c\u4e00\u4ee3\u53e3\u670d cephalosporins \u4f5c\u70ba\u7d93\u9a57\u6027\u6297\u751f\u7d20\u6cbb\u7642\u3002 (D)\u5982\u62bd\u53d6\u8179\u6c34\u505a\u5316\u9a57\uff0c\u9808\u770b\u5230 leukocyte \u5927\u65bc 250/mm3\uff0c\u5408\u4f75\u4e2d\u6027\u7403\u5927\u65bc50%\u59cb\u80fd\u78ba\u8a3a\u3002 (E)\u6240\u6709 PD catheter \u611f\u67d3\u75c5\u4eba \u5747\u61c9\u4f4f\u9662\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "17\u6b72\u7537\u6027\uff0c\u56e0\u776a\u4e38\u75bc\u75db\u96e3\u8010\u800c\u81f3\u8a3a\u6240\u6c42\u8a3a\uff0c\u8a3a\u6240\u91ab\u5e2b\u61f7\u7591\u662f\u6025\u6027\u776a\u4e38\u626d\u8f49(testicular torsion )\u800c\u5c07\u75c5\u4eba\u8f49\u4ecb\u81f3\u6025\u8a3a\u3002\u95dc\u65bc\u6b64\u75c5\u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u60a3\u5074\u4e4b\u776a\u4e38\u6703\u6709\u5c40\u90e8\u58d3\u75db\u3002 (B)\u8eab\u9ad4 \u6aa2\u67e5\u6642\uff0c\u60a3\u5074\u4e4b\u63d0\u776a\u808c\u53cd\u5c04(cremasteric reflex )\u53ef\u80fd\u70ba\u6b63\u5e38\u6216\u6d88\u5931\u3002 (C)\u8eab\u9ad4 \u6aa2\u67e5\u6642\uff0c\u6258\u8d77\u60a3\u5074\u776a\u4e38\u6703\u6e1b\u7de9\u75bc\u75db\uff0c\u7528\u4f86\u9451\u5225\u776a\u4e38\u626d\u8f49\u6216\u526f\u776a\u708e\u7684\u654f\u611f\u5ea6\u76f8\u7576\u597d\u3002 (D)\u6b64\u75c5\u5c6c\u65bc\u6ccc\u5c3f\u6025\u75c7\uff0c\u61c9\u7dca\u6025\u6703\u8a3a\u6ccc\u5c3f\u79d1\u91ab\u5e2b\uff0c\u4e26\u8003\u616e\u9032\u884c\u624b\u52d5\u5fa9\u4f4d(manual detorsion )\u3002 (E)\u624b\u52d5\u5fa9\u4f4d\uff0c\u5982\u75bc\u75db\u611f\u6e1b\u7de9\uff0c\u53ef\u7528\u675c\u535c\u52d2\u8d85\u97f3\u6ce2\u78ba\u8a8d\u776a\u4e38\u662f\u5426\u6062\u5fa9\u8840\u6d41\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "25\u6b72\u7537\u6027\uff0c\u4e3b\u8a34\u6f38\u9032\u5f0f\u5de6\u4e0b\u8179\u75db 3\u5929\uff0c\u5c0f\u4fbf\u75bc\u75db\u4ee5\u53ca\u5c3f\u9053\u53e3\u6709\u9ec3\u6fc1\u8272\u5206\u6ccc\u7269\uff0c\u751f\u547d\u5fb5\u8c61\u5982\u4e0b\uff1a\u8840\u58d3 135/80mmHg\uff0c\u5fc3\u8df3 110\u6b21/min\uff0c\u547c\u5438 22\u6b21/min\uff0c\u9ad4\u6eab 38.4\u00b0C\u3002\u5c3f\u6db2\u5be6\u9a57\u5ba4\u6aa2\u67e5\uff1aRBC 0 -3/HPF\uff0cWBC 50 -99/HPF\u3002\u95dc\u65bc\u6b64\u75c5\u4eba\u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u5982\u89f8\u8a3a\u9670\u56ca\u767c\u73fe\u5de6\u5074\u58d3\u75db\uff0c\u53ef\u80fd\u5408\u4f75\u776a\u4e38\u526f\u776a\u4e38\u708e(epididymo -orchitis)\u3002 (B)\u82e5\u9019\u4f4d\u75c5\u4eba\u8a3a\u65b7\u70ba\u526f\u776a\u4e38\u708e\uff0c\u5e38\u898b\u4e4b\u81f4\u75c5\u83cc\u4e3b\u8981\u662f E.coli\u3001K.pneumoniae \u7b49\u683c\u862d\u6c0f\u9670\u6027\u687f\u83cc\u3002 (C)\u6b64\u75c5\u4eba\u5de6\u4e0b\u8179\u75db\u53ef\u80fd\u662f\u8f49\u79fb\u75db( refer pain )\u3002 (D)\u82e5\u5408\u4f75\u776a\u4e38\u526f\u776a\u4e38\u708e\uff0c\u5f69\u8272\u675c\u535c\u52d2\u8d85\u97f3\u6ce2\u4e0b\uff0c\u53ef\u770b\u5230\u5de6\u5074\u776a\u4e38\u4e4b\u8840\u6d41\u6bd4\u53f3\u5074\u7a0d\u5fae\u589e\u52a0\u3002 (E)\u6297\u751f\u7d20\u4e4b\u9996\u9078\u70ba\u55ae\u6b21\u808c\u8089\u6ce8\u5c04 ceftriaxone 250mg\u53ca\u53e3\u670d doxycycline 10\u5929\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "45\u6b72\u7537\u6027\u56e0\u5de6\u5074\u8170\u75db\u81f3\u6025\u8a3a\uff0c\u5c3f\u6db2\u6aa2\u67e5\u7d50\u679c\u5982\u4e0b\uff1a RBC >100/HPF \u3001WBC 0-3/HPF\uff0cBacteria (-) \u3002\u8d85\u97f3\u6ce2\u6aa2\u67e5\u767c\u73fe\u6709\u4e00\u9846 0.8\u516c\u5206\u7684\u5de6\u5074\u8f38\u5c3f\u7ba1\u7d50\u77f3\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u8f38\u5c3f\u7ba1\u814e\u76c2\u4ea4\u754c\u8655(ureteropelvic junction)\u662f\u5e38\u898b\u597d\u767c\u7684\u4f4d\u7f6e\u4e4b\u4e00\u3002 (B)\u6709 10%- 15%\u7684\u75c5\u4eba\u4e0d\u6703\u6709\u8840\u5c3f\u7684\u8868\u73fe\u3002 (C)\u8a72\u75c5\u4eba\u7d50\u77f3\u6709 98%\u7684\u6a5f\u6703\u80fd\u5728\u4e00\u500b\u6708\u5167\u96a8\u8457\u5c3f\u6db2\u81ea\u884c\u6392\u51fa\u3002 (D)\u6025\u6027\u767c\u4f5c\u4e4b\u75bc\u75db\u63a7\u5236\u4ee5 NSAID\u70ba\u9996\u9078\u85e5\u7269\u3002 (E)\u6bd4\u8d77\u8d85\u97f3\u6ce2\uff0cnon -contrast CT \u70ba\u66f4\u654f\u611f\u7684\u8a3a\u65b7\u5de5\u5177\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "35\u6b72\u5973\u6027\u75c5\u4eba\u56e0\u982d\u6688\u3001\u5614\u5410\u4f86\u8a3a\uff0c\u8a3a\u67e5\u767c\u73fe\u75c5\u4eba\u8e81\u52d5( agitation) \u3001\u6709\u6c34\u5e73\u773c\u9707( nystagmus ) \u3001\u8907\u8996(diplopia ) \u3001\u6b65\u614b\u4e0d\u7a69(ataxia )\u53ca\u7259\u9f66\u589e\u751f(gingival hyperplasia )\u73fe\u8c61\uff0c\u4e0b\u5217\u4f55\u8005\u662f\u6700\u53ef\u80fd \u7684\u8a3a\u65b7\uff1f", + "Options": "(A)Amphetamine intoxication \u3002 (B)Hyperthyroidism \u3002 (C)Opioid withdraw syndrome \u3002 (D)Phenytoin intoxication\u3002 (E)Rabies \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "65\u6b72\u5973\u6027\u5728\u5bb6\u660f\u5012\u88ab\u5bb6\u5c6c\u5e36\u4f86\u6025\u8a3a\uff0c BT\uff1a35.5\u2103\uff0cHR\uff1a50\u6b21/min\uff0cRR\uff1a16\u6b21/min\uff0cBP\uff1a80/50mmHg \uff0cGCS\uff1aE3V5M6\uff0c\u4e3b\u8a34\u6700\u8fd1\u611f\u5192\u3001\u5168\u8eab\u7121\u529b\u3001\u8fd1\u4e00\u500b\u6708\u90fd\u5403\u4e0d\u4e0b\u3001\u4fbf\u79d8\uff0c\u4f46\u6c92\u8b8a\u7626\u3001\u6389\u982d\u9aee\u3001\u591a\u8655\u95dc\u7bc0\u75db\uff0c\u770b\u8d77\u4f86\u773c\u76ae\u6d6e\u816b\u3001\u76ae\u819a\u4e7e\u8e81\uff0c\u4e0b\u5217\u4f55\u8005\u6700\u53ef\u80fd \u70ba\u5176\u8a3a\u65b7\uff1f", + "Options": "(A)Angiostrongylus cantonensis infection\u3002 (B)Digoxin intoxication\u3002 (C)Hepatic encephalopathy \u3002 (D)Lead poisoning\u3002 (E)Myxedema coma \u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "50\u6b72\u5973\u6027\u56e0\u6700\u8fd1\u6578\u65e5\u5026\u6020\u7121\u529b\u3001\u81c9\u90e8\u6613\u62bd\u7b4b\u4f86\u8a3a\uff0c\u4e3b\u8a34 \u624b\u6307\u672b\u68a2\u53ca\u5634\u9644\u8fd1\u767c\u9ebb\uff0c\u751f\u547d\u5fb5\u8c61\u6b63\u5e38\uff0c\u6aa2\u50b7\u8b77\u7406\u5e2b\u8aaa\u75c5\u4eba\u91cf\u8840\u58d3\u6642\u51fa\u73fe \u300c\u84ee\u82b1\u6307 \u300d(\u624b\u6307 interphalangeal joints \u4f38\u5f35\u3001 metacarpophalangeal joints \u5f4e\u66f2\u3001\u624b\u8155flexion) \uff0c\u61f7\u7591\u5979\u662f\u904e\u5ea6\u63db\u6c23\uff0c\u8acb\u554f\u4e0b\u5217\u54ea\u9805\u6aa2\u9a57\u6700\u70ba\u5fc5\u8981 \uff1f", + "Options": "(A)Arterial blood gas\u3002 (B)Calcium \u3002 (C)Glucose \u3002 (D)Potassium \u3002 (E)Troponin\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "70\u6b72\u7537\u6027\u4e3b\u8a34 1\u5c0f\u6642\u524d\u7a81\u767c\u982d\u75db\u3001\u53f3\u908a\u770b\u4e0d\u5230\uff0c\u6aa2\u67e5\u767c\u73fe\u5de6\u53f3\u5169\u773c\u7684\u53f3\u534a\u908a\u90fd\u770b\u4e0d\u5230\uff0c\u96d9\u773c\u77b3\u5b54\u7b49\u5927\uff0c\u5149\u53cd\u61c9\u6b63\u5e38\uff0c\u56db\u80a2\u808c\u529b\u6b63\u5e38\uff0c\u4e0b\u5217\u4f55\u8005\u662f \u6700\u53ef\u80fd\u7684\u9451\u5225\u8a3a\u65b7\uff1f", + "Options": "(A)Glaucoma \u3002 (B)Left occipital lobe infarction \u3002 (C)Pituitary apoplexy \u3002 (D)Right occipital lobe arteriovenous malformation \u3002 (E)Right optic neuritis\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8178\u963b\u585e\u7684\u75c7\u72c0\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u53ea\u6709\u7d04\u4e00\u534a\u75c5\u4eba\u6709\u8179\u75db\u3002 (B)\u8fd1\u7aef\u963b\u585e(proximal obstruction )\u8f03\u5c11\u6709\u5614\u5410\u3002 (C)\u75db\u5927\u591a\u662f\u6301\u7e8c\u7684\uff0c\u5f88\u5c11\u6709\u9663\u767c\u6027\u7d5e\u75db\u3002 (D)\u7121\u52d5\u6027\u8178\u963b\u585e(adynamic ileus )\u901a\u5e38\u75bc\u75db\u7a0b\u5ea6\u8f03\u6a5f\u68b0\u6027\u963b\u585e(mechanical obstruction )\u56b4\u91cd\u3002 (E)\u5927\u8178\u963b\u585e\u5e38\u75db\u5728\u4e0b\u8179\u90e8(hypogastric )\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "32\u6b72\u5973\u6027\u56e0\u6182\u9b31\u75c7\u670d\u7528\u5927\u91cf\u85e5\u7269\u5f8c\u610f\u8b58\u660f\u8ff7\u88ab\u9001\u81f3\u6025\u8a3a\uff0c\u660f\u8ff7\u6307\u6578E2V3M4\u3001\u8840\u58d3 70/45 mmHg\u3001\u5fc3\u8df3 115\u6b21/min\u3001\u547c\u5438 25\u6b21/min\u3001\u9ad4\u6eab36.5\u00b0C\uff0c\u5fc3\u96fb\u5716\u767c\u73fe prolonged QRS \u53caterminal R wave in aVR \uff0c\u8acb\u554f\u6700\u4e0d\u53ef\u80fd\u662f\u4e0b\u5217\u4f55\u8005\u85e5\u7269\u4e2d\u6bd2\uff1f", + "Options": "(A)T razodone\u3002 (B)D iphenhydramine \u3002 (C)Carbamazepine \u3002 (D)A mitriptyline \u3002 (E)H ydroxyzine \u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "25\u6b72\u5973\u6027\u559d\u4e86 3\u5929\u524d\u716e\u7684\u56db\u7269\u6e6f\u5f8c\uff0c\u56e0\u89ba\u5f97\u982d\u75db\u3001\u547c\u5438\u6025\u4fc3\u53ca\u5168\u8eab\u7121\u529b\u800c\u81f3\u6025\u8a3a\u5c31\u91ab\uff0c\u62bd\u8840\u6642\u767c\u73fe\u75c5\u4eba\u8840\u6db2\u662f\u5de7\u514b\u529b\u7684\u984f\u8272(chocolate brown)\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u52d5\u8108\u6c23\u9ad4\u5206\u6790\u986f\u793a methemoglobin \u6fc3\u5ea6 9%\u3002 (B)pulse oximetry \u65bc\u6b64\u75c5\u4eba\u53ef\u80fd\u6703\u9ad8\u4f30\u771f\u5be6\u7684\u52d5\u8108\u8840\u6db2\u6c27\u5408\u72c0\u614b\u3002 (C)\u75c5\u4eba\u6307\u7532\u6703\u5448\u73fe\u7070\u85cd\u8272(gray -blue discoloration )\u3002 (D)\u9700\u8981\u7d66\u4e88\u7532\u57fa\u85cd( methylene blue )\u6cbb\u7642\u3002 (E)\u56db\u7269\u6e6f\u53ef\u80fd\u542b\u6709\u4e9e\u785d\u9178\u9209(sodium nitrite )\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "55\u6b72\u5973\u6027\u5169\u5c0f\u6642\u524d\u559d\u5927\u91cf\u9664\u8349\u5291\uff0c\u56e0\u6301\u7e8c\u5614\u5410\u3001\u610f\u8b58\u4e0d\u6e05\u9001\u81f3\u6025\u8a3a\uff0c\u75c5\u4eba\u8863\u670d\u4e0a\u6709\u85cd\u7da0\u8272\u6db2\u9ad4\uff0c\u660f\u8ff7\u6307\u6578 E1V2M5\u3001\u8840\u58d3 100/65 mmHg \u3001\u5fc3\u8df3 105\u6b21/min\u3001\u547c\u5438 26\u6b21/min\u3001SpO 2 86%\uff0c\u4e0b\u5217\u4f55\u8005\u6558\u8ff0 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u75c5\u4eba\u9700\u8981\u6c23\u7ba1\u63d2\u7ba1\u6cbb\u7642\u3002 (B)\u662f\u5df4\u62c9\u5208(paraquat )\u4e2d\u6bd2\u3002 (C)\u75c5\u4eba\u809d\u529f\u80fd\u6307\u6578\u53ef\u80fd\u6703\u5347\u9ad8\u3002 (D)\u76ee\u524d\u7121\u89e3\u6bd2\u5291\u3002 (E)\u4e3b\u8981\u6cbb\u7642\u70ba \u652f\u6301\u6027\u7642\u6cd5\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6839\u64da\u9732\u6613\u7d72\u6e56\u6025\u6027\u9ad8\u5c71\u75c5( Lake Louise Acute Mountain Sickness)\u8a3a\u65b7\uff0c\u4e0b\u5217\u54ea\u4e00\u500b\u81e8\u5e8a\u75c7\u72c0\u5fc5\u9808\u51fa\u73fe\uff0c\u624d\u80fd\u8a3a\u65b7\u70ba\u6025\u6027\u9ad8\u5c71\u75c5\uff1f", + "Options": "(A)\u982d\u75db\u3002 (B)\u80c3\u53e3\u4e0d\u4f73\u3001\u5641\u5fc3\u6216\u5614\u5410\u7b49\u8178\u80c3\u9053\u75c7\u72c0\u3002 (C)\u75b2\u7d2f\u6216\u865b\u5f31\u3002 (D)\u982d\u6688\u3002 (E)\u5931\u7720\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "25\u6b72\u7537\u6027\uff0c\u6500\u767b\u7389\u5c71\uff0c\u7b2c\u4e00\u5929\u665a\u4e0a\u4f4f\u5728\u6392\u96f2\u5c71\u838a(\u9ad8\u5ea6 3,402\u516c\u5c3a) \uff0c\u7b2c\u4e8c\u5929\u6500\u767b\u7389\u5c71\u4e3b\u5cf0\u5f8c\uff0c\u4e0b\u5348\u5230\u9054\u7389\u5c71\u5317\u5cf0(\u9ad8\u5ea6 3,850\u516c\u5c3a) \uff0c\u665a\u4e0a\u5728\u7389\u5c71\u5317\u5cf0\u767c\u751f\u547c\u5438\u56f0\u96e3\uff0c\u4e26\u54b3\u51fa\u6ce1\u6cab\u5e36\u8840\u4e4b\u75f0\u6db2\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u6700\u4e0d \u9069\u7576\uff1f", + "Options": "(A)\u7d66\u4e88\u6c27\u6c23\u3002 (B)\u4e0b\u964d\u9ad8\u5ea6\u3002 (C)\u4f7f\u7528\u52a0\u58d3\u888b(hyperbaric chamber )\u6cbb\u7642\u3002 (D)\u4f7f\u7528 nifedipine \u6cbb\u7642\u3002 (E)\u4f7f\u7528 Diamox(acetazolamide )\u6cbb\u7642\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6e1b\u58d3\u75c5( decompression sickness)\u7684\u9632\u6cbb\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u6e1b\u58d3\u75c5\u4e3b\u56e0\u6c2e\u6c23\u7d2f\u7a4d\u5728\u7d44\u7e54\u6216\u8840\u7ba1\u6240\u81f4\u3002 (B)\u7b2c\u4e00\u578b\u6e1b\u58d3\u75c5(Type I decompression sickness )\u6240\u7522\u751f\u7684\u6df1\u90e8\u95dc\u7bc0\u75bc\u75db\uff0c\u6700\u5e38\u767c\u751f\u65bc\u819d\u6216\u80a9\u95dc\u7bc0\u3002 (C)\u5c0d\u65bc\u56b4\u91cd\u75c7\u72c0\u4e4b\u6e1b\u58d3\u75c5\uff0c\u61c9\u76e1\u5feb\u4f7f\u7528\u518d\u52a0\u58d3(recompression )\u6cbb\u7642\u3002 (D)\u5efa\u8b70\u7d66\u4e88\u9ede\u6ef4\u6ce8\u5c04\uff0c\u4ee5\u589e\u52a0\u7d44\u7e54\u704c\u6d41\u3002 (E)\u5c0d\u65bc\u904b\u9001\u52d5\u8108\u6c23\u9ad4\u6813\u585e(arterial gas embolism )\u7684\u75c5\u4eba\uff0c\u4e0d\u5efa\u8b70\u4ee5\u5e73\u8eba\u7684\u59ff\u52e2\u904b\u9001\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "55\u6b72\u4e2d\u5e74\u5a66\u5973\uff0c\u9ad4\u578b\u5fae\u80d6\uff0c\u56e0\u70ba\u4e0a\u8179\u75db\u5408\u4f75\u5641\u5fc3\u5614\u5410\u4f86\u6025\u8a3a\uff0c\u62bd\u8840\u6aa2\u9a57\u5982\u4e0b\uff1a WBC 18,000/mm3(\u6b63\u5e38\u7bc4\u570d<10 ,000/mm3)\uff0cGOT( AST)150 IU/L(\u6b63\u5e38\u503c\u70ba:8\uff5e40 IU/L )\uff0cTotal Bilirubin 1.2 mg/dL (\u6b63\u5e38\u503c\u70ba\uff1a0.4 -1.2 mg/dL)\uff0cDirect bilirubin 0.4 mg/dL (\u6b63\u5e38\u7bc4\u570d\uff1a<0.4 mg/dL ) \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6700\u9069\u7576 \uff1f", + "Options": "(A)Acute acalculous cholecystitis \u6bd4 calculous cholecystitis \u5e38\u898b\u3002 (B)Emphysematous cholecystitis \u597d\u767c\u65bc\u5e74\u8f15\u4eba\u53ca\u7cd6\u5c3f\u75c5\u60a3\u8005\u3002 (C)Murphy's sign \u70ba\u6309\u4f4f\u53f3\u4e0a\u8179\uff0c\u75c5\u4eba\u5410\u6c23\u6642\u6703\u56e0\u75bc\u75db\u800c\u4e2d\u6b62\u3002 (D)\u8179\u90e8\u8d85\u97f3\u6ce2\u6aa2\u67e5\u986f\u793a gallbladder wall thickness > 2mm \u52a0\u4e0apericholecystic fluid \u5373\u53ef\u8a3a\u65b7 cholecystitis \u3002 (E)\u8179\u90e8\u8d85\u97f3\u6ce2\u6aa2\u67e5\u70ba\u6b64\u75c5\u4eba\u7684\u9996\u9078\u5f71\u50cf\u8a3a\u65b7\u5de5\u5177\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8179\u7009 \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u5927\u90e8\u5206\u75c5\u4eba\u8179\u7009\u591a\u70ba\u75c5\u6bd2\u5f15\u8d77\u3002 (B)Clostridium difficile \u611f\u67d3\u5e38\u898b\u65bc\u9662\u5167\u4f7f\u7528\u6297\u751f\u7d20 7\u81f310\u5929\u5f8c\u3002 (C)\u507d\u819c\u6027\u7d50\u8178\u708e(p seudomembranous colitis )\u5927\u90e8\u5206\u767c\u751f\u65bc\u5927\u8178\uff0c\u5167\u8996\u93e1\u53ef\u898b \u9ec3\u767d\u8272\u507d\u819c\u3002 (D)\u65c5\u884c\u8005\u8179\u7009( Traveler's diarrhea )\u591a\u70ba\u7d30\u83cc\u611f\u67d3\u3002 (E)\u611f\u67d3\u6027\u8179\u7009\u75c5\u4eba\u4e0d\u53ef\u4ee5\u4f7f\u7528 loperamide \u4ee5\u6e1b\u8f15\u75c7\u72c0\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u81ea\u767c\u6027\u7d30\u83cc\u8179\u819c\u708e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u809d\u786c\u5316\u8179\u6c34\u75c5\u4eba\uff0c\u6bcf\u5e74\u767c\u751f\u81ea\u767c\u6027\u7d30\u83cc\u8179\u819c\u708e\u7387\u7d04\u70ba 30%\u3002(B)\u8a3a\u65b7\u6a19\u6e96\u70ba\u767d\u8840\u7403 >250/mm3\uff0c\u6216\u55dc\u4e2d\u6027\u767d\u8840\u7403 >50/mm3\u3002(C)\u6700\u5e38\u898b\u75c5\u539f\u83cc\u70ba Escherichia coli \uff0cKlebsiella pneumoniae \uff0cStreptococcal pneumoniae \u3002(D)\u4f7f\u7528\u7b2c\u4e09\u4ee3 cephalosporins \u6cbb\u7642\u662f\u5408\u7406\u7684\u9078\u64c7\u3002(E)\u5728\u8a3a\u65b7\u81ea\u767c\u6027\u7d30\u83cc\u8179\u819c\u708e\u6642\uff0c\u7d66\u4e88 albumin 1.5g/kg\uff0c\u53ca\u7b2c\u4e09\u5929\u7d66\u4e88albumin 1g/kg \u6709\u52a9\u65bc\u964d\u4f4e\u6025\u6027\u814e\u8870\u7aed\u7684\u6a5f\u6703\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "18\u6b72\u7537\u6027\u5e74\u8f15\u4eba\u98f2\u9152\u72c2\u6b61\uff0c\u9152\u5f8c\u5287\u70c8\u5614\u5410\u5f15\u8d77\u80f8\u75db\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u98df\u9053\u7834\u88c2\u9020\u6210\u7684\u75bc\u75db\u5e38\u5e38\u662f\u6025\u6027\uff0c\u4e14\u6703\u8f3b\u5c04\u5230\u80cc\u90e8\u3002 (B)\u75c5\u4eba\u53ef\u80fd\u6703\u6709\u541e\u56a5\u56f0\u96e3\u3001\u547c\u5438\u56f0\u96e3\u3001\u5410\u8840\u53ca\u767c\u7d3a\u7684\u8868\u73fe\u75c7\u72c0\u3002 (C)\u82e5\u7b2c\u4e00\u6642\u9593 X\u5149\u6aa2\u67e5\u6c92\u6709\u770b\u5230\u7e31\u8188\u8154\u6c23\u816b( mediastinal emphysema ) \uff0c\u4e5f\u4e0d\u80fd\u6392\u9664\u4e0b\u6bb5\u98df\u9053\u7834\u88c2\u3002 (D)\u82e5\u7834\u88c2\u8655\u4f4d\u65bc\u9ad8\u4f4d\u98df\u9053(cervical perforations) \uff0c\u5e38\u4f75\u767c\u808b\u819c\u7a4d\u6db2\u3002 (E)\u5e38\u767c\u751f\u98df\u9053\u7834\u88c2\u8655\u70ba\u9060\u7aef\u98df\u9053\u5de6\u5074\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6025\u6027\u80f0\u81df\u708e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)80% \u5de6\u53f3\u7684\u75c5\u4eba\u53ea\u6709\u8f15\u5fae\u7684\u767c\u708e\uff0c\u6b7b\u4ea1\u7387\u5c0f\u65bc 1%\u3002 (B)\u5927\u90e8\u5206\u7684\u75c5\u4eba\u4e0d\u9700\u6297\u751f\u7d20\u6cbb\u7642\u3002 (C)\u5e38\u898b\u7684\u539f\u56e0\u5305\u62ec gall stones\u3001alcohol\u7b49\u3002 (D)\u9808\u7b49\u8179\u75db\u6d88\u5931\u5f8c\uff0c\u624d\u80fd\u5617\u8a66\u6d41\u8cea\u98f2\u98df\u3002 (E)\u7576\u75c5\u4eba\u81e8\u5e8a\u8868\u73fe\u53ca\u5404\u9805\u6aa2\u9a57\u6578\u64da\u7686\u7b26\u5408\u6025\u6027\u80f0\u81df\u708e\u8a3a\u65b7\u6642\uff0c\u4e0d\u4e00\u5b9a\u9700\u8981\u5b89\u6392\u8179\u90e8\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "5\u6b72\u5973\u7ae5\uff0c\u4e3b\u8a34 3\u5929\u524d\u958b\u59cb\u6709\u8f15\u5ea6\u611f\u5192\u75c7\u72c0\uff0c 2\u5929\u524d\u958b\u59cb\u65b7\u65b7\u7e8c\u7e8c\u8179\u75db\uff0c\u56e0\u8179\u75db\u52a0\u5287\u5230\u6025\u8a3a\u5ba4\u6c42\u8a3a\uff0c\u7576\u6642\u5169\u5074\u819d\u95dc\u7bc0\u53ca\u4e0b\u80a2\u75bc\u75db\u73fe\u8c61\u660e\u986f\uff0c\u4e0b\u80a2\u4e26\u51fa\u73fe\u7d05\u8272\u6591\u9ede\u53ca\u985e\u4f3c\u7600\u9752\u75c5\u7076\uff0c\u5927\u4fbf\u5e36\u6709\u8840\u7d72\uff0c\u7121\u767c\u71d2\uff0c\u7121\u5614\u5410\uff0c\u4e5f\u7121\u5916\u50b7\u53f2\uff0c\u904e\u53bb\u7121\u4efb\u4f55\u6162\u6027\u75be\u75c5\uff0c\u7121\u904e\u654f\u75c5\u53f2\u3002\u6025\u8a3a\u8840\u6db2\u6aa2\u9a57\u7d50\u679c\u5982\u4e0b\uff1as ugar 78 mg/dL \uff0cBUN 18mg/dL\uff0camylase 51 U/L \uff0cAST 45 U/L \uff0cCRP 0.85 mg/L\uff0c WBC 12 ,100/uL\uff0cHb 11.8 g/dL \uff0cHct 36.5 % \uff0cplatelet 389 k/uL \uff0c\u5c3f\u6db2\u6aa2\u67e5\u7d50\u679c\uff1a WBC 5/HPF \uff0cRBC 40/HPF\u3002\u6b64\u60a3\u8005\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\u70ba\u4e0b\u5217\u4f55\u8005\uff1f", + "Options": "(A)Immune thrombocytopenic purpura (ITP)\u3002 (B)Hemophilia \u3002 (C)Henoch -Schonlein purpura \u3002 (D)V on Willebrand disease\u3002 (E)Meningocococemia \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u61f7\u5b55 27\u9031\u5b55\u5a66\u65bc\u6025\u8a3a\u5ba4\u6025\u7522\u5f8c\uff0c\u7531\u6025\u8a3a\u91ab\u5e2b\u5b8c\u6210\u65b7\u81cd\uff0c\u7576\u6642\u6aa2\u67e5\u767c\u73fe\u5916\u89c0\u7121\u767c\u7d3a\uff0c\u8ec0\u5e79\u53ca\u624b\u8db3\u5c1a\u7d05\u6f64\uff0c\u80a2\u9ad4\u5448\u73fe\u5f4e\u66f2\uff0c\u62bd\u5438\u547c\u5438\u9053\u5206\u6ccc\u7269\u6642\u81c9\u90e8\u6709\u53cd\u61c9\uff0c\u54ed\u8072\u5fae\u5f31\uff0c\u5fc3\u8df3 88\u6b21/min\uff0c\u8acb\u554f APGAR score \u8a08\u7b97\u7d50\u679c\u70ba\u4f55\uff1f", + "Options": "(A)3\u3002 (B)4\u3002 (C)5\u3002 (D)6\u3002 (E)7\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "9\u500b\u6708\u5927\u5973\u7ae5\uff0c\u9ad4\u91cd 10\u516c\u65a4\uff0c\u5bb6\u5c6c\u4ee3\u4e3b\u8a34\u5973\u7ae5 20\u5206\u9418\u524d\u767c\u751f\u62bd\u6410\uff0c\u81e8\u5e8a\u8868\u73fe\u70ba\u773c\u775b\u4e0a\u540a\uff0c\u610f\u8b58\u55aa\u5931\uff0c\u5169\u5074\u56db\u80a2\u50f5\u76f4\u4e14\u96a8\u5f8c\u62bd\u52d5\uff0c\u6301\u7e8c 15-20\u5206\u9418\uff0c\u5230\u9054\u6025\u8a3a\u6642\u8868\u73fe\u55dc\u7761\uff0c\u5bb6\u5c6c\u8868\u793a\u8fd1\u65e5\u6709\u611f\u5192\u75c7\u72c0\uff0c\u98df\u617e\u6b20\u4f73\uff0c\u751f\u547d\u5fb5\u8c61\u5982\u4e0b\uff1a\u547c\u5438 26\u6b21/min\uff0c\u5fc3\u8df3 162\u6b21/min\uff0c\u672a\u4f7f\u7528\u8f14\u52a9\u6c27\u6c23\u6642\u8840\u6c27 \u98fd\u548c\u5ea697%\uff0ccapillary refilling time<2 \u79d2\u3002\u75c5\u7ae5 \u5076\u723e\u54ed\u9b27\uff0c\u547c\u5438\u6dfa\u5feb\u4f46\u4e0d\u8cbb\u529b\uff0c\u819a\u8272\u7d05\u6f64\uff0c\u8179\u90e8\u89f8\u8a3a\u7d50\u679c\u70ba\u67d4\u8edf\u7121\u660e\u986f\u58d3\u75db\uff0c\u7121\u809d\u813e\u816b\u5927\uff0c\u80ba\u97f3\u807d\u8a3a\u6b63\u5e38\uff0c\u7121\u5fc3\u96dc\u97f3\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u9996\u8981\u4efb\u52d9\u662f\u78ba\u4fdd\u547c\u5438\u9053\u66a2\u901a\uff0c\u7a69\u5b9a\u751f\u547d\u5fb5\u8c61\u3002 (B)\u5982\u679c\u4f4e\u8840\u7cd6\u5c0e\u81f4\uff0c\u61c9\u7acb\u5373\u4f7f\u7528 10% glucose water 100m L\u975c\u8108\u6ce8\u5165\u3002 (C)\u82e5\u62bd\u6410\u6301\u7e8c\uff0c\u61c9\u8003\u616e\u7d66\u4e88\u975c\u6ce8 lorazepam 1mg \u3002 (D)\u82e5\u62bd\u6410\u6301\u7e8c\uff0c\u9ede\u6ef4\u6253\u4e0d\u4e0a\uff0c\u61c9\u7d93\u7531\u809b\u9580\u7d66\u85e5 diazepam 5mg \u3002 (E)\u82e5\u62bd\u6410\u6301\u7e8c\uff0c\u53ef\u8003\u616e\u975c\u6ce8 midazolam 2mg load \uff0c\u518d\u52a0\u4e0a midazolam 1mcg/kg/min \u9023\u7e8c\u975c\u6ce8\u7d66\u85e5\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6025\u6027\u80a2\u9ad4\u52d5\u8108\u963b\u585e\u76f8\u95dc\u75be\u75c5\u7684\u539f\u56e0\u3001\u75c7\u72c0\u53ca\u6cbb\u7642\u7684\u63cf\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u6813\u585e( embolism )\u662f\u56e0\u5fc3\u623f\u986b\u52d5\u3001\u98a8\u6ebc\u6027\u5fc3\u81df\u75c5\u7b49\u9020\u6210\uff0c\u75c7\u72c0\u70ba\u9593\u6b47\u6027\u8ddb\u884c\uff0c\u61c9\u5148\u85e5\u7269\u6cbb\u7642\uff0c\u518d\u8003\u616e\u4ecb\u5165\u8655\u7f6e\u3002 (B)\u96f7\u8afe\u6c0f\u75c7(Raynaud's disease )\u56e0\u70ba\u51b7\u6216\u58d3\u529b\u9020\u6210\u5c0f\u52d5\u8108\u8840\u7ba1\u75d9\u6523\uff0c\u9020\u6210\u75bc\u75db\u3001\u84bc\u767d\u3001\u767c\u7d3a\u7b49\uff0c\u7d66\u4e88\u56de\u6eab\u53ca\u85e5\u7269\u5982\u9223\u96e2\u5b50\u963b\u65b7\u5291\u6216 \u03b2\u963b\u65b7\u5291\u6cbb\u7642\u3002 (C)\u5783\u573e\u8173(trash foot )\u6216\u85cd\u8173\u8dbe( blue toe)\u75c7\u5019\u7fa4\uff0c\u662f\u56e0\u81bd\u56fa\u9187/ \u8840\u5c0f\u677f\u805a\u96c6\u6813\u585e\u9020\u6210\u8173\u90e8\u4efd\u75bc\u75db\u767c\u7d3a\uff0c\u5176\u9918\u90e8\u4efd\u6eab\u6696\u3002 (D)\u4f2f\u683c\u75c5(Buerger's disease )\u5e38\u898b\u65bc\u62bd\u83f8\u8005\uff0c\u70ba\u975e\u7ca5\u7624\u786c\u5316\u7684\u4e2d\u5c0f\u8840\u7ba1\u767c\u708e\uff0c\u9020\u6210\u75bc\u75db\u7d50\u7bc0\u3001\u6f70\u760d\u6216\u58de\u75bd\u3002 (E)\u5c0f\u9b5a\u808c\u9318(h ypothenar hammer )\u75c7\u5019\u7fa4\uff0c\u662f\u56e0\u4f7f\u7528\u9707\u52d5\u5de5\u5177\uff0c\u5c0e\u81f4\u5c3a\u52d5\u8108\u6216\u52d5\u8108\u7624\u9000\u5316\u72f9\u7a84\uff0c\u9020\u6210\u9664\u62c7\u6307\u5916\u7684\u5c3a\u5074\u624b\u6307(\u4e00\u6839\u4ee5\u4e0a)\u75bc\u75db\u8b8a\u8272\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc QT\u5ef6\u9577\u9020\u6210 Torsades de Pointes \u4e4b\u539f\u56e0\uff0c\u4e0d\u5305\u62ec \u4e0b\u5217\u4f55\u9805\uff1f", + "Options": "(A)\u8166\u4e2d\u98a8(\u542b\u8718\u86db\u819c\u4e0b\u8154\u51fa\u8840) \u3002 (B)\u56b4\u91cd\u5fc3\u640f\u904e\u7de9\u6216\u623f\u5ba4\u963b\u65b7\u3002 (C)\u85e5\u7269\u5982\u6709\u6a5f\u78f7\u3001\u6297\u7d44\u7e54\u80fa\u3002 (D)\u6297\u751f\u7d20\uff0c\u7279\u5225\u662f\u7b2c\u4e09\u4ee3\u982d\u5b62\u5b50\u83cc\u7d20\u3002 (E)IA \u53caIC\u985e\u6297\u5fc3\u5f8b\u4e0d\u6574\u85e5\u7269\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4f9d\u64da\u7f8e\u570b\u5fc3\u81df\u5354\u6703 2015\u5e74\u516c\u5e03\u4e4b\u5fc3\u80ba\u5fa9\u7526\u6307\u5f15\uff0c\u6709\u95dc\u6210\u4eba\u57fa\u672c\u6551\u547d\u8853\u7684\u6280\u5de7\u63cf\u8ff0\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03 \u9069\u7576\uff1f", + "Options": "(A)\u5982\u679c\u75c5\u4eba\u61f7\u7591\u662f opioid intoxication \u4e14\u5fc3\u8df3\u505c\u6b62\uff0c\u61c9\u8003\u616e\u5728\u5be6\u65bd CPR\u524d\u5148\u7d66\u4e88\u89e3\u6bd2\u5291 naloxone\u4f7f\u7528\u3002 (B)\u4f9d\u7167\u76ee\u524d\u7684\u5c11\u6578\u5be6\u8b49\u7814\u7a76\u6240\u793a\uff0c\u58d3\u80f8\u7684\u4f4d\u7f6e\u4e0d\u8ad6\u662f\u80f8\u90e8\u4e2d\u592e\u6216\u80f8\u9aa8\u4e0b\u534a\u90e8\u5c0d\u65bc\u75c5\u4eba\u5747\u7121\u5dee\u5225\uff0c\u6545\u5efa\u8b70\u80f8\u9aa8\u4e0b\u534a\u90e8\u70ba\u58d3\u80f8\u4f4d\u7f6e\u3002 (C)\u58d3\u80f8\u901f\u5ea6\u8a02\u5728 100-120\u4e0b/\u5206\u9418\uff0c\u662f\u56e0\u70ba\u7814\u7a76\u986f\u793a\u592a\u5feb\u7684\u58d3\u80f8\u901f\u5ea6\u6703\u9020\u6210\u65bd\u6551\u8005\u8fc5\u901f\u904e\u52de\uff0c\u5f71\u97ff\u58d3\u80f8\u54c1\u8cea\u3002 (D)\u58d3\u80f8\u6df1\u5ea6\u8a02\u5728 5-6\u516c\u5206\uff0c\u56e0\u70ba\u7814\u7a76\u986f\u793a\u6df1\u5ea6\u8d85\u904e 6\u516c\u5206\u6613\u9020\u6210\u75c5\u4eba\u50b7\u5bb3\uff0c\u4e14\u5c08\u696d\u65bd\u6551\u8005\u5e38\u5e38\u6703\u58d3\u7684\u904e\u6df1\u3002 (E)\u91dd\u5c0d\u80f8\u524d\u6309\u6469\uff0c\u52d9\u5fc5\u76e1\u91cf\u505a\u5230\u4e0d\u53ef\u4e2d\u65b7\u8d85\u904e 10\u79d2\u9418\u4ee5\u53ca chest compression fraction (CCF)\u81f3\u5c11\u8981\u9054\u5230 50%\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "80\u6b72\u8001\u5148\u751f\uff0c\u672c\u8eab\u6709\u6c23\u5598\u75c5\u53f2\uff0c\u6b64\u6b21\u56e0\u80ba\u708e\u5408\u4f75\u6557\u8840\u75c7\u53ca\u591a\u91cd\u5668\u5b98\u8870\u7aed\uff0c\u9700\u8981\u7acb\u5373\u63d2\u7ba1\uff0c\u8840\u58d3 60/40 mmHg \uff0c\u5fc3\u8df3 110\u6b21/min\uff0c\u814e\u529f\u80fd creat inine 12.6mg/dL \uff0c\u9240\u96e2\u5b50 7.0 mmol/L \u3002\u57f7\u884c\u5feb\u901f\u63d2\u7ba1\u6280\u8853(rapid sequence intubation)\u6642\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u63d2\u7ba1\u524d\u9700\u7d66\u4e88\u9ad8\u6fc3\u5ea6\u6c27\u6c23\uff0c\u76e1\u53ef\u80fd\u7dad\u6301\u63d2\u7ba1\u524d\u8840\u6c27\u6fc3\u5ea6 100%\u3002 (B)\u5148\u884c\u85e5\u7269 (premedication ) \uff0c\u53ef\u4ee5\u7d66\u4e88 lidocaine\uff0c\u4ee5\u6e1b\u5c11\u56e0\u63d2\u7ba1\u9020\u6210\u7684\u4e0d\u826f\u751f\u7406\u53cd\u61c9\u3002 (C)\u61c9\u5feb\u901f\u7d66\u4e88\u5927\u91cf\u8f38\u6db2\uff0c\u6cbb\u7642\u4f4e\u8840\u58d3\u3002 (D)\u93ae\u975c\u85e5\u7269\u53ef\u4ee5\u512a\u5148\u9078\u64c7 propofol\u3002 (E)\u808c\u8089\u9b06\u5f1b\u5291\u53ef\u4ee5\u9078\u64c7 rocuronium \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u61f7\u5b55 26\u9031\u5b55\u5a66\u56e0\u5fc3\u60b8\u5192\u51b7\u6c57\u81f3\u6025\u8a3a\u5c31\u91ab\uff0c\u8840\u58d3 60/40 mmHg \uff0c\u5fc3\u8df3 170\u6b21/min\uff0c\u547c\u5438 30\u6b21/min\uff0c\u6709\u95dc\u5b55\u5a66\u7684\u7dca\u6025\u5fa9\u7526\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u6839\u64da 2015\u5e74AHA ACLS \u6307\u5f15\uff0c\u5728\u5fa9\u7526\u904e\u7a0b\u4e2d\uff0c\u61c9\u4f7f\u7528\u9577\u80cc\u677f\u53ca\u5e8a\u88ab\u8f14\u52a9\u588a\u9ad8\uff0c\u7dad\u6301\u5b55\u5a66\u5de6\u5074\u8eba\uff0c\u4ee5\u7dad\u6301\u9ad4\u6db2\u7684\u56de\u6d41\u3002 (B)\u5982\u679c\u9700\u8981\u6c23\u7ba1\u63d2\u7ba1\uff0c\u9084\u662f\u53ef\u4ee5\u7167\u5e38\u4f7f\u7528 rapid -sequence intubation \u7684\u85e5\u7269\uff0c\u85e5\u7269\u5291\u91cf\u4e5f\u8207\u4e00\u822c\u6210\u4eba\u7121\u7570\u3002 (C)\u975c\u8108\u6ce8\u5c04\u9014\u5f91\u61c9\u512a\u5148\u9078\u64c7\u8179\u80a1\u6e9d\u7f6e\u5165\u4e2d\u592e\u975c\u8108\u5c0e\u7ba1\u3002 (D)\u80ce\u5152 28\u9031\u4ee5\u4e0b\u4e0d\u9700\u8003\u616e\u7dca\u6025\u5256\u8179\u7522\u3002 (E)Adenosine \u5c0d\u80ce\u5152\u6703\u7522\u751f\u56b4\u91cd\u4e0d\u826f\u5f71\u97ff\uff0c\u61c9\u907f\u514d\u4f7f\u7528\u65bc\u5b55\u5a66\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "60\u6b72\u7537\u6027\u6709\u62bd\u83f8\u53ca\u7cd6\u5c3f\u75c5\u75c5\u53f2\uff0c\u4eca\u5929\u4e0b\u5348\u5728\u516c\u53f8\u7a81\u7136\u5012\u5730\u4e0d\u7701\u4eba\u4e8b\uff0c\u7531119\u9001\u81f3\u6025\u8a3a\uff0c\u5230\u9662\u524d\u7121\u751f\u547d \u5fb5\u8c61\uff0c\u7d93 CPR\u53ca\u53bb\u986b\u96fb\u64ca\u5f8c\u6062\u5fa9\u81ea\u4e3b\u5faa\u74b0\uff0c\u4f9d\u64da 2015 AHA \u5728post-cardiac arrest care \u7684\u6a19\u6e96\u6cbb\u7642\u6d41\u7a0b\u4e2d\uff0c\u4e0b\u5217\u6558\u8ff0 \u4f55\u8005\u8f03\u70ba\u9069\u7576 \uff1f", + "Options": "(A)\u82e5\u75c5\u4eba\u6301\u7e8c\u660f\u8ff7\uff0c\u53ef\u80fd\u9700\u8981\u4f4e\u6eab\u6cbb\u7642\uff0c\u76ee\u6a19\u662f\u7dad\u6301\u9ad4\u6eab 31-33\u2103\u3002 (B)\u82e5\u75c5\u4eba\u8840\u58d3\u592a\u4f4e\uff0c\u9808\u7d66\u4e88 dopamine 5-10mcg/kg/min \u7dad\u6301 mean arterial pressure\u226590mmHg\u3002 (C)\u75c5\u4eba\u4e0d\u9700\u5168\u7a0b\u7d66 100%\u6c27\u6c23\uff0c\u8abf\u6574 FiO 2\u5230\u75c5\u4eba\u7684 SpO 2\u226594%\u5373\u53ef\u3002 (D)\u75c5\u4eba\u5982\u679c\u5728\u5fa9\u7526\u5f8c 12\u5c0f\u6642\u5167\u9084\u6c92\u6e05\u9192\uff0c\u5c31\u53ef\u4ee5\u5224\u5b9a\u70ba\u795e\u7d93\u5b78\u9810\u5f8c\u4e0d\u4f73(neurologic poor prognosis ) \uff0c\u9700\u8981\u8207\u5bb6\u5c6c\u8a0e\u8ad6\u653e\u68c4\u6025\u6551\u4e8b\u5b9c\u3002 (E)\u5fc3\u96fb\u5716\u6c92\u6709\u5448\u73fe STEMI\uff0c\u5c31\u4e0d\u9808\u8003\u616e\u4f5c coronary reperfusion \u7684\u6cbb\u7642\uff0c\u8981\u8d95\u5feb\u627e\u5176\u4ed6\u539f\u56e0\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5375\u5de2\u626d\u8f49( ovarian torsion )\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5927\u591a\u6578\u7684\u626d\u8f49\u767c\u751f\u5728\u5de6\u908a\uff0c\u56e0\u70ba\u5de6\u908a\u5b50\u5bae\u5375\u5de2\u97cc\u5e36\u8f03\u9577\u3002 (B)\u5178\u578b\u7684\u8868\u73fe\u662f\u767c\u751f\u5728\u904b\u52d5\u5f8c\u6f38\u9032\u5f0f\u7684\u55ae\u5074\u4e0b\u8179\u75bc\u75db\u3002 (C)\u626d\u8f49\u5e7e\u4e4e\u7e3d\u662f\u8207\u5375\u5de2\u816b\u5927\u6709\u95dc\u3002 (D)\u7d93\u8179\u90e8\u675c\u535c\u52d2\u8d85\u97f3\u6ce2\u662f\u8a3a\u65b7\u5de5\u5177\u7684\u9996\u9078\u3002 (E)\u8d77\u56e0\u65bc\u52d5\u8108\u8840\u6813\u963b\u585e\uff0c\u7522\u751f\u5375\u5de2\u7684\u5c40\u90e8\u7f3a\u8840\u548c\u58de\u6b7b\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "30\u6b72\u5973\u6027\u4e3b\u8a34\u53f3\u4e0b\u8179\u75db\u4e00\u5929\uff0c\u4f34\u96a8\u982d\u6688\u5641\u5fc3\u60f3\u5410\uff0c\u6025\u8a3a\u5c31\u91ab\u6642\u751f\u547d\u5fb5\u8c61\u70ba\u8840\u58d3 90/50 mmHg \uff0c\u5fc3\u8df3 115\u6b21/min\uff0c\u547c\u5438 20\u6b21/min\uff0c\u9ad4\u6eab 37.5\u2103\uff0c\u8eab\u9ad4\u6aa2\u67e5\u6574\u500b\u4e0b\u8179\u90e8\u6709\u58d3\u75db\u53ca\u53cd\u5f48\u75db\uff0c\u4e0a\u6b21\u6708\u7d93\u70ba 5\u9031\u524d\uff0c\u4f46\u75c5\u4eba\u8868\u793a\u5df2\u7d93\u505a\u904e\u7d50\u7d2e\u624b\u8853\u4e0d\u53ef\u80fd\u61f7\u5b55\uff0c\u800c\u4e14\u6708\u7d93\u672c\u4f86\u5c31\u4e0d\u898f\u5247\uff0c\u62bd\u8840\u5831\u544a\u767d\u8840\u740318,000/m L\uff0c\u8840\u7d05\u7d20 7.8g/dL\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5df2\u7d93\u505a\u904e\u7d50\u7d2e\u624b\u8853\uff0c\u4e0d\u9700\u8981\u9a57\u5b55\uff0c\u61c9\u76e1\u5feb\u5b89\u6392\u5f71\u50cf\u6aa2\u67e5\u4ee5\u6392\u9664\u9700\u8981\u624b\u8853\u4e4b\u75be\u75c5\u3002 (B)Modified Alvarado score 5 \u5206\u5c6c\u65bc\u4f4e\u98a8\u96aa\uff0c\u53ef\u6392\u9664\u6025\u6027\u95cc\u5c3e\u708e\u4e4b\u8a3a\u65b7\u3002 (C)\u8179\u90e8\u8d85\u97f3\u6ce2\u767c\u73fe\u6709\u8179\u6c34\u7a4d\u5728\u76f4\u8178\u5b50\u5bae\u9677\u51f9(Douglas pouch) \uff0c\u8840\u6e05\u6aa2\u67e5 \u03b2-hCG\u7684\u6578\u503c\u53ef\u5224\u65b7\u662f\u5426\u70ba\u5b50\u5bae\u5916\u5b55\u3002 (D)\u7591\u4f3c\u5b50\u5bae\u5916\u5b55\u7684\u60a3\u8005\uff0c\u7576\u8d85\u97f3\u6ce2\u548c\u62bd\u8840\u4e5f\u7121\u6cd5\u78ba\u5b9a\u8a3a\u65b7\u6642\uff0c\u78c1\u632f\u9020\u5f71\u70ba\u9996\u9078\u7684\u8a3a\u65b7\u65b9\u5f0f\u3002 (E)\u7576\u8d85\u97f3\u6ce2\u986f\u793a\u5b50\u5bae\u5167\u598a\u5a20(intrauterine pregnancy ) \uff0c\u9664\u975e\u60a3\u8005\u5177\u6709\u7570\u4f4d\u598a\u5a20(heterotopic pregnancy )\u7684\u9ad8\u98a8\u96aa\uff0c\u5426\u5247\u53ef\u4ee5\u6392\u9664\u5b50\u5bae\u5916\u5b55\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u81ea\u7136\u6d41\u7522\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u6839\u64da WHO\u5b9a\u7fa9\u70ba\u61f7\u5b55 20\u9031\u4e4b\u524d\uff0c\u6216\u80ce\u5152\u5c0f\u65bc 800\u516c\u514b\u3002 (B)\u5927\u90e8\u5206\u767c\u751f\u5728\u598a\u5a20 8\u9031\u524d\u3002 (C)\u6700\u5e38\u898b\u7684\u75c7\u72c0\u662f\u8179\u75db\u52a0\u4e0a\u9670\u9053\u51fa\u8840\u3002 (D)\u6700\u5e38\u898b\u7684\u539f\u56e0\u662f\u611f\u67d3\u3002 (E)\u51fa\u73fe\u5148\u5146\u6d41\u7522(t hreatened abortion )\u6642\u80ce\u5152\u5927\u90e8\u5206\u4fdd\u4e0d\u4f4f\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u598a\u5a20\u5287\u5410( hyperemesis gravidarum ) \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u88ab\u5b9a\u7fa9\u70ba\u4f34\u6709\u9ad4\u91cd\u6e1b\u8f15\uff0c\u812b\u6c34\u548c\u9ad8\u8840\u9209\u7684\u9811\u56fa\u6027\u5614\u5410\u3002 (B)\u8b49\u64da\u986f\u793a\u812b\u6c34\u6240\u9020\u6210\u7684\u916e\u8840\u75c7\u5c0d\u80ce\u5152\u6709\u5bb3\u3002 (C)\u7cfb\u5217\u6e2c\u91cf\u5c3f\u916e\u53ef\u7528\u65bc\u78ba\u5b9a\u6cbb\u7642\u7684\u6210\u529f\u8207\u5426\u3002 (D)\u5f88\u5e38\u4f34\u96a8\u8179\u75db\uff0c\u8981\u5c0f\u5fc3\u8207\u5176\u4ed6\u75be\u75c5\u4f5c\u9451\u5225\u8a3a\u65b7\u3002 (E)\u53ef\u4ee5\u4f7f\u7528\u7dad\u4ed6\u547d B12\u6cbb\u7642\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u61f7\u5b55\u6642\u63a5\u53d7 \u653e\u5c04\u7dda\u5f71\u50cf \u6aa2\u67e5\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u63a5\u53d7 50\u6beb\u683c\u96f7( mGy)\u4ee5\u5167\u70ba\u5b89\u5168\u5291\u91cf\u3002 (B)\u63a5\u53d7\u8179\u90e8\u96fb\u8166\u65b7\u5c64\u662f\u4e0d\u5b89\u5168\u7684\u3002 (C)\u63a5\u53d7 100\u6beb\u683c\u96f7( mGy)\u4ee5\u4e0a\u7684\u5291\u91cf\u6703\u6709\u81f4\u7578\u80ce\u6027\u3002 (D)\u70ba\u6aa2\u67e5\u80ba\u6813\u585e\u6240\u505a\u7684\u96fb\u8166\u65b7\u5c64\u662f\u5b89\u5168\u7684\u3002 (E)\u9aa8\u76c6\u8154\u7684 X\u5149\u5c0d\u80ce\u5152\u6c92\u6709\u5f71\u97ff\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u5df2\u7d93\u751f\u7522\u904e\u5169\u80ce\u7684 40\u6b72\u5a66\u5973\uff0c\u76ee\u524d \u61f7\u5b55 33\u9031\uff0c\u4e3b\u8a34\u53f3\u4e0a\u8179\u75db\u4e00\u9031 \uff1b\u8840\u58d3160/110 mmHg \uff1b\u62bd\u8840\u5831\u544a\uff1a\u8840\u7d05\u7d20 7.0 g/dL(12- 15g/dl) \uff0c\u8840\u5c0f\u677f90,000/\u03bcL(160 ,000-400,000/\u03bcL)\uff0cALT 120 U/L(5-25 U/L)\uff0cAST 230 U/L(5-35 U/L) \uff0c\u7e3d\u81bd\u7d05\u7d20 3.2 mg/dL(0.2-1.2mg/dL )\uff0cINR 4(0.8 -1.2)\uff0cAPTT 70\u79d2(28.0- 39.0\u79d2) \uff1b\u8179\u90e8\u8d85\u97f3\u6ce2\u6aa2\u67e5\u7121\u81bd\u7d50\u77f3 \u3001\u81bd\u56ca\u58c1\u816b \u3001\u814e\u81df\u7570\u5e38\u6216\u8179\u6c34\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u53ef\u767c\u751f\u65bc\u598a\u5a20> 20 \u9031\u6216\u7522\u5f8c 7\u5929\u5167\u4f34\u6709\u8179\u75db\u7684\u5b55\u5a66\u3002 (B)\u8a3a\u65b7\u662f\u4e00\u7a2e\u5b50\u7647\u524d\u75c7(preeclampsia )\u81e8\u5e8a\u8b8a\u7570\u3002 (C)\u521d\u59cb\u6cbb\u7642\u8207\u5b50\u7647(eclampsia )\u76f8\u4f3c\uff1b\u975c\u8108\u6ce8\u5c04\u9382\u96e2\u5b50\uff0c\u63a7\u5236\u8840\u58d3\uff0c\u4f4f\u9662\u3002 (D)\u78ba\u5207\u7684\u6cbb\u7642\u65b9\u6cd5\u662f\u5206\u5a29\uff0c\u7279\u5225\u662f\u598a\u5a20\u226528 \u9031\u3002 (E)\u9084\u4e0d\u9069\u5408\u5206\u5a29\u7684\u5b55\u5a66\uff0c\u76ae\u8cea\u985e\u56fa\u9187\u53ef\u4ee5\u5e6b\u52a9\u5ef6\u7de9\u5206\u5a29\u4e26\u6539\u5584\u80ce\u5152\u9810\u5f8c\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5361\u897f\u916e\u985e\u85e5\u7269\u7684\u526f\u4f5c\u7528\u6216\u4f75\u767c\u75c7\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u8154\u5ba4\u75c7\u5019\u7fa4( compartment syndrome )\u3002 (B)\u56de\u6eaf\u6027\u5931\u61b6\u75c7(retrograde amnesia )\u3002 (C)\u6025\u6027\u814e\u640d\u50b7(acute kidney injury )\u3002 (D)\u9ad4\u6eab\u5347\u9ad8(h yperthermia )\u3002 (E)\u8b6b\u5984(d elirium)\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u67d0\u5c0f\u93ae\u906d\u651c\u5e36\u6bd2\u6c23\u70b8\u5f48\u4e4b\u98db\u6a5f\u653b\u64ca\uff0c\u73fe\u5834\u591a\u4eba\u6b7b\u50b7\uff0c \u4e2d\u6bd2\u7684\u75c7\u72c0\u70ba\u652f\u6c23\u7ba1\u5206\u6ccc\u7269\u589e\u52a0\u3001\u77b3\u5b54\u7e2e\u5c0f\u3001\u5641\u5fc3\u5614\u5410\u3001\u8179\u7d5e\u75db\uff0c \u5247\u8f03\u4e0d\u53ef\u80fd \u70ba\u4e0b\u5217\u4f55\u7a2e\u6bd2\u6c23\u9020\u6210\uff1f", + "Options": "(A)Sarin (GB)\u3002 (B)Tabun (GA)\u3002 (C)Sulfur mustard (HD)\u3002 (D)Cyclosarin (GF)\u3002 (E)Soman (GD)\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8001\u4eba\u80f8\u90e8\u5916\u50b7\u808b\u9aa8\u9aa8\u6298\u7684\u8a55\u4f30\u8207\u8655\u7406\uff0c\u4e0b \u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u7559\u9662\u689d\u4ef6\u8981\u5bec\uff0c\u89c0\u5bdf\u6642\u9593\u8981\u5920\u3002 (B)\u6301\u7e8c\u76e3\u63a7\u52d5\u8108\u8840\u6c27\u98fd\u548c\u5ea6\uff0c\u4f9b\u6c27\uff0c\u4fdd\u6301>95% \u3002 (C)\u8981\u78ba\u8a8d\u54b3\u75f0\u80fd\u529b\u548c\u75bc\u75db\u63a7\u5236\u5df2\u7a69\u5b9a\uff0c\u624d\u53ef\u653e\u5fc3\u8b93\u75c5\u4eba\u51fa\u9662\u3002 (D)\u53d7\u50b7\u5f8c\u767c\u751f\u69e4\u67b7\u80f8\u3001\u80ba\u632b\u50b7\u3001\u6216\u6c23\u8840\u80f8\u6642\uff0c\u8001\u4eba\u5931\u53bb\u4ee3\u511f\u80fd\u529b\u7684\u6a5f\u6703\u9ad8\uff0c\u8207\u539f\u6709\u80ba\u529f\u80fd\u7121\u95dc\u3002 (E)\u8001\u4eba\u5c0d\u9d09\u7247\u985e\u6b62\u75db\u5291\u8010\u53d7\u5ea6\u6e1b\u4f4e\uff0c\u6613\u7522\u751f\u547c\u5438\u8870\u7aed\u3001\u4f4e\u8840\u58d3\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e00\u540d\u5916\u50b7\u75c5\u4eba\uff0c\u8eca\u798d\u5f8c\u610f\u8b58\u660f\u8ff7( GCS E2V3M4 ) \uff0c\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\u3002\u53f3\u5074\u7b2c1\u30012\u53ca\u5de6\u5074\u7b2c 9\u300110\u808b\u9aa8\u5747\u7bc0\u6bb5\u6027(segmental )\u9aa8\u6298\uff0c\u7b2c\u4e00\u5f35\u80f8\u90e8 X\u5149\u7121\u6c23\u80f8\u3002\u4ee5\u4e0b\u63cf\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u6b64\u75c5\u4eba\u4e0d\u7b26\u69e4\u67b7\u80f8\u8a3a\u65b7\u3002 (B)\u80f8\u90e8 X\u5149\u5e38\u6703\u4f4e\u4f30\u80f8\u90e8\u5916\u50b7\u7684\u7a0b\u5ea6\u3002 (C)\u8d85\u97f3\u6ce2\u5c0d\u6c23\u80f8\u8a3a\u65b7 \u7684\u654f\u611f\u6027\u548c\u6e96\u78ba\u6027\u5747\u9ad8\u65bc\u80f8\u90e8 X\u5149\u3002 (D)\u96fb\u8166\u65b7\u5c64\u5c0d\u6f5b\u5728\u6c23\u80f8\u7684\u8a3a\u65b7\uff0c\u6e96\u78ba\u5ea6\u9060\u6bd4\u8d85\u97f3\u6ce2\u9ad8\u3002 (E)\u7b2c\u4e5d\u3001\u5341\u808b\u9aa8\u9aa8\u6298\u5408\u4f75\u96e3\u89e3\u91cb\u7684\u4f4e\u8840\u58d3\u6642\uff0c\u9700\u8003\u616e\u809d\u3001\u813e\u51fa\u8840\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u95dc\u65bc\u6025\u6027\u5fc3\u81df\u8870\u7aed( acute heart failure )\u75c5\u4eba\u7684\u6aa2\u67e5\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)B- type natriuretic peptide \u6578\u503c\u5927\u65bc 500 pg/mL \uff0c\u9700\u9ad8\u5ea6\u61f7\u7591\u5fc3\u81df\u8870\u7aed\u3002 (B)\u5fc3\u96fb\u5716\u5e38\u51fa\u73fe\u5fc3\u623f\u9707\u986b(a trial fibrillation )\u3002 (C)\u8d85\u97f3\u6ce2\u4e0b\u51fa\u73fe\u96d9\u5074 B lines\u53ef\u78ba\u8a3a\u5408\u4f75\u80ba\u6c34\u816b\u3002 (D)\u80f8\u90e8 X\u5149\u6709 20%\u53ef\u80fd\u6b63\u5e38\u3002 (E)\u807d\u8a3a\u53ef\u80fd\u51fa\u73fe S3 gallop\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u81ea\u767c\u6027\u6d41\u9f3b\u8840( epistaxis)\u7684\u767c\u751f\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u8f03\u5e38\u767c\u751f\u65bc\u4e7e\u71e5\u7684\u5b63\u7bc0\u3002 (B)\u8f03\u5e38\u767c\u751f\u65bc 30\u81f350\u6b72\u7684\u4e2d\u5e74\u4eba\u3002 (C)\u524d\u9f3b\u8154\u51fa\u8840\u8f03\u5f8c\u9f3b\u8154\u591a\u3002 (D)\u524d\u9f3b\u8154\u51fa\u8840\u6700\u5e38\u4f86\u81ea Kiesselbach plexus\u3002 (E)\u5f8c\u9f3b\u8154\u51fa\u8840\u6700\u5e38\u4f86\u81ea sphenopalatine artery \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u96e2\u5cf6\u4e00\u540d\u5916\u50b7\u75c5 \u4eba\u8981\u7a7a\u4e2d\u8f49\u8a3a\u81f3\u672c\u5cf6\uff0c\u8acb\u554f\u6a5f\u4e0a\u7684\u91ab\u7642\u4eba\u54e1\u7d44\u5408\uff0c\u4f55\u8005\u5c0d\u75c5\u4eba\u6709\u6700\u4f73 \u9810\u5f8c\uff1f", + "Options": "(A)\u8b77\u7406\u5e2b\u3001\u6551\u8b77\u54e1\u3002 (B)\u8b77\u7406\u5e2b\u3001\u8b77\u7406\u5e2b\u3002 (C)\u8b77\u7406\u5e2b\u3001\u91ab\u5e2b\u3002 (D)\u8b77\u7406\u5e2b\u3001\u547c\u5438\u6cbb\u7642\u5e2b\u3002 (E)\u6c92\u6709\u7279\u5225\u5dee\u7570\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u8acb\u554f\u4e0b\u5217\u4f55\u8005\u975e \u53f0\u7063\u7a7a\u4e2d\u6551\u8b77\u4e4b\u9069\u61c9\u75c7\uff1f", + "Options": "(A)\u4e8c\u8655\u4ee5\u4e0a\u4e4b\u9577\u9aa8\u9aa8\u6298\u3002 (B)\u6703\u9670\u90e8\u4f4d\u71d2\u50b7\u3002 (C)\u4e09\u5ea6\u71d2\u50b7\u9762\u7a4d\u9054\u767e\u5206\u4e4b\u5341\u3002 (D)\u5df2\u5c0e\u81f4\u80a2\u9ad4\u7671\u7613\u7684\u5275\u50b7\u3002 (E)\u65b7\u6307\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "35\u6b72\u7537\u6027\u56e0\u8eca\u798d\u53d7\u50b7\uff0c\u4e0b\u534a\u8eab\u7671\u7613( paraplegia )\u88ab\u9001\u81f3\u6025\u8a3a\u5c31\u91ab\uff0c\u6aa2\u67e5\u767c\u73fe\u5176\u810a\u9ad3\u53d7\u50b7\u9ad8\u5ea6(injury level )\u7d04\u5728 T10\uff0c\u9664\u4e86 paraplegia \u5916\uff0c\u75c5\u4eba\u5728T10 level \u4ee5\u4e0b\u7bc4\u570d\u5931\u53bb\u75db\u89ba\u548c\u6eab\u611f\uff0c\u4f46\u4ecd\u4fdd\u6709\u89f8\u89ba\uff0c\u8acb\u554f\u9019\u4f4d\u75c5\u4eba\u5c6c\u65bc\u4f55\u7a2e\u810a\u9ad3\u640d\u50b7(spinal cord injury )\uff1f", + "Options": "(A)Anterior cord syndrome \u3002 (B)Brown -S\u00e9quard syndrome \u3002 (C)Cauda -Equina syndrome \u3002 (D)Central cord synd rome\u3002 (E)Posterior cord syndrome \u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "2\u6b72\u7537\u5b69\u88ab\u7236\u6bcd\u9001\u81f3\u6025\u8a3a\u5ba4\uff0c\u9ad4\u91cd 13\u516c\u65a4\uff0c\u5fc3\u8df3 160\u6b21/min\uff0c\u8840\u58d384/38mmHg \uff0c\u8840\u6c27\u98fd\u548c\u5ea6 90%\uff0cX\u5149\u6aa2\u67e5\u986f\u793a\u5de6\u5074\u8840\u6c23\u80f8\u3001\u808b\u9aa8\u9aa8\u6298\u53ca\u80b1\u9aa8\u65cb\u8f49\u6027\u9aa8\u6298\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u6b64\u9aa8\u6298\u5f37\u70c8\u6697\u793a\u5152\u7ae5\u8650\u5f85\uff0c48 \u5c0f\u6642\u5167\u9700\u901a\u5831\u5152\u7ae5\u4fdd\u8b77\u6a5f\u69cb\u3002 (B)\u5fc3\u8df3\u904e\u5feb\uff0c\u4f46\u8840\u58d3\u4ecd\u8d85\u904e\u8a72\u5e74\u9f61\u4e4b\u8840\u58d3\u4e0b\u9650\u3002 (C)\u5118\u901f\u7d66\u4e88\u751f\u7406\u98df\u9e7d\u6c34 260 mL\u3002 (D)\u80f8\u7ba1\u9700\u63d2\u5728\u6bd4\u6210\u4eba\u66f4\u9ad8\u7684\u5730\u65b9\uff0c\u56e0\u70ba\u5152\u7ae5\u7684\u6a6b\u9694\u819c\u8f03\u6210\u4eba\u66f4\u9ad8\u3002 (E)\u5de6\u5074\u80f8\u7ba1\u653e\u7f6e\u5f8c\uff0c\u82e5\u6bcf\u5c0f\u6642\u6301\u7e8c\u51fa\u8840\u8d85\u904e 130 mL\uff0c\u5247\u53ef\u80fd\u50b7\u53ca\u5927\u8840\u7ba1\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u4f60\u4eca\u5929\u5728\u4e00\u822c\u7d1a\u6025\u6551\u8cac\u4efb\u91ab\u9662\u6025\u8a3a\u503c\u73ed\uff0c\u7576\u65e5\u7121\u5916\u79d1\u7cfb\u503c\u73ed\u91ab\u5e2b\uff0c\u6551\u8b77\u8eca\u9001\u4f86 1\u540d28\u6b72\u7537\u6027\u9a0e\u6a5f\u8eca\u81ea\u6454\uff0c\u610f\u8b58\u6e05\u695a\uff0c\u5fc3\u8df3 128\u6b21/min\uff0c\u8840\u58d3 78/42 mmHg\uff0c\u62b1\u6028\u56b4\u91cd\u9aa8\u76c6\u53ca\u53f3\u5927\u817f\u75bc\u75db\uff0c\u7121\u660e\u986f\u9838\u690e\u58d3\u75db\uff0c\u96d9\u4e0a\u80a2\u53ef\u81ea\u7531\u6d3b\u52d5\u4e14\u7121\u9ebb\u75db\u611f\uff0c\u53f3\u5927\u817f\u8b8a\u5f62\u4f75\u80a1\u9aa8\u5916\u9732\uff0c\u89f8\u8a3a\u767c\u73fe\u9aa8\u76c6\u4f4d\u79fb\u53ca\u660e\u986f\u58d3\u75db\uff0c\u8d85\u97f3\u6ce2\u6c92\u6709\u770b\u5230\u8179\u6c34\uff0c\u4e0b\u5217 \u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u7121\u6cd5\u4f9d\u64da NEXUS criteria\u4f86\u6c7a\u5b9a\u8a72\u500b\u6848\u662f\u5426\u9700\u5b89\u6392\u9838\u690e\u5f71\u50cf\u5b78\u6aa2\u67e5\u3002 (B)\u75c5\u4eba\u5931\u8840\u7d04\u70ba 750mL -1,500mL\uff0c\u7acb\u5373\u7d66\u4e88\u6797\u683c\u6c0f\u6db2\u53ca\u8f38\u8840\u3002 (C)\u8d85\u97f3\u6ce2\u7121\u6cd5\u6392\u9664\u8179\u5167\u51fa\u8840\uff0c\u8f49\u9662\u524d\u9808\u5b8c\u6210\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u3002 (D)\u61f7\u7591\u4e0d\u7a69\u5b9a\u9aa8\u76c6\u9aa8\u6298\uff0c\u61c9\u5118\u901f\u653e\u7f6e\u5c0e\u5c3f\u7ba1\u3002 (E)\u53f3\u5927\u817f\u958b\u653e\u6027\u9aa8\u6298\u61c9\u5118\u901f\u6c96\u6d17\u4e7e\u6de8\u4ee5\u964d\u4f4e\u611f\u67d3\u98a8\u96aa\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6025\u6027\u8178\u5782\u8102\u708e( epiploic appendagitis )\u7684\u6558\u8ff0\uff0c\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u5927\u591a\u4e0d\u9700\u8981\u958b\u5200\u6cbb\u7642\u3002 (B)\u5927\u591a\u4e0d\u6703\u767c\u71d2\u548c\u5614\u5410\u3002 (C)\u5927\u591a\u9700\u8981\u4f7f\u7528\u6297\u751f\u7d20\u6cbb\u7642\u3002 (D)\u5927\u591a\u6703\u5728 1-2\u9031\u5167\u75ca\u7652\u3002 (E)\u8178\u5782\u8102(epiploic appendage )\u6700\u5e38\u5728\u4e59\u72c0\u7d50\u8178\u548c\u76f2\u8178(cecum )\u9644\u8fd1\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "25\u6b72\u5973\u6027\uff0c\u61f7\u5b55 8\u500b\u6708\u3002\u7a81\u7136\u89ba\u5f97\u53f3\u80f8\u75db\u53ca\u547c\u5438\u56f0\u96e3\uff0c\u8eab\u9ad4\u6d3b\u52d5\u6642\u6703\u89ba\u5f97\u66f4\u5598\u3002\u5230\u6025\u8a3a\u6aa2\u50b7\u6642\u610f\u8b58\u6e05\u695a\uff0c\u5fc3\u8df3 120\u6b21/min\uff0c\u547c\u5438 30\u6b21/min\uff0c\u8840\u58d3 85/50 mmHg \uff0c\u9ad4\u6eab 37.5\u2103\uff0c\u8840\u6c27\u6fc3\u5ea6 90%\u3002\u807d\u8a3a\u5169\u5074\u80ba\u97f3\u6e05\u695a\u4e7e\u6de8\uff0c\u7121\u660e\u986f\u5fc3\u96dc\u97f3\u3002ECG \u6709\u5ee3\u6cdb\u7684 T\u6ce2\u5012\u7f6e\u3002\u4e0b\u80a2\u975c\u8108\u8d85\u97f3\u6ce2 compression test\u6b63\u5e38\u3002\u4e0b\u5217\u4f55\u8005\u6cbb\u7642\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u53ef\u8003\u616e\u76ae\u4e0b\u6ce8\u5c04 low molecular weight heparin \uff0c\u540c\u6642\u7d66\u4e88\u53e3\u670dwarfarin\u3002 (B)\u5148\u7d66\u4e88\u6c27\u6c23\uff0c\u5b89\u6392\u80f8\u90e8\u96fb\u8166\u65b7\u5c64\u78ba\u8a3a\u3002 (C)\u53ef\u5148\u7d66\u5438\u5165\u6027\u652f\u6c23\u7ba1\u64f4\u5f35\u5291\uff0c\u4e26\u958b\u59cb\u4f7f\u7528\u985e\u56fa\u9187\u3002 (D)\u61c9\u7d66\u4e88\u6297\u751f\u7d20\uff0c\u53ef\u9078\u7528 amoxicillin/clavulanate \u548c clarithromycin \u3002 (E)\u9032\u5c55\u81f3\u6557\u8840\u6027\u4f11\u514b\u4e4b\u98a8\u96aa\u9ad8\uff0c\u61c9\u8003\u616e\u555f\u52d5 sepsis bundle \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "56\u6b72\u7537\u6027\u4e3b\u8a34\u5410\u8840\uff0c\u6709\u809d\u786c\u5316\u75c5\u53f2\uff0c\u6aa2\u50b7\u751f\u547d\u5fb5\u8c61\u9ad4\u6eab 37.3\u2103\u3001\u547c\u5438 26\u6b21/min\u3001\u5fc3\u8df3 124\u6b21/min\u3001\u8840\u58d3 86/60 mmHg\uff0c\u6709\u95dc\u6b64\u75c5\u4eba\u7684\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u51fa\u8840\u539f\u56e0\u5e7e\u4e4e\u90fd\u662f\u98df\u9053\u975c\u8108 \u7624\u7834\u88c2\uff0c\u9664\u4e86\u6975\u5c11\u6578\u4f8b\u5916\u3002 (B)\u9f3b\u80c3\u7ba1\u704c\u6d17(nasogastric lavage )\u76ee\u7684\u5728\u8b93\u505a\u80c3\u93e1\u6642\u8996\u91ce\u66f4\u6e05\u6670\u3002 (C)\u5bb6\u5c6c\u8868\u793a\u75c5\u4eba\u4e4b\u524d\u6709\u8f38\u8840\u904e\u654f\u53cd\u61c9\uff0c\u82e5\u9700\u8f38\u8840\u6642\u4f7f\u7528\u6e1b\u767d\u8840\u7403\u7d05\u8840\u7403\u6fc3\u539a\u6db2(leukocyte -poor PRBC )\u53ef\u907f\u514d\u6b64\u60c5\u6cc1\u518d\u6b21\u767c\u751f\u3002 (D)\u9019\u500b\u75c5\u4eba\u61c9\u53ca\u65e9\u4f7f\u7528\u6297\u751f\u7d20\u5982 ciprofloxacin \uff0c\u4ee5\u6e1b\u4f4e\u6b7b\u4ea1\u7387\u3002 (E)\u82e5\u6b64\u75c5\u4eba\u8840\u7d05\u7d20\u70ba 8.0 g/dL\uff0c\u5373\u4e0d\u9700\u8981\u4f7f\u7528 massive transfusion protocol\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4f9d\u64da\u5168\u6c11\u5065\u5eb7\u4fdd\u96aa\u91ab\u7642\u670d\u52d9\u7d66\u4ed8\u9805\u76ee\u53ca\u652f\u4ed8\u6a19\u6e96\uff0c\u5fc3\u8df3\u505c\u6b62\u4e4b\u75c5\u4eba\u6062\u5fa9\u81ea\u767c\u6027\u5faa\u74b0\u5f8c\uff0c\u4e0b\u5217\u4f55\u8005\u9069\u5408 \u4f7f\u7528\u76ee\u6a19\u9ad4\u6eab\u7ba1\u7406 (TTM, targeted temperature management )\uff1f", + "Options": "(A)\u6062\u5fa9\u81ea\u767c\u6027\u5faa\u74b0\u8d85\u904e 12\u5c0f\u6642\u3002 (B)\u6536\u7e2e\u8840\u58d3 100 mmHg \u3002 (C)\u8166\u90e8\u96fb\u8166\u65b7\u5c64\u986f\u793a\u9871\u5167\u51fa\u8840\u3002 (D)\u5fc3\u8df3\u505c\u6b62\u7d93\u5fa9\u7526\u6025\u6551\u5f8c\u610f\u8b58 GCS 9\u3002 (E)\u6709\u5927\u91cf\u6d3b\u52d5\u6027\u5167\u51fa\u8840\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u54ea\u4e00\u500b\u52d5\u4f5c\u5982\u679c\u51fa\u73fe\u5728\u53f3\u9838\u53ca\u53f3\u80a9\u75bc\u75db\u7684\u75c5\u4eba\u6642\uff0c\u6bd4\u8f03\u50cf\u662f\u808c\u8089\u62c9\u50b7\u7684\u554f\u984c\uff1f", + "Options": "(A)\u75c5\u4eba \u982d\u9838\u5f8c\u4ef0\u4e26\u5411\u5074\u65b9\u65cb\u8f49\uff0c\u6aa2\u67e5\u8005\u7acb\u65bc\u80cc\u5f8c\uff0c\u7528\u96d9\u624b\u6309\u58d3\u75c5\u4eba \u984d\u9802\u90e8\uff0c\u51fa\u73fe\u4e0a\u80a2\u653e\u5c04\u75db\u6216\u9ebb\u6728\u8005\u3002 (B)\u75c5\u4eba \u5c07\u53f3\u5074\u7684\u624b\u638c\u8209\u8d77\u653e\u5728 \u75c5\u4eba\u7684\u982d\u9802\u4e0a\u53ef\u4ee5\u6e1b\u8f15\u60a3\u5074\u7684\u75bc\u75db\u3002 (C)\u75c5\u4eba \u9838\u90e8\u4e0b\u5f4e\u8b93\u4e0b\u5df4\u78b0\u5230\u524d\u80f8\u6642\u6703\u8a98\u767c\u51fa\u53f3\u4e0a\u81c2\u50cf\u88ab\u96fb\u5230(electric shock sensation )\u6216\u7570\u5e38\u611f\u89ba(paresthesias )\u3002 (D)\u75c5\u4eba \u982d\u8f49\u5411\u5de6\u5074\u6642\u6703\u66f4\u75db\u3002 (E)\u6301\u7e8c\u7684\u9589\u6c23\u7528\u529b\u6703\u589e\u52a0\u53f3\u9838\u53ca\u53f3\u80a9\u7684\u75bc\u75db\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u6709\u95dc\u5927\u91cf\u54b3\u8840\u7684\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u80ba\u52d5\u8108\u8ca0\u8cac 99%\u5230\u9054\u80ba\u90e8\u7684\u8840\u6d41\uff0c\u56e0\u800c\u4e5f\u5e38\u662f\u54b3\u8840\u7684\u4e3b\u8981\u539f\u56e0\u3002 (B)Rasmussen's aneurysm \u591a\u662f\u5728 Aspergillus \u611f\u67d3\u5f8c\u7522\u751f\u3002 (C)\u5927\u91cf\u54b3\u8840\u4e14\u4e0d\u7a69\u5b9a\u7684\u75c5\u4eba\uff0c\u63d2\u7ba1\u5f8c\u505a\u652f\u6c23\u7ba1\u93e1\u662f\u7b2c\u4e00\u7dda\u7684\u8a3a\u65b7\u548c\u6cbb\u7642\u3002 (D)\u6cbb\u7642\u5927\u91cf\u54b3\u8840\u75c5\u4eba\u70ba\u4e86\u907f\u514d\u63d2\u7ba1\u56f0\u96e3\u901a\u5e38\u9078\u64c7\u8f03\u5c0f\u865f\u6578\u7684\u6c23\u7ba1\u5167\u7ba1\u3002 (E)\u6c23\u5207\u75c5\u4eba\u82e5\u6709 trachea -innominate fistula \u5927\u591a\u7121\u6cd5\u52a0\u58d3\u66ab\u6642\u6b62\u8840\uff0c\u61c9\u7acb\u5373\u8acb\u5916\u79d1\u624b\u8853\u8655\u7406\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "70\u6b72\u7537\u6027\uff0c\u904e\u53bb\u6709\u7cd6\u5c3f\u75c5\u53f2\uff0c\u5169\u9031\u524d\u56e0\u53f3\u5074\u6c23\u80f8\u958b\u5200 (thoracotomy )\u3002\u4eca\u5929\u56e0\u767c\u71d2\u3001\u547c\u5438\u56f0\u96e3(dyspnea )\u4e14\u5438\u6c23\u6642\u80f8\u53e3\u5287\u75db\u81f3\u6025\u8a3a\u5c31\u91ab\uff0c\u80f8\u90e8 X\u5149\u6aa2\u67e5\u986f\u793a\u53f3\u5074\u6709\u4e2d\u91cf\u808b\u819c\u7a4d\u6db2\uff0c\u4ee5\u7d30\u91dd\u62bd\u5438\u5f8c\u6aa2\u9a57\u767c\u73fe\u808b\u819c\u7a4d\u6db2\u5448\u73fe\u81bf\u6a23\u5316\u6db2\u9ad4 (purulent material )\u3002\u6709\u95dc\u6b64\u75c5\u4eba\u7684\u8a3a\u65b7\u53ca\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u672c\u75c5\u4eba\u6700\u5e38\u898b\u53ef\u80fd\u7684\u81f4\u75c5\u83cc\u70ba S. pneumococcus \u3002 (B)\u81bf\u80f8(empyema )\u7684\u8a3a\u65b7\u6a19\u6e96\u5305\u62ec\u808b\u819c\u6db2\u8840\u7cd6\u503c\u5927\u65bc 40mg/dL \u548cLDH\u5927\u65bc 1,000 U/L \u3002 (C)\u808b\u819c\u6db2\u7684 pH\u503c\u70ba 6.9\u53ef\u4ee5\u52a0\u5f37\u8a3a\u65b7\u7684\u78ba\u7acb\u3002 (D)\u6297\u751f\u7d20\u7684\u4f7f\u7528\u9996\u9078 amoxicillin/clavulanate \u3002 (E)\u75be\u75c5\u5728 organizational stage \uff0c\u53ef\u85c9\u7531\u6297\u751f\u7d20\u548c\u80f8\u7ba1\u5f15\u6d41\u6839\u6cbb\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "67\u6b72\u7537\u6027\uff0c\u76ee\u524d\u65bc\u5fc3\u81df\u79d1\u898f\u5247\u670d\u7528 rivaroxaban \uff0c\u56e0\u8eca\u798d\u81f4\u9aa8\u76c6\u53ca\u80a1\u9aa8\u9838\u9aa8\u6298\uff0c\u95dc\u65bc\u8a72\u75c5\u4eba\u6558\u8ff0\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u53ef\u4f7f\u7528\u53cd\u8f49\u5291\u907f\u514d\u5927\u51fa\u8840\u3002 (B)\u82e5\u8981\u4e86\u89e3\u51dd\u8840\u72c0\u6cc1\uff0caPTT \u7684\u6642\u9593\u6703\u6bd4 PT\u6642\u9593\u6e96\u78ba\u3002 (C)\u6b64\u75c5\u4eba\u5e73\u6642\u61c9\u898f\u5247\u6027\u8ffd\u8e64\u51dd\u8840\u56e0\u5b50\u3002 (D)\u82e5\u814e\u529f\u80fd\u4e0d\u4f73\u6703\u5c0e\u81f4 rivaroxaban \u85e5\u7269\u6392\u51fa\u7387\u4e0b\u964d\u3002 (E)\u82e5\u8a72\u75c5\u4eba\u6709\u5927\u91cf\u51fa\u8840\uff0c\u5efa\u8b70\u53ef\u4ee5\u7dca\u6025\u4e88\u4ee5\u8840\u6db2\u900f\u6790\u5c07\u85e5\u7269\u4ee3\u8b1d\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "30\u6b72\u5973\u6027\uff0c\u61f7\u5b55 32\u9031\uff0c\u9ad4\u91cd 60kg\u3002\u5728\u5bb6\u5168\u8eab\u62bd\u6410\u800c\u4f86\u6025\u8a3a\u3002\u5bb6\u4eba\u8868\u793a\u75c5\u4eba\u4e4b\u524d\u7121\u7672\u7647\u75c5\u53f2\u3002\u75c5\u4eba\u5728\u6025\u8a3a\u53c8\u7672\u7647\u767c\u4f5c\u4e86\u597d\u5e7e\u6b21\uff0c\u8840\u58d3 180/90 mmHg\u3002\u4e0b\u5217\u4f55\u8005\u85e5\u7269\u61c9\u8003\u616e \u512a\u5148\u7d66\u4e88\uff1f", + "Options": "(A)Lorazepam 6mg iv\u3002 (B)Labetalol 10mg iv \u3002 (C)Magnesium sulfate 4g iv \u3002 (D)Midazolam 10mg im \u3002 (E)Propofol 60mg iv \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "5\u6b72\u5973\u7ae5\uff0c\u5728\u5e7c\u5152\u5712\u7591\u4f3c\u884c\u70ba\u4e0d\u6b63\u5e38\uff0c\u6bcd\u89aa\u5e36\u4f86\u6025\u8a3a\u5c31\u91ab\u3002\u8001\u5e2b\u767c\u73fe\u5973\u7ae5\uff0c\u6700\u8fd1\u5e38\u5e38\u54ac\u5634\u5507\u9054 10\u4f86\u5206\u9418\uff0c\u773c\u795e\u5446\u6eef\uff0c\u4e92\u52d5\u4e0d\u4f73\uff0c\u8eab\u4e0a\u7121\u7600\u9752\uff0c\u547c\u53eb\u5973\u7ae5\u6642\u5076\u800c\u6703\u8f49\u982d\u56de\u61c9\u3002\u6bcd\u89aa\u8868\u793a\u5728\u5bb6\u4e5f\u767c\u73fe\u8207\u5728\u5e7c\u5152\u5712\u985e\u4f3c\u7684\u60c5\u5f62\u3002\u6025\u8a3a\u6e2c\u91cf\u751f\u547d\u5fb5\u8c61\uff0c\u8840\u58d3 106/55 mmHg \uff0c\u5fc3\u8df3 96\u6b21/min\uff0c\u547c\u5438 20\u6b21/min\uff0c\u9ad4\u6eab 36.3\u2103\uff0c\u6700\u8fd1\u7121\u767c\u71d2\u54b3\u55fd\u3002\u8eab\u9ad4\u8a3a\u5bdf\u6642\u8207\u5973\u7ae5\u5c0d\u8a71\u6e9d\u901a\u7121\u8aa4\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5973\u7ae5\u884c\u70ba\u4e0d\u6b63\u5e38\uff0c\u7591\u53d7\u7cbe\u795e\u523a\u6fc0\uff0c\u61c9\u555f\u52d5\u5152\u7ae5\u9810\u9632\u4fdd\u8b77\u6d41\u7a0b(\u5bb6\u66b4\u6216\u662f\u6027\u4fb5) \u3002 (B)\u5973\u7ae5\u773c\u795e\u5446\u6eef\uff0c\u7591\u4f3c\u611f\u67d3\u75c7\uff0c\u9032\u884c\u62bd\u8840\u6aa2\u9a57\uff0c\u548c\u9a57\u8840\u7cd6\u3002 (C)\u5973\u7ae5\u884c\u70ba\uff0c \u53cd\u8986\u767c\u4f5c\uff0c\u7591\u4f3c\u8166\u90e8\u816b\u7624\uff0c\u9032\u884c\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u3002 (D)\u5973\u7ae5\u5e38\u5e38\u54ac\u5634\u5507\uff0c\u53cd\u8986\u767c\u4f5c\uff0c\u7591\u4f3c\u7672\u7647\uff0c\u5b89\u6392\u8166\u6ce2\u6aa2\u67e5\u3002 (E)\u5973\u7ae5\u4e92\u52d5\u4e0d\u4f73\uff0c\u7591\u4f3c\u767c\u5c55\u9072\u7de9\uff0c\u9032\u884c\u9451\u5b9a\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u814e\u81df\u50b7\u5bb3\u5206\u7d1a (renal injury scale \uff0cGrade I -V)\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)Grade III \u4ee5\u4e0a\u5efa\u8b70\u958b\u5200\u63a2\u67e5\u3002 (B)\u50b7\u5230\u9ad3\u8cea( medulla)\u81f3\u5c11\u6709 Grade III\u3002 (C)\u5927\u90e8\u5206\u7684\u814e\u81df\u69cd\u50b7\u53ca\u7a7f\u523a\u50b7\u90fd\u9700\u8981\u958b\u5200\u63a2\u67e5\u3002 (D)\u5f71\u50cf\u5b78\u4e0a\u4e4b\u5c3f\u6db2\u5916\u6f0f(urinary extravasation )\u70ba\u958b\u5200\u63a2\u67e5\u9069\u61c9\u75c7\u3002 (E)\u814e\u81df\u50b7\u5bb3\u5f8c\u7e8c\u4f75\u767c\u75c7\u53ef\u80fd\u6709\u5ef6\u9072\u6027\u51fa\u8840\u3001\u5c3f\u7a4d\u6db2(urinoma ) \u3001\u9ad8\u8840\u58d3\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u7537\u6027\u75c5\u4eba\uff0c\u4e3b\u8a34\u80f8\u60b6\u3001\u6c23\u4fc3\u81f3\u6025\u8a3a\uff0c\u7b2c\u4e00\u7dda\u4f4f\u9662\u91ab\u5e2b\u8a3a\u7642\u7d66\u4e88\u75c5\u4ebanitroglycerin \u975c\u8108\u5e6b\u6d66\u8f38\u6ce8\u5f8c\uff0c\u75c5\u4eba\u8840\u58d3\u56b4\u91cd\u4e0b\u964d\uff0c\u4f60 \u63a5\u624b\u8655\u7406\u3002\u8acb\u554f\u4e0b\u5217\u75c5\u56e0\u4f55\u8005\u53ef\u80fd\u6027 \u8f03\u4f4e\uff1f", + "Options": "(A)\u963b\u585e\u6027\u80a5\u539a\u5fc3\u808c\u75c7(hypertrophic obstructive cardiomyopathy )\u3002 (B)\u53f3\u5fc3\u5ba4\u5fc3\u808c\u6897\u585e(right ventricular infarction) \u3002 (C)\u4e3b\u52d5\u8108\u74e3\u72f9\u7a84(aortic stenosis )\u3002 (D)\u904e\u654f\u6027\u4f11\u514b(anaphylaxis )\u3002 (E)\u4e8c\u5c16\u74e3\u9006\u6d41( mitral regurgitation )\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6025\u6027\u814e\u640d\u50b7 (acute kidney injury )\u7684\u63cf\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u5927\u90e8\u5206\u793e\u5340\u578b\u7684\u6025\u6027\u814e\u640d\u50b7\u75c5\u4eba\u70ba prerenal(\u814e\u81df\u704c\u6d41\u4e0d\u8db3) \uff0c\u88dc\u5145\u9ad4\u6db2( crystalloid )\u70ba\u4e3b\u8981\u6cbb\u7642\u65b9\u5f0f\u3002 (B)\u5927\u90e8\u5206\u91ab\u9662\u578b\u7684\u6025\u6027\u814e\u640d\u50b7\u75c5\u4eba\u70ba\u814e\u6e90\u6027\u7684\u7f3a\u8840\u6027\u814e\u5c0f\u7ba1\u58de\u6b7b(ischemic tubular necrosis)\u3002 (C)\u4f7f\u7528 angiotensin -converting enzyme (ACE)inhibitors \u7684\u75c5\u4eba\uff0c\u82e5\u814e\u529f\u80fd\u6025\u907d\u60e1\u5316\uff0c\u6975\u53ef\u80fd\u96d9\u5074\u814e\u52d5\u8108\u72f9\u7a84\u3002 (D)\u82e5\u75c5\u4eba\u814e\u81df\u529f\u80fd\u6975\u5dee\uff0c\u4f46\u60c5\u6cc1\u7a69\u5b9a\u4e14\u6709\u5fc5\u8981\u4f7f\u7528\u986f\u5f71\u5291\uff0c\u5b89\u6392Gadolinium -based\u986f\u5f71\u7684 MRI\u53ef\u907f\u514d\u814e\u640d\u50b7\u3002 (E)\u5b8c\u5168\u963b\u585e\u9020\u6210\u7684 post-obstructive \u814e\u640d\u50b7\uff0c\u5728 10-14\u5929\u5f8c\u6703\u9020\u6210\u6c38\u4e45\u6027\u7684\u814e\u529f\u80fd\u7f3a\u640d\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "2\u6b72\u7537\u7ae5\uff0c\u4e09\u65e5\u524d\u958b\u59cb\u767c\u71d2\u53ca\u547c\u5438\u5598\uff0c\u88ab\u9001\u81f3\u6025\u8a3a\u3002\u5728\u6025\u8a3a\u6642\uff0c\u4f60\u6c7a\u5b9a\u8981\u9032\u884c\u6c23\u7ba1\u5167\u63d2\u7ba1\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u9032\u884c\u6c23\u7ba1\u5167\u63d2\u7ba1\u6642\uff0c\u82e5\u770b\u4e0d\u5230\u8072\u9580(glottis ) \uff0c\u5b9c\u5728\u7537\u7ae5\u9838\u90e8\u5f8c\u65b9\u653e\u7f6e\u6795\u982d\uff0c\u4f7f\u6c23\u7ba1\u53ca\u53e3\u54bd\u6210\u4e00\u76f4\u7dda\u3002 (B)\u82e5\u767c\u751f\u56f0\u96e3\u63d2\u7ba1\u6642\uff0c\u5b9c\u7dca\u6025\u9032\u884c\u74b0\u7532\u819c\u5207\u958b\u8853(surgical cricothyroidotomy )\u3002 (C)\u82e5\u9032\u884c\u7d93\u53e3\u6c23\u7ba1\u63d2\u7ba1(oral endotracheal intubation )\u591a\u6b21\u5931\u6557\u6642\uff0c\u53ef\u5617\u8a66\u4f7f\u7528\u7d93\u9f3b\u6c23\u7ba1\u63d2\u7ba1(nasal endotracheal intubation)\u3002 (D)\u82e5\u9078\u64c7\u4f7f\u7528 4.5mm\u7684\u6c23\u7ba1\u5167\u7ba1\u9032\u884c\u6c23\u7ba1\u5167\u63d2\u7ba1\uff0c\u53ef\u4f7f\u7528\u6709\u6c23\u56ca(cuffed)\u7684\u6c23\u7ba1\u5167\u7ba1\uff0c\u4e26\u6301\u7e8c\u76e3\u63a7\u6c23\u56ca\u58d3\u529b\u3002 (E)\u9032\u884c\u6c23\u7ba1\u5167\u63d2\u7ba1\u6642\uff0c\u5b9c\u4f7f\u7528\u5f4e\u66f2\u5f0f(curved )\u7684\u5589\u982d\u93e1\u8449\u7247\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "50\u6b72\u5973\u6027\u8179\u819c\u900f\u6790\u591a\u5e74\u75c5\u4eba\uff0c\u56e0\u5614\u5410\u3001\u8179\u75db 2\u65e5\u4f75\u5fae\u71d2\uff0c\u81f3\u6025\u8a3a\u5c31\u8a3a\u3002\u8179\u819c\u900f\u6790\u6db2\u7684\u5206\u6790\u767c\u73fe\uff1a WBC 90/mm3\uff0c\u5176\u4e2d Neutrophils \u4f5440%\u3002\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5f88\u6709\u53ef\u80fd\u662f\u8179\u819c\u708e\uff0c\u7acb\u5373\u6703\u8a3a\u4e00\u822c\u5916\u79d1\u3002 (B)\u5f88\u6709\u53ef\u80fd\u662f\u8179\u819c\u900f\u6790\u76f8\u95dc\u7684\u8179\u819c\u708e\uff0c\u7acb\u5373\u7d66\u4e88 IV\u6297\u751f\u7d20\u3002 (C)\u5f88\u6709\u53ef\u80fd\u662f\u8179\u819c\u900f\u6790\u76f8\u95dc\u7684\u8179\u819c\u708e\uff0c\u7acb\u5373\u7d66\u4e88 IP\u6297\u751f\u7d20(\u65bc\u900f\u6790\u6db2\u4e2d\u52a0\u5165\u6297\u751f\u7d20) \u3002 (D)\u4e0d\u592a\u50cf\u8179\u819c\u900f\u6790\u76f8\u95dc\u7684\u8179\u819c\u708e\uff0c\u7acb\u5373\u505c\u6b62\u8179\u819c\u900f\u6790\u4e26\u6703\u8a3a\u814e\u81df\u79d1\u3002 (E)\u4e0d\u592a\u50cf\u8179\u819c\u900f\u6790\u76f8\u95dc\u7684\u8179\u819c\u708e\uff0c\u7acb\u5373\u5b89\u6392\u5176\u4ed6\u6aa2\u67e5\u4ee5\u78ba\u5b9a\u8a3a\u65b7\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "3\u6b72\u7537\u7ae5\uff0c\u56e0\u547c\u5438\u56f0\u96e3\u4e09\u65e5\uff0c\u4e14\u75c7\u72c0\u8d8a\u4f86\u8d8a\u52a0\u5287\uff0c\u65bc\u662f\u524d\u4f86\u6025\u8a3a\u5c31\u91ab\u3002\u5bb6\u5c6c\u8868\u793a\u7537\u7ae5\u904e\u53bb\u90fd\u6709\u6309\u6642\u65bd\u6253\u75ab\u82d7\uff0c\u9019\u5e7e\u5929\u547c\u5438\u8f03\u6025\u4fc3\u8cbb\u529b\uff0c\u4e14\u8f03\u6c92\u7cbe\u795e\u3002\u8eab\u9ad4\u6aa2\u67e5\u767c\u73fe\uff1a\u80f8\u90e8\u807d\u8a3a\u53ef\u5728\u7537\u7ae5\u4f11\u606f\u6642\u660e\u986f\u807d\u5230\u5598\u9cf4\u97f3(stridor )\uff0c\u4e14\u7537\u7ae5\u4e0d\u505c\u7684\u54b3\u55fd\uff0c\u8072\u97f3\u7336\u5982\u72d7\u5420 \u8072(barking cough) \uff1b\u5916\u89c0\u7684\u90e8\u5206\uff1a\u547c\u5438\u6642\u6709\u80f8\u51f9 (retraction )\u7684\u60c5\u6cc1\u3002\u63a5\u4e0b\u4f86\u7684\u8655\u7f6e\uff0c\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u7d66\u4e88\u6297\u751f\u7d20\u6cbb\u7642\u3002 (B)\u7acb\u5373\u7d66\u4e88\u985e\u56fa\u9187(dexamethasone )\u6cbb\u7642\uff0c\u4e14\u7d93\u975c\u8108\u9014\u5f91\uff0c\u4e0d\u5b9c\u53e3\u670d\u3002 (C)\u4e0d\u5efa\u8b70\u7d66\u4e88\u5438\u5165\u6027 Beta-agonist\u85e5\u7269\uff0c\u56e0\u70ba\u6b64\u8209\u53ef\u80fd\u52a0\u91cd\u4e0a\u547c\u5438\u9053\u963b\u585e\u7684\u60c5\u6cc1\u3002 (D)\u7acb\u5373\u7d66\u4e88\u5438\u5165\u6027\u7684 Epinephrine \u6cbb\u7642\uff0c\u5c0d\u7537\u7ae5\u75c5\u60c5\u4e26\u7121\u5e6b\u52a9\u3002 (E)\u4f7f\u7528\u8f03\u7c97\u7684\u6c23\u7ba1\u5167\u7ba1\u9032\u884c\u6c23\u7ba1\u5167\u63d2\u7ba1\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u57f7\u884c Dix-Hallpike\u6aa2\u67e5\uff0c\u4f60\u9700\u8981\u5b89\u6392\u4ee5\u4f55\u7a2e\u59ff\u52e2\u958b\u59cb\uff1f", + "Options": "(A)\u75c5\u4eba\u5750\u59ff\u5728\u6aa2\u67e5\u5e8a\u4e0a\u3002 (B)\u75c5\u4eba\u4ef0\u81e5\u5728\u6aa2\u67e5\u5e8a\u4e0a\uff0c\u982d\u9762\u671d\u4e0a\u3002 (C)\u75c5\u4eba\u4ef0\u81e5\u5728\u6aa2\u67e5\u5e8a\u4e0a\uff0c\u982d\u504f\u4e00\u5074\u3002 (D)\u75c5\u4eba\u4ef0\u81e5\uff0c\u982d\u90e8\u5728\u5e8a\u982d\u5916\u570d\u5f8c\u4ef0\uff0c\u982d\u9762\u671d\u4e0a\u3002 (E)\u75c5\u4eba\u4ef0\u81e5\uff0c\u982d\u90e8\u5728\u5e8a\u982d\u5916\u570d\u5f8c\u4ef0\uff0c\u982d\u504f\u4e00\u5074\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u8178\u963b\u585e\u7684\u75c5\u4eba\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u624b\u8853\u5f8c\u6cbe\u9ecf( adhesions) \uff0c\u5f88\u5c11\u6703\u5c0e\u81f4\u5927\u8178\u963b\u585e\u3002 (B)\u6297\u75d9\u6523\u85e5\u7269\u5982 Buscopan(hyoscine butylbromide )\u61c9\u53ca\u65e9\u4f7f\u7528\uff0c\u4ee5\u7de9\u89e3\u75c5\u4eba\u7684\u8179\u75db\u3002 (C)\u5d4c\u9813\u578b\u8179\u80a1\u6e9d\u759d\u6c23(incarcerated groin hernia ) \uff0c\u662f\u5c0f\u8178\u963b\u585e\u7684\u6700\u5e38\u898b\u539f\u56e0\u3002 (D)\u9f3b\u80c3\u7ba1\u7684\u7f6e\u653e\u7d93\u5e38\u662f\u9700\u8981\u7684\uff0c\u61c9\u53ca\u65e9\u4f7f\u7528\u3002 (E)\u56b4\u91cd\u8178\u963b\u585e\u5c0e\u81f4\u8178\u7f3a\u8840\u6027\u58de\u6b7b\uff0c\u75c5\u4eba\u6b7b\u4ea1\u7387\u7d04 50%\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u6709\u95dc Toxic epidermal necrolysis \u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)Toxic epidermal necrolysis \u6b7b\u4ea1\u7387\u5e73\u5747\u70ba 60-70%\u3002 (B)Toxic epidermal necrolysis \u5f71\u97ff\u5927\u65bc 30%\u9ad4\u8868\u9762\u7a4d(BSA )\u6642\uff0c\u7a31\u70baStevens- Johnson syndrome \u3002 (C)Toxic epidermal necrolysis \u4e0d\u6703\u4fb5\u72af\u7d50\u819c\u53ca\u89d2\u819c\u3002 (D)\u5e38\u4ee5\u767c\u71b1\u3001\u5589\u56a8\u75db\u3001\u808c\u8089\u75db\u70ba\u521d\u671f\u8868\u5fb5\u3002 (E)\u5168\u8eab\u90fd\u53ef\u80fd\u51fa\u73fe\u76ae\u819a\u7d05\u75b9\uff0c\u5c24\u5176\u4ee5\u8ec0\u5e79\u6700\u70ba\u5e38\u898b\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5b89\u5be7\u7de9\u548c\u7642\u8b77( palliative care )\u7684\u75c7\u72c0\u6cbb\u7642\u63cf\u8ff0\uff0c\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u7a4d\u6975\u4f7f\u7528\u9d09\u7247\u985e\u85e5\u7269\u4f86\u63a7\u5236\u75bc\u75db\uff0c\u6700\u5927\u7684\u7591\u616e\u662f\u6703\u7522\u751f\u7a81\u767c\u6027\u7684\u547c\u5438\u6291\u5236\u3002 (B)\u91dd\u5c0d\u547c\u5438\u6025\u4fc3\u7684\u672b\u671f\u75c5\u4eba\uff0c\u9664\u8655\u7406\u6f5b\u5728\u7684\u75c5\u60c5\u5916\uff0c\u4ee5\u6cbb\u7642\u75bc\u75db\u5169\u500d\u5291\u91cf\u7684\u55ce\u5561\u70ba\u8d77\u59cb\u5291\u91cf\u3002 (C)\u5c0d\u65bc\u9811\u56fa\u578b\u7684\u5641\u5fc3\u3001\u5614\u5410\uff0c\u53ef\u4ee5\u4f7f\u7528\u6cbb\u7642\u75bc\u75db\u4e00\u534a\u5291\u91cf\u7684\u55ce\u5561\u4f86\u6cbb\u7642\u3002 (D)\u958b\u7acb\u9d09\u7247\u985e\u85e5\u7269\u6cbb\u7642\u672b\u671f\u75bc\u75db\u6642\uff0c\u9700\u540c\u6642\u958b\u7acb\u523a\u6fc0\u6027\u6216\u6ef2\u900f\u6027\u7684\u7009\u5291\u4f86\u9810\u9632\u4fbf\u7955\u3002 (E)\u5c0d\u65bc\u672b\u671f\u8e81\u52d5\u7684\u75c5\u4eba\uff0c\u4f7f\u7528\u6297\u7cbe\u795e\u85e5\u7269\u3001\u5b89\u7720\u5291\u3001\u6216\u9d09\u7247\u985e\u85e5\u7269\uff0c\u6709\u8b49\u64da\u986f\u793a\u6703\u52a0\u901f\u6b7b\u4ea1\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "25\u6b72\u7537\u6027\u6cb3\u5ddd\u6eba\u6c34\u5408\u4f75\u77ed\u66ab\u610f\u8b58\u55aa\u5931\uff0c\u9001\u81f3\u6025\u8a3a Glasgow Coma Scale \u5206\u6578\u70ba15\u5206\u4e14 SaO 2 95%\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u7d93\u5e38\u5408\u4f75\u982d\u90e8\u5916\u50b7\u6216\u9838\u90e8\u904e\u5ea6\u4f38\u5c55\uff0c\u5efa\u8b70\u5e38\u898f\u4f7f\u7528\u9838\u5708\u56fa\u5b9a\u3002 (B)\u5efa\u8b70\u89c0\u5bdf 4-6\u5c0f\u6642\uff0c\u82e5\u8eab\u9ad4\u6aa2\u67e5\u80ba\u90e8\u6b63\u5e38\uff0c\u53ef\u4e0d\u9808\u8ffd\u8e64\u80f8\u90e8 X\u5149\u3002 (C)\u62bd\u8840\u6aa2\u67e5\u4f4e\u8840\u9209\u3001\u4f4e\u8840\u9240\u4e26\u4e0d\u5e38\u898b\u3002 (D)\u4e0d\u9808\u5e38\u898f\u7d66\u4e88\u9810\u9632\u6027\u6297\u751f\u7d20\u3002 (E)\u5982\u679c SaO 2\u964d\u81f3 91%\uff0c\u9664\u4e86\u80f8\u90e8 X\u5149\u53ca\u5e38\u898f\u62bd\u8840\u6aa2\u67e5\u5916\uff0c\u9808\u8003\u616e\u85e5\u7269\u7be9\u6aa2\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "25\u6b72\u5973\u6027\u8aa4\u98df\u4e0d\u660e\u5316\u5b78\u85e5\u5291\u7d04 120\u6beb\u5347\uff0c 14\u5c0f\u6642\u5f8c\u56e0\u70ba\u982d\u6688\u53ca\u5641\u5fc3\u524d\u53bb\u6025\u8a3a\u5c31\u8a3a\uff0c\u75c5\u4eba\u8868\u793a\u6b64\u85e5\u5291\u5690\u8d77\u4f86\u751c\u751c\u7684\uff0c\u5c31\u8a3a\u6642\u9ad4\u6eab 36.8\u2103\u3001\u547c\u5438 18\u6b21/min\u3001\u5fc3\u8df3 92\u6b21/min\u3001\u8840\u58d3 169/85 mmHg \u3001Na 142 mmol/L \u3001Cl 109 mmol/L\u3001BUN 7 mg/dL \u3001glucose 131 mg/dL \u3001ketone body \uff1anegative \u3001Ethanol 3 mg/dL \u3001blood osmolality 319 mOsm/Kg\uff0c\u53e6\u5916\u52d5\u8108\u8840\u6c23\u5206\u6790 pH 7.29\u3001 PCO 2 25.4 mmHg \u3001HCO 3 12.5 mmol/L \uff0curine analysis \u6709\u9a57\u5230\u8349\u9178\u9223\u7d50\u6676\uff0c\u8acb\u554f\u75c5\u4eba \u6700\u6709\u53ef\u80fd\u559d\u4e0b\u4e0b\u5217\u54ea\u7a2e\u7269\u8cea\uff1f", + "Options": "(A)\u7532\u9187\u3002 (B)\u7532\u82ef\u3002 (C)\u4e59\u4e8c\u9187\u3002 (D)2 -\u6c2f\u4e59\u9187\u3002 (E)\u7570\u4e19\u9187\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "6\u6b72\u7537\u5b69\u6b65\u884c\u904e\u8857\uff0c\u88ab\u4e00\u8f1b\u4ee5\u6642\u901f 35\u516c\u91cc\u884c\u99db\u7684\u6c7d\u8eca\u649e \u64ca\u3002\u95dc\u65bc\u9019\u540d\u50b7\u8005\u7167\u8b77\u7684\u6ce8\u610f\u4e8b\u9805\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u56e0\u70ba\u80f8\u5ed3\u7684\u649e\u64ca\u5927\uff0c\u5e38\u898b\u9023\u67b7\u80f8\u7684\u767c\u751f\u3002 (B)\u51fa\u73fe\u75c7\u72c0\u6027\u5fc3\u81df\u632b\u50b7\u7684\u53ef\u80fd\u6027\u9ad8\u65bc\u6210\u4eba\u3002 (C)\u9020\u6210\u5f35\u529b\u6027\u6c23\u80f8\u7684\u6a5f\u6703\u6bd4\u6210\u4eba\u9ad8\u3002 (D)\u6bd4\u6210\u4eba\u66f4\u53ef\u80fd\u9020\u6210\u80f8\u4e3b\u52d5\u8108\u7684\u6a6b\u65b7\u3002 (E)\u808b\u9aa8\u9aa8\u6298\u5e38\u898b\u65bc\u9019\u7a2e\u640d\u50b7\u6a5f\u5236\u7684\u5152\u7ae5\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4ee5\u4e0b\u6709\u95dc\u8840\u6813\u6eb6\u89e3\u5291( r-tPA)\u6cbb\u7642\u7f3a\u8840\u6027\u8166\u4e2d\u98a8\u7684\u6558\u8ff0\uff0c\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u82e5\u5408\u4f75\u7672\u7647\u767c\u4f5c\u4e14\u610f\u8b58\u4e0d\u6e05\uff0c\u5247\u4e0d\u8003\u616e\u4f7f\u7528\u8840\u6813\u6eb6\u89e3\u5291\u6cbb\u7642\u3002 (B)\u82e5\u5404\u9805\u689d\u4ef6\u7686\u7b26\u5408\uff0c\u7d93\u6cbb\u7652\u5df2\u8d85\u904e\u4e09\u500b\u6708\u7684\u8166\u90e8\u816b\u7624\u53ef\u4ee5\u8003\u616e\u7d66 r-tPA\u3002 (C)\u75c5\u4eba\u7d66\u85e5\u524d\u8840\u58d3\u61c9\u7dad\u6301\u5728\u6536\u7e2e\u58d3\u5c0f\u65bc 185 mmHg\u53ca\u8212\u5f35\u58d3\u5c0f\u65bc 110 mmHg\u3002 (D)\u7d55\u5c0d\u4e0d\u80fd\u4f7f\u7528\u5728\u75c7\u72c0\u767c\u751f\u6642\u9593\u4e0d\u660e\u78ba\u7684\u75c5\u4eba\u8eab\u4e0a\u3002 (E)\u75c5\u4eba\u82e5\u7b26\u5408\u9032\u884c\u52d5\u8108\u53d6\u6813\u8853\u6cbb\u7642\uff0c\u4ecd\u53ef\u5728\u53d6\u6813\u8853\u524d\u7d66\u4e88 r-tPA\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "50\u6b72\u7537\u6027\u6c7d\u8eca\u99d5\u99db\u906d\u5927\u8ca8\u8eca\u5074\u649e\uff0c\u5230\u9054\u6025\u8a3a\u5ba4\u6642\u7684\u751f\u547d\u5fb5\u8c61\u5982\u4e0b\uff1a\u9ad4\u6eab36.2\u2103\uff0c\u547c\u5438 40\u6b21/min\uff0c\u5fc3\u8df3 140\u6b21/min\uff0c\u8840\u58d3 70/40 mmHg\uff0c\u8840\u6c27 80\uff05\uff0c\u610f\u8b58\u6a21\u7cca\uff0c\u660f\u8ff7\u6307\u6578 14\u5206\u3002\u521d\u7d1a\u8a55\u4f30\u547c\u5438\u9053\u901a\u66a2\u7121\u7570\u7269\uff0c\u6c23\u7ba1\u504f\u79fb\u81f3\u5de6\u908a\uff0c\u9838\u975c\u8108\u6012\u5f35\uff0c\u53f3\u80f8\u58c1\u76ae\u4e0b\u6c23\u816b\u3002\u4e0b\u5217\u8655\u7f6e\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u65bc\u53f3\u5074\u7dca\u6025\u958b\u80f8(emergent thoracotomy )\u3002 (B)\u7d66\u4e88\u888b- \u74e3-\u9762\u7f69\u5f0f\u901a\u6c23(bag -valve -mask ventilation )\u3002 (C)\u7d66\u4e88\u975e\u4fb5\u8972\u6027\u6b63\u58d3\u547c\u5438\u5668(non-invasive positive pressure ventilator )\u3002 (D)\u65bc\u53f3\u5074\u7b2c\u4e94\u808b\u9593\u7f6e\u653e\u80f8\u7ba1(tube thoracotomy )\u3002 (E)\u65bc\u53f3\u5074\u7b2c\u4e94\u808b\u9593\u7f6e\u653e\u91dd\u982d\u6e1b\u58d3(needle decompression )\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u5e7c\u7a1a\u5712\u51fa\u904a\u8eca\u798d\uff0c\u4e00\u4f4d\u516d\u6b72 20kg\u5b69\u7ae5\u56e0\u8179\u90e8\u632b\u50b7\u9001\u81f3\u6025\u8a3a\uff0c\u547c\u5438\u9053\u53ca\u547c\u5438\u7121\u7570\u5e38\u767c\u73fe\uff0c\u8179\u90e8\u6709\u58d3\u75db\u5408\u4f75\u53cd\u5f48\u75db\uff0c\u8840\u58d3 70/30 mmHg \u5408\u4f75\u4f11\u514b\u75c7\u72c0\uff0c\u8acb\u554f\u6025\u8a3a\u8655\u7406\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u9ad4\u6db2\u5fa9\u7526\u61c9\u7d66\u4e88 1,000 ml \u7b49\u5f35\u6676\u8cea\u8f38\u6db2(isotonic crystalloid solution) \uff0c\u518d\u6b21\u8a55\u4f30\u3002 (B)\u9ad4\u6db2\u5fa9\u7526\u61c9\u7d66\u4e88 400 ml\u7b49\u5f35\u6676\u8cea\u8f38\u6db2\u3002 (C)\u521d\u6b21\u7d66\u4e88\u8f38\u6db2\u5f8c\uff0c\u82e5\u4ecd\u5448\u73fe\u4f11\u514b\u72c0\u614b\uff0c\u5247\u53ef\u4ee5\u7d66\u7b2c\u4e8c\u6216\u7b2c\u4e09\u6b21\u6bcf\u516c\u65a4\u7d66\u4e88 10 ml\u7b49\u5f35\u6676\u8cea\u8f38\u6db2\u3002 (D)\u5b69\u7ae5\u56e0\u5c0d\u4f11\u514b\u5fcd\u53d7\u5ea6\u8f03\u4f4e\uff0c\u53ef\u512a\u5148\u76f4\u63a5\u8f38\u8840\u6cbb\u7642\u3002 (E)\u8f38\u8840\u6cbb\u7642\u4ee5\u6bcf\u516c\u65a4 20 ml packed RBC \u8f38\u6db2\u6cbb\u7642\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4f60\u6b63\u6e96\u5099\u62bd\u53d6\u819d\u95dc\u7bc0\u6db2\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u9032\u884c\u62bd\u53d6\u6642\u6700\u597d\u662f\u4ee5\u5750\u59ff\u65b9\u5f0f\u3002 (B)\u9032\u884c\u62bd\u53d6\u6642\u6700\u597d\u5448\u73fe\u66f2\u819d\u59ff\u52e2\u3002 (C)\u4ee5\u9ad5\u9aa8(patella )\u6b63\u4e0b\u65b9\u4e8c\u6307\u5e45 (\u7d04 3\u516c\u5206)\u8655\u70ba\u5b9a\u4f4d\u9ede\u3002 (D)\u4e0b\u91dd\u8655\u5728\u5b9a\u4f4d\u9ede\u7684\u5167\u5074\u6216\u5916\u5074 \uff0c\u671d\u9ad5\u9aa8 (patella)\u5f8c\u5074\u7684\u4e2d\u9ede\u6c34\u5e73\u524d\u9032\u3002 (E)\u62bd\u53d6\u6642\u61c9\u907f\u514d\u5728\u540c\u6642\u95dc\u7bc0\u8154\u4e0a\u4e0b\u8f15\u64e0( milking) \u4ee5\u514d\u9020\u6210\u95dc\u7bc0\u8154\u51fa\u8840\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u504f\u982d\u75db( Migraine)\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u9078\u9805\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5408\u4f75\u4f7f\u7528\u6297\u7d44\u7e54\u80fa\u85e5\u7269\u548c\u975e\u985e\u56fa\u9187\u6297\u767c\u708e\u85e5\u7269( NSAID)\u5c0d\u504f\u982d\u75db\u6703\u6709\u5e6b\u52a9\uff0c\u4f46\u55ae\u7368\u4f7f\u7528\u6297\u7d44\u7e54\u80fa\u85e5\u7269\u6c92\u6709\u5e6b\u52a9\u3002 (B)\u597d\u767c\u7684\u5e74\u7d00\u5728 40\u6b72\u5de6\u53f3\uff0c\u76db\u884c\u7387\u662f\u7537\u6027\u5927\u65bc\u5973\u6027\u3002 (C)\u4f7f\u7528\u985e\u56fa\u9187\u85e5\u7269\u4e0d\u80fd\u964d\u4f4e\u6025\u8a3a\u96e2\u9662\u5f8c\u982d\u75db\u5fa9\u767c\u7684\u98a8\u96aa\u3002 (D)\u8d77\u59cb\u6cbb\u7642\u5efa\u8b70\u4f7f\u7528\u55ce\u5561\u985e\u85e5\u7269\u5408\u4f75\u6b62\u5410\u85e5\u3002 (E)\u901a\u5e38\u662f\u55ae\u5074\uff0c\u7121\u8108\u52d5\u6027(pulsatile ) \uff0c\u53ef\u80fd\u6703\u754f\u61fc\u5149\u53ca\u8072\u97f3\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "75\u6b72\u5973\u6027\u6709\u98a8\u6fd5\u6027\u5fc3\u81df\u75c5( rheumatic heart disease )\u53ca\u9ad8\u8840\u58d3\u75c5\u53f2\uff0c\u6700\u8fd1\u4e3b\u8a34\u80f8\u60b6\u3001\u6c23\u4fc3\u7684\u60c5\u5f62\u3002\u4eca\u5929\u56e0\u70ba\u660f\u53a5(syncope )\u9001\u4f86\u6025\u8a3a\u3002\u5230\u9662\u6642\u7684\u8840\u58d3108/76 mmHg\u3001\u5fc3\u8df3 135\u6b21/min\u3001\u547c\u5438 25\u6b21/min\u3001 SpO 2 89%\uff0c\u807d\u8a3a\u96d9\u5074\u56c9\u97f3\uff0c\u5fc3\u97f3\u6709\u807d\u5230 S4 gallop\uff0c\u80f8\u90e8 X\u5149\u5448\u73fe\u96d9\u5074\u80ba\u6c34\u816b(pulmonary edema)\uff0c\u5fc3\u96fb\u5716\u5448\u73fe\u5fc3\u623f\u986b\u52d5\u3002\u8acb\u554f\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u53ef\u4ee5\u7d66\u4e88\u4e59\u578b\u963b\u65b7\u5291\u6216\u662f\u9223\u96e2\u5b50\u963b\u65b7\u5291\u5c0d\u65bc\u63a7\u5236\u5fc3\u5f8b\u6709\u4e0d\u932f\u7684\u6548\u679c\u3002 (B)\u6b64\u75c5\u7076\u5e38\u56e0\u5fc3\u5167\u819c\u708e(endocarditis)\u5f15\u8d77\uff0c\u56e0\u6b64\u9700\u5e38\u898f\u7684\u7d66\u4e88\u9810\u9632\u6027\u6297\u751f\u7d20\u3002 (C)\u82e5\u6b64\u75c5\u7076\u56b4\u91cd\uff0c\u5e38\u9700\u8981\u958b\u5200\u8655\u7f6e\uff0c\u82e5\u4e0d\u958b\u5200\u4e00\u5e74\u5167\u6b7b\u4ea1\u7387\u9ad8\u3002 (D)\u7d66\u4e88\u6c27\u6c23\u3001\u820c\u4e0b NTG\u53cafurosemide \uff0c\u6709\u6642\u9700\u8981\u6b63\u58d3\u547c\u5438\u4f86\u6cbb\u7642\u80ba\u6c34\u816b\u3002 (E)\u9700\u8981\u7d66\u4e88 aspirin\u3001clopidogrel \uff0c\u6aa2\u67e5 Troponin\uff0c\u7acb\u5373\u5b89\u6392\u5fc3\u5c0e\u7ba1\u6aa2\u67e5\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u95dc\u65bc\u5fc3\u8df3\u505c\u6b62 \u75c5\u4eba\u7684\u5fa9\u7526\u5f8c\u7167\u8b77 (post-cardiac arrest care )\u5efa\u8b70\u6558\u8ff0\uff0c\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5230\u9662\u524d\u4ee5\u51b0\u6c34\u958b\u59cb\u5e6b \u75c5\u4eba\u964d\u6eab\uff0c\u6709\u52a9\u65bc\u75c5\u4eba\u7684\u795e\u7d93\u5b78\u9810\u5f8c\u8207\u51fa\u9662\u5b58\u6d3b\u7387\u3002 (B)\u5fa9\u7526\u5f8c\u82e5\u75c5\u4eba\u610f\u8b58\u4e0d\u6e05\uff0c\u7121\u6cd5\u9075\u5f9e\u53e3\u982d\u547d\u4ee4\uff0c\u53ef\u8003\u616e\u9032\u884c 32-36\u2103\u7684\u76ee\u6a19\u9ad4\u6eab\u7ba1\u7406 (targeted temperature management )\u6301\u7e8c 48-72\u5c0f\u6642\u3002 (C)\u5fa9\u7526\u5f8c\u7684\u7dca\u6025\u5fc3\u5c0e\u7ba1\u6aa2\u67e5(coronary angiography )\u8207\u7d93\u76ae\u51a0\u72c0\u52d5\u8108\u4ecb\u5165\u6027\u6cbb\u7642(Percutaneous Coronary Intervention, PCI)\u5df2\u88ab\u8b49\u5be6\u6709\u52a9\u65bc\u75c5\u4eba\u9810\u5f8c\u3002 (D)\u964d\u6eab\u6642\u5bb9\u6613\u767c\u751f\u5fc3\u8df3\u904e\u6162\u3001\u51dd\u8840\u529f\u80fd\u7570\u5e38\u3001\u9ad8\u8840\u9240\u8207 QT prolongation \u7684\u4f75\u767c\u75c7\u3002 (E)\u75c5\u4eba\u56de\u6eab\u5b8c\u6210\u5f8c\u82e5\u51fa\u73fe\u767c\u71d2\u75c7\u72c0\uff0c\u61c9\u7a4d\u6975\u63a7\u5236\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6025\u6027\u80f0\u81df\u708e\u76f8\u95dc\u4e4b\u8a3a\u65b7\u53ca\u6cbb\u7642\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5be6\u9a57\u5ba4\u6aa2\u9a57\u9700\u540c\u6642\u5305\u542b\u6fb1\u7c89\u9176(amylase )\u53ca\u8102\u80aa\u9176(lipase )\uff0c \u4ee5 \u6c42\u6b63\u78ba\u8a3a\u65b7\u3002 (B)\u8102\u80aa\u9176(lipase )\u6578\u503c\u9ad8\u4f4e\uff0c\u53ef\u4ee3\u8868\u75be\u75c5\u56b4\u91cd\u7a0b\u5ea6\u3002 (C)\u8179\u90e8\u96fb\u8166\u65b7\u5c64\u70ba\u826f\u597d\u7684\u8a3a\u65b7\u5de5\u5177\uff0c\u53ef\u53ca\u65e9\u5b89\u6392\u6b64\u5f71\u50cf\u6aa2\u67e5\u3002 (D)\u70ba\u907f\u514d\u75c5\u60c5\u60e1\u5316\uff0c\u9808\u7981\u6b62\u75c5\u4eba\u7d93\u53e3\u9032\u98df\uff0c\u6539\u4ee5\u975c\u8108\u8f38\u6db2\u3002 (E)\u6297\u751f\u7d20\u7121\u52a9\u65bc\u9810\u9632\u611f\u67d3\u4e4b\u4f75\u767c\u75c7\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "27\u6b72\u7537\u6027\uff0c\u767c\u71d2\u3001\u5589\u56a8\u75db\u4e8c\u65e5\u5f8c\uff0c\u56e0\u6301\u7e8c\u75bc\u75db\u52a0\u5287\u3001\u541e\u56a5\u56f7\u96e3\u3001\u547c\u5438\u56f0\u96e3\u81f3\u6025\u8a3a\uff0c\u9ad4\u6eab 38.3\u2103\uff0c\u547c\u5438 20\u6b21/min\uff0c\u5fc3\u8df3 108\u6b21/min\uff1b\u8840\u58d3 123/76 mmHg\uff0c\u95dc\u65bc\u9019\u500b\u75c5\u4eba\uff0c\u4e0b\u9762\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u6025\u6027\u6703\u53ad\u708e\u75c5\u4eba\u5e38\u540c\u6642\u5408\u4f75\u6d41\u53e3\u6c34(drooling) \uff0c\u541e\u56a5\u56f0\u96e3(dysphagia )\u548c\u547c\u5438\u7a98\u8feb(respiratory distress)\u75c7\u72c0\u3002 (B)\u6839\u64da original Centor criteria \uff1a\u6241\u6843\u9ad4\u6ef2\u51fa\u7269\u3001\u9838\u524d\u90e8\u6dcb\u5df4\u7d50\u816b\u5927\u3001\u6c92\u6709\u54b3\u55fd\u3001\u767c\u71d2\uff0c\u56db\u9805\u53ea\u8981\u7b26\u5408\u5169\u9805\u4ee5\u4e0a\uff0c\u53ef\u61f7\u7591 Group A \u03b2-hemolytic Streptococcus( GABHS)pharyngitis \uff0c\u8003\u616e\u7d66\u4e88\u6297\u751f\u7d20\u6cbb\u7642\u3002 (C)Ludwig's angina \u5e38\u662f\u6e90\u81ea\u65bc retropharyngeal s pace\u611f\u67d3\uff0c\u9032\u4e00\u6b65\u64f4\u6563\u5230\u820c\u4e0b(sublingual )\u548c\u4e0b\u9837(submental )\u9593\u9699\u7684\u611f\u67d3\u3002 (D)\u7576\u75c5\u4eba\u51fa\u73fe\u5598\u9cf4\u97f3(stridor )\u548c\u541e\u56a5\u56f0\u96e3\u7684\u6642\u5019\uff0c\u53ef\u4ee5\u8acb\u75c5\u4eba\u5e73\u8eba\u4e26\u7d66\u4e88\u814e\u4e0a\u817a\u7d20\u9727\u5316\u5438\u5165\u6cbb\u7642\u7de9\u89e3\u75c7\u72c0\u3002 (E)\u54bd\u5f8c\u81bf\u760d(retropharyngeal abscess ) \uff0c\u9664\u4e86\u5589\u56a8\u75db\u4ee5\u5916\uff0c\u5e38\u6703\u5408\u4f75\u9838\u90e8\u816b\u8139\u548c\u8072\u97f3\u4f4e\u6c89( muffled voice )\u7684\u75c7\u72c0\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u5178\u578b\u7684\u5ddd\u5d0e\u75c7( Kawasaki disease )\u75c7\u72c0\u6709\u767c\u71d2 \uff1e39\u523040\u2103\u81f3\u5c11 5\u5929\u3002\u9664\u4e86\u767c\u71d2\u4e4b\u5916\uff0c\u53e6\u6709 5\u500b\u5178\u578b\u7684\u8a3a\u65b7\u8981\u4ef6\u5176\u4e2d\u81f3\u5c11\u8981\u51fa\u73fe 4\u9805\uff0c\u4f46\u4e0d\u5305\u62ec \uff1f", + "Options": "(A)\u5634\u5507\u4e7e\u88c2\u3001\u7d05\u6591\u3001\u8349\u8393\u820c\u3001\u53e3\u8154\u53ca\u54bd\u90e8\u767c\u7d05\u5145\u8840\u3002 (B)\u7121\u5206\u6ccc\u7269\u7684\u96d9\u5074\u7d50\u819c\u5145\u8840\u3002 (C)\u76ae\u75b9\uff1a\u6591\u4e18\u75b9\u3001\u7030\u6f2b\u6027\u7d05\u76ae\u75c5\u3001\u6216\u591a\u578b\u6027\u7d05\u75b9\u3002 (D)\u6025\u6027\u671f\u624b\u8173\u51fa\u73fe\u7d05\u816b\uff0c\u4e14\u6216\u5728\u4e9e\u6025\u6027\u671f\u51fa\u73fe\u56db\u80a2\u6307(\u8dbe)\u7532\u672b\u7aef\u812b\u76ae\u3002 (E)\u9838\u90e8\u6dcb\u5df4\u7d50\u75c5\u8b8a(\u901a\u5e38\u662f\u96d9\u5074\u4e14\u76f4\u5f91\u22671.5 \u516c \u5206 )\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "30\u6b72\u7537\u6027\u70ba\u601d\u89ba\u5931\u8abf\u75c7\u75c5\u4eba\uff0c\u670d\u7528\u85e5\u7269\u63a7\u5236\uff0c\u4f46\u662f\u8fd1\u65e5\u56e0\u70ba\u60c5\u7dd2\u4f4e\u843d\u6182\u9b31\uff0c\u5e38\u5e38\u5230\u8655\u5c31\u91ab\u670d\u7528\u85e5\u7269\uff0c\u7531\u5bb6\u5c6c\u9001\u81f3\u6025\u8a3a\u3002\u4e3b\u8a34\u4eca\u5929\u65e9\u4e0a\u958b\u59cb\u610f\u8b58\u6df7\u4e82\uff0c\u5168\u8eab\u50f5\u786c\u7b49\u73fe\u8c61\u3002 GCS E3V3M3\uff0c\u8840\u58d3 187/78 mmHg\uff0c\u5fc3\u8df3 120\u6b21/min\uff0c\u547c\u5438 30\u6b21/min\uff0c\u9ad4\u6eab 39\u00b0C\uff0c\u9838\u975c\u8108\u7121\u6012\u5f35\uff0c\u80ba\u90e8\u807d\u8a3a\u6e05\u6f88\u7121\u6fd5\u56c9\u97f3\uff0c\u5fc3\u5f8b\u4e0d\u898f\u5247\uff0c\u7121\u5fc3\u81df\u96dc\u97f3\uff0c\u8179\u90e8\u67d4\u8edf\uff0c\u56db\u80a2\u7570\u5e38\u50f5\u76f4\uff0c\u7121\u6cd5\u5c48\u66f2\u3002\u521d\u6b65\u5be6\u9a57\u5ba4\u6aa2\u67e5:WBC 20,600/\u03bcL \uff0cHb 13.9 g/dL\uff0cplatelet 160,000/\u03bcL \uff0cCRP 1.9 mg/dL\uff0cBUN 50 mg/dL\uff0cCr 2.0 mg/dL\uff0cGOT 40 U/L\uff0cNa 140 mmol/L\uff0cK 4.2 mmol/L\uff0cCK 1,250 U/L \uff0carterial blood gas: metabolic acidosis\uff0c\u4ee5\u76ee\u524d\u7684\u6aa2\u67e5\u7d50\u679c\uff0c\u4e0b\u5217\u8a3a\u65b7\u81c6\u6e2c\u9078\u9805\u7576\u4e2d\uff0c\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)Epilepsy \u3002 (B)Meningitis\u3002 (C)Neuroleptic malignant syndrome \u3002 (D)Serotonin syndrome \u3002 (E)Thyroid storm \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u8001\u5e74 \u4eba\u5916\u50b7\u7684\u521d\u7d1a\u8a55\u4f30\u53ca\u5fa9\u7526\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5728\u64cd\u4f5c\u5feb\u901f\u9806\u5e8f\u63d2\u7ba1(rapid sequence intubation)\u6642\uff0c\u85e5\u7269\u5291\u91cf\u4e0d\u8b8a\u3002 (B)\u7f3a\u6c27\u7015\u81e8\u547c\u5438\u8870\u7aed\u6642\uff0c\u5fc3\u8df3\u6703\u660e\u986f\u8b8a\u5feb\u3002 (C)\u5efa\u8b70\u4f7f\u7528\u4e0b\u5217\u8f14\u52a9\u65b9\u5f0f\u4f86\u8fa8\u8b58\u4f11\u514b\u65e9\u671f\u75c7\u72c0\u5305\u62ec\u5982 base deficit \u3001serum lactate \u3001shock index \u7b49\u3002 (D)\u91dd\u5c0d\u5916\u50b7\u4f11\u514b\u7684\u75c5\u4eba \uff0c\u63d0\u65e9\u653e\u7f6e\u9032\u968e\u76e3\u6e2c\u5982\u4e2d\u592e\u975c\u8108\u58d3(central venous pressure )\u4e26\u7121\u52a9\u76ca\u3002 (E)\u70ba\u907f\u514d\u6f5b\u5728\u53ca\u5c19\u672a\u767c\u73fe\u7684\u810a\u690e\u640d\u50b7\uff0c\u9838\u5708\u53ca\u9577\u80cc\u677f\u56fa\u5b9a\u4e0d\u5b9c\u904e\u65e9\u79fb\u9664\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5168\u8eab\u578b\u904e\u654f\u6027\u53cd\u61c9( anaphylaxis )\u7684\u81e8\u5e8a\u8868\u73fe\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u521d\u671f\u5178\u578b\u75c7\u72c0\u70ba\u6414\u7662\u53ca\u8541\u9ebb\u75b9\u3002 (B)\u6613\u4f75\u767c\u8072\u5e36\u9ebb\u75fa\u800c\u8072\u97f3\u6c99\u555e\u3002 (C)\u75c7\u72c0\u767c\u751f\u8d8a\u5feb\u8005\u75c5\u60c5\u8d8a\u56b4\u91cd\u3002 (D)\u7d04\u6709\u4e00\u534a\u7684\u6b7b\u4ea1\u662f\u767c\u751f\u5728\u75c7\u72c0\u958b\u59cb 60\u5206\u9418\u5167\u3002 (E)\u75c7\u72c0\u6d88\u5931\u5f8c\u4ecd\u6709\u5fa9\u767c\u7684\u98a8\u96aa\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "82\u6b72\u7537\u6027\uff0c\u56e0\u767c\u71d2\u3001\u547c\u5438\u5598\u4f75\u547c\u5438\u8f14\u52a9\u808c\u4f7f\u7528\uff0c\u660e\u986f\u547c\u5438\u5598\u9cf4\u8072\uff0c\u610f\u8b58\u6539\u8b8a\u9001\u81f3\u6025\u8a3a\u3002\u5230\u9662\u6642\u9ad4\u6eab 39\u00b0C\uff0c\u5fc3\u8df3 120\u6b21/min\uff0c\u547c\u5438 28\u6b21/min\uff0c\u8840\u58d3132/84 mmHg \uff0c\u8840\u6c27\u6fc3\u5ea6 85%\u3002\u52d5\u8108\u8840\u6db2\u6c23\u9ad4\u5206\u6790 PaCO 2 80 mmHg \u3002\u8acb\u554f\u5c0d\u65bc\u6b64\u75c5\u4eba\u7684\u6cbb\u7642\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u61c9\u7d66\u4e88\u6c27\u6c23\u6cbb\u7642\uff0c\u7dad\u6301\u8840\u6c27\u6fc3\u5ea6\u81f3\u5c11 90%\u4ee5\u4e0a\u3002 (B)\u61c9\u7d66\u4e88\u975e\u4fb5\u8972\u6027\u6b63\u58d3\u547c\u5438\u5668\uff0c\u4ee5\u9f3b\u80c3\u7ba1\u6e1b\u58d3\u9810\u9632\u5438\u5165\u6027\u4e8b\u4ef6\u767c\u751f\u3002 (C)\u61c9\u7d66\u4e88\u4e59\u4e8c\u578b\u64ec\u4ea4\u611f\u4f5c\u7528\u5291\u53ca\u6297\u81bd\u9e7c\u5291\u5438\u5165\u6cbb\u7642\u3002 (D)\u82e5\u54b3\u55fd\u5e36\u6709\u6fc3\u75f0\uff0c\u61c9\u7d66\u4e88\u5ee3\u6548\u6297\u751f\u7d20\uff0c\u6db5\u84cb Streptococcus pneumoniae \u3001Haemophilus influenzae \u3001Moraxella catarrhalis \u83cc\u7a2e\u3002 (E)\u61c9\u8003\u616e\u7d66\u4e88\u6c23\u7ba1\u5167\u7ba1\u63d2\u7ba1\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u9032\u884c\u773c\u775b\u7684\u5b8c\u6574\u6aa2\u67e5\uff0c\u4f9d\u5e8f\u6aa2\u67e5\u6642\u7684 \u7b2c\u4e00\u512a\u5148 \u9805\u76ee\u662f\uff1f", + "Options": "(A)\u6aa2\u6e2c\u773c\u58d3\u3002 (B)\u6aa2\u6e2c\u8996\u529b\u3002 (C)\u6aa2\u6e2c\u77b3\u5b54\u5927\u5c0f\u3002 (D)\u6aa2\u6e2c\u773c\u77bc\u548c\u7d50\u819c\u3002 (E)\u6aa2\u6e2c\u773c\u7403\u5916\u808c\u8089\u6d3b\u52d5\u529b\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "75\u6b72\u5973\u6027\u88ab\u5bb6\u4eba\u767c\u73fe\u5012\u81e5\u5bb6\u4e2d\uff0c\u5614\u5410\u7da0\u8272\u7269\u9ad4\uff0c\u7591\u4f3c\u670d\u7528\u4e0d\u660e\u6db2\u9ad4\u4e2d\u6bd2\u3002\u5728\u6025\u8a3a\u63d2\u7ba1\u5f8c\u91cf\u6e2c\u7684\u751f\u547d\u5fb5\u8c61\u5982\u4e0b\uff1a E1V TM4\uff0c\u8840\u58d3 85/51 mmHg \uff0c\u5fc3\u8df3148\u6b21/min\uff0c\u9ad4\u6eab 35.4\u2103\uff0c\u547c\u5438 32\u6b21/min\uff0cSpO 2 83%\uff0c\u5169\u5074\u77b3\u5b54\u7686\u70ba3mm\u7121\u5149\u53cd\u5c04\u3002\u75c5\u4eba\u8e81\u52d5\u4e0d\u5b89\uff0c\u5168\u8eab\u76dc\u6c57\u3002\u8166\u90e8\u96fb\u8166\u65b7\u5c64\u7121\u660e\u986f\u7570\u5e38\uff0c\u5fc3\u96fb\u5716\u70ba\u7ac7\u6027\u983b\u8108\u3002\u52d5\u8108\u8840\u6c27\u6aa2\u67e5\uff1apH 7.35\uff0c PCO 2 36.7 mmHg\uff0cPO 2 314.8 mmHg\uff0cHCO 3 19.8 mm/L \uff0cSBE -5.8 mm/L\uff0cSat 99.7% \uff0cP( A-a)O 2 341.0 mmHg\uff0cFiO 2 100%\u3002\u5728\u61f7\u7591\u4e2d\u6bd2\u60c5\u6cc1\u4e0b\uff0c\u4e0b\u5217\u4f55\u7a2e\u70ba \u6700\u6709\u53ef\u80fd\u7684\u8a3a\u65b7 \uff1f", + "Options": "(A)\u5f37\u9178\u4e2d\u6bd2( caustics intoxication )\u3002 (B)\u6c30\u5316\u7269\u4e2d\u6bd2(cyanide intoxication)\u3002 (C)\u7532\u9187\u4e2d\u6bd2( methanol intoxication)\u3002 (D)\u8b8a\u6027\u8840\u7d05\u7d20\u8840\u75c7( methemoglobinemia )\u3002 (E)\u5df4\u62c9\u5208\u4e2d\u6bd2(paraquat intoxication)\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "36\u6b72\u7537\u6027\uff0c\u4e3b\u8a34\u9670\u8396\u4e0a\u51fa\u73fe\u591a\u500b\u75bc\u75db\u6027\u6f70\u760d\uff0c\u4e14\u96d9\u5074\u8179\u80a1\u6e9d\u4ea6\u6709\u5316\u81bf\u6027\u7d50\u7bc0\uff0c\u8acb\u554f\u4e0b\u5217\u6cbb\u7642\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)Ceftriaxone \u3002 (B)Doxycycline \u3002 (C)Metronidazole \u3002 (D)Pencillin-G benzathine \u3002 (E)Valacyclovir \u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "60\u6b72\u7537\u6027\u56e0\u53f3\u5c0f\u817f\u75bc\u75db\u3001\u9593\u6b47\u6027\u8ddb\u884c (claudication )\u7d04 7\u5929\u81f3\u6025\u8a3a\u5c31\u8a3a\uff0c\u8eab\u9ad4\u6aa2\u67e5\u767c\u73fe\u53f3\u5074\u8db3\u80cc\u52d5\u8108\u5fae\u5f31\uff0c\u53f3\u81c2\u8840\u58d3 160/100 mmHg\uff0c\u53f3\u8e1d\u8840\u58d3100/60 mmHg\u3002\u6709\u95dc\u6b64\u75c5\u4eba\u4e4b\u6558\u8ff0\uff0c\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u75bc\u75db\u5f88\u96e3\u5b9a\u4f4d\uff0c\u4f11\u606f\u901a\u5e38\u4e0d\u6703\u6539\u5584\uff0c\u5e38\u9700\u5c07\u80a2\u9ad4\u62ac\u9ad8\u624d\u80fd\u6539\u5584\u75c7\u72c0\u3002 (B)\u6b64\u75c5\u4eba\u6700\u6709\u53ef\u80fd\u662f\u53f3\u7e3d\u80a1\u52d5\u8108(common femoral artery ) \u7684\u75c5\u7076\u3002 (C)\u6b64\u75c5\u4eba\u4e4b ankle -brachial index \u70ba0.625\u3002 (D)\u6cbb\u7642\u4ee5\u4f4e\u5206\u5b50\u91cf\u809d\u7d20(low molecular weight heparin, LMWH)\u70ba\u9996\u9078\u6cbb\u7642\u3002 (E)\u5373\u4f7f\u6cbb\u7642\u6210\u529f\uff0cankle -brachial index \u4e5f\u4e0d\u6703\u56de\u5fa9\u5230\u6b63\u5e38\u7bc4\u570d\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "30\u6b72\u7537\u6027\uff0c\u7d93\u5e38\u9700\u8981\u559d\u9152\u61c9\u916c\u3002\u4e00\u500b\u6708\u524d\uff0c\u56e0\u5c0f\u4fbf\u6709\u523a\u75db\u707c\u71b1\u611f\uff0c\u81f3\u6ccc\u5c3f\u79d1\u9580\u8a3a\u5c31\u91ab\uff0c\u7d93\u6aa2\u67e5\u5f8c\uff0c\u8a3a\u65b7\u70ba\u62ab\u8863\u83cc\u5c3f\u9053\u708e\uff0c\u7d93\u904e\u4e00\u500b\u7642\u7a0b\u4e4b\u6297\u751f\u7d20\u6cbb\u7642\u5f8c\u75ca\u7652\u3002\u6700\u8fd1\u4ed6\u958b\u59cb\u89ba\u5f97\u4e0b\u80cc\u50f5\u786c\u9178\u75db\uff0c\u751a\u81f3\u53f3\u819d\u96b1\u96b1\u4f5c\u75db\uff0c\u81ea\u5df1\u5230\u85e5\u5c40\u8cb7\u5916\u7528\u9178\u75db\u85e5\u5e03\u4f7f\u7528\uff0c\u4f46\u662f\u4e26\u6c92\u6709\u7de9\u89e3\u6548\u679c\uff0c\u53cd\u800c\u96d9\u5074\u8173\u8e1d\u95dc\u7bc0\u53ca\u53f3\u8173\u8dbe\u816b\u8139\u75bc\u75db\u5230\u4e0d\u80fd\u8d70\u8def\uff0c\u5408\u4f75\u773c\u775b\u7d05\u816b\uff0c\u6b64\u75c5\u4eba\u6700\u53ef\u80fd \u7684\u8a3a\u65b7\u70ba\u4f55\uff1f", + "Options": "(A)\u8c9d\u8cfd\u6c0f\u75c7\u5019\u7fa4( Behcet's disease )\u3002 (B)\u4e7e\u766c\u6027\u95dc\u7bc0\u708e(Psoriatic arthritis )\u3002 (C)\u840a\u7279\u6c0f\u75c7\u5019\u7fa4(Reiter's syndrome )\u3002 (D)\u6dcb\u75c5\u6027\u95dc\u7bc0\u708e( Gonococcal arthritis)\u3002 (E)\u50f5\u76f4\u6027\u810a\u690e\u708e( Ankylosing spondylitis )\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u80ba\u90e8\u8d85\u97f3\u6ce2( pulmonary ultrasound )\u7684\u8d85\u97f3\u6ce2 B\u7dda( sonographic B lines)\u4e4b\u6558\u8ff0\uff0c\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u53ef\u914d\u5408\u4e0b\u8154\u975c\u8108\u8d85\u97f3\u6ce2\u5354\u52a9\u8a3a\u65b7\u5fc3\u81df\u8870\u7aed\u3002 (B)\u51fa\u73fe\u5728\u6025\u6027\u547c\u5438\u7a98\u8feb\u75c7\u5019\u7fa4\u3001\u80ba\u7e96\u7dad\u5316\u3001\u80ba\u708e\u3001\u5927\u91cf\u6c23\u80f8\u7b49\u75c5\u4eba\u3002 (C)\u8d70\u5411\u5e73\u884c\u65bc\u808b\u819c\u3002 (D)\u75c5\u4eba\u80ba\u90e8\u7121\u8d85\u97f3\u6ce2 B\u7dda(sonographic B lines)\u5373\u53ef\u6392\u9664\u5fc3\u81df\u8870\u7aed\u3002 (E)\u75c5\u4eba\u80ba\u90e8\u96d9\u5074\u7686\u6709\u8d85\u97f3\u6ce2 B\u7dda(sonographic B lines)\u5373\u53ef\u8a3a\u65b7\u5fc3\u81df\u8870\u7aed\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6025\u6027\u5fc3\u81df\u8870\u7aed (acute heart failure )\u7684\u6cbb\u7642\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u76f8\u8f03\u65bc\u55ae\u7368\u4f7f\u7528\u85e5\u7269\u6cbb\u7642\uff0c\u5408\u4f75\u4f7f\u7528\u975e\u4fb5\u5165\u6027\u901a\u6c23(noninvasive ventilation)\u53ca\u85e5\u7269\u6cbb\u7642\u7121\u6cd5\u964d\u4f4e\u63d2\u7ba1\u6a5f\u7387\u3002 (B)\u6025\u6027\u5fc3\u81df\u8870\u7aed\u75c5\u4eba\u82e5\u51fa\u73fe\u4f4e\u8840\u58d3\uff0c\u61c9\u5148\u7d66\u4e88\u5145\u8db3\u8f38\u6db2\u5f8c\u518d\u4f7f\u7528\u5f37\u5fc3\u85e5\u7269\uff0c\u5982 norepinephrine \u3002 (C)\u4f7f\u7528\u666e\u62ff\u75bc(acetaminophen )\u7de9\u89e3\u785d\u5316\u7518\u6cb9(nitroglycerin )\u9020\u6210\u7684\u982d\u75db\uff0c\u6642\u5e38\u6548\u679c\u4e0d\u4f73\u3002 (D)\u4f7f\u7528\u55ce\u5561( morphine )\u6cbb\u7642\u6025\u6027\u5fc3\u81df\u8870\u7aed\uff0c\u53ef\u4ee5\u6e1b\u8f15\u75c5\u4eba \u7684\u7126\u616e\u611f\uff0c\u4f46\u662f\u6703\u5ef6\u9577\u4f4f\u9662\u6642\u9593\u53ca\u589e\u52a0\u6b7b\u4ea1\u7387\u3002 (E)\u5f8c\u671f\u5fc3\u8870\u7aed(late -stage heart failure )\u56e0\u70ba\u80ba\u5fae\u8840\u7ba1\u6954\u58d3(wedge pressure)\u8f03\u9ad8\uff0c\u80f8\u90e8 X\u5149\u5e7e\u4e4e\u90fd\u6703\u51fa\u73fe\u5178\u578b\u7684\u80ba\u6c34\u816b\u73fe\u8c61\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "20\u6b72\u7537\u6027\u65bc\u4e00\u9031\u524d\u525b\u5f9e\u975e\u6d32\u80af\u4e9e\u56de\u570b\u3002\u5169\u5929\u524d\u51fa\u73fe\u767c\u71d2\u3001\u982d\u75db\u3001\u5641\u5fc3\u3001\u5614\u5410\u3002\u81f3\u6025\u8a3a\u6642\u751f\u547d\u5fb5\u8c61\u70ba\u610f\u8b58 E2M4V2\u3001\u8840\u58d3 120/70 mmHg\u3001\u9ad4\u6eab39.1\u2103\u3001\u5fc3\u8df3 110\u6b21/min\u3001\u547c\u5438 20\u6b21/min\u3002\u8eab\u9ad4\u6aa2\u67e5\u767c\u73fe\u9664\u9838\u90e8\u50f5\u786c\u5916\uff0c\u7121\u5176\u4ed6\u7570\u5e38\u3002\u8840\u6db2\u6aa2\u67e5\u7d50\u679c WBC 17,000/\u03bcL \u3001creatinine 1.0 mg/dL \u3002\u80f8\u90e8 X\u5149\u3001\u8166\u90e8\u96fb\u8166\u65b7\u5c64\u7121\u7570\u5e38\u767c\u73fe\u3002\u958b\u59cb\u7684\u8166\u810a\u9ad3\u6db2(cerebrospinal fluid )\u58d3\u529b180mmH 2O\u3001\u810a\u9ad3\u6db2\u6df7\u6fc1 (turbid) \uff0c\u9769\u862d\u6c0f\u9670\u6027\u96d9\u7403\u83cc(+ )\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u56e0\u70ba\u66fe\u7d93\u53bb\u904e\u300c\u6d41\u8166\u5e36\u300d (Meningitis belt )\u570b\u5bb6\uff0c\u61f7\u7591\u7d30\u83cc\u6027\u8166\u819c\u708e\uff0c\u61c9\u5148\u9032\u884c\u8166\u90e8\u96fb\u8166\u65b7\u5c64\u53ca\u5b8c\u6210\u810a\u9ad3\u7a7f\u523a(lumbar puncture )\u6aa2\u67e5\u5f8c\uff0c\u518d\u7d66\u4e88\u6297\u751f\u7d20\u3002 (B)\u6b64\u75c5\u4eba\u958b\u59cb\u7684\u8166\u810a\u9ad3\u6db2\u58d3\u529b\u503c\u904e\u9ad8\uff0c\u4e14\u810a\u9ad3\u6db2\u6df7\u6fc1\u4ee3\u8868\u767d\u8840\u7403\uff1e200 cells/mm3\uff0c\u6240\u4ee5\u61f7\u7591\u7d30\u83cc\u6027\u8166\u819c\u708e\u3002 (C)\u70ba\u4e86\u9810\u9632\u6b64\u83cc\u611f\u67d3\uff0c\u53ef\u4ee5\u5728\u65c5\u904a\u7684\u4e09\u5929\u524d\uff0c\u63a5\u7a2e\u75ab\u82d7\u3002 (D)\u901a\u5e38\u4f7f\u7528 ceftriaxone \u52a0\u4e0a vancomycin\uff0c\u4e26\u5efa\u8b70\u4f7f\u7528\u985e\u56fa\u9187hydrocortisone 50 mg iv \u3002 (E)\u8207\u6b64\u75c5\u4eba\u540c\u5be2\u5ba4\u7684\u540c\u5b78\uff0c\u6709\u53ef\u80fd\u88ab\u50b3\u67d3\uff0c\u5efa\u8b70\u8981\u5403 rifampin 600 mg Q12H\uff0c\u5171\u56db\u6b21\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "32\u6b72\u7537\u6027\uff0c\u56e0\u70ba\u9593\u65b7\u6027\u767c\u71d2\u53ca\u53e3\u8154\u6f70\u760d\u4e8c\u661f\u671f\u5230\u6025\u8a3a\uff0c\u4e8c\u500b\u6708\u524d\u66fe\u6709\u5e36\u72c0\u76b0\u75b9\uff0c\u56e0\u81e8\u5e8a\u61f7\u7591\u4eba\u985e\u514d\u75ab\u7f3a\u4e4f\u75c5\u6bd2 (Human immunodeficiency virus, HIV)\u611f\u67d3\uff0c\u4e0b\u5217\u654d\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u76ee\u524d\u591a\u4ee5 HIV 1+2 ELISA test \u505a\u70ba\u521d\u6b65\u6aa2\u67e5\uff0c\u53ef\u5075\u6e2c HIV\u75c5\u6bd2\u6297\u539f\u3002 (B)\u53f0\u7063\u75c5\u4eba\u591a\u70ba HIV-2\u611f\u67d3\u3002 (C)\u5982\u8a3a\u65b7\u51fa HIV\uff0c\u75c5\u4eba\u4e4b\u5f8c\u4e0d\u9069\u5408\u65bd\u6253\u7834\u50b7\u98a8\u75ab\u82d7\u3002 (D)\u5c0d\u65bc\u53e3\u4e2d\u75c5\u7076\uff0c\u61f7\u7591\u5ff5\u73e0\u83cc\u611f\u67d3\u53ef\u9996\u5148\u7d66\u4e88 amphotericin B \u6cbb\u7642\u3002 (E)\u6dcb\u5df4\u7624(lymphoma )\u662f HIV\u611f\u67d3\u75c5\u4eba\u6700\u5e38\u898b\u7684\u816b\u7624\uff0c\u4e5f\u6703\u8b93\u75c5\u4eba\u767c\u71d2\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "60\u6b72\u7537\u6027\uff0c\u4e3b\u8a34 30\u5206\u9418\u524d\u66fe\u77ed\u66ab\u660f\u53a5\uff0c\u73fe\u5728\u5598\u4e14\u80f8\u75db\u3002\u5fc3\u97f3\u807d\u8a3a\u767c\u73fe\u6536\u7e2e\u671f\u5fc3\u96dc\u97f3\uff1b\u6478\u5176\u53f3\u624b\u8108\u640f\u6642\uff0c\u767c\u73fe\u6709\u660e\u986f\u80b1\u6a48\u52d5\u8108\u5ef6\u9072(brachioradial delay)\u73fe\u8c61\u3002\u6709\u95dc\u9019\u4f4d\u75c5\u4eba\u7684\u8a3a\u65b7\u6cbb\u7642\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5fc3\u96fb\u5716\u5e38\u5e38\u53ef\u4ee5\u767c\u73fe\u5de6\u5fc3\u5ba4\u80a5\u5927\u60c5\u5f62\uff0c\u6cbb\u7642\u4e0a\u61c9\u7d66\u4e88\u6c27\u6c23\u4f7f\u7528\u3002 (B)\u75c5\u4eba\u80f8\u90e8 X\u5149\u53ef\u80fd\u6703\u770b\u5230\u80ba\u6c34\u816b\uff0c\u6b64\u6642\u61c9\u907f\u514d\u4f7f\u7528\u6b63\u58d3\u547c\u5438\uff0c\u6cbb\u7642\u9996\u9078\u70ba nitroglycerin\u3002 (C)\u6b64\u75be\u75c5\u901a\u5e38\u4e0d\u9700\u8981\u5916\u79d1\u624b\u8853\u6cbb\u7642\u3002 (D)\u82e5\u5728\u6cbb\u7642\u89c0\u5bdf\u671f\u9593\uff0c\u51fa\u73fe\u5fc3\u623f \u986b\u52d5\u60c5\u5f62\uff0c\u512a\u5148\u8003\u616e\u4f7f\u7528\u4e59\u578b\u963b\u65b7\u5291(\u03b2-blocker )\u505a\u5fc3\u81df\u901f\u7387\u63a7\u5236\u3002 (E)\u5fc3\u5167\u819c\u708e\u662f\u8a72\u75be\u75c5\u5f88\u5e38\u898b\u7684\u4f75\u767c\u75c7\uff0c\u6545\u61c9\u7d66\u4e88\u9810\u9632\u6027\u6297\u751f\u7d20\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u4e00\u540d\u5e74\u8f15\u5973\u5b50\u56e0\u6a5f\u8eca\u649e\u96fb\u7dda\u687f\uff0c\u5b89\u5168\u5e3d\u98db\u843d\u800c\u982d\u90e8\u56b4\u91cd\u53d7\u50b7\u3002\u5728\u6025\u8a3a\u5ba4\uff0cGCS\u662f6\u5206\u3001\u8840\u58d3 140/90 mmHg \u3001\u5fc3\u8df3 80\u6b21/min\u3002\u63a5\u53d7\u6c23\u7ba1\u63d2\u7ba1\u548c\u547c\u5438\u5668\u901a\u6c23\u5f8c\uff0c\u77b3\u5b54\u7b49\u5927\u70ba 3mm\uff0c\u5169\u5074\u5c0d\u5149\u6709\u53cd\u61c9\uff0c\u6c92\u6709\u5176\u4ed6\u660e\u986f\u7684\u50b7\u5bb3\u3002\u6b64\u75c5\u4eba\u6700\u91cd\u8981 \u7684\u6cbb\u7642\u539f\u5247\u662f\uff1f", + "Options": "(A)\u907f\u514d\u4f4e\u8840\u58d3\u767c\u751f\u3002 (B)\u7d66\u4e88\u6ef2\u900f\u6027\u5229\u5c3f\u5291(osmotic diuretic )\u3002 (C)\u7a4d\u6975\u6cbb\u7642\u9ad8\u8840\u58d3\u3002 (D)\u589e\u52a0\u8166\u7d44\u7e54\u7684\u4ee3\u8b1d\u7387\u3002 (E)\u5340\u5206\u9871\u5167\u8840\u816b\u548c\u8166\u6c34\u816b(intracranial hematoma and cerebral edema)\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "27\u6b72\u5b55\u5a66\u983b\u7e41\u5bae\u7e2e\u7834\u6c34\uff0c\u61f7\u5b55\u5468\u6578\u70ba 38\u9031\uff0c\u7b2c\u4e8c\u80ce\uff0c\u62b5\u9054\u91ab\u9662\u4e0d\u4e45\u5f8c\u5373\u5728\u6025\u8a3a\u751f\u7522\u3002\u7522\u5a66\u5916\u89c0\u986f\u6d88\u7626\u84bc\u767d( Hb 5.0 g/dL ) \uff0c\u6025\u8a3a\u91cf\u6e2c\u751f\u547d\u5fb5\u8c61\uff1a\u610f\u8b58\u6e05\u695a\uff0c\u8840\u58d3 126/75 mmHg \uff0c\u5fc3\u8df3 130\u6b21/min\uff0c\u547c\u5438 20\u6b21/min\uff0c\u9ad4\u6eab36.3\u2103\uff0c\u7522\u5a66\u7591\u4f3c\u70ba\u6bd2\u766e\u8005\u3002\u65b0\u751f\u5152\u5448\u73fe\u6d3b\u52d5\u529b\u4e0d\u4f73\uff0c\u547c\u5438\u6dfa\uff0c\u5fc3\u8df3 75\u6b21/min\uff0c\u7d66\u4e88\u80cc\u90e8\u523a\u6fc0\u5f8c\uff0c\u4ecd \u7136\u7121\u6539\u5584\u3002\u6709\u95dc\u6b64\u65b0\u751f\u5152 \u7684\u7dca\u6025\u8655\u7f6e \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u65b0\u751f\u5152\u6d3b\u52d5\u529b\u4e0d\u4f73\u4e14 \u7522\u5a66\u7834\u6c34\uff0c\u7591 \u4f3c\u6557\u8840\u75c7 \u61c9\u8a72\u7acb\u5373 \u6ce8\u5c04\u6297\u751f\u7d20\u3002 (B)\u65b0\u751f\u5152\u6d3b\u52d5\u529b\u4e0d\u4f73\u4e14 \u7522\u5a66\u56b4\u91cd\u8ca7\u8840\uff0c\u65b0\u751f\u5152\u9700 \u5099\u8840\u8f38\u8840\u3002 (C)\u7d66\u4e88\u523a\u6fc0\u4ecd\u7121\u6539\u5584\uff0c\u7d66\u4e88\u65b0\u751f\u5152\u58d3\u80f8\u6025\u6551\uff0c\u4e26\u6ce8\u5c04 epinephrine \u3002 (D)\u7591\u812b\u766e\u75c7\u5019\u7fa4( withdrawal syndrome ) \uff0c\u6ce8\u5c04\u542b\u7cd6\u6eb6\u6db2\u548c\u7d66\u4e88\u89e3\u6bd2\u5291\u3002 (E)\u7d66\u4e88\u523a\u6fc0\u4ecd\u7121\u6539\u5584\uff0c\u7d66\u4e88\u547c\u5438\u9053\u6e05\u6f54\u548c\u6b63\u58d3\u547c\u5438\u6c27\u6c23\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "28\u6b72\u5973\u6027\uff0c\u751f\u547d\u5fb5\u8c61\u70ba\u8840\u58d3 132/84 mmHg \u3001\u5fc3\u8df3 85\u6b21/min\u3001\u547c\u5438 18\u6b21/min\u3001\u9ad4\u6eab 36.4\u2103\uff1b\u65bc\u6025\u8a3a\u4e3b\u8a34\u4e0b\u8179 \u75bc\u75db\u53ca\u9670\u9053 \u7570\u5e38\u51fa\u8840\uff0c\u81ea\u8ff0\u6700\u5f8c\u4e00\u6b21\u6708\u7d93\u5927\u7d04\u70ba\u5169\u9031 \u524d\uff0c\u7121\u904e\u53bb\u75c5\u53f2\uff0cG0P0 \u3002\u8eab\u9ad4\u6aa2\u67e5\u767c\u73fe\u5de6\u4e0b\u8179\u8207\u9aa8\u76c6\u8154\u6709\u58d3\u75db\u7121\u53cd\u5f48\u75db\uff1b\u62bd\u8840\u6aa2\u67e5\u5982\u4e0b\uff1a\u767d\u8840\u7403 9,300/\u03bcL\u3001\u8840\u7d05\u7d20 10.3 g/dL \u3001\u8840\u5c0f\u677f263,000 /\u03bcL\uff1b\u03b2-hCG 3,600 mIU/mL\uff1b\u7d93\u8179\u90e8\u8d85\u97f3\u6ce2\u6aa2\u8996\u7121\u7570\u5e38\u8179\u6c34\uff0c\u4e14\u5b50\u5bae\u5167\u672a\u767c\u73fe\u598a\u5a20\u56ca\uff0c\u4e0b\u5217\u63a8\u65b7\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u63a8\u4f30\u61f7\u5b55\u9031\u671f\u7d04\u70ba\u5169\u9031\uff0c\u82e5\u5169\u5929\u5f8c\u03b2- hCG\u9806\u5229\u4e0a\u5347\uff0c\u53ef\u80fd\u8a3a\u65b7\u70ba\u8feb\u5207\u6027\u6d41\u7522(threatened abortion)\u3002 (B)\u63a8\u4f30\u61f7\u5b55\u9031\u671f\u7d04\u70ba\u5169\u9031\uff0c\u82e5\u5169\u5929\u5f8c\u03b2- hCG\u4e0b\u964d\uff0c\u53ef\u80fd\u8a3a\u65b7\u70ba\u5b8c\u5168\u6027\u6d41\u7522( missed abortion) (C)\u63a8\u4f30\u61f7\u5b55\u9031\u671f\u8d85\u904e\u4e94\u9031\uff0c\u82e5\u7d93\u9670\u9053\u8d85\u97f3\u6ce2\u4e5f\u672a\u767c\u73fe\u5b50\u5bae\u5167\u598a\u5a20\u56ca\uff0c\u53ef\u80fd\u8a3a\u65b7\u70ba\u8feb\u5207\u6027\u6d41\u7522(threatened abortion)\u3002 (D)\u63a8\u4f30\u61f7\u5b55\u9031\u671f\u8d85\u904e\u4e94\u9031\uff0c\u82e5\u7d93\u9670\u9053\u8d85\u97f3\u6ce2\u4e5f\u672a\u767c\u73fe\u5b50\u5bae\u5167\u598a\u5a20\u56ca\uff0c\u53ef\u80fd\u8a3a\u65b7\u70ba\u5b50\u5bae\u5916\u5b55(ectopic pregnancy ) (E)\u63a8\u4f30\u61f7\u5b55\u9031\u671f\u8d85\u904e\u4e94\u9031\uff0c\u82e5\u7d93\u9670\u9053\u8d85\u97f3\u6ce2\u4e5f\u672a\u767c\u73fe\u5b50\u5bae\u5167\u598a\u5a20\u56ca\uff0c\u53ef\u80fd\u70ba\u8457\u5e8a\u51fa\u8840(implantation bleeding )\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "3\u6b72\u7537\u5b69\u56e0\u70ba\u8dcc\u5012\u9020\u6210\u81c9\u90e8\u6495\u88c2\u50b7\uff0c\u7e2b\u5408\u6642\u4f7f\u7528 ketamine \u93ae\u5b9a\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u808c\u8089\u6216\u975c\u8108\u6ce8\u5c04\u90fd\u53ef\u4ee5\uff0c\u93ae\u975c\u6548\u679c\u6301\u7e8c\u6642\u9593\u76f8\u540c\u3002 (B)\u808c\u8089\u6ce8\u5c04\u7684\u5291\u91cf\u70ba 1 mg/kg\u3002 (C)\u85e5\u7269\u4f5c\u7528\u5f8c\uff0c\u75c5\u4eba\u53ef\u80fd\u9084\u6703\u6709\u52d5\u4f5c\u53ca\u808c\u8089\u5f35\u529b\u3002 (D)\u8ffd\u52a0\u5291\u91cf\u4e3b\u8981\u662f\u589e\u52a0\u9ebb\u9189\u6df1\u5ea6\uff0c\u4e0d\u662f\u7528\u4f86\u5ef6\u9577\u4f5c\u7528\u6642\u9593\u3002 (E)\u8207\u5176\u4ed6\u93ae\u5b9a\u85e5\u7269\u76f8\u6bd4\uff0c\u8f03\u6703\u6709\u547c\u5438\u6291\u5236\u53ca\u8840\u58d3\u5f71\u97ff\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6ccc\u5c3f \u9053\u611f\u67d3(urinary tract infection )\u4e4b\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u76ee\u8996\u6aa2\u67e5\u6216\u8a55\u4f30\u5c3f\u6db2\u7684\u6c23\u5473\u901a\u5e38\u7121\u52a9\u65bc\u78ba\u5b9a\u662f\u5426\u611f\u67d3\u3002 (B)\u91dd\u5c0d HIV/AIDS \u75c5\u4eba\uff0c\u7d93\u9a57\u6027\u6297\u751f\u7d20\u5efa\u8b70\u4f7f\u7528 fluoroquinolones\u3002 (C)\u967d\u6027\u7684\u5c3f \u6db2\u6c2e\u7d20\u6e2c\u8a66( urine nitrite )\u5408\u4f75\u967d\u6027 leukocyte esterase \u53ef\u4ee5\u63d0\u9ad8\u6ccc\u5c3f\u9053\u611f\u67d3\u7684\u8a3a\u65b7\u7387\u3002 (D)Pseudomonas \u6703\u5c07\u5c3f\u6db2\u4e2d\u7684\u785d\u9178\u9e7d\u8f49\u5316\u70ba\u4e9e\u785d\u9178\u9e7d\uff0c\u56e0\u6b64\u5c3f \u6db2\u6c2e\u7d20\u6e2c\u8a66( urine nitrite )\u6703\u5448\u73fe\u967d\u6027\u53cd\u61c9\u3002 (E)\u5b55\u5a66\u548c\u5373\u5c07\u63a5\u53d7\u4fb5\u5165\u6027\u6ccc\u5c3f\u9053\u624b\u8853\u5982\u679c\u6709\u7121\u75c7\u72c0\u83cc\u5c3f\u75c7(asymptom atic bacteriuria )\u4ecd\u61c9\u63a5\u53d7\u6cbb\u7642\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "60\u6b72\u7537\u6027\u904e\u53bb\u75c5\u53f2\u6709\u9ad8\u8840\u58d3\u8207\u7cd6\u5c3f\u75c5\uff0c\u4e3b\u8a34\u6025\u6027\u80f8\u75db\u5ef6\u4f38\u81f3\u80cc\u5f8c\u800c\u88ab\u9001\u81f3\u6025\u8a3a\u3002\u6aa2\u50b7\u6642\u8840\u58d3 220/110 mmHg \u3001\u5fc3\u8df3 98\u6b21/min\u3001\u547c\u5438 20\u6b21/min\uff0c\u80f8\u90e8X\u5149\u770b\u5230\u7e31\u8188\u8154\u8b8a\u5bec( mediastinum widening )\uff0c\u5fc3\u96fb\u5716\u7121\u7279\u6b8a\u8b8a\u5316\u3002\u95dc\u65bc\u6b64\u75c5\u4eba\u7684\u8a3a\u65b7\u8207\u81e8\u5e8a\u8655\u7f6e\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5982\u5be6\u9a57\u5ba4\u6aa2\u9a57 D-dimer\u6b63\u5e38\uff0c\u53ef\u6392\u9664\u80ba\u6813\u585e\u8207\u4e3b\u52d5\u8108\u525d\u96e2\u7684\u53ef\u80fd\u6027\u3002 (B)\u4e3b\u52d5\u8108\u525d\u96e2\u7684\u75c5\u4eba\u96d9\u5074\u80a2\u9ad4\u8840\u58d3\u6709\u5dee\u7570(pulse deficits)\u7684\u654f\u611f\u5ea6\u9ad8\u3002 (C)\u4e3b\u52d5\u8108\u525d\u96e2\u7684\u75c5\u4eba\u80f8\u90e8 X\u5149\u6709 80-90\uff05\u6703\u6709\u7570\u5e38\u3002 (D)\u4e3b\u52d5\u8108\u525d\u96e2\u6709\u6642\u6703\u5f71\u97ff\u5230\u51a0\u72c0\u52d5\u8108\u7684\u704c\u6d41\uff0c\u6700\u5e38\u88ab\u5f71\u97ff\u5230\u51a0\u72c0\u52d5\u8108\u662f\u5de6\u51a0\u72c0\u52d5\u8108\uff0c\u6703\u9020\u6210\u524d\u58c1 \u5fc3\u808c\u6897\u585e\u3002 (E)\u61c9\u8a72\u512a\u5148\u4f7f\u7528 nitroglycerin \u6216nicardipine \u63a7\u5236\u8840\u58d3\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4e00\u4f4d\u525b\u5230\u6025\u8a3a\u5373\u5448\u4f11\u514b\u72c0\u614b\u7684\u975e\u5916\u50b7\u6210\u5e74\u5973\u6027\uff0c\u7acb\u5373\u65bc\u5e8a\u908a\u4f7f\u7528\u8d85\u97f3\u6ce2\u8a55\u4f30\uff0c\u5728\u528d\u7a81\u4e0b\u65b9 (subxiphoid)\u6e2c\u5f97\u75c5\u4eba \u4e0b\u8154\u975c\u8108\u76f4\u5f91\u7d04 2.4\u516c\u5206\uff0c \u4e14\u547c\u5438\u6642\u4e0b\u8154\u975c\u8108\u76f4\u5f91\u8b8a\u5316\u91cf\uff1c50% \uff0c\u5fc3\u81df\u8d85\u97f3\u6ce2\u8a55\u4f30 apical four chamber view\u767c\u73fe RV/LV end -diastolic diameter ratio \uff1e1\uff0c \u4e0b\u5217\u4f55\u8005\u662f\u6700\u53ef\u80fd \u5f15\u8d77\u9019\u4f4d\u75c5\u4eba\u4f11\u514b\u7684\u539f\u56e0\uff1f", + "Options": "(A)\u4e0a\u6d88\u5316\u9053\u5927\u91cf\u51fa\u8840\u3002 (B)\u6025\u6027\u80ba\u6813\u585e\u3002 (C)\u6025\u6027\u5fc3\u8870\u7aed\u5408\u4f75\u80ba\u6c34\u816b\u3002 (D)\u6557\u8840\u6027\u4f11\u514b\u3002 (E)\u8179\u90e8\u4e3b\u52d5\u8108\u7624\u7834\u88c2\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6025\u6027\u95cc\u5c3e\u708e\u75c5\u4eba\u7684\u8a3a\u65b7\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)Alvarado score \u662f\u81e8\u5e8a\u8a3a\u65b7\u7684\u9ec3\u91d1\u6a19\u6e96\u3002 (B)\u8a31\u591a\u5be6\u8b49\u8cc7\u6599\u986f\u793a\u8179\u90e8\u8d85\u97f3\u6ce2\u80fd\u63d0\u5347\u6025\u6027\u95cc\u5c3e\u708e\u7684\u8a3a\u65b7\u7387\u3002 (C)\u65e9\u671f\u95cc\u5c3e\u708e\u901a\u5e38\u4ee5\u4e0a\u8179\u75db(epigastric pain )\u8868\u73fe\u3002 (D)\u591a\u9054 50%\u7684\u75c5\u4eba\u662f\u4ee5\u975e\u5178\u578b\u75c7\u72c0\u8868\u73fe\u3002 (E)\u55ae\u7d14\u53f3\u8170\u75db\u75c5\u4eba\uff0c\u61c9\u53ef\u5408\u7406\u6392\u9664\u6025\u6027\u95cc\u5c3e\u708e\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u54ea\u4e00\u7a2e\u6aa2\u67e5\u80fd\u5354\u52a9\u5224\u65b7\u8170\u690e\u4e4b\u690e\u9593\u76e4\u7a81\u51fa\u75c7\u5019\u7fa4\uff0c\u5176\u7279\u7570\u6027\u6700\u9ad8\uff1f", + "Options": "(A)Straight leg raise test \u3002 (B)Lhermitte's sign \u3002 (C)Spurling's sign \u3002 (D)Abductor sign\u3002 (E)Cr ossed straight leg raise test \u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "17\u6b72\u5973\u6027\uff0c\u5728\u591c\u5e97\u51fa\u73fe\u610f\u8b58\u6df7\u4e82\uff0c \u884c\u70ba\u8e81\u52d5\uff0c\u9ad4\u6eab 39\u2103\uff0c\u8840\u58d3 150/96 mmHg\uff0c\u88ab\u9001\u81f3\u6025\u8a3a\uff0c\u670b\u53cb\u8868\u793a\uff0c\u75c5\u4eba\u6709\u670d\u7528\u6416\u982d\u4e38\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u75c5\u4eba\u5e38\u51fa\u73fe\u9ad8\u6eab\u3001\u9ad8\u8840\u58d3\u3001\u812b\u6c34\u53ca\u9ad8\u8840\u9209\u73fe\u8c61\u3002 (B)\u7d66\u4e88\u6d3b\u6027\u78b3\u5e6b\u52a9\u4e0d\u5927\u3002 (C)\u75c5\u4eba\u5982\u679c\u51fa\u73fe\u767c\u71d2\u8d85\u904e 40\u2103\uff0c\u5247\u9810\u5f8c\u4e0d\u4f73\uff0c\u4f46\u964d\u6eab\u4e0d\u5b9c\u904e\u5feb\uff0c\u4ee5\u514d\u5f15\u767c\u7672\u7647\u3002 (D)\u5982\u679c\u7d93\u964d\u6eab\u8655\u7406\uff0c\u75c5\u4eba\u4ecd\u9ad8\u71d2\u4e0d\u9000\uff0c\u8003\u616e\u4f7f\u7528 dantrolene \u3002 (E)\u5982\u679c\u75c5\u4eba\u51fa\u73fe\u985e\u4f3c serotonin syndrome \u8868\u73fe\u6642\uff0c\u53ef\u4ee5\u8003\u616e\u4f7f\u7528serotonin agonist \u985e\u85e5\u7269\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "88\u6b72\u8b77\u7406\u4e4b\u5bb6\u7537\u6027\u4f4f\u6c11\uff0c\u56e0\u54b3\u55fd\u3001\u767c\u71d2\u3001\u6c23\u4fc3\u81f3\u6025\u8a3a\u5c31\u8a3a\u3002\u80f8\u90e8 X\u5149\u986f\u793a\u53f3\u5074\u80ba\u708e\uff0c\u91ab\u5e2b\u5efa\u8b70\u4f4f\u9662\u6cbb\u7642\u3002\u4e0b\u5217\u4f55\u8005\u8f03 \u4e0d\u9069\u5408\u505a\u70ba\u5176\u7d93\u9a57\u6027\u6297\u751f\u7d20\u4e4b\u9078\u64c7\uff1f", + "Options": "(A)Vancomycin \u3002 (B)Tazocin (Piperacillin/Tazobactam )\u3002 (C)Levofloxacin\u3002 (D)Cefepime\u3002 (E)Cef uroxime\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u4ee5\u4e0b\u6709\u95dc\u6297\u8840\u5c0f \u677f\u53ca\u6297\u8840\u6813\u85e5\u7269\u5728\u6025\u6027\u8166\u4e2d\u98a8\u7684\u6cbb\u7642\u6558\u8ff0\uff0c\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u5728\u5408\u4f75\u6709\u6025\u6027\u5fc3\u623f\u7e96\u7dad\u986b\u52d5(acute atrial fibrillation )\u7684\u7f3a\u8840\u6027\u4e2d\u98a8\u75c5\u4eba\uff0c\u61c9\u5118\u65e9\u5728\u6025\u8a3a\u4f7f\u7528\u6297\u8840\u6813\u85e5\u7269\u4ee5\u9632\u4e2d\u98a8\u60e1\u5316\u6216\u4e8c\u6b21\u4e2d\u98a8\u3002 (B)\u5728\u8840\u6813\u6eb6\u89e3\u5291\u6cbb\u7642\u5f8c\u7684 24\u5c0f\u6642\u5167\uff0c\u4e0d\u80fd\u4f7f\u7528\u6297\u8840\u5c0f\u677f\u6216\u6297\u8840\u6813\u85e5\u7269\u3002 (C)\u6297\u8840\u5c0f\u677f\u85e5\u7269\u61c9\u8a72\u5728\u4e2d\u98a8\u75c7\u72c0\u767c\u751f\u5f8c\u7684 24\u523048\u5c0f\u6642\u5167\u7d66\u4e88\u3002 (D)\u66ab\u6642\u6027\u8166\u7f3a\u8840(transient ischemic attack )\u75c5\u4eba\uff0c\u53ef\u5408\u4f75\u4f7f\u7528\u5169\u7a2e\u4e0d\u540c\u7684\u6297\u8840\u5c0f\u677f\u85e5\u7269\u3002 (E)\u4f7f\u7528 ABCD2 score\u8fa8\u8b58\u66ab\u6642\u6027\u8166\u7f3a\u8840(transient ischemic attack )\u9ad8\u98a8\u96aa\u75c5\u4eba\u7684\u6548\u679c\u4e0d\u4f73\u3002", + "Answer": "A\u3001B\u3001C\u3001D" + }, + { + "\ufeffQuestion": "30\u6b72\u7537\u6027\u6c23\u5598\u767c\u4f5c\u81f3\u6025\u8a3a\u5c31\u91ab\uff0c\u6c92\u6709\u767c\u71d2\uff0c\u80f8\u90e8 X\u5149\u7121\u7279\u6b8a\u767c\u73fe\uff0c\u5728\u6025\u8a3a\u5438\u904e\u4e09\u6b21 albuterol \u548cipratropium \uff0c\u5df2\u7d93\u7d66\u4e88 IV steroid \uff0c\u4e4b\u5f8c\u8ffd\u8e64 SpO 2 90%\uff0c\u52d5\u8108\u8840 PCO 2 45 mmHg \u3001\u8840\u58d3 102/75 mmHg \u3001\u5fc3\u8df3 145\u6b21/min\u3001\u547c\u543835\u6b21/min\uff0c\u5408\u4f75\u4f7f\u7528\u547c\u5438\u8f14\u52a9\u808c\u8089\uff0c\u5c0d\u65bc\u6b64\u75c5\u4eba\u4e0b\u5217\u6558\u8ff0\u8207\u8655\u7f6e\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u518d\u6b21\u807d\u8a3a\u6642\u82e5\u547c\u5438\u97f3\u6c92\u6709 wheezing \uff0c\u6b64\u6642\u518d\u7d66\u4e88\u652f\u6c23\u7ba1\u64f4\u5f35\u5291\u61c9\u8a72\u662f\u7121\u52a9\u76ca\u7684\u3002 (B)Salmeterol xinafoate \u548cformoterol \u5c0d\u65bc\u9023\u7d50\u03b2 2-receptor \u6548\u679c\u6bd4albuterol \u597d\uff0c\u53ef\u8003\u616e\u7d66\u75c5\u4eba \u4f7f\u7528\u3002 (C)\u53ef\u8003\u616e Magnesium 2 grams IV drip \uff0c\u4f46\u4e0d\u8003\u616e nebulized magnesium \u3002 (D)\u82e5\u7121\u6c23\u80f8\uff0c\u975e\u4fb5\u8972\u6027\u6b63\u58d3\u547c\u5438\u5668( NIPPV)\u6709\u6a5f\u6703\u589e\u52a0 airflow\uff0c\u4f46\u4e0d\u6703\u6e1b\u5c11\u63d2\u7ba1\u53ca\u4f4f\u9662\u7684\u6a5f\u7387\u3002 (E)\u5982\u679c\u9700\u8981\u63d2\u7ba1\uff0c ketamine \u662f\u5f88\u597d\u7684\u9078\u64c7\uff0c\u4f46\u63d2\u7ba1\u7121\u6cd5\u89e3\u6c7a airflow\u963b\u585e\u554f\u984c\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "23\u6b72\u61f7\u5b55 12\u9031\u7684\u5b55\u5a66\uff0c\u7522\u6aa2\u6642\u7a81\u767c\u5fc3\u60b8\u3001\u6c23\u4fc3\u53ca\u76dc\u6c57\u3002\u88ab\u9001\u81f3\u6025\u8a3a \u6642\uff0c\u9ad4\u6eab 38.8\u00b0C\u3001\u5fc3\u8df3 148\u6b21/min\u3001\u547c\u5438 25\u6b21/min\uff0c\u8840\u58d3\u70ba 145/100 mmHg \uff0c\u7121\u904e\u53bb\u6216\u5bb6\u65cf\u75c5 \u53f2\uff1b\u8eab\u9ad4\u6aa2\u67e5\u986f\u793a\u7532\u72c0\u817a\u7565\u5fae\u589e\u5927\u3002\u5c24\u5176\u7576\u89f8\u6478\u7532\u72c0\u817a\u6642\uff0c\u75c5\u4eba\u7684\u5fc3\u8df3 160\u6b21/min\u3002\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u7d66\u4e88\u652f\u6301\u6027\u7642\u6cd5\u5305\u62ec\uff1a\u6c27\u6c23\u3001\u975c\u8108\u8f38\u6db2\uff1b\u5fc5\u8981\u6642\u53ef\u4ee5\u7d66\u4e88\u53e3\u670dacetaminophen 325-650 mg \u5e6b\u52a9\u964d\u6eab\u3002 (B)\u7d66\u4e88 methimazole 40 mg \u53e3\u670d\uff0c\u6bcf 4\u5c0f\u6642\u7d66\u4e88 25 mg\uff1b\u6bcf\u65e5\u7e3d\u5291\u91cf120 mg\u3002 (C)\u4e0a\u8ff0\u7684\u8655\u7f6e\u6b65\u9a5f\u5b8c\u6210\u5f8c 1\u5c0f\u6642\uff1b\u6bcf\u9694 6-8\u5c0f\u6642\u7d66\u4e88 Lugol\u6eb6\u6db2 8-10\u6ef4\uff0c\u81f3\u9810\u671f\u6548\u679c\u3002 (D)\u7d66\u4e88 propranolol \u7de9\u6162\u975c\u8108\u6ce8\u5c04 1-2 mg\uff0c\u6bcf 10\u81f315\u5206\u9418\u91cd\u8907\u4e00\u6b21\uff0c\u81f3\u9810\u671f\u6548\u679c\u3002 (E)\u7d66\u4e88 hydrocortisone 100 mg \u975c\u8108\u6ce8\u5c04\uff0c24 \u5c0f\u6642\u5167 100 mg\u52063\u6b21\u91cd\u8907\u7d66\u4e88\uff0c\u81f3\u9810\u671f\u6548\u679c\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "46\u6b72\u5973\u6027\uff0c\u904e\u53bb\u7121\u75be\u75c5\u53f2\uff0c\u5e73\u6642\u65bc\u91d1\u9580\u50b3\u7d71\u5e02\u5834\u7d93\u71df\u5c0f\u5403\u6524\uff0c\u6700\u8fd1\u66fe\u81f3\u82b1\u84ee\u5c71\u5340\u904a\u73a9\uff0c\u4e3b \u8a34\u7d0410\u5929\u524d\u958b\u59cb\u9593\u65b7\u6027\u767c\u71d2\uff0c\u982d\u75db\uff0c\u96d9\u5c0f\u817f\u808c\u8089\u9178\u75db\uff0c\u8f15\u5fae\u54b3\u55fd\uff0c\u96d9\u773c\u975e\u5316\u81bf\u6027\u7d50\u819c\u708e\uff0c\u4e0a\u8ff0\u75c7\u72c0\u65bc 5\u5929\u5f8c\u6e1b\u7de9\uff0c\u4f46 3\u5929\u524d\u958b\u59cb\u51fa\u73fe\u5c0f\u4fbf\u984f\u8272\u8b8a\u6df1\u53ca\u5c3f\u91cf\u4e0b\u964d\u4e4b\u60c5\u5f62\u3002\u8840\u58d3 125/78 mmHg\uff0c\u5fc3\u8df3 100\u6b21/min\uff0c\u547c\u5438 25\u6b21/min\uff0c\u9ad4\u6eab 38\u2103\u3002\u8840\u6db2\u6aa2\u67e5\u7d50\u679c WBC 12,500/\u03bcL (Seg. 89%, Lym. 9% )\uff0cHb 11.8 g/dL \uff0cPlatelet 230,000 /\u03bcL\uff0cAST 658 U/L \uff0cALT 586 U/L\uff0cT-Bil. 3 mg/dL \uff0ccreatinine 4.5 mg/dL \uff0c\u80f8\u90e8 X\u5149\u7121\u660e\u986f\u8b8a\u5316\u3002\u4e0b\u5217\u75c5\u539f\u9ad4\u4f55\u8005\u6700\u6709\u53ef\u80fd \uff1f", + "Options": "(A)A \u578b\u809d\u708e\u75c5\u6bd2( Hepatitis A virus)\u3002 (B)\u6059\u87f2 \u71b1\u7acb\u514b\u6b21\u9ad4 (Rickettsia tsutsugamushi )\u3002 (C)\u9ebb\u75b9\u75c5\u6bd2 (Measles virus)\u3002 (D)\u9264\u7aef\u87ba\u65cb\u9ad4( Leptospirosis)\u3002 (E)\u767b\u9769\u75c5\u6bd2 (Dengue virus) \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u5de5\u5ee0\u54e1\u5de5\u5728\u610f\u5916\u9032\u5165\u5de5\u696d\u7167\u5c04\u5ba4\uff0c\u88ab\u4e0a\u65b9\u7684\u8f3b\u5c04\u6e90\u7167\u5c04\u5f8c\uff0c\u5168\u8eab\u4e0d\u9069\u88ab\u5e36\u5230\u6025\u8a3a\u5ba4\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u8a62\u554f\u75c5\u4eba\u88ab\u8f3b\u5c04\u6e90\u7167\u5c04\u5f8c\u51fa\u73fe\u5614\u5410\u7684\u6642\u9593\uff0c\u53ef\u63a8\u4f30\u66b4\u9732\u8f3b\u5c04\u5291\u91cf\u3002 (B)\u7d55\u5c0d\u4e2d\u6027\u7403\u6578\u76ee\u6e1b\u5c11\u6bd4\u7d55\u5c0d\u6dcb\u5df4\u7403\u6578\u76ee\u6e1b\u5c11\u66f4\u5e38\u62ff\u4f86\u63a8\u4f30\u66b4\u9732\u5291\u91cf\u3002 (C)\u75c5\u4eba\u8840\u7403\u6578\u76ee\u6e1b\u5c11\u6642\uff0c\u7d30\u80de\u805a\u843d\u523a\u6fc0\u56e0\u5b50(CSF )\u7684\u6548\u7528\u4e26\u4e0d\u9ad8\u3002 (D)\u8655\u7406\u75c5\u4eba\u6642\uff0c\u6025\u8a3a\u91ab\u8b77\u4eba\u54e1\u61c9\u7a7f B\u7d1a\u9632\u8b77\u8863\u907f\u514d\u5438\u5165\u653e\u5c04\u6027\u7269\u8cea\u3002 (E)\u75c5\u4eba\u9032\u884c\u9664\u6c61\u6642\uff0c\u9700\u5feb\u901f\u4f7f\u7528 \u5927\u91cf\u6e05\u6c34 \u6c96\u6d17\uff0c\u907f\u514d\u50b7\u5bb3\u60e1\u5316\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u525b\u51fa\u751f 14\u5929\u7684\u7537\u5b30\uff0c\u4eca\u5929\u56e0\u8336\u8272\u5c3f\u3001\u5927\u4fbf\u5448\u73fe\u7070\u767d\u8272\u3001\u978f\u819c\u53ca\u819a\u8272\u9ec3\u88ab\u5bb6\u4eba\u5e36\u4f86\u6025\u8a3a\u3002\u5bb6\u4eba\u6307\u51fa\u75c5\u7ae5\u5f9e\u51fa\u751f\u958b\u59cb\u5c31\u4e88\u4ee5\u9935\u98df\u6bcd\u4e73\uff0c\u7b2c 2\u5929\u51fa\u73fe\u76ae\u819a\u9ec3\u53ca\u978f\u819c\u9ec3\u7684\u73fe\u8c61\uff0c\u4e14\u5408\u4f75\u6709\u53ad\u98df\u3001\u6d3b\u52d5\u529b\u5dee\u7684\u60c5\u6cc1\uff0c\u81f3\u4eca\u672a\u6539\u5584\u3002\u5728\u6025\u8a3a\uff0c\u809b\u9580\u6eab\u5ea6\u6e2c\u91cf\u70ba 37.4\u2103\u3002\u8acb\u554f\u9020\u6210\u75c5\u7ae5\u9ec3\u75b8\u7684\u539f\u56e0\u6700\u6709\u53ef\u80fd\u70ba\u4f55\uff1f", + "Options": "(A)\u751f\u7406\u6027\u9ec3\u75b8( physiology jaundice )\u3002 (B)\u54fa\u4e73\u76f8\u95dc\u9ec3\u75b8(breast milk jaundice )\u3002 (C)\u81bd\u9053\u9589\u9396(biliary atresia )\u3002 (D)\u611f\u67d3\u6027\u9ec3\u75b8(septic jaundice )\u3002 (E)\u6eb6\u8840\u76f8\u95dc\u9ec3\u75b8 (hemolysis jaundice )\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u80a9\u90e8\u75bc\u75db\u7684\u539f\u56e0\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u6700\u56b4\u91cd\u7684\u8840\u7ba1\u6027\u50b7\u5bb3\u662f\u6025\u6027\u814b\u52d5\u8108\u8840\u6813(acute thrombosis of the axillary artery )\u3002 (B)\u80f8\u5ed3\u51fa\u53e3\u75c7\u5019\u7fa4(thoracic outlet syndrome )\u662f\u80a9\u90e8\u75bc\u75db\u53ef\u80fd\u7684\u9451\u5225\u8a3a\u65b7\uff0c\u597d\u767c\u65bc\u4e2d\u5e74\u7537\u6027\u3002 (C)\u813e\u81df\u53d7\u50b7\u75c5\u4eba\uff0c\u53ef\u80fd\u56e0\u70ba\u6a6b\u9694\u819c\u523a\u6fc0\u5c0e\u81f4\u75c7\u72c0\u4e0a\u51fa\u73fe\u53f3\u80a9\u75bc\u75db\u3002 (D)\u9838\u90e8\u795e\u7d93\u58d3\u8feb\u7d93\u5e38\u5c0e\u81f4\u80a9\u90e8\u75bc\u75db\uff0c\u4f8b\u5982 C7-C8 disc herniation\u3002 (E)\u81c2\u53e2\u795e\u7d93\u708e(brachial plexus neuritis )\u662f\u53ef\u80fd\u9020\u6210\u80a9\u90e8\u75bc\u75db\u7684\u75c5\u56e0\uff0c\u75c7\u72c0\u4e0a\u901a\u5e38\u6703\u5148\u6709\u7121\u529b\u5f8c\u624d\u6703\u51fa\u73fe\u75bc\u75db\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "70\u6b72\u5973\u6027\u75c5\u4eba\uff0c\u8d77\u5e8a\u6642\u7522\u751f\u7a81\u767c\u6027\u982d\u6688\u75c7\u72c0\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u75c5\u4eba\u51fa\u73fe\u65cb\u8f49\u53ca\u6c34\u5e73\u773c\u9707\u60c5\u5f62\uff0c\u5e38\u662f\u4e2d\u6a1e\u795e\u7d93\u75c5\u8b8a\u8868\u73fe\u3002 (B)\u75c5\u4eba\u5f35\u773c\uff0c\u96d9\u8173\u80fd\u7a69\u5b9a\u7ad9\u7acb\uff0c\u624b\u672a\u767c\u6296\uff0c\u5247\u8868\u793a\u5c0f\u8166\u529f\u80fd\u6b63\u5e38\u3002 (C)\u7531\u65bc\u75c5\u4eba\u6f31\u53e3\u6642\uff0c\u6c34\u6703\u7531\u5634\u89d2\u6d41\u51fa\uff0c\u559d\u6c34\u6613\u55c6\uff0c\u81e8\u5e8a\u5224\u65b7\u70ba\u5468\u908a\u578b\u984f\u9762\u795e\u7d93\u9ebb\u75fa(Bell's palsy )\u3002 (D)\u82e5\u8a3a\u65b7\u70ba\u5de6\u5074 lateral medullary infarction \uff0c\u75c7\u72c0\u61c9\u70ba\u53f3\u81c9\u9ebb\u3001\u89d2\u819c\u53cd\u5c04\u6d88\u5931\u3001Horner's syndrome \u3001\u541e\u56a5\u56f0\u96e3\u3002 (E)\u82e5\u56e0\u59ff\u52e2\u6027\u4f4e\u8840\u58d3\u5f15\u8d77\u7684\u982d\u6688\uff0c\u5247\u4e0d\u8981\u4f7f\u7528 prochlorperazine \u53cachlorpromzine \u7528\u65bc\u6b62\u5410\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6025\u6027\u80a2\u9ad4\u7121\u529b\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u82e5\u75c5\u4eba\u7684\u7121\u529b\u8868\u73fe\u662f\u5148\u4e0a\u80a2\u7121\u529b\u4e4b\u5f8c\u9032\u5c55\u81f3\u4e0b\u80a2\u7121\u529b\u6642\uff0c\u9700\u8003\u616e\u53ef\u80fd\u662f\u58c1\u8671\u6027\u9ebb\u75f9(tick paralysis )\u3002 (B)\u7576\u75c5\u4eba\u7121\u529b\u8868\u73fe\u662f\u9060\u7aef\u80a2\u9ad4\u7121\u529b\u5927\u65bc\u8fd1\u7aef\uff0c\u9700\u512a\u5148\u8003\u616e\u91cd\u75c7\u808c\u7121\u529b\u7684\u53ef\u80fd\u6027\u3002 (C)\u683c\u6797- \u5df4\u5229\u75c7\u5019\u7fa4(Guillain -Barre syndrome )\u6703\u5c0e\u81f4\u81ea\u4e3b\u795e\u7d93\u7cfb\u7d71\u5931\u80fd(autonomic dysfunction )\u3002 (D)\u591a\u767c\u6027\u786c\u5316\u75c7( multiple sclerosis )\u5c6c\u65bc\u53bb\u9ad3\u9798\u75be\u75c5\uff0c\u81e8\u5e8a\u4e0a\u53ef\u80fd\u51fa\u73fe\u56e0\u70ba\u6eab\u5ea6\u4e0a\u5347\u800c\u75c7\u72c0\u6539\u5584\u7684\u60c5\u5f62\u3002 (E)\u5f9e\u75c7\u72c0\u4e0a\uff0c\u53ef\u4ee5\u7531\u662f\u5426\u6709\u5408\u4f75\u8907\u8996\u6216\u541e\u56a5\u56f0\u96e3\u4f86\u5340\u5206\u662f\u5426\u70ba\u4e2d\u6a1e\u795e\u7d93\u7cfb\u7d71\u6216\u662f\u5468\u908a\u795e\u7d93\u7cfb\u7d71\u554f\u984c\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5b55\u5a66\u7684\u6c23\u9053\u8655\u7406\u539f\u5247\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5b55\u5a66\u9ad4\u91cd\u589e\u52a0\u6108\u591a\u3001\u63d2\u7ba1\u524d\u8a55\u4f30\u7684 Mallampati Class \u5206\u7d1a\u6307\u6578\u6703\u6108\u4f4e\u3002 (B)\u61f7\u5b55\u5f8c\u671f\u8f03\u5e38\u6709\u4e0a\u547c\u5438\u9053\u6c34\u816b\uff0c\u6240\u4ee5\u56f0\u96e3\u63d2\u7ba1\u7684\u5b55\u5a66\u4e26\u4e0d\u5efa\u8b70\u4f7f\u7528\u5589\u7f69\u6c23\u9053 (LMA)\u3002 (C)\u7d93\u8a55\u4f30\u56f0\u96e3\u63d2\u7ba1\u7684\u5b55\u5a66\uff0c\u5efa\u8b70\u5148\u5617\u8a66\u975e\u8996\u93e1\u7d93\u9f3b\u6c23\u7ba1\u63d2\u7ba1\u3002 (D)\u6b32\u4f7f\u7528\u5feb\u901f\u85e5\u7269\u5f15\u5c0e\u63d2\u7ba1\u6642\uff0c\u5b55\u5a66\u4f7f\u7528\u7684\u85e5\u7269\u548c\u5291\u91cf\u8003\u91cf\u8207\u4e00\u822c\u75c5\u4eba\u4e26\u7121\u4e0d\u540c\u3002 (E)\u63d2\u7ba1\u5b8c\u6210\u5f8c\u53ef\u4ee5\u589e\u52a0\u63db\u6c23\u6b21\u6578\u9020\u6210\u8f15\u5fae\u547c\u5438\u6027\u9e7c\u8840\u72c0\u614b\uff0c\u4ee5\u589e\u52a0\u5b50\u5bae\u80ce\u76e4\u8840\u6d41\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "35\u6b72\u7537\u6027\uff0c\u7121\u904e\u53bb\u75c5\u53f2\uff0c\u4e3b\u8a34\u809b\u9580\u53e3\u75bc\u75db\u4e09\u5929\uff0c\u8eab\u9ad4\u6aa2\u67e5\u5f8c\u8a3a\u65b7\u70baperianal abscess \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u75c5\u4eba\u4e3b\u8a34\u591a\u70ba\u767c\u71d2\u5408\u4f75\u809b\u9580\u53e3\u75bc\u75db\u3002 (B)\u5c11\u90e8\u5206\u75c5\u4eba\u4e5f\u6703\u5408\u4f75\u809b\u9580\u763b\u7ba1( fistula)\u3002 (H)Staphylococcus aureus, Escherichia coli \u70ba\u5e38\u898b\u7684\u81f4\u75c5\u83cc\u3002 (C)\u6cbb\u7642\u70ba\u5c40\u90e8\u5f15\u6d41(incision and drainage )\u4ee5\u53ca\u53e3\u670d\u6297\u751f\u7d20\u3002 (D)\u5f15\u6d41\u5f8c\u518d\u4f7f \u7528WASH(warm water, analgesics, stool softeners, high-fiber diet) regimen\u5c0d\u75c7\u72c0\u6539\u5584\u5df2\u7121\u5e6b\u52a9\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u98df\u9053\u7834\u88c2\u7684\u75c5\u4eba\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)Boerhaave's syndrome \u901a\u5e38\u662f\u7531\u65bc\u9838\u90e8\u920d\u632b\u50b7\u5f15\u8d77\u3002 (B)\u81ea\u767c\u6027\u7834\u88c2\u5e38\u4f4d\u65bc\u98df\u9053\u7684\u53f3\u5f8c\u5916\u5074\u3002 (C)\u5c0d\u65bc\u541e\u98df\u8150\u8755\u6027\u7269\u8cea\u7684\u75c5\u4eba\uff0c\u541e\u98df\u5f8c 12\u5c0f\u6642\u5185\u662f\u65bd\u884c\u5167\u8996\u93e1\u6aa2\u67e5\u7684\u6700\u4f73\u6642\u6a5f\u3002 (D)\u7e31\u9694\u8154\u6c23\u816b (mediastinal emphysema )\u662f\u8a3a\u65b7\u672c\u75be\u75c5\u7684\u4f9d\u64da\u3002 (E)\u91ab\u6e90\u6027\u7834\u88c2\u5e38\u898b\u5728\u98df\u9053\u9060\u7aef\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "65\u6b72\u7684\u7537\u6027\uff0c\u559d\u4e0b\u4e0d\u77e5\u540d\u8fb2\u85e5\uff0c\u6578\u5c0f\u6642\u5f8c\u56e0\u70ba\u8178\u80c3\u4e0d\u9069\u524d\u53bb\u6025\u8a3a\uff0c\u96a8\u5373\u767c\u751f\u610f\u8b58\u6539\u8b8a\uff0c\u4e0d\u4e45\u4e4b\u5f8c\u751a\u81f3\u7672\u7647\u767c\u4f5c\u53ca\u547c\u5438\u8870\u7aed\uff0c\u62bd\u8840\u5831\u544a\u986f\u793a\u6709\u9ad8\u6c28\u8840\u75c7(hyperammonemia ) \uff0c\u96d6\u7136\u7d93\u904e\u7a4d\u6975\u6436\u6551\uff0c\u6578\u65e5\u5f8c\u610f\u8b58\u6162\u6162\u6062\u5fa9\uff0c\u4f46\u662f\u6301\u7e8c\u6709\u9806\u884c\u6027\u53ca\u9006\u884c\u6027\u5931\u61b6\u75c7(anterograde and retrograde amnesia ) \uff0c\u8a66\u554f\u6700\u6709\u53ef\u80fd \u662f\u54ea\u4e00\u7a2e\u8fb2\u85e5\u4e2d\u6bd2\uff1f", + "Options": "(A)\u5df4\u62c9\u5208\u4e2d\u6bd2\u3002 (B)\u6709\u6a5f\u78f7\u4e2d\u6bd2\u3002 (C)\u56fa\u6bba\u8349\u4e2d\u6bd2\u3002 (D)\u9664\u87f2\u83ca\u7cbe\u4e2d\u6bd2\u3002 (E)\u5609\u78f7\u585e\u4e2d\u6bd2\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "15\u6b72\u5973\u5b78\u751f\uff0c\u56db\u5929\u524d\u8207\u7537\u53cb\u767c\u751f\u6027\u95dc\u4fc2\uff0c\u88ab\u5bb6\u4eba\u5e36\u4f86\u6025\u8a3a\uff0c\u8981\u6c42\u9032\u884c\u6027\u4fb5\u8655\u7406\u6d41\u7a0b\u3002\u79c1\u4e0b\u8a62\u554f\u5f8c\u5973\u5b69\u8868\u793a\u9019\u662f\u5169\u60c5\u76f8\u6085\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u4f9d\u64da\u5152\u7ae5\u6b0a\u5229\u516c\u7d04\u61c9\u4ee5\u5152\u7ae5\u6700\u4f73\u5229\u76ca\u70ba\u512a\u5148\u8003\u91cf\uff0c\u6545\u5a49\u8f49\u544a\u77e5\u7236\u6bcd\uff0c\u8acb\u4ed6\u5011\u5c0a\u91cd\u5973\u5152\u7684\u610f\u9858\uff0c\u9054\u6210\u5171\u8b58\u5f8c\u518d\u544a\u8a34\u91ab\u5e2b\u662f\u5426\u9032\u884c\u6027\u4fb5\u8655\u7406\u6d41\u7a0b\u3002 (B)\u4f9d\u6aa2\u50b7\u5206\u985e\u898f\u5b9a\uff0c\u9019\u662f\u7b2c\u4e8c\u7d1a\u72c0\u6cc1\u3002 (C)\u70ba\u78ba\u5b9a\u662f\u5426\u906d\u53d7\u66b4\u529b\u50b7\u5bb3\uff0c\u52d9\u5fc5\u812b\u9664\u8863\u670d\u7167\u76f8\uff0c\u4e26\u4ed4\u7d30\u67e5\u770b\u662f\u5426\u6709\u50b7\u53e3\u3001\u7600\u9752\u3001\u58d3\u75db\uff0c\u7279\u5225\u662f\u56db\u80a2\u3001\u9838\u8207\u6703\u9670\u90e8\u3002 (D)\u5167\u8a3a\u6216\u4f7f\u7528\u9670\u9053\u93e1\u6aa2\u8996\u9670\u9053\u3001\u5b50\u5bae\u9838\u662f\u5426\u6709\u50b7\u53e3\uff0c\u4f7f\u7528\u4f0d\u6c0f\u71c8(Wood's lamp)\u67e5\u770b\u9ad4\u8868\u662f\u5426\u6709\u7cbe\u6db2\u6b98\u7559\u3002 (E)\u62bd\u8840\u6aa2\u6e2c\u5168\u8840\u7403\u8a08\u6578\u3001\u809d\u529f\u80fd\u3001B/C \u809d\u708e\u3001\u6885\u6bd2\u53ca HIV\u75c5\u6bd2\uff0c\u4e14\u61c9\u9a57\u5c3f\u6aa2\u9a57\u662f\u5426\u61f7\u5b55\u4ee5\u53ca\u88ab\u4e0b\u85e5(drug -facilit ated rape) \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "40\u6b72\u7537\u6027\u53f3\u4e0b\u984e\u7b2c\u4e09\u81fc\u9f52\u75bc\u75db\u4e00\u661f\u671f\uff0c\u4eca\u5929\u767c\u71d2\u53ca\u7121\u6cd5\u5e73\u8eba\uff0c\u553e\u6db2\u4e0d\u65b7\u5f9e\u5634\u89d2\u6ea2\u51fa\uff0c\u547c\u5438\u6709\u660e\u986f\u5598\u9cf4\u97f3(stridor ) \uff0c\u7406\u5b78\u6aa2\u67e5\u767c\u73fe\u53f3\u5074\u81c9\u90e8\u7d05\u816b\uff0c\u4e26\u4e14\u5ef6\u4f38\u5230\u4e0b\u5df4\u53ca\u9838\u90e8\u3001\u7259\u95dc\u7dca\u9589( trismus) \uff0c\u4f7f\u7528 simple mask 6L/min \u5f8c\u8840\u6c27\u6fc3\u5ea6\u70ba 95%\u3002\u95dc\u65bc\u5f8c\u7e8c\u8655\u7f6e\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u61c9\u5118\u5feb\u4f7f\u7528 rapid sequence intubation \u5efa\u7acb\u9032\u968e\u547c\u5438\u9053\u3002 (B)\u65bd\u6253 rocuronium \u53ef\u4ee5\u7de9\u89e3\u7259\u95dc\u7dca\u9589\u554f\u984c\u3002 (C)\u65bd\u6253 succinylcholine \u6703\u60e1\u5316\u7259\u95dc\u7dca\u9589\u554f\u984c\u3002 (D)\u4f7f\u7528 bag-valve mask \u4e3b\u52d5\u7d66\u6c27\u6642\uff0c\u57f7\u884c jaw thrust \u53ef\u4ee5\u6709\u6548\u6253\u958b\u75c5\u4eba\u7684\u547c\u5438\u9053\u3002 (E)\u61c9\u5118\u5feb\u5b89\u6392 awake intubation\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u4f55\u8005 \u4e0d\u662f\u5c6c\u65bc\u9ad8\u58d3\u96fb\u50b7 (electrical injuries )\u5f8c\uff0c\u5e38\u898b\u9020\u6210\u7684\u4f75\u767c\u75c7\uff1f", + "Options": "(A)\u5438\u5165\u6027\u80ba\u708e\u3002 (B)\u5ef6\u9072\u6027\u767d\u5167\u969c(delayed cataract )\u3002 (C)\u807d\u529b\u53d7\u640d\u3002 (D)\u53d7\u50b7\u80a2\u7aef\u7522\u751f\u5ef6\u9072\u6027\u8840\u6813(delayed thrombosis )\u3002 (E)\u9aa8\u982d\u58de\u6b7b\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u53f0\u7063\u5730\u8655\u5730\u9707\u5e36 \uff0c\u6bcf\u5e74\u90fd\u53ef\u80fd\u767c\u751f\u82ae\u6c0f\u5927\u898f\u6a21\u5730\u9707\uff0c\u4f9d\u7167\u4e2d\u592e\u707d\u5bb3\u61c9\u8b8a\u4e2d\u5fc3\u4f5c\u696d\u8981\u9ede\uff0c\u4ee5\u4e0b\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u82e5\u4e2d\u592e\u6210\u7acb\u4e00\u7d1a\u707d\u5bb3\u61c9\u8b8a\u4e2d\u5fc3\uff0c\u6700\u9ad8\u6a5f\u95dc\u61c9\u7531\u7e3d\u7d71\u5e9c\u7d71\u7c4c\uff0c\u591a\u7531\u6642\u4efb\u7e3d\u7d71\u70ba\u707d\u5bb3\u61c9\u8b8a\u4e2d\u5fc3\u6307\u63ee\u5b98\u3002 (B)\u61c9\u8b8a\u4e2d\u5fc3\u958b\u8a2d\u6642\u6a5f\u7d93\u7814\u5224\u70ba\u4e2d\u592e\u6c23\u8c61\u5c40\u767c\u5e03\u4e4b\u5730\u9707\u9707\u5ea6\u9054\u4e03\u7d1a\u4ee5\u4e0a\u3002 (C)\u82e5\u5916\u7e23\u5e02\u6551\u8b77\u968a\u6b32\u5354\u52a9\u6551\u63f4\uff0c\u96c6\u7d50\u5f8c\u61c9\u5148\u76f4\u63a5\u524d\u5f80\u73fe\u5834\uff0c\u65b9\u4fbf\u7576\u5730\u6307\u63ee\u5b98\u6d3e\u9063\u3002 (D)\u82e5\u6709\u570b\u5916\u641c\u6551\u968a\u6b32\u5354\u52a9\u6551\u63f4\uff0c\u61c9\u7531\u5167\u653f\u90e8\u6d88\u9632\u7f72\u8a55\u4f30\u4eba\u529b\u9700\u6c42\u5f8c\u7d71\u7c4c\u6307\u63ee\u3002 (E)\u56e0\u9707\u707d\u4f75\u540c\u767c\u751f\u8f3b\u5c04\u707d\u5bb3\u6642\uff0c\u884c\u653f\u9662\u539f\u5b50\u80fd\u59d4\u54e1\u6703\u4e3b\u4efb\u59d4\u54e1\u64d4\u4efb\u6307\u63ee\u5b98\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "20\u6b72\u5973\u6027\u884c\u4eba\u88ab\u6642\u901f 70\u516c\u91cc\u7684\u8f4e\u8eca\u649e\u98db\uff0c\u5230\u9054\u6025\u8a3a\u5ba4\u6642\u751f\u547d\u5fb5\u8c61\u5982\u4e0b\uff1a\u9ad4\u6eab 36.4\u2103\uff0c\u547c\u5438 12\u6b21/min\uff0c\u5fc3\u8df3 120\u6b21/min\uff0c\u8840\u58d3 88/60 mmHg \uff0c\u8840\u6c2796%\uff0c\u660f\u8ff7\u6307\u6578 15\uff0c\u521d\u7d1a\u8a55\u4f30\u547c\u5438\u9053\u901a\u66a2\u7121\u7570\u7269\uff0c\u547c\u5438\u6b63\u5e38\u7121\u8cbb\u529b\uff0c\u7121\u6c23\u7ba1\u504f\u79fb\uff0c\u5169\u5074\u80ba\u97f3\u6b63\u5e38\uff0c\u5fc3\u97f3\u6b63\u5e38\u3002\u8179\u90e8\u58d3\u75db\u53ca\u9aa8\u76c6\u8154\u4e0d\u7a69\u5b9a\uff0c\u8d85\u97f3\u6ce2\u986f\u793a\u5f8c\u8179\u8154\u7a4d\u6db2\u3002 \u4e0b\u5217\u4f55\u8005\u8655\u7f6e\u61c9\u512a\u5148 \u9032\u884c\uff1f", + "Options": "(A)\u5b89\u6392\u8179\u90e8\u53ca\u9aa8\u76c6\u8154\u7684\u96fb\u8166\u65b7\u5c64\u3002 (B)\u7167\u6703\u9aa8\u79d1\u91ab\u5e2b\u6e96\u5099\u4ee5\u5916\u56fa\u5b9a\u65b9\u5f0f\u56fa\u5b9a\u9aa8\u76c6\u3002 (C)\u7167\u6703\u5916\u79d1\u91ab\u5e2b\u6e96\u5099\u7dca\u6025\u5256\u8179\u624b\u8853(emergency laparotomy )\u3002 (D)\u7167\u6703\u653e\u5c04\u79d1\u91ab\u5e2b\u6e96\u5099\u8840\u7ba1\u651d\u5f71(angiography )\u3002 (E)\u6253\u4e0a\u5169\u689d 18\u53e3\u5f91\u7684\u9ede\u6ef4\uff0c\u7d66\u4e88 1,000\u6beb\u5347\u6eab\u6696\u7684\u751f\u7406\u98df\u9e7d\u6c34\uff0c\u6e96\u5099\u8840\u54c1\uff0c\u4ee5\u9aa8\u76c6\u56fa\u5b9a\u5e36\u56fa\u5b9a\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u71b1\u4e2d\u6691( heat stroke )\u7684\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u8a3a\u65b7\u9700\u7b26\u5408\u9ad4\u6eab\u5927\u65bc 40\u2103\u3001\u610f\u8b58\u6539\u8b8a\u53ca\u7121\u6c57(anhidrosis)\u4e09\u9805\u81e8\u5e8a\u75c7\u72c0\u3002 (B)\u56e0\u70ba\u5c0f\u8166\u5c0d\u65bc\u9ad8\u9ad4\u6eab\u654f\u611f\uff0c\u6b65\u614b\u4e0d\u7a69(ataxia)\u53ef\u80fd\u662f\u71b1\u4e2d\u6691\u65e9\u671f\u7684\u81e8\u5e8a\u75c7\u72c0\u3002 (C)\u7672\u7647\u767c\u4f5c\u5728\u71b1\u4e2d\u6691\u4e2d\u5e38\u898b\uff0c\u5c24\u5176\u6700\u5e38\u767c\u4f5c\u5728\u75c5\u4eba\u9ad4\u6eab\u6700\u9ad8\u6642\u3002 (D)\u964d\u6eab\u6cbb\u7642\u6642\uff0c\u4e0d\u8ad6\u7528\u4ec0\u9ebc\u65b9\u5f0f\uff0c\u9700\u5118\u901f\u5c07\u9ad4\u6eab\u964d\u81f3\u76ee\u6a19\u9ad4\u6eab 37\u2103\uff0c\u4e26\u907f\u514d\u4f4e\u9ad4\u6eab\u7522\u751f\u3002 (E)\u81e8\u5e8a\u4e0a\u6cbb \u7642\u4f7f\u7528\u51b7\u6c34\u80c3\u704c\u6d17 (gastric lavage )\u53ca\u8180\u80f1\u704c\u6d17(urinary bladder lavage )\u964d\u6eab\u662f\u5b89\u5168\u6709\u6548\u7684\uff0c\u4f46\u61c9\u6ce8\u610f\u6c34\u4e2d\u6bd2\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u65b0\u751f\u5152\u5fa9\u7526\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5c0d\u65bc\u51fa\u751f\u6642\u4e0d\u9700\u8981\u5fa9\u7526\u7684\u8db3\u6708\u51fa\u751f\u548c\u65e9\u7522\u5152\uff0c\u5ef6\u9072\u81cd\u5e36\u593e\u9589\u7d04 20\u79d2\u61c9\u662f\u9069\u7576\u7684\u505a\u6cd5\u3002 (B)\u7576 tracheal intubation \u7121\u6cd5\u6210\u529f\u5efa\u7acb\u6642\uff0claryngeal mask \u4e0d\u5efa\u8b70\u4f7f\u7528\u5728\u8db3\u6708\u65b0\u751f\u5152\u6216 34\u9031\u4ee5\u4e0a\u65e9\u7522\u5152\u3002 (C)\u5982\u679c\u5b30\u5152\u51fa\u751f\u6642\u7d93\u904e\u80ce\u4fbf\u6c61\u67d3\u7684\u7f8a\u6c34\uff0c\u4e26\u4e14\u51fa\u73fe\u808c\u8089\u5f35\u529b\u4e0d\u826f\u548c\u4e0d\u7576\u7528\u529b\u547c\u5438\u7684\u60c5\u6cc1\uff0c\u61c9\u8a72\u653e\u5728\u8f3b\u5c04\u52a0\u6eab\u5668\u4e0b\u65b9\uff0c\u5fc5\u8981\u6642\u9808\u958b\u59cb\u9032\u884c\u6b63\u58d3\u7d66\u6c27 (positive pressure ventilation )\u3002 (D)\u65b0\u751f\u5152\u5fc3\u81df\u505c\u6b62\u5118\u65e9\u58d3\u80f8\u662f\u521d\u6b65\u5fa9\u7526\u7684\u91cd\u9ede\u3002 (E)\u70ba\u4f4e\u65bc 35\u9031\u598a\u5a20\u7684\u65e9\u7522\u65b0\u751f\u5152\u9032\u884c\u5fa9\u7526\u6642\uff0c\u61c9\u5f9e\u9ad8\u6c27\u6c23\u6fc3\u5ea6\u63a5\u8fd1100%\u958b\u59cb\uff0c\u7136\u5f8c\u518d\u8abf\u6574\u6c27\u6c23\uff0c\u4ee5\u9054\u5230\u63a5\u8fd1\u5065\u5eb7\u8db3\u6708\u51fa\u751f\u5b30\u5152\u7684\u7ba1\u524d\u8840\u6c27\u98fd\u548c\u5ea6(preductal oxygen saturation )\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u61f7\u5b55 28\u9031\u5973\u6027\u4e4b\u5916\u50b7\u8655\u7406\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u8840\u6db2\u7e3d\u9ad4\u7a4d 10-15%\u4e4b\u5931\u8840\u5373\u6703\u5f15\u8d77\u4f11\u514b\u5fb5\u5019\u3002 (B)\u6b21\u7d1a\u8a55\u4f30\u6642\u9aa8\u76c6\u6aa2\u67e5\u512a\u5148\u65bc\u8d85\u97f3\u6ce2\u3002 (C)\u53ef\u4f9d pH\u503c\u5206\u8fa8\u662f\u5426\u70ba\u7f8a\u6c34\u7834\u88c2\u6216\u9670\u9053\u5206\u6ccc\u7269\uff1a\u504f\u4e2d\u6027\u70ba\u7f8a\u6c34\uff0c\u504f\u9178\u6027\u70ba\u9670\u9053\u5206\u6ccc\u7269\u3002 (D)\u7d93\u8179\u8d85\u97f3\u6ce2\u8a3a\u65b7\u7a4d\u6db2(ascites)\u4e4b\u654f\u611f\u5ea6\u53ca\u7279\u7570\u6027\u7686\u6bd4\u975e\u61f7\u5b55\u75c5\u4eba\u5dee\u3002 (E)\u82e5\u7121\u660e\u986f \u8179\u90e8\u5916\u50b7\uff0c\u8d85\u97f3\u6ce2\u6aa2\u67e5\u7121\u5167\u51fa\u8840\u8b49\u64da\u4e14\u80ce\u5fc3\u97f3\u5927\u65bc 120\u6b21/min\uff0c\u9069\u7576\u885b\u6559\u5f8c\u5373\u53ef\u8b93\u5b55\u5a66\u96e2\u9662\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "50\u6b72\u5973\u6027\u75c5\u4eba\u56e0\u5168\u8eab\u7121\u529b\u9001\u81f3\u6025\u8a3a\uff0c\u6aa2\u67e5\u6642\u5448\u73fe\u610f\u8b58\u4e0d\u6e05\uff0c\u8840\u58d3 100/70 mmHg\uff0c\u5fc3\u96fb\u5716\u5448\u73fe\u7ac7\u6027\u5fc3\u5f8b\uff0c\u5fc3\u8df3 54\u6b21/min\uff0c\u9ad4\u6eab 34\u2103\u3001\u547c\u5438 10\u6b21/min\uff1b\u8840\u9209\u70ba 128 meq/L \u3001\u8840\u7cd6\u503c\u70ba 90 mg/dL \uff1b\u81c9\u90e8\u8207\u4e0b\u80a2\u5448\u73fe\u975e\u51f9\u9677\u6027(non -pitting)\u6c34\u816b\u3002\u4e0b\u5217\u6709\u95dc\u9451\u5225\u8a3a\u65b7\u53ca\u8655\u7f6e\u7684\u63cf\u8ff0\u54ea\u4e00\u9805\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u8a3a\u65b7\u70ba\u814e\u4e0a\u817a\u5371\u8c61(adrenal crisis )\uff0c \u7d66 \u4e88 hydrocortisol \u3002 (B)\u8a3a\u65b7\u70ba\u4f4e\u8840\u7cd6\u660f\u8ff7\uff0c\u7d66\u4e88 D50W \u975c\u8108\u6ce8\u5c04\u3002 (C)\u8a3a\u65b7\u70ba\u6c34\u4e2d\u6bd2\uff0c\u7d66\u4e88 3% saline \u77ef\u6b63\u4f4e\u8840\u9209\u3002 (D)\u8a3a\u65b7\u70ba\u5fc3\u640f\u904e\u7de9\u4f75\u5fc3\u56e0\u6027\u4f11\u514b\uff0c\u7d66\u4e88 dopamine \u3002 (E)\u8a3a\u65b7\u70ba\u9ecf\u6db2\u6c34\u816b\u6027\u660f\u8ff7( myxedema coma ) \uff0c\u7d66\u4e88 thyroxine \u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "58\u6b72\u7537\u6027\uff0c\u81ea\u8ff0\u7d04\u4e00\u5929\u524d\u81f3\u5357\u6295\u5c71\u5340\u6253\u7375\u6642\uff0c\u88ab\u906d\u88dc\u7375\u593e\u56f0\u4f4f\u4e4b\u767d\u9f3b\u5fc3\u54ac\u50b7\u53f3\u524d\u81c2\uff0c\u50b7\u53e3\u5916\u89c0\u6709\u660e\u986f\u6df1\u9f52\u75d5\u53ca\u4e7e\u71e5\u8840\u8de1\uff0c\u50b7\u53e3\u5468\u570d\u6cdb\u7d05\u3002\u88ab\u88dc\u7372\u4e4b\u767d\u9f3b\u5fc3\u88ab\u95dc\u5728\u7c60\u4e2d\u4e5f\u88ab\u5e36\u4f86\uff0c\u4e14\u770b\u4f3c\u5e73\u975c\u3002\u8acb\u554f\u4f9d\u64da\u6cbb\u7642\u6307\u5f15\u53ca\u6700\u65b0\u570b\u5bb6\u653f\u7b56\uff0c\u5728\u50b7\u53e3\u6e05\u6f54\u53ca\u7834\u50b7\u98a8\u75ab\u82d7\u6ce8\u5c04\u5f8c\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u7d66\u4e88\u5b8c\u6574\u72c2\u72ac\u75c5\u75ab\u82d7\u6ce8\u5c04\u7642\u7a0b\uff0c\u4e26\u7acb\u5373\u5728\u50b7\u53e3\u5468\u570d\u9032\u884c\u72c2\u72ac\u75c5\u514d\u75ab\u7403\u86cb\u767d\u6d78\u6f64\u5f0f\u6ce8\u5c04\u3002 (B)\u7d66\u4e88\u72c2\u72ac\u75c5\u75ab\u82d7\u55ae\u4e00\u6ce8\u5c04\uff0c\u4e26\u5c07\u767d\u9f3b\u5fc3\u9001\u4ea4\u8fb2\u653f\u55ae\u4f4d\u6aa2\u9a57\u662f\u5426\u6709\u72c2\u72ac\u75c5\uff0c\u82e5\u6aa2\u9a57\u967d\u6027\uff0c\u5247\u5b8c\u6210\u5f8c\u7e8c\u75ab\u82d7\u7642\u7a0b\u3002 (C)\u7d66\u4e88\u72c2\u72ac\u75c5\u75ab\u82d7\u55ae\u4e00\u6ce8\u5c04\uff0c\u4e26\u5c07\u767d\u9f3b\u5fc3\u9001\u4ea4\u8fb2\u653f\u55ae\u4f4d\u6aa2\u9a57\u662f\u5426\u6709\u72c2\u72ac\u75c5\uff0c\u82e5\u6aa2\u9a57\u9670\u6027\uff0c\u5247\u505c\u6b62\u5f8c\u7e8c\u75ab\u82d7\u6ce8\u5c04\u7642\u7a0b\u3002 (D)\u7d66\u4e88\u5b8c\u6574\u72c2\u72ac\u75c5\u75ab\u82d7\u6ce8\u5c04\u7642\u7a0b\u3002 (E)\u7d66\u4e88\u53e3\u670d\u6297\u751f\u7d20\u6cbb\u7642\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u4e0a\u6d88\u5316\u9053\u51fa\u8840\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)BUN \u548ccreatinine \u7684\u6bd4\u503c\u226720\uff0c\u53ef\u4f5c\u70ba\u4e0a\u6d88\u5316\u9053\u51fa\u8840\u7684\u81e8\u5e8a\u8a3a\u65b7\u53c3\u8003\u3002 (B)\u61c9\u53ca\u65e9\u5b89\u6392\u5e38\u898f\u7684\u8179\u90e8\u651d\u5f71(abdominal radiograph )\u3002 (C)\u9f3b\u80c3\u7ba1\u7f6e\u653e\u4e0d\u6703\u589e\u52a0\u98df\u9053\u975c\u8108\u66f2\u5f35\u8655\u51fa\u8840\u7684\u6a5f\u7387\u3002 (D)\u9f3b\u80c3\u7ba1\u62bd\u51fa\u6db2\u5448\u6f5b\u8840\u9670\u6027\uff0c\u61c9\u53ef\u5408\u7406\u6392\u9664\u4e0a\u6d88\u5316\u9053\u51fa\u8840\u3002 (E)\u7dca\u6025\u5185\u8996\u93e1\u6aa2\u67e5\u4e0d\u61c9\u4f7f\u7528\u5728\u6025\u6551\u5f8c\u7684\u9ad8\u5371\u75c5\u4eba\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u6709\u95dc\u6297\u8840\u6813\u6cbb\u7642\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u4f4e\u5206\u5b50\u91cf\u809d\u7d20\u7684\u512a\u9ede\u662f\u4e0d\u9700\u8981\u62bd\u8840\u76e3\u6e2c\u3002 (B)Warfarin \u904e\u91cf\u53ef\u4ee5\u8003\u616e\u8f38\u5165\u65b0\u9c9c\u51b7\u51cd\u8840\u6f3f\u3002 (C)\u6297\u8840\u5c0f\u677f\u85e5\u7269\u5c0d\u65bc\u975c\u8108\u6813\u585e\u6bd4\u6297\u51dd\u8840\u85e5\u7269\u6709\u6548\u3002 (D)\u65b0\u578b\u6297\u51dd\u8840\u85e5\u7269 rivaroxaban \u662f\u7b2c\u5341\u51dd\u8840\u56e0\u5b50\u7684\u6291\u5236\u5291\u3002 (E)\u6297\u8840\u5c0f\u677f\u85e5\u7269\u963f\u65af\u5339\u9748\u6297\u51dd\u8840\u6548\u679c\u6703\u6301\u7e8c 7\u5929\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "San Francisco Syncope Rule \u662f\u7528\u4f86\u8a55\u4f30\u6688\u53a5\u98a8\u96aa\u7684\u5de5\u5177\uff0c\u9700\u8a55\u4f30\u4e94\u9805\u6307\u6a19\uff0c\u6709\u95dc\u4e94\u9805\u6307\u6a19\u4ee5\u4e0b\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u51a0\u72c0\u52d5\u8108\u75be\u75c5( coronary artery disease )\u75c5\u53f2\u3002 (B)\u8840\u7d05\u7d20\u5c0f\u65bc 9.0 g/dL\u8868\u793a\u75c5\u4eba\u6709\u6025\u6027\u51fa\u8840\u4e4b\u53ef\u80fd\u3002 (C)\u8166\u6ce2(EEG)\u8868\u793a\u75c5\u4eba\u6709\u7672\u7647\u4e4b\u53ef\u80fd\u3002 (D)\u75c5\u7ac7\u75c7\u5019\u7fa4(sick sinus syndrome ) \uff0c\u56e0\u5fc3\u640f\u904e\u7de9\u5c0e\u81f4\u6688\u53a5\u3002 (E)\u6536\u7e2e\u58d3(systolic pressure )\uff0c\u6536\u7e2e\u58d3\u5c0f\u65bc 90 mmHg \u70ba\u9ad8\u98a8\u96aa\u56e0\u7d20\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "63\u6b72\u7537\u6027\u81f3 A\u91ab\u9662\u6025\u8a3a\u5c31\u8a3a\uff0c\u4e3b\u8a34\u4e00\u5c0f\u6642\u524d\u958b\u59cb\u6301\u7e8c\u80f8\u75db\uff0c\u5fc3\u96fb\u5716\u5448\u73feII\u3001III\u8207aVF\u5c0e\u7a0b ST\u7bc0\u6bb5\u4e0a\u5347\u3002\u82e5 A\u91ab\u9662\u7121\u6cd5 \u63d0\u4f9b primary percutaneous coronary intervention (PCI)\u6cbb\u7642\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)A \u91ab\u9662\u6025\u8a3a\u91ab\u5e2b\u61c9\u7acb\u5373\u806f\u7d61\u6025\u8a3a\u75c5\u4eba\u8f49\u8a3a\u7db2\u7d61\u7684\u57fa\u5730\u91ab\u9662\uff0c\u4ee5\u78ba\u8a8d\u75c5\u4eba\u53ef\u63a5\u53d7 primary PCI \u6cbb\u7642\u7684\u6642\u9593\u3002 (B)A \u91ab\u9662\u6025\u8a3a\u61c9\u5118\u65e9\u8b93\u75c5\u4eba\u51fa\u767c\u524d\u5f80\u57fa\u5730\u91ab\u9662\uff0c\u6700\u597d\u80fd\u5920\u5728 30\u5206\u9418\u5167\u51fa\u767c\u3002 (C)\u82e5\u57fa\u5730\u91ab\u9662\u8a55\u4f30\u75c5\u4eba\u4e0d\u80fd\u65bc 120\u5206\u9418\u5167\u63a5\u53d7 primary PCI \u6cbb\u7642\uff0c\u61c9\u544a\u77e5 A\u91ab\u9662\u3002 (D)\u82e5\u4f86\u4e0d\u53ca\u5728 120\u5206\u9418\u5167\u9032\u884c primary PCI\uff0c\u5247 A\u91ab\u9662\u61c9\u5118\u65e9\u5c07 \u75c5\u4eba\u8f49\u5230\u57fa\u5730\u91ab\u9662\uff0c\u63a5\u53d7\u8840\u6813\u6eb6\u89e3\u5291\u6cbb\u7642\u3002 (E)\u63a5\u53d7\u8840\u6813\u6eb6\u89e3\u5291\u6cbb\u7642\uff0c\u61c9\u65bc\u5230\u9662\u5f8c 30\u5206\u9418\u5167\uff0c\u958b\u59cb\u8840\u6813\u6eb6\u89e3\u5291\u7684\u6ce8\u5c04\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "20\u6b72\u5973\u6027\uff0c\u56e0\u4e0b\u8179\u75db\u6578\u65e5\u800c\u639b\u6025\u8a3a\uff0c\u751f\u547d\u5fb5\u8c61\u6b63\u5e38\u3002\u9aa8\u76c6\u8154\u6aa2\u67e5( pelvic examination )\u767c\u73fe\u75c5\u4eba\u4e0b\u8179\u3001\u5b50\u5bae\u3001\u5169\u5074\u5b50\u5bae\u9644\u5c6c\u5668 (adnexa )\u53ca\u5b50\u5bae\u9838\u5747\u6709\u58d3\u75db\uff0c\u4e14\u9670\u9053\u6709\u7c98\u6db2\u81bf\u6027\u5206\u6ccc\u7269\u3002\u5c3f\u6db2\u61f7\u5b55\u6e2c\u8a66\u9670\u6027\uff0c\u5c3f\u6db2\u5206\u6790\u7121\u7279\u6b8a\u767c\u73fe\u3002\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5148\u6392 \u96fb\u8166\u65b7\u5c64 \u78ba\u8a3a\u9aa8\u76c6\u8154\u767c\u708e\u5f8c\u518d\u6cbb\u7642\u3002 (B)\u5148\u5b89\u6392\u9670\u9053\u8d85\u97f3\u6ce2\u78ba\u8a3a\u9aa8\u76c6\u8154\u767c\u708e\u5f8c\u518d\u6cbb\u7642\u3002 (C)\u62bd\u8840\u9a57 Procalcitonin\uff0c\u82e5\u6578\u503c\uff1c0.5 ng/mL \uff0c\u5247\u4e0d\u9700\u4f7f\u7528\u6297\u751f\u7d20\u3002 (D)\u7b49\u5f85\u5b50\u5bae\u9838\u57f9\u990a\u5831\u544a\uff0c\u518d\u6c7a\u5b9a\u6700\u6709\u6548\u7684\u6cbb\u7642\u65b9\u5f0f\u3002 (E)\u76f4\u63a5\u6295\u4ee5\u6297\u751f\u7d20\u6cbb\u7642\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "26\u6b72\u7537\u6027\u7531 EMT\u8207\u8b66\u65b9\u6212\u8b77\u9001\u5165\u6025\u8a3a\uff0c\u56db\u80a2\u88ab\u7d04\u675f\u5728\u64d4\u67b6\u5e8a\u4e0a\u3002\u6839\u64da\u5bb6\u4eba\u63cf\u8ff0\uff0c\u4ed6\u5df2\u7d93\u4e94\u3001\u516d\u5929\u6c92\u7761\uff0c\u6574\u5929\u5ff5\u5ff5\u6709\u8a5e\u3002\u4eca\u5929\u8ddf\u5bb6\u4eba\u8d77\u885d\u7a81\u4e14\u6709\u66b4\u529b\u884c\u70ba\u3002\u770b\u5230\u75c5\u4eba\u6642\uff0c\u4ecd\u7136\u60c5\u7dd2\u6fc0\u52d5\uff0c\u4e0d\u65b7\u5730\u5927\u8072\u5486\u54ee\u8aaa\u8981\u8ddf\u8b66\u5bdf\u55ae\u6311\uff0c\u4e26\u4e14\u4e0d\u505c\u5730\u626d\u52d5\u60f3\u8981\u6399\u812b\u7d04\u675f\uff0c\u751a\u81f3\u64d4\u67b6\u5e8a\u9084\u8981 EMT\u6276\u4f4f\u624d\u80fd\u7a69\u5b9a\u3002\u4f60\u662f\u8ca0\u8cac\u770b\u8a3a\u7684\u91ab\u5e2b\uff0c\u76ee\u524d\u6700\u5408\u7406 \u7684\u4e0b\u4e00\u6b65\u662f\u4ec0\u9ebc\uff1f", + "Options": "(A)\u7d66\u4e88\u53e3\u670d olanzapine FC 5 mg(\u819c\u8863\u9320) \u3002 (B)\u70ba\u4e86\u5feb\u901f\u58d3\u5236\u75c7\u72c0\u4fdd\u8b77\u75c5\u4eba\u8207\u91ab\u8b77\uff0c\u61c9\u975c\u8108\u6ce8\u5c04 lorazepam 2 mg \u8207haloperidol 5 mg\u3002 (C)\u75c5\u4eba\u76ee\u524d\u7684\u75c7\u72c0\u8207\u63a5\u8457\u662f\u5426\u80fd\u5920\u5f37\u5236\u4f4f\u9662\u6709\u95dc\uff0c\u4e0d\u53ef\u4ee5\u7d66\u85e5\uff0c\u4ee5\u514d\u7cbe\u795e\u79d1\u7167\u6703\u91ab\u5e2b\u7121\u6cd5\u638c\u63e1\u8b49\u64da\u3002 (D)\u808c\u8089\u6ce8\u5c04 olanzapine 5 mg\u3002 (E)\u808c\u8089\u6ce8\u5c04 ketamine 5 mg \u8b93\u75c5\u4eba\u66ab\u6642\u9032\u5165\u89e3\u96e2\u72c0\u614b\uff0c\u4f46\u8981\u76e3\u6e2c\u547c\u5438\u72c0\u6cc1\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u95dc\u65bc\u74e3\u819c\u6027\u5fc3\u81df\u75c5( valvular heart disease )\u7684\u6558\u8ff0\uff0c\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u4f11\u606f\u6642\u6709\u75c7\u72c0\uff0c\u4e14\u767c\u73fe\u6709\u8212\u5f35\u671f\u96dc\u97f3(diastolic murmur) \uff0c\u5373\u4f7f\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\uff0c\u5efa\u8b70\u7dca\u6025\u9032\u884c\u5fc3\u81df\u8d85\u97f3\u6ce2\u6aa2\u67e5\u3002 (B)\u82e5\u6b64\u75c5\u4eba\u51fa\u73fe\u660f\u53a5(syncope ) \uff0c\u9700\u9451\u5225\u662f\u5426\u70ba\u4e3b\u52d5\u8108\u74e3\u72f9\u7a84(aortic stenosis) \uff0c\u5efa\u8b70\u4f4f\u9662\u89c0\u5bdf\u4e26\u5b89\u6392\u5fc3\u81df\u8d85\u97f3\u6ce2\u6aa2\u67e5\u3002 (C)\u82e5\u80f8\u90e8 X\u5149\u986f\u793a\u5fc3\u81df\u5927\u5c0f\u6b63\u5e38\uff0c\u4f46\u51fa\u73fe\u56b4\u91cd\u80ba\u6c34\u816b\uff0c\u9700\u9451\u5225\u662f\u5426\u70ba\u6025\u6027\u4e8c\u5c16\u74e3\u9006\u6d41(acute mitral regurgitation )\u3002 (D)\u4e3b\u52d5\u8108\u74e3\u72f9\u7a84\u7684\u5178\u578b\u75c7\u72c0\u662f\u5598\u3001\u80f8\u75db\u3001\u6688\u53a5\u3002\u4f46\u662f\u8a31\u591a\u56b4\u91cd\u4e3b\u52d5\u8108\u74e3\u72f9\u7a84\u7684\u75c5\u4eba\u662f\u6c92\u6709\u75c7\u72c0\u7684\u3002 (E)\u82e5\u8a3a\u65b7\u70ba\u4e3b\u52d5\u8108\u525d\u96e2\u5408\u4f75\u6025\u6027\u4e3b\u52d5\u8108\u74e3\u9006\u6d41(acute aortic regurgitation )\uff0c\u5efa\u8b70\u4f7f\u7528 \u03b2-blocker\u6cbb\u7642\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u75c5\u4eba\u7684\u884c\u70ba\u75c7\u72c0\u6558\u8ff0\u4f55\u8005\u8f03\u7b26\u5408 functional (Psychiatric )psychosis \uff1f", + "Options": "(A)\u5e74\u9f61\u5927\u65bc 40\u6b72\uff0c\u6709\u9157\u9152\u7fd2\u6163\uff0c\u6709\u6642\u6613\u6012\u884c\u70ba\u7570\u5e38\uff0c\u6709\u6642\u53c8\u6b63\u5e38\u3002 (B)\u5076\u6709\u5e7b\u8996\uff0c\u55dc\u7761\uff0c\u5e38\u5e38\u4e0d\u77e5\u9053\u6642\u9593\uff0c\u5730\u9ede\u4e5f\u4e0d\u8a8d\u8b58\u4eba\u3002 (C)\u7a81\u7136\u51fa\u73fe\u7684\u610f\u8b58\u6a21\u7cca\uff0c\u7121\u6cd5\u8aaa\u8a71\uff0c\u53ea\u80fd\u767c\u51fa\u8072\u97f3\uff0c\u624b\u8173\u7121\u529b\u3002 (D)\u7121\u6cd5\u505a\u7c21\u55ae\u7684\u8a08\u7b97\uff0c\u8fd1\u671f\u8a18\u61b6\u5dee\uff0c\u4f46\u9060\u671f\u8a18\u61b6\u9084\u597d\uff0c\u7121\u6cd5\u81ea\u5df1\u9032\u98df\u3002 (E)\u5984\u60f3\uff0c\u8868\u60c5\u5e73\u6de1\uff0c\u8a9e\u7121\u502b\u6b21\uff0c\u5e7b\u807d\uff0c\u5076\u800c\u7dad\u6301\u50f5\u76f4\u59ff\u52e2\u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "35\u6b72\u7537\u6027\u75c5\u4eba\u4e3b\u8a34\u5728\u4f11\u606f\u7684\u6642\u5019\u7a81\u7136\u6d41\u9f3b\u8840\uff0c\u6aa2\u67e5\u767c\u73fe\u53f3\u5074\u9f3b\u5b54\u6301\u7e8c\u6d41\u8840\uff0c\u8acb\u554f\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u4f7f\u7528\u9f3b\u6490\u958b\u5f35\u5668(nasal speculum )\u6aa2\u67e5\u9f3b\u5b54\u6642\uff0c\u5fc5\u9808\u6c34\u5e73\u6490\u958b\uff0c\u9019\u6a23\u624d\u80fd\u6aa2\u8996\u9f3b\u4e2d\u8188\u3002 (B)\u524d\u5074\u6d41\u9f3b\u8840(anterior epistaxis)\u6700\u5e38\u767c\u751f\u7684\u4f4d\u7f6e\u662f\u4e0b\u9f3b\u7532(inferior nasal concha )\u3002 (C)\u6301\u7e8c\u51fa\u8840\u6642\uff0c\u4f7f\u7528 silver nitrate \u5316\u5b78\u71d2\u707c\u662f\u6bd4\u8f03\u597d\u7684\u6b62\u8840\u65b9\u5f0f\u3002 (D)\u5982\u679c\u7528 nasal packing \uff0c\u5fc5\u9808\u958b\u7acb\u6297\u751f\u7d20\uff0c\u4ee5\u9810\u9632 toxic shock syndrome \u3002 (E)\u6d41 \u9f3b\u8840\u7684\u75c5\u4eba\u53ef\u4ee5\u8003\u616e\u6ce8\u5c04 tranexamic acid \u3002", + "Answer": "E" + }, + { + "\ufeffQuestion": "50\u6b72\u7537\u6027\u5230\u9662\u524d\u5fc3\u81df\u505c\u6b62\uff0c\u9001\u81f3\u6025\u8a3a\u7d93\u5fc3\u80ba\u5fa9\u7526\u8655\u7f6e \u5f8c\u56de\u5fa9\u81ea\u767c\u6027\u5faa\u74b0(return of spontaneous circulation, ROSC) \uff0c\u7576\u4e0b\u8a55\u4f30\u53ca\u76ee\u6a19\u9ad4\u6eab\u63a7\u5236(targeted temperature management, TTM)\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)TTM \u671f\u9593\u53ef\u80fd\u5f15\u8d77\u9ad8\u8840\u9240\u3001\u51dd\u8840\u529f\u80fd\u589e\u5f37\u3001\u5168\u8eab\u986b\u6296\u7b49\u526f\u4f5c\u7528\u3002 (B)TTM \u53ef\u4ee5\u540c\u6642\u63d0\u6607\u5b58\u6d3b\u7387\u53ca\u795e\u7d93\u529f\u80fd\u7d50\u679c\u3002 (C)\u75c5\u4eba\u82e5\u610f\u8b58\u6e05\u695a\uff0c\u53ef\u4ee5\u7d66\u4e88\u93ae\u5b9a\u85e5\u7269\u5f8c\u518d\u57f7\u884c TTM\u3002 (D)\u8166\u90e8\u50b7\u5bb3\u53ca\u6c34\u816b\uff0c\u5728 ROSC\u5f8c\u6703\u505c\u6b62\u60e1\u5316\u3002 (E)\u81e8\u5e8a\u795e\u7d93\u5b78\u53cd\u5c04\u7684\u7f3a\u640d\u6216\u4e0d\u6b63\u5e38\uff0c\u53ef\u4ee5\u9810\u6e2c\u7d50\u679c\u4e0d\u4f73\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u61f7\u5b55 32\u9031\u5a66\u5973\u9a0e\u6a5f\u8eca\u81ea\u6454\u3002\u75c5\u4eba\u610f\u8b58\u6e05\u695a\uff0c\u5fc3\u8df3 100\u6b21/min\uff0c\u8840\u58d3 120/80 mmHg\uff0c\u547c\u5438 18\u6b21/min\uff0c\u56db\u80a2\u591a\u8655\u64e6\u50b7\uff0c\u8179\u90e8\u7121\u660e\u986f\u5916\u50b7\u4f46\u6709\u7dca\u7e43\u611f\u3002\u8179\u90e8\u8d85\u97f3\u6ce2\u986f\u793a\u7121\u8179\u5167\u51fa\u8840\uff0c\u80ce\u5152\u5fc3\u8df3\u7d04 140\u6b21/min\u3002\u95dc\u65bc\u6b64\u61f7\u5b55\u75c5\u4eba\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u9700\u7acb\u5373\u4f4f\u9662\u5b89\u6392\u5256\u8179\u751f\u7522\u3002 (B)\u5373\u4f7f\u7121\u660e\u986f\u8179\u90e8\u50b7\u5bb3\uff0c\u4ecd\u5efa\u8b70\u4f7f\u7528 tocodynamometry \u89c0\u5bdf 2\u5c0f\u6642\u518d\u51fa\u9662\u3002 (C)\u75c5\u4eba\u8840\u578b\u70ba Rh\u9670\u6027\uff0c\u7d66\u4e88 Rho(D)\u514d\u75ab\u7403\u86cb\u767d\u53ef\u907f\u514d\u5b50\u7672\u524d\u75c7(pre- eclampsia )\u767c\u751f\u3002 (D)\u6ce8\u5c04\u7834\u50b7\u98a8\u985e\u6bd2\u7d20(Tetanus toxoid )\u7522\u751f\u7684\u6297\u9ad4\u53ef\u901a\u904e\u80ce\u76e4\uff0c\u6e1b\u5c11\u65b0\u751f\u5152\u7834\u50b7\u98a8\u7684\u53ef\u80fd\u3002 (E)\u82e5\u9670\u9053\u5206\u6ccc\u6db2\u9ad4\u589e\u52a0\uff0c\u4e14 pH\u7b49\u65bc 5\uff0c\u9700\u9ad8\u5ea6\u61f7\u7591\u7f8a\u819c\u7834\u88c2 (amniotic membrane rupture )\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e00\u5834\u706b\u707d\u610f\u5916\u4e2d\uff0c\u82e5\u8981\u4f9d\u64da\u7c21\u6613\u6aa2\u50b7\u53ca\u5feb\u901f\u6cbb\u7642\u6cd5\u5247( simple triage and rapid treatment, START) \uff0c\u4ee5\u4e0b\u60c5\u5883\u7684\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u56db\u6b72\u5973\u7ae5\u5de6\u817f\u8b8a\u5f62\uff0c\u4e0d\u65b7\u653e\u8072\u54ed\u558a\u5c0b\u627e\u6bcd\u89aa\uff0c\u6aa2\u50b7\u70ba\u7da0\u8272\u3002 (B)\u5e74\u7d04\u516d\u5341\u6b72\u7537\u6027\uff0c\u53e3\u9f3b\u7686\u78b3\u7c92\uff0c\u6253\u958b\u547c\u5438\u9053\u5f8c\u4ecd\u7121\u547c\u5438\uff0c\u6aa2\u50b7\u70ba\u7d05\u8272\u3002 (C)\u5f9e\u6a13\u68af\u9593\u88ab\u6551\u51fa\u7684\u5e74\u8f15\u5973\u6027\uff0c\u50c5\u984d\u982d\u64e6\u50b7\u7834\u76ae\uff0c\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\uff0c\u78ba\u8a8d\u8eab\u4efd\u6642\u7b54\u975e\u6240\u554f\uff0c\u7121\u6cd5\u9075\u5f9e\u7c21\u55ae\u6307\u4ee4\uff0c\u6aa2\u50b7\u70ba\u7d05\u8272\u3002 (D)\u4e09\u5341\u591a\u6b72\u5973\u6027\uff0c\u56db\u80a2\u5927\u9762\u7a4d\u71d2\u50b7\uff0c\u7126\u6025\u5954\u8dd1\u547c\u558a\u5973\u5152\uff0c\u6aa2\u50b7\u70ba\u9ec3\u8272\u3002 (E)\u4e2d\u5e74\u7537\u6027\u5012\u81e5\u5730\u9762\uff0c\u6478\u4e0d\u5230\u56db\u80a2\u8108\u640f\uff0c\u547c\u5438\u6dfa\u5feb\uff0c\u6aa2\u50b7\u70ba\u9ec3\u8272\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4ee5\u4e0b\u54ea\u4e00\u7a2e\u7269\u8cea\u7684\u4e2d\u6bd2\u6a5f\u8f49\u63cf\u8ff0\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u6cb3\u8c5a\u4e2d\u6bd2\uff1a\u53ef\u589e\u52a0\u795e\u7d93\u8ef8\u7a81\u53ca\u808c\u8089\u7d30\u80de\u5c0d\u9209\u96e2\u5b50\u7684\u901a\u900f\u6027\uff0c\u9032\u800c\u6539\u8b8a\u7d30\u80de\u5167\u5916\u96e2\u5b50\u7684\u5e73\u8861\u3002 (B)\u6709\u6a5f\u78f7\u4e2d\u6bd2\uff1a\u4e3b\u8981\u548c\u5176\u6240\u542b\u7684\u8868\u9762\u64f4\u5f35\u5291 POEA(polyoxyethylene -amine)\u6709\u95dc\u3002 (C)\u5f37\u9178\uff1a\u7522\u751f\u66b4\u9732\u90e8\u4f4d\u7684\u6db2\u614b\u5316\u58de\u6b7b(liquefaction necrosis) \uff0c\u53ef\u7834\u58de\u8840\u7ba1\u3001\u7d30\u80de\u3001\u76ae\u4e0b\u7d44\u7e54\uff0c\u5c0e\u81f4\u6df1\u5c64\u7684\u7d44\u7e54\u7834\u58de\u3002 (D)\u6c30\u5316\u7269\u4e2d\u6bd2\uff0c\u70ba\u6c30\u6839\u96e2\u5b50\u8207\u7c92\u7dda\u9ad4\u7d30\u80de\u8272\u7d20\u6c27\u5316\u9176(cytochrome oxidase aa3)\u7684\u4e09\u50f9\u9435\u96e2\u5b50\u7d50\u5408\uff0c\u4f7f\u5176\u5931\u53bb\u529f\u80fd\uff0c\u6291\u5236\u7d44\u7e54\u5c0d\u6c27\u7684\u904b\u7528\uff0c\u9020\u6210\u7d30\u80de\u5167\u7f3a\u6c27\uff0c\u5f15\u8d77\u4ee3\u8b1d\u6027\u9178\u4e2d\u6bd2\u3002 (E)\u73ca\u745a\u7901\u9b5a \u6bd2\u7d20\u4e2d\u6bd2\uff1a\u53ef\u6291\u5236\u7d30\u80de\u819c\u4e0a\u5c0d\u9209\u96e2\u5b50\u7684\u901a\u900f\u6027\uff0c\u4e5f\u53ef\u6291\u5236\u4e2d\u6a1e\u6216\u795e\u7d93\u7bc0\u4e0a\u4e4b\u81bd\u9e7c\u63a5\u6536\u5668(cholinergic receptor )\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "9\u500b\u6708\u5973\u7ae5\uff0c\u9ad4\u91cd 10\u516c\u65a4\uff0c\u4e3b\u8a34\u516d\u5c0f\u6642\u524d\u958b\u59cb\u6ce8\u610f\u5230\u5c0f\u5b69\u6709\u9663\u767c\u6027\u8179\u75db\u53ca\u54ed\u9b27\u4e0d\u5b89\uff0c\u5973\u7ae5\u5728\u6aa2\u50b7\u7ad9\u5614\u5410\u4e00\u6b21\uff0c\u5bb6\u5c6c\u6253\u958b\u5c3f\u5e03\u4e26\u7121\u767c\u73fe\u6709\u8840\u7d72\u4fbf\u60c5\u5f62\uff0c\u4e0b\u5217\u8a3a\u65b7\u8f03\u4e0d\u53ef\u80fd \uff1f", + "Options": "(A)Midgut volvulus\u3002 (B)Pyloric stenosis \u3002 (C)Intussusception \u3002 (D)Incarcerated hernia \u3002 (E)Vir al enterocolitis\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u9031\u908a\u6027\u7729\u6688( peripheral vertigo )\u548c\u4e2d\u6a1e\u6027\u7729\u6688( central vertigo )\uff0c \u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u9031\u908a\u6027\u7729 \u6688\u4e00\u822c\u6301\u7e8c\u6642\u9593\u8f03\u77ed\uff0c\u800c\u4e2d\u6a1e\u6027\u7684\u75c7 \u72c0\u53ef\u80fd\u9577\u9054 \u6578\u9031\u81f3\u6578\u6708\u3002 (B)\u9031\u908a\u6027\u7729 \u6688\u7684\u75c7\u72c0\u6bd4\u8f03\u6703\u53d7\u982d\u90e8\u59ff\u52e2\u5f71\u97ff\uff0c\u800c\u4e2d\u6a1e\u6027\u8f03\u5c11\u3002 (C)Horizontal head impulse test \u5728\u9031\u908a\u6027\u7729\u6688\u7684\u75c5\u4eba\u8eab\u4e0a\u6703\u51fa\u73fe\u7570\u5e38\u53cd\u61c9\u3002 (D)\u773c\u9707\u5728\u9031\u908a\u6027\u7729\u6688\u901a\u5e38\u662f direction -changing horizontal nystagmus\uff0c\u800c\u5728\u4e2d\u6a1e\u6027\u7729\u6688 \u5247\u53ef\u80fd\u70ba\u6c34\u5e73\u3001\u74b0\u578b\u6216\u5782\u76f4\u3002 (E)\u7729\u6688\u5408\u4f75\u807d\u529b\u55aa\u5931(hearing loss)\u6216\u8033\u9cf4(tinnitus)\u6bd4\u8f03\u50cf\u662f\u9031\u908a\u6027\u7729\u6688\uff0c\u800c\u51fa\u73fe \u982d\u75db\u6216\u9838\u90e8\u75bc\u75db\u5247\u9808\u8003\u616e\u4e2d\u6a1e\u6027\u7729\u6688\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u4f55\u7a2e\u75c5\u4eba\u8f03\u5e38\u767c\u751f \u975e\u5178\u578b\u80f8\u75db( non-classic chest pain )\uff1f", + "Options": "(A)\u4e2d\u5e74\u7537\u6027\u3002 (B)\u9ad8\u8840\u58d3\u3002 (C)\u9ad8\u8840\u8102\u3002 (D)\u7cbe\u795e\u75be\u75c5\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "57\u6b72\u5973\u6027\u75c5\u4eba\u56e0\u610f\u8b58\u4e0d\u6e05\u88ab\u9001\u81f3\u6025\u8a3a\uff0c\u5bb6\u5c6c\u63d0\u53ca\u75c5\u4eba\u56e0\u9577\u671f\u95dc\u7bc0\u75bc\u75db\u800c\u670d\u7528\u96fb\u53f0\u8cfc\u8cb7\u4e4b\u4e0d\u660e\u85e5\u7269\uff0c\u4f46\u6700\u8fd1\u56e0\u8178\u80c3\u4e0d\u9069\u800c\u505c\u85e5\uff0c\u5176\u8840\u58d3 90/60mmHg \u3001\u8840\u7cd6\u503c\u70ba 65 mg/dL \u3001\u8840\u9209\u70ba 123 mEq/L\u3002\u4e0b\u5217\u54ea\u4e00\u9805\u6cbb\u7642\u8655\u7f6e\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u8170\u690e\u7a7f\u523a( lumbar puncture )\u5f8c\u7d66\u4e88\u6297\u751f\u7d20 Ceftriaxone \u3002 (B)Hydrocortisol \u3002 (C)Thyroxine \u3002 (D)3% Saline \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "28 \u6b72\u7537\u6027\u982d\u75db\u3001\u4e0b\u8179\u75db\u3001\u7d05\u773c\u7b49\u75c7\u72c0\u7d04 10\u5929\uff0c\u66fe\u53bb\u8a3a\u6240\u6aa2\u67e5\uff0c\u88ab\u544a\u77e5\u662f\u611f\u5192\u75c7\u72c0\u7a0d\u5fae\u7de9\u89e3\u5f8c\uff0c\u537b\u51fa\u73fe\u767c\u71d2\u808c\u8089\u75e0\u75db\u3001\u9ec3\u75b8\u8207\u5c11\u5c3f\u3002\u51fa\u73fe\u75c7\u72c0\u4e00\u9031\u524d\uff0c\u66fe\u7d93\u53bb\u767b\u5c71\u6578\u5929\uff0c\u5728\u6cb3\u4e2d\u6e38\u6cf3\u4e26\u751f\u98f2\u6cb3\u6c34\u3002\u6025\u8a3a\u62bd\u8840\u6aa2\u67e5\u7d50\u679c\uff1a WBC 10,600/\u00b5 L\u300170.0% PMN\u3001platelet s 100,000/ \u00b5L\u3001AST 157 IU/L\u3001 ALT 57 IU/L\u3001bilirubin 4.0 mg/dL \u3001BUN 47 mg/dL \u3001Cr 5.7 mg/dL \u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u6b64\u75c5\u4eba\u70ba\u8f15\u5fae\u578b\uff0c\u4f54 10~20%\u5927\u591a\u53ef\u4ee5\u81ea\u7652\u3002 (B)\u6b64\u75c5\u4eba\u61c9\u8a72\u8003\u616e\u8981\u901a\u5831\u7b2c\u56db\u985e\u6cd5\u5b9a\u50b3\u67d3\u75c5\uff0c\u4e26\u4e14\u7d66\u4e88\u9694\u96e2\u3002 (C)\u570b\u5167\u5df2\u6709\u6b64\u75c5\u7684\u5feb\u7be9\u6aa2\u9a57\u8a66\u5291\u4e0a\u5e02\u53ef\u4f5c\u70ba\u78ba\u8a8d\u5224\u5b9a\u3002 (D)\u5efa\u8b70\u4f7f\u7528\u975c\u8108\u6ce8\u5c04 Penicillin \u6216\u7b2c\u4e09\u4ee3 Cephalosporins \u6cbb\u7642\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "14\u6b72\u570b\u4e2d\u751f\u5728\u53f3\u5927\u817f\u9aa8\u9aa8\u6298\u5f8c\u5169\u5929\u767c\u751f\u6025\u6027\u547c\u5438\u5598\u53ca\u610f\u8b58\u6539\u8b8a\uff0c\u75c5\u4eba\u80f8\u524d\u51fa\u73fe\u6578\u500b\u5c0f\u7600\u9ede(p etechiae) \u3002\u751f\u547d\u5fb5\u8c61\u70ba\u8840\u58d3 95/45mmHg\uff0c\u5fc3\u8df3 130\u6b21/min\uff0c\u547c\u5438 36\u6b21/min\uff0c\u9ad4\u6eab 38.6\u00b0C\uff0c\u5728\u7d66 100%\u6c27\u6c23\u9762\u7f69\u4e0b SpO 2 80%\u3002\u4e0b\u5217\u4f55\u7a2e\u6cbb\u7642\u61c9\u8a72 \u512a\u5148\u7d66\u4e88 \uff1f", + "Options": "(A)1L \u751f\u7406\u98df\u9e7d\u6c34 fluid bolus\u3002 (B)\u809d\u7d20( Heparin)bolus \u5291\u91cf 80 Units/kg \u3002 (C)\u8102\u80aa\u4e73\u5291\u975c\u8108\u6ce8\u5c04(intravenous lipid emulsion )\u3002 (D)\u4ee5 rapid sequence intubation \u9032\u884c\u6c23\u7ba1\u5167\u7ba1\u63d2\u7ba1\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "75\u6b72\u7684\u5b89\u990a\u4e2d\u5fc3\u4f4f\u6c11\uff0c\u4e3b\u8a34\u767c\u71d2\uff0c\u54b3\u55fd\uff0c\u547c\u5438 \u5598\u4fc3\u88ab\u9001\u81f3\u6025\u8a3a\u5c31\u91ab\uff0c\u80f8\u90e8X\u5149\u61f7\u7591\u5de6\u5074\u80ba\u81bf\u760d(lung abscess )\u5408\u4f75\u808b\u819c\u7a4d\u6db2\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u80ba\u81bf\u760d\u591a\u5728 basal segments of lower lobes or posterior segment of upper lobes \u3002 (B)\u80ba\u81bf\u760d\u82e5\u540c\u6642\u51fa\u73fe\u5728\u591a\u8655\u80ba\u8449\u61c9\u61f7\u7591\u5fc3\u5167\u819c\u708e\u6216 Lemierre\u2019s syndrome \u3002 (C)\u5c0d\u65bc\u6b64\u75c5\u4eba\u9078\u64c7\u4f7f\u7528 Piperacillin -tazoba ctam\u662f\u5408\u7406\u7684\u7d93\u9a57\u6027\u7528\u85e5\u3002 (D)\u81bf\u80f8( empyema )\u7684\u767c\u5c55\u5982\u679c\u53ea\u5728\u7b2c\u4e00\u968e\u6bb5\u7684 exudative stage \uff0c\u9084\u672a\u767c\u5c55\u6210 fibrinopurulent stage \uff0c\u9069\u7576\u7684\u6297\u751f\u7d20\u6cbb\u7642\u662f\u5f88\u91cd\u8981\u7684\uff0c\u901a\u5e38\u4e0d\u9700\u8981\u80f8\u7ba1\u5f15\u6d41\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6a6b\u9694\u819c\u50b7\u5bb3( diaphragmatic injury ) \uff0c\u4e0b\u5217\u63cf\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u901a\u5e38\u53f3\u5074\u6bd4\u5de6\u5074\u591a\u3002 (B)\u8f03\u5e38\u51fa\u73fe\u5728\u80f8\u8179\u90e8\u7684\u7a7f\u523a\u50b7\u3002 (C)\u5c0d\u751f\u547d\u5fb5\u8c61\u7684\u5371\u5bb3\u4e3b\u8981\u662f\u9020\u6210\u51fa\u8840\u6027\u4f11\u514b\u3002 (D)\u5c0d \u8f15\u5fae\u7684\u6a6b\u9694\u819c\u50b7\u5bb3\uff0c\u7528\u96fb\u8166\u65b7\u5c64\u6383\u63cf(CT scan )\u7684\u8a3a\u65b7\u7387\u5f88\u9ad8\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u6709\u95dc\u7cd6\u5c3f\u75c5\u916e\u9178\u4e2d\u6bd2( diabetic ketoacidosis , DKA)\u8207\u9ad8\u8840\u7cd6\u9ad8\u6ef2\u900f\u58d3\u72c0\u614b(h yperosmolar hyperglycemic state , HHS)\u7684\u6558\u8ff0\uff0c\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5169\u8005\u6cbb\u7642\u4e0a\u7686\u9996\u91cd\u8f38\u6db2\u5fa9\u7526\u3002 (B)\u5169\u8005\u7686\u6703\u56e0\u8840\u4e2d\u916e\u9ad4(blood ketones)\u5347\u9ad8\u7522\u751f\u56b4\u91cd\u9178\u8840\u75c7\u3002 (C)DKA \u7684\u8840\u7cd6\u503c\u5e38\u6bd4 HHS\u9ad8\u3002 (D)DKA \u5e38\u898b\u65bc\u8001\u5e74\u4eba\uff0c\u800c HHS\u5247\u5e38\u898b\u65bc\u5e74\u8f15\u4eba\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u9871\u984f\u90e8\u4f4d\u7684\u795e\u7d93\u9ebb\u75fa\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u540c\u6642\u51fa\u73fe\u773c\u77bc\u4e0b\u5782\u548c\u77b3\u5b54\u7e2e\u5c0f\u53ca\u8116\u5b50\u75bc\u75db\u9700\u8003\u616e\u690e\u52d5\u8108\u525d\u96e2\u3002 (B)\u53d7\u5230\u8840\u7ba1\u7624\u58d3\u8feb\u5f15\u8d77\u7684\u7b2c\u4e09\u5c0d\u8166\u795e\u7d93\u9ebb\u75fa\uff0c\u77b3\u5b54\u5448\u73fe\u7e2e\u5c0f\u3002 (C)\u9ad8\u8840\u58d3\u548c\u7cd6\u5c3f\u75c5\u5f15\u767c\u7684\u7b2c\u4e09\u5c0d\u8166\u795e\u7d93\u9ebb\u75fa\uff0c\u77b3\u5b54\u5927\u5c0f\u4e0d\u53d7\u5f71\u97ff\u3002 (D)\u984f\u9762\u795e\u7d93\u5408\u4f75\u540c\u5074\u7b2c\u516d\u5c0d\u8166\u795e\u7d93\u9ebb\u75fa\u6642\u61c9\u5148\u8003\u616e\u75c5\u6bd2\u611f\u67d3\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5c0f\u5152\u8178\u5957\u758a\uff0c\u4e0b\u5217\u654d\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5927\u90e8\u5206\u8178\u5957\u758a\u7684\u985e\u578b\u662f\u7d50\u8178\u5957\u5165\u53e6\u4e00\u7aef\u7684\u7d50\u8178\u3002 (B)\u5927\u90e8\u5206\u5152\u7ae5\u8178\u5957\u758a\u53ef\u4ee5\u627e\u51fa\u78ba\u5207\u4e4b\u75c5\u56e0\uff0c\u5982 Meckel \u6c0f\u61a9\u5ba4\uff0cintestinal polyps \uff0ccongenital duplications\uff0clymphoma and Henoch \u2013Sch\u00f6nlein purpura \u7b49\u3002 (C)\u8179\u90e8\u96fb\u8166\u65b7\u5c64\u6383\u63cf\u662f\u5e38\u898b\u4e4b\u8a3a\u65b7\u5de5\u5177\u3002 (D)\u82e5\u5152\u7ae5\u5448\u73fe\u8179\u819c\u708e\u6216\u4f11\u514b\u7684\u81e8\u5e8a\u75c7\u72c0\uff0c\u61c9\u907f\u514d air-contrast enema reduction\uff0c\u53ef\u8003\u616e\u76f4\u63a5\u624b\u8853\u6cbb\u7642\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u95dc\u65bc\u5916\u50b7\u75c5\u4eba\u51fa\u8840\u6027\u4f11\u514b\u7684\u8655\u7f6e\u63cf\u8ff0\uff0c\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u96d9\u5074\u9ad6\u9aa8\u9aa8\u6298\u4f75\u4f4e\u8840\u58d3\u60a3\u8005\uff0c\u61c9\u5148\u4ee5\u6676\u8cea\u6eb6\u6db2(crystalloid fluid )\u8f38\u6db2\uff0c\u76ee\u6a19\u662f\u8b93\u75c5\u4eba\u8840\u58d3\u6062\u5fa9\u6b63\u5e38\u3002 (B)\u5c0d\u65bc\u5916\u50b7\u75c5\u4eba\u800c\u8a00\uff0c\u76e1\u5feb\u4e14\u8db3\u5920\u7684\u8f38\u6db2\u6cbb\u7642\u9060\u6bd4\u63a7\u5236\u51fa\u8840\u4f86\u5f97\u91cd\u8981\u3002 (C)3\u5c0f\u6642\u5167\u7d66\u4e88 Tranexamic acid \u53ef\u4ee5\u6539\u5584\u5916\u50b7\u75c5\u4eba\u7684\u5b58\u6d3b\u7387\u3002 (D)\u5927\u91cf\u8f38\u8840( massive transfusion )\u7684\u5b9a\u7fa9\u662f 24\u5c0f\u6642\u5167\u8f38\u6ce8\u8d85\u904e 10\u55ae\u4f4d\u7684\u7d05\u8840\u7403\u53ca\u8840\u6f3f\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u7cfb\u7d71\u6027\u7d05\u6591\u6027\u72fc\u7621( systemic lupus erythematosus, SLE )\u7684\u81e8\u5e8a\u8868\u73fe\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u9020\u6210\u51a0\u72c0\u52d5\u8108\u75be\u75c5\u53ca\u975c\u8108\u6813\u585e\u7684\u98a8\u96aa\u4e0a\u5347\u3002 (B)C \u53cd\u61c9\u86cb\u767d(CRP )\u4e0a\u5347\u61c9\u512a\u5148\u8003\u616e\u611f\u67d3\u800c\u975e\u75be\u75c5\u6d3b\u6027\u3002 (C)\u55ae\u7368\u51dd\u8840\u9176\u539f\u6642\u9593(PT )\u4e0a\u5347\u61c9\u8003\u616e\u75c5\u4eba\u6709\u6297\u78f7\u8102\u8cea\u6297\u9ad4\u3002 (D)\u6240\u6709\u5668\u5b98\u7cfb\u7d71\u7686\u6703\u53d7\u5230\u8a72\u75be\u75c5\u7684\u5f71\u97ff\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "12\u6b72\u5973\u6027\uff0c\u8dcc\u5012\u5f8c\u53f3\u624b\u8098\u812b\u81fc\uff0c\u7121\u6cd5\u5916\u5c55( abduct)\u624b\u6307\uff0c\u5c0f\u6307\u982d\u638c\u9762\u9ebb\u6728\uff0c\u8acb\u554f\u662f\u4e0b\u5217\u54ea\u689d\u795e\u7d93\u53d7\u640d\uff1f", + "Options": "(A)Median nerve \u3002 (B)M usculocutaneous nerve \u3002 (C)Radial nerve \u3002 (D)U lnar nerve \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "40\u6b72\u5973\u6027\uff0c\u88ab\u5200\u523a \u5165\u5de6\u5f8c\u8170\u90e8\uff0c\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\uff0c\u4e0b\u5217\u95dc\u65bc\u5f8c\u7e8c\u8655\u7f6e\u7684\u6558\u8ff0\u4f55\u8005\u8f03\u512a\u5148\u4e14 \u9069\u7576\uff1f", + "Options": "(A)\u61c9\u8a72\u9032\u884c\u6709\u986f\u5f71\u5291\u7684\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u3002 (B)\u5728\u9069\u7576\u5149\u6e90\u53ca\u5c40\u90e8\u9ebb\u9189\u4e0b\u53ef\u63a2\u67e5\u50b7\u53e3\uff0c\u8a55\u4f30\u53d7\u50b7\u60c5\u5f62\u3002 (C)\u5982\u679c FAST\u70ba\u9670\u6027\uff0c\u75c5\u4eba\u61c9\u8a72\u5c31\u6c92\u6709\u56b4\u91cd\u7684\u50b7\u5bb3\u3002 (D)\u75c5\u4eba\u61c9\u8a72\u4f4f\u9662\u8ffd\u8e64\u8840\u7d05\u7d20\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u91dd\u5c0d\u4f11\u514b\u75c5\u4eba\uff0c\u9650\u5236\u8f38\u6db2\u7d66\u4e88\u7684\u80ba\u90e8\u8d85\u97f3\u6ce2\u6383\u63cf( FALLS protocol )\uff0c \u9010 \u6b65\u6392\u9664\u8a3a\u65b7\u5404\u985e\u578b\u4f11\u514b\uff0c\u4e0b\u5217\u4f55\u8005\u7b2c\u4e00\u512a\u5148 \uff1f", + "Options": "(A)\u963b\u585e\u6027\u4f11\u514b\u3002 (B)\u5fc3\u56e0\u6027\u4f11\u514b\u3002 (C)\u4f4e\u8840\u5bb9\u6027\u4f11\u514b\u3002 (D)\u5206\u4f48\u6027\u4f11\u514b\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "56\u6b72\u7537\u6027\u53cd\u8986\u6688\u53a5( syncope)\u81f3\u6025\u8a3a\uff0c\u88ab\u8a3a\u65b7\u70ba\u9396\u9aa8\u4e0b\u52d5\u8108\u7aca\u8840\u75c7\u5019\u7fa4(subclavian steal syndrome ) \uff0c\u4e0b\u5217\u63cf\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u6b64\u75c5\u7076\u5c6c\u65bc\u795e\u7d93\u6027\u6688\u53a5 (neurologic syncope ) (B)\u6b64\u75c5\u7076\u6bd4\u8f03\u5e38\u767c\u751f\u5728\u53f3\u4e0a\u80a2\u3002 (C)\u6b64\u75c5\u7076\u6703\u5c0e\u81f4\u77ed\u66ab\u5927\u8166\u524d\u984d\u7f3a\u8840\u7684\u60c5\u6cc1\u3002 (D)\u60a3\u5074\u7684\u8840\u58d3\u901a\u5e38\u6703\u6bd4\u8f03\u9ad8\uff0c\u53d7\u5f71\u97ff\u5074\u7684\u4e0a\u80a2\uff0c\u8108\u640f\u6478\u8d77\u4f86\u8f03\u5f37\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "8\u6b72\u7537\u7ae5\u56e0\u767c\u71d2 2\u5929\uff0c\u65bc 30\u5206\u9418\u5167\u62bd\u6410 \u767c\u4f5c\u4e8c\u6b21\u9001\u81f3\u6025\u8a3a\uff0c\u5230\u6aa2\u50b7\u7ad9\u6642\u5df2\u7121\u62bd\u6410\uff0c\u8840\u58d3 70/50 mmHg \uff0c\u5be6\u9a57\u5ba4\u6aa2\u67e5\u767c\u73fe WBC 21,000/\u00b5 L\uff0c\u8840\u91a3 45mg /dL\uff0c\u8840\u9209 120 mEq/L\uff0c\u8166\u810a\u9ad3\u6db2\u6aa2\u67e5\u7ed3\u679c\u5982\u4e0b\uff1aglucose 37 mg/dL \u3001protein 300 mg/dL \uff0cWBC 1,120 /\u00b5 L\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u53ef\u80fd\u70ba\u7d30\u83cc\u6027\u8166\u819c\u708e\uff0c\u5efa\u8b70 Ampicillin \u53caGentamicin \u4f75\u7528\u3002 (B)\u5148\u77ef\u6b63\u4f4e\u8840\u91a3\u53ca\u4f4e\u8840\u9209\uff0c\u518d\u6cbb\u7642\u7672\u7647\u3002 (C)\u5148\u7a69\u5b9a\u751f\u547d\u5fb4\u8c61\uff0c\u518d\u8170\u690e\u7a7f\u523a\uff0c\u518d\u982d\u90e8\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u3002 (D)\u5efa\u8b70\u7d66\u4e88 Dexamethasone \u6cbb\u7642\uff0c\u964d\u4f4e\u4e2d\u6a1e\u795e\u7d93\u7cfb\u7d71\u767c\u708e\uff0c\u9700\u65bc\u6297\u751f\u7d20\u4f7f\u7528\u5f8c\u7d66\u4e88\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u547c\u5438\u9053\u50b3\u67d3\u6027\u75be\u75c5\uff0c\u54ea\u4e00\u7a2e\u75be\u75c5\u662f\u6f5b\u4f0f\u671f( incubation period )\u6bd4\u6f5b\u85cf\u671f(latent period )\u4f86\u5f97\u77ed\uff1f", + "Options": "(A)\u56b4\u91cd\u7279\u6b8a\u50b3\u67d3\u6027\u80ba\u708e(Coronavirus disease 2019, COVID -19)\u3002 (B)\u5b63\u7bc0\u6027\u6d41\u611f( seasonal influenza )\u3002 (C)\u6025\u6027\u56b4\u91cd\u547c\u5438\u75c7\u5019\u7fa4(severe acute respiratory syndrome, SARS )\u3002 (D)\u9ebb\u75b9( Measles)\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6025\u6027\u8179\u75db\u75c5\u4eba\u7684\u8a3a\u65b7\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u8179\u90e8 X\u5149\u7247\u662f\u5404\u7a2e\u8179\u75db\u75c5\u56e0\u7684\u5e38\u7528\u7be9\u6aa2\u5de5\u5177\u3002 (B)\u8179\u75db\u7684\u5287\u70c8\u60c5\u6cc1\u548c\u75be\u75c5\u7684\u56b4\u91cd\u5ea6\u6210\u6b63\u6bd4\u3002 (C)\u9d09\u7247\u985e\u6b62\u75db\u85e5\u6703\u9020\u6210\u75be\u75c5\u8a3a\u65b7\u7684\u5ef6\u8aa4\u3002 (D)\u71df\u990a\u4e0d\u826f\u6703\u5f71\u97ff\u75c5\u4eba\u8179\u75db\u7684\u81e8\u5e8a\u8868\u73fe\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "1\u6b7210\u500b\u6708\u5927\u7537\u5b69\u4e3b\u8a34\u9032\u98df\u56f0\u96e3\u5408\u4f75\u54b3\u55fd\uff0c\u5bb6\u5c6c\u61f7\u7591\u53ef\u80fd\u6709\u7570\u7269\u963b\u585e\u4f46\u7121\u6cd5\u78ba\u5b9a\uff0c\u8acb\u554f\u4e0b\u5217\u8655\u7f6e\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u82e5 X\u5149\u6aa2\u67e5\u6b63\u5e38\u53ef\u6392\u9664\u98df\u9053\u7570\u7269\uff0c\u61c9\u8003\u616e\u5176\u4ed6\u8a3a\u65b7\u3002 (B)\u98df\u9053\u651d\u5f71( esophagogram )\u4e5f\u53ef\u505a\u70ba\u8a3a\u65b7\u5de5\u5177\u4e4b\u4e00\u3002 (C)\u82e5 X\u5149\u767c\u73fe\u70ba\u786c\u5e63\u963b\u585e\u65bc\u98df\u9053\u4e0a\u6bb5\uff0c\u5728\u6025\u8a3a\u53ef\u76f4\u63a5\u4f7f\u7528\u5c3f\u7ba1(Foley catheter )\u5c07\u7570\u7269\u53d6\u51fa\u3002 (D)\u82e5\u7570\u7269\u70ba\u9215\u6263\u96fb\u6c60\uff0c\u4e14\u5df2\u7d93\u541e\u98df\u8d85\u904e 2\u5c0f\u6642\uff0c\u4e00\u5b9a\u8981\u7acb\u523b\u7528\u5167\u8996\u93e1\u79fb\u9664\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "60\u6b72\u7537\u6027\uff0c 1\u5c0f\u6642\u524d\u7a81\u7136\u53f3\u5074 \u80a2\u9ad4\u7121\u529b\uff0c\u8840\u58d3 200/120 mmHg \uff0c\u8840\u6c27\u6fc3\u5ea6 95%\uff0c\u9ad4\u6eab 38.1\u2103\u3002\u96fb\u8166\u65b7\u5c64\u986f\u793a\u7121\u9871\u5167\u51fa\u8840\uff0c\u7d93\u6703\u8a3a\u795e\u7d93\u79d1\u91ab\u5e2b\u5f8c\uff0c\u8a3a\u65b7\u70ba\u6025\u6027\u7f3a\u8840\u6027\u4e2d\u98a8\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u75c5\u4eba\u82e5\u540c\u610f\u63a5\u53d7\u8840\u6813\u6eb6\u89e3\u5291\u6cbb\u7642\uff0c\u9700\u5148\u7d66\u4e88\u964d\u8840\u58d3\u85e5\u7269\uff0c\u82e5\u6536\u7e2e\u58d3\u6301\u7e8c\uff1e185mmHg \u5c31\u4e0d\u80fd\u6253\u8840\u6813\u6eb6\u89e3\u5291\u3002 (B)\u75c5\u4eba\u63a5\u53d7\u8840\u6813\u6eb6\u89e3\u5291\u6cbb\u7642\u5f8c\uff0c\u61c9\u5728 24\u5c0f\u6642\u4e4b\u5167\u7d66\u4e88 Aspirin\uff0c\u6e1b\u5c11\u77ed\u671f\u5167\u518d\u6b21\u4e2d\u98a8\u7684\u6a5f\u7387\u3002 (C)\u767c\u71d2\u70ba\u6b63\u5e38\u4e4b\u751f\u7406\u53cd\u61c9\uff0c\u4e0d\u9700\u9000\u71d2\uff0c\u4f46\u9700\u5c0b\u627e\u6709\u7121\u6f5b\u5728\u611f\u67d3\uff0c\u5fc5\u8981\u6642\u7d66\u4e88\u6297\u751f\u7d20\u3002 (D)\u61c9\u7531\u9f3b\u5c0e\u7ba1\u7d66\u4e88\u6c27\u6c23\uff0c\u7a4d\u6975\u7dad\u6301\u8840\u6c27\u6fc3\u5ea6\u5728 98%\u4ee5\u4e0a\uff0c\u907f\u514d\u8166\u90e8\u9032\u4e00\u6b65\u7f3a\u6c27\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "25\u6b72\u5973\u6027\u6c92\u6709\u904e\u53bb\u75c5\u53f2\uff0c\u4e3b\u8a34\u80f8\u60b6\u3001\u8d70\uf937\u53ca\u8eba\u8457\u6703\u5598\u4e00\u5929\u3002 4\u5929\u524d\u958b\u59cb\u6709\u5168\u8eab\u75e0\u75db\u3001\u54b3\u55fd\u7b49\u611f\u5192\u75c7\u72c0\u3002\u5230\u9662\u6642\u7684\u8840\u58d3 78/56mmHg \u3001\u5fc3\u8df3 128\u6b21/min\u3001\u547c\u5438 30\u6b21/min\u3001\u9ad4\u6eab 37.7\u2103\u3001SpO 2 90%\uff0c\u807d\u8a3a\u96d9\u5074\u56c9\u97f3\uff0cCXR \u5448\u73fe\u96d9\u5074\u80ba\u7d0b\uf937\u589e\u52a0\uff0c\u5fc3\u96fb\u5716\u5448\u73fe\u5fc3\u8df3\u5feb\u53ca diffuse T wave inversion\u3002\u8acb\u554f\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u7d66\u4e88 \u03b2-blocker\u4e26\u6aa2\u67e5\u662f\u5426\u6709\u7532\u72c0\u817a\u4ea2\u9032\u3002 (B)\u7d66\u4e88 Aspirin\u3001Levophed\uff0c\u6aa2\u67e5 troponin\uff0c\u6703\u8a3a\u5fc3\u81df\u79d1\u6e96\u5099\u505a\u5fc3\u5c0e\u7ba1\u3002 (C)\u7d66\u4e88\u9069\u7576\u8f38\u6db2\uff0c\u8d85\u97f3\u6ce2\u6aa2\u67e5\uff0c\u5fc5\u8981\u6642\u9700\u555f\u52d5\u8449\u514b\u819c( ECMO) (D)\u6aa2\u67e5 D-dimer\uff0c\u7acb\u5373\u5b89\u6392\u80f8\u90e8\u96fb\u8166\u65b7\u5c64\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "35\u6b72\u7537\u6027\uff0c\u5169\u9031\u524d\u63a5\u53d7\u7e2e\u80c3\u624b\u8853( bariatric surgery ) \uff0c\u4eca\u665a\u5287\u70c8\u8179\u75db\u3001\u5641\u5fc3\u3001\u5614\u5410\u4f86\u8a3a\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5e38\u898b\u8853\u5f0f\u6709\u7d81\u5e36\u7e2e\u80c3\u3001\u90e8\u5206\u5207\u9664\u7e2e\u80c3(sleeve gastrectomy )\u3001Roux -en-Y\u80c3\u7e5e\u9053\u3001\u4ee5\u53ca\u7a7a\u8178\u622a\u77ed\u8853\u3002 (B)\u8178\u80c3\u9053\u963b\u585e\u5fc5\u9808\u512a\u5148\u8003\u616e\uff0c\u76f4\u63a5\u5148\u7167\u8179\u90e8 X\u5149\u3001\u53ef\u7591\u8005\u9015\u884c\u57f7\u884c\u8179\u90e8\u96fb\u8166\u65b7\u5c64\u651d\u5f71\u5373\u53ef\u78ba\u8a3a\u3002 (C)\u9664\u4e86\u7d81\u5e36\u7e2e\u80c3\u5916\uff0c\u5176\u4ed6\u8853\u5f0f\u5747\u6703\u5207\u9664\u5927\u90e8\u5206\u7684\u80c3\u518d\u91cd\u5efa\uff0c\u56e0\u6b64\u5fc5\u9808\u512a\u5148\u6392\u9664\u7e2b\u5408\u8655\u6ef2\u6f0f\u6216\u51fa\u8840\u3002 (D)\u7d81\u5e36\u7e2e\u80c3\u8005\u5e38\u56e0\u7d81\u5f97\u592a\u7dca\u9020\u6210\u8fd1\u7aef\u80c3\u56ca(gastric pouch)\u8207\u98df\u9053\u64f4\u5f35\uff0c\u9700\u7dca\u6025\u4e0a\u6d88\u5316\u9053\u5167\u8996\u93e1\u78ba\u8a3a\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u56e0\u70ba\u8033\u5ed3\u7e2b\u5408\u800c\u5fc5\u9808\u9032\u884c\u5c40\u90e8\u795e\u7d93\u963b\u65b7\u8853( auricular never block )\u6642\uff0c\u9ebb\u85e5\u7684\u4e0b\u91dd\u9ede\u5728\u8033\u5ed3\u7684\u54ea\u500b\u65b9\u4f4d\uff1f", + "Options": "(A)\u4e0a\u65b9\u8207\u4e0b\u65b9\u3002 (B)\u524d\u65b9\u8207\u5f8c\u65b9\u3002 (C)\u4e0a\u65b9\u8207\u5f8c\u65b9\u3002 (D)\u4e0b\u65b9\u8207\u524d\u65b9\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "45\u6b72\u7537\u6027\u5169\u5e74\u524d\u88ab\u8a3a\u65b7\u70ba\u611b\u6ecb\u75c5( Acquired Immunodeficiency Syndrome ) \uff0c\u4e0d\u898f\u5247\u670d\u7528\u6297\u75c5\u6bd2\u85e5\uff0c\u4e0a\u500b\u6708\u6aa2\u6e2c CD4+ 450 cells/\u00b5L \u3002\u767c\u71d2\u3001\u982d\u75db\u3001\u5026\u6020\u4e94\u5929\u5f8c\uff0c\u56e0\u6301\u7e8c\u9ad8\u71d2\u9001\u81f3\u6025\u8a3a\u3002\u80f8\u90e8 X\u5149\u3001\u8166\u90e8\u96fb\u8166\u65b7\u5c64\u7121\u7570\u5e38\u767c\u73fe\u3002\u75c5\u4eba\u5074\u81e5\u63a5\u53d7\u810a\u9ad3\u7a7f\u523a\u6aa2\u67e5\uff0c\u958b\u59cb\u7684\u810a\u9ad3\u6db2\u58d3\u529b 280 mmH 2O\u3001\u810a\u9ad3\u6db2\u6536\u96c6 12 ml\u9001\u9a57\uff1a\u767d\u8840\u7403 40 /\u00b5L\u3001sugar 87mg/dL \u3001protein 27 mg/dL \uff0c\u6297\u9178\u83cc\u67d3\u8272(Acid -fast stain ) \u3001\u9769\u862d\u6c0f\u67d3\u8272\u8207\u5370\u5ea6\u58a8\u6c34\u67d3\u8272(India ink stain)\u7686\u9670\u6027\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u6b64\u75c5\u4eba\u4e4b\u810a\u9ad3\u7a7f\u523a\u6aa2\u67e5\u7d50\u679c\uff0c\u7d30\u83cc\u6027\u8166\u819c\u708e\u53ef\u80fd\u6027\u6700\u9ad8\u3002 (B)\u5074\u81e5\u4e4b\u810a\u9ad3\u7a7f\u523a\u6aa2\u67e5\uff0c\u6e2c\u91cf\u7684\u810a\u9ad3\u6db2\u58d3\u529b\u503c\u6bd4\u63a1\u5750\u59ff\u53ef\u9760\u3002 (C)\u5370\u5ea6\u58a8\u6c34\u67d3\u8272\u9670\u6027\uff0c\u53ef\u4ee5\u6392\u9664\u96b1\u7403\u83cc\u8166\u819c\u708e\u3002 (D)\u7528>10ml \u8166\u810a\u9ad3\u6db2\uff0c\u6297\u9178\u83cc\u67d3\u8272\u8a3a\u65b7\u7d50\u6838\u83cc\u8166\u819c\u708e\u4e4b\u654f\u611f\u6027\u7d0480%\u3002", + "Answer": "B\u3001D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8702\u87ab\u53ca\u904e\u654f\u6027\u4f11\u514b\u7684\u6558\u8ff0\u4f55\u8005\u81e8\u5e8a\u75c7\u72c0\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u904e\u654f\u6027\u4f11\u514b\u591a\u767c\u751f\u5728\u8702\u87ab\u5f8c 15\u5206\u9418\u5167\uff0c\u8702\u87ab\u6578\u8d8a\u591a\u9020\u6210\u4f11\u514b\u6a5f\u6703\u8d8a\u5927 \u3002 (B)\u51fa\u73fe\u5168\u8eab\u76ae\u819a\u7d05\u75b9\u53ca\u6301\u7e8c\u8179\u75db\u5614\u5410\uff0c\u7d66\u4e88 Epinephrine 0.3mg IM \u6ce8\u5c04\u3002 (C)\u5927\u91cf\u8702\u87ab( >100 stings)\u591a\u5f15\u8d77\u5fc3\u81df\u8870\u7aed\uff0c\u4ee5\u53ca\u9020\u6210\u809d\u81df\u53ca\u814e\u81df\u8870\u7aed\u3002 (D)\u8541\u9ebb\u75b9\u3001\u6dcb\u5df4\u816b\u53ca\u95dc\u7bc0\u708e\u7b49\u75c7\u72c0\u591a\u767c\u751f\u5728\u8702\u87ab 72\u5c0f\u6642\u5f8c\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4f9d\u64da 2019\u5e74\u7f8e\u570b\u5fc3\u81df\u5b78\u6703\u6240\u767c\u5e03\u7684\u5152\u7ae5\u6025\u6551\u6e96\u5247\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u5230\u9662\u524d\u5fc3\u8df3\u505c\u6b62\u671f\u9593\uff0c\u9ad8\u7d1a\u547c\u5438\u9053\u88dd\u7f6e(\u6c23\u7ba1\u63d2\u7ba1\u6216\u8072\u9580\u4e0a\u90e8\u547c\u5438\u9053\u88dd\u7f6e)\u76f8\u8f03\u65bc\u888b\u74e3\u7f69\u901a\u6c23\u70ba\u76f8\u5c0d\u5408\u7406\u7684\u5b69\u7ae5\u8655\u7f6e\u3002 (B)\u5c0d\u65bc\u51fa\u751f\u6642\u63a5\u53d7\u547c\u5438\u652f\u6301\u7684\u8db3\u6708\u53ca\u665a\u671f\u65e9\u7522\u65b0\u751f\u5152(\u598a\u5a20 35 \u9031\u6216\u4ee5\u4e0a) \uff0c21% \u6c27\u6c23\u7684\u521d\u59cb\u4f7f\u7528\u70ba\u5408\u7406\u4e4b\u505a\u6cd5\u3002 (C)\u5c0d\u65bc OHCA\u4e4b\u5c0f\u65bc 18\u6b72\u75c5\u4eba\uff0c\u6062\u5fa9\u81ea\u767c\u6027\u547c\u5438\u5fc3\u8df3\u5f8c\u4ecd\u7121\u610f\u8b58\u6062\u5fa9\uff0c\u5efa\u8b70\u4f7f\u7528\u4f4e\u9ad4\u6eab\u7642\u6cd5\u3002 (D)\u5728\u5177\u5099 ECMO\u7d93\u9a57\u7684\u91ab\u8b77\u4eba\u54e1\u60c5\u6cc1\u4e0b\uff0c\u6709\u5fc3\u81df\u75c5\u4e14\u9662\u5167\u5fc3\u8df3\u505c\u6b62\u7684\u5152\u7ae5\uff0c\u53ef\u4ee5\u8003\u616e\u9ad4\u5916 CPR( ECPR)\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u5c0d\u65bc\u6025\u6027\u547c\u5438\u7a98\u8feb\u75c7\u5019\u7fa4( ARDS)\u75c5\u4eba\u4e4b\u6cbb\u7642\uff0c\u4e0b\u5217\u4f55\u8005\u88ab\u8b49\u5be6\u70ba\u80fd\u964d\u4f4e\u6b7b\u4ea1\u7387\uff1f", + "Options": "(A)\u65e9\u671f\u7d66\u4e88\u5ee3\u6548\u6027\u6297\u751f\u7d20\u3002 (B)\u547c\u5438\u5668\u8a2d\u5b9a\u4f7f\u7528\u4f4e\u7684\u6f6e\u6c23\u5bb9\u7a4d(low tidal volume )\u3002 (C)\u7d66\u4e88 Packed RBC \u8f38\u8840\u3002 (D)\u7d66\u4e88\u9810\u9632\u6027\u985e\u56fa\u9187\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5152\u7ae5\u62bd\u6410( seizure) \uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u63d0\u65e9\u4f7f\u7528\u6297\u7672\u7647\u85e5\u7269\uff0c\u5c0d\u7672\u7647\u91cd\u7a4d\u75c7\u7684\u6cbb\u7642\u6548\u679c\u7121\u660e\u986f\u5dee\u7570\u3002 (B)\u7672\u7647\u91cd\u7a4d\u75c7\u5f8c\u7dda\u85e5\u7269\uff0c\u53ef\u8003\u616e\u4f7f\u7528 Ketamine \uff0c\u4e14\u4e0d\u9700\u64d4\u5fc3\u5176\u5c0e\u81f4\u8166\u58d3\u4e0a\u5347\u3002 (C)\u5927\u65bc 1\u6b72\u7684\u55ae\u7d14\u6027\u71b1\u6027\u75d9\u6523\u75c5\u4eba\uff0c\u7d04 50%\u6703\u6709\u7b2c\u4e8c\u6b21\u71b1\u6027\u75d9\u6523\u3002 (D)\u5c0d\u65bc\u8907\u96dc\u6027\u71b1\u6027\u75d9\u6523\u5152\u7ae5\uff0c\u5efa\u8b70\u5e38\u898f\u5b89\u6392\u62bd\u8840\u53ca\u5f71\u50cf\u6aa2\u67e5\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6025\u8a3a 3\u540d\u75c5\u4eba\uff0c\u4e00\u8d77\u98df\u7528\u5916\u8cb7\u5348\u9910\u9bd6\u9b5a\u4fbf\u7576\u5f8c\u7d04 1\u5c0f\u6642\u5f8c\u51fa\u73fe\u75c7\u72c0\uff0c\u5305\u62ec\u982d\u75db\u3001\u982d\u6688\u3001\u8179\u7009\u3001\u4e0a\u8179\u90e8\u75bc\u75db\u3002\u75c5\u4eba\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\uff0c\u7121\u767c\u71d2\uff0c\u8eab\u9ad4\u8a3a\u5bdf\u767c\u73fe\u6709 2\u4f4d\u75c5\u4eba\u81c9\u90e8\u3001\u80f8\u90e8\u6709\u6f6e\u7d05(flushing) \uff0c\u5176\u9918\u90e8\u4f4d\u5747\u70ba\u6b63\u5e38 \uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5feb\u901f\u51fa\u73fe\u75c7\u72c0\uff0c\u81f4\u75c5\u539f\u6700\u53ef\u80fd\u70ba\u91d1\u9ec4\u8272\u8461\u8404\u7403\u83cc\u5167\u6bd2\u7d20(staphylococcal enterotoxin)\u3002 (B)\u63a1\u96c6\u75c5\u4eba\u5c4e\u4fbf\u6aa2\u9ad4\uff0c\u7d66\u4e88\u652f\u6301\u6027\u7642\u6cd5\u8207\u53e3\u670d\u6297\u751f\u7d20\u85e5\u7269\u3002 (C)\u7d66\u4e88\u652f\u6301\u6027\u7642\u6cd5\u8207\u6297\u7d44\u7e54\u80fa(anti -histamine )\u85e5\u7269\u3002 (D)\u9ad8\u6eab\u70f9\u716e\u98df\u6750\uff0c\u53ef\u9810\u9632\u6b64\u985e\u98df\u7269\u4e2d\u6bd2\u4e8b\u6545\u767c\u751f\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u7576\u4f7f\u7528 Flumazenil \u5f8c\u7522\u751f\u62bd\u6410( seizure) \uff0c\u4e0b\u5217\u4f55\u8005\u85e5\u7269 \u70ba\u4e2d\u6b62\u62bd\u6410\u6700\u4f73\u9078\u64c7\uff1f", + "Options": "(A)Benzodiazepine \u3002 (B)Phenytoin \u3002 (C)Propofol \u3002 (D)Sodium Valproate \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u95dc\u65bc\u9ebb\u75b9( measles)\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u53ef\u7d93\u7531\u7a7a\u6c23\u3001\u98db\u6cab\u50b3\u64ad\u6216\u63a5\u89f8\u75c5\u4eba\u9f3b\u54bd\u5206\u6ccc\u7269\u800c\u611f\u67d3\uff0c\u4f46\u611f\u67d3\u5f8c\u5247\u5177\u6709\u7d42\u8eab\u514d\u75ab\u529b\u3002 (B)\u6703\u5148\u51fa\u73fe\u54b3\u55fd\u3001\u9f3b\u708e\u3001\u7d50\u819c\u708e\u3001\u9ad8\u71d2\u3001\u5026\u6020\u7b49\u75c7 \u72c0\uff0c\u63a5\u8457\u53e3\u8154\u4e0b\u81fc\u9f52\u5c0d\u9762\u5167\u9830\u5074\u9ecf\u819c\u6703\u51fa\u73fe\u767d\u9ede\uff0c\u7a31\u70ba\u67ef\u6c0f\u6591\u9ede\u3002 (C)\u5178\u578b\u7684\u6591\u4e18\u75b9\u6703\u5448\u96e2\u5fc3\u72c0\u51fa\u73fe\uff0c\u9996\u5148\u51fa\u73fe\u65bc\u8ec0\u5e79\uff0c\u518d\u9010\u6f38\u64f4\u6563\u81f3\u6574\u500b\u8033\u5f8c\u3001\u81c9\u9762\u4ee5\u53ca\u56db\u80a2\u3002 (D)\u5c0f\u6642\u5019\u63a5\u7a2e\u904e MMR\u75ab\u82d7\u96d6\u7136\u53ef\u4ee5\u7522\u751f\u4e3b\u52d5\u514d\u75ab\u529b\uff0c\u4f46\u6210\u5e74\u5f8c\u82e5\u8981\u524d\u5f80\u9ebb\u75b9\u6d41\u884c\u75ab\u5340\uff0c\u5efa\u8b70\u63a5\u7a2e\u4e00\u5291 MMR\u75ab\u82d7\u5f8c\u518d\u884c\u524d\u5f80\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6691\u5047\u6642\uff0c\u5c0f\u660e\u53c3\u52a0\u99ac\u62c9\u677e\u6bd4\u8cfd\u3002\u904e\u7a0b\u4e2d\u5c0f\u660e\u89ba\u5f97\u53e3\u6e34\u3001\u5168\u8eab\u7121\u529b\u8207\u982d\u6688\uff0c\u65bc\u662f\u8d70\u5230\u91ab\u7642\u7ad9\u5750\u4e0b\u4f11\u606f\uff0c\u91ab\u7642\u7ad9\u4eba\u54e1\u767c\u73fe\u5c0f\u660e\u9ad4\u6eab 39.5\u2103\uff0cE4V5M6\uff0c\u80fd\u6e05\u695a\u61c9\u7b54\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u56e0\u590f\u5929\u5929\u71b1\uff0c\u5c0f\u660e\u53ef\u80fd\u5df2\u7d93\u71b1\u4e2d\u6691(heat stroke )\u3002 (B)\u91ab\u7642\u7ad9\u8b93\u5c0f\u660e\u8eba\u4e0b\u3001\u88dc\u5145\u6c34\u5206\u5916\uff0c\u4e5f\u7d66\u4e88 Acetaminophen 500mg \u8f14\u52a9\u964d\u6eab\u3002 (C)\u82e5\u5c0f\u660e\u5728\u4f11\u606f\u904e\u7a0b\u4e2d\uff0c\u610f\u8b58\u6162\u6162\u6df7\u4e82\uff0c\u53ef\u5efa\u7acb\u975c\u8108\u7ba1\uf937\u7d66\u4e88\u751f\u7406\u98df\u9e7d\u6c34\u3002 (D)\u91ab\u7642\u7ad9\u4e0d\u61c9\u7b49\u5230\u5c0f\u660e\u610f\u8b58\u6539\u8b8a\uff0c\u4e00\u958b\u59cb\u5c31\u61c9\u8003\u616e\u4f7f\u7528 4\u2103\u9ede\u6ef4\u6ce8\u5c04\uff0c\u5feb\u901f\u964d\u6eab\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8840\u5c3f\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5916\u50b7\u9020\u6210\u7684\u814e\u81df\u640d\u50b7\uff0c\u5176\u640d\u50b7\u56b4\u91cd\u7a0b\u5ea6\u8207\u8840\u5c3f\u7684\u591a\u5be1\uff0c\u6709\u5bc6\u5207\u95dc\u806f\u3002 (B)\u5c3f\u6db2\u6aa2\u67e5\u767c\u73fe\u7d05\u8840\u7403\u5713\u67f1\u9ad4(red cell casts )\u53ef\u80fd\u70ba\u81ea\u9ad4\u514d\u75ab\u75be\u75c5(autoimmune disease )\u3002 (C)\u5152\u7ae5\u7684\u8840\u5c3f\uff0c\u4e0d\u9808\u8003\u616e\u816b\u7624\u7684\u53ef\u80fd\u3002 (D)\u814e\u7d72\u7403\u814e\u708e( glomerulonephritis )\u9020\u6210\u7684\u8840\u5c3f\uff0c\u591a\u898b\u65bc\u4e2d\u8001\u5e74\u4eba\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "4\u6b72\u7537\u7ae5\uff0c\u56e0\u767c\u71d2\u3001\u54b3\u55fd\u3001\u547c\u5438\u56f0\u96e3\u53ca\u610f\u8b58\u55dc\u7761\u88ab\u9001\u81f3\u6025\u8a3a\uff0c\u751f\u547d\u5fb4\u8c61\uff1a\u8840\u58d3 70/55mmHg \uff0c\u5fc3\u8df3 149\u6b21/min\uff0c\u547c\u5438 28\u6b21/min\uff0c\u56db\u80a2\u51b0\u51b7\uff0c\u819a\u8272\u6591\u99c1\uff0c\u5fae\u8840\u7ba1\u56de\u5145\u70ba 5\u79d2\uff0c\u8840\u6db2\u6aa2\u67e5\u767d\u8840\u7403 21,000/\u00b5 L\uff0cX\u5149\u5448\u73fe\u53f3\u5074\u80ba\u708e\uff0c\u4e0b\u5217\u5224\u65b7\u548c\u8655\u7f6e\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u53ef\u80fd\u70ba cold septic shock \u3002 (B)\u9996\u9078\u5347\u58d3\u85e5\u7269\u70ba Norepinephrine \u512a\u65bc Dopamine \u6216Epinephrine \u3002 (C)\u611f\u67d3\u83cc\u53ef\u80fd\u70ba\u9769\u862d\u6c0f\u967d\u6027\u83cc\u3002 (D)\u9700\u65bc 1\u5c0f\u6642\u5167\u7d66\u4e88\u5ee3\u6548\u6297\u751f\u7d20\u53ca 30ml/kg\u8f38\u6db2\u5fa9\u7526\u3002", + "Answer": "B\u3001D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u5167\u9838\u975c\u8108\u4e2d\u5fc3\u975c\u8108\u5c0e\u7ba1\u7f6e\u5165\u8853\u8207\u8d85\u97f3\u6ce2\u5c0e\u5f15\u7684\u6b65\u9a5f\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u6709\u4e09\u7a2e\u7f6e\u5165\u7684\u9014\u5f91(approach )\uff1a\u4e2d\u592e\u5f0f(central ) \u3001\u5f8c\u5074\u5f0f(posterior ) \u3001\u4e0a\u5074\u5f0f(superior )\u3002 (B)\u4f7f\u7528\u4e2d\u592e\u5f0f\u9014\u5f91\u6642\uff0c\u4e0b\u91dd\u7684\u65b9\u5411\u662f\u671d\u8457\u75c5\u60a3\u5c0d\u5074\u7684\u4e73\u982d (contralateral nipple )\u3002 (C)\u8d85\u97f3\u6ce2\u4e0b\u5167\u9838\u975c\u8108\u4f4d\u7f6e\u5728\u5167\u9838\u52d5\u8108\u7684\u5916\u5074\uff0c\u5f62\u72c0\u8f03\u6241\u800c\u4e14\u4e0d\u6703\u56e0\u58d3\u8feb\u800c\u8b8a\u5f62\u3002 (D)\u8d85\u97f3\u6ce2\u4e0b\u5fc5\u9808\u8fa8\u8a8d\u51fa\u5167\u9838\u975c\u8108\u3001\u5167\u9838\u52d5\u8108\u8207\u7532\u72c0\u817a\u4e09\u6a23\u69cb\u9020\uff0c\u624d\u53ef\u4ee5\u4e0b\u91dd\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "65\u6b72\u7537\u6027\u75c5\u4eba\uff0c\u4e3b\u8a34\u6688\u5012\uff0c\u610f\u8b58\u55aa\u5931\u7d04 3\u5206\u9418\uff0c\u8840\u58d3 167/88 mmHg \u3001\u5fc3\u8df3 77 \u6b21/ min\u3001EKG\u986f\u793a ST depression over lead II \u3001III\u3001aVF\uff0ctroponin\u5347\u9ad8\uff0cD -dimer 300 ng/mL \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u75c5\u4eba\u70ba\u975e ST\u6ce2\u6bb5\u4e0a\u5347\u7684\u5fc3\u808c\u6897\u585e\uff0c\u6b7b\u4ea1\u7387\u5927\u65bc ST elevation MI \u3002 (B)\u75c5\u4eba\u70ba cardiac -related syncope \uff0c\u534a\u5e74\u6b7b\u4ea1\u7387\u8d85\u904e 10%\uff0c\u662f\u6700\u5371\u96aa\u7684syncope type \u3002 (C)\u75c5\u4eba\u5728 24~48\u5c0f\u6642\u5167\u9032\u884c\u5fc3\u5c0e\u7ba1\u624b\u8853(PCI )\u7121\u6cd5\u964d\u4f4e\u6b7b\u4ea1\u7387\u6216recurrent MI \u3002 (D)troponin \u7d04\u5728 48\u5c0f\u6642\u9054\u5230\u9ad8\u5cf0\uff0c\u4e0a\u5347\u53ef\u9054 10\u5929\u4e4b\u4e45\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "30\u6b72\u7537\u6027\uff0c\u65e9\u4e0a\u8d77\u5e8a\u6642\u767c\u73fe\u5168\u8eab\u7121\u529b\u3001\u52d5\u5f48\u4e0d\u5f97\u800c\u81f3\u6025\u8a3a\u3002\u75c5\u4eba\u6558\u8ff0 3\u500b\u6708\u524d\u4ea6\u6709\u4e00\u6b21\u985e\u4f3c\u767c\u4f5c\u3002\u9019\u534a\u5e74\u4f86\u75c5\u4eba\u6709\u5fc3\u60b8\u53ca\u9ad4\u91cd\u4e0b\u964d\u7b49\u75c7\u72c0\u3002\u5230\u9662\u6642\u8840\u58d3 120/70 mmHg \u3001\u5fc3\u8df3 110\u6b21/min\u3001\u547c\u5438 20\u6b21/min\u3001\u9ad4\u6eab 37\u2103\uff0c\u5176\u4ed6\u8eab\u9ad4\u8a3a\u5bdf\u9664\u56db\u80a2\u5c0d\u7a31\u7121\u529b\u5916\uff0c\u4e26\u7121\u7570\u5e38\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u8a3a\u65b7\u53ef\u80fd\u70ba\u7532\u72c0\u817a\u6a5f\u80fd\u4ea2\u9032\u5408\u4f75\u9663\u767c\u6027\u80a2\u9ad4\u7121\u529b(periodic paralysis)\u3002 (B)\u5f71\u97ff\u7684\u808c\u7fa4\u5927\u591a\u662f\u9060\u7aef\u808c\u8089\uff0c\u4e0b\u80a2\u6bd4\u4e0a\u80a2\u6613\u53d7\u5230\u5f71\u97ff\uff0c\u6709\u5c0d\u7a31\u6027\uff0c\u591a\u5408\u4f75\u611f\u89ba\u7570\u5e38\u3002 (C)\u8a72\u75c5\u4eba\u98df\u7528\u6fb1\u7c89\u53ca\u9e7d\u5206\u591a\u4e4b\u98df\u7269\u8f03\u6613\u767c\u4f5c\u3002 (D)\u4e0d\u53ef\u7d66\u4e88\u75c5\u4eba dextrose\u6eb6\u6db2\u52a0 KCL\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u8001\u4eba\u5916\u50b7\u7684\u521d\u7d1a\u8a55\u4f30\u8207\u5fa9\u7526\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u53ef\u5728\u7259\u9f66\u8207\u81c9\u9830\u9593\u585e\u5165\u7d17\u5e03\u4ee5\u589e\u52a0 BVM\u6642\u9762\u7f69\u7684\u5bc6\u5408\u5ea6\u3002 (B)\u4f7f\u7528 BVM\u7d66\u6c27\u6642\u61c9\u5148\u79fb\u9664\u5047\u7259\uff0c\u4ee5\u514d\u5047\u7259\u812b\u843d\u9020\u6210\u547c\u5438\u9053\u963b\u585e\u3002 (C)\u5fc3\u8df3\u52a0\u5feb\u70ba\u767c\u751f\u7f3a\u8840\u6027\u4f11\u514b\u6642\u7684\u65e9\u671f\u5fb5\u5146\u3002 (D)\u9700\u8981\u6536\u7e2e\u58d3\u5c0f\u65bc 100 mmHg \u6642\u624d\u53ef\u8996\u70ba\u4f11\u514b\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "25\u6b72\u5973\u6027\uff0c\u5de6\u4e0b\u8179\u75db\u5408\u4f75\u9670\u9053\u5206\u6ccc\u7269\u904e\u591a\u7d04\u4e00\u9031\u3002\u4f86\u6025\u8a3a\u6642\u6709\u767c\u71d2\uff0c\u5167\u8a3a\u767c\u73fe\u81bf\u6a23\u9670\u9053\u5206\u6ccc\u7269\uff0c\u5b50\u5bae\u9838\u8209\u75db\uff0c\u8d85\u97f3\u6ce2\u986f\u793a\u5de6\u5074\u5b50\u5bae\u65c1\u6709\u816b\u584a\u3002\u5c0d\u65bc\u6b64\u75c5\u4eba\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u82e5\u4e0d\u6cbb\u7642\uff0c\u816b\u584a\u53ef\u80fd\u7834\u88c2\u5c0e\u81f4\u8179\u819c\u708e\u3002 (B)\u5167\u8a3a\u6642\u5b50\u5bae\u9838\u8209\u75db\u5c0d\u8a3a\u65b7\u9aa8\u76c6\u8154\u611f\u67d3\u5177\u9ad8\u5c08\u4e00\u6027\u3002 (C)\u8a3a\u65b7\u70ba Fitz-Huge -Curtis syndrome \u3002 (D)\u82e5\u81bf\u6db2\u57f9\u990a\u975e Neisseria gonorrhoeae \u5373\u53ef\u6392\u9664 Neisseria gonorrhoeae\u611f\u67d3\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "60\u6b72\u7537\u6027\uff0c\u5de6\u4e0a\u81c2\u75bc\u75db\u4e00\u9031 \uff0c\u4e0b\u5217\u795e\u7d93\u5b78\u6aa2\u67e5\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u82e5\u5408\u4f75\u795e\u7d93\u611f\u89ba\u7570\u5e38\uff0c\u70ba\u795e\u7d93\u6839\u75c5\u8b8a(radiculopathy )\u4e4b\u5fb5\u8c61\u3002 (B)\u4f5c Valsalva maneuver \u6703\u589e\u52a0\u75bc\u75db\uff0c\u53ef\u70ba\u795e\u7d93\u6839\u75c5\u8b8a\u3002 (C)\u5c07\u5de6\u81c2\u5916\u5c55( Abduction)\u4e0a\u8209\u6703\u589e\u52a0\u5de6\u9838\u75bc\u75db\uff0c\u53ef\u70ba\u795e\u7d93\u6839\u58d3\u8feb\u75c7\u72c0\u3002 (D)\u5c48\u9838\u5c07\u4e0b\u5df4\u63a5\u8fd1\u80f8\u58c1\u6642\uff0c\u4e0a\u81c2\u6703\u7522\u751f\u50cf\u96fb\u523a\u6fc0\u822c\u75bc\u75db\uff0c\u53ef\u70ba\u9838\u90e8\u810a\u9ad3\u58d3\u8feb\u75c7\u72c0\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "55\u6b72\u5973\u6027\uff0c\u56e0\u9ad8\u71d2 39.5\u00b0C\u53ca\u53f3\u4e0a\u8179\u75db\u81f3\u6025\u8a3a\uff0c\u75c5\u4eba\u610f\u8b58\u55dc\u7761\uff0c\u5fc3\u8df3 95 \u6b21/min\u3001\u8840\u58d3 98/56 mmHg \uff0c\u76ae\u819a\u978f\u819c\u767c\u9ec3\uff0c\u767d\u8840\u7403\u8a08\u6578 16,000 /\u00b5L \uff0c\u521d\u6b65\u81c6\u65b7\u70ba\u6025\u6027\u81bd\u7ba1\u708e\u3002\u4e0b\u5217 \u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u6839\u64da 2016\u5e74Sepsis -3 guideline \uff0c\u4ee5\u9ad8\u71d2\u226739\u00b0C \u53ca\u6536\u7e2e\u58d3\u2266100 mmHg\u4f86\u8a08\u7b97 qSOFA \u5f972\u5206\uff0c\u61f7\u7591\u75c5\u4eba\u611f\u67d3\u5df2\u5408\u4f75\u6557\u8840\u75c7\u3002 (B)\u958b\u59cb\u6cbb\u7642\u7684\u524d 3\u5c0f\u6642\u5167\uff0c\u975c\u8108\u7d66\u4e88\u81f3\u5c11 30 mL/kg \u7684\u6676\u9ad4\u8f38\u6db2(crystalloid)\u3002 (C)\u7576\u9700\u8981\u4f7f\u7528\u6607\u58d3\u5291\u6642\uff0c\u6b63\u814e\u4e0a\u817a\u7d20(Norepinephrine )\u662f\u9996\u9078\uff0c\u5b83\u53ea\u6709\u03b1-adrenergic effect \u9020\u6210\u5468\u908a\u8840\u7ba1\u6536\u7e2e\uff0c\u4f46\u6bd4\u8f03\u4e0d\u5bb9\u6613\u5f71\u97ff\u5fc3\u8df3\u901f\u7387\u3002 (D)\u7576\u5927\u91cf\u8f38\u6db2\u53ca\u7d66\u4e88\u6607\u58d3\u5291\u6642\uff0c\u82e5\u8840\u58d3\u4ecd\u504f\u4f4e\uff0c\u61c9\u5118\u5feb\u6ce8\u5c04\u76ae\u8cea\u985e\u56fa\u9187\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u54ea\u4f4d\u5fc3\u8df3\u505c\u6b62\u7d93\u6025\u6551\u5fa9\u7526\u6210\u529f\u75c5\u4eba\u9069\u5408\u9032\u884c\u76ee\u6a19\u9ad4\u6eab\u7ba1\u7406( targeted temperature management )\uff1f", + "Options": "(A)60 \u6b72\u7537\u6027\u6709\u9ad8\u8840\u58d3\uff0c\u982d\u90e8\u96fb\u8166\u65b7\u5c64\u767c\u73fe\u8166\u5e79\u6709\u7d04 10 cc\u51fa\u8840\u3002 (B)29 \u6b72\u5973\u6027\u8eca\u798d\u5230\u9662\u5f8c\u6b7b\u4ea1\uff0c\u5fa9\u7526\u5f8c\u767c\u73fe\u5927\u91cf\u8179\u5167\u7a4d\u8840\u3002 (C)70 \u6b72\u7537\u6027\u7121\u904e\u53bb\u75c5\u53f2\uff0c\u9f3b\u80c3\u7ba1\u5f15\u6d41\u51fa 30 cc\u5496\u5561\u8272\u80c3\u6db2\u3002 (D)35 \u6b72\u7537\u6027\u6025\u6551\u5f8c\u53ef\u9ede\u982d\u793a\u610f\uff0c\u5fc3\u96fb\u5716\u986f\u793a ST-segment \u4e0a\u5347\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6241\u6843\u817a\u81bf\u760d( peritonsillar abscess )\u7684\u8a3a\u65b7\u6cbb\u7642\uff0c\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u597d\u767c\u65bc\u62b5\u6297\u529b\u8f03\u5dee\u7684\u8001\u4eba\u8207\u5b78\u9f61\u524d\u5152\u7ae5\u3002 (B)\u4ee5\u5f71\u50cf\u5b78\u6aa2\u67e5\u70ba\u8a3a\u65b7\u6a19\u6e96\u3002 (C)\u5207\u958b\u5f15\u6d41( incision and drainage )\u8207\u7d30\u91dd\u62bd\u5438(needle aspiration ) \u6cbb\u7642\u6548\u679c\u76f8\u540c\u3002 (D)Tonsillectomy \u662f\u9996\u9078\u6cbb\u7642\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc Bell\u2019s palsy \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5f71\u97ff\u5230\u984f\u9762\u795e\u7d93(cranial nerve VII ) \uff0c\u75c5\u4eba\u53ef\u80fd\u6703\u51fa\u73fe\u807d\u89ba\u904e\u654f(hyperacusis )\u7684\u75c7\u72c0\u3002 (B)\u5f71\u97ff\u5230\u820c\u54bd\u795e\u7d93(cranial nerve IX ) \uff0c\u75c5\u4eba\u820c\u5f8c\u4e09\u5206\u4e4b\u4e00\u7684\u5473\u89ba\u53ef\u80fd\u6703\u4e0b\u964d( decreased taste )\u3002 (C)\u7531\u65bc\u8033\u5167\u611f\u67d3\u8f03\u5c11\u898b\uff0c\u4e0d\u9700\u8981\u4f8b\u884c\u5b89\u6392\u8033\u90e8\u6aa2\u67e5\uff0c\u53ef\u5148\u7d66\u4e88\u53e3\u670d\u985e\u56fa\u9187\u85e5\u7269\u6cbb\u7642\u3002 (D)\u540c\u6642\u7d66\u4e88\u6297\u75c5\u6bd2\u85e5\u7269\u548c\u985e\u56fa\u9187\u6cbb\u7642\u75c5\u4eba\u6703\u7522\u751f\u8f03\u591a\u526f\u4f5c\u7528\uff0c\u6545\u4e0d\u5efa\u8b70\u5408\u4f75\u4f7f\u7528\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "19\u6b72\u7537\u6027\uff0c\u7591\u4f3c\u5728\u591c\u5e97\u670d\u7528\u4e0d\u660e\u8ff7\u5e7b\u85e5( hallucinogens )\u5f8c\uff0c\u51fa\u73fe\u8e81\u52d5\u3001\u795e\u667a\u4e0d\u6e05\u88ab\u9001\u5230\u6025\u8a3a\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u8ff7\u5e7b\u85e5\u4e2d\u6bd2\u5e38\u898b\u5fc3\u640f\u904e\u901f\u8207\u8840\u58d3\u964d\u4f4e\uff0c\u56e0\u6b64\u5fc5\u9700\u8981\u52a0\u5f37\u76e3\u6e2c\u75c5\u4eba\u7684\u751f\u547d\u5fb5\u8c61\u3002 (B)\u652f\u6301\u6027\u7642\u6cd5\u662f\u6700\u5e38\u7528\u7684\u624b\u6bb5\uff0c\u9700\u8981\u6d17\u80c3\u52a0\u6d3b\u6027\u78b3\u4f7f\u7528\uff0c\u4f86\u6e05\u9664\u85e5\u7269\u3002 (C)\u5fc5\u9808\u8981\u99ac\u4e0a\u9a57\u5c3f\uff0c\u4ee5 \u6aa2\u9a57\u51fa\u75c5\u4eba\u670d\u7528\u7684\u662f\u4f55\u7a2e\u8ff7\u5e7b\u85e5\uff0c\u7d66\u4e88\u5c0d\u61c9\u7684\u89e3\u6bd2\u5291\u3002 (D)\u5982\u679c\u75c5\u4eba\u51fa\u73fe\u5341\u5206\u8e81\u52d5\u6216\u5fc3\u60b8\u7684\u75c7\u72c0\uff0c\u5927\u90e8\u4efd\u90fd\u53ef\u4ee5\u7d66\u4e88 BZD\u6cbb\u7642\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u79fb\u690d\u7269\u5c0d\u6297\u5bbf\u4e3b\u75be\u75c5( graft versus host disease, GVHD )\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u65bc\u79fb\u690d\u5f8c\u4e00\u767e\u5929\u5167\u767c\u751f\u53ef\u7a31\u70ba acute GVHD\u3002 (B)Acute GVHD \u6700\u5e38\u898b\u7684\u75c7\u72c0\u70ba\u767c\u71d2\u548c\u8179\u7009\u3002 (C)Acute GVHD \u75c5\u4eba\u6062\u5fa9\u5f8c\uff0c\u5bb9\u6613\u4f75\u767c chronic GVHD\u3002 (D)\u76ee\u524d\u5e38\u7528\u65bc\u9810\u9632 GVHD\u7684\u85e5\u7269\u5305\u62ec Tacrolimus \u548cMethotrexate \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "20\u6b72\u7537\u6027\uff0c\u8df3\u6c34\u6642\u982d\u90e8\u649e\u5230\u6cf3\u6c60\u5e95\u90e8\u3002\u75c5\u4eba\u610f\u8b58\u6e05\u695a\uff0c\u4e3b\u8a34\u96d9\u624b\u53ca\u96d9\u8173\u5b8c\u5168\u4e0d\u80fd\u52d5\uff0c\u5168\u8eab\u81ea\u9396\u9aa8\u4ee5\u4e0b\u5373\u611f\u89ba\u4e0d\u5230\u75db\u89ba\uff0c\u4f46\u56db\u80a2\u7684\u672c\u9ad4\u611f\u89ba\u53ca\u9707\u52d5\u611f\u89ba\u6b63\u5e38\u3002\u9838\u690e X\u5149\u6aa2\u67e5\u986f\u793a\u7121\u9aa8\u6298\uff0c\u6b64\u75c5\u4eba\u6700\u53ef\u80fd\u662f\u4f55\u7a2e\u8a3a\u65b7\uff1f", + "Options": "(A)Central cord syndrome \u3002 (B)Anterior cord syndrome \u3002 (C)Cauda equina syndrome \u3002 (D)Brown -S\u00e9quard syndrome \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "25\u6b72\u7537\u6027\uff0c\u56e0\u53f3\u5074\u982d\u75db\u4f34\u96a8\u5641\u5fc3\u3001\u754f\u5149\u81f3\u6025\u8a3a\u5c31\u8a3a\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576\uff1f ", + "Options": "(A)\u5178\u578b\u504f\u982d\u75db\u7684\u8868\u73fe\u70ba\u55ae\u5074\u6301\u7e8c\u6027\u800c\u975e\u640f\u52d5\u6027\u75bc\u75db\uff0c\u4f34\u96a8\u754f\u5149(photophobia )\u53ca\u754f\u8072(phonophobia )\u3002 (B)\u55ae\u7368\u4f7f\u7528\u6297\u7d44\u7e54\u80fa(\u5982\u975c\u8108\u6ce8\u5c04 Diphenhydramine )\u5c0d\u504f\u982d\u75db\u4e5f\u6709\u6b62\u75db\u7684\u6548\u679c\u3002 (C)\u6392\u9664\u81f4\u547d\u6027\u75be\u75c5\u5f8c\uff0c\u53ef\u5408\u4f75\u4f7f\u7528\u975e\u985e\u56fa\u9187\u6d88\u708e\u85e5\u53ca\u6b62\u5410\u85e5\u6cbb\u7642\u504f\u982d\u75db\u3002 (D)\u985e\u56fa\u9187\u5c0d\u6e1b\u5c11\u504f\u982d\u75db\u518d\u767c\u4f5c\u6c92\u6709\u5e6b\u52a9\u3002", + "Answer": "C\u3001D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8179\u90e8\u6025\u75c7\u7684\u8eab\u9ad4\u8a3a\u5bdf\u53ca\u81e8\u5e8a\u75c7\u72c0\u8868\u73fe\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u80f0\u81df\u708e\u75c5\u4eba\u5728\u809a\u81cd\u5468\u570d\u6709\u7600\u9752\u51fa\u8840\u70ba Grey Turner\u2019s sign \u3002 (B)\u4f7f\u7528\u975e\u985e\u56fa\u9187\u6d88\u708e\u6b62\u75db\u85e5(NSAID)\u6b62\u75db\u76f8\u8f03\u65bc\u55ce\u5561\u985e\u85e5\u7269\uff0c\u8f03\u4e0d\u6703\u96b1\u85cf\u81e8\u5e8a\u75c7\u72c0\u800c\u5ef6\u9072\u8a3a\u65b7\u3002 (C)L ow risk modified Alvarado score (0~4\u5206)\u654f\u611f\u6027\u4f4e\uff0c\u4e0d\u5b9c\u62ff\u4f86\u7576\u4f5c\u6392\u9664\u8a3a\u65b7\u7684\u4e3b\u8981\u5de5\u5177\u3002 (D)Fitz -Curtis-Hugh syndrome \u75bc\u75db\u90e8\u4f4d\u4e3b\u8981\u4f4d\u65bc\u5de6\u4e0a\u8179\u90e8\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u611f\u67d3\u6027\u5fc3\u5167\u819c\u708e\u7684\u8a3a\u65b7\u4e3b\u8981\u6216\u6b21\u8981\u6a19\u6e96\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u5169\u5957\u5206\u958b\u7684\u8840\u6db2\u57f9\u990a\u9577\u51fa\u5178\u578b\u6027\u7d30\u83cc\u3002 (B)\u5fc3\u81df\u8d85\u97f3\u6ce2\u53ef\u898b\u74e3\u819c\u4e0a\u98c4\u52d5\u8d05\u751f\u7269\u6216\u81bf\u816b(abscess )\u3002 (C)\u65b0\u767c\u751f\u7684\u53f3\u675f\u652f\u50b3\u5c0e\u963b\u6eef(RBBB)\u3002 (D)\u767c\u71d2\u9ad4\u6eab\u5927\u65bc 38\u2103\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u6709\u95dc\u6025\u6027\u8e81\u52d5( agitation)\u7684\u93ae\u975c\u85e5\u7269\u63cf\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)Benzodiazepines \u85e5\u7269\u6703\u9020\u6210\u5fc3\u96fb\u5716\u8b8a\u5316\u5982 QTc prolongation\u3002 (B)\u7b2c\u4e00\u4ee3\u6297\u7cbe\u795e\u75c5\u85e5\u7269\u5982 Haloperidol \u4e0d\u6703\u5f15\u8d77\u547c\u5438\u6291\u5236 (respiratory depression )\u3002 (C)\u7b2c\u4e8c\u4ee3\u6297\u7cbe\u795e\u75c5\u85e5\u7269\u5982 Quetiapine \u4e0d\u6703\u9020\u6210\u5fc3\u96fb\u5716\u8b8a\u5316\u5982 QTc prolongation\u3002 (D)\u7b2c\u4e8c\u4ee3\u6297\u7cbe\u795e\u75c5\u85e5\u7269\u5982 Risperidone \u4e0d\u6703\u5f15\u8d77\u9310\u9ad4\u5916\u75c7\u5019\u7fa4\u75c7\u72c0(extrapyramidal symptoms )\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "66\u6b72\u5973\u6027\uff0c\u4e09\u5929\u524d\u958b\u59cb\u6709\u4e0a\u5507\u53ca\u820c\u982d\u816b\u8139\u75c7\u72c0\u800c\u6c42\u8a3a\uff0c\u75c5\u4eba\u7121\u767c\u71d2\u3001\u7121\u7662\u75b9\u3001\u7121\u5c40\u90e8\u7d44\u7e54\u611f\u67d3\u5fb5\u5146\uff0c\u75c5\u4eba\u56e0\u9ad8\u8840\u58d3\u53ca\u9ad8\u8840\u8102\uff0c\u4e00\u9031\u524d\u958b\u59cb\u4f7f\u7528Enalapril 10mg qd\u3001Atorvastatin 10mg qd \u6cbb\u7642\uff0c\u6b64\u5916\u4e26\u7121\u4f7f\u7528\u5176\u4ed6\u85e5\u7269\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u81f4\u75c5\u6a5f\u8f49\u548c bradykinin \u6709\u95dc\u3002 (B)\u9700\u6ce8\u610f\u662f\u5426\u51fa\u73fe\u547c\u5438\u9053\u963b\u585e\u3002 (C)\u76ee\u524d\u6cbb\u7642\u61c9\u4ee5\u53e3\u670d\u985e\u56fa\u9187\u53ca\u6297\u7d44\u7e54\u80fa\u70ba\u4e3b\u3002 (D)\u82e5\u6539\u7528\u5176\u4ed6\u964d\u8840\u58d3\u85e5\u7269\uff0c\u61c9\u907f\u514d\u4f7f\u7528 angiotensin II receptor -blocking agents\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "65\u6b72\u7537\u6027\uff0c\u6709\u7672\u7647\u3001\u7cbe\u795e\u75c5\u53f2\uff0c\u56e0\u670d\u7528\u904e\u91cf Phenytoin \uff0c\u51fa\u73fe\u610f\u8b58\u6a21\u7cca\uff0c\u88ab\u9001\u81f3\u6025\u8a3a\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u773c\u9707( nystagmus)\u8207\u75c5\u4eba\u4e2d\u6bd2\u7684\u5291\u91cf\u6709\u76f8\u95dc\u6027\uff0c\u5982\u679c\u773c\u9707\u72c0\u6cc1\u6e1b\u7de9\uff0c\u53ef\u4ee5\u6392\u9664\u56b4\u91cd\u4e2d\u6bd2\u7684\u53ef\u80fd\u6027\u3002 (B)Phenytoin \u7684\u5fc3\u81df\u6bd2\u6027\uff0c\u5e38\u898b\u65bc\u975c\u8108\u85e5\u7269\u7d66\u4e88\uff0c\u53e3\u670d\u85e5\u7269\u8f03\u5c11\u767c\u751f\u3002 (C)\u8840\u6db2\u900f\u6790\uff0c\u5c0d\u65bc Phenytoin \u7684\u79fb\u9664\u6709\u5e6b\u52a9\uff0c\u4f46\u5c0d\u795e\u7d93\u5b78\u4e2d\u6bd2\u7684\u75c7\u72c0\u6539\u5584\u6548\u679c\u6709\u9650\u3002 (D)\u901a\u5e38 Phenytoin \u8840\u6e05\u85e5\u7269\u6fc3\u5ea6\u964d\u81f3\u6b63\u5e38\u503c\u4ee5\u4e0b\uff0c\u5728\u7cbe\u795e\u79d1\u6703\u8a3a\u5f8c\uff0c\u53ef\u4ee5\u8b93\u75c5\u4eba\u51fa\u9662\uff0c\u56de\u5bb6\u89c0\u5bdf\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u95dc dissemi nated intravascular coagulation (DIC)\u6cbb\u7642\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u82e5\u8840\u5c0f\u677f<100,000/ \u00b5L\uff0c\u61c9\u8003\u616e\u8f38\u8840\u5c0f\u677f\u3002 (B)\u82e5 aPTT\u5ef6\u9577\u5927\u65bc 1.5\u500d\uff0c\u8003\u616e\u8f38 Fresh frozen plasma (FFP)\u3002 (C)\u5728\u5e74\u8001\u75c5\u4eba\u8003\u616e\u7d66\u4e88\u9810\u9632\u6027 Tranexamic acid \u3002 (D)\u5728 PT\u5ef6\u9577\u4e4b\u75c5\u4eba\u8003\u616e\u7d66\u4e88\u7dad\u4ed6\u547d K\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc quick sepsis -related organ failure assessment score (qSOFA)\u7528\u65bc\u8a55\u4f30\u611f\u67d3\u75c7\u75c5\u4eba\uff0c\u9010\u6f38\u53d7\u5230\u91cd\u8996\uff0c\u6709\u95dc qSOFA\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)qSOFA \u8a55\u4f30\u9805\u76ee\u7e3d\u5171\u6709\u4e09\u9805\uff0c\u53ea\u8981\u7b26\u5408\u5169\u9805\uff0c\u5c31\u53ef\u4ee5\u8a3a\u65b7\u75c5\u4eba\u6709\u6557\u8840\u75c7\u3002 (B)\u8840\u5c0f\u677f\u5c0f\u65bc 10,000/ \u00b5L\u70baqSOFA\u8a55\u4f30\u9805\u76ee\u4e4b\u4e00\u3002 (C)\u547c\u5438\u6b21\u6578 \u226720\u6b21/min\u70baqSOFA\u8a55\u4f30\u9805\u76ee\u4e4b\u4e00\u3002 (D)\u6536\u7e2e\u8840\u58d3\u5c0f\u65bc\u7b49\u65bc 100 mmHg \u70baqSOFA\u8a55\u4f30\u9805\u76ee\u4e4b\u4e00\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "3\u6b72\u7537\u7ae5\uff0c\u7121\u7279\u5225\u904e\u53bb\u75c5\u53f2\uff0c 30\u5206\u9418\u524d\u5403\u5b8c\u86cb\u7cd5\u5f8c\uff0c\u5168\u8eab\u8d77\u7d05\u75b9\u5408\u4f75\u547c\u5438\u56f0\u96e3\u800c\u88ab\u9001\u81f3\u6025\u8a3a\u3002\u5230\u9662\u6642\u7126\u8e81\u4e0d\u5b89\u3001\u547c\u5438\u56f0\u96e3\u3001\u8072\u97f3\u6c99\u555e\u3001\u819a\u8272\u84bc\u767d\u3001\u5fae\u8840\u7ba1\u56de\u5145\u6642\u9593> 3 \u79d2\u3001\u9ad4\u6eab 37.1\u00b0C\u3001\u5fc3\u8df3 150\u6b21/min\u3001\u547c\u5438 40\u6b21/min\u3001\u8840\u58d3 70/45 mmHg \u3002\u6709\u95dc\u6b64\u75c5\u7ae5\u7684\u8655\u7f6e\u53ca\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u904e\u654f\u6027\u4f11\u514b\u7b2c\u4e00\u7dda\u7dca\u6025\u6cbb\u7642\u5305\u62ec\u547c\u5438\u9053\u3001\u7d66\u6c27\u3001\u9664\u6c59\u3001\u814e\u4e0a\u817a\u7d20\u53ca\u8f38\u6db2\uff0c\u4f46\u4e0d\u5305\u542b\u985e\u56fa\u9187\u548c\u6297\u7d44\u7e54\u80fa\u3002 (B)\u82e5\u78ba\u8a8d\u662f\u98df\u7269\u9020\u6210\u7684\u904e\u654f\uff0c\u53ef\u5b89\u6392\u6d17\u80c3\u3002 (C)\u53ef\u7d66 0.01 mg/kg (0.01cc/kg, 1 \uff1a1,000\u7a00\u91cb) \u814e\u4e0a\u817a\u7d20\u6ce8\u5c04\u65bc\u5927\u817f\uff1b\u800c\u4e14\u808c\u8089\u6ce8\u5c04\u6bd4\u76ae\u4e0b\u6ce8\u5c04\u597d\u3002 (D)\u82e5\u7d66\u4e88\u6b64\u75c5\u7ae5\u65bd\u6253\u814e\u4e0a\u817a\u7d20\u5f8c\u75c7\u72c0\u6301\u7e8c\u7121\u660e\u986f\u6539\u5584\uff0c\u53ef 5~15\u5206\u9418\u5f8c\u91cd\u8907\u65bd\u6253\u814e\u4e0a\u817a\u7d20\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u5fc3\u808c\u6897\u585e\u75c5\u4eba\u7684\u85e5\u7269\u6cbb\u7642\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u4ee5\u8840\u58d3\u4e0b\u964d\u7a0b\u5ea6\u7576\u4f5c\u6cbb\u7642\u76ee\u6a19\u4f86\u8abf\u6574 Nitroglycerin \u6ef4\u6ce8\u5291\u91cf\uff0c\u800c\u975e\u4ee5\u75c5\u4eba\u80f8\u75db\u7de9\u89e3\u7a0b\u5ea6\u7576\u4f5c\u8abf\u6574\u6a19\u7684\u3002 (B)\u65e9\u671f\u7d66\u4e88 Clopidogrel \u7121\u6cd5\u6e1b\u5c11 NSTEMI \u6b7b\u4ea1\u7387\uff0cClopidogrel \u7528\u65bc\u75c5\u4eba\u5c0d\u963f\u65af\u5339\u9748\u904e\u654f\u7684\u66ff\u4ee3\u85e5\u7269\u3002 (C)\u963f\u65af\u5339\u9748\u6cbb\u7642\u6642\u540c\u6642\u642d\u914d H2\u963b\u65b7\u5291\u6703\u5f71\u97ff\u6297\u8840\u5c0f\u677f\u7684\u6cbb\u7642\u6548\u679c\u3002 (D)\u4f7f\u7528\u4e59\u578b\u963b\u65b7\u5291\u6cbb\u7642\uff0c\u53ef\u6e1b\u5c11\u5fc3\u56e0\u6027\u4f11\u514b\u7684\u767c\u751f\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "24\u6b72\u7537\u6027\uff0c 10\u5206\u9418\u524d\u88ab\u4e09\u79d2\u81a0\u6ef4\u5230\u53f3\u773c\u5167\uff0c\u5546\u54c1\u4e3b\u8981\u6210\u5206\u70ba\u6c30\u57fa\u4e19\u70ef\u9178\u916f(Cyanoacrylate ) \uff0c\u6aa2\u67e5\u767c\u73fe\u4e0a\u4e0b\u773c\u776b\u6bdb\u6709\u4e00\u5c0f\u90e8\u5206\u88ab\u9ecf\u4f4f\u7121\u6cd5\u775c\u958b\uff0c\u978f\u819c\u8f15\u5fae\u5145\u8840\uff0c\u773c\u7403\u8f49\u52d5\u81ea\u5982\uff0c\u8996\u529b\u6b63\u5e38\u3002\u91ab\u9662\u6c92\u6709\u773c\u79d1\u91ab\u5e2b\uff0c\u4e0b\u5217\u8655\u7f6e \u4f55\u8005\u512a\u5148\uff1f", + "Options": "(A)\u7528\u68c9\u82b1\u68d2\u6cbe\u4e19\u916e(acetone )\u5857\u5728\u6cbe\u9ecf\u8655\u4f86\u6eb6\u89e3\u4e09\u79d2\u81a0\u7684\u9ecf\u6027\u3002 (B)\u53ef\u4ee5\u5617\u8a66\u5f92\u624b\u64a5\u96e2\u9ecf\u4f4f\u7684\u776b\u6bdb\u3002 (C)\u544a\u77e5\u75c5\u4eba\u672a\u4f86\u53ef\u80fd\u6703\u5c0e\u81f4\u767d\u5167\u969c(Cataract )\u3002 (D)\u5fc5\u9808\u7acb\u5373\u8f49\u8a3a\u5230\u6709\u773c\u79d1\u91ab\u5e2b\u503c\u73ed\u7684\u91ab\u9662\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "61\u6b72\u5973\u6027\uff0c\u4e73\u764c\u4e26\u63a5\u53d7\u5316\u7642\u7d04 1\u500b\u6708\uff0c\u75c5\u4eba\u5169\u4e09\u5929\u524d\u958b\u59cb\u6709\u8f15\u5fae\u54b3\u55fd\u3001\u5641\u5fc3\u3001\u98df\u617e\u4e0d\u4f73\u3001\u8179\u8139\u7b49\u75c7\u72c0\uff0c\u4eca\u5929\u9032\u5c55\u70ba\u610f\u8b58\u4e0d\u6e05\u4e14\u6709\u767c\u71d2\u7684\u60c5\u6cc1\uff0c\u75c5\u4eba\u5c31\u91ab\u6642\uff0cGCS E2M4V1\uff0c\u8840\u58d3 140/68 mmHg \u3001\u5fc3\u8df3 126\u6b21/min\u3001\u547c\u5438 26\u6b21/min\u3001SpO 2 96%\u3001\u9ad4\u6eab 38.3\u2103\uff0c\u95dc\u65bc\u8a72\u75c5\u4eba\u8a55\u4f30\u8655\u7f6e\uff0c\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u4f9d\u64da\u53f0\u7063\u6025\u8a3a\u6aa2\u50b7\u6025\u8feb\u5ea6\u5206\u7d1a\u91cf\u8868\u7684\u610f\u8b58\u8868\u73fe\u4f86\u5224\u5b9a\uff0c\u6aa2\u50b7\u7d1a\u6578\u70ba2\u7d1a\u3002 (B)\u75c5\u4eba\u7684\u547c\u5438\u97f3\u6b63\u5e38\u3001\u8840\u6c27\u6b63\u5e38\u4e14\u80f8\u90e8 X\u5149\u7247\u7121\u80ba\u708e\u8868\u73fe\u53ef\u6392\u9664\u80ba\u708e\u8a3a\u65b7\u3002 (C)WBC 1,000/ \u00b5L\uff0cSegment 30% \uff0c\u7121\u660e\u986f\u611f\u67d3\u6e90\u6642\uff0c\u9808\u76e1\u5feb\u9032\u884c\u809b\u9580\u6307\u8a3a\u78ba\u5b9a\u6709\u7121\u76f4\u8178\u81bf\u760d\u3002 (D)\u8840\u9223\u70ba 15.2 mg/dL (3.8 m Eq/L) \uff0c\u9808\u7acb\u5373\u7d66\u4e88\u8f38\u6db2\u6cbb\u7642\uff0c\u52a0\u901f\u9223\u96e2\u5b50\u5f9e\u5c3f\u4e2d\u6392\u9664\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5b55\u671f\u7684\u751f\u7406\u8b8a\u5316\u8207\u61c9\u8b8a\u7684\u6025\u6551\u8655\u7f6e\uff0c\u4f55\u8005\u6558\u8ff0\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5fc3\u640f\u8f38\u51fa\u8207\u8840\u91cf\u6703\u589e\u52a0\uff0c\u6240\u4ee5\u8840\u58d3\u53ef\u4ee5\u8f03\u672a\u61f7\u5b55\u6642\u70ba\u9ad8\u3002 (B)\u547c\u5438\u9053\u5206\u6ccc\u7269\u6e1b\u5c11\uff0c\u4e0d\u5f71\u97ff\u63d2\u7ba1\u3002 (C)\u5ef6\u9577\u80c3\u6392\u7a7a\u6642\u9593\u8207\u8cc1\u9580\u64f4\u7d04\u808c\u8f03\u70ba\u9b06\u5f1b\uff0c\u9700\u9810\u9632\u5438\u5165\u6027\u80ba\u708e\u3002 (D)\u6f6e\u6c23\u5bb9\u7a4d( tidal volume )\u6703\u56e0\u70ba\u8377\u723e\u8499\u7684\u56e0\u7d20\u800c\u589e\u52a0\uff0c\u4f7f\u5f97\u5b55\u5a66\u8f03\u4e0d\u6613\u767c\u751f\u7f3a\u6c27\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4f9d\u64da\u53f0\u7063\u75be\u75c5\u7ba1\u5236\u7f72\u516c\u544a\uff0c\u65b0\u578b\u51a0\u72c0\u75c5\u6bd2\u611f\u67d3\u75ab\u60c5\u76f8\u95dc\u5c45\u5bb6\u63aa\u65bd\uff0c\u4f55\u8005\u6558\u8ff0\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5c45\u5bb6\u6aa2\u75ab\u6c11\u773e\uff0c\u9700\u63a1\u8cb7\u6c11\u751f\u5fc5\u9700\u54c1\u6642\uff0c\u53ef\u901a\u5831\u5f8c\u5916\u51fa\u3002 (B)\u81ea\u4e3b\u5065\u5eb7\u7ba1\u7406\u8005\u7531\u91cc\u9577\u6216\u91cc\u5e79\u4e8b\u8ca0\u8cac\u9032\u884c\u5065\u5eb7\u95dc\u61f7\u3002 (C)\u5c45\u5bb6\u9694\u96e2\u6c11\u773e\uff0c\u8ca0\u8cac\u55ae\u4f4d\u662f\u5730\u65b9\u885b\u751f\u4e3b\u7ba1\u6a5f\u95dc\u3002 (D)\u5c45\u5bb6\u6aa2\u75ab\u6c11\u773e\uff0c\u8ca0\u8cac\u55ae\u4f4d\u662f\u5730\u65b9\u885b\u751f\u4e3b\u7ba1\u6a5f\u95dc\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "22\u6b72\u5973\u6027\uff0c\u4e0b\u8179\u5ffd\u7136\u5287\u75db\uff0c\u81f3\u6025\u8a3a\u5c31\u91ab\u3002\u610f\u8b58\u6e05\u695a\uff0c\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\u3002\u7121\u5275\u50b7\uff0c\u6c92\u6709\u767c\u71d2\uff0c\u8fd1\u671f\u6708\u7d93\u7d04 2\u9031\u524d\uff0c\u6708\u7d93\u898f\u5247\u7d04 30~32\u5929\u9031\u671f\uff0c\u8d70\uf937\u8a98\u767c\u8179\u75db\u3002\u8840\u8272\u7d20 12.4 g/dL \uff0c\u9a57\u5b55\u5448\u9670\u6027\uff0c\u8179\u90e8\u96fb\u8166\u65b7\u5c64\uff1a \u53f3\u5074\u5375\u5de2\u7d04 3.8\u516c\u5206\u56ca\u816b(cystic mass ) \uff0c\u5167\u542b\u9ad8\u986f\u50cf\u7570\u5e38(high density content )\u7121\u9223\u5316\u56ca\u816b\uff0c\u9aa8\u76c6\u7a4d\u6db2\u3002\u4e0b\u5217\u8a3a\u65b7\u6216 \u8655\u7f6e\uff0c\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)Ovary torsion\uff0c\u7167\u6703\u5a66\u7522\u79d1\uff0c\u7acb\u5373\u5b89\u6392\u624b\u8853\u3002 (B)Rupture of appendicitis \uff0c\u7167\u6703\u5916\u79d1\uff0c\u5b89\u6392\u624b\u8853\u3002 (C)Rupture of corpus luteum cyst\uff0c\u7167\u6703\u5a66\u7522\u79d1\uff0c\u8ffd\u8e64\u8179\u90e8\u8d85\u97f3\u6ce2\u3002 (D)Complicated nephrolithiasis \uff0c\u6b62\u75db\uff0c\u7559\u89c0\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "65\u6b72\u7537\u6027\uff0c\u56e0\u80f8\u60b6\u88ab\uf937\u4eba\u9001\u81f3\u6025\u8a3a\uff0c\u75c5\u4eba\u4e3b\u8a34\u6709\u64e0\u58d3\u75bc\u75db\u611f\u81f3\u4e0b\u5df4\u53ca\u5de6\u80a9\u3002\u904e\u53bb\u8eab\u9ad4\u72c0\u6cc1\u826f\u597d\uff0c\u7121\u5fc3\u81df\u76f8\u95dc\u75c5\u53f2\uff0c\u76ee\u524d\u552f\u4e00\u670d\u7528\u7684\u85e5\u70ba\u6a02\u5a01\u58ef(Levitra\uff0cVardenafil ) \u3002\u5fc3\u96fb\u5716\u986f\u793a ST-segment elevation \uff0c\u62bd\u8840\u5831\u544a\u986f\u793atroponin -I\u53caCK-MB\u4e0a\u5347\uff0cD -Dimer\u6b63\u5e38\u503c\u3002\u7d93\u7531\u6025\u8a3a\u91ab\u5e2b\u521d\u6b65\u5224\u65b7\u70ba\u6025\u6027\u51a0\u5fc3\u75c7(acute coronary syndrome ) \uff0c\u63a5\u4e0b\u4f86\u7684\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u7acb\u5373\u7d66\u4e88 nitroglycerin (0.4mg \u820c\u4e0b\u9320) \uff0c\u6700\u591a\u5291\u91cf\u53ef\u4ee5\u7d66\u5230\u4e09\u6b21(\u6bcf\u6b21\u9593\u9694 5\u5206 \u9418 )\u3002 (B)\u9664\u975e\u6709\u8840\u58d3\u904e\u4f4e\u7b49\u7981\u5fcc\uff0c\u61c9\u4f8b\u884c\u53e6\u7d66\u4e88 morphine (4mg\uff0cIVP)\u6e1b\u7de9\u80f8\u60b6\u75c7\u72c0\u3002 (C)\u5373\u4f7f\u75c5\u4eba\u672c\u8eab\u5c0d\u65bc aspirin\u904e\u654f\uff0c\u4ecd\u61c9\u4f7f\u7528 clopidogrel (300mg)\u4ee3\u66ff\u3002 (D)ACE inhibitors \u4e0d\u61c9\u4f7f\u7528\u5728 LVEF(left ventricu lar ejection fraction)\u6b63\u5e38\u7684\u75c5\u4eba\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "28\u6b72\u5973\u6027\u61f7\u5b55\u7d04 32\u9031\uff0c\u904e\u99ac \uf937\u6642\u88ab\u6a5f\u8eca\u649e\u5012\u9001\u91ab\uff0c\u610f\u8b58\u6e05\u695a\uff0c\u751f\u547d\u5fb5\u8c61\uff1a\u8840\u58d3 132 /84 mmHg \u3001\u8108\u640f 85\u6b21/min\u3001\u547c\u5438 15\u6b21/min\u3001\u9ad4\u6eab 36.4\u2103\uff1b\u75c5\u4eba\u4e3b\u8a34\u4e0b\u8179\u4e0d\u9069\u4e14\u6709\u6db2\u9ad4\u81ea\u9670\u9053\u6d41\u51fa\uff0c\u8eab\u9ad4\u8a3a\u5bdf\u767c\u73fe\u4e0b\u8179\u7121\u660e\u986f\u58d3\u75db\uff0c\u6709\u95dc\u6b64\u5b55\u5a66\u7684\u8655\u7f6e\u8207\u5224\u65b7\uff0c\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u82e5\u78ba\u5b9a\u6db2\u9ad4\u70ba\u7f8a\u6c34\uff0c\u6b64\u75c5\u4eba\u4ecd\u6709\u8d85\u904e\u4e00\u534a\u7684\u6a5f\u6703\u65bc 3\u5929\u5f8c\u624d\u9032\u5165\u7522\u7a0b\u3002 (B)\u4f9d\u6b64\u75c5\u4eba\u7684\u61f7\u5b55\u9031\u6578\u53ef\u4f30\u8a08\u80ce\u5152\u80ba\u90e8\u5df2\u6210\u719f\uff0c\u7d66\u4e88 corticosteroids \u53ea\u6703\u589e\u52a0\u6bcd\u9ad4\u8207\u65b0\u751f\u5152\u6557\u8840\u75c7\u7684\u98a8\u96aa\u3002 (C)\u6234\u4e0a\u7121\u83cc\u624b\u5957\u9032\u884c\u9670\u9053\u6307\u6aa2\uff0c\u4f86\u78ba\u8a8d\u5b50\u5bae\u9838\u662f\u5426\u6709\u64f4\u5f35\u3002 (D)\u4f7f\u7528 nitrazine paper \u6e2c\u8a66\u9670\u9053\u6d41\u51fa\u7684\u6db2\u9ad4\uff0c\u82e5\u6df7\u6709\u8840\u6db2\uff0c\u53ef\u80fd\u6703\u6709\u507d\u967d\u6027\u7684\u7591\u616e\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u9583\u96fb\u50b7\u5bb3\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u9583\u96fb\u50b7\u5bb3\u901a\u5e38\u662f\u81f4\u547d\u7684\u3002 (B)\u9583\u96fb\u4e0d\u6703\u6253\u5728\u540c\u4e00\u500b\u5730\u65b9\u5169\u6b21\u3002 (C)\u884c\u52d5\u96fb\u8a71\u96fb\u5b50\u7522\u54c1\u6703\u5438\u5f15\u9583\u96fb\u3002 (D)\u9583\u96fb\u64ca\u50b7\u6703\u51fa\u73fe\u795e\u7d93\u76f8\u95dc\u7f3a\u640d\u53ca\u5f8c\u907a\u75c7\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "63\u6b72\u7537\u6027\uff0c\u4e3b\u8a34\u547c\u5438\u56f0\u96e3\u8207\u80f8\u60b6\uff0c\u6709\u7aef\u5750\u547c\u5438\u8207\u96d9\u8173\u6c34\u816b\u60c5\u5f62\uff0c\u9ad4\u6eab36.8\u00baC\uff0c\u5fc3\u8df3 143\u6b21/min\uff0c\u547c\u5438 23\u6b21/min\uff0c\u8840\u58d3 187/110mmHg \u300212\u5c0e\u7a0b\u5fc3\u96fb\u5716\u5448\u73fe\u5fc3\u623f\u986b\u52d5\uff0c\u8207\u5de6\u5fc3\u5ba4\u80a5\u5927\u3002\u8acb\u554f\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u4f7f\u7528 Diltiazem \u4f86\u964d\u4f4e\u6bcf\u5206\u9418\u5fc3\u8df3\u6578\u3002 (B)\u4f7f\u7528 Labetalol \u4f86\u964d\u4f4e\u8840\u58d3\u3002 (C)\u4f7f\u7528 Dobutamine \u4f86\u7de9\u89e3\u80ba\u90e8\u5145\u8840\u75c7\u72c0\u3002 (D)\u4f7f\u7528 Captopril \u4f86\u964d\u4f4e\u8840\u58d3\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u5c0d\u65bc\u8a3a\u65b7\u6ccc\u5c3f\u9053\u611f\u67d3( urinary tract infection, UTI )\u7684\u63cf\u8ff0\uff0c\u4ee5\u4e0b\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)Urine culture \u8207blood culture \u5c0dUTI\u7684\u8a3a\u65b7\u8207\u8655\u7f6e\u5f88\u91cd\u8981\u3002 (B)\u4ee5\u75c5\u4eba\u7684\u4e3b\u8a34\u8207\u5c0d\u75c7\u72c0\u7684\u63cf\u8ff0\uff0c\u53ef\u6b63\u78ba\u8a3a\u65b7\u51fa\u6ccc\u5c3f\u9053\u611f\u67d3\u3002 (C)\u5c3f\u6db2\u6aa2\u9a57 WBC\u6578\u91cf\uff0c\u5c0d\u8a3a\u65b7\u7121\u5e6b\u52a9\u3002 (D)\u5c3f\u6db2\u6aa2\u9a57 nitrite reaction \uff0c\u5c0d\u8a3a\u65b7 UTI\u6709\u5f88\u9ad8\u7684 specificity \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "21\u6b72\u7537\u6027\uff0c\u4e3b\u8a34\u53f3\u80f8\u75db\u3001\u547c\u5438\u56f0\u96e3\u524d\u4f86\u6025\u8a3a\u3002\u5230\u9662\u6642\u5fc3\u8df3 140\u6b21/min\uff0c\u8840\u58d376/50mmHg \uff0c\u547c\u5438 34\u6b21/min\uff0c\u8840\u6c27\u6fc3\u5ea6 86\uff05\uff0c\u8eab\u9ad4\u8a3a\u5bdf\u53f3\u5074\u547c\u5438\u97f3\u807d\u4e0d\u5230\uff0c\u6263\u8a3a\u53f3\u5074\u5448\u904e\u5ea6\u53cd\u97ff\u97f3\u3002\u8acb\u554f\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u6b64\u75c5\u4eba\u61c9\u70ba\u5f35\u529b\u6027\u6c23\u80f8\uff0c\u9700\u7acb\u523b\u9032\u884c\u80f8\u90e8\u91dd\u523a\u6e1b\u58d3(needle decompression )\u3002 (B)\u5728\u53f3\u5074\u80f8\u8154\u9032\u884c\u8d85\u97f3\u6ce2\u6aa2\u67e5\uff0csliding sign \u61c9\u70ba\u967d\u6027\u3002 (C)\u4f7f\u7528\u6c27\u6c23\u5206\u7387( FiO 2)\u5927\u65bc 28\uff05\u4e4b\u6c27\u6c23\u6cbb\u7642\u5c07\u80fd\u589e\u52a0\u808b\u819c\u8154\u6c23\u9ad4\u5438\u65363~4\u500d\u3002 (D)\u6b64\u75c5\u4eba\u5728\u9032\u884c\u80f8\u90e8\u91dd\u523a\u6e1b\u58d3\u5f8c\u9700\u4f7f\u7528 24~36 French \u4e4b\u80f8\u7ba1\u5f15\u6d41\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u8db3\u6708\u751f\u7522\u7684 3\u6b72\u5065\u5eb7\u7537\u7ae5\uff0c\u6309\u6642\u63a5\u53d7\u75ab\u82d7\u6ce8\u5c04\uff0c\u5305\u62ec\u80ba\u708e\u93c8\u7403\u83cc\u75ab\u82d7\uff0c\u56e0\u767c\u71d2\u5169\u5929\uff0c\u4e3b\u8a34\u53f3\u8033\u75bc\u75db\uff0c\u6aa2\u67e5\u767c\u73fe\u53f3\u5074\u8033\u819c\u9f13\u8139\u3001\u767c\u7d05\u4e26\u6709\u5206\u6ccc\u7269\u3002\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)Penicillin V \u662f\u5b89\u5168\u6709\u6548\u7684\u7b2c\u4e00\u7dda\u9996\u9078\u7528\u85e5\u3002 (B)\u5982\u679c\u75c5\u4eba\u5c0d Penicillin \u904e\u654f\uff0cClindamycin \u5247\u662f\u9996\u9078\u85e5\u7269\u3002 (C)\u75c5\u4eba\u5fc5\u9808\u5728 3\u5929\u5167\u518d\u6b21\u63a5\u53d7\u8a55\u4f30\u3002 (D)\u6297\u7d44\u7e54\u80fa\u53ca\u985e\u56fa\u9187\u4e5f\u662f\u91cd\u8981\u7684\u6cbb\u7642\u85e5\u7269\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "40\u6b72\u5de5\u4eba\uff0c\u5728\u5de5\u5ee0\u9032\u884c\u7ba1\uf937 \u7dad\u4fee\uff0c\u88dd\u6709\u82ef\u80fa( Aniline)\u7684\u7ba1\uf937\u7834\u88c2\u9020\u6210\u5674\u6ffa\uff0c4\u5c0f\u6642\u5f8c\u51fa\u73fe\u8eab\u9ad4\u4e0d\u9069\u7684\u60c5\u5f62\uff0c\u81ea\u884c\u81f3\u6025\u8a3a\u5ba4\u5c31\u91ab\uff0c\u95dc\u65bc\u75c5\u4eba\u7684\u8655\u7f6e\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u82e5\u8eab\u4e0a\u6709\u6c61\u67d3\u7269\u5247\u9032\u884c\u9664\u6c61\u3001\u6d17\u80c3\u53ca\u4f7f\u7528\u6d3b\u6027\u78b3\u3002 (B)\u82e5\u8840\u58d3\u964d\u4f4e\u5247\u7d66\u4e88\u8f38\u6db2\u53ca\u5347\u58d3\u5291( Dopamine \u6216Norepinephrine )\u3002 (C)\u82e5\u610f\u8b58\u6539\u8b8a\u5247\u7d66\u4e88\u7532\u70ef\u85cd(Methylene blue \uff0c1%\u6eb6\u6db2)5~10 mg/kg\u975c\u8108\u6ef4\u6ce8\u3002 (D)\u82e5\u80a2\u9ad4\u672b\u7aef\u767c\u7d3a\u5247\u7d66\u4e88\u6c27\u6c23\u4e26\u4ee5\u8840\u6c27\u76e3\u8996\u5668(Pulse oximeter )\u505a\u76e3\u6e2c\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc 5\u6b72\u5152\u7ae5\u547c\u5438\u9053\u7684\u69cb\u9020\u8207\u6210\u4eba\u4e0d\u540c\u4e4b\u8655\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)Hyoepiglottic ligament \u8f03\u70ba\u5805\u786c\uff0c\u6545\u63d2\u7ba1\u6642\u5589\u93e1\u4e0d\u6613\u6311\u8d77\u3002 (B)\u5c0f\u5152\u6703\u53ad( epiglottis)\u8f03\u7a84\u4e14\u8207\u6c23\u7ba1\u4ea4\u89d2\u8f03\u5782\u76f4\u3002 (C)\u5c0f\u5152\u5589\u90e8\u7684\u4f4d\u7f6e\u7d04\u5728\u9838\u690e\u7b2c\u56db\u81f3\u7b2c\u4e94\u7bc0\u8655\u3002 (D)\u80f8\u90e8\u8edf\u9aa8\u8f03\u591a\uff0c\u56e0\u6b64\u80f8\u90e8\u5f48\u6027\u56de\u5f48(elastic recoil )\u80fd\u529b\u8f03\u5927\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "40\u6b72\u7537\u6027\uff0c\u9ad4\u91cd 60\u516c\u65a4\uff0c\u6709\u6c23\u5598\u75c5\u53f2\uff0c\u7121\u5fc3\u81df\u65b9\u9762\u75be\u75c5\uff0c\u56e0\u9ad8\u71d2\u547c\u5438\u55983\u5929\u4f86\u6025\u8a3a\uff0c\u8a3a\u65b7\u53ef\u80fd\u70ba\u6c23\u5598\u6025\u6027\u767c\u4f5c\u4f75\u767c\u80ba\u708e\uff0c\u5fc3\u8df3 118\u6b21/min\uff0c\u8840\u58d3 92/45 mmHg \uff0c\u6b64\u6642\u9700\u8981\u63d2\u7ba1\uff0crapid -sequence intubation( RSI)\u4f60\u6700\u512a\u5148\u9078\u64c7\u7684\u85e5\u7269\u7d44\u5408\u70ba\u4f55\uff1f", + "Options": "(A)20 mg Etomidate \u300150mg Rocuronium \u3002 (B)100mg Ketamine \u300150mg Rocuronium \u3002 (C)100mg Lidocaine \u300120mg Etomidate \u3002 (D)100mg Lidocain e\u300110mg Midazolam \u300120mg Etomidate \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6025\u8a3a\u50b7\u53e3\u8655\u7406\uff0c\u7834\u50b7\u98a8\u985e\u6bd2\u7d20 toxoid\u9810\u9632\u6ce8\u5c04\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)1\u6b72\u4ee5\u4e0b\u5b30\u5152\u6709\u50b7\u53e3\u90fd\u61c9\u6ce8\u5c04 toxoid 0.01ml/kg \u3002 (B)65\u6b72\u4ee5\u4e0a\u8001\u4eba\u5291\u91cf\u61c9\u70ba 0.5mL\u3002 (C)\u5b55\u5a66\u5728 first trimester \u61c9\u907f\u514d\u6ce8\u5c04 toxoid\u3002 (D)\u6ce8\u5c04 toxoid\u4e0d\u53ef\u4f75\u7528 Tetanus Immune Globulin (TIG)\u4ee5\u514d\u4e2d\u548c\u985e\u6bd2\u7d20\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4f9d\u64da\u53f0\u7063\u75be\u75c5\u7ba1\u5236\u7f72\u53ca WHO\u5efa\u8b70\uff0c\u7591\u4f3c\u65b0\u578b\u51a0\u72c0\u75c5\u6bd2\u611f\u67d3\u75c5\u4eba\u8655\u7f6e\uff0c\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u9000\u71d2\u85e5\u7269\u5efa\u8b70\u4f7f\u7528 Ibuprofen \uff0c\u4e0d\u5efa\u8b70\u4f7f\u7528 Acetaminophen \u3002 (B)\u7528\u5bc6\u9589\u5f0f\u62bd\u75f0\u7ba1\uff0c\u5728\u65b7\u958b\u547c\u5438\u7ba1\uf937\u9023\u63a5\u6642\uff0c\u9700\u593e\u4f4f\u6c23\u7ba1\u5167\u7ba1\u3002 (C)\u75c5\u4eba\u4ecd\u6709\u81ea\u4e3b\u547c\u5438\u6642\uff0c\u53ef\u7528\u7526\u9192\u7403\u64e0\u58d3\u63db\u6c23\u3002 (D)\u63d2\u7ba1\u6642\u70ba\u907f\u514d\u98db\u6cab\u5674\u6ffa\uff0c\u4e0d\u61c9\u7528\u5f71\u50cf\u5589\u93e1(video -assisted laryngoscope )\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u4f55\u8005\u70ba\u6c23\u5598\u767c\u4f5c\u9020\u6210\u731d\u6b7b\u7684\u5371\u96aa\u56e0\u5b50\u4e4b\u4e00\uff1f", + "Options": "(A)\u904e\u53bb\u4e00\u5e74\u6709\u6c23\u5598\u767c\u4f5c\u800c\u4f4f\u9662\u4f46\u6700\u8fd1\u4e00\u500b\u6708\u6c92\u6709\u56e0\u6c23\u5598\u4f4f\u9662\u3002 (B)\u76ee\u524d\u6709\u4f7f\u7528 systemic corticosteroids \u3002 (C)\u75c5\u4eba\u611f\u89ba\u76ee\u524d\u6c23\u5598\u767c\u4f5c\u662f\u56b4\u91cd\u7684\u3002 (D)\u76ee\u524d\u4f7f\u7528 over-the-counter(OTC)\u85e5\u7269\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u570b\u5916\u65c5\u904a\u53f2\u7684\u75c5\u4eba\uff0c\u51fa\u73fe\u767c\u71d2\u4f86\u5230\u6025\u8a3a\uff0c\u4f9d\u64da 2019\u5e74\u75be\u7ba1\u5c40\u75c5\u4f8b\u7d71\u8a08\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u53f0\u7063\u5730\u5340\u6cd5\u5b9a\u50b3\u67d3\u75c5\u5883\u5916\u79fb\u5165\u75c5\u4f8b\u4ee5\u767b\u9769\u71b1\u75c5\u4f8b\u6578\u6700\u591a\u3002 (B)\u6025\u6027\u75c5\u6bd2\u6027 A\u578b\u809d\u708e\u611f\u67d3\u4ee5\u8d8a\u5357\u3001\u5370\u5c3c\u8fd4\u570b\u4e4b\u75c5\u4eba\u70ba\u4e3b\u3002 (C)\u82e5\u5f9e\u65b0\u52a0\u5761\u8fd4\u570b\u5408\u4f75\u767c\u71d2\u8207\u76ae\u819a\u7d05\u75b9\uff0c\u9700\u9ad8\u5ea6\u61f7\u7591\u767b\u9769\u71b1\u6216\u9ebb\u75b9\u4e4b\u611f\u67d3\u3002 (D)\u963f\u7c73\u5df4\u75e2\u75be\uff0c\u5e38\u51fa\u73fe\u65bc\u975e\u6d32\u8fd4\u570b\u5408\u4f75\u767c\u71d2\u3001\u8179\u75db\u8207\u8179\u7009\u4e4b\u75c5\u4eba\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "50\u6b72\u7537\u6027\uff0c\u559d\u4e0b\u79c1\u91c0\u7684\u7c73\u9152 10\u5c0f\u6642\u5f8c\u56e0\u70ba\u982d\u6688\u3001\u5641\u5fc3\u3001\u8996\u529b\u6a21\u7cca\u81f3\u6025\u8a3a\uff0c\u751f\u547d\u5fb5\u8c61\uff1a \u9ad4\u6eab 36.8\u2103\u3001\u547c\u5438 18\u6b21/min\u3001\u5fc3\u8df3 92\u6b21/min\u3001\u8840\u58d3 169/85 mmHg \uff0c\u6aa2\u9a57\u5831\u544a\uff1aNa 142 mEq/L\u3001Cl 109 mEq/L\u3001BUN 14 mg/dL\u3001Glu 126 mg/dL \u3001Ketone body \uff1anegative\u3001Ethanol 9 mg/dL\u3001Blood osmolality 320 mOsm/Kg\uff0c\u53e6\u5916\u52d5\u8108\u8840\u70ba ABG pH 7.29\u3001 PCO 2 25.4 mmHg\u3001HCO 3 12.5 m Eq/L\uff0c\u6839\u64da\u4ee5\u4e0a\u7684\u6578\u64da\uff0c\u7814\u5224\u500b\u6848\u53ef\u80fd\u8aa4\u98df\u7532\u9187\uff0c\u8acb\u554f\u500b\u6848\u6b64\u6642\u8840\u4e2d\u7684\u7532\u9187\u6fc3\u5ea6 \u6700\u6709\u53ef\u80fd \u662f\u591a\u5c11\uff1f", + "Options": "(A)20 mg/dL \u3002 (B)40 mg/dL \u3002 (C)70 mg/dL \u3002 (D)150 mg/dL \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "35\u6b72\u5065\u5eb7\u7537\u6027\uff0c\u6bcf\u5929\u81f3\u5065\u8eab\u623f\u7a4d\u6975\u8a13\u7df4 1\u500b\u534a\u5c0f\u6642\uff0c\u9023\u7e8c 2\u5929\u5f8c\u5168\u8eab\u808c\u8089\u75e0\u75db\u7121\u529b\uff0c\u5c3f\u6db2\u984f\u8272\u8b8a\u300c\u53ef\u6a02\u300d\u984f\u8272\uff0c\u8a3a\u65b7\u70ba\u6a6b\u7d0b\u808c\u6eb6\u89e3\u75c7\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u75c5\u4eba\u5728\u75be\u75c5\u65e9\u671f\u6703\u6709\u4f4e\u8840\u78f7\u7684\u60c5\u5f62\u3002 (B)\u75c5\u4eba\u56e0\u70ba\u5168\u8eab\u808c\u8089\u75e0\u75db\u53ca\u767c\u708e\u7684\u72c0\u6cc1\u7d66\u4e88 NSAID\u6b62\u75db\u53ca\u6297\u767c\u708e\u3002 (C)\u5230\u9662\u524d\u61c9\u7acb\u523b\u7d66\u4e88\u542b\u4e73\u9178\u8f38\u6db2( Lactate Ringer )\u3002 (D)\u7121\u524d\u77bb\u6027\u7814\u7a76\u8b49\u5be6\u7d66\u4e88 sodium bicarbonate \u9e7c\u5316\u5c3f\u6db2\u5c0d\u9810\u5f8c\u6709\u5e6b\u52a9\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u904b\u7528\u5e8a\u908a\u4f11\u514b\u5feb\u901f\u8d85\u97f3\u6ce2\u6383\u63cf( Rapid Ultrasound in Shock, RUSH protocol) \uff0c\u9451\u5225\u8a3a\u65b7\u4e0d\u660e\u539f\u56e0\u4f11\u514b\uff0c\u4e0b\u5217\u6b65\u9a5f\u9806\u5e8f\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u4e0b\u8154\u975c\u8108\u2192 \u4e3b\u52d5\u8108\u2192 \u5fc3\u81df\u2192\u8179\u8154\u5167(Morison\u2019s Pouch, EFAST ) \u2192\u80ba\u90e8\u3002 (B)\u5fc3\u81df \u2192\u4e3b\u52d5\u8108 \u2192\u4e0b\u8154\u975c\u8108\u2192 \u8179\u8154\u5167(Morison\u2019s Pouch, EFAST ) \u2192\u80ba\u90e8\u3002 (C)\u4e3b\u52d5\u8108 \u2192\u5fc3\u81df \u2192\u4e0b\u8154\u975c\u8108\u2192 \u8179\u8154\u5167(Morison\u2019s Pouch, EFAST ) \u2192\u80ba\u90e8\u3002 (D)\u5fc3\u81df \u2192\u4e0b\u8154\u975c\u8108\u2192 \u8179\u8154\u5167(Morison\u2019s Pouch, EFAST )\u2192\u4e3b\u52d5\u8108\u2192 \u80ba\u90e8\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "36\u6b72\u5168\u8eab\u9152\u6c23\u7684\u4e2d\u5e74\u7537\u6027\u56e0\u70ba\u5bb6\u66b4\u88ab EMT\u8207\u8b66\u65b9\u9001\u5165\u6025\u8a3a\uff0c\u592a\u592a\u8868\u793a\u75c5\u4eba\u9577\u671f\u9157\u9152\uff0cEMT \u63cf\u8ff0\u73fe\u5834\u6709\u653b\u64ca\u884c\u70ba\uff0c\u6240\u4ee5\u5df2\u7d93\u88ab\u7d04\u675f\u3002\u4f60\u5feb\u901f\u6aa2\u67e5\u77b3\u5b54\u8207\u624b\u8173\u808c\u529b\u6c92\u6709\u7570\u5e38\uff0c\u982d\u90e8\u6c92\u6709\u660e\u986f\u5916\u50b7\u3002\u4e0b\u5217\u4f55\u7a2e\u8655\u7f6e\u8f03\u9069\u7576 \uff1f", + "Options": "(A)Olanzapine 5 mg + Loraze pam 1 m g\u808c\u8089\u6ce8\u5c04\u3002 (B)Haloperidal 10 mg \u975c\u8108\u6ce8\u5c04\u3002 (C)Lorazepam \u5c0d\u6b64\u985e\u75c5\u4eba\u6703\u7522\u751f\u904e\u5ea6\u93ae\u975c\uff0c\u4e0d\u5efa\u8b70\u4f7f\u7528\u3002 (D)\u82e5\u75c5\u4eba\u9858\u610f\uff0c\u53ef\u4ee5\u7d66\u4e88 Olanzapine \u901f\u6eb6\u9320 5 mg\u53e3\u670d\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "21\u6b72\u7537\u6027\uff0c\u4e3b\u8ff0\u9593\u6b47\u6027\u767c\u71d2\u548c\u5589\u56a8\u75db 14\u5929\u3002\u75c5\u4eba\u6709\u591a\u4f4d\u6027\u4f34\u4fb6\u3002\u8eab\u9ad4\u8a3a\u5bdf\u767c\u73fe\u4e0a\u5507\u6709\u6578\u500b\u5c0f\u6c34\u6ce1\uff0c\u53e3\u8154\u9ecf\u819c\u6709\u591a\u8655\u6f70\u760d\uff0c\u96d9\u5074\u6241\u6843\u817a\u816b\u4f75\u6709\u767d\u8272\u5206\u6ccc\u7269\uff0c\u9838\u90e8\u6dcb\u5df4\u7bc0\u75bc\u75db\uff0c\u809d\u81df\u8f15\u5fae\u816b\u5927\uff0c\u8eab\u4e0a\u6c92\u6709\u76ae\u819a\u75b9\u3002\u54ea\u4e00\u7a2e\u75c5\u539f\u9ad4\u662f\u6700\u6709\u53ef\u80fd\u5f15\u767c\u4e0a\u8ff0\u75c7\u72c0\uff1f", + "Options": "(A)HIV \u3002 (B)Cytomegalovirus \u3002 (C)Epstein -Barr virus \u3002 (D)Herpes simplex virus \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u5982\u810a\u690e\u9aa8\u6298\u6703\u5f71\u97ff\u547c\u5438\u53ca\u6a6b\u8188\u819c\uff0c\u7576\u61f7\u7591\u54ea\u4e00\u7bc0(\u542b)\u4ee5\u4e0a\u640d\u50b7\u9700\u8981\u4f7f\u7528\u9032\u968e\u547c\u5438\u9053\uff1f", + "Options": "(A)C5 \u3002 (B)C6 \u3002 (C)C7 \u3002 (D)T1\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u8179\u819c\u900f\u6790\u76f8\u95dc\u7684\u8179\u819c\u708e( PD-related peritonitis )\u4e4b\u6558\u8ff0\uff0c\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u8179\u6c34\u7684 cell count \u901a\u5e38\u5927\u65bc 500 WBC/ \u00b5L\u5408\u4f75\u5927\u65bc 50\uff05 PMN\u3002 (B)\u5e38\u898b\u81f4\u75c5\u83cc\u70ba S. epidermidis \uff0cS. aureus \uff0cStreptococcus species \u548cgram -negative bacteria \u3002 (C)\u5e38\u898b\u7684\u75c7\u72c0\u662f\u8179\u75db\uff0c\u6709\u6642\u4e5f\u53ef\u80fd\u5408\u4f75\u767c\u71d2\u3002 (D)\u6297\u751f\u7d20\u512a\u5148\u4f7f\u7528\u8179\u819c\u5167\u7d66\u4e88\u7b2c\u4e00\u4ee3 Cephalosporin \u52a0\u4e0aGentamycin \u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "65\u6b72\u5973\u6027\uff0c\u56e0\u4e0b\u80cc\u75db\u8207\u53f3\u5c0f\u817f\u5916\u5074\u75bc\u75db\u5169\u5929\u81f3\u6025\u8a3a\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u7591\u4f3c\u690e\u9593\u76e4\u7a81\u51fa\uff0c\u78ba\u5b9a\u8a3a\u65b7\u61c9\u5b89\u6392\u76f8\u95dc\u90e8\u4f4d\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u3002 (B)\u61f7\u7591\u5750\u9aa8\u795e\u7d93\u75db\uff0c\u82e5\u7121\u5176\u4ed6\u56b4\u91cd\u75be\u75c5\u98a8\u96aa\uff0c\u6025\u8a3a\u4e0d\u9700\u505a\u8a3a\u65b7\u6027\u6aa2\u67e5\u3002 (C)\u985e\u56fa\u9187\u6cbb\u7642\u690e\u9593\u76e4\u7a81\u51fa\uff0c\u80fd\u6539\u5584\u795e\u7d93\u529f\u80fd\uff0c\u4f46\u4e0d\u80fd\u964d\u4f4e\u9700\u9032\u884c\u624b\u8853\u7684\u53ef\u80fd\u6027\u3002 (D)\u61c9\u5efa\u8b70\u75c5\u4eba\u81e5\u5e8a\u4f11\u606f 2\u9031\uff0c\u907f\u514d\u6301\u7e8c\u6027\u65e5\u5e38\u6d3b\u52d5\uff0c\u4ee5\u6e1b\u5c11\u75bc\u75db\u75c7\u72c0\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u54ea\u4e00\u7a2e\u6297\u7672\u7647\u53e3\u670d\u85e5\u7269\u904e\u91cf\u6642\uff0c \u6700\u9700\u8981\u9032\u884c\u5fc3\u96fb\u5716\u76e3\u6e2c\uff1f", + "Options": "(A)Carbamazepine \u3002 (B)Levetiracetam \u3002 (C)Phenytoin \u3002 (D)Valproic acid \u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "4\u6b72\u7537\u7ae5\uff0c\u54b3\u55fd\u6709\u72d7\u5420\u8072\uff0c\u767c\u71d2 2\u5929\uff0c\u6628\u5929 \u5df2\u65bc\u6025\u8a3a\u4f7f\u7528\u814e\u4e0a\u817a\u7d20(Epinephrine )\u84b8\u6c23\u6cbb\u7642\u672a\u6539\u5584\u3002\u4eca\u65e5\u88ab\u767c\u73fe\u8072\u97f3\u6c99\u555e\uff0c\u9032\u5c55\u6027\u547c\u5438\u56f0\u96e3\uff0c\u8eab\u9ad4\u8a3a\u5bdf\u767c\u73fe\u5438\u6c23\u548c\u5410\u6c23\u90fd\u6709\u5598\u9cf4\u8072(stridor ) \uff0c\u610f\u8b58\u55dc\u7761\uff0c\u81c9\u90e8\u767c\u7d3a\uff0c\u547c\u5438\u4f7f\u7528\u8f14\u52a9\u547c\u5438\u808c\uff0c\u5fae\u8840\u7ba1\u56de\u5145\u6642\u9593\u70ba 2\u79d2\uff0c\u4e0b\u5217\u4f55\u8005\u70ba \u6700\u53ef\u80fd\u8a3a\u65b7\uff1f", + "Options": "(A)\u7d30\u83cc\u6027\u6c23\u7ba1\u708e( bacterial tracheitis )\u3002 (B)\u54ee\u543c( croup)\u3002 (C)\u6703\u53ad\u708e(epiglottitis)\u3002 (D)\u5f8c\u54bd\u90e8\u81bf\u760d( retropharyngeal abscess )\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u7cbe\u795e\u8e81\u52d5( agitation)\u4e4b\u8655\u7f6e\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5b89\u975e\u4ed6\u547d\u4e2d\u6bd2\u5f15\u8d77\u4e4b\u7cbe\u795e\u8e81\u52d5\u61c9\u6295\u8207 5-10mg Olanzapine \u3002 (B)\u9152\u7cbe\u4e2d\u6bd2\u75c5\u4eba\u5f15\u8d77\u4e4b\u7cbe\u795e\u8e81\u52d5\u61c9\u6295\u8207 2-10mg Haloperidol \u3002 (C)\u9152\u7cbe\u6212\u65b7\u5fb5\u5019\u7fa4\u4e4b\u75c5\u4eba\u61c9\u6295\u8207 2mg Risperidone \u3002 (D)\u8907\u96dc\u4e14\u96e3\u4ee5\u5340\u5206\u4e4b\u7cbe\u795e\u8e81\u52d5\u75c5\u4eba\u4e0d\u61c9\u6295\u8207\u85e5\u7269\u6cbb\u7642\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u81bd\u56ca\u7d50\u77f3\u53ca\u5176\u4f75\u767c\u75c7\u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u8179\u90e8\u96fb\u8166\u65b7\u5c64\u6383\u63cf\u8a3a\u65b7\u81bd\u56ca\u7d50\u77f3\u4e4b\u654f\u611f\u6027(sensitivity )\u8f03\u8d85\u97f3\u6ce2\u6aa2\u67e5\u9ad8\u3002 (B)\u975e\u985e\u56fa\u9187\u6d88\u708e\u6b62\u75db\u85e5( NSAIDs)\u53ef\u4f5c\u70ba\u81bd\u7d5e\u75db\u767c\u4f5c\u6642\u4e4b\u9996\u9078\u6b62\u75db\u85e5\u3002 (C)\u6aa2\u9a57 C\u53cd\u61c9\u86cb\u767d(C-reactive protein)\u5c0d\u8a3a\u65b7\u6025\u6027\u81bd\u56ca\u708e\u6c92\u6709\u5e6b\u52a9\u3002 (D)\u8d85\u97f3\u6ce2\u8a3a\u65b7\u81bd\u56ca\u708e\uff0c\u81bd\u58c1\u589e\u539a\u53ca\u81bd\u56ca\u9031\u570d\u7a4d\u6db2\u7684\u767c\u73fe\u5177\u6709\u5f88\u9ad8\u7684\u7279\u7570\u6027(specificity )\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "45\u6b72\u5973\u6027\uff0c\u904e\u53bb\u6709\u6c23\u5598\u75c5\u53f2\uff0c\u9577\u671f\u5728\u80f8\u8154\u5167\u79d1\u9580\u8a3a\u8ffd\u8e64\uff0c\u6b64\u6b21\u56e0\u547c\u5438\u5598(dyspnea )\u81f3\u6025\u8a3a\u5c31\u91ab\u3002\u4ed4\u7d30\u8a62\u554f\u75c5\u4eba\u5598\u7684\u72c0\u6cc1\uff0c\u75c5\u4eba\u8868\u793a\u9023\u4f11\u606f\u6642\u90fd\u6703\u5598\uff0c\u96d6\u4e0d\u81f3\u65bc\u5598\u5230\u9023\u5b57\u90fd\u8aaa\u4e0d\u51fa\u4f86\uff0c\u4f46\u6703\u5f71\u97ff\u8207\u4eba\u5c0d\u8a71\u3002\u6709\u95dc\u75c5\u4eba\u7684\u81e8\u5e8a\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u4f9d\u64da\u75c5\u4eba\u7684\u75c7\u72c0\u63cf\u8ff0\uff0c\u9810\u6e2c\u5176\u5c16\u5cf0\u5410\u6c23\u6d41\u901f(peak expiratory flow, PEF)\u61c9\u70ba\u6c23\u5598\u6025\u6027\u767c\u4f5c\u56b4\u91cd\u5ea6\u7684\u4e2d\u7b49 (moderate)\u7a0b\u5ea6\u3002 (B)\u4f9d\u64da\u6b64\u75c5\u4eba\u7684\u6c23\u5598\u767c\u4f5c\u56b4\u91cd\u5ea6\uff0c\u4e0d\u592a\u9700\u8981\u9032\u884c\u52d5\u8108\u8840\u6c23\u9ad4\u5206\u6790\u3002 (C)\u8003\u616e\u4f7f\u7528\u9577\u6548\u578b\u7684 \u03b22 agonist \u642d\u914d Ipratropium \u5438\u5165\u5291\u578b\uff0c\u8fc5\u901f\u8b93\u652f\u6c23\u7ba1\u64f4\u5f35\u3002 (D)\u4f9d\u64da\u6b64\u75c5\u4eba\u75c7\u72c0\uff0c\u53ef\u4ee5\u4f7f\u7528\u53e3\u670d\u985e\u56fa\u9187\uff0c\u8d8a\u65e9\u4f7f\u7528\u53ef\u4ee5\u964d\u4f4e\u75c5\u4eba\u4f4f\u9662\u7684\u9700\u8981\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "36\u6b72\u5973\u6027\uff0c\u6c92\u6709\u904b\u52d5\u7fd2\u6163\uff0c\u5831\u540d\u99ac\u62c9\u677e\u8cfd\u4e8b\u3002\u7d93\u904e\u6578 \u9031\u7684\u7df4\u7fd2\u5f8c\uff0c\u8d70\uf937 \u548c\u722c\u6a13\u68af\u5e38\u6703\u611f\u5230\u819d\u84cb\u524d\u5074\u75bc\u75db\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u597d\u767c\u65bc\u80a1\u56db\u982d\u808c\u7684\u808c\u529b\u4e0d\u8db3\uff0c Q\u89d2\u5ea6( Q angle)\u5c0f\u65bc 20\u5ea6\u7684\u5973\u6027\u3002 (B)\u75c7\u72c0\u5e38\u70ba\u96d9\u8173\u540c\u6642\u767c\u751f\uff0c\u4e14\u70ba\u6f38\u9032\u5f0f\u7684\u75bc\u75db\u3002 (C)\u82e5\u6d3b\u52d5\u6642\u611f\u5230\u819d\u84cb\u4e0d\u9069\uff0c\u61c9\u4fdd\u6301\u819d\u84cb\u5f4e\u66f2\u4f11\u606f\u3002 (D)\u95dc\u7bc0\u93e1\u624b\u8853\u53ef\u80fd\u6703\u4fc3\u4f7f\u7126\u78f7\u9178\u9223(calcium pyrophosphate )\u91cb\u653e\uff0c\u9020\u6210\u56b4\u91cd\u7684\u6ed1\u819c\u708e\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u601d\u89ba\u5931\u8abf\u75c7\u7684\u8a3a\u65b7\u6e96\u5247\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5fc5\u9808\u8981\u6709\u5169\u9805\u8ca0\u6027\u75c7\u72c0(negative symptoms)\u3002 (B)\u5fc5\u9808\u8981\u6709\u50f5\u76f4\u884c\u70ba\u3002 (C)\u5fc5\u9808\u8981\u6709\u5984\u60f3\u3001\u5e7b\u89ba\u6216\u80e1\u8a00\u4e82\u8a9e\u5176\u4e2d\u4e00\u9805\u3002 (D)\u6d3b\u8e8d\u671f\u75c7\u72c0\u4f34\u96a8\u9b31\u75c7\u767c\u4f5c\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "82\u6b72\u7537\u6027\u5728\u5b89\u990a\u6a5f\u69cb\u51fa\u73fe\u6ce8\u610f\u529b\u7121\u6cd5\u96c6\u4e2d\u3001\u60c5\u7dd2\u8d77\u4f0f\u8f03\u5927\u548c\u8a8d\u77e5\u7570\u5e38\u7b49\u75c7\u72c0\u88ab\u9001\u81f3\u6025\u8a3a\uff0c\u904e\u53bb\u6709\u5931\u667a\u75c7\u75c5\u53f2\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u61c9\u76e1\u65e9\u63d0\u4f9b\u75c5\u4eba\u8212\u9069\u7684\u9694\u96e2\u74b0\u5883\uff0c\u7531\u91ab\u9662\u6d3e\u54e1\u6212\u8b77\uff0c\u6e1b\u5c11\u56e0\u5bb6\u5c6c\u63a5\u89f8\u800c\u523a\u6fc0\u75c5\u4eba\u3002 (B)\u82e5\u75c5\u4eba\u51fa\u73fe\u8e81\u52d5\u60c5\u6cc1\uff0c\u5efa\u8b70\u512a\u5148\u7d66\u4e88 Benzodiazepines \u985e\u85e5\u7269\uff0c\u5e6b\u52a9\u7de9\u89e3\u75c7\u72c0\u3002 (C)\u80a2\u9ad4\u7d04\u675f\u5efa\u8b70\u76e1\u65e9\u4f7f\u7528\u5728\u8e81\u52d5\u7684\u75c5\u4eba\u8eab\u4e0a\uff0c\u907f\u514d\u75c5\u4eba\u51fa\u73fe\u81ea\u50b7\u7684\u60c5\u5f62\u3002 (D)\u6182\u9b31\u75c7\u75c5\u4eba\u4e4b\u75c7\u72c0\u53ef\u80fd\u548c\u4f4e\u6d3b\u52d5\u6027\u5931\u667a\u75c7\u76f8\u50cf\uff0c\u4f46\u6182\u9b31\u75c7\u75c5\u4eba\u75c7\u72c0\u8f03\u5c11\u5feb\u901f\u6ce2\u52d5\u8d77\u4f0f\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u4f55\u8005\u70ba Ottawa knee rule \u6240\u5217\u9700\u8981\u7167 X\u5149\u7247\u7684\u689d\u4ef6\uff1f", + "Options": "(A)Fibular head \u58d3\u75db\u3002 (B)Tibial condyle \u58d3\u75db\u3002 (C)\u5e74\u7d00\u5927\u65bc 65\u6b72\u3002 (D)\u80fd\u5426\u627f\u8f09\u9ad4\u91cd\u884c\u8d70 2\u6b65\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u85e5\u7269\u7576\u4e2d\uff0c\u4f55\u8005\u4e0d\u80fd\u6e1b\u5c11\u6025\u6027\u5fc3\u808c\u6897\u585e\u4e4b\u5f8c\u7684\u4e3b\u8981\u5fc3\u81df\u4e0d\u826f\u4e8b\u4ef6 (major adverse cardiac events )\u7684\u767c\u751f\uff1f", + "Options": "(A)Aspirin and Clopidogrel \u3002 (B)Bisoprolol \u3002 (C)Captopril \u3002 (D)Dilitazem \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "70\u6b72\u7537\u6027\u56e0\u5916\u50b7\u6027\u6c23\u8840\u80f8\uff0c\u9aa8\u76c6\u8154\u9aa8\u6298\u5408\u4f75\u9aa8\u76c6\u8154\u51fa\u8840\u5f9e\u4ed6\u9662\u8f49\u8a3a\uff0c\u76ee\u524d\u5df2\u7d93\u8f38\u8840 10\u55ae\u4f4d\u7684\u7d05\u8840\u7403\u6fc3\u539a\u6db2(p acked RBC) \uff0c\u91dd\u5c0d\u8a72\u75c5\u4eba\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u6839\u64da\u5927\u91cf\u8f38\u8840\u7684\u5b9a\u7fa9\u4f86\u8aaa\uff0c\u8a72\u75c5\u4eba\u5c1a\u672a\u9054\u5230\u5927\u91cf\u8f38\u8840\u3002 (B)\u75c5\u4eba\u63a5\u4e0b\u4f86\u8f38\u8840\u6700\u597d\u53ef\u4ee5\u52a0\u4e0a\u8840\u5c0f\u677f\u53ca\u8840\u6f3f\u8f38\u6ce8\uff0c\u5be6\u8b49\u986f\u793a\u4e09\u8005\u6bd4\u4f8b\u9808\u70ba 1\uff1a1\uff1a1\u3002 (C)\u9808\u6ce8\u610f\u75c5\u4eba\u662f\u5426\u6709\u4f4e\u9ad4\u6eab\u3001\u51dd\u8840\u7570\u5e38\u3001\u4ee5\u53ca\u8f38\u8840\u5c0e\u81f4\u80ba\u6c34\u816b\u7522\u751f\uff0c\u6b64\u4e09\u4e8b\u4ef6\u7a31\u70ba\u5916\u50b7\u81f4\u547d\u4e09\u89d2\u3002 (D)\u6301\u7e8c\u8f38\u8840\uff0c\u9700\u8981\u6ce8\u610f\u56e0\u6ab8\u6aac\u9178\u8207\u8840\u4e2d\u9223\u96e2\u5b50\u7d50\u5408\u800c\u7522\u751f\u4f4e\u8840\u9223\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "54\u6b72\u5065\u5eb7\u5973\u6027\uff0c\u904e\u53bb 14\u5929\u66fe\u6709\u570b\u5916\u65c5\u904a\u53f2\uff0c 3\u5929\u524d\u958b\u59cb\u767c\u71d2\u3001\u808c\u8089\u75e0\u75db\u3001\u54b3\u55fd\u5408\u4f75\u5473\u89ba\u8207\u55c5\u89ba\u7570\u5e38\u3002\u56e0\u6301\u7e8c\u9ad8\u71d2\uff0c\u5168\u8eab\u5026\u6020\u8207\u5598\u5230\u6025\u8a3a\uff0c\u80f8\u90e8X\u5149\u986f\u793a\u96d9\u5074\u4e0b\u8449\u6591\u584a\u72c0\u9593\u8cea\u6d78\u6f64(patchy interstitial infiltrates ) \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u53ef\u80fd\u662f COVID-19 (2019 novel coronavirus disease ) \uff0c\u75c5\u539f\u662f alpha\u5c6c\u7684\u51a0\u72c0\u75c5\u6bd2\u3002 (B)\u7b26\u5408\u75be\u7ba1\u7f72\u7b2c\u4e94\u985e\u6cd5\u5b9a\u50b3\u67d3\u75c5\u56b4\u91cd\u7279\u6b8a\u6027\u50b3\u67d3\u6027\u80ba\u708e\u901a\u5831\u689d\u4ef6\uff0c\u9700\u8981\u63a1\u9001\u54bd\u5589\u64e6\u62ed\u6db2\u8207\u75f0\u6db2\u8207\u8840\u6e05\u3002 (C)\u6b64\u75c5\u4eba\u82e5\u70ba\u78ba\u8a3a\u500b\u6848\uff0c\u540c\u4f4f\u7121\u75c7\u72c0\u7684\u5148\u751f\u9700\u8981\u81ea\u4e3b\u5065\u5eb7\u7ba1\u7406\u3002 (D)COVID-19 \u662f\u4ee5\u6838\u9178\u6aa2\u6e2c PCR\u967d\u6027\u70ba\u8a3a\u65b7\u4f9d\u64da\uff0c\u75c5\u6bd2\u57f9\u990a\u4e0d\u5bb9\u6613\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u6709\u95dc\u6025\u6027\u80ba\u6c34\u816b\u6cbb\u7642\u7684\u6558\u8ff0\uff0c\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u964d\u4f4e\u5fc3\u81df\u5f8c\u8ca0\u8377\uff0c\u53ef\u964d\u4f4e\u63d2\u7ba1\u6a5f\u7387\u3002 (B)\u76f8\u8f03\u65bc\u540c\u6642\u4f7f\u7528\u8840\u7ba1\u8212\u5f35\u5291\uff0c\u55ae\u7368\u4f7f\u7528\u975c\u8108\u6ce8\u5c04 Furosemide \u4e26\u4e0d\u80fd\u964d\u4f4e\u63d2\u7ba1\u6a5f\u7387\u3002 (C)\u7528\u55ce\u5561\u985e\u85e5\u7269\u4f86\u6cbb\u7642\uff0c\u53ef\u80fd\u589e\u52a0\u4f4f\u9662\u6642\u9593\u8207\u6b7b\u4ea1\u7387\u3002 (D)\u975e\u4fb5\u5165\u6027\u6b63\u58d3\u547c\u5438\u6703\u589e\u52a0\u5fc3\u81df\u5f8c\u8ca0\u8377\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "28\u6b72\u5973\u6027\uff0c\u61f7\u5b55 24\u9031\uff0c\u958b\u8eca\u8ffd\u649e\u524d\u8eca\uff0c\u6709\u7e6b\u5b89\u5168\u5e36\uff0c\u5b89\u5168\u6c23\u56ca\u672a\u7206\u958b\uff0c\u751f\u547d\u5fb5\u8c61\u6b63\u5e38\uff0c\u8179\u75db\u7a0b\u5ea6 5/10\uff0c\u65bc\u6025\u8a3a\u4e4b\u8d85\u97f3\u6ce2\u6aa2\u67e5\u7121\u8179\u6c34\uff0c\u672a\u898b\u5b50\u5bae\u6216\u80ce\u76e4\u7570\u5e38\uff0c\u7f8a\u6c34\u91cf\u6b63\u5e38\u4e14\u660e\u986f\u53ef\u898b\u80ce\u5152\u5fc3\u8df3 150\u6b21/min\uff0c\u4e0b\u5217\u4f55\u9805\u8655\u7f6e\u61c9\u512a\u5148\u5b89\u6392 \uff1f", + "Options": "(A)\u4ee5 open supra -umbilical \u65b9\u5f0f\u9032\u884c diagnostic peritoneal lavage (DPL)\u3002 (B)\u5b89\u6392\u8179\u90e8\u6838\u78c1\u5171\u632f\u6383\u63cf\u3002 (C)\u6703\u8a3a\u7522\u79d1\u9032\u884c fetal tocodynamometry \u76e3\u6e2c\u3002 (D)\u89c0\u5bdf 4~6\u5c0f\u6642\u5f8c\u518d\u8ffd\u8e64\u8d85\u97f3\u6ce2\u6aa2\u67e5\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "55\u6b72\u7537\u6027\uff0c\u7a81\u767c\u6027\u5929\u65cb\u5730\u8f49\uff0c\u5614\u5410 2\u6b21\uff0c\u81c9\u8272\u84bc\u767d\uff0c\u56db\u80a2\u7121\u529b\uff0c\u5bb6\u4eba\u5c07\u4ed6\u9001\u81f3\u6025\u8a3a\u3002\u6aa2\u50b7\u5206\u985e\u6642\u8840\u58d3 180/110 mmHg \uff0c\u5fc3\u8df3 95\u6b21/min\uff0c\u9ad4\u6eab 37\u2103\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u6688\u7729\u56b4\u91cd\u5408\u4f75\u5614\u5410\uff0c\u5c6c\u65bc\u4e2d\u6a1e\u6027\u7729\u6688\u75c7(central vertigo )\u3002 (B)\u7acb\u5373\u5b89\u6392\u8166\u90e8\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u3002 (C)\u982d\u90e8\u885d\u52d5\u6e2c\u8a66( head impulse test )\u6b63\u5e38\uff0c\u5e38\u898b\u65bc\u5468\u908a\u6027\u7729\u6688(peripheral vertigo )\u3002 (D)\u82e5\u57f7\u884c Dix-Hallpike\u9ad4\u4f4d\u8a66\u9a57\u6aa2\u67e5\u70ba\u967d\u6027\uff0c\u5247\u75c5\u4eba\u5c6c\u65bc\u826f\u6027\u9663\u767c\u6027\u59ff\u52e2\u6027\u7729\u6688(benign paroxysmal positional vertigo )\u3002", + "Answer": "C\u3001D" + }, + { + "\ufeffQuestion": "\u8840\u6db2\u900f\u6790\u4e2d\u7684\u75c5\u4eba\uff0c\u56e0\u8840\u58d3\u4e0b\u964d\u81f3 80/40mmHg \u8f49\u9001\u5230\u6025\u8a3a\uff0c\u5e8a\u908a\u8d85\u97f3\u6ce2\u767c\u73fe\u5fc3\u81df\u65c1\u908a\u6709\u7a4d\u6db2(pericardial effusion ) \u3001\u53f3\u5fc3\u5ba4\u8207\u5de6\u5fc3\u5ba4\u7b49\u5927\uff0c\u5728\u8d85\u97f3\u6ce2parasternal short axis view \u4e0b\u5de6\u5fc3\u5ba4\u51fa\u73fe\u5fc3\u5ba4\u7e31\u8188\u504f\u5411\u5de6\u5fc3\u5ba4\u7684 D sign\uff0c\u4e0b\u5217\u4f55\u8005\u70ba\u6700\u6709\u53ef\u80fd \u7684\u8a3a\u65b7\uff1f", + "Options": "(A)Air embolism \u3002 (B)Cardiac tamponade \u3002 (C)Sepsis\u3002 (D)Myocardial ischemia \u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "40\u6b72\u7537\u6027\uff0c\u5728\u5de5\u5730\u88ab\u91cd\u7269\u58d3\u50b7\u5de6\u5c0f\u817f\uff0c\u5169\u500b\u9418\u982d\u5f8c\u812b\u56f0\u4e26\u9001\u4f86\u6025\u8a3a\u5ba4\u3002\u4e3b\u8a34\u5de6\u5c0f\u817f\u7570\u5e38\u75bc\u75db\u4e14\u9ebb\uff0c\u5916\u89c0\u816b\u8139\u8b8a\u5f62\uff0c\u76ee\u524d\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\uff0c\u4e0b\u5217\u91dd\u5c0d\u6b64\u75c5\u4eba\u7684\u76f8\u95dc\u63cf\u8ff0\uff0c\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u9700\u76e1\u5feb\u8a55\u4f30\u53d7\u50b7\u8655\u9060\u5fc3\u7aef\u8108\u640f\uff0c\u56e0\u70ba\u6709\u7121\u8108\u640f\u662f\u8a3a\u65b7\u8154\u5ba4\u75c7\u5019\u7fa4\u7684\u5fc5\u8981\u689d\u4ef6\u4e4b\u4e00\u3002 (B)\u96d6\u7136\u7d44\u7e54\u58d3\u529b\u8d85\u904e 30mmHg \u662f\u8154\u5ba4\u75c7\u5019\u7fa4\u8a3a\u65b7\u689d\u4ef6\u4e4b\u4e00\uff0c\u4f46\u4e0d\u9700\u8981\u9760\u6e2c\u91cf\u58d3\u529b\u4f86\u78ba\u5b9a\u8a3a\u65b7\u3002 (C)\u5fae\u8840\u7ba1\u5145\u586b\u6642\u9593(capillary refill time )\u662f\u8a3a\u65b7\u8154\u5ba4\u75c7\u5019\u7fa4\u53ef\u4fe1\u5ea6\u5f88\u9ad8\u7684\u8eab\u9ad4\u8a3a\u5bdf\u3002 (D)\u7d66\u4e88\u75c5\u4eba\u9aa8\u9abc\u727d\u5f15\u4f75\u77f3\u818f\u56fa\u5b9a\u4ee5\u6e1b\u8f15\u9aa8\u6298\u5e36\u4f86\u7684\u75bc\u75db\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "32\u6b72\u7537\u6027\u88ab\u9001\u5165\u6025\u8a3a\uff0c\u540c\u884c\u53cb\u4eba\u63cf\u8ff0\u8a72\u75c5\u4eba\u65bc\u6f5b\u6c34\u6d3b\u52d5\u4e2d\uff0c\u7531\u6d77\u4e2d 50\u516c\u5c3a\u6df1\u8655\u6d6e\u4e0a\u6d77\u9762\uff0c\u4e0a\u5cb8 10\u5206\u9418\u5f8c\u5931\u53bb\u610f\u8b58\u3002\u5230\u9662\u5f8c\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\u4f46\u660f\u8ff7\u6307\u6578\u70ba E2V3M3\u3002\u8840\u4e2d\u52d5\u8108\u6c23\u9ad4\u5206\u6790( room air)\u7d50\u679c\u70ba pH 7.236\u3001 PaO 2 82.3mmHg\u3001 PCO 2 48.2mmHg \u3001HCO 3 20mM/L\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u75c5\u4eba\u70ba\u7b2c\u4e00\u578b\u6e1b\u58d3\u75c7(type I decompression sickness )\u5408\u4f75\u52d5\u8108\u6c23\u9ad4\u6813\u585e\u3002 (B)\u61c9\u7acb\u5373\u7d66\u4e88 100%\u6c27\u6c23\u3001\u975c\u8108\u8f38\u6db2\u3001\u4e26\u5b89\u6392\u9ad8\u58d3\u6c27\u6cbb\u7642\u3002 (C)\u61c9\u76e1\u91cf\u8b93\u75c5\u4eba\u63a1\u53d6\u982d\u4f4e\u8173\u9ad8\u7684\u4ef0\u81e5\u59ff\u52e2( Trendelenburg position)\u3002 (D)\u7d66\u4e88\u75c5\u4eba\u6c23\u7ba1\u5167\u63d2\u7ba1\u4f75\u547c\u5438\u5668\u6cbb\u7642\u512a\u5148\u65bc\u9ad8\u58d3\u6c27\u6cbb\u7642\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u5c0f\u5152\u5916\u50b7\u7684\u8655\u7f6e\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u547c\u5438\u9053\u8655\u7f6e\u5efa\u8b70\u4f7f\u7528\u85e5\u7269\u5354\u52a9\u6c23\u7ba1\u5167\u7ba1\u63d2\u7ba1(drug -assisted intubation) \uff0c\u91dd\u5c0d\u982d\u90e8\u5916\u50b7\u9871\u5167\u58d3\u9ad8\u7684\u60a3\u8005\uff0c\u4e0d\u5efa\u8b70\u4f7f\u7528Ketamine \uff0c\u56e0\u70ba\u6703\u9020\u6210\u8166\u90e8\u8840\u6d41\u5faa\u74b0\u60e1\u5316\u3002 (B)\u91dd\u5c0d\u51fa\u8840\u6027\u4f11\u514b\u60a3\u8005\u7684\u8f38\u6db2\u9078\u64c7\uff0c\u53ef\u4ee5\u5148\u7528\u6676\u8cea\u6eb6\u6db2\u4ee5\u6bcf\u516c\u65a4\u9ad4\u91cd20ml\u9032\u884c\u8f38\u6db2\u6cbb\u7642\uff0c\u4ee5\u9054\u5230\u5bb9\u8a31\u6027\u4f4e\u8840\u58d3(permissive hypotension )\u70ba\u76ee\u6a19\u3002 (C)\u805a\u7126\u5f0f\u5275\u50b7\u8d85\u97f3\u6ce2 focused assessment with sonography for trauma (FAST)\u5c0d\u65bc\u5152\u7ae5\u8179\u8154\u5167\u5be6\u8cea\u5668\u5b98\u640d\u50b7\u7684\u8a55\u4f30\uff0c\u6bd4\u6210\u4eba\u6709\u66f4\u597d\u7684\u9670\u6027\u9810\u6e2c\u503c( negative predictive value )\u3002 (D)\u91dd\u5c0d\u591a\u91cd\u920d\u50b7\u60a3\u8005\u800c\u8a00\uff0c\u5168\u8eab\u6027\u96fb\u8166\u65b7\u5c64\u7684\u6aa2\u67e5\u5f88\u5c11\u5f71\u97ff\u5230\u5f8c\u7e8c\u8655\u7f6e\u7684\u6c7a\u5b9a\u3002\u57fa\u65bc\u653e\u5c04\u7dda\u5c0d\u5152\u7ae5\u7684\u50b7\u5bb3\uff0c\u5efa\u8b70\u805a\u7126\u5f0f\u7684\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u70ba\u4f73\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u6025\u6027\u85e5\u7269\u4e2d\u6bd2\uff0c\u4f55\u8005\u4e0d\u9069\u5408 \u5229\u7528\u8840\u6db2\u900f\u6790( hemodialysis )\u79fb\u9664\u4ee5\u6e1b\u5c11\u6bd2\u6027\uff1f", + "Options": "(A)Diclofenac \u3002 (B)Metformin \u3002 (C)Theophylline \u3002 (D)Valproic acid \u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u74b0\u7532\u819c\u5207\u958b\u8853\u7684\u6b65\u9a5f\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u6163\u7528\u53f3\u624b\u8005\uff0c\u61c9\u7ad9\u5728\u75c5\u60a3\u7684\u53f3\u5074\u65bd\u884c\u70ba\u4f73\u3002 (B)\u74b0\u7532\u819c\u7684\u4f4d\u7f6e\uff0c\u5728\u4e0b\u5df4(chin )\u8207\u80f8\u9aa8\u89d2(sternal notch )\u7684\u6b63\u4e2d\u9ede\u3002 (C)\u5b9a\u4f4d\u74b0\u7532\u819c\u5f8c\u4e0b\u5200\u5207\u958b\u76ae\u819a\uff0c\u5207\u53e3\u4ee5\u6c34\u5e73\u5207\u53e3\u70ba\u4f73\u3002 (D)\u74b0\u7532\u819c\u5207\u958b\u5f8c\u4ee5 6\u865f\u7684\u6c23\u7ba1\u5167\u7ba1\u7f6e\u5165\uff0c\u56fa\u5b9a\u6df1\u5ea6\u7d04\u70ba 10\u516c\u5206\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "44\u6b72\u7537\u6027\u7d93\u6b77\u5fc3\u81df\u505c\u6b62\u4e26\u56de\u5fa9\u81ea\u767c\u6027\u5faa\u74b0( return of spontaneous circulation ) \uff0c\u95dc\u65bc\u5f8c\u7e8c\u7167\u9867\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u76ee\u6a19\u9ad4\u6eab\u7ba1\u7406( targeted temperature management, TTM )\u53ef\u4ee5\u5e6b\u52a9\u964d\u4f4e\u795e\u7d93\u5b78\u7684\u640d\u5bb3\u3002 (B)\u57f7\u884c\u8166\u90e8\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\uff0c\u53ef\u4ee5\u8a55\u4f30\u8166\u90e8\u51fa\u8840\u53ca\u8166\u90e8\u6c34\u816b\u7684\u56b4\u91cd\u7a0b\u5ea6\u3002 (C)TTM \u6392\u9664\u689d\u4ef6\u5305\u62ec\u610f\u8b58\u6e05\u9192\u53ef\u4ee5\u9075\u5f9e\u6307\u4ee4\u548c\u539f\u672c\u795e\u7d93\u5b78\u8868\u73fe\u5df2\u7d93\u4e0d\u4f73\u3002 (D)TTM \u964d\u6eab\u671f\u9593\u9700\u8981\u6ce8\u610f\u96fb\u89e3\u8cea\u7684\u4e0d\u5e73\u8861\uff0c\u4e3b\u8981\u662f\u9ad8\u8840\u9240\u548c\u9ad8\u8840\u9382\u7684\u8868\u73fe\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u5404\u7a2e\u9ad8\u8840\u58d3\u6025\u75c7\u7684\u8840\u58d3\u63a7\u5236(\u8840\u58d3 190/110 mmHg ) \uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u4e0d\u9069\u5408\u6253\u8840\u6813\u6eb6\u89e3\u5291\u4e4b\u6025\u6027\u8166\u4e2d\u98a8\u75c5\u4eba\uff0c\u61c9\u4f7f\u7528 Labetalol \u3002 (B)\u4e3b\u52d5\u8108\u525d\u96e2\u6240\u81f4\uff0c\u512a\u5148\u4f7f\u7528 Nicardipine \u3002 (C)\u5b89\u975e\u4ed6\u547d\u4e2d\u6bd2\u6240\u81f4\uff0c\u512a\u5148\u4f7f\u7528 Benzodiazepine \u3002 (D)\u6025\u6027\u814e\u8870\u7aed\u6240\u81f4\uff0c\u512a\u5148\u4f7f\u7528 Nitroprusside \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u8179\u4e3b\u52d5\u8108\u7624( abdominal aortic aneurysms )\u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u76f4\u5f91\u5927\u65bc 5\u516c\u5206\uff0c\u7834\u88c2\u6a5f\u7387\u5927\u589e\u3002 (B)\u5973\u6027\u8f03\u7537\u6027\u597d\u767c\u3002 (C)\u52d5\u8108\u7624\u7834\u88c2\uff0c\u82e5\u8840\u884c\u52d5\u529b\u5b78\u7a69\u5b9a\uff0c\u53ef\u4ee5\u5148\u89c0\u5bdf\u3002 (D)\u9032\u884c\u8840\u7ba1\u5167\u4fee\u88dc\u8853\u5f8c\uff0c\u4e0d\u6703\u518d\u6709\u7834\u88c2\u7684\u98a8\u96aa\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u809d\u786c\u5316\u8207\u81ea\u767c\u6027\u8179\u819c\u708e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u75c5\u60a3\u6c92\u6709\u767c\u71d2\uff0c\u53ef\u6392\u9664\u81ea\u767c\u7d30\u83cc\u6027\u8179\u819c\u708e\u3002 (B)\u767d\u8840\u7403\u8102\u9176( leukocyte esterase )\u8a66\u7d19\u6e2c\u8a66\u8179\u6c34\u53ef\u4f5c\u70ba\u5feb\u901f\u8a3a\u65b7\u53c3\u8003\u3002 (C)\u8179\u6c34\u5206\u6790\u767c\u73fe\u55dc\u4e2d\u6027\u767d\u8840\u7403\u5927\u65bc 100/\u00b5L\u5373\u53ef\u8a3a\u65b7\u3002 (D)\u809d\u786c\u5316\u4f75\u8179\u6c34\u75c5\u60a3\uff0c\u6709\u9ad8\u9054 70%\u6703\u6709\u81ea\u767c\u6027\u8179\u819c\u708e\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u5c0d\u65bc\u6709\u6bd2\u7269\u8cea\u9032\u884c\u9664\u6c61\u6642\uff0c\u6309\u7167\u6d88\u9632\u6a5f\u95dc\u914d\u5408\u57f7\u884c\u5371\u5bb3\u6027\u5316\u5b78\u54c1\u707d\u5bb3\u6436\u6551\u6307\u5c0e\u539f\u5247\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5371\u5bb3\u6027\u5316\u5b78\u54c1\u707d\u5bb3\u8655\u7406\u904e\u7a0b\u4ee5\u63a7\u5236\u706b\u52e2\u53ca\u963b\u537b\u5ef6\u71d2\u70ba\u539f\u5247\uff0c\u5982\u73fe\u5834\u7121\u4eba\u547d\u5371\u5bb3\u4e4b\u865e\uff0c\u4ecd\u9808\u57f7\u884c\u5371\u96aa\u6027\u6551\u707d\u884c\u52d5\u3002 (B)\u521d\u671f\u73fe\u5834\u61c9\u8b8a\u6307\u63ee\u5b98\u539f\u5247\u7531\u6700\u5148\u62b5\u9054\u4e8b\u6545\u73fe\u5834\u4e4b\u6551\u707d\u4eba\u54e1\u64d4\u4efb\uff0c\u82e5\u70ba\u6d88\u9632\u4eba\u54e1\uff0c\u5247\u7531\u6d88\u9632\u5206\u968a\u9577\u64d4\u4efb\u3002 (C)\u6696\u5340\u70ba\u71b1\u5340\u8207\u51b7\u5340\u9593\u7de9\u885d\u5340\u57df\uff0c\u4e3b\u8981\u529f\u7528\u70ba\u75c5\u4eba\u6025\u6551\u3002 (D)\u5371\u5bb3\u6027\u5316\u5b78\u54c1\u707d\u5bb3\u8655\u7406\u904e\u7a0b\uff0c\u8655\u7406\u300c\u5feb\u300d\u6bd4\u8655\u7406\u300c\u5c0d\u300d\u91cd\u8981\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "9\u6b72\u7537\u7ae5\uff0c\u904e\u53bb\u6709\u6c23\u5598\u75c5\u53f2\uff0c\u5e73\u6642\u6c92\u6709\u670d\u85e5\u63a7\u5236\u4e14\u4e00\u5e74\u4f86\u90fd\u6c92\u767c\u4f5c\uff0c\u5169\u5929\u524d\u958b\u59cb\u6709\u4e0a\u547c\u5438\u9053\u611f\u67d3\u5c0e\u81f4\u6025\u6027\u6c23\u5598\u767c\u4f5c\u88ab\u9001\u81f3\u6025\u8a3a\u3002\u5230\u9662\u6642\uff0c\u9ad4\u6eab 37.2\u00baC\uff0c\u5fc3\u8df3 112\u6b21/min\uff0c\u8840\u58d3 110/72 mmHg \uff0c\u547c\u5438 33\u6b21/min\uff0c\u8840\u6c27\u6fc3\u5ea6 93%\uff0c\u5410\u6c23\u53ca\u5438\u6c23\u6642\u6709\u5598\u9cf4\u8072(wheezing ) \uff0c\u5176\u9918\u6aa2\u67e5\u7121\u660e\u986f\u7570\u5e38\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u4f9d Pediatric Respiratory Assessment Measure (PRAM)\u5206\u7d1a\uff0c\u8a72\u75c5\u7ae5\u5c6c\u65bc\u8f15\u5ea6\u6c23\u5598\u767c\u4f5c\u3002 (B)\u5efa\u8b70\u7d66\u4e59\u4e8c\u578b\u4ea4\u611f\u795e\u7d93\u523a\u6fc0\u5291\u53ca\u985e\u56fa\u9187\u6cbb\u7642\u3002 (C)\u82e5\u8840\u6c27\u98fd\u548c <92%\u5efa\u8b70\u7d66\u4e88\u6c27\u6c23\uff0c\u4e26\u7dad\u6301\u8840\u6c27\u98fd\u548c\u5ea6\u5728 93~98%\u3002 (D)\u5438\u5165\u6027\u7684\u786b\u9178\u9382(MgSO 4)\u5c0d\u4efb\u4f55\u5206\u7d1a\u7684\u5152\u7ae5\u6c23\u5598\u60a3\u8005\u90fd\u6c92\u6709\u5e6b\u52a9\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "33\u6b72\u5973\u6027\uff0c\u56e0\u6628\u65e5\u958b\u59cb\u51fa\u73fe\u767c\u71d2\u75c7\u72c0\uff0c\u5408\u4f75\u5de6\u5074\u819d\u95dc\u7bc0\u7d05\u816b\u75bc\u75db\u4e14\u7121\u6cd5\u5f4e\u66f2\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u904a\u8d70\u6027\u95dc\u7bc0\u708e( migratory arthritis )\u5e38\u767c\u751f\u65bc\u91d1\u9ec3\u8272\u8461\u8404\u7403\u83cc\u611f\u67d3\u5f8c\u3002 (B)\u4f7f\u7528 ESR >30mm/h \u4f86\u8a55\u4f30\u6557\u8840\u6027\u95dc\u7bc0\u708e\u7279\u7570\u6027\u9ad8\uff0c\u662f\u8f03\u4f73\u7684\u8a3a\u65b7\u5de5\u5177\u3002 (C)Neisseria gonorrhoeae \u611f\u67d3\uff0c\u95dc\u7bc0\u6db2>60% \u53ef\u57f9\u990a\u51fa\u8a72\u83cc\u7a2e\u3002 (D)\u942e\u5200\u578b\u7d05\u8840\u7403\u75c5\u4eba\u7684\u6557\u8840\u6027\u95dc\u7bc0\u708e\u4ee5\u6c99\u9580\u6c0f\u687f\u83cc\u6700\u5e38\u898b\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "74\u6b72\u5973\u6027\u75c5\u4eba\u7a81\u767c\u8aaa\u8a71\u56f0\u96e3\u3001\u541e\u56a5\u4e0d\u9806\uff0c\u8eab\u9ad4\u8a3a\u5bdf\u986f\u793a\u767c\u97f3\u969c\u7919\uff0c\u820c\u982d\u504f\u5411\u53f3\u5074\uff0c\u5de6\u5074\u8edf\u984e\u7671\u7613\uff0c\u5de6 \u81c9\u4e0b\u5782\uff0c\u5de6\u5074\u9762\u90e8\u611f\u89ba\u55aa\u5931\uff0c\u53ca\u53f3\u81c2\u7121\u529b\uff0c\u4ee5\u4e0a\u8868\u5fb5\u6700\u53ef\u80fd \u70ba\u4f55\u8655\u4e4b\u75c5\u8b8a\uff1f", + "Options": "(A)\u5de6\u5074\u8166\u5e79\u3002 (B)\u53f3\u5074\u5c0f\u8166\u3002 (C)\u5de6\u5074\u5927\u8166\u3002 (D)\u53f3\u5074\u4e2d \u8166\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "30\u6b72\u7537\u6027\uff0c\u56e0\u767c\u71d2\u3001\u982d\u75db\u3001\u9838\u90e8\u50f5\u786c 3\u5929\u5c31\u91ab\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u81e8\u5e8a\u61f7\u7591\u7d30\u83cc\u6027\u8166\u819c\u708e\uff0c\u53ef\u5728\u672a\u57f7\u884c\u8166\u90e8\u5f71\u50cf\u6aa2\u67e5\u53ca\u8170\u690e\u7a7f\u523a\u6aa2\u67e5\u524d\uff0c\u76f4\u63a5\u4f7f\u7528\u6297\u751f\u7d20\u3002 (B)\u61f7\u7591\u7d30\u83cc\u6027\u8166\u819c\u708e\u6642\uff0c\u70ba\u907f\u514d\u5f71\u97ff\u75c5\u4eba\u514d\u75ab\u529f\u80fd\uff0c\u4e0d\u61c9\u4f7f\u7528Dexamethasone \u3002 (C)\u5728\u7cd6\u5c3f\u75c5\u5408\u4f75\u9f3b\u7ac7\u611f\u67d3\u6240\u9020\u6210\u7684\u8166\u819c\u708e\u4e2d\uff0c\u5176\u8166\u810a\u9ad3\u6db2\u6aa2\u67e5\u70ba WBC 300/ \u00b5L\uff0c65% PMN\uff0c\u8981\u512a\u5148\u8003\u616e Aspergillus \u611f\u67d3\u3002 (D)\u8a3a\u65b7\u70ba\u55ae\u7d14\u76b0\u75b9\u75c5\u6bd2(herpes simplex virus )\u8166\u708e\u75c5\u4eba\uff0c\u5176\u5178\u578bMRI\u5f71\u50cf\u986f\u793a\u70ba\u6795\u8449\u7070\u8cea\u4fb5\u72af\uff0c\u800c\u7522\u751f\u7cbe\u795e\u53ca\u884c\u70ba\u7570\u5e38\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "8\u6b72\u5973\u7ae5\u4f86\u5152\u7ae5\u6025\u8a3a\u4e3b\u8a34\u767c\u71d2 3\u5929\uff0c\u8eab\u9ad4\u8a3a\u5bdf\u6642\u767c\u73fe\u5973\u7ae5\u81c9\u9830\u51fa\u73fe\u5982\u860b\u679c\u81c9\u7684\u7d05\u6591(slapped- cheek appearance ) \uff0c\u56db\u80a2\u4e5f\u6709\u7db2\u72c0\u76ae\u75b9( lacy, reticulated appearance ) \uff0c\u76ae\u75b9\u4e26\u4e0d\u6703\u7662\uff0c\u8acb\u554f \u6700\u6709\u53ef\u80fd\u7684\u8a3a\u65b7\u6b63\u78ba\u70ba\uff1f", + "Options": "(A)\u7329\u7d05\u71b1(scarlet fever )\u3002 (B)\u611f\u67d3\u6027\u7d05\u6591( erythema infectiosum )\u3002 (C)\u5ddd\u5d0e\u75c5(Kawasaki disease )\u3002 (D)\u73ab\u7470\u75b9\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4f9d\u64da\u53f0\u7063\u75be\u75c5\u7ba1\u5236\u7f72\u516c\u544a\uff0c\u56e0\u61c9\u65b0\u578b\u51a0\u72c0\u75c5\u6bd2\u611f\u67d3\u7684\u91ab\u7642\u7167\u8b77\u4eba\u54e1\u500b\u4eba\u9632\u8b77\u88dd\u5099\uff0c\u4f55\u8005\u6558\u8ff0 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5354\u52a9\u75c5\u4eba\u8f49\u8a3a\u7684\u6551\u8b77\u4eba\u54e1\uff0c\u9700\u6234\u5916\u79d1\u53e3\u7f69\u4f5c\u70ba\u547c\u5438\u9053\u9632\u8b77\u3002 (B)N95 \u53e3\u7f69\u53ca\u5916\u79d1\u53e3\u7f69\u4f7f\u7528\u524d\u9808\u57f7\u884c\u5bc6\u5408\u5ea6\u6aa2\u9ede\u3002 (C)\u812b\u9664 N95\u53e3\u7f69\u6642\uff0c\u61c9\u5148\u79fb\u9664\u4e0b\u5074\u9b06\u7dca\u5e36\uff0c\u518d\u79fb\u9664\u4e0a\u5074\u9b06\u7dca\u5e36\u3002 (D)\u6025\u8a3a\u6aa2\u50b7\u8b77\u7406\u5e2b\u8a62\u554f\u4e3b\u8a34\u53ca TOCC\u6642\uff0c\u9808\u7a7f\u9023\u8eab\u5f0f\u9694\u96e2\u8863\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "35\u6b72\u5973\u6027\uff0c\u767c\u71d2 4\u5929\u5c31\u8a3a\uff0c\u75c5\u4eba\u4e0a\u661f\u671f\u66fe\u5230\u6771\u5357\u4e9e\u65c5\u884c\uff0c\u9ad4\u6eab 39\u2103\u5168\u8eab\u9178\u75db\uff0c\u6709\u5641\u5fc3\u3001\u5614\u5410\u3001\u4e0a\u8179\u75bc\u75db\u53ca\u58d3\u75db\u60c5\u5f62\uff0c\u8840\u6db2\u6aa2\u67e5\u767d\u8840\u7403 2,500/\u03bcl\uff0c\u8840\u8272\u7d20 14g/dl\uff0c\u8840\u5c0f\u677f 85,000/\u03bcl \uff0cAST/ALT 135/110 U/L \uff0c\u80f8\u90e8 X\u5149\u548c\u5c3f\u6db2\u6aa2\u67e5\u6b63\u5e38\uff0c\u4e0b\u5217\u654d\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u75c5\u4eba\u5408\u4e4e\u75be\u7ba1\u7f72\u767b\u9769\u71b1\u901a\u5831\u81e8\u5e8a\u689d\u4ef6\u3002 (B)\u82e5\u75c5\u4eba\u767b\u9769\u71b1 NS1(non -structural protein 1 )\u6297\u539f\u6aa2\u6e2c\u967d\u6027\u70ba\u78ba\u8a3a\u75c5\u4f8b\u3002 (C)\u82e5\u75c5\u4eba\u767b\u9769\u71b1\u967d\u6027\u5247\u7b26\u5408\u767b\u9769\u71b1\u91cd\u75c7\u8a3a\u65b7(2009 WHO \u75c5\u4f8b\u5206\u985e\u5b9a\u7fa9 )\u3002 (D)\u82e5\u75c5\u4eba\u767b\u9769 \u71b1\u967d\u6027\u4e14\u8179\u90e8\u5f71\u50cf\u6aa2\u67e5\u767c\u73fe\u81bd\u56ca\u58c1\u6c34\u816b\u7591\u4f3c\u6025\u6027\u81bd\u56ca\u708e\uff0c\u61c9\u907f\u514d\u4fb5\u5165\u6027\u8655\u7f6e\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u5730\u9707\u5f8c\u4e00\u540d\u88ab\u5012\u584c\u6a11\u67f1\u58d3\u7838\u53d7\u56f0\u9577\u9054 16\u5c0f\u6642\u7684\u6c11\u773e\uff0c\u73fe\u5834\u641c\u6551\u53ca\u91ab\u7642\u6551\u8b77\u4eba\u54e1\u9808\u6ce8\u610f\u4e4b\u4e8b\u9805\uff0c\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u88ab\u58d3\u7838\u80a2\u9ad4\u53ef\u80fd\u7522\u751f\u8154\u5ba4\u75c7\u5019\u7fa4\uff0c\u6700\u5e38\u898b\u75c7\u72c0\u662f\u9ebb\u6728\u7121\u529b\u3002 (B)\u50b7\u8005\u53ef\u80fd\u7522\u751f\u9ad8\u8840\u9240\u53ca\u9ad8\u8840\u9223\uff0c\u9032\u4e00\u6b65\u5f15\u767c\u81f4\u547d\u6027\u5fc3\u5f8b\u4e0d\u6574\u3002 (C)\u53ea\u8981\u6c92\u6709\u814e\u8870\u7aed\uff0c\u5927\u91cf\u975c\u8108\u8f38\u6db2\u5efa\u8b70\u4f7f\u7528\u4e73\u9178\u6797\u683c\u6c0f\u6db2\u3002 (D)\u7b4b\u819c\u5207\u958b\u56e0\u70ba\u8b93\u611f\u67d3\u8207\u622a\u80a2\u6a5f\u6703\u589e\u52a0\uff0c\u4e26\u975e\u5e38\u898f\u8655\u7f6e\u5efa\u8b70\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6025\u6027\u95cc\u5c3e\u708e\u7684\u81e8\u5e8a\u75c7\u72c0\u53ca\u5fb5\u5019\uff0c\u4e0b\u5217\u4f55\u8005\u7684\u967d\u6027\u6982\u4f3c\u6bd4( positive likelihood ratio )\u6700\u9ad8\uff1f", + "Options": "(A)\u5728\u8179\u75db\u75c7\u72c0\u51fa\u73fe\u524d\u767c\u751f\u5614\u5410\u3002 (B)\u9589\u5b54\u808c\u5fb5\u5019( obturator sign)\u5448\u967d\u6027\u3002 (C)\u8170\u5927\u808c\u5fb5\u5019( psoas sign )\u5448\u967d\u6027\u3002 (D)\u8179\u75db\u90e8\u4f4d\u7531\u4e0a\u8179\u6216\u81cd\u5468\u570d\u8f49\u79fb\u81f3\u53f3\u4e0b\u8179\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "35\u6b72\u5973\u6027\uff0c\u63a5\u53d7\u4e0d\u5b55\u75c7\u7684\u6cbb\u7642\u3002\u4eca\u5929\u7a81\u7136\u5de6\u4e0b\u8179\u75db\u4f86\u6025\u8a3a\u3002\u5c3f\u6db2\u61f7\u5b55\u6e2c\u8a66\u967d\u6027\uff0c\u5c3f\u6db2\u5206\u6790\u7121\u660e\u986f\u7570\u5e38\u3002\u5e8a\u908a\u8d85\u97f3\u6ce2\u770b\u5230\u5b50\u5bae\u5167\u61f7\u5b55\u7d04 6\u9031\uff0c\u6709\u4e2d\u91cf\u8179\u6c34\u3002\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u75c5\u4eba\u8a3a\u65b7\u53ef\u80fd\u662f\u5375\u5de2\u904e\u5ea6\u523a\u6fc0\u75c7\u5019\u7fa4(ovarian hyperstimulation syndrome, OHSS ) \uff0c\u61c9\u8a72\u8981\u9032\u884c\u9aa8\u76c6\u8154\u6aa2\u67e5\uff0c\u5b8c\u6574\u8a55\u4f30\u75c5\u4eba\u72c0\u6cc1\u3002 (B)\u75c5\u4eba\u8a3a\u65b7\u53ef\u80fd\u662f OHSS\uff0c\u53ef\u7d66\u4e88\u5229\u5c3f\u5291\u4ee5\u7de9\u89e3\u75c7\u72c0\u3002 (C)\u75c5\u4eba\u6709\u53ef\u80fd\u662f\u5408\u4f75\u598a\u5a20(heterotopic pregnancy )\u3002 (D)\u75c5\u4eba\u5df2\u78ba\u8a8d\u6709\u5b50\u5bae\u5167\u61f7\u5b55\uff0c\u82e5\u80fd\u9032\u4e00\u6b65\u770b\u5230\u80ce\u5152\u5fc3\u8df3\uff0c\u5247\u53ef\u6392\u9664\u5b50\u5bae\u5916\u5b55\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6025\u6027\u7cbe\u795e\u75c5( Acute psychosis )\u75c5\u4eba\u7684\u6025\u8a3a\u8655\u7f6e\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u9700\u5efa\u7acb\u7cbe\u795e\u79d1\u8a3a\u65b7\uff0c\u4ee5\u5229\u6025\u8a3a\u91ab\u5e2b\u6c7a\u5b9a\u75c5\u4eba\u5f8c\u7e8c\u52d5\u5411(disposition)\u3002 (B)\u767c\u71d2\u6216\u662f\u5fc3\u8df3\u5feb\u901a\u5e38\u662f\u56e0\u70ba\u75c5\u4eba\u60c5\u7dd2\u9ad8\u5f35\u6216\u662f\u8e81\u52d5\u6240\u5f15\u8d77\uff0c\u4e0d\u9700\u7279\u5225\u6aa2\u9a57\u6aa2\u67e5\u3002 (C)\u5e7b\u807d\u6bd4\u5e7b\u8996\u66f4\u6709\u53ef\u80fd\u662f\u751f\u7406\u539f\u56e0\u6240\u5f15\u8d77\u7684\u3002 (D)\u5982\u679c\u75c5\u4eba\u6e05\u9192\u6642\u627f\u8a8d\u6709\u559d\u9152\u6216\u975e\u6cd5\u4f7f\u7528\u85e5\u7269\uff0c\u4e0d\u4e00\u5b9a\u8981\u518d\u505a\u6aa2\u67e5\u78ba\u8a8d\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u8001\u4eba\u5916\u50b7\u7684\u521d\u7d1a\u8a55\u4f30\u8207\u5fa9\u7526\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u70ba\u907f\u514d\u6f5b\u5728\u672a\u767c\u73fe\u7684\u810a\u690e\u640d\u50b7\uff0c\u4e0d\u5b9c\u904e\u65e9\u79fb\u9664\u9838\u5708\u3002 (B)\u56e0\u8001\u4eba\u5916\u50b7\u6027\u8166\u50b7\u7684\u56b4\u91cd\u5ea6\u9ad8\uff0c\u56e0\u6b64\u6b7b\u4ea1\u7387\u4e5f\u8f03\u9ad8\u3002 (C)\u8001\u4eba\u9aa8\u6298\u5982\u9aa8\u76c6\u9aa8\u6298\u3001\u9ad6\u9aa8\u9aa8\u6298\u591a\u56e0\u8eca\u798d\u6240\u9020\u6210\u3002 (D)\u8001\u4eba\u7684\u5916\u50b7\u521d\u7d1a\u8a55\u4f30\u9806\u5e8f\u53ca\u9805\u76ee\u8207\u5e74\u8f15\u4eba\u662f\u4e0d\u540c\u7684\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u53f0\u7063\u5e38\u898b\u6bd2\u86c7\u54ac\u50b7\u7684\u81e8\u5e8a\u8868\u73fe\u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u51fa\u8840\u6027\u6bd2\u86c7\u54ac\u50b7\u6703\u51fa\u73fe\u7259\u75d5\u548c\u5c40\u90e8\u816b\u8139\u53ca\u75bc\u75db\uff0c\u53ef\u898b\u76ae\u4e0b\u7600\u8840\uff0c\u6c34\u6ce1\u6216\u8840\u6ce1\u3002 (B)\u51fa\u8840\u6027\u6bd2\u86c7\u54ac\u50b7\u53ef\u80fd\u4f75\u767c\u75c7\u5982\u6eb6\u8840\u3001\u6a6b\u7d0b\u808c\u6eb6\u89e3\u3001\u7030\u6f2b\u6027\u8840\u7ba1\u5167\u51dd\u7d50( DIC)\u3002 (C)\u773c\u93e1\u86c7\u86c7\u6bd2\u5177\u6709\u7d30\u80de\u6bd2\u7d20\uff0c\u6703\u9020\u6210\u5c40\u90e8\u816b\u8139\u53ca\u75bc\u75db\u3001\u51fa\u8840\u6027\u7684\u76ae\u4e0b\u7600\u8840\u3001\u6c34\u6ce1\u6216\u8840\u6ce1\uff0c\u56b4\u91cd\u8005\u6703\u9020\u6210\u76ae\u819a\u58de\u6b7b\u3002 (D)\u88ab\u773c\u93e1\u86c7\u54ac\u50b7\uff0c\u75c5\u4eba\u6703\u5641\u5fc3\u3001\u5614\u5410\u3001\u8179\u75db\u3001\u8179\u7009\uff0c\u4e14\u6709\u56b4\u91cd\u795e\u7d93\u808c\u8089\u50b3\u5c0e\u963b\u65b7\u75c7\u72c0\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u6709\u95dc\u80ba\u6813\u585e\u7684\u6558\u8ff0\uff0c\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u5927\u91cf( massive)\u80ba\u6813\u585e\u70ba\u8840\u58d3\u6536\u7e2e\u58d3\u4f4e\u65bc 90 mmHg \u8d85\u904e 15\u5206\u9418\uff1b\u6478\u4e0d\u5230\u8108\u640f\uff1b\u6216\u5fc3\u8df3\u5c0f\u65bc 40\u6b21/min\uff0c\u5408\u4f75\u4f11\u514b\u75c7\u72c0\u3002 (B)\u7576\u8840\u4e2d troponin\u6fc3\u5ea6\u5347\u9ad8\uff0c\u6216\u8840\u4e2d NT-proBNP \u6fc3\u5ea6\u8d85\u904e 900 pg/ml\uff0c\u8868\u793a\u75c5\u4eba\u7684\u80ba\u6813\u585e\u5df2\u767c\u751f\u53f3\u5fc3\u5ba4\u52de\u640d(strain)\u3002 (C)\u82e5\u767c\u751f\u5fc3\u8df3\u505c\u6b62\u3001\u4f4e\u8840\u58d3\u3001\u547c\u5438\u8870\u7aed\uff0c\u6216\u53f3\u5fc3\u5ba4\u52de\u640d\u6642\uff0c\u61c9\u8003\u616e\u7d66\u4e88\u975c\u8108\u6ce8\u5c04\u8840\u6813\u6eb6\u89e3\u5291\u6cbb\u7642\u3002 (D)\u8207\u7d93\u975c\u8108\u6ce8\u5c04\u8840\u6813\u6eb6\u89e3\u5291\u76f8\u6bd4\uff0c\u7d93\u80ba\u52d5\u8108\u6ce8\u5c04\u8840\u6813\u6eb6\u89e3\u5291\u7684\u6eb6\u6813\u6548\u679c\u8f03\u597d\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u4f55\u8005\u4e0d\u662f\u80ba\u6813\u585e\u7684\u6392\u9664\u4f9d\u64da Pulmonary Embolism Rule -Out Criteria \uff1f", + "Options": "(A)Age < 50\u202f \u6b72\u3002 (B)No hormone use \u3002 (C)No hemoptysis \u3002 (D)Oxygen saturation > 90% \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u5c0d\u65bc\u6557\u8840\u75c7( sepsis)\u6cbb\u7642\u7684\u8ad6\u8ff0\uff0c\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)Sepsis \u6cbb\u7642\u9996\u5148\u8981\u7d66\u4e88\u75c5\u4eba\u5927\u91cf\u7684\u8f38\u6db2\uff0c\u5f85\u9ad4\u5167\u6c34\u5206\u8db3\u5920\u5f8c\u518d\u7d66\u4e88\u5347\u58d3\u85e5\u3002 (B)Sepsis \u75c5\u4eba\u7d66\u4e88\u904e\u591a\u7684\u8f38\u6db2\uff0c\u6703\u9020\u6210\u75c5\u4eba\u7684\u9810\u5f8c\u8b8a\u5dee\u3002 (C)Sepsis \u7684\u8f38\u6db2\u9996\u9078\u70ba colloid\uff0c\u6bd4\u8d77 normal saline \uff0ccolloid \u6bd4\u8f03\u4e0d\u6703\u9020\u6210\u75c5\u4eba acute kidney injury \u6216\u9700\u8981\u8840\u6db2\u900f\u6790\u3002 (D)\u61c9\u8f38\u8840\u4fdd\u6301\u75c5\u4eba\u7684 Hb>8 g/dL \uff0c\u4ee5\u7dad\u6301\u7d44\u7e54\u4f9b\u6c27\u8207\u704c\u6d41\u91cf\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u95dc\u65bc\u6025\u6027\u5fc3\u5305\u819c\u708e( acute pericarditis )\u4e4b\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5178\u578b\u5fc3\u96fb\u5716\u7684\u8b8a\u5316\u70ba ST\u6bb5\u4e0b\u964d( ST-segment depression ) \uff0c\u5c24\u5176\u5728lead I, V5, V6 \u53ef\u898b\u3002 (B)\u5be6\u9a57\u5ba4\u8a3a\u65b7\u6578\u64da\u88e1\u8840\u6db2\u4e2d troponin\u6fc3\u5ea6\u4e0a\u5347\u8868\u793a\u53ef\u80fd\u5408\u4f75\u5fc3\u808c\u708e\u3002 (C)\u96fb\u8166\u65b7\u5c64\u5c0d\u65bc\u8a3a\u65b7\u5fc3\u5305\u819c\u7a4d\u6db2(pericardial effusion )\u7684\u654f\u611f\u6027\u6bd4\u5fc3\u81df\u8d85\u97f3\u6ce2(echocardiography )\u9ad8\u51fa\u8a31\u591a\u3002 (D)\u6cbb\u7642\u85e5\u7269\u5305\u62ec\u975e\u985e\u56fa\u9187\u6d88\u708e\u6b62\u75db\u85e5(NSAIDs) \u3001\u985e\u56fa\u9187(steroids ) \u3001\u79cb\u6c34\u4ed9\u7d20(colchicine ) \uff0c\u75c5\u4eba\u5fc5\u9808\u8981\u4f4f\u9662\u6cbb\u7642\u89c0\u5bdf\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u5152\u7ae5\u8840\u5c3f\uff0c\u4e0b\u5217\u6558\u8ff0\u54ea\u4e00\u9805\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u82e5\u70ba\u8840\u5c3f\u540c\u6642\u4f75\u6709\u86cb\u767d\u5c3f\u3001\u6025\u6027\u814e\u529f\u80fd\u53d7\u640d\u3001\u6c34\u816b\u3001\u9ad8\u8840\u58d3\u53ca\u95dc\u7bc0\u75c5\u8b8a\u7b49\u75c7\u72c0\u53ef\u80fd\u70ba\u814e\u7d72\u7403\u814e\u708e(glomerulonephritis)\u3002 (B)\u82e5\u4e0a\u547c\u5438\u9053\u611f\u67d3\u5f8c\u51fa\u73fe\u8840\u5c3f\uff0c\u8840\u6e05\u4e2d ANA \u9670\u6027\u3001 C3\u6b63\u5e38\u3001\u5247\u9ad8\u5ea6\u61f7\u7591\u662f IgA nephropathy \u3002 (C)\u82e5\u6709\u5408\u4f75\u80c3\u8178\u9053\u8179\u75db\u75c7\u72c0\uff0c\u76ae\u819a\u7600\u9ede\u4e14\u6709\u814e\u529f\u80fd\u640d\u50b7\u9808\u8003\u616eHenoch-Sch\u00f6nlein purpura (HSP)\uff0c \u4f7f \u7528 Corticosteroid \u53ef\u4ee5\u7de9\u89e3\u8179\u75db\u75c7\u72c0\u4e14\u6539\u5584\u814e\u529f\u80fd\u640d\u50b7\u3002 (D)\u6ccc\u5c3f\u9053\u611f\u67d3\u662f\u9752\u5c11\u5e74\u6700\u5e38\u898b\u7684\u8840\u5c3f\u539f\u56e0\uff0c\u75c5\u4eba\u5e38\u6709\u767c\u71d2\uff0c\u5c40\u90e8\u7684\u4e0b\u6ccc\u5c3f\u9053\u75c7\u72c0\uff0c\u5982\u983b\u5c3f\u3001\u5c3f\u6025\u3001\u6392\u5c3f\u56f0\u96e3\uff0c\u9700\u8003\u616e\u6ccc\u5c3f\u9053\u611f\u67d3\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u58de\u6b7b\u6027\u8edf\u7d44\u7e54\u611f\u67d3( necrotizing soft tissue infection )\u7684\u8a3a\u65b7\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u7531\u65bc\u6df1\u90e8\u7d44\u7e54\u56b4\u91cd\u6f70\u721b\u767c\u708e\uff0c\u75c5\u4eba\u51fa\u73fe\u4e0d\u6210\u6bd4\u4f8b\u7684\u5287\u70c8\u75bc\u75db\u662f\u8a3a\u65b7\u7684\u5fc5\u8981\u689d\u4ef6\u3002 (B)\u7531\u65bc\u6df1\u90e8\u7b4b\u819c\u611f\u67d3\u5f15\u8d77\u76ae\u819a\u8840\u7ba1\u58de\u6b7b\u6813\u585e(thrombosis ) \uff0c\u56e0\u6b64\u75c5\u4eba\u60a3\u90e8\u7684\u76ae\u819a\u5728\u65e9\u671f\u6703\u51fa\u73fe\u51fa\u8840\u6027\u6c34\u76b0\u3002 (C)\u5982\u679c\u986f\u5f71\u5291\u6ce8\u5c04\u7684\u78c1\u632f\u9020\u5f71\u6aa2\u67e5(MRI with contrast )\u5f71\u50cf\u986f\u793a\u60a3\u90e8\u808c\u8089\u9593\u7b4b\u819c\u6c92\u6709\u7570\u5e38\uff0c\u5247\u53ef\u6392\u9664\u6b64\u8a3a\u65b7\u3002 (D)\u75c5\u4eba\u4e00\u5b9a\u6709\u514d\u75ab\u529f\u80fd\u4f4e\u4e0b\u7684\u5171\u75c5\u75c7\u5982\u8001\u5e74\u3001\u7cd6\u5c3f\u75c5\u3001\u809d\u786c\u5316\uff0c\u6216\u63a5\u53d7\u5316\u5b78\u6cbb\u7642\u6216\u514d\u75ab\u6291\u5236\u5291\uff0c\u56e0\u800c\u611f\u67d3\u75c5\u7a0b\u5f80\u5f80\u60e1\u5316\u8fc5\u901f\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u4e0a\u6d88\u5316\u9053\u51fa\u8840\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u89e3\u9bae\u7d05\u8272\u8840\u4fbf\u53ef\u4ee5\u6392\u9664\u51fa\u8840\u9ede\u6e90\u81ea\u65bc\u4e0a\u6d88\u5316\u9053\u3002 (B)\u82e5\u662f\u6709\u8a31\u591a\u5171\u75c5\u75c7\u7684\u8001\u4eba\uff0c\u5efa\u8b70\u8840\u8272\u7d20\u2264 7 g/dL \u518d\u8003\u616e\u8f38\u8840\u3002 (C)\u5982\u679c\u8981\u505a\u80c3\u93e1\u6aa2\u67e5\uff0c\u4f7f\u7528\u4fc3\u9032\u8178\u80c3\u8815\u52d5\u4e4b\u85e5\u7269\u5982 Metoclopramide \u70ba\u7981\u5fcc\u75c7\u3002 (D)\u75c5\u4eba\u540c\u6642\u6709\u809d\u786c\u5316\u75c5\u53f2\uff0c\u53ef\u8003\u616e\u7d66\u4e88\u6297\u751f\u7d20 Ceftriaxone 1 gram IV \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6025\u8a3a\u5e38\u898b\u7d05\u773c\u75c7\u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u89d2\u819c\u7570\u7269( corneal foreign body )\u6703\u75bc\u75db\u5408\u4f75\u5ee3\u6cdb\u6027\u5145\u8840\uff0c\u8f03\u5c11\u754f\u5149\u3002 (B)\u904e\u654f\u6027\u7d50\u819c\u708e( allergic conjunctivitis )\u6703\u7662\u6703\u75db\uff0c\u4f46\u8f03\u5c11\u754f\u5149\u3002 (C)\u9685\u89d2\u9589\u9396\u6027\u9752\u5149\u773c(acute angle -closure glucoma )\u5e38\u5408\u4f75\u8996\u529b\u6a21\u7cca\u3001\u754f\u5149\u8207\u982d\u75db\u3002 (D)\u7d50\u819c\u4e0b\u51fa\u8840( subconjunctival hemorrhage )\u4e0d\u75db\u4e5f\u4e0d\u7662\uff0c\u7d93\u5e38\u6703\u5f71\u97ff\u8996\u529b\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u9ad8\u5c71\u5927\u96ea\uff0c\u5c0f\u660e\u80cc\u8457\u865b\u5f31\u7684\u670b\u53cb\u5f9e\u5c71\u9802\u5230\u5708\u8c37\u4f11\u606f\u3002 \uf937\u4e0a\u7a4d\u96ea\u751a\u6df1\uff0c\u4e0b\u64a4\u81f3\u5c71\u838a\u4f30\u8a08\u8981 4\u500b\u5c0f\u6642\uff0c\u6e96\u5099 1\u5c0f\u6642\u5f8c\u51fa\u767c\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u5c0f\u660e\u96d9\u8173\u6709\u5c40\u90e8\u6e05\u6f88\u6c34\u6ce1\uff0c\u9664\u53bb\u51b0\u6fd5\u978b\u896a\u5f8c\uff0c\u53ef\u5148\u6d78\u6ce1\u5728 37\u2103\u6eab\u6c34\u6162\u6162\u56de\u6eab\u3002 (B)\u670b\u53cb\u8033\u6eab 34\u2103\uff0c\u5168\u8eab\u767c\u6296\uff0c\u9664\u53bb\u51b0\u6fd5\u5916\u5957\u5f8c\uff0c\u4f7f\u7528\u6bdb\u6bef\u8207\u6eab\u71b1\u98f2\u56de\u6eab\u3002 (C)\u5c0f\u660e\u96d9\u624b\u75bc\u75db\u6709\u6414\u7662\u611f\uff0c\u9664\u53bb\u6fd5\u51b7\u624b\u5957\u5f8c\uff0c\u96d9\u624b\u6469\u64e6\u53d6\u6696\u3002 (D)\u5c0f\u660e\u4e3b\u8a34\u96d9\u8173\u96d9\u624b\u75bc\u75db\uff0c\u6551\u8b77\u4eba\u54e1\u628a\u96a8\u8eab\u6b62\u75db\u85e5\u7d66\u5c0f\u660e\u670d\u7528\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "40\u6b72\u5973\u6027\uff0c\u61f7\u5b55 34\u9031\uff0c\u56e0\u8173\u816b\u53ca\u8179\u75db\u800c\u4f86\u6025\u8a3a\u3002\u8840\u58d3 180/100mmHg \uff0c\u5c3f\u86cb\u767d 3+\u3002\u4f7f\u7528 MgSO 4\u53caHydralazine \u5f8c\uff0c\u5c3f\u9084\u662f\u5f88\u5c11\uff0c\u6c34\u816b\u6d88\u4e0d\u6389\uff0c\u75c7\u72c0\u6c92\u6709\u6539\u5584\u3002\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)25% Albumin 1g/kg iv\u3002 (B)Furosemide 40mg iv \u3002 (C)Mannitol 0.5mg/kg iv \u3002 (D)\u7e7c\u7e8c\u5c0f\u5fc3\u6162\u6162\u7d66 IV fluid\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u5c0d\u65bc\u958b\u6d1e\u6027\u80ba\u90e8\u75c5\u7076\uff0c\u9664\u4e86\u80ba\u81bf\u760d( lung abscess )\u4e4b\u5916\uff0c\u4e0b\u5217\u7684\u9451\u5225\u8a3a\u65b7\uff0c\u54ea\u4e00\u7a2e\u8f03\u4e0d\u53ef\u80fd \uff1f", + "Options": "(A)\u8089\u82bd\u816b\u4f75\u591a\u767c\u6027\u8840\u7ba1\u708e( Wegener's granulomatosis)\u3002 (B)\u80ba\u6813\u585e(pulmonary embolism )\u3002 (C)\u80ba\u90e8\u9eb4\u83cc\u75c7( pulmonary aspergillosis )\u3002 (D)\u96b1\u7403\u83cc\u611f\u67d3( Cryptococcus )\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "60\u6b72\u7537\u6027\uff0c\u56e0\u547c\u5438\u56f0\u96e3\u81f3\u6025\u8a3a\u5c31\u91ab\uff0c\u5176\u80f8\u8154 X\u5149\u986f\u793a\u96d9\u5074\u808b\u819c\u7a4d\u6c34\u3002\u7d93\u9032\u884c\u8a3a\u65b7\u6027\u808b\u819c\u7a7f\u523a\u5f8c\u80f8\u6c34\u4e4b\u5be6\u9a57\u5ba4\u5206\u6790\u7d50\u679c\u5982\u4e0b\uff1a \u9178\u9e7c\u503c pH 7.57\uff0c\u80f8\u6c34/\u8840\u6e05\u4e73\u9178\u812b\u6c2b\u9176\u6bd4\u503c(LDH ratio)0.4\uff0c\u80f8\u6c34/ \u8840\u6e05\u86cb\u767d\u8cea\u6bd4\u503c(Protein ratio)0.2 \uff0c\u7d30\u80de\u5206\u985e\u8a08\u6578 WBC 133 / \u00b5L(\u5176\u4e2d 65%\u70balymphocyte ) \u3002\u4e0b\u5217\u8a3a\u65b7\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5fc3\u8870\u7aed\u3002 (B)\u7d30\u83cc\u6027\u80ba\u708e\u3002 (C)\u80ba\u7d50\u6838\u3002 (D)\u7d05\u6591\u6027\u72fc \u7621\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u4e0b\u5df4\u812b\u81fc( mandible dislocation )\u7684\u8a3a\u65b7\u8207\u6cbb\u7642\uff0c\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5e38\u898b\u7684\u812b\u81fc\u65b9\u5f0f\u70ba\u524d\u812b\u81fc\uff0c\u5f8c\u812b\u81fc\u5f88\u5c11\u898b\u3002 (B)\u9032\u884c\u5fa9\u4f4d\u6642\u75c5\u60a3\u7684\u59ff\u52e2\u53ea\u80fd\u5728\u5750\u59ff\u4e0b\u9032\u884c\u3002 (C)\u5fa9\u4f4d\u65bd\u529b\u65b9\u5411\u70ba\u5c07\u75c5\u60a3\u4e0b\u5df4\u671d\u4e0a\u65b9\u53ca\u5f8c\u65b9\u63a8\u52d5\u3002 (D)\u5fa9\u4f4d\u5f8c\u901a\u5e38\u9700\u8981\u7acb\u523b\u7167 X\u5149\u4ee5\u78ba\u5b9a\u5fa9\u4f4d\u6210\u529f\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u611f\u67d3\u6027\u8179\u7009\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u82e5\u7121\u7981\u5fcc\u75c7\uff0c\u53ef\u8003\u616e\u4f7f\u7528 Ciprofloxacin \u3002 (B)Loperamide \u4e26\u4e0d\u80fd\u6539\u5584\u9810\u5f8c\u3002 (C)\u5982\u679c\u8179\u7009\u5e36\u8840\u6216\u61f7\u7591\u767c\u708e\u6027\u8179\u7009\uff0c\u5efa\u8b70\u5408\u4f75\u4f7f\u7528\u6297\u8178\u8815\u52d5\u85e5\u7269\u3002 (D)\u76ca\u751f\u83cc\u5728\u6cbb\u7642\u611f\u67d3\u6027\u8179\u7009\u4e0a\u6c92\u6709\u5e6b\u52a9\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "25\u6b72\u7537\u6027\uff0c\u56e0\u934b\u7210\u7206\u70b8\u9020\u6210\u984f\u9762\u591a\u8655\u88c2\u50b7\u53ca\u81c9\u9830\u71d9\u50b7\u81f3\u6025\u8a3a\u5c31\u91ab\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u70ba\u9810\u9632\u4e0a\u547c\u5438\u9053\u8840\u816b\u963b\u585e\u3001\u6240\u6709\u7684\u820c\u982d\u6495\u88c2\u50b7\u90fd\u9700\u8981\u7e2b\u5408\u3002 (B)\u8ddd\u96e2\u773c\u5167\u7725 0.6~0.8cm \u4ee5\u5167\u7684\u50b7\u53e3\u9700\u7167\u6703\u773c\u79d1\u3002 (C)\u9f3b\u6dda\u7ba1\u65b7\u88c2\u9700\u5728 12\u5c0f\u6642\u5167\u7531\u773c\u79d1\u4fee\u88dc\u7e2b\u5408\u3002 (D)\u9830\u71d9\u50b7\u53ef\u4f7f\u7528\u78fa\u80fa\u5627\u5576\u9280(Silver sulfadiazine )\u85e5\u818f\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "30\u6b72\u7537\u6027\u81ea 6\u516c\u5c3a\u9ad8\u8dcc\u4e0b\u88ab\u9001\u81f3\u6025\u8a3a\uff0c\u8eab\u9ad4\u8a3a\u5bdf\u767c\u73fe\u6709\u660e\u986f\u53f3\u5074\u69e4\u67b7\u80f8(flail chest ) \uff0c\u547c\u5438\u6025\u4fc3\uff0c\u547c\u5438 26\u6b21/min\uff0c\u807d\u8a3a\u96d9\u5074\u7686\u6709\u5c0d\u7a31\u547c\u5438\u97f3\uff0c\u53e9\u8a3a\u7121\u920d\u97f3(dullness)\u6216\u9ad8\u53cd\u97ff\u97f3(hyperresonance ) \uff0c\u7d66\u4e88\u6c27\u6c23\u9762\u7f69 6 L/min \u5f8c\uff0c\u52d5\u8108\u8840\u6c27\u5206\u6790(ABG )\u986f\u793a\uff1aPaO 2 45 mmHg \uff0cPCO 2 28 mmHg\uff0cpH 7.47 \uff0c\u4e0b\u5217\u4f55\u7a2e\u50b7\u5bb3\u6700\u6709\u53ef\u80fd \u662f\u6b64 ABG\u7570\u5e38\u4e4b\u6210\u56e0\uff1f", + "Options": "(A)\u5927\u91cf\u8840\u80f8( massive hemothorax )\u3002 (B)\u80ba\u632b\u50b7(pulmonary contusion)\u3002 (C)\u63db\u6c23\u4e0d\u8db3( hypoventilation )\u3002 (D)\u5f35\u529b\u6027\u6c23\u80f8( tension pneumothorax )\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u4f55\u8005\u70ba acute pulmonary thromboembolism \u65bd\u884c\u8840\u6813\u6eb6\u89e3\u6cbb\u7642\u4e4b\u9069\u61c9\u75c7\uff1f", + "Options": "(A)\u6025\u6027\u80f8\u75db\u767c\u751f\u4e09\u5c0f\u6642\u4ee5\u5167\u3002 (B)\u5fc3\u96fb\u5716\u51fa\u73fe S1Q3T3 pattern \u3002 (C)\u8840\u884c\u52d5\u529b\u5b78\u4e0d\u7a69\u5b9a\u4f75\u56b4\u91cd\u7f3a\u6c27\u3002 (D)\u80ba\u90e8 perfu sion scan \u53caventilation scan \u51fa\u73fe mismatch \u73fe\u8c61\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "2\u6b72\u7684\u7537\u7ae5( 11\u516c\u65a4)\u8eca\u798d\uff0c\u9001\u9054\u6025\u8a3a\u6642\u7684\u751f\u547d\u5fb5\u8c61 \uff1a\u9ad4\u6eab 37.8\u2103\uff0c\u547c\u5438 50\u6b21/min\uff0c\u5fc3\u8df3 150\u6b21/min\uff0c\u8840\u58d3 90/60 mmHg \uff0c\u8840\u6c27 89\uff05\uff0c\u4e0d\u505c\u54ed\u9b27\u3002\u4e0b\u5217\u7537\u7ae5\u7684\u5916\u50b7\u8655\u7f6e\uff0c\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u7f6e\u653e\u53e3\u54bd\u547c\u5438\u9053\u4ee5\u907f\u514d\u56e0\u982d\u90e8\u5916\u50b7\u5408\u4f75\u7684\u4e0a\u547c\u5438\u9053\u963b\u585e\u3002 (B)\u4ee5\u5f92\u624b\u56fa\u5b9a\u9838\u690e\uff0c\u6253\u958b\u547c\u5438\u9053\uff0c\u6e05\u9664\u53e3\u8154\u53ca\u9f3b\u8154\u5206\u6ccc\u7269\u53ca\u7570\u7269\u5f8c\uff0c\u7d66\u4e88\u6c27\u6c23\u4ee5\u7dad\u6301\u9069\u7576\u8840\u6c27\u3002 (C)\u65bc\u6795\u90e8\u4e0b\u588a\u4e00\u67d4\u8edf\u588a\u5b50\u4ee5\u4fbf\u5e73\u8eba\u6642\u80fd\u7dad\u6301\u901a\u66a2\u7684\u547c\u5438\u9053\u3002 (D)\u9078\u64c7 4.5\u865f\u7684\u6c23\u7ba1\u5167\u7ba1\u5f8c\uff0c\u7531\u9f3b\u8154\u9032\u884c\u63d2\u7ba1(nasotracheal intubation)\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "2\u6b72\u7537\u7ae5\uff0c\u56e0\u6301\u7e8c\u767c\u71d2 5\u5929\u5408\u4f75\u547c\u5438\u9053\u75c7\u72c0\uff0c\u5e36\u81f3\u6025\u8a3a\u5c31\u91ab\u3002\u8eab\u9ad4\u8a3a\u5bdf\u767c\u73fe\u96d9\u773c\u7d50\u819c\u5145\u8840\u4e14\u7121\u5206\u6ccc\u7269\u3001\u5634\u5507\u4e7e\u88c2\u3001\u8349\u8393\u820c\u3001\u8ec0\u5e79\u51fa\u73fe\u7d05\u8272\u6591\u4e18\u75b9\uff0c\u4f46\u7121\u9838\u90e8\u6dcb\u5df4\u7d50\u816b\u5927\u3001\u7121\u56db\u80a2\u7d05\u816b\u812b\u76ae\u3002\u95dc\u65bc\u6b64\u75c5\u4eba\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u6b64\u7537\u7ae5\u70ba\u5178\u578b\u5ddd\u5d0e\u6c0f\u75c7\uff0c\u61c9\u8003\u616e\u4f7f\u7528\u975c\u8108\u6ce8\u5c04\u514d\u75ab\u7403\u86cb\u767d(IVIG )\u53ca\u9ad8\u5291\u91cf\u963f\u65af\u5339\u6797\u6cbb\u7642\u3002 (B)\u6b64\u7537\u7ae5\u70ba\u975e\u5178\u578b\u5ddd\u5d0e\u6c0f\u75c7\uff0c\u8f14\u52a9\u8a3a\u65b7\u6a19\u6e96\u5305\u62ec \uff1a\u767d\u8840\u7403( WBC)\u3001\u8840\u8272\u7d20(Hb ) \u3001\u8840\u5c0f\u677f(PLT ) \u3001\u767d\u86cb\u767d( Albumin) \u3001\u9ea9\u4e19\u916e\u9178\u8f49\u80fa\u9176( ALT) \u3001\u808c\u9150\u9178( Creatinine )\u3002 (C)\u9ad8\u71d2\u6642\u53ef\u4f7f\u7528 Ibuprofen \u9000\u71d2\u3002 (D)\u82e5\u540c\u6642\u611f\u67d3\u6d41\u884c\u6027\u611f\u5192\uff0c\u61c9\u907f\u514d\u4f7f\u7528\u963f\u65af\u5339\u6797\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "60\u6b72\u7537\u6027\uff0c\u56e0\u8eca\u798d\u53d7\u50b7\u81f3\u6025\u8a3a\u5c31\u91ab\uff0c\u7dca\u6025\u6551\u8b77\u54e1\u5df2\u7d93\u7d66\u4e88\u9838\u5708\u53ca\u9577\u80cc\u677f\u56fa\u5b9a\u3002\u4f86\u9662\u6642\u610f\u8b58\u6e05\u695a\uff0c\u62b1\u6028\u9838\u90e8\u75bc\u75db\uff0c\u5176\u4ed6\u5916\u89c0\u7121\u660e\u986f\u64e6\u632b\u50b7\u3002\u8840\u58d3 60/30mmHg \uff0c\u5fc3\u8df3 80\u6b21/min\uff0c\u76ae\u819a\u6478\u8d77\u4f86\u6eab\u6696\u3002\u4e0b\u5217\u91dd\u5c0d\u6b64\u75c5\u4eba\u7684\u8a55\u4f30\u8207\u8655\u7f6e\uff0c\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u4f9d\u64da\u75c5\u53f2\u8a62\u554f\u53ca\u521d\u6b65\u8eab\u9ad4\u8a3a\u5bdf\uff0c\u8179\u8154\u5167\u81df\u5668\u640d\u50b7\u9020\u6210\u7684\u4f4e\u8840\u58d3\u53ef\u4ee5\u6392\u9664\u3002 (B)\u6b64\u75c5\u4eba\u61c9\u8a72\u6703\u51fa\u73fe\u4e0b\u80a2\u7671\u7613\u53ca\u6df1\u90e8\u53cd\u5c04\u589e\u52a0\u7684\u72c0\u6cc1\u3002 (C)\u9019\u6a23\u7684\u75c7\u72c0\u8868\u73fe\u53ef\u80fd\u51fa\u73fe\u5728\u80f8\u690e\u7b2c\u56db\u7bc0\u53d7\u50b7\u7684\u60a3\u8005\u3002 (D)\u8840\u7ba1\u5347\u58d3\u5291( vasopressors )\u5c0d\u65bc\u9019\u985e\u75c5\u4eba\u6c92\u6709\u597d\u8655\uff0c\u6703\u589e\u52a0\u7d44\u7e54\u704c\u6d41\u4e0d\u8db3\u7684\u98a8\u96aa\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "67\u6b72\u7537\u6027\u56e0\u534a\u5c0f\u6642\u524d\u958b\u59cb\u7a81\u767c\u6027\u5168\u8eab\u62bd\u6410\u4e14\u53eb\u4e0d\u9192\uff0c\u88ab\u5bb6\u5c6c\u9001\u81f3\u6025\u8a3a\u3002\u5bb6\u5c6c\u8868\u793a\u75c5\u4eba\u6709\u7672\u7647\u75c5\u53f2\uff0c\u4f46\u4e0d\u6e05\u695a\u662f\u5426\u6709\u898f\u5247\u670d\u7528\u85e5\u7269\u63a7\u5236\uff0c\u62bd\u6410\u6301\u7e8c\u6642\u9593\u7d04 15\u5206\u9418\u5de6\u53f3\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u9001\u81f3\u6025\u8a3a\u6642\uff0c\u75c5\u4eba\u6301\u7e8c\u6709\u62bd\u6410\u7684\u75c7\u72c0\uff0c\u53ef\u5148\u7d66\u4e88 Phenytoin \u4f5c\u70ba\u521d\u671f\u7b2c\u4e00\u7dda\u7528\u85e5\u3002 (B)\u4f7f\u7528\u5169\u7a2e\u6297\u7672\u7647\u85e5\u7269\u6cbb\u7642 1\u5c0f\u6642\u4e4b\u5f8c\u75c7\u72c0\u4ecd\u7121\u6539\u5584\uff0c\u6b64\u6642\u518d\u7d66\u4e88Barbiturates \u985e\u85e5\u7269\u5e6b\u52a9\u4e0d\u5927\u3002 (C)\u4f7f\u7528 Barbiturates \u985e\u85e5\u7269\u6cbb\u7642\u9811\u56fa\u6027\u7672\u7647\u91cd\u7a4d\u72c0\u614b\u7684\u75c5\u4eba\uff0c\u56e0\u70ba\u85e5\u7269\u534a\u8870\u671f\u8f03\u77ed\uff0c\u6709\u52a9\u65bc\u63d2\u7ba1\u75c5\u4eba\u63d0\u65e9\u62d4\u7ba1\u3002 (D)Valproic acid\u61c9\u548c Phenytoin \u5408\u4f75\u4f7f\u7528\u4ee5\u9054\u6210\u8f03\u597d\u6cbb\u7642\u6548\u679c\uff0c\u4f46\u9808\u5c0f\u5fc3Valproic acid \u53ef\u80fd\u6703\u9020\u6210\u809d\u8870\u7aed\u548c\u80f0\u81df\u708e\u7b49\u526f\u4f5c\u7528\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "27\u6b72\u5973\u6027\uff0c\u56e0\u5fc3\u60c5\u4e0d\u4f73\uff0c\u541e\u670d\u5927\u91cf\u6b62\u75db\u5291\u5f8c\uff0c\u88ab\u9001\u4f86\u6025\u8a3a\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u4e0d\u7ba1\u662f\u4f7f\u7528\u90a3\u4e00\u7a2e NSAIDs\u51fa\u73fe\u526f\u4f5c\u7528\u7684\u6bd4\u4f8b\u5927\u81f4\u76f8\u540c\uff0c\u6cbb\u7642\u4ee5\u652f\u6301\u6027\u7642\u6cd5\u70ba\u4e3b\u3002 (B)\u53ef\u8003\u616e\u4f7f\u7528\u53e3\u670d\u9ad4\u91cd\u6bcf\u516c\u65a4 1\u514b\u6d3b\u6027\u78b3\uff0c\u4f46\u662f\u5982\u679c\u51fa\u73fe\u62bd\u6410\u6642\uff0c\u4f7f\u7528BZD\u662f\u7121\u6548\u7684\u3002 (C)\u75c5\u4eba\u4e00\u65e6\u51fa\u73fe\u4e0d\u9069\u75c7\u72c0\uff0c\u901a\u5e38\u9810\u5f8c\u4e0d\u4f73\u3002 (D)\u5927\u90e8\u4efd\u75c5\u4eba\u5728\u89c0\u5bdf 4\u5c0f\u6642\u5f8c\uff0c\u6c92\u6709\u4e0d\u9069\u75c7\u72c0\uff0c\u53ef\u7d93\u7cbe\u795e\u79d1\u6703\u8a3a\u5f8c\uff0c\u56de\u5bb6\u89c0\u5bdf\u3002", + "Answer": "A\u3001B\u3001C\u3001D" + }, + { + "\ufeffQuestion": "4\u6b72\u5973\u7ae5\u70ba\u9ad8\u901f\u8eca\u798d\u7684\u5f8c\u5ea7\u4e58\u5ba2\uff0c\u6709\u5750\u5b89\u5168\u5ea7\u6905\uff0c\u8eab\u9ad4\u8a3a\u5bdf\u767c\u73fe\u8179\u90e8\u6709\u660e\u986f\u5b89\u5168\u5e36\u52d2\u75d5\uff0c\u5408\u4f75\u809a\u81cd\u5468\u570d\u58d3\u75db\uff0c FAST\u770b\u5230\u9aa8\u76c6\u6709\u5c11\u91cf\u7a4d\u6c34\uff0c\u5c3f\u6db2\u6aa2\u67e5\u6709\u8840\u5c3f\uff0c\u6b64\u6642\u8840\u58d3 110/70 mmHg \uff0c\u5fc3\u8df3 85\u6b21/min\uff0c\u95dc\u65bc\u63a5\u4e0b\u4f86\u8a55\u4f30\u8840\u5c3f\u7684\u8655\u7f6e\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u8179\u90e8\u53ca\u9aa8\u76c6\u96fb\u8166\u65b7\u5c64\u6383\u63cf\u3002 (B)\u8180\u80f1\u93e1\u3002 (C)\u814e\u81df\u8d85\u97f3\u6ce2\u3002 (D)\u9006\u884c\u6027 \u5c3f\u9053\u651d\u5f71\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u4ee3\u8b1d\u7570\u5e38\u4f55\u8005\u6bd4\u8f03\u4e0d\u6613 \u9020\u6210\u5c0f\u5152\u4f11\u514b\uff1f", + "Options": "(A)Hypoglycemia \u3002 (B)Hypercalcemia \u3002 (C)Hyperkalemia \u3002 (D)Metabolic acidosis \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u958b\u653e\u6027\u50b7\u53e3\u61f7\u7591\u6709\u8f3b\u50b7\u75c7\u5019\u7fa4\u6642\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u73fe\u5834\u50b7\u8005\u6709\u5496\u5561\u8272\u5614\u5410\u7269\uff0c\u53ef\u4f30\u8a08\u5176\u66fe\u63a5\u6536\u4e4b\u8f3b\u5c04\u91cf\u70ba 3~4 Gray \u3002 (B)\u5728\u91ab\u9662\u5167\u53ef\u7528\u6aa2\u5b9a\u7d30\u80de\u57fa\u56e0\u5291\u91cf\u6aa2\u6e2c(cytogenetic dosimetry )\u4f86\u8a55\u4f30\u50b7\u5bb3\u56b4\u91cd\u7a0b\u5ea6\u8207\u9810\u5f8c\u3002 (C)\u6b64\u50b7\u8005\u81e8\u5e8a\u8868\u73fe\u70ba\u5641\u5fc3\u3001\u5614\u5410\u3001\u4f4e\u8840\u58d3\u53ca\u4e0a\u80c3\u8178\u9053\u51fa\u8840\u7b49\u75c7\u72c0\uff0c\u4e0d\u53ef\u7d66\u4e88\u6b62\u5410\u5291\u3002 (D)\u6dcb\u5df4\u7403\u6578\u91cf\u65bc\u66b4\u9732\u8f3b\u5c04\u5f8c\u6703\u5927\u91cf\u6e1b\u5c11\uff0c\u6545\u9023\u7e8c\u6e2c\u8a66 48\u5c0f\u6642\u6dcb\u5df4\u7403\u91cf\u53ef\u63a8\u6e2c\u50b7\u8005\u4e4b\u66b4\u9732\u5291\u91cf\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u7532\u72c0\u817a\u98a8\u66b4( thyroid storm)\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)Burch &Wartofsky score \u226745\u5206\u53ef\u80fd\u662f\u7532\u72c0\u817a\u98a8\u66b4\uff0c\u4f46\u4ecd\u9700\u81e8\u5e8a\u4e4b\u9451\u5225\u8a3a\u65b7\u3002 (B)\u7532\u72c0\u817a\u98a8\u66b4\u56e0\u70ba\u6301\u7e8c\u9ad8\u71d2\uff0c\u6545\u7a4d\u6975\u4ee5 Acetaminophen \u8207Aspirin\u964d\u6eab\u662f\u5fc5\u9700\u7684\u3002 (C)\u9577\u6548\u578b beta-blocker\u80fd\u5e36\u4f86\u8f03\u597d\u7684\u5fc3\u7387\u904e\u5feb\u7684\u63a7\u5236\uff0c\u8f03\u9069\u7528\u6709\u5fc3\u8870\u7aed\u75c5\u60a3\u3002 (D)\u92f0\u5869\u5728\u56b4\u91cd\u7684\u7532\u72c0\u817a\u98a8\u66b4\u53ef\u7528\u4f86\u6291\u5236\u5468\u908a\u7684 T4\u8f49\u70ba T3\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u6688\u53a5( syncope)\u70ba\u66ab\u6642\u6027\u7684\u5927\u8166\u704c\u6d41\u91cf\u4e0d\u8db3\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u8840\u7ba1\u5f35\u529b\u5931\u8abf\u6027\u6688\u53a5(vasovagal syncope )\u5e38\u4f34\u96a8\u8457\u611f\u89ba\u5bd2\u51b7\u3001\u982d\u6688\u548c\u5641\u5fc3\u611f\u7b49\u524d\u5146\u3002 (B)\u9020\u6210\u8001\u5e74\u4eba\u59ff\u52e2\u6027\u4f4e\u8840\u58d3\u539f\u56e0\u53ef\u80fd\u662f\u4f7f\u7528\u85e5\u7269\uff0c\u5982\u6297\u5df4\u91d1\u68ee\u6c0f\u75c7\u85e5(antiparkinsonism drugs )\u3002 (C)\u795e\u7d93\u6027\u6688\u53a5( neuogenic syncope )\u9020\u6210\u7684\u539f\u56e0\u901a\u5e38\u662f\u9838\u52d5\u8108\u4f9b\u8840\u4e0d\u8db3\u6216\u8166\u8840\u7ba1\u525d\u96e2\u7b49\u3002 (D)\u4e3b\u52d5\u8108\u74e3\u72f9\u7a84( aortic valve stenosis )\u70ba\u8001\u5e74\u4eba\u6700\u5e38\u898b\u7684\u6688\u53a5\u539f\u56e0\u4e4b\u4e00\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8001\u5e74\u75c5\u4eba\u7684\u8b6b\u5984\u8fa8\u8b58\u8207\u8655\u7406\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u7279\u5fb5\u662f\u6025\u6027\u51fa\u73fe\uff0c\u75c5\u60c5\u53cd\u8986\uff0c\u53ef\u80fd\u6709\u5e7b\u89ba\uff0c\u4f46\u6ce8\u610f\u529b\u4e0d\u53d7\u5f71\u97ff\u3002 (B)\u5c3f\u6eef\u7559\u6703\u5c0e\u81f4\u8b6b\u5984\uff0c\u4f46\u7559\u7f6e\u5c3f\u7ba1\u4e5f\u6703\u589e\u52a0\u8b6b\u5984\u7684\u767c\u751f\u6a5f\u6703\u3002 (C)\u85e5\u7269\u6cbb\u7642\u7684\u9996\u9078\u662f Benzodiazepines \u3002 (D)\u56e0\u8b6b\u5984\u800c\u8e81\u52d5\u7684\u75c5\u4eba\uff0c\u53ef\u4ee5\u4f7f\u7528 Antihistamine \u4f86\u6cbb\u7642\u6bd4\u8f03\u5b89\u5168\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4f60\u6b63\u6e96\u5099\u70ba\u4e00\u4f4d\u547c\u5438\u7a98\u8feb\u7684 6\u6b72\u5973\u5b69\u9032\u884c Rapid Sequence Intubation (RSI) \uff0c\u8acb\u554f\u4e0b\u5217\u85e5\u7269\u4f55\u8005 \u6700\u6709\u53ef\u80fd \u5f15\u767c\u6b64\u75c5\u60a3\u54ac\u808c\u75d9\u6523( masseter muscle spasm )\u800c\u5c0e\u81f4\u56f0\u96e3\u63d2\u7ba1\uff1f", + "Options": "(A)Fentanyl \u3002 (B)Ketamine \u3002 (C)Succinylcholine \u3002 (D)Vecuronium \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u65bc\u6297\u8840\u6813\u6cbb\u7642 \uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u6297\u8840\u5c0f\u677f\u85e5\u7269\u5c0d\u65bc\u975c\u8108\u6813\u585e\u6bd4\u6297\u51dd\u8840\u85e5\u7269\u66f4\u6709\u6548\u3002 (B)Warfarin \u4f5c\u7528\u5728\u7dad\u4ed6\u547d K\u6709\u95dc\u7684\u51dd\u8840\u9014\u5f91\u3002 (C)\u65b0\u578b\u6297\u51dd\u8840\u85e5\u7269 Dabigatran \u662f\u51dd\u8840\u9176(thrombin)\u76f4\u63a5\u6291\u5236\u5291\u3002 (D)\u65b0\u578b\u6297\u51dd\u8840\u85e5\u7269 Rivaroxaban \u662f\u7b2c\u5341\u51dd\u8840\u56e0\u5b50\u7684\u6291\u5236\u5291\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "72\u6b72\u7537\u6027\u75c5\u4eba\uff0c\u56e0\u8179\u8139\u3001\u547c\u5438\u6025\u4fc3\u81f3\u6025\u8a3a\u6c42\u6cbb\u3002\u8eab\u9ad4\u8a3a\u5bdf\u6709\u9838\u975c\u8108\u6012\u5f35\uff0c\u8179\u90e8\u6709 shifting dullness\uff0c\u8179\u6c34\u6aa2\u67e5\u7d50\u679c\u986f\u793a\u767d\u8840\u7403\u8a08\u6578 280/\u00b5L\uff0c40%\u70ba\u591a\u6838\u7403\u3002\u8179\u6c34\u4e4b albumin\u70ba1.3 g/dL\uff0ctriglyceride \u70ba300 mg/dL\uff1b\u8840\u4e2d\u4e4balbumin\u70ba2.6 g/dL\u3002\u5176\u8179\u6c34\u4e4b\u6210\u56e0\uff0c\u4f55\u8005\u6700\u53ef\u80fd \uff1f", + "Options": "(A)\u7d30\u83cc\u6027\u8179\u819c\u708e\u3002 (B)\u8179\u5167\u6563\u5e03\u6027\u764c\u75c7\u3002 (C)\u5145\u8840\u6027\u5fc3\u8870\u7aed\u3002 (D)\u4e73\u7cdc \u8179\u6c34\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6d41\u884c\u6027\u611f\u5192\u7684\u8a3a\u65b7\u8207\u6cbb\u7642\uff0c\u4ee5\u4e0b\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u6d41\u884c\u671f\u6642\uff0c\u70ba\u4e86\u63a7\u5236\u75ab\u60c5\uff0c\u75c5\u4eba\u9808\u7d93\u5feb\u901f\u7be9\u6aa2\u78ba\u8a3a\u5f8c\u6295\u85e5\u3002 (B)\u4ee5\u514b\u6d41\u611f\u6cbb\u7642\u7121\u4f75\u767c\u75c7\u6d41\u611f\u75c5\u4eba\u61c9\u5728 72\u5c0f\u6642\u5167\u958b\u59cb\u5c0d\u75c5\u60c5\u6062\u5fa9\u6709\u6240\u52a9\u76ca\u3002 (C)\u82e5\u4f75\u767c\u56b4\u91cd\u80ba\u708e\u9700\u6295\u4e88\u6297\u751f\u7d20\u6cbb\u7642\uff0c\u5fc5\u9808\u80fd\u6db5\u84cb\u6297\u85e5\u6027\u91d1\u9ec3\u8272\u8461\u8404\u7403\u83cc\u3002 (D)5\u6b72\u81f3 50\u6b72\u9593\u7f79\u60a3\u6d41\u611f\uff0c\u8f03\u5bb9\u6613\u767c\u751f\u80ba\u708e\u3001\u8166\u819c\u708e\u7b49\u4f75\u767c\u75c7\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "70\u6b72\u5973\u6027\uff0c\u7cd6\u5c3f\u75c5\u75c5\u53f2\uff0c\u56e0\u5de6\u5074\u8996\u529b\u6a21\u7cca 2\u5929\u5408\u4f75\u75bc\u75db\u3001\u754f\u5149\u81f3\u6025\u8a3a\uff0c\u6aa2\u50b7\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\uff0c \u9ad4\u6eab 37.7\u2103\uff0c\u5de6\u773c\u7d50\u819c\u5145\u8840\u7121\u5206\u6ccc\u7269\uff0c\u89d2\u819c\u7121\u7570\u5e38\uff0c\u524d\u623f\u6709\u7d30\u80de\u61f8\u6d6e\uff0c\u5de6\u773c\u773c\u58d3 22mmHg \uff0c\u773c\u5e95\u56e0\u767d\u5167\u969c\u7121\u6cd5\u8a55\u4f30\uff0c\u4e0b\u5217\u4f55\u8005\u70ba\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\uff1f", + "Options": "(A)Acute angle -closure glaucoma \u3002 (B)Endophthalmitis\u3002 (C)Orbital cellulitis\u3002 (D)Viral conjunctivitis\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u809d\u6027\u8166\u75c5\u8b8a( hepatoencephalopathy ) \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u4f7f\u7528 Flumazenil \u6cbb\u7642\u53ef\u80fd\u6709\u6548\u3002 (B)Asterixis \u5e38\u5728\u7b2c\u4e00\u968e\u6bb5\u809d\u6027\u8166\u75c5\u8b8a\u51fa\u73fe\u3002 (C)\u809d\u6027\u8166\u75c5\u8b8a\u56b4\u91cd\u7a0b\u5ea6\u548c\u8166\u810a\u9ad3\u6db2\u4e2d glutamine \u6fc3\u5ea6\u6709\u5bc6\u5207\u76f8\u95dc\u3002 (D)\u8840\u6c28\u7a7f\u8d8a blood -brain barrier \u5f8c\u5f62\u6210\u4e4b glutamine \u4ee5\u53ca tryptophan \u7b49\u7269\u8cea\uff0c\u5c0d\u65bc\u809d\u6027 \u8166\u75c5\u8b8a\u4e4b\u8868\u73fe\u626e\u6f14\u91cd\u8981\u89d2\u8272\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u9670\u8396\u6301\u7e8c\u52c3\u8d77\u75c7( priapism) \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u4f4e\u8840\u6d41\u91cf\u578b\u6700\u5e38\u898b\u7684\u539f\u56e0\u662f\u9670\u8396\u548c\u6703\u9670\u5275\u50b7\uff0c\u9020\u6210\u9670\u8396\u6d77\u7dbf\u9ad4\u52d5\u8108(cavernosal artery )\u7684\u8840\u6d41\u88ab\u963b\u65b7\u3002 (B)\u9ad8\u8840\u6d41\u91cf\u578b\u53ca\u4f4e\u8840\u6d41\u91cf\u578b\uff0c\u5e38\u898b\u9670\u8396\u75bc\u75db\u7684\u75c7\u72c0\u3002 (C)\u5340\u5206\u9ad8\u8840\u6d41\u91cf\u578b\u53ca\u4f4e\u8840\u6d41\u91cf\u578b\u65b9\u6cd5\u4e4b\u4e00\uff0c\u662f\u62bd\u53d6\u9670\u8396\u6d77\u7dbf\u9ad4\u7684\u8840\u6db2\u505ablood gas \u5206\u6790\u3002 (D)\u5152\u7ae5\u767c\u751f\u9670\u8396\u6301\u7e8c\u52c3\u8d77\u75c7\uff0c\u591a\u56e0\u7f79\u60a3\u8840\u6db2\u75be\u75c5\u3002", + "Answer": "C\u3001D" + }, + { + "\ufeffQuestion": "12\u6b72\u7537\u7ae5\uff0c\u9ad4\u91cd 60\u516c\u65a4\uff0c\u6709\u7b2c\u4e00\u578b\u7cd6\u5c3f\u75c5\uff0c\u4e3b\u8a34\u5168\u8eab\u7121\u529b\uff0c\u547c\u5438\u5598\uff0c\u610f\u8b58\u6e05\u695a\uff0c\u6aa2\u50b7\u8840\u58d3 80/50 mm Hg \uff0c\u5fc3\u8df3 145\u6b21/min\uff0c\u547c\u5438 28\u6b21/min\uff0c\u8840\u91a3613 mg/dL\uff0cpH 7.04\uff0c HCO 3 2.1 mEq/ L\uff0cNa 134 mEq/ L\uff0cK 2.8 mEq/ L\uff0c\u7d93\u8f38\u6db2\u53ca\u80f0\u5cf6\u7d20\u6cbb\u7642 6\u5c0f\u6642\u5f8c\uff0c\u76ee\u524d\u8840\u91a3 180mg/dL \uff0cpH 7.283 HCO 3 13.8 mEq /L\uff0cNa 144 mEq/L \uff0cK 3.0 mEq/ L\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)6\u5c0f\u6642\u5f8c\u7684\u8f38\u6db2\u6cbb\u7642\u53ef\u9078\u64c7 5%\u8461\u8404\u7cd6\u52a0 0.45%\u751f\u7406\u98df\u9e7d\u6c34\u6ef3\u6ce8\u3002 (B)6\u5c0f\u6642\u9020\u6210\u4f4e\u8840\u9240\u4e3b\u8981\u70ba\u80f0\u5cf6\u7d20\u6cbb\u7642\u548c\u4ee3\u8b1d\u9178\u6539\u5584\u7684\u5f71\u97ff\uff0c\u6b64\u6642\u53ef\u75280.2~0.3 mEq KCL/kg/hr \u6cbb\u7642\u3002 (C)\u521d\u59cb\u548c 6\u5c0f\u6642\u5f8c\u5747\u4e0d\u9700\u8981\u78b3\u9178\u6c2b\u9209(s odium bicarbonate )\u6cbb\u7642\u3002 (D)\u521d\u59cb\u8f38\u6db2\u6cbb\u7642\u9806\u5e8f\u70ba\u5148\u7d66\u4e88 6U RI(Regular Insulin)\u975c\u8108\u63a8\u6ce8\uff0c\u6bcf\u5c0f\u6642\u7dad\u6301\u7684 6U\u6ef4\u6ce8\u5f8c\uff0c\u518d 1\u5c0f\u6642\u5167\u7d66\u4e88\u751f\u7406\u98df\u9e7d\u6c34 1,200ml\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u51fa\u8840\u9ad4\u8cea\uff0c \u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u8840\u5c0f\u677f\u6e1b\u5c11\u7684\u554f\u984c\uff0c\u6bd4\u8f03\u5bb9\u6613\u51fa\u73fe\u9ede\u72c0\u51fa\u8840\uff0c\u8840\u5c3f\u6216\u7259\u9f66\u51fa\u8840\u3002 (B)\u51dd\u8840\u56e0\u5b50\u7684\u554f\u984c\uff0c\u6bd4\u8f03\u5bb9\u6613\u51fa\u73fe\u6df1\u90e8\u51fa\u8840\uff0c\u5982\u5f8c\u8179\u8154\u51fa\u8840\u53ca\u95dc\u7bc0\u51fa\u8840\u3002 (C)\u514d\u75ab\u5f15\u8d77\u7684\u8840\u5c0f\u677f\u904e\u5c11(ITP )\u4e0d\u5b9c\u8f38\u8840\u5c0f\u677f\uff0c\u56e0\u70ba\u6703\u9020\u6210\u9032\u4e00\u6b65\u8840\u5c0f\u677f\u7834\u58de\u3002 (D)ITP \u53ef\u4ee5\u8003\u616e\u6ce8\u5c04\u985e\u56fa\u9187\u53ca\u514d\u75ab\u7403\u86cb\u767d\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u91dd\u5c0d\u4f4e\u8840\u9223\u7522\u751f\u7684\u75c7\u72c0\u53ca\u81e8\u5e8a\u8868\u73fe\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u4f4e\u8840\u9223\u7522\u751f\u7684\u75c7\u72c0\u8207\u8840\u9223\u4e0b\u964d\u7684\u901f\u5ea6\u7121\u95dc\u3002 (B)\u4f4e\u8840\u9223\u4e0d\u6703\u7522\u751f\u5e7b\u89ba(hallucination )\u3002 (C)\u4f4e\u8840\u9223\u53ef\u80fd\u6703\u7522\u751f\u610f\u8b58\u8b8a\u5316\u3002 (D)\u81e8\u5e8a\u4e0a\u8868\u73fe\u51fa Chvostek sign \u5c0d\u8a3a\u65b7\u4f4e\u8840\u9223\u7279\u7570\u6027\u9ad8\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5152\u7ae5\u7cd6\u5c3f\u75c5\u916e\u9178\u4e2d\u6bd2( diabetic ketoacidosis, DKA ) \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u53ef\u4ee5\u4f7f\u7528\u78b3\u9178\u6c2b\u9209(sodium bicarbonate )\u6cbb\u7642\u3002 (B)\u6557\u8840\u75c7\u662f\u9020\u6210\u5152\u7ae5 DKA\u6b7b\u4ea1\u7684\u4e3b\u8981\u539f\u56e0\u3002 (C)\u61c9\u7d66\u4e88 IV loading bolus Regular Insulin 0.1 units/kg \u6cbb\u7642\u3002 (D)\u5e74\u9f61\u5c0f\u65bc 5\u6b72\u662f DKA\u4f75\u767c\u8166\u6c34\u816b\u7684\u5371\u96aa\u56e0\u5b50\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6eba\u6c34\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u9838\u690e\u53d7\u50b7( cervical spine injury )\u50c5\u767c\u751f\u65bc\u5c11\u6578\u7684\u6eba\u6c34\u500b\u6848\uff0c\u5176\u6a5f\u8f49\u4ee5\u8df3\u6c34\u3001\u9ad8\u8655\u589c\u843d\u548c\u8eca\u798d\u5f8c\u6eba\u6c34\u70ba\u4e3b\u3002 (B)\u82e5\u6eba\u6c34\u500b\u6848\u62b5\u9054\u6025\u8a3a\u6642 GCS\u6eff\u5206\u4e14\u547c\u5438\u7121\u7570\u5e38\uff0c\u4ecd\u9808\u5e38\u898f\u57f7\u884c\u9838\u5708\u4fdd\u8b77\u548c\u982d\u90e8\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u3002 (C)\u82e5\u6eba\u6c34\u500b\u6848\u62b5\u9054\u6025\u8a3a\u6642\u5df2 OHCA\u4e14\u9ad4\u6eab\u53ea\u6709 20\u2103\uff0c\u5247\u53ef\u5224\u5b9a\u660e\u986f\u6b7b\u4ea1\u4e26\u52f8\u5bb6\u5c6c\u653e\u68c4\u6025\u6551\u3002 (D)\u6eba\u6c34\u5c0e\u81f4\u7684 OHCA\u500b\u6848\uff0c\u5176\u6b7b\u56e0\u5728 Utstein templates \u4e2d\u662f\u88ab\u6b78\u985e\u70ba\u5916\u50b7\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "65\u6b72\u7537\u6027\uff0c\u7121\u904e\u53bb\u75c5\u53f2\uff0c\u751f\u547d\u8de1\u8c61\u6b63\u5e38\uff0c\u4e3b\u8a34\u6f38\u9032\u5f0f\u80a2\u9ad4\u7121\u529b\u7d04 4\u9031\uff0c\u8eab\u9ad4\u8a3a\u5bdf\u767c\u73fe\u5c0d\u7a31\u6027\u8fd1\u7aef\u808c\u8089\u7121\u529b\uff0c\u611f\u89ba\u3001\u53cd\u5c04\u53ca\u773c\u808c\u6b63\u5e38\uff0c\u4e0b\u5217\u9451\u5225\u8a3a\u65b7\u4f55\u8005\u53ef\u80fd\u6027\u6700\u4f4e \uff1f", + "Options": "(A)\u76ae\u808c\u708e\u3002 (B)\u591a\u767c\u6027\u808c\u708e\u3002 (C)\u91cd\u75c7\u808c\u7121\u529b\u3002 (D)Lambert -Eaton \u75c7\u5019\u7fa4\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u624b\u90e8\u975e\u5275\u50b7\u7684\u75be\u75c5\uff0c\u4e0b\u5217\u4f55\u8005\u6558\u8ff0\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u7532\u6e9d\u708e(Paronychia )\u53ef\u56e0\u8f15\u5fae\u5275\u50b7\u3001\u54ac\u6307\u7532\u6240\u81f4\uff0c\u6700\u5e38\u898b\u683c\u862d\u6c0f\u9670\u6027\u83cc\u611f\u67d3\u3002 (B)Kanavel\u2019s signs \u7686\u70ba\u9670\u6027\u53ef\u6392\u9664\u5c48\u6307\u8171\u9798\u6ed1\u6db2\u56ca\u708e( flexor tenosynovitis)\u7684\u8a3a\u65b7\u3002 (C)\u5c0d\u65bc\u6df1\u5c64\u611f\u67d3( deep space infection ) \uff0c\u61c9\u6309\u58d3\u638c\u9762\uff0c\u6aa2\u67e5\u662f\u5426\u75bc\u75db\u3001\u786c\u584a\u6216\u7a4d\u6db2\u3002 (D)\u76b0\u75b9\u6027\u6307\u982d\u708e( herpetic whitlow)\u5e38\u6703\u7522\u751f\u6c34\u6ce1\u7a4d\u81bf\uff0c\u6cbb\u7642\u5e38\u9700\u85c9\u5207\u958b\u5f15\u6d41\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u521d\u7522\u5a66\u7522\u5f8c\u5927\u51fa\u8840\uff0c\u5df2\u7d93\u8f38\u8840\u7d04 2,000\u6beb\u5347\uff0c\u4e26\u6ce8\u5c04\u85e5\u7269 Oxytocin\uff0c\u76ee\u524d\u751f\u547d\u5fb5\u8c61 \uff1a\u8840\u58d3 76/32 mmHg \uff0c\u5fc3\u8df3 132\u6b21/min\uff0c\u547c\u5438 28\u6b21/min\uff0c\u9ad4\u6eab 36.0\u2103\uff0cSpO 2 95%(room air)\uff0cGCS E3M6V5 \u3002\u4e0b\u5217\u4f55\u9805\u8655\u7f6e\uff0c\u6709\u6548\u4e14\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u7dca\u6025\u5927\u91cf\u8f38 FFP\u53caplatelet s\u3002 (B)\u5927\u91cf\u8f38\u8840\uff0c\u6ce8\u5c04 vitamin K \u8f14\u52a9\u3002 (C)\u901a\u77e5\u5a66\u7522\u79d1\u91ab\u5e2b\uff0c\u5b89\u6392\u5b50\u5bae\u5207\u9664\u624b\u8853\u3002 (D)\u7167\u6703\u653e\u5c04\u79d1\u91ab\u5e2b\uff0c\u5b89\u6392\u6813\u585e\u8853 pelvic vessel embolization \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u95dc\u65bc\u982d\u75db\u4e4b\u6558\u8ff0\uff0c\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u504f\u982d\u75db\u3001\u53e2\u96c6\u6027\u982d\u75db\u548c\u7dca\u5f35\u6027\u982d\u75db\u7684\u767c\u751f\u7387\u6703\u96a8\u8457\u5e74\u9f61\u589e\u52a0\u800c\u6e1b\u5c11\u3002 (B)\u982d\u75db\u662f\u767c\u71d2\u7684\u5e38\u898b\u75c7\u72c0\uff0c\u800c\u767c\u71d2\u4e26\u975e\u982d\u75db\u7684\u7d05\u65d7\u5fb5\u5019(red flag sign)\u3002 (C)\u8166\u90e8\u8840\u7ba1\u6536\u7e2e\u548c\u53cd\u5f48\u6027\u8840\u7ba1\u8212\u5f35\uff0c\u70ba\u504f\u982d\u75db\u7684\u5e38\u898b\u539f\u56e0\u3002 (D)\u539f\u767c\u6027\u9ad8\u8840\u58d3\u5e38\u9020\u6210\u96f7\u64ca\u6027\u982d\u75db(\"thunderclap\" headache )\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8f38\u8840\u76f8\u95dc\u7684\u6025\u6027\u80ba\u50b7\u5bb3( transfusion -related acute lung injury ) \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u5927 \u591a\u8ddf\u65b0\u9bae\u51b7\u51cd\u8840\u6f3f\u53ca\u8840\u5c0f\u677f\u7684\u8f38\u8840\u76f8\u95dc\u3002 (B)\u55ae\u7368\u8f38\u6fc3\u7e2e\u7d05\u8840\u7403(Packed RBC)\u4e5f\u5e38\u767c\u751f\u3002 (C)\u5e38\u5e38\u9020\u6210\u5169\u908a\u80ba\u6d78\u6f64(infiltrate )\u3002 (D)\u5e38\u5e38\u5728\u8f38 \u8840\u5f8c 6\u5c0f\u6642\u5167\u767c\u751f\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u72c2\u72ac\u75c5\u75ab\u82d7\u8207\u514d\u75ab\u7403\u86cb\u767d\u6ce8\u5c04\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5609\u7fa9\u7e23\u5a66\u4eba\u906d\u95d6\u5165\u5f8c\u9662\u9f2c\u737e\u8f15\u5fae\u54ac\u50b7\uff0c\u82e5\u5224\u65b7\u70ba\u7b2c\u4e8c\u985e\u50b7\u53e3\uff0c\u7d93\u6aa2\u9a57\u9f2c\u737e\u9451\u5b9a\u70ba\u75c5\u6bd2\u967d\u6027\u5f8c\u63a5\u7a2e\u514d\u75ab\u7403\u86cb\u767d\u3002 (B)\u50b7\u53e3\u9700\u540c\u6642\u65bd\u4e88\u514d\u75ab\u7403\u86cb\u767d\u6d78\u6f64\u6ce8\u5c04\u5f8c\uff0c\u5982\u9808\u7e2b\u5408\u5efa\u8b70\u5728 30\u5206\u9418\u5167\u9032\u884c\u7e2b\u5408\uff0c\u907f\u514d\u514d\u75ab\u7403\u86cb\u767d\u96a8\u5206\u6ccc\u7269\u6ef2\u6f0f\u6d41\u5931\u3002 (C)\u906d\u6d41\u6d6a\u8c93\u72d7\u54ac\u50b7\uff0c\u66ab\u6642\u4e0d\u7d66\u4e88\u75ab\u82d7\u3002\u61c9\u89c0\u5bdf\u72ac\u8c93 7\u65e5\uff0c\u82e5\u72ac\u8c93\u51fa\u73fe\u75c7\u72c0\u9ad8\u5ea6\u61f7\u7591\u72c2\u72ac\u75c5\uff0c\u5247\u7d66\u4e88\u75ab\u82d7\u3002 (D)\u72c2\u72ac\u75c5\u514d\u75ab\u7403\u86cb\u767d\u53ef\u8207\u66b4\u9732\u5f8c\u9996\u5291\u72c2\u72ac\u75c5\u75ab\u82d7\u540c\u6642\u65bd\u6253\u5728\u540c\u4e00\u8eab\u9ad4\u90e8\u4f4d\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "10\u6b72\u7537\u7ae5\uff0c\u5728 4\u5c0f\u6642\u524d\u541e\u4e0b 25\u9846Acetaminophen 500mg/tab \uff0c\u6025\u8a3a\u6aa2\u50b7\u751f\u547d\u5fb5\u8c61\u6b63\u5e38\uff0c\u5373\u6642\u6aa2\u6e2c\u8840\u4e2d Acetaminophen \u503c\u70ba 300mg/mL \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u9054\u5230\u85e5\u7269\u4e2d\u6bd2\u5291\u91cf\uff0c\u9700\u7acb\u523b\u7d66\u4e88 N-acetylcysteine \u6cbb\u7642\u3002 (B)\u5728 24\u5c0f\u6642\u5167\u6709\u7522\u751f\u809d\u660f\u8ff7\u7684\u98a8\u96aa\u3002 (C)\u53ef\u4ee5\u5148\u7d93\u9f3b\u80c3\u7ba1\u6216\u53e3\u670d\u7d66\u4e88\u6d3b\u6027\u78b3\u6cbb\u7642\uff0c\u518d\u7b49\u5019 4\u5c0f\u6642\u5f8c\u8840\u4e2dAcetaminophen \u6fc3\u5ea6\u518d\u6c7a\u5b9a N-acetylcysteine \u7684\u6cbb\u7642\u3002 (D)\u82e5\u4e2d\u6bd2\u5247\u7d66\u4e88\u53e3\u670d N-acetylcysteine \u55ae\u6b21 160mg/kg\uff0c\u4e4b\u5f8c\u6bcf 4\u5c0f\u6642\u4ee570mg/kg \u7684\u5291\u91cf\u9023\u7e8c\u7d66\u4e88 17\u6b21\u3002", + "Answer": "A\u3001C" + }, + { + "\ufeffQuestion": "\u7ad9\u7acb\u5f0f\u80f8\u90e8 X\u5149( upright chest film )\u5c0d\u5075\u6e2c\u8179\u90e8\u6025\u75c7\u6e38\u96e2\u7a7a\u6c23( free air)\u4e4b\u654f\u611f\u6027\u7d04\u70ba\uff1f", + "Options": "(A)1 0%\u3002 (B)30% \u3002 (C)50% \u3002 (D)70% \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u75c5\u4eba\u56e0\u54b3\u8840\u81f3\u6025\u8a3a\uff0c\u8acb\u554f\u5176\u8a3a\u65b7\u53ca\u8655\u7f6e\u4f55\u9805\u6558\u8ff0\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5927\u91cf\u54b3\u8840\u8f03\u5e38\u898b\u7684\u5b9a\u7fa9\u662f\u65bc 24\u5c0f\u6642\u5167\u54b3\u8840\u5927\u65bc 1,500m l\u3002 (B)\u54b3\u8840\u75c5\u4eba\u7684\u7b2c\u4e00\u7dda\u5f71\u50cf\u8a3a\u65b7\u5de5\u5177\u70ba\u80f8\u90e8 X\u5149\uff0c\u4e14\u53ef\u5728 50%\u7684\u75c5\u4eba\u5f97\u5230\u521d\u6b65\u7684\u53ef\u80fd\u8a3a\u65b7\u3002 (C)\u5149\u7e96\u5f0f\u652f\u6c23\u7ba1\u93e1(fiberoptic bronchoscopy )\u76f8\u8f03\u786c\u5f0f\u652f\u6c23\u7ba1\u93e1(rigid bronchoscopy)\u66f4\u65b9\u4fbf\u5c0d\u51fa\u8840\u9ede\u4f5c\u6b62\u8840\u7684\u52d5\u4f5c\u3002 (D)\u5927\u91cf\u54b3\u8840\u75c5\u4eba\u82e5\u7121\u7dad\u6301\u547c\u5438\u9053\u66a2\u901a\u800c\u9700\u63d2\u7ba1\uff0c\u5efa\u8b70\u9078\u7528\u5c0f\u865f\u7684\u6c23\u7ba1\u5167\u7ba1(e ndotracheal tube )\u8f03\u4e0d\u6703\u50b7\u5230\u6c23\u7ba1\u9ecf\u819c\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u98df\u9053\u7834\u88c2\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u9838\u90e8\u920d\u50b7\u5f88\u5c11\u9020\u6210\u98df\u9053\u7834\u88c2\u3002 (B)\u7570\u7269\u6897\u585e\u6703\u589e\u52a0\u98df\u9053\u7834\u88c2\u7684\u98a8\u96aa\u3002 (C)Boerhaave\u2019s syndrome \u4e3b\u8981\u5e38\u898b\u65bc\u98df\u9053\u4e0a\u6bb5\u7684\u7834\u88c2\u3002 (D)Boerhaave\u2019s syndrome \u662f\u56e0\u70ba\u98df\u9053\u5167\u58d3\u529b\u7a81\u7136\u589e\u52a0\u800c\u7834\u88c2\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "35\u6b72\u7537\u6027\uff0c\u5f9e\u8173\u8e0f\u8eca\u6454\u843d\uff0c\u53f3\u5074\u4e0a\u9580\u7259\u812b\u843d\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5c07\u50b7\u53e3\u6e05\u6d17\u4e7e\u6de8\u5373\u53ef\uff0c\u4e0d\u9700\u8981\u65bd\u6253\u7834\u50b7\u98a8\u75ab\u82d7\u3002 (B)\u5c07\u812b\u843d\u7684\u7259\u9f52\u690d\u5165\u7259\u69fd\u524d\uff0c\u5fc5\u9808\u4f7f\u7528\u751f\u7406\u98df\u9e7d\u6c34\u53ca\u7d17\u5e03\u5c07\u6574\u9846\u7259\u9f52\u6e05\u6f54\u4e7e\u6de8\u3002 (C)\u53e3\u670d Doxycycline \u662f\u9996\u9078\u6cbb\u7642\u85e5\u7269\u3002 (D)\u4e0a\u5634\u5507\u5167\u5074\u6709\u500b 2\u516c\u5206\u6495\u88c2\u50b7\uff0c\u5c07\u50b7\u53e3\u6c96\u6d17\u4e7e\u6de8\u4e26\u78ba\u8a8d\u6c92\u6709\u7570\u7269\u6b98\u7559\uff0c\u7136\u5f8c\u58d3\u8feb\u6b62\u8840\uff0c\u4e0d\u9700\u8981\u7e2b\u5408\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6025\u6027\u4e3b\u52d5\u8108\u74e3\u9589\u9396\u4e0d\u5168( acute aortic regurgitation )\u6cbb\u7642\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u9808\u8003\u616e\u7acb\u5373\u958b\u5200\u4ecb\u5165\u8655\u7f6e(immediate surgical intervention )\u3002 (B)\u53ef\u4f7f\u7528 \u03b2-blockers \u964d\u4f4e\u5fc3\u81df\u8017\u6c27\u9700\u6c42\u3002 (C)Nitroprusside \u5408\u7528 Dobutamine \u53ef\u4f7f\u7528\u65bc\u4e0a\u8ff0\u75c5\u4eba\u3002 (D)Diuretics \u8207Nitrates\u5c0d\u4e0a\u8ff0\u75c5\u4eba\u901a\u5e38\u662f\u7121\u6548\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4e2d\u5e74\u5973\u6027\uff0c\u7d04 20\u5c0f\u6642\u524d\u670d\u7528\u5927\u91cf\u4e0d\u660e\u85e5\u7269\u7531\u670b\u53cb\u9001\u5165\uff0c\u53ea\u77e5\u904e\u53bb\u6709\u7cbe\u795e\u75be\u75c5\u3002\u81e8\u5e8a\u8868\u73fe \uff1a\u9ad4\u6eab 41\u2103\u3001\u610f\u8b58\u6df7\u4e82\u3001\u8e81\u52d5\u3001\u5168\u8eab\u767c\u6c57\u3001 \u77b3\u5b54\u653e\u5927\u3001\u53cd\u5c04\u589e\u5f37\u53ca\u808c\u62bd\u8e8d( myoclonus ) \u3002\u4e0b\u5217\u8655\u7f6e\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u7d66\u4e88\u6d3b\u6027\u78b3\uff0c\u6e1b\u5c11\u85e5\u7269\u5438\u6536\u3002 (B)\u7d66\u4e88 Dantrolene \u63a7\u5236\u808c\u62bd\u8e8d\u3002 (C)\u7d66\u4e88 Acetaminophen \u63a7\u5236\u9ad4\u6eab\u3002 (D)\u82e5\u8981\u63d2\u7ba1\uff0c\u4e0d\u5efa\u8b70\u4f7f\u7528 Succinylcholine \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u9152\u7cbe\u6212\u65b7\u75c7\u5019\u7fa4( alcohol withdrawal syndrome )\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u6700\u5feb\u6709\u53ef\u80fd\u5728\u505c\u6b62\u559d\u9152\u6216\u6e1b\u5c11\u559d\u9152 24\u5c0f\u6642\u5f8c\u767c\u751f\u3002 (B)\u82e5\u6709\u7672\u7647\u767c\u4f5c\uff0c\u5c11\u65bc\u4e00\u534a\u7684\u75c5\u4eba\u6703\u518d\u767c\u4f5c\u3002 (C)\u70ba\u4e86\u9810\u9632\u7672\u7647\u767c\u4f5c\uff0c\u53ef\u8003\u616e\u7d66\u4e88\u6297\u7672\u7647\u85e5\u7269 Phenytoin \u3002 (D)\u6cbb\u7642\u85e5\u7269\u7576\u4e2d\uff0c Lorazepam 1mg \u7684\u5291\u91cf\u7b49\u65bc Midazolam 2mg\uff0c\u4e5f\u76f8\u7576\u65bc Diazepam 5mg \u7684\u5291\u91cf\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6025\u6027\u6c23\u5598\u4e4b \u57fa\u672c\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u4f7f\u7528\u9ad8\u5291\u91cf\u7684 corticosteroid \u6cbb\u7642\uff0c\u6bd4\u4f4e\u5291\u91cf\u7684\u505a\u6cd5\u66f4\u80fd\u7de9\u89e3\u75c7\u72c0\u3002 (B)\u53ef\u4ee5\u7d66\u75c5\u4eba\u4f7f\u7528\u5438\u5165\u6027\u7684 adrenergic agents \u3002 (C)\u7d66\u4e88\u6c27\u6c23\u6cbb\u7642\u7dad\u6301 SaO 2\u226790%\u3002 (D)\u4f7f\u7528\u77ed\u6548\u7684\u9078\u64c7\u6027 beta-agonist\u52a0\u5165 Ipratropium \u6709\u52a9\u6539\u5584\u652f\u6c23\u7ba1\u64f4\u5f35\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u75c5\u4eba\u4e3b\u8a34\u8907\u8996\uff0c\u95dc\u65bc\u8a55\u4f30\u53ca\u8a3a\u65b7\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u55ae\u773c\u8907\u8996\uff0c\u5373\u4f7f\u53e6\u4e00\u773c\u9589\u773c\u775b\u4ecd\u6301\u7e8c\uff0c\u5c11\u6578\u70ba\u8996\u529b\u5149\u50b3\u5c0e \uf937\u5f91\u7684\u554f\u984c\u3002 (B)\u7c73\u52d2 -\u8cbb\u96ea\u75c7\u5019\u7fa4(Miller -Fisher syndrome ) \uff0c\u8207\u81ea\u9ad4\u514d\u75ab\u6297\u9ad4\u6709\u95dc\uff0c\u9451\u5225\u7279\u5fb5\u70ba\u773c\u7403\u904b\u52d5\u9ebb\u75fa\u3001\u904b\u52d5\u5931\u8abf\u3001\u7121\u53cd\u5c04\u3002 (C)\u773c\u808c\u9ebb\u75fa\u6027\u504f\u982d\u75db(ophthalmoplegic migraine )\u662f\u767c\u708e\u6027\u9871\u795e\u7d93\u75c5\u8b8a\uff0c\u70ba\u81ea\u9650\u6027\u75be\u75c5\uff0c\u901a\u5e38\u70ba\u7b2c\u516d\u5c0d\u8166\u795e\u7d93\u9ebb\u75fa\u3002 (D)\u52d5\u8108\u7624\u816b\u5927\uff0c\u6703\u76f4\u63a5\u58d3\u8feb\u8166\u795e\u7d93\u9020\u6210\u8907\u8996\uff0c\u9451\u5225\u7279\u5fb5\u70ba\u7b2c\u516d\u5c0d\u8166\u795e\u7d93\u58d3\u8feb\u53ca\u5f71\u97ff\u77b3\u5b54\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "30\u6b72\u5973\u6027\uff0c\u61f7\u5b55 32\u9031\uff0c\u547c\u5438\u5598\u5c31\u91ab\uff0c\u610f\u8b58\u6e05\u695a\uff0c\u751f\u547d\u5fb5\u8c61\uff1a\u8840\u58d3 126/72 mmHg\uff0c\u5fc3\u8df3 110\u6b21/min\uff0c\u547c\u5438 28\u6b21/min\uff0c\u9ad4\u6eab 36.0\u2103\uff0cSpO 2 85%(room air) \uff0c\u547c\u5438\u97f3\u7121\u7570\u5e38\u3002\u6aa2\u67e5\u8207\u6aa2\u9a57\uff0c\u7b26\u5408\u9451\u5225\u8a3a\u65b7\u6548\u76ca\uff0c\u4e14\u5c0d\u80ce\u5152\u50b7\u5bb3\u6700\u5c0f\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)Chest radiography \u3002 (B)Chest CT pulmonary angiography (CTPA)\u3002 (C)P ulmonary perfusion scan \u3002 (D)C hest magnetic resonance imaging with gadolinium contrast enhancement \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "70\u6b72\u7537\u6027\uff0c\u6709\u6c23\u5598\u8207\u5fc3\u8870\u7aed\u75c5\u53f2\uff0c\u5728\u5bb6\u80f8\u75db\u5192\u51b7\u6c57\uff0c\u547c\u5438\u6025\u4fc3\uff0c\u6025\u8a3a\u5c31\u91ab\u6642\u8840\u58d3 220/130 mmHg\uff0c\u547c\u5438 26\u6b21/min\uff0c\u5fc3\u8df3 114\u6b21/min\uff0c\u9ad4\u6eab 36\u2103\uff0c\u8840\u6c27\u6fc3\u5ea6\u70ba 92%\uff0c\u8a3a\u65b7\u70ba\u6025\u6027\u4e3b\u52d5\u8108\u525d\u96e2\uff0c\u4e0b \u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5c6c\u65bc\u9ad8\u8840\u58d3\u7dca\u6025\u72c0\u6cc1(hypertensive urgency )\u3002 (B)\u96d9\u5074\u4e0a\u80a2\u7684\u8840\u58d3\u53ef\u80fd\u4e0d\u540c\uff0c\u901a\u5e38\u76f8\u5dee 5 ~10 mmHg \u3002 (C)\u9700\u7dca\u6025\u7d66\u4e88\u964d\u8840\u58d3\u85e5\u7269\u6cbb\u7642\uff0c\u85e5\u7269\u9996\u9078 Labetalol \u975c\u8108\u6ce8\u5c04\u3002 (D)\u6536\u7e2e\u58d3\u9700\u63a7\u5236\u5728 100~140 mmHg \u4e4b\u9593\uff0c\u5fc3\u8df3\u9700\u63a7\u5236\u5728\u5c0f\u65bc 60\u6b21/min\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u7dca\u6025\u5e8a\u908a\u80ba\u90e8\u8d85\u97f3\u6ce2\u6383\u63cf( BLUE protocol ) \uff0c\u591a\u7a2e\u7279\u5fb5\u9808\u8003\u616e\u8a3a\u65b7\u70ba\u80ba\u708e\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u6709\u80ba\u90e8\u6ed1\u52d5\uff0c C-profile(+)\u3002 (B)\u6709\u80ba\u90e8\u6ed1\u52d5\uff0c A/B profile (+)\u3002 (C)\u6709\u80ba\u90e8\u6ed1\u52d5\uff0c A-profile(+)\uff0cDVT(-)\uff0cPALPS(-)\u3002 (D)\u7121\u80ba\u90e8\u6ed1\u52d5\uff0c B\u2019-profile(+)\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u5c0d\u65bc\u795e\u7d93\u963b\u65b7\u8853\u904e\u7a0b\u4e2d\u53ef\u80fd\u7522\u751f\u7684\u4f75\u767c\u75c7\u5c40\u90e8\u9ebb\u9189\u85e5\u5168\u8eab\u6bd2\u6027\u53cd\u61c9( local anesthetic systemic toxicity, LAST ) \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u4e00\u822c\u4f86\u8aaa\uff0c\u4f7f\u7528\u8d8a\u9577\u6548\u7684\u5c40\u90e8\u9ebb\u9189\u85e5\u8d8a\u5c11\u767c\u751f LAST\u3002 (B)\u51fa\u73fe LAST\u6642\uff0c\u5c40\u90e8\u808c\u8089\u62bd\u6410\u6bd4\u820c\u982d\u9ebb\u66f4\u65e9\u51fa\u73fe\u3002 (C)\u7576\u75c5\u4eba\u56e0\u70ba LAST\u7522\u751f\u5fc3\u81df\u505c\u6b62\u6642\uff0c\u61c9\u4f7f\u7528\u975c\u8108\u6ce8\u5c04 lipid emulsion\u6cbb\u7642\u3002 (D)\u7576\u767c\u751f\u7672\u7647\u6642\uff0c\u9700\u5148\u8003\u616e\u4f7f\u7528\u786b\u9178\u9382(MgSO 4)\u6cbb\u7642\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u767c\u73fe\u5347\u7d50\u8178\u61a9\u5ba4\u708e\u4f75\u5468\u570d\u81bf\u760d 3\u516c\u5206\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u53ef\u4ee5\u4f7f\u7528\u6d41\u8cea\u98df\u7269\u3002 (B)\u901a\u5e38\u4e0d\u9700\u8981\u81bf\u760d\u5f15\u6d41\u624b\u8853\u3002 (C)\u5927\u91cf\u8f38\u6db2\u6cbb\u7642\u88dc\u5145\u6c34\u5206\u3002 (D)\u7d66\u4e88\u5ee3\u6cdb\u6027\u6297\u751f\u7d20\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc Guillain -Barr\u00e9 syndrome (GBS) \uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u4e3b\u8981\u5f71 \u97ff\u7684\u662f\u904b\u52d5\u795e\u7d93\uff0c\u8868\u73fe\u70ba\u4e0d\u5c0d\u7a31\u7684\u80a2\u9ad4\u7121\u529b\uff0c\u901a\u5e38\u5148\u5f71\u97ff\u4e0b\u80a2\u7136\u5f8c\u662f\u4e0a\u80a2\u3002 (B)\u795e\u7d93\u5b78\u6aa2\u67e5\u6700\u660e\u986f\u7684\u5c31\u662f\u75c5\u4eba\u6703\u5931\u53bb\u6df1\u90e8\u808c\u8171\u53cd\u5c04( absence of deep tendon reflex )\u3002 (C)\u96d6\u7136\u75c5\u4eba\u6703\u6709\u4e00\u4e9b\u611f\u89ba\u7570\u5e38\u7684\u4e3b\u8a34\uff0c\u4f46\u662f\u795e\u7d93\u5b78\u6aa2\u67e5\u611f\u89ba\u795e\u7d93\u61c9\u8a72\u662f\u6b63\u5e38\u7684\u3002 (D)Guillain -Barr\u00e9 syn drome\u7684\u767c\u751f\u548c\u6025\u6027 campylobacter jejuni \u611f\u67d3\u6709\u95dc\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "1\u6b72\u7537\u7ae5\uff0c\u5168\u8eab\u591a\u8655\u6709\u7600\u9752\u8207\u51fa\u8840\u9ede\uff0c\u7121\u5176\u5b83\u75c7\u72c0\uff0c\u7cbe\u795e\u6d3b\u529b\u548c\u98df\u617e\u4f73\uff0c\u9a57\u8840\u7d50\u679c \uff1aWBC 13,900/ \u00b5L(segment 40% \u3001lymphocyte 52% \u3001monocyte 8%)\u3001Hb 11g/dL \u3001Platelets <5,000/\u00b5 L\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u7279\u767c\u6027\u8840\u5c0f\u677f\u4f4e\u4e0b\u7d2b\u6591\u75c7(idiopathic thrombocytopenic purpura, ITP)\u4e00\u822c\u8840\u5c0f\u677f\u4f4e\u4e0b\u6703\u8f49\u8b8a\u70ba\u6162\u6027\u4e14\u6301\u7e8c\u8d85\u904e 6\u500b\u6708\u3002 (B)ITP \u7684\u8a3a\u65b7\u4e3b\u8981\u6839\u64da\u75c5\u53f2\u3001\u8eab\u9ad4\u8a3a\u5bdf\u3001\u5168\u8840\u7403\u8a08\u6578\u53ca\u9031\u908a\u8840\u6db2\u62b9\u7247\u6aa2\u67e5\uff0c\u62b9\u7247\u53ef\u4ee5\u770b\u5230\u7e2e\u5c0f\u7684\u8840\u5c0f\u677f\u3002 (C)\u9aa8\u9ad3\u6aa2\u67e5\u975e\u7acb\u5373\u5fc5\u8981\u4e4b\u6aa2\u67e5\u3002 (D)\u53ef\u4ee5\u4f7f\u7528\u985e\u56fa\u9187\u6cbb\u7642\u4e14\u9808\u8d95\u5feb\u8f38\u8840\u5c0f\u677f\u9810\u9632\u53ef\u80fd\u4e4b\u51fa\u8840\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6c23\u7ba1\u652f\u6c23\u7ba1\u50b7\u5bb3( tracheobronchial injury ) \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u6700\u5e38\u9020\u6210\u7684\u539f\u56e0\u70ba\u9838\u90e8\u7a7f\u523a\u50b7\u3002 (B)\u5927\u7d04 1/3\u75c5\u4eba\u75c7\u72c0\u8f15\u5fae\u6216\u7121\u75c7\u72c0\u3002 (C)\u5927\u591a\u6578\u80f8\u8154\u5167\u6c23\u7ba1\u652f\u6c23\u7ba1\u50b7\u5bb3\u767c\u751f\u5728\u74b0\u72c0\u8edf\u9aa8\u4e0b 2\u516c\u5206\u8655\u3002 (D)\u652f\u6c23\u7ba1\u6495\u88c2\u50b7\u5927\u65bc\u652f\u6c23\u7ba1\u5468\u9577\u7684 1/3\u4ee5\u4e0a\u6642\uff0c\u9700\u505a\u624b\u8853\u4fee\u88dc\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6839\u64da WHO\u6307\u5f15\u5efa\u8b70\uff0c\u4e0b\u5217\u5404\u9805\u4fb5\u5165\u6027\u6cbb\u7642\uff0c\u54ea\u4e00\u7a2e\u76f8\u5c0d\u6bd4\u8f03\u4e0d\u6703 \u5f15\u8d77\u6c23\u6eb6\u81a0\u6548\u61c9( aerosol -generating effect )\u800c\u589e\u52a0\u50b3\u67d3\u529b\uff1f", + "Options": "(A)\u80f8\u5916\u6309\u58d3( external chest compression )\u3002 (B)\u6c23\u7ba1\u5167\u7ba1\u63d2\u7ba1( tracheal intubation)\u3002 (C)\u6c23\u74e3\u7403\u6b63\u58d3\u7d66\u6c27( manual bag- valve -mask ventilation )\u3002 (D)\u96d9\u5411\u6b63\u58d3\u547c\u5438\u5668(biphasic positive airway pressure, BiPAP )\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8f3b\u5c04\u50b7\u5bb3\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u8a62\u554f\u75c5\u53f2\u6642 \uff0c\u53ef\u85c9\u7531\u51fa\u73fe\u5614\u5410\u6642\u9593\u4f86\u63a8\u7b97\u66b4\u9732\u8f3b\u5c04\u5291\u91cf\u3002 (B)\u6aa2\u67e5\u7d55\u5c0d\u6dcb\u5df4\u7403\uff0c\u53ef\u7528\u4f86\u63a8\u4f30\u66b4\u9732\u8f3b\u5c04\u5291\u91cf\u3002 (C)\u7576\u8f3b\u5c04\u5075\u6aa2\u5668\u4e0a\u7684\u8b80\u6578\u7b49\u65bc\u6216\u4f4e\u65bc\u80cc\u666f\u503c\u4e94\u500d\u6642\u624d\u7b97\u5b8c\u6210\u9664\u6c61\u3002 (D)\u82e5\u61f7\u7591\u6709\u611f\u67d3\u53ef\u9069\u7576\u7d66\u4e88\u9810\u9632\u6027\u6297\u751f\u7d20\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "75\u6b72\u7537\u6027\uff0c\u904e\u53bb\u75c5\u53f2\u6709\u5fc3\u808c\u6897\u585e\u53ca\u8166\u6897\u585e\uff0c\u5b9a\u671f\u670d\u7528\u6297\u51dd\u8840\u85e5\u7269\u3002\u56e0\u9a0e\u8173\u8e0f\u8eca\u8dcc\u5012\u53d7\u50b7\u5c31\u8a3a\u3002\u982d\u90e8\u65b7\u5c64\u6aa2\u67e5\u767c\u73fe\u53f3\u5074\u786c\u8166\u819c\u4e0b\u51fa\u8840\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u53ef\u7d66\u4e88 prothrombin concentrate complex \u3001\u8840\u6f3f\u53ca Vitamin K \u6cbb\u7642\u3002 (B)\u82e5\u75c5\u4eba\u6b63\u5728\u670d\u7528\u65b0\u578b\u6297\u51dd\u8840\u85e5\u7269\u5982 Xarelto\uff0c\u53ef\u7d66\u4e88\u53cd\u8f49\u85e5\u7269\u6cbb\u7642\u3002 (C)\u53ef\u4ee5\u62bd\u8840\u6aa2\u9a57\u78ba\u8a8d\u75c5\u4eba\uff0c\u662f\u5426\u6709\u670d\u7528\u6297\u8840\u6813\u85e5\u7269\u800c\u9020\u6210\u7684\u51dd\u8840\u529f\u80fd\u7570\u5e38\u3002 (D)\u82e5\u75c5\u4eba\u6b63\u5728\u670d\u7528 Coumadin\uff0c\u53ef\u7d66\u4e88 Protamine sulfate \u6cbb\u7642\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u5168\u8eab\u6027\u98a8\u6fd5\u514d\u75ab\u75be\u75c5\u9838\u90e8\u4e4b\u4f75\u767c\u75c7\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u50f5\u76f4\u6027\u810a\u690e\u708e\u6bd4\u8d77\u985e\u98a8\u6ebc\u6027\u95dc\u7bc0\u708e\u66f4\u6613\u767c\u751f\u9838\u690e\u7684\u4e0d\u7a69\u5b9a\u3002 (B)\u985e\u98a8\u6ebc\u6027\u95dc\u7bc0\u708e\u75c5\u4eba \u5373\u4fbf\u8f15\u5fae\u5275\u50b7\uff0c\u4e5f\u61c9\u7dad\u6301\u9838\u690e\u7684\u7a69\u5b9a\u3002 (C)\u50f5\u76f4\u6027\u810a\u690e\u708e\u75c5\u4eba\u63d2\u7ba1\u6642\u61c9\u907f\u514d\u5c48\u66f2\u548c\u4f38\u5c55\uff0c\u4ee5\u514d\u56e0\u5bf0\u6a1e\u95dc\u7bc0(atlantoaxial joint )\u4e0d\u7a69\u9020\u6210\u9838\u690e\u810a\u9ad3\u75c5\u8b8a\u3002 (D)\u985e\u98a8\u6ebc\u6027\u95dc\u7bc0\u708e \u75c5\u4eba\u51fa\u73fe\u56b4\u91cd\u9838\u90e8\u75bc\u75db\u4f75\u8f3b\u5c04\u81f3\u6795\u90e8\u5408\u4f75\u4e0a\u80a2\u611f\u89ba\u7570\u5e38\u6642\uff0c\u9700\u61f7\u7591\u6709\u9838\u690e\u7684\u4e0d\u7a69\u5b9a\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "60\u6b72\u5973\u6027\u53f3\u9838\u53ca\u53f3\u80a9\u75bc\u75db\u4e00\u9031\uff0c\u4e0b\u5217\u54ea\u4e00\u500b\u8eab\u9ad4\u8a3a\u5bdf \u8f03\u53ef\u80fd\u662f\u808c\u8089\u62c9\u50b7\u7684\u554f\u984c\uff1f", + "Options": "(A)\u6301\u7e8c\u7684\u9589\u6c23\u7528\u529b(Valsalva )\u6703\u589e\u52a0\u53f3\u9838\u53ca\u53f3\u80a9\u7684\u75bc\u75db\u3002 (B)\u75c5\u4eba\u5c07\u53f3\u5074\u4e0a\u81c2\u5916\u5c55 (abduction)\u4e0a\u8209\u53ef\u4ee5\u6e1b\u8f15\u60a3\u5074\u7684\u75bc\u75db\u3002 (C)\u5c48\u9838\u5c07\u4e0b\u5df4\u63a5\u8fd1\u80f8\u58c1\u6642\uff0c\u4e0a\u81c2\u6703\u7522\u751f\u50cf\u96fb\u523a\u6fc0\u822c\u75bc\u75db\u3002 (D)\u75c5\u4eba\u7684\u982d\u8f49\u5411\u5de6\u5074\u6642\u6703\u66f4\u75bc\u75db\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u80ba\u764c( non-small cell carcinoma )\u75c5\u4eba\u3001\u4f75\u8166\u3001\u809d\u3001\u814e\u4e0a\u817a\u8207\u591a\u8655\u9aa8\u8f49\u79fb\uff0c\u4e0a\u500b\u6708\u63a5\u53d7 Ipilimumab \u514d\u75ab\u6cbb\u7642\uff0c\u9019\u4e09\u5929\u9ad8\u71d2\u3001\u8179\u7009\u3001\u795e\u667a\u8d8a\u4f86\u8d8a\u5dee\uff0c\u88ab\u5e36\u4f86\u6025\u8a3a \uff0c\u4ee5\u4e0b\u6558\u8ff0\u6216\u8655\u7f6e\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u6b64\u85e5\u70ba\u5408\u6210\u7684\u55ae\u682a\u6297\u9ad4\uff0c\u85c9\u523a\u6fc0\u7279\u5b9a\u767d\u8840\u7403 anti-PD-1\u6297\u539f\uff0c\u5f37\u5316 T\u6dcb\u5df4\u7403\u53ca NK\u7d30\u80de\u6bba\u816b\u7624\u7d30\u80de\u7684\u80fd\u529b\u3002 (B)\u665a\u671f\u764c\u75c7\u75c5\u4eba\u514d\u75ab\u529b\u5dee\u5e38\u906d\u611f\u67d3\uff0c\u521d\u6b65\u8a55\u4f30\u5373\u4f7f\u627e\u4e0d\u5230\u611f\u67d3\u6e90\uff0c\u53ef\u5148\u7d66\u5ee3\u6548\u6297\u751f\u7d20\u3001\u6297\u75c5\u6bd2\u53ca\u9ef4\u83cc\u85e5\u7269\u3002 (C)\u82e5\u7591\u514d\u75ab\u6cbb\u7642\u526f\u4f5c\u7528 (immune -related adverse event )\uff0c\u5148\u7d66methylprednisolone, 1-2 mg/k g/day\uff0c\u4e09\u5929\u5f8c\u6e1b\u91cf\u3002 (D)Ipilimumab \u514d\u75ab\u6cbb\u7642\u5e38\u898b\u7684\u526f\u4f5c\u7528\u662f\u80ba\u7e96\u7dad\u5316\u6216\u5fc3\u808c\u708e\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6025\u6027\u8179\u75db\u4e4b\u8a3a\u65b7\u8207\u6cbb\u7642\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u4e0d \u660e\u539f\u56e0\u8179\u75db\u4e4b\u75c5\u4eba\u4e0d\u61c9\u8a72\u7d66\u4e88\u6b62\u75db\u5291 \u6cbb\u7642\u3002 (B)\u4f7f\u7528 Metoclopramide \uff0c\u6709\u6642\u53ef\u5408\u4f75\u4f7f\u7528 Diphenhydramine \u9810\u9632dystonia\u7684\u767c\u751f\u3002 (C)\u8102\u80aa\u9176\u6578\u503c\u6b63\u5e38\uff0c\u53ef\u6392\u9664\u6025\u6027\u80f0\u81df\u708e\u3002 (D)Serum lactate \u6b63\u5e38\uff0c\u53ef\u6392\u9664 mesenteric ischemia \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "80\u6b72\u7537\u6027\uff0c\u4e3b\u8a34\u6f38\u9032\u5f0f\u5598\u4e00\u9031\uff0c\u5408\u4f75\u96d9\u4e0b\u80a2\u6c34\u816b\uff0c\u751f\u547d\u5fb5\u8c61\u5982\u4e0b\uff0c\u9ad4\u6eab36.3\u2103\uff0c\u5fc3\u8df3 80\u6b21/min\uff0c\u547c\u5438 26\u6b21/min\uff0c\u8840\u58d3 180/155 mmHg \uff0cSpO 2 90%\uff0c\u6839\u64da POCUS Blue Protocol \u767c\u73fe\u96d9\u5074\u80ba\u90e8\u5747\u5448 B Profile\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u65e9\u671f\u7d66\u4e88 Morphine \u53ef\u4ee5\u6e1b\u5c11\u4f4f\u9662\u5929\u6578\u53ca\u6b7b\u4ea1\u7387\u3002 (B)\u5728\u5c1a\u672a\u5efa\u7acb\u975c\u8108\u6ce8\u5c04\u9014\u5f91\u524d\u53ef\u5148\u7d66\u4e88\u7d93\u76ae\u5291\u578b NTG\u3002 (C)\u82e5\u75c5\u4eba\u6709\u963b\u585e\u6027\u80a5\u539a\u5fc3\u808c\u75c7\u4e4b\u75c5\u53f2\uff0c\u61c9\u907f\u514d\u4f7f\u7528 NTG\u3002 (D)\u55ae\u7368\u4f7f\u7528 \u5229\u5c3f\u5291\u53ef\u4ee5\u964d\u4f4e\u75c5\u4eba\u7684\u6b7b\u4ea1\u7387\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6416\u982d\u4e38( MDMA)\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u4f5c\u7528\u6a5f\u8f49\u662f\u85c9\u7531\u6291\u5236 cytochrome P -450 2D6 \uff0c\u4ee5\u9054\u5230\u964d\u4f4e\u8840\u6e05\u7d20\u3001\u591a\u5df4\u80fa\u3001\u6b63\u814e\u4e0a\u817a\u7d20\u7684\u6fc3\u5ea6\u9032\u800c\u767c\u63ee\u4f5c\u7528\u3002 (B)\u6703\u5f15\u8d77\u6297\u5229\u5c3f\u6fc0\u7d20(ADH )\u904e\u91cf\u5206\u6ccc\uff0c\u9032\u800c\u9020\u6210\u9ad8\u8840\u9209\u7684\u73fe\u8c61\u3002 (C)\u9020\u6210\u6025\u6027\u4e2d\u6bd2\u6642\uff0c\u6703\u6709\u610f\u8b58\u6539\u8b8a\u3001\u547c\u5438\u6291\u5236\u3001\u7e2e\u77b3\u7b49\u73fe\u8c61\u3002 (D)\u4e2d\u6bd2\u7684\u6cbb\u7642\u4e3b\u8981\u662f\u652f\u6301\u7642\u6cd5\uff0c\u76ee\u524d\u4e26\u7121\u5c08\u4e00\u7684\u89e3\u6bd2\u5291\u53ef\u4f9b\u4f7f\u7528\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6c23\u5598\u91cd\u7a4d\u75c7( status asthmaticus )\u7684\u6cbb\u7642\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u7576\u75c5\u4eba\u8840\u6c27\u6fc3\u5ea6\u4e0b\u964d\uff0c\u610f\u8b58\u6539\u8b8a\uff0c\u61c9\u5118\u901f\u63d2\u7ba1\uff0c\u53ef\u964d\u4f4e\u6c23\u7ba1\u5167\u6c23\u6d41\u7684\u963b\u585e\u3002 (B)\u975c\u8108\u6ce8\u5c04 Aminophylline \u964d\u968e\u70ba\u7b2c\u4e8c\u7dda\u85e5\u7269\uff0c\u5728\u5438\u5165\u6027\u85e5\u7269\u6cbb\u7642\u8207\u985e\u56fa\u9187\u4e4b\u5f8c\u4f7f\u7528\u3002 (C)\u4f7f\u7528\u975e\u4fb5\u8972\u6027\u6b63\u58d3\u547c\u5438(noninvasive positive -pressure ventilation )\u7121\u6cd5\u6e1b\u5c11\u63d2\u7ba1\u6a5f\u7387\u3002 (D)Epinephrine \u5e73\u5e38\u7528\u5728 anaphylaxis \u9020\u6210\u7684\u6c23\u5598\uff0c\u5728\u6c23\u5598\u91cd\u7a4d\u75c7\u6642\u4e5f\u53ef\u505a\u70ba\u8f14\u52a9\u4f7f\u7528\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u5152\u8650\u9020\u6210\u7684\u9aa8\u6298\uff0c\u4e0b\u5217\u5224\u65b7\u53ca\u654d\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u5c0f\u5152\u808b\u9aa8\u9aa8\u6298\u6216\u5b30\u5152\u7684\u5e79\u9aba\u7aef\u9aa8\u6298( metaphyseal fracture )\uff0c \u5747 \u9808\u9ad8\u5ea6\u61f7\u7591\u5152\u8650\u3002 (B)\u5152\u8650\u9aa8\u6298\u5e38\u767c\u751f\u65bc\u5e74\u9f61\u5c0f\u65bc 18\u500b\u6708\u5927\uff0c\u70ba\u8eab\u9ad4\u8650\u5f85\u6700\u5e38\u898b\u7684\u81e8\u5e8a\u8868\u5fb5\u3002 (C)\u82e5\u767c\u73fe\u80a1\u9aa8\u9aa8\u6298\uff0c\u5b30\u5152\u56e0\u5152\u8650\u9020\u6210\u6a5f\u7387\u9ad8\u65bc 2-3\u6b72\u5c0f\u5152\u3002 (D)9\u500b\u6708\u81f3 4\u6b72\u7684 Toddler's fracture \u662f\u610f\u5916\u9020\u6210\u7684\u70ba\u4e3b\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5b50\u7672\u75c7( eclampsia )\u548c\u5b50\u7672\u524d\u75c7( preeclampsia )\u7684\u4f7f\u7528\u85e5\u7269\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u63a7\u5236\u8840\u58d3\u6642\uff0c Hydralazine \u6bd4Labetalol\u4f5c\u7528\u901f\u5ea6\u5feb\uff0c\u6545\u70ba\u7b2c\u4e00\u7dda\u7528\u85e5\u3002 (B)\u7576\u767c\u751f\u7672\u7647\u6642\uff0c\u7b2c\u4e00\u7dda\u7528\u85e5\u70ba Diazepam\u6216Lorazepam \u3002 (C)\u5728\u5b55\u5a66\u907f\u514d\u4f7f\u7528\u6297\u8840\u5c0f\u677f\u85e5\u7269\uff0c\u4ee5\u514d\u767c\u751f preeclampsia \u6216HELLP syndrome \u3002 (D)\u6cbb\u7642\u6642 \u82e5\u767c\u751f\u9ad8\u8840\u9382\u7684\u526f\u4f5c\u7528\u6642\uff0c\u53ef\u65bd\u6253 Calcium gluconate \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc REBOA(Resuscitative Endovascular Balloon Occlusion of the Aorta )\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u6a6b\u8188\u819c\u4e0b\u5916\u50b7\u4f75\u51fa\u8840\u6027\u4f11\u514b\u4e14\u5df2\u5371\u53ca\u751f\u547d\u8005\uff0c\u53ef\u8003\u616e\u4f7f\u7528REBOA\u3002 (B)\u52d5\u8108\u525d\u96e2 (arterial dissection )\u3001\u80a2\u9ad4\u7f3a\u8840 (extremity ischemia )\u53ca\u810a\u9ad3\u640d\u50b7(spinal cord injury )\u90fd\u662f\u65bd\u884c REBOA\u5f8c\u53ef\u80fd\u7522\u751f\u7684\u4f75\u767c\u75c7\u3002 (C)\u82e5\u7528\u65bc\u56b4\u91cd\u8179\u8154\u5167\u51fa\u8840\u3001\u5f8c\u8179\u8154\u51fa\u8840\uff0c\u751a\u81f3\u4f75\u767c\u5916\u50b7\u6027\u5fc3\u8df3\u505c\u6b62\u8005\uff0c\u5247\u61c9\u5c07 balloon\u7f6e\u653e\u5728 Zone 2\u8655\uff0c\u5373\u9060\u7aef\u80f8\u4e3b\u52d5\u8108\u3002 (D)\u82e5\u7528\u65bc\u56b4\u91cd\u8fd1\u7aef\u4e0b\u80a2\u5916\u50b7\u4f75\u4f4e\u8840\u5bb9\u6027\u4f11\u514b\u75c5\u4eba \uff0c\u5247\u61c9\u5c07 balloon\u7f6e\u653e\u5728 Zone 3\u8655\uff0c\u5373\u9060\u7aef\u8179\u4e3b\u52d5\u8108\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "24\u6b72\u5973\u6027\u88ab\u767c\u73fe\u610f\u8b58\u4e0d\u6e05\u800c\u9001\u81f3\u6025\u8a3a\uff0c\u5176\u8868\u73fe\u70ba\u77b3\u5b54\u653e\u5927\uff0c\u773c\u7403\u9707\u986b\uff0c\u795e\u7d93\u808c\u8089\u53cd\u5c04\u589e\u5f37\uff0c\u8179\u7009\u5192\u6c57\uff0c\u8840\u58d3 190/108 mmHg\uff0c\u5fc3\u8df3 126\u6b21/min\uff0c\u9ad4\u6eab39\u2103\uff0c\u4e0b\u5217\u8a3a\u65b7\u4f55\u8005\u8f03\u4e0d\u53ef\u80fd\uff1f", + "Options": "(A)Cholinergic toxidrome s\u3002 (B)Sympathomimetics \u3002 (C)Serotonin toxidrome s\u3002 (D)Neuroleptic Malignant Syndrome \u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u4f55\u8005 \u7121\u52a9\u65bc\u5354\u52a9\u8a3a\u65b7\u975e\u5178\u578b\u5ddd\u5d0e\u6c0f\u75c7\uff1f", + "Options": "(A)Creatinine \u3002 (B)Urine analysis \u3002 (C)C-reactive protein \u3002 (D)Albumin \u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u4f55\u8005\u662f\u8170\u690e\u7a7f\u523a\u5f8c\u982d\u75db( post\u2013lumbar puncture headache )\u7684\u5371\u96aa\u56e0\u5b50\uff1f", + "Options": "(A)\u5f15\u6d41\u904e\u591a\u7684\u8166\u810a\u9ad3\u6db2\u3002 (B)\u4f7f\u7528\u8f03\u5927\u865f\u7684\u91dd\u982d(>22 gauge )\u3002 (C)\u65bd\u4f5c\u5f8c\u6c92\u6709\u8eba\u5e8a\u4f11\u606f\u3002 (D)\u8166\u810a\u9ad3\u6db2\u7684 opening pressure \u9ad8\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "30\u6b72\u5973\u6027\uff0c\u8aa4\u98df\u5927\u82b1\u66fc\u9640\u7f85\u4e4b\u5f8c\uff0c\u958b\u59cb\u80e1\u8a00\u4e82\u8a9e\u5168\u8eab\u6478\u8d77\u4f86\u53c8\u4e7e\u53c8\u71d9\u3002\u9ad4\u6eab38.5\u2103\u3001\u547c\u5438 25\u6b21/min\u3001\u5fc3\u8df3 120\u6b21/min\u3001\u8840\u58d3 162/105 mmHg\uff0cGCS E4V2M5\uff0c\u4e0b\u5217\u4f55\u8005\u8655\u7f6e\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u7d66\u4e88\u75c5\u4eba\u9069\u7576\u8f38\u6db2\u8207\u76e3\u6e2c\u3002 (B)\u7d66\u4e88\u75c5\u4eba\u93ae\u975c\u53ef\u9078\u7528 Lorazepam \u3002 (C)\u7d66\u4e88\u75c5\u4eba\u964d\u6eab\u53ef\u9078\u7528 Acetaminophen \u3002 (D)\u8840\u6db2\u900f\u6790\u4e26\u7121\u6cd5\u6539\u5584\u6b64\u75c5\u4eba\u9810\u5f8c\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u95dc\u65bc\u5916\u79d1\u547c\u5438\u9053( surgical airway )\u7684\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)8\u6b72\u4ee5\u4e0b\u5152\u7ae5\uff0c\u5efa\u8b70\u4f7f\u7528\u74b0\u7532\u819c\u5207\u958b\u8853(cricothyrotomy )\u3002 (B)\u6c23\u7ba1\u6216\u5589\u90e8 (larynx)\u640d\u50b7\u6642\uff0c\u5efa\u8b70\u4f7f\u7528\u74b0\u7532\u819c\u5207\u958b\u8853\u3002 (C)\u74b0\u7532\u819c\u5207\u958b\u8853\u6613\u9020\u6210\u547c\u5438\u9053\u72f9\u7a84\uff0c\u901a\u5e38\u5728 24\u5c0f\u6642\u5167\u91cd\u65b0\u9032\u884c\u6c23\u7ba1\u5207\u958b\u8853(tracheostomy )\u3002 (D)\u826f\u597d\u7684\u5674\u5c04\u901a\u6c23(jet ventilation)\u53ef\u63d0\u4f9b\u8db3\u5920\u901a\u6c23\uff0c\u4e0d\u9808\u7acb\u523b\u91cd\u65b0\u5efa\u7acb\u5176\u4ed6\u985e\u578b\u547c\u5438\u9053\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "65\u6b72\u7537\u6027\u75c5\u4eba\uff0c\u56e0\u53f3\u8033\u75bc\u75db\u53ca\u807d\u529b\u8b8a\u5dee\u81f3\u8a3a\u6240\u5c31\u91ab\uff0c\u8a3a\u65b7\u70ba\u4e2d\u8033\u708e\uff0c\u7d93 3\u5929\u53e3\u670d\u6297\u751f\u7d20(Amoxicillin 1g TID) \u6cbb\u7642\u4ecd\u672a\u6539\u5584\u81f3\u6025\u8a3a\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u82e5\u7121\u4e2d\u8033\u7a4d\u6db2\uff0c\u53ef\u4ee5\u8acb\u75c5\u4eba\u7e7c\u7e8c\u670d\u7528\u8a3a\u6240\u958b\u7acb\u7684\u6297\u751f\u7d20\u3002 (B)\u82e5\u6709\u4e2d\u8033\u7a4d\u6db2\uff0c\u61c9\u8a72\u6703\u8a3a\u8033\u9f3b\u5589\u79d1\u91ab\u5e2b\u57f7\u884c\u9f13\u819c\u7a7f\u523a\u5f15\u6d41\u6cbb\u7642\u3002 (C)\u807d\u529b\u8870\u9000\u554f\u984c\u901a\u5e38\u6703\u96a8\u8457\u4e2d\u8033\u7a4d\u6db2\u5438\u6536\u5f8c\u800c\u6539\u5584\u3002 (D)\u984f\u9762\u795e\u7d93\u75f2\u75f9\u662f\u5e38\u898b\u7684\u4f75\u767c\u75c7\uff0c\u53ef\u4ee5\u4f7f\u7528\u985e\u56fa\u9187\u6cbb\u7642\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "56\u6b72\u7537\u6027\u75c5\u4eba\uff0c\u6709\u7cd6\u5c3f\u75c5\u53f2\u898f\u5247\u670d\u85e5\uff0c 10\u5929\u524d\u66fe\u81f3\u82b1\u84ee\u65c5\u904a\u5230\u6eaa\u908a\u6232\u6c34\u3002\u4e3b\u8a34\u65bc 5\u5929\u524d\u958b\u59cb\u51fa\u73fe\u53cd\u8986\u6027\u5bd2\u986b\u5408\u4f75\u767c\u71d2\u3001\u982d\u75db\u8207\u808c\u8089\u75e0\u75db\u75c7\u72c0\u3002\u8fd1\u4e09\u5929\u51fa\u73fe\u8f15\u5fae\u9ec3\u75b8\uff0c\u5c0f\u4fbf\u5c3f\u91cf\u6e1b\u5c11\u3002\u6025\u8a3a\u751f\u547d\u5fb5\u8c61\u8840\u58d3 106/62 mmHg \u3001\u9ad4\u6eab 37.8\u2103\u3001\u5fc3\u8df3 122\u6b21/min\u3001\u547c\u5438 20\u6b21/min\u3001SpO 2 96%\uff0c\u7121\u5fc3\u96dc\u97f3\u3002\u8840\u4e2d\u767d\u8840\u7403\u7e3d\u6578\u70ba 12,600/\u03bcL \uff0c\u809d\u529f\u80fd\u7570\u5e38\u53ca\u8f15\u5fae\u9ec3\u75b8\u8207\u814e\u529f\u80fd\u7570\u5e38\u3002\u95dc\u65bc\u8a3a\u65b7\u8207\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u9264\u7aef\u87ba\u65cb\u9ad4\u75c5\u3001\u7d30\u83cc\u6027\u5fc3\u5167\u819c\u708e\u3001\u963b\u585e\u6027\u9ec3\u75b8\u4f75\u767c\u81bd\u7ba1\u708e\u4ee5\u53ca\u809d\u81bf\u760d\u5747\u70ba\u53ef\u80fd\u7684\u9451\u5225\u8a3a\u65b7\u3002 (B)\u8179\u90e8\u8d85\u97f3\u6ce2\u6216\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u70ba\u8a3a\u65b7\u809d\u81bf\u760d\u8207\u963b\u585e\u6027\u9ec3\u75b8\u4f75\u767c\u81bd\u7ba1\u708e\u7684\u91cd\u8981\u8a3a\u65b7\u5de5\u5177\u3002 (C)\u8840\u6db2\u57f9\u990a\u53ef\u4ee5\u7528\u65bc\u8a3a\u65b7\u524d\u8ff0\u4e09\u7a2e\u611f\u67d3\u75c7\uff0c\u4f46\u82e5\u61f7\u7591\u70ba HACEK\u985e\u83cc\u7fa4\u6240\u5f15\u8d77\u7684\u7d30\u83cc\u6027\u5fc3\u5167\u819c\u708e\uff0c\u5247\u9700\u8981\u6bd4\u8f03\u4e45\u7684\u8840\u6db2\u57f9\u990a\u5929\u6578\u3002 (D)\u7d93\u9a57\u6027\u6297\u751f\u7d20\u6cbb\u7642\uff0c\u53ef\u8003\u616e\u7d66\u4e88\u7b2c\u4e09\u4ee3\u74b0\u5b62\u9ef4\u7d20\uff0c\u540c\u6642\u5408\u4f75\u975c\u8108Penicillin -G\u6216\u53e3\u670d Doxycycline \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u6709\u95dc\u8f38\u8840\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u6e1b\u767d\u4e4b\u7d05\u8840\u7403\u6fc3\u7e2e\u6db2\u8f03\u4e0d\u6613\u5728\u8f38\u8840\u6642\u904e\u654f\u767c\u71d2\u3002 (B)\u57f7\u884c\u8170\u690e\u7a7f\u523a\u524d\uff0c\u8840\u5c0f\u677f\u6578\u76ee\u61c9\u7dad\u6301\u5728 50,000/\u00b5L \u4ee5\u4e0a\u3002 (C)\u5c3f\u6bd2\u75c7\u5f15\u767c\u4e4b\u51fa\u8840\u53ef\u8003\u616e\u51b7\u51cd\u6c89\u6fb1\u54c1(cryoprecipitate )\u3002 (D)\u8f38\u8840\u5f15\u8d77\u4e4b\u6025\u6027\u80ba\u640d\u50b7\u61c9\u4f7f\u7528\u5229\u5c3f\u5291\u6cbb\u7642\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6ccc\u5c3f\u9053\u611f\u67d3\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u6ccc\u5c3f\u9053\u611f\u67d3\u6642\uff0c\u6297\u751f\u7d20\u6cbb\u7642\u7684\u5929\u6578\u81f3\u5c11\u9808 1\u9031\u4ee5\u4e0a\uff0c\u65b9\u80fd\u6cbb\u7652\u3002 (B)\u611f\u67d3\u4eba\u985e\u514d\u75ab\u7f3a\u4e4f\u75c5\u6bd2\u7684\u75c5\u4eba\uff0c\u5408\u4f75\u6ccc\u5c3f\u9053\u611f\u67d3\u6642\u7d93\u9a57\u6027\u6297\u751f\u7d20\u7684\u4f7f\u7528\uff0c\u512a\u5148\u9078\u7528\u78fa\u80fa\u985e\u85e5\u7269\u3002 (C)\u7814\u7a76\u986f\u793a\u6027\u884c\u70ba\u5f8c\u6392\u5c3f\uff0c\u4e26\u7121\u6cd5\u9632\u6b62\u5e74\u8f15\u5973\u6027\u7684\u8180\u80f1\u708e\u3002 (D)\u907f\u514d\u85e5\u7269\u6216\u6297\u751f\u7d20\u6feb\u7528\uff0c\u7121\u75c7\u72c0\u83cc\u5c3f\u75c7\u7684\u75c5\u4eba\uff0c\u5747\u4e0d\u7d66\u4e88\u6297\u751f\u7d20\u6cbb\u7642\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "8\u6b72\u7537\u7ae5\uff0c\u6709\u6c23\u5598\u75c5\u53f2\uff0c\u5728\u8eca\u798d\u4e8b\u4ef6\u4e2d\uff0c\u53f3\u80f8\u906d\u53d7\u649e\u64ca\uff0c\u4e0b\u80a2\u58d3\u50b7\u816b\u75db\u3002\u6c23\u5598\u767c\u4f5c\u3001\u8e81\u52d5\u3001\u5192\u51b7\u6c57\u3002\u8840\u58d3 82/58 mmHg \uff0c\u5fc3\u8df3 120\u6b21/min\uff1b\u80f8\u90e8 X\u5149\uff1a\u53f3\u5074\u7591\u4f3c\u6709\u808b\u9aa8\u9aa8\u6298\u3002\u52d5\u8108\u6c23\u9ad4\u5206\u6790\uff1apH 7.35\uff0c PaCO 2 30 mmHg \uff0cPaO 2 80mmHg \uff0cHCO 3 22 mEq/L \uff0c\u9240\u96e2\u5b50 5.8 mEq/L \u3002\u75c5\u4eba\u5982\u9700\u63d2\u7ba1\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)K etamine\u5177\u93ae\u975c\u6b62\u75db\u548c\u5fc3\u8840\u7ba1\u523a\u6fc0\u4f5c\u7528\uff0c\u70ba\u672c\u4f8b\u75c5\u4eba\u7684\u9996\u9078\u8a98\u5c0e\u9ebb\u9189\u3002 (B)E tomidate\u5177\u6709\u7a69\u5b9a\u8840\u884c\u52d5\u529b\uff0c\u5728\u8207\u55ce\u5561\u4f75\u7528\u4e0b\uff0c\u70ba\u672c\u4f8b\u75c5\u4eba\u7684\u9996\u9078\u8a98\u5c0e\u9ebb\u9189\u3002 (C)K etamine\u8207Propofol\u4e26\u7528\uff0c\u56e0 Propofol\u964d\u4f4e Ketamine\u6bd2\u6027\uff0c\u8f03\u9069\u5408\u4f5c\u70ba\u8a72\u672c\u4f8b\u75c5\u4eba\u7684\u9996\u9078\u8a98\u5c0e\u9ebb\u9189\u3002 (D)\u75c5\u4eba\u5728\u8a98\u5c0e\u9ebb\u9189\u5f8c\uff0c\u4ecd\u8e81\u52d5\u808c\u8089\u7dca\u7e2e\uff0c\u53ef\u9078\u7528 Succinylcholine \u9b06\u5f1b\u808c\u8089\uff0c\u518d\u884c\u63d2\u7ba1\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6025\u6027\u51a0\u5fc3\u75c7\u4e4b\u4f75\u767c\u75c7\uff0c\u4e0b\u5217\u4f55\u8005\u6558\u8ff0 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5fc3\u96fb\u5716\u986f\u793a\u70ba\u52a0\u901f\u6027\u5fc3\u5ba4\u81ea\u4e3b\u7bc0\u5f8b(accelerated idioventricular rhythms) \uff0c\u5176\u9810\u5f8c\u8f03\u5dee\u3002 (B)\u5fc3\u81df\u4e73\u7a81\u808c\u65b7\u88c2\uff0c\u8f03\u5e38\u767c\u751f\u65bc\u524d\u58c1\u6897\u585e\u3002 (C)\u82e5\u75c5\u4eba\u4f75\u767c\u539f\u767c\u6027\u5fc3\u5ba4\u986b\u52d5\uff0c\u53ea\u8981\u53ca\u6642\u6cbb\u7642\uff0c\u4e0d\u592a\u5f71\u97ff\u9810\u5f8c\u3002 (D)\u82e5\u767c\u751f Dressler\u2019s syndrome \uff0c\u61c9\u6bcf\u65e5\u670d\u7528\u963f\u65af\u5339\u9748 100\u6beb\u514b\u6cbb\u7642\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "3\u6b72\u7537\u7ae5\uff0c\u5750\u5728\u6c7d\u8eca\u5f8c\u5ea7\u4e4b\u5b89\u5168\u5ea7\u6905\u767c\u751f\u8eca\u798d\uff0c\u4f75\u982d\u76ae\u6495\u88c2\u50b7 3\u516c\u5206\u53ca\u8179\u90e8\u7600\u9752\uff0c\u8840\u58d3 100/65 mmHg \u3002\u75c5\u7ae5\u7dca\u62b1\u6bcd\u89aa\uff0c\u6709\u6642\u5927\u8072\u54ed\u9b27\uff0c\u96d9\u773c\u7dca\u9589\uff0c\u5abd\u5abd\u53eb\u559a\u624d\u6253\u958b\u3002\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u4f9d\u6cd5\u898f \u8981\u5f37\u5236\u9078\u7528\u5f8c\u5411\u5f0f\u5b89\u5168\u5ea7\u6905\u3002 (B)\u53ef\u7528\u8d85\u97f3\u6ce2\u6392\u9664\u8179\u5167\u5be6\u8cea\u5668\u5b98\u640d\u50b7\u3002 (C)\u82e5\u75c5\u7ae5\u9032\u5c55\u81f3\u4f11\u514b\uff0c\u982d\u76ae\u6495\u88c2\u50b7\u61c9\u8a72\u4e0d\u6703\u662f\u4e3b\u56e0\u3002 (D)\u6b64\u75c5\u7ae5 Modified Pediatric Glasgow Coma Scale 14 \u5206\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u5c0d\u65bc\u5e36\u72c0\u75b1\u75b9\u7d66\u4e88\u6297\u75c5\u6bd2\u85e5\u7269\u6cbb\u7642\u7684\u81e8\u5e8a\u8003\u91cf\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u53ef\u4ee5\u7e2e\u77ed\u75c5\u7a0b\u3002 (B)\u53ef\u4ee5\u6e1b\u5c11\u65b0\u7684\u6c34\u75d8\u51fa\u73fe\u3002 (C)\u53ef\u4ee5\u964d\u4f4e\u75b1\u75b9\u5f8c\u795e\u7d93\u75db\u7684\u56b4\u91cd\u5ea6\u3002 (D)\u514d\u75ab\u529f\u80fd\u4e0d\u5168\u75c5\u4eba\u75c7\u72c0\u8d85\u904e 72\u5c0f\u6642\u5f8c\uff0c\u4ea6\u61c9\u7d66\u4e88\u6297\u75c5\u6bd2\u85e5\u7269\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "38\u9031\u7684\u5b55\u5a66\uff0c\u6a5f\u8eca\u8eca\u798d\u5f8c\u88ab\u9001\u81f3\u6025\u8a3a\uff0c GCS E3V4M5 \uff0c\u5de6\u81c9\u64e6\u50b7\uff0c\u5de6\u80f8\u6709\u76ae\u4e0b\u6c23\u816b\uff0c\u5de6\u8179\u90e8\u6709\u632b\u64e6\u50b7\u75d5\u8de1\uff0c\u5167\u8932\u4e0a\u767c\u73fe\u6709\u5c11\u8a31\u8840\u6c34\uff0c\u8840\u58d3 87/45 mmHg\uff0c\u5fc3\u8df3 146\u6b21/min\uff0c\u547c\u5438 23\u6b21/min\uff0cSpO 2 95%\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5148\u7a69\u5b9a\u5b55\u5a66\u624d\u80fd\u8b93\u80ce\u5152\u6709\u8f03\u597d\u9810\u5f8c\uff0c\u61c9\u5728\u5b55\u5a66\u6025\u6551\u7a69\u5b9a\u548c\u6b21\u7d1a\u8a55\u4f30\u5f8c\uff0c\u958b\u59cb\u8a55\u4f30\u80ce\u5152\u72c0\u6cc1\u3002 (B)\u52d5\u8108\u8840\u986f\u793a PaO 2 91mmHg \uff0cPaCO 2 38mmHg\uff0c\u61c9\u8003\u616e\u5b55\u5a66\u5373\u5c07\u547c\u5438\u8870\u7aed\u3002 (C)\u9664\u4e86\u5c07\u5b50\u5bae\u5f80\u5de6\u63a8\u6216\u5de6\u5074\u8eba\u5916\uff0c\u61c9\u958b\u59cb\u8f38\u6db2\u3001\u8f38\u8840\u3001\u5118\u65e9\u7d66\u5347\u58d3\u85e5\u7269\uff0c\u4ee5\u907f\u514d\u80ce\u5152\u7f3a\u6c27\u3002 (D)\u9670\u9053\u4e4b\u6db2\u9ad4\u7d93\u8a66\u7d19\u6aa2\u6e2c\uff0cpH \u503c5\uff0c\u61c9\u9ad8\u5ea6\u61f7\u7591\u7f8a\u819c\u7834\u88c2\uff0c\u5118\u65e9\u6703\u8a3a\u5a66\u7522\u79d1\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "24\u6b72\u7537\u6027\u75c5\u4eba\u56e0\u89e3\u8840\u4fbf 2\u5929\u81f3\u6025\u8a3a\u5c31\u8a3a\uff0c\u81e8\u5e8a\u4e0a\u7591\u4f3c\u611f\u67d3\u6027\u80c3\u8178\u708e\u3002\u53ef\u80fd\u7684\u83cc\u7a2e\u5305\u62ec Salmonella, Shigella, Yersinia, Vibrio \u548cE. coli\uff0c\u7b2c\u4e00\u7dda\u6297\u751f\u7d20\u7684\u9078\u64c7\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)Trimethoprim -sulfamethoxazole \u3002 (B)Metronidazole \u3002 (C)Erythromycin\u3002 (D)Ciprofloxacin \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u5fd7\u8cc0\u6c0f\u687f\u83cc( Shigella spp )\u53ca\u5176\u5c0e\u81f4\u4e4b\u8179\u7009\u75be\u75c5\u7684\u63cf\u8ff0\uff0c\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u65e5\u6258\u4e2d\u5fc3\u5e7c\u7ae5\u662f\u6613\u53d7\u611f\u67d3\u65cf\u7fa4\u3002 (B)\u53ef\u4f7f\u7528 Azithromycin \u6cbb\u7642\u3002 (C)\u53ef\u4ee5\u662f\u81ea\u9650\u6027(self -limited)\u75c5\u7a0b\u3002 (D)S. sonnei \u5f15\u8d77\u4e4b\u75c7\u72c0\u8f03\u5176\u4ed6\u4e9e\u7fa4\u56b4\u91cd\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "38\u6b72\u7537\u6027\u56e0\u4e0b\u5348\u62d4\u7259\u5f8c\u3001\u7259\u9f66\u50b7\u53e3\u5728\u534a\u591c\u8840\u6d41\u4e0d\u6b62\u81f3\u6025\u8a3a\u5c31\u91ab\uff0c \u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u4f7f\u7528\u7d17\u5e03\u5728\u50b7\u53e3\u8655\u8b93\u75c5\u4eba\u54ac\u4f4f\u3001\u5c40\u90e8\u58d3\u8feb\u51fa\u8840\u90e8\u4f4d 20\u5206\u9418\u3002 (B)\u9032\u4e00\u6b65\u53ef\u4f7f\u7528\u6b62\u8840\u81a0\u68c9 Gelfoam\u6216\u4f7f\u7528\u6ce1\u904e tranexamic acid \u7684\u7d17\u5e03\u3002 (C)\u7d17\u5e03\u6b62\u8840\u82e5\u5931\u6557\uff0c\u53ef\u4ee5\u4f7f\u7528\u7e2b\u7dda\u5c07\u7259\u9f66\u7684\u50b7\u53e3\u9032\u884c\u7dca\u5bc6\u7e2b\u5408\u3002 (D)\u82e5\u4e0a\u8ff0\u65b9\u6cd5\u7121\u6548\uff0c\u53ef\u4ee5\u5728\u50b7\u53e3\u5468\u570d\u5c40\u90e8\u6ce8\u5c04Lidocaine +Epinephrine \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6025\u8a3a\u5152\u79d1 4\u4f4d\u767c\u71d2\u4e00\u5929\u7684\u5152\u7ae5\u639b\u865f\uff0c\u56db\u4eba\u7686\u6d3b\u52d5\u529b\u6b63\u5e38\u3001\u7121\u660e\u986f\u547c\u5438\u9053\u6216\u8178\u80c3\u9053\u75c7\u72c0\uff0c\u4e14\u90fd\u6709\u6309\u6642\u63a5\u7a2e\u75ab\u82d7\u3002 \u54ea\u4e00\u4f4d\u521d\u6b65\u4e0d\u9700\u8981 \u5c3f\u6db2\u6aa2\u67e5\uff1f", + "Options": "(A)3\u500b\u6708\u5927\u7684\u7537\u5b30\uff0c\u9ad4\u6eab 38.5\u2103\u3002 (B)1.5 \u6b72\u7537\u7ae5\uff0c\u7121\u5272\u5305\u76ae\uff0c\u9ad4\u6eab 38.0\u2103\u3002 (C)1.5 \u6b72\u5973\u7ae5\uff0c\u9ad4\u6eab 38.0\u2103\u3002 (D)4\u6b72\u5973\u7ae5\uff0c\u9ad4\u6eab 38.0\u2103\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u5728\u9032\u884c\u6210\u4eba\u975e\u5275\u50b7\u75c5\u4eba\u7684\u50b3\u7d71\u5589\u982d\u93e1\u6c23\u7ba1\u63d2\u7ba1\uff0c\u7528\u5589\u982d\u93e1\u6311\u53ea\u80fd\u770b\u898b\u4e00\u534a\u7684\u8072\u9580\u4e09\u89d2\u6642\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u91cd\u65b0\u64fa\u4f4d\uff0c\u5c07\u75c5\u4eba\u5448\u5e73\u8eba\u9ede\u982d\u59ff\u52e2\u3002 (B)\u91cd\u65b0\u64fa\u4f4d\u5728\u75c5\u4eba\u982d\u4e0b (\u6795\u90e8)\u588a\u9ad8\u7d04 10\u516c\u5206\u3002 (C)\u4f7f\u7528\u5f8c\u4e0a\u53f3\u624b\u6280(BURP Maneuver )\u5c0d\u74b0\u72c0\u8edf\u9aa8\u58d3\u8feb\u3002 (D)\u4f7f\u7528\u859b\u7acb\u514b\u624b\u6280(Sellick Maneuver )\u5c0d\u74b0\u72c0\u8edf\u9aa8\u58d3\u8feb\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u5c0d\u65bc\u4eba\u985e\u514d\u75ab\u7f3a\u4e4f\u75c5\u6bd2( HIV)\u611f\u67d3\u75c5\u4eba\u80ba\u708e\u7684\u6558\u8ff0\uff0c\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u76f8\u5c0d\u65bc\u5176\u4ed6\u75c5\u539f\u9ad4\uff0c\u7d30\u83cc\u6027\u80ba\u708e\u7684\u767c\u751f\u7387\u4ecd\u6700\u9ad8\u3002 (B)Pneumocystic pneumonia \u7684\u6700\u5927\u7279\u5fb5\u662f\u4f4e\u8840\u6c27\u75c7\u3002 (C)\u80ba\u7d50\u6838\u611f\u67d3\u7684\u5178\u578b\u80f8\u90e8 X\u5149\u8868\u73fe\uff0c\u4e0d\u5e38\u898b\u65bc\u672b\u671f\u75c5\u4eba\u3002 (D)HIV \u611f\u67d3\u521d\u671f\u5e38\u898b cytomegalovirus \u80ba\u708e\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5c0f\u5152\u5927\u91cf\u50b7\u60a3\u7684\u6aa2\u50b7 JumpSTART \u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u8ddf\u6210\u4eba\u6aa2\u50b7\u4e00\u6a23\uff0c\u4e00\u958b\u59cb\u5148\u8a55\u4f30\u6709\u7121\u547c\u5438\u3002 (B)AV P U \u662fJumpSTART \u8a55\u4f30\u610f\u8b58\u7684\u5de5\u5177\uff0c\u7b2c\u4e00\u500b A\u662fairway\u3002 (C)\u8a55\u4f30\u7684\u9806\u5e8f\uff1a\u53ef\u5426\u884c\u8d70\u2192\u8108\u640f\u2192\u547c\u5438\u3002 (D)\u53ea\u8981\u53ef\u4ee5\u884c\u8d70\u90fd\u662f minor\uff0c\u9032\u5165\u7b2c\u4e8c\u6b21\u6aa2\u50b7\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "35\u6b72\u7537\u6027\u8eca\u798d\u53d7\u50b7\uff0c\u6838\u78c1\u5171\u632f\u6aa2\u67e5\u767c\u73fe\u5176\u810a\u9ad3\u53d7\u50b7\u4f4d\u7f6e\u7d04\u5728 T10\uff0c\u9664\u4e86\u96d9\u4e0b\u80a2\u7121\u529b\u5916\uff0c\u75c5\u4eba\u4ea6\u5931\u53bb\u4e0b\u534a\u8eab\u75db\u89ba\u548c\u6eab\u89ba\uff0c\u4f46\u4ecd\u4fdd\u6709\u672c\u9ad4\u611f\u89ba\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u767c\u751f\u795e\u7d93\u6027\u4f11\u514b\u6a5f\u6703\u5f88\u9ad8\u3002 (B)\u96d9\u4e0b\u80a2\u7684\u8f15\u89f8\u89ba(light touch)\u4e0d\u6703\u5b8c\u5168\u6d88\u5931\u3002 (C)\u6eab\u89ba\u55aa\u5931\u7684\u7bc4\u570d\uff0c\u53ef\u80fd\u81ea T6\u4ee5\u4e0b\u958b\u59cb\u51fa\u73fe\u3002 (D)\u4e0b\u80a2\u795e\u7d93\u5b78\u6aa2\u67e5\u6703\u5448\u73fe\u6df1\u5c64\u808c\u8171\u53cd\u5c04\u4e0b\u964d\u53ca Barbinski\u2019s sign(\u967d\u6027)\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5916\u50b7\u75c5\u4eba\u8f38\u8840\u7684\u6558\u8ff0\uff0c \u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)24\u5c0f\u6642\u5167\u8f38\u8840\u8d85\u904e 8\u55ae\u4f4d\u7b26\u5408\u5927\u591a\u6578\u5927\u91cf\u8f38\u8840 (massive transfusion )\u5b9a\u7fa9\u3002 (B)\u5927\u91cf\u8f38\u8840\u9808\u540c\u6642\u88dc\u5145\u9223\uff0c\u9810\u9632\u4f4e\u8840\u9223\u3002 (C)\u61c9\u76e1\u5feb\u7d66\u4e88\u7b26\u5408\u8840\u578b\u548c\u7d93 crossmatch \u4e4bPRBCs\uff0c\u4f46\u5927\u91cf\u50b7\u60a3\u6642\u53ef\u4f8b\u5916\u3002 (D)\u7dca\u6025\u6642\u53ef\u7d66\u4e88 O\u578b\u4e4b PRBCs\u548cfresh frozen plasma \uff0c\u800c platelet\u4e0d\u8a08\u8840\u578b\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6025\u6027\u7f3a\u8840\u6027\u4e2d\u98a8\u7684\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u8981\u7a4d\u6975\u63a7\u5236\u6536\u7e2e\u58d3\u5230 120 mmHg \u4ee5\u4e0b\uff0c\u624d\u80fd\u65bd\u6253\u975c\u8108\u8840\u6813\u6eb6\u89e3\u5291\u3002 (B)\u65bd\u6253\u975c\u8108\u8840\u6813\u6eb6\u89e3\u5291\u4e4b\u5f8c\uff0c\u82e5\u8212\u5f35\u58d3\u8d85\u904e 140 mmHg\uff0c\u53ef\u8003\u616e\u4f7f\u7528nitroprusside \u975c\u8108\u6ef4\u6ce8\u63a7\u5236\u8840\u58d3\u3002 (C)\u65bd\u6253\u975c\u8108\u8840\u6813\u6eb6\u89e3\u5291 12\u5c0f\u6642\u4e4b\u5f8c\uff0c\u5c31\u8981\u958b\u59cb\u53e3\u670d Aspirin\uff0c\u4ee5\u6e1b\u5c11\u8840\u7ba1\u518d\u6b21\u963b\u585e\u3002 (D)\u82e5\u8840\u7cd6\u5c0f\u65bc 50 mg/dL \uff0c\u4f46\u81e8\u5e8a\u4e0a\u8868\u73fe\u50cf\u4e2d\u98a8\uff0c\u9084\u662f\u8981\u5148\u65bd\u6253\u975c\u8108\u8840\u6813\u6eb6\u89e3\u5291\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc valproic acid \u4e2d\u6bd2\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u7de9\u91cb\u578b valproic acid \u4e2d\u6bd2\uff0c\u53ea\u9808\u55ae\u6b21\u6d3b\u6027\u78b3\u6cbb\u7642\u3002 (B)\u5728\u4e2d\u6bd2\u75c5\u4eba\u4e2d\uff0c\u8840\u4e2d\u6fc3\u5ea6\u8207\u75c5\u4eba\u767c\u751f\u7672\u7647\u6709\u5f37\u70c8\u76f8\u95dc\u3002 (C)\u7121\u6cd5\u4ee5\u8840\u6db2\u900f\u6790\u589e\u52a0\u6392\u51fa\u3002 (D)\u6703\u9020\u6210\u8840\u4e2d ammonia \u4e0a\u5347\uff0c\u53ef\u7528 L-carnitine \u6cbb\u7642\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4f7f\u7528\u8996\u93e1\u5589\u93e1( Video laryngoscopes, VL)\u63d2\u7ba1\u8207\u50b3\u7d71\u5589\u93e1( Direct laryngoscopes, DL)\u63d2\u7ba1\u7684\u6bd4\u8f03\uff0c\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)VL \u8207DL\u7684\u5589\u93e1\uff0c\u5176\u8449\u7247(blade )\u5f4e\u66f2\u89d2\u5ea6\u901a\u5e38\u662f\u4e00\u6a23\u7684\u3002 (B)VL \u8207DL\u7f6e\u5165\u6642\uff0c\u90fd\u5fc5\u9808\u5148\u7531\u53e3\u89d2\u5074\u5165\u4f5c\u6383\u820c (tongue sweep) \u3002 (C)VL \u8207DL\u7f6e\u5165\u5f8c\uff0c\u8449\u7247\u524d\u7aef\u7684\u76ee\u6a19\u90fd\u662f\u843d\u5728\u6703\u53ad\u8c3f(vallecula )\u3002 (D)\u4f7f\u7528 VL\u7684\u9996\u6b21\u63d2\u7ba1\u6210\u529f\u7387\u986f\u8457\u9ad8\u65bc DL\uff0c\u4e14\u4f75\u767c\u75c7\u6bd4\u7387\u8f03\u4f4e\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8840\u54c1\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u9805 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u65b0\u9bae\u51b7\u51cd\u8840\u6f3f( FFP)\u5728\u7dca\u6025\u8f38\u8840\u72c0\u6cc1\u4e0b\uff0c\u53ef\u76f4\u63a5\u52a0\u71b1\u89e3\u51cd\uff0c\u4e14\u89e3\u51cd\u5f8c\u53ef\u4ee5\u7dad\u6301\u4e94\u5929\u6d3b\u6027\u3002 (B)\u65b0\u9bae\u51b7\u51cd\u8840\u6f3f\u51fa\u5eab\u524d\uff0c\u7121\u9700\u914d\u5c0d\u8840\u578b\u3002 (C)\u51b7\u51cd\u6c88\u6fb1\u54c1(cryoprecipitate )\u9069\u61c9\u75c7\u5305\u62ec Fibrinogen \u5c0f\u65bc 100 mg/dL\u7684\u56b4\u91cd\u809d\u75c5\u75c5\u4eba\u51fa\u8840\u3002 (D)\u65b0\u578b\u53e3\u670d\u6297\u51dd\u8840\u5291\u904e\u91cf\u51fa\u8840\u7684\u75c5\u4eba\u5efa\u8b70\u4f7f\u7528\u65b0\u9bae\u51b7\u51cd\u8840\u6f3f\u4f86\u505a\u6cbb\u7642\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "50\u6b72\u7537\u6027\u60a3\u6709\u91cd\u75c7\u808c\u7121\u529b\uff0c\u56e0\u547c\u5438\u6025\u4fc3\u4f86\u6025\u8a3a\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u82e5\u9700\u8981\u63d2\u7ba1\uff0c\u907f\u514d\u7d66\u4e88 depolarizing \u6216nondepolarizing paralytic agents\u3002 (B)\u9838\u90e8\u75c7\u72c0\u662f\u5c48\u808c(flexor )\u7684\u7121\u529b\u6bd4\u4f38\u808c(extensor )\u660e\u986f\u3002 (C)\u9060\u7aef\u80a2\u9ad4\u7121\u529b\u70ba\u9019\u985e\u75c5\u4eba\u6700\u5e38\u898b\u4e4b\u75c7\u72c0\u3002 (D)\u53ea\u8981\u75c5\u4eba\u6709\u547c\u5438\u9053\u75c7\u72c0\uff0c\u5373\u4f7f\u5f88\u8f15\u5fae\u4e5f\u9700\u5165\u4f4f\u52a0\u8b77\u75c5\u623f\u89c0\u5bdf\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "45\u6b72\u5973\u6027\uff0c\u4e73\u764c\u5408\u4f75\u8166\u90e8\u8f49\u79fb\u75c5\u53f2\uff0c\u4e3b\u8a34 1\u5c0f\u6642\u524d\u958b\u59cb\u5598\uff0c\u9ad4\u6eab 37.5\u2103\uff0c\u5fc3\u8df3 130\u6b21/min\uff0c\u547c\u5438 30\u6b21/min\uff0c\u8840\u58d3 80/50 mmHg \uff0cSpO 2 88%\uff0c\u8eab\u9ad4\u8a3a\u5bdf\u96d9\u5074\u80ba\u90e8\u807d\u8a3a\u7121\u7570\u5e38\uff0c\u53f3\u5c0f\u817f\u4ee5\u4e0b\u7d05\u816b\u58d3\u75db\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u8d85\u97f3\u6ce2\u767c\u73fe\u5de6\u5fc3\u5ba4\u5448 D\u578b\uff0c\u53ef\u4ee5\u78ba\u8a3a\u70ba\u6025\u6027\u80ba\u6813\u585e\u3002 (B)\u82e5\u7b26\u5408\u56b4\u91cd\u80ba\u6813\u585e\u4e4b\u8a3a\u65b7\uff0c\u7d66\u4e88\u8840\u6813\u6eb6\u89e3\u5291\u6cbb\u7642\u3002 (C)\u8d85\u97f3\u6ce2\u5c0d\u65bc\u80ba\u6813\u585e\u4e4b\u654f\u611f\u6027\u7d04 70%\u3002 (D)\u53ef\u4f7f\u7528\u4f4e\u5206\u5b50\u91cf\u809d\u7d20\u6cbb\u7642\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc Crohn's disease \u7684\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u597d\u767c\u90e8\u4f4d\u70ba\u7a7a\u8178\u3002 (B)\u8ca7\u8840\u4e26\u975e\u6b64\u75c5\u75c7\u4e4b\u5e38\u898b\u75c7\u72c0\u3002 (C)\u8f03\u5e38\u767c\u751f\u65bc\u4e9e\u6d32\u4eba\u3002 (D)\u75c7\u72c0\u56b4\u91cd\u6642\u53ef\u4ee5\u7d66\u4e88 Prednisolone (60 mg per day )\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u8b77\u7406\u5e2b\u5e6b\u75c5\u4eba\u62bd\u8840\u5f8c\u91dd\u624e\uff0c\u4e0b\u5217\u4f55\u8005\u8655\u7f6e\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u82e5\u6b64\u8b77\u7406\u5e2b\u5f9e\u672a\u63a5\u53d7 B\u578b\u809d\u708e\u75ab\u82d7\uff0c\u4e14\u7121\u6cd5\u5f97\u77e5\u75c5\u4eba\u662f\u5426\u611f\u67d3HBV\uff0c\u61c9\u7d66\u4e88 B\u578b\u809d\u708e\u514d\u75ab\u7403\u86cb\u767d\u3002 (B)\u82e5\u7b26\u5408\u7d66\u4e88 B\u578b\u809d\u708e\u514d\u75ab\u7403\u86cb\u767d\u7684\u60c5\u6cc1\u4e0b\uff0c\u61c9\u65bc\u91dd\u624e\u5f8c 24\u5c0f\u6642\u5167\u7d66\u4e88\u3002 (C)\u82e5\u75c5\u4eba\u6709\u5f8c\u5929\u514d\u75ab\u7f3a\u4e4f\u75c7\u5019\u7fa4\uff0c\u8b77\u7406\u5e2b\u6b64\u6b21\u611f\u67d3\u611b\u6ecb\u75c5\u75c5\u6bd2\u6a5f\u7387\u7d04\u70ba0.3%\u3002 (D)\u611b\u6ecb\u75c5\u6bd2\u66b4\u9732\u5f8c\u9810\u9632\u6027\u6295\u85e5\u5efa\u8b70\u8d8a\u5feb\u7d66\u4e88\u8d8a\u597d\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u4e2d\u6691( Heat stroke )\u7684\u63cf\u8ff0\uff0c\u4ee5\u4e0b\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u9451\u5225\u51fa\u52de\u52d5\u578b (exertional )\u6216\u975e\u52de\u52d5\u578b\u4e2d\u6691(non-exertional heat stroke)\uff0c\u5c0d\u5f8c\u7e8c\u964d\u6eab\u6cbb\u7642\u7684\u9078\u64c7\u5341\u5206\u91cd\u8981\u3002 (B)\u57fa\u5e95\u6838\u70ba\u4e2d\u6a1e\u795e\u7d93\u4e2d\u6700\u6613\u53d7\u71b1\u50b7\u5bb3\u7684\u90e8\u4f4d\u3002 (C)\u7121\u6c57 (anihydrosis )\u70ba\u4e2d\u6691\u7684\u8a3a\u65b7\u6e96\u5247\u3002 (D)\u52de\u52d5\u578b\u4e2d\u6691 (exertional heat stroke )\uff0c\u5e38\u898b\u4e73\u9178\u9178\u8840\u75c7(l actic acidosis)\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8072\u9580\u4e0a\u547c\u5438\u9053 (supraglottic airway )\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u56e0\u6c23\u7ba1\u5167\u7ba1\u8f03\u9069\u5408\u9577\u671f\u901a\u6c23\u4f7f\u7528\uff0c\u9662\u524d\u4f7f\u7528\u5589\u7f69\u547c\u5438\u9053(laryngeal mask airway, LMA)\u7684\u75c5\u4eba\uff0c\u5230\u9662\u5f8c\u61c9\u7acb\u5373\u66f4\u63db\u70ba\u6c23\u7ba1\u5167\u7ba1\u3002 (B)\u76f8\u8f03\u65bc\u6709\u6c23\u56ca\u7684\u6c23\u7ba1\u5167\u7ba1\uff0c\u8072\u9580\u4e0a\u547c\u5438\u9053\u9020\u6210\u5438\u5165(aspiration) \u53ca\u4e0b\u54bd\u90e8\u9ecf\u819c\u640d\u50b7\u7684\u98a8\u96aa\u8f03\u9ad8\u3002 (C)\u5589\u7f69\u547c\u5438\u9053\u4e0d\u9700\u76ee\u8996\u8072\u9580\u5373\u53ef\u7f6e\u653e\uff0c\u5728\u53f0\u7063\u53ef\u7531\u521d\u7d1a\u6551\u8b77\u6280\u8853\u54e1(EMT -I)\u9032\u884c\u3002 (D)\u7f6e\u653e\u8072\u9580\u4e0a\u547c\u5438\u9053\u5f8c\uff0c\u4e0d\u5b9c\u4f7f\u7528\u6f6e\u6c23\u672b\u4e8c\u6c27\u5316\u78b3 (end -tidal carbon dioxide)\u6fc3\u5ea6\u78ba\u8a8d\u4f4d\u7f6e\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6025\u6027\u75c5\u6bd2\u6027\u809d\u708e\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)A \u578b\u809d\u708e\u5f88\u5c11\u6f14\u8b8a\u6210\u6162\u6027\u809d\u708e\u3002 (B)C \u578b\u809d\u708e\u7684\u6025\u6027\u611f\u67d3\u901a\u5e38\u6c92\u6709\u75c7\u72c0\u3002 (C)\u6210\u5e74\u5f8c\u611f\u67d3 B\u578b\u809d\u708e\uff0c\u6709 75%\u6703\u6f14\u8b8a\u6210\u6162\u6027\u809d\u708e\u3002 (D)B \u578b\u809d\u708e\u548c D\u578b\u809d\u708e\u91cd\u8907\u611f\u67d3\u5bb9\u6613\u6f14\u8b8a\u6210\u731b\u7206\u6027\u809d\u708e\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "35\u6b72\u5973\u6027\u61f7\u5b55 38\u9031\uff0c\u9a0e\u6a5f\u8eca\u81ea\u6454\u9001\u91ab\uff0c\u610f\u8b58\u6e05\u695a\uff0c\u8840\u58d3 100/50 mmHg \u3001\u5fc3\u8df3 120\u6b21/min\u3001\u547c\u5438 20\u6b21/min\u3001\u9ad4\u6eab 36\u2103\uff1b\u4e3b\u8a34\u4e0b\u8179\u4e0d\u9069\uff0c\u8eab\u9ad4\u8a3a\u5bdf\u767c\u73fe\u4e0b\u8179\u58d3\u75db\u4f46\u7121\u660e\u986f\u8179\u819c\u708e\u5fb5\u8c61\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5b50\u5bae\u8840\u6d41\u5145\u8db3\u4f46\u9ad4\u7a4d\u76f8\u5c0d\u8f03\u5c0f\uff0c\u53d7\u50b7\u5f8c\u4e0d\u6703\u9020\u6210\u5b55\u5a66\u4f11\u514b\u3002 (B)\u56e0\u5b50\u5bae\u64f4\u5927\u727d\u626f\u8179\u819c\uff0c\u53ef\u80fd\u9020\u6210\u8179\u5167\u51fa\u8840\u5f8c\u7684\u8179\u819c\u708e\u5fb5\u8c61\u4e0d\u660e\u986f\u3002 (C)\u6b64\u6642\u671f\u80ce\u982d\u5df2\u4e0b\u964d\u81f3\u9aa8\u76c6\u8154\u5167\uff0c\u5373\u4f7f\u9aa8\u76c6\u9aa8\u6298\u4ea6\u4e0d\u6703\u76f4\u63a5\u50b7\u5bb3\u5230\u80ce\u5152\u982d\u90e8\u3002 (D)\u7e3d\u8840\u91cf\u70ba\u61f7\u5b55\u671f\u9593\u6700\u9ad8\uff0c\u5931\u8840\u91cf\u9054\u8840\u6db2\u7e3d\u9ad4\u7a4d 30%\u4ee5\u4e0a\u624d\u6703\u51fa\u73fe\u4f11\u514b\u5fb5\u5019\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u91ab\u6cd5\u502b( medicolegal & ethical )\u8003\u91cf\uff0c\u4e0b\u5217\u4f5c\u70ba\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u5047\u65e5\u8981\u6c42\u8655\u7406\u81c9\u4e0a\u5b58\u5728\u5df2\u4e45\u7684 \u201c\u8089\u7624\u201d\uff0c\u7d93\u91ab\u5e2b\u6aa2\u8996\u7121\u6025\u75c7\uff0c\u56d1\u5490\u5e73\u65e5\u5916\u79d1\u9580\u8a3a\u8655\u7406\u5f8c\u9000\u639b\u3001\u7121\u9808\u8a18\u9304\u3002 (B)\u9152\u5f8c\u6253\u67b6\u53d7\u50b7\u75c5\u4eba\uff0c\u50b7\u53e3\u8655\u7f6e\u5f8c\u4e0d\u544a\u800c\u5225\uff0c\u5fc5\u9808\u4f9d\u7167\u91ab\u9662\u6d41\u7a0b\u76e1\u4e00\u5207\u53ef\u884c\u8fa6\u6cd5\u5c0b\u627e\u3001\u8acb\u4ed6\u56de\u4f86\u4e26\u8a18\u9304\u3002 (C)\u6b65\u5165\u8981\u6c42\u9a57\u5b55\uff0c\u9084\u662f\u8981\u57f7\u884c\u57fa\u672c\u8a55\u4f30\u78ba\u5b9a\u662f\u5426\u6709\u91ab\u7642\u6025\u75c7\u3002\u4e0d\u9858\u914d\u5408\u8005\u53ef\u5efa\u8b70\u5230\u9069\u5408\u5730\u9ede\u7372\u5f97\u6b64\u9700\u6c42\u3002 (D)\u4ed6\u79d1\u91ab\u5e2b\u8981\u75c5\u4eba\u5230\u6025\u8a3a\u7b49\u4ed6\u70ba\u75c5\u4eba\u505a\u8a3a\u6cbb\uff0c\u9084\u662f\u8981\u5148\u9032\u884c\u57fa\u672c\u8a55\u4f30\uff0c\u82e5\u6709\u6025\u75c7\u5fc5\u9808\u5148\u63d0\u4f9b\u5fc5\u8981\u4e4b\u8655\u7f6e\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6cd5\u91ab\u6bd2\u7269\u5b78\u7684\u6982\u8ad6\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u6b7b\u5f8c\u7684\u8840\u6db2\u662f\u4e00\u7a2e\u5916\u8868\u770b\u8d77\u4f86\u50cf\u6eb6\u8840\u5f8c\u7684\u81a0\u8cea\u3002 (B)\u5c3f\u6db2\u6240\u6e2c\u5f97\u7684\u6aa2\u9ad4\u6fc3\u5ea6\u548c\u85e5\u7269\u5728\u9ad4\u5167\u7576\u6642\u7684\u4f5c\u7528\u76f8\u95dc\u6027\u975e\u5e38\u8584\u5f31\u3002 (C)\u773c\u7403\u6db2\u4e2d\u9152\u7cbe\u6fc3\u5ea6\u7684\u6e2c\u5b9a\u662f\u6e2c\u5b9a\u6b7b\u8005\u751f\u524d\u662f\u5426\u98f2\u9152\u7684\u91cd\u8981\u4f9d\u64da\u3002 (D)\u81bd\u6c41\u4e2d\u6240\u6e2c\u5f97\u7684\u6bd2\u85e5\u7269\u6fc3\u5ea6\u4e0d\u53d7\u8178\u809d\u5faa\u74b0(enterohepatic circulation)\u7684\u5f71\u97ff\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u5973\u5b50\u56e0\u5272\u8155\u9001\u81f3\u6025\u8a3a\uff0c\u5979\u7684\u5927\u62c7\u6307\u7121\u6cd5\u505a\u5c0d\u638c( opposition )\u52d5\u4f5c\uff0c\u6b64 \u61c9\u61f7\u7591\u4e0b\u5217\u4f55\u8005\u4e4b\u640d\u50b7\uff1f", + "Options": "(A)median nerve \u3002 (B)palmar digital nerve \u3002 (C)radial nerve \u3002 (D)ulnar nerve \u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u56e0\u5b55\u5a66\u5916\u50b7\u5c0e\u81f4\u80ce\u5152\u6b7b\u4ea1\u7684\u539f\u56e0\uff0c\u9664\u4e86\u56e0\u6bcd\u89aa\u4f11\u514b\u6216\u6bcd\u89aa\u6b7b\u4ea1\u5916 \u6700\u5e38\u898b\u4e4b\u8087\u56e0\u70ba\uff1f", + "Options": "(A)Abruptio placentae \u3002 (B)Premature rupture of membranes \u3002 (C)Rh blood type incompatibility \u3002 (D)Uterine rupture \u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u5c0d\u65bc\u6d41\u9f3b\u8840\u75c5\u4eba\u7684\u8a3a\u65b7\u53ca\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u6700\u53ef\u80fd\u51fa\u8840\u7684\u4f4d\u7f6e\u662f Kiesselbach's plexus \u3002 (B)\u521d\u6b65\u6b62\u8840\u8655\u7f6e\u53ef\u4ee5\u8acb\u75c5\u4eba\u982d\u5f80\u524d\u50be\uff0c\u7528\u624b\u6307\u634f\u4f4f\u9f3b\u7ffc\u3002 (C)\u53ef\u4ee5\u8003\u616e\u5408\u4f75\u4f7f\u7528 NSAIDs\u52a0\u5f37\u8840\u7ba1\u6536\u7e2e\uff0c\u9054\u5230\u66f4\u597d\u7684\u6b62\u8840\u6548\u679c\u3002 (D)\u82e5 nasal packing \u653e\u7f6e\u8d85\u904e 48\u5c0f\u6642\uff0c\u9700\u5408\u4f75\u6297\u751f\u7d20\u4f7f\u7528\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u751f\u6b96\u6ccc\u5c3f\u7cfb\u7d71\u5275\u50b7\u7684\u6cbb\u7642\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u7537\u6027\u9aa8\u76c6\u9aa8\u6298\u9020\u6210\u7684\u5f8c\u5c3f\u9053\u640d\u50b7\u9700\u7acb\u5373\u624b\u8853\u6cbb\u7642\u3002 (B)\u8f38\u5c3f\u7ba1\u640d\u50b7\u5408\u4f75\u5c3f\u6db2\u6ef2\u51fa\uff0c\u53ef\u63a1\u4fdd\u5b88\u6027\u7642\u6cd5\uff0c\u4e0d\u9700\u624b\u8853\u3002 (C)\u8180\u80f1\u8179\u819c\u5167\u7834\u88c2(intraperitoneal ruptures of the bladder )\u6642\u82e5\u5408\u4f75\u9aa8\u76c6\u9aa8\u6298\uff0c\u53ef\u4fdd\u5b88\u6cbb\u7642\u3002 (D)\u8180\u80f1\u8179\u819c\u5916\u7834\u88c2(extraperitoneal ruptures of the bladder )\u6642\u82e5\u5c0e\u5c3f\u7ba1\u7121\u6cd5\u9069\u7576\u5f15\u6d41\u5c3f\u6db2\u6642\uff0c\u9700\u8003\u616e\u624b\u8853\u6cbb\u7642\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc thyrotoxic hypokalemic periodic paralysis \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u814e\u6d41\u5931\u662f\u9020\u6210\u4f4e\u8840\u9240\u75c7\u7684\u539f\u56e0\u3002 (B)Spot urinary p otassium Uk+> 10 Eq/L\u3002 (C)Transtubular K+ gradient \u503c>3 mEq/L \u3002 (D)\u5c3f\u6db2\u4e2d\u9223/ \u78f7\u9178\u9e7d\u6bd4\u7387>1.7 \u5c0d\u6b64\u75be\u75c5\u8a3a\u65b7\u6709\u5f88\u9ad8\u7684\u654f\u611f\u6027\u548c\u7279\u7570\u6027\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6c23\u5598\u7684\u6cbb\u7642\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)Rapid -onset \u03b21 -adrenergic agonist \u662f\u6cbb\u7642\u652f\u6c23\u7ba1\u6536\u7e2e\u7684\u9996\u9078\u3002 (B)\u5230\u6025\u8a3a\u4e00\u5c0f\u6642\u5167\u7d66\u4e88\u985e\u56fa\u9187\uff0c\u6709\u53ef\u80fd\u6e1b\u5c11\u4f4f\u9662\u6a5f\u7387\u3002 (C)\u6025\u6027\u767c\u4f5c\u7de9\u89e3\u5f8c\uff0c\u51fa\u9662\u6642\u5118\u91cf\u6e1b\u5c11\u958b\u7acb\u5438\u5165\u578b\u985e\u56fa\u9187\u3002 (D)\u56b4\u91cd\u7684\u6c23\u5598\u53ef\u7d66\u4e88\u975c\u8108 MgSO 4\uff0c\u4f46\u4e0d\u5efa\u8b70\u4f7f\u7528\u84b8\u6c7d\u5438\u5165\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "1\u6b72\u534a\u7684\u7537\u7ae5\u89e3\u8840\u4fbf 3\u5929\u88ab\u5e36\u4f86\u6025\u8a3a\u5c31\u8a3a\u3002\u7537\u7ae5\u6c92\u6709\u767c\u71d2\u3001\u8179\u75db\u3001\u5614\u5410\u3001\u8179\u6c34\u3001\u95dc\u7bc0\u75db\u7b49\u75c7\u72c0\uff0c\u4ea6\u7121\u8840\u5c3f\uff0c\u62bd\u8840\u5305\u542b\u8840\u7d05\u7d20\u3001\u8840\u5c0f\u677f\u3001\u51dd\u8840\u529f\u80fd\u7686\u6b63\u5e38\u3002\u6b64\u7537\u7ae5 \u6700\u6709\u53ef\u80fd \u7684\u8a3a\u65b7\u70ba\u4f55\uff1f", + "Options": "(A)Intussusception \u3002 (B)Meckel\u2019s diverticulum \u3002 (C)Henoch -Sch\u00f6nlein purpura \u3002 (D)Hemolytic -uremic syndrome \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "16\u6b72\u9752\u5c11\u5e74\uff0c\u53c3\u52a0\u805a\u6703\u5f8c\uff0c\u773c\u795e\u5446\u6eef\uff0c\u7121\u6cd5\u5c0d\u8ac7\uff0c\u670b\u53cb\u4f9b\u7a31\u4f7f\u7528\u7b11\u6c23\u3002\u4e0b\u5217\u8655\u7f6e\u6216\u662f\u6aa2\u67e5\u6aa2\u9a57\uff0c\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u982d\u90e8\u6838\u78c1\u5171\u632f\u6aa2\u67e5\u53ef\u767c\u73fe\u7570\u5e38\u3002 (B)\u6ce8\u5c04 Vitamin B12 \u53ef\u6e1b\u7de9\u75c7\u72c0\u3002 (C)\u5c3f\u6db2\u7be9\u6aa2\u53ef\u78ba\u8a3a\u3002 (D)\u8840\u6db2\u6aa2\u67e5\u53ef\u78ba\u8a3a\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u95dc\u65bc Guillain -Barre' syndrome \u7684\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u795e\u7d93\u5b78\u6aa2\u67e5\u53ef\u767c\u73fe\u6df1\u808c\u8171\u53cd\u5c04\u589e\u5f37\u4ee5\u53ca\u8f15\u5fae\u611f\u89ba\u7570\u5e38\u3002 (B)\u53ef\u80fd\u5728\u75c5\u6bd2\u6216\u7d30\u83cc\u611f\u67d3\u4e4b\u5f8c\u767c\u751f\uff0c\u901a\u5e38\u5f9e\u4e0b\u80a2\u958b\u59cb\u5f80\u4e0a\u9032\u5c55\u3002 (C)\u4e3b\u8981\u78ba\u8a3a\u65b9\u6cd5\u70ba\u8170\u690e\u7a7f\u523a\u6aa2\u67e5\u3002 (D)\u985e\u56fa\u9187\u6cbb\u7642\u53ef\u4ee5\u7e2e\u77ed\u75c7\u72c0\u6062\u5fa9\u7684\u6642\u9593\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u5927\u91cf\u670d\u7528\u4e0b\u5217\u4f55\u7a2e\u7dad\u4ed6\u547d\u6642 \u6bd4\u8f03\u9700\u8981 \u64d4\u5fc3\u6703\u6709\u6bd2\u6027\uff1f", + "Options": "(A)\u7dad\u4ed6\u547d B1\u3002 (B)\u7dad\u4ed6\u547d B2\u3002 (C)\u7dad\u4ed6\u547d B3\u3002 (D)\u7dad\u4ed6\u547d B12\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u7b2c\u516b\u51dd\u8840\u56e0\u5b50\u7f3a\u4e4f\u7684\u8840\u53cb\u75c5\u75c5\u4eba\uff0c\u56e0\u7a81\u767c\u6027\u5de6\u9ad6\u95dc\u7bc0\u75bc\u75db\u53ca\u5de6\u8173\u9ebb\u6728\u4f86\u8a3a\uff0c\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\uff0c\u7121\u767c\u71d2\uff0c\u8acb\u554f\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5354\u52a9\u75c5\u4eba\u5c07\u5de6\u5927\u817f\u4f38\u76f4\uff0c\u75c5\u4eba\u75bc\u75db\u75c7\u72c0\u61c9\u53ef\u6539\u5584\u3002 (B)\u8d85\u97f3\u6ce2\u6aa2\u67e5\u767c\u73fe\u9ad6\u95dc\u7bc0\u7121\u7a4d\u6db2\u7684\u73fe\u8c61\uff0c\u5247\u7121\u9808\u8003\u616e\u51dd\u8840\u56e0\u5b50\u88dc\u5145\u3002 (C)\u82e5\u767c\u751f\u4f11\u514b\u72c0\u6cc1\uff0c\u9808\u8003\u616e\u5f8c\u8179\u8154\u51fa\u8840\u3002 (D)\u4f11\u514b\u6642\u5efa\u8b70\u7acb\u5373\u5efa\u7acb\u4e2d\u592e\u975c\u8108\u7ba1\u8def\u7d66\u4e88\u51dd\u8840\u56e0\u5b50\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u5c0f\u5152\u6d88\u5316\u9053\u7570\u7269\u8655\u7f6e\u539f\u5247\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u541e\u98df\u76f4\u5f91 1.5\u516c\u5206\u9215\u6263\u96fb\u6c60\uff0c\u8179\u90e8 X\u5149\u767c\u73fe\u5728\u80c3\u5167\uff0c\u9700\u7dca\u6025\u5b89\u6392\u4e0a\u6d88\u5316\u9053\u5167\u8996\u93e1\u6aa2\u67e5\u3002 (B)\u541e\u98df\u5927\u7d04 3\u516c\u5206\u7e2b\u91dd\uff0c\u8179\u90e8 X\u5149\u4f4d\u65bc\u5c0f\u8178\uff0c\u82e5\u7121\u75c7\u72c0\uff0c\u9700\u8981\u7cfb\u5217\u8ffd\u8e64X\u5149\uff0c\u89c0\u5bdf\u81e8\u5e8a\u75c7\u72c0\u53ca\u662f\u5426\u6392\u51fa\u3002 (C)\u541e\u98df\u53f0\u5e63 50\u5143\u9322\u5e63(\u76f4\u5f91 2.8\u516c\u5206) \uff0c\u4e0d\u6613\u901a\u904e\u5e7d\u9580\uff0c\u9700\u5118\u65e9\u5167\u8996\u93e1\u53d6\u51fa\u3002 (D)\u541e\u98df\u591a\u584a\u78c1\u9435\u61c9\u5118\u65e9\u5167\u8996\u93e1\u6aa2\u67e5\u53ca\u6703\u8a3a\u5c0f\u5152\u5916\u79d1\u91ab\u5e2b\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u7206\u70b8\u50b7\u53ca\u58d3\u7838\u50b7( blast and c rush injury )\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u539f\u767c\u6027\u7206\u70b8\u50b7 (primary blast injury )\u6700\u5e38\u898b\u7684\u6b7b\u56e0\u70ba\u80ba\u90e8\u7684\u58d3\u529b\u640d\u50b7(barotrauma )\u3002 (B)\u65b7\u80a2\u8655(exsanguination)\u9020\u6210\u7684\u50b7\u53e3\u51fa\u8840\uff0c\u53ef\u52a0\u58d3\u6b62\u8840\uff0c\u4f46\u4e0d\u5efa\u8b70\u6b62\u8840\u5e36\u4f7f\u7528\u3002 (C)\u8154\u5ba4\u75c7\u5019\u7fa4 (compartment syndrome )\u7684 5P\u75c7\u72c0\u4e4b\u4e2d\uff0c\u6700\u5e38\u898b\u7684\u662f\u9ebb\u6728(pare sthesia)\u3002 (D)\u58d3\u7838\u75c7\u5019\u7fa4 (crush syndrome )\u53ef\u80fd\u7522\u751f\u9ad8\u8840\u9240\u548c\u9ad8\u8840\u9223\uff0c\u9032\u4e00\u6b65\u53ef\u80fd\u7522\u751f\u5fc3\u8df3\u505c\u6b62\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "28\u6b72\u611b\u6ecb\u75c5\u4eba\uff0c\u534a\u5e74\u672a\u898f\u5247\u8ffd\u8e64\u670d\u85e5\uff0c\u56e0\u767c\u71d2\u3001\u547c\u5438\u6025\u4fc3\u88ab\u9001\u4f86\u6025\u8a3a\u3002\u5230\u9054\u6025\u8a3a\u6642\u610f\u8b58\u6e05\u695a\uff0c\u8840\u58d3 107/73 mmHg\uff0c\u547c\u5438 32\u6b21/min\uff0c\u5fc3\u8df3 120\u6b21/min\uff0cSpO 2 85%\uff0cCXR\u6709pulmonary consolidation \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u61c9\u8003\u616e\u662f\u80ba\u7d50\u6838\uff0c\u53ef\u5c07\u75c5\u4eba\u5148\u884c\u7f6e\u65bc\u9694\u96e2\u5ba4\u3002 (B)\u91dd\u5c0d\u6700\u5e38\u898b\u7684\u81f4\u75c5\u83cc\u53ef\u7d66\u4e88 \u03b2-lactam antibiotics \u52a0\u4e0a Macrolides \u3002 (C)\u6aa2\u6e2c CD4 count s\u53ef\u5e6b\u52a9\u81f4\u75c5\u539f\u63a8\u65b7\u3002 (D)\u6700\u5e38\u898b\u7684\u81f4\u75c5\u83cc\u70ba Pneumocystis jirovecii \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u773c\u79d1\u8d85\u97f3\u6ce2\u65bc\u6025\u8a3a\u7684\u61c9\u7528\u3001\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u61c9\u4f7f\u7528\u4f4e\u80fd\u91cf\u8d85\u97f3\u6ce2\u3002 (B)\u53ef\u4ee5\u5f9e\u773c\u7403\u8d85\u97f3\u6ce2\u5224\u65b7\u9871\u5167\u58d3\u5347\u9ad8\u3002 (C)\u8d85\u97f3\u6ce2\u53ef\u4ee5\u5354\u52a9\u8a3a\u65b7\u73bb\u7483\u9ad4\u51fa\u8840\u3002 (D)\u61f7\u7591\u773c\u7403\u7834\u88c2\u61c9\u4f7f\u7528\u8d85\u97f3\u6ce2\u78ba\u8a3a\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6210\u4eba\u5fc3\u8df3\u4f11\u6b62\u7684\u6025\u6551\u4e2d\uff0c\u6301\u7e8c\u51fa\u73fe\u300c\u7a84\u578b QRS\u8907\u5408\u6ce2\u7684\u7121\u8108\u640f\u96fb\u6c23\u6d3b\u52d5 (narrow -QRS complex PEA )\u300d \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u901a\u5e38\u4ee3\u8868\u5faa\u74b0\u51fa\u73fe\u4ee3\u8b1d\u6027\u7684\u969c\u7919( metabolic causes )\u3002 (B)\u5e38\u898b\u7684\u539f\u56e0\u5305\u62ec\u9ad8\u8840\u9240\u3001\u9178\u8840\u75c7\u6216\u9209\u96e2\u5b50\u901a\u9053\u963b\u65b7\u5291\u4e2d\u6bd2\u3002 (C)\u82e5\u4ee5\u8d85\u97f3\u6ce2\u6aa2\u67e5\u5fc3\u81df\uff0c\u5e38\u5e38\u6703\u767c\u73fe\u904e\u52d5\u6027(hyperdynamic )\u7684\u5de6\u5fc3\u5ba4\u3002 (D)\u76f8\u8f03\u65bc\u5bec\u578b QRS\u8907\u5408\u6ce2\u7684\u7121\u8108\u640f\u96fb\u6c23\u6d3b\u52d5(wide -QRS complex PEA)\uff0c\u8d85\u97f3\u6ce2\u6aa2\u67e5\u5728\u6b64\u985e\u75c5\u4eba\u6bd4\u8f03\u7121\u6cd5\u627e\u51fa\u75c5\u56e0\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u526f\u776a\u708e( epididymitis )\u6216\u776a\u4e38\u708e( orchitis)\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u5728\u5e74\u9577\u7684\u7537\u6027\uff0c\u526f\u776a\u708e\u5e38\u6e90\u81ea\u6ccc\u5c3f\u9053\u611f\u67d3\u7684\u81f4\u75c5\u83cc\u3002 (B)\u5c3f\u6db2\u5206\u6790\u82e5\u6c92\u6709\u81bf\u5c3f\uff0c\u5247\u53ef\u4ee5\u6392\u9664\u526f\u776a\u708e\u6216\u776a\u4e38\u708e\u3002 (C)\u55ae\u7368\u7684\u776a\u4e38\u708e\u975e\u5e38\u7f55\u898b\uff0c\u901a\u5e38\u8207\u5176\u4ed6\u5168\u8eab\u6027\u611f\u67d3\u4f8b\u5982\u816e\u817a\u708e\u6216\u5176\u4ed6\u75c5\u6bd2\u6027\u75be\u75c5\u4e00\u8d77\u51fa\u73fe\u3002 (D)\u5c0d\u65bc\u6027\u751f\u6d3b\u6d3b\u8e8d\u7684\u7537\u6027\uff0c\u6297\u751f\u7d20\u8981\u5305\u542b Gonorrhea \u548cChlamydia \u7684\u6cbb\u7642\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u61f7\u5b55 32\u9031\u5b55\u5a66 HELLP\u75c7\u5019\u7fa4\u4e4b\u63cf\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u7d93\u7522\u5a66\u8f03\u521d\u7522\u5a66\u5e38\u898b\u6b64\u75c7\u5019\u7fa4\u3002 (B)\u9ad8\u5291\u91cf Labetalol \u53ef\u80fd\u9020\u6210\u65b0\u751f\u5152\u9ad8\u8840\u7cd6\u3002 (C)\u814e\u81df\u529f\u80fd\u53ef\u80fd\u6b63\u5e38\u3002 (D)\u7d66\u4e88\u985e\u56fa\u9187\u6cbb\u7642\u53ef\u6539\u5584\u80ce\u5152\u9810\u5f8c\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc acute pancreatitis \u7684\u5be6\u9a57\u5ba4\u6aa2\u67e5\u53ca\u8a3a\u65b7\u5de5\u5177\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)Lipase \u5c0d\u65bc\u9152\u7cbe\u6027 pancreatitis \u6bd4amylase\u66f4\u6709\u654f\u611f\u6027\u3002 (B)Amylase \u5728\u75c7\u72c0\u767c\u4f5c\u6578\u5c0f\u6642\u5167\u958b\u59cb\u4e0a\u5347\uff0c48 \u5c0f\u6642\u5167\u9054\u5230\u9ad8\u5cf0\u3002 (C)\u5df2\u6709\u660e\u986f acute pancreatitis \u7684\u75c7\u72c0\u548c\u5be6\u9a57\u5ba4\u6aa2\u67e5\u5831\u544a\uff0c\u9700\u8981\u65e9\u671f\u5b89\u6392\u8179\u90e8\u96fb\u8166\u65b7\u5c64\u8a55\u4f30\u75be\u75c5\u56b4\u91cd\u5ea6\u3002 (D)ALT \u572848\u5c0f\u6642\u5167\u5927\u65bc 150 U/L\uff0c\u6709\u5927\u65bc 85\uff05\u7684\u967d\u6027\u9810\u6e2c\u7387\u662fgallstone pancreatitis\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc Acute coronary syndrome \u4e4b\u63cf\u8ff0\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u5fc3\u96fb\u5716\u5448\u73fe LBBB\uff0c\u4f9d Sgarbossa criteria \u6709V1-V3 discordant ST elevation>5 mm\u5c31\u53ef\u8a3a\u65b7 STEMI equivalent \u3002 (B)\u61c9\u8a72\u7d66\u4e88\u2265 162 mg\u7684Aspirin\uff0c\u82e5\u75c5\u4eba\u6c92\u7528\u904e Aspirin\uff0c\u5247\u9700\u7d66\u4e88325mg\u3002 (C)\u9700\u4f7f\u7528 IV NTG\u6642\uff0c\u82e5\u80f8\u75db\u75c7\u72c0\u6709\u7de9\u89e3\uff0c\u8981\u4f9d\u8840\u58d3\u7684\u9ad8\u4f4e\u53bb\u505a\u5291\u91cf\u7684\u8abf\u6574\u3002 (D)STEMI/NSTEMI \u75c5\u4eba\u7121\u7981\u5fcc\u75c7\u53ef\u8003\u616e\u5728 24\u5c0f\u6642\u5167\u7d66\u4e88\u53e3\u670d \u03b2-blocker\u85e5\u7269\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u7db2\u8def\u5df2\u662f\u751f\u6d3b\u7684\u4e00\u90e8\u5206\uff0c\u4e0b\u5217\u4f55\u8005\u5c0d\u65bc\u75c5\u4eba\u96b1\u79c1\u53ca\u91ab\u7642\u4fe1\u8cf4(confidentiality )\u7684\u50b7\u5bb3\u6700\u5927\uff1f", + "Options": "(A)\u6a5f\u8eca\u9a0e\u58eb\u906d\u5361\u8eca\u8f3e\u904e\uff0c\u5c07\u8179\u90e8\u58d3\u75d5\u7528\u500b\u4eba\u624b\u6a5f\u7167\u76f8\u4e26\u540c\u6b65\u5165\u500b\u4eba\u96f2\u7aef\u786c\u789f\uff0c\u4ee5\u4f9b\u65e5\u5f8c\u6559\u5b78\u4e4b\u7528\u3002 (B)\u5c07\u72e9\u7375\u906d\u7bad\u8aa4\u5c04\u982d\u90e8\u50b7\u60a3\u7684\u7167\u7247\u8cbc\u81c9\u66f8\u4e26\u516c\u958b\u5206\u4eab\uff0c\u63d0\u9192\u5927\u5bb6\u6ce8\u610f\u5b89\u5168\u8207\u6025\u6551\u91cd\u9ede\u3002 (C)\u67d0\u7db2\u7d05\u4f7f\u7528\u624b\u6a5f\u76f4\u64ad\u81ea\u5df1\u6025\u8a3a\u5c31\u91ab\uff0c\u7acb\u523b\u63d0\u9192\u7d55\u5c0d\u4e0d\u53ef\u4ee5\u7167\u5230\u5176\u4ed6\u75c5\u4eba\u3001\u5bb6\u5c6c\u8207\u5de5\u4f5c\u4eba\u54e1\u3002 (D)\u9047\u5230\u7591\u96e3\u96dc\u75c7\uff0c\u5373\u6642\u5c07\u4e0d\u542b\u500b\u8cc7\u7684\u6587\u5b57\u8207\u5f71\u50cf\u8cc7\u6599\u8cbc\u5230\u5c08\u696d\u7fa4\u7d44\uff0c\u5c0b\u6c42\u5176\u4ed6\u5c08\u696d\u4eba\u54e1\u610f\u898b\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6f01\u5de5 4\u5929\u524d\u88ab\u8239\u677f\u5272\u50b7\uff0c\u6628\u5929\u958b\u59cb\u5f35\u5634\u56f0\u96e3\uff0c\u4eca\u65e5\u56e0\u81c9\u90e8\u75d9\u7b11( risus sardonicus )\u8179\u90e8\u50f5\u786c\u53ca\u808c\u8089\u75d9\u6523\u524d\u4f86\u5c31\u8a3a\uff0c\u610f\u8b58\u6e05\u695a\uff0c\u6709\u95dc\u6b64\u75be\u75c5\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u6b7b\u4ea1\u7387\u7d04 4\u6210\uff0c\u70ba\u9769\u862d\u6c0f\u9670\u6027\u687f\u83cc\u611f\u67d3\uff0c\u53ef\u4f7f\u7528 ceftriaxone \u6cbb\u7642\u3002 (B)\u6f5b\u4f0f\u671f\u53ef\u4ee5\u77ed\u65bc\u4e00\u5929\u4e5f\u53ef\u4ee5\u8d85\u904e\u4e00\u500b\u6708\uff0c\u6f5b\u4f0f\u671f\u8d8a\u9577\u7684\u75c5\u4eba \u9810\u5f8c\u8d8a\u5dee\u3002 (C)\u53ef\u8003\u616e\u5728\u65bd\u6253\u514d\u75ab\u7403\u86cb\u767d\u524d\u9032\u884c\u50b7\u53e3\u6e05\u5275\uff0c\u6210\u4eba\u514d\u75ab\u7403\u86cb\u767d\u5291\u91cf\u70ba250 unit IM \u6ce8\u5c04\u3002 (D)\u7167\u8b77\u6642\u6e1b\u5c11\u74b0\u5883\u523a\u6fc0\uff0c\u82e5\u547c\u5438\u8870\u7aed\u6642\u53ef\u4f7f\u7528 succinylcholine \u5354\u52a9\u63d2\u7ba1\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u7d30\u83cc\u6027\u8166\u819c\u708e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u672a\u4f5c\u5b8c\u8170\u690e\u7a7f\u523a\u4e0d\u61c9\u7d66\u4e88\u6297\u751f\u7d20\u3002 (B)\u82e5\u61f7\u7591 pneumococcal meningitis \uff0c\u5efa\u8b70\u7d66\u4e88 Dexamethasone \u3002 (C)\u8166\u810a\u9ad3\u6db2\u5206\u6790\u5e38\u898b opening pressure \u9ad8\u3001\u767d\u8840\u7403\u4e0a\u5347\u3001\u9ad8\u8840\u7cd6\u3002 (D)\u7d93\u9a57\u6027\u6297\u751f\u7d20\u53ef\u4f7f\u7528 Ceftriaxone \u548cLevofloxacin\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u75c5\u4eba\u7684\u884c\u70ba\u75c7\u72c0\u6558\u8ff0\u4f55\u8005\u8f03\u7b26\u5408 functional (psychiatric )psychosis \uff1f", + "Options": "(A)\u5076\u6709\u5e7b\u8996\uff0c\u55dc\u7761\uff0c\u5e38\u5e38\u4e0d\u77e5\u9053\u6642\u9593\uff0c\u5730\u9ede\u4e5f\u4e0d\u8a8d\u8b58\u4eba\u3002 (B)\u7a81\u7136\u51fa\u73fe\u7684\u610f\u8b58\u6a21\u7cca\uff0c\u7121\u6cd5\u8aaa\u8a71\uff0c\u53ea\u80fd\u767c\u51fa\u8072\u97f3\uff0c\u624b\u8173\u7121\u529b\u3002 (C)\u7121\u6cd5\u505a\u7c21\u55ae\u7684\u8a08\u7b97\uff0c\u8fd1\u671f\u8a18\u61b6\u5dee\uff0c\u4f46\u9060\u671f\u8a18\u61b6\u9084\u597d\uff0c\u7121\u6cd5\u81ea\u5df1\u9032\u98df\u3002 (D)\u5984\u60f3\uff0c\u8868\u60c5\u5e73\u6de1\uff0c\u8a9e\u7121\u502b\u6b21\uff0c\u5e7b\u807d\uff0c\u5076\u800c\u7dad\u6301\u50f5\u76f4\u59ff\u52e2\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u7591\u4f3c\u80ba\u6813\u585e\u75c5\u4eba\uff0c\u4e0b\u5217\u72c0\u6cc1 \u6700\u53ef\u80fd\u6703\u9020\u6210 D-dimer\u6aa2\u9a57\u6578\u503c\u507d\u9670\u6027 \u8868\u73fe\uff1f", + "Options": "(A)\u61f7\u5b55\u3002 (B)\u9ad8\u8102\u8840\u75c7\u3002 (C)\u985e\u98a8\u6fd5\u6027\u95dc\u7bc0\u708e\u3002 (D)\u4e09\u5929\u524d\u63a5\u53d7\u904e\u62bd\u8102\u9686\u4e73\u624b\u8853\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u95dc\u65bc\u6d41\u884c\u6027\u611f\u5192\u7684\u6558\u8ff0\uff0c\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)Amantadine \u56e0\u6297\u85e5\u6027\u56b4\u91cd\uff0c\u5df2\u4e0d\u5efa\u8b70\u4f7f\u7528\u65bc\u6cbb\u7642\u6d41\u611f\u3002 (B)Zanamivir (Relenza\u00ae)\u56e0\u662f\u5438\u5165\u5291\u578b\uff0c\u4e0d\u9069\u7528\u65bc\u814e\u81df\u529f\u80fd\u4e0d\u826f\u75c5\u4eba\u3002 (C)\u75c5\u4eba\u82e5\u5408\u4f75\u80ba\u708e\u9700\u4f4f\u9662\u6cbb\u7642\uff0c\u61c9\u7acb\u5373\u901a\u5831\u7b2c\u56db\u985e\u50b3\u67d3\u75c5- \u6d41\u611f\u4f75\u767c\u91cd\u75c7\u3002 (D)\u91cd\u75c7\u75c5\u4eba\u7684\u5bc6\u5207\u63a5\u89f8\u5bb6\u5c6c\uff0c\u4f9d\u6700\u65b0\u898f\u5b9a\u53ef\u4ee5\u76f4\u63a5\u6295\u4e88\u516c\u8cbb\u9810\u9632\u6027\u6297\u6d41\u611f\u85e5\u7269\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5e74\u9f61\u5927\u65bc 85\u6b72\u7684\u75c5\u4eba\u767c\u751f\u5fc3\u808c\u6897\u585e\uff0c\u4e0b\u5217\u75c7\u72c0\u4f55\u8005 \u8f03\u5e38\u898b\uff1f", + "Options": "(A)\u80f8\u75db\u3002 (B)\u547c\u5438\u56f0\u96e3\u3002 (C)\u660f\u53a5\u3002 (D)\u610f\u8b58\u6539\u8b8a\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6025\u6027\u8e81\u52d5( agitation)\u7684\u93ae\u975c\u85e5\u7269\u63cf\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)Benzodiazepines \u85e5\u7269\u6703\u9020\u6210\u5fc3\u96fb\u5716\u8b8a\u5316\u5982 QTc prolongation\u3002 (B)\u7b2c\u4e00\u4ee3\u6297\u7cbe\u795e\u75c5\u85e5\u7269\u5982 Haloperidol \u4e0d\u6703\u5f15\u8d77\u547c\u5438\u6291\u5236\u3002 (C)\u7b2c\u4e8c\u4ee3\u6297\u7cbe\u795e\u75c5\u85e5\u7269\u5982 Quetiapine \u4e0d\u6703\u9020\u6210\u5fc3\u96fb\u5716\u8b8a\u5316\u5982 QTc prolongation\u3002 (D)\u7b2c\u4e8c\u4ee3\u6297\u7cbe\u795e\u75c5\u85e5\u7269\u5982 Risperidone \u4e0d\u6703\u5f15\u8d77\u9310\u9ad4\u5916\u75c7\u5019\u7fa4\u75c7\u72c0(extrapyramidal symptoms )\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "18\u6b72\u5973\u6027\uff0c\u9ad4\u91cd 45\u516c\u65a4\uff0c\u670d\u7528 30\u9846Acetaminophen (500 mg/\u9846)\u81ea\u6bba\uff0c4\u5c0f\u6642\u5f8c\u88ab\u9001\u81f3\u6025\u8a3a\uff0c\u4e3b\u8a34\u5641\u5fc3\u4e14\u4e0a\u8179\u75bc\u75db\uff0c\u610f\u8b58\u6e05\u9192\uff0c\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\u3002\u62bd\u8840\u6aa2\u67e5\u767c\u73fe GPT 28 IU/L \uff0cGOT 32 IU/L\uff0c T-Bil 0.8 mg/dL \uff0c\u8840\u4e2dAcetaminophen \u6fc3\u5ea6\u70ba 250 mg/L \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)24 \u5c0f\u6642\u4e4b\u5f8c\u809d\u6307\u6578\u4ecd\u6b63\u5e38\uff0c\u8868\u793a\u4e2d\u6bd2\u7a0b\u5ea6\u4e26\u4e0d\u56b4\u91cd\uff0c\u53ef\u8fd4\u5bb6\u89c0\u5bdf\u3002 (B)5\u5929\u5f8c\u51fa\u73fe\u814e\u81df\u8870\u7aed\uff0c\u8f03\u4e0d\u53ef\u80fd\u662f Acetaminophen \u4e2d\u6bd2\u5f15\u8d77\uff0c\u61c9\u627e\u5c0b\u5176\u4ed6\u539f\u56e0\u3002 (C)\u958b\u59cb\u4f7f\u7528 N-acetylcysteine \u7684\u6cbb\u7642\uff0c\u4e26\u8fa6\u7406\u4f4f\u9662\u3002 (D)\u5b89\u6392\u75c5\u4eba\u4f4f\u9662\u89c0\u5bdf\uff0c\u53ef\u66ab\u4e0d\u7d66\u4e88 N-acetylcysteine \uff0c\u5bc6\u5207\u8ffd\u8e64\u809d\u6307\u6578\uff0c\u82e5\u6709\u5347\u9ad8\u518d\u7d66\u4e88\u89e3\u6bd2\u5291\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5927\u8166\u975c\u8108\u8840\u6813 (cerebral venous thrombosis )\u7684\u6558\u8ff0\uff0c\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u662f\u4e00\u7a2e\u7f55\u898b\u4e14\u5371\u96aa\u7684\u982d\u75db\u539f\u56e0\uff0c\u5e73\u5747\u767c\u75c5\u5e74\u9f61\u70ba 60\u6b72\u4ee5\u4e0a\u3002 (B)\u7537\u6027\u8f03\u5e38\u898b\uff0c\u5c24\u5176\u662f\u6700\u8fd1\u6709\u5916\u79d1\u624b\u8853\u53f2\u7684\u75c5\u4eba\u3002 (C)\u5927\u7d04 8\u6210\u6703\u767c\u5c55\u70ba\u8166\u51fa\u8840\u3002 (D)\u81e8\u5e8a\u8868\u73fe\u53ef\u80fd\u51fa\u73fe\u96f7\u64ca\u6027\u982d\u75db (thunderclap headache )\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u660f\u53a5( syncope) \uff0c\u4ee5\u4e0b\u4f55\u8005\u6558\u8ff0\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u9664\u5fc3\u81df\u8870\u7aed\u53ca\u5fc3\u5f8b\u4e0d\u6574\u4e4b\u5916\uff0c\u82e5\u75c5\u4eba\u65bc\u4ef0\u81e5\u6642\u6216\u7121\u524d\u9a45\u75c7\u72c0\u7684\u6688\u53a5\uff0c\u5247\u9700\u8003\u616e\u4f4f\u9662\u89c0\u5bdf\u3002 (B)\u9838\u52d5\u8108\u7ac7\u6309\u6469\u6aa2\u67e5\u6642\uff0c\u82e5\u75c7\u72c0\u88ab\u91cd\u73fe\u4e14\u5fc3\u96fb\u5716\u986f\u73fe asystole\u5927\u65bc 3\u79d2\uff0c\u5247\u53ef\u8a3a\u65b7\u9838\u52d5\u8108\u7ac7\u654f\u611f\u75c7\u3002 (C)\u5fc3\u96fb\u5716\u82e5\u6709\u5de6\u5206\u652f\u675f\u963b\u65b7\uff0c\u4e0d\u7ba1\u65b0\u6216\u820a\uff0c\u5176\u6b7b\u4ea1\u7387\u660e\u986f\u4e0a\u5347\u3002 (D)\u6700\u5e38\u898b\u7684\u539f\u56e0\u70ba\u5fc3\u56e0\u6027\u660f\u53a5\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5152\u7ae5\u7cd6\u5c3f\u75c5\u916e\u9178\u8840\u75c7( DKA)\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u6a19\u6e96\u8a3a\u65b7\u70ba\u8840\u6db2 pH\u503c\u5c0f\u65bc 7.3\uff0cBicarbonate \u5c0f\u65bc 15 mEq/L\uff0c\u8840\u7cd6\u5927\u65bc 250 mg/dL\u3001\u8840\u6db2\u6709\u916e\u9ad4\u3002 (B)\u82e5\u8840\u7cd6\u5927\u65bc 500mg/dL \uff0c\u80f0\u5cf6\u7d20\u6cbb\u7642\u53ef\u7d66\u4e88 loading bolus 0.1 unit/kg\u3002 (C)\u82e5\u8840\u6db2 pH\u503c7.1\u5408\u4f75\u8840\u884c\u52d5\u529b\u5b78\u4e0d\u7a69\u5b9a\uff0c\u53ef\u7d66\u4e88 Sodium bicarbonate 0.5- 2 mEq/kg\u3002 (D)\u5152\u7ae5\u7cd6\u5c3f\u75c5\u916e\u9178\u8840\u75c7 \u75c5\u4eba\u6b7b\u4ea1\u539f\u56e0\uff0c 60%\u4ee5\u4e0a\u8ddf\u5927\u8166\u6c34\u816b\u6709\u95dc\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "23\u6b72\u7537\u6027\u4e00\u9031\u524d\u81ea\u975e\u6d32\u8fd4\u56de\u53f0\u7063\u3002 \u4e3b\u8a34\u9ad8\u71d2 40.2\u2103\u3001\u986b\u6296\u3001\u5168\u8eab\u7121\u529b\u4ee5\u53ca\u8179\u75db\u3002\u5fc3\u8df3 122\u6b21/min\u3001\u547c\u5438 24\u6b21/min\u3002\u8eab\u4e0a\u6c92\u6709\u660e\u986f\u7d05\u75b9\uff0c\u4e5f\u6c92\u6709\u95dc\u7bc0\u75bc\u75db\u3002\u5be6\u9a57\u5ba4\u6aa2\u67e5\u767c\u73fe total bilirubin 4.9 mg/dL\u3001direct bilirubin 1.1 mg/dL\u3001ALT 247 U/L\u3001 AST 236 U/L \u3002\u8d85\u97f3\u6ce2\u6aa2\u67e5\u767c\u73fe\u809d\u81df\u816b\u5927\uff0c\u6c92\u6709\u81bd\u7d50\u77f3\u6216\u81bd\u7ba1\u64f4\u5927\uff0c\u4e5f\u6c92\u6709\u767c\u73fe\u809d\u81bf\u760d\u3002\u4e0b\u5217\u4f55\u8005\u6aa2\u67e5 \u6700\u6709\u52a9\u65bc\u8a3a\u65b7\uff1f", + "Options": "(A)\u8840\u6db2\u62b9\u7247( blood smear )\u3002 (B)\u809d\u708e\u6a19\u8a18(hepatitis markers )\u3002 (C)\u9264\u7aef\u87ba\u65cb\u9ad4\u986f\u5fae\u51dd\u96c6\u6e2c\u8a66(Leptospiral microscopic agglutination test)\u3002 (D)\u7cde\u4fbf\u6aa2\u67e5\u5bc4\u751f\u87f2\u53ca\u87f2\u5375\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u9838\u90e8\u75c5\u7076\u5e38\u6709\u80a9\u90e8\u8f49\u79fb\u75db\uff0e\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u80f8\u5ed3\u51fa\u53e3\u75c7\u5019\u7fa4 (Thoracic outlet syndrome )\u4ee5\u5973\u6027\u5c45\u591a\uff0c\u5e38\u56e0\u58d3\u8feb\u81c2\u795e\u7d93\u53e2\u4ee5\u53ca\u8840\u7ba1\u9020\u6210\u3002 (B)\u6f58\u8003\u6c0f\u816b\u7624 (Pancoast\u2019s tumor )\u9664\u6703\u9020\u6210\u80a9\u8180\u75bc\u75db\u4ee5\u5916\uff0c\u9084\u6709\u53ef\u80fd\u56e0\u6b64\u9020\u6210\u970d\u7d0d\u6c0f\u75c7\u5019\u7fa4(Horner syndrome )\uff0c\u75c7\u72c0\u70ba\u55ae\u5074\u7e2e\u77b3\uff0c\u5782\u77bc\u4ee5\u53ca\u6d41\u6c57\u3002 (C)\u81c2\u53e2\u795e\u7d93\u708e (Brachial plexus neuritis )\u4ee5\u7121\u529b\u5c45\u591a\uff0c\u5927\u90e8\u5206\u4e0d\u6703\u4f34\u96a8\u75bc\u75db\u3002 (D)C3 -C4\u690e\u9593\u76e4\u7a81\u51fa\u9020\u6210\u7684\u9838\u690e\u58d3\u8feb\u75c7\u72c0\u6703\u548c\u65cb\u8f49\u808c\u6495\u88c2\u50b7 (rotator cuff tear)\u985e\u4f3c\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "79\u6b72\u5973\u6027\u75c5\u4eba\u88ab\u5bb6\u5c6c\u5e36\u4f86\u6025\u8a3a\uff0c\u4e3b\u8a34\u6700\u8fd1\u4e09\u5929\u6bd4\u8f03\u55dc\u7761\uff0c\u4f46\u6709\u6642\u53c8\u53ef\u4ee5\u6e05\u9192\u8868\u73fe\u6b63\u5e38\u3002\u9019\u4e00\u500b\u6708\u4f86\u6c92\u6709\u767c\u71d2\u6216\u662f\u982d\u90e8\u5916\u50b7\uff0c\u548c\u75c5\u4eba\u8ac7\u8a71\u6642\u9700\u7528\u529b\u6416\u9192\u75c5\u4eba\u3002\u91dd\u5c0d\u6b64\u75c5\u4eba\uff0c\u4ee5\u4e0b\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u611f\u67d3\u53ef\u4ee5\u9020\u6210\u4e0a\u8ff0\u60c5\u6cc1\uff0c\u5176\u4e2d\u6700\u5e38\u898b\u7684\u611f\u67d3\u4f86\u6e90\u662f\u8166\u819c\u708e\u3002 (B)\u5c3f\u6eef\u7559\u53ef\u80fd\u52a9\u9577\u6216\u9020\u6210\u4e0a\u8ff0\u60c5\u6cc1\u3002 (C)\u5982\u679c\u75c5\u4eba\u6709\u8e81\u52d5\u8868\u73fe\uff0c\u9996\u9078\u7684\u85e5\u7269\u662f anti-histamine \u985e\u85e5\u7269\u3002 (D)\u907f\u514d\u75c5\u4eba\u4f7f\u7528\u52a9\u807d\u5668\uff0c\u4ee5\u514d\u904e\u591a\u523a\u6fc0\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "4\u500b\u6708\u5927\u7537\u5b30\uff0c\u6628\u65e5\u98df\u7528\u542b\u8702\u871c\u526f\u98df\u54c1\u5f8c\uff0c\u9678\u7e8c\u51fa\u73fe\u4fbf\u79d8\u3001\u98df\u617e\u5dee\u7b49\u75c7\u72c0\uff0c\u65bc\u6025\u8a3a\u5c31\u8a3a\u6642\u767c\u73fe\u80a2\u9ad4\u7121\u529b\u53ca\u9ad4\u6eab 38.3\u2103\uff0c\u8eab\u9ad4\u8a3a\u5bdf\u767c\u73fe\u77b3\u5b54\u64f4\u5f35\u4e14\u5c0d\u5149\u53cd\u5c04\u6c92\u6709\u53cd\u61c9\uff0c\u95dc\u65bc\u6b64\u7537\u7ae5\u53ef\u80fd\u7684\u75be\u75c5\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u6700\u5f8c\u53d7\u5230\u5f71\u97ff\u7684\uff0c\u662f\u9871\u795e\u7d93\u6240\u652f\u914d\u7684\u808c\u8089\u3002 (B)\u53ef\u80fd\u51fa\u73fe\u5641\u5fc3\uff0c\u5614\u5410\uff0c\u8179\u90e8\u7d5e\u75db\u548c\u8179\u7009\u6216\u4fbf\u79d8\uff0c\u5f88\u5bb9\u6613\u88ab\u8aa4\u8a3a\u70ba\u6025\u6027\u80c3\u8178\u708e\u3002 (C)\u53ef\u80fd\u51fa\u73fe\u64ec\u4ea4\u611f\u795e\u7d93\u4f5c\u7528\u75c7\u72c0 (sympathomimetic symptoms) \u3002 (D)\u5178\u578b\u500b\u6848\u6703\u51fa\u73fe\u5c0d\u7a31\u6027\u4e0a\u884c\u5f0f\u9ebb\u75fa\uff0c\u4e14\u4e0d\u6703\u6709\u611f\u89ba\u7f3a\u5931\u53ca\u75bc\u75db\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "50\u6b72\u7537\u6027\u56e0\u5de6\u4e0a\u8179\u90e8\u7a81\u767c\u75bc\u75db\uff0c\u5408\u4f75\u5614\u5410\u81f3\u6025\u8a3a\u6c42\u8a3a\u3002\u904e\u53bb\u75c5\u53f2\u6709\u6a6b\u8188\u819c\u759d\u6c23\u53ca\u80c3\u98df\u9053\u9006\u6d41\u3002\u8840\u58d3 86/40 mmHg \u3001\u5fc3\u8df3 121\u6b21/min\u3001\u9ad4\u6eab 37\u2103\u3001\u547c\u543820\u6b21/min\u3001SpO 2 98%\u3002\u8eab\u9ad4\u8a3a\u5bdf\u4e3b\u8981\u7570\u5e38\u70ba\u4e0a\u8179\u8139\u75db\uff0c\u53e9\u8a3a\u70ba\u9f13\u97f3(tympanic ) \uff0c\u4e14\u5de6\u4e0b\u80ba\u547c\u5438\u97f3\u6e1b\u5c11\u3002\u5be6\u9a57\u5ba4\u5831\u544a\u767c\u73fe lactate 28 mg/dL\u3001pH 7.13\u3001 HCO 3 -8.1 m Eq/L\u3001Hb 12 g/dL\u3002\u80f8\u90e8 X\u5149\u767c\u73fe\u80c3\u8139\u5927\uff0c\u4e14\u4f4d\u5728\u6a6b\u8188\u819c\u4ee5\u4e0a\u3002\u9664\u4e86\u9069\u7576\u7684\u8f38\u6db2\u6cbb\u7642\u4e4b\u5916\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u6703\u8a3a\u5916\u79d1\u958b\u5200\u6cbb\u7642\u3002 (B)\u5b89\u6392\u80c3\u93e1\u3002 (C)\u8f38\u7d05\u8840\u7403\u6fc3\u7e2e\u6db2(P RBC s)\u3002 (D)\u975c\u8108\u6ce8\u5c04 Sodium bicarbonate \u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u798f\u5c3c\u723e\u5f0f\u58de\u75bd( Fournier\u2019s gangrene )\u70ba\u4e00\u7a2e\u767c\u751f\u65bc\u6703\u9670\u90e8\u4f4d\u4e4b\u58de\u6b7b\u6027\u7b4b\u819c\u708e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5973\u6027\u767c\u751f\u6a5f\u7387\u6bd4\u7537\u6027\u9ad8\u3002 (B)\u624b\u8853\u524d\u53ca\u624b\u8853\u5f8c\u65bd\u4e88\u9ad8\u58d3\u6c27\u7684\u6cbb\u7642\uff0c\u53ef\u4ee5\u6539\u5584\u75c5\u4eba\u7684\u6b7b\u4ea1\u7387\u3002 (C)\u7d04 40%\u7684\u75c5\u4eba\u4e00\u958b\u59cb\u9664\u4e86\u75bc\u75db\u4e4b\u5916\uff0c\u7121\u660e\u986f\u7d05\u816b\u7684\u5c40\u90e8\u75c7\u72c0\u3002 (D)\u5371\u96aa\u56e0\u5b50\u5305\u542b\u9152\u7cbe\u6feb\u7528\u53ca\u5371\u96aa\u7684\u6027\u884c\u70ba\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "58\u6b72\u7537\u6027\uff0c 2\u5c0f\u6642\u524d\u958b\u59cb\u547c\u5438\u56f0\u96e3\uff0c SpO 2 86%\uff0c\u547c\u5438 35\u6b21/min\uff0c\u8840\u58d3108/76 mmHg \uff0c\u5fc3\u8df3 122\u6b21/min\u3002\u75c5\u6cc1\u60e1\u5316\uff0c\u63a5\u53d7\u6c23\u7ba1\u63d2\u7ba1\u3002\u4e0b\u5217\u654d\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u547c\u5438\u5668\u6a21\u5f0f\u8981\u7528\u5bb9\u7a4d\u5c0e\u5411\u6a21\u5f0f(volume -targeted mode ) \uff0c\u56e0\u70ba\u58d3\u529b\u5c0e\u5411\u6a21\u5f0f(pressure -targeted mode )\u8f03\u6613\u9020\u6210\u50b7\u5bb3\u3002 (B)\u5728\u7d66\u4e88 100%\u6c27\u6c23\u6642\u75c5\u4eba\u8840\u6c27\u5206\u6790 PaO 2 96 mmHg\uff0c\u4f9d\u64da\u6025\u6027\u547c\u5438\u7a98\u8feb\u5fb5\u5019\u7fa4\u5b9a\u7fa9\uff0c\u8a72\u75c5\u4eba\u61c9\u70ba\u4e2d\u5ea6\u7b49\u7d1a\u7684\u547c\u5438\u7a98\u8feb\u3002 (C)\u7576\u75c5\u4eba\u4f7f\u7528\u5bb9\u7a4d\u5c0e\u5411\u6a21\u5f0f\uff0c\u6f6e\u6c23\u5bb9\u7a4d 10 mL/kg\u7406\u60f3\u9ad4\u91cd\u6703\u6709\u8f03\u597d\u7684\u7d50\u679c\u3002 (D)\u7576\u75c5\u4eba\u75c5\u6cc1\u6539\u5584\u4e14\u53ef\u81ea\u884c\u547c\u5438\u6642\uff0c\u53ef\u5c07\u5bb9\u7a4d\u5c0e\u5411\u6a21\u5f0f\u8b8a\u66f4\u70ba\u58d3\u529b\u652f\u6301\u6a21\u5f0f\uff0c\u75c5\u4eba\u6703\u6bd4\u8f03\u8212\u9069\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u5927\u8178\u61a9\u5ba4\u708e( diverticulitis )\u75c5\u4eba\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u767c\u751f\u7387\u96a8\u5e74\u7d00\u589e\u52a0\u800c\u589e\u52a0\uff0c\u5728 40\u6b72\u4ee5\u4e0b\uff0c\u7537\u6027\u6bd4\u5973\u6027\u5bb9\u6613\u767c\u751f\u3002 (B)\u6709\u4e00\u534a\u7684\u75c5\u4eba\uff0c\u8868\u9054\u904e\u53bb\u66fe\u7d93\u51fa\u73fe\u76f8\u4f3c\u7684\u8179\u75db\u3002 (C)\u597d\u767c\u90e8\u4f4d\u4f9d\u5e8f\u70ba\u6a6b\u7d50\u8178\u3001\u4e59\u72c0\u7d50\u8178\u3001\u5347\u7d50\u8178\u3002 (D)\u8179\u90e8\u96fb\u8166\u65b7\u5c64\u662f\u9996\u9078\u78ba\u5b9a\u8a3a\u65b7\u7684\u6aa2\u67e5\u5de5\u5177\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u6709\u95dc\u51dd\u8840\u529f\u80fd\u6e2c\u8a66\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)INR \u5ef6\u9577\u53ef\u898b\u65bc\u4f7f\u7528 Cefoperazone \u7684\u75c5\u4eba\u3002 (B)\u809d\u7d20\u53ef\u5c0e\u81f4 aPTT\u5ef6\u9577\u3002 (C)D -dimer\u5347\u9ad8\u53ef\u80fd\u662f\u80ba\u6813\u585e\u6216\u809d\u75c5\u3002 (D)Protein C \u548cProtein S \u5347\u9ad8\u5e38\u898b\u65bc\u5c0f\u65bc 50\u6b72\u7684\u8840\u6813\u6027\u4e2d\u98a8\u75c5\u4eba\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u808b\u9593\u795e\u7d93\u963b\u65b7\u9ebb\u9189( intercostal nerve b lock)\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u808b\u9aa8\u9aa8\u6298 (rib fractures )\u70ba\u9069\u61c9\u75c7\u4e4b\u4e00\u3002 (B)\u5c0d\u65bc\u80f8\u58c1\u7684\u5e36\u72c0\u75b1\u75b9 (thoracic herpes zoster )\uff0c\u6709\u4e0d\u932f\u7684\u6b62\u75db\u6548\u679c\u3002 (C)\u5982\u4f7f\u7528\u9577\u6548\u578b\u5c40\u90e8\u9ebb\u9189\u85e5\u7269 (\u5982Bupivacaine )\uff0c\u6b62\u75db\u6548\u679c\u53ef\u9054 8\u5c0f\u6642\u4ee5\u4e0a\u3002 (D)\u5c40\u90e8\u6ce8\u5c04\u5b8c\u6210\u5f8c\uff0c\u9700\u5e38\u898f\u7167\u5c04\u80f8\u90e8 X\u5149\u4ee5\u5075\u6e2c\u662f\u5426\u6709\u4f75\u767c\u6c23\u80f8\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u9583\u96fb\u64ca\u50b7\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f ", + "Options": "(A)\u5bb9\u6613\u5f15\u8d77\u5fc3\u5ba4\u7e96\u7dad\u986b\u52d5\u3002 (B)\u610f\u8b58\u660f\u8ff7\u75c5\u4eba\uff0c\u77b3\u5b54\u64f4\u5f35\u70ba\u4e0d\u826f\u9810\u5f8c\u7684\u8868\u73fe\u3002 (C)\u50b7\u5bb3\u591a\u70ba\u8868\u5c64\u7d44\u7e54\uff0c\u8f03\u5c11\u9700\u9032\u884c\u7b4b\u819c\u5207\u958b\u8853\u3002 (D)\u5e38\u6703\u767c\u751f\u6025\u6027\u814e\u81df\u640d\u50b7\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6ccc\u5c3f\u9053\u7d50\u77f3\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u7532\u578b\u963b\u65b7\u5291( \u03b1-blockers)\u7121\u6cd5\u4fc3\u4f7f\u6ccc\u5c3f\u9053\u7d50\u77f3\u7684\u6392\u51fa\uff0c\u56e0\u6b64\u4e0d\u5efa\u8b70\u4f7f\u7528\u65bc\u5c3f\u8def\u7d50\u77f3\u7684\u75c5\u4eba\u3002 (B)\u5c3f\u9178\u7d50\u77f3\u5e38\u5e38\u5728 X\u5149\u7247\u4e0a\u7121\u6cd5\u986f\u73fe\u5f71\u50cf\uff0c\u4e14\u5c3f\u6db2\u7684 pH\u503c\u591a\u5448\u73fe\u9178\u6027\u3002 (C)\u9020\u6210\u814e\u7d50\u77f3\u7684\u5371\u96aa\u56e0\u5b50\u5f88\u591a\uff0c\u5305\u542b\u80a5\u80d6\u3001\u5c11\u9e7d\u3001\u5c11\u8089\u98f2\u98df\u3001\u75db\u98a8\u53ca\u7532\u72c0\u817a\u6a5f\u80fd\u4ea2\u9032\u7b49\u3002 (D)\u7d66\u4e88\u5927\u91cf\u7684\u975c\u8108\u8f38\u6db2\u6709\u52a9\u65bc\u75bc\u75db\u63a7\u5236\u6216\u63d0\u9ad8\u7d50\u77f3\u6392\u51fa\u7684\u6bd4\u7387\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u8179\u819c\u900f\u6790\u7684\u75c5\u4eba\u56e0\u70ba\u8179\u75db\u3001\u900f\u6790\u6db2\u8b8a\u6df7\u6fc1\u800c\u81f3\u6025\u8a3a\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u53ea\u8981\u6709\u767c\u71d2\uff0c\u7686\u9700\u8981\u4f4f\u9662\u3002 (B)\u8179\u6c34\u6aa2\u9a57 leukocyte \u81f3\u5c11\u5927\u65bc 250 /mm3\uff0c\u5408\u4f75\u4e2d\u6027\u7403\u5927\u65bc 50%\u59cb\u80fd\u78ba\u8a3a\u8179\u819c\u708e\u3002 (C)\u6297\u751f\u7d20\u61c9\u4f7f\u7528\u7b2c\u4e00\u4ee3\u982d\u5b62\u5b50\u7d20 (Cefazolin) \uff0c\u975c\u8108\u9014\u5f91\u7d66\u85e5\u3002 (D)\u6700\u5e38\u898b\u7684\u75c5\u539f\u83cc\u662f Staphylococcus epidermidis\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u89d2\u819c\u64e6\u50b7\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u88c2\u9699\u71c8\u6aa2\u67e5\u524d\u5148\u4ee5\u85cd\u8272\u7684\u87a2\u5149\u7d20(fluorescein )\u5c0d\u89d2\u819c\u9032\u884c\u67d3\u8272\u3002 (B)\u64cd\u4f5c\u88c2\u9699\u71c8\u6642\u4ee5\u9ec3\u7da0\u8272\u5149\u6e90\u7167\u5c04\u773c\u89d2\u819c\u8868\u9762\u9032\u884c\u6aa2\u67e5\u3002 (C)\u82e5\u78ba\u8a3a\u773c\u89d2\u819c\u64e6\u50b7\uff0c\u901a\u5e38\u5efa\u8b70\u7d66\u4e88\u75c5\u4eba\u6297\u751f\u7d20\u773c\u85e5\u818f\u3002 (D)\u89d2\u819c\u7d30\u80de\u751f\u9577\u8f03\u6162\u3001\u8868\u6dfa\u64e6\u50b7\u7684\u5fa9\u539f\u901a\u5e38\u9700\u4e94\u5929\u4ee5\u4e0a\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "78\u6b72\u7537\u6027\uff0c\u9577\u671f\u62bd\u83f8\u3002\u7a81\u7136\u767c\u751f\u53f3\u80f8\u75bc\u75db\u5408\u4f75\u547c\u5438\u5598\uff0c\u75bc\u75db\u56e0\u6df1\u547c\u5438\u800c\u52a0\u91cd\uff0c\u800c\u54b3\u55fd\u8207\u75f0\u4e26\u6c92\u6709\u660e\u986f\u589e\u52a0\u3002SpO 2 90%\u3001\u8840\u58d3\u5fc3\u8df3\u5728\u6b63\u5e38\u7bc4\u570d\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u82e5\u5f37\u70c8\u61f7\u7591\u5f35\u529b\u6027\u6c23\u80f8\uff0c\u61c9\u5118\u5feb\u505a CXR\u78ba\u8a3a\u3002 (B)CXR AP view \u82e5\u51fa\u73fe deep sulcus sign \uff0c\u61c9\u61f7\u7591\u75c5\u4eba \u6709\u6c23\u80f8\u3002 (C)\u8d85\u97f3\u6ce2\u6aa2\u67e5\u51fa\u73fe seashore sign\uff0c\u61c9\u61f7\u7591\u75c5\u4eba\u6709\u6c23\u80f8\u3002 (D)COPD \u70ba\u539f\u767c\u6027\u6c23\u80f8\u6700\u5e38\u898b\u7684\u81f4\u75c5\u539f\u56e0\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u767c\u751f\u776a\u4e38\u626d\u8f49\u6642\uff0c\u901a\u5e38\u6703\u6709\u5287\u70c8\u7684\u9670\u56ca\u75bc\u75db\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u9670\u56ca\u5916\u50b7\u5f8c\u7684\u776a\u4e38\u75bc\u75db\uff0c\u8207\u776a\u4e38\u626d\u8f49\u6c92\u6709\u95dc\u806f\u6027\u3002 (B)\u82e5\u5c07\u53d7\u5f71\u97ff\u7684\u776a\u4e38\u62ac\u9ad8\uff0c\u5247\u75bc\u75db\u6703\u7de9\u6e1b\uff0c\u6b64\u7a31\u70ba Prehn\u2019s sign \u967d\u6027\uff0c\u85c9\u6b64\u5fb5\u8c61\u53ef\u8207\u526f\u776a\u708e\u4f5c\u9451\u5225\u8a3a\u65b7\u3002 (C)\u82e5\u80fd\u5728 12\u5c0f\u6642\u5167\u9032\u884c\u624b\u8853\u6cbb\u7642\uff0c\u776a\u4e38\u6551\u56de\u7684\u6a5f\u7387\u9ad8\u9054 80%\u4ee5\u4e0a\u3002 (D)\u96b1\u776a\u75c7\u7684\u75c5\u4eba\u4e5f\u5bb9\u6613\u9020\u6210\u776a\u4e38\u626d\u8f49\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "60\u6b72\u7537\u6027\uff0c\u904e\u53bb\u6709\u652f\u6c23\u7ba1\u64f4\u5f35\u75c5\u53f2\uff0c\u6b64\u6b21\u56e0\u54b3\u8840(\u7d04 30 mL)\u53ca\u547c\u5438\u5598\uff0c\u81f3\u6025\u8a3a\u5c31\u91ab\u3002\u8840\u58d3 120/80 mmHg \uff0c\u5fc3\u8df3 85\u6b21/min\uff0c\u547c\u5438 19\u6b21/min\uff0cSpO 2 96\uff05\u3002\u6709\u95dc\u75c5\u4eba\u7684\u8a55\u4f30\u53ca\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u6b64\u75c5\u4eba\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\u4e14\u55ae\u6b21\u54b3\u8840\u91cf\u5c11\uff0c\u7b26\u5408\u81e8\u5e8a\u4e0a\u5c11\u91cf\u54b3\u8840( minor hemoptysis )\u5b9a\u7fa9\u3002 (B)\u5c11\u91cf\u54b3\u8840\u7684\u75c5\u4eba\uff0c\u56e0\u70ba\u6709\u518d\u51fa\u8840\u7684\u98a8\u96aa\uff0c\u5927\u591a\u9700\u8981\u4f4f\u9662\u89c0\u5bdf\u5e7e\u5929\uff0c\u7b49\u7a69\u5b9a\u624d\u80fd\u56de\u5bb6\u3002 (C)\u7b49\u5f85\u6aa2\u9a57\u6642\uff0c\u75c5\u4eba\u53c8\u6301\u7e8c\u54b3\u8840 200 mL\uff0c\u6b64\u6642\u7684\u57fa\u790e\u8840\u7d05\u7d20\u53ef\u80fd\u6703\u6709\u5047\u6027\u7684\u6b63\u5e38\u3002 (D)\u91dd\u5c0d\u5927\u91cf\u54b3\u8840\u75c5\u4eba\u7684\u65e9\u671f\u6b62\u8840\u8655\u7f6e\uff0c\u5efa\u8b70\u5148\u4f7f\u7528 flexible fiberoptic bronchoscopy \u505a\u5c40\u90e8\u6b62\u8840\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "30\u6b72\u7537\u6027\u56e0\u5287\u70c8\u982d\u75db\u81f3\u6025\u8a3a\uff0c\u6700\u8fd1\u4e26\u7121\u982d\u90e8\u5275\u50b7\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u82e5\u75c5\u4eba\u62b1\u6028\u6709\u751f\u4ee5\u4f86\u5f9e\u672a\u5982\u6b64\u75db\u904e\uff0c\u8d85\u904e 50%\u4ee5\u4e0a\u6709\u8718\u86db\u7db2\u819c\u4e0b\u8154\u51fa\u8840\u3002 (B)\u982d\u75db\u5c1a\u672a\u8d85\u904e 6\u500b\u5c0f\u6642\uff0c\u96fb\u8166\u65b7\u5c64\u5c0d\u65bc\u8718\u86db\u7db2\u819c\u4e0b\u8154\u51fa\u8840\u7684\u967d\u6027\u9810\u6e2c\u503c\u5c07\u8fd1 100%\u3002 (C)\u982d\u75db\u5df2\u8d85\u904e 24\u5c0f\u6642\uff0c\u96fb\u8166\u65b7\u5c64\u6b63\u5e38\u53ef\u6392\u9664\u8718\u86db\u7db2\u819c\u4e0b\u8154\u51fa\u8840\u3002 (D)\u8166\u90e8\u6838\u78c1 \u5171\u632f\u6b63\u5e38\uff0c\u53ef\u6392\u9664\u8718\u86db\u7db2\u819c\u4e0b\u8154\u51fa\u8840\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u984f\u9762\u90e8\u5916\u50b7\u75c5\u4eba\u96fb\u8166\u65b7\u5c64\u6383\u63cf\u767c\u73fe\u773c\u7aa9\u9aa8\u6298( orbital fracture )\u4e26\u6709\u773c\u7aa9\u5167\u7600\u8840\uff0c\u75c5\u4eba\u4e3b\u8a34\u8996\u529b\u6a21\u7cca\uff0c\u773c\u775b\u51f8\u816b\u75bc\u75db\uff0c\u773c\u76ae\u7dca\u7e43\u96e3\u4ee5\u9589\u5408\uff0c\u6e2c\u91cf\u773c\u58d3\u660e\u986f\u5347\u9ad8\uff0c\u8f03\u9069\u7576 \u7684\u6cbb\u7642\u9078\u64c7\u662f\uff1f", + "Options": "(A)Canthotomy(\u773c\u89d2\u5207\u958b\u8853 )\u3002 (B)Canthotomy(\u773c\u89d2\u5207\u958b\u8853)+ cantholysis (\u773c\u89d2\u96e2\u65b7\u8853) \u3002 (C)Ice packing \u3002 (D)Mann itol 20% 1g/kg bolus \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "50\u6b72\u5973\u6027\u56e0\u98a8\u6fd5\u6027\u5fc3\u81df\u75c5\uff0c\u66fe\u7d93\u63a5\u53d7\u4eba\u5de5\u5fc3\u81df\u74e3\u819c\u7f6e\u63db\u624b\u8853\uff0c\u9ad8\u71d2\u3001\u547c\u5438\u6025\u4fc3\u3002\u9ad4\u6eab 38.7\u00b0C\u3001\u8840\u58d3 105/65 mmHg\u3001\u5fc3\u8df3 105\u6b21/min\u3001SpO 2 95%\u3002\u75c5\u4eba\u6709 grade III systolic murmur \u3002CXR\u53ca\u5c3f\u6db2\u6aa2\u67e5\u5747\u7121\u7570\u5e38\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u8981\u7b26\u5408\u611f\u67d3\u6027\u5fc3\u5167\u819c\u708e Duke criteria \u81e8\u5e8a\u8a3a\u65b7\u689d\u4ef6\u5fc5\u9700\u8981\u6709\u5fc3\u81df\u8d85\u97f3\u6ce2\u76f8\u95dc\u7570\u5e38\u767c\u73fe\u3002 (B)\u82e5\u8840\u6db2\u57f9\u990a\u51fa Coxiella burnetii \uff0c\u5df2\u5408\u4e4e possible infective endocarditis \u7684\u689d\u4ef6\u3002 (C)\u61f7\u7591\u6b64\u75c5\u4eba\u6709\u611f\u67d3\u6027\u5fc3\u5167\u819c\u708e\uff0c\u6297\u751f\u7d20\u5408\u4f75\u4f7f\u7528 Gentamycin \u662f\u5408\u7406\u7684\u9078\u64c7\u3002 (D)\u61f7\u7591\u6b64\u75c5\u4eba \u6709\u611f\u67d3\u6027\u5fc3\u5167\u819c\u708e\uff0c\u75c5\u4eba\u53ef\u7e7c\u7e8c\u4f7f\u7528\u539f\u672c\u4e4b\u6297\u51dd\u8840\u5291\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u61f7\u5b55 25\u9031\u5b55\u5a66\uff0c\u5750\u5728\u6c7d\u8eca\u526f\u99d5\uff0c\u56e0\u8eca\u798d\u88ab\u9001\u4f86\u6025\u8a3a\u3002\u8840\u58d3\u6b63\u5e38\uff0c\u4f46\u8179\u90e8\u6709\u660e\u986f\u58d3\u75db\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5b89\u5168\u5e36\u4ecd\u5efa\u8b70\u4f7f\u7528\uff0c\u4f46\u4e0d\u5efa\u8b70\u5750\u5728\u914d\u6709\u5b89\u5168\u6c23\u56ca\u7684\u5ea7\u4f4d\u3002 (B)\u80ce\u5152\u7684\u6025\u6551\u53ca\u76e3\u6e2c\u512a\u65bc\u5b55\u5a66\u3002 (C)\u5916\u50b7\u8d85\u97f3\u6ce2\u986f\u793a\u8179\u6c34\uff0c\u4ea6\u4e0d\u5efa\u8b70\u505a\u96fb\u8166\u65b7\u5c64\u5224\u660e\u50b7\u52e2\u3002 (D)\u5efa\u8b70\u5728\u4e0d\u5f71\u97ff\u6025\u6551\u4e0b\u5118\u65e9\u5b89\u6392\u80ce\u5fc3\u97f3\u76e3\u6e2c\u53ca\u7522\u79d1\u8d85\u97f3\u6ce2\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u8d85\u97f3\u6ce2\u5c0e\u5f15\u5167\u9838\u975c\u8108\u4e2d\u5fc3\u975c\u8108\u5c0e\u7ba1\u7f6e\u5165\u8853\u7684\u6b65\u9a5f\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u8d85\u97f3\u6ce2\u4e0b\u5fc5\u9808\u8fa8\u8a8d\u51fa\u5167\u9838\u975c\u8108\u3001\u5167\u9838\u52d5\u8108\u8207\u7532\u72c0\u817a\u4e09\u6a23\u69cb\u9020\uff0c\u624d\u53ef\u4ee5\u4e0b\u91dd\u3002 (B)\u6709\u4e09\u7a2e\u7f6e\u5165\u7684\u9014\u5f91\uff1a\u4e2d\u592e\u5f0f (central)\u3001\u5f8c\u5074\u5f0f (posterior )\u3001\u524d\u5074\u5f0f(anterior )\u3002 (C)\u4f7f\u7528\u4e2d\u592e\u5f0f\u9014\u5f91\u6642\uff0c\u4e0b\u91dd\u7684\u65b9\u5411\u662f\u671d\u8457\u75c5\u4eba\u7684\u528d\u7a81(xiphoid) \u3002 (D)\u4f7f\u7528\u5f8c\u5074\u5f0f\u9014\u5f91\u6642\uff0c\u4e0b\u91dd\u7684\u65b9\u5411\u662f\u671d\u8457\u75c5\u4eba\u7684\u80f8\u9aa8\u5207\u8de1(sternal notch)\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u95dc\u65bc\u7ae0\u9b5a\u58fa\u5fc3\u808c\u75c7( Takotsubo cardiomyopathy )\u7684\u6558\u8ff0\uff0c\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u53ef\u4ee5\u662f\u4f7f\u7528 cocaine\u5f8c\u5f15\u8d77\u4e4b\u5fc3\u808c\u75c5\u8b8a\u3002 (B)\u75c5\u4eba\u4e2d\u4ee5\u505c\u7d93\u5f8c\u5a66\u5973\u8f03\u591a\u3002 (C)\u5e38\u9020\u6210\u5de6\u5fc3\u5ba4\u5fc3\u5c16\u6c23\u7403\u75c7\u5019\u7fa4 (apical ballooning) \u3002 (D)\u9020\u6210\u5fc3\u808c\u4ea4\u611f\u795e\u7d93\u6c38\u4e45\u6027\u7834\u58de\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5168\u8eab\u6027\u98a8\u6fd5\u6027\u75be\u75c5\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u9ad8\u5b89\u6c0f\u8840\u7ba1\u708e (Takayasu\u2019s arteritis )\u597d\u767c\u65bc\u5e74\u8f15\u7537\u6027\u5c45\u591a\uff0c\u5e38\u4f34\u96a8\u767c\u71d2\u3001\u8179\u75db\u7b49\u75c7\u72c0\u3002 (B)\u7db2\u72c0\u9752\u6591 (Livedo reticularis )\u4f34\u96a8\u8840\u5c0f\u677f\u4f4e\u4e0b\u70ba\u8a3a\u65b7 Catastrophic antiphospholipid syndrome \u7684\u91cd\u8981\u7dda\u7d22\uff0c\u901a\u5e38\u7b2c\u4e00\u500b\u5f71\u97ff\u7684\u5668\u5b98\u70ba\u80ba\u90e8\uff0c\u81f4\u6b7b\u7387\u70ba 50%\u3002 (C)\u96f7\u8afe\u6c0f\u73fe\u8c61 (Raynaud phenomenon )\u5e38\u898b\u65bc\u786c\u76ae\u75c7\u75c5\u4eba(Systemic sclerosis) \uff0c\u6cbb\u7642\u65b9\u5f0f\u5305\u542b\u56de\u6eab\uff0c\u7d66\u4e88\u53e3\u670d\u9223\u96e2\u5b50\u963b\u65b7\u5291 \u4ee5\u53ca\u785d\u5316\u7518\u6cb9\u85e5\u818f\u3002 (D)\u5de8\u7d30\u80de\u52d5\u8108\u708e( Giant cell arteritis )\u4e00\u822c\u597d\u767c\u65bc\u8001\u5e74\u4eba\uff0c\u5e38\u4f34\u96a8\u982d\u75db\u3001\u5f35\u53e3\u56f0\u96e3(j aw claudication )\u4ee5\u53ca\u807d\u529b\u53d7\u640d\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u53f0\u7063\u7dca\u6025\u91ab\u7642\u6551\u8b77\u7cfb\u7d71\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5c6c\u5fb7\u6cd5\u7cfb\u7d71 (Franco -German EMSS )\uff0c\u7531\u53d7\u8a13\u904e\u7684\u6551\u8b77\u6280\u8853\u54e1(EMT)\u5c07\u50b7\u75c5\u4eba\u9001\u5f80\u91ab\u9662\u3002 (B)\u512a\u5148\u6d3e\u9063(Priority Dispatch ) \uff0c\u662f\u6307\u6d3e\u9063\u54e1\u53d7\u7406\u5831\u6848\u6642\uff0c\u52d5\u4f5c\u8fc5\u901f \uff0c\u6551\u8b77\u6d3e\u9063\u8d8a\u5feb\u8d8a\u597d\u3002 (C)\u6839\u64da\u6551\u8b77\u6280\u8853\u54e1\u7ba1\u7406\u8fa6\u6cd5\uff0cEMT -I\u3001EMT -II\u53caEMT -P\u5747\u53ef\u57f7\u884c\u5230\u9662\u524d\u6025\u7522\u63a5\u751f\u3002 (D)\u6839\u64da\u6551\u8b77\u6280\u8853\u54e1\u7ba1\u7406\u8fa6\u6cd5\uff0cEMT -I\u3001EMT -II\u53caEMT -P\u5747\u53ef\u66ff\u75c5\u4eba\u91cf\u6e2c\u6307\u5c16\u8840\u7cd6\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8b6b\u5984( Delirium) \u3001\u5931\u667a( Dementia )\u548c\u7cbe\u795e\u75be\u75c5( Psychiatric disorder)\u7684\u9451\u5225\u8a3a\u65b7\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u8b6b\u5984\u75c7\u72c0\u767c\u751f\u7684\u671f\u7a0b\u901a\u5e38\u6bd4\u5931\u667a\u7de9\u6162\u3002 (B)\u5931\u667a\u548c\u7cbe\u795e\u75be\u75c5\u901a\u5e38\u6703\u6709\u5e7b\u89ba\uff0c\u8b6b\u5984\u8f03\u4e0d\u6703\u767c\u751f\u3002 (C)\u5931\u667a\u8f03\u6703\u6709\u64b2\u7ffc\u6a23\u9707\u986b(asterixis) \uff0c\u8b6b\u5984\u548c\u7cbe\u795e\u75be\u75c5\u8f03\u4e0d\u6703\u767c\u751f\u3002 (D)\u5931\u667a\u548c\u7cbe\u795e\u75be\u75c5\u901a\u5e38\u662f alert\uff0c\u8b6b\u5984\u7684\u75c5\u4eba\u8f03\u53ef\u80fd\u662f\u610f\u8b58\u660f\u6c89\u6216\u662fhyperalert \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "2\u6b72\u7537\u7ae5\u9700\u63d2\u7ba1\u6025\u6551\u6642\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u53ef\u9078\u64c7 3.5\u865f\u7121\u6c23\u56ca\u6c23\u7ba1\u5167\u7ba1\u3002 (B)\u6c23\u7ba1\u5167\u7ba1\u7f6e\u5165\u6df1\u5ea6\u7d04\u70ba 12\u516c\u5206\u3002 (C)\u5b9c\u4f7f\u7528\u5f4e\u66f2\u5f0f\u5589\u982d\u93e1\u9032\u884c\u63d2\u7ba1\u6cbb\u7642\u3002 (D)\u82e5\u767c\u751f\u56f0\u96e3\u63d2\u7ba1\u7684\u60c5\u6cc1\uff0c\u5b9c\u7acb\u5373\u9032\u884c needle cricothyrotomy \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5feb\u901f\u5f15\u5c0e\u63d2\u7ba1 (Rapid sequence intubation )\u7684\u76f8\u95dc\u85e5\u7269\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)Ketamine \u4e0d\u5b9c\u4f7f\u7528\u65bc\u91cd\u7a4d\u6027\u6c23\u5598\u7684\u75c5\u4eba\u3002 (B)Succinylcholine \u4e0d\u5b9c\u4f7f\u7528\u65bc\u91cd\u75c7\u808c\u7121\u529b\u7684\u75c5\u4eba\u3002 (C)\u5c0d\u65bc\u8840\u4e2d\u81bd\u9e7c\u8102\u9176(cholinersterase )\u7f3a\u4e4f\u7684\u75c5\u4eba\uff0c\u795e\u7d93\u808c\u8089\u963b\u65b7\u5291\u5b9c\u9078\u64c7 Succinylcholine \u70ba\u512a\u5148\u3002 (D)Sugammadex \u53ef\u9006\u8f49\u53bb\u6975\u5316\u795e\u7d93\u808c\u8089\u963b\u65b7\u5291(depolarizing neuromuscular blocking agents )\u4e4b\u4f5c\u7528\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u95dc\u65bc\u4f7f\u7528\u5c40\u90e8\u9ebb\u9189\u85e5\u7269\u7684\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u52a0\u5165\u78b3\u9178\u6c2b\u9209 NaHCO 3\u53ef\u4f7f\u9ebb\u9189\u6642\u9593\u5ef6\u9577\u3002 (B)\u52a0\u5165\u814e\u4e0a\u817a\u7d20(epinephrine )\u53ef\u4f7f\u6548\u679c\u66f4\u5feb\u767c\u63ee\u3002 (C)\u4e2d\u6bd2\u9020\u6210\u7672\u7647\u6642\uff0c\u6cbb\u7642\u7684\u9996\u9078\u85e5\u7269\u70ba Levetiracetam \u3002 (D)\u4e2d\u6bd2\u9020\u6210\u5fc3\u8df3\u4f11\u6b62\u6642\uff0c\u53ef\u8003\u616e\u4f7f\u7528 20%\u8102\u80aa\u4e73\u5316\u5291(lipid emulsion)\u975c\u8108\u6ce8\u5c04\u6cbb\u7642\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "32\u6b72\u5973\u6027\u60a3\u6709 Graves' disease \uff0c\u6700\u8fd1\u56e0\u85e5\u7269\u526f\u4f5c\u7528\u800c\u81ea\u884c\u505c\u85e5\uff1b\u610f\u8b58\u6df7\u4e82\uff0c\u9ad4\u6eab 40.1\u2103\uff0c\u5fc3\u8df3 172\u6b21/min\u4e14\u4e0d\u898f\u5247\uff0c\u547c\u5438 30\u6b21/min\uff0c\u8840\u58d3177/76 mmHg \uff0c\u8eab\u9ad4\u8a3a\u5bdf\u767c\u73fe\u978f\u819c\u504f\u9ec3\uff0c\u96d9\u4e0b\u80ba\u6709\u6fd5\u56c9\u97f3\u4e14\u96d9\u8173\u6c34\u816b\u3002\u4e0b\u5217\u6cbb\u7642\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u7d66\u4e88 Amiodarone \u6cbb\u7642\u5fc3\u640f\u904e\u901f\u3002 (B)\u5408\u4f75\u4f7f\u7528 Acetaminophen \u8207Aspirin\u9000\u71d2\u3002 (C)\u7d66\u4e88\u5229\u5c3f\u5291\u8207 Nitroglycerine \u6cbb\u7642\u9ad8\u8f38\u51fa\u6027\u5fc3\u8870\u7aed\u3002 (D)\u5148\u884c\u53e3\u670d Methimazole \u5f8c1\u5c0f\u6642\u518d\u7d66\u4e88 Lugol solution\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u4e0b\u58c1\u5fc3\u808c\u6897\u585e\u7684\u63cf\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u53ef\u80fd\u662f\u7531\u65bc left circumflex artery \u6216right coronary artety \u963b\u585e\u6240\u81f4\u3002 (B)Lead II ST -segment elevation \u5927\u65bc lead III \u50be\u5411 right coronary artety\u963b\u585e\u3002 (C)Right side EKG V4R \u5448\u73fe ST-segment elevation \u8868\u793a\u5408\u4f75\u53f3\u5fc3\u5ba4\u6897\u585e\u3002 (D)\u4e0b\u58c1\u5408\u4f75\u53f3\u5fc3\u5ba4\u6897\u585e\u6b7b\u4ea1\u7387\u6bd4\u50c5\u4e0b\u58c1\u6897\u585e\u9ad8\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6025\u6027\u8f3b\u5c04\u7d9c\u5408\u75c7( Acute radiation syndrome )\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u82e5\u6709\u767c\u751f\u767d\u8840\u7403\u6e1b\u5c11\u75c7\u3001\u8868\u76ae\u707c\u50b7\u53ca\u8178\u80c3\u75c7\u72c0\u53ef\u4ee5\u521d\u6b65\u8a3a\u65b7\u70ba\u6025\u6027\u8f3b\u5c04\u7d9c\u5408\u75c7\u3002 (B)\u7576\u5291\u91cf\u8d85\u904e 2Gy\u6642\u6703\u767c\u751f\u6301\u7e8c\u6027\u548c\u9811\u56fa\u6027\u4f4e\u8840\u58d3 \u3001\u865b\u812b\u3001\u5641\u5fc3\u3001\u5614\u5410\u548c\u7206\u767c\u6027\u8840\u6027\u8179\u7009\u3002 (C)\u6f5b\u4f0f\u6301\u7e8c\u6642\u9593\u8207\u6240\u63a5\u53d7\u7684\u5291\u91cf\u7121\u95dc\uff0c\u53ef\u80fd\u6301\u7e8c 1\u81f33\u9031\u3002 (D)\u767c\u75c5\u7387\u548c\u6b7b\u4ea1\u7387\u53d6\u6c7a\u65bc\u6240\u5c0e\u81f4\u7684\u5168\u8840\u7d30\u80de\u6e1b\u5c11 \u3001\u514d\u75ab\u6291\u5236\u548c\u51fa\u8840\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u95dc\u65bc\u4e0b\u80a2\u975c\u8108\u8840\u6813( DVT)\u7684\u81e8\u5e8a\u8868\u73fe\u53ca\u8eab\u9ad4\u8a3a\u5bdf\uff0c\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u65bc\u811b\u9aa8\u7d50\u7bc0\u4e0b 10\u516c\u5206\u8655\u6e2c\u91cf\u5de6\u53f3\u817f\u4e4b\u9593\u76f4\u5f91\u5dee\uff0c\u82e5\u5dee\u7570\u2265 2\u516c\u5206\u6642\uff0c DVT\u7684\u53ef\u80fd\u6027\u500d\u589e\u3002 (B)\u5927\u96b1\u975c\u8108\u7684 DVT\u8f03\u4e0d\u6613\u9020\u6210\u975c\u8108\u708e\u3002 (C)DVT \u75c5\u4eba\u4e2d\u7d04\u56db\u5206\u4e4b\u4e09\u5728\u80a2\u9ad4\u816b\u8139\u8655\u6709\u58d3\u75db\u548c\u767c\u7d05\uff0c\u5e38\u5e38\u88ab\u8aa4\u5224\u70ba\u8702\u7aa9\u6027\u7d44\u7e54\u708e\u3002 (D)\u5c0f\u817f\u975c\u8108 DVT\u53ef\u80fd\u9020\u6210 Homan's sign \u967d\u6027\uff0c\u8a72\u6e2c\u8a66\u7684\u654f\u611f\u5ea6\u5f88\u9ad8\uff0c\u4f46\u7279\u7570\u6027\u5f88\u4f4e\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u8db3\u6708\u65b0\u751f\u5152\u767c\u7d3a\u9451\u5225\u8a3a\u65b7\u53ca\u8a55\u4f30\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u7d66\u4e88 100%\u6c27\u6c23 10\u5206\u9418\uff0c\u4ecd\u7121\u6cd5\u63d0\u6607\u8840\u6c27\u6fc3\u5ea6\u53ef\u80fd\u6709\u5148\u5929\u6027\u5fc3\u81df\u75c5\uff0c\u5fc5\u8981\u6642\u53ef\u4ee5\u7528 prostaglandin E1 \u6cbb\u7642\u3002 (B)\u82e5\u547c\u5438\u6b21\u6578\u589e\u52a0\u4e26\u767c\u73fe\u6709\u808b\u9593\u51f9\u9677\uff0c\u547c\u5438\u97f3\u5448\u73fe rhonchi\uff0c\u53ef\u80fd\u662f\u80ba\u90e8\u539f\u56e0\u5f15\u8d77\uff0c\u9700\u8003\u616e\u80ce\u4fbf\u5438\u5165\u75c7\u5019\u7fa4\u3002 (C)\u65b0\u751f\u5152\u6709\u4f4e\u8840\u7cd6\u73fe\u8c61\uff0c\u4e5f\u662f\u9020\u6210\u767c\u7d3a\u539f\u56e0\u4e4b\u4e00\uff0c\u9700\u4ee5\u6bcf\u516c\u65a4 2\u6beb\u5347\uff0c10% \u8461\u8404\u7cd6\u6c34\u975c\u8108\u63a8\u6ce8\u6cbb\u7642\u3002 (D)\u65b0\u751f\u5152\u9664\u8840\u6c27\u6fc3\u5ea6\u7570\u5e38\uff0c\u5176\u4ed6\u8840\u58d3\u3001\u547c\u5438\u6b21\u6578\u53ca\u5fc3\u8df3\u70ba\u6b63\u5e38\u7684\u751f\u547d\u5fb5\u8c61\uff0c\u5176\u767c\u7d3a\u70ba\u4e2d\u592e\u767c\u7d3a\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u91dd\u5c0d\u4e0b\u5217\u6d3b\u52d5\u529b\u7686\u6b63\u5e38\u7684\u5152\u7ae5\u75c5\u4eba \uff0c\u8acb\u554f\u54ea\u4f4d \u6700\u9700\u8981\u958b\u7acb\u9810\u9632\u6027\u6297\u751f\u7d20\u6cbb\u7642\uff1f", + "Options": "(A)5\u6b72\u7684\u7537\u7ae5\uff0c\u96a8\u7236\u6bcd\u8d74\u6771\u5357\u4e9e\u63a2\u89aa\u5f8c\u56de\u570b\uff0c\u6aa2\u75ab\u671f\u9593\u51fa\u73fe\u591a\u6b21\u7121\u6cd5\u63a7\u5236\u7684\u7c73\u6e6f\u6a23(rice water )\u7a00\u6c34\u4fbf\uff0c\u4f46\u7121\u660e\u986f\u8179\u7d5e\u75db\u73fe\u8c61\u3002 (B)4\u6b72\u7684\u5973\u7ae5\uff0c\u5403\u4e86\u751f\u96de\u86cb\u5f8c\u958b\u59cb\u767c\u71d2\u3001\u8179\u90e8\u7d5e\u75db\uff0c\u4e14\u7cde\u4fbf\u4e2d\u5e36\u6709\u8840\u7d72\u53ca\u9ecf\u6db2\uff0c\u4f46\u7121\u95dc\u7bc0\u75db\u75c7\u72c0\u3002 (C)6\u6b72\u7684\u7537\u7ae5\uff0c\u5403\u5b8c\u6c92\u716e\u719f\u7684\u96de\u8089\u5f8c\u958b\u59cb\u767c\u71d2\u3001\u8179\u90e8\u75bc\u75db\u3001\u8179\u7009\uff0c\u4f46\u7121\u62bd\u7b4b\u73fe\u8c61\u3002 (D)5\u6b72\u7684\u7537\u7ae5\uff0c\u8207\u7236\u6bcd\u53bb\u9732\u71df\u6642\u8aa4\u559d\u751f\u6c34\u5f8c\u958b\u59cb\u767c\u71d2\u3001\u53f3\u4e0b\u8179\u75db\uff0c\u6c34\u7009\u4fbf\u4e2d\u5e36\u6709\u8840\u53ca\u9ecf\u6db2\uff0c\u4f46\u7121\u80f8\u60b6\u73fe\u8c61\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5fc3\u81df\u5916\u50b7\uff0c\u4ee5\u4e0b\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5fc3\u81df\u7a7f\u523a\u50b7\u6700\u597d\u767c\u70ba\u53f3\u5fc3\u5ba4\u3002 (B)\u920d\u50b7\u6027\u5fc3\u81df\u505c\u6b62\u7d93\u6025\u6551 20\u5206\u9418\u5f8c\u672a\u6062\u5fa9\u5fc3\u8df3\uff0c \u53ef\u8003\u616e\u9032\u884cresuscitative thoracotomy \u3002 (C)\u5fc3\u81df\u920d\u50b7 Troponin \u7684\u8a3a\u65b7\u654f\u611f\u5ea6\u5927\u7d04 70%\u3002 (D)\u5fc3\u81df\u920d\u50b7\u9020\u6210\u4e4b\u5fc3\u81df\u7834\u88c2\u6700\u597d\u767c\u70ba\u53f3\u5fc3\u5ba4\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u5c0d\u65bc\u54ee\u543c( croup)\u7684\u6cbb\u7642\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u985e\u56fa\u9187\u7d66\u55ae\u4e00\u5291\u91cf\u5373\u53ef\uff0c\u4e0d\u9700\u8981\u7d66\u4e88\u7dad\u6301\u5291\u91cf\u3002 (B)\u985e\u56fa\u9187\u975c\u8108\u6ce8\u5c04\u7684\u6548\u679c\u8f03\u53e3\u670d\u6548\u679c\u597d\u3002 (C)\u56b4\u91cd\u7a0b\u5ea6\u8f15\u5ea6\u7684\u75c5\u4eba\uff0c\u4e0d\u9700\u8981\u7d66\u4e88\u985e\u56fa\u9187\u3002 (D)\u985e\u56fa\u9187\u4e0d\u5efa\u8b70\u4f7f\u7528 Dexamethasone \u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "35\u6b72\u7537\u6027\u767b\u7389\u5c71\u671f\u9593\u51fa\u73fe\u982d\u75db\u3001\u6301\u7e8c\u54b3\u55fd\u6709\u8840\u75f0\u8207\u547c\u5438\u56f0\u96e3\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u7d66\u4e88 Acetazolamide \u6cbb\u7642\u3002 (B)\u7d66\u4e88 Dexamethasone \u6cbb\u7642\u3002 (C)\u7d66\u4e88 Acetaminophen \u6cbb\u7642\u3002 (D)\u7d66\u4e88 Nifedipine \u6cbb\u7642\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc Atypical Pneumonia \u4e4b\u63cf\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)Chlamydia infection \u80f8\u90e8 X\u5149\u5e38\u986f\u793a\u6591\u584a\u72c0\u90e8\u5206\u6d78\u6f64(patchy subsegmental infiltrat ion)\u3002 (B)Mycoplasma \u6709\u6642\u6703\u5f15\u8d77\u80ba\u5916\u75c7\u72c0\uff0c\u4f8b\u5982\u95dc\u7bc0\u708e\u3001\u76ae\u75b9\u3001\u795e\u7d93\u5b78\u75c7\u72c0\u3002 (C)\u9577\u671f\u5438\u7159\u3001\u66fe\u63a5\u53d7\u79fb\u690d\u3001\u514d\u75ab\u4e0d\u5168\u8005\u8f03\u5bb9\u6613\u611f\u67d3 Legionella\u3002 (D)\u7d93\u9a57\u6027\u6297\u751f\u7d20\u6cbb\u7642\u81f3\u5c11\u8981\u9078\u64c7\u7b2c\u4e8c\u4ee3\u4ee5\u4e0a\u7684 \u03b2-lactam antibiotics Cephalosporins \u6216Penicillin s\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5c0f\u5152\u5916\u50b7\u521d\u7d1a\u8a55\u4f30\u4e2d\u7684\u5faa\u74b0\u90e8\u5206\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u4ee3\u511f\u4e0d\u5168 (decompensated )\u7684\u51fa\u8840\u6027\u4f11\u514b\u61c9\u76e1\u65e9\u8f38\u8840\u3002 (B)\u9808\u8f38\u8840\u7684\u75c5\u4eba\uff0ctranexamic acid \u61c9\u65bc 3\u5c0f\u6642\u5167\u76e1\u65e9\u7d66\u4e88\u3002 (C)\u5c0d\u65bc\u591a\u91cd\u90e8\u4f4d\u5916\u50b7\u7684\u75c5\u4eba\uff0c\u5efa\u8b70\u63a5\u53d7\u5141\u8a31\u6027\u4f4e\u8840\u58d3(permissive hypotension )\u8655\u7f6e\u3002 (D)\u5b30\u5152\u982d\u76ae\u7684\u5916\u50b7\u53ef\u4ee5\u9020\u6210\u91cd\u5927\u7684\u5931\u8840\u91cf\uff0c\u61c9\u76e1\u65e9\u6b62\u8840\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "65\u6b72\u7537\u6027\uff0c\u6709\u5fc3\u623f\u986b\u52d5\u75c5\u53f2\u670d\u7528 Warfarin \u4e2d\uff0c\u56e0\u5de6\u5074\u982d\u75db\u53ca\u53f3\u5074\u7121\u529b\u81f3\u6025\u8a3a\u5c31\u8a3a\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u670d\u7528 Warfarin \u662f\u8166\u51fa\u8840\u7684\u5371\u96aa\u56e0\u5b50\uff0c\u4f46\u98a8\u96aa\u7a0b\u5ea6\u8207 INR\u7684\u6578\u503c\u4e26\u7121\u76f8\u95dc\u3002 (B)\u65b0\u578b\u53e3\u670d\u6297\u51dd\u8840\u85e5(Novel oral anticoagulants )\u76f8\u8f03\u65bc Warfarin \u4f86\u8aaa\uff0c\u5f15\u767c\u8166\u51fa\u8840\u7684\u98a8\u96aa\u7a0b\u5ea6\u8f03\u4f4e\u3002 (C)\u6cbb\u7642\u5305\u62ec\u907f\u514d\u767c\u71d2\uff0c\u76e3\u63a7\u8840\u58d3\uff0c\u77ef\u6b63\u51dd\u8840\u7570\u5e38\uff0c\u82e5\u8166\u58d3\u4e0a\u5347\u53ef\u4f7f\u7528\u985e\u56fa\u9187\u6e1b\u5c11\u5927\u8166\u767c\u708e\u53cd\u61c9\u3002 (D)\u7a4d\u6975\u63a7\u5236\u6536\u7e2e\u58d3\u65bc 110-139 mmHg \u4e4b\u9593\uff0c\u76f8\u8f03\u65bc\u6536\u7e2e\u58d3 140-179 mmHg\uff0c\u53ef\u660e\u986f\u6e1b\u5c11\u6b7b\u4ea1\u7387\u53ca\u5931\u80fd\u7387\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "30\u6b72\u7537\u6027\u81ea\u8ff0\u5de6\u5074\u9873\u90e8\u982d\u75db\uff0c\u4f34\u96a8\u540c\u5074\u773c\u6dda\u53ca\u9f3b\u6c34\u4e0d\u6b62\uff0c 2\u500b\u6708\u524d\u4e5f\u6709\u985e\u4f3c\u60c5\u6cc1\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5b89\u6392\u5728\u5b89\u975c\u4e14\u7121\u5149\u7684\u74b0\u5883\u8eba\u5e8a\u4f11\u606f\u3002 (B)\u808c\u8089\u6ce8\u5c04\u6297\u7d44\u7e54\u80fa\u3002 (C)\u63a5\u4e0a 2-4 L/minute \u7684\u6c27\u6c23\u6cbb\u7642\u3002 (D)\u7d66\u4e88 intranasal lidocaine 10% solution 1 mL \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4f9d\u7dca\u6025\u91ab\u7642\u6551\u8b77\u6cd5\u898f\u5b9a\u4e2d\uff0c\u6709\u95dc\u7dca\u6025\u91ab\u7642\u6551\u8b77\u8cc7\u8a0a\u901a\u5831\u8fa6\u6cd5\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u7dca\u6025\u91ab\u7642\u6551\u8b77\u8cc7\u8a0a\u901a\u5831\u4f5c\u696d\uff0c\u5982\u9047\u901a\u8a0a\u50b3\u8f38\u6545\u969c\u4e2d\u65b7\uff0c\u5f97\u4ee5\u5176\u4ed6\u65b9\u5f0f\u5148\u884c\u901a\u5831\uff0c\u4e26\u65bc\u6545\u969c\u6392\u9664\u5f8c 24\u5c0f\u6642\u5167\u5b8c\u6210\u901a\u5831\u8cc7\u8a0a\u767b\u9304\u4f5c\u696d\u3002 (B)\u9047\u975e\u5927\u91cf\u50b7\u75c5\u4eba\u4e8b\u4ef6\u6642\uff0c\u5730\u65b9\u885b\u751f\u4e3b\u7ba1\u6a5f\u95dc\u77e5\u6089\u4e26\u5224\u5b9a\u70ba\u300c\u7279\u6b8a\u4e8b\u4ef6\u300d\u5f8c\uff0c\u5f97\u65bc\u7dca\u6025\u91ab\u7642\u7ba1\u7406\u7cfb\u7d71\u5efa\u7acb\u300c\u707d\u5bb3\u4e8b\u4ef6\u6a94\u300d \u3002 (C)\u5340\u57df\u7dca\u6025\u91ab\u7642\u61c9\u8b8a\u4e2d\u5fc3\u5f97\u5354\u52a9\u5730\u65b9\u885b\u751f\u4e3b\u7ba1\u6a5f\u95dc\u53ca\u6025\u6551\u8cac\u4efb\u91ab\u9662\u9032\u884c\u76f8\u95dc\u8cc7\u6599\u8490\u96c6\u53ca\u767b\u9304\u3002 (D)\u6025\u6551\u8cac\u4efb\u91ab\u9662\u61c9\u65bc 60\u5206\u9418\u5167\u63d0\u4f9b\u7576\u6642\u4e8b\u4ef6\u76f8\u95dc\u4e4b\u6536\u6cbb\u50b7\u75c5\u4eba\u521d\u6b65\u6aa2\u50b7\u4eba\u6578\u8cc7\u6599\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6025\u6027\u5fc3\u8870\u7aed\u4e4b\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u4f7f\u7528 Nitroglycerin \u5f8c\u767c\u73fe\u4f4e\u8840\u58d3\uff0c\u53ef\u8003\u616e\u5f8c\u7e8c\u7d66\u4e88\u751f\u7406\u98df\u9e7d\u6c34 250-1,000 mL\u3002 (B)\u8d85\u97f3\u6ce2\u770b\u5230\u96d9\u5074 B line\u548c\u4e0b\u8154\u975c\u8108\u5927\u65bc 2\u516c\u5206\uff0c\u5373\u53ef\u8a3a\u65b7\u6025\u6027\u5fc3\u81df\u8870\u7aed\u3002 (C)\u975e\u4fb5\u5165\u6027\u6b63\u58d3\u547c\u5438\u53ef\u4ee5\u964d\u4f4e\u63d2\u7ba1\u6a5f\u7387\u548c\u6539\u5584\u547c\u5438\u7a98\u8feb\u7684\u73fe\u8c61\u3002 (D)\u55ae\u7368\u4f7f\u7528\u5229\u5c3f\u5291\u53ef\u80fd\u6703\u589e\u52a0\u6b7b\u4ea1\u7387\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "62\u6b72\u5973\u6027\u75c5\u4eba\u56e0\u70ba\u5de6\u4e0b\u8179\u75db\u81f3\u6025\u8a3a\uff0c\u81e8\u5e8a\u4e0a\u7591\u4f3c\u6025\u6027\u4e59\u72c0\u7d50\u8178\u61a9\u5ba4\u708e(sigmoid diverticulitis) \uff0c\u4e0b\u5217\u4f34\u96a8\u7684\u75c7\u72c0\u4f55\u8005\u8f03\u5e38\u898b \uff1f", + "Options": "(A)\u5614 \u5410\u3002 (B)\u89e3\u5c3f\u56f0\u96e3\u3002 (C)\u6392\u4fbf\u7fd2\u6163\u6539\u8b8a\u3002 (D)\u53ad\u98df\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u4f55\u8005\u662f\u81ea\u767c\u6027\u7e31\u9694\u7a4d\u6c23( spontaneous pneumomediastinum )\u8207\u81ea\u767c\u6027\u6c23\u80f8( spontaneous pneumothorax )\u4e3b\u8981\u7684\u5dee\u7570\uff1f", + "Options": "(A)\u54b3\u55fd (cough) \u3002 (B)\u904b\u52d5\u6642\u767c\u751f (during strenuous exertion) \u3002 (C)\u80f8\u75db(chest pain )\u3002 (D)\u5fc3\u640f\u904e\u901f (tachycardia )\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u4f55\u8005\u70ba\u81ea\u6bba\u6210\u529f\u7684\u9ad8\u5371\u96aa\u65cf\u7fa4 \uff1f", + "Options": "(A)\u4e0a\u500b\u6708\u670d\u7528\u591c\u591c\u5be7 24\u9846\u3002 (B)\u4e0d\u559c\u6b61\u63a5\u53d7\u4ed6\u4eba\u7684\u5354\u52a9\u3002 (C)\u55aa\u5931\u81ea\u6211\u63a7\u5236\u7684\u80fd\u529b\u3002 (D)\u7269\u8cea\u6feb\u7528\u7684\u75c5\u4eba\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u8102\u80aa\u4e73\u5316\u5291( lipid emulsion )\u7528\u65bc\u6cbb\u7642\u6bd2\u85e5\u7269\u4e2d\u6bd2\u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u8102\u80aa\u4e73\u5316\u5291\u7528\u4f86\u6cbb\u7642\u5c40\u90e8\u9ebb\u9189\u85e5\u4e2d\u6bd2\u662f\u7121\u6548\u7684\u3002 (B)\u51e1\u662f\u8102\u6eb6\u6027\u85e5\u7269\u4e2d\u6bd2 (\u5982 \u03b2\u963b\u65b7\u5291)\uff0c\u5c0d\u5176\u4ed6\u7642\u6cd5\u7121\u6548\u6642\uff0c\u53ef\u4ee5\u8003\u616e\u4f7f\u7528\u3002 (C)\u8840\u58d3\u4f4e\u7684\u75c5\u4eba\uff0c\u4e0d\u5efa\u8b70\u4f7f\u7528\u3002 (D)\u5e38\u898b\u526f\u4f5c\u7528\uff0c\u5982\u6025\u6027\u904e\u654f\u3001\u9ad8\u8840\u8102\u3001\u80f0\u81df\u708e\u3001\u8102\u80aa\u6813\u585e\uff0c\u6545\u4e0d\u80fdbolus\u7d66\u4e88\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "88\u6b72\u7537\u6027\uff0c\u8fd1\u5169\u5929\u767c\u71d2\u3001\u547c\u5438\u5598\u3001\u610f\u8b58\u6a21\u7cca\u3002\u904e\u53bb\u56e0 COPD\u4f75\u611f\u67d3\u4f4f\u9662\u56db\u6b21\uff0c\u5169\u9031\u524d\u624d\u525b\u51fa\u9662\u8fd4\u5bb6\u3002\u95dc\u65bc\u6b64\u75c5\u4eba\u7684\u72c0\u6cc1\uff0c\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)COPD \u6025\u6027\u767c\u4f5c\u75c5\u4eba\uff0c\u5e38\u898b\u83cc\u7a2e\u70ba Streptococcus pneumoniae \u3001Haemophilus influenzae \u53caMoraxella catarrhalis\u3002 (B)\u9664\u4e86\u611f\u67d3\u75c7\u5916\uff0c\u4ecd\u7136\u8981\u8003\u616e\u5176\u4ed6\u539f\u56e0\uff0c\u5982 pneumothorax \u3001pulmonary embolism \u7b49\u3002 (C)\u8003\u91cf\u75c5\u4eba\u5169\u9031\u524d\u525b\u4f4f\u904e\u9662\uff0c\u9078\u64c7\u6297\u751f\u7d20\u6642\u8981\u6db5\u84cb Pseudomonas aeruginosa\u3002 (D)\u52d5\u8108\u8840\u6aa2\u9a57\uff1a pH 7.01\uff0cPCO 2 90 mmHg\uff0c\u518d\u8a55\u4f30\u75c5\u4eba\u767c\u73fe GCS E2V2M4\uff0c\u61c9\u76e1\u5feb\u4f7f\u7528 BiPAP\u4f86\u6539\u5584\u81e8\u5e8a\u72c0\u6cc1\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6839\u64da\u6211\u570b\u5065\u4fdd\u7f72\u898f\u5b9a\u6240\u63a1\u7528\u7684\u570b\u969b\u7259\u79d1\u806f\u76df\u7259\u4f4d\u8868\u793a\u6cd5\uff0c \u300c\u5de6\u4e0a\u72ac\u9f52\u300d\u7de8\u865f\u61c9\u662f\u4f55\u8005 \uff1f", + "Options": "(A)13\u3002 (B)23\u3002 (C)33\u3002 (D)43\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "30\u6b72\u5065\u5eb7\u7537\u6027\uff0c\u4e00\u5929\u524d\u958b\u59cb\u767c\u71d2\u53ca\u5168\u8eab\u5026\u6020\uff0c\u610f\u8b58\u6539\u8b8a\uff0c\u88ab\u592a\u592a\u5e36\u4f86\u6025\u8a3a\uff0c\u75c5\u4eba\u8166\u810a\u9ad3\u6db2\u9769\u862d\u6c0f\u67d3\u8272\u5448\u73fe\u9769\u862d\u6c0f\u967d\u6027\u96d9\u7403\u83cc\uff0c\u91dd\u5c0d\u592a\u592a\u7684\u85e5\u7269\u9810\u9632\u6cbb\u7642\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)Ciprofloxacin 500 mg PO \u00d7 1 dose \u3002 (B)Rocephin 250 mg IM \u00d7 1 dose \u3002 (C)Rifampin 600 mg PO Q12H \u5169\u5929\u3002 (D)\u4e0d\u9700\u8981\u9810\u9632\u6027\u85e5\u7269\u6cbb\u7642\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "26\u6b72\u5973\u6027\u75c5\u4eba\u81f3\u6025\u8a3a\uff0c\u4e3b\u8a34\u904e\u53bb\u4e00\u5e74\u7d93\u5e38\u6709\u66b4\u98df\u884c\u70ba\uff0c\u4e26\u5e38\u4ee5\u50ac\u5410\u4f86\u6e05\u9664\u5403\u9032\u4e4b\u98df\u7269\uff0c\u75c5\u4eba\u7684 BMI\u70ba21\uff0c\u6839\u64da\u4e0a\u8ff0\u72c0\u6cc1\uff0c\u4ee5\u4e0b\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u6839\u64da DSM -V\uff0cBMI\u6b63\u5e38\u7684\u4eba\u4e0d\u7b26\u5408 eating disorder \u7684\u8a3a\u65b7\u3002 (B)\u7d93\u5e38\u50ac\u5410\u7684\u4eba\uff0c\u53ef\u80fd\u6703\u6709\u7121\u75db\u6027\u816e\u817a\u816b\u5927\uff0c\u4e14\u624b\u6307\u80cc\u5074\u6703\u7522\u751f\u80fc\u80dd(callus) \u3002 (C)\u9577\u671f\u71df\u990a\u7f3a\u4e4f\u7684\u75c5\u4eba\u5728\u7d66\u4e88\u91dd\u5291\u71df\u990a\u6642\uff0c\u8981\u7279\u5225\u6ce8\u610f\u662f\u5426\u6703\u5c0e\u81f4\u9ad8\u78f7\u8840\u75c7\u3002 (D)\u592a\u904e\u7528\u529b\u50ac\u5410\u53ef\u80fd\u9020\u6210 Boerhaave syndrome \uff0c\u5408\u4f75\u53f3\u5074\u81bf\u80f8\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u5152\u7ae5\u5668\u8cea\u6027\u7cbe\u795e\u75c5 (organic psychosis )\u7684\u4e00\u822c\u7279\u5fb5\uff0c \u4e0d\u5305\u62ec\u4e0b\u5217\u54ea\u4e00\u9805\uff1f", + "Options": "(A)\u8b6b\u5984\u3002 (B)\u8996\u5e7b\u89ba\u3002 (C)\u807d\u5e7b\u89ba\u3002 (D)\u6025\u6027\u767c\u4f5c\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "50\u6b72\u5973\u6027\u5f9e\u9ad8\u8655\u8dcc\u843d\uff0c\u610f\u8b58\u4e0d\u6e05\u61f7\u7591\u9871\u5167\u51fa\u8840\uff0c\u8840\u58d3 105/71 mmHg \uff0c\u5fc3\u8df395\u6b21/min\uff0cSpO 2 92%\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u63d2\u7ba1\u7528\u85e5 (induction agent )\u9996\u9078\u70ba Ketamine \u3002 (B)\u63d2\u7ba1\u6642\u53ef\u5148\u6253\u958b\u9838\u5708\uff0c\u63d2\u5b8c\u5f8c\u9838\u5708\u7e8c\u7528\uff0c\u6b64\u904e\u7a0b\u81f3\u5c11\u9700\u8981\u5169\u4eba\u5408\u4f5c\u3002 (C)Permissive hypotension \u4ea6\u9069\u7528\u6b64\u75c5\u4eba\u3002 (D)Mannitol \u5df2\u88ab\u8b49\u5be6\u5c0d\u6b64\u75c5\u4eba\u7121\u6548\uff0c\u8840\u58d3\u6b63\u5e38\u4e5f\u4e0d\u5efa\u8b70\u4f7f\u7528\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "55\u6b72\u7537\u6027\uff0c\u6162\u6027\u80ba\u9ad8\u58d3\u75c5\u53f2\uff0c\u4e3b\u8a34\u7121\u6d3b\u52d5\u6027\u547c\u5438\u5598 1\u5929\uff0c\u9ad4\u6eab 36.1\u2103\uff0c\u5fc3\u8df3140\u6b21/min\uff0c\u547c\u5438 35\u6b21/min\uff0c\u8840\u58d3 115/80 mmHg\uff0cSpO 2 75%\uff0c\u5230\u9662\u6642\u7acb\u5373\u4e88\u4ee5\u6c23\u7ba1\u5167\u7ba1\u63d2\u7ba1\u4f75\u547c\u5438\u5668\u4f7f\u7528\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u4f7f\u7528 Dopamine \u6cbb\u7642\uff0c\u56e0\u5176 \u03b2-agonist effect \u53ef\u4ee5\u63d0\u5347 RCA\u704c\u6d41\u3001inotropic effect \u53ef\u4ee5\u7de9\u89e3\u53f3\u5fc3\u8870\u7aed\u3002 (B)\u8840\u6c27\u76ee\u6a19\u7dad\u6301 SpO 2>90%\uff0c\u4e26\u76e1\u53ef\u80fd\u8abf\u9ad8\u547c\u6c23\u672b\u671f\u6b63\u58d3(PEEP )\u4ee5\u907f\u514d\u6c23\u9053\u584c\u9677\u3002 (C)\u907f\u514d\u4f7f\u7528 Norepinephrine \uff0c\u56e0\u70ba\u5176 \u03b2-agonist effect \u6703\u589e\u52a0\u80ba\u52d5\u8108\u58d3\u3002 (D)\u53ef\u4f7f\u7528 Milrinone \u6cbb\u7642\uff0c\u9808\u5bc6\u5207\u76e3\u6e2c\u907f\u514d\u4f4e\u8840\u58d3\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u95dc\u65bc\u80ba\u6813\u585e\u7684\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)D -dimer\u7684\u53c3\u8003\u503c\u61c9\u96a8\u5e74\u9f61\u5f80\u4e0a\u8abf\u6574\uff0c\u6700\u5e38\u4f7f\u7528\u7684\u65b9\u5f0f\u662f(age x 10 ng/m L)\u3002 (B)D -dimer\u654f\u611f\u5ea6\u8207\u7279\u7570\u6027\u8db3\u5920\uff0c\u4e14\u80ba\u6813\u585e\u767c\u751f 6\u5929\u5f8c\u4ecd\u6709\u8db3\u5920\u7684\u4fe1\u6548\u5ea6\u3002 (C)POCUS \u53ef\u770b\u5230 RV/LV ratio>1 \u8207dilated IVC \u3002 (D)ECG \u5e38\u898b\u7684\u7570\u5e38\u5305\u62ec sinus tachycardia \u3001V1-4 T wave inversion \u8207RBBB\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u80a5\u539a\u6027\u5fc3\u808c\u75c7( hypertrophic cardiomyopathy )\u4e4b\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u81e8\u5e8a\u8868\u73fe\u70ba\u6d3b\u52d5\u6642\u5598\u5408\u4f75\u80f8\u75db\u3001\u5fc3\u60b8\u548c\u660f\u53a5\u3002 (B)\u80f8\u75db\u4f7f\u7528 Nitroglycerin \u7684\u6548\u679c\u5f88\u597d\u3002 (C)\u78ba\u8a3a\u7684\u65b9\u6cd5\u4f7f\u7528\u5fc3\u81df\u7684\u6838\u78c1\u5171\u632f\u6216\u5fc3\u81df\u8d85\u97f3\u6ce2\u3002 (D)\u6709\u660f\u53a5\u75c7\u72c0\u7684\u80a5\u539a\u6027\u5fc3\u808c\u75c7\u9700\u4f4f\u9662\u6cbb\u7642\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "35\u6b72\u5973\u6027\uff0c\u4e3b\u8a34\u4e0b\u8179\u56b4\u91cd\u75bc\u75db\u4f75\u5641\u5fc3\u611f\u7d04\u4e00\u65e5\uff0c\u8840\u58d3 132/84 mmHg \u3001\u5fc3\u8df365\u6b21/min\u3001\u547c\u5438 22\u6b21/min\u3001\u9ad4\u6eab 36.4\u2103\uff0c\u8fd1\u671f\u65bc\u8a3a\u6240\u63a5\u53d7\u8a66\u7ba1\u5b30\u5152\u7684\u7642\u7a0b\uff0c\u65bc 2\u9031\u524d\u63a5\u53d7\u53d6\u5375\u624b\u8853\uff0c\u4e14\u65bc\u53d6\u5375\u5f8c 3\u65e5\u690d\u5165 2\u9846\u80da\u80ce\uff1b\u8eab\u9ad4\u8a3a\u5bdf\u767c\u73fe\u4e0b\u8179\u8207\u9aa8\u76c6\u8154\u6709\u660e\u986f\u58d3\u75db\u7121\u53cd\u5f48\u75db\uff1b\u767d\u8840\u7403 14,600/mm3\u3001Cr 0.78 mg/dL\u3001Na 132 m Eq/L\u3001\u03b2-hCG 453 mIU/mL\uff1b\u8179\u90e8\u8d85\u97f3\u6ce2\u767c\u73fe\u816b\u8139\u7684\u5375\u5de2\u8207\u8179\u6c34\uff0c\u5b50\u5bae\u5167\u672a\u767c\u73fe\u598a\u5a20\u56ca\uff0c\u4e0b\u5217\u8655\u7f6e\u8207\u5224\u65b7\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u7167\u6703\u5a66\u7522\u79d1\u91ab\u5e2b\uff0c\u9032\u884c bimanual pelvic examination \u3002 (B)\u9808\u5c07\u5b50\u5bae\u5916\u5b55\u5217\u5165\u9451\u5225\u8a3a\u65b7\uff0c\u53ef\u65bc 48\u5c0f\u6642\u5f8c\u8ffd\u8e64 \u03b2-hCG\u7684\u6307\u6578\u3002 (C)\u9808\u5c07\u8105\u8feb\u6027\u6d41\u7522\u5217\u5165\u8003\u616e\uff0c\u7d66\u4e88\u9ec3\u9ad4\u7d20\u808c\u8089\u6ce8\u5c04\u3002 (D)\u9069\u5ea6\u7d66\u4e88\u975c\u8108\u8f38\u6db2\u8207 NSAIDs\u6b62\u75db\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u4e0b\u80a2\u808c\u8171\u50b7\u5bb3\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u963f\u57fa\u91cc\u65af\u8171 (Achilles tendon)\u65b7\u88c2\u5e38\u8868\u73fe\u70ba\u7a81\u767c\u6027\u75bc\u75db\uff0c\u4e14\u7121\u6cd5\u4ee5\u8173\u5c16\u7ad9\u7acb\u3002 (B)\u5c11\u90e8\u5206\u963f\u57fa\u91cc\u65af\u8171\u5b8c\u5168\u65b7\u88c2\u8005\u80fd\u5920\u8d70\u52d5\uff0c\u5bb9\u6613\u88ab\u8aa4\u8a3a\u70ba\u8173\u8e1d\u626d\u50b7\u3002 (C)\u811b\u524d\u808c\u808c\u8171 (anterior tibialis tendon )\u65b7\u88c2\u975e\u5e38\u5c11\u898b\uff0c\u4e00\u822c\u4e0d\u6703\u975e\u5e38\u75bc\u75db\uff0c\u591a\u6578\u4e0d\u9700\u624b\u8853\u3002 (D)\u811b\u5f8c\u808c\u808c\u8171 (posterior tibialis tendon )\u65b7\u88c2\uff0c\u75c5\u7a0b\u8868\u73fe\u8f03\u7de9\u6162\u4e14\u4e0d\u660e\u986f\uff0c\u5e38\u767c\u751f\u5728 40\u6b72\u4ee5\u4e0b\u7684\u5e74\u8f15\u7537 \u6027\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "30\u6b72\u7537\u6027\u75c5\u4eba\u5927\u7b11\u4e4b\u5f8c\u9873\u984e\u95dc\u7bc0\u812b\u81fc\uff0c\u5c0d\u6b64\u75c5\u4eba\u7684\u8655\u7f6e\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u53ef\u4ee5\u76f4\u63a5\u5728\u6025\u8a3a\u5fa9\u4f4d\u5f8c\u8b93\u75c5\u4eba\u51fa\u9662\u3002 (B)\u5fa9\u4f4d\u524d\u53ef\u8003\u616e\u5728\u8033\u524d\u9873\u984e\u95dc\u7bc0\u8655\u6ce8\u5c04\u5c40\u90e8\u9ebb\u9189\u5291\u3002 (C)\u8f03\u5e38\u70ba\u5f8c\u812b\u4f4d\uff0c\u61c9\u6ce8\u610f\u5916\u8033\u9053\u662f\u5426\u640d\u50b7\u3002 (D)\u6700\u5e38\u4f7f\u7528\u7684\u5fa9\u4f4d\u65b9\u6cd5\u662f\u8b93\u75c5\u4eba\u5448\u5750\u59ff\uff0c\u62b5\u4f4f\u75c5\u4eba\u96d9\u5074\u7684\u4e0b\u81fc\u9f52\u5f80\u4e0b\u5f80\u5f8c\u65bd\u529b\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u61a9\u5ba4\u708e\u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u518d\u5fa9\u767c\u4e4b\u75c5\u4eba\u9700\u8981\u624b\u8853\u6cbb\u7642\u3002 (B)\u6297\u751f\u7d20\u4f7f\u7528\u80fd\u9810\u9632\u4f75\u767c\u75c7\u53ca\u5fa9\u767c\u7387\u3002 (C)\u7121\u4f75\u767c\u75c7\u8005\u53ef\u8003\u616e\u7531\u6025\u8a3a\u51fa\u9662\uff0c\u53e3\u670d\u85e5\u7269\u6cbb\u7642\u3002 (D)\u78ba\u8a3a\u75c5\u4eba\u9700\u7981\u98df\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u91dd\u5c0d\u6025\u8a3a\u547c\u5438\u5598\u7684\u75c5\u4eba\uff0c\u57f7\u884c\u7dca\u6025\u5e8a\u908a\u80ba\u90e8\u8d85\u97f3\u6ce2\u6383\u63cf (BLUE protocol)\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)A -profile\uff0c\u6700\u53ef\u80fd\u8a3a\u65b7\u70ba\u6c23\u80f8\u3002 (B)B- profile\uff0c\u6700\u53ef\u80fd\u8a3a\u65b7\u70ba\u80ba\u6c34\u816b\uff0c\u4e5f\u53ef\u80fd\u662f\u9593\u8cea\u6027\u80ba\u708e\u53ca\u80ba\u7e96\u7dad\u5316\u3002 (C)A/B -profile\uff0c\u6700\u53ef\u80fd\u8a3a\u65b7\u70ba\u6c23\u8840\u80f8\u3002 (D)B\u2019 \u6216C-profile\uff0c\u6700\u53ef\u80fd\u8a3a\u65b7\u70ba\u80ba\u708e\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "76\u6b72\u7537\u6027\uff0c\u7121\u6162\u6027\u75c5\u53f2\uff0c\u4e5f\u6c92\u6709\u4f7f\u7528\u6297\u51dd\u8840\u5291\u3002\u56e0\u54b3\u8840\u81f3\u6025\u8a3a\uff0c\u751f\u547d\u5fb5\u8c61\u6b63\u5e38\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5927\u91cf\u54b3\u8840\u8f03\u5e38\u898b\u7684\u5b9a\u7fa9\u662f\u65bc 48\u5c0f\u6642\u5167\u54b3\u8840\u5927\u65bc 1,000 mL\u3002 (B)\u7b2c\u4e00\u7dda\u5f71\u50cf\u8a3a\u65b7\u5de5\u5177\u70ba\u80f8\u90e8 X\u5149\uff0c\u8fd1 50%\u7684\u75c5\u4eba\u5f97\u5230\u521d\u6b65\u7684\u53ef\u80fd\u8a3a\u65b7\u3002 (C)F iberoptic bronchoscopy \u76f8\u8f03 rigid bronchoscopy \u66f4\u65b9\u4fbf\u5c0d\u5927\u91cf\u54b3\u8840\u505a\u6b62\u8840\u7684\u52d5\u4f5c\u3002 (D)\u9700\u63d2\u7ba1\u6642\u5efa\u8b70\u9078\u7528\u5c0f\u865f\u7684\u6c23 \u7ba1\u5167\u7ba1\u907f\u514d\u50b7\u5230\u6c23\u7ba1\u9ecf\u819c\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u5916\u50b7\u6642\u4f7f\u7528\u6b62\u8840\u5e36\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u82e5\u70ba\u80a2\u9ad4\u5927\u91cf\u51fa\u8840\uff0c\u61c9\u7acb\u5373\u4f7f\u7528\u3002 (B)\u653e\u7f6e\u4f4d\u7f6e\u82e5\u70ba\u8179\u80a1\u6e9d\u6216\u814b\u4e0b\uff0c\u5fc5\u8981\u6642\u53ef\u4ee5\u4f7f\u7528\u7b2c\u4e8c\u689d\u6b62\u8840\u5e36\u3002 (C)\u653e\u7f6e\u65bc\u4e0a\u80a2\u7684\u6b62\u8840\u5e36\u76f8\u5c0d\u65bc\u4e0b\u80a2\uff0c\u9700\u8981\u66f4\u5927\u7684\u58d3\u529b\u624d\u80fd\u6b62\u8840\u3002 (D)\u4f7f\u7528\u6642\u9593\u904e\u9577\u6642\uff0c\u5df2\u8b49\u5be6\u53ef\u80fd\u589e\u52a0\u795e\u7d93\u6216\u808c\u8089\u640d\u50b7\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "30\u6b72\u5973\u6027\u5f9e\u706b\u5834\u88ab\u6551\u51fa\uff0c\u9ad4\u91cd 60\u516c\u65a4\uff0c\u71d2\u50b7\u9762\u7a4d\u70ba 40%\u9ad4\u8868\u9762\u7a4d\uff0c\u53e3\u54bd\u90e8\u6709\u78b3\u7c92\u6c88\u7a4d\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u6839\u64da Parkland Formula \uff0c\u524d 8\u5c0f\u6642\u6ef4\u6ce8\u6797\u683c\u6c0f\u6db2\u6bcf\u5c0f\u6642 150\u6beb\u5347\u3002 (B)\u653e\u7f6e\u9f3b\u80c3\u7ba1\u6e1b\u58d3\uff0c\u4f46\u4e00\u822c\u524d 24\u5c0f\u6642\u4e0d\u9700\u8981\u8461\u8404\u7cd6\u8f38\u6db2\u3002 (C)\u7d66\u4e88\u55ce\u5561\u6b62\u75db\uff0c\u70ba\u964d\u4f4e\u547c\u5438\u6291\u5236\u98a8\u96aa\uff0c\u808c\u8089\u6ce8\u5c04\u8f03\u975c\u8108\u6ce8\u5c04\u4f73\u3002 (D)\u7d66\u4e88\u985e\u56fa \u9187\u964d\u4f4e\u5589\u982d\u6c34\u816b\uff0cHydrocortisone 100mg STAT+Q8H IV \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "77\u6b72\u7537\u6027\uff0c\u6709\u5fc3\u808c\u6897\u585e\u75c5\u53f2\uff0c\u56e0\u8fd1\u5169\u9031\u547c\u5438\u8cbb\u529b\u3001\u7aef\u5750\u547c\u5438\u3001\u96d9\u8173\u6c34\u816b\u52a0\u5287\u81f3\u6025\u8a3a\u5c31\u8a3a\uff0c\u4ee5\u4e0b\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5728\u7d66\u4e88 Nitroglycerin \u6cbb\u7642\u5f8c\u82e5\u767c\u751f\u4f4e\u8840\u58d3\uff0c\u9808\u5148\u505c\u6b62\u85e5\u7269\uff0c\u82e5\u4f4e\u8840\u58d3\u4ecd\u6301\u7e8c\uff0c\u5247\u9808\u4f7f\u7528\u5f37\u5fc3\u85e5\u7269\u6cbb\u7642\u3002 (B)\u82e5\u767c\u751f\u4f11\u514b\u4f75\u80a5\u539a\u578b\u963b\u585e\u6027\u5fc3\u808c\u75c5\u8b8a\uff0c\u4f7f\u7528 Phenylephrine \u6cbb\u7642\u662f\u4e00\u500b\u597d\u7684\u9078\u64c7\u3002 (C)\u82e5\u4f7f\u7528\u975e\u4fb5\u8972\u6027\u6b63\u58d3\u547c\u5438\u5668\u52a0\u4e0a\u85e5\u7269\u6cbb\u7642\uff0c\u53ef\u660e\u986f\u964d\u4f4e\u4f4f\u9662\u6b7b\u4ea1\u7387\u3002 (D)\u57f7\u884c\u91cd\u9ede\u5f0f\u7167\u8b77\u8d85\u97f3\u6ce2\u6642\uff0cE -point septal separation \u548cfractional shortening \u662f\u8a55\u4f30\u5de6 \u5fc3\u5ba4\u529f\u80fd\u53ef\u4fe1\u5ea6\u9ad8\u7684\u6307\u6a19\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u95dc\u65bc toxic epidermal necrolysis \u7684\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5176\u8868\u73fe\u70ba\u76ae\u819a\u5927\u9762\u7a4d\u75bc\u75db\u6027\u7d05\u6591\u3001\u6c34\u6ce1\u53ca\u8868\u76ae\u525d\u843d\uff0c\u4e14\u4e0d\u4fb5\u72af\u7c98\u819c\u90e8\u4f4d\u3002 (B)\u6cbb\u7642\u4e0a\u5efa\u8b70\u65e9\u671f\u4f7f\u7528\u9810\u9632\u6027\u6297\u751f\u7d20\u4f86\u9810\u9632\u50b7\u53e3\u611f\u67d3\u3002 (C)\u6b64\u76ae\u819a\u75c5\u7076\u8f03\u4e0d\u6703\u5448\u73fe Nikolsky sign\u3002 (D)\u85e5\u7269\u70ba\u9020\u6210 \u6b64\u75be\u75c5\u4e4b\u6700\u5e38\u898b\u7684\u539f\u56e0\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "3\u6b72\u7537\u7ae5\uff0c\u9ad4\u91cd 15\u516c\u65a4\uff0c\u4e0a\u5410\u4e0b\u7009 2\u5929\uff0c\u610f\u8b58\u72c0\u614b\u55dc\u7761\u4e14\u6d3b\u52d5\u529b\u4f4e\u4e0b\u3001\u8840\u58d380/60 mmHg \u3001\u5fc3\u8df3 130\u6b21/min\u3001\u547c\u5438 25\u6b21/min\u3001\u9ad4\u6eab 37.5\u2103\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u9810\u4f30\u7684\u812b\u6c34\u91cf\u70ba 0.45\u516c\u65a4\u3002 (B)\u7b2c\u4e00\u7dda\u7684\u6cbb\u7642\u70ba\u53e3\u670d\u88dc\u5145\u6c34\u4efd\u3002 (C)\u6c34\u4efd\u88dc\u5145\u8d77\u59cb\u5291\u91cf\u70ba 1,000 cc\u7684\u751f\u7406\u98df\u9e7d\u6c34\u3002 (D)\u6c34\u4efd\u88dc\u5145\u7dad\u6301\u5291\u91cf\u70ba\u6bcf\u5929 1,250 cc\u76840.9%\u751f\u7406\u98df\u9e7d\u6c34\u6216 D5S\u8461\u8404\u7cd6\u98df\u9e7d\u6c34\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u60c5\u7dd2\u969c\u7919\u75c7\u75c5\u4eba\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u9b31\u75c7\u8f03\u96d9\u76f8\u60c5\u7dd2\u969c\u7919\u75c7\u5bb9\u6613\u907a\u50b3\u3002 (B)\u8e81\u75c7\u75c5\u4eba\u610f\u5ff5\u98db\u8e8d\u7684\u75c7\u72c0\u6703\u6301\u7e8c\u8d85\u904e\u4e03\u5929\u3002 (C)\u5c0d\u53ef\u80fd\u767c\u751f\u7cbe\u795e\u6fc0\u8d8a(agitation)\u7684\u75c5\u4eba\u5b9c\u76e1\u65e9\u6295\u4e88\u6297\u6182\u9b31\u5291\u3002 (D)\u5df4\u91d1\u68ee\u6c0f \u75c7\u8207\u9b31\u75c7\u8f03\u7121\u95dc\u806f\u6027\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "26\u6b72\u5973\u6027\u75c5\u4eba\uff0c\u6709\u6df1\u5c64\u975c\u8108\u6813\u585e( DVT)\u7684\u75c5\u53f2\uff0c\u5728\u61f7\u5b55\u524d\u9577\u671f\u670d\u7528warfarin\uff0c\u73fe\u56e0\u61f7\u5b55\u505c\u85e5\u3002\u547c\u5438\u56f0\u96e3\u61f7\u7591\u5927\u7bc4\u570d\u80ba\u6813\u585e\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u8a72\u75c5\u4eba\u5728\u7dca\u6025\u8655\u7f6e\u7a69\u5b9a\u5f8c\uff0c\u53ef\u7e7c\u7e8c\u670d\u7528 warfarin\uff0c\u4ee5\u9810\u9632\u8840\u6813\u6813\u585e\u7684\u518d\u767c\u751f\u3002 (B)\u75c5\u4eba\u5728\u6ca1\u6709\u6025\u6027\u51fa\u8840\u50be\u5411\u7684\u72c0\u6cc1\u4e0b\uff0c\u4e0d\u5fc5\u7b49\u5230\u78ba\u5be6\u8a3a\u65b7\uff0c\u53ef\u76f4\u63a5\u975c\u8108\u7d66\u4e88 heparin\u6cbb\u7642\u3002 (C)\u5982\u679c\u75c5\u4eba\u6709\u814e\u8870\u7aed\u6642\uff0c\u4f7f\u7528 low molecular weight heparin \u8981\u6bd4unfractionated heparin \u8981\u597d\u3002 (D)\u4f4e\u5206\u5b50\u91cf\u809d\u7d20 \u6703\u901a\u904e\u80ce\u76e4\uff0c\u9020\u6210\u7578\u80ce\u53ef\u80fd\uff0c\u56e0\u6b64\u50c5\u80fd\u76ae\u4e0b\u7d66\u85e5\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u4f4e\u8840\u7cd6\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u4f4e\u8840\u7cd6\u7684\u81e8\u5e8a\u8868\u73fe\u53ef\u5206\uff1a\u795e\u7d93\u6027\u8840\u7cd6\u904e\u4f4e(neuroglycopenic )\u548c\u81ea\u4e3b\u795e\u7d93\u75c7\u72c0(autonomic )\uff1b\u795e\u7d93\u6027\u4f4e\u8840\u7cd6\u7684\u8868\u73fe\u5305\u62ec\uff1a\u7126\u616e\u3001\u9707\u986b\u3001\u611f\u89ba\u7570\u5e38\u548c\u51fa\u6c57\u3002 (B)\u78fa\u91af\u57fa\u5c3f\u7d20 (sulfonylurea )\u85e5\u7269\u904e\u91cf\u5f15\u8d77\u7684\u4f4e\u8840\u7cd6\u75c7\uff0c\u61c9\u5e38\u898f\u4f7f\u7528\u8840\u6db2\u900f\u6790\u548c\u6d3b\u6027\u78b3\u8840\u6db2\u704c\u6d41\u6cbb\u7642\u3002 (C)\u78fa\u91af\u57fa\u5c3f\u7d20 (sulfonylurea )\u85e5\u7269\u5f15\u8d77\u7684\u53cd\u8986\u6027\u4f4e\u8840\u7cd6\uff0c\u5728\u8461\u8404\u7cd6\u6cbb\u7642\u5f8c\uff0c\u53ef\u8003\u616e\u4f7f\u7528 Octreotide \u4f86\u964d\u4f4e\u5fa9\u767c\u6027\u4f4e\u8840\u7cd6\u7684\u98a8\u96aa\u3002 (D)\u4f4e\u8840\u7cd6\u7684\u75c5 \u4eba\u4f7f\u7528 Glucagon \u6cbb\u7642\uff0c\u53ef\u4f7f\u8840\u7cd6\u4e0a\u5347 200 mg/dL \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u5375\u5de2\u626d\u8f49( ovarian torsion) \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u5375\u5de2\u626d\u8f49\u767c\u751f\u6a5f\u7387\u53f3\u5074\u8f03\u9ad8\uff0c\u591a\u6578\u75c5\u4eba\u8868\u73fe\u6709\u5641\u5fc3\u548c\u5614\u5410\u3002 (B)\u626d\u8f49\u7684\u5375\u5de2\u6216\u816b\u584a\u591a\u5927\u65bc 4\u62165\u516c\u5206\uff0c\u4f46\u5728\u521d\u7d93\u4f86\u4e4b\u524d\u767c\u751f\u7684\u5375\u5de2\u626d\u8f49\u5e38\u70ba\u6b63\u5e38\u7684\u5927\u5c0f\u3002 (C)\u5728\u61f7\u5b55\u671f\u9593\u767c\u751f\u626d\u8f49\u5e38\u5728 first trimester \u548cearly second trimester \u3002 (D)\u675c\u535c\u52d2\u8d85\u97f3\u6ce2\u82e5\u6709\u5375\u5de2\u8840\u6d41\u4e4b\u8a0a\u865f\u53ef\u6392\u9664\u5375\u5de2\u626d\u8f49\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6f5b\u6c34\u76f8\u95dc\u7684\u75be\u75c5\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5728\u6dfa\u6c34\u5340\u6f5b\u6c34\u4e26\u4e0d\u6703\u7522\u751f pulmonary b arotrauma\u3002 (B)\u6dfa\u6c34\u5340\u6f5b\u6c34\u5b8c\u5f8c\u4e0d\u518d\u6f5b\u6c34\uff0c2 \u5929\u5f8c\u642d\u6a5f\u662f\u76f8\u5c0d\u5b89\u5168\u7684\u3002 (C)\u6e1b\u58d3\u75c7\u7684\u75c7\u72c0\u591a\u5728\u6f5b\u6c34\u6d3b\u52d5\u6578\u5929\u5f8c\u9010\u6f38\u7522\u751f\u3002 (D)\u6f5b\u6c34\u5f8c\u62b1 \u6028\u80a9\u8180\u75bc\u75db\uff0c\u662f\u7b2c\u4e8c\u578b\u6e1b\u58d3\u75c7\u5e38\u898b\u75c7\u72c0\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u982d\u90e8\u5916\u50b7\u4f75\u767c\u75c7\u7684\u63cf\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u8166\u9707\u76ea\u5f8c\u75c7\u5019\u7fa4 (post concussion syndrome )\u9810\u5f8c\u826f\u597d\uff0c\u53d7\u50b7\u4e00\u5e74\u5f8c\u7684\u76db\u884c\u7387\u5c0f\u65bc 5%\u3002 (B)\u6162\u6027\u5275\u50b7\u6027\u8166\u75c5\u8b8a(chronic traumatic encephalopathy )\u597d\u767c\u65bc\u8001\u5e74\u4eba\uff0c\u5e38\u65bc\u591a\u6b21\u982d\u90e8\u5916\u50b7\u5f8c\u7522\u751f\u3002 (C)\u786c\u8166\u819c\u4e0b\u51fa\u8840(subdural hemorrhage )\u662f\u4e2d\u5ea6\u53ca\u91cd\u5ea6\u982d\u90e8\u5916\u50b7\u75c5\u4eba\u65b7\u5c64\u6383\u63cf\u5f71\u8c61\u4e0b\u6700\u5e38\u898b\u7684\u7570\u5e38\u3002 (D)\u4e8c\u5ea6\u649e\u64ca\u75c7\u5019\u7fa4(second impact syndrome )\u8087\u56e0\u65bc\u982d\u90e8\u649e\u64ca\u5f8c\u5feb\u901f\u767c\u751f\u7684\u8166\u6c34\u816b\uff0c\u6b7b\u4ea1\u7387\u53ef\u9ad8\u9054 60%\u4ee5\u4e0a\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "26\u6b72\u7684\u7537\u5b50\u4e3b\u8a34\u767c\u71d2\u3001\u6392\u5c3f\u56f0\u96e3\u4e26\u5e36\u6709\u767d\u8272\u5206\u6ccc\u7269\u53ca\u53f3\u819d\u95dc\u7bc0\u6709\u7d05\u6591\u6027\u75bc\u75db\u816b\u8139\u6301\u7e8c 3\u5929\u3002\u7d93\u62bd\u53d6\u53f3\u819d\u95dc\u7bc0\u6db2\u986f\u793a\u767d\u8840\u7403\u6578\u70ba 68,000 /mm3\uff0c\u4e2d\u6027\u740392%\u3002\u91dd\u5c0d\u6b64\u75c5\u4eba\u4e4b\u6cbb\u7642\uff0c\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u9996\u9078\u85e5\u7269\u70ba Ceftriaxone \uff0c\u5291\u91cf\u70ba\u6ce8\u5c04 1 gm QD\u3002 (B)\u82e5\u6cbb\u7642\u5408\u4f75 Chlamydia trachomatis \u7684\u5171\u75c5\u611f\u67d3\uff0c\u53ef\u4ee5\u4f7f\u7528Azithromycin\uff0c\u5291\u91cf\u70ba\u53e3\u670d 1 gm\u4e00\u6b21\u3002 (C)\u66ff\u4ee3\u85e5\u7269\u70ba Doxycycline \uff0c\u5291\u91cf\u70ba\u53e3\u670d 100 mg BID \u3002 (D)\u95dc\u7bc0\u6db2 glucose\u53caprotein\u6709\u52a9\u65bc\u6b64\u75c5\u81e8\u5e8a\u8a3a\u65b7\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u95dc\u65bc\u52d5\u8108\u7624\u7684\u81e8\u5e8a\u8868\u73fe\uff0c\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u8195\u52d5\u8108\u7624 (popliteal artery aneurysm )\u5b9a\u7fa9\u70ba\u5927\u65bc 3\u516c\u5206\u6216\u6b63\u5e38\u8840\u7ba1\u5f91\u7684 200%\uff0c\u70ba\u5468\u908a\u6700\u5e38\u898b\u7684\u8840\u7ba1\u7624\uff0c\u81e8\u5e8a\u8868\u5fb5\u53ef\u898b\u819d\u90e8\u5f8c\u816b\u8139\u5408\u4f75\u4e0d\u9069\u611f\u3002 (B)\u82e5\u75c5\u4eba\u51fa\u73fe\u4e0a\u80a2\u75bc\u75db\u3001\u7121\u529b\u4ee5\u53ca\u975e\u76ae\u7bc0\u5206\u4f48\u7684\u611f\u89ba\u6539\u8b8a\u6642\uff0c\u9700\u8003\u616e\u9396\u9aa8\u4e0b\u52d5\u8108\u7624(s ubclavian artery aneurysm )\u3002 (C)\u809d\u52d5\u8108\u7624 (hepatic artery aneurysm )\u81e8\u5e8a\u8868\u5fb5\u53ef\u80fd\u51fa\u73fe\u81bd\u7d5e\u75db\u53ca\u4e0a\u6d88\u5316\u9053\u51fa\u8840\uff0c\u82e5\u7834\u88c2\u9032\u5165\u7e3d\u81bd\u7ba1\uff0c\u53ef\u80fd\u51fa\u73fe\u81bd\u9053\u51fa\u8840(hemobilia )\uff0c\u4f46\u4e0d\u6703\u4ee5\u9ec3\u75b8\u8868\u73fe\u3002 (D)\u814e\u52d5\u8108\u7624 (renal artery aneurysm )\u81e8\u5e8a\u53ef\u80fd\u51fa\u73fe\u8170\u75db\u53ca\u8840\u5c3f\uff0c\u4e00\u65e6\u7834\u88c2\u53ef\u80fd\u9020\u6210\u4f11\u514b\uff0c\u4f46\u4e0d\u6703\u9020\u6210\u96c6\u5c3f\u7cfb\u7d71\u7684\u963b\u585e\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6839\u64da AHA 2020 \u5e74ACLS\u6307\u5f15\uff0c\u95dc\u65bc\u5fc3\u81df\u505c\u6b62\u7d93\u5fa9\u7526\u5f8c\u7684\u75c5\u4eba\u4e4b\u7167\u8b77\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u4f7f\u7528\u547c\u5438\u5668\u7684\u75c5\u4eba\uff0c\u5efa\u8b70 SpO 2\u7dad\u6301\u5728 92%- 98%\uff0c\u4e26\u76e1\u91cf\u907f\u514d\u9577\u6642\u9593\u7684\u904e\u9ad8\u8840\u6c27 PaO 2>300 mmHg \u3002 (B)\u5efa\u8b70\u8840\u6db2\u4e2d\u4e8c\u6c27\u5316\u78b3\u5206\u58d3 PaCO 2 \u7dad\u6301\u5728 35-45 mmHg\u3002 (C)\u82e5\u6709\u6025\u6027\u547c\u5438\u7a98\u8feb\u75c7\u5019\u7fa4(ARDS )\uff0c\u547c\u5438\u5668\u6f6e\u6c23\u91cf\u61c9\u7dad\u6301\u5728 4-8 mL/kg of predictive body weight \u3002 (D)\u5fa9\u7526\u5f8c\u75c5 \u4eba\u80ba\u708e\u767c\u751f\u7387\u9ad8\uff0c\u4e14\u767c\u751f\u80ba\u708e\u8005\u9810\u5f8c\u8f03\u5dee\uff0c\u5efa\u8b70\u5e38\u898f\u7d66\u4e88\u5ee3\u6548\u6027\u6297\u751f\u7d20\u9810\u9632\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6025\u6027\u5fc3\u808c\u6897\u585e (AMI)\u8207troponin(TnI)\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)AMI \u4e4b\u5f8c 6\u5c0f\u6642\uff0cTnI \u7684specificity \u7d04\u70ba 95%\u3002 (B)AMI \u4e4b\u5f8c 6\u5c0f\u6642\uff0cTnI \u7684sensitivity \u7d04\u70ba 95%\u3002 (C)AMI \u4e4b\u5f8c TnI\u7684\u6578\u503c\u7d04\u5728 36\u5c0f\u6642\u9054\u5230\u9ad8\u5cf0\u3002 (D)AMI \u4e4b\u5f8c TnI\u7684\u6578\u503c\u7d04\u5728 72\u5c0f\u6642\u5167\u56de\u5fa9\u81f3\u539f\u4f86\u6578\u503c(baseline )\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u547c\u5438\u56f0\u96e3\u75c5\u4eba\u7684\u8a55\u4f30\u53ca\u8655\u7f6e\u65b9\u5f0f\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u767c\u7d3a (cyanosis) \u662f\u4f4e\u8840\u6c27\u75c7\u75c5\u4eba\u5177\u7279\u7570\u6027\u53ca\u654f\u611f\u6027\u7684\u6307\u6a19\u3002 (B)\u7d66\u6c27\u5f8c\u7121\u6cd5\u63d0\u5347\u52d5\u8108\u8840\u6c27\u6fc3\u5ea6\u662f\u5224\u65b7\u53f3\u81f3\u5de6\u5206\u6d41 (right -to-left shunt)\u7684\u91cd\u8981\u6307\u6a19\u3002 (C)\u91dd\u5c0d\u6240\u6709\u6162\u6027\u80ba\u75c5\u75c5\u4eba\u7684\u9ad8\u78b3\u9178\u8840\u75c7\uff0c\u907f\u514d\u6c27\u6c23\u7d66\u4e88\uff0c\u4ee5\u523a\u6fc0\u901a\u6c23\u3002 (D)\u4e00\u6c27\u5316\u78b3\u4e2d\u6bd2\u75c5\u4eba\u56e0\u70ba\u8840\u7d05\u7d20\u4e2d\u7684\u6c27\u6c23\u88ab\u53d6\u4ee3\uff0c\u4f7f\u7528\u8840\u6c27\u6fc3\u5ea6\u8a08\u6e2c\u91cf\u6642\uff0c\u53ef\u898b\u6578\u503c\u4e0b\u964d\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "32\u9031\u7684\u5b55\u5a66\uff0c\u56e0\u898f\u5247\u4e14\u6108\u76ca\u983b\u7e41\u7684\u5bae\u7e2e\u548c\u9670\u9053\u6709\u8840\u6a23\u5206\u6ccc\u7269\u81f3\u6025\u8a3a\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u80ce\u5152\u76e3\u8996\u5668\u986f\u793a\u80ce\u5152\u5fc3\u8df3 103\u6b21/min\uff0c\u5c6c\u65bc\u80ce\u5152\u7a98\u8feb(fetal distress)\u3002 (B)\u82e5\u8981\u505a\u9670\u9053\u6307\u6aa2\uff0c\u61c9\u5148\u505a\u5e8a\u908a\u8d85\u97f3\u6ce2\u6392\u9664\u524d\u7f6e\u80ce\u76e4(placenta previa)\u3002 (C)\u82e5\u75c5\u4eba\u5df2\u7d93\u7834\u6c34\uff0c\u4e0d\u8981\u505a\u9670\u9053\u6307\u6aa2\u63a2\u67e5\u5b50\u5bae\u9838\u64f4\u5f35\u7a0b\u5ea6\uff0c\u4ee5\u907f\u514d\u611f\u67d3\u3002 (D)\u82e5\u7d93\u9670\u9053 \u6025\u7522\uff0c\u5206\u5a29\u5f8c\u7acb\u5373\u7528\u81cd\u5e36\u593e\u56fa\u5b9a\u4e26\u526a\u65b7\u81cd\u5e36\uff0c\u4ee5\u5229\u65b0\u751f\u5152\u8a55\u4f30\u548c\u8655\u7f6e\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u751f\u6b96\u5668\u6f70\u760d\u4e4b\u63cf\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f ", + "Options": "(A)\u751f\u6b96\u5668\u7121\u75db\u4e0b\u75b3\u53ef\u4ee5\u662f\u7b2c\u4e00\u671f\u6885\u6bd2\u4e4b\u8868\u73fe\uff0c\u6cbb\u7642\u6642\u53ef\u80fd\u6703\u51fa\u73fe Jarisch-Herxheimer \u53cd\u61c9\u3002 (B)\u6885\u6bd2\u4e4b\u75c5\u539f\u9ad4\u70ba Treponena pallidum \uff0c\u800c Penicillin \u4ecd\u662f\u76ee\u524d\u6297\u751f\u7d20\u6cbb\u7642\u7684\u9996\u9078\u85e5\u7269\u3002 (C)\u7121\u75db\u4e0b\u75b3\u51fa\u73fe\u6642\uff0c\u6aa2\u67e5 VDRL/RPR (Venereal Disease Research Laboratory/Rapid Plasma Reagin ) \u53ef\u8a3a\u65b7\u6885\u6bd2\u3002 (D)HSV(Herpes simplex virus )\u6703\u9020\u6210\u75bc\u75db\u6027\u751f\u6b96\u5668\u6f70\u760d\u3002\u76ee\u524d HSV -2\u4f54\u5927\u591a\u6578\uff0c\u4f46 HSV-1\u7684\u611f\u67d3\u8005\u4e5f\u6301\u7e8c\u4e0a\u5347\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u8003\u616e\u5b89\u5be7\u7de9\u548c\u91ab\u7642 (hospice and palliative care )\u7684\u75c5\u4eba\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u80ba\u764c\u5408\u4f75\u80ba\u3001\u8166\u3001\u591a\u8655\u9aa8\u9abc\u8f49\u79fb\uff0c\u5617\u8a66\u904e\u6a19\u9776\u53ca\u514d\u75ab\u6cbb\u7642\u4ecd\u6301\u7e8c\u60e1\u5316\uff0c\u4e0a\u500b\u6708\u958b\u59cb\u7ba1\u9935\u3001\u795e\u667a\u6f38\u6f38\u8b8a\u5dee\u3002 (B)80 \u6b72\u8001\u7fc1\uff0c\u591a\u6b21\u5fc3\u808c\u6897\u585e\u3001\u5171\u88dd\u7f6e 9\u96bb\u8840\u7ba1\u652f\u67b6\uff0c\u56e0\u5fc3\u8870\u7aed\u4e09\u500b\u6708\u5167\u4f4f\u9662\u56db\u6b21\u3001\u4e14\u51fa\u9662\u5929\u6578\u8d8a\u4f86\u8d8a\u77ed\u3002 (C)\u5927\u8178\u53ca\u8180\u80f1\u764c\u8853\u5f8c\uff0c\u672b\u671f\u814e\u75c5\u8840\u6db2\u900f\u6790\u5df2\u516b\u5e74\uff0c\u6700\u8fd1\u56e0\u900f\u6790\u8840\u7ba1\u591a\u6b21\u963b\u585e\u3001\u8868\u9054\u4e0d\u60f3\u518d\u900f\u6790\u3002 (D)\u706b\u5834\u53d7\u56f0 40\u6b72\u7537\u6027\uff0c\u56e0\u6fc3\u7159\u5438\u5165\u812b\u56f0\u5f8c\u5df2\u63d2\u6c23\u7ba1\u5167\u7ba1\uff0c\u62b5\u9662\u6642E2M5Vt\u3001\u9664\u6703\u9670\u90e8 \u4ee5\u5916\u5747\u70ba 2~3\u5ea6\u71d2\u50b7\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u6709\u95dc Wellens \u2019 syndrome \u63cf\u8ff0\uff0c\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u75c5\u4eba\u7684\u5fc3\u81df\u9175\u7d20\u6aa2\u9a57\u5f88\u6709\u53ef\u80fd\u5728\u6b63\u5e38\u503c\u7bc4\u570d\u5167\u3002 (B)\u75c5\u4eba\u80f8\u75db\u767c\u4f5c\u7684\u6642\u5019\uff0c\u5fc3\u96fb\u5716\u53ef\u80fd\u6c92\u6709\u7570\u5e38\u8b8a\u5316\u3002 (C)\u53ef\u80fd\u767c\u73fe\u5fc3\u96fb\u5716\u90e8\u5206\u80a2\u7aef\u5c0e\u6975\u6709\u6df1\u800c\u5c0d\u7a31\u7684\u5012 T\u6ce2\u3002 (D)25% \u7684\u75c5\u4eba\u5fc3\u96fb\u5716\u6703\u6709\u96d9\u5411 T\u6ce2(biphasic T wave )\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "1\u6b72\u5b30\u5152\u5614\u5410 5\u6b21\u3001\u6c34\u7009 5\u6b21\u3001\u751f\u547d\u8de1\u8c61\u7a69\u5b9a\u3001\u7406\u5b78\u53ca\u62bd\u8840\u6aa2\u67e5\u7121 \u660e\u986f\u7570\u5e38\uff0c\u5c1a\u7121\u812b\u6c34\u73fe\u8c61\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u53ef\u4f7f\u7528 Loperamide \u3002 (B)\u5efa\u8b70\u4f7f\u7528 BRAT\u98f2\u98df( Banana, Rice, Applesauce, and Toast diet )\u3002 (C)\u75c5\u7ae5\u75c7\u72c0\u5c1a\u8f15\u5fae\uff0c\u53ef\u5148\u7981\u98df\u56db\u81f3\u516d\u5c0f\u6642\u3002 (D)\u4e0d\u53ef\u4f7f \u7528dopamine receptor agonists\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u5c0f\u5152\u7d30\u83cc\u6027\u6c23\u7ba1\u708e( bacterial tracheitis )\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u6c23\u7ba1\u5340\u57df\u58d3\u75db\u8f03\u5c11\u898b\u3002 (B)\u9838\u90e8 X\u5149\u6aa2\u67e5\u53ef\u898b\u8072\u9580\u4e0a\u72f9\u7a84\u53ca\u6c23\u7ba1\u908a\u7de3\u4e0d\u898f\u5247\u3002 (C)\u6c23\u7ba1\u63d2\u7ba1\u5f8c\uff0c\u518d\u505a\u652f\u6c23\u7ba1\u93e1 (bronchoscopy )\u6709\u52a9\u65bc\u8a3a\u65b7\u53ca\u6cbb\u7642\u3002 (D)\u6a19\u6e96\u6cbb\u7642 \u9808\u4f7f\u7528\u5ee3\u6548\u6027\u6297\u751f\u7d20\u53ca\u985e\u56fa\u9187\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u7cd6\u5c3f\u75c5\u916e\u9178\u8840\u75c7( DKA)\u7684\u6558\u8ff0\uff0c\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5b55\u5a66\u767c\u751f DKA\u6642\u7684\u521d\u59cb\u8840\u7cd6\u503c\u8f03\u4e00\u822c\u75c5\u4eba\u66f4\u9ad8\u3002 (B)\u8840\u7cd6\u4e0b\u964d\u901f\u5ea6\u9700\u63a7\u5236\u5728\u6bcf\u5c0f\u6642 50-75 mg/dL \u3002 (C)\u8166\u6c34\u816b\u662f\u6cbb\u7642 DKA\u7684\u4f75\u767c\u75c7\uff0c\u8f03\u5e38\u767c\u751f\u5728\u8001\u5e74\u4eba\u3002 (D)\u82e5\u521d\u59cb\u8840\u7cd6\u70ba 270 mg/dL \u4ee5\u4e0b\uff0c\u5373\u53ef\u6392\u9664 DKA\u7684\u53ef\u80fd\u6027\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u984f\u9762\u5275\u50b7\u7684\u6aa2\u67e5\u8207\u8a3a\u65b7\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u773c\u90e8\u53d7\u50b7\u6642\uff0c\u82e5\u51fa\u73fe\u96d9\u773c\u8907\u8996\uff0c\u53ef\u80fd\u662f\u6c34\u6676\u9ad4\u812b\u4f4d\u6240\u81f4\u3002 (B)\u58d3\u820c\u677f\u6e2c\u8a66 (tongue blade test )\u53ef\u8a55\u4f30\u75c5\u4eba\u662f\u5426\u70ba\u773c\u7736\u9aa8\u9aa8\u6298\u3002 (C)\u773c\u90e8\u5c0d\u5149\u53cd\u61c9\u51fa\u73fe Marcus Gunn pupil \u6642\uff0c\u9700\u8003\u616e\u8996\u795e\u7d93\u53d7\u640d\u3002 (D)\u61f7\u7591\u75c5\u4eba\u9f3b\u8154\u5206\u6ccc\u7269\u70ba\u8166\u810a\u9ad3\u6db2\u5916\u6f0f\u6642\uff0c\u53ef\u6aa2\u6e2c\u5206\u6ccc\u7269\u7684 beta-2 microglobulin \u505a\u70ba\u9451\u5225\u8a3a\u65b7\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5b55\u5a66\u6df1\u975c\u8108\u6813\u585e\u6216\u80ba\u6813\u585e\u7684\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)Wells score \u9069\u7528\u65bc\u5b55\u5a66\u8a55\u4f30\u6df1\u975c\u8108\u6813\u585e\u3002 (B)\u6709\u986f\u5f71\u5291\u7684 MRI/MRV \u8b49\u5be6\u80fd\u6709\u6548\u8a3a\u65b7\u9aa8\u76c6\u8154\u6df1\u975c\u8108\u6813\u585e\uff0c\u5c0d\u65bc\u5b55\u5a66\u548c\u80ce\u5152\u662f\u5b89\u5168\u7121\u5bb3\u7684\u3002 (C)\u5c0d\u65bc\u80ba\u6813\u585e\u800c\u8840\u884c\u52d5\u529b\u5b78\u4e0d\u7a69\u5b9a\u7684\u5b55\u5a66\uff0c\u61c9\u8a72\u4f7f\u7528 Warfarin \u6cbb\u7642\u3002 (D)\u5c0d\u65bc\u8840\u884c\u52d5\u529b\u5b78\u7a69\u5b9a\u7684\u5b55\u5a66\uff0c\u8d85\u97f3\u6ce2\u767c\u73fe\u6709\u6df1\u975c\u8108\u6813\u585e\uff0c\u81e8\u5e8a\u61f7\u7591\u80ba\u6813\u585e\u5373\u53ef\u4f7f\u7528 \u6297\u51dd\u8840\u5291\u6cbb\u7642\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "26\u6b72\u60a3\u6709\u601d\u89ba\u5931\u8abf\u75c7\u7684\u5973\u6027\u75c5\u4eba\uff0c\u7121\u9152\u7cbe\u6feb\u7528\u53f2\uff0c\u88ab\u9001\u81f3\u6025\u8a3a\u3002\u75c5\u4eba\u5728\u64d4\u67b6\u5e8a\u4e0a\u5927\u8072\u5486\u54ee\u3001\u6fc0\u52d5\u4e0d\u5b89\u3002\u4e0b\u4e00\u6b65\u8655\u7f6e\u4ee5\u4f55\u8005\u8f03\u70ba\u9069\u7576 \uff1f", + "Options": "(A)\u85e5\u7269\u61c9\u4ee5 Benzodiazepine \u70ba\u9996\u9078\u85e5\u7269\uff0c\u4f8b\u5982\u808c\u8089\u6ce8\u5c04 Lorazepam \u3002 (B)\u8003\u616e\u75c5\u53f2\uff0c\u6b64\u6642\u53ef\u9078\u64c7 Olanzapine IM \u4f5c\u70ba\u9996\u9078\u85e5\u7269\u3002 (C)\u5118\u5feb\u4f7f\u7528\u7d04\u675f\u5e36\u4fdd\u8b77\u75c5\u4eba\uff0c\u6e1b\u5c11\u91dd\u5291\u4f7f\u7528\u4ee5\u907f\u514d\u547c\u5438\u6291\u5236\u3002 (D)\u82e5\u75c5\u4eba\u6709\u61f7\u5b55\u53ef\u80fd\uff0c\u5efa\u8b70\u4ee5 Haloperidol \u6cbb\u7642\u512a\u5148\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u6c23\u5598\u75c5\u53f2\u4e14\u898f\u5247\u670d\u85e5\u7684 40\u6b72\u5973\u6027\uff0c\u56e0\u547c\u5438\u8cbb\u529b\u81f3\u6025\u8a3a\u3002\u95dc\u65bc\u6b64\u75c5\u4eba\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u6b64\u75c5\u4eba\u63d2\u5b8c\u6c23\u7ba1\u5167\u7ba1\u5f8c\uff0c\u80fd\u900f\u904e\u547c\u5438\u5668\u6539\u5584\u75c5\u4eba\u6c23\u7ba1\u963b\u585e\u58d3\u529b\u3002 (B)\u82e5\u6b64\u75c5\u4eba\u9700\u8981\u63d2\u7ba1\uff0cKetamine \u6703\u9020\u6210 catecholamine \u5927\u5e45\u589e\u52a0\uff0c\u5728\u6b64\u985e\u75c5\u4eba\u662f\u7981\u7528\u7684\u3002 (C)\u6c23\u5598\u6025\u6027\u767c\u4f5c\u800c\u4f4f\u9662\u7684\u75c5\u4eba\u8981\u7167 CXR\uff0c\u56e0\u6709\u9ad8\u9054 5\u6210\u6a5f\u7387\u6703\u6709\u7570\u5e38\u3002 (D)\u77ed\u6548 \u03b2-agonist\u5408\u4f75\u4f7f\u7528\u591a\u5291 Ipratropium \u80fd\u6e1b\u4f4e\u4e2d\u91cd\u5ea6\u6c23\u5598\u6025\u6027\u767c\u4f5c\u75c5\u4eba\u7684\u4f4f\u9662\u7387\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u5589\u56a8\u75db\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u5408\u4f75\u541e\u56a5\u56f0\u96e3\u3001\u547c\u5438\u6025\u4fc3\u7684\u75c5\u4eba\uff0c\u9808\u7acb\u5373\u9032\u884c\u9838\u90e8\u96fb\u8166\u65b7\u5c64\u8a3a\u65b7\u3002 (B)Group A \u03b2 -hemolytic Streptococcus \u6025\u6027\u54bd\u5589\u708e\uff0c\u7528 Penicillin \u4f5c\u70ba\u7b2c\u4e00\u7dda\u6cbb\u7642\u3002 (C)\u5927\u90e8\u5206\u6df1\u9838\u90e8\u611f\u67d3\u591a\u70ba\u7259\u6e90\u6027\uff0c\u4e0b\u984e\u7259\u9f52\u5c45\u591a\u3002 (D)\u9032\u884c\u6241\u6843\u817a\u81bf\u760d\u7d30\u91dd\u62bd\u5438\u6642\uff0c\u9032\u91dd\u6df1\u5ea6\u4e0d\u53ef\u8d85\u904e 1\u516c\u5206\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u91dd\u5c0d\u5fc3\u8df3\u505c\u6b62\u5f8c\u75c7\u5019\u7fa4( post-cardiac arrest syndrome )\u5f8c\u4e4b\u7167\u8b77\uff0c\u4e0b\u5217\u4f55\u8005\u6558\u8ff0\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u525b \u6062\u5fa9\u81ea\u767c\u6027\u5faa\u74b0(ROSC)\u5f8c\uff0c\u82e5\u96d9\u5074\u77b3\u5b54\u5149\u53cd\u5c04\u6d88\u5931\uff0c\u53ef\u4ee5\u9810\u6e2c\u75c5\u4eba\u6062\u5fa9\u610f\u8b58\u7684\u6a5f\u6703\u5f88\u4f4e\u3002 (B)\u5230\u9662\u524d\u547c\u5438\u5fc3\u8df3\u505c\u6b62 (OHCA)\u7684\u75c5\u4eba\uff0c\u82e5\u521d\u59cb\u5fc3\u5f8b\u70ba\u975e\u53ef\u96fb\u64ca\u5fc3\u5f8b(non -shockable rhythm )\uff0c\u5247\u4e0d\u5efa\u8b70\u4f7f\u7528\u76ee\u6a19\u9ad4\u6eab\u7ba1\u7406 (targeted temperature management )\u3002 (C)\u91dd\u5c0d\u5fc3\u8df3\u505c\u6b62\u5fa9\u7526\u5f8c\u610f\u8b58\u4e0d\u6e05\u75c5\u4eba\uff0c\u5efa\u8b70\u5e38\u898f\u4f7f\u7528\u6297\u7672\u7647\u85e5\u7269\uff0c\u53ef\u4ee5\u6e1b\u5c11\u975e\u62bd\u6410\u6027\u7684\u300c\u7672\u7647\u91cd\u7a4d\u72c0\u614b\u300d (non-convulsive status epilepticus )\u6a5f\u7387\u3002 (D)ROSC \u5f8c\u7684\u610f\u8b58\u72c0\u6cc1\u8207\u795e\u7d93\u5b78\u6aa2\u67e5\u7d50\u679c\uff0c\u4e0d\u61c9\u8a72\u7528\u4f86\u6c7a\u5b9a\u75c5\u4eba\u662f\u5426\u63a5\u53d7\u7dca\u6025\u5fc3\u5c0e\u7ba1\u6aa2 \u67e5\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "60\u6b72\u7537\u6027\u75c5\u4eba\uff0c 2\u5c0f\u6642\u524d\u958b\u59cb\u4e0a\u8179\u75db\uff0c 1\u5c0f\u6642\u524d\u767c\u751f\u56b4\u91cd\u7684\u5641\u5fc3\u53ca\u591a\u6b21\u81bd\u6027\u6c41\u5614\u5410 (bilious vomiting )\uff0c\u75c5\u4eba\u7121\u5fc3\u81df\u75c5\u53f2\uff0c\u6b64\u6b21\u5fc3\u96fb\u5716\u6b63\u5e38\uff0c\u4e0b\u5217\u4f55\u8005\u662f\u6700\u53ef\u80fd \u9020\u6210\u75c5\u4eba\u5614\u5410\u7684\u539f\u56e0\uff1f", + "Options": "(A)\u98df \u9053\u5f1b\u7de9\u4e0d\u80fd (Achalasia )\u3002 (B)\u80c3\u51fa\u53e3\u963b\u585e (Gastric outlet obstruction )\u3002 (C)\u5927\u8178\u963b\u585e (Large bowel obstruction )\u3002 (D)\u5c0f\u8178\u963b\u585e (Small bowel obstruction )\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6025\u8a3a\u4e0b\u80cc\u75db\u75c5\u4eba\u4e4b\u6aa2\u67e5\u8207\u8655\u7f6e\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u975e \u75c7\u72c0\u5074\u7684\u4e0b\u80a2\u76f4\u817f\u62ac\u9ad8\u8a66\u9a57 (crossed straight leg raise test )\u967d\u6027\uff0c\u5c0d\u65bc\u690e\u9593\u76e4\u7a81\u51fa\u75c7\u8a3a\u65b7\u5177\u6709\u9ad8\u5ea6\u7279\u7570\u6027(specificity)\u4f46\u4f4e\u654f\u611f\u5ea6(sensitivity )\u3002 (B)\u5c0d\u65bc\u7591\u4f3c\u816b\u7624\u9020\u6210\u786c\u819c\u58d3\u8feb\u75c7\uff0cdexamethasone \u61c9\u5728\u78ba\u5b9a\u6027\u6aa2\u67e5\u78ba\u8a8d\u524d\u4f7f\u7528\u3002 (C)\u8170\u690e\u810a\u67f1\u72f9\u7a84(spinal stenosis)\u6240\u7522\u751f\u795e\u7d93\u6027\u9593\u6b47\u8ddb\u884c\uff0c\u5728\u810a\u690e\u524d\u5c48\u6642\u75c7\u72c0\u52a0\u91cd\uff0c\u800c\u810a\u690e\u4f38\u5c55\u6642\u8f03\u6e1b\u7de9\u3002 (D)\u6a6b\u8cab\u6027\u810a\u9ad3\u708e(transverse myelitis )\u7684\u8166\u810a\u9ad3\u6db2\u6aa2\u67e5\u7d93\u5e38\u5448\u73fe\u6dcb\u5df4\u7403\u6dcb\u5df4\u7d30\u80de\u589e\u591a (lym phocytosis) \u548c\u86cb\u767d\u8cea\u5347\u9ad8\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc catastrophic antiphospholipid syndrome \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u53ea \u6709\u5c11\u6578\u75c5\u4eba\u53ef\u627e\u5230\u8a98\u767c\u56e0\u5b50\uff0c\u4f8b\u5982\u611f\u67d3\u3001\u624b\u8853\u3001\u5916\u50b7\u53ca\u5916\u6e90\u6027\u96cc\u6fc0\u7d20\u66b4\u9732\u3002 (B)\u80ba\u81df\u662f\u6700\u4e3b\u8981\u53d7\u5f71\u97ff\u7684\u5668\u5b98\uff0c\u5176\u6b21\u662f\u814e\u81df\uff0c\u4e2d\u6a1e\u795e\u7d93\u3001\u5fc3\u81df\u53ca\u76ae\u819a\u3002 (C)\u8179\u90e8\u53ef\u767c\u73fe\u7db2\u72c0\u9752\u6591 (Livedo reticularis )\uff0c\u5c11\u6578\u75c5\u4eba\u6703\u51fa\u73fe\u8840\u5c0f\u677f\u6e1b\u5c11\u3002 (D)\u56e0 unfractionated heparin \u5177\u6297\u767c\u708e\u7279\u8cea\u53ca\u5b89\u5168\u8207\u6709\u6548\u6027\uff0c\u5efa\u8b70\u7528\u65bc\u6b64\u985e\u65cf\u7fa4\u7684\u6297\u51dd\u5291 \u6cbb\u7642\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u61f7\u5b55\u5973\u6027 \u6025\u6027\u8179\u75db\u8a3a\u65b7\u70ba\u6025\u6027\u95cc\u5c3e\u708e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5b55 \u5a66\u767c\u751f\u95cc\u5c3e\u708e\u7684\u6bd4\u7387\u7d04\u70ba\u672a\u61f7\u5b55\u7684 2\u500d\u3002 (B)\u5927\u90e8\u5206\u7684\u5b55\u5a66\u5373\u4f7f\u5728\u7b2c 3\u5b55\u671f(third trimester )\uff0c\u95cc\u5c3e\u708e\u8179\u75db\u7684\u4f4d\u7f6e\u4ecd\u4f4d\u65bc\u53f3\u4e0b\u8179\u3002 (C)\u5b55\u5a66\u7531\u65bc\u89e3\u5256\u4f4d\u7f6e\u7684\u6539\u8b8a\uff0c\u6025\u6027\u95cc\u5c3e\u708e\u6700\u5e38\u767c\u751f\u5728\u7b2c 3\u5b55\u671f\u3002 (D)\u5b55\u5a66\u7f79\u60a3 \u6025\u6027\u95cc\u5c3e\u708e\u5408\u4f75\u7a7f\u5b54\uff0c\u767c\u751f\u80ce\u5152\u6d41\u7522\u7684\u6bd4\u7387\u7d04\u70ba 50%\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u4e00\u6c27\u5316\u78b3\u4e2d\u6bd2\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u82e5\u51fa\u73fe\u7672\u7647\u75c7\u72c0\uff0c\u5c1a\u4e0d\u7b26\u5408\u9ad8\u58d3\u6c27\u6cbb\u7642\u9069\u61c9\u75c7\u3002 (B)\u82e5\u70ba\u5b55\u5a66\uff0c\u795e\u667a\u6e05\u9192\uff0c\u8840\u4e2d COHb\u70ba10%\uff0c\u7b26\u5408\u9ad8\u58d3\u6c27\u6cbb\u7642\u9069\u61c9\u75c7\u3002 (C)\u82e5\u7d93\u8108\u885d\u5f0f\u8840\u6c27\u6fc3\u5ea6\u5668\u6e2c\u5f97 SpO 2>94%\uff0c\u5c1a\u4e0d\u9700\u8981\u7d66\u4e88\u6c27\u6c23\u6cbb\u7642\u3002 (D)\u82e5\u51fa\u73fe\u56b4\u91cd \u4ee3\u8b1d\u6027\u9178\u4e2d\u6bd2\uff0c\u7b26\u5408\u9ad8\u58d3\u6c27\u6cbb\u7642\u9069\u61c9\u75c7\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u98df\u9053\u5167\u7570\u7269\u7684\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5c0f\u5b69\u8aa4\u541e\u9215\u6263\u96fb\u6c60\uff0c\u901a\u5e38\u63a1\u4fdd\u5b88\u7642\u6cd5\u6703\u6bd4\u8f03\u5b89\u5168\u3002 (B)\u5c16\u92b3\u7570\u7269\u901a\u904e\u80c3\u90e8\u5f8c\uff0c\u5e38\u5c0e\u81f4\u8178\u7a7f\u5b54\u3002 (C)\u98df\u9053\u963b\u585e\u7684\u75c5\u4eba\u5728\u81e8\u5e8a\u4e0a\u4e0d\u6703\u51fa\u73fe\u547c\u5438\u56f0\u96e3\u3002 (D)\u92f0\u96fb\u6c60\u56e0\u70ba \u96fb\u58d3\u8f03\u4f4e\uff0c\u56e0\u6b64\u9020\u6210\u7684\u50b7\u5bb3\u6703\u8f03\u5c0f\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "44\u6b72\u7537\u6027\u6709\u7cd6\u5c3f\u75c5\u75c5\u53f2\uff0c\u53f3\u4e0b\u80a2\u7d05\u816b 3\u5929\u53ca\u767c\u71d2\u81f3\u6025\u8a3a\uff0c\u8acb\u554f\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u82e5\u66fe\u63a5\u89f8\u6d77\u6c34\uff0c\u61c9\u8003\u616e\u6d77\u6d0b\u5f27\u83cc( Vibrio vulnificus )\u611f\u67d3\uff0c\u9996\u9078Vancomycin \u6cbb\u7642\u3002 (B)\u7d05\u816b\u8655\u76ae\u819a\u5b8c\u6574\u7121\u50b7\u53e3\u53ca\u6c34\u6ce1\uff0c\u5247\u53ef\u6392\u9664\u58de\u6b7b\u6027\u7b4b\u819c\u708e\u3002 (C)\u76ae\u819a\u7d05\u816b\u8655\u51fa\u73fe\u6c34\u6ce1\uff0c\u9700\u5148\u9032\u884c\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u4ee5\u78ba\u8a3a\u58de\u6b7b\u6027\u7b4b\u819c\u708e\u3002 (D)\u96fb\u8166\u65b7\u5c64 \u6aa2\u67e5\u767c\u73fe\u8edf\u7d44\u7e54\u5167\u6709\u7a7a\u6c23\u53ef\u8a3a\u65b7\u70ba\u58de\u6b7b\u6027\u7b4b\u819c\u708e\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "9\u6b72\u5b69\u7ae5 30\u516c\u65a4\uff0c\u56e0\u8179\u90e8\u632b\u50b7\u9001\u81f3\u6025\u8a3a\uff0c\u610f\u8b58\u6e05\u695a\u4f46\u547c\u5438\u6025\u4fc3\u5192\u51b7\u6c57\uff0c\u8179\u90e8\u58d3\u75db\u5408\u4f75\u53cd\u5f48\u75db\uff0c\u8840\u58d3 100/50 mmHg\uff0c\u5fc3\u8df3 130\u6b21/min\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u7d93\u8a55\u4f30\u82e5\u6709\u5167\u51fa\u8840\uff0c\u51fa\u8840\u7b49\u7d1a\u70ba\u4e2d\u5ea6(blood volume loss 30 -45%)\u3002 (B)\u7b2c\u4e00\u6b21\u8f38\u6db2\u7d66\u4e88 10 mL/kg\u7b49\u5f35\u6676\u8cea\u8f38\u6db2 (isotonic crystalloid solution)\uff0c\u518d\u6b21\u8a55\u4f30\u3002 (C)\u7b2c\u4e00\u6b21\u8f38\u6db2\u5f8c\u82e5\u4ecd\u4f11\u514b\uff0c\u5247\u53ef\u4ee5\u7d66\u7b2c\u4e8c\u6216\u7b2c\u4e09\u6b21 20 mL/kg\u7b49\u5f35\u6676\u8cea\u8f38\u6db2\u3002 (D)\u82e5\u8f38\u8840\u6cbb\u7642 \u4ee520 mL/kg PRBC s\u8f38\u8840\u6cbb\u7642\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6839\u64da 2020\u65b0\u7248 AHA\u5152\u7ae5\u9ad8\u7d1a\u6551\u547d\u8853 (AHA -PALS)\u6700\u65b0\u5efa\u8b70\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u5c0f\u5152\u751f\u5b58\u4e4b\u93c8\u589e\u52a0\u4e86\u7b2c\u516d\u500b\u9023\u7d50\u300c\u5fa9\u539f recovery\u300d\u53ca IHCA\u751f\u5b58\u4e4b\u93c8\u3002 (B)\u5b30\u5152\u548c\u5152\u7ae5\u6709\u8108\u640f\u4f46\u6c92\u6709\u547c\u5438\u6216\u547c\u5438\u4e0d\u6b63\u5e38\uff0c\u6bcf 2-3\u79d2\u9032\u884c 1\u6b21\u4eba\u5de5\u547c\u5438\u662f\u5408\u7406\u7684\u3002 (C)\u5df2\u7f6e\u5165\u9032\u968e\u547c\u5438\u9053\u7684\u5b30\u5152\u548c\u5152\u7ae5\u65bd\u884c CPR\u6642\uff0c\u547c\u5438\u901f\u7387\u76ee\u6a19\u8a2d\u5b9a\u70ba\u6bcf 2-3\u79d2\u901a\u6c23\u3002 (D)\u5c0f\u5152\u61c9\u512a\u5148\u9078\u64c7\u7121\u6c23\u56ca\u7684\u6c23\u7ba1\u5167\u7ba1\u63d2\u7ba1\uff0c\u5982\u4f7f\u7528\u6709\u6c23\u56ca\u7684\u5167\u7ba1\u6642\uff0c\u61c9\u6ce8\u610f\u5145\u6c23\u58d3\u529b\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u91dd\u5c0d\u4e0d\u540c\u90e8\u4f4d\u9aa8\u6298\u75bc\u75db\uff0c\u5728\u6025\u8a3a\u57f7\u884c\u8d85\u97f3\u6ce2\u5c0e\u5f15\u795e\u7d93\u963b\u65b7\u8853\u6b62\u75db\uff0c\u4e0b\u5217\u914d\u5c0d\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u9396\u9aa8\u4e2d\u6bb5\u9aa8\u6298\u2192\u9396\u9aa8\u4e0a\u81c2\u53e2\u795e\u7d93\u963b\u65b7\u8853 (supraclavicular brachial plexus nerve block )\u3002 (B)\u53f3\u80a9\u812b\u81fc\u4f75\u80b1\u9aa8\u9838\u9aa8\u6298\u2192\u659c\u89d2\u808c\u9593\u81c2\u53e2\u795e\u7d93\u963b\u65b7\u8853(interscalene brachial plexus nerve block )\u3002 (C)\u5de6\u5074\u80f8\u58c1\u808b\u9aa8\u9aa8\u6298\u2192\u810a\u690e\u65c1\u795e\u7d93\u963b\u65b7\u8853 (paravertebral nerve block)\u3002 (D)\u80a1\u9aa8\u9838\u9aa8\u6298\u2192\u9ac2\u7b4b\u819c\u795e\u7d93\u963b\u65b7\u8853(fascia iliaca nerve block )\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "25\u6b72\u7537\u6027\uff0c\u9577\u671f\u4f7f\u7528\u67d0\u4e00\u7269\u8cea\uff0c\u4f7f\u7528\u5f8c\u6703\u7522\u751f\u6b23\u5feb\u611f\u53ca\u89e3\u9664\u7126\u616e\uff0c\u7576\u6fc3\u5ea6\u904e\u9ad8\u6642\u53ef\u80fd\u6703\u9020\u6210\u982d\u75db\u3001\u62bd\u6410\u3001\u5fc3\u5f8b\u4e0d\u6574\u3001\u4f4e\u8840\u58d3\uff0c\u751a\u81f3\u9020\u6210\u6b7b\u4ea1\uff1b\u9577\u671f\u6162\u6027\u6feb\u7528\u5247\u53ef\u80fd\u6703\u9020\u6210\u810a\u9ad3\u795e\u7d93\u75c5\u8b8a\u3001\u5168\u8840\u7403\u6e1b\u5c11\u75c7( pancytopenia )\u7b49\uff0c\u8a72\u500b\u6848\u8f03\u6709\u53ef\u80fd \u4f7f\u7528\u54ea\u4e00\u7a2e\u7269\u8cea\uff1f", + "Options": "(A)\u6416 \u982d\u4e38\u3002 (B)K \u4ed6\u547d\u3002 (C)\u6d74\u9e7d\u3002 (D)\u7b11\u6c23\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u5c0d\u65bc\u764c\u75c7\u672b\u671f\u63a5\u53d7\u5b89\u5be7\u7de9\u548c\u91ab\u7642\u7684\u75c5\u4eba\uff0c\u5982\u6709\u56b4\u91cd\u75bc\u75db\u7121\u6cd5\u7de9\u89e3\u4f86\u5230\u6025\u8a3a\uff0c\u4e0b\u5217\u6b62\u75db\u65b9\u5f0f\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u4f7f\u7528\u53e3\u670d Morphine\uff0c60\u5206\u9418\u5f8c\u82e5\u6548\u679c\u4e0d\u826f\u518d\u52a0\u4e0a\u975c\u8108\u6ce8\u5c04Morphine \u3002 (B)\u4f7f\u7528\u76ae\u4e0b\u6ce8\u5c04 Morphine\uff0c30\u5206\u9418\u5f8c\u82e5\u6548\u679c\u4e0d\u826f\u518d\u52a0\u4e0a\u975c\u8108\u6ce8\u5c04Morphine \u3002 (C)\u4f7f\u7528\u975c\u8108\u6ce8\u5c04 Morphine\uff0c15\u5206\u9418\u53ef\u518d\u6ce8\u5c04\u4e00\u6b21\u76f4\u5230\u75bc\u75db\u7de9\u89e3\u3002 (D)\u4f7f\u7528\u808c\u8089\u6ce8\u5c04 Morphine\uff0c20\u5206\u9418\u53ef\u518d\u6ce8\u5c04\u4e00\u6b21\u76f4\u5230\u75bc\u75db\u7de9\u89e3\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc post-tonsillectomy bleeding \u4e4b\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u8a72\u90e8\u4f4d\u4e0d\u9069\u7528\u8840\u7ba1\u6813\u585e\u3002 (B)\u82e5\u51fa\u8840\u9ede\u53ef\u898b\uff0c\u53ef\u5728\u5c40\u90e8\u9ebb\u9189\u5f8c\uff0c\u7528\u785d\u9178\u9280\u71d2\u707c\u6b62\u8840\u3002 (C)\u53ef\u7528 Epinephrine \u7d17\u5e03\u586b\u585e\uff0c\u4e14\u53ef\u4ee5\u7e2b\u5408\u56fa\u5b9a\u4f4d\u7f6e\u3002 (D)\u56b4\u91cd\u500b\u6848\uff0c\u53ef\u8003\u616e\u4f7f\u7528\u9727\u5316 Epinephrine \u6216 Tranexamic acid \u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "38\u6b72\u5973\u6027\uff0c\u6709\u6182\u9b31\u75c7\u75c5\u53f2\u4e26\u9577\u671f\u559d\u9152\uff0c\u904e\u53bb\u7121\u7672\u7647\u75c5\u53f2\uff0c\u5bb6\u4eba\u767c\u73fe\u75c5\u4eba\u610f\u8b58\u4e0d\u6e05\u5168\u8eab\u62bd\u6410 2\u5206\u9418\u9001\u5230\u6025\u8a3a\uff0c\u5230\u9662\u6642\u4ecd\u5448\u660f\u8ff7\uff0c\u4e0b\u5217\u8655\u7f6e \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u5b89\u6392\u8166\u90e8\u96fb\u8166\u65b7\u5c64\u3002 (B)\u7d66\u4e88 Thiamine \u3002 (C)\u7d66\u4e88 Flumazenil \u3002 (D)\u5b89\u6392\u8166\u6ce2\u5716 (EEG)\u6aa2\u67e5\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "4\u6b72\u7537\u7ae5\u56e0\u70ba\u5fc3\u8df3\u505c\u6b62\u88ab\u9001\u5165\u6025\u8a3a\uff0c\u6839\u64da\u7f8e\u570b\u5fc3\u81df\u5354\u6703 (AHA)\u63d0\u4f9b\u76842020\u5e74\u9ad8\u7d1a\u5fc3\u81df\u8840\u7ba1\u6551\u547d\u8853\u6307\u5f15\uff0c\u6709\u95dc\u6b64\u75c5\u4eba\u6025\u6551\u5fa9\u7526\u7684\u6558\u8ff0\uff0c\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u512a\u5148\u4f7f\u7528\u6709\u6c23\u56ca\u7684\u6c23\u7ba1\u5167\u7ba1\u8207\u76f4\u5f0f\u93e1\u8449\u9032\u884c\u63d2\u7ba1\u3002 (B)\u8003\u616e\u74b0\u72c0\u8edf\u9aa8\u58d3\u8feb\u6cd5\uff0c\u53ef\u589e\u52a0\u63d2\u7ba1\u6210\u529f\u7684\u6a5f\u7387\u8207\u964d\u4f4e\u80c3\u98df\u9053\u9006\u6d41\u7684\u6a5f\u7387\u3002 (C)\u82e5\u5df2\u63d2\u7ba1\uff0c\u5247\u4ee5\u7d04\u6bcf 6\u79d2\u5439\u6c23 1\u6b21\u7684\u901f\u7387\u901a\u6c23\uff0c\u671f\u9593\u4e0d\u5f97\u4e2d\u65b7\u80f8\u90e8\u6309\u58d3\u3002 (D)\u82e5\u6025\u6551\u5f8c\u53ef\u6478\u5230\u660e\u986f\u7684\u8108\u640f\u4f46\u547c\u5438\u4e0d\u6b63\u5e38\uff0c\u5247\u4ee5\u6bcf\u5206\u9418\u7d04 12-20\u6b21\u7684\u901f\u7387\u9032\u884c\u4eba\u5de5\u547c\u5438\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u904e\u654f\u6027\u7d2b\u6591 (Henoch -Sch\u00f6nlein purpura )\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u6613\u6709\u7030\u6f2b\u6027\u8179\u75db\u6216\u8178\u7d5e\u75db\u4e26\u4f34\u96a8\u5614\u5410\u3002 (B)\u6613\u5f71\u97ff\u819d\u6216\u8e1d\u95dc\u7bc0\uff0c\u6703\u6709\u816b\u8139\u8207\u75bc\u75db\u3002 (C)\u5178\u578b\u76ae\u75b9\u597d\u767c\u5728\u81c9\u90e8\u3001\u81c0\u90e8\u8207\u8173\u638c\u8655\u3002 (D)\u8089\u773c\u53ef\u898b\u8840\u5c3f\uff0c\u8868\u793a\u814e\u81df\u6709\u53d7\u5230\u5f71\u97ff\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u526f\u776a\u4e38\u708e( Epididymitis )\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u5c3f\u6db2\u6aa2\u67e5\u53ef\u80fd\u6709\u81bf\u5c3f\u3002 (B)\u75c5\u6bd2\u611f\u67d3\u662f\u5176\u4e2d\u4e00\u7a2e\u539f\u56e0\u3002 (C)\u8d85\u97f3\u6ce2\u4e0b\u53ef\u898b\u526f\u776a\u4e38\u8840\u6d41\u91cf\u589e\u52a0\u3002 (D)\u628a\u53d7\u5f71\u97ff\u7684\u776a\u4e38\u5f80\u4e0a\u62ac\uff0c\u6703\u56e0\u727d\u626f\u800c\u66f4\u75db\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "60\u6b72\u75c5\u4eba\u4f7f\u7528\u6c23\u5207\u547c\u5438\u7ba1( tracheostomy tube )\u5df2 1\u500b\u6708\uff0c\u56e0\u6c23\u5207\u9020\u53e3\u5927\u91cf\u51fa\u8840\u4f86\u5230\u6025\u8a3a\u3002\u4e0b\u5217\u4f55\u8005\u70ba \u8f03\u9069\u7576\u7684\u521d\u6b65\u6b62\u8840\u63aa\u65bd\uff1f", + "Options": "(A)Utley maneuver \u3002 (B)\u7528\u5c0e\u5c3f\u7ba1\u6c23\u56ca\u5f9e\u98df\u9053\u52a0\u58d3\u3002 (C)\u652f\u6c23\u7ba1\u93e1\u5c40\u90e8\u6ce8\u5c04\u6216\u7d50\u7d2e\u8840\u7ba1\u3002 (D)\u628a\u6c23\u5207\u547c\u5438\u7ba1\u7684\u6c23\u56ca\u518d\u6253\u6eff\u4e00\u4e9b\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "40\u6b72\u7537\u6027\uff0c\u7121\u904e\u53bb\u75c5\u53f2\uff0c\u7a81\u767c\u56b4\u91cd\u4e0a\u8179\u75db\uff0c\u4e0b\u5217\u6cbb\u7642\u53ca\u8655\u7f6e\u8003\u91cf\u4f55\u8005\u8f03\u70ba\u9069\u7576\uff1f", + "Options": "(A)\u76f8\u5c0d\u65bc\u975e\u985e\u56fa\u9187\u985e\u6d88\u708e\u6b62\u75db\u85e5\uff0c\u7d66\u4e88\u55ce\u5561\u975c\u8108\u6ce8\u5c04\u6b62\u75db\uff0c\u8f03\u4e0d\u6703\u5f71\u97ff\u8a3a\u65b7\u3002 (B)\u7814\u7a76\u986f\u793a\uff0c\u6025\u8a3a\u53ef\u5efa\u7acb\u4e26\u4f7f\u7528\u8179\u75db\u7d44\u5957\u6aa2\u9a57\uff0c\u53ef\u5feb\u901f\u9032\u884c\uff0c\u5177\u6709\u81e8\u5e8a\u6548\u76ca\u3002 (C)\u8179\u90e8 X\u5149(plain radiographs)\u65bc\u591a\u6578\u8179\u90e8\u6025\u75c7\u6709\u7be9\u6aa2\u7684\u6548\u679c\uff0c\u53ef\u5217\u5165\u5e38\u898f\u6aa2\u67e5\u3002 (D)\u5e8a\u908a\u8d85\u97f3\u6ce2\u767c\u73fe\u8179\u4e3b\u52d5\u8108\u7624\uff0c\u4e14\u808c\u9178\u9150 3 mg/dL\u6642\uff0c\u61c9\u7dca\u6025\u5b89\u6392\u78c1\u632f\u9020\u5f71\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "30\u6b72\u7537\u6027\u65bc 3\u5c0f\u6642\u524d\u8aa4\u98df\u4e0d\u660e\u5316\u5b78\u85e5\u5291\u7d04 150 mL\uff0c\u55dc\u7761\u3001\u5614\u5410\u53ca\u8e81\u52d5\u4e0d\u5b89\u800c\u9001\u91ab\uff0c\u9ad4\u6eab 36.5\u2103\u3001\u547c\u5438 14\u6b21/min\u3001\u5fc3\u8df3 70 \u6b21/min\u3001\u8840\u58d3 140/80 mmHg\u3001 \u62bd\u8840\u6aa2\u9a57 Na 135 meq/L \u3001 Cl 100 meq/L \u3001 BUN 28 mg/dL \u3001ethanol <0.2 mg/dL \u3001glucose 90 mg/dL \u3001blood ketone 6 mmol/L \u3001blood osmolality 320 mOsm/Kg\uff0c\u52d5\u8108\u8840\u6c23\u9ad4\u5206\u6790 pH 7.40\u3001 PCO 2 42 mmHg \u3001HCO 3- 23 meq/L \uff0c\u6700\u6709\u53ef\u80fd\u7684\u7269\u8cea\u4e2d\u6bd2\uff0c\u4f55\u8005 \u6700\u9069\u7576\uff1f", + "Options": "(A)\u7532\u9187 (methanol)\u3002 (B)\u4e59\u4e8c\u9187(ethylene glycol )\u3002 (C)\u4e19\u4e8c\u9187(propylene glycol )\u3002 (D)\u7570\u4e19\u9187(isopropanol )\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "82\u6b72\u7537\u6027\uff0c\u56e0\u767c\u71d2\u3001\u547c\u5438\u5598\u4f75\u547c\u5438\u8f14\u52a9\u808c\u4f7f\u7528\uff0c\u660e\u986f\u547c\u5438\u5598\u9cf4\u8072\uff0c\u610f\u8b58\u6539\u8b8a\u9001\u81f3\u6025\u8a3a\u3002\u5230\u9662\u6642\u9ad4\u6eab 39\u00b0C\uff0c\u5fc3\u8df3 120 \u6b21/min\uff0c\u547c\u5438 28 \u6b21/min\uff0c\u8840\u58d3 132/84 mmHg \uff0c\u8840\u6c27\u6fc3\u5ea6 85%\u3002\u52d5\u8108\u8840\u6db2\u6c23\u9ad4\u5206\u6790 PaCO 2 80 mmHg \u3002\u8acb\u554f\u5c0d\u65bc\u6b64\u75c5\u4eba\u7684\u6cbb\u7642\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u61c9\u7d66\u4e88\u6c27\u6c23\u6cbb\u7642\uff0c\u7dad\u6301\u8840\u6c27\u6fc3\u5ea6\u81f3\u5c11 90%\u4ee5\u4e0a\u3002 (B)\u61c9\u7d66\u4e88\u975e\u4fb5\u8972\u6027\u6b63\u58d3\u547c\u5438\u5668\uff0c\u4ee5\u9f3b\u80c3\u7ba1\u6e1b\u58d3\u9810\u9632\u5438\u5165\u6027\u4e8b\u4ef6\u767c\u751f\u3002 (C)\u61c9\u7d66\u4e88\u4e59\u4e8c\u578b\u64ec\u4ea4\u611f\u4f5c\u7528\u5291\u53ca\u6297\u81bd\u9e7c\u5291\u5438\u5165\u6cbb\u7642\u3002 (D)\u61c9\u8003\u616e\u7d66\u4e88\u6c23\u7ba1\u5167\u7ba1\u63d2\u7ba1\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "55\u6b72\u7537\u6027\u88ab\u5bb6\u4eba\u767c\u73fe\u610f\u8b58\u6539\u8b8a\uff0c\u6b64\u5916\u6700\u8fd1 1\u9031\u958b\u59cb\u8b8a\u5f97\u865b\u5f31\u3001\u80c3\u53e3\u8b8a\u5dee\uff0c\u540c\u6642\u4e5f\u6709\u4e9b\u6df7\u4e82\uff0c\u6aa2\u67e5\u767c\u73fe\u53e3\u8154\u9ecf\u819c\u4e7e\u71e5\uff0c\u76ae\u819a\u5f48\u6027\u5dee\uff0c E2V3M4\uff0c\u9ad4\u91cd70 Kg\u3002\u62bd\u8840\u6aa2\u67e5\u70ba\uff1apH 7.30 \u3001PCO 2 40 mmHg \u3001 HCO 3 22 meq/L \u3001 Na 118 meq/L \u3001K 3.0 meq/L \u3001Cl 96 meq/L \u3001BUN 50 mg/dL \u3001Cr 2.2 mg/dL \u3001Glu 780 mg/dL \uff0c\u6709\u95dc\u6b64\u75c5\u4eba\u7684\u512a\u5148\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)Normal Saline 3L stat in 1 hour \u3002 (B)3% Saline 100 mL stat in 15 -20 mins\u3002 (C)Regular Insulin 7U IV bolus\u3002 (D)\u5f9e\u4e2d\u592e\u975c\u8108\u7d66 Normal Saline 1L + KCl 40 mEq stat in 1 hour \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5152\u7ae5\u86c7\u54ac\u50b7\u7684\u6297\u6bd2\u8840\u6e05\u6cbb\u7642\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5152\u7ae5\u65bd\u6253\u8840\u6e05\u5291\u91cf\u9700\u8996\u9ad4\u91cd\u6e1b\u91cf\u3002 (B)\u82e5\u7121\u6cd5\u5efa\u7acb\u975c\u8108\u7ba1\u8def\uff0c\u53ef\u9aa8\u5167\u6ce8\u5c04\u3002 (C)\u8d77\u59cb\u5291\u91cf\u5148\u5f9e\u5c11\u91cf\u958b\u59cb\uff0c\u8996\u60c5\u6cc1\u518d\u589e\u52a0\u3002 (D)\u80a2\u9ad4\u816b\u8139\u6642\uff0c\u61c9\u8003\u616e\u7b4b\u819c\u5207\u958b\u8853(fasciotomy )\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "65\u6b72\u7537\u6027\uff0c\u60a3\u6709\u80ba\u817a\u764c\u4f75\u591a\u8655\u8f49\u79fb\uff0c\u6700\u8fd1\u51fa\u73fe\u4e0b\u80cc\u75db\u8207\u96d9\u4e0b\u80a2\u7121\u529b\u7684\u75c7\u72c0\uff0c\u4eca\u65e9\u8d77\u5e8a\u56e0\u5b8c\u5168\u7121\u6cd5\u884c\u8d70\u3001\u96d9\u4e0b\u80a2\u5931\u53bb\u77e5\u89ba\u5408\u4f75\u5927\u4fbf\u5931\u7981\u81f3\u6025\u8a3a\u6c42\u8a3a\uff0c\u4e0b\u5217\u8a55\u4f30\u8207\u8655\u7f6e\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5728\u9032\u884c\u810a\u690e\u78c1\u632f\u9020\u5f71\u524d\uff0c\u5148\u7d66\u4e88\u975c\u8108\u6ce8\u5c04 10 mg\u7684dexamethasone \u3002 (B)\u6b64\u75c5\u4eba\u9032\u884c\u7dca\u6025\u810a\u690e\u5916\u79d1\u6e1b\u58d3\u624b\u8853\uff0c\u6709\u5f88\u5927\u7684\u6a5f\u6703\u53ef\u4ee5\u6062\u5fa9\u4e0b\u80a2\u7684\u529f\u80fd\u3002 (C)\u505a\u5b8c\u6574\u7684\u795e\u7d93\u5b78\u8a55\u4f30\uff0c\u4f86\u6c7a\u5b9a\u810a\u690e\u78c1\u632f\u9020\u5f71\u9700\u7167\u651d\u7684\u90e8\u4f4d\u3002 (D)\u7dca\u6025\u5b89\u6392\u4e0d\u542b\u91d3\u986f\u5f71\u5291(gadolinium -based contrast agents )\u7684\u810a\u690e\u78c1\u632f\u9020\u5f71\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u80a9\u96e3\u7522( shoulder dystocia )\u72c0\u6cc1\uff0c\u8acb\u554f\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u56db\u80a2\u8dea\u5f0f\u7684\u751f\u7522\u65b9\u5f0f Gaskin maneuver\u6703\u589e\u52a0\u6b64\u6b21\u751f\u7522\u96e3\u5ea6\u3002 (B)\u8003\u616e\u57f7\u884c McRoberts \u624b\u6cd5\uff0c\u4e26\u65bc\u5b50\u5bae\u5e95\u52a0\u58d3\u3002 (C)\u53ef\u4ee5\u624b\u6307\u4f38\u5165\u7522\u9053\uff0c\u5c07\u65b0\u751f\u5152\u524d\u80a9\u76e1\u91cf\u5f80\u80f8\u90e8\u58d3\u3002 (D)\u61c9\u5148\u8b93\u7522\u5a66\u76e1\u53ef\u80fd\u5f4e\u66f2\u817f\u90e8\u5408\u4f75\u628a\u819d\u84cb\u5916\u7ffb\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u9ad8\u8840\u58d3\u6025\u75c7( hypertensive emergency ) \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5982\u679c\u662f\u5408\u4f75\u4e3b\u52d5\u8108\u525d\u96e2\uff0c\u9700\u8981\u5118\u65e9\u5c07\u8840\u58d3\u63a7\u5236\u5230\u6536\u7e2e\u58d3 120 mmHg\u4ee5\u4e0b\uff0c\u540c\u6642\u5fc3\u8df3\u63a7\u5236\u4e0d\u8d85\u904e 100 \u6b21/min\u3002 (B)\u6897\u585e\u6027\u4e2d\u98a8\u75c5\u4eba\uff0c\u82e5\u8981\u65bd\u6253\u8840\u6813\u6eb6\u89e3\u85e5\u7269\uff0c\u8840\u58d3\u9808\u63a7\u5236\u5728\u6536\u7e2e\u58d3185 mmHg \u4ee5\u4e0b\u3002 (C)\u5982\u679c\u662f\u8d77\u56e0\u65bc\u4ea4\u611f\u795e\u7d93\u5371\u8c61 (acute sympathetic crisis) \uff0c\u7b2c\u4e00\u7dda\u964d\u58d3\u85e5\u7269\u662f\u9223\u96e2\u5b50\u901a\u9053\u963b\u65b7\u5291\u3002 (D)\u9ad8\u8840\u58d3\u6027\u8166\u75c5\u8b8a(hypertensive encephalopathy ) \uff0c\u662f\u6392\u9664\u6897\u585e\u6216\u51fa\u8840\u6027\u4e2d\u98a8\u5f8c\u7684\u81e8\u5e8a\u8a3a\u65b7\uff0c\u6838\u78c1\u5171\u632f\u53ef\u898b\u524d\u984d\u8449\u6c34\u816b\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "26\u6b72\u7537\u6027\u64cd\u4f5c\u6a5f\u53f0\u6642\u53f3\u624b\u4e0d\u614e\u53d7\u50b7\u3002\u4ee5\u4e0b\u8655\u7f6e\u4f55\u7a2e \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u624b\u6307\u6495\u88c2\u50b7\u82e5\u6c92\u6709\u9aa8\u982d\u5916\u9732\uff0c\u6216\u662f\u50b7\u5230\u6307\u5e8a\uff0c\u5c0f\u65bc 1\u516c\u5206\u4e4b\u50b7\u53e3\u53ef\u8003\u616e\u50b7\u53e3\u63db\u85e5\u4e26\u9580\u8a3a\u8ffd\u8e64\u3002 (B)\u624b\u6307\u6495\u88c2\u50b7\u82e5\u6307\u5c16\u76ae\u74e3\u8840\u6d41\u4e0d\u6b62\uff0c\u53ef\u8003\u616e\u4f7f\u7528\u6b62\u8840\u5e36\u7d81\u5728\u8fd1\u7aef\u6307\u7bc0\uff0c\u4f86\u6b62\u8840\u4e26\u8655\u7406\u50b7\u53e3\u3002 (C)\u7576\u61f7\u7591\u75c5\u4eba\u53f3\u524d\u81c2\u6709\u8840\u7ba1\u6027\u640d\u50b7\u6642\uff0c\u82e5\u5408\u4f75\u51fa\u73fe\u5c0f\u578b\u3001\u7a69\u5b9a\u7684\u8840\u816b\uff0c\u53ef\u8003\u616e\u5148\u6301\u7e8c\u89c0\u5bdf\u8840\u816b\u4e4b\u60c5\u5f62\u3002 (D)\u82e5\u7121\u6cd5\u6478\u5230\u53f3\u624b\u6a48\u9aa8\u52d5\u8108\uff0c\u8003\u616e\u7acb\u523b\u6703\u8a3a\u8840\u7ba1\u5916\u79d1\u91ab\u5e2b\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u5728\u5927\u91cf\u50b7\u60a3\u4e8b\u4ef6\u4e2d\uff0c\u5c0d\u5c0f\u5152\u75c5\u4eba\u4e4b\u6aa2\u50b7\u5206\u985e\uff0c\u76ee\u524d\u63a1\u7528 JumpSTART \u5c0f\u5152\u5927\u91cf\u50b7\u60a3\u6aa2\u50b7\u7cfb\u7d71(JumpSTART Pediatric MCI Triage\u00a9) \uff0c\u6709\u95dc\u6b64\u7cfb\u7d71\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u8a55\u4f30\u70ba\uff1a\u80fd\u5426\u884c\u52d5\u6216\u8d70\u8def\u2192 \u6709\u7121\u547c\u5438\u2192 \u547c\u5438\u901f\u7387 \u2192\u6709\u7121\u8108\u640f\u2192 \u610f\u8b58\u72c0\u614b\u3002 (B)\u6aa2\u50b7\u5206\u985e\u5206\u70ba\u6b7b\u4ea1\u3001\u7acb\u5373\u5f8c\u9001\u3001\u5ef6\u5f8c\u5f8c\u9001\u3001\u8f15\u75c7\u56db\u985e\u3002 (C)\u610f\u8b58\u72c0\u614b\u63a1\u7528 modified Glasgow Coma Scale \u3002 (D)\u5927\u91cf\u50b7\u60a3\u4e8b\u4ef6\u6aa2\u50b7\u5206\u985e\u904e\u7a0b\u4e2d\uff0c\u539f\u5247\u4e0a\u4e0d\u5c0d\u5fc3\u8df3\u505c\u6b62\u8005\u65bd\u884c\u5fc3\u81df\u6309\u58d3\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "61\u6b72\u5973\u6027\uff0c\u4e73\u764c\u4e26\u63a5\u53d7\u5316\u7642\u7d04 1\u500b\u6708\uff0c\u75c5\u4eba\u5169\u4e09\u5929\u524d\u958b\u59cb\u6709\u8f15\u5fae\u54b3\u55fd\u3001\u5641\u5fc3\u3001\u98df\u617e\u4e0d\u4f73\u3001\u8179\u8139\u7b49\u75c7\u72c0\uff0c\u4eca\u5929\u9032\u5c55\u70ba\u610f\u8b58\u4e0d\u6e05\u4e14\u6709\u767c\u71d2\u7684\u60c5\u6cc1\uff0c\u75c5\u4eba\u5c31\u91ab\u6642\uff0cGCS E2M4V1\uff0c\u8840\u58d3 140/68 mmHg \u3001\u5fc3\u8df3 126 \u6b21/min\u3001\u547c\u5438 26 \u6b21/min\u3001SpO 2 96%\u3001\u9ad4\u6eab 38.3\u2103\uff0c\u95dc\u65bc\u8a72\u75c5\u4eba\u8a55\u4f30\u8655\u7f6e\uff0c\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u4f9d\u64da\u53f0\u7063\u6025\u8a3a\u6aa2\u50b7\u6025\u8feb\u5ea6\u5206\u7d1a\u91cf\u8868\u7684\u610f\u8b58\u8868\u73fe\u4f86\u5224\u5b9a\uff0c\u6aa2\u50b7\u7d1a\u6578\u70ba2\u7d1a\u3002 (B)\u75c5\u4eba\u7684\u547c\u5438\u97f3\u6b63\u5e38\u3001\u8840\u6c27\u6b63\u5e38\u4e14\u80f8\u90e8 X\u5149\u7247\u7121\u80ba\u708e\u8868\u73fe\u53ef\u6392\u9664\u80ba\u708e\u8a3a\u65b7\u3002 (C)WBC 1,000/\u00b5L \uff0cSegment 30% \uff0c\u7121\u660e\u986f\u611f\u67d3\u6e90\u6642\uff0c\u9808\u5118\u5feb\u9032\u884c\u809b\u9580\u6307\u8a3a\u78ba\u5b9a\u6709\u7121\u76f4\u8178\u81bf\u760d\u3002 (D)\u8840\u9223\u70ba 15.2 mg/dL (3.8 mEq/L ) \uff0c\u9808\u7acb\u5373\u7d66\u4e88\u8f38\u6db2\u6cbb\u7642\uff0c\u52a0\u901f\u9223\u96e2\u5b50\u5f9e\u5c3f\u4e2d\u6392\u9664\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "40\u6b72\u5973\u6027\u56e0\u7df4\u7fd2\u99ac\u62c9\u677e\u8def\u8dd1\u5f8c\u7522\u751f\u53f3\u8db3\u5e95\u75bc\u75db\u73fe\u8c61\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u8db3\u5e95\u8ddf\u9aa8\u524d\u5167\u5074\u7522\u751f\u58d3\u75db\u53ef\u80fd\u662f\u8ddf\u9aa8\u6ed1\u56ca\u708e(calcaneus bursitis )\u3002 (B)X \u5149\u82e5\u660e\u986f\u770b\u898b\u8db3\u8ddf\u90e8\u4f4d\u7522\u751f\u9aa8\u523a\u53ef\u8a3a\u65b7\u8db3\u5e95\u7b4b\u819c\u708e(plantar fasciitis)\u3002 (C)\u5c40\u90e8\u6ce8\u5c04\u985e\u56fa\u9187\u85e5\u7269\u6709\u9577\u671f\u6548\u679c\uff0c\u4f46\u6709\u8f03\u591a\u7684\u526f\u4f5c\u7528\u3002 (D)\u8db3\u8dbe\u80cc\u66f2 (dorsiflexion )\u6309\u6469\u8db3\u5e95\u5c0d\u75c7\u72c0\u6539\u5584\u6709\u5e6b\u52a9\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u547c\u5438\u9053\u50b3\u67d3\u6027\u75be\u75c5\uff0c\u54ea\u4e00\u7a2e\u75be\u75c5\u662f\u6f5b\u4f0f\u671f( incubation period )\u6bd4\u6f5b\u85cf\u671f(latent period )\u4f86\u5f97\u77ed\uff1f", + "Options": "(A)\u56b4\u91cd\u7279\u6b8a\u50b3\u67d3\u6027\u80ba\u708e(Coronavirus disease 2019, COVID -19)\u3002 (B)\u5b63\u7bc0\u6027\u6d41\u611f(seasonal influenza )\u3002 (C)\u6025\u6027\u56b4\u91cd\u547c\u5438\u75c7\u5019\u7fa4(severe acute respiratory syndrome, SARS )\u3002 (D)\u9ebb\u75b9(Measles)\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u7672\u7647\u91cd\u7a4d\u72c0\u614b (status epilepticus )\u4e4b\u85e5\u7269\u6cbb\u7642\u9078\u64c7\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u4f7f\u7528 Lorazepam \u53ef\u80fd\u6703\u9020\u6210\u547c\u5438\u6291\u5236\u8207\u4f4e\u8840\u58d3\u3002 (B)\u4f7f\u7528 Phenytoin \u8f38\u6ce8\u6d41\u901f\u4e0d\u53ef\u4ee5\u904e\u5feb\uff0c\u4e26\u6ce8\u610f\u4e0d\u53ef\u8207\u542b\u8461\u8404\u7cd6\u9ede\u6ef4\u4e26\u7528\u3002 (C)\u4f7f\u7528 Valproic acid \u53ef\u80fd\u9020\u6210\u809d\u529f\u80fd\u53d7\u640d\u6216\u80f0\u81df\u767c\u708e\u3002 (D)\u4f7f\u7528 Propofol\u9700\u8981\u6ce8\u610f\u53ef\u80fd\u6703\u9020\u6210\u4f4e\u8840\u9240\u3001\u6a6b\u7d0b\u808c\u6eb6\u89e3\u7b49\u526f\u4f5c\u7528\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "60\u6b72\u5973\u6027\u75c5\u4eba\u904e\u53bb\u6709\u7cd6\u5c3f\u75c5\u53ca\u9ad8\u8840\u58d3\uff0c\u9019\u6b21\u56e0\u6ccc\u5c3f\u9053\u611f\u67d3\u4f75\u6557\u8840\u6027\u4f11\u514b\u800c\u5728\u6025\u8a3a\u6cbb\u7642\uff0c\u76ee\u524d\u5df2\u7d93\u7d66\u4e88 NS 1,000 mL\uff0c\u53e3\u8154\u9ecf\u819c\u4e7e\u71e5\uff0c2 \u5c0f\u6642\u904e\u53bb\u90fd\u6c92\u6709\u5c3f\uff0c\u6aa2\u67e5\u5831\u544a\u767c\u73fe\u8840\u7cd6\u503c\u70ba 380 mg/dL \uff0c\u6709\u95dc\u6b64\u75c5\u4eba\u7684\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5f9e IV\u7d66\u4e88 regular Insulin\u3002 (B)\u8840\u7cd6\u76ee\u6a19\u662f\u5e0c\u671b\u63a7\u5236\u5728 200-250 mg/dL \u3002 (C)\u5148 IV hydration \uff0c\u66ab\u6642\u4e0d\u7528\u7d66\u4e88\u964d\u8840\u7cd6\u85e5\u7269\u3002 (D)\u6309\u7167\u9580\u8a3a\u958b\u7acb\u7684\u85e5\u7269 (Glyburide \u53caRepaglinide )\u7d66\u4e88\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u4e00\u540d\u5de5\u4eba\u88ab\u5de5\u5ee0\u6a5f\u5668\u58d3\u65b7\u624b\u6307\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u63a5\u65b7\u6307\u7684\u7981\u5fcc\u75c7 (\u542b\u76f8\u5c0d )\u5305\u62ec\u5c0f\u5b69\u3001\u58d3\u7838\u50b7\u3001\u622a\u80a2\u90e8\u4efd\u7f3a\u6c27\u5927\u65bc12\u5c0f\u6642\u3002 (B)\u82e5\u70ba\u9060\u7aef\u6307\u5c16\u8edf\u7d44\u7e54\u622a\u80a2\uff0c\u9762\u7a4d\u5c0f\u65bc 1\u5e73\u65b9\u516c\u5206\uff0c\u6c92\u6709\u66b4\u9732\u9aa8\u9abc\u6216\u7532\u5e8a\uff0c\u53ef\u4ee5\u6bcf\u5929\u63db\u85e5\u4fdd\u5b88\u6cbb\u7642\u3002 (C)\u82e5\u6307\u5c16\u622a\u65b7\u6709\u66b4\u9732\u9aa8\u9abc\u4f46\u5c0f\u65bc 0.5\u516c\u5206\u4e14\u8edf\u7d44\u7e54\u7f3a\u640d\u5c0f\u65bc 1\u5e73\u65b9\u516c\u5206\uff0c\u4ecd\u53ef\u5c07\u9aa8\u9abc\u5411\u5f8c\u4fee\u526a\u4e26\u63db\u85e5\u4fdd\u5b88\u6cbb\u7642\u3002 (D)\u60a3\u5074\u6307\u8179 (volar pad )\u7684\u5169\u9ede\u8fa8\u5225\u611f\u89ba(two -point discrimination )\u82e5\u4e00\u5074\u660e\u986f\u5927\u65bc\u53e6\u4e00\u5074\uff0c\u6216\u8d85\u904e 10 mm\uff0c\u8981\u61f7\u7591\u624b\u6307\u795e\u7d93\u640d\u50b7\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u4f11\u514b\u81ea\u4e3b\u53cd\u61c9\u7684\u63cf\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u5c0f\u52d5\u8108\u8840\u7ba1\u8212\u5f35\uff0c\u5c0e\u81f4\u8eab\u9ad4\u8840\u6d41\u91cd\u65b0\u5206\u4f48\u3002 (B)\u589e\u52a0 cardiac output \u7684\u5fc3\u5f8b\u548c\u6536\u7e2e\u529b\u589e\u52a0\u3002 (C)\u975c\u8108\u5bb9\u91cf\u8840\u7ba1\u6536\u7e2e\uff0c\u589e\u52a0\u975c\u8108\u56de\u6d41\u3002 (D)\u91cb\u653e vasoactive hormones \u4ee5\u589e\u52a0\u5c0f\u52d5\u8108\u548c\u975c\u8108\u5f35\u529b\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6ccc\u5c3f\u9053\u7d50\u77f3\u7684\u81e8\u5e8a\u8868\u73fe\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)X \u5149\u8207\u96fb\u8166\u65b7\u5c64\u91cf\u6e2c\u7684\u7d50\u77f3\u5927\u5c0f\u5747\u6703\u6bd4\u5be6\u969b\u5c0f\u3002 (B)\u53ef\u80fd\u6703\u4ee5\u53cd\u5f48\u75db\u8207\u808c\u8089\u50f5\u786c (guarding)\u4f5c\u70ba\u8868\u73fe\u3002 (C)\u8d85\u904e 95%\u4ee5\u4e0a\u7684\u75c5\u4eba\u6709\u8840\u5c3f\u3002 (D)\u82e5\u6025\u6027\u963b\u585e\u9020\u6210\u55ae\u5074\u6c34\u814e\uff0c\u5927\u591a\u6578\u75c5\u4eba\u7684\u808c\u9178\u9150\u6703\u4e0a\u5347\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u9583\u96fb\u8207\u96fb\u640d\u50b7\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u548c\u4f4e\u96fb\u58d3\u4ea4\u6d41\u96fb\u76f8\u6bd4\uff0c\u9583\u96fb\u96fb\u64ca\u66f4\u5bb9\u6613\u9020\u6210\u5fc3\u5ba4\u986b\u52d5\u3002 (B)\u9583\u96fb\u9020\u6210\u7684\u50b7\u5bb3\u5e38\u5f71\u97ff\u5230\u75c5\u4eba\u7684\u773c\u775b\uff0c\u6700\u5e38\u898b\u7684\u5f8c\u907a\u75c7\u662f\u8996\u7db2\u819c\u640d\u50b7\u3002 (C)\u9583\u96fb\u96fb\u64ca\u6bd4\u9ad8\u96fb\u58d3\u4ea4\u6d41\u96fb\u66f4\u5bb9\u6613\u9020\u6210\u6df1\u90e8\u808c\u8089\u640d\u50b7\uff0c\u4ee5\u53ca\u9700\u8981\u7b4b\u819c\u5207\u958b\u8853\u3002 (D)\u88ab\u9583\u96fb\u64ca\u4e2d\u4e4b\u660f\u8ff7\u75c5\u4eba\uff0c\u96d9\u773c\u77b3\u5b54\u4e0d\u7b49\u5927\u4e0d\u4e00\u5b9a\u9810\u5f8c\u4e0d\u4f73\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u982d\u90e8\u5916\u50b7\u75c5\u4eba\uff0c\u8840\u58d3\u70ba 228/132 mmHg \uff0c\u9871\u5167\u58d3 (ICP)\u70ba 86 mmHg \uff0c\u76f8\u95dc\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u8a72\u75c5\u4eba\u5e73\u5747\u52d5\u8108\u58d3(MAP )\u70ba 164 mmHg \uff0c\u5927\u8166\u704c\u6ce8\u58d3(CPP )\u70ba78 mmHg \u3002 (B)\u8a72\u75c5\u4eba\u5e73\u5747\u52d5\u8108\u58d3\u70ba 180 mmHg \uff0c\u5927\u8166\u704c\u6ce8\u58d3\u70ba 94 mmHg \u3002 (C)\u5728\u6b63\u5e38\u60c5\u6cc1\u4e0b\uff0c\u81ea\u52d5\u8abf\u7bc0\u53ef\u4ee5\u8abf\u6574\u4ee5\u9069\u61c9 50~120 mmHg \u7684CPP\uff0cCPP < 50 mmHg \u88ab\u8a8d\u70ba\u662f\u4eba\u985e\u81ea\u52d5\u8abf\u7bc0\u7684\u4e0b\u9650\u3002 (D)\u9871\u5167\u58d3\u5347\u9ad8\uff0c\u6703\u5f15\u8d77\u5eab\u6b23\u53cd\u5c04 (Cushing reflex )\uff0c\u5305\u62ec\u9ad8\u8840\u58d3\u3001\u5fc3\u52d5\u904e\u7de9\u548c\u547c\u5438\u6dfa\u5feb\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u9577\u671f\u8f15\u5fae\u54b3\u55fd\u7684 59\u6b72HIV\u7537\u6027\uff0c\u7167\u80f8\u90e8 X\u5149\u767c\u73fe\u808b\u819c\u7a4d\u6db2\uff0c\u9451\u5225\u8a3a\u65b7\u9664\u80ba\u708e\u5916\uff0c\u4e0b\u5217\u4f55\u8005 \u767c\u751f\u6a5f\u7387\u6700\u4f4e \uff1f", + "Options": "(A)\u975e\u970d\u5947\u91d1\u6c0f\u6dcb\u5df4\u7624(Non -Hodgkin lymphoma )\u3002 (B)\u5361\u6ce2\u897f\u6c0f\u8089\u7624( Kaposi sarcoma )\u3002 (C)\u80ba\u817a\u764c(Adenocarcinoma )\u3002 (D)\u9c57\u72c0\u7d30\u80de\u764c( Squamous cell carcinoma )\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "38\u6b72\u7537\u6027\uff0c\u7b2c\u4e00\u578b\u7cd6\u5c3f\u75c5\u53f2\u3002 2\u9031\u524d\u56e0\u904e\u5ea6\u80a5\u80d6\u63a5\u53d7\u90e8\u5206\u80c3\u5207\u9664\u624b\u8853\u53ca\u80c3\u7a7a\u8178\u543b\u5408\u8853(Roux -en-Y)\u3002\u4eca\u5929\u56e0\u767c\u71d2\u3001\u8179\u90e8\u75bc\u75db\u3001\u5641\u5fc3\u5614\u5410\u5c31\u8a3a\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u8eab\u9ad4\u8a3a\u5bdf\u82e5\u767c\u73fe\u958b\u5200\u50b7\u53e3\u6709\u7d05\u816b\u53ca\u6ef2\u6db2\uff0c\u53ef\u958b\u7acb\u53e3\u670d\u6297\u751f\u7d20\uff0c\u8b93\u75c5\u4eba\u56de\u5bb6\u9580\u8a3a\u8ffd\u8e64\u3002 (B)\u82e5\u81e8\u5e8a\u61f7\u7591\u543b\u5408\u8655\u6709\u6ef2\u6f0f(anastomotic leak )\uff0c\u9808\u7981\u98df\u3001\u975c\u8108\u6ce8\u5c04\u6297\u751f\u7d20\u4fdd\u5b88\u6cbb\u7642\u3002 (C)\u543b\u5408\u8655\u6ef2\u6f0f\u597d\u767c\u5728\u98df\u9053\u548c\u5927\u8178\u624b\u8853\u8655\u3002 (D)\u6b64\u6642\u9593\u9ede\u7684\u611f\u67d3\u6e90\u6700\u5e38\u70ba\u80ba\u708e\u6216\u5c3f\u9053\u611f\u67d3\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u8001\u4eba\u6025\u6027\u8e81\u52d5\u7684\u85e5\u7269\u6cbb\u7642\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)Antihistamine \u85e5\u7269\u53ef\u7de9\u89e3\u77bb\u5984\u3002 (B)\u85e5\u7269\u9996\u9078\u70ba Benzodiazepine \u3002 (C)Ziprasidone \u8f03\u5bb9\u6613\u9020\u6210 QTc\u5ef6\u9577\u3002 (D)Olanzapine \u53caBenzodiazepine \u85e5\u7269\u5efa\u8b70\u540c\u6642\u4f7f\u7528\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "32\u6b72\u7537\u6027\uff0c\u56e0\u7a81\u767c\u6027\u80f8\u60b6\u3001\u80f8\u75db\u3001\u547c\u5438\u6025\u4fc3\uff0c\u7531\u6551\u8b77\u8eca\u8f09\u9001\u81f3\u6025\u8a3a\u5ba4\u3002\u75c5\u4eba\u4e3b\u8a34\u75c7\u72c0\u767c\u751f\u6642\u6b63\u5750\u5728\u6c99\u767c\u4e0a\uff0c\u96a8\u5f8c\u51fa\u73fe\u624b\u6307\u672b\u68a2\u523a\u75db\u3001\u8179\u75db\u3001\u8179\u7009\u73fe\u8c61\u3002 EMT\u5230\u9054\u73fe\u5834\u6642\uff0c\u75c5\u4eba\u751f\u547d\u5fb5\u8c61\u70ba\u5fc3\u8df3 118 \u6b21/min\u3001\u547c\u5438 24 \u6b21/min\uff1b\u62b5\u9054\u6025\u8a3a\u5ba4\u6642\u75c5\u4eba\u5fc3\u8df3 92 \u6b21/min\u3001\u547c\u5438 16 \u6b21/min\u3002\u6839\u64da\u75c5\u6b77\u8a18\u8f09\uff0c\u8a72\u75c5\u4eba 1\u500b\u6708\u5167\u5df2\u56e0\u985e\u4f3c\u75c7\u72c0\u5c31\u8a3a\u6578\u6b21\uff0c\u76f8\u95dc\u62bd\u8840\u6aa2\u9a57\u3001\u5fc3\u96fb\u5716\u6aa2\u67e5\u53ca\u80f8\u90e8 X\u5149\u5f71\u50cf\u7686\u7121\u986f\u8457\u7570\u5e38\u3002\u4e0b\u5217\u8a3a\u65b7\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)Agoraphobia \u3002 (B)Acute stress disorder \u3002 (C)Munchausen syndrome \u3002 (D)Panic disorder \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u5b55\u5a66\u611f\u67d3\u80ba\u708e\u7684\u76f8\u95dc\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u598a\u5a20\u6703\u5ef6\u9577\u7d30\u83cc\u6027\u80ba\u708e\u7684\u75c5\u7a0b\u3002 (B)\u598a\u5a20\u671f\u75c5\u6bd2\u6027\u80ba\u708e\u7684\u9810\u5f8c\u8207\u975e\u598a\u5a20\u75c5\u4eba\u56b4\u91cd\u5ea6\u76f8\u7576\u3002 (C)\u6c34\u75d8\u80ba\u708e\u75c5\u4eba\u5118\u65e9\u7d66\u4e88 acyclovir \u6703\u6539\u5584\u9810\u5f8c\u3002 (D)\u6d41\u611f\u75c5\u6bd2\u6027\u80ba\u708e\uff0c\u5c24\u5176\u662f H1N1\uff0c\u61c9\u5118\u65e9\u7d66\u4e88\u6297\u75c5\u6bd2\u85e5\u7269\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "45\u6b72\u7537\u6027\u660e\u986f\u9152\u9189\uff0c\u5230\u9662\u6642\u6fc0\u52d5\u4e0d\u914d\u5408\uff0c\u70ba\u8655\u7f6e\u5176\u6fc0\u52d5\u60c5\u5f62\uff0c\u4e0b\u5217\u85e5\u7269\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)Flumazenil \u3002 (B)Haloperidol \u3002 (C)Lorazepam \u3002 (D)Thiamine \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "22\u6b72\u7537\u6027\u4e0a\u500b\u6708\u88ab\u8a3a\u65b7\u70ba\u601d\u89ba\u5931\u8abf\u75c7\uff0c\u958b\u59cb\u670d\u7528\u6297\u7cbe\u795e\u75c5\u85e5\u7269\uff0c\u8fd1\u65e5\u537b\u51fa\u73fe\u984f\u9762\u3001\u80cc\u90e8\u808c\u8089\u75d9\u6523\u3001\u9838\u90e8\u626d\u8f49\u3001\u773c\u775b\u4e0a\u540a\u7b49\u75c7\u72c0\uff0c\u4e0a\u8ff0\u75c7\u72c0 \u6700\u53ef\u80fd\u8a3a\u65b7\u70ba\u6297\u7cbe\u795e\u75c5\u85e5\u7269\u8a98\u767c\u4e4b\u526f\u4f5c\u7528\uff1f", + "Options": "(A)\u975c\u5750\u5931\u80fd( Neuroleptic -Induced Akathisia )\u3002 (B)\u5df4\u91d1\u68ee\u6c0f\u75c7( Neuroleptic -Induced Parkinsonism )\u3002 (C)\u808c\u5f35\u529b\u4e0d\u5168( Neuroleptic -Induced dystonia)\u3002 (D)\u9072\u6eef\u6027\u904b\u52d5\u5931\u80fd(Neuroleptic -Induced Tardive Dyskinesia )\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u5230\u9662\u524d\u5fc3\u81df\u505c\u6b62\uff0c\u5728\u6025\u8a3a\u7d93\u5fc3\u80ba\u5fa9\u7526\u8655\u7f6e\u5f8c\u5efa\u7acb\u81ea\u767c\u6027\u5faa\u74b0\uff0c\u65bd\u4ee5\u76ee\u6a19\u9ad4\u6eab\u63a7\u5236(targeted temperature management, TTM )\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u7dad\u6301\u4f4e\u6eab\u6642\uff0c\u56e0\u70ba\u9240\u96e2\u5b50\u5f80\u7d30\u80de\u5916\u79fb\uff0c\u9700\u6ce8\u610f\u9ad8\u8840\u9240\u3002 (B)\u56e0\u70ba\u4f4e\u6eab\u6703\u4f7f\u51dd\u8840\u529f\u80fd\u7570\u5e38\uff0c\u4f7f\u7528\u6297\u51dd\u8840\u5291\u6cbb\u7642\u6216\u6b63\u5728\u51fa\u8840\u7684\u75c5\u4eba\u9700\u6392\u9664\u3002 (C)\u82e5\u75c5\u4eba\u610f\u8b58\u6e05\u695a\u5bb9\u6613\u5168\u8eab\u986b\u6296\uff0c\u9700\u7d66\u4e88\u93ae\u5b9a\u85e5\u7269\u5f8c\u518d\u57f7\u884c\u3002 (D)\u4f4e\u6eab\u6642\u5e38\u8a98\u767c\u5fc3\u640f\u904e\u7de9\uff0c\u901a\u5e38\u4e0d\u9700\u8981\u7d66\u4e88\u85e5\u7269\u6cbb\u7642\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "65\u6b72\u5973\u6027\uff0c 6\u9031\u524d\u56e0\u98df\u9053\u764c\u958b\u5200\u4e14\u653e\u7f6e\u7a7a\u8178\u9020\u5ed4\u7ba1( jejunostomy )\u4ee5\u4f9b\u704c\u98df\uff0c\u672c\u6b21\u56e0\u9020\u5ed4\u7ba1\u6ed1\u812b\u4f86\u6025\u8a3a\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u6b64\u9020\u5ed4\u53e3\u5c1a\u672a\u6210\u719f\uff0c\u9020\u5ed4\u7ba1\u4e0d\u61c9\u7acb\u5373\u653e\u56de\uff0c\u9808\u5148\u7167\u6703\u5916\u79d1\u3002 (B)\u7a7a\u8178\u9020\u5ed4\u7ba1\u901a\u5e38\u6bd4\u8f03\u5c0f\uff0c\u61c9\u4ee5 8-14 French \u5c08\u7528\u7ba1\u8def\u6216\u5c3f\u7ba1\u653e\u7f6e\u3002 (C)\u82e5\u5916\u79d1\u91ab\u5e2b\u5efa\u8b70\u4ee5\u5c3f\u7ba1\u653e\u56de\u9020\u5ed4\u53e3\uff0c\u653e\u7f6e\u5b8c\u6210\u5f8c\u61c9\u6253\u6c34\u7403 5-10 mL\u907f\u514d\u6ed1\u812b\u3002 (D)\u82e5\u9020\u5ed4\u53e3\u9031\u908a\u7d05\u816b\u5408\u4f75\u5316\u81bf\uff0c\u53ef\u6539\u653e\u8f03\u5927\u865f\u9020\u5ed4\u7ba1\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5916\u79d1\u547c\u5438\u9053 (surgical airway )\u7684\u5efa\u7acb\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5916\u79d1\u74b0\u7532\u819c\u5207\u958b\u8853(surgical cricothyroidotomy )\u9069\u7528\u65bc 10\u6b72\u4ee5\u4e0a\u7684\u75c5\u4eba\u3002 (B)\u7dca\u6025\u6642\uff0c\u6c23\u7ba1\u5207\u958b\u8853 (tracheostomy )\u6bd4\u74b0\u7532\u819c\u5207\u958b\u8853 (cricothyroidotomy )\u66f4\u5feb\u53ef\u5efa\u7acb\u78ba\u5b9a\u7684\u547c\u5438\u9053\u3002 (C)\u8fd1\u5e74\u4f86\u7d93\u76ae\u6c23\u7ba1\u5207\u958b\u8853(percutaneous tracheostomy )\u5df2\u7d93\u88ab\u8b49\u5be6\u6bd4\u50b3\u7d71\u6c23\u7ba1\u5207\u958b\u8853\u66f4\u9069\u7528\u65bc\u7dca\u6025\u5916\u50b7\u75c5\u4eba\u3002 (D)\u5916\u79d1\u74b0\u7532\u819c\u5207\u958b\u8853(surgical cricothyroidotomy )\u53ef\u9078\u7528\u5167\u5f91 5 mm\u52307 mm\u7684\u6c23\u7ba1\u5167\u7ba1\u3002", + "Answer": "A\u3001D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u4e0b\u6d88\u5316\u9053\u51fa\u8840\u4e4b\u76f8\u95dc\u8655\u7f6e\uff0c\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u6700\u5e38\u898b\u7684\u539f\u56e0\u662f\u5927\u8178\u606f\u8089\uff0c\u7d04 80%\u7684\u500b\u6848\u51fa\u8840\u60c5\u5f62\u6703\u81ea\u884c\u6b62\u8840\u3002 (B)\u7f3a\u8840\u6027\u5927\u8178\u708e(ischemic colitis )\u901a\u5e38\u9700\u8981\u5118\u901f\u5916\u79d1\u624b\u8853\u4ecb\u5165\u6cbb\u7642\u3002 (C)\u4e00\u822c\u4f86\u8aaa\u89e3\u8840\u4fbf\u75c5\u4eba\uff0c\u540c\u6642\u8840\u8272\u7d20\u4f4e\u65bc 8 g/dL\uff0c\u61c9\u5b89\u6392\u8f38\u8840\u3002 (D)\u8840\u884c\u72c0\u6cc1\u7a69\u5b9a\u3001\u6c92\u6709\u6301\u7e8c\u89e3\u5927\u91cf\u8840\u4fbf\u53ca\u76f8\u95dc\u5171\u75c5\u4e4b\u75c5\u4eba\uff0c\u53ef\u9580\u8a3a\u8ffd\u8e64\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "65\u6b72\u7684\u7537\u6027\uff0c\u559d\u4e0b\u4e0d\u77e5\u540d\u8fb2\u85e5\uff0c\u6578\u5c0f\u6642\u5f8c\u56e0\u70ba\u8178\u80c3\u4e0d\u9069\u524d\u53bb\u6025\u8a3a\uff0c\u96a8\u5373\u767c\u751f\u610f\u8b58\u6539\u8b8a\uff0c\u4e0d\u4e45\u4e4b\u5f8c\u751a\u81f3\u7672\u7647\u767c\u4f5c\u53ca\u547c\u5438\u8870\u7aed\uff0c\u62bd\u8840\u5831\u544a\u986f\u793a\u6709\u9ad8\u6c28\u8840\u75c7(hyperammonemia ) \uff0c\u96d6\u7136\u7d93\u904e\u7a4d\u6975\u6436\u6551\uff0c\u6578\u65e5\u5f8c\u610f\u8b58\u6162\u6162\u6062\u5fa9\uff0c\u4f46\u662f\u6301\u7e8c\u6709\u9806\u884c\u6027\u53ca\u9006\u884c\u6027\u5931\u61b6\u75c7(anterograde and retrograde amnesia ) \uff0c\u8a66\u554f\u6700\u6709\u53ef\u80fd \u662f\u54ea\u4e00\u7a2e\u8fb2\u85e5\u4e2d\u6bd2\uff1f", + "Options": "(A)\u5df4\u62c9\u5208\u4e2d\u6bd2\u3002 (B)\u6709\u6a5f\u78f7\u4e2d\u6bd2\u3002 (C)\u56fa\u6bba\u8349\u4e2d\u6bd2\u3002 (D)\u9664\u87f2\u83ca\u7cbe\u4e2d\u6bd2\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5728\u6025\u8a3a\u9032\u884c\u9aa8\u6298\u56fa\u5b9a\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5c0d\u65bc\u9396\u9aa8\u9aa8\u6298\u56fa\u5b9a\uff0c\u516b\u5b57\u80a9\u5e36\u6bd4\u624b\u81c2\u540a\u5e36\u7684\u56fa\u5b9a\u6548\u679c\u8f03\u4f73\u3002 (B)\u8c4e\u8155\u526f\u6728( cock -up wrist splint )\u5c0d\u65bc\u624b\u8155\u9aa8\u6298\u7684\u56fa\u5b9a\u6548\u679c\u826f\u597d\u3002 (C)\u5927\u62c7\u6307\u56fa\u5b9a\u578b\u526f\u6728(thumb spica splint )\u4ee5 OK\u59ff\u52e2\u56fa\u5b9a\uff0c\u4fdd\u7559\u634f\u7684\u529f\u80fd\u3002 (D)\u5c0d\u65bc\u963f\u57fa\u91cc\u65af\u8171\u65b7\u88c2\uff0c\u9700\u5c07\u8173\u8e1d\u5782\u76f4\u65bc\u5c0f\u817f\uff0c\u7528\u77ed\u817f\u77f3\u818f\u56fa\u5b9a\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "53\u6b72\u7537\u6027\uff0c\u9577\u671f\u9157\u9152\uff0c\u8fd1 3\u500b\u6708\u56e0\u96d9\u8173\u6709\u6162\u6027\u50b7\u53e3\u63a5\u53d7\u5b9a\u671f\u50b7\u53e3\u7167\u8b77\u3002\u4e3b\u8a34\u54b3\u55fd\u4f34\u96a8\u767c\u71d2\u4ee5\u53ca\u5bd2\u986b 3\u5929\uff0c\u807d\u8a3a\u5728\u53f3\u5074\u80f8\u90e8\u6709\u4e7e\u56c9\u97f3(rhonchi )\uff0c\u80f8\u90e8X\u5149\u53ef\u898b\u53f3\u5074\u80ba\u8449\u6d78\u6f64(lobar infiltrate )\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u7b26\u5408\u91ab\u7642\u7167\u8b77\u76f8\u95dc\u6027\u80ba\u708e(healthcare -associated pneumonia )\u7684\u5b9a\u7fa9\u3002 (B)\u6700\u5e38\u898b\u7684\u75c5\u539f\u9ad4\u70ba Klebsiella pneumoniae \u3002 (C)\u5b89\u6392\u5f8c\u7e8c\u6aa2\u67e5\u53ca\u6cbb\u7642\u6642\uff0c\u4e5f\u9700\u8003\u616e\u75c5\u4eba\u83cc\u8840\u75c7\u7684\u98a8\u96aa\u3002 (D)\u80ba\u708e\u56b4\u91cd\u5ea6\u6307\u6a19(pneumonia severity index )\u7684\u8a55\u4f30\u5728\u6b64\u75c5\u4eba\u8f03\u4e0d\u9069\u7528\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "65\u6b72\u7537\u6027\uff0c\u56e0\u7a81\u7136\u6027\u6301\u7e8c\u4e0a\u8179\u75db\u4e26\u8f49\u79fb\u81f3\u80cc\u90e8\u5230\u6025\u8a3a\u5c31\u8a3a\uff0c\u8eab\u9ad4\u5411\u524d\u5f4e\u66f2\u5247\u75bc\u75db\u6703\u7de9\u89e3\u3002\u75bc\u75db\u6307\u6578 9\u5206\uff0c\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\uff0c Chvostek\u2019s and Trousseau\u2019s signs: \u9670\u6027\u3002 WBC 18,000/mm3\u3001Glucose 220 mg/dL \u3001AST 270 IU/L\uff0cLipase 200 U/L (13- 60 U/L)\uff0cCalcium 7.5 mg/dL (8.5 to 10.2 mg/dL )\u4e0b\u5217\u8655\u7f6e\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u65e9\u671f\u7d66\u4e88\u8f38\u6db2\u5fa9\u7526\u6cbb\u7642\u5f88\u91cd\u8981\uff0c\u56e0\u70ba\u53ef\u4ee5\u6e1b\u5c11\u5176\u6b7b\u4ea1\u7387\u3002 (B)\u8f38\u6db2\u5efa\u8b70\u512a\u5148\u4f7f\u7528 Lactated Ringer\u2019s solutions\uff0c\u56e0\u70ba\u5c0d\u65bc\u9810\u5f8c\u6bd4\u8f03\u597d\u3002 (C)\u4f7f\u7528 Quinolone \u8207Metronidazole \uff0c\u53ef\u4ee5\u6e1b\u5c11\u672a\u4f86\u9700\u8981\u5916\u79d1\u4ecb\u5165\u8207\u964d\u4f4e\u6b7b\u4ea1\u7387\u3002 (D)\u4f4e\u8840\u9223\u53ef\u80fd\u662f\u56e0\u70ba hypoalbuminemia \uff0c\u7d66\u4e88\u8f38\u6db2\u6cbb\u7642\u6642\u61c9\u7d66\u4e88\u9223\u96e2\u5b50\u88dc\u5145\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u81ea\u7136\u707d\u5bb3\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u98b6\u98a8(Hurricanes )\u6240\u9020\u6210\u7684\u50b7\u5bb3\u548c\u6b7b\u4ea1\u4eba\u6578\u5e38\u662f\u6025\u6027\u671f\u8981\u6bd4\u6062\u5fa9\u671f\u591a\u3002 (B)\u5730\u9707(Earthquakes)\u6240\u9020\u6210\u7684\u6b7b\u4ea1\u5e38\u767c\u751f\u5728\u6700\u521d\u7684 3\u5c0f\u6642\u5167\u3002 (C)\u6d2a\u6c34(Floods)\u6240\u9020\u6210\u7684\u50b3\u67d3\u75c5\u5e38\u51fa\u73fe\u5728\u6025\u6027\u671f\u5f8c\u3002 (D)\u66b4\u98a8\u96ea(Blizzards)\u7684\u81ea\u7136\u707d\u5bb3\u4e00\u6c27\u5316\u78b3\u4e2d\u6bd2\u5bb9\u6613\u5728\u707d\u5bb3\u671f\u9593\u548c\u4e4b\u5f8c\u589e\u52a0\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6709\u75c7\u72c0\u4e0d\u7a69\u5b9a\u7684 abdominal aortic aneurysms \u75c5\u4eba\u7684\u8655\u7f6e\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u7d66\u4e88\u5169\u689d\u5927\u865f IV\u4e26\u7d66\u4e88\u5927\u91cf\u7684\u8f38\u6db2\u63a7\u5236\u8840\u58d3\u5728 120 mmHg \u4ee5\u4e0a\u3002 (B)\u6703\u8a3a\u5fc3\u81df\u5916\u79d1\u91ab\u5e2b\u5b89\u6392\u7dca\u6025\u4fee\u88dc\u624b\u8853\u3002 (C)\u82e5\u8655\u7f6e\u5f8c\u75c5\u4eba\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\uff0c\u53ef\u4ee5\u5b89\u6392\u96fb\u8166\u65b7\u5c64\u3002 (D)\u53ef\u4ee5\u7528\u8d85\u97f3\u6ce2\u6aa2\u67e5\u4e26\u91cf\u6e2c\u4e3b\u52d5\u8108\u76f4\u5f91\u4f5c\u70ba\u521d\u6b65\u8a3a\u65b7\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u65b0\u751f\u5152\u6025\u6551\u89c0\u5ff5\uff0c\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u65b0\u751f\u5152 bradycardia \u7684\u539f\u56e0\uff0c\u5927\u90e8\u5206\u5f80\u5f80\u662f\u56e0\u70ba\u7f3a\u6c27\u6216\u662f\u547c\u5438\u8870\u7aed\u9020\u6210\u7684\uff0c\u7b2c\u4e00\u6b65\u9700\u5148\u7d66\u4e88\u6c27\u6c23\u8ddf\u518d\u6b21\u8655\u7406 airway\u800c\u975e\u5148\u4f7f\u7528\u85e5\u7269\u8655\u7f6e\u8b8a\u6162\u7684\u5fc3\u5f8b\u3002 (B)\u65b0\u751f\u5152\u7d66\u904e\u6b63\u58d3\u547c\u5438 30\u79d2\u5f8c\uff0c\u4ecd\u7136 bradycardia < 60 \u6b21/min\uff0c \u5c31\u8981\u99ac\u4e0a\u958b\u59cb CPR\u3002 (C)\u65b0\u751f\u5152 CPR\u7684\u58d3\u80f8\u53ca\u5439\u6c23\u6bd4\u70ba 15:2\u3002 (D)\u7576\u5fc3\u8df3\u8d85\u904e 60 \u6b21/min\u6642\uff0c\u9808\u7acb\u5373\u505c\u6b62 CPR\u4e26\u958b\u59cb\u7d66\u4e88\u6b63\u58d3\u547c\u5438\u901f\u7387\u7d04 40-60 \u6b21/min\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6025\u6027\u5fc3\u81df\u8870\u7aed\u7684\u8a3a\u65b7\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u654f\u611f\u5ea6\u6700\u9ad8\u7684\u75c7\u72c0\u70ba\u904b\u52d5\u6642\u547c\u5438\u56f0\u96e3(dyspnea on exertion) \u3002 (B)90% \u4ee5\u4e0a\u7684\u75c5\u4eba\u80f8\u90e8 X\u5149\u6703\u51fa\u73fe\u80ba\u5145\u8840 (pulmonary congestion )\u3002 (C)BNP (B-type natriuretic peptide )\u5927\u65bc 500 pg/mL \u70ba\u8a3a\u65b7\u7684\u9ec3\u91d1\u6a19\u6e96\u3002 (D)\u8d85\u97f3\u6ce2\u5f71\u50cf\u51fa\u73fe\u4e0b\u8154\u975c\u8108\u5927\u65bc 2\u516c\u5206\uff0c\u800c\u4e14\u96a8\u547c\u5438\u584c\u9677\u5c0f\u65bc 50%\u5373\u53ef\u8a3a\u65b7\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "30\u6b72\u7537\u91ab\u5e2b\u5728\u70ba\u75c5\u4eba\u7e2b\u5408\u50b7\u53e3\u6642\uff0c\u53f3\u624b\u98df\u6307\u88ab\u7e2b\u5408\u904e\u7684\u91dd\u982d\u523a\u50b7\uff0c\u50b7\u53e3\u6709\u6d41\u8840\u3002\u75c5\u4eba\u7684\u62bd\u8840\u6aa2\u67e5\u986f\u793a HIV antibody test \u70ba\u967d\u6027\u3001HBsAg \u70ba\u967d\u6027\u3001Anti-HCV\u70ba\u967d\u6027\uff1b\u91ab\u5e2b\u7684\u62bd\u8840\u5247\u986f\u793a anti-HBs\u70ba\u967d\u6027\u3002\u95dc\u65bc\u6b64\u91ab\u5e2b\u7684\u8077\u696d\u6027\u66b4\u9732\u5f8c\u7e8c\u8655\u7f6e\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u6b64\u91ab\u5e2b\u61c9\u4f7f\u7528\u6d88\u6bd2\u6d17\u624b\u6db2(disinfectants)\u6e05\u6d17\u50b7\u53e3\u3002 (B)\u6b64\u91ab\u5e2b\u61c9\u63a5\u53d7 HIV\u66b4\u9732\u5f8c\u9810\u9632\u6cbb\u7642(PEP )\u3002 (C)\u6b64\u91ab\u5e2b\u61c9\u63a5\u53d7 B\u578b\u809d\u708e\u514d\u75ab\u7403\u86cb\u767d(HBIG )\u6cbb\u7642\u3002 (D)\u6b64\u91ab\u5e2b\u61c9\u63a5\u53d7 C\u578b\u809d\u708e\u6297\u75c5\u6bd2\u85e5\u7269\u6cbb\u7642\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u95dc\u65bc\u54b3\u8840\u4e4b\u6558\u8ff0\uff0c\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)75% \u7684\u54b3\u8840\u6e90\u81ea\u65bc\u652f\u6c23\u7ba1\u52d5\u8108\u5206\u652f\uff0c\u53e6\u5916 25%\u54b3\u8840\u5247\u6e90\u81ea\u65bc\u80ba\u52d5\u8108\u5206\u652f\u3002 (B)\u547c\u5438\u9053\u3001\u80ba\u5be6\u8cea\u3001\u5fc3\u8840\u7ba1\u7b49\u75be\u75c5\u7686\u53ef\u80fd\u5c0e\u81f4\u54b3\u8840\uff0c\u5927\u91cf\u54b3\u8840\u6642\u5f80\u5f80\u4f86\u81ea\u5fc3\u8840\u7ba1\u75c5\u7076\u3002 (C)Rasmussen\u2019s aneurysm \u70ba\u6162\u6027\u80ba\u7d50\u6838\u958b\u6d1e\u4e0a\u4e4b\u5047\u6027\u8840\u7ba1\u7624\u3002 (D)\u652f\u6c23\u7ba1\u64f4\u5f35\u75c5\u4eba\uff0c\u54b3\u55fd\u4f34\u96a8\u54b3\u8840\uff0c\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\uff0c\u4e0d\u9700\u4f7f\u7528\u6c27\u6c23\uff0c\u7b26\u5408\u5c11\u91cf\u54b3\u8840\u5b9a\u7fa9\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "7\u6b72\u7537\u5b69\uff0c 10\u5206\u9418\u524d\u4e0d\u614e\u8dcc\u5012\u5c0e\u81f4\u53f3\u4e0a\u9580\u7259\u6574\u500b\u6495\u812b (avulsion)\uff0c\u6bcd\u89aa\u5e36\u4ed6\u53ca\u5b8c\u6574\u7259\u9f52\u4f86\u5230\u6025\u8a3a\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u5148\u8fa6\u5225\u662f\u5426\u70ba\u6046\u7259\uff0c\u82e5\u53ea\u662f\u4e73\u9f52\u5247\u4e0d\u53ef\u690d\u56de\u3002 (B)\u82e5\u8981\u690d\u56de\uff0c\u5247\u5148\u4ee5\u7259\u5237\u8f15\u8f15\u5237\u6389\u7259\u9f52\u4e0a\u9ad2\u6c61\u4e26\u4ee5\u751f\u7406\u98df\u9e7d\u6c34\u6c96\u6d17\u3002 (C)\u82e5\u53ef\u690d\u56de\uff0c\u5247\u5148\u5c07\u7259\u9f52\u7f6e\u65bc\u51b0\u725b\u5976\u4e2d\u4fdd\u5b58\uff0c\u4e26\u529b\u6c42\u6108\u5feb\u690d\u56de\u6108\u597d\u3002 (D)\u7259\u9f52\u690d\u56de\u6642\u9593\u82e5\u62d6\u5230\u4e8b\u4ef6\u767c\u751f\u5f8c 1\u500b\u5c0f\u6642\u4ee5\u4e0a\uff0c\u6210\u529f\u690d\u56de\u6a5f\u7387\u5e7e\u8fd1\u65bc\u96f6\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u5730\u9707\u5f15\u8d77\u5927\u6a13\u574d\u584c\uff0c\u4e00\u540d\u7537\u6027\u53f3\u8173\u88ab\u50be\u5012\u8863\u6ac3\u58d3\u4f4f 14\u5c0f\u6642\u5f8c\u88ab\u641c\u6551\u4eba\u54e1\u627e\u5230\uff0c\u6e96\u5099\u812b\u56f0\u524d\uff0c\u4e0b\u5217\u4f55\u9805\u8655\u7f6e \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u4f11\u514b\u6642\u624d\u5927\u91cf\u8f38\u6db2\uff0c\u907f\u514d\u80a2\u9ad4\u592a\u904e\u816b\u8139\u3002 (B)\u4e73\u9178\u6797\u683c \u6c0f\u6db2\u4e5f\u662f\u73fe\u5834\u5927\u91cf\u8f38\u6db2\u7684\u597d\u9078\u64c7\u3002 (C)NaHCO 3\u642d\u914d\u5927\u91cf\u751f\u7406\u98df\u9e7d\u6c34\u8f38\u6db2\u3002 (D)\u6b62\u8840\u5e36\u6703\u52a0\u91cd\u75c5\u4eba\u75bc\u75db\uff0c\u4e0d\u5efa\u8b70\u5e38\u898f\u4f7f\u7528\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u9023\u74b0\u8eca\u798d\u5927\u91cf\u50b7\u60a3\uff0c\u4e0b\u5217\u54ea\u4e00\u4f4d\u75c5\u4eba\u6703\u9700\u8981 \u6700\u512a\u5148\u5f8c\u9001\u81f3\u91ab\u9662\uff1f", + "Options": "(A)\u4e2d\u5e74\u7537\u6027\uff0c\u53e3\u9f3b\u6709\u51fa\u8840\uff0c\u6253\u958b\u547c\u5438\u9053\u4ecd\u7121\u547c\u5438\u3002 (B)\u5e74\u8f15\u5973\u6027\uff0c\u5de6\u5927\u817f\u8b8a\u5f62\uff0c\u4e0d\u505c\u5730\u547c\u558a\u6551\u547d\u3002\u547c\u5438 20 \u6b21/min\uff0c\u6a48\u52d5\u8108\u6478\u5f97\u5230\u3002 (C)\u5e74\u8f15\u7537\u6027\uff0c\u53f3\u80f8\u75bc\u75db\u6709\u7600\u9752\uff0c\u7126\u6025\u5730\u5c0b\u627e\u5973\u5152\u7684\u4e0b\u843d\u3002 (D)\u4e2d\u5e74\u5973\u6027\uff0c\u53f3\u524d\u984d\u8840\u816b\uff0c\u7b54\u975e\u6240\u554f\u7121\u6cd5\u9075\u5f9e\u91ab\u56d1\u3002\u547c\u5438 20\u6b21/min\uff0c\u5fae\u8840\u7ba1\u586b\u5145\u6642\u9593 2\u79d2\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u95dc\u65bc\u7729\u6688\u4e4b\u6558\u8ff0\uff0c\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u524d\u5ead\u795e\u7d93\u708e\u7684\u75c5\u4eba\u5408\u4f75\u6709\u8033\u6735\u75bc\u75db\u3001\u807d\u529b\u6e1b\u9000\u3001\u8033\u9cf4\u7b49\u75c7\u72c0\u3002 (B)\u4e2d\u98a8\u7684\u75c5\u4eba\u5e38\u5728\u6025\u8a3a\u88ab\u8aa4\u8a3a\u70ba\u9031\u908a\u6027\u7729\u6688(peripheral vestibular disorder)\u3002 (C)\u9031\u908a\u578b\u6216\u4e2d\u6a1e\u578b\u7729\u6688\uff0c\u7686\u6703\u56e0\u52d5\u4f5c\u6539\u8b8a\u982d\u90e8\u4f4d\u7f6e\u800c\u5c0e\u81f4\u75c7\u72c0\u60e1\u5316\u3002 (D)\u5728\u6025\u8a3a\u8a55\u4f30\u7729\u6688\u75c5\u4eba\u6642\uff0c\u61c9\u540c\u6642\u57f7\u884c Dix-Hallpike testing \u8207 HINT plus testing \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6025\u6027\u814e\u640d\u50b7\u7684\u6558\u8ff0\u548c\u8655\u7f6e\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u793e\u5340\u578b\u6025\u6027\u814e\u640d\u50b7\u8f03\u591a\u70ba\u53ef\u9006\u6027\uff0c\u4f46\u8207\u5176\u76f8\u95dc\u7684 3\u5e74\u5167\u6b7b\u4ea1\u7387\u9ad8\u905445%~ 66% \u3002 (B)\u5fc3\u96fb\u5716\u53ef\u5feb\u901f\u7be9\u6aa2\u9ad8\u8840\u9240\uff0c\u7576 K > 6.5 meq/L \uff0c\u591a\u6703\u9020\u6210\u9ad8\u8073\uff34\u6ce2\uff0c\u5176\u654f\u611f\u5ea6\u53ef\u9054 80%\u3002 (C)\u7d66\u4e88\u4f4e\u5291\u91cf( renal -dose)\u7684 Dopamine \u7121\u6cd5\u4fc3\u9032\u814e\u529f\u80fd\u6062\u5fa9\uff0c\u4e5f\u7121\u6cd5\u964d\u4f4e\u6b7b\u4ea1\u7387\u3002 (D)\u814e\u7d72\u7403\u904e\u6ffe\u7387\u226630 mL/min/1.73 m2\u7684\u75c5\u4eba\u63a5\u53d7\u986f\u5f71\u5291\u6ce8\u5c04\uff0c\u8981\u505c\u6b62Metformin \u7684\u4f7f\u7528 48\u5c0f\u6642\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u72c0\u6cc1\u4f55\u8005\u65bd\u4e88\u8840\u5c0f\u677f\u8f38\u6ce8\u6cbb\u7642 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u8178\u80c3\u9053\u51fa\u8840\u4e2d\u7684\u985e\u8840\u53cb\u75c5(V on Willebran\u2019s disease )\u75c5\u4eba\uff0cplatelet 40,000 /mm3\u3002 (B)\u5c3f\u6bd2\u75c7\u75c5\u4eba\uff0c\u653e\u7f6e\u4e2d\u592e\u975c\u8108\u5c0e\u7ba1\u524d\uff0cplatelet 25,000 /mm3\u3002 (C)\u7591\u8166\u819c\u708e\u75c5\u4eba\u5728\u8170\u690e\u7a7f\u523a\u524d\uff0cplatelet 60,000 /mm3\u3002 (D)\u7121\u51fa\u8840\u75c7\u72c0\u7684\u81ea\u767c\u6027\u8840\u5c0f\u677f\u4f4e\u4e0b\u7d2b\u6591\u75c7\u75c5\u4eba\uff0cplatelet 6,000 /mm3\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "60\u6b72\u7537\u6027\uff0c 30\u5206\u9418\u524d\u5403\u91ce\u83c7\u5f8c\u4e0a\u5410\u4e0b\u7009\uff0c\u4f34\u96a8\u76dc\u6c57\u3001\u5931\u7981\uff0c\u8eab\u9ad4\u8a3a\u5bdf\u767c\u73fe\u76ae\u819a\u6fd5\u51b7\u3001\u96d9\u5074\u80ba\u90e8\u6fd5\u56c9\u97f3\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u9664\u6bd2\u7d20\u4e2d\u6bd2\u5916\u4ea6\u53ef\u80fd\u662f\u8178\u9053\u4fb5\u8972\u75c5\u539f\uff0c\u5982\uff1a\u8178\u9053\u963f\u7c73\u5df4\u3001\u970d\u4e82\u5f27\u83cc\u7b49\u611f\u67d3\u3002 (B)\u4e0d\u53ef\u7d66\u4e88\u6b62\u5410\u85e5\uff0c\u4ee5\u907f\u514d\u5ef6\u9577\u4e2d\u6bd2\u4e4b\u75c5\u7a0b\u3002 (C)\u6b64\u6bd2\u6027\u75c7\u5019\u7fa4\u7d93\u6cbb\u7642\u5f8c\uff0c\u591a\u6578\u65bc 12\u5c0f\u6642\u5167\u7de9\u89e3\u3002 (D)\u6b64\u70ba\u81bd\u9e7c\u6027\u6bd2\u6027\u75c7\u5019\u7fa4(cholinergic toxidrome )\uff0c\u7d66\u4e88\u89e3\u6bd2\u5291Pralidoxime 1g \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u81bf\u80f8\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u81bf\u80f8\u7684\u8a3a\u65b7\u6a19\u6e96\u5305\u62ec\u80f8\u8154\u7a7f\u523a\u6db2 pH < 7.35 \u3002 (B)\u7d50\u6838\u6027\u81bf\u80f8\uff0c\u80f8\u8154\u7a7f\u523a\u6db2\u7684\u6dcb\u5df4\u7403\u6578\u91cf\u6703\u660e\u986f\u589e\u52a0\u3002 (C)POCUS \u80fd\u5920\u5340\u5206\u80f8\u8154\u7a4d\u6db2\u8207\u81bf\u80f8\u3002 (D)\u7e96\u7dad\u86cb\u767d\u6eb6\u89e3\u5291(fibrinolytics )\u53ef\u6539\u5584\u81bf\u80f8\u7684\u5f15\u6d41\uff0c\u660e\u986f\u964d\u4f4e\u6b7b\u4ea1\u7387\u6216\u624b\u8853\u9700\u6c42\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u7d30\u83cc\u6027\u80ba\u708e\u7684\u76f8\u95dc\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)Pneumococcal pneumonia \u5be6\u9a57\u5ba4\u6aa2\u67e5\u7d50\u679c\uff0c\u53ef\u51fa\u73fe\u8840\u6e05\u81bd\u7d05\u7d20\u5347\u9ad8\u6216\u4f4e\u9209\u8840\u75c7\u3002 (B)Klebsiella pneumonia \u5728\u81e8\u5e8a\u4e0a\u5e38\u898b\u5230\u918b\u6817\u679c\u51cd\u75f0 (currant jelly sputum)\u3002 (C)Haemophilus influenzae pneumonia \u597d\u767c\u65bc\u8001\u5e74\u4eba\uff0c\u5e38\u898b\u80f8\u8154\u7a4d\u6db2\u548c\u591a\u8449\u6d78\u6f64\u3002 (D)\u6709\u5438\u5165\u6027\u80ba\u708e\u98a8\u96aa\u7684\u75c5\u4eba\uff0c\u61c9\u8003\u616e\u91d1\u9ec3\u8272\u8461\u8404\u7403\u83cc\u611f\u67d3\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u6700\u4e0d\u50cf\u89aa\u5bc6\u4f34\u4fb6\u66b4\u529b\u50b7\u5bb3\uff1f", + "Options": "(A)\u6307\u7532\u522e\u50b7\u3001\u54ac\u50b7\u7b49\u5177\u6709\u66b4\u529b\u7279\u5fb5\u7684\u50b7\u75d5\u3002 (B)\u8eab\u9ad4\u6709\u591a\u8655\u4e0d\u540c\u6642\u671f\u7684\u50b7\uff0c\u4e14\u5206\u4f48\u5728\u8eab\u9ad4\u4e2d\u592e (\u982d\u3001\u8ec0\u5e79 )\u3002 (C)\u53d7 \u50b7\u90e8\u4f4d\u65bc\u624b\u638c\u3001\u819d\u84cb\u7b49\u6613\u6d3b\u52d5\u4e4b\u8655\u3002 (D)\u5ef6\u9072\u5c31\u91ab\u4e14\u6709\u81ea\u6bba\u50be\u5411\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u9451\u5225\u8b6b\u5984\u3001\u5931\u667a\u8207\u7cbe\u795e\u75be\u75c5\u6642\u7684\u8003\u91cf\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u5c08\u6ce8\u529b\u4e09\u8005\u90fd\u6703\u964d\u4f4e\uff0c\u4ee5\u5931\u667a\u964d\u4f4e\u8f03\u70ba\u660e\u986f\u3002 (B)\u64b2\u7ffc\u6a23\u9707\u986b (asterixis )\u8f03\u5e38\u767c\u751f\u5728\u8b6b\u5984\u7684\u75c5\u4eba\u8eab\u4e0a\u3002 (C)\u8b6b\u5984\u5bb9\u6613\u6709\u8996\u5e7b\u89ba\u6216\u807d\u5e7b\u89ba\uff0c\u5931\u667a\u75c5\u4eba\u5247\u8f03\u5c11\u898b\u3002 (D)\u5931\u667a\u8207\u7cbe\u795e\u75be\u75c5\u901a\u5e38\u662f\u610f\u8b58\u6e05\u9192\uff0c\u8b6b\u5984\u7684\u75c5\u4eba\u8f03\u53ef\u80fd\u662f\u610f\u8b58\u660f\u6c89(reduced consciousness )\u6216\u9ad8\u5ea6\u8b66\u6212( hyperalert )\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "25\u6b72\u7537\u6027\u56e0 \u70ba\u6578\u5c0f\u6642\u524d\u88ab\u786c\u8731\u53ee\u54ac\u5de6\u5c0f\u817f\u7121\u6cd5\u79fb\u9664\u524d\u4f86\u6025\u8a3a\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u79fb\u9664\u524d\u53ef\u4f7f\u7528 Lidocaine jelly\u5857\u62b9\u9ebb\u75f9\u786c\u8731\u3002 (B)\u7528\u9477\u5b50\u6458\u9664\u524d\u61c9\u5148\u7834\u58de\u786c\u8731\u8ec0\u9ad4\uff0c\u907f\u514d\u4f2f\u6c0f\u758f\u87ba\u65cb\u9ad4\u7d93\u7531\u786c\u8731\u8ec0\u9ad4\u5206\u6ccc\u81f3\u553e\u6db2\u5167\u3002 (C)\u79fb\u9664\u7684\u786c\u8731\u61c9\u4fdd\u7559\u5728\u9152\u7cbe\u4e2d\u4ee5\u4f9b\u8fa8\u8b58\u3002 (D)\u75c5\u4eba\u61c9\u53e3\u670d doxycycline \u9810\u9632\u840a\u59c6\u75c5\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u773c\u7736\u9aa8\u6298( orbital fracture )\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u9f3b\u6a11\u53d7\u91cd\u64ca\u6642\u9808\u8003\u616e\u6dda\u817a\u50b7\u5bb3\u3002 (B)\u773c\u90e8\u920d\u50b7\u6700\u5e38\u898b\u7684\u773c\u7736\u9aa8\u6298\u662f\u4e0b\u58c1\u53ca\u5167\u5074\u58c1\u9aa8\u6298\u3002 (C)Orbital floor \u9aa8\u6298\u6642\uff0c\u75c5\u4eba\u8f03\u5e38\u5728\u773c\u775b\u5411\u4e0b\u770b\u6642\u6709\u8907\u8996\u73fe\u8c61\u3002 (D)\u773c\u7736\u9aa8\u6298\u4e4b\u75c5\u4eba\u9808\u4f7f\u7528\u9810\u9632\u6027\u6297\u751f\u7d20\uff0c\u4ee5\u907f\u514d\u9f3b\u7ac7\u4e4b\u75c5\u539f\u83cc\u611f\u67d3\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "28\u6b72\u5973\u6027\u65bc\u5c71\u5340\u906d\u9f2c\u737e\u54ac\u50b7\u53f3\u524d\u81c2\uff0c\u6709 3\u516c\u5206\u6495\u88c2\u50b7\uff0c\u5728\u8655\u7406\u50b7\u53e3\u5f8c\u8ddf\u4f60\u8aee\u8a62\u72c2\u72ac\u75c5\u76f8\u95dc\u885b\u6559\uff0c\u54ea\u4e00\u9805\u885b\u6559 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u72c2\u72ac\u75c5\u6f5b\u4f0f\u671f\u7d04\u5728 1\u81f33\u500b\u6708\uff0c\u4f46\u4e5f\u53ef\u80fd\u6f5b\u4f0f\u6578\u5e74\u4e4b\u4e45\u3002 (B)\u82e5\u4fb5\u72af\u4e2d\u6a1e\u795e\u7d93\u7cfb\u7d71\uff0c\u5e38\u4ee5\u8166\u819c\u708e( meningitis) \u8868\u73fe\u3002 (C)\u5e38\u898b\u982d\u75db\u767c\u71d2\uff0c\u8e81\u52d5\u4e0d\u5b89\u8868\u73fe\uff0c\u5c11\u6709\u610f\u8b58\u660f\u8ff7\u7684\u72c0\u6cc1\u3002 (D)\u82e5\u6709\u4efb\u4f55\u7591\u4f3c\u75c7\u72c0\uff0c\u5efa\u8b70\u75c5\u4eba\u56de\u8a3a\u63a5\u53d7\u985e\u56fa\u9187\u6cbb\u7642\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "2\u6b72\u7537\u7ae5\u56e0\u7672\u7647\u767c\u4f5c\u9001\u81f3\u6025\u8a3a\uff0c\u5728\u7d66\u4e88\u5169\u6b21 Lorazepam \u5f8c\u4ecd\u7121\u6cd5\u63a7\u5236\uff0c\u4e0b\u6b21\u7d66\u7684\u85e5\u7269\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)Fosphenytoin \u3002 (B)Levetiracetam \u3002 (C)Phenobarbital \u3002 (D)Propofol \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "48\u6b72\u5973\u6027\u904e\u53bb\u6709\u6c23\u5598( asthma)\u75c5\u53f2\uff0c\u7a81\u767c\u547c\u5438\u56f0\u96e3\u9001\u5165\u6025\u8a3a\uff0c\u6aa2\u50b7\u767c\u73fe\u75c5\u4eba SpO 2 80%\uff0c\u819a\u8272\u84bc\u767d\u767c\u7d3a\uff0c\u8a3a\u65b7\u70ba\u6c23\u5598\u6025\u6027\u767c\u4f5c\uff0c\u7d93\u6cbb\u7642\u5f8c\u5979\u75c7\u72c0\u6539\u5584\u8981\u6c42\u56de\u5bb6\uff0c\u6709\u95dc\u589e\u52a0\u51fa\u9662\u6b7b\u4ea1\u98a8\u96aa\uff0c\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u4e0a\u500b\u6708\u4f7f\u7528\u5b8c\u4e00\u7f50 Fenoterol \u5b9a\u91cf\u5674\u9727\u6db2\u3002 (B)\u672c\u6b21\u6025\u8a3a\u4f7f\u7528\u4e09\u6b21\u7684 \u03b22-agonists\u3002 (C)\u904e\u53bb\u4e00\u5e74\u5167\u56e0\u6c23\u5598\u6025\u6027\u767c\u4f5c\u4f86\u6025\u8a3a\u5c31\u91ab 4\u6b21\u3002 (D)\u547c\u5438\u4ecd\u6709\u5598\u9cf4\u97f3(wheezing)\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u810a\u7d22\u640d\u50b7( spinal cord injury)\u8eca\u798d\u53d7\u50b7\u7684\u75c5\u4eba\u4e4b\u8eab\u9ad4\u8a3a\u5bdf\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u82e5\u75c5\u4eba\u4e4b\u6b98\u9918\u5c3f\u91cf\u5927\u65bc 100-200 mL\uff0c\u5373\u9ad8\u5ea6\u61f7\u7591\u6709\u810a\u7d22\u58d3\u8feb\u3002 (B)\u6709\u810a\u7d22\u640d\u50b7 \u7684\u75c5\u4eba\u53ef\u80fd\u51fa\u73fe\u53cd\u5c04\u589e\u5f37(hyperactive reflex )\uff0c\u4f46\u4e0d\u6703\u51fa\u73fe\u9663\u6523 (clonus) \u3002 (C)\u53d7\u50b7\u5f8c 1\u5c0f\u6642\u5167\u90fd\u6c92\u51fa\u73fe\u53cd\u5c04\u589e\u5f37(hyperactive reflex )\u7684\u73fe\u8c61\uff0c\u5373\u53ef\u6392\u9664\u6709\u810a\u9ad3\u50b7\u5bb3\u3002 (D)\u4e0d\u6703\u51fa\u73fe Babinski\u2019s sign \u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u95dc\u65bc\u6025\u8a3a\u91ab\u7642\u6587\u4ef6\u7684\u76f8\u95dc\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u82e5\u70ba\u81ea\u52d5\u96e2\u9662\uff0c\u9700\u8a18\u9304\u75c5\u4eba\u96e2\u9662\u6642\u4e4b\u72c0\u614b\u3001\u81ea\u52d5\u96e2\u9662\u4e4b\u539f\u56e0\u3001\u4ee5\u53ca\u53ef\u80fd\u52d5\u5411\u3002 (B)\u6025\u8a3a\u75c5\u6b77\u5beb\u4f5c\u9700\u805a\u7126\uff0c\u800c\u975e\u7cfb\u7d71\u6027\u5730\u6536\u96c6\u6240\u6709\u8cc7\u8a0a\u52a0\u4ee5\u8a18\u9304\uff0c\u6587\u6cd5\u5b8c\u6574\u7684\u8a9e\u53e5\u4e5f\u4e26\u975e\u5fc5\u8981\u3002 (C)\u7279\u6b8a\u60c5\u5883\u5982\u5bb6\u66b4\u3001\u5152\u8650\u7b49\uff0c\u9664\u4e86\u8a73\u5be6\u8a18\u8f09\u65bc\u75c5\u6b77\u5916\uff0c\u53e6\u9700\u5b8c\u6210\u4e3b\u7ba1\u6a5f\u95dc\u4e4b\u76f8\u95dc\u901a\u5831\u4f5c\u696d\u3002 (D)\u8a3a\u65b7\u66f8\u662f\u6cd5\u5f8b\u6587\u4ef6\uff0c\u5728\u6025\u8a3a\u53ea\u80fd\u7531\u770b\u8a3a\u91ab\u5e2b\u89aa\u81ea\u958b\u7acb\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u6558\u8ff0\u95dc\u65bc Group A \u03b2 -hemolytic Streptococcus \u5f15\u8d77\u7684 pharyngitis \u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5e38\u6709\u767c\u71d2\u3001\u54b3\u55fd\u3001\u5589\u56a8\u75db\u7b49\u75c7\u72c0\u3002 (B)\u56e0\u540c\u4f4f\u5bb6\u5ead\u6210\u54e1\u7d04\u6709 10%\u7684\u6a5f\u6703\u611f\u67d3\uff0c\u5efa\u8b70\u7d66\u4e88\u9810\u9632\u6027\u6297\u751f\u7d20\u3002 (C)\u61c9\u65bc 3\u65e5\u5167\u5118\u65e9\u7d66\u4e88\u6297\u751f\u7d20\uff0c\u624d\u80fd\u6709\u6548\u9810\u9632\u91cd\u5927\u975e\u5316\u81bf\u6027\u5f8c\u907a\u75c7(major nonsuppurative sequelae )\u3002 (D)\u6c92\u6709\u660e\u78ba\u7684\u8b49\u64da\u986f\u793a\u7d66\u4e88\u9069\u7576\u7684\u6297\u751f\u7d20\uff0c\u53ef\u907f\u514d\u7522\u751f\u814e\u7d72\u7403\u814e\u708e(glomerulonephritis )\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u54ea\u4e00\u500b\u72c0\u6cc1 \u8f03\u6709\u53ef\u80fd \u662f\u66b4\u9732\u5230\u751f\u7269\u6bd2\u7d20( biotoxin)\u7684\u751f\u7269\u6050\u6016\u4e8b\u4ef6\uff1f", + "Options": "(A)\u5177\u6709\u5178\u578b\u5371\u96aa\u56e0\u5b50\u7684\u75c5\u4eba\u7f79\u60a3\u76f8\u4f3c\u7684\u75be\u75c5\u3002 (B)\u6d41\u884c\u75c5\u5b78\u7684\u8abf\u67e5\u8ffd\u6eaf\u5230\u8a31\u591a\u4e0d\u540c\u7684\u611f\u67d3\u6e90\u3002 (C)\u540c\u4e00\u500b\u5340\u57df\u7684\u52d5\u7269\u8207\u4eba\u90fd\u51fa\u73fe\u76f8\u540c\u7684\u75be\u75c5\u3002 (D)\u77ed\u6642\u9593\u5167\u591a\u91cd\u6162\u6027\u75c5\u4eba\u7a81\u7136\u5927\u91cf\u6b7b\u4ea1\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc virus pericarditis \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u5fc3\u96fb\u5716\u53ef\u80fd\u51fa\u73fe\u591a\u5c0e\u7a0b\u7684 ST\u6bb5\u4e0a\u5347\u548c PR\u6bb5\u4e0b\u964d\u3002 (B)\u53ef\u4ee5\u7d66\u4e88 NSAIDs\u53caColchicine \u6cbb\u7642\u3002 (C)\u82e5\u5c0d NSAIDs\u8010\u53d7\u4e0d\u4f73\uff0c\u53ef\u4ee5\u8003\u616e\u4f7f\u7528 corticosteroid \u6cbb\u7642\u3002 (D)\u5927\u90e8\u5206\u75c5\u4eba\u9700\u8981\u4f4f\u9662\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5728\u6025\u8a3a\u9032\u884c\u95dc\u7bc0\u7a7f\u523a\u8853\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u6709\u53e3\u670d\u6297\u51dd\u8840\u5291\u7684\u75c5\u4eba\uff0c\u5728\u95dc\u7bc0\u7a7f\u523a\u8853\u524d\uff0c\u5b9c\u5e38\u898f\u6aa2\u67e5\u51dd\u8840\u529f\u80fd\u3002 (B)\u5728\u57f7\u884c\u7591\u4f3c\u6557\u8840\u6027\u95dc\u7bc0\u708e\u7684\u95dc\u7bc0\u7a7f\u523a\u8853\u6642\uff0c\u53ef\u5148\u6ce8\u5c04\u5c40\u90e8\u9ebb\u9189\u5291\u65bc\u95dc\u7bc0\u8154\u5167\u4f86\u6e1b\u8f15\u75bc\u75db\u3002 (C)\u8098\u95dc\u7bc0\u6db2\u7684\u62bd\u53d6\uff0c\u53ef\u512a\u5148\u9078\u64c7\u7531\u624b\u8098\u5167\u5074\u9032\u91dd\u3002 (D)\u8155\u95dc\u7bc0\u6db2\u7684\u62bd\u53d6\uff0c\u5b9c\u7531\u5c3a\u5074\u6a48\u9aa8\u7d50\u7bc0\u548c\u4f38\u62c7\u9577\u808c\u8171\u53ca\u98df\u6307\u7e3d\u4f38\u808c\u8171\u7684\u4e2d\u9593\u4e0b\u91dd\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u9078\u64c7\u6027\u8840\u6e05\u7d20\u518d\u5438\u6536\u6291\u5236\u5291( selective serotonin reuptake inhibitors, SSRIs)\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u5e38\u898b\u526f\u4f5c\u7528\u5305\u542b\u5641\u5fc3\u3001\u5614\u5410\u3001\u55dc\u7761\u53ca\u982d\u75db\u3002 (B)\u53ef\u80fd\u6703\u589e\u52a0\u81ea\u6bba\u610f\u5ff5\uff0c\u5c24\u5176\u662f\u4e0d\u5230 25\u6b72\u7684\u75c5\u4eba\u3002 (C)\u7a81\u7136\u505c\u7528\u5f8c\u7522\u751f\u7684\u75c7\u72c0\u5e38\u662f\u81f4\u547d\u7684\uff0c\u9700\u8981\u7dca\u6025\u8655\u7406\u3002 (D)\u4f75\u7528\u53ef\u80fd\u589e\u52a0\u8840\u6e05\u7d20\u7684\u85e5\u7269\u6642\uff0c\u9808\u6ce8\u610f\u8840\u6e05\u7d20\u75c7\u5019\u7fa4\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u8840\u7ba1\u5f35\u529b\u7d20\u8f49\u5316\u9176\u6291\u5236\u5291( Angiotensin converting enzyme inhibitor )\u5f15\u8d77\u7684\u8840\u7ba1\u6027\u6c34\u816b(angioedema ) \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u50b3\u660e\u9178(Tranexamic Acid )\u662f\u6cbb\u7642\u9996\u9078\u85e5\u7269\u3002 (B)\u9ad8\u5291\u91cf\u76ae\u8cea\u985e\u56fa\u9187(Corticosteroid )\u5c0d\u65bc\u5589\u982d\u6c34\u816b\u6cbb\u7642\u6548\u679c\u4f73\u3002 (C)\u6cbb\u7642\u85e5\u7269\u7f3a\u4e4f\u6642\uff0c\u53ef\u7d66\u4e88\u51b7\u51cd\u6c88\u6fb1\u54c1(Cryoprecipitate )\u8f38\u6db2\u6cbb\u7642\u3002 (D)\u82e5\u9700\u8981\u6cbb\u7642\u9ad8\u8840\u58d3\uff0c\u53ef\u6539\u7d66\u4e88\u8840\u7ba1\u5f35\u529b\u7d20\u53d7\u9ad4\u963b\u65b7\u5291(Angiotensin receptor blocker )\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u8001\u5e74\u4eba\u8179\u90e8\u75be\u75c5\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u75c5\u6bd2\u6027\u8178\u708e\u6bd4\u7d30\u83cc\u6027\u8178\u708e\uff0c\u8f03\u5e38\u767c\u751f\u8001\u5e74\u4eba\u8eab\u4e0a\u3002 (B)\u8178\u963b\u585e\u662f\u8001\u5e74\u4eba\u8179\u90e8\u624b\u8853\u6700\u5e38\u898b\u7684\u539f\u56e0\u3002 (C)\u8001\u5e74\u4eba\u53ef\u4ee5\u591a\u8003\u616e\u4f7f\u7528\u5f71\u50cf\u5b78\u6aa2\u67e5\uff0c\u4f86\u6392\u9664\u4e0d\u660e\u539f\u56e0\u8179\u75db\u3002 (D)\u8001\u5e74\u4eba\u8179\u75db\u8f03\u5c11\u9700\u8981\u958b\u5200\uff0c\u75c7\u72c0\u5f80\u5f80\u8f03\u4e0d\u660e\u986f\u96e3\u4ee5\u8a3a\u65b7\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u9583\u96fb\u96fb\u64ca\u50b7\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u5e38\u898b\uff1f", + "Options": "(A)\u773c\u775b\u50b7\u5bb3\u3002 (B)\u814e\u8870\u7aed\u3002 (C)\u6a6b\u7d0b\u808c\u6eb6\u89e3\u3002 (D)\u5fc3\u5ba4\u986b\u52d5\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8166\u90e8\u96fb\u8166\u65b7\u5c64 (computed tomography, CT)\u7684\u6c7a\u7b56\uff0c\u7d10\u5967\u826f\u6a19\u6e96(New Orleans Criteria )\u548c\u52a0\u62ff\u5927 CT\u982d\u90e8\u898f\u5247 (Canadian CT Head Rule )\u7684\u63cf\u8ff0\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u7d10\u5967\u826f\u6a19\u6e96\uff0c\u662f\u91dd\u5c0d\u8f15\u5ea6\u982d\u90e8\u5916\u50b7\uff0c\u660f\u8ff7\u6307\u6578 GCS 13~15 \u5206\u7684\u65cf\u7fa4\u3002 (B)\u52a0\u62ff\u5927 CT\u982d\u90e8\u898f\u5247\uff0c\u662f\u91dd\u5c0d GCS 15\u5206\uff0c\u5c0f\u65bc 15\u5206\u7684\u90fd\u4e0d\u9069\u7528\u3002 (C)\u4f9d\u64da\u7d10\u5967\u826f\u6a19\u6e96\u9805\u76ee\uff0c\u5305\u62ec\uff1a\u982d\u75db\uff0c\u5614\u5410\uff0c\u6301\u7e8c\u9806\u884c\u6027\u5931\u61b6\uff0c\u9396\u9aa8\u4ee5\u4e0a\u5916\u50b7\u8b49\u64da\uff0c\u9871\u5e95\u9aa8\u6298\u5fb5\u8c61\uff0c\u7672\u7647\u767c\u4f5c\u3002 (D)\u4f9d\u64da\u52a0\u62ff\u5927 CT\u982d\u90e8\u898f\u5247\u9805\u76ee\uff0c\u5305\u62ec\uff1a2 \u5c0f\u6642\u7684 GCS<15\u5206\uff0c\u5614\u5410 1\u6b21\u4ee5\u4e0a\uff0c\u9006\u884c\u6027\u5931\u61b6>30 \u5206\u9418\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u81ea\u767c\u6027\u8166\u51fa\u8840 (spontaneous intra -cranial hemorrhage )\u75c5\u4eba\u6cbb\u7642\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u5982 3\u5c0f\u6642\u5167\u6709\u4f7f\u7528 Heparin\uff0c\u61c9\u7d66\u4e88 Protamine \u3002 (B)\u5982\u6709\u4f7f\u7528 Warfarin\uff0c\u4e0d\u8ad6\u8840\u6db2\u6aa2\u9a57 INR\u6578\u503c\u9ad8\u4f4e\uff0c\u61c9\u7d66\u4e88 Vit-K\u8207Prothrombin complex concentrate \u3002 (C)\u5982\u6709\u4f7f\u7528 anti-platelet agent \uff0c\u61c9\u8f38\u6ce8\u8840\u5c0f\u677f\u8207\u7d66\u4e88 Desmopressin \u3002 (D)\u5982\u6709\u4f7f\u7528 Dabigatran \uff0c\u61c9\u7d66\u4e88 Idarucizumab \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u6709\u95dc\u5c0f\u5152\u6025\u6027\u8178\u80c3\u708e\u4e4b\u8a55\u4f30\u548c\u8655\u7f6e\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)C \u53cd\u61c9\u6027\u86cb\u767d(C-reactive protein)\u53ef\u7528\u4f86\u9451\u5225\u7d30\u83cc\u6027\u6216\u75c5\u6bd2\u6027\u8178\u80c3\u708e\u3002 (B)\u6709\u56b4\u91cd\u812b\u6c34\u8005\uff0c\u5747\u8981\u6aa2\u67e5\u8840\u7cd6\u548c\u8840\u6db2\u96fb\u89e3\u8cea\u3002 (C)BUN \u6578\u503c\u4e0d\u6613\u5206\u8fa8\u8f15\u5fae\u812b\u6c34\u8005\uff0c\u78b3\u9178\u6c2b\u6839(HCO 3-)\u6578\u503c\u53ef\u7528\u4f86\u6392\u9664\u7121\u812b\u6c34\u8005\u3002 (D)\u4ecd\u53ef\u6301\u7e8c\u9032\u98df\u6e1b\u7de9\u812b\u6c34\u53ca\u4fc3\u9032\u8178\u9053\u9ecf\u819c\u5fa9\u539f\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u5c0d\u65bc\u624b\u90e8\u591a\u8655\u6495\u88c2\u50b7\uff0c\u5728\u6025\u8a3a\u8a55\u4f30\u53ca\u6e96\u5099\u7e2b\u5408\u904e\u7a0b\u4e2d\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u82e5\u6aa2\u67e5\u767c\u73fe\u75c5\u4eba\u5927\u62c7\u6307\u7121\u6cd5\u6bd4\u300c\u8b9a\u300d\u7684\u59ff\u52e2\uff0c\u53ef\u80fd\u70ba\u6b63\u4e2d\u795e\u7d93(medial nerve )\u53d7\u640d\u3002 (B)\u5728\u6025\u8a3a\u57f7\u884c digital nerve block \u6642\uff0c\u7528\u542b\u814e\u4e0a\u817a\u7d20\u7684\u5c40\u90e8\u9ebb\u9189\u85e5\u662f\u4e0d\u5b89\u5168\u7684\u3002 (C)\u6307\u5c16\u6495\u88c2\u50b7\uff0c\u53ef\u4f7f\u7528\u5169\u9ede\u8fa8\u5225\u529b(t wo point discrimination )\u4f86\u6e2c\u8a66\u611f\u89ba\u7f3a\u640d\uff0c\u6b63\u5e38\u5169\u9ede\u8fa8\u5225\u529b< 6 mm\u3002 (D)\u5982\u679c\u50b7\u53e3\u6df1\u800c\u4e14\u61f7\u7591\u95dc\u7bc0\u8154\u53d7\u640d\uff0c\u53ef\u7528 saline load test \u6e2c\u8a66\uff0c\u4f46\u4e0d\u5efa\u8b70\u52a0\u5165\u7532\u57fa\u85cd\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u810a\u690e\u5916\u50b7\u4e4b\u6558\u8ff0\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u80f8\u690e\u56e0\u8207\u808b\u9aa8\u5f62\u6210\u95dc\u7bc0\u4fdd\u8b77\uff0c\u810a\u9ad3\u640d\u50b7\u4e4b\u6a5f\u6703\u76f8\u5c0d\u4f4e\u3002 (B)\u7b2c\u4e09\u8170\u690e\u53d7\u640d\u53ef\u5f71\u97ff\u810a\u9ad3\u672b\u7aef\u795e\u7d93\u800c\u9020\u6210\u8180\u80f1\u529f\u80fd\u53d7\u640d\u3002 (C)\u58d3\u8feb\u6027\u9aa8\u6298\u5e38\u56e0\u53d7\u50b7\u904e\u7a0b\u4e2d\u904e\u5ea6\u4f38\u5c55(hyperextension )\u64e0\u58d3\u810a\u690e\u524d\u90e8\u6240\u9020\u6210\u3002 (D)\u8170\u690e\u690e\u9ad4\u9ad8\u5ea6\u584c\u9677 20%\u4e4b\u58d3\u8feb\u6027\u9aa8\u6298\uff0c\u53ef\u8003\u616e\u9580\u8a3a\u6cbb\u7642\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u904e\u654f\u6027\u4f11\u514b( anaphylactic shock )\u6cbb\u7642\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u53ef\u4f7f\u7528\u767d\u86cb\u767d\u4f86\u9032\u884c\u9ad4\u6db2\u5fa9\u7526\uff0c\u6e1b\u5c11\u5927\u91cf\u6676\u72c0\u6db2(crystalloid fluid)\u5e36\u4f86\u7684\u554f\u984c\u3002 (B)\u5e73\u6642\u670d\u7528\u4e59\u578b\u963b\u65b7\u5291\u7684\u75c5\u4eba\uff0c\u7528 Epinephrine \u6cbb\u7642\u53ef\u80fd\u6703\u9020\u6210\u56b4\u91cd\u9ad8\u8840\u58d3\u3002 (C)\u4e09\u89d2\u808c\u8102\u80aa\u5c64\u8f03\u8584\uff0c\u53ef\u78ba\u4fdd EpiPen\u00ae\u5b8c\u5168\u6ce8\u5c04\u5165\u808c\u8089\u5c64\uff0c\u662f\u6700\u9069\u7576\u6ce8\u5c04\u4f4d\u7f6e\u3002 (D)\u8d85\u904e\u6548\u671f\u7684 EpiPen\u00ae\u85e5\u6548\u8870\u9000\u5feb\uff0c\u4e0d\u5efa\u8b70\u6b64\u72c0\u6cc1\u4e0b\u4f7f\u7528\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8155\u90e8\u9aa8\u6298\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)Scaphoid fracture \u70ba\u624b\u8155\u6700\u5e38\u898b\u4e4b\u9aa8\u6298\uff0c\u81e8\u5e8a\u53ef\u898b\u60a3\u5074 snuffbox\u58d3\u75db\uff0c\u4ee5\u53ca\u6d3b\u52d5\u60a3\u5074\u5927\u62c7\u6307\u6642\u75bc\u75db\u3002 (B)Capitate fracture \u5e38\u548c scaphoid bone fracture \u4e00\u8d77\u767c\u751f\uff0c\u5bb9\u6613\u6703\u6709\u5931\u8840\u7ba1\u6027\u58de\u6b7b(avascular necrosis )\u3002 (C)Lunate fracture \u5e38\u898b\u4e4b\u6a5f\u8f49\u70ba\u8dcc\u5012\u6642\u624b\u6490\u5730\u677f\uff0c\u6216\u662f\u624b\u8155\u4e4bhyperextension \u3002 (D)Triquetrum fracture \u8f03\u70ba\u7f55\u898b\uff0c\u5728\u624b\u8155 X\u5149\u7684\u6b63\u9762\u5f71\u50cf(A -P view)\u8f03\u5bb9\u6613\u8a3a\u65b7\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u7f8a\u6c34\u6813\u585e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u62bd\u8840\u6aa2\u67e5\u53ef\u80fd\u6703\u767c\u73fe\u6709 DIC\u73fe\u8c61\u3002 (B)\u5fc3\u81df\u8d85\u97f3\u6ce2\u53ef\u80fd\u6703\u6709\u5de6\u5fc3\u5ba4\u529f\u80fd\u7570\u5e38\u3002 (C)\u5fc3\u81df\u8d85\u97f3\u6ce2\u53ef\u80fd\u6703\u6709\u53f3\u5fc3\u5ba4\u529f\u80fd\u7570\u5e38\u3002 (D)\u7a4d\u6975\u8f38\u8840\u5f8c\u75c5\u4eba\u5b58\u6d3b\u7387\u90fd\u5f88\u9ad8\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4f55\u8005\u6700\u80fd\u9810\u6e2c \u9ad8\u9f61\u75c5\u4eba\u53cd\u8986\u5165\u6025\u8a3a\u6216\u4f4f\u9662\uff1f", + "Options": "(A)\u6709\u7121\u764c\u75c7\u3002 (B)\u6709\u7121\u5931\u667a\u75c7\u3002 (C)\u6162\u6027\u75c5\u591a\u5be1\u3002 (D)\u6025\u6027\u529f\u80fd\u4e0b\u964d\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u95dc\u65bc\u6688\u53a5\u4e4b\u6558\u8ff0\uff0c\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u7d04\u6709\u5169\u6210\u7684\u75c5\u4eba\u7d93\u6025\u8a3a\u6aa2\u67e5\u5f8c\u7121\u6cd5\u627e\u51fa\u78ba\u5207\u75c5\u56e0\u3002 (B)\u5728\u5354\u52a9\u5340\u5206\u7672\u7647\u767c\u4f5c\u8207\u6688\u53a5\u6642\uff0c\u5c3f\u5931\u7981\u662f\u5f88\u6709\u7528\u7684\u8cc7\u8a0a\u3002 (C)18 \u6b72\u5973\u6027\u7121\u904e\u53bb\u75c5\u53f2\uff0c\u76ee\u64ca\u5931\u53bb\u610f\u8b58\u7d04 1\u5206\u9418\uff0c\u81f3\u6025\u8a3a\u5f8c\u610f\u8b58\u6e05\u9192\u4f46\u8179\u90e8\u75bc\u75db\uff0c\u5fc3\u96fb\u5716\u70ba\u7ac7\u6027\u983b\u8108\uff0c\u75c5\u4eba\u62d2\u7d55\u7559\u89c0\uff0c\u512a\u5148\u5b89\u6392\u5fc3\u81df\u79d1\u9580\u8a3a\u8ffd\u8e64\u3002 (D)65 \u6b72\u7537\u6027\u7121\u904e\u53bb\u75c5\u53f2\uff0c\u5750\u8457\u7a81\u7136\u5931\u53bb\u610f\u8b58\u7d04 1\u5206\u9418\uff0c\u81f3\u6025\u8a3a\u5f8c\u610f\u8b58\u6e05\u9192\u7121\u8eab\u9ad4\u4e0d\u9069\uff0c\u5fc3\u96fb\u5716\u986f\u793a\u70ba\u4e00\u5ea6\u623f\u5ba4\u963b\u65b7\uff0c\u4ecd\u5efa\u8b70\u5b89\u6392\u4f4f\u9662\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "23\u6b72\u61f7\u5b55 12\u9031\u7684\u5b55\u5a66\uff0c\u7522\u6aa2\u6642\u7a81\u767c\u5fc3\u60b8\u3001\u6c23\u4fc3\u53ca\u76dc\u6c57\u3002\u88ab\u9001\u81f3\u6025\u8a3a\u6642\uff0c\u9ad4\u6eab 38.8\u00b0C\u3001\u5fc3\u8df3 148 \u6b21/min\u3001\u547c\u5438 25 \u6b21/min\uff0c\u8840\u58d3\u70ba 145/100 mmHg \uff0c\u7121\u904e\u53bb\u6216\u5bb6\u65cf\u75c5\u53f2\uff1b\u8eab\u9ad4\u6aa2\u67e5\u986f\u793a\u7532\u72c0\u817a\u7565\u5fae\u589e\u5927\u3002\u5c24\u5176\u7576\u89f8\u6478\u7532\u72c0\u817a\u6642\uff0c\u75c5\u4eba\u7684\u5fc3\u8df3 160\u6b21/min\u3002\u4e0b\u5217\u8655\u7f6e\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u7d66\u4e88 hydrocortisone 100 mg \u975c\u8108\u6ce8\u5c04\uff0c24 \u5c0f\u6642\u5167 100 mg\u52063\u6b21\u91cd\u8907\u7d66\u4e88\uff0c\u81f3\u9810\u671f\u6548\u679c\u3002 (B)\u7d66\u4e88 methimazole 40 mg \u53e3\u670d\uff0c\u6bcf 4\u5c0f\u6642\u7d66\u4e88 25 mg\uff1b\u6bcf\u65e5\u7e3d\u5291\u91cf120 mg\u3002 (C)\u4e0a\u8ff0\u7684\u8655\u7f6e\u6b65\u9a5f\u5b8c\u6210\u5f8c 1\u5c0f\u6642\uff1b\u6bcf\u9694 6-8\u5c0f\u6642\u7d66\u4e88 Lugol\u6eb6\u6db2 8-10\u6ef4\uff0c\u81f3\u9810\u671f\u6548\u679c\u3002 (D)\u7d66\u4e88 propranolol \u7de9\u6162\u975c\u8108\u6ce8\u5c04 1-2 mg\uff0c\u6bcf 10\u81f315\u5206\u9418\u91cd\u8907\u4e00\u6b21\uff0c\u81f3\u9810\u671f\u6548\u679c\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6709\u6a5f\u78f7\u88fd\u5291\u4e2d\u6bd2\u7684\u8655\u7f6e\uff0c\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u63d2\u7ba1\u6642\u82e5\u4f7f\u7528 Succinylcholine \uff0c\u85e5\u6548\u8d77\u59cb\u4f5c\u7528\u6642\u9593\u6703\u5ef6\u5f8c\u3002 (B)\u9593\u671f\u75c7\u5019\u7fa4 (intermediate syndrome )\uff0c\u5e38\u767c\u751f\u65bc\u6025\u6027\u4e2d\u6bd2\u5f8c\u7684 1-4\u5929\uff0c\u4e3b\u8981\u75c7\u72c0\u70ba\u9060\u7aef\u80a2\u9ad4\u7121\u529b\u3002 (C)\u89e3\u6bd2\u5291 Atropine\uff0c\u4f9d\u7167\u5fc3\u8df3\u901f\u7387\u8abf\u6574\u85e5\u7269\u5291\u91cf\u3002 (D)\u89e3\u6bd2\u5291 Pralidoxime \uff0c\u8d8a\u65e9\u7d66\u85e5\u6548\u679c\u8d8a\u597d\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u5152\u7ae5\u76ae\u75b9\u75c7\u72c0\u8207\u767c\u71d2\u7684\u63cf\u8ff0\uff0c\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u9ebb\u75b9\u5148\u767c\u71d2\uff0c\u6578\u65e5\u5f8c\u76ae\u75b9\u7531\u81c9\u90e8\u958b\u59cb\u64f4\u6563\u3002 (B)\u5fb7\u570b\u9ebb\u75b9\u767c\u71d2\u5f8c\u76ae\u75b9\u8ddf\u8457\u51fa\u73fe\uff0c\u7531\u81c9\u90e8\u958b\u59cb\u64f4\u6563\u3002 (C)\u7329\u7d05\u71b1\u767c\u71d2\u5f8c\u4e00\u5169\u5929\u76ae\u75b9\u51fa\u73fe\uff0c\u7531\u56db\u80a2\u958b\u59cb\u5f80\u8ec0\u5e79\u8207\u81c9\u90e8\u3002 (D)\u73ab\u7470\u75b9(Roseola infantum )\u7684\u76ae\u75b9\u6703\u5728\u767c\u71d2\u5f8c\u51fa\u73fe\uff0c\u64f4\u6563\u65b9\u5411\u7121\u660e\u986f\u5148\u5f8c\u4e4b\u5225\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u7cbe\u795e\u79d1\u85e5\u7269\u5e38\u898b\u4e0d\u826f\u53cd\u61c9\u7684\u76e3\u6e2c\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)Aripiprazole \u75c5\u4eba\u82e5\u51fa\u73fe\u767c\u71d2\u3001\u56b4\u91cd\u808c\u8089\u50f5\u786c\u53ca\u610f\u8b58\u4e0d\u6e05\uff0c\u61c9\u76e3\u6e2c\u8840\u7cd6\u503c\u3002 (B)Carbamazepine \u4f7f\u7528\u524d\u5efa\u8b70\u5148\u4f5c HLA-B 1502 \u57fa\u56e0\u6aa2\u6e2c\u3002 (C)Clozapine \u75c5\u4eba\u82e5\u51fa\u73fe\u80f8\u75db\u3001\u547c\u5438\u56f0\u96e3\u3001\u767c\u71d2\uff0c\u61c9\u76e3\u6e2c\u5fc3\u96fb\u5716\u3002 (D)Olanzapine \u75c5\u4eba\u61c9\u5b9a\u671f\u76e3\u6e2c\u6ccc\u4e73\u6fc0\u7d20\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "30\u6b72\u5973\u6027\u7121\u904e\u53bb\u75c5\u53f2\uff0c\u4e3b\u8a34\u54b3\u55fd\u6709\u75f0\u7d04\u4e00\u661f\u671f\u3002\u75c5\u4eba\u9ad4\u6eab 37.1\u2103\uff0c\u8840\u58d3 114/72 mmHg \uff0c\u547c\u5438 16 \u6b21/min\uff0c\u8840\u6c27\u6fc3\u5ea6 96%\u3002\u80f8\u90e8 X\u5149\u4e26\u7121\u660e\u986f\u80ba\u708e\u60c5\u6cc1\uff0c\u547c\u5438\u97f3\u4ea6\u7121\u7279\u5225\u7570\u5e38\u3002\u95dc\u65bc\u6b64\u4f4d\u75c5\u4eba\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5e38\u898f\u4f7f\u7528\u4e59\u4e8c\u578b\u4ea4\u611f\u795e\u7d93\u5291 (\u03b22-agonists)\u7de9\u89e3\u75c7\u72c0\u3002 (B)\u975e\u5178\u578b\u7d30\u83cc (atypical bacteria)\u4ea6\u662f\u53ef\u80fd\u7684\u75c5\u539f\u9ad4\u3002 (C)\u82e5\u75f0\u5448\u73fe\u9ec3\u7da0\u8272\uff0c\u53ef\u63a8\u8ad6\u70ba\u7d30\u83cc\u6027\u611f\u67d3\u3002 (D)\u7b2c\u4e00\u79d2\u5410\u6c23\u91cf(FEV1)\u53ef\u5e6b\u52a9\u9451\u5225\u8a3a\u65b7\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u80a5\u539a\u6027\u5fc3\u808c\u75c7( hypertrophic cardiomyopathy )\u7684\u75c5\u4eba\uff0c\u53ef\u80fd\u5728\u5fc3\u5c16\u8655\u807d\u5230\u6536\u7e2e\u671f\u5fc3\u96dc\u97f3\uff0c\u4e0b\u5217\u4f55\u7a2e\u52d5\u4f5c \u53ef\u589e\u52a0\u6b64\u5fc3\u96dc\u97f3\u7684\u5f37\u5ea6 \uff1f", + "Options": "(A)\u7531\u8e72\u59ff\u8d77\u7acb\u3002 (B)\u96d9\u624b\u7528\u529b\u63e1\u62f3\u3002 (C)\u7dad\u6301\u8e72\u5750\u59ff\u52e2\u3002 (D)\u88ab\u52d5\u5f0f\u5c07\u817f\u62ac\u9ad8\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u7a81\u767c\u6027\u807d\u529b\u55aa\u5931( sudden hearing loss )\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u53ef\u5206\u70ba\u611f\u97f3\u795e\u7d93\u6027(sensorineural )\u8207\u50b3\u5c0e\u6027 (conductive )\u807d\u529b\u55aa\u5931\u5169\u7a2e\uff0c\u7d04 70%\u7684\u75c5\u4eba\u90fd\u80fd\u627e\u51fa\u5f15\u767c\u7684\u539f\u56e0\u3002 (B)\u75c5\u6bd2\u611f\u67d3\u70ba\u807d\u529b\u55aa\u5931\u5e38\u898b\u7684\u539f\u56e0\u4e4b\u4e00\uff0c\u5176\u4e2d\u4ee5\u76b0\u75b9\u75c5\u6bd2(Herpes simplex virus )\u6700\u5e38\u898b\u3002 (C)\u4f7f\u7528\u97f3\u53c9\u653e\u7f6e\u5728\u75c5\u4eba\u984d\u982d\u9032\u884c Weber test \uff0c\u5982\u679c\u53f3\u8033\u53ef\u4ee5\u807d\u5230\u6e05\u695a\u7684\u8072\u97f3\uff0c\u4ee3\u8868\u53f3\u8033\u6709\u50b3\u5c0e\u6027 (conductive )\u807d\u529b\u55aa\u5931\uff0c\u6216\u5de6\u8033\u6709\u611f\u97f3\u795e\u7d93\u6027(sensorineural )\u807d\u529b\u55aa\u5931\u3002 (D)\u4f7f\u7528\u97f3\u53c9\u5728\u53f3\u8033\u4e73\u7a81\u8207\u5916\u8033\u9053\u9032\u884c Rinne test \uff0c\u5982\u679c\u5728\u4e73\u7a81\u8655\u8072\u97f3\u8f03\u6e05\u695a\uff0c\u4ee3\u8868\u53f3\u8033\u6709\u611f\u97f3\u795e\u7d93\u6027(sensorineural )\u807d\u529b\u55aa\u5931\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u7279\u6b8a\u75be\u75c5\u7684\u7f3a\u8840\u6027\u8166\u4e2d\u98a8\u75c7\u5019\u7fa4\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)Type B \u7684\u4e3b\u52d5\u8108\u525d\u96e2\uff0c\u53ef\u80fd\u540c\u6642\u4ee5\u7f3a\u8840\u6027\u8166\u4e2d\u98a8\u548c\u5fc3\u808c\u6897\u585e\u4f86\u8868\u73fe\u3002 (B)\u82e5\u6392\u9664\u7981\u5fcc\u75c7\uff0c\u540c\u6642\u5408\u4f75\u7f3a\u8840\u6027\u8166\u4e2d\u98a8\u53ca\u5fc3\u808c\u6897\u585e\u6642\uff0c\u4e00\u6a23\u53ef\u4ee5\u6ce8\u5c04\u8840\u6813\u6eb6\u89e3\u5291\u3002 (C)\u942e\u5200\u578b\u8ca7\u8840\u75c7(sickle cell anemia )\u76f8\u95dc\u7684\u7f3a\u8840\u6027\u8166\u4e2d\u98a8\uff0c\u5247\u4e0d\u5efa\u8b70\u6ce8\u5c04\u8840\u6813\u6eb6\u89e3\u5291\u3002 (D)\u5e74\u8f15\u578b\u4e2d\u98a8\u7684\u75c5\u4eba\uff0c\u82e5\u6700\u8fd1\u6709\u5275\u50b7\u75c5\u53f2\u5247\u8981\u5c0f\u5fc3\u690e\u52d5\u8108\u525d\u96e2\uff0c\u4f46\u901a\u5e38\u56b4\u91cd\u9838\u90e8\u5275\u50b7\u624d\u9700\u8003\u616e\u6b64\u8a3a\u65b7\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "30\u6b72\u5973\u6027\u61f7\u5b55 35\u9031\uff0c\u9670\u9053\u7a81\u7136\u6d41\u51fa\u5927\u91cf\u900f\u660e\u6db2\u9ad4\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u82e5\u6709\u9700\u8981\uff0c\u53ef\u57f7\u884c\u6307\u8a3a(digital examination) \u3002 (B)\u4f7f\u7528\u9d28\u5634\u6aa2\u67e5(speculum examination )\u6642\uff0c\u4e0d\u5b9c\u4f7f\u7528\u6f64\u6ed1\u5291\u3002 (C)\u6db2\u9ad4\u7684\u9178\u9e7c\u503c(pH )\u901a\u5e38\u4ecb\u65bc 4.5\u81f35.5\u3002 (D)\u5c07\u6db2\u9ad4\u99ac\u4e0a\u653e\u5728\u986f\u5fae\u93e1\u4e0b\uff0c\u53ef\u898b\u7f8a\u9f52\u6a39\u8449\u72c0\u7d50\u6676 (ferning test )\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u5b30\u5e7c\u5152\u6ccc\u5c3f\u9053\u611f\u67d3\uff0c\u4f55\u8005\u4e0d\u662f\u9020\u6210 urine culture - negative pyuria\u53ef\u80fd\u539f\u56e0\uff1f", + "Options": "(A)Kawasaki's disease\u3002 (B)\u95cc\u5c3e\u767c\u708e\u3002 (C)Chlamydia Sexually Transmitted Disease \u3002 (D)Balanitis \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u7834\u50b7\u98a8\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u82e5\u7834\u50b7\u98a8\u7684\u6f5b\u4f0f\u671f\u6108\u77ed\uff0c\u5247\u75be\u75c5\u56b4\u91cd\u5ea6\u6108\u4f4e\uff0c\u4e14\u9810\u5f8c\u8f03\u4f73\u3002 (B)Local tetanus \u901a\u5e38\u5c0e\u81f4\u53d7\u50b7\u90e8\u4f4d\u9060\u7aef\u808c\u8089\u50f5\u786c\uff0c\u4e26\u5728\u6578\u9031\u81f3\u6578\u6708\u5f8c\u5b8c\u5168\u5eb7\u5fa9\u3002 (C)General tetanus \u901a\u5e38\u7531\u8f03\u77ed\u7684\u8ef8\u7a81\u795e\u7d93\u958b\u59cb\u53d7\u5f71\u97ff\uff0c\u9020\u6210 descending paralysis\u3002 (D)Cephalic tetanus \u901a\u5e38\u7531\u982d\u90e8\u5916\u50b7\u6240\u5f15\u8d77\uff0c\u4e26\u5c07\u5c0e\u81f4\u7b2c\u4e94\u5c0d\u8166\u795e\u7d93\u529f\u80fd\u5931\u8abf\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5275\u50b7\u6027\u4f11\u514b\u7684\u75c5\u751f\u7406\u6a5f\u8f49\u548c\u81e8\u5e8a\u8868\u73fe\u7684\u63cf\u8ff0\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u5275\u50b7\u5167\u76ae\u640d\u50b7\uff0c\u523a\u6fc0\u5167\u76ae\u4e0a\u8840\u6813\u8abf\u7bc0\u86cb\u767d(thrombomodulin )\u8868\u73fe\u589e\u52a0\u8207\u51dd\u8840\u9176(thrombin )\u7d50\u5408\uff0c\u9032\u800c\u6fc0\u6d3b\u86cb\u767d C\u3002 (B)\u65e9\u671f\u5275\u50b7\u5f15\u8d77\u51dd\u8840\u75c5\u8b8a\uff0c\u7d93\u7531\u86cb\u767d C\u9014\u5f91\uff0c\u8abf\u7bc0\u6297\u51dd\u8840(anticoagulation)\u548c\u7e96\u7dad\u86cb\u767d\u6eb6\u89e3\u4ea2\u9032(hyperfibrinolysis )\u3002 (C)\u6839\u64da\u6536\u7e2e\u58d3\u3001\u5fc3\u7387\u548c\u660f\u8ff7\u6307\u6578 (GCS)\u4f30\u7b97\u5931\u8840\u767e\u5206\u6bd4\uff0c\u9032\u884c\u51fa\u8840\u56b4\u91cd\u5ea6\u5206\u985e\uff0c\u6b64\u5206\u985e\u5f88\u53ef\u9760\uff0c\u53ef\u7528\u65bc\u6307\u5c0e\u5fa9\u7526\u3002 (D)\u8179\u5167\u51fa\u8840\u75c5\u4eba\uff0c\u7531\u65bc\u8179\u8154\u7a4d\u8840\u5f15\u8d77\u7684\u8ff7\u8d70\u795e\u7d93\u5f35\u529b\u589e\u52a0\uff0c\u53ef\u80fd\u51fa\u73fe\u5fc3\u640f\u904e\u7de9\u6216\u6b63\u5e38\u5fc3\u8df3\u901f\u5ea6\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6c23\u80f8\u7684\u8a3a\u65b7\u53ca\u6cbb\u7642\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5728\u60a3\u5074\u7684\u808b\u8188\u89d2(costophrenic angle )\u51fa\u73fe\u6df1\u6e9d\u5fb5\u8c61(deep sulcus sign) \uff0c\u8f03\u5e38\u51fa\u73fe\u5728\u5750\u8457\u7167 X\u5149\u7684\u75c5\u4eba\u3002 (B)\u7d66\u75c5\u4eba\u4f7f\u7528 non-rebreathing mask \u8f03nasal cannula \u7d66\u6c27\u66f4\u80fd\u52a0\u901f\u6c23\u80f8\u5438\u6536\u3002 (C)\u5982\u75c5\u4eba\u51fa\u73fe\u6c23\u7ba1\u504f\u79fb\u3001\u4f4e\u8840\u58d3\u7b49\u75c7\u72c0\uff0c\u9700\u5118\u5feb\u5728\u814b\u4e2d\u7dda\u7b2c\u56db\u808b\u9593\u7684\u808b\u9aa8\u4e0a\u65b9\u65bd\u884c\u91dd\u523a\u6e1b\u58d3\u3002 (D)\u80f8\u7ba1\u7f6e\u5165\u7684\u5b89\u5168\u4f4d\u7f6e\u5728\u7531\u7b2c\u4e94\u808b\u9593\u3001\u80f8\u5927\u808c(pectoralis major muscle)\u548c\u95ca\u80cc\u808c(latissimus dorsi muscle )\u4e4b\u9593\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "70\u6b72\u7537\u6027\u9577\u671f\u6d17\u814e\uff0c\u5e73\u6642\u624b\u8173\u78b0\u649e\u5373\u5bb9\u6613\u7600\u9752\u548c\u51fa\u8840\uff0c\u672c\u6b21\u5410\u8840\u81f3\u6025\u8a3a\u5c31\u91ab\uff0c\u62bd\u8840\u6aa2\u9a57\u6578\u64da\u9664\u8ca7\u8840\u53ca\u814e\u529f\u80fd\u5dee\u5916\u5176\u9918\u90fd\u6b63\u5e38\u3002\u80c3\u93e1\u767c\u73fe\u6d88\u5316\u6f70\u760d\u4e0d\u6613\u6b62\u8840\uff0c\u4e26\u5728\u6f70\u760d\u8868\u9762\u6301\u7e8c\u6ef2\u8840\u3002\u7d66\u4e88\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)Cryoprecipitate, 10 units over 30 mins \u3002 (B)Conjugated estrogens, 25 mg IV \u3002 (C)Desmopressin, 0.3 \u03bcg/kg IV \u3002 (D)Vitamin K1, 10mg slow IV \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6ccc\u5c3f\u751f\u6b96\u5668\u6025\u75c7\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u776a\u4e38\u626d\u8f49\u53ef\u7528\u985e\u4f3c\u7ffb\u66f8\u7684\u65b9\u5f0f\u5f92\u624b\u5fa9\u4f4d\uff0c\u65bc\u60a3\u5074\u7d04\u65cb\u8f49 360\u5ea6\u3002 (B)\u9670\u8396\u6d77\u7dbf\u9ad4\u62bd\u53d6\u8840\u6db2\u6c23\u9ad4\u5206\u6790\u80fd\u5206\u8fa8\u7f3a\u8840\u6216\u975e\u7f3a\u8840\u6027\u9670\u8396\u7570\u5e38\u52c3\u8d77(priapism )\u3002 (C)\u5d4c\u9813\u6027\u5305\u8396(paraphimosis )\u53ef\u7528\u5f48\u6027\u7e43\u5e36\u7e8f\u7e5e\u9f9c\u982d 5\u5206\u9418\u4ee5\u5e6b\u52a9\u6e1b\u7de9\u6c34\u816b\u3002 (D)\u7591\u4f3c\u6025\u6027\u651d\u8b77\u817a\u708e\u6642\u505a\u651d\u8b77\u817a\u6309\u6469\u4f86\u78ba\u8a3a\u901a\u5e38\u662f\u4e0d\u9700\u8981\uff0c\u53ef\u80fd\u6703\u9020\u6210\u83cc\u8840\u75c7\u6216\u6557\u8840\u75c7\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "65\u6b72\u7537\u6027\u75c5\u4eba\u56e0\u70ba\u7a81\u767c\u6027\u80f8\u75db\u3001\u547c\u5438\u56f0\u96e3\u81f3\u6025\u8a3a\u3002\u8eab\u9ad4\u8a3a\u5bdf\u65bc\u5de6\u5074\u81e5\u6642\uff0c\u5728\u5fc3\u5c16\u53ef\u4ee5\u807d\u5230 mid-diastolic murmur \u3001\u51fa\u73fe Corrigan pulse\u3001Duroziez sign\u3001 de Musset sign \u548cQuincke sign\u3002\u5fc3\u8840\u7ba1\u96fb\u8166\u65b7\u5c64\u986f\u793a\u70ba Stanford Type A aortic dissection \uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u7d66\u4e88\u6c27\u6c23\u6cbb\u7642\u3002 (B)\u7d66\u4e88 Labetalol \u3002 (C)\u7d66\u4e88 Nitroglycerin\u3002 (D)\u5b89\u6392\u624b\u8853\u6cbb\u7642\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "60\u6b72\u7537\u6027\uff0c\u56e0\u8eca\u798d\u53d7\u50b7\u81f3\u6025\u8a3a\u5c31\u91ab\uff0c\u7dca\u6025\u6551\u8b77\u54e1\u5df2\u7d93\u7d66\u4e88\u9838\u5708\u53ca\u9577\u80cc\u677f\u56fa\u5b9a\u3002\u4f86\u9662\u6642\u610f\u8b58\u6e05\u695a\uff0c\u62b1\u6028\u9838\u90e8\u75bc\u75db\uff0c\u5176\u4ed6\u5916\u89c0\u7121\u660e\u986f\u64e6\u632b\u50b7\u3002\u8840\u58d3 60/30 mmHg\uff0c\u5fc3\u8df3 80\u6b21/min\uff0c\u76ae\u819a\u6478\u8d77\u4f86\u6eab\u6696\u3002\u4e0b\u5217\u91dd\u5c0d\u6b64\u75c5\u4eba\u7684\u8a55\u4f30\u8207\u8655\u7f6e\uff0c\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u4f9d\u64da\u75c5\u53f2\u8a62\u554f\u53ca\u521d\u6b65\u8eab\u9ad4\u8a3a\u5bdf\uff0c\u8179\u8154\u5167\u81df\u5668\u640d\u50b7\u9020\u6210\u7684\u4f4e\u8840\u58d3\u53ef\u4ee5\u6392\u9664\u3002 (B)\u6b64\u75c5\u4eba\u61c9\u8a72\u6703\u51fa\u73fe\u4e0b\u80a2\u7671\u7613\u53ca\u6df1\u90e8\u53cd\u5c04\u589e\u52a0\u7684\u72c0\u6cc1\u3002 (C)\u9019\u6a23\u7684\u75c7\u72c0\u8868\u73fe\u53ef\u80fd\u51fa\u73fe\u5728\u80f8\u690e\u7b2c\u56db\u7bc0\u53d7\u50b7\u7684 \u75c5\u4eba\u3002 (D)\u8840\u7ba1\u5347\u58d3\u5291(vasopressors )\u5c0d\u65bc\u9019\u985e\u75c5\u4eba\u6c92\u6709\u597d\u8655\uff0c\u6703\u589e\u52a0\u7d44\u7e54\u704c\u6d41\u4e0d\u8db3\u7684\u98a8\u96aa\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u51cd\u50b7\u6027\u51b7\u50b7\u5bb3 (frostbite)\u8655\u7f6e\uff0c\u4e0b\u5217\u4f55\u8005\u6558\u8ff0 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u51fa\u8840\u6027\u6c34\u6ce1\u5f62\u6210\u6642\uff0c\u61c9\u9032\u884c\u6e05\u5275\u3002 (B)\u7121\u8b49\u64da\u652f\u6301\u4f7f\u7528\u9810\u9632\u6027\u6297\u751f\u7d20\u53ca\u7834\u50b7\u98a8\u3002 (C)\u8606\u8588\u8edf\u818f\u53ef\u4fc3\u9032\u50b7\u53e3\u4fee\u5fa9\u3002 (D)\u8003\u616e\u65e9\u671f\u5916\u79d1\u624b\u8853\u4ecb\u5165\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "40\u6b72\u7537\u6027\uff0c\u9152\u7cbe\u6027\u809d\u786c\u5316\u75c5\u4eba\uff0c\u56e0\u5410\u9bae\u8840\u81f3\u6025\u8a3a\uff0c\u8acb\u554f\u4e0b\u5217\u4f55\u8005\u6cbb\u7642\u8655\u7f6e\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u53ef\u80fd\u662f\u98df\u9053\u975c\u8108\u66f2\u5f35\u51fa\u8840\uff0c\u4e0d\u53ef\u653e\u7f6e\u9f3b\u80c3\u7ba1\u3002 (B)\u5118\u901f\u7d66\u4e88\u9810\u9632\u6027\u6297\u751f\u7d20\u3002 (C)\u5167\u8996\u93e1\u6aa2\u67e5\u9700\u7b49\u75c5\u4eba\u80fd\u914d\u5408\u518d\u9032\u884c\u3002 (D)Tranexamic acid \u7528\u65bc\u6b64\u75c5\u4eba\u7121\u597d\u8655\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u67d0\u907f\u96e3\u6240\u88ab\u98db\u5f48\u547d\u4e2d\uff0c\u5efa\u7bc9\u7269\u53d7\u640d\u8f15\u5fae\u4f46\u672a\u8d77\u706b\uff0c\u6578\u5341\u4f4d\u6c11\u773e\u7121\u660e\u986f\u5916\u50b7\u4f46\u62bd\u6410\u3001\u53e3\u5410\u767d\u6cab\u5012\u5730\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u82e5\u75c5\u4eba\u5448\u73fe\u660f\u8ff7\u3001\u547c\u5438\u5fae\u5f31\u3001\u53e3\u9f3b\u5206\u6ccc\u7269\u591a\uff0c\u7acb\u523b\u5f92\u624b\u4fdd\u8b77\u9838\u690e\u76f4\u63a5\u9032\u884c\u6c23\u7ba1\u5167\u63d2\u7ba1\u8207\u62bd\u75f0\uff0c\u7dad\u6301\u547c\u5438\u9053\u901a\u66a2\u3002 (B)\u7d66\u6d95\u6dda\u7e31\u6a6b\u75c5\u4eba Atropine \u975c\u8108\u6216\u76ae\u4e0b\u6ce8\u5c04 0.5~1.0 mg\uff0c\u76f4\u5230\u53e3\u9f3b\u5206\u6ccc\u7269\u6e1b\u5c11\u81f3\u53ef\u63a7\u7a0b\u5ea6\u6216\u7e3d\u5291\u91cf\u5df2\u9054 0.1 mg/Kg\u3002 (C)\u5168\u8eab\u75c7\u72c0\u660e\u986f\u7684\u75c5\u4eba\u5118\u5feb\u7de9\u6162\u975c\u6ce8 Prolidoxime 1~2 g \u3002\u7576\u75c5\u4eba\u6578\u91cf\u591a\u65bc\u85e5\u54c1\u5b58\u91cf\uff0c\u53ef\u6e1b\u534a\u5291\u91cf\u8b93\u66f4\u591a\u4eba\u7372\u5f97\u6cbb\u7642\u3002 (D)\u62bd\u6410\u75c5\u4eba\u9664\u4e86\u4fdd\u8b77\u547c\u5438\u9053\u901a\u66a2\u5916\uff0c\u76e1\u5feb\u975c\u8108\u6ce8\u5c04\u4efb\u4f55Benzodiazepines \uff0c\u4e26\u975c\u8108\u6ef4\u6ce8 Phynetoin \u8d77\u59cb\u5291\u91cf 20 mg/Kg\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u75bc\u75db\u8207\u5176\u6cbb\u7642\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u751f\u547d\u5fb5\u8c61\u4e4b\u8b8a\u5316\u53ca\u75c5\u4eba\u7684\u8868\u60c5\u52d5\u4f5c\uff0c\u548c\u75c5\u4eba\u81ea\u89ba\u4e4b\u75bc\u75db\u6307\u6578\u6709\u9ad8\u5ea6\u76f8\u95dc\u3002 (B)\u91cd\u5927\u5275\u50b7\u75c5\u4eba\u56e0\u808c\u8089\u9aa8\u9abc\u75bc\u75db\uff0c\u9069\u5408\u512a\u5148\u7d66\u4e88\u975e\u985e\u56fa\u9187\u985e\u6297\u767c\u708e\u85e5\u3002 (C)\u7121\u8ad6\u6025\u6027\u75bc\u75db\u7684\u56b4\u91cd\u7a0b\u5ea6\uff0c\u5747\u9700\u63a1\u7528\u968e\u68af\u5f0f\u6b62\u75db(tiered approach)\u3002 (D)\u8179\u75db\u75c5\u4eba\u7d93\u6cbb\u7642\u5f8c\u5982\u75bc\u75db\u6539\u5584\uff0c\u4e26\u4e0d\u4e00\u5b9a\u4ee3\u8868\u75c5\u60c5\u6709\u6240\u6539\u5584\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u53cd\u61c9\u6027\u95dc\u7bc0\u708e (reactive arthritis )\u7684\u63cf\u8ff0\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5e38\u65bc\u611f\u67d3\u6027\u75be\u75c5\u5f8c\u4e00\u9031\u5167\u767c\u751f\u3002 (B)\u4e0a\u80a2\u95dc\u7bc0\u8f03\u4e0b\u80a2\u95dc\u7bc0\u5bb9\u6613\u88ab\u4fb5\u72af\u3002 (C)\u7d50\u819c\u708e\u8f03\u5c11\u898b\u65bc\u8178\u9053\u611f\u67d3\u5f8c\u7684\u53cd\u61c9\u6027\u95dc\u7bc0\u708e\u3002 (D)\u62ab\u8863\u83cc(Chlamydia )\u662f\u53cd\u61c9\u6027\u95dc\u7bc0\u708e\u8f03\u5e38\u898b\u611f\u67d3\u83cc\u7a2e\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u80ba\u52d5\u8108\u9ad8\u58d3 (pulmonary hypertension )\u7684\u6cbb\u7642\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u53f3\u5fc3\u8870\u7aed\u5408\u4f75\u4f11\u514b\u75c7\u72c0\u6642\uff0c\u53ef\u4f7f\u7528 Dobutamine \u3002 (B)\u9ad8\u5291\u91cf Norepinephrine \u53ef\u80fd\u589e\u52a0\u80ba\u8840\u7ba1\u963b\u529b\u4f7f\u75c5\u60c5\u60e1\u5316\u3002 (C)\u4f7f\u7528\u547c\u5438\u5668\u6642\uff0c\u9700\u63a1\u7528\u4f4e\u6f6e\u6c23\u5bb9\u7a4d\u3001\u9ad8\u5410\u6c23\u672b\u6b63\u58d3\u7684\u8a2d\u5b9a\u3002 (D)\u56e0\u5de6\u5fc3\u5ba4\u704c\u6d41\u4e0d\u8db3\u5408\u4f75\u4f11\u514b\u6642\uff0c\u53ef\u5148\u5927\u91cf\u8f38\u6db2 1L\u4ee5\u7dad\u6301\u8840\u58d3\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "65\u6b72\u7cd6\u5c3f\u75c5\u75c5\u4eba( \u9580\u8a3a\u7528\u85e5\uff1a Metformin, Glipizide, Pioglitazone )\uff0c\u9019\u6b21\u56e0\u4f4e\u8840\u7cd6\u660f\u8ff7\u800c\u9001\u5230\u6025\u8a3a\uff0c\u7d93\u904e\u6cbb\u7642\u5f8c\u75c5\u4eba\u6062\u5fa9\u610f\u8b58\uff0c\u4e86\u89e3\u5230\u662f\u75c5\u4eba\u56e0\u80c3\u53e3\u8f03\u5dee\u5403\u5f97\u8f03\u5c11\uff0c\u6709\u95dc\u6b64\u75c5\u4eba\u7684\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u6aa2\u67e5\u809d\u814e\u529f\u80fd\uff0c\u6392\u9664\u85e5\u7269\u4ee3\u8b1d\u8b8a\u5dee\u6240\u5c0e\u81f4\u3002 (B)\u82e5\u5728\u6cbb\u7642\u904e\u7a0b\u4e2d\u4ecd\u53cd\u8986\u767c\u751f\u4f4e\u8840\u7cd6\uff0c\u53ef\u7528 Octreotide \u6cbb\u7642\u3002 (C)\u6aa2\u67e5\u662f\u5426\u6709\u611f\u67d3\uff0c\u5305\u62ec\u80ba\u90e8\u611f\u67d3\u3001\u5c3f\u9053\u611f\u67d3\u3001\u76ae\u819a\u611f\u67d3\u7b49\u3002 (D)\u6392\u9664\u611f\u67d3\u53ca\u809d\u814e\u7570\u5e38\uff0c\u4ee5\u53ca\u9023\u7e8c 3\u6b21Q1H\u8840\u7cd6\u90fd\u6b63\u5e38\uff0c\u53ef\u8b93\u75c5\u4eba\u51fa\u9662\u53ca\u9580\u8a3a\u8ffd\u8e64\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5728\u6025\u8a3a\u9032\u884c\u9aa8\u91dd\u7684\u7f6e\u653e\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u9aa8\u91dd\u8207\u4e2d\u592e\u975c\u8108\u5c0e\u7ba1\u7f6e\u653e\u76f8\u6bd4\uff0c\u4f75\u767c\u75c7\u8f03\u591a\uff0c\u4ee5\u8840\u7ba1\u5916\u6ef2\u6f0f\u6700\u5e38\u898b\u3002 (B)\u9aa8\u9ad3\u8840\u6db2\u4e2d\u7684\u9178\u9e7c\u503c\u3001\u78b3\u9178\u6c2b\u9e7d\u548c\u4e8c\u6c27\u5316\u78b3\u5206\u58d3\uff0c\u8207\u975c\u8108\u8840\u7684\u76f8\u95dc\u6027\u90fd\u5f88\u597d\u3002 (C)\u5c07\u9aa8\u91dd\u7f6e\u5165\u5152\u7ae5\u9060\u7aef\u811b\u9aa8\u6642\uff0c\u9700\u5782\u76f4\u5167\u8e1d\u6b63\u4e2d\u5fc3\u7f6e\u5165\uff0c\u907f\u514d\u50b7\u5230\u5927\u96b1\u975c\u8108\u3002 (D)\u82e5\u65bc\u9aa8\u91dd\u6ef4\u6ce8\u751f\u7406\u98df\u9e7d\u6c34\u6642\u75bc\u75db\uff0c\u53ef\u7d93\u9aa8\u91dd\u7d66\u4e88 2% Lidocaine 0.5 mg/Kg\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "21\u6b72\u7537\u6027\u4e3b\u8a34\u767c\u71d2\u8207\u610f\u8b58\u6539\u8b8a\uff0c\u7d93\u8170\u690e\u7a7f\u523a\u8a3a\u65b7\u7d30\u83cc\u6027\u8166\u819c\u708e\uff0c\u7576\u5929\u540c\u4f4f\u5bb6\u4eba\u4e5f\u51fa\u73fe\u767c\u71d2\u75c7\u72c0\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u7d30\u83cc\u6027\u8166\u819c\u708e\u4e3b\u8981\u900f\u904e\u98db\u6cab\u50b3\u64ad\uff0c\u5c0d\u5bc6\u5207\u63a5\u89f8\u8005\u50b3\u67d3\u529b\u9ad8\u3002 (B)\u82e5\u57f9\u990a\u7d50\u679c\u662f N. meningitidis \u6216S. pneumoniae \uff0c\u63a5\u89f8\u8005\u9700\u8981\u7d66\u4e88\u9810\u9632\u6027\u6297\u751f\u7d20\u3002 (C)\u5118\u65e9\u5728\u63a5\u89f8 24\u5c0f\u6642\u5167\u6295\u4e88\u9810\u9632\u6027\u6297\u751f\u7d20\uff0c\u53ef\u4ee5\u9054\u5230\u8f03\u9ad8\u4fdd\u8b77\u6548\u679c\u3002 (D)\u9810\u9632\u6027\u6295\u85e5\u53ef\u4ee5\u8003\u616e\u53e3\u670d Rifampin \u3001Ciprofloxacin\uff0c\u6216\u662f\u808c\u8089\u6ce8\u5c04Ceftriaxone \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5fa9\u7526\u6027\u4e3b\u52d5\u8108\u8840\u7ba1\u5167\u7403\u56ca\u9589\u585e( REBOA\uff1aResuscitative Endovascular Balloon Occlusion of the Aorta)\u7684\u63cf\u8ff0\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)REBOA \u7d93\u904e\u80a1\u7e3d\u52d5\u8108\uff0c\u5c07\u8840\u7ba1\u5167\u7403\u56ca\u63d2\u5165\u548c\u81a8\u8139\u5230\u8fd1\u7aef\u4e3b\u52d5\u8108\u4e2d\u3002 (B)\u5728 1\u5340(zone 1)\u5145\u6c23\u7403\u56ca\uff0c\u662f\u70ba\u4e86\u63a7\u5236\u5f9e\u6a6b\u8188\u819c\u4e0b\u65b9\u5230\u814e\u52d5\u8108\u4e0a\u65b9\u7684\u51fa\u8840\u3002 (C)\u7b2c 2\u5340(zone 2)\u5f9e\u6a6b\u8188\u819c\u5ef6\u4f38\u5230\u814e\u52d5\u8108\uff0c\u82e5\u814e\u81df\u640d\u50b7\u51fa\u8840\uff0c\u5efa\u8b70\u5728\u7b2c 2\u5340\u5145\u6c23\u3002 (D)\u5982\u679c\u51fa\u8840\u6e90\u4f4e\u65bc\u814e\u52d5\u8108\uff0c\u5305\u62ec\u56b4\u91cd\u7684\u9aa8\u76c6\u8154\u3001\u8179\u80a1\u6e9d\u6216\u4e0b\u80a2\u8fd1\u7aef\u51fa\u8840\uff0c\u5247\u7403\u56ca\u53ef\u5728 3\u5340(zone 3 )\u5145\u6c23\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5152\u7ae5\u6025\u6027\u4e2d\u8033\u708e( acute otitis media )\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u6558\u8ff0 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u6700\u5e38\u898b\u7684\u81f4\u75c5\u83cc\u70ba\u80ba\u708e\u93c8\u7403\u83cc Streptococcus pneumoniae \u548c\u6d41\u884c\u6027\u611f\u5192\u55dc\u8840\u687f\u83cc(Haemophilus influenzae )\u3002 (B)\u6709\u8033\u819c\u767c\u7d05\u7684\u7279\u7570\u5fb5\u5019\u53ef\u4ee5\u8a3a\u65b7\u70ba\u4e2d\u8033\u708e\u3002 (C)\u6297\u751f\u7d20\u6cbb\u7642\u662f\u9700\u8981\u7684\uff0c\u4f46\u4e26\u4e0d\u5efa\u8b70\u7d66\u4e88\u6b62\u75db\uff0c\u56e0\u70ba\u6b62\u75db\u6703\u5c0e\u81f4\u5ef6\u8aa4\u5224\u65b7\u75c5\u60c5\u751a\u81f3\u53ef\u80fd\u5f71\u97ff\u75c5\u7a0b\u3002 (D)\u5982\u679c\u521d\u59cb\u53e3\u670d Amoxicillin \u6297\u751f\u7d20\u6cbb\u7642\u53cd\u8986\u7121\u6548\u7684\u8a71\uff0c\u9700\u8f49\u63dbAmoxicillin-Clavulanate \u6216\u662f Ceftriaxone \uff0c\u5c0d\u65bc\u4e4b\u524d\u6709 Penicillin \u904e\u654f\u53f2\u8005 Clindamycin \u4e5f\u4e0d\u5efa\u8b70\u4f7f\u7528\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "20\u6b72\u5973\u6027\uff0c 2\u5929\u524d\u7591\u4f3c\u98df\u7528\u672a\u716e\u719f\u7684\u96de\u8089\uff0c\u4eca\u65e5\u56e0\u8179\u75db\u3001\u5641\u5fc3\u3001\u8840\u7009(bloody diarrhea )\u524d\u4f86\u6025\u8a3a\u5c31\u91ab\u3002\u95dc\u65bc\u6b64\u75c5\u4eba\u6700\u6709\u53ef\u80fd\u7684\u81f4\u75c5\u539f\uff0c\u4e0b\u5217\u9078\u9805\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)Vibrio cholerae \u3002 (B)Campylobacter \u3002 (C)Clostridium botulinum \u3002 (D)Giardia \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5fc3\u808c\u6897\u585e\u5f8c\u75c5\u4eba\u8840\u58d3\u7684\u63a7\u5236\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)Labetalol + Captopril \u3002 (B)Thiazide + Captopril \u3002 (C)Nifedipine + Captopril \u3002 (D)Metoprolol + Nifedipine \u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u5c0d\u65bc\u5c3f\u8def\u611f\u67d3\u7684\u8a3a\u65b7\u548c\u6cbb\u7642\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u5e74\u8f15\u5973\u6027\uff0c\u6027\u4f34\u4fb6\u6709\u5c3f\u8def\u611f\u67d3\uff0c\u5c3f\u6db2\u6aa2\u67e5\u6709\u8f15\u5fae\u81bf\u5c3f\u4f46\u7121\u7d30\u83cc\uff0c\u61c9\u61f7\u7591 Chlamydia \u611f\u67d3\u3002 (B)\u4f4f\u9662\u75c5\u4eba\u5c3f\u6db2\u6aa2\u67e5 nitrite\u967d\u6027\u53cd\u61c9\uff0c\u61c9\u61f7\u7591 Pseudomonas or Acinetobacter species\u7b49\u611f\u67d3\u3002 (C)\u5e74\u8f15\u7537\u6027\u7684\u96e2\u5fc3\u5c3f\u6db2\u6aa2\u9ad4\u4e2d\u6709\u7d30\u83cc\u548c 2 WBCs/HPF \uff0c\u61c9\u6295\u4e88\u6ccc\u5c3f\u9053\u611f\u67d3\u6cbb\u7642\u7684\u85e5\u7269\u3002 (D)HIV \u75c5\u4eba\u6709\u5c3f\u8def\u611f\u67d3\u6642\uff0cFluoroquinolones \u6703\u662f\u6bd4 Trimethoprim -Sulfamethoxazole \u66f4\u597d\u7684\u9078\u64c7\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "20\u6b72\u5b78\u751f\u4e0a\u67d4\u9053\u8ab2\u649e\u5230\u53f3\u80a9\u8180\uff0c\u4e3b\u8a34\u75bc\u75db\u7121\u6cd5\u6d3b\u52d5\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u82e5\u53f3\u624b\u638c\u7121\u6cd5\u78b0\u89f8\u5230\u5de6\u908a\u80a9\u8180\uff0c\u5247\u7591\u4f3c Anterior dislocation\u3002 (B)\u80a9\u8180\u4e4b X\u5149\u6aa2\u67e5\u61c9\u5305\u542b AP view\uff0c\u4ee5\u53ca scapular lateral view \u3002 (C)\u80a9\u8180\u812b\u81fc\u4e4b\u4f75\u767c\u75c7\uff0c\u6700\u5e38\u898b\u7684\u662f\u80a9\u65cb\u8f49\u808c\u7fa4\u4e4b\u6495\u88c2\u50b7(Rotator cuff tears)\u3002 (D)\u795e\u7d93\u5931\u7528 (Neurapraxia )\u6709\u53ef\u80fd\u51fa\u73fe\uff0c\u6703\u6709 motor\u548csensory\u4e4b\u7570\u5e38\uff0c\u4f46\u901a\u5e38\u6703\u81ea\u884c\u6062\u5fa9\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u5c0d\u65bc\u75c5\u4eba\u7684\u795e\u7d93\u5b78\u6aa2\u67e5\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u7528\u7b46\u71c8\u6aa2\u67e5\u96d9\u773c\u6642\uff0c\u767c\u73fe\u75c5\u4eba\u55ae\u5074\u77b3\u5b54\u653e\u5927\uff0c\u53ef\u80fd\u662f\u55ae\u5074\u7b2c\u4e8c\u5c0d\u8166\u795e\u7d93\u7684\u554f\u984c\u3002 (B)\u660f\u8ff7\u75c5\u4eba\uff0c\u91ab\u5e2b\u53ef\u63e1\u6301\u75c5\u4eba\u524d\u81c2\u4e26\u89c0\u5bdf\u662f\u5426\u6709\u5167\u8f49\u6216\u4e0b\u6c89\uff0c\u4ee5\u8a55\u4f30\u662f\u5426\u6709\u4e0a\u80a2\u7121\u529b\u7684\u554f\u984c\u3002 (C)\u82e5\u70ba\u9031\u908a\u6027\u7b2c\u4e03\u5c0d\u8166\u795e\u7d93\u6709\u554f\u984c\uff0c\u5247\u540c\u5074\u984f\u9762\u5634\u89d2\u6b6a\u659c\uff0c\u773c\u775b\u9589\u4e0d\u7dca\uff0c\u4f46\u4ecd\u6703\u6709\u62ac\u982d\u7d0b\u3002 (D)\u82e5\u70ba\u4e2d\u6a1e\u6027\u7b2c\u4e03\u5c0d\u8166\u795e\u7d93\u6709\u554f\u984c\uff0c\u5247\u5c0d\u5074\u984f\u9762\u4e0a\u4e0b\u5747\u6703\u53d7\u5230\u5f71\u97ff\uff0c\u5305\u62ec\u62ac\u982d\u7d0b\u6d88\u5931\uff0c\u5634\u89d2\u6b6a\u659c\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u982d\u90e8\u5916\u50b7\u75c5\u4eba\u7684\u8166\u759d\u75c7\u5019\u7fa4\uff0c\u82e5\u6709\u96d9\u5074\u91dd\u72c0\u77b3\u5b54\u3001\u96d9\u5074\u5df4\u6c0f\u5fb5\u8c61(Babinski\u2019s)\u548c\u808c\u5f35\u529b\u589e\u52a0\uff0c \u8f03\u53ef\u80fd\u662f\u4e0b\u5217\u4f55\u7a2e\u8166\u759d\uff1f", + "Options": "(A)\u9264\u72c0(uncal transtentorial )\u8166\u759d\u3002 (B)\u4e2d\u592e(central transtentorial )\u8166\u759d\u3002 (C)\u5c0f\u8166\u6241\u6843\u9ad4 (cerebellotonsillar )\u8166\u759d\u3002 (D)\u5f8c\u9871\u7aa9\u5411\u4e0a (upward posterior fossa )\u8166\u759d\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u786c\u76ae\u75c7( Scleroderma )\u75c5\u4eba\u51fa\u73fe\u6025\u6027\u814e\u6027\u5371\u8c61( renal crisis )\u6642\uff0c\u4e0b\u5217\u6cbb\u7642\u85e5\u7269\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u8840\u7ba1\u6536\u7e2e\u7d20\u8f49\u5316\u9176\u6291\u5236\u5291(a ngiotensin -converting enzyme inhibitor)\u3002 (B)\u4e59\u578b\u53d7\u9ad4\u963b\u65b7\u5291(b eta-blocker)\u3002 (C)\u80fa\u7532\u8776\u5464( Methotrexate )\u3002 (D)\u9ad8\u5291\u91cf\u76ae\u8cea\u985e\u56fa\u9187(c orticosteroid)\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "62\u6b72\u7537\u6027\uff0c\u66fe\u6709\u964d\u7d50\u8178\u8655\u61a9\u5ba4\u708e\u75c5\u53f2\uff0c\u9019\u6b21\u53c8\u56e0\u70ba\u5de6\u4e0b\u8179\u75db\u5c31\u8a3a\uff0c\u8a3a\u65b7\u61f7\u7591\u70ba\u61a9\u5ba4\u708e\u5fa9\u767c\u3002\u751f\u547d\u5fb5\u8c61\u6b63\u5e38\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5b89\u6392\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u3002 (B)\u5e38\u898f\u7d66\u4e88\u6297\u751f\u7d20\u6cbb\u7642\u3002 (C)\u6297\u751f\u7d20\u53ef\u9078\u64c7 Metronidazole \u52a0\u4e0a Ciprofloxacin\u3002 (D)\u82e5\u75c5\u4eba\u9577\u671f\u4f7f\u7528\u9d09\u7247\u985e\u6b62\u75db\u85e5\uff0c\u4e0d\u6703\u589e\u52a0\u61a9\u5ba4\u708e\u7a7f\u5b54\u7684\u98a8\u96aa\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u6709\u95dc\u5b55\u5a66\u7522\u7a0b\u4e4b\u63cf\u8ff0\uff0c\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u6d3b\u8e8d\u671f(active phase)\u70ba\u5b50\u5bae\u9838\u958b\u5230 3-4\u516c\u5206\uff0c\u521d\u7522\u5a66\u6bcf\u5c0f\u6642\u5b50\u5bae\u9838\u7d04\u64f4\u5f35 1.5\u516c\u5206\u3002 (B)\u7b2c\u4e00\u671f(first stage )\u70ba\u7834\u6c34\u5f8c\u81f3\u5b50\u5bae\u9838\u5b8c\u5168\u64f4\u5f35\u3002 (C)\u7b2c\u4e09\u671f(third stage )\u70ba\u5b50\u5bae\u9838\u5168\u958b\u5230\u80ce\u5152\u7522\u51fa\uff0c\u521d\u7522\u5a66\u5e73\u5747\u6642\u9593\u70ba\u7d93\u7522\u5a66\u5169\u500d\u4ee5\u4e0a\u3002 (D)\u6f5b\u4f0f\u671f(latent phase )\u70ba\u4e0d\u898f\u5247\u5b50\u5bae\u6536\u7e2e\uff0c\u5b50\u5bae\u9838\u958b\u59cb\u8edf\u5316\u8b8a\u8584\uff0c\u70ba\u751f\u7522\u524d\u9810\u5099\u6642\u671f\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "29\u6b72\u7537\u6027\uff0c\u6709\u5438\u6bd2\u524d\u79d1\u3002 1\u500b\u591a\u6708\u524d\u958b\u59cb\u547c\u5438\u56f0\u96e3\uff0c\u5176\u5f8c\u9010\u6f38\u52a0\u91cd\uff0c\u4e14\u4f34\u6709\u98df\u617e\u4e0d\u632f\uff0c\u5076\u6709\u7aef\u7acb\u6027\u547c\u5438\u56f0\u96e3\uff0c\u54b3\u55fd\uff0c\u7d42\u81f3\u96d9\u8173\u6c34\u816b\u53ca\u6e1b\u5c11\u5c3f\u91cf\u3002\u8840\u58d3102/64 mmHg \u3001\u5fc3\u8df3 140 \u6b21/min\u3001\u9ad4\u6eab 38.5\u2103\u3001\u547c\u5438 37\u6b21/min\u3001\u6709\u8ca7\u8840\u53ca\u96d9\u5074\u80ba\u90e8\u6709\u6fd5\u56c9\u8072\u3001\u5fc3\u81df\u807d\u8a3a\u6709\u5fc3\u96dc\u97f3\u3001\u6709 S3\u3001X\u5149\u986f\u793a\u5fc3\u81df\u64f4\u5927\u3002\u8179\u90e8\u672a\u6709\u809d\u813e\u816b\u5927\u3001\u96d9\u8173\u6c34\u816b\uff0c\u76ae\u819a\u51b7\u6c57\uff0c\u6709\u7d2b\u6591\u53ca\u51fa\u8840\u75d5\u6591\u3002\u8840\u6db2\u7d30\u83cc\u57f9\u990a\u5448\u73fe\uff1a Viridans streptococci \u3002\u4f9d\u64da Duke Criteria \u8a3a\u65b7\u6025\u6027\u5fc3\u5167\u819c\u708e\u7684\u6839\u64da\u662f\uff1f", + "Options": "(A)2 major criteria \u3002 (B)5 minor criteria \u3002 (C)1 major criterion & 3 minor criteria \u3002 (D)2 major criteria & 2 minor criteria \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5728\u6025\u8a3a\u9032\u884c\u547c\u5438\u9053\u7684\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u6210\u5e74\u4eba\u63d2\u7ba1\u6642\uff0c\u9700\u5c07\u80a9\u90e8\u588a\u9ad8 10\u516c\u5206\uff0c\u7dad\u6301\u5916\u8033( external ear )\u8207\u80f8\u9aa8\u5207\u8de1(sternal notch )\u5c0d\u9f4a\uff0c\u4ee5\u53d6\u5f97\u6700\u4f73\u7684\u8072\u9580\u8996\u91ce\u3002 (B)\u6210\u5e74\u4eba\u63d2\u7ba1\u6642\uff0c\u53ef\u4f7f\u7528 BURP(backward -upward- rightward pressure)\u65bd\u52a0\u58d3\u529b\u65bc\u74b0\u72c0\u8edf\u9aa8\uff0c\u61c9\u907f\u514d Sellick\u6cd5\uff0c\u4ee5\u514d\u963b\u7919\u8072\u9580\u8996\u91ce\u3002 (C)\u5b30\u5152\u56e0\u70ba\u6709\u8f03\u5927\u7684\u982d\u90e8\u3001\u8f03\u5c0f\u7684\u820c\u982d\u3001\u8f03\u5c0f\u7684\u4e0b\u9837\u9aa8\u548c\u8f03\u524d\u4f4d\u7684\u5589\u90e8\uff0c\u6545\u9700\u5c07\u80a9\u90e8\u588a\u9ad8\uff0c\u4ee5\u53d6\u5f97\u6700\u4f73\u7684\u8072\u9580\u8996\u91ce\u3002 (D)9\u6b72\u7537\u7ae5\uff0c\u9ad4\u91cd 30\u516c\u65a4\uff0c\u81e8\u5e8a\u5224\u65b7\u70ba\u6703\u53ad\u708e(epiglottitis)\u4f75\u6025\u6027\u547c\u5438\u8870\u7aed\uff0c\u57f7\u884c\u91dd\u523a\u74b0\u7532\u819c\u5207\u958b\u8853(needle cricothyrotomy )\u5f8c\uff0c\u53ef\u63a5\u4e0a 15 psi\u7684\u6c27\u6c23\u901a\u6c23\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "40\u6b72\u9838\u90e8\u816b\u7624\u75c5\u4eba\uff0c 5\u5929\u524d\u525b\u505a\u5b8c\u6c23\u5207\u9020\u53e3\u8853( tracheostomy )\uff0c\u56e0\u54b3\u55fd\u9020\u6210\u6c23\u5207\u547c\u5438\u7ba1\u6ed1\u812b\u3002\u8840\u6c27\u6fc3\u5ea6 95%\uff0c\u547c\u5438\u5e73\u9806\u4f46\u6709\u4e00\u9ede\u75f0\u97f3\u3002\u8981\u91cd\u65b0\u7f6e\u63db\u6c23\u5207\u547c\u5438\u7ba1\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u4f7f\u7528\u652f\u6c23\u7ba1\u93e1\u7f6e\u63db\u3002 (B)\u7531\u6709\u7d93\u9a57\u7684\u5916\u79d1\u91ab\u5e2b\u66f4\u63db\u3002 (C)\u4f7f\u7528 obturator \u53ca\u6e96\u5099\u5c0f\u4e00\u865f\u7684\u6c23\u5207\u547c\u5438\u7ba1\u3002 (D)\u4f7f\u7528 modified Seldinger technique (\u4ee5\u9f3b\u80c3\u7ba1\u6216\u62bd\u75f0\u7ba1\u7576\u4f5cguidewire )\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u4e0d\u540c\u4f4d\u7f6e\u7684 pericardiocentesis approaches \u65b9\u6cd5\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)Apical approach \uff1a\u56e0\u70ba\u6700\u9760\u8fd1\u5de6\u5fc3\u623f\u6700\u5bb9\u6613\u9020\u6210 ventricular puncture\uff0c\u9700\u8981\u5c0f\u5fc3\u6c23\u80f8\u98a8\u96aa \uff0c\u4f46\u662f\u512a\u9ede\u70ba\u6700\u9760\u8fd1 pericardium \u8def\u5f91\u6700\u77ed\u3002 (B)Parasternal approach \uff1a\u4e0b\u91dd\u7684\u4f4d\u7f6e\u70ba\u7b2c\u4e94 intercostal space \u9760\u8fd1 sternal margin \uff0c\u9700\u8981\u5c0f\u5fc3\u7a7f\u523a internal thoracic vessels \u53ca\u6c23\u80f8\u98a8\u96aa \u3002 (C)Subxiphoid approach \uff1a\u8def\u5f91\u8f03\u9577\uff0c\u5982\u679c\u624b\u6301\u89d2\u5ea6\u904e\u65bc\u5782\u76f4\u76ae\u819a\uff0c\u5bb9\u6613\u9020\u6210\u7a7f\u523a peritoneal cavity \u4e14\u82e5\u65b9\u5411\u904e\u65bc\u504f\u4e2d\u7dda\uff0c\u6703\u589e\u52a0\u53f3\u5fc3\u623f\u7a7f\u523a\u98a8\u96aa\uff0c\u4f46\u662f\u512a\u9ede\u70ba\u6c23\u80f8\u7684\u98a8\u96aa\u76f8\u5c0d\u8f03\u5c0f\u3002 (D)\u5982\u679c\u624b\u908a\u6c92\u6709\u8d85\u97f3\u6ce2\u53ef\u4ee5\u4f7f\u7528\uff0c\u53ef\u4ee5\u5c07\u5fc3\u96fb\u5716\u6a5f\u5668 V4\u5c0e\u806f\u7684\u63a5\u4e0a\u91dd\u7aef\uff0c\u5982\u679c\u7a81\u7136\u6709 \u5bec\u7684 QRS\u51fa\u73fe\uff0c\u5c31\u9808\u5c0f\u5fc3\u91dd\u5c16\u523a\u5230\u4e86myocardium \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "9\u6b72\u7537\u7ae5\uff0c\u56e0\u6025\u6027\u8179\u75db\u53ca\u76f8\u95dc\u75c7\u72c0\u88ab\u7236\u6bcd\u5e36\u4f86\u6025\u8a3a\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u82e5\u662f\u6025\u6027\u95cc\u5c3e\u708e\uff0c\u9019\u5e74\u7d00\u7684\u75c5\u4eba\u7d04 70%\u521d\u59cb\u6703\u611f\u5230\u809a\u81cd\u5468\u570d\u75db\uff0c\u7136\u5f8c\u75db\u8f49\u5230\u53f3\u4e0b\u8179\uff0c\u4e26\u6709\u767c\u71d2\u53ca\u5614\u5410\u60c5\u5f62\u3002 (B)\u82e5\u6709\u5614\u5410\u5408\u4f75\u8179\u7009\u60c5\u5f62\uff0c\u57fa\u672c\u4e0a\u53ef\u4ee5\u6392\u9664\u6025\u6027\u95cc\u5c3e\u708e\u7684\u53ef\u80fd\u6027\u3002 (C)\u8acb\u5c0f\u670b\u53cb\u7528\u529b\u54b3\u6216\u662f\u8d70\u8def\u3001\u8df3\u8e8d\u662f\u7121\u6cd5\u5e6b\u5fd9\u5224\u65b7\u8179\u819c\u708e\u3002 (D)\u8d85\u97f3\u6ce2\u4e0b\u82e5\u767c\u73fe\u95cc\u5c3e\u76f4\u5f91 7 mm\uff0c\u58c1\u539a 3 mm\u4e14\u7121\u6cd5\u58d3\u6241(non -compressibility )\u7279\u6027\uff0c\u57fa\u672c\u4e0a\u53ef\u4ee5\u4e0b\u95cc\u5c3e\u708e\u8a3a\u65b7\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "40\u6b72\u5973\u6027\uff0c\u56e0\u70ba\u4e0a\u8179\u75db\u3001\u80f8\u75db\u3001\u5614\u5410\u8207\u541e\u56a5\u56f0\u96e3 2\u5929\u3002\u4eca\u5929\u56e0\u70ba\u7a81\u7136\u51fa\u73fe\u767c\u71d2(38.5\u2103 )\u4f86\u6025\u8a3a\u3002\u8eab\u9ad4\u8a3a\u5bdf\u767c\u73fe\u9838\u90e8\u6709\u76ae\u4e0b\u6c23\u816b\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u6b64\u75c5\u4eba\u4e26\u672a\u51fa\u73fe Mackler\u2019s triad \u3002 (B)\u5148\u505a\u80f8\u90e8\u6216\u76f4\u7acb\u8179\u90e8 X\u5149\u6aa2\u67e5\u3002 (C)\u53ef\u4ee5\u5b89\u6392\u5167\u8996\u93e1\u6aa2\u67e5\u3002 (D)\u5148\u5b89\u6392\u80f8\u90e8\u96fb\u8166\u65b7\u5c64\uff0c\u518d\u8003\u616e\u98df\u9053\u986f\u5f71\u6aa2\u67e5\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "76\u6b72\u5a66\u5973\u55dc\u7761 3\u5929\uff0c\u6709\u6642\u5019\u6703\u9192\u4f86\uff0c\u4f46\u662f\u81ea\u8a00\u81ea\u8a9e\uff0c\u7b54\u975e\u6240\u554f\u4e14\u65e5\u591c\u985b\u5012\u3002\u4eca\u5929\u8b8a\u5f97\u66f4\u56b4\u91cd\uff0c\u4e0d\u8d77\u5e8a\u5403\u65e9\u9910\uff0c\u5bb6\u5c6c\u9001\u81f3\u6025\u8a3a\u3002\u6709\u95dc\u6b64\u75c5\u4eba\u4e4b\u8a55\u4f30\u65b9\u5f0f\uff0c\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u6df7\u4e82\u8a55\u4f30\u91cf\u8868(Confusion Assessment Methods)\u3002 (B)\u7c21\u77ed\u667a\u80fd\u6e2c\u9a57(Mini -Mental State Examination )\u3002 (C)\u8fa8\u5225\u8001\u4eba\u98a8\u96aa\u7be9\u6aa2\u7684\u5de5\u5177(Identification of Seniors at Risk )\u3002 (D)\u81e8\u5e8a\u5931\u667a\u8a55\u4f30\u91cf\u8868(Clinical Dementia Rating)\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc Amiodarone \u7684\u4f7f\u7528\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u4e00\u5929\u7684\u5291\u91cf\u7e3d\u548c\u4e0d\u53ef\u8d85\u904e 2.2 g\u3002 (B)\u85e5\u5291\u9700\u8981\u7528 5% dextrose water \u6ce1\u88fd\u3002 (C)\u9700\u8981\u4f9d\u7167\u814e\u529f\u80fd\u8abf\u6574\u5291\u91cf\u3002 (D)\u8ddf Warfarin \u5408\u7528\u6642\uff0c\u9700\u8981\u6e1b\u5c11\u5291\u91cf\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5728\u6025\u8a3a\u9032\u884c\u7ba1\u8def\u7684\u653e\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u53ef\u5e38\u898f\u653e\u7f6e\u9f3b\u80c3\u7ba1\u4f86\u6cbb\u7642\u8178\u963b\u585e(i leus)\u7684\u75c5\u4eba \u3002 (B)\u7528\u5c3f\u7ba1\u7f6e\u63db\u7a7a\u8178\u9020\u53e3\u8853(j ejunostomy )\u7684\u7ba1\u8def\u6642\uff0c\u53ef\u5c07\u7403\u56ca\u5145\u6c23\uff0c\u907f\u514d\u6ed1\u812b\u3002 (C)\u5f35\u529b\u6027\u6c23\u80f8\u505a\u91dd\u523a\u6e1b\u58d3\u6642\uff0c\u53ef\u5728\u80f8\u58c1\u6700\u8584\u7684\u7b2c\u4e8c\u808b\u9593\u9396\u9aa8\u4e2d\u7dda\u8655\u4e0b\u91dd\u3002 (D)\u5275\u50b7\u6027\u8840\u80f8\u5728\u7f6e\u5165\u80f8\u7ba1\u5f8c\uff0c\u82e5\u81e8\u5e8a\u60e1\u5316\uff0c\u53ef\u593e\u4f4f\u80f8\u7ba1\u4e26\u9001\u5165\u958b\u5200\u623f\u4f5c\u7dca\u6025\u958b\u80f8\u624b\u8853\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "40\u6b72\u5973\u6027\uff0c\u4e3b\u8a34\u8179\u8139\u4e0d\u9069\u81f3\u6025\u8a3a\uff0c\u56e0\u4e0d\u5b55\u75c7\u4e00\u661f\u671f\u524d\u6709\u6253\u6392\u5375\u91dd\uff0c\u8acb\u554f\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u53ef\u8003\u616e\u96d9\u624b\u9aa8\u76c6\u8154\u6aa2\u67e5(bimanual pelvic examination )\u3002 (B)\u75c7\u72c0\u53ef\u80fd\u6703\u6709\u591a\u5c3f\u3001\u8179\u8139\u3001\u547c\u5438\u5598\u3001\u9ad4\u91cd\u589e\u52a0\u3002 (C)\u8179\u8139\u5408\u4f75\u5927\u91cf\u8179\u6c34\uff0c\u53ef\u8003\u616e\u7d93\u9670\u9053\u8d85\u97f3\u6ce2\u8179\u6c34\u5f15\u6d41\u3002 (D)\u91cd\u5ea6\u75c5\u4eba\u901a\u5e38\u5375\u5de2\u816b\u5927\u4e0d\u8d85\u904e 8\u516c\u5206\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u80a9\u9838\u90e8\u75bc\u75db\u7684\u795e\u7d93\u5b78\u6aa2\u67e5\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u9838\u690e\u9593\u76e4\u7a81\u51fa\u75c7\u4e00\u822c\u8f03\u5e38\u767c\u751f\u5728\u9838\u690e C5/6\u548cC6/7\u3002 (B)Valsalva maneuver \u589e\u52a0\u75bc\u75db\uff0c\u8f03\u53ef\u80fd\u662f\u808c\u8089\u9aa8\u9abc\u6027\u75bc\u75db\u3002 (C)\u5de6\u81c2\u808c\u8089\u50f5\u786c\u6216\u5916\u5c55\u4e0a\u8209\u75bc\u75db\u589e\u52a0\uff0c\u8f03\u53ef\u80fd\u662f\u808c\u8089\u9aa8\u9abc\u6027\u75bc\u75db\u3002 (D)\u5c48\u9838\u4e0b\u5df4\u8cbc\u8fd1\u80f8\u58c1\u7522\u751f\u75bc\u75db\u50b3\u5230\u53f3\u624b\u81c2\uff0c\u8f03\u53ef\u80fd\u662f\u795e\u7d93\u6839\u58d3\u8feb\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "18\u6b72\u5973\u6027\uff0c\u9ad4\u91cd 45\u516c\u65a4\uff0c\u670d\u7528 30\u9846Acetaminophen (500 mg/\u9846)\u81ea\u6bba\uff0c4\u5c0f\u6642\u5f8c\u88ab\u9001\u81f3\u6025\u8a3a\uff0c\u4e3b\u8a34\u5641\u5fc3\u4e14\u4e0a\u8179\u75bc\u75db\uff0c\u610f\u8b58\u6e05\u9192\uff0c\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\u3002\u62bd\u8840\u6aa2\u67e5\u767c\u73fe GPT 28 IU/L \uff0cGOT 32 IU/L\uff0c T-Bil 0.8 mg/dL \uff0c\u8840\u4e2dAcetaminophen \u6fc3\u5ea6\u70ba 250 mg/L \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u670d\u7528\u85e5\u7269\u5f8c 24\u5c0f\u6642\u6aa2\u67e5\u809d\u6307\u6578\u4ecd\u6b63\u5e38\uff0c\u8868\u793a\u4e2d\u6bd2\u7a0b\u5ea6\u4e26\u4e0d\u56b4\u91cd\uff0c\u53ef\u8fd4\u5bb6\u89c0\u5bdf\u3002 (B)5\u5929\u5f8c\u51fa\u73fe\u814e\u81df\u8870\u7aed\uff0c\u8f03\u4e0d\u53ef\u80fd\u662f Acetaminophen \u4e2d\u6bd2\u5f15\u8d77\uff0c\u61c9\u627e\u5c0b\u5176\u4ed6\u539f\u56e0\u3002 (C)\u958b\u59cb\u4f7f\u7528 N-acetylcysteine \u7684\u6cbb\u7642\uff0c\u4e26\u8fa6\u7406\u4f4f\u9662\u3002 (D)\u5b89\u6392\u75c5\u4eba\u4f4f\u9662\u89c0\u5bdf\uff0c\u53ef\u66ab\u4e0d\u7d66\u4e88 N-acetylcysteine \uff0c\u5bc6\u5207\u8ffd\u8e64\u809d\u6307\u6578\uff0c\u82e5\u6709\u5347\u9ad8\u518d\u7d66\u4e88\u89e3\u6bd2\u5291\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u8003\u616e\u4e00\u6c27\u5316\u78b3\u4e2d\u6bd2\u6642\uff0c\u6aa2\u9a57 COHb\u7684\u7d50\u679c\u5224\u8b80\uff0c\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u4e00\u6c27\u5316\u78b3\u4e2d\u6bd2\u662f\u9760\u81e8\u5e8a\u8a3a\u65b7\u3002 (B)< 2% \u53ef\u6392\u9664\u4e00\u6c27\u5316\u78b3\u4e2d\u6bd2\u3002 (C)>15% \u70ba\u56b4\u91cd\u4e2d\u6bd2\u3002 (D)\u5438\u83f8\u8005\u4e5f\u4e0d\u61c9\u8d85\u904e 5%\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "7\u6b72\u5152\u7ae5\u8eca\u798d\uff0c\u9ad4\u91cd 16\u516c\u65a4\uff0c\u547c\u5438\u9053\u66a2\u901a\uff0c\u547c\u5438 24 \u6b21/min\uff0c\u6536\u7e2e\u58d3 84 mmHg\uff0c\u5448\u73fe\u55dc\u7761\u72c0\u614b\uff0c\u5c0d\u75db\u523a\u6fc0\u6703\u5f35\u958b\u773c\u775b\uff0c\u8aaa\u8a71\u8a9e\u7121\u502b\u6b21\uff0c\u75db\u523a\u6fc0\u80a2\u9ad4\u7e2e\u56de\uff0c\u5de6\u80a9\u3001\u5de6\u80f8\u6709\u5927\u958b\u653e\u6027\u6495\u88c2\u50b7\uff0c\u5de6\u5c0f\u817f\u6709\u958b\u653e\u6027\u9aa8\u6298\u3002\u5176\u5152\u7ae5\u5275\u50b7\u8a55\u5206(PTS \uff1aPediatric Trauma Score )\u53ca\u4fee\u8a02\u5275\u50b7\u8a55\u5206 (RTS\uff1aRevised Trauma Score )\u5404\u70ba\u5e7e\u5206\uff1f", + "Options": "(A)PTS \u70ba4\u5206\uff0c RTS\u70ba10\u5206\u3002 (B)PTS \u70ba3\u5206\uff0c RTS\u70ba10\u5206\u3002 (C)PTS \u70ba3\u5206\uff0c RTS\u70ba9\u5206\u3002 (D)PTS \u70ba2\u5206\uff0c RTS\u70ba9\u5206\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8178\u75c5\u6bd2\u611f\u67d3\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u70ba\u6e1b\u7de9\u5589\u56a8\u75bc\u75db\uff0c\u53ef\u7d66\u4e88\u5c40\u90e8 Lidocaine \u3002 (B)\u53ef\u80fd\u6703\u6709\u75c5\u6bd2\u6027\u8166\u708e\u8207\u5fc3\u808c\u708e\u7684\u4f75\u767c\u75c7\u3002 (C)\u4e3b\u8981\u662f\u81e8\u5e8a\u8a3a\u65b7\uff0c\u4e5f\u53ef\u7528 PCR(polymerase chain reaction )\u8a3a\u65b7\u3002 (D)\u5e38\u898b\u75c5\u6bd2\u5305\u62ec Coxsackievirus A16 \u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "32\u6b72\u7537\u6027\u88ab\u9001\u5165\u6025\u8a3a\uff0c\u540c\u884c\u53cb\u4eba\u63cf\u8ff0\u8a72\u75c5\u4eba\u65bc\u6f5b\u6c34\u6d3b\u52d5\u4e2d\uff0c\u7531\u6d77\u4e2d 50\u516c\u5c3a\u6df1\u8655\u6d6e\u4e0a\u6d77\u9762\uff0c\u4e0a\u5cb8 10\u5206\u9418\u5f8c\u5931\u53bb\u610f\u8b58\u3002\u5230\u9662\u5f8c\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\u4f46\u660f\u8ff7\u6307\u6578\u70ba E2V3M3\u3002\u8840\u4e2d\u52d5\u8108\u6c23\u9ad4\u5206\u6790( room air)\u7d50\u679c\u70ba pH 7.236\u3001 PaO 2 82.3 mmHg\u3001 PCO 2 48.2 mmHg\u3001 HCO 3 20mM/L\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u75c5\u4eba\u70ba\u7b2c\u4e00\u578b\u6e1b\u58d3\u75c7(type I decompression sickness )\u5408\u4f75\u52d5\u8108\u6c23\u9ad4\u6813\u585e\u3002 (B)\u61c9\u7acb\u5373\u7d66\u4e88 100%\u6c27\u6c23\u3001\u975c\u8108\u8f38\u6db2\u3001\u4e26\u5b89\u6392\u9ad8\u58d3\u6c27\u6cbb\u7642\u3002 (C)\u61c9\u76e1\u91cf\u8b93\u75c5\u4eba\u63a1\u53d6\u982d\u4f4e\u8173\u9ad8\u7684\u4ef0\u81e5\u59ff\u52e2( Trendelenburg position)\u3002 (D)\u7d66\u4e88\u75c5\u4eba\u6c23\u7ba1\u5167\u63d2\u7ba1\u4f75\u547c\u5438\u5668\u6cbb\u7642\u512a\u5148\u65bc\u9ad8\u58d3\u6c27\u6cbb\u7642\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u5152\u7ae5\u8207\u6210\u4eba\u9838\u690e X\u5149\u5e38\u898b\u91cd\u8981\u5dee\u7570\uff0c\u4e0b\u5217\u4f55\u9805 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u5152\u7ae5\u4ef0\u81e5 (supine)\u4f4d\u7f6e\u6216\u6234\u786c\u5f0f\u9838\u5708\u7167\u5f71\u6642\uff0c\u6b63\u5e38\u9838\u690e\u524d\u51f8(lordosis)\u53ef\u80fd\u6d88\u5931\u3002 (B)\u7b2c\u4e00\u9838\u690e (C1)\u7684\u5f8c\u5f13\u7d04\u5728 3\u6b72\u6642\u878d\u5408\uff0c\u524d\u5f13\u7d04\u5728 10\u6b72\u6642\u878d\u5408\u3002 (C)10 \u6b72\u7684\u5152\u7ae5\uff0c\u7531\u7b2c\u4e8c\u751f\u9577\u4e2d\u5fc3\u5f15\u8d77\u7684\u690e\u9aa8\u5f8c\u6954\u5f62 (posterior wedging) \uff0c\u53ef\u80fd\u88ab\u8aa4\u8a8d\u70ba\u58d3\u8feb\u6027\u9aa8\u6298\u3002 (D)4\u6b72\u7684\u5152\u7ae5\uff0c\u9838\u690e\u5074\u4f4d X\u5149\u7247\uff0c\u5728 C2-C3\u4f4d\u7f6e\u53ef\u80fd\u6703\u51fa\u73fe\u5047\u6027\u534a\u812b\u4f4d(pseudo -subluxation) \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6025\u6027\u814e\u7d5e\u75db\u7684\u6558\u8ff0\u548c\u8655\u7f6e\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u82e5\u808c\u9178\u9150\u4e0a\u5347\uff0c\u61c9\u8003\u616e\u75c5\u4eba\u672c\u6709\u6162\u6027\u814e\u8870\u7aed\u6216\u55ae\u4e00\u814e\uff0c\u800c\u975e\u672c\u6b21\u963b\u585e\u6240\u9020\u6210\u3002 (B)\u975e\u985e\u56fa\u9187\u6027\u6d88\u708e\u85e5\u3001\u55ce\u5561\u985e\u6216 Lidocaine IV \u7b49\u90fd\u53ef\u9054\u5230\u6b62\u75db\u6216\u7de9\u89e3\u75c7\u72c0\u7684\u6548\u679c\u3002 (C)\u4f7f\u7528 Tamsulosin \u53ef\u7e2e\u77ed\u7d50\u77f3\u6392\u51fa\u7684\u6642\u9593\uff0c\u5c24\u5176\u662f\u5927\u65bc 5 mm\u7684\u7d50\u77f3\u3002 (D)\u82e5\u5b55\u5a66\u8170\u75db\uff0c\u4f46\u8d85\u97f3\u6ce2\u7121\u6cd5\u89e3\u91cb\u5176\u81e8\u5e8a\u75c7\u72c0\uff0c\u61c9\u6703\u8a3a\u6ccc\u5c3f\u79d1\u548c\u5a66\u7522\u79d1\u4e26\u5b89\u6392 KUB\u6aa2\u67e5\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e2d\u5e74\u7537\u6027\u906d\u53d7\u9838\u90e8\u7a7f\u523a\u50b7\uff0c\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\uff0c\u6aa2\u67e5\u767c\u73fe\u50b7\u5bb3\u6df1\u53ca\u9838\u64f4\u808c(platysma )\uff0c\u6709\u8072\u97f3\u6c99\u555e\u3001\u9838\u90e8\u58d3\u75db\u53ca\u76ae\u4e0b\u6c23\u816b\uff0c\u7d93\u96fb\u8166\u65b7\u5c64\u8840\u7ba1\u651d\u5f71\u6aa2\u67e5\u7121\u660e\u986f\u8840\u7ba1\u640d\u50b7\uff0c\u4f46\u61f7\u7591\u53ef\u80fd\u6709\u54bd\u90e8\u6c23\u7ba1\u640d\u50b7(laryngotracheal injury )\uff0c\u4e0b\u5217\u9032\u4e00\u6b65\u6aa2\u67e5\u8655\u7f6e\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u98df\u9053\u651d\u5f71\u6216\u98df\u9053\u93e1\u6aa2\u67e5\u3002 (B)\u4e0a\u6d88\u5316\u9053\u6cdb\u5167\u8996\u93e1\u6aa2\u67e5\u3002 (C)\u4ecb\u5165\u6027\u8840\u7ba1\u651d\u5f71\u6aa2\u67e5\u3002 (D)\u5f69\u8272\u90fd\u666e\u52d2 (Color Doppler )\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "30\u6b72\u7537\u6027\u5f9e\u897f\u975e\u5948\u53ca\u5229\u4e9e\u8fd4\u53f0\u5df2\u7d93 14\u5929\uff0c\u56e0\u6301\u7e8c\u767c\u71d2\u982d\u75db\u524d\u4f86\u6025\u8a3a\uff0c\u65b0\u51a0\u75c5\u6bd2\u6838\u9178\u5448\u73fe\u9670\u6027\uff0c\u62bd\u8840\u5831\u544a\u6709\u8ca7\u8840\u3001\u9ec3\u75b8\u53ca\u8840\u5c0f\u677f\u4f4e\u4e0b\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5373\u4f7f\u672a\u78ba\u8a3a\uff0c\u914d\u5408\u81e8\u5e8a\u75c7\u72c0\u4ee5\u53ca\u65c5\u904a\u53f2\uff0c\u61c9\u5728 24\u5c0f\u6642\u5167\u4e3b\u52d5\u901a\u5831\u7b2c\u56db\u985e\u6cd5\u5b9a\u50b3\u67d3\u75c5\u3002 (B)\u61c9\u5b89\u6392\u8166\u90e8\u96fb\u8166\u65b7\u5c64\uff0c\u77ef\u6b63\u8840\u5c0f\u677f\u4f4e\u4e0b\u81f3\u8840\u5c0f\u677f\u5927\u65bc 20,000 /mm3\uff0c\u57f7\u884c\u8170\u690e\u7a7f\u523a\u3002 (C)\u61c9\u5b89\u6392\u539a\u5c64\u8207\u8584\u5c64\u8840\u6db2\u62b9\u7247\uff0c\u5176\u4e2d\u8584\u5c64\u8840\u6db2\u62b9\u7247\u8f03\u80fd\u78ba\u8a8d\u611f\u67d3\u7a2e\u985e\u3002 (D)\u56e0\u6cbb\u7642\u85e5\u7269\u7686\u6709\u56b4\u91cd\u526f\u4f5c\u7528\uff0c\u5728\u78ba\u8a8d\u8a3a\u65b7\u524d\u4e0d\u61c9\u8cbf\u7136\u4f7f\u7528\u85e5\u7269\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "50\u6b72\u5973\u6027\u56e0\u4e0a\u5410\u4e0b\u7009\u81f3\u6025\u8a3a\u5c31\u91ab\uff0c\u81ea\u8a34\u6578\u5c0f\u6642\u524d\u98df\u7269\u906d\u4eba\u52a0\u7812\u971c (\u4e09\u6c27\u5316\u4e8c\u7837)\u4e0b\u6bd2\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u7837\u4e2d\u6bd2\u6700\u5e38\u5c0e\u81f4\u6b7b\u4ea1\u7684\u539f\u56e0\u70ba\u4f4e\u8840\u58d3\u53ca\u5fc3\u5f8b\u4e0d\u6574\u3002 (B)\u8179\u90e8 X\u5149\u53ef\u80fd\u767c\u73fe\u7837\u7684\u6591\u9ede( metallic flecks )\u3002 (C)\u62bd\u8840\u6aa2\u9a57\u8840\u6e05\u7837\u6fc3\u5ea6\uff0c\u4ee5\u6c7a\u5b9a\u662f\u5426\u7d66\u4e88\u87af\u5408\u5291 Dimercaprol \u3002 (D)\u8eab\u9ad4\u8a3a\u5bdf\u82e5\u767c\u73fe\u6307\u7532\u6709\u6a6b\u7d0b\u2500 \u7c73\u6c0f\u7dda(Mees' lines ) \uff0c\u9808\u61f7\u7591\u5408\u4f75\u6162\u6027\u4e2d\u6bd2\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "60\u6b72\u7537\u6027\u6709\u9ad8\u8840\u58d3\u5fc3\u81df\u75c5\u53f2\uff0c\u5f9e 6\u5e74\u524d\u958b\u59cb\u6709\u904b\u52d5\u6027\u5fc3\u81df\u4e0d\u9069\uff0c\u8fd1 2\u5e74\u66fe\u6709\u660f\u53a5\u60c5\u5f62\u767c\u751f\u3002\u7a81\u7136\u547c\u5438\u56f0\u96e3\uff0c\u5169\u5074\u80f8\u90e8\u6709\u56c9\u97f3\uff1b\u5fc3\u97f3\u5448\u73fe Gr. III systolic murmur over right upper sternal border with carotid transmission \uff0cparadoxical splitting of S2 \u3002\u80f8\u90e8 X\u5149\u53ca ECG\u5982\u5716\u6240\u793a\u3002\u75c5\u4eba \u6700\u53ef\u80fd\u7684\u8a3a\u65b7\u662f\uff1f", + "Options": "(A)\u50e7\u5e3d\u74e3\u9589\u9396\u4e0d\u5168( mitral regurgitation )\u3002 (B)\u4e3b\u52d5\u8108\u74e3\u72f9\u7a84(aortic stenosis )\u3002 (C)\u80a5\u539a\u6027\u963b\u585e\u578b\u5fc3\u808c\u75c5\u8b8a(hypertrophic obstructive cardiomyopathy )\u3002 (D)\u4e3b\u52d5\u8108\u74e3\u9589\u9396\u4e0d\u5168(aortic regurgitation )\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "30\u6b72\u5973\u6027\uff0c\u61f7\u5b55 34\u9031\uff0c\u56e0\u8eca\u798d\u9001\u5165\u6025\u8a3a\uff0c\u8d85\u97f3\u6ce2\u986f\u793a\u53f3\u5074\u6c23\u8840\u80f8\uff0c\u6709\u95dc\u6b64\u75c5\u4eba\u4e4b\u8655\u7f6e\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u82e5\u8003\u616e\u653e\u7f6e\u80f8\u7ba1\uff0c\u9078\u64c7 24F\u621628F\u7684\u5c3a\u5bf8\u3002 (B)\u80f8\u7ba1\u653e\u7f6e\u4f4d\u7f6e\u8003\u616e\u7b2c\u4e09\u6216\u7b2c\u56db\u808b\u9593\u8207\u814b\u524d\u7dda\u7684\u4ea4\u53c9\u9ede\u3002 (C)\u653e\u7f6e\u80f8\u7ba1\u6642\uff0c\u5efa\u8b70\u505a\u8207\u76ee\u6a19\u808b\u9593\u5e73\u884c\u4e14\u540c\u4e00\u6c34\u5e73\u4e4b 1~2\u516c\u5206\u76ae\u819a\u5207\u53e3\u3002 (D)\u7f6e\u653e\u80f8\u7ba1\u7684\u8def\u5f91\u61c9\u5faa\u808b\u9aa8\u7684\u4e0b\u7de3\u9032\u5165\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "20\u6b72\u5973\u6027\uff0c\u61f7\u5b55\u7d04 20\u9031\uff0c\u672a\u898f\u5247\u7522\u6aa2\u3002\u6301\u7e8c\u5614\u5410\u4f86\u8a3a\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u82e5\u8a3a\u65b7\u70ba\u598a\u5a20\u5287\u5410\u75c7\uff0c\u5efa\u8b70\u53ef\u4ee5\u7d66\u4e88\u5927\u91cf\u6c34\u4efd\u88dc\u5145\u9ad4\u6db2\u3002 (B)\u82e5\u8840\u7cd6\u503c\u70ba 180 mg/dL \uff0c\u53ef\u4ee5\u6392\u9664\u916e\u9178\u4e2d\u6bd2\u7684\u53ef\u80fd\u6027\uff0c\u4ee5\u598a\u5a20\u5287\u5410\u75c7\u6cbb\u7642\u3002 (C)\u82e5\u8a3a\u65b7\u70ba\u7cd6\u5c3f\u916e\u9178\u8840\u75c7\uff0c\u8ddf\u7121\u61f7\u5b55\u8005\u7684\u80f0\u5cf6\u7d20\u5e6b\u6d66\u6cbb\u7642\u96f7\u540c\u3002 (D)\u9811\u56fa\u578b(intractable )\u598a\u5a20\u5287\u5410\u75c7\uff0c\u53ef\u4ee5\u8003\u616e\u7d66\u4e88\u985e\u56fa\u9187\u6cbb\u7642\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6839\u64da\u7814\u7a76\u986f\u793a\uff0c\u4e0b\u5217\u95dc\u65bc\u8001\u5e74\u4eba\u6210\u70ba\u53d7\u8650\u8005\u6216\u4e0b\u4e00\u4ee3\u6210\u70ba\u52a0\u5bb3\u8005\u7684\u5371\u96aa\u56e0\u5b50\uff0c\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u9ad8\u793e\u7d93\u5730\u4f4d\u3001\u5de5\u4f5c\u5fd9\u788c\u7684\u4e0b\u4e00\u4ee3\u8f03\u6613\u6210\u70ba\u52a0\u5bb3\u8005\u3002 (B)\u5973\u6027\u3001\u7121\u6cd5\u81ea\u4e3b\u884c\u52d5\u7684\u8001\u4eba\u8f03\u6613\u6210\u70ba\u53d7\u8650\u8005\u3002 (C)\u6709\u8ca1\u52d9\u56f0\u96e3\u7684\u4e0b\u4e00\u4ee3\u8f03\u6613\u6210\u70ba\u52a0\u5bb3\u8005\u3002 (D)\u990a\u8b77\u6a5f\u69cb\u7684\u8001\u4eba\u4f4f\u6c11\u8f03\u6613\u6210\u70ba\u53d7\u8650\u8005\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u5c0f\u660e\u9810\u8a08\u53bb\u722c\u7389\u5c71\uff0c\u64d4\u5fc3\u767c\u751f\u9ad8\u5c71\u75c7\uff0c\u4e0b\u5217\u5efa\u8b70\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)Dexamethasone \u53ef\u9810\u9632\u9ad8\u5c71\u75c7\u3002 (B)\u5728\u767b\u5c71\u524d 24\u5c0f\u6642\uff0c\u53ef\u670d\u7528 Acetazolamide \u3002 (C)Acetaminophen \u5c0d\u9ad8\u5c71\u75c7\u5f15\u8d77\u4e4b\u982d\u75db\u7121\u6548\u679c\u3002 (D)\u767c\u751f\u9ad8\u6d77\u62d4\u8166\u6c34\u816b\u6642\uff0c\u9700\u7528 Nifedipine \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6c99\u6797\u4e2d\u6bd2\u7684\u6a5f\u8f49\u8207\u4e0b\u5217\u4f55\u8005\u5316\u5408\u7269 \u6700\u70ba\u76f8\u8fd1 \uff1f", + "Options": "(A)Cyanide \u3002 (B)Halothane \u3002 (C)Organophosphate \u3002 (D)Phosphine \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u85e5\u7269\u4f55\u8005 \u8f03\u6613\u9020\u6210\u5c3f\u6db2\u9d09\u7247\u5b9a\u6027\u7be9\u6aa2( qualitative urine opioid screen)\u5448\u73fe\u507d\u967d\u6027\uff1f", + "Options": "(A)Chlorpromazine \u3002 (B)Levofloxacin\u3002 (C)Ibuprofen \u3002 (D)Verapamil \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "50\u6b72\u7537\u6027\u7121\u904e\u53bb\u75c5\u53f2\uff0c\u56e0\u767c\u71d2\u6578\u65e5\u4e14\u6709\u4e0a\u8179\u75db\u53ca\u5641\u5fc3\u5614\u5410\u81f3\u6025\u8a3a\u3002\u751f\u547d\u5fb5\u8c61\uff1a\u9ad4\u6eab 39\u2103\uff0c\u8840\u58d3 110/83 mmHg \uff0c\u5fc3\u8df3 100 \u6b21/min\uff0c\u547c\u5438 20 \u6b21/min\u3002\u8eab\u9ad4\u8a3a\u5bdf\u767c\u73fe\u8179\u90e8\u58d3\u75db\u53ca\u7259\u9f66\u51fa\u8840\u3002\u62bd\u8840\u6aa2\u9a57\u767c\u73fe\u8840\u5c0f\u677f 70,000 /\u03bcL \uff0cGPT 200 IU/L \uff0c\u82e5\u61f7\u7591\u70ba\u767b\u9769\u71b1\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u61c9\u76e1\u5feb\u4f7f\u7528 NSAIDs\u9000\u71d2\u3002 (B)\u8d85\u97f3\u6ce2\u767c\u73fe\u81bd\u56ca\u58c1\u6c34\u816b\u4e14\u81bd\u56ca\u65c1\u6709\u4e9b\u8a31\u7a4d\u6db2\uff0c\u61c9\u6703\u8a3a\u5916\u79d1\u91ab\u5e2b\u5b89\u6392\u624b\u8853\u3002 (C)\u5efa\u8b70\u4f4f\u9662\u4e26\u6ce8\u610f\u662f\u5426\u6f14\u8b8a\u70ba\u91cd\u75c7\uff0c\u82e5\u672a\u63a5\u53d7\u9069\u7576\u652f\u6301\u6027\u6cbb\u7642\u5f8c\u6b7b\u4ea1\u7387\u53ef\u9054 10-20%\u3002 (D)\u767b\u9769\u71b1\u70ba\u7b2c\u4e8c\u985e\u50b3\u67d3\u75c5\uff0c\u61c9\u65bc 1\u9031\u5167\u901a\u5831\uff0c\u4e26\u63a1\u96c6\u6aa2\u9ad4\u9001\u9a57\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u9f52\u6e90\u6027\u611f\u67d3 (odontogenic infection )\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5e38\u540c\u6642\u5408\u4f75\u591a\u7a2e\u7d30\u83cc\u611f\u67d3\uff0c\u4ee5\u55dc\u6c27\u83cc\u611f\u67d3\u70ba\u4e3b\uff0c\u53ad\u6c27\u83cc\u611f\u67d3\u4e0d\u5e38\u898b\u3002\u9664\u6297\u751f\u7d20\u6cbb\u7642\u5916\uff0c\u5e38\u9700\u8981\u624b\u8853\u5f15\u6d41\u6e05\u5275\u3002 (B)\u4e0a\u9837\u81fc\u9f52\u5e38\u5f15\u8d77\u5480\u56bc\u808c\u9593\u9699 (masticator space )\u611f\u67d3\uff0c\u81e8\u5e8a\u75c7\u72c0\u4e3b\u8981\u70ba\u81c9\u90e8\u816b\u75db\u548c\u7259\u95dc\u7dca\u9589\u3002\u5480\u56bc\u808c\u9593\u9699\u7684\u611f\u67d3\u4e0d\u6613\u64f4\u67d3\u5230\u5176\u4ed6\u6df1\u9838\u90e8\u9593\u9699(deep neck space )\u3002 (C)\u4e0b\u9837\u81fc\u9f52\u5f15\u8d77\u7684\u4e0b\u9837\u4e0b\u3001\u820c\u4e0b\u8207\u9826\u4e0b(submental )\u9593\u9699\u611f\u67d3\uff0c\u7a31\u4e4b\u70baLudwig\u2019s Angina \u3002\u820c\u982d\u5e38\u56e0\u611f\u67d3\u800c\u5f8c\u79fb\uff0c\u5f15\u8d77\u547c\u5438\u9053\u963b\u585e\u3002 (D)Ludwig\u2019s Angina \u9032\u5c55\u5feb\u901f\uff0c\u9664\u4f7f\u7528\u6297\u751f\u7d20\u6cbb\u7642\u5916\uff0c\u61c9\u53ca\u65e9\u4f7f\u7528\u5feb\u901f\u5f15\u5c0e\u63d2\u7ba1 (Rapid Sequence Intubation )\u5efa\u7acb\u547c\u5438\u9053\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u9020\u6210\u61f7\u5b55\u671f\u9593\u9ad8\u51dd\u8840\u72c0\u614b\u7684\u539f\u56e0\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u5b50\u5bae\u58d3\u8feb\u9020\u6210\u975c\u8108\u963b\u585e\u3002 (B)\u53f3\u9ac2\u975c\u8108\u6a6b\u904e\u53f3\u9ac2\u52d5\u8108\u3002 (C)\u8840\u5c0f\u677f\u6d3b\u5316\u589e\u52a0\u3002 (D)\u7f3a\u4e4f Protein C \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u4f55\u8005\u6558\u8ff0 \u6700\u53ef\u80fd\u4ee3\u8868\u75c5\u4eba\u767c\u751f\u759d\u6c23( hernia)\u5408\u4f75\u8178\u7d5e\u627c(strangulation)\uff1f", + "Options": "(A)\u75c5\u4eba\u56b4\u91cd\u5641\u5fc3\u5614\u5410\u3002 (B)\u8d85\u97f3\u6ce2\u767c\u73fe\u9f13\u8d77\u8655\u8178\u5b50\u8178\u58c1\u8b8a\u539a\u4e14\u6709 free fluid\u3002 (C)\u90fd\u666e\u52d2\u8d85\u97f3\u6ce2\u767c\u73fe\u9f13\u8d77\u8655\u8178\u5b50\u6709 arterial flow \u3002 (D)\u8d85\u97f3\u6ce2\u767c\u73fe\u9f13\u8d77\u8655\u7684\u8178\u5b50\u5feb\u901f\u8815\u52d5\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5916\u50b7\u6027\u4e3b\u52d5\u8108\u640d\u50b7\uff0c\u4e0b\u5217\u96fb\u8166\u65b7\u5c64\u5f71\u50cf\u4f55\u8005 \u6700\u5e38\u51fa\u73fe \uff1f", + "Options": "(A)\u4e3b\u52d5\u8108\u5047\u6027\u52d5\u8108\u7624(aortic pseudoaneurysm )\u3002 (B)\u5167\u819c\u7834\u88c2\u90e8\u4f4d(intimal disruption )\u7684\u7ba1\u8154\u8840\u584a\u3002 (C)\u4e3b\u52d5\u8108\u6a6b\u65b7 (transection )\u3002 (D)\u5f9e\u4e3b\u52d5\u8108\u5230\u7e31\u9694\u8154\u7684\u6d3b\u52d5\u6027\u51fa\u8840\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "26\u6b72\u61f7\u5b55 28\u9031\u5a66\u5973\u56e0\u70ba\u809a\u81cd\u53f3\u4e0b\u65b9\u75bc\u75db\u4f86\u8a3a\uff0c\u75c5\u4eba\u8868\u793a\u4eca\u5929\u6709\u6301\u7e8c\u5614\u5fc3\u611f\uff0c\u4f46\u7121\u767c\u71d2\u3002\u95dc\u65bc\u6b64\u75c5\u4eba\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u61f7\u5b55\u5a66\u5973\u95cc\u5c3e\u708e\u6a5f\u7387\u8f03\u4e00\u822c\u5a66\u5973\u8f03\u9ad8 1.4\u500d\uff0c\u4e14\u6613\u8aa4\u8a3a\u3002 (B)\u5c31\u9031\u6578\u53ca\u8179\u75db\u4f4d\u7f6e\u800c\u8a00\uff0c\u7d55\u5927\u591a\u6578\u7684\u95cc\u5c3e\u708e\u90fd\u662f\u53f3\u5074\u504f\u4e0a\u75bc\u75db\u3002 (C)\u898b\u53f3\u5074\u814e\u6c34\u816b\uff0c\u4e14\u5c0f\u4fbf\u6709\u767d\u8840\u7403\u4e0a\u5347\uff0c\u5247\u53ef\u4f9d\u6ccc\u5c3f\u9053\u611f\u67d3\u6cbb\u7642\u3002 (D)\u82e5\u57f7\u884c\u8d85\u97f3\u6ce2\u6aa2\u67e5\uff0c\u6709\u770b\u5230\u95cc\u5c3e\u708e\u7684\u5178\u578b\u8868\u73fe\uff0c\u5247\u5efa\u8b70\u958b\u5200\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u5c0f\u5152\u80ba\u708e\u7684\u75c5\u539f\u83cc\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u9ef4\u6f3f\u83cc\u80ba\u708e( Mycoplasma pneumoniae )\uff1a\u6703\u6709\u4e7e\u54b3 (hacking dry cough)\uff0c\u80ba\u5916\u8868\u73fe\u53ef\u80fd\u6703\u6709\u4e2d\u6a1e\u795e\u7d93\u7cfb\u7d71\u75be\u75c5\uff0c\u95dc\u7bc0\u75bc\u75db\uff0c\u8d77\u75b9\u5b50rash\u7b49\u76ae\u819a\u75be\u75c5\u3002 (B)\u62ab\u8863\u83cc\u80ba\u708e (Chlamydia trachomatis )\uff1a\u901a\u5e38\u75c5\u7a0b\u5feb\u4e14\u6703\u767c\u9ad8\u71d2\uff0c\u751a\u81f3\u6703\u5f15\u8d77\u80ba\u81bf\u760d\uff0c\u5e38\u767c\u751f\u5728 influenza\u611f\u67d3\u5f8c\u7684 secondary infection \u3002 (C)\u767e\u65e5\u54b3\u80ba\u708e( Bordetella pertussi )\uff1a\u5c0f\u5152\u54b3\u4e0d\u505c\u8d85\u904e\u5169\u661f\u671f\uff0c\u8981\u5c0f\u5fc3\u767e\u65e5\u54b3\u7684\u98a8\u96aa\u3002 (D)\u80ba\u7d50\u6838\u687f\u83cc\u80ba\u708e(Mycobacterium tuberculosis)\u6301\u7e8c\u6027\u9577\u671f\u54b3\u55fd\u53ca\u767c\u71d2\u800c\u4e14\u6709\u80ba\u5916\u7684\u8868\u73fe\uff0c\u800c\u5c0f\u5152\u80ba\u7d50\u6838\u53ef\u80fd\u4e0d\u6703\u6709\u54b3\u8840\u75c7\u72c0\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "48\u6b72\u7537\u6027\uff0c\u4e3b\u8a34\u54b3\u55fd\u5408\u4f75\u547c\u5438\u56f0\u96e3\u4ee5\u53ca\u767c\u71d2\u6578\u65e5\uff0c\u8fd1\u671f\u6709\u4e0d\u660e\u539f\u56e0\u7684\u53cd\u8986\u6162\u6027\u9f3b\u7ac7\u708e\u3001\u95dc\u7bc0\u75bc\u75db\u3001\u86cb\u767d\u5c3f\u4ee5\u53ca\u76ae\u4e0b\u7d50\u7bc0\u7b49\u3002\u80f8\u90e8 X\u5149\u53ef\u898b\u96d9\u5074\u80ba\u90e8\u6709\u7a0b\u5ea6\u4e0d\u4e00\u7684\u6d78\u6f64\u4ee5\u53ca\u7d50\u7bc0\u3002\u4e0b\u5217\u4f55\u8005\u70ba \u8f03\u53ef\u80fd\u8a3a\u65b7 \uff1f", + "Options": "(A)Hypersensitivity pneumonitis \u3002 (B)Sarcoidosis\u3002 (C)Wegener\u2019s granulomatosis \u3002 (D)Goodpasture\u2019s syndrome \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "30\u6b72\u540c\u6027\u6200\u7684\u7537\u6027\u5eda\u5e2b\uff0c\u524d\u4e00\u6b21\u6027\u884c\u70ba\u7d04 1\u500b\u6708\u524d\uff0c\u56e0\u70ba\u5168\u8eab\u5026\u6020\u4e0d\u9069\u3001\u98df\u617e\u4e0d\u632f\u30012 \u5929\u524d\u5230\u9580\u8a3a\u6aa2\u67e5\u3002\u4eca\u5929\u56e0\u70ba\u7a81\u7136\u51fa\u73fe\u767c\u71d2 (38.5\u2103 )\u3001\u5614\u5410\u3001\u5641\u5fc3\u53ca\u8179\u90e8\u4e0d\u8212\u670d\u4f86\u6025\u8a3a\u3002\u9580\u8a3a\u62bd\u8840\u5831\u544a\uff1aBilirubin 9.2 mg/dL \u3001AST 2238 U/L\u3001 ALT 3806 U/L \u3001Anti-H AV I g M \uff1apositive \u3001Anti-H AV I g G \uff1aNegative\uff0c\u4ee5\u4e0b HBcAb IgM \u3001IgG\u3001HBsAb\u3001Anti-HCV\u90fd\u662f\u9670\u6027\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u6b64\u75c5\u4eba\u8f03\u4e0d\u53ef\u80fd\u662f\u7537\u7537\u9593\u6027\u884c\u70ba\u800c\u611f\u67d3\u3002 (B)\u4f9d\u64da CDC\u898f\u5b9a\uff0c\u6b64\u75c5\u4eba\u5728\u51fa\u73fe\u9ec3\u75b8\u5f8c 14\u5929\u5373\u53ef\u89e3\u9664\u9694\u96e2\u6062\u5fa9\u5de5\u4f5c\u3002 (C)\u5efa\u8b70\u6b64\u75c5\u4eba\u540c\u6642\u9032\u884c\u611b\u6ecb\u75c5\u3001\u6885\u6bd2\u53ca\u6dcb\u75c5\u7b49\u6027\u75c5\u6aa2\u67e5\u3002 (D)\u6b64\u75c5\u4eba\u901a\u5831\u70ba\u300c\u78ba\u8a3a\u75c5\u4f8b\u300d\u6642\uff0c\u4e0d\u9700\u63a1\u96c6\u7cde\u4fbf\u6aa2\u9ad4\u9032\u884c\u6aa2\u6e2c\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u56b4\u91cd\u982d\u75db\uff0c\u61f7\u7591\u70ba\u8718\u86db\u7db2\u819c\u4e0b\u8154\u51fa\u8840\u7684\u75c5\u4eba\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u9996\u9078\u6aa2\u67e5\u70ba\u7121\u986f\u5f71\u5291\u8166\u90e8\u96fb\u8166\u65b7\u5c64\uff0c\u5176\u654f\u611f\u5ea6\u5728 24\u5c0f\u6642\u5f8c\u9010\u6f38\u5347\u9ad8\uff0c\u4e26\u5728\u7b2c 3\u5929\u5de6\u53f3\u53ef\u9054 98%\u3002 (B)\u82e5\u96fb\u8166\u65b7\u5c64\u7121\u7570\u5e38\u4f46\u4ecd\u9ad8\u5ea6\u61f7\u7591\uff0c\u6838\u78c1\u5171\u632f\u9020\u5f71\u53ef\u53d6\u4ee3\u8170\u690e\u7a7f\u523a\uff0c\u4ee5\u78ba\u8a8d\u662f\u5426\u6709\u8718\u86db\u7db2\u819c\u4e0b\u8154\u51fa\u8840\u3002 (C)Xanthochromia \u7684\u6210\u56e0\u662f\u8840\u7d05\u7d20\u964d\u89e3\u6210\u81bd\u7d05\u7d20(bilirubin degradation )\uff0c\u9001\u6aa2\u524d\u61c9\u8a72\u907f\u514d\u5149\u7167\u3002 (D)\u8166\u90e8\u52d5\u8108\u7624\u7834\u88c2\u51fa\u8840\u5f8c\u7684 1\u5c0f\u6642\u5167\uff0c\u96fb\u8166\u65b7\u5c64\u7121\u7570\u5e38\uff0c\u8166\u810a\u9ad3\u6db2\u53ef\u5448\u73fe xanthochromia \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "7\u6b72\u5c0f\u5973\u5b69\uff0c\u547c\u5438\u5598\u3001\u8179\u75db\u3001\u591a\u5c3f\u53ca\u610f\u8b58\u6539\u8b8a\u81f3\u6025\u8a3a\u5c31\u91ab\uff0c\u6aa2\u67e5\u6642\u767c\u73fe\u55dc\u7761\u3001\u819a\u8272\u84bc\u767d\u3001\u5fae\u8840\u7ba1\u56de\u5145\u6642\u9593>3 \u79d2\u3001\u9ad4\u6eab 37.1\u2103\u3001\u5fc3\u8df3 152 \u6b21/min\u3001\u547c\u5438 42 \u6b21/min\u3001\u8840\u58d3 78/46 mmHg \uff0cK 4.5 mEq/L \uff0cglucose 450 mg/dL \uff0cpH 7.18\uff0cketone body 3.2mmol/L \u3002\u4e0b\u5217\u8655\u7f6e\u53ca\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u61c9\u7acb\u5373\u975c\u8108\u6ce8\u5c04\u7d66\u4e88 Insulin 0.1 unit/kg \u4ee5\u77ef\u6b63\u9ad8\u8840\u7cd6\u3002 (B)\u8003\u616e\u65bc\u7b2c\u4e00\u5c0f\u6642\u5feb\u901f\u7d66\u4e88 0.9%\u751f\u7406\u98df\u9e7d\u6c34 20 mL/kg\u3002 (C)\u5728\u7d66\u4e88\u8db3\u91cf\u751f\u7406\u98df\u9e7d\u6c34\u704c\u6ce8\u5f8c\uff0c\u7dca\u63a5\u8457\u7d66\u4e88 Insulin 0.04 unit/kg/hr\u4ee5\u6e05\u9664\u916e\u9178\u3002 (D)\u76ee\u524d\u8840\u4e2d\u9240\u96e2\u5b50\u5728\u6b63\u5e38\u7bc4\u570d\u5167\uff0c\u4e0d\u9700\u88dc\u5145\u9240\u96e2\u5b50\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4ee5\u4e0b\u91dd\u5c0d\u808b\u819c\u7a4d\u6db2\u7684\u5224\u8b80\uff0c\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u98df\u9053\u7834\u88c2\u53ef\u80fd\u9020\u6210\u808b\u819c\u7a4d\u6db2\u7684 amylase\u5347\u9ad8\u3002 (B)\u80ba\u6813\u585e\u6240\u9020\u6210\u7684\u808b\u819c\u7a4d\u6db2\u6709\u53ef\u80fd\u662f transudates \u3002 (C)\u98a8\u6fd5\u6027\u95dc\u7bc0\u708e\u9020\u6210\u7684\u808b\u819c\u7a4d\u6db2\u5176\u8461\u8404\u7cd6\u6703\u4e0a\u5347\u3002 (D)\u7576 pH\u503c\u5c0f\u65bc 7.1\uff0c\u53ef\u8a3a\u65b7\u81bf\u80f8\uff0c\u4e26\u4e14\u662f\u80f8\u7ba1\u5f15\u6d41\u7684\u9069\u61c9\u75c7\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u95dc\u65bc\u8178\u80c3\u9053\u51fa\u8840\u4e4b\u6558\u8ff0\uff0c\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u75c5\u4eba\u89e3\u9ed1\u4fbf (melena)\uff0c\u76ee\u8996\u9f3b\u80c3\u7ba1\u62bd\u5438\u7269\u70ba coffee -ground\u4e26\u4e0d\u8db3\u4ee5\u8a3a\u65b7\u70ba\u4e0a\u6d88\u5316\u9053\u51fa\u8840\u3002 (B)\u75c5\u4eba\u89e3\u9ed1\u4fbf\u6709\u53ef\u80fd\u662f\u4e0b\u6d88\u5316\u9053\u7de9\u6162\u51fa\u8840\u3002 (C)\u75c5\u4eba\u89e3\u8840\u4fbf (hematochezia )\uff0c\u82e5\u809b\u9580\u6307\u6aa2\u767c\u73fe\u75d4\u7621\u4e14\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\uff0c\u53ef\u8f49\u4ecb\u81f3\u5927\u8178\u76f4\u8178\u79d1\u9580\u8a3a\u3002 (D)\u809d\u786c\u5316\u7684\u75c5\u4eba\u5410\u8840\u6700\u5e38\u898b\u7684\u539f\u56e0\u662f\u6d88\u5316\u6027\u6f70\u760d\u51fa\u8840\uff0c\u5176\u6b21\u624d\u662f\u98df\u9053\u975c\u8108\u66f2\u5f35\u51fa\u8840\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8001\u4eba\u5275\u50b7\u7684\u81e8\u5e8a\u7279\u6027\u8207\u8a3a\u65b7\u8655\u7f6e\u7684\u63cf\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u8001\u4eba\u9838\u690e\u53d7\u50b7\uff0c\u5efa\u8b70\u8df3\u904e X\u5149\u6aa2\u67e5\uff0c\u76f4\u63a5\u5b89\u6392\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u3002 (B)\u8001\u5e74\u904e\u5ea6\u4f38\u5c55\u640d\u50b7\uff0c\u53ef\u80fd\u51fa\u73fe\u4e2d\u7d22\u75c7\u5019\u7fa4(central cord syndrome )\uff0c\u4e0a\u80a2\u904b\u52d5\u529f\u80fd\u969c\u7919\u6bd4\u4e0b\u80a2\u66f4\u5e38\u898b\u3002 (C)\u9838\u690e\u548c\u8170\u690e\u9aa8\u6298\u5e7e\u4e4e\u4f54\u6240\u6709\u9aa8\u8cea\u758f\u9b06\u6027\u9aa8\u6298\u7684\u4e00\u534a\uff0c\u6700\u5e38\u898b\u65bc\u7b2c\u4e8c\u9838\u690e\u548c\u7b2c\u4e8c\u8170\u690e\u3002 (D)\u670d\u7528 Warfarin \u6216Plavix\u6709\u8f15\u5ea6\u982d\u90e8\u5916\u50b7\u7121\u75c7\u72c0\u8001\u4eba\uff0c\u6703\u5efa\u8b70\u9032\u884c\u7121\u986f\u5f71\u5291\u8166\u90e8\u96fb\u8166\u65b7\u5c64\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "50\u6b72\u5973\u6027\u4e3b\u8a34 1\u9031\u524d\u96d9\u4e0b\u80a2\u7121\u529b\uff0c\u5176\u5f8c\u9010\u6f38\u9032\u5c55\u5230\u4e0a\u80a2\u7121\u529b\u8207\u8b1b\u8a71\u542b\u7cca\u4e0d\u6e05\uff0c\u751f\u547d\u5fb5\u8c61\u8840\u58d3 100/60 mmHg \uff0c\u5fc3\u8df3 110 \u6b21/min\uff0c\u547c\u5438 30 \u6b21/min\uff0cSpO 2 96%\uff0c\u8eab\u9ad4\u8a3a\u5bdf\u767c\u73fe\u56db\u80a2\u6df1\u5c64\u808c\u8171\u53cd\u5c04(DTR )\u7686\u964d\u4f4e\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u5982\u679c\u6e2c\u91cf\u80ba\u6d3b\u91cf(vital capacity )< 15 mL/Kg \u5247\u9700\u8981\u8003\u616e\u6c23\u7ba1\u5167\u7ba1\u63d2\u7ba1\u3002 (B)\u9032\u884c\u6c23\u7ba1\u63d2\u7ba1\u6642\u56e0\u70ba\u808c\u8089\u9b06\u5f1b\u5291\u5bb9\u6613\u6548\u679c\u4e0d\u4f73\uff0c\u9700\u8003\u616e\u5c07 Succinylcholine \u5291\u91cf\u63d0\u9ad8\u81f3 2-3 mg/Kg\u3002 (C)\u975c\u8108\u6ce8\u5c04\u514d\u75ab\u7403\u86cb\u767d\u53ef\u4ee5\u6e1b\u5c11\u75c5\u7a0b\uff0c\u4f46\u662f\u53ef\u80fd\u6703\u589e\u52a0\u8840\u6813\u98a8\u96aa\u3002 (D)\u985e\u56fa\u9187\u6cbb\u7642\u5c0d\u65bc\u6b64\u985e\u75be\u75c5\u8b49\u64da\u529b\u4e0d\u5f37\uff0c\u751a\u81f3\u53ef\u80fd\u6709\u5bb3\uff0c\u4e0d\u5efa\u8b70\u5e38\u898f\u4f7f\u7528\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6162\u6027\u963b\u585e\u6027\u80ba\u75c5\u6025\u6027\u767c\u4f5c\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u75f0\u91cf\u589e\u52a0\u548c\u75f0\u8272\u8b8a\u5316\u5b9c\u7d66\u4e88\u6297\u751f\u7d20\u6cbb\u7642\uff0c\u75f0\u6db2\u7d30\u83cc\u57f9\u990a\u6709\u52a9\u65bc\u6025\u8a3a\u6297\u751f\u7d20\u9078\u64c7\u3002 (B)\u77ed\u671f\u4f7f\u7528 3\u5929\u7684\u985e\u56fa\u9187\u7642\u7a0b\uff0c\u53ef\u7e2e\u77ed\u6062\u5fa9\u6642\u9593\u3002 (C)\u88dc\u5145\u6c27\u6c23\u53ef\u5e6b\u52a9\u9006\u8f49\u80ba\u8840\u7ba1\u6536\u7e2e\u3002 (D)\u80c3\u98df\u9053\u9006\u6d41\u662f\u6162\u6027\u963b\u585e\u6027\u80ba\u75c5\u52a0\u91cd\u7684\u5371\u96aa\u56e0\u7d20\uff0c\u6cbb\u7642\u80c3\u98df\u9053\u9006\u6d41\u53ef\u6e1b\u5c11\u75c5\u60c5\u52a0\u91cd\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "6\u5929\u5927\u7684\u65b0\u751f\u5152\u56e0\u9ad8\u71d2\u3001\u55dc\u7761\u53ca\u7cbe\u795e\u8f03\u5dee\u9001\u6025\u8a3a\u5c31\u91ab\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u53ef\u80fd\u8207\u5abd\u5abd\u6216\u5468\u7522\u671f\u56e0\u7d20\u6709\u95dc\uff0c\u4f8b\u5982\u65e9\u671f\u7834\u6c34\uff0c\u4e14\u901a\u5e38\u75c5\u7a0b\u8f03\u70ba\u7de9\u6162\u9032\u5c55\u3002 (B)\u57f7\u884c\u6557\u8840\u75c7\u6aa2\u67e5(septic workup)\u5982\u62bd\u8840\u3001\u9a57\u5c3f\u53ca\u8170\u690e\u7a7f\u523a\u7684\u9580\u6abb\u8207\u4e00\u822c\u8f03\u5927\u5b30\u5152\u7121\u4e0d\u540c\u3002 (C)\u5118\u65e9\u4f7f\u7528\u6297\u751f\u7d20\u6cbb\u7642\uff0c\u9700\u6db5\u84cb\u9769\u862d\u6c0f\u967d\u6027\u83cc\u53ca\u8178\u5167\u83cc\uff0c\u4f46\u8981\u907f\u514d\u4f7f\u7528Ceftriaxone \u3002 (D)\u81e8\u5e8a\u8868\u73fe\u4e5f\u53ef\u80fd\u6703\u51fa\u73fe\u547c\u5438\u6025\u4fc3\u3001\u98df\u617e\u4e0d\u4f73\u751a\u81f3\u5614\u5410\uff0c\u4e5f\u5e38\u6703\u6709Kernig\u53caBrudzinski sign\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u809d\u7d20\u8a98\u767c\u8840\u5c0f\u677f\u4f4e\u4e0b\u75c7( Heparin -induced thrombocytopenia ) \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u767c\u751f\u5f8c\u53ef\u4f7f\u7528 Protamine \u9032\u884c\u6cbb\u7642\u3002 (B)\u56e0\u6a5f\u8f49\u76f8\u4f3c\uff0c\u767c\u751f\u5f8c\u4e0d\u53ef\u6539\u4f7f\u7528 Fondaparinux \u4f86\u9032\u884c\u6297\u51dd\u8840\u3002 (C)\u5c11\u6578\u767c\u751f\u8005\u5728\u975c\u8108\u65bd\u6253 Heparin\u5f8c\u7684 30\u5206\u9418\u5167\uff0c\u6703\u51fa\u73fe\u985e\u4f3c\u904e\u654f\u7684\u53cd\u61c9\u3002 (D)\u767c\u751f\u5f8c\u6709\u9ad8\u51fa\u8840\u50be\u5411\uff0c\u61c9\u9810\u9632\u6027\u7d66\u4e88\u8840\u5c0f\u677f\u8f38\u6ce8\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6025\u6027\u80f8\u75db\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)18 \u6b72\u7537\u6027\u6709\u4f7f\u7528\u53e4\u67ef\u9e7c\uff0c\u80f8\u75db 2\u5929\uff0c\u8f03\u4e0d\u53ef\u80fd\u70ba\u6025\u6027\u51a0\u5fc3\u75c7\u3002 (B)64 \u6b72\u5973\u6027\u6709\u7cd6\u5c3f\u75c5\uff0c\u4e0a\u8179\u75db\u5408\u4f75\u96d9\u81c2\u75e0\u75db\uff0c\u8f03\u4e0d\u53ef\u80fd\u662f\u5fc3\u81df\u7684\u554f\u984c\u3002 (C)70 \u6b72\u7537\u6027\u809d\u786c\u5316\u4e14\u9577\u671f\u9157\u9152\uff0c\u5287\u70c8\u5614\u5410\u5f8c\u80f8\u53e3\u75bc\u75db\uff0c\u9700\u8003\u616eBoerhaave\u2019s syndrome \u3002 (D)\u6025\u6027\u8166\u4e2d\u98a8\u75c5\u4eba\u6c92\u6709\u5f71\u97ff\u5230\u5fc3\u81df\uff0c\u6545\u5fc3\u808c\u6307\u6578\u4e0d\u6703\u4e0a\u5347\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "45\u6b72\u5973\u6027\u6709\u7cd6\u5c3f\u75c5\u53f2\uff0c\u8170\u75db\u548c\u4e0b\u8179\u8139 2\u5929\uff0c\u983b\u5c3f\u4f46\u89e3\u5c3f\u4e0d\u9806\u66a2\uff0c\u5c0f\u4fbf\u6642\u7528\u529b\u624d\u80fd\u89e3\u51fa\uff0c\u4e14\u6703\u9023\u5927\u4fbf\u4e00\u8d77\u89e3\u51fa\uff0c\u809b\u9580\u9644\u8fd1\u7684\u5c41\u80a1\u548c\u5167\u5074\u5927\u817f\u6703\u6709\u9ebb\u6728\u7684\u611f\u89ba\u3002\u8d85\u97f3\u6ce2\u9810\u4f30\u9918\u5c3f\u91cf 900 mL\uff0c\u96d9\u5074\u8f15\u5fae\u6c34\u814e\u3002\u4e0b\u5217\u6558\u8ff0\u6216\u8655\u7f6e\uff0c\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u61c9\u653e\u7f6e\u5c3f\u7ba1\uff0c\u4e26\u62bd\u8840\u6aa2\u9a57\u814e\u529f\u80fd\u548c\u96fb\u89e3\u8cea\u3002 (B)\u61c9\u6aa2\u67e5\u662f\u5426\u6709\u5a66\u79d1\u816b\u584a\u6216\u9aa8\u76c6\u8154\u767c\u708e\u9020\u6210\u963b\u585e\u3002 (C)\u82e5\u61f7\u7591\u816b\u7624\u58d3\u8feb\u795e\u7d93\u61c9\u5148\u6253 Dexamethasone \uff0c\u518d\u5b89\u6392\u8170\u90e8\u78c1\u632f\u9020\u5f71\u3002 (D)\u5927\u65bc 95%\u7684\u75c5\u4eba\u809b\u9580\u62ec\u7d04\u808c\u5f35\u529b\u6703\u964d\u4f4e\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "70\u6b72\u7537\u6027\uff0c\u4e00\u500b\u6708\u524d\u56e0\u70ba\u5fc3\u623f\u986b\u52d5\u5408\u4f75\u6897\u585e\u6027\u8166\u4e2d\u98a8\uff0c\u8f49\u9662\u81f3\u672c\u9662\u6025\u8a3a\uff0c\u9810\u8a08\u4f4f\u9662\u5fa9\u5065\u6cbb\u7642\u4e00\u500b\u6708\u3002\u75c5\u4eba\u75c5\u6cc1\u4ecd\u9700\u7d66\u4e88\u975c\u8108\u85e5\u7269\uff0c\u56e0\u5468\u908a\u975c\u8108\u5c0e\u7ba1\u7f6e\u653e\u56f0\u96e3\u800c\u5efa\u8b70\u8981\u653e\u7f6e\u4e2d\u592e\u975c\u8108\u5c0e\u7ba1\u3002\u5c0d\u65bc\u6b64\u75c5\u4eba\uff0c\u6025\u8a3a\u91ab\u5e2b\u9078\u64c7\u4e2d\u592e\u975c\u8108\u5c0e\u7ba1\u653e\u7f6e\u4f4d\u7f6e\uff0c\u4f55\u8655 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u53f3\u5074\u5167\u9838\u975c\u8108\u3002 (B)\u53f3\u5074\u5916\u9838\u975c\u8108\u3002 (C)\u53f3\u5074\u9396\u9aa8\u4e0b\u975c\u8108\u3002 (D)\u53f3\u5074\u80a1\u975c\u8108\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "15\u500b\u6708\u5927\u7684\u7537\u7ae5\u56e0\u54b3\u55fd\u3001\u6d41\u9f3b\u6d95\u53ca\u547c\u5438\u6025\u4fc3\u5230\u6025\u8a3a\u6c42\u8a3a\uff0c\u76ee\u524d\u6c92\u6709\u767c\u71d2\u75c7\u72c0\uff0c\u8eab\u9ad4\u8a3a\u5bdf\u767c\u73fe\u80f8\u90e8\u6709\u808b\u51f9\u73fe\u8c61\uff0c\u4e14\u807d\u8a3a\u6709\u54ee\u9cf4(wheezing )\u8072\uff0c\u6709\u95dc\u6b64\u75c5\u4eba\u6cbb\u7642\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u5fc5\u8981\u6642\u7d66\u6c27\u6c23\u6cbb\u7642\uff0c\u7dad\u6301\u8840\u6c27\u6fc3\u5ea6\u5927\u65bc 90%\u3002 (B)\u5408\u4f75\u4f7f\u7528\u985e\u56fa\u9187 Dexamethasone \u53ca\u814e\u4e0a\u817a\u7d20 Epinephrine \uff0c\u53ef\u80fd\u6703\u964d\u4f4e\u4f4f\u9662\u7387\u3002 (C)\u4f7f\u7528\u4e59\u4e8c\u578b\u64ec\u4ea4\u611f\u4f5c\u7528(\u03b22 agonists)\u6c23\u7ba1\u64f4\u5f35\u5291\u6cbb\u7642\uff0c\u6709\u52a9\u65bc\u964d\u4f4e\u4f4f\u9662\u7387\u53ca\u4f4f\u9662\u5929\u6578\u3002 (D)\u82e5\u547c\u5438\u7a98\u8feb\uff0c\u4f7f\u7528\u975e\u4fb5\u8972\u6027\u6b63\u58d3\u901a\u6c23(NIPPV )\uff0c\u53ef\u80fd\u6703\u964d\u4f4e\u6216\u5ef6\u9072\u63d2\u7ba1\u7684\u9700\u8981\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u5e6b\u7591\u4f3c\u7d30\u83cc\u6027\u8166\u819c\u708e\u75c5\u4eba\u505a\u810a\u9ad3\u7a7f\u523a\u6aa2\u67e5\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u62bd\u8840\u5831\u544a\u7121\u660e\u986f\u7570\u5e38\uff0c\u7121\u660e\u986f\u795e\u7d93\u5b78\u75c7\u72c0\uff0c\u53ef\u4e0d\u7528\u505a\u8166\u90e8\u96fb\u8166\u65b7\u5c64\u5c31\u5148\u4f5c\u810a\u9ad3\u7a7f\u523a\u3002 (B)\u810a\u9ad3\u7a7f\u523a\u61c9\u5728\u6297\u751f\u7d20\u4f7f\u7528\u5f8c\u518d\u57f7\u884c\uff0c\u4ee5\u514d\u5f71\u97ff\u7d30\u83cc\u57f9\u990a\u3002 (C)\u7d30\u83cc\u6027\u8166\u819c\u708e\u6613\u9020\u6210\u8166\u810a\u9ad3\u6db2\u58d3\u529b\u4e0a\u5347\uff0c\u5b9c\u5e38\u898f\u5b8c\u6210\u8166\u90e8\u96fb\u8166\u65b7\u5c64\uff0c\u518d\u57f7\u884c\u810a\u9ad3\u7a7f\u523a\u3002 (D)\u5982\u679c\u75c5\u4eba\u7121\u6cd5\u5074\u8eba\uff0c\u53ef\u8003\u616e\u5750\u59ff\u505a\u810a\u9ad3\u7a7f\u523a\uff0c\u6240\u6e2c\u5f97\u7684\u8166\u810a\u9ad3\u6db2\u58d3\uff0c\u5169\u8005\u4e0d\u6703\u5dee\u592a\u591a\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u4f9d\u64da\u53f0\u7063\u75be\u75c5\u7ba1\u5236\u7f72\u767c\u4f48\u7684\u65b0\u578b\u51a0\u72c0\u75c5\u6bd2( SARS -CoV-2)\u611f\u67d3\u81e8\u5e8a\u8655\u7f6e\u66ab\u884c\u6307\u5f15 (2022\u5e744\u670819\u65e5\u7b2c 17\u7248)\uff0c\u4e0b\u5217\u54ea\u4e00\u4f4d\u65b0\u578b\u51a0\u72c0\u75c5\u6bd2\u611f\u67d3\u6210\u4eba\u7684\u8868\u73fe\u53ef\u6b78\u985e\u70ba\u56b4\u91cd\u80ba\u708e \uff1f", + "Options": "(A)\u6709\u767c\u71d2\u6216\u547c\u5438\u9053\u611f\u67d3\uff0c\u5408\u4f75\u547c\u5438\u901f\u7387 26 \u6b21/min\u3002 (B)\u6709\u767c\u71d2\u6216\u547c\u5438\u9053\u611f\u67d3\uff0c\u5408\u4f75 room air\u4e0b\u8840\u6c27\u98fd\u548c\u5ea6\u70ba 94%\u3002 (C)\u6709\u767c\u71d2\u6216\u547c\u5438\u9053\u611f\u67d3\uff0c\u5408\u4f75\u80f8\u90e8 X\u5149\u80ba\u6d78\u6f64(infiltration)\u70ba40%\u3002 (D)\u6709\u767c\u71d2\u6216\u547c\u5438\u9053\u611f\u67d3\uff0c\u5408\u4f75\u56b4\u91cd\u547c\u5438\u7a98\u8feb PaO 2/FiO 2=350\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "70\u6b72\u7537\u6027\u75c5\u4eba\uff0c\u6709\u7cd6\u5c3f\u75c5\u53f2\uff0c\u6700\u8fd1\u5e7e\u5929\u809b\u9580\u53e3\u816b\u8139\u3001\u7662\uff0c\u53ea\u8981\u6392\u4fbf\u5c31\u6709\u816b\u8139\u7269\u8dd1\u51fa\u809b\u9580\u53e3\uff0c\u4f46\u662f\u53ef\u4ee5\u81ea\u884c\u63a8\u56de\u53bb\uff0c\u4e14\u885b\u751f\u7d19\u4e0a\u767c\u73fe\u6709\u9bae\u8840\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u6b64\u75c5\u4eba\u53ef\u80fd\u662f\u809b\u9580\u975c\u8108\u66f2\u5f35\u5f15\u8d77\u7684\uff0c\u9700\u6ce8\u610f\u662f\u5426\u6709\u9580\u8108\u9ad8\u58d3( portal hypertension )\u3002 (B)\u53ef\u4ee5\u5efa\u8b70\u6b64\u75c5\u4eba\u4ee5\u6eab\u6c34(30\u2103 )\u5750\u6d74\u3001\u7d66\u4e88\u8edf\u4fbf\u5291\u5f8c\u5373\u53ef\u96e2\u958b\u6025\u8a3a\u3002 (C)\u53ef\u4ee5\u5efa\u8b70\u6b64\u75c5\u4eba\u4f7f\u7528\u5c40\u90e8\u7684 Nifedipine (0.3%) and Lidocaine (1.5%) \u51dd\u81a0\u7de9\u89e3\u75c7\u72c0\u3002 (D)\u53ef\u4ee5\u5efa\u8b70\u6b64\u75c5\u4eba\u591a\u559d\u6c34\u3001\u5403\u4f4e\u7e96\u7dad\u98df\u7269\u8b93\u6392\u4fbf\u4e0d\u56f0\u96e3\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u85e5\u7269\u4f55\u8005\u548c\u8461\u8404\u67da\u6c41\uff0c \u8f03\u4e0d\u6613\u7522\u751f\u4ea4\u4e92\u4f5c\u7528\uff1f", + "Options": "(A)Amiodarone \u3002 (B)Calcium channel blocker \u3002 (C)Carbamazepine \u3002 (D)Theophylline \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "82\u6b72\u7537\u6027\uff0c 2\u5c0f\u6642\u524d\u958b\u59cb\u5ee3\u6cdb\u6027\u8179\u75db\uff0c\u7121\u8f3b\u5c04\u81f3\u80cc\u90e8\uff0c\u5408\u4f75\u56b4\u91cd\u7684\u5641\u5fc3\u53ca\u591a\u6b21\u81bd\u6027\u6c41\u5614\u5410(bilious vomiting ) \uff0c\u75c5\u4eba\u7121\u5fc3\u81df\u75c5\u53f2\uff0c\u6b64\u6b21\u5fc3\u96fb\u5716\u6b63\u5e38\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u6b64\u75c5\u4eba\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\u70ba\u5927\u8178\u963b\u585e(large bowel obstruction)\u3002 (B)\u56e0\u75c5\u4eba\u5e74\u7d00\u5927\uff0c\u8a55\u4f30\u662f\u5426\u63a5\u53d7\u5f71\u50cf\u6aa2\u67e5\u7684\u6a19\u6e96\u61c9\u66f4\u56b4\u683c\uff0c\u907f\u514d\u904e\u91cf\u7684\u986f\u5f71\u5291\u53ca\u8f3b\u5c04\u50b7\u5bb3\u3002 (C)\u75c5\u4eba serum lactate \u6578\u503c\u6b63\u5e38\uff0c\u4ecd\u7121\u6cd5\u6392\u9664\u6025\u6027\u8178\u7cfb\u819c\u7f3a\u8840(acute mesenteric ischemia )\u7684\u53ef\u80fd\u3002 (D)\u9d09\u7247\u985e\u6b62\u75db\u85e5\u6703\u964d\u4f4e\u8178\u80c3\u8815\u52d5\uff0c\u5c0e\u81f4\u75c5\u4eba\u7684\u6b7b\u4ea1\u7387\u4e0a\u5347\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u6558\u8ff0\u95dc\u65bc\u8996\u529b\u6e1b\u9000\u7684\u5e38\u898b\u75c7\u72c0\u914d\u5c0d\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)Acute angle -closure glaucoma \u70ba\u7a81\u767c\u6027\u8996\u529b\u8b8a\u5316\u53ca\u55ae\u5074\u773c\u775b\u75db\u3001\u982d\u75db\u3002 (B)Uveitis \u70ba\u6f38\u9032\u5f0f\u7684\u8996\u529b\u8b8a\u5316\u53ca\u75bc\u75db\u3002 (C)Vitreous hemorrhage \u70ba\u7121\u75db\u4e4b\u7a81\u767c\u6027\u8996\u529b\u8b8a\u5316\u3002 (D)Central retinal artery occlusion(CRAO )\u70ba\u7f3a\u8840\u6027\u75bc\u75db\u53ca\u7a81\u767c\u6027\u8996\u529b\u8b8a\u5316\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "70\u6b72\u7537\u6027\u56e0\u5168\u8eab\u865b\u5f31\u81f3\u6025\u8a3a\u6c42\u6cbb\uff0c\u62bd\u8840\u6aa2\u9a57\u5f8c\u767c\u73fe BUN 84 mg/dL \u3001Creatinine 2.5 mg/dL \u3001Na 143 mEq/L \u3001K 4.0 mEq/L \u3002\u4e0b\u5217\u95dc\u65bc\u6b64\u75c5\u4eba\u4e4b\u6558\u8ff0\uff0c\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u5176\u75c5\u56e0\u53ef\u80fd\u4f86\u81ea\u4f4e\u8840\u5bb9\u3001\u4f4e\u8840\u58d3\u3001\u9ad8\u8840\u9223\u3001\u5c0f\u8840\u7ba1\u963b\u585e(microvascular thrombosis )\u7b49\u539f\u56e0\u6240\u9020\u6210\u3002 (B)\u5982\u4e0d\u7576\u4f7f\u7528 NSAID\u3001 ACEI\u3001ARB\u7b49\u85e5\u7269\uff0c\u4e5f\u6709\u53ef\u80fd\u52a0\u91cd\u6b64\u7a2e\u60c5\u5f62\u3002 (C)\u8d85\u97f3\u6ce2\u4e0b\u91cf\u6e2c\u814e\u81df\u5927\u5c0f\u7d04 12\u516c\u5206\uff0c\u63a8\u6e2c\u53ef\u80fd\u70ba CKD\u4e4b\u75c5\u4eba\u3002 (D)\u9ad4\u6db2\u88dc\u5145\u4e0a\uff0c\u9078\u64c7 lactate ringer \u53ef\u80fd\u6bd4 normal saline \u66f4\u9069\u5408\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6ccc\u5c3f\u79d1\u8853\u5f8c\u4f75\u767c\u75c7\u7684\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u6ccc\u5c3f\u9053\u611f\u67d3\u662f\u7d93\u5c3f\u9053\u524d\u5217\u817a\u522e\u9664\u8853(transurethral resection of the prostate)\u6700\u5e38\u898b\u7684\u4f75\u767c\u75c7\u3002 (B)\u7d93\u5c3f\u9053\u524d\u5217\u817a\u522e\u9664\u8853\u8853\u5f8c\uff0c\u767c\u751f\u8840\u584a\u963b\u585e\u9020\u6210\u6025\u6027\u5c3f\u6eef\u7559\u8005\uff0c\u5e7e\u4e4e\u90fd\u9700\u8981\u7167\u6703\u6ccc\u5c3f\u79d1\u4e26\u5b89\u6392\u75c5\u4eba\u4f4f\u9662\u3002 (C)\u7d93\u5c3f\u9053\u524d\u5217\u817a\u522e\u9664\u8853\u8853\u5f8c\u767c\u751f\u8840\u584a\u963b\u585e\u75c5\u4eba\u6709\u4f7f\u7528\u751f\u7406\u98df\u9e7d\u6c34\u9032\u884c\u8180\u80f1\u6c96\u6d17 (bladder irrigation) \uff0c\u9700\u8981\u62bd\u8840\u6aa2\u9a57\u662f\u5426\u6709\u4f4e\u8840\u9209\u3002 (D)\u4eba\u5de5\u5c3f\u9053\u62ec\u7d04\u808c(artificial urinary sphincters )\u624b\u8853\u8853\u5f8c\u82e5\u767c\u751f\u6025\u6027\u5c3f\u6eef\u7559\uff0c\u4e0d\u53ef\u7531\u5c3f\u9053\u653e\u7f6e\u5c0e\u5c3f\u7ba1\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "70\u6b72\u7537\u6027\uff0c\u904e\u53bb\u6709\u7cd6\u5c3f\u75c5\u53f2\uff0c\u5169\u9031\u524d\u56e0\u53f3\u5074\u6c23\u80f8\u958b\u5200( thoracotomy )\u3002 \u4eca\u5929\u56e0\u767c\u71d2\u3001\u547c\u5438\u56f0\u96e3(dyspnea )\u4e14\u5438\u6c23\u6642\u80f8\u53e3\u5287\u75db\u81f3\u6025\u8a3a\u5c31\u91ab\uff0c\u80f8\u90e8 X\u5149\u6aa2\u67e5\u986f\u793a\u53f3\u5074\u6709\u4e2d\u91cf\u808b\u819c\u7a4d\u6db2\uff0c\u4ee5\u7d30\u91dd\u62bd\u5438\u5f8c\u6aa2\u9a57\u767c\u73fe\u808b\u819c\u7a4d\u6db2\u5448\u73fe\u81bf\u6a23\u5316\u6db2\u9ad4(purulent material ) \u3002\u6709\u95dc\u6b64\u75c5\u4eba\u7684\u8a3a\u65b7\u53ca\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u672c\u75c5\u4eba\u6700\u5e38\u898b\u53ef\u80fd\u7684\u81f4\u75c5\u83cc\u70ba S. pneumococcus \u3002 (B)\u81bf\u80f8(empyema )\u7684\u8a3a\u65b7\u6a19\u6e96\u5305\u62ec\u808b\u819c\u6db2\u8840\u7cd6\u503c\u5927\u65bc 40 mg/dL\u548cLDH\u5927\u65bc 1,000 U/L \u3002 (C)\u808b\u819c\u6db2\u7684 pH\u503c\u70ba 6.9\u53ef\u4ee5\u52a0\u5f37\u8a3a\u65b7\u7684\u78ba\u7acb\u3002 (D)\u6297\u751f\u7d20\u7684\u4f7f\u7528\u9996\u9078 amoxicillin/clavulanate \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "26\u6b72\u91ab\u5e2b\uff0c\u5728\u70ba\u75c5\u4eba\u7e2b\u5408\u50b7\u53e3\u6642\uff0c\u98df\u6307\u88ab\u7e2b\u5408\u904e\u7684\u91dd\u982d\u523a\u50b7\uff0c\u75c5\u4eba\u7684\u62bd\u8840\u6aa2\u9a57\u986f\u793a\uff1a HIV antibody test \u6aa2\u9a57\u70ba\u967d\u6027\uff0c HBsAg\u70ba\u9670\u6027\uff0canti -HCV\u70ba\u967d\u6027\uff1b\u8a72\u91ab\u5e2b\u5f9e\u672a\u65bd\u6253\u904e B\u809d\u75ab\u82d7\uff0c\u95dc\u65bc\u6b64\u91ab\u5e2b\u7684\u8077\u696d\u6027\u66b4\u9732\u8655\u7f6e\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u61c9\u4f7f\u7528\u6d88\u6bd2\u6db2(disinfectants )\u6d88\u6bd2\u50b7\u53e3\u3002 (B)\u516d\u5230\u5341\u4e8c\u9031\u5167\u5f9e\u4e8b\u6027\u884c\u70ba\u61c9\u4f7f\u7528\u4fdd\u96aa\u5957\u3002 (C)\u61c9\u63a5\u53d7 B\u578b\u809d\u708e\u514d\u75ab\u7403\u86cb\u767d (HBIG)\u6cbb\u7642\u3002 (D)\u61c9\u63a5\u53d7 C\u578b\u809d\u708e\u6297\u75c5\u6bd2\u85e5\u7269\u6cbb\u7642\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "4\u6b72\u7537\u7ae5\u5728\u5e7c\u5152\u5712\u56e0\u8179\u7009\u591a\u6b21\u3001\u98df\u617e\u4e0d\u4f73\uff0c\u7cbe\u795e\u6d3b\u52d5\u8b8a\u5dee\u5e36\u4f86\u6025\u8a3a\uff0c\u8acb\u554f\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u4f4e\u8840\u7cd6\u6642\uff0c\u9700\u6aa2\u67e5\u8840\u6db2\u6216\u5c3f\u6db2\u7684\u916e\u9ad4\u3002 (B)\u53e3\u670d\u88dc\u5145\u9ad4\u6db2\u7121\u6cd5\u6709\u6548\u964d\u4f4e\u6b7b\u4ea1\u7387\u3002 (C)\u53e3\u670d\u88dc\u5145\u9ad4\u6db2\uff0c\u56e0\u904b\u52d5\u98f2\u6599\u7cd6\u5206\u8f03\u9ad8\uff0c\u61c9\u7a00\u91cb\u4e00\u534a\u4f7f\u7528\u3002 (D)\u82e5\u6709\u812b\u6c34\u53ca\u4f11\u514b\u60c5\u6cc1\uff0c\u53ef\u7d66\u4e88\u751f\u7406\u98df\u9e7d\u6c34 20 ml/kg \u6ef4\u6ce8 1\u5c0f\u6642\uff0c\u91cd\u8907\u4e09\u6b21\uff0c\u76f4\u5230\u6709\u521d\u6b65\u53cd\u61c9\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "50\u6b72\u7537\u6027\uff0c\u56e0\u5de6\u4e0b\u80a2\u50b7\u53e3\u5468\u570d\u7d05\u816b 3\u5929\uff0c\u5408\u4f75\u767c\u71d2\uff0c\u524d\u4f86\u6025\u8a3a\u5c31\u91ab\u3002\u75c5\u4eba\u7121\u904e\u53bb\u75c5\u53f2\uff0c\u8077\u696d\u70ba\u8fb2\u592b\uff0c7 \u5929\u524d\u5de5\u4f5c\u6642\u5de6\u8173\u4e0d\u614e\u53d7\u50b7\uff0c\u9020\u6210\u4e00\u500b 2\u516c\u5206\u9577\u7684\u6495\u88c2\u50b7\u3002\u75c5\u4eba\u4e0d\u4ee5\u70ba\u610f\uff0c\u6301\u7e8c\u5de5\u4f5c\u4e26\u5c07\u50b7\u53e3\u6d78\u6ce1\u65bc\u6fd5\u571f\u4e2d\u3002\u8acb\u554f\u95dc\u65bc\u6b64\u75c5\u4eba\u7684\u611f\u67d3\u83cc\u7a2e\uff0c\u4e0b\u5217\u9078\u9805\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)Vibrio vulnificus \u3002 (B)Aeromonas hydrophila\u3002 (C)Pseudomonas aeruginosa\u3002 (D)Pasteurella species\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6025\u6027\u8e81\u52d5\u7684\u8fa8\u8b58\u8207\u8655\u7406\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u8001\u5e74\u6025\u6027\u8e81\u52d5\u75c5\u4eba\u9700\u8b39\u614e\u8a55\u4f30\u5176\u610f\u8b58\u72c0\u614b\uff0c\u82e5\u5176\u610f\u8b58\u548c\u8a8d\u77e5\u529f\u80fd\u70ba\u6025\u6027\u8b8a\u5316\u3001\u75c5\u7a0b\u6ce2\u52d5\u8d77\u4f0f\u3001\u6ce8\u610f\u529b\u4e0d\u4f73\u3001\u4e14\u610f\u8b58\u8b66\u9192\u5ea6\u4e0d\u4f73(alerted level of consciousness )\u6216\u601d\u8003\u6df7\u4e82 (disorganized thinking) \uff0c\u5373\u7b26\u5408\u300c\u8b6b\u5984\u8a55\u4f30\u91cf\u8868\u300d ( Confusion Assessment Methods)\u7684\u8b6b\u5984\u8a3a\u65b7\u3002 (B)\u82e5\u8e81\u52d5\u75c5\u4eba\u6709\u9577\u671f\u98f2\u7528\u70c8\u9152\u7684\u7fd2\u6163\uff0c\u8fd1\u5169\u65e5\u56e0\u6545\u7a81\u7136\u6c92\u6709\u98f2\u9152\uff0c\u8e81\u52d5\u540c\u6642\u4ea6\u8868\u73fe\u4ea4\u611f\u795e\u7d93\u904e\u5ea6\u8208\u596e\u4e14\u986b\u6296\uff0c\u9808\u8003\u616e\u9152\u7cbe\u6212\u65b7\uff0c\u4e26\u7d66\u4e88\u8db3\u5920\u5291\u91cf\u4e4b benzodiazepines \u85e5\u7269\uff0c\u9810\u9632\u51fa\u73fe\u9707\u986b\u6027\u8b6b\u5984(delirium tremens)\u3002 (C)\u6025\u6027\u8e81\u52d5\u75c5\u4eba\u82e5\u540c\u6642\u8868\u73fe\u7cbe\u795e\u75c7\u72c0(psychotic symptoms) \uff0c\u5982\u8996\u5e7b\u89ba\u3001\u807d\u5e7b\u89ba\u6216\u88ab\u5bb3\u5984\u60f3\uff0c\u6025\u6027\u93ae\u975c\u85e5\u7269\u53ef\u9078\u64c7 antipsychotics \u985e\u85e5\u7269\uff1b\u82e5\u7121\u660e\u986f\u7cbe\u795e\u75c7\u72c0\u4f46\u60c5\u7dd2\u6fc0\u8e81\u6216\u6613\u6012(irritability )\uff0c\u53ef\u8003\u616e\u9078\u64c7Benzodiazepines \u85e5\u7269\u3002 (D)\u8001\u5e74\u8b6b\u5984\u75c5\u4eba\u9996\u8981\u8655\u7f6e\u539f\u5247\u70ba\u8fa8\u8b58\u53ca\u6cbb\u7642\u8b6b\u5984\u539f\u56e0\uff0c\u800c\u93ae\u975c\u85e5\u7269\u61c9\u76e1\u91cf\u9078\u64c7 Benzodiazepines \u3001Antihistamines \u6216muscle relaxants \u985e\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u5e74\u8f15\u4eba\u5728\u6d3e\u5c0d\u4e2d\u7b2c\u4e00\u6b21\u4f7f\u7528\u7b11\u6c23( N2O)\u6c23\u7403\uff0c\u7522\u751f\u8b6b\u5984\u3001\u71e5\u52d5\u53ca\u7121\u6cd5\u5b89\u975c\u4e0b\u4f86\u7684\u73fe\u8c61\u9001\u4f86\u6025\u8a3a\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u53ef\u7d66\u4e88 Benzodiazepines (BZD)\u6e1b\u5c11\u8b6b\u5984\u73fe\u8c61\u3002 (B)\u7121\u9700\u7d66\u4e88 Vitamin B 12\u6cbb\u7642\u3002 (C)\u82e5\u7d66\u4e88\u6c27\u6c23\u5f8c\u4ecd\u6709\u4f4e\u8840\u6c27\u60c5\u5f62\uff0c\u61c9\u8003\u616e\u9ad8\u58d3\u6c27\u6cbb\u7642\u3002 (D)\u82e5\u51fa\u73fe\u4f4e\u8840\u58d3\uff0c\u61c9\u512a\u5148\u7d66\u4e88\u6607\u58d3\u5291 Norepinephrine \u6ef4\u6ce8\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u75c5\u4eba\u5728\u809d\u81df\u79fb\u690d\u624b\u8853\u5f8c\u4e09\u500b\u6708\u5167\u8f03\u6613 \u56e0\u4e0b\u5217\u4f55\u7a2e\u75c5\u539f\u9ad4\u9020\u6210\u80ba\u708e\uff1f", + "Options": "(A)\u55dc\u8840\u687f\u83cc( Haemophilus influenzae )\u3002 (B)\u5361\u4ed6\u83ab\u62c9\u83cc( Moraxella catarrhalis )\u3002 (C)\u91d1\u9ec3\u8272\u8461\u8404\u7403\u83cc(Staphylococcus aureus)\u3002 (D)\u80ba\u708e\u93c8\u7403\u83cc(Streptococcus pneumoniae )\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4e2d\u5e74\u7537\u6027\u88ab\u767c\u73fe\u8eba\u5728\u6377\u904b\u7ad9\u9580\u53e3\u4e0d\u77e5\u9053\u591a\u4e45\uff0c\u6307\u5c16\u8840\u7cd6\u503c 130 mg/dL\uff0c\u8eab\u4e0a\u6709\u660e\u986f\u9152\u5473\uff0c\u4f46\u6c92\u6709\u91dd\u5b54\u6ce8\u5c04\u75d5\u8de1\uff0c\u7121\u6cd5\u805a\u7126\u56de\u7b54\u554f\u984c\uff0c GCS E3V4M5\uff0c\u8840\u4e2d\u9152\u7cbe\u6fc3\u5ea6 150 mg/dL \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u70ba\u8f03\u9069\u7576 \uff1f", + "Options": "(A)ABG pH 7.10\uff0c HCO 3 10 mmol/L\uff0cKetone 3 +\uff0cLactate negative \uff0c\u7d66\u4e88 insulin \u6cbb\u7642\u3002 (B)ABG pH 7.10\uff0c HCO 3 10 mmol/L\uff0cKetone negative \uff0cLactate negative\uff0c\u7d66\u4e88\u975c\u8108\u8f38\u6db2\u6cbb\u7642\u3002 (C)\u65bc\u6025\u8a3a\u7559\u89c0 24\u5c0f\u6642\u5f8c\u7a81\u7136\u767c\u751f seizure\uff0c\u7d66\u4e88 Lorazepam \u6ce8\u5c04\u6cbb\u7642\u3002 (D)\u65bc\u6025\u8a3a\u7559\u89c0 24\u5c0f\u6642\u5f8c\u4ecd\u6c92\u6709\u6062\u5fa9\u610f\u8b58\uff0c\u61c9\u7d66\u4e88\u975c\u8108\u8f38\u6db2\u6cbb\u7642\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8178\u75c5\u6bd2\u7684\u63cf\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5f15\u8d77\u75b1\u75b9\u6027\u54bd\u5cfd\u708e\u7684\u75c5\u6bd2\u4e3b\u8981\u70ba\u514b\u6c99\u5947 B\u578b\u75c5\u6bd2\u3002 (B)\u5152\u7ae5\u76f8\u8f03\u65bc\u6210\u4eba\u611f\u67d3\u8178\u75c5\u6bd2\u5371\u96aa\u6027\u8f03\u4f4e\uff0c\u56e0\u6b64\u591a\u6578\u5152\u7ae5\u8178\u75c5\u6bd2\u70ba\u8f15\u75c7\u3002 (C)\u75c5\u4eba\u5728\u6709\u75c7\u72c0\u4e4b\u524d\u5c31\u6709\u50b3\u67d3\u529b\uff0c\u4e0d\u904e\u611f\u67d3\u5f8c\u4e0d\u6703\u9577\u671f\u6392\u653e\u75c5\u6bd2\u3002 (D)\u8178\u75c5\u6bd2\u80fd\u901a\u904e\u80ce\u76e4\uff0c\u9020\u6210\u6bcd\u5b30\u5782\u76f4\u50b3\u67d3\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8033\u9f3b\u5589\u7570\u7269\u79fb\u9664\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u8033\u6735\u7570\u7269\u82e5\u662f\u9215\u6263\u96fb\u6c60\uff0c\u5efa\u8b70\u76f4\u63a5\u6703\u8a3a ENT\u3002 (B)\u8033\u9053\u5167\u8dd1\u9032\u5927\u87f2\u5b50\uff0c\u53ef\u5148\u7528\u5668\u68b0\u5617\u8a66\u79fb\u9664\u3002 (C)\u79fb\u9664\u5f8c\u82e5\u6709\u767c\u708e\u73fe\u8c61\u53ef\u4f7f\u7528\u53e3\u670d\u6297\u751f\u7d20\u3002 (D)\u5e7c\u5152\u975c\u8108\u6ce8\u5c04 Midazolam \u65b9\u4fbf\u79fb\u9664\u7570\u7269\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u7528\u85e5\u5c0d\u65bc\u5b55\u5a66\u548c\u80ce\u5152\u7684\u4e0d\u826f\u5f71\u97ff\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)Lithium \u92f0\u9e7d\u6703\u6210\u80ce\u5152\u8166\u795e\u7d93\u7570\u5e38\u3002 (B)Tetracyclines \u6703\u9020\u6210\u80ce\u5152\u9aa8\u982d\u7570\u5e38\u3002 (C)Fluoroquinolones \u6703\u9020\u6210\u80ce\u5152\u8edf\u9aa8\u7570\u5e38\u3002 (D)Angiotensin -converting enzyme inhibitors \u6703\u9020\u6210\u7f8a\u6c34\u904e\u5c11\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "68\u6b72\u7537\u6027\u6709\u9152\u7cbe\u6027\u809d\u786c\u5316\u8207\u7cd6\u5c3f\u75c5\u75c5\u53f2\uff0c\u56e0\u5410\u4e00\u5927\u53e3\u9bae\u8840\u7d04 500\u6beb\u5347\u81f3\u6025\u8a3a\uff0c\u4e0b\u5217\u76f8\u95dc\u8655\u7f6e\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5f9e\u75c5\u4eba\u5410\u51fa\u5614\u5410\u7269\u4e2d\u5e36\u6709\u8840\u7d05\u6216\u5496\u5561\u8272\u6db2\u9ad4\uff0c\u4f86\u5feb\u901f\u5224\u65b7\u6709\u4e0a\u6d88\u5316\u9053\u51fa\u8840\u7684\u65b9\u5f0f\u5f88\u4e0d\u53ef\u9760\u3002 (B)\u9a57\u8840\u8840\u8272\u7d20 8.0 g/dL\uff0c\u6b64\u6642\u5148\u4e0d\u7528\u8f38\u8840\uff0c\u53ef\u4ee5\u5148\u89c0\u5bdf\u751f\u547d\u8de1\u8c61\u8207\u51fa\u8840\u91cf\u3002 (C)\u76e1\u5feb\u7d66\u4e88\u6297\u751f\u7d20\u6cbb\u7642\uff0c\u53ef\u4ee5\u9810\u9632\u611f\u67d3\u4e26\u6e1b\u5c11\u518d\u51fa\u8840\u3002 (D)\u4f7f\u7528 Balloon tamponade \u7684\u65b9\u6cd5\u50c5\u662f\u66ab\u6642\u8655\u7406\u975c\u8108\u66f2\u5f35\u51fa\u8840\u7684\u65b9\u5f0f\uff0c\u76ee\u524d\u5df2\u4e0d\u518d\u5efa\u8b70\u65bc\u6025\u8a3a\u4f7f\u7528\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "37\u6b72\u5973\u6027\uff0c\u904e\u53bb\u6709\u7cbe\u795e\u75c5\u53f2\u5728\u670d\u85e5\u63a7\u5236\u4e2d\uff0c\u56e0\u610f\u8b58\u6df7\u4e82\u9001\u4f86\u6025\u8a3a\uff0c\u5230\u9662\u6642\u767c\u73fe\u75c5\u4eba\u6709\u9ad4\u6eab\u9ad8\u3001\u8840\u58d3\u9ad8\u3001\u5fc3\u8df3\u5feb\u3001\u5192\u6c57\u3001\u808c\u62bd\u8e8d( myoclonus )\u3001 \u53cd \u5c04\u589e\u52a0(hyperreflexia )\u7b49\u73fe\u8c61\uff0c\u8acb\u554f\u4f9d\u64da\u75c5\u4eba\u7684\u72c0\u6cc1\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u75c5\u4eba\u61c9\u70ba\u670d\u7528\u6297\u7cbe\u795e\u75c5\u85e5\u7269\u5c0e\u81f4\u7684 neuroleptic malignant syndrome \u3002 (B)\u53ef\u4ee5\u4f7f\u7528 Bromocriptine \uff0c\u4ee5\u6e1b\u7de9\u767c\u71d2\u53ca\u5168\u8eab\u50f5\u786c\uff0c\u4f46\u53ef\u80fd\u9020\u6210\u9ad8\u8840\u58d3\u3002 (C)\u5927\u90e8\u4efd\u75c5\u4eba 24\u5c0f\u6642\u5f8c\u53ef\u80fd\u7de9\u89e3\uff0c\u800c\u6700\u5e38\u898b\u7684\u6b7b\u4ea1\u539f\u56e0\u662f\u56b4\u91cd\u7684\u9ad4\u6eab\u904e\u9ad8\u3002 (D)\u53ef\u4ee5\u4f7f\u7528 Dantrolene \u964d\u6eab\u53ca\u6cbb\u7642\u808c\u8089\u50f5\u76f4\uff0c\u964d\u4f4e\u6b7b\u4ea1\u7387\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4ee5\u4e0b\u91dd\u5c0d\u808b\u819c\u7a4d\u6db2\u7684\u5224\u8b80\uff0c\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u98df\u9053\u7834\u88c2\u53ef\u80fd\u9020\u6210\u808b\u819c\u7a4d\u6db2\u7684 amylase\u5347\u9ad8\u3002 (B)\u80ba\u6813\u585e\u6240\u9020\u6210\u7684\u808b\u819c\u7a4d\u6db2\u6709\u53ef\u80fd\u662f transudates \u3002 (C)\u98a8\u6fd5\u6027\u95dc\u7bc0\u708e\u9020\u6210\u7684\u808b\u819c\u7a4d\u6db2\u5176\u8461\u8404\u7cd6\u6703\u4e0a\u5347\u3002 (D)\u764c\u75c7\u6240\u9020\u6210\u7684\u808b\u819c\u7a4d\u6db2\uff0c\u5176\u767d\u8840\u7403\u5206\u985e\u6703\u4ee5\u6dcb\u5df4\u7403\u70ba\u4e3b\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u9838\u90e8\u5916\u50b7\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u54b3\u55fd\u975e\u9838\u90e8\u52d2\u50b7\u7684\u56b4\u91cd\u8c61\u5fb5 (hard sign) \u3002 (B)\u9838\u90e8\u7684\u7a7f\u523a\u50b7\u6709\u9ad8\u9054 20%\u4f34\u96a8\u6c23\u80f8\u6216\u8840\u80f8\u3002 (C)\u82e5\u9838\u90e8\u6709\u56e0\u70ba\u7a81\u52a0\u901f\u6e1b\u901f\u800c\u9020\u6210\u904e\u5ea6\u4f38\u5c55\u9808\u5c0f\u5fc3\u98df\u9053\u640d\u50b7\u3002 (D)\u9838\u90e8\u7a7f\u523a\u50b7\u82e5\u6c92\u6709\u7a7f\u900f\u9838\u95ca\u808c( Platysma)\u901a\u5e38\u7121\u751f\u547d\u5371\u96aa\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u53e3\u670d\u964d\u8840\u7cd6\u85e5\u7269\u4e2d\uff0c\u4f55\u8005\u8f03\u5bb9\u6613 \u767c\u751f\u6b63\u5e38\u8840\u7cd6\u916e\u9178\u8840\u75c7( Euglycemic Ketoacidosis )\uff1f", + "Options": "(A)Biguanides \uff0c\u4f8b\u5982 Metformin \u3002 (B)Sulfonylureas \uff0c\u4f8b\u5982 Glimepiride \u3002 (C)DPP4 Inhibitors( Dipeptidyl peptidase -4 inhibitor )\uff0c \u4f8b \u5982 Sitagliptin\u3002 (D)SGLT2 Inhibitors( Sodium -Glucose Cotransporter 2 Inhibitors )\uff0c \u4f8b \u5982Dapagliflozin\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "37\u6b72\u7f8e\u570b\u7537\u6027\u4e4b\u524d\u6709\u964d\u7d50\u8178\u61a9\u5ba4\u708e\u7d93\u4fdd\u5b88\u6cbb\u7642\u7684\u75c5\u53f2\uff0c\u4f86\u8a3a\u4e3b\u8a34\u70ba\u767c\u71d2\u5408\u4f75\u5de6\u4e0b\u8179\u75db\uff0c\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\uff0c\u7121\u5614\u5410\u8179\u7009\u4ea6\u7121\u89e3\u5c3f\u4e0d\u9069\u7b49\u75c7\u72c0\u3002\u8eab\u9ad4\u8a3a\u5bdf\u70ba\u5de6\u4e0b\u8179\u5c40\u90e8\u58d3\u75db\uff0c\u7121\u53cd\u5f48\u75db\u6216\u662f\u8179\u819c\u708e\u8de1\u8c61\u3002\u5be6\u9a57\u5ba4\u6aa2\u67e5 WBC 8,300 /\u00b5L\uff0cHb 13.5 g/dL\uff0ccreatinine 0.8 mg/dL \uff0cCRP 12 mg/d L\u3002\u95dc\u65bc\u6b64\u75c5\u4eba\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u56e0\u75c5\u4eba\u75c7\u72c0\u8868\u73fe\u548c\u4e4b\u524d\u61a9\u5ba4\u708e\u985e\u4f3c\uff0c\u56e0\u6b64\u53ef\u4e0d\u9032\u884c\u5f71\u50cf\u5b78\u6aa2\u67e5\u3002 (B)\u75c5\u4eba\u7684\u61a9\u5ba4\u708e\u767c\u751f\u4f4d\u7f6e\u548c\u76ee\u524d\u5168\u4e16\u754c\u6d41\u884c\u75c5\u5b78\u7684\u7d71\u8a08\u76f8\u7b26\u5408\u3002 (C)Metronidazole \u52a0\u4e0a Aztreonam \u662f\u5408\u7406\u7684\u6297\u751f\u7d20\u7528\u85e5\u9078\u64c7\u4e4b\u4e00\u3002 (D)\u5229\u7528 procalcitonin \u4f86\u6307\u5f15\u61a9\u5ba4\u708e\u662f\u5426\u4f7f\u7528\u6297\u751f\u7d20\u7684\u89d2\u8272\u5c1a\u4e0d\u660e\u78ba\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u8de8\u6027\u5225( Transgender )\u65cf\u7fa4\u7d93\u5e38\u4f7f\u7528\u7684\u85e5\u7269\u53ca\u5176\u526f\u4f5c\u7528\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u776a\u56fa\u916e(testosterone )\u7684\u4f7f\u7528\u8005\uff0c\u56e0\u5176\u907f\u5b55\u4e4b\u7279\u6027\uff0c\u56e0\u6b64\u81e8\u5e8a\u6aa2\u67e5\u6642\u53ef\u4e0d\u5fc5\u9a57\u5b55\u3002 (B)17 -\u03b2-Estradiol \u6703\u589e\u52a0\u51dd\u8840\u56e0\u5b50\u7684\u88fd\u9020\uff0c\u800c\u5c0e\u81f4\u7f79\u60a3\u8840\u6813\u75be\u75c5(venous thromboembolism )\u7684\u98a8\u96aa\u4e0a\u5347\u3002 (C)\u6210\u4eba\u5973\u6027\u50be\u5411\u8de8\u6027\u522b\u8005\u5e38\u4f7f\u7528\u85e5\u7269 spironolactone \uff0c\u53ef\u80fd\u5c0e\u81f4\u9ad8\u8840\u9240\u3001\u4f4e\u8840\u58d3\u3001\u6392\u5c3f\u589e\u52a0\u7b49\u526f\u4f5c\u7528\u3002 (D)\u4f7f\u7528\u776a\u56fa\u916e\u6703\u9020\u6210\u767d\u8840\u7403\u4e0a\u5347 (leukoc ytosis)\uff0c\u9032\u800c\u589e\u52a0\u7f79\u60a3\u8166\u8840\u7ba1\u75be\u75c5\u548c\u8840\u6813\u75be\u75c5\u7684\u98a8\u96aa\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5c0f\u5152\u982d\u75db\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5152\u7ae5\u8166\u90e8\u816b\u7624\u6700\u5e38\u751f\u9577\u5728\u4e2d\u9871\u7aa9\uff0cMRI \u53ef\u5f97\u5230\u8f03\u597d\u7684\u8a3a\u65b7\u3002 (B)\u5152\u7ae5\u7684\u504f\u982d\u75db( migraine)\u6bd4\u6210\u4eba\u66f4\u5e38\u5177\u6709\u640f\u52d5\u6027 (pulsating) \u3002 (C)\u5152\u7ae5\u7684\u53e2\u767c\u6027\u982d\u75db(Cluster headache )\u6bd4\u6210\u4eba\u66f4\u5e38\u767c\u751f\u3002 (D)\u91dd\u5c0d\u504f\u982d\u75db\uff0c\u53ef\u5408\u4f75\u4f7f\u7528 Ketorolac \uff0cProchlorperazine \u53caDiphenhydramine \u7684\u96de\u5c3e\u9152\u7642\u6cd5\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "25\u6b72\u5f8c\u5929\u514d\u75ab\u7f3a\u4e4f\u75c7\u5019\u7fa4\u7537\u6027\u75c5\u4eba\uff0c\u767c\u751f\u767c\u71d2\u548c\u75b2\u52de\u60c5\u6cc1\uff0c\u5f8c\u4f86\u56e0\u751f\u6b96\u5668\u8207\u6703\u9670\u90e8\u51fa\u73fe\u76ae\u75b9\u6c34\u6ce1\u4e14\u8179\u80a1\u6e9d\u6dcb\u5df4\u7d50\u816b\u5927\u5230\u6025\u8a3a\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u53ef\u80fd\u662f\u7531\u6b63\u75d8\u75c5\u6bd2(Orthopoxvirus)\u5c6c\u75c5\u6bd2\u611f\u67d3\u9020\u6210\uff0c\u6b64\u500b\u6848\u4e0d\u6613\u6210\u70ba\u91cd\u75c7\u3002 (B)\u6b64\u75be\u75c5\u53ef\u50b3\u67d3\u671f\u662f\u7531\u51fa\u73fe\u7d05\u75b9\u524d 5\u5929\u8d77\uff0c\u5230\u6240\u6709\u75c5\u7076\u7d50\u75c2\u70ba\u6b62\u3002 (C)\u6b64\u75be\u75c5\u4e4b\u7591\u4f3c\u75c5\u4f8b\u8655\u7f6e\uff0c\u4ee5\u5c31\u5730\u6536\u6cbb\u65bc\u91ab\u9662\u5177\u7368\u7acb\u885b\u6d74\u4e4b\u55ae\u4eba\u75c5\u5ba4\u70ba\u539f\u5247\u3002 (D)\u4f9d\u7167\u75be\u7ba1\u7f72\u4e4b\u5efa\u8b70\uff0c\u6b64\u500b\u6848\u4e0d\u9700\u4f7f\u7528\u6297\u75c5\u6bd2\u85e5\u7269\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6025\u6027\u80f0\u81df\u708e\u7684\u56b4\u91cd\u5ea6\u5224\u65b7\u5c0d\u5f8c\u7e8c\u75c5\u4eba\u7684\u8655\u7f6e\u548c\u9810\u5f8c\u76f8\u7576\u91cd\u8981\uff0c\u4f9d\u64da\u4e9e\u7279\u862d\u5927\u5206\u985e\u6e96\u5247(Atlanta criteria ) \uff0c\u4e0b\u5217\u5747\u53ef\u9810\u6e2c\u56b4\u91cd\u80f0\u81df\u708e\u7684\u6307\u6a19\uff0c\u4f55\u8005\u9664\u5916\uff1f", + "Options": "(A)APACHE II score \u2264 8\u3002 (B)Ranson score \u2267 3 \u3002 (C)Serum creatinine > 2mg/dL \uff0cbefore fluid resuscitation \u3002 (D)Serum calcium \u2266 7.5 mg/dL \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "19\u6b72\u5973\u6027\uff0c\u4e3b\u8a34 3\u5929\u524d\u5728\u9152\u5427\u906d\u5230\u6027\u4fb5\u5bb3\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u9700\u6aa2\u9a57\u6885\u6bd2\u3001 B\u578b\u809d\u708e\u3001C \u578b\u809d\u708e\u53ca HIV\u3002 (B)\u9700\u9810\u9632\u6027\u4f7f\u7528\u6297\u751f\u7d20 Ceftriaxone \u53cadoxycycline \u3002 (C)\u4f7f\u7528 Levonorgestrel \u907f\u5b55\u6548\u679c\u8f03 Ulipristal acetate \u4f73\u3002 (D)\u82e5\u4f7f\u7528\u7dca\u6025\u907f\u5b55\u85e5\u4e0d\u9700\u5408\u4f75\u4f7f\u7528\u6b62\u5410\u85e5\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6025\u6027\u5fc3\u808c\u6897\u585e\u5f8c\u7684\u65e9\u671f\u5fc3\u5f8b\u4e0d\u6574\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u51fa\u73fe\u7ac7\u6027\u7de9\u8108(sinus bradycardia )\u6b7b\u4ea1\u7387\u8f03\u9ad8\u3002 (B)\u51fa\u73fe\u5b8c\u5168\u6027\u623f\u5ba4\u50b3\u5c0e\u963b\u6eef(complete A V block )\u6642\uff0c\u4f7f\u7528\u66ab\u6642\u6027\u5fc3\u5f8b\u8abf\u7bc0(temporary pacing )\u80fd\u964d\u4f4e\u6b7b\u4ea1\u7387\u3002 (C)\u6301\u7e8c\u6027\u7ac7\u6027\u983b\u8108(persistent sinus tachycardia )\u8207\u9810\u5f8c\u5dee\u6709\u95dc\u806f\u3002 (D)\u51fa\u73fe\u5fc3\u5ba4\u983b\u8108(ventricular tachycardia )\u4ee3\u8868\u9810\u5f8c\u4e0d\u4f73\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "55\u6b72\u7537\u6027\uff0c\u56e0\u5927\u91cf\u54b3\u8840\u5408\u4f75\u547c\u5438\u8870\u7aed\uff0c\u7d93\u5916\u9662\u7dca\u6025\u63d2\u7ba1\u5f8c\u8f49\u81f3\u672c\u9662\u3002\u6aa2\u50b7\u9ad4\u6eab 36\u2103\uff0c\u5fc3\u8df3 110\u6b21/min\uff0c\u8840\u58d3 120/80 mmHg \uff0c\u8840\u6c27\u6fc3\u5ea6 86%\uff0c\u547c\u5438\u9053\u6709\u6301\u7e8c\u51fa\u8840\u4e4b\u60c5\u5f62\uff0c\u5e8a\u908a X\u5149\u986f\u793a\u5de6\u80ba\u660e\u986f\u6d78\u6f64\uff0c\u6c23\u7ba1\u5167\u7ba1\u524d\u7aef\u4f4d\u65bc\u6c23\u7ba1\u9686\u7a81(carina)\u4e0a\u65b9 3\u516c\u5206\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u5c07\u75c5\u4eba\u53f3\u5074\u8eba\u3002 (B)\u5c07\u6c23\u7ba1\u5167\u7ba1\u6301\u7e8c\u5167\u63a8\u81f3\u53f3\u80ba\u4e3b\u652f\u6c23\u7ba1(right main bronchus )\u3002 (C)\u5b89\u6392\u652f\u6c23\u7ba1\u93e1(bronchoscopy )\u5c0b\u627e\u51fa\u8840\u9ede\u3002 (D)\u82e5\u652f\u6c23\u7ba1\u93e1\u7121\u6cd5\u6b62\u8840\uff0c\u5b89\u6392\u652f\u6c23\u7ba1\u52d5\u8108\u6813\u585e(bronchial artery embolization )\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "60\u6b72\u7537\u6027\u6709 B\u578b\u809d\u708e\u5408\u4f75\u809d\u786c\u5316\u75c5\u53f2\u4f46\u672a\u5b9a\u671f\u8ffd\u8e64\uff0c\u4f86\u8a3a\u4e3b\u8a34\u70ba\u767c\u71d2\u8179\u8139\u4ee5\u53ca\u53cd\u61c9\u9072\u920d\u3002\u5be6\u9a57\u5ba4\u6aa2\u67e5 WBC 6,700/\u00b5L \uff0cHb 11.5 g/dL\uff0c ALT 47 U/L\uff0ccreatinine 3.7 mg/dL \uff0cT-bil 3.7 mg/dL \uff0cAmmonia 130 \u00b5g/dL \u3002\u5e8a\u908a\u8d85\u97f3\u6ce2\u986f\u793a\u75c5\u4eba\u6709\u8179\u6c34\u7684\u8de1\u8c61\u3002\u95dc\u65bc\u6b64\u75c5\u4eba\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)Runyon criteria \u53ef\u5e6b\u52a9\u6b64\u4f4d\u75c5\u4eba\u611f\u67d3\u6e90\u7684\u9451\u5225\u8a3a\u65b7\u3002 (B)\u53ef\u4ee5\u6aa2\u9a57 HBeAg\u548cHBV DNA \u4f86\u6aa2\u6e2c\u75c5\u6bd2\u7684\u8907\u88fd\u91cf\u3002 (C)\u53ef\u4f7f\u7528\u767d\u86cb\u767d\u4ee5\u53ca\u8840\u7ba1\u6d3b\u6027 (vasoactive )\u85e5\u7269\u6cbb\u7642\u3002 (D)\u9664 Lactulose \u4e4b\u5916\uff0c\u4e5f\u53ef\u4f7f\u7528\u53e3\u670d Neomycin \u8f14\u52a9\u6cbb\u7642\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "45\u6b72\u7537\u6027\u75c5\u4eba\u5728\u4e00\u500b\u6708\u524d\u56e0\u5fc3\u808c\u6897\u585e\u6709\u57f7\u884c\u5fc3\u5c0e\u7ba1\u624b\u8853\u3002\u4eca\u5929\u56e0\u70ba\u767c\u71d2\u3001\u865b\u5f31\u3001\u80f8\u75db\u5230\u6025\u8a3a\u5c31\u91ab\u3002\u9ad4\u6eab 38\u2103\u3001\u8840\u58d3 100/60mmHg \u3001\u5fc3\u8df3 120\u6b21/min\u3002\u5fc3\u81df\u8d85\u97f3\u6ce2\u986f\u793a\u4e9b\u8a31\u5fc3\u5305\u819c\u7a4d\u6db2\u3001\u5fc3\u96fb\u5716\u4e26\u7121\u65b0\u7684\u8b8a\u5316\u3001\u80f8\u90e8 X\u5149\u6709\u4e9b\u8a31\u808b\u819c\u7a4d\u6db2\u7121\u80ba\u708e\u3002\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u9032\u884c\u5fc3\u5305\u819c\u62bd\u5438\u8853\u3002 (B)\u7acb\u5373\u7d66\u4e88\u6297\u751f\u7d20\u3002 (C)\u5b89\u6392\u5fc3\u5c0e\u7ba1\u3002 (D)\u7d66\u4e88\u9ad8\u5291\u91cf Aspirin\u548cColchicine \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4ee5\u4e0b\u95dc\u65bc\u7532\u72c0\u817a\u98a8\u66b4( thyroid storm )\u7684\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u4f9d\u7167 Burch and Wartofsky\u2019s \u4e4b\u8a3a\u65b7\u6a19\u6e96\uff0c\u9700\u91dd\u5c0d\u516d\u5927\u9805\u76ee\u8a55\u5206\uff0c\u5176\u4e2d\u5305\u542b\u9ad4\u6eab\u3001\u4e2d\u6a1e\u795e\u7d93\u8a55\u4f30\u3001\u8178\u80c3\u9053\u75c7\u72c0\u8a55\u4f30\u3001\u5fc3\u640f\u901f\u7387\u3001\u5fc3\u8870\u7aed\u7a0b\u5ea6\u53ca\u662f\u5426\u6709\u5fc3\u623f\u986b\u52d5\u3002 (B)\u627f\u4e0a\u6558\u8ff0\uff0c\u52a0\u7e3d\u5206\u6578\u53ea\u8981\u5927\u65bc 8\u5206\uff0c\u5c31\u53ef\u61f7\u7591\u6709\u7532\u72c0\u817a\u98a8\u66b4\u3002 (C)\u6cbb\u7642\u65b9\u9762\uff0c\u53ef\u7528 Propylthiouracil (PTU)\u6216 Methimazole \u4ee5\u964d\u4f4e\u7532\u72c0\u817a\u7d20\u4e4b\u5408\u6210\u3002Methimazole \u61c9\u907f\u514d\u65bc\u7b2c\u4e00\u5b55\u671f\u7d66\u4e88\u3002 (D)\u4f7f\u7528\u7898\u7684\u6cbb\u7642\uff0c\u5982 Lugol solution\uff0c\u5fc5\u9808\u5728\u7d66\u5b8c Thionamides \u985e\u7684\u85e5\u7269\u4e4b\u5f8c\u624d\u80fd\u7d66\u4e88\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "26\u9031\u5b55\u5a66\uff0c\u7522\u6aa2\u6642\u6709\u86cb\u767d\u5c3f\uff0c\u4e3b\u8a34\u982d\u6688\u8996\u529b\u6a21\u7cca\uff0c\u767c\u751f\u62bd\u6410\uff0c\u76ee\u524d\u610f\u8b58GCS E3V5M5\uff0c\u8840\u58d3 197/115 mmHg \uff0c\u5fc3\u8df3 105\u6b21/min\uff0c\u547c\u5438 20\u6b21/min\uff0cSpO 2 99%\u3002\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u7d66\u4e88 Magnesium sulfate 4~6 g \uff0c\u63a5\u7e8c\u6bcf\u5c0f\u6642 2 g \u61c9\u6301\u7e8c\u4f7f\u7528 24\u5c0f\u6642\u3002 (B)\u5b89\u6392\u8166\u90e8\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u3002 (C)\u7d66\u4e88 Labetalol 5 mg IV \uff0c20\u5206\u9418\u5f8c\u518d\u6b21\u8a55\u4f30\u91cd\u8907\u7d66\u85e5\u3002 (D)\u7d66\u4e88\u985e\u56fa\u9187 Corticosteroid \u6709\u52a9\u65bc\u5ef6\u9072\u751f\u7522\u4e26\u6539\u5584\u80ce\u5152\u9810\u5f8c\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "33\u9031\u5b55\u5a66\uff0c\u7a81\u767c\u6027\u4e0b\u8179\u90e8\u9663\u75db\uff0c\u5408\u4f75\u6709\u9670\u9053\u5e36\u8840\u4e4b\u900f\u660e\u5206\u6ccc\u7269\u3002\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u80ce\u5152\u5fc3\u8df3\u986f\u793a 103\u6b21/min\uff0c\u5df2\u7d93\u662f\u80ce\u5152\u7a98\u8feb\uff0c\u61c9\u5de6\u5074\u8eba\u3001\u9ede\u6ef4\u8f38\u6db2\u548c\u7d66\u6c27\u3002 (B)\u505a\u96d9\u624b\u9aa8\u76c6\u8154\u6aa2\u67e5(bimanual examination )\u524d\uff0c\u61c9\u4f7f\u7528\u8d85\u97f3\u6ce2\u5148\u6392\u9664\u524d\u7f6e\u80ce\u76e4\u3002 (C)\u4f7f\u7528\u9d28\u5634\u5668\u6aa2\u67e5(speculum examination )\u6642\uff0c\u4e0d\u61c9\u4f7f\u7528\u6f64\u6ed1\u5291\u4ee5\u907f\u514d\u5f71\u97ff\u8a66\u7d19\u6aa2\u6e2c\u7d50\u679c\u3002 (D)\u9670\u9053\u4e4b\u6db2\u9ad4\u7d93\u8a66\u7d19\u6aa2\u6e2c\uff0cp H\u503c5\uff0c\u7591\u4f3c\u7f8a\u819c\u7834\u6c34\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "84\u6b72\u7537\u6027\u88ab\u5bb6\u5c6c\u5e36\u81f3\u6025\u8a3a\uff0c\u4e3b\u8a34\u9019\u5169\u5929\u958b\u59cb\u51fa\u73fe\u6ce8\u610f\u529b\u4e0d\u96c6\u4e2d\u3001\u80e1\u8a00\u4e82\u8a9e\u3001\u591c\u9593\u4ea2\u596e\u53ca\u767d\u5929\u55dc\u7761\u7684\u60c5\u5f62\uff0c\u5176\u9ad4\u6eab 37.6\u2103\u3001\u5fc3\u8df3 115\u6b21/min\u3001\u8840\u58d3 154/96 mmHg \u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u8b6b\u5984(delirium )\u53ef\u5206\u70ba\u9ad8\u6d3b\u52d5\u5ea6\u578b(hyperactive ) \u3001\u4f4e\u6d3b\u52d5\u5ea6\u578b(hypoactive )\u53ca\u6df7\u5408\u578b( mixed) \uff0c\u5176\u4e2d\u53c8\u4ee5\u9ad8\u6d3b\u52d5\u5ea6\u578b\u6700\u5e38\u898b\u3002 (B)\u548c\u5931\u667a(dementia )\u76f8\u6bd4\uff0c\u8b6b\u5984\u8f03\u4e0d\u6613\u7522\u751f\u8996\u5e7b\u89ba\u53ca\u807d\u5e7b\u89ba\u3002 (C)\u907f\u514d\u4f7f\u7528 antihistamines \u985e\u85e5\u7269\u65bc\u8a72\u75c5\u4eba\u8eab\u4e0a\uff0c\u4ee5\u514d\u75c7\u72c0\u60e1\u5316\u3002 (D)\u75c5\u4eba\u65bc\u6025\u8a3a\u5ba4\u6301\u7e8c\u8e81\u52d5\u53ca\u7522\u751f\u812b\u5e8f\u884c\u70ba\uff0c\u77ed\u6548\u7684 Benzodiazepines \u985e\u85e5\u7269\u70ba\u6cbb\u7642\u9996\u9078\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u5229\u7528\u570b\u5bb6\u7dca\u6025 X\u5c04\u7dda\u651d\u5f71\u61c9\u7528\u7814\u7a76 NEXUS(National Emergency X -radiography Utilization Study )\u6a19\u6e96\u8a55\u4f30\u9838\u690e\u53d7\u50b7\u7684\u75c5\u4eba\uff0c\u4ee5\u4e0b\u60c5\u6cc1 \u53ef\u4ee5\u8003\u616e\u79fb\u9664\u75c5\u4eba\u4e4b\u9838\u5708\uff1f", + "Options": "(A)\u9838\u90e8\u88ab\u79fb\u52d5\u6642\u7522\u751f\u75bc\u75db\u3002 (B)\u9ad8\u901f\u885d\u64ca\u6240\u7522\u751f\u7684\u50b7\u5bb3\u3002 (C)\u6709\u6bd2\u7269\u53ca\u9152\u7cbe\u53cd\u61c9\u4e4b\u50b7\u5bb3\u3002 (D)\u7cbe\u795e\u610f\u8b58\u6709\u6539\u8b8a\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u7533\u8acb\u5df2\u63d2\u7ba1\u53ca\u653e\u7f6e\u80f8\u7ba1\u4e4b\u5275\u50b7\u75c5\u4eba\u7a7a\u4e2d\u91ab\u7642\u8f49\u9001\uff0c\u8d77\u98db\u524d\u4e0b\u5217\u8655\u7f6e\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u6c23\u7ba1\u5167\u7ba1\u7684\u6c23\u56ca\u5347\u7a7a\u524d\u5148\u6d29\u6c23\u3002 (B)\u547c\u5438\u5668 FiO 2\u8a2d\u5b9a\u70ba 100%\u3002 (C)\u80f8\u7ba1\u5f15\u6d41\u4f7f\u7528 Heimlich valve \u6216\u63a5\u4e0a suction\u3002 (D)\u653e\u7f6e\u9f3b\u80c3\u7ba1\u6216\u53e3\u80c3\u7ba1\u5f15\u6d41\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "24\u6b72\u5973\u6027\uff0c 2\u65e5\u524d\u6771\u5357\u4e9e\u871c\u6708\u65c5\u884c\u5f8c\u8fd4\u81fa\uff0c\u51fa\u73fe\u5641\u5fc3\u3001\u8179\u7009\u53ca\u9ecf\u6db2\u8840\u4fbf\u75c7\u72c0\u5c31\u91ab\u3002\u6aa2\u50b7\u751f\u547d\u5fb5\u8c61\uff1a\u9ad4\u6eab 37.7\u2103\u3001\u5fc3\u8df3 110\u6b21/min\u3001\u547c\u5438 18\u6b21/min\u3001\u8840\u58d3 105/75 mmHg \uff0c\u7d93\u521d\u6b65\u554f\u8a3a\u53ca\u8eab\u9ad4\u8a3a\u5bdf\u5f8c\uff0c\u75c5\u4eba\u7121\u6cd5\u78ba\u77e5\u6700\u5f8c\u4e00\u6b21\u751f\u7406\u671f\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5efa\u8b70\u4f7f\u7528\u542b\u8461\u8404\u7cd6\u548c\u4e73\u7cd6\u7684\u96fb\u89e3\u8cea\u6eb6\u6db2\u9032\u884c\u53e3\u670d\u88dc\u5145\u9ad4\u6db2\u3002 (B)Loperamide \u53ef\u548c\u6297\u751f\u7d20\u4f75\u7528\u6539\u5584\u75c5\u6cc1\uff0c\u9069\u7528\u65bc\u6b64\u8179\u7009\u3001\u9ecf\u6db2\u8840\u4fbf\u75c5\u4eba\u3002 (C)Probiotics \u548cProton pump inhibitors \u8207\u88dc\u5145\u8f38\u6db2\u7642\u6cd5\u4e00\u8d77\u4f7f\u7528\u662f\u5b89\u5168\u4e14\u6709\u76ca\u7684\u3002 (D)\u7d93\u78ba\u8a8d\u7121\u5176\u4ed6\u7981\u5fcc\u75c7\u5f8c\uff0c\u6297\u751f\u7d20\u9996\u9078\u70ba Azithromycin 1,000mg \u55ae\u6b21\u670d\u7528\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "55\u6b72\u7537\u6027\u75c5\u4eba\uff0c\u7121\u904e\u53bb\u75c5\u53f2\uff0c\u80f8\u90e8 X\u5149\u6709\u53f3\u5074\u80ba\u708e\uff0c\u4f9d\u80ba\u708e\u56b4\u91cd\u5ea6\u98a8\u96aa\u8a55\u4f30\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u8a55\u4f30\u98a8\u96aa\u53ca\u5efa\u8b70\u662f\u5426\u4f4f\u9662 Pneumonia Severity Index \u512a\u65bc CURB- 65 rule\u3002 (B)CURB- 65\u8a55\u4f30\u8840\u4e2d BUN\uff0cPneumonia Severity Index \u8a55\u4f30creatinine \u3002 (C)\u82e5\u8a08\u7b97\u5f8c CURB-65 rule \u5206\u6578\u70ba 1\uff0c\u5247\u53ef\u4ee5\u8003\u616e\u9580\u8a3a\u6cbb\u7642\u3002 (D)\u82e5\u8a08\u7b97\u5f8c Pneumonia Severity Index \u75c5\u4eba\u70ba class II\uff0c\u5247\u5efa\u8b70\u9580\u8a3a\u6cbb\u7642\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u982d\u90e8\u91cd\u64ca\u73fe\u5834\u660f\u8ff7\u50b7\u60a3\uff0c\u5916\u89c0\u5728\u524d\u984d\u53ca\u982d\u9802\u8655\u51fa\u73fe\u5927\u7247\u8840\u816b\uff0c\u96d9\u5074\u8033\u9f3b\u6709\u8840\u3002\u795e\u7d93\u5b78\u6aa2\u67e5\u767c\u73fe\u5169\u5074\u91dd\u72c0\u77b3\u5b54\u3001\u53bb\u76ae\u8cea\u50f5\u786c(decorticate rigidity )\u53ca\u5169\u5074 Babinski\u2019s signs \u967d\u6027\u53cd\u61c9\u3002\u8a72\u50b7\u60a3 \u8f03\u53ef\u80fd\u70ba\u4e0b\u5217\u4f55\u7a2e\uff1f", + "Options": "(A)\u4e2d\u592e\u5c0f\u8166\u5929\u5e55\u8166\u759d(Central transtentorial herniation )\u3002 (B)\u5c0f\u8166\u6241\u6843\u9ad4\u8166\u759d(Cerebellotonsillar herniation) \u3002 (C)\u9264\u8ff4\u8166\u759d (Uncal transtentorial herniation )\u3002 (D)\u4e0a\u884c\u5f8c\u9871\u7aa9\u8166\u759d(upward posterior fossa herniation )\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u4e00\u4f4d\u904a\u5ba2\u5728\u58be\u4e01\u6f5b\u6c34\u88ab\u4e0d\u660e\u9b5a\u985e\u54ac\u50b7\u53f3\u4e0b\u80a2\uff0c\u8acb\u554f\u4ee5\u4e0b\u6cbb\u7642\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u4f7f\u7528\u5c40\u90e8 Lidocaine \u6b62\u75db\u3002 (B)\u7528 20\u2103\u81f330\u2103\u7684\u5e38\u6eab\u6c34\u6d78\u6ce1\u60a3\u80a2\u3002 (C)\u4ee5\u6d77\u6c34\u6e05\u6d17\u50b7\u53e3\u3002 (D)\u53e3\u670d Fluoroquinolone \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "2\u500b\u534a\u6708\u5927\u7537\u5b30\uff0c\u8db3\u6708\u7522\uff0c\u56e0\u5614\u5410\u56db\u5929\uff0c\u7531\u5bb6\u9577\u5e36\u5230\u6025\u8a3a\u6c42\u8a3a\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u8179\u90e8\u4e0a\u6d88\u5316\u9053\u651d\u5f71\u6aa2\u67e5(upper GI tract contrast study )\u53ef\u5e6b\u52a9\u9451\u5225\u8a3a\u65b7\u3002 (B)\u82e5\u5614\u5410\u7269\u6709\u81bd\u6c41\u984f\u8272\uff0c\u61c9\u8003\u616e\u5148\u5929\u6027\u5e7d\u9580\u72f9\u7a84\u3002 (C)\u82e5\u662f\u5148\u5929\u6027\u5e7d\u9580\u72f9\u7a84\uff0c\u75c5\u4eba\u5bb9\u6613\u812b\u6c34\uff0c\u75be\u75c5\u65e9\u671f\u5bb9\u6613\u5408\u4f75\u9178\u8840\u75c7\u3002 (D)\u82e5\u8179\u90e8\u8d85\u97f3\u6ce2\u767c\u73fe\u662f\u5148\u5929\u6027\u5e7d\u9580\u72f9\u7a84\uff0c\u61c9\u8a72\u7dca\u6025\u6703\u8a3a\u5916\u79d1\u9032\u884c\u624b\u8853\u6cbb\u7642\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6025\u6027\u7532\u6e9d\u708e\u8655\u7406\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u82e5\u6709\u81bf\u760d\u9700\u8981\u5f15\u6d41\uff0c\u9808\u4f8b\u884c\u7d30\u83cc\u57f9\u990a\u3002 (B)\u5305\u542b\u55dc\u6c27\u8207\u53ad\u6c27\u83cc\uff0c\u9808\u4f8b\u884c\u7d66\u4e88\u6297\u751f\u7d20\u6cbb\u7642\u3002 (C)\u9808\u8981\u4f8b\u884c X\u5149\u6aa2\u67e5\uff0c\u6392\u9664\u7570\u7269\u6216\u9aa8\u6298\u3002 (D)\u5f15\u6d41\u6642\u4e0d\u9808\u5b8c\u5168\u6307\u7532\u5207\u9664\uff0c\u90e8\u5206\u5207\u9664\u5373\u53ef\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6025\u6027\u4e0b\u80cc\u75db\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u82e5\u75c5\u4eba\u75c5\u53f2\u53ca\u8eab\u9ad4\u8a3a\u5bdf\u7121\u660e\u986f\u5371\u96aa\u56e0\u5b50\uff0c\u53ef\u4fdd\u5b88\u6cbb\u7642\uff0c\u4e0d\u9700\u5728\u6025\u8a3a\u505a\u4efb\u4f55\u8a3a\u65b7\u6aa2\u67e5\u3002 (B)\u82e5\u75c5\u4eba\u51fa\u73fe\u5c3f\u6eef\u7559\u8d85\u904e 500 ml\uff0c\u61c9\u6703\u8a3a\u795e\u7d93\u5916\u79d1\u5b89\u6392\u5f8c\u7e8c\u6aa2\u67e5\u3002 (C)\u795e\u7d93\u6027\u8ddb\u884c (neurogenic claudication )\u6703\u56e0\u70ba\u5ef6\u5c55\u810a\u690e(extending)\u800c\u6539\u5584\uff0c\u56e0\u70ba\u5411\u524d\u5f4e\u66f2\u810a\u690e(forward flexing )\u800c\u60e1\u5316\u3002 (D)\u82e5\u6709\u99ac\u5c3e\u75c7\u5019\u7fa4(Cauda equina syndrome )\u7684\u75c7\u72c0\uff0c\u6700\u5e38\u4ee5\u5c3f\u6eef\u7559\u4f86\u8868\u73fe\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u5408\u505a\u7dca\u6025\u7684\u80f8\u5ed3\u5207\u958b\u8853 (emergent thoracotomy )\uff1f", + "Options": "(A)75 \u6b72\u7537\u6027\uff0c\u88ab\u9130\u5c45\u7528\u7f8e\u5de5\u5200\u523a\u5230\u5de6\u80f8\uff0c\u88ab\u9001\u81f3\u91ab\u9662\u5df2 asystole\uff0cE-FAST\u6c92\u6709\u5fc3\u5305\u819c\u7a4d\u6db2\u3002 (B)39 \u6b72\u5973\u6027\uff0c\u61f7\u5b55 24\u9031\uff0c\u88ab\u83dc\u5200\u523a\u5230\u5de6\u80f8\uff0c\u9032\u5165\u6025\u6551\u5ba4\u5f8c\u8b8a\u6210PEA\u3002 (C)57 \u6b72\u7537\u6027\uff0c\u767c\u751f\u8eca\u798d\u98db\u51fa\u8eca\u5916\uff0c\u80f8\u524d\u6709\u5f88\u6df1\u7684\u6495\u88c2\u50b7\uff0c\u50b7\u53e3\u6301\u7e8c\u6709\u6c23\u6ce1\u5192\u51fa\uff0c\u73fe\u5834\u70ba asystole\u3002 (D)25 \u6b72\u5973\u6027\uff0c\u6a5f\u8eca\u99d5\u99db\u8eca\u798d\uff0c\u660e\u986f\u53f3\u80f8\u5927\u9762\u7a4d\u632b\u50b7\uff0c\u5f9e\u73fe\u5834\u81f3\u9001\u91ab20\u5206\u9418\u7686\u7121\u81ea\u767c\u6027\u5fc3\u8df3\u53ca\u547c\u5438\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u75c5\u4eba\u9577\u671f\u6709\u9ad6\u95dc\u7bc0\u75bc\u75db\uff0c\u53ef\u80fd\u60a3\u6709 Paget\u2019s Disease \u3002\u4ee5\u4e0b\u6aa2\u67e5\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u8840\u6e05\u9223(Calcium )\u6fc3\u5ea6\u3002 (B)\u8840\u6e05\u7dad\u751f\u7d20 D(vitamin D )\u6fc3\u5ea6\u3002 (C)\u8840\u6e05\u9e7c\u6027\u78f7\u9178\u9176(alkaline phosphatase )\u6fc3\u5ea6\u3002 (D)\u8840\u6e05\u526f\u7532\u72c0\u817a\u6fc0\u7d20(parathyroid hormone )\u6fc3\u5ea6\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6c23\u5598\u75c5\u4eba\u6025\u6027\u767c\u4f5c\u6cbb\u7642\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)Rapid -onset \u03b22 -adrenergic agonists \u5efa\u8b70\u7528\u65bc\u6025\u6027\u652f\u6c23\u7ba1\u75d9\u6523\u6240\u6709\u56b4\u91cd\u5ea6\u6cbb\u7642\u3002 (B)Inhaled ipratropium bromide \u7528\u65bc\u4e2d\u91cd\u5ea6\u767c\u4f5c\u75c5\u4eba\uff0c\u53ef\u6e1b\u5c11\u5176\u4f4f\u9662\u53ef\u80fd\u6027\u3002 (C)\u5728\u6025\u8a3a\u7d66\u4e88 Corticosteroids \u6ce8\u5c04\u53ef\u6e1b\u5c11\u767c\u4f5c\u75c5\u4eba\u7684\u4f4f\u9662\u6bd4\u7387\u3002 (D)\u7b2c\u4e00\u7dda\u6cbb\u7642\u7121\u6548\u5f8c\uff0cEpinephine \u975c\u8108\u6ce8\u5c04\u6216 inhalation \u53ef\u505a\u70ba\u4e8c\u7dda\u6cbb\u7642\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "10\u6b72\u7537\u5b69\u56e0\u53f3\u5074\u9670\u56ca\u75bc\u75db\u88ab\u7236\u6bcd\u5e36\u81f3\u6025\u8a3a\u5c31\u91ab\uff0c\u4f60\u61f7\u7591\u662f\u776a\u4e38\u9644\u4ef6\u626d\u8f49(appendage torsion) \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u4e0d\u652f\u6301 \u4f60\u7684\u8a3a\u65b7 \uff1f", + "Options": "(A)\u53f3\u5074\u9670\u56ca\u770b\u5230 \u201cblue dot sign\u201d \u3002 (B)\u53f3\u5074\u9ad8\u4f4d\u776a\u4e38(high riding testis )\u3002 (C)Color Doppler \u8d85\u97f3\u6ce2\u4e0b\u776a\u4e38\u8840\u6d41\u70ba\u6b63\u5e38\u3002 (D)\u8eab\u9ad4\u8a3a\u5bdf\u767c\u73fe\u75bc\u75db\u9ede\u4fb7\u9650\u65bc\u53f3\u5074\u776a\u4e38\u4e0a\u65b9\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u982d\u90e8\u5916\u50b7\u75c5\u4eba\uff0c\u8840\u58d3 228/132 mmHg\uff0c\u9871\u5167\u58d3( ICP)86 mmHg \uff0c\u76f8\u95dc\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u8a72\u75c5\u4eba\u5e73\u5747\u52d5\u8108\u58d3(MAP )\u70ba 164 mmHg \uff0c\u5927\u8166\u704c\u6ce8\u58d3(CPP )\u70ba78 mmHg \u3002 (B)\u8a72\u75c5\u4eba\u5e73\u5747\u52d5\u8108\u58d3\u70ba 180 mmHg \uff0c\u5927\u8166\u704c\u6ce8\u58d3\u70ba 94 mmHg \u3002 (C)\u5728\u6b63\u5e38\u60c5\u6cc1\u4e0b\uff0c\u81ea\u52d5\u8abf\u7bc0\u53ef\u4ee5\u8abf\u6574\u4ee5\u9069\u61c9 50~120 mmHg \u7684CPP\uff0cCPP < 50 mmHg \u88ab\u8a8d\u70ba\u662f\u4eba\u985e\u81ea\u52d5\u8abf\u7bc0\u7684\u4e0b\u9650\u3002 (D)\u9871\u5167\u58d3\u5347\u9ad8\uff0c\u6703\u5f15\u8d77\u5eab\u6b23\u53cd\u5c04(Cushing reflex ) \uff0c\u5305\u62ec\u9ad8\u8840\u58d3\u3001\u5fc3\u640f\u904e\u7de9\u548c\u547c\u5438\u6dfa\u5feb\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5fc3\u5305\u819c\u586b\u585e\u53ca\u5fc3\u5305\u819c\u653e\u6db2\u8853\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u920d\u50b7\u5fc3\u81df\u7834\u88c2\u5f88\u5c11\u898b\uff0c\u5916\u50b7\u5f15\u8d77\u5fc3\u5305\u586b\u585e\uff0c\u6700\u597d\u7528\u5fc3\u5c16\u5fc3\u5305\u7a7f\u523a\u8853\u8655\u7f6e\u3002 (B)\u5fc3\u81df\u8d85\u97f3\u6ce2\u6700\u5178\u578b\u7684\u5fb5\u5146\u662f\u53f3\u5074\u5fc3\u81df\u584c\u9677\u3002\u5728\u8212\u5f35\u671f\uff0c\u53f3\u5fc3\u623f\u5411\u5167\u58d3\uff0c\u5728\u6536\u7e2e\u671f\uff0c\u53f3\u5fc3\u5ba4\u5411\u5167\u58d3\u3002 (C)\u51fa\u73fe\u53f3\u5fc3\u623f\u584c\u9677\u6bd4\u767c\u73fe\u53f3\u5fc3\u5ba4\u584c\u9677\u5c0d\u5fc3\u81df\u586b\u585e\u66f4\u654f\u611f\uff0c\u5de6\u5fc3\u623f\u584c\u9677\u5247\u662f\u6700\u665a\u671f\u767c\u73fe\u3002 (D)\u4e0d\u540c\u5fc3\u5305\u7a7f\u523a\u65b9\u6cd5\u7684\u7279\u9ede\uff0c\u5fc3\u5c16\u6cd5\u8f03\u528d\u7a81\u4e0b\u6cd5\uff0c\u9020\u6210\u6c23\u80f8\u767c\u751f\u7387\u8f03\u5c0f\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "70\u6b72\u7684\u963f\u4f2f\u5728\u5c71\u4e0a\u63a1\u7af9\u7b4d\u88ab\u4e0d\u660e\u86c7\u985e\u54ac\u50b7\u53f3\u8173\uff0c\u4ee5\u4e0b\u8655\u7406\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u82e5\u5c40\u90e8\u7121\u816b\u8139\uff0c\u4f46\u6709\u5c40\u90e8\u9ebb\u6216\u808c\u8089\u7121\u529b\uff0c\u53ef\u8003\u616e\u6253\u6297\u795e\u7d93\u6027\u86c7\u6bd2\u8840\u6e05\u3002 (B)\u82e5\u5c40\u90e8\u6709\u816b\u8139\uff0c\u6709\u7d44\u7e54\u58de\u6b7b\u6216\u795e\u7d93\u75c7\u72c0\uff0c\u53ef\u8003\u616e\u6253\u6297\u795e\u7d93\u6027\u86c7\u6bd2\u8840\u6e05\u3002 (C)\u82e5\u5c40\u90e8\u6709\u816b\u8139\uff0c\u660e\u986f\u7600\u8840\uff0c\u5c11\u91cf\u8840\u6ce1\uff0c\u51dd\u8840\u6a5f\u80fd\u5927\u81f4\u6b63\u5e38\uff0c\u53ef\u8003\u616e\u6253\u6297\u9396\u93c8\u86c7\u6bd2\u8840\u6e05\u3002 (D)\u82e5\u5c40\u90e8\u6709\u816b\u8139\uff0c\u660e\u986f\u7600\u8840\uff0c\u591a\u500b\u8840\u6ce1\uff0cPT \u53caAPTT\u5ef6\u9577\uff0c\u8840\u5c0f\u677f\u660e\u986f\u6e1b\u5c11\uff0c\u53ef\u8003\u616e\u6253\u767e\u6b65\u86c7\u6bd2\u8840\u6e05\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "25\u6b72HIV\u7537\u6027\u54b3\u55fd\u4e00\u9031\uff0c\u8f15\u5fae\u767c\u71d2\u5c31\u8a3a\uff0c X\u5149\u986f\u793a\u53f3\u4e0a\u80ba\u6d78\u6f64\u9700\u61f7\u7591\u80ba\u7d50\u6838\uff0c\u4e0b\u5217\u8655\u7f6e\u6558\u8ff0\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u9032\u884c Interferon \u03b3 release assays (IGRAs)\u6aa2\u9a57\u6709\u52a9\u65bc\u8a3a\u65b7\u3002 (B)\u75c5\u4eba\u56e0\u514d\u75ab\u4e0d\u5168\u8f03\u5bb9\u6613\u5728\u75f0\u62b9\u7247\u4e2d\u770b\u5230\u7d50\u6838\u83cc\u3002 (C)nucleic acid amplification test (NAAT)\u7684\u8a3a\u65b7\u654f\u611f\u6027\u8f03\u75f0\u62b9\u7247\u9ad8\u3002 (D)\u4e0d\u9700\u8981\u6703\u8a3a\u61c9\u8a72\u5728\u6025\u8a3a\u5148\u7d66\u4e88\u7d93\u9a57\u6027\u6297\u7d50\u6838\u85e5\u7269\uff0c\u4e4b\u5f8c\u518d\u5b89\u6392\u9580\u8a3a\u8ffd\u8e64\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "78\u6b72\u7537\u6027\u5177\u9ad8\u8840\u58d3\u3001\u5fc3\u5f8b\u4e0d\u6574\u75c5\u53f2\uff0c\u4e3b\u8a34\u8fd1\u5169\u5929\u54b3\u55fd\u51fa\u73fe\u8840\u7d72\u3001\u65bc\u6025\u8a3a\u5c31\u91ab\u524d\u534a\u5c0f\u6642\u5167\u9678\u7e8c\u54b3\u51fa\u7d04 600 mL\u9bae\u8840\u3002\u75c5\u4eba\u795e\u667a\u6e05\u9192\u4f46\u865b\u5f31\uff0c\u547c\u5438 22\u6b21/min\uff0c\u8840\u58d3 86/46 mmHg \uff0c\u5fc3\u8df3 137\u6b21/min\u4f46\u4e0d\u898f\u5247\uff0c\u80f8\u90e8 X\u5149\u5448\u73fe\u5de6\u4e0b\u80ba\u91ce\u6d78\u6f64\uff0c\u8acb\u554f\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u7d66\u4e88\u6301\u7e8c\u6027\u6b63\u58d3\u7d66\u6c27\u4ee5\u77ef\u6b63\u7f3a\u6c27\u3002 (B)\u7167\u6703\u80f8\u8154\u5916\u79d1\u91ab\u5e2b\u9032\u884c\u7dca\u6025\u958b\u80f8\u624b\u8853\u3002 (C)\u7f6e\u653e\u5927\u53e3\u5f91\u6c23\u7ba1\u5167\u7ba1\uff0c\u4e14\u6df1\u9054\u53f3\u5074\u4e3b\u652f\u6c23\u7ba1\u3002 (D)\u5149\u7e96\u5f0f\u652f\u6c23\u7ba1\u93e1\u76f8\u8f03\u65bc\u786c\u5f0f\u652f\u6c23\u7ba1\u93e1\u66f4\u9069\u5408\u6b62\u8840\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u590f\u65e5\u6d77\u908a\u7e3d\u662f\u5145\u6eff\u6232\u6c34\u4eba\u6f6e\uff0c\u4e0b\u5217\u5e7e\u4f4d\u6025\u8a3a\u75c5\u4eba\u8655\u7f6e\uff0c\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)8\u6b72\u7537\u7ae5\u7901\u5ca9\u4e0a\u8dcc\u5012\uff0c\u5de6\u5c0f\u817f\u6709 5\u516c\u5206\u6495\u88c2\u50b7\uff0c\u5728\u6025\u8a3a\u7d66\u4e88\u7e2b\u5408\u3002 (B)24 \u6b72\u5973\u6027\uff0c\u53f3\u5c0f\u817f\u88ab\u6c34\u6bcd\u87ab\u50b7\uff0c\u5148\u7d66\u4e88\u51b0\u6577\u6b62\u75db\u3002 (C)30 \u6b72\u7537\u6027\uff0c\u8e29\u5230\u6d77\u81bd\uff0c\u6709\u597d\u5e7e\u6839\u68d8\u523a\u63d2\u5165\u8173\u5e95\uff0c\u5c40\u90e8\u9ebb\u9189\u79fb\u9664\u68d8\u523a\u3002 (D)42 \u6b72\u5973\u6027\uff0c\u5de6\u524d\u81c2\u906d\u6c34\u6bcd\u87ab\u50b7\uff0c\u4ee5\u51b0\u918b\u9178\u5857\u62b9\u5c40\u90e8\u50b7\u53e3\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u61f7\u5b55\u6642\u7684\u5916\u50b7\u6cbb\u7642\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u7531\u65bc\u5b55\u5a66\u53ef\u80fd\u5728\u9ad4\u6db2\u7f3a\u5931\u8f03\u5c11\u6642\u958b\u59cb\u6709\u4f11\u514b\u5fb5\u8c61\uff0c\u8f38\u6db2\u5fa9\u7526\u7684\u8f38\u6db2\u91cf\u61c9\u8003\u616e\u6e1b\u5c11\u81f3\u5e73\u6642 50~75%\u3002 (B)\u82e5\u5b55\u5a66\u5fc3\u8df3\u505c\u6b62\u5927\u65bc 7\u5206\u9418\uff0c\u4e14\u80ce\u5152\u5df2\u5927\u65bc 24\u9031\uff0c\u61c9\u8003\u616e\u7dca\u6025\u5256\u8179\u7522\u3002 (C)\u5b55\u5a66\u7684\u521d\u7d1a\u8a55\u4f30\u9806\u5e8f\u8207\u975e\u61f7\u5b55\u8005\u4e0d\u540c\uff0c\u61c9\u5c07 circulation \u653e\u5728\u7b2c\u4e00\u4f4d\u3002 (D)\u82e5\u5916\u50b7\u6642\u5b55\u5a66\u9670\u9053\u5206\u6ccc\u7269 pH\u503c\u9a57\u51fa 7\uff0c\u53ef\u5408\u7406\u61f7\u7591\u5b55\u5a66\u6709\u7834\u6c34\u60c5\u5f62\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6b79\u5f92\u624b\u6301\u5c16\u5200\u653b\u64ca\u8def\u4eba\uff0c 4\u540d\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\u88ab\u523a\u50b7\u60a3\u9001\u5230\u6025\u8a3a\u5ba4\uff0c\u4e0b\u5217\u4f55\u8005\u8655\u7f6e\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u5f8c\u9838\u90e8\u4e00\u8655\u7a7f\u523a\u5200\u50b7\uff0c\u7121\u795e\u7d93\u5b78\u75c7\u72c0\uff0c\u53ef\u4e0d\u8981\u4f7f\u7528\u9838\u5708\u56fa\u5b9a\u9838\u90e8\uff0c\u907f\u514d\u63a9\u84cb\u9838\u90e8\u50b7\u52e2\u8b8a\u5316\u3002 (B)\u809a\u81cd\u65c1\u4e00\u8655\u5200\u50b7\uff0c\u5efa\u8b70\u4e0d\u8981\u5728\u6025\u8a3a\u5c40\u90e8\u63a2\u67e5\u50b7\u53e3\u3002 (C)\u5f8c\u8170\u90e8\u5169\u8655\u5200\u50b7\uff0c\u4e0d\u5efa\u8b70\u5728\u6025\u8a3a\u5c40\u90e8\u63a2\u67e5\u5f8c\u8170\u90e8\u50b7\u53e3\u3002 (D)\u53f3\u5074\u80f8\u90e8\u4e00\u8655\u5200\u50b7\uff0c\u50b7\u53e3\u8655\u96a8\u8457\u547c\u5438\u800c\u6f0f\u51fa\u6c23\u9ad4\uff0c\u4e0d\u5efa\u8b70\u5f9e\u50b7\u53e3\u8655\u653e\u7f6e\u80f8\u7ba1\u5f15\u6d41\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "4\u6b72\u5973\u7ae5\uff0c\u5403\u96de\u8089\u5f8c\u51fa\u73fe\u6301\u7e8c\u7570\u7269\u611f\uff0c\u5bb6\u9577\u5617\u8a66\u8b93\u75c5\u7ae5\u559d\u6c34\uff0c\u4f46\u53cd\u800c\u9020\u6210\u5287\u70c8\u7684\u55c6\u54b3\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u98df\u9053\u5167\u82e5\u6709\u98df\u7269\u6897\u585e\uff0c\u56e0\u98df\u9053\u5167\u58c1\u4ea6\u6709\u5206\u6ccc\u9ecf\u6db2\u529f\u80fd\uff0c\u6f64\u6ed1\u5f8c\u6709\u6a5f\u6703\u81ea\u884c\u7de9\u89e3\uff0c\u4e0d\u9700\u52c9\u5f37\u559d\u6c34\uff0c\u4ee5\u514d\u55c6\u5230\u3002 (B)\u98df\u9053\u7684\u751f\u7406\u89e3\u5256\u69cb\u9020\u4e2d\uff0c\u6210\u4eba\u6709\u4e09\u8655\u72f9\u7a84\uff1b\u5152\u7ae5\u9ad4\u578b\u8f03\u5c0f\uff0c\u6709\u56db\u8655\u72f9\u7a84\u3002 (C)\u82e5\u75c5\u53f2\u660e\u78ba\u662f\u86cb\u767d\u8cea\u985e\u6897\u585e\uff0c\u53ef\u8003\u616e\u670d\u7528\u86cb\u767d\u9175\u7d20\u4f86\u8edf\u5316\u8089\u5718\u3002 (D)\u82e5\u5f71\u50cf\u5b78\u6aa2\u67e5\u767c\u73fe\u98df\u9053\u98df\u5718\u4e2d\u7591\u4f3c\u6709\u5c11\u91cf\u788e\u9aa8\uff0c\u61c9\u65bc 24\u5c0f\u6642\u5167\u5b89\u6392\u80c3\u93e1\u6aa2\u67e5\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "38\u6b72\u5973\u6027\u524d\u5f80\u6025\u8a3a\uff0c\u4e3b\u8a34\u53f3\u5927\u817f\u524d\u90e8\u5df2\u75bc\u75db\u4e00\u9031\uff0c\u7a7f\u7dca\u8eab\u8932\u548c\u904b\u52d5\u6642\u75bc\u75db\u6703\u52a0\u5287\uff0c \u5979\u5426\u8a8d\u8a72\u90e8\u4f4d\u6709\u4efb\u4f55\u5916\u50b7\u6216\u624b\u8853\uff0c\u4ee5\u4e0b\u4f55\u8005\u662f \u6700\u53ef\u80fd\u7684\u8a3a\u65b7 \uff1f", + "Options": "(A)\u5927\u817f\u5916\u5074\u76ae\u795e\u7d93\u53d7\u58d3\u8feb\u75c7(Lateral femoral cutaneous nerve entrapment )\u3002 (B)Obturator \u795e\u7d93\u53d7\u58d3\u8feb\u75c7(Obturator n erve entrapment )\u3002 (C)\u8179\u80a1\u6e9d\u795e\u7d93\u53d7\u58d3\u8feb\u75c7 (Ilioinguinal nerve entrapment) \u3002 (D)\u68a8\u72c0\u808c\u75c7\u5019\u7fa4(Piriformis syndrome)\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "66\u6b72\u7537\u6027\uff0c\u6709\u985e\u98a8\u6fd5\u6027\u5fc3\u81df\u75c5\u53f2\u63a5\u53d7\u904e\u4e8c\u5c16\u74e3\u819c\u7f6e\u63db\u8853\uff0c\u56e0\u767c\u71d2\u3001\u5168\u8eab\u4e0d\u9069\u540c\u6642\u624b\u4e0a\u51fa\u73fe\u7121\u75db\u6027\u7d05\u6591\u5230\u6025\u8a3a\u3002\u904e\u53bb\u7121\u6ce8\u5c04\u6bd2\u54c1\u3002\u9ad4\u6eab 38.5\u2103\u3001\u8840\u58d3 130/80 mmHg \uff0c\u5fc3\u7387 95\u6b21/min\u3002\u5fc3\u81df\u8d85\u97f3\u6ce2\u7121\u7279\u6b8a\u7570\u5e38\u767c\u73fe\uff0c\u4e09\u5957\u8840\u6db2\u7d30\u83cc\u57f9\u990a\u6709\u4e00\u5957\u767c\u73fe Streptococcus bovis\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u4f9d\u64da Modified Duke \u8a3a\u65b7\u6a19\u6e96\u70ba\u660e\u78ba\u7684\u5fc3\u5185\u819c\u708e (definite endocarditis) \u3002 (B)Streptococcus bovis \u662f\u5fc3\u5185\u819c\u708e\u6700\u5e38\u898b\u3002 (C)\u6b64\u75c5\u4eba\u7684\u76ae\u75b9\u662f\u514d\u75ab\u5b78\u73fe\u8c61 (immunologic phenomena )\uff0c\u7a31\u70baOsler\u2019s nodes \u3002 (D)\u53ef\u5408\u4f75\u4f7f\u7528 Vancomycin \uff0cGentamicin \u53caRifampin \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u95dc\u65bc\u5152\u7ae5\u541e\u98df\u7570\u7269\u7684\u6558\u8ff0\uff0c\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)X \u5149\u5927\u591a\u7121\u6cd5\u767c\u73fe\u547c\u5438\u9053\u7570\u7269\uff0c\u4ecd\u61c9\u4f8b\u884c\u6027\u7167\u5c04\u3002 (B)\u541e\u5165\u9215\u6263\u96fb\u6c60\u5df2\u5728\u80c3\u90e8\u4e14\u7121\u4efb\u4f55\u75c7\u72c0\uff0c\u53ef\u5148\u89c0\u5bdf\u8ffd\u8e64\u3002 (C)\u82e5 X\u5149\u524d\u5f8c\u7167(anteroposterior film )\u767c\u73fe\u662f\u786c\u5e63\u4e14\u5448\u73fe\u786c\u5e63\u5713\u76e4\u9762\u800c\u4e0d\u662f\u5074\u9762\uff0c\u8a72\u786c\u5e63\u63a8\u6e2c\u662f\u5361\u5728\u98df\u9053\u800c\u975e\u6c23\u7ba1\u3002 (D)\u82e5\u767c\u73fe\u662f\u8089\u584a\u98df\u7269\u5835\u585e\u98df\u9053\u800c\u7121\u660e\u986f\u4f75\u767c\u75c7\uff0c\u53ef\u5148\u89c0\u5bdf\u5373\u53ef\u3002\u82e5\u8d85\u904e12\u5c0f\u6642\u4ecd\u672a\u6539\u5584\uff0c\u53ef\u9935\u98df\u86cb\u767d\u6c34\u89e3\u9176(proteolytic enzymes )\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u88ab50%\u6c2b\u6c1f\u9178(HF)\u5674\u6ffa\u53f3\u524d\u81c2\u7d04 3%\u9ad4\u8868\u9762\u7a4d\uff0c\u4e0b\u5217\u6cbb\u7642\u65b9\u5f0f\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5229\u7528\u4e2d\u592e\u975c\u8108\u5c0e\u7ba1\u7d66\u4e88\u6c2f\u5316\u9223 (CaCl 2)\u6ce8\u5c04\u3002 (B)\u76f4\u63a5\u5c07\u53f3\u624b\u81c2\u6d78\u6ce1\u5728\u8461\u8404\u7cd6\u9178\u9223(Calcium gluconate )\u6eb6\u6db2\u4e2d\u3002 (C)\u65bc\u53f3\u624b\u8098\u975c\u8108\u5167\u6ef4\u6ce8\u8461\u8404\u7cd6\u9178\u9223(Calcium gluconate )\u3002 (D)\u6ce8\u5c04\u6c2f\u5316\u9223 (CaCl 2)\u6eb6\u6db2\u65bc\u66b4\u9732\u90e8\u4f4d\uff0c\u9032\u884c\u6ef2\u900f\u6cbb\u7642(infiltration therapy)\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u8154\u5ba4\u75c7\u5019\u7fa4 (compartment syndrome )\u7684\u63cf\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u5927\u65bc 35\u6b72\u7684\u75c5\u4eba\u8f03\u4e0d\u6613\u767c\u751f\u8154\u5ba4\u75c7\u5019\u7fa4\u3002 (B)\u82e5\u6c92\u6709\u5916\u50b7\u75c5\u53f2\uff0c\u53ef\u6392\u9664\u6b64\u8a3a\u65b7\u3002 (C)\u7576\u8212\u5f35\u58d3\u8207\u8154\u5ba4\u58d3\u4e4b\u5dee\u5c0f\u65bc 30 mmHg \u6642\uff0c\u61c9\u57f7\u884c\u7b4b\u819c\u5207\u958b\u8853\u3002 (D)\u82e5\u8154\u5ba4\u75c7\u5019\u7fa4\u767c\u751f\u5df2\u8d85\u904e 48\u5c0f\u6642\uff0c\u5247\u4e0d\u5b9c\u518d\u57f7\u884c\u7b4b\u819c\u5207\u958b\u8853\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "51\u6b72\u7537\u6027\uff0c\u6709\u5927\u8178\u764c\u75c5\u53f2\uff0c\u672c\u6b21\u56e0\u6392\u4fbf\u75bc\u75db\u53ca\u767c\u71d2\u5c31\u91ab\uff0c\u8eab\u9ad4\u8a3a\u5bdf\u767c\u73fe\u6709\u809b\u9580\u5468\u908a\u7d44\u7e54\u58d3\u75db\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5148\u78ba\u8a8d\u75c5\u4eba\u7684\u514d\u75ab\u529b\u662f\u5426\u56e0\u5316\u7642\u6e1b\u5f31\uff0c\u4e0d\u5efa\u8b70\u8cbf\u7136\u9032\u884c\u809b\u9580\u6307\u8a3a\u3002 (B)\u809b\u9580\u76f4\u8178\u81bf\u760d\u5e38\u898b\u70ba\u55ae\u4e00\u83cc\u7a2e\u611f\u67d3\uff0c\u4e14\u591a\u70ba\u53ad\u6c27\u83cc\u70ba\u4e3b\u3002 (C)\u809b\u9580\u76f4\u8178\u81bf\u760d\u4f4d\u7f6e\u591a\u8b8a\uff0c\u5176\u4e2d\u4ee5\u9aa8\u76c6\u76f4\u8178\u9031\u570d (pelvirectal )\u81bf\u760d\u6700\u70ba\u5e38\u898b\u3002 (D)\u82e5\u7d93\u6aa2\u67e5\u5f8c\uff0c\u75c5\u4eba\u70ba\u55ae\u7d14\u76f4\u8178\u9031\u570d(perirectal )\u81bf\u760d\uff0c\u53ef\u65bc\u6025\u8a3a\u5f15\u6d41\uff0c\u61c9\u65bc\u6025\u8a3a\u5b89\u6392\u7a7f\u523a\u5f15\u6d41\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u6c34\u694a\u9178\u4e2d\u6bd2\u4f75\u56b4\u91cd\u4ee3\u8b1d\u9178\u4e2d\u6bd2\u75c5\u4eba\u7684\u6cbb\u7642\u65b9\u5f0f\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u53e3\u670d\u91cd\u78b3\u9178\u9209( NaHCO 3)\u7684\u6548\u679c\u548c\u975c\u8108\u6ce8\u5c04\u4e00\u6a23\u597d\u3002 (B)\u8840\u6db2\u900f\u6790 (hemodialysis )\u548c\u8840\u6db2\u704c\u6ce8(hemoperfusion)\u5747\u80fd\u79fb\u9664\u6c34\u694a\u9178\u3002 (C)\u5c0d\u65bc\u6c23\u7ba1\u5167\u63d2\u7ba1\u7684\u75c5\u4eba\uff0c\u7d66\u4e88\u904e\u5ea6\u63db\u6c23\u9054\u5230\u547c\u5438\u9e7c\uff0c\u4ee5\u7dad\u6301\u8840\u6db2\u6b63\u5e38pH\u503c\u3002 (D)\u81e8\u5e8a\u4e0a\u6613\u9020\u6210\u9ad8\u8840\u7cd6\uff0c\u61c9\u907f\u514d\u88dc\u5145\u542b\u8461\u8404\u7cd6\u9ede\u6ef4\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5b55\u5a66\u5916\u50b7\u4e4b\u63cf\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u5b55\u5a66\u56e0\u6574\u9ad4\u5faa\u74b0\u8840\u6db2\u91cf\u589e\u52a0\uff0c\u51fa\u8840\u8d85\u904e\u5faa\u74b0\u9ad4\u7a4d\u7684 3\u6210\u4ee5\u4e0a\u624d\u6703\u51fa\u73fe\u4f11\u514b\u75c7\u72c0\u3002 (B)\u8a3a\u65b7\u80ce\u76e4\u65e9\u671f\u525d\u96e2(placental abruption)\u6700\u6709\u6548\u65b9\u5f0f\u70ba\u80ce\u5152\u5fc3\u5f8b\u76e3\u6e2c\u986f\u793a\u5b50\u5bae\u6536\u7e2e> 3 \u6b21/min\u3002 (C)\u53ef\u4ee5\u7528\u8d85\u97f3\u6ce2\u4f86\u8a3a\u65b7\u5b50\u5bae\u7834\u88c2\u3002 (D)\u5927\u65bc 20\u9031\u4e4b\u5b55\u5a66\uff0c\u5efa\u8b70\u9700\u8981\u9023\u7e8c\u9032\u884c 4~6\u5c0f\u6642\u4e4b\u80ce\u5152\u5fc3\u5f8b\u76e3\u6e2c\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "45\u6b72\u7537\u6027\u56e0\u6c23\u5598\u767c\u4f5c\u4f86\u8a3a\uff0c\u610f\u8b58\u6e05\u695a\u3001\u6c92\u6709\u767c\u71d2\u3001\u6aa2\u50b7\u6642 SpO 2\u70ba89%\uff0c\u547c\u5438 32\u6b21/min \u4f75\u7528\u8f14\u52a9\u547c\u5438\u808c\uff0c\u80f8\u90e8 X\u5149\u6aa2\u67e5\u7121\u660e\u986f\u7570\u5e38\uff0c\u7d93\u4f7f\u7528albuterol\u3001ipratropium \u5438\u5165\u5291\u4f46\u6548\u679c\u4e0d\u4f73\uff0c\u4e88\u4ee5 IV methylprednisolone \u5f8c\u75c7\u72c0\u4ecd\u672a\u6539\u5584\uff0c\u8acb\u554f\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)Aminophylline 250 mg IV \u6ef4\u6ce8\u7d04 20\u5206\u9418\u3002 (B)\u5408\u4f75\u4f7f\u7528 Nebulized magnesium \u6548\u679c\u826f\u597d\u3002 (C)Magnesium sulfate 10 g IV \u6ef4\u6ce8\u7d04 30\u5206\u9418\u3002 (D)Formoterol \u5c0d\u03b22\u53d7\u5668\u7684\u89aa\u548c\u529b\u66f4\u597d\uff0c\u8003\u616e\u4f7f\u7528\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "65\u6b72\u7537\u6027\u56e0\u541e\u56a5\u56f0\u96e3\u6578\u5c0f\u6642\u4f86\u8a3a\uff0c\u53e3\u8154\u53ef\u4ee5\u898b\u5230 double tongue sign \uff0c\u8acb\u554f\u4e0b\u5217\u63cf\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u75be\u75c5\u9032\u5c55\u53ef\u80fd\u76f8\u7576\u8fc5\u901f\uff0c\u61c9\u8003\u616e\u53ca\u65e9\u63d2\u7ba1\u3002 (B)\u63d2\u7ba1\u6642\u61c9\u9069\u7576\u7d66\u4e88\u93ae\u5b9a\u5291\u53ca\u808c\u8089\u9b06\u5f1b\u5291\uff0c\u6e1b\u7de9\u75c5\u4eba\u4e0d\u9069\u53ca\u589e\u52a0\u6210\u529f\u7387\u3002 (C)\u82e5\u7121\u547c\u5438\u7a98\u8feb\uff0c\u53ef\u8003\u616e\u5148\u4e0d\u63d2\u7ba1\uff0c\u5148\u7528\u6297\u751f\u7d20\u6cbb\u7642 3\u5929\u3002 (D)\u82e5\u6709\u54b3\u75f0\u56f0\u96e3\uff0c\u53ef\u4ee5\u8003\u616e\u5148\u7d66\u5316\u75f0\u5438\u5165\u5291\u6cbb\u7642\uff0c\u723e\u5f8c\u89c0\u5bdf\u662f\u5426\u6539\u5584\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u56e0\u5b50\u764e\u75c7 (eclampsia )\u5b55\u5a66\u9700\u63d2\u7ba1\uff0c\u8acb\u554f\u4e0b\u5217\u4f55\u8005\u6558\u8ff0 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u547c\u5438\u5668\u7684\u8a2d\u5b9a\u8207\u975e\u5b55\u5a66\u76f8\u540c\uff0cPaCO 2\u8a2d\u5b9a 28~35 mmHg \u3002 (B)\u6c23\u7ba1\u5167\u7ba1\u7684\u9078\u64c7\u8207\u4e00\u822c\u75c5\u4eba\u76f8\u4f3c\u3002 (C)\u56e0\u5b55\u5a66\u9ad4\u91cd\u589e\u52a0\uff0c\u4f7f\u7528 RSI\u6642\u8981\u8abf\u6574\u85e5\u7269\u7684\u5291\u91cf\u3002 (D)Pre -oxygenation \u5f8c\u4e0d\u9808\u6301\u7e8c\u4f7f\u7528\u9f3b\u5c0e\u7ba1\u7d66\u6c27(nasal cannula )\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u7729\u6688 (Vertigo)\u75c5\u4eba\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)HINTS (Head Impulse test, Nystagmus, and Test of Skew deviation ) test\u9069\u7528\u65bc\u7729\u6688\u505c\u6b62\u4e14\u7121\u773c\u9707\u6642\u3002 (B)\u51fa\u73fe\u65b0\u767c\u751f\u7684\u807d\u529b\u640d\u5931\u8f03\u53ef\u80fd\u662f\u9031\u908a\u578b\u7729\u6688\u3002 (C)Epley maneuver \u53ef\u8a3a\u65b7\u826f\u6027\u9663\u767c\u6027\u59ff\u52e2\u6027\u7729\u6688(benign paroxysmal positional vertigo )\u3002 (D)\u64cd\u4f5c Head Impulse Test \u6642\uff0c\u9031\u908a\u578b\u7729\u6688\u75c5\u4eba\u5e38\u6703\u51fa\u73fe\u8ffd\u6355\u6027\u6383\u8996(catch up saccade )\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5229\u7528\u8d85\u97f3\u6ce2\u91cf\u6e2c\u8996\u795e\u7d93\u9798( Optic nerve sheath )\u4f86\u76e3\u63a7\u8166\u58d3\uff0c\u8acb\u554f\u4e0b\u5217\u63cf\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u56e0\u70ba\u8d85\u97f3\u6ce2\u986f\u5f71\u5728\u773c\u7403\u5f8c\u65b9 5 mm\u8655\u986f\u5f71\u8f03\u4f73\uff0c\u6545\u91cf\u6e2c\u6b64\u8655\u795e\u7d93\u9798\u7684\u76f4\u5f91\u3002 (B)\u7576\u8996\u795e\u7d93\u9798\u7684\u76f4\u5f91\u9054\u5230 6 mm\uff0c\u75c5\u4eba\u8166\u58d3\u5927\u65bc 20 mmHg \u7684\u6a5f\u7387\u6709\u4e03\u6210\u4ee5\u4e0a\u3002 (C)\u773c\u7403\u5916\u50b7\u3001\u8996\u795e\u7d93\u708e\u7b49\u90fd\u6709\u53ef\u80fd\u6709\u9020\u6210\u8996\u795e\u7d93\u9798\u7684\u76f4\u5f91\u589e\u52a0\u3002 (D)\u5c0d\u65bc\u7591\u4f3c\u773c\u7403\u7834\u88c2\u7684\u75c5\u4eba\uff0c\u4e0d\u5efa\u8b70\u4f7f\u7528\u8a72\u6aa2\u67e5\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "45\u6b72\u5973\u6027\uff0c\u904e\u53bb\u75c5\u53f2\u70ba\u91cd\u75c7\u808c\u7121\u529b (myasthenia gravis )\uff1b\u56e0\u547c\u5438\u5598\u81f3\u6025\u8a3a\u6c42\u6cbb\uff0c\u4e0b\u5217\u6558\u8ff0\u53ca\u8655\u7f6e\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u6700\u5e38\u898b\u4e4b\u4e3b\u8a34\u53ef\u80fd\u70ba\u80a2\u9ad4\u808c\u8089\u3001\u9838\u90e8\u4f38\u808c(neck extensor )\u3001\u4ee5\u53ca\u984f\u9762\u808c\u7121\u529b\u7b49\u75c7\u72c0\u3002 (B)\u8003\u616e\u662f\u5426\u6709 myasthenic crisis \uff0c\u61c9\u76e1\u5feb\u7d66\u4e88 acetylcholinesterase inhibitors\uff0c\u5982 Pyridostigmine \u7b49\u3002 (C)\u5982\u5408\u4f75\u80ba\u708e\u611f\u67d3\uff0c\u6297\u751f\u7d20\u9078\u64c7\u61c9\u8a72\u907f\u514d\u4f7f\u7528 aminoglycosides \u6216\u662fquinolone \uff0c\u4ee5\u514d\u75c5\u60c5\u52a0\u5287\u3002 (D)\u5982\u75c5\u4eba\u547c\u5438\u8870\u7aed\u9700\u8981\u63d2\u7ba1\uff0c\u61c9\u907f\u514d\u4f7f\u7528 succinylcholine \uff0c\u53ef\u4f7f\u7528rocuronium \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6297\u51dd\u5291\u7684\u4f5c\u7528\u6a5f\u8f49\u5206\u5167\u5728\u3001\u5916\u5728\u548c\u5171\u540c\u8def\u5f91\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)Enoxaparin \u4f5c\u7528\u4f4d\u7f6e\u8f03 heparin\u5177\u5c08\u4e00\u6027\uff0c\u4e3b\u8981\u7684\u4f5c\u7528\u4f4d\u7f6e\u8207Dabigatran \u76f8\u540c\u3002 (B)Heparin \u4f5c\u7528\u5728\u5916\u5728\u8def\u5f91\uff0c\u4f7f\u7528\u6642\u9700\u5e38\u898f\u76e3\u6e2c aPTT\u3002 (C)Rivaroxaban \u53caDabigatran \u4f5c\u7528\u5728\u5171\u540c\u8def\u5f91\u3002 (D)Warfarin \u4f5c\u7528\u5728\u55ae\u4e00\u8def\u5f91\uff0c\u4f7f\u7528\u6642\u9700\u5e38\u898f\u76e3\u6e2c PT/INR\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "33\u6b72\u5973\u6027\uff0c\u5df2\u5a5a\u751f\u904e\u5c0f\u5b69\uff0c\u56e0\u9670\u9053\u4e0d\u660e\u539f\u56e0\u51fa\u8840\uff0c\u88ab\u8a3a\u6240\u8f49\u4f86\u6025\u8a3a\uff0c\u8acb\u554f\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5c0d\u65bc\u5b55\u9f61\u5973\u6027\u90fd\u8981\u8003\u616e\u61f7\u5b55\u7684\u53ef\u80fd\uff0c\u9664\u975e\u75c5\u4eba\u6709\u88dd\u5b50\u5bae\u907f\u5b55\u5668\u3002 (B)\u82e5\u75c5\u4eba\u6709\u61f7\u5b55\uff0c\u5247\u9670\u9053\u51fa\u8840\u8ddf\u61f7\u5b55\u8f03\u4e0d\u76f8\u95dc\uff0c\u8981\u8003\u616e\u5176\u4ed6\u539f\u56e0\u3002 (C)\u5982\u679c\u662f\u5728\u6708\u7d93\u671f\u9593\u9694\u4e2d\u9593\u51fa\u73fe\u7684\u51fa\u8840\uff0c\u5403\u907f\u5b55\u85e5\u53ef\u80fd\u662f\u5e38\u898b\u7684\u539f\u56e0\u3002 (D)NSAID \u5c0d\u7d93\u75db\u51fa\u8840\u6709\u6e1b\u7de9\u75bc\u75db\u6548\u679c\uff0c\u4f46\u7121\u6cd5\u6e1b\u5c11\u51fa\u8840\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "80\u6b72\u7537\u6027\u6709\u651d\u8b77\u817a\u80a5\u5927\u7684\u75c5\u53f2\uff0c\u5df2\u4f7f\u7528\u77fd\u8cea\u9577\u671f\u7559\u7f6e\u5c0e\u5c3f\u7ba1\u8d85\u904e\u4e00\u5e74\uff0c\u4e26\u6709\u6309\u6642\u5b9a\u671f\u66f4\u63db\uff0c\u6700\u5f8c\u4e00\u6b21\u66f4\u63db\u5c3f\u7ba1\u70ba 30\u5929\u524d\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u82e5\u6b64\u75c5\u4eba\u4f86\u8a3a\u4e3b\u8a34\u70ba\u4e0a\u8179\u75db\uff0c\u7121\u767c\u71d2\u6216\u5176\u4ed6\u75c7\u72c0\u3002\u5c3f\u6db2\u6aa2\u67e5\u51fa\u81bf\u5c3f(pyuria)\u52a0\u4e0a\u5c3f\u6db2\u57f9\u990a\u9577\u51fa gram -positive cocci \u53ef\u8a3a\u65b7\u70ba\u6ccc\u5c3f\u9053\u611f\u67d3\u3002 (B)\u4f7f\u7528\u9577\u671f\u7559\u7f6e\u5c0e\u5c3f\u7ba1\u7684\u75c5\u4eba\u767c\u751f\u6ccc\u5c3f\u9053\u611f\u67d3\u6642\u901a\u5e38\u53ef\u57f9\u990a\u51fa\u591a\u7a2e\u83cc\u7a2e\u3002 (C)\u82e5\u6b64\u75c5\u4eba\u7684\u8a3a\u65b7\u70ba\u6ccc\u5c3f\u9053\u611f\u67d3\uff0c Morganella morganii \u53caProteus mirabilis \u5c6c\u65bc\u5e38\u898b\u7684\u81f4\u75c5\u83cc\u3002 (D)\u82e5\u6b64\u75c5\u4eba\u7684\u8a3a\u65b7\u70ba\u6ccc\u5c3f\u9053\u611f\u67d3\uff0c\u5efa\u8b70\u8981\u79fb\u9664\u5c3f\u7ba1\u6216\u66f4\u63db\u65b0\u7684\u5c3f\u7ba1\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5fa9\u7526\u671f\u9593\u4f7f\u7528\u85e5\u7269\uff0c\u598a\u5a20\u98a8\u96aa\u985e\u5225\uff0c\u4e0b\u5217\u4f55\u8005\u70ba \u6700\u9ad8\u98a8\u96aa\uff1f", + "Options": "(A)Epinephrine \u3002 (B)Lidocaine \u3002 (C)Dobutamine \u3002 (D)Magnesium sulfate\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "36\u6b72\u5973\u6027\u6709\u7d05\u6591\u6027\u72fc\u7621\u75c5\u53f2\uff0c\u898f\u5247\u5728\u9580\u8a3a\u670d\u85e5\u63a7\u5236\uff0c\u4eca\u65e5\u5287\u70c8\u982d\u75db\uff0c\u8996\u529b\u6a21\u7cca\uff0c\u5f8c\u4f86\u56e0\u6709\u62bd\u6410( seizure)\u9001\u81f3\u6025\u8a3a\uff0c\u8840\u58d3 210/100 mmHg \uff0c\u773c\u5e95\u6aa2\u67e5\u7121\u8996\u4e73\u7a81\u6c34\u816b\uff0c\u8166\u90e8\u96fb\u8166\u65b7\u5c64\u7121\u7279\u6b8a\u7570\u5e38\u767c\u73fe\uff0c\u95dc\u65bc\u9451\u5225\u8a3a\u65b7\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)Intracranial hypotension \u3002 (B)Occipital neuralgia \u3002 (C)Posterior reversible encephalopathy syndrome \u3002 (D)Pseudotumor cerebri syndrome \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "35\u6b72\u5973\u6027\uff0c\u7121\u9ad8\u8840\u58d3\u8207\u51a0\u72c0\u52d5\u8108\u75be\u75c5\u75c5\u53f2\u3002\u56e0 3\u500b\u6708\u4f86\u6709\u5168\u8eab\u4e0d\u9069\u3001\u75b2\u52de\u3001\u767c\u71b1\u3001\u98df\u6b32\u4e0d\u632f\u3001\u5641\u5fc3\u7b49\u75c7\u72c0\u3002\u6d3b\u52d5\u6642\u51fa\u73fe\u80a2\u9ad4\u7121\u529b\uff0c\u4e0a\u80a2\u8f03\u70ba\u660e\u986f\uff1b\u5fc3\u81df\u807d\u8a3a\u6b63\u5e38\uff0c\u4f46\u4e00\u5074\u80b1\u52d5\u8108 (brachial artery )\u640f\u52d5\u6709\u6e1b\u5f31\u73fe\u8c61\u3002\u4ee5\u4e0b\u4f55\u7a2e\u80a2\u9ad4\u52d5\u8108\u7f3a\u8840(arterial ischemia )\u4e4b\u8a3a\u65b7 \u8f03\u70ba\u9069\u7576 \uff1f", + "Options": "(A)Thromboangiitis obliterans (Buerger\u2019s disease )\u3002 (B)Takayasu\u2019s arteritis \u3002 (C)Hypothenar hammer syndrome \u3002 (D)Raynaud\u2019s disease \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u9aa8\u6298\u60c5\u5883\uff0c\u4f55\u8005\u5152\u8650\u53ef\u80fd\u6027\u6700\u4f4e \uff1f", + "Options": "(A)\u56db\u6b72\u7537\u5b69\uff0c\u5de6\u5074\u80b1\u9aa8\u5e79\u9aba\u7aef (metaphyseal )\u9aa8\u6298\uff0c\u7236\u89aa\u8aaa\u662f\u727d\u624b\u904e\u99ac\u8def\u9020\u6210\u3002 (B)11 \u500b\u6708\u5927\u5b30\u5152\u53f3\u5074\u80a1\u9aa8\u9aa8\u6298\uff0c\u6bcd\u89aa\u8aaa\u4e0d\u614e\u5f9e\u5b30\u5152\u5e8a\u4e0a\u6389\u843d\u9020\u6210\u3002 (C)\u4e09\u6b72\u7537\u5b69\u53f3\u5074\u811b\u9aa8\u9060\u7aef\u7121\u79fb\u4f4d\u87ba\u65cb\u6027\u9aa8\u6298\uff0c\u7236\u89aa\u8aaa\u4e0d\u51fa\u539f\u56e0\u3002 (D)\u4e94\u6b72\u7537\u5b69\u5de6\u5f8c\u65b9\u7b2c 7\u7b2c8\u808b\u9aa8\u9aa8\u6298\uff0c\u6bcd\u89aa\u8aaa\u662f\u8dd1\u6b65\u8dcc\u5012\u9020\u6210\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u544a\u77e5\u6b7b\u4ea1\u7684\u6b65\u9a5f GRIEV_ING protocol \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)G \u4ee3\u8868 Gathering \uff0c\u5c07\u5bb6\u5c6c\u805a\u96c6\u5728\u4e00\u500b\u5b89\u975c\u7684\u74b0\u5883\u9032\u884c\u8a0e\u8ad6\u3002 (B)R \u4ee3\u8868 Respect\uff0c\u5728\u8207\u5bb6\u5c6c\u6e9d\u901a\u7684\u904e\u7a0b\u8981\u5c0a\u91cd\u6bcf\u500b\u5bb6\u5c6c\u7684\u610f\u898b\u3002 (C)E \u4ee3\u8868 Empathy\uff0c\u61c9\u8003\u91cf\u5bb6\u5c6c\u7684\u60c5\u7dd2\u4e26\u5c55\u73fe\u540c\u7406\u5fc3\u3002 (D)V \u4ee3\u8868 Vacancy\uff0c\u505c\u6b62\u8aaa\u8a71\uff0c\u7559\u7d66\u5bb6\u5c6c\u4e00\u6bb5\u7a7a\u767d\u3001\u8655\u7406\u54c0\u50b7\u7684\u6642\u9593\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u6839\u64da\u5927\u91cf\u50b7\u60a3\u6aa2\u50b7 SALT triage algorithm \uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u9996\u5148\u5c07\u75c5\u4eba\u5206\u6210\u4e09\u985e\uff0c\u5340\u5225\u8a55\u4f30\u512a\u5148\u9806\u5e8f\u3002 (B)\u4e0d\u80fd\u884c\u8d70\u4f46\u53ef\u4ee5\u63ee\u624b\u4e4b\u75c5\u4eba\u70ba\u8a55\u4f30\u7684\u7b2c\u4e00\u9806\u4f4d\u3002 (C)\u82e5\u767c\u73fe\u5f35\u529b\u6027\u6c23\u80f8\uff0c\u9700\u7acb\u5373\u76e1\u5feb\u5be6\u65bd\u80f8\u90e8\u7a7f\u523a\u6e1b\u58d3\u3002 (D)\u82e5\u610f\u8b58\u72c0\u6cc1\u4e0d\u4f73\u4f46\u53ef\u80fd\u5b58\u6d3b\uff0c\u5247\u6b64\u75c5\u4eba\u6aa2\u50b7\u70ba\u7d05\u8272\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u80f8\u90e8\u5916\u50b7\u4e4b\u63cf\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u5927\u7d04 50%\u4e4b\u808b\u9aa8\u9aa8\u6298\u5728\u80f8\u90e8 X\u5149\u4e0d\u660e\u986f\u3002 (B)\u7576\u767c\u73fe\u7b2c\u4e00\u3001\u4e8c\u808b\u9aa8\u9aa8\u6298\u6642\uff0c\u9808\u6ce8\u610f\u662f\u5426\u6709\u5408\u4f75\u5fc3\u81df\u3001\u6c23\u7ba1\u3001\u6216\u4e3b\u52d5\u8108\u53d7\u50b7\u3002 (C)\u6c23\u7ba1\u53d7\u50b7\u901a\u5e38\u767c\u751f\u5728 carina\u9644\u8fd1\u3002 (D)\u56b4\u91cd\u80f8\u90e8\u5916\u50b7\u5e38\u5408\u4f75\u5438\u5165\u6027\u80ba\u708e\uff0c\u5efa\u8b70\u4f7f\u7528\u6297\u751f\u7d20\u9810\u9632\u611f\u67d3\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "62\u6b72\u7537\u6027\uff0c\u6709\u9152\u7cbe\u6027\u809d\u786c\u5316\u5408\u4f75\u8179\u6c34\u75c5\u53f2\uff0c\u904e\u53bb\u814e\u529f\u80fd\u6b63\u5e38\uff0c\u9019\u6b21\u767c\u71d2 5\u5929\u5408\u4f75\u5641\u5fc3\u3001\u5614\u5410\u3001\u5c3f\u5c11\uff0c\u81f3\u6025\u8a3a\u6c42\u6cbb\u3002\u9ad4\u6eab 38.8\u2103\uff0c\u62bd\u8840\u5831\u544a\u986f\u793a\u814e\u529f\u80fd\u986f\u8457\u60e1\u5316\uff0c\u808c\u9178\u9150\u503c(creatinine )\u70ba\u6aa2\u9a57\u6b63\u5e38\u503c\u4e0a\u9650\u7684 3\u500d\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u6b64\u75c5\u4eba\u8a3a\u65b7\u53ef\u80fd\u70ba\u809d\u814e\u75c7\u5019\u7fa4\uff0c\u5e38\u4f34\u96a8\u81ea\u767c\u7d30\u83cc\u6027\u8179\u819c\u708e\u3002 (B)\u82e5\u75c5\u4eba\u7121\u8179\u90e8\u75bc\u75db\u4ee5\u53ca\u8179\u90e8\u58d3\u75db\uff0c\u53ef\u6392\u9664\u81ea\u767c\u7d30\u83cc\u6027\u8179\u819c\u708e\u3002 (C)\u814e\u81df\u7d30\u80de\u5b78\u6aa2\u67e5\u901a\u5e38\u6709\u7570\u5e38\u767c\u73fe\u3002 (D)\u8179\u6c34\u5206\u6790\u767d\u8840\u7403> 100 /mm3\uff0c\u4e14\u55dc\u4e2d\u6027\u767d\u8840\u7403> 50% \u53ef\u8a3a\u65b7\u81ea\u767c\u6027\u8179\u819c\u708e\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "46\u6b72\u63a5\u53d7\u8179\u819c\u900f\u6790\u5973\u6027\u56e0\u6025\u6027\u8179\u75db\u81f3\u6025\u8a3a\uff0c\u8179\u819c\u900f\u6790\u6db2\u5206\u6790\u5982\u4e0b \uff1aWBC count 182/mm3\u3001Neutrophil 64% \u3001Mononuclear 36% \u3001Protein <0.1 g/dL \u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u8eab\u9ad4\u8a3a\u5bdf\u9700\u6ce8\u610f\u662f\u5426\u6709\u8179\u58c1\u759d\u6c23\uff0c\u5fc5\u8981\u6642\u9700\u8981\u958b\u5200\u6cbb\u7642\u3002 (B)\u53ef\u8003\u616e\u5728\u8179\u819c\u900f\u6790\u6db2\u4e2d\u52a0\u5165 heparin\uff0c\u4f86\u6e1b\u5c11 fibrin clot \u4e4b\u7522\u751f\u3002 (C)\u8179\u819c\u900f\u6790\u6db2\u57f9\u990a\u6700\u5e38\u898b\u4e4b\u83cc\u7a2e\u70ba Streptococcus species\u3002 (D)\u8179\u819c\u900f\u6790\u6db2\u7684 Gram stain \u986f\u793a GNB\uff0c\u5247\u7d93\u9a57\u6027\u6297\u751f\u7d20\u6cbb\u7642\u9078\u64c7\u4f7f\u7528\u7b2c\u4e09\u4ee3 Cephalosporin \u6216Amionoglycoside \u85e5\u7269\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "80\u6b72\u5973\u6027\u56e0\u81bd\u56ca\u708e\u6557\u8840\u75c7\u4f4f\u9662 2\u9031\uff0c\u525b\u51fa\u9662 3\u5929\u53c8\u4f86\u6025\u8a3a\uff0c\u4e3b\u8a34\u591a\u65e5\u672a\u89e3\u4fbf\uff0c\u8eab\u9ad4\u8a3a\u5bdf\u767c\u73fe\u75c5\u4eba\u660e\u986f\u8179\u8139\uff0c\u809b\u9580\u6307\u8a3a\u4e26\u672a\u767c\u73fe\u786c\u4fbf\u963b\u585e\u5728\u76f4\u8178\uff0c\u8179\u90e8X\u5149\u898b\u5927\u8178\u660e\u986f\u8139\u5927\u76f4\u5f91\u9054 10\u516c\u5206\uff0c\u4f46\u8840\u6db2\u96fb\u89e3\u8cea\u7121\u7570\u5e38\uff0c\u96fb\u8166\u65b7\u5c64\u4ea6\u672a\u898b\u9020\u6210\u963b\u585e\u4e4b\u75c5\u7076\uff0c\u4f55\u8005\u662f\u6700\u6709\u53ef\u80fd \u7684\u8a3a\u65b7\uff1f", + "Options": "(A)Ischemic colitis \u3002 (B)Ogilvie\u2019s syndrome \u3002 (C)Pseudomembranous colitis \u3002 (D)Sigmoid volvulus \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5152\u7ae5\u7d50\u819c\u708e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u8033\u524d\u6dcb\u5df4\u7d50\u816b\u5927\uff0c\u5e38\u898b\u65bc\u75c5\u6bd2\u611f\u67d3\u3002 (B)\u7d30\u83cc\u6027\u7d50\u819c\u708e\u53ef\u4e0d\u4f7f\u7528\u53e3\u670d\u6297\u751f\u7d20\u6cbb\u7642\u3002 (C)\u5982\u679c\u5408\u4f75\u6709\u4e2d\u8033\u708e\uff0c\u5e38\u898b\u662f H. influenza \u611f\u67d3\u3002 (D)\u7d30\u83cc\u611f\u67d3\u5e38\u898b\u91d1\u9ec3\u8272\u8461\u8404\u7403\u83cc (S. aureus)\u8207\u7da0\u81bf\u687f\u83cc (P. aeruginosa) \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6839\u64da 2020 AHA Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care \u95dc\u65bc\u5152\u79d1\u6c23\u9053\u7d66\u6c27\u6025\u6551\u5fa9\u7526\u90e8\u5206 , \u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u5c0d\u65bc\u6240\u6709\u60c5\u6cc1\u4e0b\u7684\u5c0f\u5152\u5fa9\u7526\u8853\uff0c\u5efa\u8b70\u7684\u8f14\u52a9\u901a\u6c23\u901f\u7387\u52a0\u5feb\u81f3\u6bcf 2~3 \u79d2\u901a\u6c23 1\u6b21(\u6bcf\u5206\u9418\u901a\u6c23 20~30\u6b21)\u3002 (B)\u63d2\u7ba1\u4e0d\u518d\u5efa\u8b70\u4f8b\u884c\u57f7\u884c\u74b0\u72c0\u8edf\u9aa8\u58d3\u8feb\u3002 (C)\u5c0d\u65bc\u9700\u8981\u63d2\u7ba1\u7684\u4efb\u4f55\u5e74\u9f61\u5c64\u75c5\u4eba\uff0c\u4e0d\u518d\u5efa\u8b70\u4f7f\u7528\u6709\u6c23\u56ca\u7684\u6c23\u7ba1\u5167\u7ba1ETT\uff0c\u4ee5\u6e1b\u5c11\u6c23\u7ba1\u58d3\u8feb\u53d7\u50b7\u983b\u7387\u3002 (D)\u5c0d\u65bc\u5df2\u63d2\u5165\u52d5\u8108\u5c0e\u7ba1\u7684\u75c5\u4eba\uff0c\u85c9\u7531\u6301\u7e8c\u6e2c\u91cf\u52d5\u8108\u8840\u58d3\u6240\u7522\u751f\u7684\u56de\u994b\u53ef\u63d0\u9ad8 CPR\u54c1\u8cea\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u95dc\u65bc\u773c\u79d1\u6025\u75c7\u7684\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u61f7\u7591\u6709\u958b\u653e\u578b\u773c\u7403\u50b7\u5bb3(open -globe injury )\u7684\u75c5\u4eba\uff0c\u521d\u6b65\u8655\u7406\u61c9\u70ba\u5305\u8986\u4fdd\u8b77\u773c\u7403\uff0c\u907f\u514d\u5728\u75c5\u4eba\u7121\u6cd5\u914d\u5408\u7684\u60c5\u6cc1\u4e0b\u5f37\u884c\u775c\u958b\u75c5\u4eba\u7684\u773c\u775b\u505a\u6aa2\u67e5\u3002 (B)\u61f7\u7591\u6709\u958b\u653e\u578b\u773c\u7403\u50b7\u5bb3(open -globe injury )\u7684\u75c5\u4eba\uff0c\u82e5\u773c\u76ae\u6c34\u816b\u7121\u6cd5\u505a\u8a73\u7d30\u7684\u773c\u79d1\u6aa2\u67e5\u6642\uff0c\u53ef\u5ef6\u9072\u81f3\u624b\u8853\u7684\u540c\u6642\u518d\u4e00\u4f75\u6aa2\u67e5\u5373\u53ef\u3002 (C)\u5c0d\u65bc\u773c\u5167\u7570\u7269(intraocular foreign body )\u7684\u75c5\u4eba\uff0c\u96fb\u8166\u65b7\u5c64\u662f\u5fc5\u8981\u6aa2\u67e5\u9805\u76ee\u3002 (D)\u773c\u5167\u7570\u7269 (intraocular foreign body )\u4ee5\u9285\u7684\u6bd2\u6027\u8f03\u5927\uff0c\u61c9\u8a72\u5118\u901f\u624b\u8853\u53d6\u51fa\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "36\u6b72\u7537\u6027\uff0c\u53f3\u5927\u817f\u906d\u92fc\u7b4b\u7a7f\u523a\u50b7\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u9032\u884c\u521d\u7d1a\u8a55\u4f30\u6642\uff0c\u82e5\u50b7\u53e3\u6b63\u5728\u51fa\u8840\uff0c\u9996\u5148\u61c9\u8003\u616e\u5c40\u90e8\u58d3\u8feb\u6b62\u8840\u6216\u8005\u4f7f\u7528\u6b62\u8840\u5e36\u3002 (B)\u9032\u884c\u6b21\u7d1a\u8a55\u4f30\u6642\uff0c\u61c9\u8a55\u4f30\u662f\u5426\u6709\u52d5\u8108\u53d7\u50b7\u4e4b\u8de1\u8c61\uff1a\u5982\u8108\u640f\u6d88\u5931\u3001\u9060\u7aef\u80a2\u9ad4\u51b0\u51b7\u7b49\u3002 (C)ankle -brachial index > 0.9 \uff0c\u5247\u61c9\u8003\u616e\u662f\u5426\u6709\u8840\u7ba1\u53d7\u50b7\u3002 (D)\u80a1\u795e\u7d93(femoral nerve )\u6709\u53d7\u50b7\uff0c\u53ef\u6e2c\u8a66\u819d\u95dc\u7bc0\u4f38\u5c55(knee extension)\u4ee5\u8a55\u4f30\u529f\u80fd\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4ee5\u4e0b\u95dc\u65bc\u6ccc\u5c3f\u9053\u7d50\u77f3\u7684\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u5728 X\u5149\u5f71\u50cf\u4e0a\u91cf\u6e2c\u5230\u7684\u5c3a\u5bf8\uff0c\u7d55\u5927\u591a\u6578\u6703\u6bd4\u5be6\u969b\u4e0a\u7684\u5c3a\u5bf8\u5c0f\uff0c\u5dee\u8ddd\u53ef\u80fd\u6703\u5230 20%\u3002 (B)\u6ccc\u5c3f\u9053\u7d50\u77f3\u70ba\u8179\u4e3b\u52d5\u8108\u7624\u7834\u88c2\uff0c\u6700\u5e38\u88ab\u8aa4\u5224\u7684\u8a3a\u65b7\u3002 (C)\u6ccc\u5c3f\u9053\u7d50\u77f3\u3001\u6025\u6027\u814e\u76c2\u814e\u708e\u3001\u6025\u6027\u814e\u81df\u6897\u585e\u90fd\u6709\u53ef\u80fd\u6703\u4ee5\u80cc\u75db\u53ca\u8840\u5c3f\u8868\u73fe\u3002 (D)\u9ad8\u8840\u58d3\u3001\u7cd6\u5c3f\u75c5\u3001\u55ae\u5074\u814e\u5207\u9664\u53ca\u814e\u79fb\u690d\u8853\u5f8c\u7686\u70ba\u6ccc\u5c3f\u9053\u7d50\u77f3\u75c5\u4eba \u5408\u4f75\u6025\u6027\u814e\u8870\u7aed\u7684\u98a8\u96aa\u56e0\u5b50\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u75c5\u4eba\u4e3b\u8a34\u8d70\u8def\u7d46\u5012\uff0c\u82e5\u61f7\u7591\u89aa\u5bc6\u4f34\u4fb6\u66b4\u529b\u4e4b\u5fb5\u8c61\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u9020\u6210\u5168\u8eab\u53ca\u8ec0\u5e79\u591a\u8655\u7600\u9752\u3002 (B)\u96d9\u819d\u7600\u9752\u53ca\u8840\u816b\u3002 (C)\u6162\u6027\u9aa8\u76c6\u8154\u75bc\u75db\u591a\u6b21\u81f3\u6025\u8a3a\u5c31\u8a3a\u3002 (D)\u9838\u90e8\u53ca\u96d9\u5074\u524d\u81c2\u591a\u8655\u7600\u9752\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u4f55\u8005\u662f\u9ecf\u8457\u6027\u95dc\u7bc0\u708e( adhesive capsulitis )\u6700\u91cd\u8981\u7684\u7279\u5fb5\uff1f", + "Options": "(A)\u80a9\u8180\u6709\u5c40\u90e8\u7684\u523a\u75db\u3002 (B)\u4e3b\u52d5\u548c\u88ab\u52d5\u6d3b\u52d5\u7bc4\u570d\u53d7\u9650\u3002 (C)\u4e0a\u81c2\u5b8c\u5168\u5931\u53bb\u611f\u89ba\u3002 (D)\u8d85\u97f3\u6ce2\u986f\u793a\u8840\u7ba1\u6d41\u91cf\u589e\u52a0\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5e74\u9577\u8005\u4e4b\u5916\u50b7\uff0c\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u5bb9\u6613\u56e0\u80f8\u90e8\u5916\u50b7\u800c\u7522\u751f\u808b\u9aa8\u9aa8\u6298\u7e7c\u800c\u9020\u6210\u80ba\u708e\u53ca\u547c\u5438\u8870\u7aed\uff0c\u61c9\u5efa\u8b70\u4f4f\u9662\u6cbb\u7642\u3002 (B)\u82e5 X\u5149\u6b63\u5e38\u4f46\u61f7\u7591\u6709\u9ad6\u90e8\u9aa8\u6298\uff0c\u5efa\u8b70\u5b89\u6392\u9032\u4e00\u6b65\u5f71\u50cf\u6aa2\u67e5\u3002 (C)\u982d\u90e8\u5916\u50b7\u6bd4\u5e74\u8f15\u4eba\u66f4\u5bb9\u6613\u6709\u786c\u819c\u4e0a\u51fa\u8840\u3002 (D)\u82e5\u6709\u670d\u7528\u6297\u51dd\u8840\u5291\u8005\u7684\u982d\u90e8\u5916\u50b7\u4e0d\u8ad6\u662f\u5426\u6709\u75c7\u72c0\uff0c\u5efa\u8b70\u5b89\u6392\u982d\u90e8\u96fb\u8166\u65b7\u5c64\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "65\u6b72\u7537\u6027\u56e0\u4e0b\u54bd\u764c\u65bc 2\u9031\u524d\u505a\u6c23\u5207\uff0c\u4eca\u56e0\u6c23\u5207\u7ba1\u8def\u8f15\u5fae\u51fa\u8840\u5c31\u91ab\uff0c\u7559\u89c0\u671f\u9593\u5ffd\u7136\u5927\u91cf\u51fa\u8840\uff0c\u4e0b\u5217\u63cf\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u82e5\u6301\u7e8c\u51fa\u8840\uff0c\u53ef\u4ee5\u58d3\u4f4f\u6c23\u7ba1\u4e26\u5c07\u6c23\u5207\u7ba1\u7de9\u6162\u5916\u62c9\u6b62\u8840\u3002 (B)\u82e5\u6301\u7e8c\u51fa\u8840\uff0c\u53ef\u4ee5\u8003\u616e\u79fb\u9664\u6c23\u5207\u7ba1\uff0c\u7d93\u53e3\u7f6e\u5165\u6c23\u7ba1\u5167\u7ba1\uff0c\u4e26\u5c07\u6c23\u56ca\u76e1\u91cf\u653e\u5728\u51fa\u8840\u9ede\u4e0b\u65b9\u3002 (C)\u82e5\u6301\u7e8c\u51fa\u8840\uff0c\u53ef\u4ee5\u5c07\u624b\u6307\u6cbf\u8457\u6c23\u5207\u53e3\u7f6e\u5165\u4e26\u58d3\u5728\u80f8\u9aa8\u5f8c\u65b9\u7684\u7121\u540d\u52d5\u8108\u5354\u52a9\u6b62\u8840\u3002 (D)\u8a72\u75c5\u4eba\u53ef\u80fd\u662f\u6c23\u56ca\u58d3\u529b\u904e\u5927\u5c0e\u81f4\u6c23\u7ba1\u7121\u540d\u52d5\u8108\u763b\u7ba1(tracheoinnominate artery fistula ) \uff0c\u61c9\u8a72\u7acb\u5373\u5c07\u6c23\u56ca\u6d88\u6c23\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "65\u6b72\u7537\u6027 30\u5206\u9418\u524d\u56e0\u53f3\u4e0a\u80a2\u7121\u529b\uff0c\u982d\u75db\uff0c\u53ca\u53e3\u9f52\u4e0d\u6e05\u9001\u81f3\u6025\u8a3a\u3002\u5165\u9662\u6642\u9ad4\u6eab 36\u00b0C\uff0c\u5fc3\u8df3 85\u6b21/min\uff0c\u547c\u5438 20\u6b21/min\uff0c\u8840\u58d3 201/145 mmHg \u3002\u4ee5\u4e0b\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u75c5\u4eba\u5408\u4f75\u6709\u5c0d\u5074\u504f\u76f2 (contralateral homonymous hemianopia )\u4e4b\u795e\u7d93\u5b78\u75c7\u72c0\u6642\uff0c\u61f7\u7591 PCA infarction\u3002 (B)\u75c5\u4eba\u8981\u65bd\u6253 thrombolytic \u524d\uff0c\u9808\u5c07\u8840\u58d3\u63a7\u5236\u81f3 SBP\u2266185mmHg \uff0cDBP\u2266110 mmHg \u3002 (C)\u4e0d\u8ad6\u6709\u7121\u63a5\u53d7 thrombolytic \uff0c\u61c9\u7acb\u5373\u7d66\u4e88 antiplatelet agent \uff0c\u5982aspirin\u3002 (D)\u52d5\u8108\u5167\u53d6\u6813\u8853\u61c9\u65bc\u75c7\u72c0\u958b\u59cb 6\u5c0f\u6642\u5167\u958b\u59cb\u57f7\u884c\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u6025\u6027\u5916\u8033\u708e\u4e4b\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u4f7f\u7528 Ofloxacin \u8033\u6ef4\u5291\u5728\u8033\u819c\u7834\u88c2\u4e4b\u75c5\u4eba\u662f\u5b89\u5168\u7684\u3002 (B)Methicillin -resistant S. aureus \u70ba\u60e1\u6027\u5916\u8033\u708e (malignant otitis externa)\u6700\u5e38\u898b\u611f\u67d3\u83cc\u7a2e\u3002 (C)\u5916\u8033\u708e\u7981\u7528\u918b\u9178\u8033\u6ef4\u5291\u3002 (D)\u82e5\u61f7\u7591\u9ef4\u83cc\u611f\u67d3\u4e0d\u5efa\u8b70\u4f7f\u7528\u6297\u9ef4\u83cc\u8033\u6ef4\u5291\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u9f3b\u9aa8\u9aa8\u6298\u8655\u7406\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u4f8b\u884c\u7167 X\u5149\u5354\u52a9\u8a3a\u65b7\uff0c\u5408\u4f75\u5176\u4ed6\u984f\u9762\u9aa8\u6298\u518d\u7167\u96fb\u8166\u65b7\u5c64\u3002 (B)\u9f3b\u4e2d\u8188\u8840\u816b\u53ef\u5148\u89c0\u5bdf\uff0c\u6c92\u5438\u6536\u518d\u5f15\u6d41\u3002 (C)\u9f3b\u9aa8\u9aa8\u6298\u5408\u4f75\u6495\u88c2\u50b7\u8207\u5176\u4ed6\u958b\u653e\u6027\u9aa8\u6298\u6cbb\u7642\u539f\u5247\u4e0d\u540c\u3002 (D)\u9f3b\u5b50\u8b8a\u5f62\u9700\u6703\u8a3a\u8033\u9f3b\u5589\u79d1\u8a0e\u8ad6\uff0c6 ~10\u5929\u5167\u6d88\u816b\u5f8c\u518d\u9032\u884c\u8a55\u4f30\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u7206\u70b8\u50b7\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u75c5\u4eba\u53d7\u50b7\u7684\u773c\u775b\u82e5\u4e00\u958b\u59cb\u7684\u8996\u529b\u4e0d\u4f73\uff0c\u5176\u9810\u5f8c\u4e0d\u597d\u3002 (B)\u8033\u819c\u53d7\u50b7\u7684\u72c0\u6cc1\uff0c\u53ef\u4ee5\u7528\u4f86\u8a55\u4f30\u7206\u70b8\u50b7\u7684\u56b4\u91cd\u7a0b\u5ea6\u3002 (C)\u8179\u5167\u5668\u5b98\u56e0\u7206\u70b8\u800c\u53d7\u50b7\u7684\u75c5\u4eba\uff0c\u610f\u5473\u8457\u96e2\u7206\u70b8\u6e90\u5f88\u8fd1\u3002 (D)\u5fc3\u5f8b\u4e0d\u6574\u662f\u7206\u70b8\u50b7\u6700\u5e38\u898b\u7684\u6b7b\u56e0\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u81bd\u56ca\u75be\u75c5\u4e4b\u6558\u8ff0\uff0c\u4ee5\u4e0b\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u975e\u985e\u56fa\u9187\u6d88\u708e\u6b62\u75db\u85e5( NSAIDs)\u53ef\u4f5c\u70ba\u81bd\u7d5e\u75db (biliary colic)\u767c\u4f5c\u6642\u4e4b\u9996\u9078\u6b62\u75db\u85e5\u3002 (B)\u8d85\u97f3\u6ce2\u8a3a\u65b7\u81bd\u56ca\u708e\uff0c\u81bd\u58c1\u589e\u539a\u53ca\u81bd\u56ca\u9031\u570d\u7a4d\u6db2\u7684\u767c\u73fe\u5177\u6709\u5f88\u9ad8\u7684\u7279\u7570\u5ea6(specificity )\u3002 (C)\u7522\u6c23\u6027(emphysematous )\u81bd\u56ca\u708e\u6b7b\u4ea1\u7387\u6bd4\u4e00\u822c\u81bd\u56ca\u708e\u4f4e\u3002 (D)\u7121\u7d50\u77f3\u6027 (acalculous )\u81bd\u56ca\u708e\u6bd4\u7d50\u77f3\u6027\u81bd\u56ca\u708e\u8f03\u4e0d\u6613\u767c\u751f\u4f75\u767c\u75c7\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8f38\u8840\u76f8\u95dc\u79fb\u690d\u9ad4\u6297\u5bbf\u4e3b\u75be\u75c5( transfusion -associated graft -versus -host disease)\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u82e5\u662f\u767c\u751f\u6b64\u75be\u75c5\u6b7b\u4ea1\u7387\u6975\u9ad8\u3002 (B)\u4f7f\u7528\u6e1b\u767d\u4e4b\u8840\u54c1(Leukocyte -reduces products )\u80fd\u964d\u4f4e\u767c\u751f\u6a5f\u6703\u3002 (C)\u5148\u5929\u514d\u75ab\u4e0d\u5168\u7684\u75c5\u4eba\u70ba\u6b64\u75be\u75c5\u7684\u9ad8\u98a8\u96aa\u65cf\u7fa4\u3002 (D)\u5df2\u7de9\u89e3\u7684\u4f55\u6770\u91d1\u6c0f\u75c5 (Hodgkin's disease )\u75c5\u4eba\u4f9d\u7136\u70ba\u9ad8\u98a8\u96aa\u65cf\u7fa4\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u4e3b\u52d5\u8108\u74e3\u72f9\u7a84 (aortic stenosis )\u7684\u63cf\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)EKG \u53ef\u80fd\u6703\u6709\u5de6\u5fc3\u5ba4\u80a5\u5927(left ventricular hypertrophy )\u7684\u60c5\u5f62\u3002 (B)\u82e5\u75c5\u4eba\u51fa\u73fe\u80ba\u6c34\u816b\uff0c\u4f7f\u7528 nitrates\u6216diuretics\u6642\u61c9\u5bc6\u5207\u76e3\u63a7\u75c5\u4eba\u8840\u58d3\u3002 (C)\u4e3b\u52d5\u8108\u74e3\u72f9\u7a84 classic triad \u70ba\u5598\u3001\u80f8\u75db\u3001\u660f\u53a5\u3002 (D)\u5e38\u4f34\u96a8\u767c\u751f endocarditis\uff0c\u9700\u8981\u7d66\u4e88\u9810\u9632\u6027\u6297\u751f\u7d20\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5b55\u5a66\u6216\u7522\u5f8c\uff0c\u4f7f\u7528\u4ee5\u4e0b\u7684\u5de5\u5177\u4f86\u8a3a\u65b7\u6216\u6392\u9664\u80ba\u6813\u585e\u8207\u975c\u8108\u6813\u585e\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u6a19\u6e96\u80ba\u52d5\u8108\u96fb\u8166\u65b7\u5c64\u5f8c\u4e0d\u9700\u505c\u6b62\u54fa\u4e73\u3002 (B)\u80ba\u81df\u8840\u6d41\u704c\u6ce8\u6aa2\u67e5(ventilation -perfusion scan )\u9808\u505c\u6b62\u54fa\u4e73 12\u5c0f\u6642\u3002 (C)\u4e0d\u7528\u986f\u5f71\u5291\u7684\u78c1\u632f\u9020\u5f71\u5c0d\u65bc\u8a3a\u65b7\u9aa8\u76c6\u8154\u7684\u975c\u8108\u6813\u585e\u5177\u6709\u53ef\u4fe1\u8cf4\u7684\u654f\u611f\u5ea6\u548c\u7279\u7570\u6027\u3002 (D)\u80ba\u81df\u8840\u6d41\u704c\u6ce8\u6aa2\u67e5\u6bd4\u8d77\u6a19\u6e96\u80ba\u52d5\u8108\u96fb\u8166\u65b7\u5c64\u80fd\u6e1b\u5c11\u80ce\u5152\u7684\u8f3b\u5c04\u66b4\u9732\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u8001\u4eba\u9ad6\u90e8\u5916\u50b7\u7684\u63cf\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)Shenton line \u662f\u8a3a\u65b7\u80a1\u9aa8\u9838\u9aa8\u6298\u4e0d\u53ef\u9760\u7684\u5f71\u50cf\u5b78\u4f9d\u64da\u3002 (B)\u80a1\u9aa8\u9838\u9aa8\u6298\uff0c\u53ef\u5148\u4ee5\u9aa8\u9abc\u727d\u5f15(skeletal traction )\u56fa\u5b9a\u60a3\u8655\u3002 (C)\u82e5 X\u5149\u7247\u7121\u7570\u5e38\uff0c\u4f46\u9084\u662f\u75bc\u75db\u81f3\u7121\u6cd5\u884c\u52d5\uff0c\u61c9\u5b89\u6392 CT\u6216MRI\u3002 (D)MRI \u5c0d\u8a3a\u65b7\u9ad6\u90e8\u9aa8\u6298\u7684\u654f\u611f\u5ea6\u63a5\u8fd1 100%\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "80\u6b72\u5973\u6027\uff0c\u904e\u53bb\u6709\u5fc3\u5f8b\u4e0d\u6574\u3001\u9ad8\u8840\u58d3\u3001\u5fc3\u8870\u7aed\u75c5\u53f2\uff0c\u4eca\u56e0\u547c\u5438\u5598\u4e14\u7aef\u5750\u547c\u5438\u81f3\u6025\u8a3a\u5c31\u8a3a\uff0c\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u80f8\u524d\u8d85\u97f3\u6ce2\u5728\u540c\u4e00\u756b\u9762\u4e2d\u51fa\u73fe\u4e00\u689d\u4ee5\u4e0a\u7684 B line\uff0c\u5177\u6709\u9ad8\u5ea6\u7279\u7570\u6027\u7684\u8a3a\u65b7\u80ba\u6c34\u816b\u3002 (B)\u9ad8\u5291\u91cf Nitroglycerin \u5c0d\u65bc\u9ad8\u8840\u58d3\u6027\u5fc3\u8870\u7aed\u5728\u6025\u6027\u671f\u6cbb\u7642\u6709\u5e6b\u52a9\uff0c\u4f46\u662f\u6709\u4e3b\u52d5\u8108\u8fa6\u9589\u9396\u4e0d\u5168\u6642\u53ef\u80fd\u6703\u5c0e\u81f4\u4f4e\u8840\u58d3\u3002 (C)Morphine \u4f7f\u7528\u65bc\u6025\u6027\u5fc3\u8870\u7aed\u75c5\u4eba\uff0c\u53ef\u4ee5\u4f7f\u8840\u7ba1\u64f4\u5f35\u3001\u964d\u4f4e\u6c23\u7ba1\u63d2\u7ba1\u6a5f\u6703\u3001\u6e1b\u5c11\u6b7b\u4ea1\u7387\u3002 (D)\u03b2 -Blockers \u53ef\u4ee5\u964d\u4f4e\u4ea4\u611f\u795e\u7d93\u6d3b\u6027\uff0c\u964d\u4f4e\u5fc3\u7387\uff0c\u964d\u4f4e\u6025\u6027\u5fc3\u8870\u7aed\u75c5\u4eba\u6b7b\u4ea1\u7387\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u6709\u95dc\u60c5\u7dd2\u75c5\u75c7( mood disorder )\u75c5\u4eba\uff0c\u6025\u8a3a\u8655\u7f6e\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u4e0d\u9700\u8981\u4f4f\u9662\u7684\u8f15\u5ea6\u6182\u9b31\u75c7\u75c5\u4eba\uff0c\u53ef\u8003\u616e\u958b\u59cb\u7d66\u4e88 SSRI(selective serotonin reuptake inhibitors )\u85e5\u7269\u6cbb\u7642\u3002 (B)\u5fc5\u9700\u505a\u81ea\u6bba\u98a8\u96aa\u8a55\u4f30\uff0c\u518d\u6c7a\u5b9a\u5f8c\u7e8c\u9069\u7576\u7684\u52d5\u5411\u3002 (C)\u75c5\u4eba\u5448\u73fe\u8e81\u52d5\u6642\uff0c\u6cbb\u7642\u8e81\u52d5\u512a\u5148\u65bc\u5b8c\u5168\u78ba\u8a8d\u5176\u75c5\u56e0\u3002 (D)\u5c0d\u65bc\u6025\u6027\u8e81\u75c7(acute mania )\uff0c\u975e\u5178\u578b\u6027\u6297\u7cbe\u795e\u75c5\u85e5\u7269\u5982Ziprasidone \uff0c\u4e0d\u53ef\u4f5c\u70ba\u55ae\u4e00\u8655\u65b9\uff0c\u9700\u642d\u914d\u5176\u4ed6\u7a69\u5b9a\u60c5\u7dd2\u85e5\u7269 (Lithium, Valproic acid )\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u810a\u9ad3\u640d\u50b7\u7684\u63cf\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u524d\u810a\u9ad3\u75c7\u5019\u7fa4( Anterior cord syndrome )\u5e38\u898b\u65bc\u76f4\u63a5\u524d\u810a\u9ad3\u58d3\u8feb\u6216\u9838\u690e\u5c48\u66f2 (flexion) \uff0c\u53d7\u50b7\u90e8\u4f4d\u4ee5\u4e0b\u904b\u52d5\u529f\u80fd\u53ca\u6eab\u75db\u89ba\u6d88\u5931\uff0c\u4fdd\u7559\u672c\u9ad4\u89ba\u53ca\u9707\u52d5\u89ba\u3002\u5373\u4f7f\u9069\u7576\u6cbb\u7642\uff0c\u9810\u5f8c\u4ecd\u4e0d\u4f73\u3002 (B)\u4e2d\u592e\u810a\u9ad3\u75c7\u5019\u7fa4(Central cord syndrome )\u5e38\u898b\u65bc\u9838\u690e\u9000\u5316\u5408\u4f75\u904e\u5ea6\u4f38\u5c55(hyperextension )\uff0c\u4e3b\u8981\u4ee5\u4e0a\u80a2\u75db\u89ba\u3001\u6eab\u5ea6\u89ba\u4e0b\u964d\u3001\u80a2\u9ad4\u529b\u91cf\u6e1b\u5c11\u70ba\u4e3b\uff0c\u4e0b\u80a2\u75c7\u72c0\u8f15\u5fae\u3002\u9069\u7576\u6cbb\u7642\u5f8c\uff0c\u9810\u5f8c\u826f\u597d\u3002 (C)Brown -S\u00e9quard \u75c7\u5019\u7fa4\u5e38\u898b\u65bc\u810a\u9ad3\u7a7f\u523a\u50b7\u6216\u5074\u908a\u58d3\u8feb\uff0c\u75c7\u72c0\u70ba\u53d7\u50b7\u90e8\u4f4d\u4ee5\u4e0b\u540c\u5074\u672c\u9ad4\u89ba\u3001\u9707\u52d5\u89ba\u6d88\u5931\u3001\u80a2\u9ad4\u7121\u529b\uff0c\u5c0d\u5074\u75db\u89ba\u3001\u6eab\u5ea6\u89ba\u6d88\u5931\u3002\u5373\u4f7f\u9069\u7576\u6cbb\u7642\u5f8c\uff0c\u9810\u5f8c\u4ecd\u4e0d\u4f73\u3002 (D)\u99ac\u5c3e\u75c7\u5019\u7fa4 (Cauda equina syndrome )\u5e38\u898b\u65bc\u85a6\u690e\u6a6b\u65b7\u6027\u9aa8\u6298\uff0c\u81e8\u5e8a\u8868\u73fe\u4ee5\u5927\u5c0f\u4fbf\u529f\u80fd\u7570\u5e38\u3001\u6703\u9670\u90e8\u8207\u81c0\u90e8\u5927\u817f\u5167\u5074\u611f\u89ba\u7570\u5e38\uff0c\u5408\u4f75\u4e0b\u80a2\u4e0d\u540c\u7a0b\u5ea6\u611f\u89ba\u7570\u5e38\u8207\u80a2\u9ad4\u7121\u529b\u70ba\u4e3b\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u5316\u5b78\u5de5\u5ee0\u5de5\u4eba\u5438\u5165\u4e0d\u660e\u6c23\u9ad4\u5f8c\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u74e6\u65af\u5c6c\u65bc\u5316\u5b78\u6027\u7a92\u606f\u5291\uff0c\u6cbb\u7642\u4e3b\u8981\u662f\u7d66\u4e88\u9ad8\u6fc3\u5ea6\u7684\u6c27\u6c23\u3002 (B)\u6c28\u6c23\u56e0\u70ba\u9ad8\u5ea6\u6c34\u6eb6\u6027\uff0c\u6703\u5728\u4e0b\u547c\u5438\u9053\u6eb6\u65bc\u6c34\u7522\u751f\u523a\u6fc0\u3002 (C)\u4e00\u6c27\u5316\u78b3\u9664\u4e86\u5f71\u97ff\u8840\u7d05\u7d20\u6c27\u6c23\u8f38\u9001\u5916\uff0c\u9084\u6703\u5e72\u64fe\u7d30\u80de\u5167\u6c27\u6c23\u5229\u7528\u3002 (D)\u6c1f\u5316\u6c2b\u6703\u6709\u547c\u5438\u9053\u548c\u7c98\u819c\u523a\u6fc0\u5916\uff0c\u9084\u6703\u7d50\u5408\u9382\u96e2\u5b50\u9020\u6210\u5fc3\u5f8b\u4e0d\u6574\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "50\u6b72\u5973\u6027\u5de5\u4f5c\u6642\u767c\u751f\u660f\u53a5\uff0c\u76ee\u524d\u4eba\u5b8c\u5168\u6e05\u9192\uff0c\u4f46\u4e0d\u8a18\u5f97\u767c\u751f\u7d93\u904e\uff0c\u95dc\u65bc\u8a72\u75c5\u4eba\u8a55\u4f30\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5982\u679c\u672a\u6709\u5b8c\u5168\u610f\u8b58\u55aa\u5931\uff0c\u98a8\u96aa\u8f03\u4f4e\u3002 (B)\u795e\u7d93\u6027(neurologic ) \u3001\u5fc3\u56e0\u6027( cardiac)\u548c\u53cd\u5c04\u6027( reflex mediated)\u660f\u53a5\u6709\u8f03\u9ad8\u7684\u6b7b\u4ea1\u98a8\u96aa\u3002 (C)\u660f\u53a5\u524d\u6709\u982d\u6688\u3001\u5192\u51b7\u6c57\u548c\u84bc\u767d\u7b49\u524d\u8da8\u75c7\u72c0(prodrome )\uff0c\u6bd4\u4e0d\u660e\u539f\u56e0\u660f\u53a5\u7684\u75c5\u4eba\u6709\u8f03\u4f4e\u7684\u98a8\u96aa\u3002 (D)\u85e5\u7269\u5f15\u8d77\u7684\u660f\u53a5\uff0c\u5927\u90e8\u4efd\u8d77\u56e0\u65bc\u610f\u8b58\u7684\u6291\u5236\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "50\u6b72\u7537\u6027\uff0c\u7121\u6162\u6027\u75be\u75c5\uff0c\u8d77\u5e8a\u6642\u767c\u73fe\u982d\u6688\u60f3\u5410\uff0c\u75c7\u72c0\u96a8\u6d3b\u52d5\u52a0\u5287\uff0c\u5e73\u8eba\u4f11\u606f\u4e00\u9663\u5b50\u53ef\u7de9\u89e3\uff0c\u6aa2\u50b7\u9ad4\u6eab 36\u00b0C\uff0c\u5fc3\u8df3 70\u6b21/min\uff0c\u8840\u58d3 160/90 mmHg \uff0c\u8840\u6c27\u6fc3\u5ea6 99%\uff0c\u521d\u6b65\u8a3a\u8996\u7121\u773c\u9707\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u8a62\u554f\u662f\u5426\u6709\u982d\u75db\u3001\u9838\u90e8\u75db\u3001\u5176\u5b83\u795e\u7d93\u5b78\u75c7\u72c0\u3002 (B)\u8003\u616e\u7d66\u4e88 Diphenhydramine \u3002 (C)\u8003\u616e\u57f7\u884c\u8033\u77f3\u5fa9\u4f4d\u8853\u3002 (D)\u8003\u616e\u57f7\u884c HINTS plus testing\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "64\u6b72\u7537\u6027\uff0c\u6709\u7cd6\u5c3f\u75c5\u53f2\uff0c\u65bc\u611f\u5192\u54b3\u55fd\u9f3b\u585e\u6578\u5929\u5f8c\uff0c\u767c\u751f\u5de6\u773c\u7736\u7d05\u816b\u3001\u773c\u7403\u8f49\u52d5\u75bc\u75db\u8207\u8907\u8996\uff0c\u4e0b\u5217\u6558\u8ff0\u8207\u8655\u7f6e\uff0c\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u6700\u5e38\u898b\u7684\u539f\u56e0\u662f\u4e0a\u981c\u7ac7\u9f3b\u7ac7\u708e (maxillary sinusitis )\u5408\u4f75\u773c\u7736\u4e0b\u58c1(inferior wall )\u7a7f\u5b54\uff0c\u5c0e\u81f4\u773c\u7403\u5468\u908a\u7d44\u7e54\u611f\u67d3\u3002 (B)\u7cd6\u5c3f\u75c5\u8207\u514d\u75ab\u529b\u4f4e\u4e0b\u75c5\u4eba\uff0c\u9700\u8003\u616e\u9ef4\u83cc\u611f\u67d3\uff0c\u6700\u5e38\u898b\u7684\u662f\u9eb4\u83cc\u5c6c(Aspergillus) \u3002 (C)\u5982\u679c\u75c5\u4eba\u6c92\u6709\u767c\u71d2\u3001\u8996\u529b\u8207\u77b3\u5b54\u53cd\u5c04\u6b63\u5e38\uff0c\u53ef\u958b\u7acb\u53e3\u670d\u6297\u751f\u7d20\u8207\u6b62\u75db\u85e5\u7269\u6cbb\u7642\uff0c\u8f49\u4ecb\u81f3\u9580\u8a3a\u8ffd\u8e64\u3002 (D)\u5982\u679c\u75c5\u4eba\u6709\u982d\u75db\u3001\u767c\u71d2\uff0c\u5408\u4f75\u7b2c\u4e09\u3001\u56db\u3001\u516d\u5c0d\u9871\u795e\u7d93\u529f\u80fd\u7570\u5e38\uff0c\u9700\u8003\u616e\u4f75\u767c\u6d77\u7dbf\u7ac7\u6813\u585e(cavernous sinus thrombosis )\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "80\u6b72\u8001\u4eba\u56e0\u6700\u8fd1\u5fd8\u4e86\u525b\u525b\u6c92\u6709\u5403\u98ef\uff0c\u4ee5\u70ba\u5225\u4eba\u62ff\u4e86\u4ed6\u7684\u6771\u897f\uff0c\u8a08\u7b97\u80fd\u529b\u8b8a\u5dee\uff0c\u8ff7\u8def\uff0c\u6709\u5e7b\u807d\u5e7b\u8996\u88ab\u9001\u81f3\u6025\u8a3a\u5ba4\uff0c\u4e0b\u5217\u8a55\u4f30\u548c\u8655\u7406\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)Lewy body \u5931\u667a\u75c7\u5e38\u6709\u5e7b\u89ba\u548c\u985e\u5df4\u91d1\u68ee\u8868\u5fb5\u4e4b\u75c7\u72c0\u3002 (B)Mini -cog \u7be9\u6aa2\u8a55\u4f30\uff0c3 \u5206\u9418\u5f8c\u56de\u60f3\u525b\u525b\u4e09\u6a23\u6c34\u679c\uff0c\u53ea\u8aaa\u51fa 1\u9805\uff0c\u70ba\u6709\u8a8d\u77e5\u969c\u7919(cognitive impairment )\u3002 (C)\u884c\u70ba\u7570\u5e38\u70ba\u5931\u667a\u75c7\u9001\u81f3\u6025\u8a3a\u5ba4\u5e38\u898b\u7684\u7406\u7531\u3002 (D)\u8a3a\u65b7\u5931\u667a\u75c7\u4e4b\u524d\uff0c\u9700\u5148\u8a55\u4f30\u662f\u5426\u5f71\u97ff\u7368\u7acb\u65e5\u5e38\u6d3b\u52d5\u6216\u6b78\u56e0\u65bc\u8b6b\u5984\u75c7\u3001\u6182\u9b31\u75c7\u548c\u601d\u89ba\u5931\u8abf\u75c7\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "55\u6b72\u7537\u6027\u5728\u975e\u6d32\u5de5\u4f5c\uff0c\u66fe\u7d93\u88ab\u868a\u87f2\u53ee\u54ac\uff0c 10\u5929\u524d\u8fd4\u570b\uff0c\u56e0\u70ba\u51fa\u73fe\u767c\u71d2\u3001\u754f\u5bd2\u3001\u982d\u75db\u3001\u808c\u8089\u75e0\u75db 3\u5929\uff0cCOVID-19 \u3001\u767b\u9769\u71b1\u6297\u539f\u5feb\u7be9\u7686\u9670\u6027\uff0c\u8eab\u9ad4\u8a3a\u5bdf\u767c\u73fe\u813e\u81df\u816b\u5927\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u8584\u5c64\u8840\u7247\u6aa2\u67e5\u7627\u539f\u87f2\u70ba\u9670\u6027\u6642\uff0c\u56e0\u70ba\u7627\u539f\u87f2\u5bc6\u5ea6\u53ef\u80fd\u4f4e\u65bc 100 /\u03bcL\uff0c\u6240\u4ee5\u539a\u5c64\u8840\u7247\u6aa2\u67e5\u5fc5\u9808\u65bd\u4f5c\u3002 (B)\u56e0\u70ba\u8584\u5c64\u8840\u7247\u70ba\u9670\u6027\u6642\uff0c\u518d\u505a\u4e00\u6b21\u539a\u5c64\u8840\u7247\u7627\u539f\u87f2\u4e5f\u70ba\u9670\u6027\u6642\uff0c\u5247\u53ef\u4ee5\u6392\u9664\u7627\u75be\u3002 (C)\u8d85\u904e 90%\u7684\u75c5\u4f8b\uff0c\u5728\u7b2c\u4e00\u6b21\u8840\u7247\u6aa2\u6e2c\u7d50\u679c\u70ba\u967d\u6027\u3002 (D)\u4e16\u754c\u885b\u751f\u7d44\u7e54\u65bc 1965\u5e74\u9812\u767c\u53f0\u7063\u7627\u75be\u6839\u9664\u8b49\u66f8\uff0c\u4f46\u662f\u53f0\u7063\u5404\u7e23\u5e02\u5c71\u5340\u4ecd\u904d\u5e03\u77ee\u5c0f\u7627\u868a( Anopheles minimus) \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "67\u6b72\u7537\u6027\u5177\u9ad8\u8840\u58d3\u75c5\u53f2\uff0c\u4e00\u5e74\u5167\u7121\u4f4f\u9662\u53f2\u3002\u4e3b\u8a34\u8fd1\u5169\u5929\u54b3\u55fd\u6709\u75f0\u3001\u9593\u65b7\u6027\u9ad8\u71d2\u9054 39\u2103\uff0c\u65bc\u6025\u8a3a\u5c31\u91ab\u6642\u795e\u667a\u6e05\u9192\u4f46\u865b\u5f31\uff0c\u547c\u5438 26\u6b21/min\uff0c\u8840\u58d3110/80 mmHg \uff0cSpO 2 96%\uff0c\u8840\u6db2\u6aa2\u9a57\u986f\u793a WBC 12,900 /uL \u3001CRP 16.88 mg/dL\u3001BUN 34 mg/dL \u3001Creatinine 1.6 mg/dL \uff0c\u80f8\u90e8 X\u5149\u5448\u73fe\u53f3\u4e0b\u80ba\u91ce\u5be6\u8cea\u5316\u75c5\u8b8a (consolidation) \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u6b64\u75c5\u4eba\u70ba\u793e\u5340\u578b\u80ba\u708e\u500b\u6848\u3002 (B)\u5e38\u898b\u7684\u75c5\u539f\u9ad4\u70ba S. pneumoniae , S. aureus , H. influenzae \u3002 (C)\u6839\u64da CURB- 65\u6307\u6a19\u8a55\u4f30\u56b4\u91cd\u5ea6\uff0c\u6b64\u75c5\u4eba\u70ba\u4e2d\u5ea6\u80ba\u708e\uff0c\u5efa\u8b70\u4f4f\u9662\u89c0\u5bdf\u6cbb\u7642\u3002 (D)\u6839\u64da 2018\u5e74\u53f0\u7063\u80ba\u708e\u6307\u5f15\uff0c\u6b64\u75c5\u4eba\u5efa\u8b70\u4f7f\u7528 Aztreonam \u6297\u751f\u7d20\u6cbb\u7642\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u96f7\u64ca\u6027\u982d\u75db (thunderclap headache )\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u82e5\u5728\u4f11\u606f\u6642\u767c\u751f\uff0c\u9700\u9ad8\u5ea6\u61f7\u7591\u9838\u52d5\u8108\u525d\u96e2\u3002 (B)\u5b9a\u7fa9\u70ba\u7a81\u7136\u51fa\u73fe\u4e26\u5728 1\u5206\u9418\u5167\u9054\u5230\u6700\u5927\u7a0b\u5ea6\u7684\u5287\u70c8\u982d\u75db\u3002 (C)\u82e5\u8207 Valsalva maneuve \u76f8\u95dc\uff0c\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\u662f\u6025\u6027\u9752\u5149\u773c\u3002 (D)\u5927\u8166\u975c\u8108\u6813\u585e(cerebral venous thrombosis )\u4e0d\u6703\u51fa\u73fe\u6b64\u7a2e\u982d\u75db\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u80ba\u81bf\u760d\u7684\u6cbb\u7642\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u4ee5\u91dd\u5c0d\u53ad\u6c27\u83cc\u70ba\u4e3b\u7684 Metronidazole \u70ba\u6297\u751f\u7d20\u9996\u9078\u3002 (B)\u4e09\u6210\u4ee5\u4e0a\u7684\u75c5\u4eba\u9700\u63a5\u53d7\u5916\u79d1\u5f15\u6d41\u6216\u7d93\u76ae\u5f15\u6d41(surgical or percutaneous drainage )\u3002 (C)\u7d93\u652f\u6c23\u7ba1\u5f15\u6d41(transbronchial drainage )\u8f03\u4e0d\u6613\u5f71\u97ff\u5230\u5065\u5074\u80ba\u90e8\u3002 (D)\u4f7f\u7528\u6297\u751f\u7d20\u6cbb\u7642\u6548\u679c\u4e0d\u4f73\u6642\uff0c\u518d\u8003\u616e\u7d93\u76ae(percutaneous)\u6216\u7d93\u652f\u6c23\u7ba1(transbronchial )\u6216\u958b\u653e\u5f15\u6d41(open drainage )\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6ccc\u5c3f\u9053\u7d50\u77f3\u7684\u6cbb\u7642\uff0c\u4ee5\u4e0b\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u7d66\u4e88\u5927\u91cf\u975c\u8108\u8f38\u6db2\u4e26\u7121\u6cd5\u52a0\u901f\u6ccc\u5c3f\u9053\u7d50\u77f3\u6392\u51fa\u3002 (B)\u82e5\u75c5\u4eba\u4e0d\u9069\u5408\u4f7f\u7528\u975e\u985e\u56fa\u9187\u6297\u767c\u708e\u985e\u85e5\u7269(NSAIDs) \uff0c\u53ef\u4ee5\u4f7f\u7528Narcotics \u985e\u85e5\u7269\u6b62\u75db\uff0c\u7136\u800c\u6b64\u985e\u85e5\u7269\u7121\u6cd5\u4fc3\u9032\u6ccc\u5c3f\u9053\u7d50\u77f3\u7684\u6392\u51fa\u3002 (C)\u9223\u96e2\u5b50\u901a\u9053\u963b\u65b7\u5291(calcium channel blocker )\u53ca\u7532\u578b\u963b\u65b7\u5291 (\u03b1 blocker)\u90fd\u80fd\u7528\u4f86\u4fc3\u9032\u6ccc\u5c3f\u9053\u7d50\u77f3\u7684\u6392\u51fa\u3002 (D)\u82e5\u6ccc\u5c3f\u9053\u7d50\u77f3\u5408\u4f75\u6025\u6027\u5c3f\u8def\u6557\u8840\u75c7(urosepsis) \uff0c\u61c9\u8003\u616e\u4f4f\u9662\u6cbb\u7642\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u5728\u5927\u91cf\u50b7\u60a3\u4e8b\u4ef6\u4e2d\uff0c\u5c0d\u5c0f\u5152\u75c5\u4eba\u4e4b\u6aa2\u50b7\u5206\u985e\uff0c\u76ee\u524d\u63a1\u7528 JumpSTART \u5c0f\u5152\u5927\u91cf\u50b7\u60a3\u6aa2\u50b7\u7cfb\u7d71(JumpSTART Pediatric MCI Triage\u00a9) \uff0c\u6709\u95dc\u6b64\u7cfb\u7d71\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u8a55\u4f30\u70ba\uff1a\u80fd\u5426\u884c\u52d5\u6216\u8d70\u8def\u2192 \u6709\u7121\u547c\u5438\u2192 \u547c\u5438\u901f\u7387 \u2192\u6709\u7121\u8108\u640f\u2192 \u610f\u8b58\u72c0\u614b\u3002 (B)\u6aa2\u50b7\u5206\u985e\u5206\u70ba\u6b7b\u4ea1\u3001\u7acb\u5373\u5f8c\u9001\u3001\u5ef6\u5f8c\u5f8c\u9001\u3001\u8f15\u75c7\u56db\u985e\u3002 (C)\u610f\u8b58\u72c0\u614b\u63a1\u7528 modified Glasgow Coma Scale \u3002 (D)\u6bcf\u4f4d\u50b7\u60a3\u7686\u61c9\u63a5\u53d7\u8a73\u7d30\u7684\u4e8c\u6b21\u8a55\u4f30\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "10\u6b72\u7537\u7ae5\uff0c\u8179\u75db\u5408\u4f75\u7121\u81bd\u6c41\u5614\u5410\u3002\u8840\u58d3 85/60 mmHg \uff0c\u5fc3\u8df3 130\u6b21/min\uff1b\u52d5\u8108\u6c23\u9ad4\u5206\u6790\uff1apH 7.20\uff0c PaCO 2 30 mmHg\uff0c HCO 3 12 mEq/L \uff0c\u8840\u6db2\u751f\u5316\u7d50\u679c\uff1a\u9209\u96e2\u5b50 140 mEq/L \uff0c\u9240\u96e2\u5b50 2.0 mEq/L \uff0c\u6c2f\u96e2\u5b50 108 mEq/L \uff0cGlucose 360 mg/dL \uff0cBUN 28 mg/dL \uff0c\u5c3f\u6db2\u4e2d\u6709\u916e\u9ad4\u3002\u4ee5\u4e0b\u63cf\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u9670\u96e2\u5b50\u9593\u9699 (anion -gap)\u70ba 22 mEq/L \u3002 (B)\u6709\u6548\u6ef2\u900f\u58d3 (effective osmolality )\u70ba300 mOsm/kg \u3002 (C)\u6b64\u75be\u75c5\u6700\u5e38\u898b\u9020\u6210\u6b7b\u4ea1\u4f75\u767c\u75c7\u70ba\u80ba\u6c34\u816b\u3002 (D)\u5efa\u8b70\u7acb\u5373\u7d66\u4e88 20 mL/kg bolus normal saline \u52a0\u4e0a bolus insulin 0.1 unit/kg\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u8718\u86db\u819c\u4e0b\u8154\u51fa\u8840\u7684\u6cbb\u7642\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \ufe56", + "Options": "(A)\u6536\u7e2e\u58d3\u61c9\u63a7\u5236\u5728 120~160 mmHg \uff0c\u53ef\u5148\u8003\u616e Nicardipine \u3002 (B)\u8840\u58d3\u904e\u9ad8\u63a7\u5236\u4e0d\u826f\u8005\uff0c\u53ef\u8003\u616e\u7b2c\u4e8c\u7dda\u85e5\u7269 Nitroglycerin\u3002 (C)\u9810\u9632\u5f8c\u7e8c\u7684\u8840\u7ba1\u75d9\u6523 (vasospasm )\u53ef\u8003\u616e Nimodipine \u3002 (D)\u90e8\u4efd\u75c5\u4eba\u53ef\u80fd\u51fa\u73fe\u7672\u7647\u53ef\u7528\u6297\u7672\u7647\u85e5\u7269\u9810\u9632\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u5916\u50b7\u6027\u8166\u51fa\u8840\u5e38\u4f75\u767c\u8166\u759d\u75c7\u5019\u7fa4( Brain herniation syndrome )\u3002\u95dc\u65bc\u6b64\u75c7\u5019\u7fa4\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u6700\u5e38\u898b\u7684\u662f\u9264\u8ff4\u8166\u759d (Uncal herniation) \uff0c\u5e38\u7531\u8166\u90e8\u4e2d\u7dda\u4f4d\u7f6e\u7684\u8840\u584a\uff0c\u5982\u984d\u8449\u6216\u6795\u8449\u8840\u584a\u5f15\u8d77\u3002 (B)\u9264\u8ff4\u8166\u759d (Uncal herniation )\u5e38\u58d3\u8feb\u6ed1\u8eca\u795e\u7d93\uff0c\u963b\u65b7\u77b3\u5b54\u526f\u4ea4\u611f\u795e\u7d93\u8a0a\u865f\uff0c\u81e8\u5e8a\u53ef\u898b\u55ae\u5074\u6216\u96d9\u5074\u77b3\u5b54\u653e\u5927\u3002 (C)\u4e2d\u592e\u8166\u759d (Central herniation )\u81e8\u5e8a\u75c7\u72c0\u4e3b\u8981\u4ee5\u96d9\u5074\u77b3\u5b54\u653e\u5927\u3001\u96d9\u5074Babinski\u2019s \u967d\u6027\u8207\u808c\u8089\u5f35\u529b\u589e\u52a0\u70ba\u4e3b\u3002 (D)\u5c0f\u8166\u6241\u6843\u9ad4\u8166\u759d(Cerebellotonsillar herniation)\u81e8\u5e8a\u75c7\u72c0\u5e38\u4ee5\u96d9\u5074\u77b3\u5b54\u7e2e\u5c0f\u3001\u56db\u80a2\u7671\u7613\u6216\u731d\u6b7b\u4f86\u8868\u73fe\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u7a69\u5b9a\u6c23\u80f8\u75c5\u4eba\u5224\u65b7\u6a19\u6e96\uff0c\u4e0d\u5305\u62ec \u4e0b\u5217\u4f55\u9805\uff1f", + "Options": "(A)\u672a\u5408\u4f75\u8840\u80f8\u3002 (B)\u547c\u5438\u901f\u7387\u5c0f\u65bc 24\u6b21/min\u3002 (C)PaCO 2\u5c0f\u65bc 45 mmHg \u3002 (D)Room air \u8840\u6c27\u6fc3\u5ea6\u5927\u65bc 90%\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u5275\u50b7\u6027\u4f11\u514b\u9808\u8003\u616e\u9032\u884c\u7dca\u6025\u7684 REBOA(Resuscitative Endovascular Balloon Occlusion of the Aorta )\u7f6e\u653e\u3002\u4e0b\u5217\u4f55\u8005\u6558\u8ff0\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u80f8\u90e8 X\u5149\u660e\u986f\u8e64\u9694\u7a7a\u8b8a\u5bdb\uff0c\u61c9\u5c07 REBOA\u653e\u7f6e\u5230 zone 3\u3002 (B)\u61f7\u7591\u9aa8\u76c6\u8154\u51fa\u8840\uff0cREBOA \u61c9\u653e\u7f6e\u5230 zone 2\u3002 (C)\u61f7\u7591\u8179\u5167\u51fa\u8840\uff0cREBOA \u61c9\u653e\u7f6e\u5230 zone 3\u3002 (D)\u653e\u7f6e\u7684\u6df1\u5ea6\u53ef\u53c3\u8003\u653e\u7f6e\u5165\u91dd\u8655\u81f3\u528d\u7a81\u53ca\u809a\u81cd\u7684\u8ddd\u96e2\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "40\u6b72\u7537\u6027\u6f5b\u6c34\u5f8c 2\u5c0f\u6642\uff0c\u81ea\u89ba\u982d\u6688\u3001\u8033\u6735\u4e0d\u9069\u3001\u95dc\u7bc0\u75bc\u75db\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u4e0a\u5347\u53ef\u80fd\u9020\u6210\u6c23\u58d3\u6027\u8033\u708e(barotitis) \uff0c\u5c0e\u81f4\u8033\u819c\u7834\u88c2\u3002 (B)\u4f7f\u7528 San Diego Diving and Hyperbaric Organizations Criteria \u8a55\u4f30\uff0c3\u5206\u4ee5\u4e0a\u53ef\u4ee5\u8a3a\u65b7 arterial gas embolism \u3002 (C)\u7b2c\u4e00\u578b\u6e1b\u58d3\u75c7(decompression sickness)\u6703\u7522\u751f\u95dc\u7bc0\u75bc\u75db\uff0c\u56b4\u91cd\u8005\u53ef\u80fd\u80a2\u9ad4\u7121\u529b\u6216\u9ebb\u6728\u3002 (D)\u58d3\u529b\u8b8a\u5316\u6027\u7729\u6688(alternobaric vertigo)\u901a\u5e38\u662f\u66ab\u6642\u7684\uff0c\u4e0d\u9700\u8981\u7279\u5225\u6cbb\u7642\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u9873\u984e\u95dc\u7bc0\u812b\u81fc\u75c5\u4eba\u8655\u7406\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u4f8b\u884c\u7167 X\u5149\u4ee5\u6392\u9664\u9aa8\u6298\u3002 (B)\u624b\u8155\u65cb\u8f49\u6cd5\u6700\u5e38\u7528\u3002 (C)\u9873\u984e\u95dc\u7bc0\u812b\u81fc\u5e38\u898b\u70ba\u5f8c\u812b\u4f4d\u3002 (D)\u624b\u8155\u65cb\u8f49\u6cd5\u6bd4\u50b3\u7d71\u5fa9\u4f4d\u6cd5\u66f4\u6709\u6548\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u4e0a\u80a2\u5916\u50b7\u5e38\u5408\u4f75\u795e\u7d93\u640d\u50b7\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u80a9\u95dc\u7bc0\u524d\u812b\u81fc(anterior dislocation )\u5e38\u5408\u4f75\u814b\u795e\u7d93 (axillary nerve )\u53d7\u640d\uff0c\u81e8\u5e8a\u8868\u73fe\u4ee5\u80a9\u8180\u5916\u5c55\u7121\u529b\u3001\u611f\u89ba\u7570\u5e38\u70ba\u4e3b\u3002 (B)\u80b1\u9aa8\u5e79\u9aa8\u6298 (humerus shaft fracture )\u5e38\u5408\u4f75\u6a48\u795e\u7d93 (radial nerve )\u640d\u50b7\uff0c\u4e3b\u8981\u75c7\u72c0\u70ba\u5782\u8155\u3001\u62c7\u6307\u8207\u98df\u6307\u6307\u80cc\u611f\u89ba\u7570\u5e38\u3002 (C)\u80b1\u9aa8\u8e1d\u4e0a\u9aa8\u6298(supracondylar fracture )\u5e38\u5408\u4f75\u5f9e\u6b63\u4e2d\u795e\u7d93\u5206\u51fa\u7684\u5f8c\u9aa8\u9593\u795e\u7d93 (posterior interosseous nerve )\u53d7\u640d\u3002 (D)\u5c3a\u9aa8\u9df9\u5634\u51f8\u9aa8\u6298(olecranon fracture)\u5e38\u5408\u4f75\u5c3a\u795e\u7d93\u53d7\u640d\uff0c\u4e3b\u8981\u75c7\u72c0\u70ba\u624b\u6307\u7121\u6cd5\u5916\u5c55 (abduction)\u8207\u7121\u540d\u6307\u3001\u5c0f\u6307\u611f\u89ba\u7570\u5e38\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u4f55\u8005 \u61c9\u63a5\u53d7\u7834\u50b7\u98a8\u985e\u6bd2\u7d20( tetanus toxoids )\u4e4b\u6ce8\u5c04\uff1f", + "Options": "(A)8\u6b72\u5c0f\u670b\u53cb\uff0c\u75ab\u82d7\u6ce8\u5c04\u53f2\u5b8c\u6574\uff0c\u9a0e\u81ea\u884c\u8eca\u6642\u56db\u80a2\u591a\u8655\u64e6\u632b\u50b7\u3002 (B)78 \u6b72\u7537\u6027\u8f15\u5fae\u71d9\u50b7\uff0c\u4f46 6\u5e74\u524d\u5df2\u6253\u904e\u7834\u50b7\u98a8\u985e\u6bd2\u7d20\u3002 (C)\u61f7\u5b55 28\u9031\u5b55\u5a66\u88ab\u72d7\u54ac\u50b7\uff0c\u4f46 1\u5e74\u524d\u5df2\u6253\u904e\u7834\u50b7\u98a8\u985e\u6bd2\u7d20\u3002 (D)23 \u6b72\u5de5\u4eba\u5728\u6e05\u7406\u4e0b\u6c34\u9053\u9ad2\u6c61\u6642\u4e0d\u614e\u624b\u90e8\u88ab\u73bb\u7483\u5272\u50b7\uff0c\u4f46 1\u5e74\u524d\u5df2\u6253\u904e\u7834\u50b7\u98a8\u985e\u6bd2\u7d20\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5e74\u8f15\u904b\u52d5\u54e1\u6700\u5e38\u898b\u5fc3\u56e0\u6027\u731d\u6b7b\u539f\u56e0\u70ba\u51a0\u72c0\u52d5\u8108\u75be\u75c5\u3002 (B)\u5728 Brugada syndrome \uff0c\u5e38\u898b\u5fc3\u96fb\u5716\u65bc\u80a2\u5c0e\u6709\u7570\u5e38\u3002 (C)\u907a\u50b3\u6027\u96e2\u5b50\u901a\u9053\u75be\u75c5( Hereditary channelopathies )\u8005\uff0c\u731d\u6b7b\u5e38\u51fa\u73fe\u5728\u904b\u52d5\u4e2d\u3002 (D)\u56b4\u91cd\u5de6\u5fc3\u5ba4\u529f\u80fd\u969c\u7919\u5408\u4f75 ejection fraction\u226635% \u9700\u8003\u616e\u7f6e\u653e\u690d\u5165\u5f0f\u5fc3\u5f8b\u6574\u6d41\u9664\u986b\u5668(Implanta ble cardioverter - defibrillator )\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "50\u6b72\u7537\u6027\uff0c\u559d\u4e0b\u79c1\u91c0\u7684\u7c73\u9152 10\u5c0f\u6642\u5f8c\u56e0\u70ba\u982d\u6688\u3001\u5641\u5fc3\u3001\u8996\u529b\u6a21\u7cca\u81f3\u6025\u8a3a\uff0c\u751f\u547d\u5fb5\u8c61\uff1a\u9ad4\u6eab 36.8\u2103\u3001\u547c\u5438 18\u6b21/min\u3001\u5fc3\u8df3 92\u6b21/min\u3001\u8840\u58d3 169/85 mmHg \uff0c\u6aa2\u9a57\u5831\u544a\uff1aNa 142 mEq/L \u3001Cl 109 mEq/L \u3001BUN 14 mg/dL\u3001Glu 126 mg/dL \u3001Ketone body \uff1anegative\u3001Ethanol 9 mg/dL \u3001Blood osmolality 320 mOsm/Kg\uff0c\u53e6\u5916\u52d5\u8108\u8840\u70ba ABG pH 7.29\u3001 PCO 2 25.4 mmHg\u3001HCO 3 12.5 mEq/L \uff0c\u6839\u64da\u4ee5\u4e0a\u7684\u6578\u64da\uff0c\u7814\u5224\u500b\u6848\u53ef\u80fd\u8aa4\u98df\u7532\u9187\uff0c\u8acb\u554f\u500b\u6848\u6b64\u6642\u8840\u4e2d\u7684\u7532\u9187\u6fc3\u5ea6 \u6700\u6709\u53ef\u80fd \u662f\u591a\u5c11\uff1f", + "Options": "(A)20 mg/dL \u3002 (B)40 mg/dL \u3002 (C)70 mg/dL \u3002 (D)150 mg/dL \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "68\u6b72\u7537\u6027\uff0c\u8a3a\u65b7\u70ba\u6162\u6027\u963b\u585e\u6027\u80ba\u75c5\u6025\u6027\u767c\u4f5c\u4f75\u9ad8\u78b3\u9178\u8840\u75c7\u547c\u5438\u8870\u7aed\uff0c\u7d93\u7dca\u6025\u63d2\u7ba1\u5f8c\u5b89\u6392\u5165\u4f4f\u52a0\u8b77\u75c5\u623f\uff0c\u65b0\u51a0\u80ba\u708e PCR\u70ba\u9670\u6027\uff0c\u75c5\u4eba\u65bc\u6025\u8a3a\u5ba4\u5f85\u5e8a\u4e09\u5929\u5f8c\u51fa\u73fe\u8840\u6c27\u6fc3\u5ea6\u9593\u6b47\u6027\u964d\u4f4e\uff0c\u6c23\u7ba1\u5167\u7ba1\u5206\u6ccc\u7269\u589e\u52a0\uff0c\u8ffd\u8e64\u80f8\u90e8 X\u5149\u986f\u793a\u53f3\u4e0b\u80ba\u8449\u6709\u65b0\u7684\u6d78\u6f64\uff0c\u8acb\u554f\u4e0b\u5217\u6297\u751f\u7d20\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)Ceftriaxone and metronidazole \u3002 (B)Cefepime and vancomycin \u3002 (C)Levofloxacin and metronidazole \u3002 (D)Piperacillin -tazobactam \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "25\u6b72\u7537\u6027\u88ab\u5bb6\u4eba\u767c\u73fe\u5728\u5bb6\u660f\u8ff7\uff0c\u6700\u5f8c\u4e00\u6b21\u6b63\u5e38\u6642\u9593\u4e0d\u6e05\u695a\u3002\u904e\u53bb\u75c5\u53f2\u6709\u601d\u89ba\u5931\u8abf\u75c7\uff0c\u65bc\u8a3a\u6240\u62ff\u85e5\u670d\u7528\u3002\u5230\u9662\u6642\u610f\u8b58\u72c0\u6cc1 E1M4V1\uff0c\u9ad4\u6eab 39\u2103\uff0c\u5176\u9918\u751f\u547d\u5fb5\u8c61\u6b63\u5e38\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u6b64\u75c5\u4eba\u53ef\u80fd\u70ba\u611f\u67d3\u75c7\u6216\u85e5\u7269\u5f15\u8d77\u4e4b\u75c7\u72c0\uff0c\u7121\u9808\u6392\u9664\u5668\u8cea\u6027\u75c5\u8b8a\u3002 (B)\u91dd\u5c0d neuroleptic malignant syndrome \u6700\u91cd\u8981\u7684\u6cbb\u7642\u70ba\u7d66\u4e88 BZD\u62ee\u6297\u5291Flumazenil \u3002 (C)\u75c5\u4eba\u5982\u679c\u6709\u670d\u7528 Clozapine \uff0c\u81e8\u5e8a\u8868\u73fe\u51fa\u73fe muscle rigidity \uff0c\u75c5\u4eba\u70baserotonin syndrome \u7684\u53ef\u80fd\u6027\u8f03\u9ad8\u3002 (D)\u6b64\u75c5\u4eba\u63d2 \u7ba1\u61c9\u512a\u5148\u9078\u64c7 nondepolarizing muscle relaxant \u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u7030\u6563\u6027\u8840\u7ba1\u5167\u51dd\u8840( disseminated intravascular coagulation, DIC )\u7684\u63cf\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u9996\u8981\u76ee\u6a19\u70ba\u6cbb\u7642\u9020\u6210 DIC\u7684\u6839\u672c\u539f\u56e0\u3002 (B)\u82e5\u7121\u51fa\u8840\u8b49\u64da\uff0c\u61c9\u4f7f\u7528\u4f4e\u5206\u5b50\u91cf\u809d\u7d20\u4f86\u9810\u9632\u8840\u6813\u3002 (C)\u9020\u6210 platelet\u964d\u4f4e\u53ca fibrinogen/D -dimer/FDP \u7684\u4e0a\u5347\u3002 (D)\u8207\u56b4\u91cd\u809d\u75c5\u7684\u5340\u5225\uff0c\u5728\u65bc\u809d\u75c5\u75c5\u4eba\u7684 D-dimer\u8f03\u4e0d\u6703\u986f\u8457\u5347\u9ad8\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u5c0d\u65bc BMI\u226730 kg/m2\u7684\u80a5\u80d6\u75c5\u4eba\uff0c\u7d66\u4e88\u85e5\u7269\u6642\u9700\u8981\u8003\u91cf\u75c5\u4eba\u7684\u9ad4\u91cd\u4f86\u8abf\u6574\u9069\u7576\u7684\u85e5\u7269\u5291\u91cf\u3002\u4e0b\u5217\u4f55\u7a2e\u85e5\u7269\u5728\u8a08\u7b97\u5291\u91cf\u6642\uff0c\u9700\u63a1\u7528\u75c5\u4eba\u7684\u5be6\u969b\u9ad4\u91cd(total body weight )\u4f86\u8a08\u7b97\u5291\u91cf\u8f03\u9069\u7576 \uff1f", + "Options": "(A)Enoxaparin\u3002 (B)Gentamicin \u3002 (C)Hydrocortisone \u3002 (D)Levofloxacin\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "55\u6b72\u5973\u6027\uff0c\u5de5\u4f5c\u6642\u660f\u53a5\u77ed\u66ab\u5931\u53bb\u610f\u8b58\uff0c\u88ab\u540c\u4e8b\u9001\u81f3\u6025\u8a3a\u5c31\u8a3a\uff0c\u4ee5\u4e0b\u6839\u64da\u75c5\u53f2\u8a62\u554f\u6240\u505a\u5224\u65b7\uff0c\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u82e5\u5fc3\u5f8b\u4e0d\u6574\u5f15\u8d77\u4e4b\u660f\u53a5\uff0c\u591a\u6578\u70ba\u7a81\u767c\uff0c\u6c92\u6709\u5148\u5146\u75c7\u72c0\u3002 (B)\u82e5\u7de9\u6162\u6f38\u9032\u767c\u751f\uff0c\u5408\u4f75\u7279\u5b9a\u60c5\u5883\uff0c\u61c9\u61f7\u7591 vasovagal syncope \u3002 (C)\u59ff\u52e2\u6027\u4f4e\u8840\u58d3\u9020\u6210\u660f\u53a5\u53ea\u767c\u751f\u5728\u6539\u8b8a\u59ff\u52e2\u8d77\u8eab\u5f8c 3\u5206\u9418\u4e4b\u5167\u767c\u751f\u3002 (D)\u51fa\u73fe\u54ac\u820c\u3001\u5c3f\u5931\u7981\u7b49\u75c7\u72c0\u6642\uff0c\u61c9\u8003\u616e\u662f\u7672\u7647\u767c\u4f5c\u800c\u4e0d\u662f\u55ae\u7d14\u660f\u53a5\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u884c\u4eba\u88ab\u6c7d\u8eca\u5074\u9762\u649e\u64ca\uff1b\u5230\u9662\u6642\u610f\u8b58\u6e05\u9192\uff0c\u8840\u58d3 75/45 mmHg \uff0c\u8eab\u9ad4\u8a3a\u5bdf\u767c\u73fe\u9aa8\u76c6\u8154\u58d3\u75db\uff0cE -FAST\u6aa2\u67e5\u7121\u6c23\u8840\u80f8\u3001\u7121\u5fc3\u5305\u819c\u7a4d\u6db2\u3001\u7121\u8179\u8154\u7a4d\u6db2\uff0cX\u5149\u986f\u793a\u5de6\u5074\u9aa8\u76c6 lateral compression fracture \uff1b\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u4f7f\u7528\u9aa8\u76c6\u56fa\u5b9a\u5e36\u5c0d\u6b64\u50b7\u60a3\u6709\u52a9\u65bc\u964d\u4f4e\u51fa\u8840\u91cf\u3002 (B)\u7d93\u7a4d\u6975\u9ad4\u6db2\u5fa9\u7526\u53ca\u8f38\u8840\u5f8c\u8840\u58d3 80/50 mmHg \uff0c\u4e0b\u4e00\u6b65\u5efa\u8b70\u57f7\u884c\u8840\u7ba1\u651d\u5f71\u6813\u585e\u3002 (C)\u9aa8\u76c6\u9aa8\u6298\u9020\u6210\u81c0\u4e0a(superior gluteal )\u6216\u9589\u5b54 (obturator )\u52d5\u8108\u51fa\u8840\u5c0e\u81f4\u4f11\u514b\u7684\u53ef\u80fd\u6027\u8f03\u5927\u3002 (D)\u5728\u610f\u8b58\u6e05\u9192\u7684\u50b7\u60a3\uff0c\u8eab\u9ad4\u8a3a\u5bdf\u5c0d\u65bc\u8a3a\u65b7\u9aa8\u76c6\u8154\u9aa8\u6298\u7684\u654f\u611f\u6027\u5927\u65bc90%\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "75\u6b72\u7537\u6027\uff0c\u5bb6\u5c6c\u8868\u793a\u75c5\u4eba\u525b\u624d\u5750\u5728\u6905\u5b50\u4e0a\u4f11\u606f\u6642\u7a81\u7136\u5012\u5730\uff0c\u4e14\u5931\u53bb\u610f\u8b58\u7d041\u5206\u9418\uff0c\u9192\u4f86\u5f8c\u62b1\u6028\u4e0b\u80cc\u90e8\u3001\u5f8c\u8166\u52fa\u75bc\u75db\uff0c\u75c5\u4eba\u8868\u793a\u5931\u53bb\u610f\u8b58\u524d\u6709\u5fc3\u60b8\u3002\u6aa2\u50b7\u9ad4\u6eab 36\u2103\uff0c\u5fc3\u8df3 80\u6b21/min\uff0c\u8840\u58d3 120/80 mmHg \uff0c\u8840\u6c27\u6fc3\u5ea6 98%\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u61c9\u5b89\u6392 12\u5c0e\u7a0b\u5fc3\u96fb\u5716\uff0c\u7d04\u6709 50%\u7684\u6a5f\u7387\u53ef\u4ee5\u5f97\u5230\u660e\u78ba\u8a3a\u65b7\u3002 (B)\u61c9\u5b89\u6392\u8166\u90e8\u96fb\u8166\u65b7\u5c64\uff0c\u6aa2\u67e5\u662f\u5426\u6709\u8166\u51fa\u8840\u3002 (C)\u62bd\u8840\u5831\u544a\u986f\u793a\u8840\u6bd4\u5bb9(hematocrit )35%\uff0c\u5fc3\u808c\u9175\u7d20(troponin)\u70ba\u6b63\u5e38\u503c\uff0c\u5c6c\u65bc\u4f4e\u98a8\u96aa\u65cf\u7fa4\uff0c\u53ef\u4ee5\u5b89\u6392\u51fa\u9662\u3002 (D)\u75c5\u4eba\u65bc\u7559\u89c0\u671f\u9593\u7a81\u7136\u96d9\u773c\u4e0a\u540a\u3001\u56db\u80a2\u6296\u52d5\uff0c\u61c9\u7acb\u5373\u7d66\u4e88 Diazepam 5mg\u975c\u8108\u6ce8\u5c04\uff0c\u4e26\u89c0\u5bdf\u85e5\u7269\u6548\u679c\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "65\u6b72\u75c5\u4eba\u56e0\u982d\u75db\u800c\u81f3\u6025\u8a3a\uff0c\u610f\u8b58\u6e05\u695a\u4e14\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\u3002\u4e0b\u5217\u95dc\u65bc\u8a72\u75c5\u75c7\u4e4b\u8a55\u4f30\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u4f9d\u64da Ottawa Subarachnoid Hemorrhage Rule \uff0c65\u6b72\u4ee5\u4e0a\u5c6c\u5371\u96aa\u56e0\u5b50\uff0c\u5efa\u8b70\u5b89\u6392\u982d\u90e8\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u3002 (B)\u75c5\u4eba\u6558\u8ff0\u70ba\u55ae\u5074\u982d\u75db\uff0c\u70ba carotid artery \u6216vertebral artery dissection\u6700\u5e38\u898b\u4e4b\u75c7\u72c0\uff0c\u5b9c\u8003\u616e\u5b89\u6392 CTA\u6aa2\u67e5\u3002 (C)\u6838\u78c1\u5171\u632f\u6aa2\u67e5\u654f\u611f\u5ea6\u9ad8\uff0c\u6aa2\u9a57\u9670\u6027\u5373\u53ef\u6392\u9664\u3002 (D)\u82e5\u8a3a\u65b7\u70ba SAH\uff0c\u5c07 SBP\u63a7\u5236\u81f3 120~160 mmHg \u5916\uff0c\u9810\u9632\u6027\u6297\u7672\u7647\u85e5\u7269\u4e5f\u53ef\u4ee5\u8003\u616e\u7d66\u4e88\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc sulfonylurea \u5c0e\u81f4\u7684\u4f4e\u8840\u7cd6\uff0c\u4e0b\u5217\u6cbb\u7642\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)50% Dextrose\u3002 (B)Diazoxide \u3002 (C)Glucagon\u3002 (D)Octreotide \u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "68\u6b72\u7537\u6027\u4e00\u9031\u524d\u525b\u51fa\u9662\uff0c\u4e14\u4f4f\u9662\u4e2d\u66fe\u63a5\u53d7\u9ad8\u5291\u91cf\u985e\u56fa\u9187\u6cbb\u7642\uff0c\u73fe\u56e0\u767c\u71d2\u3001\u547c\u5438\u56f0\u96e3\u53ca\u610f\u8b58\u4e0d\u6e05\u81f3\u6025\u8a3a\u5c31\u91ab\uff0c\u7d93\u6aa2\u67e5\u5f8c\u8a3a\u65b7\u70ba\u7d30\u83cc\u6027\u80ba\u708e\uff0c\u80f8\u90e8 X\u5149\u986f\u793a\u96d9\u5074\u4e0b\u80ba\u8449\u6d78\u6f64\uff0c\u81f4\u75c5\u83cc\u7a2e\u4ee5\u4e0b\u5217\u4f55\u8005\u6700\u70ba\u53ef\u80fd \uff1f", + "Options": "(A)\u514b\u96f7\u767d\u6c0f\u83cc (Klebsiella pneumoniae )\u3002 (B)\u7da0\u81bf\u687f\u83cc (Pseudomonas aeruginosa )\u3002 (C)\u91d1\u9ec3\u8272\u8461\u8404\u7403\u83cc(Staphylococcus aureus )\u3002 (D)\u80ba\u708e\u93c8\u7403\u83cc (Streptococcus pneumoniae )\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6838\u4e09\u5ee0\u56e0\u64cd\u4f5c\u7570\u5e38\u5c0e\u81f4\u653e\u5c04\u6027\u6c61\u67d3\u7269\u5927\u91cf\u5916\u6d29\uff0c\u95dc\u65bc\u6025\u8a3a\u6574\u5099\u4ee5\u53ca\u75c5\u4eba\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u65bc\u6c59\u67d3\u5340\u4e4b\u6025\u8a3a\u91ab\u8b77\u9808\u7a7f\u8457\u9632\u6c34\u9694\u96e2\u8863\u3001\u5e3d\u3001\u978b\u8207\u96d9\u5c64\u624b\u5957\u4ee5\u907f\u514d\u6c59\u67d3\u3002 (B)\u6e05\u6d17\u53d7\u6c61\u67d3\u90e8\u4f4d\u50b7\u53e3\u65b9\u6cd5\u8207\u4e00\u822c\u50b7\u53e3\u76f8\u540c\uff0c\u4f46\u9700\u9632\u6b62\u6e05\u6d17\u904e\u7a0b\u6c61\u67d3\u64f4\u6563\u3002 (C)\u75c5\u4eba \u7686\u61c9\u5148\u9032\u884c\u9664\u6c59\u81f3\u8f3b\u5c04\u503c\u5c0f\u65bc 2\u500d\u80cc\u666f\u503c\uff0c\u518d\u9032\u884c\u91ab\u7642\u8655\u7f6e\u3002 (D)\u82e5\u6709\u5614\u5410\u53ca\u8179\u7009\uff0c\u61c9\u6bcf 6\u5c0f\u6642\u8ffd\u8e64\u76e3\u63a7\u6dcb\u5df4\u7403\u6578\u91cf\u8b8a\u5316\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u5b55\u5a66\u6025\u7522\u6642\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5c0d\u65bc\u5df2\u7834\u6c34\u7684\u5b55\u5a66\uff0c\u57f7\u884c\u5167\u8a3a\u4f86\u5224\u65b7\u7522\u7a0b\u3002 (B)\u4e2d\u5916\u5074\u6703\u9670\u5207\u958b\u8853( mediolateral episiotomy )\u8f03\u5bb9\u6613\u57f7\u884c\u4e14\u5b55\u5a66\u5728\u6062\u5fa9\u671f\u8f03\u5c11\u4e0d\u9069\u611f\uff1b\u800c\u6b63\u4e2d\u6703\u9670\u5207\u958b\u8853( median episiotomy )\u80fd\u964d\u4f4e\u7522\u9053\u6495\u88c2\u50b7\u81f3\u809b\u9580\u7684\u53ef\u80fd\u6027\u3002 (C)\u80ce\u5152\u5a29\u51fa\u5f8c\uff0c\u82e5\u80ce\u5152\u72c0\u6cc1\u7a69\u5b9a\u4e0d\u8981\u99ac\u4e0a\u526a\u65b7\u81cd\u5e36\uff0c\u4e0d\u8ad6\u65e9\u7522\u6216\u8db3\u6708\u7522\u5152\u90fd\u53ef\u4ee5\u5ef6\u5f8c 1~3\u5206\u9418\u65b7\u81cd\u3002 (D)\u80ce\u5152\u5c1a\u672a\u5b8c\u5168\u5a29\u51fa\u6642\uff0c\u82e5\u81cd\u5e36\u5df2\u6389\u51fa\u9670\u9053\u5916(umbilical cord prolapse)\uff0c\u61c9\u628a\u81cd\u5e36\u63a8\u56de\u5b50\u5bae\u5167\u4e26\u7528\u624b\u6307\u62ac\u8d77\u80ce\u982d\uff0c\u9632\u6b62\u81cd\u5e36\u7684\u8840\u6d41\u53d7\u58d3\u8feb\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "20\u9031\u5b55\u5a66\uff0c\u5169\u5c0f\u6642\u524d\u7a81\u767c\u547c\u5438\u5598\u53ca\u80f8\u75db\u81f3\u6025\u8a3a\u3002\u751f\u547d\u5fb5\u8c61\u70ba\u9ad4\u6eab 36.5\u2103\uff0c\u5fc3\u8df3 170\u6b21/min\uff0c\u547c\u5438 24\u6b21/min\uff0c\u8840\u58d3 125/86 mmHg \uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u82e5\u70ba\u4e0d\u7a69\u5b9a\u7684 ventricular tachycardia \uff0c\u53ef\u7d66 100\u7126\u8033\u7684\u540c\u6b65\u96fb\u64ca\uff0c\u4e0d\u9700\u964d\u4f4e\u5291\u91cf\u3002 (B)\u82e5\u70ba\u5fc3\u808c\u6897\u585e\uff0c\u5247\u6700\u6709\u53ef\u80fd\u7684\u539f\u56e0\u70ba\u51a0\u72c0\u52d5\u8108\u75d9\u6523(coronary spasm)\u3002 (C)\u82e5\u61f7\u7591\u80ba\u6813\u585e\u9808\u5b89\u6392\u6838\u78c1\u5171\u632f\u6aa2\u67e5\uff0c\u61c9\u907f\u514d\u80ba\u90e8\u901a\u6c23\u53ca\u8840\u6d41\u704c\u6ce8\u651d\u5f71(pulmonary V/Q scan )\u6aa2\u67e5\uff0c\u56e0\u8f3b\u5c04\u5291\u91cf\u53ef\u80fd\u5c0d\u80ce\u5152\u9020\u6210\u6c38\u4e45\u6027\u7684\u50b7\u5bb3\u3002 (D)\u82e5\u70ba\u91cd\u7a4d\u578b\u6c23\u5598(status asthmaticus )\uff0c\u4e0d\u53ef\u7d66\u4e88 MgSO 4\uff0c\u56e0\u5176\u6703\u7a7f\u904e\u80ce\u76e4\u9020\u6210\u795e\u7d93\u5b78\u7684\u640d\u50b7\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "44\u6b72\u7537\u6027\uff0c\u56e0\u5de6\u4e0a\u8179\u75db\u5c31\u91ab\uff0c\u7d93\u6aa2\u67e5\u767c\u73fe Lipase\u7d04\u70ba\u6b63\u5e38\u503c\u7684 10\u500d\uff0c\u73fe\u65bc\u6025\u8a3a\u7981\u98df\u4e2d\uff0c\u5f85\u5f8c\u7e8c\u5f71\u50cf\u6aa2\u67e5\u3002\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u5178\u578b\u80f0\u81df\u708e\u7684\u8a3a\u65b7\u5fc5\u9808\u6eff\u8db3 3\u9805\u8981\u4ef6\uff0c\u5305\u542b\u81e8\u5e8a\u75c7\u72c0\uff0c\u5be6\u9a57\u5ba4\u6aa2\u67e5\uff0c\u4ee5\u53ca\u5f71\u50cf\u6aa2\u67e5\u3002 (B)\u82e5\u75c5\u4eba\u904e\u53bb\u7121\u80f0\u81df\u708e\u75c5\u53f2\uff0c\u56e0\u8d85\u97f3\u6ce2\u6709\u6642\u6613\u88ab\u8178\u6c23\u5e72\u64fe\uff0c\u61c9\u76e1\u65e9\u5b89\u6392\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u3002 (C)\u82e5\u8a3a\u65b7\u80f0\u81df\u708e\uff0c\u56e0\u75c5\u4eba\u9700\u8f03\u9577\u6642\u9593\u7981\u98df\uff0c\u61c9\u4f7f\u7528\u9810\u9632\u6027\u6297\u751f\u7d20\u907f\u514d\u8178\u9053\u7d30\u83cc\u79fb\u8f49\u3002 (D)\u6cbb\u7642\u4ee5\u652f\u6301\u6027\u7642\u6cd5\u70ba\u4e3b\uff0c\u5176\u4e2d\u65e9\u671f\u7a4d\u6975\u7684\u9ad4\u6db2\u6cbb\u7642\u53ef\u6539\u5584\u9810\u5f8c\uff0c\u9996\u9078\u4e73\u9178\u6797\u683c\u6c0f\u6db2\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u5a66\u5973\u9670\u9053\u708e( Vulvovaginitis )\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5167\u8a3a\u9032\u884c\u6aa2\u9ad4\u63a1\u6a23\uff0c\u9700\u63a1\u53d6\u81f3\u5f8c\u7a79\u9686(posterior fornix)\u7684\u6df1\u5ea6\uff0c\u56e0\u9670\u9053\u524d\u6bb5\u5206\u6ccc\u7269\u53ef\u80fd\u6703\u53d7\u5f71\u97ff pH\u503c\uff0c\u5c0e\u81f4\u7d50\u679c\u4e0d\u6e96\u78ba\u3002 (B)\u93e1\u6aa2\u770b\u5230\u83cc\u7d72(pseudohyphae )\u53ca\u51fa\u82bd(buds) \uff0cWhiff test \u82e5\u6709\u9b5a\u8165\u81ed\u5473\u5247\u66f4\u50be\u5411\u70ba\u5ff5\u73e0\u83cc(Candidiasis)\u611f\u67d3\u3002 (C)\u82e5\u7121\u6cd5\u5fcd\u53d7\u53e3\u670d\u85e5\u7269\u7684\u526f\u4f5c\u7528\uff0c\u53ef\u8003\u616e Metronidazole gel \u6216Clindamycin cream \u3002 (D)N.gonorrhoeae \u662fBartholin cyst and abscess \u6700\u5e38\u898b\u7684\u81f4\u75c5\u83cc\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "1\u6b72\u5e7c\u5152\u65bc\u4e2d\u570b\u5ee3\u6771\u51fa\u73fe\u767c\u71d2\u53ca\u5168\u8eab\u76ae\u75b9\u75c7\u72c0\u5f8c\u8fd4\u53f0\u5c31\u91ab\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u53e3\u8154\u6aa2\u67e5\u5982\u51fa\u73fe\u67ef\u6c0f\u6591(koplik spots ) \uff0c\u61c9\u5efa\u8b70\u75c5\u4eba\u4f4f\u9662\u8ca0\u58d3\u9694\u96e2\u75c5\u623f\u3002 (B)\u9451\u5225\u8a3a\u65b7\u4e2d\uff0c\u9ebb\u75b9\u901a\u5e38\u71d2\u9000\u5f8c\u9694\u5929\u624d\u6703\u51fa\u75b9\uff0c\u7d05\u75b9\u901a\u5e38\u5148\u51fa\u73fe\u5728\u624b\u8173\uff0c\u4e4b\u5f8c\u8513\u5ef6\u5230\u8ec0\u5e79\u53ca\u81c9\u90e8\uff0c\u53e3\u8154\u9ecf\u819c\u901a\u5e38\u4e0d\u53d7\u5f71\u97ff\u3002 (C)\u7329\u7d05\u71b1\u75c5\u6e90\u70ba\u55ae\u80a1 DNA\u75c5\u6bd2\uff0c\u53ef\u7d93\u7531\u98db\u6cab\u50b3\u67d3\uff0c\u5efa\u8b70\u55ae\u4eba\u75c5\u623f\u4f4f\u9662\u3002 (D)\u5b30\u5152\u73ab\u7470\u75b9\u7684\u76ae\u75b9\u548c\u767c\u71d2\u4e00\u8d77\u51fa\u73fe\uff0c\u9000\u71d2\u5f8c\u76ae\u75b9\u5373\u6d88\u5931\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "58\u6b72\u7537\u6027\u5728 30\u5206\u9418\u524d\u906d\u9047\u56b4\u91cd\u7684\u8eca\u798d\u5c0e\u81f4\u5176\u6709\u56b4\u91cd\u5589\u90e8\u5275\u50b7( laryngeal trauma)\u800c\u88ab\u9001\u4f86\u6025\u8a3a\uff0c\u8eab\u9ad4\u8a3a\u5bdf\u767c\u73fe\u524d\u9838\u90e8\u7121\u660e\u986f\u50b7\u53e3\u4f46\u6709\u5927\u7247\u7600\u9752\u53ca\u816b\u8139\u60c5\u5f62\uff0c\u7121\u6cd5\u4ee5\u624b\u6307\u89f8\u8a3a\u8fa8\u5225\u5589\u90e8\u5404\u8edf\u9aa8\u69cb\u9020\uff0c\u4e2d\u5ea6\u547c\u5438\u7a98\u8feb\u53ca\u51fa\u73fe\u96d9\u5411\u5598\u9cf4\u97f3 (biphasic stridor )\u3002\u8acb\u554f\u4e0a\u547c\u5438\u9053\u7684\u4fdd\u8b77\u65b9\u5f0f\u4ee5\u4e0b\u5217\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u7d66\u4e88\u75c5\u4eba\u6f6e\u6fd5\u7a7a\u6c23(Humidified air )\u53ca\u7d93\u975c\u8108\u7d66\u4e88\u985e\u56fa\u9187\u3002 (B)\u7d66\u4e88\u75c5\u4eba\u808c\u8089\u9b06\u5f1b\u5291\u53ca\u93ae\u5b9a\u5291\u5f8c\uff0c\u7d93\u53e3\u9032\u884c\u6c23\u7ba1\u5167\u7ba1\u63d2\u7ba1\u4f86\u4fdd\u8b77\u547c\u5438\u9053\u3002 (C)\u7dca\u6025\u6703\u8a3a\u8033\u9f3b\u5589\u79d1\u5728\u5c40\u90e8\u9ebb\u9189\u4e0b\u9032\u884c\u6c23\u7ba1\u5207\u958b\u8853 (Awake tracheostomy under local anesthesia )\u4f86\u4fdd\u8b77\u547c\u5438\u9053\u3002 (D)\u9032\u884c\u74b0\u7532\u819c\u5207\u958b\u8853(Cricothyroidotomy )\u4f86\u4fdd\u8b77\u547c\u5438\u9053\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "82\u6b72\u7537\u6027\u75c5\u4eba\uff0c\u6700\u8fd1 2\u5929\u7a81\u7136\u51fa\u73fe\u60c5\u7dd2\u6fc0\u8e81\u3001\u61f7\u7591\u5bb6\u4eba\u5728\u4ed6\u7684\u98df\u7269\u4e2d\u4e0b\u6bd2\u3001\u770b\u898b\u5df2\u7d93\u904e\u4e16\u7684\u89aa\u4eba\u56de\u4f86\u770b\u4ed6\u7b49\u7cbe\u795e\u75c7\u72c0\uff0c\u61c9\u8a72 \u512a\u5148\u8003\u616e\u7684\u9451\u5225\u8a3a\u65b7\u662f\uff1f", + "Options": "(A)\u5984\u60f3\u75c7\u3002 (B)\u8eab\u9ad4\u75be\u75c5\u5f15\u8d77\u7684\u7cbe\u795e\u75be\u60a3\u3002 (C)\u601d\u89ba\u5931\u8abf\u75c7\u3002 (D)\u8e81\u9b31\u75c7\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u91dd\u5c0d\u6709\u66b4\u529b\u50b7\u5bb3\u50be\u5411\u6025\u6027\u7cbe\u795e\u75c5\u4eba\u7684\u8a55\u4f30\u53ca\u85e5\u7269\u8655\u7f6e\uff0c\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u975e\u5178\u578b\u6297\u7cbe\u795e\u75c5\u85e5\u7269\u5982 Olanzapine \u5176\u5c0d\u591a\u5df4\u80fa\u53d7\u9ad4\u5177\u7279\u7570\u6027\uff0c\u5c0d\u6e1b\u5c11QTc\u5ef6\u9577\u526f\u4f5c\u7528\uff0c\u4e5f\u6bd4\u5178\u578b\u6297\u7cbe\u795e\u75c5\u85e5\u7269\u597d\u3002 (B)\u8eab\u9ad4\u8a3a\u5bdf\u767c\u73fe\u548c\u6025\u6027\u7cbe\u795e\u75be\u60a3\u76f8\u95dc\u5177\u6709\u7279\u7570\u6027\uff0c\u5916\u89c0\u4e4b\u7570\u5e38\u6216\u7121\u7d44\u7e54\u7684\u884c\u70ba\u975e\u4e3b\u8981\u5224\u65b7\u4f9d\u64da\u3002 (C)\u8a55\u4f30\u539f\u5247\u9996\u8981\u6392\u9664\u662f\u5426\u5b58\u6709\u5167\u79d1\u6216\u5916\u50b7\u554f\u984c\uff0c\u6b21\u8981\u6e1b\u8f15\u75c5\u4eba\u6f5b\u5728\u50b7\u5bb3\u3002 (D)\u93ae\u975c\u5b89\u7720\u85e5 (Benzodiazepines)\u548c\u9152\u7cbe\u5169\u8005\u4e2d\u6bd2\u6216\u6212\u65b7\u7686\u6703\u5f15\u8d77\u6025\u6027\u7cbe\u795e\u75c5\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "50\u6b72\u7537\u6027\u56e0\u75c5\u6bd2\u6027\u80ba\u708e\u65bc 3\u65e5\u5167\u5feb\u901f\u9032\u5c55\u81f3\u547c\u5438\u8870\u7aed\uff0c\u4f7f\u7528 100%\u6c27\u6c23\u5176PaO 2\u70ba90 mmHg \uff0c\u63d2\u7ba1\u5f8c\u4f7f\u7528\u547c\u5438\u5668\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u70ba\u56b4\u91cd\u7684 Acute Respiratory Distress Syndrome (ARDS)\u3002 (B)\u53ef\u80fd\u6703\u7522\u751f\u547c\u5438\u6027\u9e7c\u8840\u75c7(alkalosis) \uff0c\u8f15\u5fae\u7684\u8a71\u53ef\u4ee5\u63a5\u53d7\u3002 (C)\u6cbb\u7642\u904e\u7a0b\u547c\u5438\u76e3\u63a7\u53ef\u8a2d\u5b9a\u8840\u6c27\u76ee\u6a19 SpO 2\u5927\u65bc 95%\u3002 (D)\u8981\u4f7f\u7528\u4f4e\u7684\u6f6e\u6c23\u5bb9\u7a4d (tidal volume )\u8207 Positive end expiratory pressure(PEEP)\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "50\u6b72\u7537\u6027\u56e0\u5de6\u4e0a\u8179\u90e8\u7a81\u767c\u75bc\u75db\uff0c\u5408\u4f75\u5614\u5410\u81f3\u6025\u8a3a\u6c42\u8a3a\u3002\u904e\u53bb\u75c5\u53f2\u6709\u6a6b\u8188\u819c\u759d\u6c23\u53ca\u80c3\u98df\u9053\u9006\u6d41\u3002\u8840\u58d3 86/40 mmHg \u3001\u5fc3\u8df3 121\u6b21/min\u3001\u9ad4\u6eab 37\u2103\u3001\u547c\u543820\u6b21/min\u3001SpO 2 98%\u3002\u8eab\u9ad4\u8a3a\u5bdf\u4e3b\u8981\u7570\u5e38\u70ba\u4e0a\u8179\u8139\u75db\uff0c\u53e9\u8a3a\u70ba\u9f13\u97f3(tympanic ) \uff0c\u4e14\u5de6\u4e0b\u80ba\u547c\u5438\u97f3\u6e1b\u5c11\u3002\u5be6\u9a57\u5ba4\u5831\u544a\u767c\u73fe lactate 28 mg/dL \u3001pH 7.13\u3001 HCO 3- 8.1 mEq/L \u3001Hb 12 g/dL\u3002\u80f8\u90e8 X\u5149\u767c\u73fe\u80c3\u8139\u5927\uff0c\u4e14\u4f4d\u5728\u6a6b\u8188\u819c\u4ee5\u4e0a\u3002\u9664\u4e86\u9069\u7576\u7684\u8f38\u6db2\u6cbb\u7642\u4e4b\u5916\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u6703\u8a3a\u5916\u79d1\u958b\u5200\u6cbb\u7642\u3002 (B)\u5b89\u6392\u80c3\u93e1\u3002 (C)\u8f38\u7d05\u8840\u7403\u6fc3\u7e2e\u6db2(PRBCs )\u3002 (D)\u975c\u8108\u6ce8\u5c04 Sodium bicarbonate \u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u751f\u7269\u6050\u6016\u653b\u64ca\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u751f\u7269\u6230\u5291\u4e2d\uff0c\u4f7f\u7528\u50b3\u67d3\u6027\u75c5\u539f\u9ad4\u901a\u5e38\u5177\u6709\u8207\u5316\u5b78\u6230\u5291\u76f8\u4f3c\u7684\u7279\u6027\u3002 (B)\u5927\u90e8\u4efd\u751f\u7269\u6230\u5291\u7522\u751f\u7684\u521d\u671f\u75c7\u72c0\uff0c\u5bb9\u6613\u8207\u5e38\u898b\u50b3\u67d3\u75c5\u5340\u5206\u3002 (C)\u6c92\u6709\u660e\u986f\u7684\u75c7\u72c0\u6216\u78ba\u5207\u7684\u66b4\u9732\uff0c\u4e0d\u9700\u8981\u9032\u884c\u9810\u9632\u6027\u514d\u75ab\u63a5\u7a2e\u6216\u6cbb\u7642\u3002 (D)\u5728\u672a\u4e86\u89e3\u75c5\u539f\u9ad4\u4e26\u78ba\u5b9a\u5176\u50b3\u64ad\u6a21\u5f0f\u4e4b\u524d\uff0c\u63a1\u7528\u6700\u9ad8\u7684\u50b3\u64ad\u9810\u9632\u63aa\u65bd\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "70\u6b72\u7537\u6027\u7121\u6162\u6027\u75be\u75c5\uff0c\u56e0\u6025\u6027\u5de6\u5074\u80a2\u9ad4\u7121\u529b\uff0c\u767c\u75c5 1\u5c0f\u6642\u5167\u81f3\u6025\u8a3a\u5c31\u91ab\uff0c\u5176\u5de6\u4e0a\u80a2\u53ca\u5de6\u4e0b\u80a2\u7686\u53ea\u80fd\u5728\u5e8a\u4e0a\u6d3b\u52d5\u4f46\u7121\u6cd5\u8209\u9ad8\u5c0d\u6297\u91cd\u529b\uff0c\u7d93\u6aa2\u67e5\u5f8c\u7121\u5176\u4ed6\u795e\u7d93\u75c7\u72c0\uff0c\u4e14\u751f\u547d\u5fb5\u8c61\u8207\u62bd\u8840\u6aa2\u9a57\u7121\u7570\u5e38\uff0c\u8a3a\u65b7\u70ba\u7f3a\u8840\u6027\u4e2d\u98a8\uff0c\u4e0b\u5217\u6cbb\u7642\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \ufe56", + "Options": "(A)\u6b64\u75c5\u4eba\u76ee\u524d\u7b26\u5408\u6211\u570b\u4f7f\u7528\u975c\u8108\u5167\u6ce8\u5c04\u8840\u6813\u6eb6\u89e3\u5291\u7684\u9069\u61c9\u75c7\u3002 (B)\u6b64\u75c5\u4eba\u76ee\u524d\u7b26\u5408\u6211\u570b\u4f7f\u7528\u52d5\u8108\u5167\u53d6\u6813\u8853\u7684\u9069\u61c9\u75c7\u3002 (C)\u4e9e\u6d32\u4eba\u82e5\u8981\u4f7f\u7528\u8840\u6813\u6eb6\u89e3\u5291\u53ef\u7528\u8f03\u4f4e\u7684\u5291\u91cf\u4ee5\u6e1b\u5c11\u4f75\u767c\u75c7\u3002 (D)\u63a5\u53d7\u975c\u8108\u6ce8\u5c04\u8840\u6813\u6eb6\u89e3\u5291\u7684\u75c5\u4eba\u4ecd\u53ef\u4ee5\u63a5\u53d7\u52d5\u8108\u5167\u53d6\u6813\u8853\u6cbb\u7642\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u5728\u6025\u8a3a\u6642\u6703\u7f6e\u653e\u7684\u8840\u7ba1\u7ba1\u8def\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u653e\u7f6e\u53f3\u5074\u9838\u90e8\u4e2d\u592e\u975c\u8108\u5c0e\u7ba1\u6642\u6709\u6642\u53ef\u898b\u4e73\u7cdc\u80f8 (Chylothorax )\u7684\u4f75\u767c\u75c7\u3002 (B)\u5f9e\u80a1\u975c\u8108\u653e\u7f6e\u4e2d\u592e\u975c\u8108\u5c0e\u7ba1\u6642\uff0c\u5982\u9032\u91dd\u8655\u5728\u8179\u80a1\u6e9d\u97cc\u5e36\u4e4b\u4e0a\uff0c\u53ef\u80fd\u9020\u6210\u8179\u8154\u5167\u51fa\u8840\u3002 (C)\u5728\u56b4\u91cd\u7aef\u5750\u547c\u5438\u7684\u75c5\u4eba\uff0c\u5f9e\u9396\u9aa8\u4e0a\u9032\u91dd\u653e\u7f6e\u4e2d\u592e\u975c\u8108\u5c0e\u7ba1\u662f\u53ef\u884c\u7684\u65b9\u5f0f\u3002 (D)\u52d5\u8108\u5c0e\u7ba1\u5165\u91dd\u8655\u5982\u6709\u5c40\u90e8\u75bc\u75db\u3001\u7d05\u816b\u6642\uff0c\u7b2c\u4e00\u6b65\u9808\u5148\u5c40\u90e8\u52a0\u58d3 3~5\u5206\u9418\u518d\u62d4\u91dd\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u56e0\u74e6\u65af\u7ba1\u8def\u5916\u6d29\u8def\u9762\u767c\u751f\u9023\u74b0\u7206\u70b8\uff0c\u6578\u540d\u50b7\u60a3\u88ab\u9001\u81f3\u6025\u8a3a\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u56e0\u54b3\u8840\u547c\u5438\u8870\u7aed\u7dca\u6025\u63d2\u7ba1\uff0c\u547c\u5438\u5668\u8a2d\u5b9a\u7528 V olume -control mode \uff0c\u63a7\u5236 tidal volume 10 ml/kg \u3002 (B)\u5de6\u8033\u807d\u529b\u807d\u4e0d\u5230\uff0c\u8033\u93e1\u6aa2\u67e5\u767c\u73fe\u8033\u819c\u7834\u88c2\uff0c\u6b64\u5916\u7121\u5176\u4ed6\u4e0d\u9069\uff0c\u5b89\u6392\u75c5\u4eba\u7167 CXR\u3002 (C)\u53f3\u624b\u81c2\u4e00\u50b7\u53e3\u6301\u7e8c\u8108\u52d5\u5f0f(pulsatile )\u51fa\u8840\uff0c\u52a0\u58d3\u6b62\u8840\u5f8c\u4ecd\u8840\u6d41\u4e0d\u6b62\uff0c\u4f7f\u7528\u6b62\u8840\u5e36\u6b62\u8840\u3002 (D)\u53f3\u819d\u8f15\u5fae\u64e6\u50b7\uff0c\u5176\u4ed6\u8eab\u9ad4\u8a3a\u5bdf\u7121\u7570\u5e38\uff0c\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\uff0c\u7559\u9662\u89c0\u5bdf4~6\u5c0f\u6642\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "45\u6b72\u6709\u5168\u8eab\u6027\u786c\u5316\u75c7( systemic sclerosis )\u4e4b\u7537\u6027\u75c5\u4eba\uff0c\u670d\u7528\u985e\u56fa\u9187\u6cbb\u7642\uff0c\u4e0a\u500b\u6708\u814e\u529f\u80fd\u6b63\u5e38\uff0c\u6b64\u6b21\u56e0\u6f38\u9032\u6027\u982d\u75db\uff0c\u5408\u4f75\u5641\u5fc3\u611f\u8207\u547c\u5438\u5598\u4e09\u9031\uff0c\u4f86\u6025\u8a3a\u5c31\u8a3a\uff0c\u751f\u547d\u5fb5\u8c61\uff1a\u8840\u58d3 250/150 mmHg \u3001\u5fc3\u8df3 95\u6b21/min\u3001\u547c\u5438 14 \u6b21/min\u3001SpO 2 95%\u3001GCS E4V5M6\uff0c\u62bd\u8840\u6578\u503c\u5982\u4e0b\uff1aCr 21.73 mg/dl \uff0c\u95dc\u65bc\u6b64\u75c5\u4eba\u7684\u72c0\u6cc1\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u6b64\u985e\u75c5\u4eba\u7d04\u6709\u4e00\u534a\u4ee5\u4e0a\u6703\u65bc\u767c\u75c5\u56db\u5e74\u5167\u767c\u751f\u786c\u5316\u75c7\u814e\u81df\u5371\u6a5f(scleroderma renal crisis )\u3002 (B)\u985e\u56fa\u9187\u6cbb\u7642\u4e26\u975e\u4fc3\u767c\u56e0\u7d20\u3002 (C)\u4e0d\u5efa\u8b70\u7b2c\u4e00\u7dda\u4f7f\u7528 angiotensin -coverting enzyme inhibitors\u3002 (D)\u8840\u6db2\u900f\u6790\u6cbb\u7642\u5f8c\uff0c\u50c5\u7d04 10%\u75c5\u4eba\u814e\u529f\u80fd\u53ef\u80fd\u6062\u5fa9\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "70\u6b72\u5973\u6027\uff0c\u5b89\u990a\u9662\u4f4f\u6c11\uff0c\u56e0\u80ba\u708e\u4f4f\u9662\u6cbb\u7642 2\u9031\uff0c 3\u5929\u524d\u51fa\u9662\uff0c\u6628\u5929\u958b\u59cb\u89e310\u6b21\u91cf\u591a\u9ec3\u6c34\u4fbf\uff0c\u98df\u617e\u6d3b\u529b\u4e0d\u4f73\uff0c\u7121\u63a5\u89f8\u6216\u7fa4\u805a\u53f2\uff0c\u6aa2\u50b7\u9ad4\u6eab 38\u2103\uff0c\u5fc3\u8df3120\u6b21/min\uff0c\u8840\u58d3 90/60 mmHg \uff0c\u8840\u6c27\u6fc3\u5ea6 94%\uff0c\u62bd\u8840 WBC 16,000/mm3\uff0c\u7cde\u4fbf toxin A\u53catoxin B\u5448\u967d\u6027\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u7d66\u4e88 Vancomycin \u53e3\u670d\u4f7f\u7528\u3002 (B)\u7d66\u4e88 Vancomycin \u975c\u8108\u6ef4\u6ce8\u4f75\u7d93\u809b\u9580\u7d66\u85e5\u4f7f\u7528\u3002 (C)\u9700\u7b49\u5f85\u56f0\u96e3\u68ad\u72c0\u687f\u83cc(C. difficile )\u7cde\u4fbf\u57f9\u990a\u7d50\u679c\uff0c\u518d\u6c7a\u5b9a\u662f\u5426\u7d66\u4e88\u6297\u751f\u7d20\u6cbb\u7642\u3002 (D)\u56f0\u96e3\u68ad\u72c0\u687f\u83cc(C. difficile )\u7cde\u4fbf\u57f9\u990a\u5831\u544a\u51fa\u4f86\u4e4b\u524d\uff0c\u5148\u7d66\u4e88Ciprofloxacin \u53e3\u670d\u4f7f\u7528\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u4e0d\u660e\u7269\u8cea\u4e2d\u6bd2\u75c5\u4eba\u5728\u6c23\u7ba1\u4f7f\u7528\u547c\u5438\u5668\u5f8c\uff0c ABG\u7d50\u679c\u70ba\uff1a pH 7.2\u3001PaCO 2 20 mmHg \u3001PaO 2 300 mmHg \u3001HCO 3- 10 mEq/L \uff0c\u4f46\u8eab\u9ad4\u5916\u89c0\u4ecd\u53ef\u898b\u660e\u986f\u767c\u7d3a\u73fe\u8c61\u3002 \u8f03\u6709\u53ef\u80fd \u662f\u4e0b\u5217\u90a3\u7a2e\u7269\u8cea\u4e2d\u6bd0\uff1f", + "Options": "(A)\u4e00\u6c27\u5316\u78b3 (CO)\u3002 (B)\u6c30\u5316\u6c2b(HCN )\u3002 (C)\u786b\u5316\u6c2b(HS )\u3002 (D)\u4e9e\u785d\u9178\u7d0d (Sodium nitrite )\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u6162\u6027\u963b\u585e\u6027\u80ba\u75c5\u6025\u6027\u767c\u4f5c\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u6cbb\u7642\u80c3\u98df\u9053\u9006\u6d41\u53ef\u6e1b\u5c11\u6025\u6027\u767c\u4f5c\u3002 (B)\u7d66\u4e88\u6c27\u6c23\u6709\u52a9\u65bc\u6539\u5584\u80ba\u8840\u7ba1\u6536\u7e2e\u3002 (C)\u6162\u6027\u963b\u585e\u6027\u80ba\u75c5\u6025\u6027\u767c\u4f5c\u662f\u56e0\u70ba\u547c\u6c23\u6c23\u6d41\u53d7\u9650\u3002 (D)\u591a\u6578\u75c5\u4eba\u6025\u6027\u767c\u4f5c\u6642\u4e26\u7121\u75c5\u6bd2\u6216\u7d30\u83cc\u611f\u67d3\u8b49\u64da\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc Ottawa Subarachnoid Hemorrhage Rule \u7684\u4f7f\u7528\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576\ufe56", + "Options": "(A)\u5176\u8a3a\u65b7\u7279\u7570\u5ea6(specificity )\u9ad8\u9054 100%\u3002 (B)\u8a3a\u65b7\u689d\u4ef6\u5305\u62ec\u9838\u90e8\u5c48\u66f2(flexion )\u53d7\u9650\u3002 (C)\u8a3a\u65b7\u689d\u4ef6\u5305\u62ec\u81ea\u89ba\u610f\u8b58\u55aa\u5931\u3002 (D)\u8a3a\u65b7\u689d\u4ef6\u5305\u62ec\u5e74\u9f61 45\u6b72\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u88dd\u7f6e\u5de6\u5fc3\u5ba4\u8f14\u52a9\u5668\u7684\u75c5\u4eba\u65bc\u6025\u8a3a\u7684\u7dca\u6025\u8655\u7f6e\uff0c\u8acb\u554f\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u6b64\u985e\u75c5\u4eba CPCR(Cardio -Pulmonary -Cerebral -Resuscitation)\u6642\uff0c\u58d3\u80f8\u53ef\u80fd\u6703\u5c0e\u81f4\u5de6\u5fc3\u5ba4\u7834\u88c2\u3002 (B)\u82e5\u75c5\u4eba\u751f\u547d\u8de1\u8c61\u4e0d\u7a69\u5b9a\uff0c\u9700\u7acb\u5373\u57f7\u884c\u807d\u8a3a\uff0c\u82e5\u7121\u6a5f\u5668\u8072\uff0c\u5fc5\u9808\u78ba\u8a8d\u96fb\u6c60\u6216\u63a7\u5236\u5668\u529f\u80fd\u3002 (C)\u57f7\u884c CPCR\u58d3\u80f8\u6642\uff0c\u58d3\u80f8\u6df1\u5ea6\u9700\u8f03\u6b63\u5e38\u75c5\u4eba\u6df1\u3002 (D)\u82e5\u51fa\u73fe\u5fc3\u5ba4\u983b\u8108\uff0c\u5247\u96fb\u64ca\u5291\u91cf\u8207\u4e00\u822c\u75c5\u4eba\u76f8\u540c\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u7cfb\u7d71\u6027\u98a8\u6fd5\u75c5( systemic rheumatic diseases )\u7684\u75c5\u4eba\u53ef\u80fd\u6703\u56e0\u70ba\u4e0b\u5217\u539f\u56e0\u9020\u6210\u56f0\u96e3\u63d2\u7ba1\uff0c\u4f55\u8005\u6558\u8ff0\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u50f5\u76f4\u6027\u810a\u690e\u708e(ankylosing spondylitis )\u9808\u5c0f\u5fc3\u5bf0\u690e\u6a1e\u690e\u4e0d\u5b8c\u5168\u812b\u81fc\u3002 (B)\u8089\u82bd\u816b\u6027\u8840\u7ba1\u708e(granulomatosis with polyangiitis )\u53ef\u80fd\u6703\u51fa\u73fe\u8072\u9580\u4e0b\u72f9\u7a84(subglottic stenosis)\u3002 (C)\u786c\u76ae\u75c7(scleroderma )\u53ef\u80fd\u6703\u5f71\u97ff\u76ae\u819a\u7684\u5f48\u6027\u8207\u53e3\u8154\u958b\u53e3\u7684\u53e3\u5f91 \u3002 (D)\u7d05\u6591\u6027\u72fc\u7621 (systemic lupus erythematosus )\u53ef\u80fd\u6703\u4fb5\u72af\u9873\u984e\u95dc\u7bc0(temporomandibular joint )\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "40\u6b72\u7537\u6027\u56e0\u6c7d\u8eca\u5c0d\u649e\u4e8b\u6545\u9001\u6025\u8a3a\uff0c\u50b7\u60a3\u8868\u793a\u81ea\u5df1\u8179\u90e8\u75bc\u75db\uff0c\u4e0b\u5217\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u751f\u547d\u5fb5\u8c61\u4e0d\u7a69\u5b9a\uff0c \u8179\u90e8\u5916\u50b7\u91cd\u9ede\u8d85\u97f3\u6ce2\u6aa2\u67e5\u986f\u793a\u6709\u8179\u6c34\uff0c\u61c9\u6e96\u5099\u7dca\u6025\u5256\u8179\u63a2\u67e5\u624b\u8853\u3002 (B)\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\uff0c\u96fb\u8166\u65b7\u5c64\u986f\u793a\u813e\u81df\u640d\u50b7\uff0c\u7b2c\u4e00\u7dda\u6cbb\u7642\u70ba\u813e\u81df\u6458\u9664\u624b\u8853\u3002 (C)\u7121\u660e\u986f\u5916\u50b7\uff0c\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\uff0c\u96fb\u8166\u65b7\u5c64\u7121\u660e\u986f\u51fa\u8840\uff0c\u4f46\u8179\u90e8\u6301\u7e8c\u6709\u58d3\u75db\u53ca\u8179\u819c\u5fb5\u8c61\uff0c\u4ecd\u5efa\u8b70\u5256\u8179\u63a2\u67e5\u3002 (D)\u8179\u90e8\u524d\u58c1\u6709\u7591\u4f3c\u7a7f\u523a\u50b7\uff0c\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\uff0c\u5efa\u8b70\u5b89\u6392\u96fb\u8166\u65b7\u5c64\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u75c5\u4eba\u4e3b\u8a34 3\u5929\u524d\u6709\u5614\u5410\u53ca\u8179\u7009\uff0c\u7121\u767c\u71d2\uff0c\u6628\u5929\u958b\u59cb\u51fa\u73fe\u6613\u55c6\u54b3\u53ca\u5c0d\u7a31\u6027\u4e0a\u80a2\u7121\u529b\u73fe\u8c61\uff0c\u4eca\u5929\u56e0\u70ba\u96d9\u4e0b\u80a2\u7121\u529b\uff0c\u5408\u4f75\u6709\u5c3f\u5931\u7981\u800c\u81f3\u6025\u8a3a\u5c31\u91ab\uff0c\u4e0b\u5217\u4f55\u7a2e\u75be\u75c5\u8f03\u6709\u53ef\u80fd \uff1f", + "Options": "(A)\u65e5\u672c\u8166\u708e\u3002 (B)Guillain -Barre\u6c0f\u75c7\u5019\u7fa4\u3002 (C)\u8089\u6bd2\u687f\u83cc\u4e2d\u6bd2\u3002 (D)\u91cd\u75c7\u808c\u7121\u529b\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u75c7\u5019\u7fa4\u8207\u75be\u75c5\u4e4b\u914d\u5c0d\uff0c\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)Boerhaave syndrome \u662f\u6307\u80c3\u5e95\u7834\u88c2\u3002 (B)Ehlers -Danlos syndrome \u70ba\u597d\u767c\u4e3b\u52d5\u8108\u525d\u96e2\u7684\u75be\u75c5\u3002 (C)Precordial catch syndrome \u662fmyocardial contusion \u5f8c\u6240\u7522\u751f\u7684\u80f8\u75db\u3002 (D)Tietze\u2019s syndrome \u662f\u6307 tension pneumothorax \u5f8c\u6240\u7522\u751f\u7684\u80f8\u75db\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5916\u50b7\u6027\u9ad6\u95dc\u7bc0\u812b\u81fc( Hip dislocation )\u7684\u6558\u8ff0\uff0c\u4f55\u8005\u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u81e8\u5e8a\u4e0a\u4ee5 Posterior dislocation \u70ba\u4e3b\uff0c\u5e38\u767c\u751f\u65bc\u8eca\u798d\u819d\u84cb\u649e\u64ca\u5100\u8868\u677f\u6642\uff0c\u8eab\u9ad4\u8a3a\u5bdf\u53ef\u898b\u5927\u817f\u7e2e\u77ed\u3001\u5916\u7ffb\u8207\u5916\u8f49\u3002 (B)\u5e38\u5408\u4f75\u9aa8\u76c6\u8154\u3001\u9ad6\u81fc\u3001\u5927\u817f\u9aa8\u6298\u8207\u819d\u84cb\u97cc\u5e36\u640d\u50b7\uff0c\u9700\u5b89\u6392\u96fb\u8166\u65b7\u5c64\u9032\u4e00\u6b65\u8a55\u4f30\u50b7\u52e2\u3002 (C)\u9700\u8a73\u7d30\u8a55\u4f30\u795e\u7d93\u8207\u8840\u7ba1\u529f\u80fd\uff0c\u795e\u7d93\u640d\u50b7\u4ee5\u5750\u9aa8\u795e\u7d93\u6700\u70ba\u5e38\u898b\u3002 (D)\u70ba\u9aa8\u79d1\u6025\u75c7\uff0c\u61c9\u5118\u901f\u65bc 6\u5c0f\u6642\u5167\u5b8c\u6210\u9ad6\u95dc\u7bc0\u5fa9\u4f4d\u3002\u5ef6\u9072\u5fa9\u4f4d\u6703\u589e\u52a0\u80a1\u9aa8\u982d\u7f3a\u8840\u6027\u58de\u6b7b\u7684\u6a5f\u7387\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u4e0b\u5217\u9ad8\u8840\u58d3\u6025\u75c7\u8207\u5c0d\u61c9\u7684\u6cbb\u7642\u85e5\u7269\u548c\u6cbb\u7642\u76ee\u6a19\uff0c\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u4e3b\u52d5\u8108\u525d\u96e2\uff0c\u4f7f\u7528 Labetalol \u63a7\u5236\u6536\u7e2e\u58d3\u5728 100~120 mmHg \u3002 (B)\u5b89\u975e\u4ed6\u547d\u4e2d\u6bd2\uff0c\u4f7f\u7528 Benzodiazepine \u63a7\u5236\u6536\u7e2e\u58d3\u5728 140 mmHg \u4ee5\u4e0b\u3002 (C)\u5b50\u7672\u524d\u75c7\uff0c\u4f7f\u7528 ACE inhibitors \u63a7\u5236\u6536\u7e2e\u58d3\u5728 140 mmHg \u4ee5\u4e0b\u3002 (D)\u8718\u86db\u7db2\u819c\u4e0b\u8154\u51fa\u8840\uff0c\u4f7f\u7528 Nicardipine \u63a7\u5236\u6536\u7e2e\u58d3\u5728 160 mmHg \u4ee5\u4e0b\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5fc3\u81df\u9a5f\u505c\u5f8c\u7167\u8b77\u7684\u76ee\u6a19\u9ad4\u6eab\u7ba1\u7406 (TTM)\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u7d0d\u5165\u6a19\u6e96\u5305\u62ec\uff1aROSC \u548cGCS\u904b\u52d5\u8a55\u5206<6 \uff0c\u6c92\u6709\u5176\u4ed6\u660f\u8ff7\u539f\u56e0\uff0c\u6c92\u6709DNR\u6216DNI\u72c0\u614b\u7b49\u3002 (B)\u6392\u9664\u6a19\u6e96\u5305\u62ec\uff1a\u5916\u50b7\u6216\u56b4\u91cd\u51fa\u8840\u9020\u6210\u5fc3\u8df3\u505c\u6b62\uff0c\u670d\u7528\u6297\u51dd\u8840\u5291\u75c5\u4eba\u7b49\u3002 (C)\u6f5b\u5728\u4e0d\u826f\u53cd\u61c9\u5305\u62ec\uff1aPTT \u5ef6\u9577\u7684\u51dd\u8840\u969c\u7919\uff0c\u964d\u6eab\u671f\u9593\u9ad8\u9240\u8840\u75c7\uff0c\u56de\u6eab\u671f\u9593\u4f4e\u9240\u8840\u75c7\u3002 (D)\u5118\u5feb\u5728\u6062\u5fa9\u81ea\u4e3b\u5faa\u74b0\u5f8c 2\u5c0f\u6642\u5167\uff0c\u5c07\u6838\u5fc3\u9ad4\u6eab\u964d\u81f3 32~36\u2103\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "25\u6b72\u7537\u6027\uff0c\u7121\u904e\u53bb\u75c5\u53f2\uff0c\u63a5\u53d7\u6ce8\u5c04\u986f\u5f71\u5291\u7684\u96fb\u8166\u65b7\u5c64\u6aa2\u67e5\u5f8c\uff0c\u51fa\u73fe\u547c\u5438\u56f0\u96e3\u8207\u4f11\u514b\u7684\u60c5\u5f62\uff0c\u547c\u5438\u97f3\u5169\u5074\u7686\u6709\u660e\u986f\u7684 wheezing \uff0c\u4e14\u660e\u986f\u4f7f\u7528\u547c\u5438\u8f14\u52a9\u808c\uff0c\u751f\u547d\u5fb5\u8c61\u70ba 80/45 mmHg \u3001\u5fc3\u8df3 120\u6b21/min\u3001\u547c\u5438 36\u6b21/min\u3001\u9ad4\u6eab 38.3\u2103\u3001\u8840\u6c27 85%\u3001GCS E4V5M6\uff0c\u4e0b\u5217\u7684\u8a55\u4f30\u8207\u8655\u7f6e\uff0c\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)\u9996\u9078\u7531\u4e0a\u81c2\u7d66\u4e88\u808c\u8089\u6ce8\u5c04 0.3 mg Epinephrine \u3002 (B)\u7d66\u4e88\u5927\u91cf\u751f\u7406\u98df\u9e7d\u6c34 1,000~2,000 cc \u975c\u8108\u8f38\u6db2\u3002 (C)\u7d66\u4e88\u9ad8\u6fc3\u5ea6\u6c27\u6c23\uff0c\u7dad\u6301\u52d5\u8108\u8840\u6c27\u6fc3\u5ea6\u5927\u65bc 90%\u3002 (D)\u7d66\u4e88\u5438\u5165\u578b\u6c23\u7ba1\u64f4\u5f35\u5291\u8207\u975c\u8108\u6ce8\u5c04\u786b\u9178\u9382 2 g\u3002", + "Answer": "A" + }, + { + "\ufeffQuestion": "\u6025\u8a3a 3\u540d\u75c5\u4eba\uff0c\u4e00\u8d77\u98df\u7528\u5916\u8cb7\u5348\u9910\u9bd6\u9b5a\u4fbf\u7576\u5f8c\u7d04 1\u5c0f\u6642\u5f8c\u51fa\u73fe\u75c7\u72c0\uff0c\u5305\u62ec\u982d\u75db\u3001\u982d\u6688\u3001\u8179\u7009\u3001\u4e0a\u8179\u90e8\u75bc\u75db\u3002\u75c5\u4eba\u751f\u547d\u5fb5\u8c61\u7a69\u5b9a\uff0c\u7121\u767c\u71d2\uff0c\u8eab\u9ad4\u8a3a\u5bdf\u767c\u73fe\u6709 2\u4f4d\u75c5\u4eba\u81c9\u90e8\u3001\u80f8\u90e8\u6709\u6f6e\u7d05(flushing) \uff0c\u5176\u9918\u90e8\u4f4d\u5747\u70ba\u6b63\u5e38\uff0c\u4e0b\u5217\u8655\u7f6e\u4f55\u8005 \u8f03\u9069\u7576\uff1f", + "Options": "(A)\u5feb\u901f\u51fa\u73fe\u75c7\u72c0\uff0c\u81f4\u75c5\u539f\u6700\u53ef\u80fd\u70ba\u91d1\u9ec4\u8272\u8461\u8404\u7403\u83cc\u5167\u6bd2\u7d20(staphylococcal enterotoxin )\u3002 (B)\u63a1\u96c6\u75c5\u4eba\u5c4e\u4fbf\u6aa2\u9ad4\uff0c\u7d66\u4e88\u652f\u6301\u6027\u7642\u6cd5\u8207\u53e3\u670d\u6297\u751f\u7d20\u85e5\u7269\u3002 (C)\u7d66\u4e88\u652f\u6301\u6027\u7642\u6cd5\u8207\u6297\u7d44\u7e54\u80fa(anti -histamine )\u85e5\u7269\u3002 (D)\u9ad8\u6eab\u70f9\u716e\u98df\u6750\uff0c\u53ef\u9810\u9632\u6b64\u985e\u98df\u7269\u4e2d\u6bd2\u4e8b\u6545\u767c\u751f\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "35\u6b72\u5973\u6027\uff0c\u56e0\u767c\u71d2\u5408\u4f75\u610f\u8b58\u4e0d\u6e05\u5c31\u91ab\uff0c\u8166\u90e8\u65b7\u5c64\u6383\u63cf\u4e26\u7121\u8166\u51fa\u8840\uff0c\u6aa2\u9a57\u6aa2\u67e5\u767c\u73fe WBC 3,700 /\u00b5L \u3001Hb 5.0 g/dL \u3001Platelet 15,000 /\u03bcL \u3001Creatinine 3.5 mg/dL\u3001T-Bil 5.3 mg/dL \u3001D-Bil 1.2 mg/dL \u3001INR 0.9\u3001aPTT ratio 1.1 \u3001Heptoglobin 12 mg/dL(\u53c3\u8003\u503c 30~200 mg/dL ) \uff0c\u6709\u95dc\u6b64\u75c5\u4eba\u6558\u8ff0\u4e0b\u5217\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u6b64\u75c5\u7406\u6a5f\u8f49\u70ba\u86cb\u767d\u9176 ADAMTS -13\u6d3b\u6027\u904e\u5f37\u3002 (B)\u6cbb\u7642\u5305\u542b\u8840\u6f3f\u7f6e\u63db\u53ca\u88dc\u5145\u7d05\u8840\u7403\u8207\u8840\u5c0f\u677f\u3002 (C)\u9700\u9451\u5225\u8a3a\u65b7\u4eba\u985e\u514d\u75ab\u7f3a\u9677\u75c5\u6bd2 (HIV)\u611f\u67d3 \u3002 (D)\u7d93\u6cbb\u7642\u5f8c\u7684\u9810\u5f8c\u6975\u4f73\u4e14\u5fa9\u767c\u7387\u4e5f\u5f88\u4f4e\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u4f60\u6b63\u6e96\u5099\u62bd\u53d6\u819d\u95dc\u7bc0\u6db2\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576 \uff1f", + "Options": "(A)\u62bd\u53d6\u6642\u61c9\u907f\u514d\u5728\u540c\u6642\u95dc\u7bc0\u8154\u4e0a\u4e0b\u8f15\u64e0( milking)\u4ee5\u514d\u9020\u6210\u95dc\u7bc0\u8154\u51fa\u8840\u3002 (B)\u9032\u884c\u62bd\u53d6\u6642\u6700\u597d\u5448\u73fe\u66f2\u819d\u59ff\u52e2\u3002 (C)\u4ee5\u9ad5\u9aa8(patella )\u6b63\u4e0b\u65b9\u4e8c\u6307\u5e45(\u7d04 3\u516c\u5206)\u8655\u70ba\u5b9a\u4f4d\u9ede\u3002 (D)\u4e0b\u91dd\u8655\u5728\u5b9a\u4f4d\u9ede\u7684\u5167\u5074\u6216\u5916\u5074\uff0c\u671d\u9ad5\u9aa8(patella )\u5f8c\u5074\u7684\u4e2d\u9ede\u6c34\u5e73\u524d\u9032\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "32\u6b72\u7537\u6027\uff0c\u8fd1\u671f\u4e0a\u8179\u60b6\u75db\u53ca\u5641\u5fc3\u53cd\u80c3\uff0c\u5169\u5929\u524d\u66fe\u5230\u5916\u7e23\u5e02\u5c31\u91ab\uff0c\u5df2\u6709\u505a\u904e\u80c3\u93e1\u6aa2\u67e5\uff0c\u88ab\u544a\u77e5\u7591\u4f3c\u80c3\u90e8\u7d30\u83cc\u611f\u67d3\uff1b\u56e0\u70ba\u7528\u85e5\u5f8c\u75c7\u72c0\u6301\u7e8c\uff0c\u6545\u81f3\u6025\u8a3a\u5c31\u91ab\u3002\u95dc\u65bc\u6c2b\u96e2\u5b50\u5e6b\u6d66\u6291\u5236\u5291 (proton pump inhibitors, PPI )\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u76f8\u8f03\u65bc H2\u53d7\u9ad4\u62ee\u6297\u5291 (H2 receptor antagonists )\uff0cPPI\u7642\u6548\u4f73\uff0c\u4f46\u6cbb\u7642\u6f70\u760d\u7684\u901f\u5ea6\u8f03\u6162\u3002 (B)\u6709\u6291\u5236\u5e7d\u9580\u87ba\u65cb\u687f\u83cc\u7684\u6548\u679c\u3002 (C)\u9577\u671f\u670d\u7528\u53ef\u80fd\u6703\u63d0\u9ad8\u80ba\u708e\u3001\u9aa8\u6298\u3001\u9ad8\u8840\u9382\u7b49\u98a8\u96aa\u3002 (D)\u4e0d\u5c6c\u65bc\u5e7d\u9580\u87ba\u65cb\u687f\u83cc\u4e09\u5408\u4e00\u85e5\u7269\u6cbb\u7642\u7d44\u5408\uff0c\u4f46\u53ef\u4e00\u540c\u958b\u7acb\uff0c\u6539\u5584\u75c7\u72c0\u53ca\u9810\u5f8c\u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6709\u95dc\u9ad8\u6d77\u62d4\u75be\u75c5( High -Altitude Disorders )\u7684\u9810\u9632\u53ca\u6cbb\u7642\u85e5\u7269\uff0c\u4ee5\u4e0b\u4f55\u8005\u8f03\u4e0d\u9069\u7576 \uff1f", + "Options": "(A)Acetazolamide \u53ef\u7528\u65bc\u9810\u9632\u9ad8\u5c71\u75c7\uff0c\u5728\u722c\u5c71\u524d\u4e00\u5929\u5c31\u8981\u958b\u59cb\u4f7f\u7528\uff0c\u4e00\u5929\u4e8c\u6b21\uff0c\u53e3\u670d 125~250 mg\u3002 (B)Nifedipine \u53ef\u7528\u65bc\u6cbb\u7642\u9ad8\u5c71\u80ba\u6c34\u816b\uff0c\u4f7f\u7528\u53e3\u670d\u7de9\u91cb\u578b(extended -release)\uff0c \u6bcf 12\u5c0f\u6642 30 mg\u3002 (C)Tadalafil \u53ef\u7528\u65bc\u9810\u9632\u9ad8\u5c71\u80ba\u6c34\u816b\uff0c\u5728\u722c\u5c71\u524d\u4e00\u5929\u5c31\u8981\u958b\u59cb\u4f7f\u7528\uff0c\u4e00\u5929\u4e8c\u6b21\uff0c\u53e3\u670d 10 mg\u3002 (D)Dexamethasone \u53ef\u7528\u65bc\u9810\u9632\u9ad8\u5c71\u75c7\uff0c\u5728\u722c\u5c71\u6642\u958b\u59cb\u7528\uff0c\u6bcf 6\u5c0f\u6642\u53e3\u670d4 mg\u3002", + "Answer": "D" + }, + { + "\ufeffQuestion": "11\u500b\u6708\u7537\u7ae5\uff0c\u9ad4\u91cd\u7d04 10\u516c\u65a4\uff0c\u5728\u5bb6\u6301\u7e8c\u6709\u9663\u767c\u6027\u8179\u75db\u54ed\u9b27\u60c5\u5f62\uff0c\u7236\u6bcd\u662f\u4e3b\u8981\u7167\u9867\u8005\uff0c\u5c3f\u5e03\u767c\u73fe\u6709\u8840\u4fbf\uff0c\u5e8a\u908a\u8179\u90e8\u8d85\u97f3\u6ce2\u5f71\u50cf\u5224\u65b7\u662f\u8178\u5957\u758a\u53ef\u80fd\u6027\u6975\u9ad8\uff0c\u4e0b\u5217\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u9019\u5e74\u7d00\u7684\u5152\u7ae5\u901a\u5e38\u627e\u4e0d\u5230\u5f15\u5c0e\u9ede(leading point )\u3002 (B)\u6709\u8179\u819c\u708e\u8de1\u8c61\u6642\uff0c\u7a7a\u6c23\u5fa9\u4f4d(air reduction)\u7684\u58d3\u529b\u5fc5\u9808\u964d\u4f4e\uff0c\u4ee5\u514d\u5c0e\u81f4\u8178\u7a7f\u5b54\u3002 (C)\u8840\u4fbf\u7684\u51fa\u73fe\uff0c\u4e26\u975e\u662f\u63a1\u53d6\u7a7a\u6c23\u5fa9\u4f4d\u4e4b\u7981\u5fcc\u75c7\u3002 (D)\u82e5\u7a7a\u6c23\u5fa9\u4f4d\u5931\u6557\uff0c\u9700\u8981\u91cd\u65b0\u8a55\u4f30\u662f\u5426\u70ba incarcerated hernia \u3002", + "Answer": "B" + }, + { + "\ufeffQuestion": "\u6839\u64da 2020\u7f8e\u570b\u5fc3\u81df\u5354\u6703\u5efa\u8b70\uff0c\u95dc\u65bc\u5152\u7ae5\u9ad8\u7d1a\u6551\u547d\u8853\uff0c\u4e0b\u5217\u4f55\u8005\u63cf\u8ff0\u8f03\u9069\u7576\uff1f", + "Options": "(A)\u4e0d\u7a69\u5b9a\u5fc3\u640f\u904e\u901f\u5408\u4f75\u898f\u5247\u3001\u55ae\u578b\u4e14\u5bec\u7684 QRS\uff0c\u53ef\u76f4\u63a5\u7acb\u5373\u4f7f\u7528adenosine \u6cbb\u7642\u3002 (B)\u4e0d\u7a69\u5b9a\u7684\u5fc3\u640f\u904e\u7de9\uff0c\u9069\u5408\u9078\u7528\u7684\u6ef4\u6ce8\u85e5\u7269\u5305\u542b Dopamine \uff0cAtropine\uff0cEpinephrine \u3002 (C)\u7576 20\u516c\u65a4\u5152\u7ae5\u56e0\u4e0d\u7a69\u5b9a\u5fc3\u640f\u904e\u901f\u9700\u5fc3\u81df\u540c\u6b65\u6574\u6d41\u6642 10\u7126\u8033\u70ba\u5408\u7406\u7684\u8d77\u59cb\u5291\u91cf\u3002 (D)\u9700\u8981\u958b\u59cb\u9032\u884c CPR\u7684\u4e0d\u7a69\u5b9a\u7684\u5fc3\u640f\u904e\u7de9\u662f\u6307\u5fc3\u640f\u5c0f\u65bc 50\u6b21/min\u3002", + "Answer": "C" + }, + { + "\ufeffQuestion": "\u95dc\u65bc\u5152\u7ae5\u591a\u7cfb\u7d71\u708e\u6027\u75c7\u5019\u7fa4 (Multisystem inflammatory syndrome in children, MIS -C)\u7684\u63cf\u8ff0\uff0c\u4ee5\u4e0b\u4f55\u8005 \u8f03\u4e0d\u9069\u7576\uff1f", + "Options": "(A)\u5e74\u9f61 0~12\u6b72\u4e14\u767c\u71d2\u22673 \u5929\u662f\u76ee\u524d\u4e16\u754c\u885b\u751f\u7d44\u7e54( WHO)\u5c0d MIS- C \u7684\u8a3a\u65b7\u8981\u4ef6\u3002 (B)\u5e38\u6709\u5fc3\u808c\u529f\u80fd\u53d7\u640d\uff0c\u5408\u4f75\u4f11\u514b\u3002 (C)\u9700\u6709 SARS -CoV -2\u611f\u67d3\u7684\u8b49\u64da\uff0c\u4f8b\u5982\u6838\u9178 (RT -PCR)\u8840\u6e05\u5b78\u967d\u6027\u6216\u8fd1\u671f\u66fe\u63a5\u89f8\u611f\u67d3\u8005\u3002 (D)\u5e38\u7528\u6cbb\u7642\u85e5\u7269\u70ba\u514d\u75ab\u7403\u86cb\u767d\u8207\u985e\u56fa\u9187\u3002", + "Answer": "A" + } +] \ No newline at end of file